<!DOCTYPE html>
 <!--[if lt IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8 lt-ie7"> <![endif]--> <!--[if IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8"> <![endif]--> <!--[if IE 8]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9"> <![endif]--> <!--[if gt IE 8]><!--> <html class="aui ltr" dir="ltr" lang="en-US" prefix="og: http://ogp.me/ns#"> <!--<![endif]--> <head> <title>Control interventions in randomised trials among people with mental health disorders - Faltinsen, E - 2022 | Cochrane Library</title> <meta content="Control interventions in randomised trials among people with mental health disorders - Faltinsen, E - 2022 | Cochrane Library" property="og:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.MR000050.pub2/full" property="og:url"/> <meta content="article" property="og:type"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" property="og:image"/> <meta content="summary_large_image" name="twitter:card"/> <meta content="Control interventions in randomised trials among people with mental health disorders - Faltinsen, E - 2022 | Cochrane Library" name="twitter:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.MR000050.pub2/full" name="twitter:url"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" name="twitter:image"/> <meta content="initial-scale=1.0, width=device-width" name="viewport"/> <meta content="10.1002/14651858.MR000050.pub2" name="dc.identifier" scheme="DOI"/> <meta content="Control interventions in randomised trials among people with mental health disorders" name="citation_title"/> <meta content="Erlend Faltinsen&lt;sup&gt;a&lt;/sup&gt;" name="citation_author"/> <meta content="egfaltinsen@health.sdu.dk" name="citation_author_email"/> <meta content="Adnan Todorovac&lt;sup&gt;a&lt;/sup&gt;" name="citation_author"/> <meta content="Region Zealand Psychiatry" name="citation_author_institution"/> <meta content="Laura Staxen Bruun" name="citation_author"/> <meta content="Region Zealand Psychiatry" name="citation_author_institution"/> <meta content="Asbjørn Hróbjartsson" name="citation_author"/> <meta content="Christian Gluud" name="citation_author"/> <meta content="Mickey T Kongerslev" name="citation_author"/> <meta content="Erik Simonsen" name="citation_author"/> <meta content="Ole Jakob Storebø" name="citation_author"/> <meta content="Cochrane Database of Systematic Reviews" name="citation_journal_title"/> <meta content="John Wiley &amp; Sons, Ltd" name="citation_publisher"/> <meta content="4" name="citation_issue"/> <meta content="10.1002/14651858.MR000050.pub2" name="citation_doi"/> <meta content="2022" name="citation_date"/> <meta content="2022/04/04" name="citation_online_date"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.MR000050.pub2/abstract" name="citation_abstract_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.MR000050.pub2/full" name="citation_fulltext_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.MR000050.pub2/pdf/full" name="citation_pdf_url"/> <meta content="1465-1858" name="citation_issn"/> <meta content="en" name="citation_language"/> <meta content="Anxiety; Anxiety Disorders; *Depressive Disorder, Major; *Mental Health; Psychotherapy; Randomized Controlled Trials as Topic" name="citation_keywords"/> <link href="https://fonts.googleapis.com/css?family=Source+Sans+Pro:400,700,600,900" rel="stylesheet"/> <script src="https://cmp.osano.com/AzZdRbSORDOOzF9W/d594efc1-9663-477d-9528-6576640e64fd/osano.js"></script> <style> .osano-cm-widget{display: none;} </style> <script src="https://static.addtoany.com/menu/page.js"></script> <script async="" charset="utf-8" src="https://platform.twitter.com/widgets.js"></script> <script async="async" src="//script.crazyegg.com/pages/scripts/0056/6375.js" type="text/javascript"></script> <script type="text/javascript">window.dataLayer={};var xtend=function(){var a={};var b=false;var c=0;var d=arguments.length;if(Object.prototype.toString.call(arguments[0])==="[object Boolean]"){b=arguments[0];c++}var f=function(g){for(var h in g){if(Object.prototype.hasOwnProperty.call(g,h)){if(b&&Object.prototype.toString.call(g[h])==="[object Object]"){a[h]=xtend(true,a[h],g[h])}else{a[h]=g[h]}}}};for(;c<d;c++){var e=arguments[c];f(e)}return a};</script> <!-- Global site tag (gtag.js) - Google Analytics --> <script src="https://www.googletagmanager.com/gtag/js?id=UA-189672-63&amp;l=gDataLayer"></script> <script>window.gDataLayer=window.gDataLayer||[];function gtag(){gDataLayer.push(arguments)}gtag("js",new Date());gtag("config","UA-189672-63");</script> <script type="text/javascript">var o={auth:{customerIds:[],individualId:null,brandedCustomer:null,roles:["Guest"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <script type="text/javascript">var o={page:{siteSection:"Content",languageCode:"en",cms:{pageTitle:"Content"}}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <meta content="text/html; charset=utf-8" http-equiv="content-type"/> <link href="https://www.cochranelibrary.com/cochrane-theme/images/favicon.ico" rel="Shortcut Icon"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.MR000050.pub2&amp;doi=10.1002/14651858.MR000050.pub2&amp;type=cdsr&amp;contentLanguage=" rel="canonical"/> <link href="https://www.cochranelibrary.com/zh/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.MR000050.pub2&amp;doi=10.1002/14651858.MR000050.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANS" rel="alternate"/> <link href="https://www.cochranelibrary.com/zh_HANT/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.MR000050.pub2&amp;doi=10.1002/14651858.MR000050.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANT" rel="alternate"/> <link href="https://www.cochranelibrary.com/hr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.MR000050.pub2&amp;doi=10.1002/14651858.MR000050.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hr-HR" rel="alternate"/> <link href="https://www.cochranelibrary.com/nl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.MR000050.pub2&amp;doi=10.1002/14651858.MR000050.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="nl-NL" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.MR000050.pub2&amp;doi=10.1002/14651858.MR000050.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="x-default" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.MR000050.pub2&amp;doi=10.1002/14651858.MR000050.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="en-US" rel="alternate"/> <link href="https://www.cochranelibrary.com/fr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.MR000050.pub2&amp;doi=10.1002/14651858.MR000050.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="fr-FR" rel="alternate"/> <link href="https://www.cochranelibrary.com/de/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.MR000050.pub2&amp;doi=10.1002/14651858.MR000050.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="de-DE" rel="alternate"/> <link href="https://www.cochranelibrary.com/hi/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.MR000050.pub2&amp;doi=10.1002/14651858.MR000050.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hi-HI" rel="alternate"/> <link href="https://www.cochranelibrary.com/hu/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.MR000050.pub2&amp;doi=10.1002/14651858.MR000050.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hu-HU" rel="alternate"/> <link href="https://www.cochranelibrary.com/in/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.MR000050.pub2&amp;doi=10.1002/14651858.MR000050.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="in-ID" rel="alternate"/> <link href="https://www.cochranelibrary.com/ja/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.MR000050.pub2&amp;doi=10.1002/14651858.MR000050.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ja-JP" rel="alternate"/> <link href="https://www.cochranelibrary.com/ko/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.MR000050.pub2&amp;doi=10.1002/14651858.MR000050.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ko-KR" rel="alternate"/> <link href="https://www.cochranelibrary.com/ms/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.MR000050.pub2&amp;doi=10.1002/14651858.MR000050.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ms-MY" rel="alternate"/> <link href="https://www.cochranelibrary.com/fa/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.MR000050.pub2&amp;doi=10.1002/14651858.MR000050.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="fa-IR" rel="alternate"/> <link href="https://www.cochranelibrary.com/pl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.MR000050.pub2&amp;doi=10.1002/14651858.MR000050.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="pl-PL" rel="alternate"/> <link href="https://www.cochranelibrary.com/pt/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.MR000050.pub2&amp;doi=10.1002/14651858.MR000050.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="pt-PT" rel="alternate"/> <link href="https://www.cochranelibrary.com/ro/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.MR000050.pub2&amp;doi=10.1002/14651858.MR000050.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ro-RO" rel="alternate"/> <link href="https://www.cochranelibrary.com/ru/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.MR000050.pub2&amp;doi=10.1002/14651858.MR000050.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ru-RU" rel="alternate"/> <link href="https://www.cochranelibrary.com/es/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.MR000050.pub2&amp;doi=10.1002/14651858.MR000050.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="es-ES" rel="alternate"/> <link href="https://www.cochranelibrary.com/ta/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.MR000050.pub2&amp;doi=10.1002/14651858.MR000050.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ta-IN" rel="alternate"/> <link href="https://www.cochranelibrary.com/th/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.MR000050.pub2&amp;doi=10.1002/14651858.MR000050.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="th-TH" rel="alternate"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" rel="stylesheet" type="text/css"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/aui.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" rel="stylesheet" type="text/css"/> <link href="/html/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772874000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/scolaris-content-display/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/notifications-portlet/notifications/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772751000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/html/portlet/login/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772901000" rel="stylesheet" type="text/css"/> <script type="text/javascript">var Liferay={Browser:{acceptsGzip:function(){return false},getMajorVersion:function(){return 80},getRevision:function(){return"537.36"},getVersion:function(){return"80.0"},isAir:function(){return false},isChrome:function(){return true},isFirefox:function(){return false},isGecko:function(){return true},isIe:function(){return false},isIphone:function(){return false},isLinux:function(){return true},isMac:function(){return false},isMobile:function(){return false},isMozilla:function(){return false},isOpera:function(){return false},isRtf:function(){return true},isSafari:function(){return true},isSun:function(){return false},isWap:function(){return false},isWapXhtml:function(){return false},isWebKit:function(){return true},isWindows:function(){return false},isWml:function(){return false}},Data:{NAV_SELECTOR:"#navigation",isCustomizationView:function(){return false},notices:[null]},ThemeDisplay:{getLayoutId:function(){return"7"},getLayoutURL:function(){return"https://www.cochranelibrary.com/en/content"},getParentLayoutId:function(){return"0"},isPrivateLayout:function(){return"false"},isVirtualLayout:function(){return false},getBCP47LanguageId:function(){return"en-US"},getCDNBaseURL:function(){return"https://www.cochranelibrary.com"},getCDNDynamicResourcesHost:function(){return""},getCDNHost:function(){return""},getCompanyId:function(){return"20155"},getCompanyGroupId:function(){return"20195"},getDefaultLanguageId:function(){return"en_US"},getDoAsUserIdEncoded:function(){return""},getLanguageId:function(){return"en_US"},getParentGroupId:function(){return"20182"},getPathContext:function(){return""},getPathImage:function(){return"/image"},getPathJavaScript:function(){return"/html/js"},getPathMain:function(){return"/en/c"},getPathThemeImages:function(){return"https://www.cochranelibrary.com/cochrane-theme/images"},getPathThemeRoot:function(){return"/cochrane-theme"},getPlid:function(){return"20757"},getPortalURL:function(){return"https://www.cochranelibrary.com"},getPortletSetupShowBordersDefault:function(){return true},getScopeGroupId:function(){return"20182"},getScopeGroupIdOrLiveGroupId:function(){return"20182"},getSessionId:function(){return""},getSiteGroupId:function(){return"20182"},getURLControlPanel:function(){return"/group/control_panel?refererPlid=20757"},getURLHome:function(){return"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane"},getUserId:function(){return"20159"},getUserName:function(){return""},isAddSessionIdToURL:function(){return false},isFreeformLayout:function(){return false},isImpersonated:function(){return false},isSignedIn:function(){return false},isStateExclusive:function(){return false},isStateMaximized:function(){return false},isStatePopUp:function(){return false}},PropsValues:{NTLM_AUTH_ENABLED:false}};var themeDisplay=Liferay.ThemeDisplay;Liferay.AUI={getAvailableLangPath:function(){return"available_languages.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513679709000"},getCombine:function(){return true},getComboPath:function(){return"/combo/?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513679709000&"},getFilter:function(){return"min"},getJavaScriptRootPath:function(){return"/html/js"},getLangPath:function(){return"aui_lang.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513679709000"},getStaticResourceURLParams:function(){return"?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513679709000"}};Liferay.authToken="BqmVIxTs";Liferay.currentURL="\x2fweb\x2fcochrane\x2fcontent\x3ftemplateType\x3dfull\x26urlTitle\x3d\x2fcdsr\x2fdoi\x2f10\x2e1002\x2f14651858\x2eMR000050\x2epub2\x26doi\x3d10\x2e1002\x2f14651858\x2eMR000050\x2epub2\x26type\x3dcdsr\x26contentLanguage\x3d";Liferay.currentURLEncoded="\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eMR000050\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eMR000050\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D";</script> <script src="/html/js/barebone.jsp?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;colorSchemeId=01&amp;minifierType=js&amp;minifierBundleId=javascript.barebone.files&amp;languageId=en_US&amp;b=6210&amp;t=1513679709000" type="text/javascript"></script> <script type="text/javascript"></script> <script type="text/javascript">var o={database:"CDSR",page:{pageType:"Article Full Text HTML"},article:{availableLanguage:["en","es","zh_HANT","th","pt","ms","ja","hr","fa","fr"],languageCode:"en",accessStatus:"delayed-free",doi:"10.1002/14651858.MR000050.pub2",title:"Control interventions in randomised trials among people with mental health disorders",firstPublishedDate:"Apr 4, 2022 12:00:00 AM",isCurrentVersion:true,editorialGroup:"Cochrane Methodology Review Group",availableParts:["PDF Full","PDF Standard","PDF Abstract","HTML","Comments","Information","References","Stats","Related Content"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/custom.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" rel="stylesheet" type="text/css"/> <style type="text/css"></style> <script async="" src="https://assets.adobedtm.com/59640f9fa510/7cad07cf7779/launch-a215d9c51521.min.js"></script> <!--[if lt IE 9]> <script src="/cochrane-theme/vendor/respond/dest/respond.min.js?t=1738734064000" type="text/javascript"></script> <![endif]--> </head> <body class="yui3-skin-sam controls-visible guest-site signed-out public-page site"> <div class="site-container"> <a href="#main-content" id="skip-to-content">Skip to Content</a> <div class="cookie-message cookie-message--hidden system-message-container" id="js-cookie-message"> <div class="container"> <a aria-label="Close cookies message" class="fa fa-times js-cookie-close pull-right" href="#"></a> <div class="system-message-wrapper container"> <i aria-hidden="true" class="fa fa-exclamation-triangle"></i> <div class="system-message-title">Cookies</div> <div class="system-message-description"> <p> Our site uses cookies to improve your experience. You can find out more about our use of cookies in About Cookies, including instructions on how to turn off cookies if you wish to do so. By continuing to browse this site you agree to us using cookies as described in <a href="http://olabout.wiley.com/WileyCDA/Section/id-813473.html">About Cookies</a>. </p> <a class="btn secondary js-cookie-close js-cookie-accept" href="#">I accept</a> </div> </div> </div> </div> <script>document.body.className=document.body.className+" js_enabled";</script><header> <div class="container"> <div class="branding"> <h1 class="brand-container"> <a href="https://www.cochranelibrary.com/en/"> <span class="brand-name">The Cochrane Library</span> <img alt="Cochrane Library logo" class="brand-logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_logo.png" title="Cochrane Library"/> </a> </h1> <span class="additional-branding"> <p class="brand-message"> <em>Trusted evidence.</em> <em>Informed decisions.</em> <em>Better health.</em> </p> </span> </div> <div class="desktop-search basic-search-container"> <div class="desktop-search-form"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="owel__null__null" src="/scolaris-search/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=BqmVIxTs&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"/> <input name="facetDisplayName" type="hidden" value=""/> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.MR000050.pub2&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.MR000050.pub2';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<div class="search-tools-nav">
<a class="btn secondary" href="/en/browse-by-topic">Browse</a>
<a class="btn primary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
</div>
<a class="toggle-menu-switch" href="#"><i aria-hidden="true" class="fa fa-bars"></i> <div class="toggle-menu-text">Open menu</div></a>
</div>
<div class="auxiliary-container">
<div class="container">
<div class="header-auxiliary-menu">
<div class="auxiliary-menu-item language-selector">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="bvrs__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> Review language : English </a> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> Website language : English </a> </div> <div class="language-selector-modal-content" data-modal-title="Language selection" data-size="large" style="display: none;"> <div class="form-content language-selector-modal"> <div class="row-fluid"> <div> <table class="mytable" style="border: 1px solid #f0f0f0" width="90%"> <tbody> <tr class="row-box"> <td><i class="fa fa-file-text icon-size"></i></td> <td><h3>Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> </td> <td> <div> <select id="contentLanguageSelector" onchange="updateLang(this.value)"> <option class="content-language-option" data-languagecode="de" value="de"> Deutsch </option> <option class="content-language-option" data-languagecode="en" selected="" value="en"> English </option> <option class="content-language-option" data-languagecode="es" value="es"> Español </option> <option class="content-language-option" data-languagecode="fa" value="fa"> فارسی </option> <option class="content-language-option" data-languagecode="fr" value="fr"> Français </option> <option class="content-language-option" data-languagecode="hi" value="hi"> हिन्दी </option> <option class="content-language-option" data-languagecode="hr" value="hr"> Hrvatski </option> <option class="content-language-option" data-languagecode="id" value="id"> Bahasa Indonesia </option> <option class="content-language-option" data-languagecode="ja" value="ja"> 日本語 </option> <option class="content-language-option" data-languagecode="ko" value="ko"> 한국어 </option> <option class="content-language-option" data-languagecode="hu" value="hu"> Magyar </option> <option class="content-language-option" data-languagecode="ms" value="ms"> Bahasa Malaysia </option> <option class="content-language-option" data-languagecode="nl" value="nl"> Nederlands </option> <option class="content-language-option" data-languagecode="pl" value="pl"> Polski </option> <option class="content-language-option" data-languagecode="pt" value="pt"> Português </option> <option class="content-language-option" data-languagecode="ru" value="ru"> Русский </option> <option class="content-language-option" data-languagecode="ro" value="ro"> Română </option> <option class="content-language-option" data-languagecode="ta" value="ta"> தமிழ் </option> <option class="content-language-option" data-languagecode="th" value="th"> ภาษาไทย </option> <option class="content-language-option" data-languagecode="zh_HANT" value="zh_HANT"> 繁體中文 </option> <option class="content-language-option" data-languagecode="zh_HANS" value="zh_HANS"> 简体中文 </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> <tr class="row-box"> <td><i class="fa fa-globe icon-size"></i></td> <td> <div class="language-info"> <h3>Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> </div> </td> <td> <div class="language-dropdown"> <select id="portalLanguageSelector"> <option class="portal-language-selector" data-portallanguage="en" selected="" value="/en/cdsr/doi/10.1002/14651858.MR000050.pub2/full/en"> English </option> <option class="portal-language-selector" data-portallanguage="es" value="/es/cdsr/doi/10.1002/14651858.MR000050.pub2/full/es"> Español </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> </tbody> </table> </div> </div> <div style="text-align: right;"> <button class="btn primary btn-cancel" style="margin-left: 10px;" type="button">Cancel</button> <a class="btn secondary ok-btn" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<a class="auxiliary-menu-item signin last" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.MR000050.pub2%2Ffull" rel="nofollow">
<i class="icon fa fa-user"></i> Sign In
    </a>
<span class="auxiliary-container-extended"></span>
</div>
</div>
</div>
</header>
<div class="main-nav-wrapper">
<span class="main-nav-left-extended"></span>
<nav class="main container">
<ul>
<li class="nav-root-item parent">
<a href="#">Cochrane reviews<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_14" role="presentation">
<a aria-labelledby="layout_14" href="https://www.cochranelibrary.com/en/cdsr/reviews" role="menuitem">
            Search reviews (CDSR)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_15" role="presentation">
<a aria-labelledby="layout_15" href="https://www.cochranelibrary.com/en/cdsr/reviews/topics" role="menuitem">
            Browse reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_18" role="presentation">
<a aria-labelledby="layout_18" href="https://www.cochranelibrary.com/en/cdsr/table-of-contents" role="menuitem">
            Issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_17" role="presentation">
<a aria-labelledby="layout_17" href="https://www.cochranelibrary.com/en/cdsr/editorials" role="menuitem">
            Editorials
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_19" role="presentation">
<a aria-labelledby="layout_19" href="https://www.cochranelibrary.com/en/special-collections" role="menuitem">
            Special Collections
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_20" role="presentation">
<a aria-labelledby="layout_20" href="https://www.cochranelibrary.com/en/cdsr/supplements" role="menuitem">
            Supplements
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_121" role="presentation">
<a aria-labelledby="layout_121" href="https://www.cochranelibrary.com/en/about/about-cochrane-reviews" role="menuitem">
            About Cochrane reviews
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Searching for trials<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_254" role="presentation">
<a aria-labelledby="layout_254" href="https://www.cochranelibrary.com/en/search/releases" role="menuitem">
            What's new (search and CENTRAL)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_266" role="presentation">
<a aria-labelledby="layout_266" href="https://www.cochranelibrary.com/en/search-help" role="menuitem">
            Search help
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_252" role="presentation">
<a aria-labelledby="layout_252" href="https://www.cochranelibrary.com/en/search-help-quick-guides" role="menuitem">
            Search help quick guides
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_251" role="presentation">
<a aria-labelledby="layout_251" href="https://www.cochranelibrary.com/en/search-faqs" role="menuitem">
            Search FAQs
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_114" role="presentation">
<a aria-labelledby="layout_114" href="https://www.cochranelibrary.com/en/central/about-central" role="menuitem">
            About CENTRAL
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_115" role="presentation">
<a aria-labelledby="layout_115" href="https://www.cochranelibrary.com/en/central/central-creation" role="menuitem">
            How CENTRAL is created
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_241" role="presentation">
<a aria-labelledby="layout_241" href="https://www.cochranelibrary.com/en/retracted-trials" role="menuitem">
            Retracted publications in CENTRAL
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Clinical Answers<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_29" role="presentation">
<a aria-labelledby="layout_29" href="https://www.cochranelibrary.com/en/cca" role="menuitem">
            Browse Clinical Answers
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_91" role="presentation">
<a aria-labelledby="layout_91" href="https://www.cochranelibrary.com/en/cca/about" role="menuitem">
            About Clinical Answers
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">About<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_116" role="presentation">
<a aria-labelledby="layout_116" href="https://www.cochranelibrary.com/en/about/about-cochrane-library" role="menuitem">
            About the Cochrane Library
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_13" role="presentation">
<a aria-labelledby="layout_13" href="https://www.cochranelibrary.com/en/cdsr/about-cdsr" role="menuitem">
            Cochrane Database of Systematic reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_198" role="presentation">
<a aria-labelledby="layout_198" href="https://www.cochranelibrary.com/en/cdsr/editorial-policies" role="menuitem">
            Editorial policies
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_92" role="presentation">
<a aria-labelledby="layout_92" href="https://www.cochranelibrary.com/en/about/author-information" role="menuitem">
            Information for authors
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_212" role="presentation">
<a aria-labelledby="layout_212" href="https://www.cochranelibrary.com/en/about-pico" role="menuitem">
            About PICO
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_207" role="presentation">
<a aria-labelledby="layout_207" href="https://www.cochranelibrary.com/en/about/about-translations" role="menuitem">
            About translations
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_188" role="presentation">
<a aria-labelledby="layout_188" href="https://www.cochranelibrary.com/en/about/releases" role="menuitem">
            What's new
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_216" role="presentation">
<a aria-labelledby="layout_216" href="https://www.cochranelibrary.com/en/data" role="menuitem">
            Data reuse
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_235" role="presentation">
<a aria-labelledby="layout_235" href="https://www.cochranelibrary.com/en/about/about-cochrane-library/editorial-board" role="menuitem">
            Cochrane Library Editorial Board
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Help<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_259" role="presentation">
<a aria-labelledby="layout_259" href="https://m.info.wiley.com/webApp/cochranenewsletter?id=0" role="menuitem">
            Newsletter
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_177" role="presentation">
<a aria-labelledby="layout_177" href="https://www.wiley.com/en-us/customer-success/cochrane-library-training-hub" role="menuitem">
            Cochrane Library Training
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_44" role="presentation">
<a aria-labelledby="layout_44" href="https://www.cochranelibrary.com/en/help/access" role="menuitem">
            Access
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_150" role="presentation">
<a aria-labelledby="layout_150" href="https://www.cochranelibrary.com/en/help/permissions" role="menuitem">
            Permissions and reprints
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_93" role="presentation">
<a aria-labelledby="layout_93" href="https://www.cochranelibrary.com/en/help/media" role="menuitem">
            Media information
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_97" role="presentation">
<a aria-labelledby="layout_97" href="https://www.cochranelibrary.com/en/help/contact-us" role="menuitem">
            Contact us
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_125" role="presentation">
<a aria-labelledby="layout_125" href="https://www.cochranelibrary.com/en/about/terms-and-conditions" role="menuitem">
            Terms and conditions
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_176" role="presentation">
<a aria-labelledby="layout_176" href="https://cochranesupport.wiley.com/s/article/cochrane-library-known-issues" role="menuitem">
            Known issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_270" role="presentation">
<a aria-labelledby="layout_270" href="https://www.cochranelibrary.com/search-help" role="menuitem">
            Search help
        </a>
</li>
</ul>
</li>
<li class="about-link"><a href="https://www.cochrane.org/about-us" target="_blank"><span>About Cochrane</span><i class="fa fa-caret-right"></i></a></li>
</ul>
</nav>
</div>
<div class="portlet-boundary portlet-boundary_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_">
<span id="p_scolariscontentlanguagebanner_WAR_scolarislanguageportlet"></span>
<section class="portlet" id="portlet_scolariscontentlanguagebanner_WAR_scolarislanguageportlet">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Language\x20Banner\x20Portlet')">
<img alt="" id="etlj__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Language Banner Portlet</span> </span> <span class="portlet-title-text">Scolaris Content Language Banner Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentlanguagebanner_WAR_scolarislanguageportlet" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="" id="content">
<div class="columns-1" id="main-content" role="main">
<div class="portlet-layout row-fluid">
<div class="portlet-column portlet-column-only span12" id="column-1">
<div class="portlet-dropzone portlet-column-content portlet-column-content-only" id="layout-column_column-1">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="rjus__column1__0" src="/scolaris-content-display/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="publication cdsr container"> <div class="article-navigation-container" id="cdsr-nav"> <nav class="article-navigation"> <ul class="tools-row"> <li> <li class="tools pdf pulldown-menu readcube-menu closed en_US"> <a class="pulldown-menu-trigger" href="#0"> <span class="pdf-icon"> <i class="icon fa fa-file-pdf-o"></i> <span>Download PDF</span> </span> <i aria-hidden="true" class="fa fa-caret-down"></i> </a> <ul class="pulldown-menu-items"> <li class=""> <a class="download media pdf-link-full pdf-link" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/pdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> <a class="download media pdf-link-full readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/epdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> </li> <li class=""> <a class="download media pdf-link-abstract pdf-link" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/pdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> <a class="download media pdf-link-abstract readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/epdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> </li> </ul> </li> <li class="tools cite cite-article-link" data-article-id="MR000050.PUB2" data-modal-title="Cite this review"> <span><i aria-hidden="true" class="icon fa fa-share"></i></span> <span>Cite this review</span> </li> </li> </ul> <ul class="tools-row tools-secondary"> <li> <li class="tools print print-cdsr-link" data-content-language="en" data-indicator-tooltip="scolaris.print.modal.language.tooltip.en" data-print-options="[{&quot;param&quot;: &quot;abstract&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Abstract&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;چکیده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé scientifique&quot;},{&quot;language&quot;:&quot;pt&quot;,&quot;title&quot;:&quot;Resumo&quot;},{&quot;language&quot;:&quot;th&quot;,&quot;title&quot;:&quot;บทคัดย่อ&quot;}]},{&quot;param&quot;: &quot;pls&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Plain language summary&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen en términos sencillos&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;خلاصه به زبان ساده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé simplifié&quot;},{&quot;language&quot;:&quot;hr&quot;,&quot;title&quot;:&quot;Laički sažetak&quot;},{&quot;language&quot;:&quot;ja&quot;,&quot;title&quot;:&quot;一般語訳&quot;},{&quot;language&quot;:&quot;ms&quot;,&quot;title&quot;:&quot;Ringkasan bahasa mudah&quot;},{&quot;language&quot;:&quot;pt&quot;,&quot;title&quot;:&quot;Resumo para leigos&quot;},{&quot;language&quot;:&quot;th&quot;,&quot;title&quot;:&quot;ข้้อสรุปภาษาธรรมดา&quot;},{&quot;language&quot;:&quot;zh_HANT&quot;,&quot;title&quot;:&quot;淺顯易懂的口語結論&quot;}]},{&quot;param&quot;: &quot;conclusions&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors' conclusions&quot;}]},{&quot;param&quot;: &quot;summaryOfFindings&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Summary of findings&quot;}]},{&quot;param&quot;: &quot;background&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Background&quot;}]},{&quot;param&quot;: &quot;objectives&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Objectives&quot;}]},{&quot;param&quot;: &quot;methods&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Methods&quot;}]},{&quot;param&quot;: &quot;results&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Results&quot;}]},{&quot;param&quot;: &quot;discussion&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Discussion&quot;}]},{&quot;param&quot;: &quot;references&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;References&quot;}]},{&quot;param&quot;: &quot;appendices&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Appendices&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Search strategies&quot;}]},{&quot;param&quot;: &quot;characteristics&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Characteristics of studies&quot;}]},{&quot;param&quot;: &quot;data&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Analyses&quot;}]},{&quot;param&quot;: &quot;information&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Information&quot;}]},{&quot;param&quot;: &quot;authors&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors&quot;}]},{&quot;param&quot;: &quot;history&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;}]}]" data-print-urlbase="/cdsr/doi/10.1002/14651858.MR000050.pub2/print"> <span><i class="icon fa fa-print"></i></span> <span>Print</span> </li> <li class="js-old-version-modal-trigger tools comments comment-on-review" data-article-id="MR000050.PUB2" data-english-only-message="Please note, that commenting is available in English only. Apologies for any inconvenience." data-href="/cdsr/doi/10.1002/14651858.MR000050.pub2/read-comments" data-new-version="" id="comment-on-review"> <span class="comment-icon"><i class="icon fa fa-comment"></i></span> <span class="comments-count">0</span> <span>Comment</span> </li> <li class="tools share-cdsr-link" data-share-url="/cdsr/doi/10.1002/14651858.MR000050.pub2/full"> <span><i class="icon fa fa-share-alt"></i></span> <span>Share</span> </li> <li class="tools follow"> <span class="article-not-followed cochrane-link signin follow-wrapper"> <span> <i class="icon fa fa-plus"></i> </span> <span> Follow </span> </span> </li> </li> </ul> <div class="metrics-wrapper"> <div class="metrics-count"> <span>Full text views: </span> <span>4647 <i class="icon fa fa-info-circle custom-tooltip" style="padding-left: 2px;color: #962d91;" title="Usage represents full text views on Cochrane Library since January 2022 or 2023. For articles published after this date, the usage represents views since the article was first published on Cochrane Library."> </i> </span> </div> </div> <div class="metrics-wrapper nav-link-section"> <div class="altmetric-embed" data-badge-type="1" data-condensed="true" data-doi="10.1002/14651858.MR000050.pub2" data-link-target="_blank"></div> <div class="inline-status-wrapper guidelines-count" data-count-plural="Cited in $1 guidelines" data-count-single="Cited in 1 guideline"> <a href="related-content#guidelines_data" title="Guidelines"></a> </div> </div> <ul class="nav-section-header"> <li> <h3>Contents</h3> </li> </ul> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.MR000050.pub2/full"> Abstract </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.MR000050.pub2/full#MR000050-abs-0002"> Plain language summary </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.MR000050.pub2/full#MR000050-sec-0100"> Authors' conclusions </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.MR000050.pub2/full#MR000050-sec-0008"> Summary of findings </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.MR000050.pub2/full#MR000050-sec-0009"> Background </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.MR000050.pub2/full#MR000050-sec-0012"> Objectives </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.MR000050.pub2/full#MR000050-sec-0013"> Methods </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.MR000050.pub2/full#MR000050-sec-0046"> Results </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.MR000050.pub2/full#MR000050-sec-0094"> Discussion </a> </li> <li class="cdsr-nav-link"> <a class="figures-and-tables-link" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/#"> Figures and tables </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.MR000050.pub2/references"> References </a> </li> </ul> <div class="nav-section-header"> <h3>Supplementary materials</h3> </div> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.MR000050.pub2/appendices#MR000050-sec-0105"> Search strategies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.MR000050.pub2/references#characteristicStudies"> Characteristics of studies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.MR000050.pub2/references#dataAndAnalyses"> Analyses </a> </li> <li class="cdsr-nav-link download-stats-data-link" data-download-href="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/supinfo/MR000050StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> <a href="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/supinfo/MR000050StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> Download data </a> </li> </ul> <ul class="tools-row"> <li> </li> </ul> <ul class="nav-section-header"> <li><h3>Related</h3></li> </ul> <ul class="linked-content linked-content-dropdown" id="linked-content-articles" tabindex="0"> <li class="linked-cca" data-type="cca"> <div class="linked-content-section"> <span class="linked-type">Cochrane Clinical Answers<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-editorials" data-type="editorial"> <div class="linked-content-section"> <span class="linked-type">Editorials<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-podcasts" data-type="podcast"> <div class="linked-content-section"> <span class="linked-type">Podcasts<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-sc" data-type="sc"> <div class="linked-content-section"> <span class="linked-type">Special Collections<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> </ul> <div class="nav-section-header"> <h3>About this review</h3> </div> <ul class="nav-long-form nav-info nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.MR000050.pub2/information"> <i> <svg viewbox="0 0 24 24"> <path d="M11,9H13V7H11M12,20C7.59,20 4,16.41 4,12C4,7.59 7.59,4 12,4C16.41,4 20,7.59 20,12C20,16.41 16.41,20 12,20M12,2A10,10 0 0,0 2,12A10,10 0 0,0 12,22A10,10 0 0,0 22,12A10,10 0 0,0 12,2M11,17H13V11H11V17Z"></path> </svg> </i> Information </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.MR000050.pub2/information#authors"> <i> <svg viewbox="0 0 24 24"> <path d="M12,5.5A3.5,3.5 0 0,1 15.5,9A3.5,3.5 0 0,1 12,12.5A3.5,3.5 0 0,1 8.5,9A3.5,3.5 0 0,1 12,5.5M5,8C5.56,8 6.08,8.15 6.53,8.42C6.38,9.85 6.8,11.27 7.66,12.38C7.16,13.34 6.16,14 5,14A3,3 0 0,1 2,11A3,3 0 0,1 5,8M19,8A3,3 0 0,1 22,11A3,3 0 0,1 19,14C17.84,14 16.84,13.34 16.34,12.38C17.2,11.27 17.62,9.85 17.47,8.42C17.92,8.15 18.44,8 19,8M5.5,18.25C5.5,16.18 8.41,14.5 12,14.5C15.59,14.5 18.5,16.18 18.5,18.25V20H5.5V18.25M0,20V18.5C0,17.11 1.89,15.94 4.45,15.6C3.86,16.28 3.5,17.22 3.5,18.25V20H0M24,20H20.5V18.25C20.5,17.22 20.14,16.28 19.55,15.6C22.11,15.94 24,17.11 24,18.5V20Z"></path> </svg> </i> Authors </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.MR000050.pub2/information#history"> <i> <svg viewbox="0 0 24 24"> <path d="M13.5,8H12V13L16.28,15.54L17,14.33L13.5,12.25V8M13,3A9,9 0 0,0 4,12H1L4.96,16.03L9,12H6A7,7 0 0,1 13,5A7,7 0 0,1 20,12A7,7 0 0,1 13,19C11.07,19 9.32,18.21 8.06,16.94L6.64,18.36C8.27,20 10.5,21 13,21A9,9 0 0,0 22,12A9,9 0 0,0 13,3"></path> </svg> </i> Version history </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.MR000050.pub2/information#keywords"> <i> <svg viewbox="0 0 24 24"> <path d="M11 3C10.18 3 9.44 3.5 9.14 4.27L3.64 18.27C3.12 19.58 4.09 21 5.5 21H7.75C8.59 21 9.33 20.5 9.62 19.7L10.26 18H13.74L14.38 19.7C14.67 20.5 15.42 21 16.25 21H18.5C19.91 21 20.88 19.58 20.36 18.27L14.86 4.27C14.56 3.5 13.82 3 13 3M11 5H13L18.5 19H16.25L15.12 16H8.87L7.75 19H5.5M12 7.67L9.62 14H14.37Z"></path> </svg> </i> Keywords (MeSH, PICOs) </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.MR000050.pub2/related-content"> <i class="icon fa fa-sitemap fa-rotate-270"></i> Related content </a> </li> <li class="cdsr-nav-link translation-notes-link"> <a href="/cdsr/doi/10.1002/14651858.MR000050.pub2/#"> <i> <svg viewbox="0 0 24 24"> <path d="M12.87,15.07L10.33,12.56L10.36,12.53C12.1,10.59 13.34,8.36 14.07,6H17V4H10V2H8V4H1V6H12.17C11.5,7.92 10.44,9.75 9,11.35C8.07,10.32 7.3,9.19 6.69,8H4.69C5.42,9.63 6.42,11.17 7.67,12.56L2.58,17.58L4,19L9,14L12.11,17.11L12.87,15.07M18.5,10H16.5L12,22H14L15.12,19H19.87L21,22H23L18.5,10M15.88,17L17.5,12.67L19.12,17H15.88Z"></path> </svg> </i> Translation notes </a> </li> <li class="cdsr-nav-link"> <a class="request-permissions" data-copyright="Copyright © 2022 The Cochrane Collaboration. Published by John Wiley &amp; Sons, Ltd." data-creative-commons="false" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/#"> <span class="request-permissions-icon"></span> Request permissions </a> </li> <li class="cdsr-nav-link"> <a href="/data"> <i class="icon fa fa-database"></i> Request data reuse </a> </li> </ul> </nav> </div> <article> <div class="cdsr-header-top"> <div class="cdsr-header-left"> <a class="publish-database" href="/">Cochrane Database of Systematic reviews</a> <span class="publish-type">Review - Methodology</span> </div> <div class="cdsr-header-right"> </div> </div> <header class="publication-header"> <h1 class="publication-title" lang="en">Control interventions in randomised trials among people with mental health disorders</h1> <div class="publication-metadata-block"> <div class="publication-authors"> <div class="publish-meta-wrapper"> <ul class="authors"> <li class="author custom-tooltip" title="Shared first authorship"><a href="/cdsr/doi/10.1002/14651858.MR000050.pub2/information#MR000050-cr-0004"><i class="icon corresponding-author fa fa-envelope"></i>Erlend Faltinsen</a><sup>a</sup></li> <li class="author custom-tooltip" title="Shared first authorship"><a href="/cdsr/doi/10.1002/14651858.MR000050.pub2/information#MR000050-cr-0005">Adnan Todorovac</a><sup>a</sup></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.MR000050.pub2/information#MR000050-cr-0006">Laura Staxen Bruun</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.MR000050.pub2/information#MR000050-cr-0007">Asbjørn Hróbjartsson</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.MR000050.pub2/information#MR000050-cr-0008">Christian Gluud</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.MR000050.pub2/information#MR000050-cr-0009">Mickey T Kongerslev</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.MR000050.pub2/information#MR000050-cr-0010">Erik Simonsen</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.MR000050.pub2/information#MR000050-cr-0011">Ole Jakob Storebø</a></li> </ul> <span class="author declaration"> <a class="declarationsOfInterestLink" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/information/en#MR000050-sec-0143">Authors' declarations of interest</a> </span> </div> </div> </div> <div class="publication-metadata-block"> <p> <span class="publish-date">Version published: 04 April 2022 </span> <a class="whatsNewLink" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/information/en#versionTable">Version history</a> </p> <div class="doi-header"> <a href="https://doi.org/10.1002/14651858.MR000050.pub2">https://doi.org/10.1002/14651858.MR000050.pub2</a> </div> </div> </header> <div class="publication-control-bar"> <span class="publication-control-button publication-control-collapse"> Collapse all </span> <span class="publication-control-button publication-control-expand"> Expand all </span> </div> <section class="abstract"> <div class="section-header section-collapse-header" id="MR000050-abs-0001" lang="en"> <h2 class="title section-collapse-title"> Abstract <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#MR000050-abs-0001">English</a> </li> <li class="section-language"> <a class="" href="full/es#MR000050-abs-0015">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#MR000050-abs-0011">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#MR000050-abs-0013">Français</a> </li> <li class="section-language"> <a class="" href="full/pt#MR000050-abs-0006">Português</a> </li> <li class="section-language"> <a class="" href="full/th#MR000050-abs-0004">ภาษาไทย</a> </li> </nav> </div> </div> <div class="abstract full_abstract" id="MR000050-abs-0001" lang="en"> <section id="MR000050-sec-0001"> <h3 class="title" id="MR000050-sec-0001">Background</h3> <p>Control interventions in randomised trials provide a frame of reference for the experimental interventions and enable estimations of causality. In the case of randomised trials assessing patients with mental health disorders, many different control interventions are used, and the choice of control intervention may have considerable impact on the estimated effects of the treatments being evaluated. </p> </section> <section id="MR000050-sec-0002"> <h3 class="title" id="MR000050-sec-0002">Objectives</h3> <p>To assess the benefits and harms of typical control interventions in randomised trials with patients with mental health disorders. The difference in effects between control interventions translates directly to the impact a control group has on the estimated effect of an experimental intervention. We aimed primarily to assess the difference in effects between (i) wait‐list versus no‐treatment, (ii) usual care versus wait‐list or no‐treatment, and (iii) placebo interventions (all placebo interventions combined or psychological, pharmacological, and physical placebos individually) versus wait‐list or no‐treatment. Wait‐list patients are offered the experimental intervention by the researchers after the trial has been finalised if it offers more benefits than harms, while no‐treatment participants are not offered the experimental intervention by the researchers. </p> </section> <section id="MR000050-sec-0003"> <h3 class="title" id="MR000050-sec-0003">Search methods</h3> <p>In March 2018, we searched MEDLINE, PsycInfo, Embase, CENTRAL, and seven other databases and six trials registers. </p> </section> <section id="MR000050-sec-0004"> <h3 class="title" id="MR000050-sec-0004">Selection criteria</h3> <p>We included randomised trials assessing patients with a mental health disorder that compared wait‐list, usual care, or placebo interventions with wait‐list or no‐treatment . </p> </section> <section id="MR000050-sec-0005"> <h3 class="title" id="MR000050-sec-0005">Data collection and analysis</h3> <p>Titles, abstracts, and full texts were reviewed for eligibility. Review authors independently extracted data and assessed risk of bias using Cochrane’s risk of bias tool. GRADE was used to assess the quality of the evidence. We contacted researchers working in the field to ask for data from additional published and unpublished trials. </p> <p>A pre‐planned decision hierarchy was used to select one benefit and one harm outcome from each trial. For the assessment of benefits, we summarised continuous data as standardised mean differences (SMDs) and dichotomous data as risk ratios (RRs). We used risk differences (RDs) for the assessment of adverse events. We used random‐effects models for all statistical analyses. We used subgroup analysis to explore potential causes for heterogeneity (e.g. type of placebo) and sensitivity analyses to explore the robustness of the primary analyses (e.g. fixed‐effect model). </p> </section> <section id="MR000050-sec-0006"> <h3 class="title" id="MR000050-sec-0006">Main results</h3> <p>We included 96 randomised trials (4200 participants), ranging from 8 to 393 participants in each trial. 83 trials (3614 participants) provided usable data. The trials included 15 different mental health disorders, the most common being anxiety (25 trials), depression (16 trials), and sleep‐wake disorders (11 trials). </p> <p>All 96 trials were assessed as high risk of bias partly because of the inability to blind participants and personnel in trials with two control interventions. The quality of evidence was rated low to very low, mostly due to risk of bias, imprecision in estimates, and heterogeneity. </p> <p>Only one trial compared wait‐list versus no‐treatment directly but the authors were not able to provide us with any usable data on the comparison. </p> <p>Five trials compared usual care versus wait‐list or no‐treatment and found a SMD –0.33 (95% CI ‐0.83 to 0.16, I² = 86%, 523 participants) on benefits. </p> <p>The difference between all placebo interventions combined versus wait‐list or no‐treatment was SMD −0.37 (95% CI −0.49 to −0.25, I² = 41%, 65 trials, 2446 participants) on benefits. There was evidence of some asymmetry in the funnel plot (Egger’s test P value of 0.087). Almost all the trials were small. Subgroup analysis found a moderate effect in favour of psychological placebos SMD ‐0.49 (95% CI −0.64 to −0.30; I² = 53%, 39 trials, 1656 participants). The effect of pharmacological placebos versus wait‐list or no‐treatment on benefits was SMD ‐0.14 (95% CI −0.39 to 0.11, 9 trials, 279 participants) and the effect of physical placebos was SMD −0.21 (95% CI −0.35 to −0.08, I² = 0%, 17 trials, 896 participants). We found large variations in effect sizes in the psychological and pharmacological placebo comparisons. For specific mental health disorders, we found significant differences in favour of all placebos for sleep‐wake disorders, major depressive disorder, and anxiety disorders, but the analyses were imprecise due to sparse data. </p> <p>We found no significant differences in harms for any of the comparisons but the analyses suffered from sparse data. </p> <p>When using a fixed‐effect model in a sensitivity analysis on the comparison for usual care versus wait‐list and no‐treatment, the results were significant with an SMD of –0.46 (95 % CI –0.64 to –0.28). We reported an alternative risk of bias model where we excluded the blinding domains seeing how issues with blinding may be seen as part of the review investigation itself. However, this did not markedly change the overall risk of bias profile as most of the trials still included one or more unclear bias domains. </p> </section> <section id="MR000050-sec-0007"> <h3 class="title" id="MR000050-sec-0007">Authors' conclusions</h3> <p>We found marked variations in effects between placebo versus no‐treatment and wait‐list and between subtypes of placebo with the same comparisons. Almost all the trials were small with considerable methodological and clinical variability in factors such as mental health population, contents of the included control interventions, and outcome domains. All trials were assessed as high risk of bias and the evidence quality was low to very low. </p> <p>When researchers decide to use placebos or usual care control interventions in trials with people with mental health disorders it will often lead to lower estimated effects of the experimental intervention than when using wait‐list or no‐treatment controls. The choice of a control intervention therefore has considerable impact on how effective a mental health treatment appears to be. Methodological guideline development is needed to reach a consensus on future standards for the design and reporting of control interventions in mental health intervention research. </p> </section> </div> </section> <section class="pls"> <div class="section-header section-collapse-header" id="MR000050-abs-0002" lang="en"> <h2 class="title section-collapse-title"> Plain language summary <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#MR000050-abs-0002">English</a> </li> <li class="section-language"> <a class="" href="full/es#MR000050-abs-0016">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#MR000050-abs-0012">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#MR000050-abs-0014">Français</a> </li> <li class="section-language"> <a class="" href="full/hr#MR000050-abs-0010">Hrvatski</a> </li> <li class="section-language"> <a class="" href="full/ja#MR000050-abs-0009">日本語</a> </li> <li class="section-language"> <a class="" href="full/ms#MR000050-abs-0008">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="full/pt#MR000050-abs-0007">Português</a> </li> <li class="section-language"> <a class="" href="full/th#MR000050-abs-0005">ภาษาไทย</a> </li> <li class="section-language"> <a class="" href="full/zh_HANT#MR000050-abs-0003">繁體中文</a> </li> </nav> </div> </div> <div class="abstract abstract_plainLanguageSummary" id="MR000050-abs-0002" lang="en"> <h3>Control interventions in randomised trials for people with a mental health disorder</h3> <p>This systematic review assesses the effects of different control interventions in randomised trials including patients with a mental health disorder. In randomised trials, patients are assigned by chance to one of two or more groups – usually an experimental intervention and a control intervention. There are many types of control interventions in mental health intervention research. Some of the most common are different types of placebos that lack what is assumed to be the active component in the experimental intervention, and usual care, where patients receive the standard treatment for their mental health disorder in the area where they live. Two other types of control interventions are wait‐list or no‐treatment where patients receive no trial‐related care during the study (although some patients may receive care outside the studies). Wait‐list patients are often offered the experimental intervention after the trial has been finalised if it is likely to provide more benefits than harms, while no‐treatment participants are not offered the experimental intervention by the researchers. </p> <p>We searched for randomised trials with patients with mental health disorders where wait‐list, usual care, or placebo interventions were compared with either wait‐list or no‐treatment. We looked at differences between all the types of control interventions on beneficial effects and whether they caused any adverse effects. We included 96 trials with a total of 4200 participants. Only 83 trials (3614 participants) provided usable data. Fifteen different mental health disorders were included. We found that all the trials were at high risk of bias in how they had been conducted, which reduced the interpretability of our findings. However, the risk of bias was mostly due to lack of blinding in the placebo studies, which may be seen as an aspect of the review's methodological question rather than a flaw with the review itself. We found no clinically important differences for usual care or wait‐list control interventions in the main analyses, however in our secondary analyses we found a clinically important favourable difference for usual care. In general, placebo control interventions tended to be favourable over no‐treatment or wait‐list control interventions across mental health disorders. We found no clinically important differences on adverse events. </p> <p>This review suggests that different control interventions have a tendency to yield very different estimates for the effects of the experimental intervention and that the choice of control intervention has a large impact on how effective a mental health treatment appears to be. Control interventions in trials with patients with mental health disorders are often poorly reported upon, and guidelines are needed to inform researchers on how to properly design, report, and interpret these trials. </p> </div> </section> <section id="vls" style="display: none"> <div class="section-header section-collapse-header"> <h2 class="title section-collapse-title">Visual summary<i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i></h2> </div> <a href="" target="_blank"><img alt="visual summary" src=""/></a> </section> <section class="conclusions"> <div class="section-header section-collapse-header" id="MR000050-sec-0100" lang="en"> <h2 class="title section-collapse-title"> Authors' conclusions <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="authorsConclusions" lang="en"> <div class="section-header" id="MR000050-sec-0100"></div> <h3 class="title" id="MR000050-sec-0101">Implication for systematic reviews and evaluations of healthcare</h3> <section id="MR000050-sec-0101"> <p>The choice of a control intervention in randomised trials with patients with mental health disorders has a considerable impact on the reported estimate of benefits in published reports. When psychiatric interventions are compared with some kind of placebo intervention, the beneficial effect of the psychiatric intervention is lower than when compared with other control interventions. The difference in effect size for the experimental intervention might be approximately a standardised mean difference (SMD) value from 0.3 to 0.4 lower when using a placebo control intervention compared with wait‐list or no intervention. </p> <p>Mental health systematic reviews and evaluations of healthcare should put equal emphasis on the reporting of the contents of control interventions, because they may have the same influence on effect size estimates as experimental interventions. This may be especially true for reviews dealing with psychosocial interventions, where the contents of control interventions such as usual care or psychological placebos are often underreported and unclear. People using reviews and evaluations should therefore be aware of how the choice of a control intervention (such as wait‐list controls or placebo controls) impacts on the reported effect estimates, both unfavourably and favourably. The evidence in the included trials in this review were rated as low to very low quality, only partly because of the inability to blind participants in randomised trials with a no‐treatment or wait‐list comparator. The issue of blinding may, however, be viewed as a methodological issue with the type of control design in mental health intervention research and not a flaw in the interpretability of this review itself. </p> <p>The choice of a control intervention in a randomised trial in patients with mental health disorders has a considerable impact on the reported estimate of benefits in the published reports. Placebos or usual care tend to increase the differences compared with wait‐list or no‐treatment. Methodological guidelines need to be developed to reach a consensus on future standards for the design and reporting of control interventions in the field of mental health. </p> </section> <h3 class="title" id="MR000050-sec-0102">Implication for methodological research</h3> <section id="MR000050-sec-0102"> <p>Currently, descriptions of both the experimental and control interventions are often poorly reported (<a href="./references#MR000050-bbs2-0208" title="HoffmannTC , EruetiC , GlasziouPP .Poor description of non-pharmacological interventions: analysis of consecutive sample of randomised trials. BMJ2013;347(7924):e1-10.">Hoffmann 2013</a>) and they need to be more adequately described (<a href="./references#MR000050-bbs2-0191" title="GuidiJ , BrakemeierEL , BocktingCL , CosciF , CuijpersP , JarrettRB , et al.Methodological recommendations for trials of psychological interventions. Psychotherapy and Psychosomatics2019;87(5):276-84.">Guidi 2018</a>). Methodological guidelines on how to properly report and design control interventions in randomised trials in mental health research are needed to advance the evidence base in the field. An adequate and systematised description of interventions would provide a platform for researchers to build on findings about control intervention design or replicate results (<a href="./references#MR000050-bbs2-0208" title="HoffmannTC , EruetiC , GlasziouPP .Poor description of non-pharmacological interventions: analysis of consecutive sample of randomised trials. BMJ2013;347(7924):e1-10.">Hoffmann 2013</a>; <a href="./references#MR000050-bbs2-0277" title="TajikaA , OgawaY , TakeshimaN , HayasakaY , FurukawaTA .Replication and contradiction of highly cited research papers in psychiatry: 10-year follow-up. British Journal of Psychiatry2015;207(4):357-62.">Tajika 2015</a>). Control interventions should be developed to answer the specific research question at hand and should be chosen based on available resources, ethical concerns and the phase of research for a particular treatment (<a href="./references#MR000050-bbs2-0188" title="GoldSM , EnckP , HasselmannH , FriedeT , HegerlU , MohrDC , et al.Control conditions for randomised trials of behavioural interventions in psychiatry: a decision framework. Lancet Psychiatry2018;4(9):725-32.">Gold 2018</a>). Future research should support the development of a methodological guideline on how to properly design and report control interventions in randomised trials with patients with mental health disorders, to ensure the validity and reliability of future mental health trials. </p> </section> </section> </section> <section class="summaryOfFindings"> <div class="section-header section-collapse-header" id="MR000050-sec-0008" lang="en"> <h2 class="title section-collapse-title"> Summary of findings <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="summaryOfFindings" lang="en"> <div class="section-header" id="MR000050-sec-0008"></div> <div class="table" id="MR000050-tbl-0001"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 1.</span> <span class="table-title">Summary of findings</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Benefits and harms of wait‐list compared with no‐treatment for mental health disorders</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population:</b> patients with mental health disorders </p> <p><b>Settings:</b> inpatient and outpatient </p> <p><b>Intervention:</b> wait‐list </p> <p><b>Comparison:</b> no‐treatment </p> </td> </tr> <tr class="separated"> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>Outcomes</b> </p> </th> <th align="" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>Relative effect<br/>(95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>No of Participants<br/>(studies)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>Quality of the evidence<br/>(GRADE)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>Comments</b> </p> </th> </tr> <tr class="separated"> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Assumed risk</b> </p> </th> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Corresponding risk</b> </p> </th> </tr> <tr class="separated"> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Wait‐list/no‐treatment</b> </p> </th> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Usual care</b> </p> </th> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Wait‐list compared with no‐treatment</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""></td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Only one cluster‐randomised trial compared a wait‐list intervention to a no‐treatment intervention was included (<a href="./references#MR000050-bbs2-0033" title="HowlinP , GordonKR , PascoG , WadeA , CharmanT .The effectiveness of picture exchange communication system (PECS) training for teachers of children with autism: a pragmatic,group randomised controlled trial. Journal of Child Psychology and Psychiatry2007;48(5):473-81. ">Howlin 2007</a>). However, no usable data were provided in the full report, and the authors did engage in correspondence. Eighty‐four elementary school children with a autism spectrum disorder were randomised to either, i) immediate treatment, ii) delayed treatment (wait‐list), and iii) no‐treatment. Conclusions were that Picture Exchange Communication System (PECS) training indicated modest effectiveness for children with autism spectrum disorder. In general there were no differences on across outcome measures between the wait‐list and no‐treatment intervention groups. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/><b>CI:</b> Confidence interval; <b>RR:</b> Risk Ratio; <b>RD:</b> Risk Difference; <b>RCT:</b> Randomised clinical trial </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/><b>High quality:</b> further research is very unlikely to change our confidence in the estimate of effect.<br/><b>Moderate quality:</b> further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/><b>Low quality:</b> further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/><b>Very low quality:</b> we are very uncertain about the estimate. </p> </td> </tr> </tbody> </table> </div> <div class="table" id="MR000050-tbl-0002"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 2.</span> <span class="table-title">Summary of findings</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Benefits and harms of usual care compared with wait‐list or no‐treatment for mental health disorders</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population:</b> patients with mental health disorders </p> <p><b>Settings:</b> inpatient and outpatient </p> <p><b>Intervention:</b> usual care </p> <p><b>Comparison:</b> wait‐list or no‐treatment </p> </td> </tr> <tr class="separated"> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>Outcomes</b> </p> </th> <th align="" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>Relative effect<br/>(95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>No of Participants<br/>(studies)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>Quality of the evidence<br/>(GRADE)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>Comments</b> </p> </th> </tr> <tr class="separated"> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Assumed risk</b> </p> </th> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Corresponding risk</b> </p> </th> </tr> <tr class="separated"> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Wait‐list/no‐treatment</b> </p> </th> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Usual care</b> </p> </th> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Usual care compared with wait‐list/no‐treatment</b> </p> <p>(Variety of continuous outcome)</p> <p>(Post‐treatment)</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""></td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>The mean score in the usual care group was <b>0.33 points lower</b> (0.83 lower to 0.16 higher) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>523</p> <p>(5 RCTs)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>⊕⊝⊝⊝<br/><b>very low <sup>a,b,c</sup> </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>TSA adjusted CI = ‐2.32 to 1.15</p> <p>TSA RIS = 1536</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Serious adverse events for all placebos</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""></td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No data</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Non‐serious adverse events for all placebos</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""></td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No data</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/><b>CI:</b> confidence interval; <b>RR:</b> risk ratio; <b>RD:</b> risk difference; <b>RCT:</b> randomised clinical trial; <b>TSA:</b> Trial Sequential Analysis </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/><b>High quality:</b> further research is very unlikely to change our confidence in the estimate of effect.<br/><b>Moderate quality:</b> further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/><b>Low quality:</b> further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/><b>Very low quality:</b> we are very uncertain about the estimate. </p> <p><sup>a</sup> We downgraded the quality of evidence by one level due to risk of bias </p> <p><sup>b</sup> We downgraded the quality of evidence by one level due to inconsistency (in terms of either clinical and methodological heterogeneity) </p> <p><sup>c</sup> We downgraded the quality of evidence by one level due to imprecision (wide confidence intervals) </p> </td> </tr> </tbody> </table> </div> <div class="table" id="MR000050-tbl-0003"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 3.</span> <span class="table-title">Summary of findings</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Benefits and harms of placebos compared with wait‐list or no‐treatment for mental health disorders</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population:</b> patients with mental health disorders </p> <p><b>Settings:</b> inpatient and outpatient </p> <p><b>Intervention:</b> all placebos combined, psychological, pharmacological and physical placebos </p> <p><b>Comparison:</b> wait‐list or no‐treatment </p> </td> </tr> <tr class="separated"> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>Outcomes</b> </p> </th> <th align="" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>Relative effect<br/>(95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>No of Participants<br/>(studies)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>Quality of the evidence<br/>(GRADE)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>Comments</b> </p> </th> </tr> <tr class="separated"> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Assumed risk</b> </p> </th> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Corresponding risk</b> </p> </th> </tr> <tr class="separated"> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Wait‐list/no‐treatment</b> </p> </th> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Placebos</b> </p> </th> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>All placebos compared with wait‐list or no‐treatment</b> </p> <p>(Variety of continuous outcome)</p> <p>(Post‐treatment)</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"></td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean score in the placebo group was <b>0.37 points lower</b> (0.49 lower to 0.25 lower) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2446</p> <p>(65 RCTs)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/><b>low <sup>a,b</sup> </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>TSA adjusted<br/>Cl = −1.85 to<br/>−0.84<br/>TSA RIS = 397 </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Psychological placebos compared with wait‐list or no‐treatment</b> </p> <p>(Variety of continuous outcome)</p> <p>(Post‐treatment)</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""></td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>The mean score in the placebo group was <b>0.49 points lower</b> (0.66 lower to 0.31 lower) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1263</p> <p>(38 RCTs)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>⊕⊕⊝⊝<br/><b>low <sup>a,b</sup> </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>TSA adjusted<br/>Cl = −2.54 to<br/>−1.02<br/>TSA RIS = 454 </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Pharmacological placebos compared with wait‐list or no‐treatment</b> </p> <p>(Variety of continuous outcome)</p> <p>(Post‐treatment)</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""></td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>The mean score in the placebo group was <b>0.14 points lower</b> (0.39 lower to 0.11 higher) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>279</p> <p>(9 RCTs)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>⊕⊝⊝⊝<br/><b>very low <sup>a,b,c</sup> </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>TSA adjusted<br/>Cl = −9.43 to<br/>6.15<br/>TSA RIS = 229 </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Physical placebos compared with wait‐list or no‐treatment</b> </p> <p>(Variety of continuous outcome)</p> <p>(Post‐treatment)</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""></td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>The mean score in the placebo group was <b>0.21 points lower</b> (0.35 lower to 0.08 lower) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>896</p> <p>(17 RCTs)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>⊕⊕⊝⊝<br/><b>low <sup>a,b</sup> </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>TSA adjusted<br/>Cl = −3.64 to<br/>−0.49<br/>TSA RIS = 194 </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Serious adverse events for all placebos compared with wait‐list or no treatment</b> </p> <p>(Spontaneous reporting of dichotomous outcomes)</p> <p>(Post‐treatment)</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p><b>43 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p><b>27 per 1000 (95% CI 32 fewer to 23 higher)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>RD ‐0.00</b> </p> <p>(95% CI ‐0.03 to 0.03)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>517</p> <p>(11 RCTs)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><sub>⊕⊝⊝⊝</sub><br/><b><sub>very low a,b,c</sub> </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not possible to calculate TSA on serious adverse events due to too little information use </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Non‐serious adverse events for all placebos compared with wait‐list or no treatment</b> </p> <p>(Spontaneous reporting of dichotomous outcomes)</p> <p>(Post‐treatment)</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p><b>93 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p><b>96 per 1000</b> </p> <p><b>(95% CI 2 fewer to 7 higher)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>RD 0.03</b> </p> <p>(95% CI ‐0.02 to 0.08)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>590</p> <p>(14 trials)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><sub>⊕⊝⊝⊝</sub><br/><b><sub>very low a,b,c</sub> </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not possible to calculate TSA on serious adverse events due to too little information use </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/><b>CI:</b> Confidence interval; <b>RR:</b> Risk Ratio; <b>RD:</b> Risk Difference; <b>RCT:</b> Randomised clinical trial; <b>RIS:</b> required information size; <b>TSA:</b> trial sequential analysis </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>GRADE Working Group grades of evidence</b> <br/><b>High quality:</b> further research is very unlikely to change our confidence in the estimate of effect.<br/><b>Moderate quality:</b> further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/><b>Low quality:</b> further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/><b>Very low quality:</b> we are very uncertain about the estimate. </p> <p><sup>a</sup> We downgraded the quality of evidence by one level due to risk of bias </p> <p><sup>b</sup> We downgraded the quality of evidence by one level due to inconsistency (in terms of either clinical and methodological heterogeneity) </p> <p><sup>c</sup> We downgraded the quality of evidence by one level due to imprecision (wide confidence intervals) </p> </td> </tr> </tbody> </table> </div> </section> </section> <section class="background"> <div class="section-header section-collapse-header" id="MR000050-sec-0009" lang="en"> <h2 class="title section-collapse-title"> Background <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="background" lang="en"> <div class="section-header" id="MR000050-sec-0009"></div> <section id="MR000050-sec-0010"> <h3 class="title" id="MR000050-sec-0010">Description of the methods being investigated</h3> <p>Control interventions in randomised trials provide a frame of reference for the experimental intervention and allow causal estimations of treatment efficacy and adverse events (<a href="./references#MR000050-bbs2-0207" title="HigginJP , ThomasJ , ChandlerJ , CumpstonM , LiT , PageMJ , et al (editors).Cochrane Handbook for Systematic Reviews of Interventions Version 6.0 (updated July 2019). Cochrane, 2019.. Available from www.training.cochrane.org/handbook.">Higgins 2019</a>; <a href="./references#MR000050-bbs2-0225" title="KazdinAE .Methodological Issues &amp; Strategies in Clinical Research. 4th edition. Washington DC: American Psychological Association, 2016.">Kazdin 2016</a>; <a href="./references#MR000050-bbs2-0271" title="SibbaldB , RolandM .Understanding controlled trials: why are randomised controlled trials important?BMJ1998;316(7126):201.">Sibbald 1998</a>). This systematic review assesses the benefits and harms of different control interventions in randomised trials that include patients with a mental health disorder. </p> <p>We included the following experimental interventions in the review (which are often described as control interventions — see <a href="#MR000050-tbl-0004">Table 1</a>): (a) wait‐list, (b) usual care, (c) psychological placebo, (d) pharmacological placebo, and (e) physical placebo. We included the following control interventions: (a) wait‐list and (b) no‐treatment. We also planned to compare wait‐list with no‐treatment. We conducted analyses across all included patient populations and within specific mental health disorders. We made direct comparisons between the control interventions by including trials with more than one control arm (often three‐armed randomised trials). </p> <div class="table" id="MR000050-tbl-0004"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Description of experimental interventions</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Name of intervention</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Other common names reported in the literature</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Definition</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Examples</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Psychological placebo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Attention placebo, credible placebo, common‐factor treatment control, sham intervention, pseudo control </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Psychological placebos target the non‐specific or shared components of psychological treatments, such as human interaction variables, attending sessions, and patient expectations </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>In an example from Tan 1986, the psychological placebo participants were exposed to sessions of supportive group counselling, which were thought to represent the non‐specific component of the active intervention, which was cognitive behavioural therapy </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Pharmacological placebo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Pill placebo, placebo tablet, dummy pill</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Pharmacological placebos are inert substances, typically in pill or liquid form, which do not contain the active ingredients of a given drug treatment </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Participants typically receive a pill containing starch, sugar, or lactose (Double 1993; Meissner 2011b). </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Physical placebo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Sham intervention, credible placebo, pseudo control</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="middle"> <p>Physical placebos target the inert components of a given physical treatment (such as acupuncture, needle injection, exercise regimens, surgery, or electromagnetic stimulation) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>This could be sham acupuncture where the needles are blunted ( <a href="./references#MR000050-bbs2-0282" title="ToughEA , WhiteAR , RichardsSH , LordB , CampbellJL .Developing and validating a sham acupuncture needle. Acupuncture in Medicine2009;27(3):118-22.">Tough 2009</a> ), or sham electromagnetic stimulation, where the machine is not turned on or electrodes are attached to inactive sites ( <a href="./references#MR000050-bbs2-0272" title="SommerJ , JansenA , DrägerB , SteinsträterO , BreitensteinC , DeppeM , et al.Transcranial magnetic stimulation - a sandwich coil design for a better sham. Clinical Neurophysiology2006;117(2):440-6.">Sommer 2006</a> ) </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Usual care</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Treatment as usual (TAU), standard care, outpatient care, standard practice, support as usual, clinical care, routine care, existing‐practice control </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Usual care reflects locally accepted treatment practices for a given mental health disorder. It is provided either by private or public practitioners and may involve both pharmacological and psychological treatment. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Patients allocated to usual care might receive a large variety of therapies with a theoretical blend of psychodynamic, humanistic and behavioural approaches ( <a href="./references#MR000050-bbs2-0158" title="BorduinCM , SchaefferCM , HeiblumN .A randomized clinical trial of multisystemic therapy with juvenile sexual offenders: effects on youth social ecology and criminal activity. Journal of Consulting and Clinical Psychology2009;77(1):26-37.">Borduin 2009</a> ) </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Wait‐list</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Minimal contact control, delayed treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Wait‐list participants are assessed on repeated occasions, but are promised the "active" intervention after the trial has ended </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>In Ertl 2011, participants allocated to the wait‐list group were reassessed at baseline and follow‐up, and subsequently offered the active treatment, which was narrative exposure therapy </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No‐treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Minimal contact control</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No‐treatment participants are assessed on repeated occasions without receiving the active treatment intervention. Unlike wait‐list interventions, no‐treatment participants are not promised the "active" intervention after trial completion </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No‐treatment participants in <a href="./references#MR000050-bbs2-0248" title="MirandaJ , ChungJY , GreenBL , KrupnickJ , SiddiqueJ , RevickiDA , et al.Treating depression in predominantly low-income young minority women: a randomized controlled trial. JAMA2003;290(1):57-65.">Miranda 2003</a> did not receive any mental‐health related treatment, and were not promised the active intervention (antidepressants or psychotherapy) after trial completion </p> </td> </tr> </tbody> </table> </div> <p><i>Wait‐list</i> participants are typically assessed before and after a given time period, and they receive the experimental intervention after the final research assessment if it provides more benefits than harms. <i>No‐treatment</i> participants are also assessed on repeated occasions but are not promised the experimental intervention after the final assessment (<a href="./references#MR000050-bbs2-0172" title="ComerJS , KendallPC .Methodology, design, and evaluation in psychotherapy research. In: LambertMJ , editors(s). Bergin and Garfields’s Handbook of Psychotherapy and Behavior Change. 6th edition. New York: Wiley, 2013:21-48.">Comer 2013</a>). Furukawa and colleagues have proposed that wait‐list participants could become motivated to remain in poor health in order to receive a desired therapy after the trial has ended, and that those receiving no‐treatment might actively seek out other forms of care outside the trial during the trial period ( <a href="./references#MR000050-bbs2-0187" title="FurukawaTA , NomaH , CaldwellDM , HonyashikiM , ShinoharaK , ImaiH , et al.Waiting list may be a nocebo condition in psychotherapy trials: a contribution from network meta-analysis. Acta Psychiatrica Scandinavica2014;130(3):181-92.">Furukawa 2014</a>). Wait‐list participants could therefore be subject to so‐called nocebo effects (i.e. negative effects from inert interventions) (<a href="./references#MR000050-bbs2-0171" title="CollocaL , BarskyAJ .Placebo and nocebo effects. New England Journal of Medicine2020;382(6):554-61.">Colloca 2020</a>), but the evidence on this is preliminary (<a href="./references#MR000050-bbs2-0190" title="Greville-HarrisM , DieppeP .Bad is more powerful than good: the nocebo response in medical consultations. American Journal of Medicine2015;128(2):126-9.">Greville‐Harris 2015</a>; <a href="./references#MR000050-bbs2-0187" title="FurukawaTA , NomaH , CaldwellDM , HonyashikiM , ShinoharaK , ImaiH , et al.Waiting list may be a nocebo condition in psychotherapy trials: a contribution from network meta-analysis. Acta Psychiatrica Scandinavica2014;130(3):181-92.">Furukawa 2014</a>). Wait‐list and no‐treatment comparators control for maturation, spontaneous improvement, regression to the mean, and observer‐expectancy effects (<a href="./references#MR000050-bbs2-0172" title="ComerJS , KendallPC .Methodology, design, and evaluation in psychotherapy research. In: LambertMJ , editors(s). Bergin and Garfields’s Handbook of Psychotherapy and Behavior Change. 6th edition. New York: Wiley, 2013:21-48.">Comer 2013</a> ; <a href="./references#MR000050-bbs2-0227" title="KienleGS , KieneH .The powerful placebo effect - fact or fiction?Journal of Clinical Epidemiology1997;50(12):1311-8.">Kienle 1997</a>). Careful monitoring of participants in wait‐list and no‐treatment interventions is important to ensure toleration of treatment delays and ethical compliance <a href="./references#MR000050-bbs2-0172" title="ComerJS , KendallPC .Methodology, design, and evaluation in psychotherapy research. In: LambertMJ , editors(s). Bergin and Garfields’s Handbook of Psychotherapy and Behavior Change. 6th edition. New York: Wiley, 2013:21-48.">Comer 2013</a>; <a href="./references#MR000050-bbs2-0251" title="MohrDC , SpringB , FreedlandKE , BecknerV , AreanP , HollonSD , et al.The selection and design of control conditions for randomized controlled trials of psychological interventions. Psychotherapy and Psychosomatics2009;78(5):275-84.">Mohr 2009</a>). </p> <p><i>Usual care</i> (sometimes also referred to as treatment as usual) is a control intervention that attempts to mirror the locally accepted treatment practices for a given mental health disorder. This control intervention may include both pharmacological and psychological treatments that are administered by relevant practitioners (<a href="./references#MR000050-bbs2-0186" title="FreedlandKE , MohrDC , DavidsonKW , SchwartzJE .Usual and unusual care: existing practice control groups in randomized controlled trials of behavioral interventions. Psychosomatic Medicine2011;73(4):323-35.">Freedland 2011</a>). The research teams are often not involved in the care of these patients. Usual care control groups are typically subject to large clinical and methodological heterogeneity, the practitioners receive little supervision, and the interventions often use a mixture of different theoretical approaches (<a href="./references#MR000050-bbs2-0172" title="ComerJS , KendallPC .Methodology, design, and evaluation in psychotherapy research. In: LambertMJ , editors(s). Bergin and Garfields’s Handbook of Psychotherapy and Behavior Change. 6th edition. New York: Wiley, 2013:21-48.">Comer 2013</a> ; <a href="./references#MR000050-bbs2-0224" title="KazdinAE .Treatment as usual and routine care in research and clinical practice. Clinical Psychology Review2015;42:168.">Kazdin 2015</a> ; <a href="./references#MR000050-bbs2-0241" title="LöfholmAC , BrännströmL , OlssonM , HanssonK .Treatment-as-usual in effectiveness studies: What is it and does it matter?International Journal of Social Welfare2013;22(1):25-34.">Löfholm 2013</a> ). Despite these issues, usual care arguably reflects routine practice better than highly controlled psychiatric interventions ( <a href="./references#MR000050-bbs2-0224" title="KazdinAE .Treatment as usual and routine care in research and clinical practice. Clinical Psychology Review2015;42:168.">Kazdin 2015</a>; <a href="./references#MR000050-bbs2-0252" title="MohrDC , HoJ , HartTL , BaronKG , BerendsenM , BecknerV , et al.Control condition design and implementation features in controlled trials: a meta-analysis of trials evaluating psychotherapy for depression. Translational Behavioral Medicine2014;4(4):407-23.">Mohr 2014</a> ) and when delivered well this type of control intervention is useful for determining whether novel psychiatric treatments are favourable to current practices (<a href="./references#MR000050-bbs2-0251" title="MohrDC , SpringB , FreedlandKE , BecknerV , AreanP , HollonSD , et al.The selection and design of control conditions for randomized controlled trials of psychological interventions. Psychotherapy and Psychosomatics2009;78(5):275-84.">Mohr 2009</a>). Usual care is sometimes standardised (<a href="./references#MR000050-bbs2-0155" title="BatemanA , FonagyP .Randomized controlled trial of outpatient mentalization-based treatment versus structured clinical management for borderline personality disorder. American Journal of Psychiatry2009;166(12):1355-64.">Bateman 2009</a>; <a href="./references#MR000050-bbs2-0168" title="ChanenAM , JacksonHJ , McCutcheonLK , JovevM , DudgeonP , HokPY , et al.Early intervention for adolescents with borderline personality disorder using cognitive analytic therapy: randomised controlled trial. British Journal of Psychiatry2008;193(6):477-84.">Chanen 2008</a>), which may involve manualisation, optimising of treatment structure, and adherence procedures (e.g. through supervision) (<a href="./references#MR000050-bbs2-0156" title="BatemanA , CampbellC , LuytenP , FonagyP .A mentalization-based approach to common factors in the treatment of borderline personality disorder. Current Opinion in Psychology2017;21:44-9.">Bateman 2017</a>; <a href="./references#MR000050-bbs2-0174" title="CristeaIA , GentiliC , CotetCD , PalombaD , BarbuiC , CuijpersP .Efficacy of psychotherapies for borderline personality disorder: A systematic review and meta-analysis. JAMA Psychiatry2017;74(4):319-28.">Cristea 2017</a>; <a href="./references#MR000050-bbs2-0231" title="KongerslevMT , ChanenAM , SimonsenE .Personality disorder in childhood and adolescence comes of age: a review of the current evidence and prospects for future research. Scandinavian Journal of Child and Adolescent Psychiatry and Psychology2015;3(1):31-48.">Kongerslev 2015</a>). </p> <p>This Cochrane methodology review distinguishes between three types of placebos. First, <i>psychological placebos</i> are designed to target the shared components of psychological treatments, such as attending sessions, the therapeutic relationship and patient expectations (<a href="./references#MR000050-bbs2-0185" title="FrankJD , FrankJB .Persuasion and Healing: a Comparative Study of Psychotherapy. 3rd edition. Baltimore: Johns Hopkins University Press, 1991.">Frank 1991</a>; <a href="./references#MR000050-bbs2-0216" title="HróbjartssonA , MillerFG .Placebo in nonpharmacological randomized trials. In: BoutronI , RavaudP , MoherD , editors(s). Randomized Clincial Trials of Nonpharmacological Treatments. Taylor &amp; Francis Group, LLC, 2012:11-26.">Hróbjartsson 2012</a>; <a href="./references#MR000050-bbs2-0265" title="RosenzweigS .Some implicit common factors in diverse methods of psychotherapy. American Journal of Orthopsychiatry1936;6(3):412-5.">Rosenzweig 1936</a>). It is both methodologically and theoretically difficult to discriminate between psychological placebos and psychological treatments (<a href="./references#MR000050-bbs2-0159" title="BorkovecTD , SibravaNJ .Problems with the use of placebo conditions in psychotherapy research, suggested alternatives, and some strategies for the pursuit of the placebo phenomenon. Journal of Clinical Psychology2005;61(7):805-18.">Borkovec 2005</a>; <a href="./references#MR000050-bbs2-0216" title="HróbjartssonA , MillerFG .Placebo in nonpharmacological randomized trials. In: BoutronI , RavaudP , MoherD , editors(s). Randomized Clincial Trials of Nonpharmacological Treatments. Taylor &amp; Francis Group, LLC, 2012:11-26.">Hróbjartsson 2012</a>; <a href="./references#MR000050-bbs2-0240" title="LocherC , GaabJ , BleaseC .When a placebo is not a placebo: problems and solutions to the gold standard in psychotherapy research. Frontiers in Psychology2018;9:2317.">Locher 2018</a>; <a href="./references#MR000050-bbs2-0252" title="MohrDC , HoJ , HartTL , BaronKG , BerendsenM , BecknerV , et al.Control condition design and implementation features in controlled trials: a meta-analysis of trials evaluating psychotherapy for depression. Translational Behavioral Medicine2014;4(4):407-23.">Mohr 2014</a>; <a href="./references#MR000050-bbs2-0286" title="WampoldBE , ImielZE .Great Psychotherapy Debate (Counseling and Psychotherapy) - The Evidence for What Makes Psychotherapy Work. 2 edition. Taylor &amp; Francis Inc, 2010.">Wampold 2010</a>; <a href="./references#MR000050-bbs2-0287" title="WampoldBE , FrostND , YulishNE .Placebo effects in psychotherapy: a flawed concept and a contorted history. Psychology of Consciousness: Theory, Research, and Practice2016;3(2):108-20.">Wampold 2016</a>). However, psychological placebos can be methodologically useful for differentiating between the proposed active and non‐active components in psychological treatments (<a href="./references#MR000050-bbs2-0251" title="MohrDC , SpringB , FreedlandKE , BecknerV , AreanP , HollonSD , et al.The selection and design of control conditions for randomized controlled trials of psychological interventions. Psychotherapy and Psychosomatics2009;78(5):275-84.">Mohr 2009</a>). Second, <i>pharmacological placebos</i> are inert substances in pill, liquid or other forms that do not contain the active ingredients of a given pharmacological treatment. Participants typically receive a pill containing starch, sugar, or lactose (<a href="./references#MR000050-bbs2-0020" title="DoubleDB , WarrenGC , EvansM , RowlandsMP .Efficacy of maintenance use of anticholinergic agents. Acta Psychiatrica Scandinavica1993;88:381-4. ">Double 1993</a>; <a href="./references#MR000050-bbs2-0244" title="MeissnerK , BingelU , CollocaL , WagerTD , WatsonA , FlatenMA .The placebo effect: advances from different methodological approaches. Journal of Neuroscience2011;31(45):16117-24.">Meissner 2011</a>). The pharmacological placebo will need to match the active drug treatment (e.g. antidepressant medication) in size, form, colour, weight, smell, texture, solubility and taste, but not include any of the active components in the experimental intervention (<a href="./references#MR000050-bbs2-0284" title="WagerTD , AtlasLY .The neuroscience of placebo effects: connecting context, learning and health. Nature Reviews Neuroscience2015;16(7):403-18.">Wager 2015</a>). Third, <i>physical placebos</i> target the inert components of physical treatments (e.g. acupuncture, exercise regimens, or surgery). Here an example could be a staged electromagnetic stimulation procedure where the machine is not turned on or electrodes are attached to inactive sites (<a href="./references#MR000050-bbs2-0272" title="SommerJ , JansenA , DrägerB , SteinsträterO , BreitensteinC , DeppeM , et al.Transcranial magnetic stimulation - a sandwich coil design for a better sham. Clinical Neurophysiology2006;117(2):440-6.">Sommer 2006</a>). </p> </section> <section id="MR000050-sec-0011"> <h3 class="title" id="MR000050-sec-0011">Why it is important to do this review</h3> <p>The need to improve and develop treatments for mental health disorders is great (<a href="./references#MR000050-bbs2-0210" title="HolmesEA , GhaderiA , HarmerCJ , RamchandaniPG , CuijpersP , MorrisonAP , et al.The Lancet Psychiatry Commission on psychological treatments research in tomorrow's science. Lancet Psychiatry2018;5(3):237-86.">Holmes 2018</a>; <a href="./references#MR000050-bbs2-0223" title="KarterudS , KongerslevMT .Psychotherapy of personality disorders needs an integrative theory of personality. Journal of Psychotherapy Integration2020;31:34-53.">Karterud 2020</a>; <a href="./references#MR000050-bbs2-0237" title="LeichsenringF , SteinertC , IoannidisJPA .Toward a paradigm shift in treatment and research of mental disorders. Psychological Medicine2019;49(13):2111-7.">Leichsenring 2019</a>; <a href="./references#MR000050-bbs2-0292" title="WeiszJR , KuppensS , NgMY , Vaughn-CoaxumRA , UguetoAM , EckshtainD , et al.Are psychotherapies for young people growing stronger? Tracking trends over time for youth anxiety, depression, attention-deficit/hyperactivity disorder, and conduct problems. Perspectives on Psychological Science2019;14(2):216-37.">Weisz 2019</a>). The type of comparator used in randomised trials with patients with mental health disorders may influence estimates of the effects of the experimental intervention, and it is important to know comparative benefits and harms of different types of comparator. However, these is a lack of consensus on how to design and report control interventions in randomised trials with these patients and evidence‐based guidelines are needed (<a href="./references#MR000050-bbs2-0182" title="ErlenJA , TamresLK , ReynoldsN , GolinCE , RosenMI , RemienRH , et al.Assessing usual care in clinical trials. Western Journal of Nursing Research2015;37(3):288-98.">Erlen 2015</a>; <a href="./references#MR000050-bbs2-0186" title="FreedlandKE , MohrDC , DavidsonKW , SchwartzJE .Usual and unusual care: existing practice control groups in randomized controlled trials of behavioral interventions. Psychosomatic Medicine2011;73(4):323-35.">Freedland 2011</a>; <a href="./references#MR000050-bbs2-0188" title="GoldSM , EnckP , HasselmannH , FriedeT , HegerlU , MohrDC , et al.Control conditions for randomised trials of behavioural interventions in psychiatry: a decision framework. Lancet Psychiatry2018;4(9):725-32.">Gold 2018</a>; <a href="./references#MR000050-bbs2-0232" title="KubeT , RiefW .Are placebo and drug-specific effects additive? Questioning basic assumptions of double-blinded randomized clinical trials and presenting novel study designs. Drug Discovery Today2017;22:729-35.">Kube 2017</a>; <a href="./references#MR000050-bbs2-0242" title="LundK , VaseL , PetersenGL , JensenTS , FinnerupNB .Randomised controlled trials may underestimate drug effects: balanced placebo trial design. PLOS One2014;9(1):1-7.">Lund 2014</a>; <a href="./references#MR000050-bbs2-0251" title="MohrDC , SpringB , FreedlandKE , BecknerV , AreanP , HollonSD , et al.The selection and design of control conditions for randomized controlled trials of psychological interventions. Psychotherapy and Psychosomatics2009;78(5):275-84.">Mohr 2009</a>). One aim of this review was to provide an empirical basis for future methodological guideline development in this field (<a href="./references#MR000050-bbs2-0208" title="HoffmannTC , EruetiC , GlasziouPP .Poor description of non-pharmacological interventions: analysis of consecutive sample of randomised trials. BMJ2013;347(7924):e1-10.">Hoffmann 2013</a>; <a href="./references#MR000050-bbs2-0277" title="TajikaA , OgawaY , TakeshimaN , HayasakaY , FurukawaTA .Replication and contradiction of highly cited research papers in psychiatry: 10-year follow-up. British Journal of Psychiatry2015;207(4):357-62.">Tajika 2015</a>). </p> <p>Wait‐list control and no‐treatment interventions may yield different effects in favour of experimental treatments depending on how they are structured, designed, and delivered, and it is very important to describe such factors. Wait‐list and no‐treatment conditions are also some of the most commonly used control interventions in psychiatric research (<a href="./references#MR000050-bbs2-0252" title="MohrDC , HoJ , HartTL , BaronKG , BerendsenM , BecknerV , et al.Control condition design and implementation features in controlled trials: a meta-analysis of trials evaluating psychotherapy for depression. Translational Behavioral Medicine2014;4(4):407-23.">Mohr 2014</a>) but may induce unwanted adverse events in participants, for instance from waiting to receive a treatment that patients may critically need (<a href="./references#MR000050-bbs2-0187" title="FurukawaTA , NomaH , CaldwellDM , HonyashikiM , ShinoharaK , ImaiH , et al.Waiting list may be a nocebo condition in psychotherapy trials: a contribution from network meta-analysis. Acta Psychiatrica Scandinavica2014;130(3):181-92.">Furukawa 2014</a>). If participants allocated to wait‐list and no‐treatment interventions show significantly more adverse events than those allocated to other control interventions, the ethical concerns and risks of overestimating the effects of clinical interventions in randomised trials should also be investigated (<a href="./references#MR000050-bbs2-0177" title="CunninghamJA , KypriK , McCambridgeJ .Exploratory randomized controlled trial evaluating the impact of a waiting list control design. BMC Medical Research Methodology2013;13(1):150.">Cunningham 2013</a>; <a href="./references#MR000050-bbs2-0187" title="FurukawaTA , NomaH , CaldwellDM , HonyashikiM , ShinoharaK , ImaiH , et al.Waiting list may be a nocebo condition in psychotherapy trials: a contribution from network meta-analysis. Acta Psychiatrica Scandinavica2014;130(3):181-92.">Furukawa 2014</a>). </p> <p>We need more evidence on the content and effects of usual care as a control intervention in randomised trials (<a href="./references#MR000050-bbs2-0264" title="RosenbergL .Assisted outpatient treatment: we can do better. Journal of Behavioral Health Services and Research2014;41(3):251-3.">Rosenberg 2014</a>; <a href="./references#MR000050-bbs2-0275" title="SwansonJW , SwartzMS .Why the evidence for outpatient commitment is good enough. Psychiatric Services2014;65(6):808-11.">Swanson 2014</a>) given the lack of discussion on how to design usual care conditions properly and how the use of usual care as a control condition may influence the reported effects (e.g. in favour of experimental treatments in study reports) (<a href="./references#MR000050-bbs2-0224" title="KazdinAE .Treatment as usual and routine care in research and clinical practice. Clinical Psychology Review2015;42:168.">Kazdin 2015</a>). </p> <p>In a series of prior reviews, Hróbjartsson and Gøtzsche found, in general, no clinically important effects of psychological, pharmacological, and physical placebos versus wait‐list and no‐treatment interventions for various medical and psychiatric conditions (<a href="./references#MR000050-bbs2-0212" title="HróbjartssonA , GøtzschePC .Is the placebo powerless? An analysis of clinical trials comparing placebo with no treatment. New England Journal of Medicine2001;344:1594-602.">Hróbjartsson 2001</a>; <a href="./references#MR000050-bbs2-0213" title="HróbjartssonA , GötzschePC .Placebo treatment versus no treatment. Cochrane Database of Systematic Reviews2002, Issue 4. Art. No: CD003974. [DOI: 10.1002/14651858.CD003974]">Hróbjartsson 2002</a>; <a href="./references#MR000050-bbs2-0214" title="HróbjartssonA , GötzschePC .Placebo interventions for all clinical conditions. Cochrane Database of Systematic Reviews2004, Issue 2. Art. No: CD003974. [DOI: 10.1002/14651858.CD003974.pub2]">Hróbjartsson 2004</a>; <a href="./references#MR000050-bbs2-0215" title="HróbjartssonA , GötzschePC .Placebo interventions for all clinical conditions. Cochrane Database of Systematic Reviews2010, Issue 1. Art. No: CD003974. [DOI: 10.1002/14651858.CD003974.pub3]">Hróbjartsson 2010</a>). For example, the most recent update of their review (2010) included 44 trials with dichotomous outcomes and 158 trials with continuous outcomes, and they found moderate heterogeneity for both outcome domains (I <sup>2</sup> = 45% and 42%, respectively). For continuous outcomes, they also found large variation in effects between small and large trials (asymmetric funnel plots). Although the design of Hróbjartsson's and Gøtzsche's reviews is similar to the design of this review, their objective was to investigate the clinical relevancy of placebos, whereas this review is focused on methodological questions related to control interventions in randomised trials with patients with mental health disorders. It is, however, relevant to compare the two reviews methodologically. The present review is also interested in how placebo interventions may depend on factors such as type of mental health disorder, context of administration, information given to participants, and type of outcome measure (<a href="./references#MR000050-bbs2-0169" title="CharlesworthJE , PetkovicG , KelleyJM , HunterM , OnakpoyaI , RobertsN , et al.Effects of placebos without deception compared with no treatment: a systematic review and meta-analysis. Journal of Evidence Based Medicine2017;10(2):97-107.">Charlesworth 2017</a>; <a href="./references#MR000050-bbs2-0184" title="FässlerM , MeissnerK , KleijnenJ , HróbjartssonA , LindeK .A systematic review found no consistent difference in effect between more and less intensive placebo interventions. Journal of Clinical Epidemiology2015;68(4):442-51.">Fässler 2015</a>; <a href="./references#MR000050-bbs2-0209" title="HolmesRD , TiwariAK , KennedyJL .Mechanisms of the placebo effect in pain and psychiatric disorders. Pharmacogenomics Journal2016;16(6):491.">Holmes 2016</a>; <a href="./references#MR000050-bbs2-0215" title="HróbjartssonA , GötzschePC .Placebo interventions for all clinical conditions. Cochrane Database of Systematic Reviews2010, Issue 1. Art. No: CD003974. [DOI: 10.1002/14651858.CD003974.pub3]">Hróbjartsson 2010</a>; <a href="./references#MR000050-bbs2-0211" title="HowickJ , WebsterR , KirbyN , HoodK .Rapid overview of systematic reviews of nocebo effects reported by patients taking placebos in clinical trials. Trials2018;19(1):674.">Howick 2019</a>; <a href="./references#MR000050-bbs2-0220" title="JensenKB , KirschI , PonténM , RosénA , YangK , GollubRL , et al.Certainty of genuine treatment increases drug responses among intellectually disabled patients. Neurology2017;88(20):1912-8.">Jensen 2017</a>; <a href="./references#MR000050-bbs2-0244" title="MeissnerK , BingelU , CollocaL , WagerTD , WatsonA , FlatenMA .The placebo effect: advances from different methodological approaches. Journal of Neuroscience2011;31(45):16117-24.">Meissner 2011</a>; <a href="./references#MR000050-bbs2-0257" title="O'LearyKD , BorkovecTD .Conceptual, methodological, and ethical problems of placebo groups in psychotherapy research. American Psychologist1978;33(9):821-30.">O'Leary 1978</a>; <a href="./references#MR000050-bbs2-0266" title="RutherfordBR , PottE , TandlerJM , WallMM , RooseSP , LiebermanJA .Placebo response in antipsychotic clinical trials: A meta-analysis. JAMA Psychiatry2014;71(12):1409-21.">Rutherford 2014</a>; <a href="./references#MR000050-bbs2-0283" title="VaseL .Can insights from placebo and nocebo mechanism studies help improve randomized controlled trials?Clinical Pharmacology and Therapeutics2019;106(6):1169-71.">Vase 2019</a><a href="./references#MR000050-bbs2-0285" title="WalachH .Placebo controls: historical, methodological and general aspects. Philosophical Transactions: Biological Sciences2011;366(1572):1870-8.">Walach 2011</a>; <a href="./references#MR000050-bbs2-0289" title="WeSR , KoogYH , ParkMS , Min B-Il.Placebo effect was influenced by publication year in three-armed acupuncture trials. Complementary Therapies in Medicine2012;20(1-2):83-92.">We 2012</a>; <a href="./references#MR000050-bbs2-0290" title="WeimerK , CollocaL , EnckP .Placebo effects in psychiatry: mediators and moderators. Lancet Psychiatry2015;2(3):246-57.">Weimer 2015</a>; <a href="./references#MR000050-bbs2-0304" title="YeungV , SharpeL , GlozierN , HackettML , ColagiuriB .A systematic review and meta-analysis of placebo versus no treatment for insomnia symptoms. Sleep Medicine Reviews2017;38:17-27.">Yeung 2017</a>), which were also investigated by Hróbjartsson and Gøtzsche. </p> <p>This review is based on our published protocol (<a href="./references#MR000050-bbs2-0306" title="FaltinsenE , TodorovacA , HróbjartssonA , GluudC , KongerslevMT , SimonsenE , StorebøOJ .Placebo, usual care and wait‐list interventions for all mental health disorders.. Cochrane Database of Systematic Reviews2019, Issue 1. Art. No: MR000050. [DOI: 10.1002/14651858.MR000050]">Faltinsen 2019</a>). </p> </section> </section> </section> <section class="objectives"> <div class="section-header section-collapse-header" id="MR000050-sec-0012" lang="en"> <h2 class="title section-collapse-title"> Objectives <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="objectives" lang="en"> <div class="section-header" id="MR000050-sec-0012"></div> <p>Our objectives were to assess the comparative benefits and harms of different control interventions used in randomised trials with patients with mental health disorders. We specifically wanted to assess whether different control interventions yield different effect estimates compared with wait‐list or no‐treatment. We included the most common control interventions in mental health intervention research: wait‐list, usual care and placebos and compared these with wait‐list or no‐treatment. We also wanted to compare wait‐list with no‐treatment interventions. </p> <p>We compared the following interventions:</p> <p> <ol id="MR000050-list-0001"> <li> <p>wait‐list versus no‐treatment interventions;</p> </li> <li> <p>usual care versus wait‐list or no‐treatment interventions;</p> </li> <li> <p>all placebos combined, psychological, pharmacological, and physical placebos versus wait‐list or no‐treatment interventions. </p> </li> </ol> </p> </section> </section> <section class="methods"> <div class="section-header section-collapse-header" id="MR000050-sec-0013" lang="en"> <h2 class="title section-collapse-title"> Methods <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="methods" lang="en"> <div class="section-header" id="MR000050-sec-0013"></div> <section id="MR000050-sec-0014"> <h3 class="title">Criteria for considering studies for this review</h3> <section id="MR000050-sec-0015"> <h4 class="title">Types of studies</h4> <p>Randomised trials comparing wait‐list, usual care, or placebo interventions with either wait‐list or no‐treatment interventions were eligible. Parallel trials irrespective of language, publication year, and publication type were eligible. We included one cross‐over trial, but only used data from the first phase of the trial as a regular parallel trial. We included one cluster‐randomised trial. In case of articles published in languages other than English, we sought translation of the relevant sections. Unpublished studies where methods and results could be assessed in written form were eligible. </p> </section> <section id="MR000050-sec-0016"> <h4 class="title">Types of data</h4> <p>All patients in each included trial were required to have a formal diagnosis of a mental health disorder according to the Diagnostic and Statistical Manual of Mental Disorders (DSM), First Edition (DSM‐I; <a href="./references#MR000050-bbs2-0146" title="American Psychiatric Association.Diagnostic and Statistical Manual of Mental Disorders. 1st edition. Washington (DC): American Psychiatric Association, 1952.">APA 1952</a>), Second Edition (DSM‐II; <a href="./references#MR000050-bbs2-0147" title="American Psychiatric Association.Diagnostic and Statistical Manual of Mental Disorders. 2nd edition. Washington (DC): American Psychiatric Association, 1968.">APA 1968</a>), Third Edition (DSM‐III; <a href="./references#MR000050-bbs2-0148" title="American Psychiatric Association.Diagnostic and Statistical Manual of Mental Disorders. 3rd edition. Washington (DC): American Psychiatric Association, 1980.">APA 1980</a>), Third Edition Revised (DSM‐III‐R; <a href="./references#MR000050-bbs2-0149" title="American Psychiatric Association.Diagnostic and Statistical Manual of Mental Disorders. 3rd revised edition. Washington (DC): American Psychiatric Association, 1987.">APA 1987</a>), Fourth Edition (DSM‐IV; <a href="./references#MR000050-bbs2-0150" title="American Psychiatric Association.Diagnostic and Statistical Manual of Mental Disorders. 4th edition. Washington (DC): American Psychiatric Association, 1994.">APA 1994</a>), Fourth Edition Text Revision (DSM‐IV‐TR; <a href="./references#MR000050-bbs2-0151" title="American Psychiatric Association.Diagnostic and Statistical Manual of Mental Disorders. 4th text revision edition. Washington (DC): American Psychiatric Association, 2000.">APA 2000</a>), and Fifth Edition (DSM‐5; <a href="./references#MR000050-bbs2-0152" title="American Psychiatric Association.Diagnostic and Statistical Manual of Mental Disorders. 5th edition. Washington (DC): American Psychiatric Association, 2013. [https://www.psychiatry.org/psychiatrists/practice/dsm]">APA 2013</a>), or according to the International Classification of Diseases and Related Health Problems (ICD), Sixth Edition (ICD‐6; <a href="./references#MR000050-bbs2-0296" title="Manual of the International Classification of Diseases, Sixth Revision (ICD-6). World Health Organization1949.">WHO 1949</a>), Seventh Edition (ICD‐7; <a href="./references#MR000050-bbs2-0297" title="Manual of the International Classification of Diseases, Seventh Revision (ICD-7). World Health Organization1955.">WHO 1955</a>), Eighth Edition (ICD‐8; <a href="./references#MR000050-bbs2-0298" title="Manual of the International Classification of Diseases, Eighth Revision (ICD-8). World Health Organization1967.">WHO 1967</a>), Ninth Edition (ICD‐9; <a href="./references#MR000050-bbs2-0299" title="Manual of the international classification of diseases, Ninth Revision (ICD-9). World Health Organization1975.">WHO 1975</a>), 10th Edition (ICD‐10; <a href="./references#MR000050-bbs2-0300" title="Manual of the International Classification of Diseases, Tenth Revision (ICD-10). World Health Organization1993.">WHO 1993</a>), or 11th Edition (ICD‐11; <a href="./references#MR000050-bbs2-0301" title="Manual of the International Classification of Diseases, Eleventh Revision (ICD-11). World Health Organization2018. [https://www.who.int/standards/classifications/classification-of-diseases]">WHO 2018</a>). In some instances, the diagnostic classification system was not mentioned in the full report, but the participants fulfilled all symptoms to receive a diagnosis of a mental health disorder or they were formally diagnosed by a mental health professional. For trials published before the introduction of DSM or ICD criteria in 1949, participants were eligible if they had received a formal diagnostic assessment of a mental health disorder by a health professional. </p> <p>We categorised the different mental health disorders according to the current nomenclature in the DSM‐5 (<a href="./references#MR000050-bbs2-0152" title="American Psychiatric Association.Diagnostic and Statistical Manual of Mental Disorders. 5th edition. Washington (DC): American Psychiatric Association, 2013. [https://www.psychiatry.org/psychiatrists/practice/dsm]">APA 2013</a>). If all participants in a trial had a mental health disorder, but not the same one, we included the trial in all the analyses except those on specific mental health disorders (see <a href="#MR000050-sec-0021">Types of outcome measures</a>). We included participants with or without comorbid conditions. Eligible participants were included irrespective of location, setting, and other demographic variables (including age). </p> </section> <section id="MR000050-sec-0017"> <h4 class="title">Types of methods</h4> <section id="MR000050-sec-0018"> <h5 class="title">Experimental interventions</h5> <p>We defined wait‐list, usual care, and placebo interventions as any interventions that were clearly labelled or reflected the properties of wait‐list, usual care, or placebo interventions, according to the criteria below (and in <a href="#MR000050-tbl-0004">Table 1</a>). We anticipated that most of the included interventions would be control interventions in three‐group randomised trials. The properties of the interventions deemed experimental for this methodology review were defined as the following (based on the work by <a href="./references#MR000050-bbs2-0215" title="HróbjartssonA , GötzschePC .Placebo interventions for all clinical conditions. Cochrane Database of Systematic Reviews2010, Issue 1. Art. No: CD003974. [DOI: 10.1002/14651858.CD003974.pub3]">Hróbjartsson 2010</a> ; <a href="./references#MR000050-bbs2-0172" title="ComerJS , KendallPC .Methodology, design, and evaluation in psychotherapy research. In: LambertMJ , editors(s). Bergin and Garfields’s Handbook of Psychotherapy and Behavior Change. 6th edition. New York: Wiley, 2013:21-48.">Comer 2013</a>; and <a href="./references#MR000050-bbs2-0225" title="KazdinAE .Methodological Issues &amp; Strategies in Clinical Research. 4th edition. Washington DC: American Psychological Association, 2016.">Kazdin 2016</a>. </p> <p> <ol id="MR000050-list-0002"> <li> <p>Wait‐list: an intervention where participants are assessed on one or more occasions, and are promised the 'active' intervention after the trial has ended. </p> </li> <li> <p>Usual care: an intervention that reflects locally accepted treatment practices for a given mental health disorder. It is provided either by private or public practitioners and may involve pharmacological, psychological treatment or both. </p> </li> <li> <p>Psychological placebo: an intervention that targets the non‐specific or shared components of psychological treatments, such as treatment exposure and human interaction variables, attending sessions, and patient expectations. </p> </li> <li> <p>Pharmacological placebo: an intervention that includes an inert substance, typically in the form of a pill or liquid, which does not contain the active ingredients of a given medication. </p> </li> <li> <p>Physical placebo: an intervention that includes the inert components of a physical treatment (such as acupuncture, exercise regimens, surgery, or electromagnetic stimulation). </p> </li> </ol> </p> </section> <section id="MR000050-sec-0019"> <h5 class="title">Comparator interventions</h5> <p>We included two comparators: wait‐list and no‐treatment (see <a href="#MR000050-tbl-0004">Table 1</a>). When wait‐list was the experimental intervention, we only compared it with no‐treatment interventions. We defined these comparator interventions as any interventions that were clearly labelled as, or reflected the properties of wait‐list and no‐treatment interventions. The properties of no‐treatment interventions were defined as the following (based on the work by <a href="./references#MR000050-bbs2-0172" title="ComerJS , KendallPC .Methodology, design, and evaluation in psychotherapy research. In: LambertMJ , editors(s). Bergin and Garfields’s Handbook of Psychotherapy and Behavior Change. 6th edition. New York: Wiley, 2013:21-48.">Comer 2013</a>). </p> <p> <ol id="MR000050-list-0003"> <li> <p>No‐treatment: an intervention where participants are assessed on repeated occasions without receiving the experimental intervention. Unlike wait‐list interventions, no‐treatment participants are not promised the experimental treatment after trial completion. </p> </li> </ol> </p> </section> <section id="MR000050-sec-0020"> <h5 class="title">Description of main comparisons</h5> <p>We conducted the comparisons on placebo and usual care interventions in the following order. </p> <p> <ol id="MR000050-list-0004"> <li> <p>We first pooled wait‐list and no‐treatment interventions when compared with placebo and usual care interventions. </p> </li> <li> <p>We then conducted subgroup analyses (see Subgroup analysis and investigation of heterogeneity) between wait‐list and no‐treatment interventions for all these pooled comparisons. If there were significant differences or substantial heterogeneity between the wait‐list and no‐treatment interventions for a given comparison, we conducted separate main analyses for the two comparison interventions. We expressed low confidence in these analyses if they had insufficient statistical power. </p> </li> </ol> </p> </section> </section> <section id="MR000050-sec-0021"> <h4 class="title">Types of outcome measures</h4> <section id="MR000050-sec-0022"> <h5 class="title">Primary outcomes</h5> <p> <ol id="MR000050-list-0005"> <li> <p>Outcomes measuring the efficacy of wait‐list, usual care, and placebo interventions versus wait‐list or no‐treatment interventions for all mental health disorders combined. </p> </li> <li> <p>Serious adverse events in wait‐list, usual care, and placebo interventions versus wait‐list or no‐treatment interventions for all mental health disorders combined and for specific mental health disorders. </p> </li> </ol> </p> </section> <section id="MR000050-sec-0023"> <h5 class="title">Secondary outcomes</h5> <p> <ol id="MR000050-list-0006"> <li> <p>Outcomes measuring the efficacy of wait‐list, usual care, and placebo interventions versus wait‐list or no‐treatment interventions for specific mental health disorders. </p> </li> <li> <p>Non‐serious adverse events in wait‐list, usual care, and placebo interventions versus wait‐list or no‐treatment interventions for all mental health disorders and for specific mental health disorders. </p> </li> </ol> </p> </section> <section id="MR000050-sec-0024"> <h5 class="title">Description of outcomes</h5> <p>We conducted analyses across all included mental health disorders and within specific disorders. We grouped the specific disorders according to the classification in the DSM‐5 (<a href="./references#MR000050-bbs2-0152" title="American Psychiatric Association.Diagnostic and Statistical Manual of Mental Disorders. 5th edition. Washington (DC): American Psychiatric Association, 2013. [https://www.psychiatry.org/psychiatrists/practice/dsm]">APA 2013</a>). We only calculated the efficacy for specific mental health disorders that had been included in at least three included trials. This was a pragmatic threshold inspired by Hróbjartsson and Gøtzsche ( <a href="./references#MR000050-bbs2-0215" title="HróbjartssonA , GötzschePC .Placebo interventions for all clinical conditions. Cochrane Database of Systematic Reviews2010, Issue 1. Art. No: CD003974. [DOI: 10.1002/14651858.CD003974.pub3]">Hróbjartsson 2010</a> ) to reduce spurious positive and negative findings in single trials. </p> <p>For the outcomes measuring efficacy, we selected one outcome from each trial report. We conducted separate analyses on dichotomous and continuous outcomes (see Measures of the effect of the methods ). We used the following decision hierarchy to select the outcomes measuring effect. </p> <p> <ol id="MR000050-list-0007"> <li> <p>We first included the outcome indicated as the primary outcome in the trial report (e.g. the one used for the sample size calculation). We preferred data from end of treatment over follow‐up data. This choice was inspired by <a href="./references#MR000050-bbs2-0215" title="HróbjartssonA , GötzschePC .Placebo interventions for all clinical conditions. Cochrane Database of Systematic Reviews2010, Issue 1. Art. No: CD003974. [DOI: 10.1002/14651858.CD003974.pub3]">Hróbjartsson 2010</a>. </p> </li> <li> <p>If the trial did not differentiate between primary and secondary outcomes or if more than one primary outcome was stated, we preferred continuous over dichotomous outcomes. </p> </li> <li> <p>If there were multiple continuous outcomes, we preferred observer‐reported over patient‐reported outcomes, and blinded over non‐blinded outcomes. </p> </li> <li> <p>If trials reported several observer‐reported outcomes, we included the outcomes that best captured the core symptoms of the mental health population being treated. Here, we preferred global scores over sub‐scores. </p> </li> <li> <p>We then identified the outcome measure with the best psychometric properties (e.g. validity and reliability). </p> </li> <li> <p>If still undecided, we randomly selected the outcome measure to use.</p> </li> </ol> </p> <p>Serious adverse events were defined as any event that lead to death (e.g. suicide), is life‐threatening (e.g. suicidality), required in‐patient hospitalisation (e.g. self‐harm), prolonged hospitalisation, resulted in persistent or significant disability, or was any other important event that jeopardised the patient’s life or required intervention for prevention (<a href="./references#MR000050-bbs2-0217" title="ICH Expert Working Group.International conference on harmonisation of technical requirements for registration of pharmaceuticals for human use. ICH harmonised tripartite guideline. Guideline for good clinical practice E6(R1). www.ich.org/fileadmin/Public_Web_Site/ICH_Products/Guidelines/Efficacy/E6/E6_R1_Guideline.pdf (accessed 24 April 2018).">ICH 2005</a> ). All other adverse events were considered non‐serious adverse events (<a href="./references#MR000050-bbs2-0217" title="ICH Expert Working Group.International conference on harmonisation of technical requirements for registration of pharmaceuticals for human use. ICH harmonised tripartite guideline. Guideline for good clinical practice E6(R1). www.ich.org/fileadmin/Public_Web_Site/ICH_Products/Guidelines/Efficacy/E6/E6_R1_Guideline.pdf (accessed 24 April 2018).">ICH 2005</a>). We conducted separate analyses for specific serious adverse events (e.g. suicide and self‐harm). We combined all non‐serious adverse events into a single estimate. </p> <p>We extracted adverse events from studies as measured by standardised psychometric rating scales, such as laboratory values, or spontaneous reporting. We also located adverse events as described in the International Conference on Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human Use (ICH) (<a href="./references#MR000050-bbs2-0217" title="ICH Expert Working Group.International conference on harmonisation of technical requirements for registration of pharmaceuticals for human use. ICH harmonised tripartite guideline. Guideline for good clinical practice E6(R1). www.ich.org/fileadmin/Public_Web_Site/ICH_Products/Guidelines/Efficacy/E6/E6_R1_Guideline.pdf (accessed 24 April 2018).">ICH 2005</a> ). Most of the adverse events data from the reports were spontaneously reported. Adverse events in randomised trials generally (<a href="./references#MR000050-bbs2-0143" title="AllenEN , ChandlerCI , MandimikaN , LeisegangC , BarnesK .Eliciting adverse effects data from participants in clinical trials. Cochrane Database of Systematic Reviews2018, Issue 1. Art. No: MR000039. [DOI: 10.1002/14651858.MR000039.pub2]">Allen 2018</a>) and for psychiatric treatments in particular, can be difficult to detect, and valid instruments to detect them are lacking (<a href="./references#MR000050-bbs2-0238" title="LilienfeldSO .Psychological treatments that cause harm. Perspectives on Psychological Science2007;2(1):53-70.">Lilienfeld 2007</a>; <a href="./references#MR000050-bbs2-0239" title="LindenM , Schermuly-HauptM .Definition, assessment and rate of psychotherapy side effects. World Psychiatry2014;13(3):306-9.">Linden 2014</a>; <a href="./references#MR000050-bbs2-0258" title="PagsbergAK , JeppesenP , KlauberDG , JensenKG , RudåD , Stentebjerg-OlesonM , et al.Quetiapine extended release versus aripiprazole in children and adolescents with first-episode psychosis: the multicentre, double-blind, randomised tolerability and efficacy of antipsychotics (TEA) trial. Lancet Psychiatry2017;4(8):605-18.">Pagsberg 2017</a>; <a href="./references#MR000050-bbs2-0274" title="StorebøOJ , PedersenN , RamstadE , KielsholmML , NielsenSS , KroghHB , et al.Methylphenidate for attention deficit hyperactivity disorder (ADHD) in children and adolescents – assessment of adverse events in non-randomised studies. Cochrane Database of Systematic Reviews2018, Issue 5. Art. No: CD012069. [DOI: 10.1002/14651858.CD012069.pub2]">Storebø 2018</a>). However, strategic searches for adverse events using standardised questionnaires are becoming more common (<a href="./references#MR000050-bbs2-0258" title="PagsbergAK , JeppesenP , KlauberDG , JensenKG , RudåD , Stentebjerg-OlesonM , et al.Quetiapine extended release versus aripiprazole in children and adolescents with first-episode psychosis: the multicentre, double-blind, randomised tolerability and efficacy of antipsychotics (TEA) trial. Lancet Psychiatry2017;4(8):605-18.">Pagsberg 2017</a>; <a href="./references#MR000050-bbs2-0274" title="StorebøOJ , PedersenN , RamstadE , KielsholmML , NielsenSS , KroghHB , et al.Methylphenidate for attention deficit hyperactivity disorder (ADHD) in children and adolescents – assessment of adverse events in non-randomised studies. Cochrane Database of Systematic Reviews2018, Issue 5. Art. No: CD012069. [DOI: 10.1002/14651858.CD012069.pub2]">Storebø 2018</a>). We corresponded with trial authors if they did not report data on adverse events. </p> </section> </section> </section> <section id="MR000050-sec-0025"> <h3 class="title">Search methods for identification of studies</h3> <section id="MR000050-sec-0026"> <h4 class="title">Electronic searches</h4> <p>We searched the electronic databases and trial registries listed below (guided by <a href="./references#MR000050-bbs2-0162" title="BramerWM , RethlefsenML , KleijnenJ , FrancoOH .Optimal database combinations for literature searches in systematic reviews: a prospective exploratory study. Systematic Reviews2017;6:245.">Bramer 2017</a>) using the search strategies shown in <a href="./appendices#MR000050-sec-0106">Appendix 1</a> . The strategy for MEDLINE was used as a template for the other databases and trial registries, with modified syntax and controlled terms as necessary. </p> </section> <section id="MR000050-sec-0027"> <h4 class="title">Bibliographic databases (April 2018)</h4> <p> <ol id="MR000050-list-0008"> <li> <p>MEDLINE Ovid (1946 to current) (see <a href="./appendices#MR000050-sec-0106">Appendix 1</a> for search strategy) </p> </li> <li> <p>PsycINFO Ovid (1806 to current)</p> </li> <li> <p>Embase Ovid (1974 to current)</p> </li> <li> <p>Cochrane Central Register of Controlled Trials (CENTRAL; current issue), in The Cochrane Library. </p> </li> <li> <p>Allied and Complementary Medicine Database (AMED; 1900 to current)</p> </li> <li> <p>Web of Science Core Collection (1900 to current)</p> </li> <li> <p>ProQuest Dissertations and Theses A&amp;I (1743 to current)</p> </li> <li> <p>Sociological Abstracts ProQuest (1952 to current)</p> </li> <li> <p>Google Scholar ( <a href="https://scholar.google.no/" target="_blank">https://scholar.google.no/</a>) </p> </li> <li> <p>BIOSIS Previews/Thomson Reuters (969 to current)</p> </li> <li> <p>Open Grey (1997 to current)</p> </li> </ol> </p> </section> <section id="MR000050-sec-0028"> <h4 class="title">Clinical trial registries (March 2019)</h4> <p> <ol id="MR000050-list-0009"> <li> <p>Australian New Zealand Clinical Trials Registry (ANZCTR; <a href="http://www.anzctr.org.au/BasicSearch.aspx" target="_blank">www.anzctr.org.au/BasicSearch.aspx</a> ). </p> </li> <li> <p>Clinical Trials ( <a href="https://clinicaltrials.gov/" target="_blank">clinicaltrials.gov</a> ). </p> </li> <li> <p>EU Clinical Trials Register ( <a href="https://www.clinicaltrialsregister.eu/ctr-search/search" target="_blank">www.clinicaltrialsregister.eu/ctr-search/search</a> ). </p> </li> <li> <p>ISRCTN Registry ( <a href="https://www.isrctn.com/" target="_blank">www.isrctn.com</a> ). </p> </li> <li> <p>UK Clinical Trials Gateway ( <a href="https://www.ukctg.nihr.ac.uk/#popoverSearchDivId" target="_blank">www.ukctg.nihr.ac.uk/#popoverSearchDivId</a> ). </p> </li> <li> <p>World Health Organization International Clinical Trials Registry Platform (WHO ICTRP; <a href="http://apps.who.int/trialsearch/" target="_blank">http://apps.who.int/trialsearch/</a> ) </p> </li> </ol> </p> </section> <section id="MR000050-sec-0029"> <h4 class="title">Searching other resources</h4> <p>We searched other resources at the end of the screening process. We surveyed relevant journals such as ACTA Psychiatrica Scandinavica, the American Journal of Psychiatry, Biological Psychiatry, the British Journal of Psychiatry, the BMJ, the International Journal of Clinical Psychopharmacology, JAMA Psychiatry, Journal of the American Academy of Child and Adolescent Psychiatry, Journal of Clinical Psychiatry, Journal of Clinical Psychopharmacology, Journal of Psychopharmacology, Lancet Psychiatry, Psychopharmacology, Psychotherapy Research and the Scandinavian Journal of Child and Adolescent Psychiatry and Psychology. We also reviewed abstracts of key psychiatric conferences, given the large proportion of conference abstracts that do not go on to full publication (<a href="./references#MR000050-bbs2-0269" title="SchererRW , MeerpohlJJ , PfeiferN , SchmuckerC , SchwarzerG , vonElmE .Full publication of results initially presented in abstracts. Cochrane Database of Systematic Reviews2018, Issue 11. Art. No: MR000005. [DOI: 10.1002/14651858.MR000005.pub4]">Scherer 2018</a>) and asked for relevant unpublished studies from experts in the field. We also checked the references in relevant literature. </p> </section> </section> <section id="MR000050-sec-0030"> <h3 class="title" id="MR000050-sec-0030">Data collection and analysis</h3> <p>We conducted this review according to the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#MR000050-bbs2-0207" title="HigginJP , ThomasJ , ChandlerJ , CumpstonM , LiT , PageMJ , et al (editors).Cochrane Handbook for Systematic Reviews of Interventions Version 6.0 (updated July 2019). Cochrane, 2019.. Available from www.training.cochrane.org/handbook.">Higgins 2019</a>), and performed analyses using the latest version of RevMan (<a href="./references#MR000050-bbs2-0263" title="Review Manager (RevMan 5).Version 5.3. Nordic Cochrane Centre, The Cochrane Collaboration, 2014.">Review Manager 5</a>) . </p> <section id="MR000050-sec-0031"> <h4 class="title">Selection of studies</h4> <p>Because we expected to retrieve large numbers of records from the electronic literature search, titles and abstracts were screened only once (divided equally between review authors EF and AT). For quality assurance, an additional review author (OJS) screened a random sample of the retrieved records to check whether there were differences in the included and excluded records between screeners. Three review authors (EF, AT and LB) independently screened the full‐text reports for studies judged to be potentially eligible. They discussed any disagreements, and an arbiter (OJS) made the final decision if agreement was not reached. Full‐text reports were obtained and assessed for inclusion based on the eligibility criteria (see <a href="#MR000050-sec-0014">Criteria for considering studies for this review</a>). Randomised trials in this general topic area that do not fulfil the inclusion criteria are listed as excluded studies. We used EPPI Reviewer 4, an online software application for systematic review development, for screening of abstracts and full‐text reports (<a href="./references#MR000050-bbs2-0279" title="EPPI-Reviewer 4: software for research synthesis..ThomasJ , BruntonJ , GraziosiS , Version 4.7.1.0. London, UK: EPPI-Centre Software. Social Science Research Unit, UCL Institute of Education, 2010. Available at www.eppi.ioe.ac.uk.">Thomas 2010</a>). We included a PRISMA flow diagram to show the flow of included and excludes studies in the full review (<a href="./references#MR000050-bbs2-0250" title="MoherD , LiberatiA , TetzlaffJ , AltmanDG , PRISMA Group.Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ (Clinical Research Ed.)2009;339:b2535. [DOI: 10.1136/bmj.b2535]">Moher 2009</a>). </p> </section> <section id="MR000050-sec-0032"> <h4 class="title">Data extraction and management</h4> <p>Three review authors (EF, AT and LB) independently extracted data from the included studies. We resolved disagreements by discussion or using an arbiter (OJS), if necessary. Two review authors (EF and AT) entered data into <a href="./references#MR000050-bbs2-0263" title="Review Manager (RevMan 5).Version 5.3. Nordic Cochrane Centre, The Cochrane Collaboration, 2014.">Review Manager 5</a>. We requested missing information by contacting relevant authors (<a href="./references#MR000050-bbs2-0305" title="YoungT , HopewellS .Methods for obtaining unpublished data. Cochrane Database of Systematic Reviews2011, Issue 1110.1002/14651858.MR000027.pub2. Art. No: MR000027. [DOI: 10.1002/14651858.MR000027.pub2]">Young 2011</a>). We developed a data extraction form to facilitate standardisation of the data extraction process. The form included the following items: methods (e.g. trial design, setting, and country), types of participants (e.g. baseline demographics, inclusion and exclusion criteria), description of experimental and comparator interventions and their components (e.g. duration and intensity), outcome measures, and risk of bias assessment (see <a href="./appendices#MR000050-sec-0107">Appendix 2</a>). </p> </section> <section id="MR000050-sec-0033"> <h4 class="title">Assessment of risk of bias in included studies</h4> <p>Three review authors (EF, AT and LB) assessed the risk of bias using Cochrane’s risk of bias tool (RoB) 1.0 (<a href="./references#MR000050-bbs2-0205" title="HigginJP , GreenS , editors.Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0. The Cochrane Collaboration, 2011. [Available from handbook.cochrane.org.]">Higgins 2011</a>). There is an updated version of this tool (<a href="./references#MR000050-bbs2-0181" title="EldrigeS , CampbellM , CampbellM , DahotaA , GiraudeauB , HigginsJ , et al.Revised Cochrane risk of bias tool for randomized trials (RoB 2.0) Additional considerations for cluster-randomized trials. University of Bristol2016.">Eldridge 2016</a> ; <a href="./references#MR000050-bbs2-0206" title="HigginsJP , AltmanDG , SterneJA .Chapter 8: Assessing risk of bias in included studies. In: Higgins JP, Green S, Editors. Cochrane Handbook for Systematic Reviews of Interventions version 5.1.0 (updated June 2017). The Cochrane Collaboration, 2017. Available from www.training.cochrane.org/handbook.">Higgins 2017</a>), but because it was still at the pilot stage when we rated risk of bias, we used the original version. For each included study, the data extractors independently categorised the risk of bias domains listed in <a href="./appendices#MR000050-sec-0108">Appendix 3</a> as being low, unclear (uncertain), or high risk of bias, according to the guidelines in the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#MR000050-bbs2-0205" title="HigginJP , GreenS , editors.Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0. The Cochrane Collaboration, 2011. [Available from handbook.cochrane.org.]">Higgins 2011</a>). Potential disagreements were resolved by discussion or using an arbiter (OJS), if necessary. </p> <p>We defined trials at 'low risk of bias' as having low risk of bias on all domains. We defined trials with one or more unclear risk of bias domain as trials at ‘high risk of bias’. We evaluated the influence of risk of bias on our results (see <a href="#MR000050-sec-0045">Sensitivity analysis</a>) due to the risk of overestimating beneficial intervention effects and underestimating adverse events in randomised trials with unclear or inadequate methodological quality (<a href="./references#MR000050-bbs2-0230" title="KjaergardLL , VillumsenJ , GluudC .Reported methodologic quality and discrepancies between large and small randomized trials in meta-analyses. Annals of Internal Medicine2001;135(11):982.">Kjaergard 2001</a>; <a href="./references#MR000050-bbs2-0243" title="LundhA , LexchinJ , MintzesB , SchrollJB , BeroL .Industry sponsorship and research outcome. Cochrane Database of Systematic Reviews2017, Issue 2. Art. No: MR000033. [DOI: 10.1002/14651858.MR000033.pub3]">Lundh 2017</a>; <a href="./references#MR000050-bbs2-0249" title="MoherM , MoherD , PhamB , Jones Al, CookDJ , JadadAR , et al.Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses?Lancet1998;352(9128):609-13.">Moher 1998</a>; <a href="./references#MR000050-bbs2-0267" title="SavovićJ , JonesH , AltmanD , HarrisR , JüniP , PildalJ , et al.Influence of reported study design characteristics on intervention effect estimates from randomised controlled trials: combined analysis of meta-epidemiological studies. Health Technology Assessment2012;16(35):1-82.">Savović 2012</a>; <a href="./references#MR000050-bbs2-0268" title="SavovicJ , TurnerRM , MawdsleyD , JonesHE , BeynonR , HigginsJP , et al.Association between Risk-of-Bias assessments and results of randomized trials in Cochrane reviews: the ROBES meta-epidemiologic study. American Journal of Epidemiology2018;187(5):1113-22.">Savovic 2018</a>; <a href="./references#MR000050-bbs2-0270" title="SchulzKF , ChalmersI , HayesRJ , AltmanDG .Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials. JAMA1995;273:408-12.">Schulz 1995</a>; <a href="./references#MR000050-bbs2-0303" title="WoodL , EggerM , GluudLL , SchulzKF , JüniP , AltmanDG , et al.Empirical evidence of bias in treatment effect estimates in controlled trials with different interventions and outcomes: meta-epidemiological study. BMJ2008;336(7644):601. [DOI: 10.1136/bmj.39465.451748.AD]">Wood 2008</a>; <a href="./references#MR000050-bbs2-0268" title="SavovicJ , TurnerRM , MawdsleyD , JonesHE , BeynonR , HigginsJP , et al.Association between Risk-of-Bias assessments and results of randomized trials in Cochrane reviews: the ROBES meta-epidemiologic study. American Journal of Epidemiology2018;187(5):1113-22.">Savovic 2018</a>). </p> <p>At the protocol stage ( <a href="./references#MR000050-bbs2-0306" title="FaltinsenE , TodorovacA , HróbjartssonA , GluudC , KongerslevMT , SimonsenE , StorebøOJ .Placebo, usual care and wait‐list interventions for all mental health disorders.. Cochrane Database of Systematic Reviews2019, Issue 1. Art. No: MR000050. [DOI: 10.1002/14651858.MR000050]">Faltinsen 2019</a> ), we decided to include all the domains in RoB 1.0 including the blinding domains when assessing risk of bias in the included studies. However, we recognise that the blinding domains are the subject of the investigation in this review in the placebo comparisons, (i.e. one goal of our review is to assess differences in blinding between placebos and no‐treatment or wait‐list seeing) and we therefore decided to report two solutions to the bias assessment post hoc for placebo interventions: one bias assessment including the blinding domains and one without. </p> <p>We assessed conflicts of interest in the included studies as a separate bias category outside of Cochrane's risk of bias tool. We assessed both financial and non‐financial conflicts of interest. Conflicts of interest were defined as situations in which professional judgments or actions regarding a primary interest are unduly influenced by a secondary interest (<a href="./references#MR000050-bbs2-0218" title="LoB , FieldMJ .Institute of Medicine (US) Committee on Conflict of Interest in Medical Research, Education, and Practice. Conflict of Interest in Medical Research, Education, and Practice. Washington DC: National Academies Press (US), 2009.">Institute of Medicine 2009</a>). Examples of financial conflicts could be when a study's authors had received payment from a company manufacturing one of the study interventions. A non‐financial conflict of interest (often termed affiliation bias in psychotherapy research) could be if a study's authors had developed the treatment manual for the intervention being evaluated (<a href="./references#MR000050-bbs2-0253" title="MunderT , BrütschO , LeonhartR , GergerH , BarthJ .Researcher allegiance in psychotherapy outcome research: an overview of reviews. Clinical Psychology Review2013;33(4):501-11.">Munder 2013</a>). </p> </section> <section id="MR000050-sec-0034"> <h4 class="title">Dichotomous data</h4> <p>We summarised dichotomous data as risk ratios (RR) for outcomes for efficacy and risk differences (RD) for adverse events. We used 95% confidence intervals (CIs) for both, and Trial Sequential Analysis (TSA)‐adjusted CIs if possible (see Subgroup analysis and investigation of heterogeneity). </p> </section> <section id="MR000050-sec-0035"> <h4 class="title">Continuous data</h4> <p>For continuous data, we estimated standardised mean differences (SMD). We used SMD because we anticipated variation in the types of outcome measures. We calculated SMDs using scores from the end of intervention. We considered a statistical significant SMD effect size of: 0.15 or less to have no clinically meaningful effect; 0.15 to 0.40 to have a clinical meaningful but small effect; 0.40 to 0.75 to have a moderate effect; and greater than 0.75 to have a large treatment effect (<a href="./references#MR000050-bbs2-0170" title="CohenJ .Statistical Power Analysis for the Behavioral Sciences. 2nd edition.. Hillsdale (NJ): Lawrence Erlbaum Associates, Publishers, 1988.">Cohen1988</a> ). When the trials only reported change data, we pooled these with scores from the end of intervention (<a href="./references#MR000050-bbs2-0178" title="da CostaBR , NüeschE , RutjesAW , JohnstonBC , ReichenbachS , TrelleS , et al.Combining follow-up and change data is valid in meta-analyses of continuous outcomes: a meta-epidemiological study. Journal of Clinical Epidemiology2013;66(8):847-55.">da Costa 2013</a>). We explored whether inclusion of change data affected the outcomes by performing a sensitivity analysis (see <a href="#MR000050-sec-0045">Sensitivity analysis</a>). If the direction of a given scale was opposite to that of most other scales, we multiplied the corresponding mean values by ‐1.00 to ensure adjusted values. If the trials did not report means and standard deviations (SDs), but reported other values such as t‐tests and P values, we attempted to transform these into means and SDs. </p> <p>We used data from means and SDs in intention‐to‐treat (ITT) analyses as well as replacing missing values when available. We otherwise conducted the analyses based on the available data. We performed all calculations using RevMan software (<a href="./references#MR000050-bbs2-0263" title="Review Manager (RevMan 5).Version 5.3. Nordic Cochrane Centre, The Cochrane Collaboration, 2014.">Review Manager 5</a>). </p> <p>We summarised the outcomes measuring adverse events from count data (e.g. spontaneous reporting) as RD (see Subgroup analysis and investigation of heterogeneity). </p> </section> <section id="MR000050-sec-0036"> <h4 class="title">Unit of analysis issues</h4> <p>We only included the first phase of cross‐over trials. We calculated study estimates on the basis of post‐treatment group results. If trials were cluster‐randomised we planned to appropriately control for cluster effects (robust standard errors or hierarchical linear models). If the necessary information was unclear or not available in the trial reports, we attempted to contact the original authors for further information. We used sensitivity analyses to assess the potential biases of inadequately controlled cluster‐randomised trials (<a href="./references#MR000050-bbs2-0179" title="DonnerA , KlarN .Issues in the meta-analysis of cluster randomized trials. Statistics in Medicine2002;21(19):2971-80.">Donner 2002</a>) (see <a href="#MR000050-sec-0045">Sensitivity analysis</a>). </p> </section> <section id="MR000050-sec-0037"> <h4 class="title">Dealing with missing data</h4> <p>We contacted trial authors for relevant missing data on our primary and secondary outcomes (<a href="./references#MR000050-bbs2-0305" title="YoungT , HopewellS .Methods for obtaining unpublished data. Cochrane Database of Systematic Reviews2011, Issue 1110.1002/14651858.MR000027.pub2. Art. No: MR000027. [DOI: 10.1002/14651858.MR000027.pub2]">Young 2011</a>). However, we did not contact authors of trials published before 1990 because of a lack of reliable contact information and the probability that these data would not have been preserved. If authors did not respond after two attempts to contact them, we stopped communications. If we were not able to obtain missing data, we used the available data (incomplete data) in our analyses. If data were not reported in a usable way, we consulted a statistician to explore its transformation. For a description of each trial with missing data see <a href="#MR000050-tbl-0005">Table 2</a> . </p> <div class="table" id="MR000050-tbl-0005"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 2.</span> <span class="table-title">Description of trials with missing data</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Trial ID</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Missing data</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Methods of data generation</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#MR000050-bbs2-0008" title="Borden, KA.Attributional Outcomes: the Subtle Messages of Treatments for Attention Deficit Disorder. Dissertation, University of Illinois at Urbana-Champaign1986. BordenKA , BrownRT .Attributional outcomes: The subtle messages of treatments for attention deficit disorder. Cognitive Therapy and Research1989;13(2):147-60. ">Borden 1986</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Missing information regarding how many participants randomised to each group</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Since 30 patients was included in total, we assumed due to randomisation that there was an equal distribution of patients in each group. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#MR000050-bbs2-0009" title="BorkovecTD , KaloupekDG , SlamaKM .The facilitative effect of muscle tension-release in the relaxation treatment of sleep disturbance. Behavior Therapy1975;6(3):301-9. ">Borkovec 1975</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>The standard deviation (SD) was not reported on the Daily Sleep Questionnaire (DSQ) – Subscale difficulty experienced in falling asleep </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>An artificial SD was imported from <a href="./references#MR000050-bbs2-0083" title="SteinmarkSW , BorkovecTD .Active and placebo treatment effects on moderate insomnia under counterdemand and positive demand instructions. Journal of Abnormal Psychology1974;83(2):157-63. ">Steinmark 1974</a> due to similar outcome, population, and control interventions </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#MR000050-bbs2-0013" title="BrillNQ , KoeglerRR , EpsteinLJ , ForgyEW .Controlled study of psychiatric outpatient treatment. Archives of General Psychiatry1964;10:581-95. BrillNQ .Results of psychotherapy. California Medicine1966;104(4):249-53. ">Brill 1964a</a> ; <a href="./references#MR000050-bbs2-0014" title="BrillNQ , KoeglerRR , EpsteinLJ , ForgyEW .Controlled study of psychiatric outpatient treatment. Archives of General Psychiatry1964;10:581-95. ">Brill 1964b</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No usable data reported</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not possible to generate data</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#MR000050-bbs2-0015" title="CarlsonCL , PelhamWE , MilichR , HozaB .ADHD boys’ performance and attributions following success and failure: drug effects and individual differences. Cognitive Therapy and Research1993;17:269-87. ">Carlson 1993</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Missing information regarding how many participants randomised to each group</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Since 28 patients was included in total, we assumed due to randomisation and ethical principles that the active arm (in this case methylphenidate) included an additional patient compared with the placebo and no‐treatment group </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#MR000050-bbs2-0018" title="CrouchG , RobsonM , HallstromC .Benzodiazepine dependent patients and their psychological treatment. Progress in Neuro-psychopharmacology &amp; Biological Psychiatry1988;12(4):503-10. HallströmC , CrouchG , RobsenM , ShineP .The treatment of tranquillizer dependence by propranolol. Postgraduate Medical Journal1988;64(Suppl 2):40-4. ">Crouch 1988</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No usable data reported</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not possible to generate data, and could not get in contact with authors</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#MR000050-bbs2-0019" title="Doty, DW.Role playing and incentives in the modification of the social interaction of chronic psychiatric patients. Journal of Consulting and Clinical Psychology1975;43(5):676-82. ">Doty 1975</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No usable data reported</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not possible to generate data</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#MR000050-bbs2-0027" title="FuchsCZ , RehnLP .A self-control behavior therapy program for depression. Journal of Consulting and Clinical Psychology1977;45(2):206-15. ">Fuchs 1977</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>The standard deviation (SD) on the improvement of the mean on Beck Depression Inventory was not reported. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>The SD was calculated from a F‐test statistic</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#MR000050-bbs2-0030" title="GoldwasserAN , AuerbachSM , HarkinsSW .Cognitive, affective, and behavioural effects of reminiscence group therapy on demented elderly. Aging and Human Development1987;25(3):209-22. ">Goldwasser 1987</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>The SD was not reported on the Mini‐Mental State (MMS)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not possible to generate data</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#MR000050-bbs2-0031" title="HekmatH , LubitzR , DealR .Semantic desensitization: a paradigmatic intervention approach to anxiety disorders. Journal of Clinical Psychology1984;40(2):463-6. ">Hekmat 1984</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>The SD was not reported on the Timed Behavior Checklist (BCL)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not possible to generate data</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#MR000050-bbs2-0033" title="HowlinP , GordonKR , PascoG , WadeA , CharmanT .The effectiveness of picture exchange communication system (PECS) training for teachers of children with autism: a pragmatic,group randomised controlled trial. Journal of Child Psychology and Psychiatry2007;48(5):473-81. ">Howlin 2007</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No usable data reported</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not possible to generate data, and could not get in contact with authors</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#MR000050-bbs2-0042" title="KrapflJE , NawasMM .Differential ordering of stimulus presentation in systematic desensitization. Journal of Abnormal Psychology1970;75(3):333-7. ">Krapfl 1970</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Mean was only reported in a figure, and the SD on the Behavioral Avoidance Test (BAT) was not reported </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Mean value was generated from figure 1, and the SD was generated from <a href="./references#MR000050-bbs2-0023" title="EtringerBD , CashTF , RimmDC .Behavioral, affective, and cognitive effects of participant modeling and an equally credible placebo. Behavior Therapy1982;13(4):476-85. ">Etringer 1982</a> ; <a href="./references#MR000050-bbs2-0076" title="RosenGM , GlasgowRE , BarreraM .A controlled study to assess the clinical efficacy of totally self-administrated systematic desensitization. Journal of Consulting and Clinical Psychology1976;44(2):208-17. ">Rosen 1976</a> , due to that both trials included similar outcome, population, and control interventions </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#MR000050-bbs2-0046" title="LangOJ , LazovikAD .Experimental desensitization of a phobia. Journal of Abnormal and Social Psychology1963;66:519-25. LangPJ , LazovikAD , ReynoldsDJ .Desensitization, suggestibility, and pseudotherapy. Journal of Abnormal Psychology1965;70(6):395-402. ">Lang 1965</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No usable data reported</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not possible to generate data</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#MR000050-bbs2-0061" title="MilichR , CarlsonCL , Pelham WE Jr, LichtBG .Effects of methylphenidate on the persistence of ADHD boys following failure experiences. Journal of Abnormal Child Psychology1991;19(5):519-36. PelhamWE , MurphyDA , VannattaK , MilichR , LichtBG , GnagyEM , et al.Methylphenidate and attributions in boys with attention-deficit hyperactivity disorder. Journal of Consulting and Clinical Psychology1992;60(2):282-92. ">Pelham 1992</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Missing information regarding how many participants randomised to each group</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Since 38 patients was included in total, we assumed due to randomisation and ethical principles that the active arm (methylphenidate) and placebo included an additional patient each </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#MR000050-bbs2-0062" title="PedletonMG , HigginsRL .A comparison of negative practice and systematic desensitization in the treatment of acrophobia. Journal of Behavior Therapy and Experimental Psychiatry1983;14(4):317-23. ">Pendleton 1983</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Missing information regarding how many participants randomised to each group</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Since 62 patients was included in total, we assumed due to randomisation and ethical principles that the two active arms (Negative practice and Desensitization) included an additional patient each </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#MR000050-bbs2-0077" title="LorrM , McNairDM , WeinsteinGJ .Early effects of chlordiazepoxide (Librium) used with psychotherapy. Journal of Psychiatric Research1963;1:257-70. RothI , RhudickPJ , ShaskanDA , SlobinMS , WilkinsonAE , YoungHH .Long-term effects on psychotherapy of initial treatment conditions. Journal of Psychiatric Research1964;2:283-97. ">Roth 1964</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>The standard deviation (SD) was not reported on either Global estimate of the severity of the patient’s illness and a global measure of over‐all improvement </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not possible to generate data</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#MR000050-bbs2-0078" title="RupertPA , HolmesDS .Effects of multiple sessions of true and placebo heart rate biofeedback training on the heart rates and anxiety levels of anxious patients during and following treatment. Psychophysiology1978;15(6):582-90. ">Rupert 1978</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No usable data reported</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not possible to generate data</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#MR000050-bbs2-0080" title="ShealyRC .The effectiveness of various treatment techniques on different degrees and durations of sleep-onset insomnia. Behaviour Research and Therapy1979;17(6):541-6. ">Shealy 1979</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Separate means missing mild to moderate group.</p> <p>The standard deviation (SD) was not reported on the Daily Sleep and Relaxation Practice Questionnaire (DSRQ) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>We pooled the means from mild and moderate due to no information of patients in each group. A mean score was generated from the two groups. SDs was generated from <a href="./references#MR000050-bbs2-0005" title="AscherLM , TurnerR .Paradoxical intention and insomnia: an experimental investigation. Behaviour Research and Therapy1979;17(4):408-11. ">Ascher 1979</a> ; <a href="./references#MR000050-bbs2-0083" title="SteinmarkSW , BorkovecTD .Active and placebo treatment effects on moderate insomnia under counterdemand and positive demand instructions. Journal of Abnormal Psychology1974;83(2):157-63. ">Steinmark 1974</a> due to that these trials hade the same outcomes and population </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#MR000050-bbs2-0081" title="SibilioJP , AndrewG , DartD , MooreKB , StehmanA .Treatment of chronic schizophrenia with promazine hydrochloride. AMA Archives of Neurology and Psychiatry1957;78(4):419-24. ">Sibilio 1957</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No usable data reported</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not possible to generate data</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#MR000050-bbs2-0082" title="SommernessMD , LuceroRJ , HamlonJS , EricksonJL , MatthewsR .A controlled study of reserpine on chronically disturbed patients. JAMA Archives of Neurology and Psychiatry1955;74(3):316-9. ">Sommerness 1955</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No usable data reported</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not possible to generate data</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#MR000050-bbs2-0085" title="TanSY , BruniJ .Cognitive-behavior therapy with adult patients with epilepsy: a controlled outcome study. Epilepsia1986;27(3):225-33. ">Tan 1986</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>The standard deviation (SD) on the improvement of the mean on Beck Depression Inventory was not reported </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>The SD was imported from <a href="./references#MR000050-bbs2-0027" title="FuchsCZ , RehnLP .A self-control behavior therapy program for depression. Journal of Consulting and Clinical Psychology1977;45(2):206-15. ">Fuchs 1977</a> due to similar outcome and population </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#MR000050-bbs2-0088" title="Trexler, L.Rational-emotive therapy, placebo, and no-treatment effects on public-speaking anxiety. Doctoral dissertation, Temple University AnnArbor, Mich.: University Microfilms1971;71-31(063). TrexlerLD , KarstTO .Rational-emotive therapy, placebo, and no-treatment effects on public-speaking anxiety. Journal of Abnormal Psyhology1972;79(1):60-7. ">Trexler 1972</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>The standard deviation (SD) was not reported on the Behavioral Checklist</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not possible to generate data</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#MR000050-bbs2-0051" title="MatsonJL , MarchettiA , AdkinsJA .Comparison of operant- and independence-training procedures for mentally retarded adults. American Journal of Mental Deficiency1980;84(5):487-94. ">Matson 1980</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No usable data reported</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not possible to generate data, and could not get in contact with authors</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#MR000050-bbs2-0059" title="PearlD , Vander KampH , OlsenAL , GreenbergPD , ArmitageSG .The effects of reserpine on schizophrenic patients. American Journal of Psychiatry1956;112:198-204. ">Pearl 1956</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No usable data reported</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not possible to generate data, and could not get in contact with authors</p> </td> </tr> </tbody> </table> </div> </section> <section id="MR000050-sec-0038"> <h4 class="title">Assessment of heterogeneity</h4> <p>We expected to find evidence of substantial heterogeneity. We created subgroups based on study characteristics such as different control intervention, study duration, participants etc. (see Subgroup analysis and investigation of heterogeneity). We evaluated methodological heterogeneity by comparing trial designs. Assessment of statistical heterogeneity was carried out for comparisons by visual inspection of the graphs and the I² statistic (<a href="./references#MR000050-bbs2-0204" title="HigginsJP , ThompsonSG , DeeksJJ , AltmanDG .Measuring inconsistency in meta-analyses. BMJ2003;327(7414):557-60.">Higgins 2003</a>). I² values between 0% and 40% indicated little heterogeneity; between 30% and 60% indicated moderate heterogeneity: between 50% and 90% indicated substantial heterogeneity; and between 75% and 100% indicated considerable heterogeneity (<a href="./references#MR000050-bbs2-0207" title="HigginJP , ThomasJ , ChandlerJ , CumpstonM , LiT , PageMJ , et al (editors).Cochrane Handbook for Systematic Reviews of Interventions Version 6.0 (updated July 2019). Cochrane, 2019.. Available from www.training.cochrane.org/handbook.">Higgins 2019</a>). We also assessed statistical heterogeneity by Chi² tests (P &lt; 0.10) and tau², an estimate of between‐study variability. </p> </section> <section id="MR000050-sec-0039"> <h4 class="title">Assessment of reporting biases</h4> <p>Funnel plots were provided for comparisons that had a sufficient number of included trials. Asymmetry in the funnel plot could be due to publication bias or other reasons for heterogeneity between small and large trials (<a href="./references#MR000050-bbs2-0207" title="HigginJP , ThomasJ , ChandlerJ , CumpstonM , LiT , PageMJ , et al (editors).Cochrane Handbook for Systematic Reviews of Interventions Version 6.0 (updated July 2019). Cochrane, 2019.. Available from www.training.cochrane.org/handbook.">Higgins 2019</a>). Egger’s statistical test was performed for primary outcomes included in the <a href="./full#MR000050-tbl-0003">summary of findings Table 3</a> to test for small‐study effects (<a href="./references#MR000050-bbs2-0180" title="EggerM , SmithGD , PhillipsAN .Meta-analysis: principles and procedures. BMJ1997;315(7121):1533-7.">Egger 1997</a>). A visual inspection of funnel plots and Egger’s statistical test was not applied if there were fewer than 10 trials in the meta‐analysis, in keeping with the recommendations in the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#MR000050-bbs2-0207" title="HigginJP , ThomasJ , ChandlerJ , CumpstonM , LiT , PageMJ , et al (editors).Cochrane Handbook for Systematic Reviews of Interventions Version 6.0 (updated July 2019). Cochrane, 2019.. Available from www.training.cochrane.org/handbook.">Higgins 2019</a>). </p> </section> <section id="MR000050-sec-0040"> <h4 class="title">Data synthesis</h4> <p>We performed statistical analyses according to the recommendations in the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#MR000050-bbs2-0207" title="HigginJP , ThomasJ , ChandlerJ , CumpstonM , LiT , PageMJ , et al (editors).Cochrane Handbook for Systematic Reviews of Interventions Version 6.0 (updated July 2019). Cochrane, 2019.. Available from www.training.cochrane.org/handbook.">Higgins 2019</a>). We applied the inverse variance method to give estimates from trials with less variance (mostly, larger studies) more weight. We used the random‐effects model for meta‐analysis because some clinical heterogeneity was expected to be present in most cases. We tested whether a fixed‐effect model provided different effect estimates in a sensitivity analysis (see <a href="#MR000050-sec-0045">Sensitivity analysis</a>). If pooling of data seemed feasible, we combined the included study effects and calculated the associated 95% CIs. </p> </section> <section id="MR000050-sec-0041"> <h4 class="title">Subgroup analyses (pre‐specified)</h4> <p> <ol id="MR000050-list-0010"> <li> <p>Type of active interventions: i) psychological intervention, ii) pharmacological intervention, iii) physical intervention, or iv) other or combination of interventions. </p> </li> <li> <p>Overall risk of bias: i) high risk of bias compared with ii) low risk of bias.</p> </li> <li> <p>Type of outcome domain: i) blinded observer‐reported, ii) non‐blinded observer‐reported, or iii) patient‐reported. </p> </li> <li> <p>Type of comparator intervention: i) wait‐list or ii) no‐treatment.</p> </li> <li> <p>Awareness of placebo intervention: i) participants were aware that they might receive a placebo or ii) participants were not aware of this. </p> </li> <li> <p>Trial objective: i) a trial’s objective was clearly to assess the effects of placebo, usual care, or wait‐list interventions, or ii) no such objectives were stated. </p> </li> <li> <p>Mean age of participants: i) &lt; 18 years, ii) 18 to 50 years, or iii) &gt; 50 years.</p> </li> <li> <p>Duration of intervention: i) three months or above or ii) below three months.</p> </li> <li> <p>Type of usual care: i) pharmacological, ii) psychological, iii) physical, or iv) other.</p> </li> <li> <p>Standardised usual care: i) the usual care intervention was intentionally standardised or manualised or ii) no standardisation or manualisation. </p> </li> <li> <p>Mode of psychological treatment in usual care and psychological placebo: i) individual psychological treatment or ii) group psychological treatment. </p> </li> </ol> </p> </section> <section id="MR000050-sec-0042"> <h4 class="title">Subgroup analyses (post hoc)</h4> <p> <ol id="MR000050-list-0011"> <li> <p>Mental health diagnoses: i) formal diagnosis according to DSM/ICD, ii) fulfil symptoms of disorder ICD/DSM while not stating classifications systems, or iii) population is classified as having a mental disorder, but full diagnostic criteria not reported. </p> </li> <li> <p>Type of psychological placebo: i) interaction placebo, ii) educational placebo, or iii) exposure placebo. </p> </li> <li> <p>Type of physical placebo: i) acupuncture or acupressure placebo, ii) exercise and relaxation placebo, iii) technical device placebo, or iv) electromagnetic stimulation placebo. </p> </li> <li> <p>Conflicts of interest: i) risk of non‐financial and financial conflicts of interest, or ii) no risk of conflicts of interest (<a href="./references#MR000050-bbs2-0237" title="LeichsenringF , SteinertC , IoannidisJPA .Toward a paradigm shift in treatment and research of mental disorders. Psychological Medicine2019;49(13):2111-7.">Leichsenring 2019</a>). </p> </li> <li> <p>Imputed data: i) analyses with available outcome data or ii) analyses following the ITT principle. </p> </li> </ol> </p> </section> <section id="MR000050-sec-0043"> <h4 class="title">Diversity‐adjusted required information size (RIS) and Trial Sequential Analysis (TSA)</h4> <p>Trial Sequential Analysis (TSA) is a methodology that combines a required information size (RIS) calculation for meta‐analyses with a threshold for statistical significance ( <a href="./references#MR000050-bbs2-0164" title="BrokJ , ThorlundK , WetterslevJ , GluudC .Apparently conclusive meta-analyses may be inconclusive -trial sequential analysis adjustment of random error risk due to repetitive testing of accumulating data in apparently conclusive neonatal meta-analyses. International Journal of Epidemiology2009;38(1):287-98.">Brok 2009</a> ; <a href="./references#MR000050-bbs2-0280" title="ThorlundK , DevereauxPJ , WetterslevJ , GuyattG , IoannidisJP , ThabaneL , et al.Can trial sequential monitoring boundaries reduce spurious inferences from meta-analyses?International Journal of Epidemiology2009;38(1):276-86.">Thorlund 2009</a>; <a href="./references#MR000050-bbs2-0293" title="WetterslevJ , ThorlundK , BrokJ , GluudC .Trial sequential analysis may establish when firm evidence is reached in cumulative meta-analysis. Journal of Clinical Epidemiology2008;61(1):64-75.">Wetterslev 2008</a>; <a href="./references#MR000050-bbs2-0294" title="WetterslevJ , ThorlundK , BrokJ , GluudC .Estimating required information size by quantifying diversity in random-effects model meta-analyses. BMC Medical Research Methodology2009;9(1):86.">Wetterslev 2009</a>; <a href="./references#MR000050-bbs2-0295" title="WetterslevJ , JakobsenJC , GluudC .Trial Sequential Analysis in systematic reviews with meta-analysis. BMC Medical Research Methodology2017;17(1):39.">Wetterslev 2017</a>). The TSA enables quantification of the statistical reliability of the data in cumulative meta‐analysis, and adjusted P values for sparse data and for repetitive testing on accumulating data (<a href="./references#MR000050-bbs2-0163" title="BrokJ , ThorlundK , GluudC , WetterslevJ .Trial sequential analysis reveals insufficient information size and potentially false positive results in many meta-analyses. Journal of Clinical Epidemiology2008;61(8):763-9.">Brok 2008</a>; <a href="./references#MR000050-bbs2-0164" title="BrokJ , ThorlundK , WetterslevJ , GluudC .Apparently conclusive meta-analyses may be inconclusive -trial sequential analysis adjustment of random error risk due to repetitive testing of accumulating data in apparently conclusive neonatal meta-analyses. International Journal of Epidemiology2009;38(1):287-98.">Brok 2009</a>; <a href="./references#MR000050-bbs2-0280" title="ThorlundK , DevereauxPJ , WetterslevJ , GuyattG , IoannidisJP , ThabaneL , et al.Can trial sequential monitoring boundaries reduce spurious inferences from meta-analyses?International Journal of Epidemiology2009;38(1):276-86.">Thorlund 2009</a>; <a href="./references#MR000050-bbs2-0293" title="WetterslevJ , ThorlundK , BrokJ , GluudC .Trial sequential analysis may establish when firm evidence is reached in cumulative meta-analysis. Journal of Clinical Epidemiology2008;61(1):64-75.">Wetterslev 2008</a>; <a href="./references#MR000050-bbs2-0295" title="WetterslevJ , JakobsenJC , GluudC .Trial Sequential Analysis in systematic reviews with meta-analysis. BMC Medical Research Methodology2017;17(1):39.">Wetterslev 2017</a>). Similar to an a priori sample size estimation in a single randomised trial, a meta‐analysis should include a RIS at least as large as the sample size of an adequately powered single trial to control the risks of random error. The TSA program can calculate the RIS in a meta‐analysis and provide an alpha‐spending boundary to adjust the significance level for sparse data and repetitive testing (<a href="./references#MR000050-bbs2-0173" title="TSA - Trial sequential analysis. Copenhagen Trial Unit. [www.ctu.dk/tsa (accessed April 23 2018)]">Copenhagen Trial Unit 2018</a>; <a href="./references#MR000050-bbs2-0293" title="WetterslevJ , ThorlundK , BrokJ , GluudC .Trial sequential analysis may establish when firm evidence is reached in cumulative meta-analysis. Journal of Clinical Epidemiology2008;61(1):64-75.">Wetterslev 2008</a>; <a href="./references#MR000050-bbs2-0295" title="WetterslevJ , JakobsenJC , GluudC .Trial Sequential Analysis in systematic reviews with meta-analysis. BMC Medical Research Methodology2017;17(1):39.">Wetterslev 2017</a>). This enables one to control for the risk of random error. </p> <p>Multiple analyses of accumulating data when new trials emerge lead to repeated significance testing and introduces multiplicity issues. Therefore, the use of a conventional naïve P value exacerbates the risk of random errors (<a href="./references#MR000050-bbs2-0157" title="BerkeyCS , MostellerF , LauJ , AntmanEM .Uncertainty of the time of first significance in random effects cumulative meta-analysis. Controlled Clinical Trials1996;17(5):357-71.">Berkey 1996</a>; <a href="./references#MR000050-bbs2-0281" title="ThorlundK , ImbergerG , WalshM , ChuR , GluudC , WetterslevJ , et al.The number of patients and events required to limit the risk of overestimation of intervention effects in meta-analysis - a simulation study. PLOS One2011;6(10):e25491.">Thorlund 2011</a>; <a href="./references#MR000050-bbs2-0295" title="WetterslevJ , JakobsenJC , GluudC .Trial Sequential Analysis in systematic reviews with meta-analysis. BMC Medical Research Methodology2017;17(1):39.">Wetterslev 2017</a>). By analysing meta‐analyses that do not reach the RIS with trial sequential alpha‐spending monitoring boundaries (analogous to interim monitoring boundaries in a single trial), this can be controlled for (<a href="./references#MR000050-bbs2-0293" title="WetterslevJ , ThorlundK , BrokJ , GluudC .Trial sequential analysis may establish when firm evidence is reached in cumulative meta-analysis. Journal of Clinical Epidemiology2008;61(1):64-75.">Wetterslev 2008</a>; <a href="./references#MR000050-bbs2-0295" title="WetterslevJ , JakobsenJC , GluudC .Trial Sequential Analysis in systematic reviews with meta-analysis. BMC Medical Research Methodology2017;17(1):39.">Wetterslev 2017</a>). </p> <p>We calculated a RIS on the outcomes reported in the summary of findings tables in this review (i.e. the major findings of the review). If the TSA does not find significant results (no crossing of the alpha‐spending boundary and no crossing of the conventional boundary of P = 0.05) before the RIS has been reached, several conclusions may be inferred. We will either conclude that more trials are needed to reject or accept an intervention effect used for the calculation of the required sample size, or reject the anticipated effect, if the cumulative Z‐curve enters the futility area. We used an assumption that the minimal relevant clinical difference (MIREDIF) was approximately ½ SD on the used scale, which can be used as a MIREDIF (<a href="./references#MR000050-bbs2-0256" title="NormanGR , SloanJA , WyrwichKW .Interpretation of changes in health-related quality of life: the remarkable universality of half a standard deviation. Medical Care2003;41(5):582-92.">Norman 2003</a>). </p> <p>We calculated the diversity‐adjusted required information size (DARIS; that is the number of participants required to detect or reject a specific intervention effect in a meta‐analysis), and performed TSAs for the primary outcomes reporting continuous data at the end of treatment, based on the following a priori assumptions: </p> <p> <ol id="MR000050-list-0012"> <li> <p>the SD of the primary outcomes;</p> </li> <li> <p>an anticipated MIREDIF as a ½ SD on the used scale;</p> </li> <li> <p>a maximum type I error of 3.3% (due to two primary outcomes; <a href="./references#MR000050-bbs2-0219" title="JakobsenJC , WetterslevJ , WinkelP , LangeT , GluudC .Thresholds for statistical and clinical significance in systematic reviews with meta-analytic methods. BMC Medical Research Methodology2014;14(1):120.">Jakobsen 2014</a>); </p> </li> <li> <p>a maximum type II error of 10% (minimum 90% power; <a href="./references#MR000050-bbs2-0166" title="CastelliniG , BruschettiniM , GianolaS , GluudC , MojaL .Assessing imprecision in Cochrane systematic reviews: a comparison of GRADE and Trial Sequential Analysis. Systematic Reviews2018;7(1):110.">Castellini 2018</a>); and </p> </li> <li> <p>the diversity observed in the meta‐analysis.</p> </li> </ol> </p> <p>For the outcomes 'total serious adverse events' (dichotomous data), we calculated the diversity‐adjusted required information size (DARIS; i.e. number of participants in the </p> <p> <ol id="MR000050-list-0013"> <li> <p>proportion of participants in the control group with serious adverse events;</p> </li> <li> <p>relative risk reduction of 25%;</p> </li> <li> <p>type I error of 3.3%;</p> </li> <li> <p>type II error of 10%;</p> </li> <li> <p>observed diversity of the meta‐analysis; and</p> </li> <li> <p>we included trials with zero events by substituting 0.5 for zero ( <a href="./references#MR000050-bbs2-0281" title="ThorlundK , ImbergerG , WalshM , ChuR , GluudC , WetterslevJ , et al.The number of patients and events required to limit the risk of overestimation of intervention effects in meta-analysis - a simulation study. PLOS One2011;6(10):e25491.">Thorlund 2011</a> ). </p> </li> </ol> </p> <p>It was not possible to calculate TSA on 'total serious adverse events' and 'non‐serious adverse events' due to a lack of information. </p> </section> <section id="MR000050-sec-0044"> <h4 class="title">Summary of findings tables</h4> <p>We used the GRADE approach to construct three summary of findings tables to document primary review outcomes. GRADE evaluates the quality of a body of evidence based on the confidence that an effect estimate or association reflects the item being assessed. These considerations were based on within‐trial risk of bias, directness of evidence, heterogeneity of data, precision of effect estimates and risk of publication bias (<a href="./references#MR000050-bbs2-0144" title="AndrewsJ , GuyattG , OxmanAD , AldersonP , DahmP , Falck-YtterY , et al.GRADE guidelines: 14. Going from evidence to recommendations: the significance and presentation of recommendations. Journal of Clinical Epidemiology2013;66(7):719-25.">Andrews 2013a</a>; <a href="./references#MR000050-bbs2-0145" title="AndrewsJC , SchünemannHJ , OxmanAD , PottieK , MeerpohlJJ , CoelloPA , et al.GRADE guidelines: 15. Going from evidence to recommendation - determinants of a recommendation's direction and strength. Journal of Clinical Epidemiology2013;66(7):726-35.">Andrews 2013b</a>; <a href="./references#MR000050-bbs2-0154" title="BalshemH , HelfandM , SchünemannHJ , OxmanAD , KunzR , BrozekJ , et al.GRADE guidelines: 3. Rating the quality of evidence. Journal of Clinical Epidemiology2018;64(4):401-6.">Balshem 2018</a>; <a href="./references#MR000050-bbs2-0165" title="BrunettiM , ShemiltI , PregnoS , ValeL , OxmanAD , LordJ , et al.GRADE guidelines: 10. Considering resource use and rating the quality of economic evidence. Journal of Clinical Epidemiology2013;66(2):140-50.">Brunetti 2013</a>; <a href="./references#MR000050-bbs2-0189" title="GRADE Working Group.Grading quality of evidence and strength of recommendations. BMJ2004;328(7454):1490.">GRADE Working Group 2004</a>; <a href="./references#MR000050-bbs2-0192" title="GuyattG , OxmanAD , AklEA , KunzR , VistG , BrozekJ , et al.GRADE guidelines: 1. Introduction - GRADE evidence profiles and summary of findings tables. Journal of Clinical Epidemiology2011;64(4):383-94.">Guyatt 2011a</a>; <a href="./references#MR000050-bbs2-0193" title="GuyattGH , OxmanAD , KunzR , AtkinsD , BrozekJ , VistG , et al.GRADE guidelines: 2. Framing the question and deciding on important outcomes. Journal of Clinical Epidemiology2011;64(4):395-400.">Guyatt 2011b</a>; <a href="./references#MR000050-bbs2-0194" title="GuyattGH , OxmanAD , VistG , KunzR , BrozekJ , Alonso-CoelloP , et al.GRADE guidelines: 4. Rating the quality of evidence - study limitations (risk of bias). Journal of Clinical Epidemiology2011;64(4):407-15.">Guyatt 2011c</a>; <a href="./references#MR000050-bbs2-0195" title="GuyattGH , OxmanAD , MontoriV , VistG , KunzR , BrozekJ , et al.GRADE guidelines: 5. Rating the quality of evidence - publication bias. Journal of Clinical Epidemiology2011;64(12):1277-82.">Guyatt 2011d</a>; <a href="./references#MR000050-bbs2-0196" title="GuyattGH , OxmanAD , KunzR , BrozekJ , Alonso-CoelloP , RindD , et al.GRADE guidelines 6. Rating the quality of evidence - imprecision. Journal of Clinical Epidemiology2011;64(12):1283-93.">Guyatt 2011e</a>; <a href="./references#MR000050-bbs2-0197" title="GuyattGH , OxmanAD , KunzR , WoodcockJ , BrozekJ , Helfand, et al.GRADE guidelines: 7. Rating the quality of evidence - inconsistency. Journal of Clinical Epidemiology2011;64(12):1294-302.">Guyatt 2011f</a> ; <a href="./references#MR000050-bbs2-0198" title="GuyattGH , OxmanAD , KunzR , WoodcockJ , BrozekJ , HelfandM , et al.GRADE guidelines: 8. Rating the quality of evidence - indirectness. Journal of Clinical Epidemiology2011;64(12):1303-10.">Guyatt 2011g</a>; <a href="./references#MR000050-bbs2-0199" title="GuyattGH , OxmanAD , SultanS , GlasziouP , AklEA , Alonso-CoelloP , et al.GRADE guidelines: 9. Rating up the quality of evidence. Journal of Clinical Epidemiology2011;64(12):1311-6.">Guyatt 2011h</a>; <a href="./references#MR000050-bbs2-0200" title="GuyattG , OxmanAD , SultanS , BrozekJ , GlasziouP , Alonso-CoelloP , et al.GRADE guidelines: 11. Making an overall rating of confidence in effect estimates for a single outcome and for all outcomes. Journal of Clinical Epidemiology2013;66(2):151-7.">Guyatt 2013a</a>; <a href="./references#MR000050-bbs2-0201" title="GuyattGH , OxmanAD , SantessoN , HelfandM , VistG , KunzR , et al.GRADE guidelines: 12. Preparing Summary of Findings tables - binary outcomes. Journal of Clinical Epidemiology2013;66(2):158-72.">Guyatt 2013b</a>; <a href="./references#MR000050-bbs2-0255" title="MustafaRA , SantessoN , BrozekJ , AklEA , WalterSD , NormanG , et al.The GRADE approach is reproducible in assessing the quality of evidence of quantitative evidence syntheses. Journal of Clinical Epidemiology2013;66(7):736-42.e5.">Mustafa 2013</a>). When possible, we used the SMD or the RR for the summary of findings table. We used the TSA as the rating for imprecision (<a href="./references#MR000050-bbs2-0219" title="JakobsenJC , WetterslevJ , WinkelP , LangeT , GluudC .Thresholds for statistical and clinical significance in systematic reviews with meta-analytic methods. BMC Medical Research Methodology2014;14(1):120.">Jakobsen 2014</a>). </p> </section> <section id="MR000050-sec-0045"> <h4 class="title">Sensitivity analysis</h4> <p>Trials contributing to statistical heterogeneity (‘outliers’) were removed to evaluate their impact on the overall pooled effect estimate. We removed outliers one by one and assessed the impact on the overall outcome. </p> <p>We conducted sensitivity analyses to determine whether findings were sensitive to the following decisions made during the review process. </p> <p> <ol id="MR000050-list-0014"> <li> <p>Analytical technique (e.g. fixed‐effect compared with random‐effects models)</p> </li> <li> <p>Combination of data in continuous outcomes (end of intervention or compared with change scores) </p> </li> <li> <p>Trial Sequential Analysis (TSA) as a sensitivity analysis for the imprecision rated with GRADE (<a href="./references#MR000050-bbs2-0166" title="CastelliniG , BruschettiniM , GianolaS , GluudC , MojaL .Assessing imprecision in Cochrane systematic reviews: a comparison of GRADE and Trial Sequential Analysis. Systematic Reviews2018;7(1):110.">Castellini 2018</a>) </p> </li> <li> <p>Including wait‐list interventions described as no‐interventions</p> </li> <li> <p>Including no‐interventions described as wait‐list interventions</p> </li> </ol> </p> <p>More information on the sensitivity analyses that we were not able to conduct is given in <a href="#MR000050-sec-0147">Differences between protocol and review</a> . </p> </section> </section> </section> </section> <section class="results"> <div class="section-header section-collapse-header" id="MR000050-sec-0046" lang="en"> <h2 class="title section-collapse-title"> Results <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="results" lang="en"> <div class="section-header" id="MR000050-sec-0046"></div> <section id="MR000050-sec-0047"> <h3 class="title">Description of studies</h3> <p>See <a href="./references#MR000050-sec-0149" title="">Characteristics of included studies</a> , <a href="./references#MR000050-sec-0150" title="">Characteristics of excluded studies</a> , <a href="./references#MR000050-sec-0151" title="">Characteristics of studies awaiting classification</a> , and <a href="./references#MR000050-sec-0152" title="">Characteristics of ongoing studies</a> . </p> <section id="MR000050-sec-0048"> <h4 class="title">Results of the search</h4> <p>All electronic databases and search periods are listed in the Methods section (see <a href="#MR000050-sec-0026">Electronic searches</a>). The search was conducted in April 2018. The search strategy was comprehensive (see <a href="./appendices#MR000050-sec-0106">Appendix 1</a> and generated 64,529 records, but only 58,943 records could be exported from the databases and imported to Endnote. We consulted our research librarian and identified some records that did not include any title, abstract, or keywords, and they could therefore not be retrieved. Another 1034 records of clinical trials across the remaining trial registries could not be imported and had to be manually screened. Ten records were identified from references in other reviews. </p> <p><a href="#MR000050-fig-0001">Figure 1</a> shows our PRISMA flowchart. After duplicate check, 13,134 studies were excluded. We used an EPPI Reviewer 4 text mining software filter to identify reports that with 97% certainty was a systematic review or a randomised trial. This filter was used in three phases. In total, 10,167 reports were excluded because they did not fulfil the criteria for being a randomised trial, leaving 35,642 reports for abstract screening in EPPI reviewer 4, and 1034 clinical trials. Following screening of titles and abstracts, 1243 records were identified for full‐text screening. Six trials are still awaiting classification due to difficulties locating the trial reports (see <a href="./references#MR000050-bbs1-0003" title="">Studies awaiting classification</a>), while four trials are ongoing (see <a href="./references#MR000050-bbs1-0004" title="">Ongoing studies</a>). In total, 96 randomised trials described in 122 reports were eligible for the full review (see <a href="#MR000050-fig-0001">Figure 1</a> for a more detailed description). </p> <div class="figure" id="MR000050-fig-0001"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 1</div> </div> <hr class="top"/><img alt='Study flow diagram.* Powers 2008 was included in both psychological and pharmacological placebo" Brill 1964 was included in both pharmacological placebo and usual care&lt; Klerman 1974 was divided into two different trials‐: Peck 1974 was included only in all placebos analyses due to that the placebo group was a mix of psychological and pharmacological placebo' data-id="MR000050-fig-0001" src="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/image_n/nMR000050-FIG-01.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Study flow diagram.</p> <p>* Powers 2008 was included in both psychological and pharmacological placebo</p> <p>" Brill 1964 was included in both pharmacological placebo and usual care</p> <p>&lt; Klerman 1974 was divided into two different trials</p> <p>‐: Peck 1974 was included only in all placebos analyses due to that the placebo group was a mix of psychological and pharmacological placebo </p> </div> </div> </div> <section id="MR000050-sec-0049"> <h5 class="title">Author correspondence</h5> <p>We contacted authors from 35 trials with unclear or missing data and requested the necessary data but only 16 responded (<a href="#MR000050-tbl-0006">Table 3</a>) The other trials did not provide contact information or were below the threshold for contact. </p> <div class="table" id="MR000050-tbl-0006"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 3.</span> <span class="table-title">Key demographic characteristics of the included studies</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Category</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Study</b> <b>frequency</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Study ID</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Author correspondence</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Contacted</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>35</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#MR000050-bbs2-0001" title="AbikoffH , HechtmanL , KleinRG .Social functioning in children with ADHD treated with long-term methylphenidate and multimodal psychosocial treatment. Journal of the American Academy of Child and Adolescent Psychiatry2004;43(7):820-9. AbikoffH .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to A Todorovac 23rd of August 2019. KleinRG , AbikoffH , HechtmanL , WeissG .Design and rationale of controlled study of long-term methylphenidate and multimodal psychosocial treatment in children with ADHD. Journal of the American Academy of Child and Adolescent Psychiatry2004;43(7):792-801. ">Abikoff 2004</a> ; <a href="./references#MR000050-bbs2-0002" title="AllenJB .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to A Todorovac 28th of August 2019. AllenJJ , SchnyerRN , HittSK .The efficacy of acupuncture in the treatment of major depression in women. Psychological Science1998;9(5):397-401. ">Allen 1998</a> ; <a href="./references#MR000050-bbs2-0003" title="AllenJB .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 28th of August 2019. AllenJJ , SchnyerRN , ChambersAS , HittSK , MorenoFA , ManberR .Acupuncture for depression: a randomized controlled trial. Journal of Clinical Psychiatry2006;67(11):1665-73. ">Allen 2006</a> ; <a href="./references#MR000050-bbs2-0006" title="AyenI , HautzingerM .Cognitive behavior therapy for depression in menopausal women. A controlled, randomized treatment study [Kognitive Verhaltenstherapie bei Depressionen im Klimakterium: Eine kontrollierte, randomiserte Interventionsstudie]. Zeitschrift für Klinische Psychologie und Psychotherapie2004;33(4):290-9. AyenI .Inclusion of study in Cochrane Systematic Review (personal communication). Email to EG Faltinsen 9th of September 2019. ">Ayen 2004</a> ; <a href="./references#MR000050-bbs2-0011" title="BornovalovaM .Inclusion of study in Cochrane Systematic Review (personal communication). Email to A Todorovac. 21st of August 2019. BornovalovaMA .Distress tolerance treatment for inner-city drug users: a preliminary trial. Doctor’s Dissertation, University of Maryland2008. ">Bornovalova 2008</a> ; <a href="./references#MR000050-bbs2-0015" title="CarlsonCL , PelhamWE , MilichR , HozaB .ADHD boys’ performance and attributions following success and failure: drug effects and individual differences. Cognitive Therapy and Research1993;17:269-87. ">Carlson 1993</a> ; <a href="./references#MR000050-bbs2-0016" title="CarterJC , OlmstedMP , KaplanAS , McCabeRE , MillsJS , AimeA .Self-help for bulimia nervosa: a randomized controlled trial. American Journal of Psychiatry2003;160(5):973-8. ">Carter 2003</a> ; <a href="./references#MR000050-bbs2-0018" title="CrouchG , RobsonM , HallstromC .Benzodiazepine dependent patients and their psychological treatment. Progress in Neuro-psychopharmacology &amp; Biological Psychiatry1988;12(4):503-10. HallströmC , CrouchG , RobsenM , ShineP .The treatment of tranquillizer dependence by propranolol. Postgraduate Medical Journal1988;64(Suppl 2):40-4. ">Crouch 1988</a> ; <a href="./references#MR000050-bbs2-0024" title="FoaEB , RothbaumBO , RiggsDS , MurdockTB .Treatment of posttraumatic stress disorder in rape victims: a comparison between cognitive-behavioral procedures and counselling. Journal of Consulting and Clinical Psychology1991;59(5):715-23. ">Foa 1991</a> ; <a href="./references#MR000050-bbs2-0025" title="FoaEB , McLeanCP , ZangY , RosenfieldD , YadinE , YarvisJS , et al.Effect of prolonged exposure therapy delivered over 2 weeks vs 8 weeks vs present-centered therapy on PTSD symptom severity in military personnel: a randomized clinical trial. JAMA2018;319(4):354-64. ">Foa 2018</a> ; <a href="./references#MR000050-bbs2-0026" title="FreireAO , SugaiGC , ChrispinFS , TogeiroSM , YamamuraY , MelloLE , et al.Treatment of moderate obstructive sleep apnea syndrome with acupuncture: a randomised, placebo-controlled pilot trial. Sleep Medicine2007;8(1):43-50. ">Freire 2007</a> ; <a href="./references#MR000050-bbs2-0028" title="GlogowskaM , RoulstoneS , EnderbyP , PetersTJ .Randomised controlled trial of community based speech and language therapy in preschool children. BMJ2000;321(7266):923-6. ">Glogowska 2000</a> ; <a href="./references#MR000050-bbs2-0029" title="GoldsteinAJ , BeursE , Chambless Dl, WilsonKA .EMDR for panic disorder with agoraphobia: comparison with waiting list and credible attention-placebo control conditions. Journal of Consulting and Clinical Psychology2000;68(6):947-56. ">Goldstein 2000</a> ; <a href="./references#MR000050-bbs2-0032" title="HippmanC , RingroseA , InglisA , CheekJ , AlbertAY , RemickR , et al.A pilot randomized clinical trial evaluating the impact of genetic counselling for serious mental illnesses. Journal of Clinical Psychiatry2016;77(2):e190-8. ">Hippman 2016</a> ; <a href="./references#MR000050-bbs2-0034" title="KarstM , WinterhalterM , MünteS , FranckiB , HondronikosA , EckardtA , et al.Auricular acupuncture for dental anxiety: a randomized controlled trial. Anesthesia and Analgesia2007;104(2):295-300. KarstM .Inclusion of study in Cochrane Systematic Review (personal communication). Email to: EG Faltinsen 5th of September 2019. ">Karst 2007</a> ; <a href="./references#MR000050-bbs2-0035" title="KelleyJ .Inclusion of study in Cochrane Systematic Review (personal communication). Email to: A Todorovac 12th of August 2019. KelleyJM , KaptchukTJ , CusinC , LipkinS , FavaM .Open-label placebo for major depressive disorder: a pilot randomized controlled trial. Psychotherapy and Psychosomatics2012;81(5):312-4. ">Kelley 2012</a> ; <a href="./references#MR000050-bbs2-0043" title="KwanR .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 26th of August 2019. KwanRY , LeungMC , LaiCK .Acupressure for agitation in nursing home residents with dementia: study protocol for a randomized controlled trial. Trials2014;15(410):1-7. KwanRY , LeungMCP , LaiCK .A randomized controlled trial examining the effect of acupressure on agitation and salivary cortisol in nursing home residents with dementia. Dementia and Geriatric Cognitive Disorders2017;44(1-2):92-104. ">Kwan 2017</a> ; <a href="./references#MR000050-bbs2-0045" title="LaiCK , ChiI , Kayser-JonesJ .A randomized controlled trial of a specific reminiscence approach to promote the well-being of nursing home residents with dementia. International Psychogeriatrics2004;16(1):33-49. LaiK .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 6th of September 2019. ">Lai 2004</a> ; <a href="./references#MR000050-bbs2-0047" title="LegrandF .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 14th of August 2019. LegrandFD , NeffEM .Efficacy of exercise as an adjunct treatment for clinically depressed inpatients during the initial stages of antidepressant pharmacotherapy: an open randomized controlled trial. Journal of Affective Disorders2016;191:139-44. ">Legrand 2016</a> ; <a href="./references#MR000050-bbs2-0055" title="MirandaA , ArlandisP , SorianoM .Instruction in strategies and attributional training: Effects on the problem-solving and self-concept of students’ with learning disabilities [Instrucción en estrategias y entrenamiento atribucional: efectos sobre la resolución de problemas y el autoconcepto de los estudiantes con dificultades en el aprendizaje]. Infancia y Aprendizaje1997;20(80):37-52. ">Miranda 1997</a> ; <a href="./references#MR000050-bbs2-0056" title="MitchellC , MansfieldD , RautenbachS .Coloured filters and reading accuracy, comprehension and rate: a placebo-controlled study. Perceptual and Motor Skills2008;106(2):517-32. ">Mitchell 2008</a> ; <a href="./references#MR000050-bbs2-0061" title="MilichR , CarlsonCL , Pelham WE Jr, LichtBG .Effects of methylphenidate on the persistence of ADHD boys following failure experiences. Journal of Abnormal Child Psychology1991;19(5):519-36. PelhamWE , MurphyDA , VannattaK , MilichR , LichtBG , GnagyEM , et al.Methylphenidate and attributions in boys with attention-deficit hyperactivity disorder. Journal of Consulting and Clinical Psychology1992;60(2):282-92. ">Pelham 1992</a> ; <a href="./references#MR000050-bbs2-0064" title="PolandRE , GertsikL , FavreauJT , SmithSI , MirochaJM , RaoU , et al.Open-label randomized parallel-group controlled clinical trial of massage for treatment of depression in HIV-infected subjects. Journal of Alternative and Complementary Medicine2013;19(4):334-40. ">Poland 2013</a> ; <a href="./references#MR000050-bbs2-0065" title="PowersMB , SmitsJA , TelchMJ .Disentangling the effects of safety-behavior utilization and safety-behavior availability during exposure-based treatment: a placebo-controlled trial. Journal of Consulting and Clinical Psychology2004;72(3):448-54. ">Powers 2004</a> ; <a href="./references#MR000050-bbs2-0066" title="PowersMB , SmithsJA , WhitleyD , BystritskyA , TelchMJ .The effect of attributional processes concerning medication taking on return of fear. Journal of Consulting and Clinical Psychology2008;76(3):478-90. ">Powers 2008a</a> ; <a href="./references#MR000050-bbs2-0067" title="PowersMB , SmithsJA , WhitleyD , BystritskyA , TelchMJ .The effect of attributional processes concerning medication taking on return of fear. Journal of Consulting and Clinical Psychology2008;76(3):478-90. ">Powers 2008b</a> ; <a href="./references#MR000050-bbs2-0068" title="ProudfootJ , ClarkeJ , BirchMR , WhittonAE , ParkerG , ManicavasagarV , et al.Impact of a mobile phone and web program on symptom and functional outcomes for people with mild- to-moderate depression, anxiety and stress: a randomized controlled trial. BMC Psychiatry2013;13(312):1-12. ProudfootJ .Re: Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 26th of August 2019. ">Proudfoot 2013</a> ; <a href="./references#MR000050-bbs2-0070" title="LiebowitzM , QuitkinFM , StewartJW , McGrathPJ , HarrisonWM , MarkowitzJS , et al.Antidepressant efficacy in atypical depression. Archives of General Psychiatry1988;45(2):129-37. QuitkinFM , McGrathPJ , StewartJW , HarrisonW , WagerSG , NunesE , et al.Phenelzine and imipramine in mood reactive depressives: further delineation of the syndrome of atypical depression. Archives of General Psychiatry1989;46(9):787-93. RabkinJG , McGrathPJ , QuitkinFM , TricamoE , StewartJW , KleinDF .Effects of pill-giving on maintenance of placebo response in patients with chronic mild depression. American Journal of Psychiatry1990;147(12):1622-6. ">Rabkin 1990</a> ; <a href="./references#MR000050-bbs2-0071" title="RapeeR .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 29th of August 2019. RapeeRM , AbbottMJ , LynehamHJ .Bibliotherapy for children With anxiety disorders using written materials for parents: a randomized controlled trial. Journal of Consulting and Clinical Psychology2006;74(3):436-44. ">Rapee 2006</a> ; <a href="./references#MR000050-bbs2-0072" title="RapeeR .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 29th of August 2019. RapeeRM , AbbottMJ , BaillieAJ , GastonJE .Treatment of social phobia through pure self-help and therapist-augmented self-help. British Journal of Psychiatry2007;191:246-52. ">Rapee 2007</a> ; <a href="./references#MR000050-bbs2-0075" title="OlivaresJ .Program IAFS. Protocol for the treatment of social phobia in adolescents [Programa IAFS. Protocolo para el tratamiento de la fobia social enadolescentes]. Madrid: Pirámide2005;1. Rosa-AlcázarAI , Olivares-OlivaresPJ , OlivaresJ .The role of non-specific effects in the psychological treatment of adolescents with social phobia [Papel de los efectos inespecíficos en el tratamiento psicológico de adolescentes con fobia social]. Anuario de Psicologia2009;40(1):43-61. ">Rosa‐Alcatraz 2009</a> ; <a href="./references#MR000050-bbs2-0079" title="ShalevAY , AnkriY , Isreali-ShalevY , PelegT , AdesskyR , FreedmanS .Prevention of posttraumatic stress disorder by early treatment. Archives of General Psychiatry2012;69(2):166-76. ">Shalev 2012</a> ; <a href="./references#MR000050-bbs2-0084" title="SzymanskiJ , O'DonohueW .The potential role of state-dependent learning in cognitive therapy with spider phobics. Journal of Rational-Emotive &amp; Cognitive-Behavior Therapy1995;13(2):131-50. SzymanskiJ .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 20th of August 2019. ">Szymanski 1995</a> ; <a href="./references#MR000050-bbs2-0086" title="TeriL , LogsdonRG , UomotoJ , McCurrySM .Behavioral treatment of depression in dementia patients: a controlled clinical trial. Journals of Gerontology. Series B, Psychological Sciences and Social Sciences1997;52(4):159-66. TeriL .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 26th of August 2019. ">Teri 1997</a> ; <a href="./references#MR000050-bbs2-0095" title="WolitzkyKB , TelchMJ .Augmenting in vivo exposure with fear antagonistic actions: a preliminary test. Behavior Therapy2009;40(1):57-71. ">Wolitzky 2009</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Authors responded</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>16</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#MR000050-bbs2-0001" title="AbikoffH , HechtmanL , KleinRG .Social functioning in children with ADHD treated with long-term methylphenidate and multimodal psychosocial treatment. Journal of the American Academy of Child and Adolescent Psychiatry2004;43(7):820-9. AbikoffH .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to A Todorovac 23rd of August 2019. KleinRG , AbikoffH , HechtmanL , WeissG .Design and rationale of controlled study of long-term methylphenidate and multimodal psychosocial treatment in children with ADHD. Journal of the American Academy of Child and Adolescent Psychiatry2004;43(7):792-801. ">Abikoff 2004</a> ; <a href="./references#MR000050-bbs2-0140" title="AbikoffH .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 23rd of August 2019.">Abikoff 2004 (pers comm)</a> ; <a href="./references#MR000050-bbs2-0002" title="AllenJB .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to A Todorovac 28th of August 2019. AllenJJ , SchnyerRN , HittSK .The efficacy of acupuncture in the treatment of major depression in women. Psychological Science1998;9(5):397-401. ">Allen 1998</a> ; <a href="./references#MR000050-bbs2-0141" title="AllenJB .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 28th of August 2019.">Allen 1998 (pers comm)</a> ; <a href="./references#MR000050-bbs2-0003" title="AllenJB .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 28th of August 2019. AllenJJ , SchnyerRN , ChambersAS , HittSK , MorenoFA , ManberR .Acupuncture for depression: a randomized controlled trial. Journal of Clinical Psychiatry2006;67(11):1665-73. ">Allen 2006</a> ; <a href="./references#MR000050-bbs2-0142" title="AllenJB .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 28th of August 2019.">Allen 2006 (pers comm)</a> ; <a href="./references#MR000050-bbs2-0006" title="AyenI , HautzingerM .Cognitive behavior therapy for depression in menopausal women. A controlled, randomized treatment study [Kognitive Verhaltenstherapie bei Depressionen im Klimakterium: Eine kontrollierte, randomiserte Interventionsstudie]. Zeitschrift für Klinische Psychologie und Psychotherapie2004;33(4):290-9. AyenI .Inclusion of study in Cochrane Systematic Review (personal communication). Email to EG Faltinsen 9th of September 2019. ">Ayen 2004</a> ; <a href="./references#MR000050-bbs2-0153" title="AyenI .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: EG Faltinsen 9th of September 2019.">Ayen 2004 (pers comm)</a> ; <a href="./references#MR000050-bbs2-0011" title="BornovalovaM .Inclusion of study in Cochrane Systematic Review (personal communication). Email to A Todorovac. 21st of August 2019. BornovalovaMA .Distress tolerance treatment for inner-city drug users: a preliminary trial. Doctor’s Dissertation, University of Maryland2008. ">Bornovalova 2008</a> ; <a href="./references#MR000050-bbs2-0160" title="BornovalovaM .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 21st of August 2019.">Bornovalova 2008 (pers comm)</a> ; <a href="./references#MR000050-bbs2-0034" title="KarstM , WinterhalterM , MünteS , FranckiB , HondronikosA , EckardtA , et al.Auricular acupuncture for dental anxiety: a randomized controlled trial. Anesthesia and Analgesia2007;104(2):295-300. KarstM .Inclusion of study in Cochrane Systematic Review (personal communication). Email to: EG Faltinsen 5th of September 2019. ">Karst 2007</a> ; <a href="./references#MR000050-bbs2-0222" title="KarstM .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: EG Faltinsen 5th of September 2019.">Karst 2007 (pers comm)</a> ; <a href="./references#MR000050-bbs2-0035" title="KelleyJ .Inclusion of study in Cochrane Systematic Review (personal communication). Email to: A Todorovac 12th of August 2019. KelleyJM , KaptchukTJ , CusinC , LipkinS , FavaM .Open-label placebo for major depressive disorder: a pilot randomized controlled trial. Psychotherapy and Psychosomatics2012;81(5):312-4. ">Kelley 2012</a> ; <a href="./references#MR000050-bbs2-0226" title="KelleyJ .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 12th of August 2019.">Kelley 2012 (pers comm)</a> ; <a href="./references#MR000050-bbs2-0043" title="KwanR .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 26th of August 2019. KwanRY , LeungMC , LaiCK .Acupressure for agitation in nursing home residents with dementia: study protocol for a randomized controlled trial. Trials2014;15(410):1-7. KwanRY , LeungMCP , LaiCK .A randomized controlled trial examining the effect of acupressure on agitation and salivary cortisol in nursing home residents with dementia. Dementia and Geriatric Cognitive Disorders2017;44(1-2):92-104. ">Kwan 2017</a> ; <a href="./references#MR000050-bbs2-0234" title="KwanR .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 26th of August 2019.">Kwan 2017 (pers comm)</a> ; <a href="./references#MR000050-bbs2-0045" title="LaiCK , ChiI , Kayser-JonesJ .A randomized controlled trial of a specific reminiscence approach to promote the well-being of nursing home residents with dementia. International Psychogeriatrics2004;16(1):33-49. LaiK .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 6th of September 2019. ">Lai 2004</a> ; <a href="./references#MR000050-bbs2-0235" title="LaiK .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 6th of September 2019.">Lai 2004 (pers comm)</a> ; <a href="./references#MR000050-bbs2-0047" title="LegrandF .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 14th of August 2019. LegrandFD , NeffEM .Efficacy of exercise as an adjunct treatment for clinically depressed inpatients during the initial stages of antidepressant pharmacotherapy: an open randomized controlled trial. Journal of Affective Disorders2016;191:139-44. ">Legrand 2016</a> ; <a href="./references#MR000050-bbs2-0236" title="LegrandF .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 14th of August 2019.">Legrand 2016 (pers comm)</a> ; <a href="./references#MR000050-bbs2-0055" title="MirandaA , ArlandisP , SorianoM .Instruction in strategies and attributional training: Effects on the problem-solving and self-concept of students’ with learning disabilities [Instrucción en estrategias y entrenamiento atribucional: efectos sobre la resolución de problemas y el autoconcepto de los estudiantes con dificultades en el aprendizaje]. Infancia y Aprendizaje1997;20(80):37-52. ">Miranda 1997</a> ; <a href="./references#MR000050-bbs2-0247" title="MirandaJ .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: EG Faltinsen 9th of September 2019.">Miranda 1997 (pers comm)</a> ; <a href="./references#MR000050-bbs2-0068" title="ProudfootJ , ClarkeJ , BirchMR , WhittonAE , ParkerG , ManicavasagarV , et al.Impact of a mobile phone and web program on symptom and functional outcomes for people with mild- to-moderate depression, anxiety and stress: a randomized controlled trial. BMC Psychiatry2013;13(312):1-12. ProudfootJ .Re: Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 26th of August 2019. ">Proudfoot 2013</a> ; <a href="./references#MR000050-bbs2-0260" title="ProudfootJ .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 26th of August 2019.">Proudfoot 2013 (pers comm)</a> ; <a href="./references#MR000050-bbs2-0071" title="RapeeR .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 29th of August 2019. RapeeRM , AbbottMJ , LynehamHJ .Bibliotherapy for children With anxiety disorders using written materials for parents: a randomized controlled trial. Journal of Consulting and Clinical Psychology2006;74(3):436-44. ">Rapee 2006</a> ; <a href="./references#MR000050-bbs2-0261" title="RapeeR .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 29th of August 2019.">Rapee 2006 (pers comm)</a> ; <a href="./references#MR000050-bbs2-0072" title="RapeeR .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 29th of August 2019. RapeeRM , AbbottMJ , BaillieAJ , GastonJE .Treatment of social phobia through pure self-help and therapist-augmented self-help. British Journal of Psychiatry2007;191:246-52. ">Rapee 2007</a> ; <a href="./references#MR000050-bbs2-0262" title="RapeeR .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 29th of August 2019.">Rapee 2007 (pers comm)</a> ; <a href="./references#MR000050-bbs2-0084" title="SzymanskiJ , O'DonohueW .The potential role of state-dependent learning in cognitive therapy with spider phobics. Journal of Rational-Emotive &amp; Cognitive-Behavior Therapy1995;13(2):131-50. SzymanskiJ .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 20th of August 2019. ">Szymanski 1995</a> ; <a href="./references#MR000050-bbs2-0276" title="SzymanskiJ .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 20th of August 2019.">Szymanski 1995 (pers comm)</a> ; <a href="./references#MR000050-bbs2-0086" title="TeriL , LogsdonRG , UomotoJ , McCurrySM .Behavioral treatment of depression in dementia patients: a controlled clinical trial. Journals of Gerontology. Series B, Psychological Sciences and Social Sciences1997;52(4):159-66. TeriL .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 26th of August 2019. ">Teri 1997</a> ; <a href="./references#MR000050-bbs2-0278" title="TeriL .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 26th of August 2019.">Teri 1997 (pers comm)</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Setting</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Studies with outpatient settings</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>74</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#MR000050-bbs2-0001" title="AbikoffH , HechtmanL , KleinRG .Social functioning in children with ADHD treated with long-term methylphenidate and multimodal psychosocial treatment. Journal of the American Academy of Child and Adolescent Psychiatry2004;43(7):820-9. AbikoffH .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to A Todorovac 23rd of August 2019. KleinRG , AbikoffH , HechtmanL , WeissG .Design and rationale of controlled study of long-term methylphenidate and multimodal psychosocial treatment in children with ADHD. Journal of the American Academy of Child and Adolescent Psychiatry2004;43(7):792-801. ">Abikoff 2004</a> ; <a href="./references#MR000050-bbs2-0002" title="AllenJB .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to A Todorovac 28th of August 2019. AllenJJ , SchnyerRN , HittSK .The efficacy of acupuncture in the treatment of major depression in women. Psychological Science1998;9(5):397-401. ">Allen 1998</a> ; <a href="./references#MR000050-bbs2-0003" title="AllenJB .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 28th of August 2019. AllenJJ , SchnyerRN , ChambersAS , HittSK , MorenoFA , ManberR .Acupuncture for depression: a randomized controlled trial. Journal of Clinical Psychiatry2006;67(11):1665-73. ">Allen 2006</a> ; <a href="./references#MR000050-bbs2-0004" title="AlvarezJR .The effects of anger management training on depression, anger, self-concept, and treatment responsibility in a sample of drug-dependent individuals in a therapeutic community. Dissertation Abstracts International: Section B: the Sciences and Engineering1997;58(4-B):2108. ">Alvarez 1997</a> ; <a href="./references#MR000050-bbs2-0005" title="AscherLM , TurnerR .Paradoxical intention and insomnia: an experimental investigation. Behaviour Research and Therapy1979;17(4):408-11. ">Ascher 1979</a> ; <a href="./references#MR000050-bbs2-0006" title="AyenI , HautzingerM .Cognitive behavior therapy for depression in menopausal women. A controlled, randomized treatment study [Kognitive Verhaltenstherapie bei Depressionen im Klimakterium: Eine kontrollierte, randomiserte Interventionsstudie]. Zeitschrift für Klinische Psychologie und Psychotherapie2004;33(4):290-9. AyenI .Inclusion of study in Cochrane Systematic Review (personal communication). Email to EG Faltinsen 9th of September 2019. ">Ayen 2004</a> ; <a href="./references#MR000050-bbs2-0007" title="BergI , ForsytheI , HoltP , WattsJ .A controlled trial of ‘Senokot’ in faecal soiling treated by behavioural methods. Journal of Child Psychology and Psychiatry1983;24(4):543-9. ">Berg 1983</a> ; <a href="./references#MR000050-bbs2-0008" title="Borden, KA.Attributional Outcomes: the Subtle Messages of Treatments for Attention Deficit Disorder. Dissertation, University of Illinois at Urbana-Champaign1986. BordenKA , BrownRT .Attributional outcomes: The subtle messages of treatments for attention deficit disorder. Cognitive Therapy and Research1989;13(2):147-60. ">Borden 1986</a> ; <a href="./references#MR000050-bbs2-0009" title="BorkovecTD , KaloupekDG , SlamaKM .The facilitative effect of muscle tension-release in the relaxation treatment of sleep disturbance. Behavior Therapy1975;6(3):301-9. ">Borkovec 1975</a> ; <a href="./references#MR000050-bbs2-0010" title="BorkovecTD , WeertsTC .Effects of progressive relaxation on sleep disturbance: an electroencephalographic evaluation. Psychosomatic Medicine1976;38(3):173-80. ">Borkovec 1976</a> ; <a href="./references#MR000050-bbs2-0013" title="BrillNQ , KoeglerRR , EpsteinLJ , ForgyEW .Controlled study of psychiatric outpatient treatment. Archives of General Psychiatry1964;10:581-95. BrillNQ .Results of psychotherapy. California Medicine1966;104(4):249-53. ">Brill 1964a</a> ; <a href="./references#MR000050-bbs2-0014" title="BrillNQ , KoeglerRR , EpsteinLJ , ForgyEW .Controlled study of psychiatric outpatient treatment. Archives of General Psychiatry1964;10:581-95. ">Brill 1964b</a> ; <a href="./references#MR000050-bbs2-0015" title="CarlsonCL , PelhamWE , MilichR , HozaB .ADHD boys’ performance and attributions following success and failure: drug effects and individual differences. Cognitive Therapy and Research1993;17:269-87. ">Carlson 1993</a> ; <a href="./references#MR000050-bbs2-0018" title="CrouchG , RobsonM , HallstromC .Benzodiazepine dependent patients and their psychological treatment. Progress in Neuro-psychopharmacology &amp; Biological Psychiatry1988;12(4):503-10. HallströmC , CrouchG , RobsenM , ShineP .The treatment of tranquillizer dependence by propranolol. Postgraduate Medical Journal1988;64(Suppl 2):40-4. ">Crouch 1988</a> ; <a href="./references#MR000050-bbs2-0021" title="EhlersA , HackmannA , GreyN , WildJ , LinessS , AlbertI , et al.A randomized controlled trial of 7-day intensive and standard weekly cognitive therapy for PTSD and emotion-focused supportive therapy. American Journal of Psychiatry2014;171(3):294-304. ">Ehlers 2014</a> ; <a href="./references#MR000050-bbs2-0022" title="EspieCA , BrooksDN , LindsayWR .An evaluation of tailored psychological treatment of insomnia. Journal of Behavior Therapy and Experimental Psychiatry1989;20(2):143-53. EspieCA , LindsayWR , BrooksDN , HoodEM , TurveyT .A controlled comparative investigation of psychological treatments for chronic sleep-onset insomnia. Behaviour Research and Therapy1989;27(1):79-88. ">Espie 1989a</a> ; <a href="./references#MR000050-bbs2-0023" title="EtringerBD , CashTF , RimmDC .Behavioral, affective, and cognitive effects of participant modeling and an equally credible placebo. Behavior Therapy1982;13(4):476-85. ">Etringer 1982</a> ; <a href="./references#MR000050-bbs2-0024" title="FoaEB , RothbaumBO , RiggsDS , MurdockTB .Treatment of posttraumatic stress disorder in rape victims: a comparison between cognitive-behavioral procedures and counselling. Journal of Consulting and Clinical Psychology1991;59(5):715-23. ">Foa 1991</a> ; <a href="./references#MR000050-bbs2-0025" title="FoaEB , McLeanCP , ZangY , RosenfieldD , YadinE , YarvisJS , et al.Effect of prolonged exposure therapy delivered over 2 weeks vs 8 weeks vs present-centered therapy on PTSD symptom severity in military personnel: a randomized clinical trial. JAMA2018;319(4):354-64. ">Foa 2018</a> ; <a href="./references#MR000050-bbs2-0026" title="FreireAO , SugaiGC , ChrispinFS , TogeiroSM , YamamuraY , MelloLE , et al.Treatment of moderate obstructive sleep apnea syndrome with acupuncture: a randomised, placebo-controlled pilot trial. Sleep Medicine2007;8(1):43-50. ">Freire 2007</a> ; <a href="./references#MR000050-bbs2-0027" title="FuchsCZ , RehnLP .A self-control behavior therapy program for depression. Journal of Consulting and Clinical Psychology1977;45(2):206-15. ">Fuchs 1977</a> ; <a href="./references#MR000050-bbs2-0028" title="GlogowskaM , RoulstoneS , EnderbyP , PetersTJ .Randomised controlled trial of community based speech and language therapy in preschool children. BMJ2000;321(7266):923-6. ">Glogowska 2000</a> ; <a href="./references#MR000050-bbs2-0029" title="GoldsteinAJ , BeursE , Chambless Dl, WilsonKA .EMDR for panic disorder with agoraphobia: comparison with waiting list and credible attention-placebo control conditions. Journal of Consulting and Clinical Psychology2000;68(6):947-56. ">Goldstein 2000</a> ; <a href="./references#MR000050-bbs2-0031" title="HekmatH , LubitzR , DealR .Semantic desensitization: a paradigmatic intervention approach to anxiety disorders. Journal of Clinical Psychology1984;40(2):463-6. ">Hekmat 1984</a> ; <a href="./references#MR000050-bbs2-0033" title="HowlinP , GordonKR , PascoG , WadeA , CharmanT .The effectiveness of picture exchange communication system (PECS) training for teachers of children with autism: a pragmatic,group randomised controlled trial. Journal of Child Psychology and Psychiatry2007;48(5):473-81. ">Howlin 2007</a> ; <a href="./references#MR000050-bbs2-0034" title="KarstM , WinterhalterM , MünteS , FranckiB , HondronikosA , EckardtA , et al.Auricular acupuncture for dental anxiety: a randomized controlled trial. Anesthesia and Analgesia2007;104(2):295-300. KarstM .Inclusion of study in Cochrane Systematic Review (personal communication). Email to: EG Faltinsen 5th of September 2019. ">Karst 2007</a> ; <a href="./references#MR000050-bbs2-0035" title="KelleyJ .Inclusion of study in Cochrane Systematic Review (personal communication). Email to: A Todorovac 12th of August 2019. KelleyJM , KaptchukTJ , CusinC , LipkinS , FavaM .Open-label placebo for major depressive disorder: a pilot randomized controlled trial. Psychotherapy and Psychosomatics2012;81(5):312-4. ">Kelley 2012</a> ; <a href="./references#MR000050-bbs2-0036" title="KennedyTD , KimuraHK .Transfer, behavioral improvement, and anxiety reduction in systematic desensitization. Journal of Consulting and Clinical Psychology1974;42(5):720-8. ">Kennedy 1974</a> ; <a href="./references#MR000050-bbs2-0037" title="KilmannPR , MilanRJ , BolandJP , NankinHR , DavidsonE , WestMO , et al.Group treatment of secondary erectile dysfunction. Journal of Sex &amp; Marital Therapy1987;13(3):168-82. KilmannPR , Milan RJ Jr, BolandJP , DavidsonE , WestMO , SablisRF , et al.The sexual interactions of men with secondary erectile dysfunction. Journal of Sex Education and Therapy1988;14(1):46-9. KilmannPR , Milan RJ Jr, BolandJP , NankinHR , SablisRF , WestMO , et al.The sexual interactions of men with secondary erectile dysfunction. Paper presented at the annual meeting of the American Psychological Association in Los Angeles1985;1:46-9. ">Kilmann 1987</a> ; <a href="./references#MR000050-bbs2-0038" title="KleinSA , DeffenbacherJL .Relaxation and exercise for hyperactive impulsive children. Perceptual and Motor Skills1977;45:1159-62. ">Klein 1977</a> ; <a href="./references#MR000050-bbs2-0039" title="KlermanGL , DimascioA , WeismannM , PrusoffB , PaykelES .Treatment of depression by drugs and psychotherapy. American Journal of Psychiatry1974;131(2):186-91. PaykelES , DimascioA , HaskellD , PrusoffBA .Effects of maintenance amitriptyline and psychotherapy on symptoms of depression. Psychological Medicine1975;5(1):67-77. PaykelES , DiMascioA , KlermanGL , PrusoffBA .Maintenance therapy of depression. Pharmakopsychiatrie, Neuro-Psychopharmakologie1976;9:127-39. PaykelES , WeissmanMM , PrusoffBA .Social maladjustment and severity of depression. Comprehensive Psychiatry1978;19(2):121-8. WeissmanMM , KlermanGL , PaykelES , PrusoffB .Treatment effects on the social adjustment of depressed patients. Archives of General Psychiatry1974;30:771-8. ">Klerman 1974a</a> ; <a href="./references#MR000050-bbs2-0040" title="KlermanGL , DimascioA , WeismannM , PrusoffB , PaykelES .Treatment of depression by drugs and psychotherapy. American Journal of Psychiatry1974;131(2):186-91. ">Klerman 1974b</a> ; <a href="./references#MR000050-bbs2-0041" title="KloskoJS , BarlowDH , TassinariR , CernyJA .A comparison of alprazolam and behavior therapy in treatment of panic disorder: correction. Journal of Psychotherapy Practice and Research1994;3(2):163-79. KloskoJS , BarlowDH , TassinariR , CernyJA .A comparison of alprazolam and behavior therapy in treatment of panic disorder. Journal of Consulting and Clinical Psychology1990;58(1):77-84. ">Klosko 1990</a> ; <a href="./references#MR000050-bbs2-0042" title="KrapflJE , NawasMM .Differential ordering of stimulus presentation in systematic desensitization. Journal of Abnormal Psychology1970;75(3):333-7. ">Krapfl 1970</a> ; <a href="./references#MR000050-bbs2-0043" title="KwanR .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 26th of August 2019. KwanRY , LeungMC , LaiCK .Acupressure for agitation in nursing home residents with dementia: study protocol for a randomized controlled trial. Trials2014;15(410):1-7. KwanRY , LeungMCP , LaiCK .A randomized controlled trial examining the effect of acupressure on agitation and salivary cortisol in nursing home residents with dementia. Dementia and Geriatric Cognitive Disorders2017;44(1-2):92-104. ">Kwan 2017</a> ; <a href="./references#MR000050-bbs2-0046" title="LangOJ , LazovikAD .Experimental desensitization of a phobia. Journal of Abnormal and Social Psychology1963;66:519-25. LangPJ , LazovikAD , ReynoldsDJ .Desensitization, suggestibility, and pseudotherapy. Journal of Abnormal Psychology1965;70(6):395-402. ">Lang 1965</a> ; <a href="./references#MR000050-bbs2-0048" title="LickJ .Expectancy, false galvanic skin response feedback, and systematic desensitization in the modification of phobic behavior. Journal of Consulting and Clinical Psychology1975;43(4):557-67. ">Lick 1975</a> ; <a href="./references#MR000050-bbs2-0049" title="LickJR , HefflerD .Relaxation training and attention placebo in the treatment of severe insomnia. Journal of Consulting and Clinical Psychology1977;45(2):153-61. ">Lick 1977</a> ; <a href="./references#MR000050-bbs2-0050" title="LiddleB , SpenceSH .Cognitive-behaviour therapy with depressed primary school children: A cautionary note. Behavioural Psychotherapy1990;18(2):85-102. ">Liddle 1990</a> ; <a href="./references#MR000050-bbs2-0051" title="MatsonJL , MarchettiA , AdkinsJA .Comparison of operant- and independence-training procedures for mentally retarded adults. American Journal of Mental Deficiency1980;84(5):487-94. ">Matson 1980</a> ; <a href="./references#MR000050-bbs2-0053" title="MealieaWL , NawasMM .The comparative effectiveness of systematic desensitization and implosive therapy in the treatment of snake phobia. Journal of Behavior Therapy and Experimental Psychiatry1971;2(2):85-94. ">Mealiea 1971</a> ; <a href="./references#MR000050-bbs2-0054" title="MilbyJB , ClarkeC , ToroC , ThorntonS , RickertD .Effectiveness of urine surveillance as an adjunct to outpatient psychotherapy for drug abusers. International Journal of the Addictions1980;15(7):993-1001. ">Milby 1980</a> ; <a href="./references#MR000050-bbs2-0055" title="MirandaA , ArlandisP , SorianoM .Instruction in strategies and attributional training: Effects on the problem-solving and self-concept of students’ with learning disabilities [Instrucción en estrategias y entrenamiento atribucional: efectos sobre la resolución de problemas y el autoconcepto de los estudiantes con dificultades en el aprendizaje]. Infancia y Aprendizaje1997;20(80):37-52. ">Miranda 1997</a> ; <a href="./references#MR000050-bbs2-0056" title="MitchellC , MansfieldD , RautenbachS .Coloured filters and reading accuracy, comprehension and rate: a placebo-controlled study. Perceptual and Motor Skills2008;106(2):517-32. ">Mitchell 2008</a> ; <a href="./references#MR000050-bbs2-0057" title="NandiDN , AjmanyS , GanguliH , BanerjeeG , BoralGC , GhoshA , et al.A clinical evaluation of depressives found in a rural survey in India. British Journal of Psychiatry1976;128:523-7. ">Nandi 1976</a> ; <a href="./references#MR000050-bbs2-0058" title="NicassioP , BootzinR .A comparison of progressive relaxation and autogenic training as treatments for insomnia. Journal of Abnormal Psychology1974;83(3):253-60. ">Nicassio 1974</a> ; <a href="./references#MR000050-bbs2-0061" title="MilichR , CarlsonCL , Pelham WE Jr, LichtBG .Effects of methylphenidate on the persistence of ADHD boys following failure experiences. Journal of Abnormal Child Psychology1991;19(5):519-36. PelhamWE , MurphyDA , VannattaK , MilichR , LichtBG , GnagyEM , et al.Methylphenidate and attributions in boys with attention-deficit hyperactivity disorder. Journal of Consulting and Clinical Psychology1992;60(2):282-92. ">Pelham 1992</a> ; <a href="./references#MR000050-bbs2-0062" title="PedletonMG , HigginsRL .A comparison of negative practice and systematic desensitization in the treatment of acrophobia. Journal of Behavior Therapy and Experimental Psychiatry1983;14(4):317-23. ">Pendleton 1983</a> ; <a href="./references#MR000050-bbs2-0064" title="PolandRE , GertsikL , FavreauJT , SmithSI , MirochaJM , RaoU , et al.Open-label randomized parallel-group controlled clinical trial of massage for treatment of depression in HIV-infected subjects. Journal of Alternative and Complementary Medicine2013;19(4):334-40. ">Poland 2013</a> ; <a href="./references#MR000050-bbs2-0065" title="PowersMB , SmitsJA , TelchMJ .Disentangling the effects of safety-behavior utilization and safety-behavior availability during exposure-based treatment: a placebo-controlled trial. Journal of Consulting and Clinical Psychology2004;72(3):448-54. ">Powers 2004</a> ; <a href="./references#MR000050-bbs2-0066" title="PowersMB , SmithsJA , WhitleyD , BystritskyA , TelchMJ .The effect of attributional processes concerning medication taking on return of fear. Journal of Consulting and Clinical Psychology2008;76(3):478-90. ">Powers 2008a</a> ; <a href="./references#MR000050-bbs2-0067" title="PowersMB , SmithsJA , WhitleyD , BystritskyA , TelchMJ .The effect of attributional processes concerning medication taking on return of fear. Journal of Consulting and Clinical Psychology2008;76(3):478-90. ">Powers 2008b</a> ; <a href="./references#MR000050-bbs2-0068" title="ProudfootJ , ClarkeJ , BirchMR , WhittonAE , ParkerG , ManicavasagarV , et al.Impact of a mobile phone and web program on symptom and functional outcomes for people with mild- to-moderate depression, anxiety and stress: a randomized controlled trial. BMC Psychiatry2013;13(312):1-12. ProudfootJ .Re: Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 26th of August 2019. ">Proudfoot 2013</a> ; <a href="./references#MR000050-bbs2-0069" title="QuayhagenMP , QuayhagenM , CorbeilRR , RothPA , RodgersJA .A dyadic remediation program for care recipients with dementia. Nursing Research1995;44(3):153-9. ">Quayhagen 1995</a> ; <a href="./references#MR000050-bbs2-0070" title="LiebowitzM , QuitkinFM , StewartJW , McGrathPJ , HarrisonWM , MarkowitzJS , et al.Antidepressant efficacy in atypical depression. Archives of General Psychiatry1988;45(2):129-37. QuitkinFM , McGrathPJ , StewartJW , HarrisonW , WagerSG , NunesE , et al.Phenelzine and imipramine in mood reactive depressives: further delineation of the syndrome of atypical depression. Archives of General Psychiatry1989;46(9):787-93. RabkinJG , McGrathPJ , QuitkinFM , TricamoE , StewartJW , KleinDF .Effects of pill-giving on maintenance of placebo response in patients with chronic mild depression. American Journal of Psychiatry1990;147(12):1622-6. ">Rabkin 1990</a> ; <a href="./references#MR000050-bbs2-0071" title="RapeeR .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 29th of August 2019. RapeeRM , AbbottMJ , LynehamHJ .Bibliotherapy for children With anxiety disorders using written materials for parents: a randomized controlled trial. Journal of Consulting and Clinical Psychology2006;74(3):436-44. ">Rapee 2006</a> ; <a href="./references#MR000050-bbs2-0072" title="RapeeR .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 29th of August 2019. RapeeRM , AbbottMJ , BaillieAJ , GastonJE .Treatment of social phobia through pure self-help and therapist-augmented self-help. British Journal of Psychiatry2007;191:246-52. ">Rapee 2007</a> ; <a href="./references#MR000050-bbs2-0073" title="RobinA .Rationing out-patients: a defence of the waiting list. British Journal of Psychiatry1976;129:138-41. ">Robin 1976</a> ; <a href="./references#MR000050-bbs2-0075" title="OlivaresJ .Program IAFS. Protocol for the treatment of social phobia in adolescents [Programa IAFS. Protocolo para el tratamiento de la fobia social enadolescentes]. Madrid: Pirámide2005;1. Rosa-AlcázarAI , Olivares-OlivaresPJ , OlivaresJ .The role of non-specific effects in the psychological treatment of adolescents with social phobia [Papel de los efectos inespecíficos en el tratamiento psicológico de adolescentes con fobia social]. Anuario de Psicologia2009;40(1):43-61. ">Rosa‐Alcatraz 2009</a> ; <a href="./references#MR000050-bbs2-0076" title="RosenGM , GlasgowRE , BarreraM .A controlled study to assess the clinical efficacy of totally self-administrated systematic desensitization. Journal of Consulting and Clinical Psychology1976;44(2):208-17. ">Rosen 1976</a> ; <a href="./references#MR000050-bbs2-0077" title="LorrM , McNairDM , WeinsteinGJ .Early effects of chlordiazepoxide (Librium) used with psychotherapy. Journal of Psychiatric Research1963;1:257-70. RothI , RhudickPJ , ShaskanDA , SlobinMS , WilkinsonAE , YoungHH .Long-term effects on psychotherapy of initial treatment conditions. Journal of Psychiatric Research1964;2:283-97. ">Roth 1964</a> ; <a href="./references#MR000050-bbs2-0079" title="ShalevAY , AnkriY , Isreali-ShalevY , PelegT , AdesskyR , FreedmanS .Prevention of posttraumatic stress disorder by early treatment. Archives of General Psychiatry2012;69(2):166-76. ">Shalev 2012</a> ; <a href="./references#MR000050-bbs2-0080" title="ShealyRC .The effectiveness of various treatment techniques on different degrees and durations of sleep-onset insomnia. Behaviour Research and Therapy1979;17(6):541-6. ">Shealy 1979</a> ; <a href="./references#MR000050-bbs2-0083" title="SteinmarkSW , BorkovecTD .Active and placebo treatment effects on moderate insomnia under counterdemand and positive demand instructions. Journal of Abnormal Psychology1974;83(2):157-63. ">Steinmark 1974</a> ; <a href="./references#MR000050-bbs2-0084" title="SzymanskiJ , O'DonohueW .The potential role of state-dependent learning in cognitive therapy with spider phobics. Journal of Rational-Emotive &amp; Cognitive-Behavior Therapy1995;13(2):131-50. SzymanskiJ .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 20th of August 2019. ">Szymanski 1995</a> ; <a href="./references#MR000050-bbs2-0085" title="TanSY , BruniJ .Cognitive-behavior therapy with adult patients with epilepsy: a controlled outcome study. Epilepsia1986;27(3):225-33. ">Tan 1986</a> ; <a href="./references#MR000050-bbs2-0086" title="TeriL , LogsdonRG , UomotoJ , McCurrySM .Behavioral treatment of depression in dementia patients: a controlled clinical trial. Journals of Gerontology. Series B, Psychological Sciences and Social Sciences1997;52(4):159-66. TeriL .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 26th of August 2019. ">Teri 1997</a> ; <a href="./references#MR000050-bbs2-0087" title="ToriC , WorellL .Reduction of human avoidant behavior. A comparison of counterconditioning, expectancy, and cognitive information approaches. Clinical Psychology1973;41(2):269-78. ">Tori 1973</a> ; <a href="./references#MR000050-bbs2-0088" title="Trexler, L.Rational-emotive therapy, placebo, and no-treatment effects on public-speaking anxiety. Doctoral dissertation, Temple University AnnArbor, Mich.: University Microfilms1971;71-31(063). TrexlerLD , KarstTO .Rational-emotive therapy, placebo, and no-treatment effects on public-speaking anxiety. Journal of Abnormal Psyhology1972;79(1):60-7. ">Trexler 1972</a> ; <a href="./references#MR000050-bbs2-0089" title="AscherML , TurnerRM .A comparison of two methods for the administration of paradoxical intention. Behaviour Research and Therapy1980;18(2):121-6. TurnerRM , AscherLM .Controlled comparison of progressive relaxation, stimulus control, and paradoxical intention therapies for insomnia. Journal of Consulting and Clinical Psychology1979;47(3):500-8. ">Turner 1979</a> ; <a href="./references#MR000050-bbs2-0090" title="VanderplateC .Electromyograph biofeedback Treatment of sleep onset Insomnia: a controlled Investigation. Dissertation, University of Southern Mississippi1978. ">Vanderplate 1983</a> ; <a href="./references#MR000050-bbs2-0094" title="WilsonA , DavidsonWJ , BlanchardR , WhiteJ .Disulfiram implantation. A placebo-controlled trial with two-year follow-up. Journal of Studies on Alcohol1978;39(5):809-19. WilsonA , DavidsonWJ , BlanchardR .Disulfiram implantation: a trial using placebo implants and two types of controls. Journal of Studies on Alcohol1980;41(5):429-36. ">Wilson 1980</a> ; <a href="./references#MR000050-bbs2-0095" title="WolitzkyKB , TelchMJ .Augmenting in vivo exposure with fear antagonistic actions: a preliminary test. Behavior Therapy2009;40(1):57-71. ">Wolitzky 2009</a> ; <a href="./references#MR000050-bbs2-0096" title="WollersheimJP , WilsonGL .Group treatment of unipolar depression: a comparison of coping, supportive, bibliotherapy, and delayed treatment groups. Professional Psychology: Research and Practice1991;22(6):496-502. ">Wollersheim 1991</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Studies with inpatient<br/>settings </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>20</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#MR000050-bbs2-0011" title="BornovalovaM .Inclusion of study in Cochrane Systematic Review (personal communication). Email to A Todorovac. 21st of August 2019. BornovalovaMA .Distress tolerance treatment for inner-city drug users: a preliminary trial. Doctor’s Dissertation, University of Maryland2008. ">Bornovalova 2008</a> ; <a href="./references#MR000050-bbs2-0012" title="BramstonP , SpenceSH .Behavioural versus cognitive social-skills training with intellectually-handicapped adults. Behaviour Research and Therapy1985;23(3):239-46. ">Bramston 1985</a> ; <a href="./references#MR000050-bbs2-0016" title="CarterJC , OlmstedMP , KaplanAS , McCabeRE , MillsJS , AimeA .Self-help for bulimia nervosa: a randomized controlled trial. American Journal of Psychiatry2003;160(5):973-8. ">Carter 2003</a> ; <a href="./references#MR000050-bbs2-0019" title="Doty, DW.Role playing and incentives in the modification of the social interaction of chronic psychiatric patients. Journal of Consulting and Clinical Psychology1975;43(5):676-82. ">Doty 1975</a> ; <a href="./references#MR000050-bbs2-0020" title="DoubleDB , WarrenGC , EvansM , RowlandsMP .Efficacy of maintenance use of anticholinergic agents. Acta Psychiatrica Scandinavica1993;88:381-4. ">Double 1993</a> ; <a href="./references#MR000050-bbs2-0030" title="GoldwasserAN , AuerbachSM , HarkinsSW .Cognitive, affective, and behavioural effects of reminiscence group therapy on demented elderly. Aging and Human Development1987;25(3):209-22. ">Goldwasser 1987</a> ; <a href="./references#MR000050-bbs2-0044" title="LacyMK .The effect of short term autogenic training on the stress reactivity of hospitalized emotionally disturbed adolescents. ProQuest Dissertations Publishing, Oklahoma State University1996. ">Lacy 1990</a> ; <a href="./references#MR000050-bbs2-0045" title="LaiCK , ChiI , Kayser-JonesJ .A randomized controlled trial of a specific reminiscence approach to promote the well-being of nursing home residents with dementia. International Psychogeriatrics2004;16(1):33-49. LaiK .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 6th of September 2019. ">Lai 2004</a> ; <a href="./references#MR000050-bbs2-0047" title="LegrandF .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 14th of August 2019. LegrandFD , NeffEM .Efficacy of exercise as an adjunct treatment for clinically depressed inpatients during the initial stages of antidepressant pharmacotherapy: an open randomized controlled trial. Journal of Affective Disorders2016;191:139-44. ">Legrand 2016</a> ; <a href="./references#MR000050-bbs2-0052" title="McLachlanDR , DaltonAJ , KruckTP , BellMY , SmithWL , KalowW , et al.Intramuscular desferrioxamine in patients with Alzheimer's disease. Lancet1991;337(8753):1304-8. McLachlanDRC , SmithWL , KruckTP .Desferrioxamine and Alzheimer’s disease: video home behavior assessment of clinical course and measures of brain aluminum. Therapeutic Drug Monitoring1993;15(6):602-7. ">McLachlan 1991</a> ; <a href="./references#MR000050-bbs2-0060" title="PeckCL .Desensitization for the treatment of fear in the high level adult retardate. Behaviour Research and Therapy1977;15(2):137-48. ">Peck 1976</a> ; <a href="./references#MR000050-bbs2-0059" title="PearlD , Vander KampH , OlsenAL , GreenbergPD , ArmitageSG .The effects of reserpine on schizophrenic patients. American Journal of Psychiatry1956;112:198-204. ">Pearl 1956</a> ; <a href="./references#MR000050-bbs2-0063" title="PetersonMA , PattersonB , PillmanBM , BattistaMA .Cognitive recovery following alcohol detoxification: a computerised remediation study. Neuropsychological Rehabilitation2002;12(1):63-74. PillmanBM .Computerized cognitive remediation with recently detoxified alcoholics. Dissertation, California School of Professional Psychology, Fresno Campus2000. ">Pillman 2001</a> ; <a href="./references#MR000050-bbs2-0074" title="RoehrichL , GoldmanMS .Experience-dependent neuropsychological recovery and the treatment of alcoholism. Journal of Consulting and Clinical Psychology1993;61(5):812-21. ">Roehrich 1993</a> ; <a href="./references#MR000050-bbs2-0078" title="RupertPA , HolmesDS .Effects of multiple sessions of true and placebo heart rate biofeedback training on the heart rates and anxiety levels of anxious patients during and following treatment. Psychophysiology1978;15(6):582-90. ">Rupert 1978</a> ; <a href="./references#MR000050-bbs2-0081" title="SibilioJP , AndrewG , DartD , MooreKB , StehmanA .Treatment of chronic schizophrenia with promazine hydrochloride. AMA Archives of Neurology and Psychiatry1957;78(4):419-24. ">Sibilio 1957</a> ; <a href="./references#MR000050-bbs2-0082" title="SommernessMD , LuceroRJ , HamlonJS , EricksonJL , MatthewsR .A controlled study of reserpine on chronically disturbed patients. JAMA Archives of Neurology and Psychiatry1955;74(3):316-9. ">Sommerness 1955</a> ; <a href="./references#MR000050-bbs2-0091" title="WatzlH , RistF , OlbrichR , CohenR .Placebo injections and surveillance of alcohol intake during inpatient treatment of female alcoholics. Addictive Behaviors1988;13(2):197-200. ">Watzl 1988</a> ; <a href="./references#MR000050-bbs2-0092" title="WeingaertnerAH .Self-administered aversive stimulation with hallucinating hospitalized schizophrenics. Journal of Consulting and Clinical Psychology1971;36(3):422-29. ">Weingaertner 1971</a> ; <a href="./references#MR000050-bbs2-0093" title="WhittakerCB , HoyRM .Withdrawal of perphenazine in chronic schizophrenia. British Journal of Psychiatry1963;109:422-7. ">Whittaker 1963</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Studies with both<br/>inpatient and outpatient<br/>settings </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#MR000050-bbs2-0017" title="CrispAH , NortonK , GowersS , HalekC , BowyerC , YeldhamD , et al.A controlled study of the effect of therapies aimed at adolescent and family psychopathology in Anorexia Nervosa. British Journal of Psychiatry: the Journal of Mental Science1991;159:325-33. GowersS , NortonK , HalekC , CrispAH .Outcome of outpatient psychotherapy in a random allocation treatment study of anorexia nervosa. International Journal of Eating Disorders1994;15(2):165-77. GowersS , NortonK , YelshamD .The St George's prospective treatment study of anorexia nervosa: a discussion of methodological problems. International Journal of Eating Disorders1989;8:445-54. ">Crisp 1991</a> ; <a href="./references#MR000050-bbs2-0032" title="HippmanC , RingroseA , InglisA , CheekJ , AlbertAY , RemickR , et al.A pilot randomized clinical trial evaluating the impact of genetic counselling for serious mental illnesses. Journal of Clinical Psychiatry2016;77(2):e190-8. ">Hippman 2016</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Sample size</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Sample size above<br/>100 participants </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#MR000050-bbs2-0025" title="FoaEB , McLeanCP , ZangY , RosenfieldD , YadinE , YarvisJS , et al.Effect of prolonged exposure therapy delivered over 2 weeks vs 8 weeks vs present-centered therapy on PTSD symptom severity in military personnel: a randomized clinical trial. JAMA2018;319(4):354-64. ">Foa 2018</a> ; <a href="./references#MR000050-bbs2-0028" title="GlogowskaM , RoulstoneS , EnderbyP , PetersTJ .Randomised controlled trial of community based speech and language therapy in preschool children. BMJ2000;321(7266):923-6. ">Glogowska 2000</a> ; <a href="./references#MR000050-bbs2-0068" title="ProudfootJ , ClarkeJ , BirchMR , WhittonAE , ParkerG , ManicavasagarV , et al.Impact of a mobile phone and web program on symptom and functional outcomes for people with mild- to-moderate depression, anxiety and stress: a randomized controlled trial. BMC Psychiatry2013;13(312):1-12. ProudfootJ .Re: Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 26th of August 2019. ">Proudfoot 2013</a> ; <a href="./references#MR000050-bbs2-0071" title="RapeeR .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 29th of August 2019. RapeeRM , AbbottMJ , LynehamHJ .Bibliotherapy for children With anxiety disorders using written materials for parents: a randomized controlled trial. Journal of Consulting and Clinical Psychology2006;74(3):436-44. ">Rapee 2006</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Gender</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Only females included</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>19</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#MR000050-bbs2-0002" title="AllenJB .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to A Todorovac 28th of August 2019. AllenJJ , SchnyerRN , HittSK .The efficacy of acupuncture in the treatment of major depression in women. Psychological Science1998;9(5):397-401. ">Allen 1998</a> ; <a href="./references#MR000050-bbs2-0006" title="AyenI , HautzingerM .Cognitive behavior therapy for depression in menopausal women. A controlled, randomized treatment study [Kognitive Verhaltenstherapie bei Depressionen im Klimakterium: Eine kontrollierte, randomiserte Interventionsstudie]. Zeitschrift für Klinische Psychologie und Psychotherapie2004;33(4):290-9. AyenI .Inclusion of study in Cochrane Systematic Review (personal communication). Email to EG Faltinsen 9th of September 2019. ">Ayen 2004</a> ; <a href="./references#MR000050-bbs2-0013" title="BrillNQ , KoeglerRR , EpsteinLJ , ForgyEW .Controlled study of psychiatric outpatient treatment. Archives of General Psychiatry1964;10:581-95. BrillNQ .Results of psychotherapy. California Medicine1966;104(4):249-53. ">Brill 1964a</a> ; <a href="./references#MR000050-bbs2-0014" title="BrillNQ , KoeglerRR , EpsteinLJ , ForgyEW .Controlled study of psychiatric outpatient treatment. Archives of General Psychiatry1964;10:581-95. ">Brill 1964b</a> ; <a href="./references#MR000050-bbs2-0016" title="CarterJC , OlmstedMP , KaplanAS , McCabeRE , MillsJS , AimeA .Self-help for bulimia nervosa: a randomized controlled trial. American Journal of Psychiatry2003;160(5):973-8. ">Carter 2003</a> ; <a href="./references#MR000050-bbs2-0017" title="CrispAH , NortonK , GowersS , HalekC , BowyerC , YeldhamD , et al.A controlled study of the effect of therapies aimed at adolescent and family psychopathology in Anorexia Nervosa. British Journal of Psychiatry: the Journal of Mental Science1991;159:325-33. GowersS , NortonK , HalekC , CrispAH .Outcome of outpatient psychotherapy in a random allocation treatment study of anorexia nervosa. International Journal of Eating Disorders1994;15(2):165-77. GowersS , NortonK , YelshamD .The St George's prospective treatment study of anorexia nervosa: a discussion of methodological problems. International Journal of Eating Disorders1989;8:445-54. ">Crisp 1991</a> ; <a href="./references#MR000050-bbs2-0021" title="EhlersA , HackmannA , GreyN , WildJ , LinessS , AlbertI , et al.A randomized controlled trial of 7-day intensive and standard weekly cognitive therapy for PTSD and emotion-focused supportive therapy. American Journal of Psychiatry2014;171(3):294-304. ">Ehlers 2014</a> ; <a href="./references#MR000050-bbs2-0024" title="FoaEB , RothbaumBO , RiggsDS , MurdockTB .Treatment of posttraumatic stress disorder in rape victims: a comparison between cognitive-behavioral procedures and counselling. Journal of Consulting and Clinical Psychology1991;59(5):715-23. ">Foa 1991</a> ; <a href="./references#MR000050-bbs2-0027" title="FuchsCZ , RehnLP .A self-control behavior therapy program for depression. Journal of Consulting and Clinical Psychology1977;45(2):206-15. ">Fuchs 1977</a> ; <a href="./references#MR000050-bbs2-0036" title="KennedyTD , KimuraHK .Transfer, behavioral improvement, and anxiety reduction in systematic desensitization. Journal of Consulting and Clinical Psychology1974;42(5):720-8. ">Kennedy 1974</a> ; <a href="./references#MR000050-bbs2-0039" title="KlermanGL , DimascioA , WeismannM , PrusoffB , PaykelES .Treatment of depression by drugs and psychotherapy. American Journal of Psychiatry1974;131(2):186-91. PaykelES , DimascioA , HaskellD , PrusoffBA .Effects of maintenance amitriptyline and psychotherapy on symptoms of depression. Psychological Medicine1975;5(1):67-77. PaykelES , DiMascioA , KlermanGL , PrusoffBA .Maintenance therapy of depression. Pharmakopsychiatrie, Neuro-Psychopharmakologie1976;9:127-39. PaykelES , WeissmanMM , PrusoffBA .Social maladjustment and severity of depression. Comprehensive Psychiatry1978;19(2):121-8. WeissmanMM , KlermanGL , PaykelES , PrusoffB .Treatment effects on the social adjustment of depressed patients. Archives of General Psychiatry1974;30:771-8. ">Klerman 1974a</a> ; <a href="./references#MR000050-bbs2-0040" title="KlermanGL , DimascioA , WeismannM , PrusoffB , PaykelES .Treatment of depression by drugs and psychotherapy. American Journal of Psychiatry1974;131(2):186-91. ">Klerman 1974b</a> ; <a href="./references#MR000050-bbs2-0042" title="KrapflJE , NawasMM .Differential ordering of stimulus presentation in systematic desensitization. Journal of Abnormal Psychology1970;75(3):333-7. ">Krapfl 1970</a> ; <a href="./references#MR000050-bbs2-0048" title="LickJ .Expectancy, false galvanic skin response feedback, and systematic desensitization in the modification of phobic behavior. Journal of Consulting and Clinical Psychology1975;43(4):557-67. ">Lick 1975</a> ; <a href="./references#MR000050-bbs2-0053" title="MealieaWL , NawasMM .The comparative effectiveness of systematic desensitization and implosive therapy in the treatment of snake phobia. Journal of Behavior Therapy and Experimental Psychiatry1971;2(2):85-94. ">Mealiea 1971</a> ; <a href="./references#MR000050-bbs2-0080" title="ShealyRC .The effectiveness of various treatment techniques on different degrees and durations of sleep-onset insomnia. Behaviour Research and Therapy1979;17(6):541-6. ">Shealy 1979</a> ; <a href="./references#MR000050-bbs2-0081" title="SibilioJP , AndrewG , DartD , MooreKB , StehmanA .Treatment of chronic schizophrenia with promazine hydrochloride. AMA Archives of Neurology and Psychiatry1957;78(4):419-24. ">Sibilio 1957</a> ; <a href="./references#MR000050-bbs2-0090" title="VanderplateC .Electromyograph biofeedback Treatment of sleep onset Insomnia: a controlled Investigation. Dissertation, University of Southern Mississippi1978. ">Vanderplate 1983</a> ; <a href="./references#MR000050-bbs2-0091" title="WatzlH , RistF , OlbrichR , CohenR .Placebo injections and surveillance of alcohol intake during inpatient treatment of female alcoholics. Addictive Behaviors1988;13(2):197-200. ">Watzl 1988</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Only males included</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>14</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#MR000050-bbs2-0015" title="CarlsonCL , PelhamWE , MilichR , HozaB .ADHD boys’ performance and attributions following success and failure: drug effects and individual differences. Cognitive Therapy and Research1993;17:269-87. ">Carlson 1993</a> ; <a href="./references#MR000050-bbs2-0019" title="Doty, DW.Role playing and incentives in the modification of the social interaction of chronic psychiatric patients. Journal of Consulting and Clinical Psychology1975;43(5):676-82. ">Doty 1975</a> ; <a href="./references#MR000050-bbs2-0037" title="KilmannPR , MilanRJ , BolandJP , NankinHR , DavidsonE , WestMO , et al.Group treatment of secondary erectile dysfunction. Journal of Sex &amp; Marital Therapy1987;13(3):168-82. KilmannPR , Milan RJ Jr, BolandJP , DavidsonE , WestMO , SablisRF , et al.The sexual interactions of men with secondary erectile dysfunction. Journal of Sex Education and Therapy1988;14(1):46-9. KilmannPR , Milan RJ Jr, BolandJP , NankinHR , SablisRF , WestMO , et al.The sexual interactions of men with secondary erectile dysfunction. Paper presented at the annual meeting of the American Psychological Association in Los Angeles1985;1:46-9. ">Kilmann 1987</a> ; <a href="./references#MR000050-bbs2-0038" title="KleinSA , DeffenbacherJL .Relaxation and exercise for hyperactive impulsive children. Perceptual and Motor Skills1977;45:1159-62. ">Klein 1977</a> ; <a href="./references#MR000050-bbs2-0059" title="PearlD , Vander KampH , OlsenAL , GreenbergPD , ArmitageSG .The effects of reserpine on schizophrenic patients. American Journal of Psychiatry1956;112:198-204. ">Pearl 1956</a> ; <a href="./references#MR000050-bbs2-0061" title="MilichR , CarlsonCL , Pelham WE Jr, LichtBG .Effects of methylphenidate on the persistence of ADHD boys following failure experiences. Journal of Abnormal Child Psychology1991;19(5):519-36. PelhamWE , MurphyDA , VannattaK , MilichR , LichtBG , GnagyEM , et al.Methylphenidate and attributions in boys with attention-deficit hyperactivity disorder. Journal of Consulting and Clinical Psychology1992;60(2):282-92. ">Pelham 1992</a> ; <a href="./references#MR000050-bbs2-0063" title="PetersonMA , PattersonB , PillmanBM , BattistaMA .Cognitive recovery following alcohol detoxification: a computerised remediation study. Neuropsychological Rehabilitation2002;12(1):63-74. PillmanBM .Computerized cognitive remediation with recently detoxified alcoholics. Dissertation, California School of Professional Psychology, Fresno Campus2000. ">Pillman 2001</a> ; <a href="./references#MR000050-bbs2-0064" title="PolandRE , GertsikL , FavreauJT , SmithSI , MirochaJM , RaoU , et al.Open-label randomized parallel-group controlled clinical trial of massage for treatment of depression in HIV-infected subjects. Journal of Alternative and Complementary Medicine2013;19(4):334-40. ">Poland 2013</a> ; <a href="./references#MR000050-bbs2-0074" title="RoehrichL , GoldmanMS .Experience-dependent neuropsychological recovery and the treatment of alcoholism. Journal of Consulting and Clinical Psychology1993;61(5):812-21. ">Roehrich 1993</a> ; <a href="./references#MR000050-bbs2-0077" title="LorrM , McNairDM , WeinsteinGJ .Early effects of chlordiazepoxide (Librium) used with psychotherapy. Journal of Psychiatric Research1963;1:257-70. RothI , RhudickPJ , ShaskanDA , SlobinMS , WilkinsonAE , YoungHH .Long-term effects on psychotherapy of initial treatment conditions. Journal of Psychiatric Research1964;2:283-97. ">Roth 1964</a> ; <a href="./references#MR000050-bbs2-0078" title="RupertPA , HolmesDS .Effects of multiple sessions of true and placebo heart rate biofeedback training on the heart rates and anxiety levels of anxious patients during and following treatment. Psychophysiology1978;15(6):582-90. ">Rupert 1978</a> ; <a href="./references#MR000050-bbs2-0082" title="SommernessMD , LuceroRJ , HamlonJS , EricksonJL , MatthewsR .A controlled study of reserpine on chronically disturbed patients. JAMA Archives of Neurology and Psychiatry1955;74(3):316-9. ">Sommerness 1955</a> ; <a href="./references#MR000050-bbs2-0092" title="WeingaertnerAH .Self-administered aversive stimulation with hallucinating hospitalized schizophrenics. Journal of Consulting and Clinical Psychology1971;36(3):422-29. ">Weingaertner 1971</a> ; <a href="./references#MR000050-bbs2-0093" title="WhittakerCB , HoyRM .Withdrawal of perphenazine in chronic schizophrenia. British Journal of Psychiatry1963;109:422-7. ">Whittaker 1963</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Diagnostic classification</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>DSM‐II diagnosis</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#MR000050-bbs2-0039" title="KlermanGL , DimascioA , WeismannM , PrusoffB , PaykelES .Treatment of depression by drugs and psychotherapy. American Journal of Psychiatry1974;131(2):186-91. PaykelES , DimascioA , HaskellD , PrusoffBA .Effects of maintenance amitriptyline and psychotherapy on symptoms of depression. Psychological Medicine1975;5(1):67-77. PaykelES , DiMascioA , KlermanGL , PrusoffBA .Maintenance therapy of depression. Pharmakopsychiatrie, Neuro-Psychopharmakologie1976;9:127-39. PaykelES , WeissmanMM , PrusoffBA .Social maladjustment and severity of depression. Comprehensive Psychiatry1978;19(2):121-8. WeissmanMM , KlermanGL , PaykelES , PrusoffB .Treatment effects on the social adjustment of depressed patients. Archives of General Psychiatry1974;30:771-8. ">Klerman 1974a</a> ; <a href="./references#MR000050-bbs2-0040" title="KlermanGL , DimascioA , WeismannM , PrusoffB , PaykelES .Treatment of depression by drugs and psychotherapy. American Journal of Psychiatry1974;131(2):186-91. ">Klerman 1974b</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>DSM‐III diagnosis</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#MR000050-bbs2-0041" title="KloskoJS , BarlowDH , TassinariR , CernyJA .A comparison of alprazolam and behavior therapy in treatment of panic disorder: correction. Journal of Psychotherapy Practice and Research1994;3(2):163-79. KloskoJS , BarlowDH , TassinariR , CernyJA .A comparison of alprazolam and behavior therapy in treatment of panic disorder. Journal of Consulting and Clinical Psychology1990;58(1):77-84. ">Klosko 1990</a> ; <a href="./references#MR000050-bbs2-0050" title="LiddleB , SpenceSH .Cognitive-behaviour therapy with depressed primary school children: A cautionary note. Behavioural Psychotherapy1990;18(2):85-102. ">Liddle 1990</a> ; <a href="./references#MR000050-bbs2-0070" title="LiebowitzM , QuitkinFM , StewartJW , McGrathPJ , HarrisonWM , MarkowitzJS , et al.Antidepressant efficacy in atypical depression. Archives of General Psychiatry1988;45(2):129-37. QuitkinFM , McGrathPJ , StewartJW , HarrisonW , WagerSG , NunesE , et al.Phenelzine and imipramine in mood reactive depressives: further delineation of the syndrome of atypical depression. Archives of General Psychiatry1989;46(9):787-93. RabkinJG , McGrathPJ , QuitkinFM , TricamoE , StewartJW , KleinDF .Effects of pill-giving on maintenance of placebo response in patients with chronic mild depression. American Journal of Psychiatry1990;147(12):1622-6. ">Rabkin 1990</a> ; <a href="./references#MR000050-bbs2-0074" title="RoehrichL , GoldmanMS .Experience-dependent neuropsychological recovery and the treatment of alcoholism. Journal of Consulting and Clinical Psychology1993;61(5):812-21. ">Roehrich 1993</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>DSM‐III‐R diagnosis</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#MR000050-bbs2-0001" title="AbikoffH , HechtmanL , KleinRG .Social functioning in children with ADHD treated with long-term methylphenidate and multimodal psychosocial treatment. Journal of the American Academy of Child and Adolescent Psychiatry2004;43(7):820-9. AbikoffH .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to A Todorovac 23rd of August 2019. KleinRG , AbikoffH , HechtmanL , WeissG .Design and rationale of controlled study of long-term methylphenidate and multimodal psychosocial treatment in children with ADHD. Journal of the American Academy of Child and Adolescent Psychiatry2004;43(7):792-801. ">Abikoff 2004</a> ; <a href="./references#MR000050-bbs2-0015" title="CarlsonCL , PelhamWE , MilichR , HozaB .ADHD boys’ performance and attributions following success and failure: drug effects and individual differences. Cognitive Therapy and Research1993;17:269-87. ">Carlson 1993</a> ; <a href="./references#MR000050-bbs2-0017" title="CrispAH , NortonK , GowersS , HalekC , BowyerC , YeldhamD , et al.A controlled study of the effect of therapies aimed at adolescent and family psychopathology in Anorexia Nervosa. British Journal of Psychiatry: the Journal of Mental Science1991;159:325-33. GowersS , NortonK , HalekC , CrispAH .Outcome of outpatient psychotherapy in a random allocation treatment study of anorexia nervosa. International Journal of Eating Disorders1994;15(2):165-77. GowersS , NortonK , YelshamD .The St George's prospective treatment study of anorexia nervosa: a discussion of methodological problems. International Journal of Eating Disorders1989;8:445-54. ">Crisp 1991</a> ; <a href="./references#MR000050-bbs2-0024" title="FoaEB , RothbaumBO , RiggsDS , MurdockTB .Treatment of posttraumatic stress disorder in rape victims: a comparison between cognitive-behavioral procedures and counselling. Journal of Consulting and Clinical Psychology1991;59(5):715-23. ">Foa 1991</a> ; <a href="./references#MR000050-bbs2-0061" title="MilichR , CarlsonCL , Pelham WE Jr, LichtBG .Effects of methylphenidate on the persistence of ADHD boys following failure experiences. Journal of Abnormal Child Psychology1991;19(5):519-36. PelhamWE , MurphyDA , VannattaK , MilichR , LichtBG , GnagyEM , et al.Methylphenidate and attributions in boys with attention-deficit hyperactivity disorder. Journal of Consulting and Clinical Psychology1992;60(2):282-92. ">Pelham 1992</a> ; <a href="./references#MR000050-bbs2-0084" title="SzymanskiJ , O'DonohueW .The potential role of state-dependent learning in cognitive therapy with spider phobics. Journal of Rational-Emotive &amp; Cognitive-Behavior Therapy1995;13(2):131-50. SzymanskiJ .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 20th of August 2019. ">Szymanski 1995</a> ; <a href="./references#MR000050-bbs2-0086" title="TeriL , LogsdonRG , UomotoJ , McCurrySM .Behavioral treatment of depression in dementia patients: a controlled clinical trial. Journals of Gerontology. Series B, Psychological Sciences and Social Sciences1997;52(4):159-66. TeriL .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 26th of August 2019. ">Teri 1997</a> ; <a href="./references#MR000050-bbs2-0096" title="WollersheimJP , WilsonGL .Group treatment of unipolar depression: a comparison of coping, supportive, bibliotherapy, and delayed treatment groups. Professional Psychology: Research and Practice1991;22(6):496-502. ">Wollersheim 1991</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>DSM‐IV diagnosis</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>15</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#MR000050-bbs2-0002" title="AllenJB .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to A Todorovac 28th of August 2019. AllenJJ , SchnyerRN , HittSK .The efficacy of acupuncture in the treatment of major depression in women. Psychological Science1998;9(5):397-401. ">Allen 1998</a> ; <a href="./references#MR000050-bbs2-0003" title="AllenJB .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 28th of August 2019. AllenJJ , SchnyerRN , ChambersAS , HittSK , MorenoFA , ManberR .Acupuncture for depression: a randomized controlled trial. Journal of Clinical Psychiatry2006;67(11):1665-73. ">Allen 2006</a> ; <a href="./references#MR000050-bbs2-0004" title="AlvarezJR .The effects of anger management training on depression, anger, self-concept, and treatment responsibility in a sample of drug-dependent individuals in a therapeutic community. Dissertation Abstracts International: Section B: the Sciences and Engineering1997;58(4-B):2108. ">Alvarez 1997</a> ; <a href="./references#MR000050-bbs2-0006" title="AyenI , HautzingerM .Cognitive behavior therapy for depression in menopausal women. A controlled, randomized treatment study [Kognitive Verhaltenstherapie bei Depressionen im Klimakterium: Eine kontrollierte, randomiserte Interventionsstudie]. Zeitschrift für Klinische Psychologie und Psychotherapie2004;33(4):290-9. AyenI .Inclusion of study in Cochrane Systematic Review (personal communication). Email to EG Faltinsen 9th of September 2019. ">Ayen 2004</a> ; <a href="./references#MR000050-bbs2-0016" title="CarterJC , OlmstedMP , KaplanAS , McCabeRE , MillsJS , AimeA .Self-help for bulimia nervosa: a randomized controlled trial. American Journal of Psychiatry2003;160(5):973-8. ">Carter 2003</a> ; <a href="./references#MR000050-bbs2-0029" title="GoldsteinAJ , BeursE , Chambless Dl, WilsonKA .EMDR for panic disorder with agoraphobia: comparison with waiting list and credible attention-placebo control conditions. Journal of Consulting and Clinical Psychology2000;68(6):947-56. ">Goldstein 2000</a> ; <a href="./references#MR000050-bbs2-0032" title="HippmanC , RingroseA , InglisA , CheekJ , AlbertAY , RemickR , et al.A pilot randomized clinical trial evaluating the impact of genetic counselling for serious mental illnesses. Journal of Clinical Psychiatry2016;77(2):e190-8. ">Hippman 2016</a> ; <a href="./references#MR000050-bbs2-0035" title="KelleyJ .Inclusion of study in Cochrane Systematic Review (personal communication). Email to: A Todorovac 12th of August 2019. KelleyJM , KaptchukTJ , CusinC , LipkinS , FavaM .Open-label placebo for major depressive disorder: a pilot randomized controlled trial. Psychotherapy and Psychosomatics2012;81(5):312-4. ">Kelley 2012</a> ; <a href="./references#MR000050-bbs2-0045" title="LaiCK , ChiI , Kayser-JonesJ .A randomized controlled trial of a specific reminiscence approach to promote the well-being of nursing home residents with dementia. International Psychogeriatrics2004;16(1):33-49. LaiK .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 6th of September 2019. ">Lai 2004</a> ; <a href="./references#MR000050-bbs2-0063" title="PetersonMA , PattersonB , PillmanBM , BattistaMA .Cognitive recovery following alcohol detoxification: a computerised remediation study. Neuropsychological Rehabilitation2002;12(1):63-74. PillmanBM .Computerized cognitive remediation with recently detoxified alcoholics. Dissertation, California School of Professional Psychology, Fresno Campus2000. ">Pillman 2001</a> ; <a href="./references#MR000050-bbs2-0064" title="PolandRE , GertsikL , FavreauJT , SmithSI , MirochaJM , RaoU , et al.Open-label randomized parallel-group controlled clinical trial of massage for treatment of depression in HIV-infected subjects. Journal of Alternative and Complementary Medicine2013;19(4):334-40. ">Poland 2013</a> ; <a href="./references#MR000050-bbs2-0071" title="RapeeR .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 29th of August 2019. RapeeRM , AbbottMJ , LynehamHJ .Bibliotherapy for children With anxiety disorders using written materials for parents: a randomized controlled trial. Journal of Consulting and Clinical Psychology2006;74(3):436-44. ">Rapee 2006</a> ; <a href="./references#MR000050-bbs2-0072" title="RapeeR .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 29th of August 2019. RapeeRM , AbbottMJ , BaillieAJ , GastonJE .Treatment of social phobia through pure self-help and therapist-augmented self-help. British Journal of Psychiatry2007;191:246-52. ">Rapee 2007</a> ; <a href="./references#MR000050-bbs2-0079" title="ShalevAY , AnkriY , Isreali-ShalevY , PelegT , AdesskyR , FreedmanS .Prevention of posttraumatic stress disorder by early treatment. Archives of General Psychiatry2012;69(2):166-76. ">Shalev 2012</a> ; <a href="./references#MR000050-bbs2-0095" title="WolitzkyKB , TelchMJ .Augmenting in vivo exposure with fear antagonistic actions: a preliminary test. Behavior Therapy2009;40(1):57-71. ">Wolitzky 2009</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>DSM‐IV‐TR diagnosis</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#MR000050-bbs2-0024" title="FoaEB , RothbaumBO , RiggsDS , MurdockTB .Treatment of posttraumatic stress disorder in rape victims: a comparison between cognitive-behavioral procedures and counselling. Journal of Consulting and Clinical Psychology1991;59(5):715-23. ">Foa 1991</a> ; <a href="./references#MR000050-bbs2-0043" title="KwanR .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 26th of August 2019. KwanRY , LeungMC , LaiCK .Acupressure for agitation in nursing home residents with dementia: study protocol for a randomized controlled trial. Trials2014;15(410):1-7. KwanRY , LeungMCP , LaiCK .A randomized controlled trial examining the effect of acupressure on agitation and salivary cortisol in nursing home residents with dementia. Dementia and Geriatric Cognitive Disorders2017;44(1-2):92-104. ">Kwan 2017</a> ; <a href="./references#MR000050-bbs2-0075" title="OlivaresJ .Program IAFS. Protocol for the treatment of social phobia in adolescents [Programa IAFS. Protocolo para el tratamiento de la fobia social enadolescentes]. Madrid: Pirámide2005;1. Rosa-AlcázarAI , Olivares-OlivaresPJ , OlivaresJ .The role of non-specific effects in the psychological treatment of adolescents with social phobia [Papel de los efectos inespecíficos en el tratamiento psicológico de adolescentes con fobia social]. Anuario de Psicologia2009;40(1):43-61. ">Rosa‐Alcatraz 2009</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>ICD‐9 diagnosis</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#MR000050-bbs2-0091" title="WatzlH , RistF , OlbrichR , CohenR .Placebo injections and surveillance of alcohol intake during inpatient treatment of female alcoholics. Addictive Behaviors1988;13(2):197-200. ">Watzl 1988</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>The most commonly assessment instrument was Structured Clinical Interview for DSM (SCID; <a href="./references#MR000050-bbs2-0273" title="SpitzerRL , WilliamJBW , GibbonM , FirstMB .Structured Clinical Interview for DSM-III-R Personality Disorders (SCID-II). 1989: Biometrics Research Department, New York State Psychiatric Institute, 1989.">Spitzer 1989</a> ) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#MR000050-bbs2-0002" title="AllenJB .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to A Todorovac 28th of August 2019. AllenJJ , SchnyerRN , HittSK .The efficacy of acupuncture in the treatment of major depression in women. Psychological Science1998;9(5):397-401. ">Allen 1998</a> ; <a href="./references#MR000050-bbs2-0003" title="AllenJB .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 28th of August 2019. AllenJJ , SchnyerRN , ChambersAS , HittSK , MorenoFA , ManberR .Acupuncture for depression: a randomized controlled trial. Journal of Clinical Psychiatry2006;67(11):1665-73. ">Allen 2006</a> ; <a href="./references#MR000050-bbs2-0006" title="AyenI , HautzingerM .Cognitive behavior therapy for depression in menopausal women. A controlled, randomized treatment study [Kognitive Verhaltenstherapie bei Depressionen im Klimakterium: Eine kontrollierte, randomiserte Interventionsstudie]. Zeitschrift für Klinische Psychologie und Psychotherapie2004;33(4):290-9. AyenI .Inclusion of study in Cochrane Systematic Review (personal communication). Email to EG Faltinsen 9th of September 2019. ">Ayen 2004</a> ; <a href="./references#MR000050-bbs2-0021" title="EhlersA , HackmannA , GreyN , WildJ , LinessS , AlbertI , et al.A randomized controlled trial of 7-day intensive and standard weekly cognitive therapy for PTSD and emotion-focused supportive therapy. American Journal of Psychiatry2014;171(3):294-304. ">Ehlers 2014</a> ; <a href="./references#MR000050-bbs2-0029" title="GoldsteinAJ , BeursE , Chambless Dl, WilsonKA .EMDR for panic disorder with agoraphobia: comparison with waiting list and credible attention-placebo control conditions. Journal of Consulting and Clinical Psychology2000;68(6):947-56. ">Goldstein 2000</a> ; <a href="./references#MR000050-bbs2-0032" title="HippmanC , RingroseA , InglisA , CheekJ , AlbertAY , RemickR , et al.A pilot randomized clinical trial evaluating the impact of genetic counselling for serious mental illnesses. Journal of Clinical Psychiatry2016;77(2):e190-8. ">Hippman 2016</a> ; <a href="./references#MR000050-bbs2-0035" title="KelleyJ .Inclusion of study in Cochrane Systematic Review (personal communication). Email to: A Todorovac 12th of August 2019. KelleyJM , KaptchukTJ , CusinC , LipkinS , FavaM .Open-label placebo for major depressive disorder: a pilot randomized controlled trial. Psychotherapy and Psychosomatics2012;81(5):312-4. ">Kelley 2012</a> ; <a href="./references#MR000050-bbs2-0064" title="PolandRE , GertsikL , FavreauJT , SmithSI , MirochaJM , RaoU , et al.Open-label randomized parallel-group controlled clinical trial of massage for treatment of depression in HIV-infected subjects. Journal of Alternative and Complementary Medicine2013;19(4):334-40. ">Poland 2013</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Trials fulfilled the symptoms of a mental health disorder from the available diagnostic classifications system at the time of the trial, but did not report classification system </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>24</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#MR000050-bbs2-0005" title="AscherLM , TurnerR .Paradoxical intention and insomnia: an experimental investigation. Behaviour Research and Therapy1979;17(4):408-11. ">Ascher 1979</a> ; <a href="./references#MR000050-bbs2-0007" title="BergI , ForsytheI , HoltP , WattsJ .A controlled trial of ‘Senokot’ in faecal soiling treated by behavioural methods. Journal of Child Psychology and Psychiatry1983;24(4):543-9. ">Berg 1983</a> ; <a href="./references#MR000050-bbs2-0008" title="Borden, KA.Attributional Outcomes: the Subtle Messages of Treatments for Attention Deficit Disorder. Dissertation, University of Illinois at Urbana-Champaign1986. BordenKA , BrownRT .Attributional outcomes: The subtle messages of treatments for attention deficit disorder. Cognitive Therapy and Research1989;13(2):147-60. ">Borden 1986</a> ; <a href="./references#MR000050-bbs2-0012" title="BramstonP , SpenceSH .Behavioural versus cognitive social-skills training with intellectually-handicapped adults. Behaviour Research and Therapy1985;23(3):239-46. ">Bramston 1985</a> ; <a href="./references#MR000050-bbs2-0013" title="BrillNQ , KoeglerRR , EpsteinLJ , ForgyEW .Controlled study of psychiatric outpatient treatment. Archives of General Psychiatry1964;10:581-95. BrillNQ .Results of psychotherapy. California Medicine1966;104(4):249-53. ">Brill 1964a</a> ; <a href="./references#MR000050-bbs2-0014" title="BrillNQ , KoeglerRR , EpsteinLJ , ForgyEW .Controlled study of psychiatric outpatient treatment. Archives of General Psychiatry1964;10:581-95. ">Brill 1964b</a> ; <a href="./references#MR000050-bbs2-0020" title="DoubleDB , WarrenGC , EvansM , RowlandsMP .Efficacy of maintenance use of anticholinergic agents. Acta Psychiatrica Scandinavica1993;88:381-4. ">Double 1993</a> ; <a href="./references#MR000050-bbs2-0022" title="EspieCA , BrooksDN , LindsayWR .An evaluation of tailored psychological treatment of insomnia. Journal of Behavior Therapy and Experimental Psychiatry1989;20(2):143-53. EspieCA , LindsayWR , BrooksDN , HoodEM , TurveyT .A controlled comparative investigation of psychological treatments for chronic sleep-onset insomnia. Behaviour Research and Therapy1989;27(1):79-88. ">Espie 1989a</a> ; <a href="./references#MR000050-bbs2-0030" title="GoldwasserAN , AuerbachSM , HarkinsSW .Cognitive, affective, and behavioural effects of reminiscence group therapy on demented elderly. Aging and Human Development1987;25(3):209-22. ">Goldwasser 1987</a> ; <a href="./references#MR000050-bbs2-0033" title="HowlinP , GordonKR , PascoG , WadeA , CharmanT .The effectiveness of picture exchange communication system (PECS) training for teachers of children with autism: a pragmatic,group randomised controlled trial. Journal of Child Psychology and Psychiatry2007;48(5):473-81. ">Howlin 2007</a> ; <a href="./references#MR000050-bbs2-0037" title="KilmannPR , MilanRJ , BolandJP , NankinHR , DavidsonE , WestMO , et al.Group treatment of secondary erectile dysfunction. Journal of Sex &amp; Marital Therapy1987;13(3):168-82. KilmannPR , Milan RJ Jr, BolandJP , DavidsonE , WestMO , SablisRF , et al.The sexual interactions of men with secondary erectile dysfunction. Journal of Sex Education and Therapy1988;14(1):46-9. KilmannPR , Milan RJ Jr, BolandJP , NankinHR , SablisRF , WestMO , et al.The sexual interactions of men with secondary erectile dysfunction. Paper presented at the annual meeting of the American Psychological Association in Los Angeles1985;1:46-9. ">Kilmann 1987</a> ; <a href="./references#MR000050-bbs2-0049" title="LickJR , HefflerD .Relaxation training and attention placebo in the treatment of severe insomnia. Journal of Consulting and Clinical Psychology1977;45(2):153-61. ">Lick 1977</a> ; <a href="./references#MR000050-bbs2-0051" title="MatsonJL , MarchettiA , AdkinsJA .Comparison of operant- and independence-training procedures for mentally retarded adults. American Journal of Mental Deficiency1980;84(5):487-94. ">Matson 1980</a> ; <a href="./references#MR000050-bbs2-0052" title="McLachlanDR , DaltonAJ , KruckTP , BellMY , SmithWL , KalowW , et al.Intramuscular desferrioxamine in patients with Alzheimer's disease. Lancet1991;337(8753):1304-8. McLachlanDRC , SmithWL , KruckTP .Desferrioxamine and Alzheimer’s disease: video home behavior assessment of clinical course and measures of brain aluminum. Therapeutic Drug Monitoring1993;15(6):602-7. ">McLachlan 1991</a> ; <a href="./references#MR000050-bbs2-0069" title="QuayhagenMP , QuayhagenM , CorbeilRR , RothPA , RodgersJA .A dyadic remediation program for care recipients with dementia. Nursing Research1995;44(3):153-9. ">Quayhagen 1995</a> ; <a href="./references#MR000050-bbs2-0073" title="RobinA .Rationing out-patients: a defence of the waiting list. British Journal of Psychiatry1976;129:138-41. ">Robin 1976</a> ; <a href="./references#MR000050-bbs2-0076" title="RosenGM , GlasgowRE , BarreraM .A controlled study to assess the clinical efficacy of totally self-administrated systematic desensitization. Journal of Consulting and Clinical Psychology1976;44(2):208-17. ">Rosen 1976</a> ; <a href="./references#MR000050-bbs2-0077" title="LorrM , McNairDM , WeinsteinGJ .Early effects of chlordiazepoxide (Librium) used with psychotherapy. Journal of Psychiatric Research1963;1:257-70. RothI , RhudickPJ , ShaskanDA , SlobinMS , WilkinsonAE , YoungHH .Long-term effects on psychotherapy of initial treatment conditions. Journal of Psychiatric Research1964;2:283-97. ">Roth 1964</a> ; <a href="./references#MR000050-bbs2-0080" title="ShealyRC .The effectiveness of various treatment techniques on different degrees and durations of sleep-onset insomnia. Behaviour Research and Therapy1979;17(6):541-6. ">Shealy 1979</a> ; <a href="./references#MR000050-bbs2-0083" title="SteinmarkSW , BorkovecTD .Active and placebo treatment effects on moderate insomnia under counterdemand and positive demand instructions. Journal of Abnormal Psychology1974;83(2):157-63. ">Steinmark 1974</a> ; <a href="./references#MR000050-bbs2-0089" title="AscherML , TurnerRM .A comparison of two methods for the administration of paradoxical intention. Behaviour Research and Therapy1980;18(2):121-6. TurnerRM , AscherLM .Controlled comparison of progressive relaxation, stimulus control, and paradoxical intention therapies for insomnia. Journal of Consulting and Clinical Psychology1979;47(3):500-8. ">Turner 1979</a> ; <a href="./references#MR000050-bbs2-0090" title="VanderplateC .Electromyograph biofeedback Treatment of sleep onset Insomnia: a controlled Investigation. Dissertation, University of Southern Mississippi1978. ">Vanderplate 1983</a> ; <a href="./references#MR000050-bbs2-0092" title="WeingaertnerAH .Self-administered aversive stimulation with hallucinating hospitalized schizophrenics. Journal of Consulting and Clinical Psychology1971;36(3):422-29. ">Weingaertner 1971</a> ; <a href="./references#MR000050-bbs2-0093" title="WhittakerCB , HoyRM .Withdrawal of perphenazine in chronic schizophrenia. British Journal of Psychiatry1963;109:422-7. ">Whittaker 1963</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Trials reported a population classified as having a mental health disorder, but full diagnostic criteria was not reported </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>35</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#MR000050-bbs2-0009" title="BorkovecTD , KaloupekDG , SlamaKM .The facilitative effect of muscle tension-release in the relaxation treatment of sleep disturbance. Behavior Therapy1975;6(3):301-9. ">Borkovec 1975</a> ; <a href="./references#MR000050-bbs2-0010" title="BorkovecTD , WeertsTC .Effects of progressive relaxation on sleep disturbance: an electroencephalographic evaluation. Psychosomatic Medicine1976;38(3):173-80. ">Borkovec 1976</a> ; <a href="./references#MR000050-bbs2-0011" title="BornovalovaM .Inclusion of study in Cochrane Systematic Review (personal communication). Email to A Todorovac. 21st of August 2019. BornovalovaMA .Distress tolerance treatment for inner-city drug users: a preliminary trial. Doctor’s Dissertation, University of Maryland2008. ">Bornovalova 2008</a> ; <a href="./references#MR000050-bbs2-0018" title="CrouchG , RobsonM , HallstromC .Benzodiazepine dependent patients and their psychological treatment. Progress in Neuro-psychopharmacology &amp; Biological Psychiatry1988;12(4):503-10. HallströmC , CrouchG , RobsenM , ShineP .The treatment of tranquillizer dependence by propranolol. Postgraduate Medical Journal1988;64(Suppl 2):40-4. ">Crouch 1988</a> ; <a href="./references#MR000050-bbs2-0019" title="Doty, DW.Role playing and incentives in the modification of the social interaction of chronic psychiatric patients. Journal of Consulting and Clinical Psychology1975;43(5):676-82. ">Doty 1975</a> ; <a href="./references#MR000050-bbs2-0023" title="EtringerBD , CashTF , RimmDC .Behavioral, affective, and cognitive effects of participant modeling and an equally credible placebo. Behavior Therapy1982;13(4):476-85. ">Etringer 1982</a> ; <a href="./references#MR000050-bbs2-0026" title="FreireAO , SugaiGC , ChrispinFS , TogeiroSM , YamamuraY , MelloLE , et al.Treatment of moderate obstructive sleep apnea syndrome with acupuncture: a randomised, placebo-controlled pilot trial. Sleep Medicine2007;8(1):43-50. ">Freire 2007</a> ; <a href="./references#MR000050-bbs2-0027" title="FuchsCZ , RehnLP .A self-control behavior therapy program for depression. Journal of Consulting and Clinical Psychology1977;45(2):206-15. ">Fuchs 1977</a> ; <a href="./references#MR000050-bbs2-0028" title="GlogowskaM , RoulstoneS , EnderbyP , PetersTJ .Randomised controlled trial of community based speech and language therapy in preschool children. BMJ2000;321(7266):923-6. ">Glogowska 2000</a> ; <a href="./references#MR000050-bbs2-0031" title="HekmatH , LubitzR , DealR .Semantic desensitization: a paradigmatic intervention approach to anxiety disorders. Journal of Clinical Psychology1984;40(2):463-6. ">Hekmat 1984</a> ; <a href="./references#MR000050-bbs2-0034" title="KarstM , WinterhalterM , MünteS , FranckiB , HondronikosA , EckardtA , et al.Auricular acupuncture for dental anxiety: a randomized controlled trial. Anesthesia and Analgesia2007;104(2):295-300. KarstM .Inclusion of study in Cochrane Systematic Review (personal communication). Email to: EG Faltinsen 5th of September 2019. ">Karst 2007</a> ; <a href="./references#MR000050-bbs2-0036" title="KennedyTD , KimuraHK .Transfer, behavioral improvement, and anxiety reduction in systematic desensitization. Journal of Consulting and Clinical Psychology1974;42(5):720-8. ">Kennedy 1974</a> ; <a href="./references#MR000050-bbs2-0038" title="KleinSA , DeffenbacherJL .Relaxation and exercise for hyperactive impulsive children. Perceptual and Motor Skills1977;45:1159-62. ">Klein 1977</a> ; <a href="./references#MR000050-bbs2-0042" title="KrapflJE , NawasMM .Differential ordering of stimulus presentation in systematic desensitization. Journal of Abnormal Psychology1970;75(3):333-7. ">Krapfl 1970</a> ; <a href="./references#MR000050-bbs2-0044" title="LacyMK .The effect of short term autogenic training on the stress reactivity of hospitalized emotionally disturbed adolescents. ProQuest Dissertations Publishing, Oklahoma State University1996. ">Lacy 1990</a> ; <a href="./references#MR000050-bbs2-0046" title="LangOJ , LazovikAD .Experimental desensitization of a phobia. Journal of Abnormal and Social Psychology1963;66:519-25. LangPJ , LazovikAD , ReynoldsDJ .Desensitization, suggestibility, and pseudotherapy. Journal of Abnormal Psychology1965;70(6):395-402. ">Lang 1965</a> ; <a href="./references#MR000050-bbs2-0048" title="LickJ .Expectancy, false galvanic skin response feedback, and systematic desensitization in the modification of phobic behavior. Journal of Consulting and Clinical Psychology1975;43(4):557-67. ">Lick 1975</a> ; <a href="./references#MR000050-bbs2-0053" title="MealieaWL , NawasMM .The comparative effectiveness of systematic desensitization and implosive therapy in the treatment of snake phobia. Journal of Behavior Therapy and Experimental Psychiatry1971;2(2):85-94. ">Mealiea 1971</a> ; <a href="./references#MR000050-bbs2-0054" title="MilbyJB , ClarkeC , ToroC , ThorntonS , RickertD .Effectiveness of urine surveillance as an adjunct to outpatient psychotherapy for drug abusers. International Journal of the Addictions1980;15(7):993-1001. ">Milby 1980</a> ; <a href="./references#MR000050-bbs2-0055" title="MirandaA , ArlandisP , SorianoM .Instruction in strategies and attributional training: Effects on the problem-solving and self-concept of students’ with learning disabilities [Instrucción en estrategias y entrenamiento atribucional: efectos sobre la resolución de problemas y el autoconcepto de los estudiantes con dificultades en el aprendizaje]. Infancia y Aprendizaje1997;20(80):37-52. ">Miranda 1997</a> ; <a href="./references#MR000050-bbs2-0056" title="MitchellC , MansfieldD , RautenbachS .Coloured filters and reading accuracy, comprehension and rate: a placebo-controlled study. Perceptual and Motor Skills2008;106(2):517-32. ">Mitchell 2008</a> ; <a href="./references#MR000050-bbs2-0057" title="NandiDN , AjmanyS , GanguliH , BanerjeeG , BoralGC , GhoshA , et al.A clinical evaluation of depressives found in a rural survey in India. British Journal of Psychiatry1976;128:523-7. ">Nandi 1976</a> ; <a href="./references#MR000050-bbs2-0058" title="NicassioP , BootzinR .A comparison of progressive relaxation and autogenic training as treatments for insomnia. Journal of Abnormal Psychology1974;83(3):253-60. ">Nicassio 1974</a> ; <a href="./references#MR000050-bbs2-0062" title="PedletonMG , HigginsRL .A comparison of negative practice and systematic desensitization in the treatment of acrophobia. Journal of Behavior Therapy and Experimental Psychiatry1983;14(4):317-23. ">Pendleton 1983</a> ; <a href="./references#MR000050-bbs2-0065" title="PowersMB , SmitsJA , TelchMJ .Disentangling the effects of safety-behavior utilization and safety-behavior availability during exposure-based treatment: a placebo-controlled trial. Journal of Consulting and Clinical Psychology2004;72(3):448-54. ">Powers 2004</a> ; <a href="./references#MR000050-bbs2-0066" title="PowersMB , SmithsJA , WhitleyD , BystritskyA , TelchMJ .The effect of attributional processes concerning medication taking on return of fear. Journal of Consulting and Clinical Psychology2008;76(3):478-90. ">Powers 2008a</a> ; <a href="./references#MR000050-bbs2-0067" title="PowersMB , SmithsJA , WhitleyD , BystritskyA , TelchMJ .The effect of attributional processes concerning medication taking on return of fear. Journal of Consulting and Clinical Psychology2008;76(3):478-90. ">Powers 2008b</a> ; <a href="./references#MR000050-bbs2-0068" title="ProudfootJ , ClarkeJ , BirchMR , WhittonAE , ParkerG , ManicavasagarV , et al.Impact of a mobile phone and web program on symptom and functional outcomes for people with mild- to-moderate depression, anxiety and stress: a randomized controlled trial. BMC Psychiatry2013;13(312):1-12. ProudfootJ .Re: Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 26th of August 2019. ">Proudfoot 2013</a> ; <a href="./references#MR000050-bbs2-0078" title="RupertPA , HolmesDS .Effects of multiple sessions of true and placebo heart rate biofeedback training on the heart rates and anxiety levels of anxious patients during and following treatment. Psychophysiology1978;15(6):582-90. ">Rupert 1978</a> ; <a href="./references#MR000050-bbs2-0081" title="SibilioJP , AndrewG , DartD , MooreKB , StehmanA .Treatment of chronic schizophrenia with promazine hydrochloride. AMA Archives of Neurology and Psychiatry1957;78(4):419-24. ">Sibilio 1957</a> ; <a href="./references#MR000050-bbs2-0082" title="SommernessMD , LuceroRJ , HamlonJS , EricksonJL , MatthewsR .A controlled study of reserpine on chronically disturbed patients. JAMA Archives of Neurology and Psychiatry1955;74(3):316-9. ">Sommerness 1955</a> ; <a href="./references#MR000050-bbs2-0085" title="TanSY , BruniJ .Cognitive-behavior therapy with adult patients with epilepsy: a controlled outcome study. Epilepsia1986;27(3):225-33. ">Tan 1986</a> ; <a href="./references#MR000050-bbs2-0087" title="ToriC , WorellL .Reduction of human avoidant behavior. A comparison of counterconditioning, expectancy, and cognitive information approaches. Clinical Psychology1973;41(2):269-78. ">Tori 1973</a> ; <a href="./references#MR000050-bbs2-0088" title="Trexler, L.Rational-emotive therapy, placebo, and no-treatment effects on public-speaking anxiety. Doctoral dissertation, Temple University AnnArbor, Mich.: University Microfilms1971;71-31(063). TrexlerLD , KarstTO .Rational-emotive therapy, placebo, and no-treatment effects on public-speaking anxiety. Journal of Abnormal Psyhology1972;79(1):60-7. ">Trexler 1972</a> ; <a href="./references#MR000050-bbs2-0094" title="WilsonA , DavidsonWJ , BlanchardR , WhiteJ .Disulfiram implantation. A placebo-controlled trial with two-year follow-up. Journal of Studies on Alcohol1978;39(5):809-19. WilsonA , DavidsonWJ , BlanchardR .Disulfiram implantation: a trial using placebo implants and two types of controls. Journal of Studies on Alcohol1980;41(5):429-36. ">Wilson 1980</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Diagnoses</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Attention Deficit Hyperactivity Disorder (ADHD) or Attention Deficit Disorder (ADD)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#MR000050-bbs2-0001" title="AbikoffH , HechtmanL , KleinRG .Social functioning in children with ADHD treated with long-term methylphenidate and multimodal psychosocial treatment. Journal of the American Academy of Child and Adolescent Psychiatry2004;43(7):820-9. AbikoffH .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to A Todorovac 23rd of August 2019. KleinRG , AbikoffH , HechtmanL , WeissG .Design and rationale of controlled study of long-term methylphenidate and multimodal psychosocial treatment in children with ADHD. Journal of the American Academy of Child and Adolescent Psychiatry2004;43(7):792-801. ">Abikoff 2004</a> ; <a href="./references#MR000050-bbs2-0008" title="Borden, KA.Attributional Outcomes: the Subtle Messages of Treatments for Attention Deficit Disorder. Dissertation, University of Illinois at Urbana-Champaign1986. BordenKA , BrownRT .Attributional outcomes: The subtle messages of treatments for attention deficit disorder. Cognitive Therapy and Research1989;13(2):147-60. ">Borden 1986</a> ; <a href="./references#MR000050-bbs2-0015" title="CarlsonCL , PelhamWE , MilichR , HozaB .ADHD boys’ performance and attributions following success and failure: drug effects and individual differences. Cognitive Therapy and Research1993;17:269-87. ">Carlson 1993</a> ; <a href="./references#MR000050-bbs2-0038" title="KleinSA , DeffenbacherJL .Relaxation and exercise for hyperactive impulsive children. Perceptual and Motor Skills1977;45:1159-62. ">Klein 1977</a> ; <a href="./references#MR000050-bbs2-0061" title="MilichR , CarlsonCL , Pelham WE Jr, LichtBG .Effects of methylphenidate on the persistence of ADHD boys following failure experiences. Journal of Abnormal Child Psychology1991;19(5):519-36. PelhamWE , MurphyDA , VannattaK , MilichR , LichtBG , GnagyEM , et al.Methylphenidate and attributions in boys with attention-deficit hyperactivity disorder. Journal of Consulting and Clinical Psychology1992;60(2):282-92. ">Pelham 1992</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Anorexia</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#MR000050-bbs2-0017" title="CrispAH , NortonK , GowersS , HalekC , BowyerC , YeldhamD , et al.A controlled study of the effect of therapies aimed at adolescent and family psychopathology in Anorexia Nervosa. British Journal of Psychiatry: the Journal of Mental Science1991;159:325-33. GowersS , NortonK , HalekC , CrispAH .Outcome of outpatient psychotherapy in a random allocation treatment study of anorexia nervosa. International Journal of Eating Disorders1994;15(2):165-77. GowersS , NortonK , YelshamD .The St George's prospective treatment study of anorexia nervosa: a discussion of methodological problems. International Journal of Eating Disorders1989;8:445-54. ">Crisp 1991</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Anxiety disorders of different kind (e.g. specific anxiety, social anxiety, panic disorder) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>25</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#MR000050-bbs2-0023" title="EtringerBD , CashTF , RimmDC .Behavioral, affective, and cognitive effects of participant modeling and an equally credible placebo. Behavior Therapy1982;13(4):476-85. ">Etringer 1982</a> ; <a href="./references#MR000050-bbs2-0029" title="GoldsteinAJ , BeursE , Chambless Dl, WilsonKA .EMDR for panic disorder with agoraphobia: comparison with waiting list and credible attention-placebo control conditions. Journal of Consulting and Clinical Psychology2000;68(6):947-56. ">Goldstein 2000</a> ; <a href="./references#MR000050-bbs2-0031" title="HekmatH , LubitzR , DealR .Semantic desensitization: a paradigmatic intervention approach to anxiety disorders. Journal of Clinical Psychology1984;40(2):463-6. ">Hekmat 1984</a> ; <a href="./references#MR000050-bbs2-0034" title="KarstM , WinterhalterM , MünteS , FranckiB , HondronikosA , EckardtA , et al.Auricular acupuncture for dental anxiety: a randomized controlled trial. Anesthesia and Analgesia2007;104(2):295-300. KarstM .Inclusion of study in Cochrane Systematic Review (personal communication). Email to: EG Faltinsen 5th of September 2019. ">Karst 2007</a> ; <a href="./references#MR000050-bbs2-0036" title="KennedyTD , KimuraHK .Transfer, behavioral improvement, and anxiety reduction in systematic desensitization. Journal of Consulting and Clinical Psychology1974;42(5):720-8. ">Kennedy 1974</a> ; <a href="./references#MR000050-bbs2-0041" title="KloskoJS , BarlowDH , TassinariR , CernyJA .A comparison of alprazolam and behavior therapy in treatment of panic disorder: correction. Journal of Psychotherapy Practice and Research1994;3(2):163-79. KloskoJS , BarlowDH , TassinariR , CernyJA .A comparison of alprazolam and behavior therapy in treatment of panic disorder. Journal of Consulting and Clinical Psychology1990;58(1):77-84. ">Klosko 1990</a> ; <a href="./references#MR000050-bbs2-0042" title="KrapflJE , NawasMM .Differential ordering of stimulus presentation in systematic desensitization. Journal of Abnormal Psychology1970;75(3):333-7. ">Krapfl 1970</a> ; <a href="./references#MR000050-bbs2-0046" title="LangOJ , LazovikAD .Experimental desensitization of a phobia. Journal of Abnormal and Social Psychology1963;66:519-25. LangPJ , LazovikAD , ReynoldsDJ .Desensitization, suggestibility, and pseudotherapy. Journal of Abnormal Psychology1965;70(6):395-402. ">Lang 1965</a> ; <a href="./references#MR000050-bbs2-0048" title="LickJ .Expectancy, false galvanic skin response feedback, and systematic desensitization in the modification of phobic behavior. Journal of Consulting and Clinical Psychology1975;43(4):557-67. ">Lick 1975</a> ; <a href="./references#MR000050-bbs2-0053" title="MealieaWL , NawasMM .The comparative effectiveness of systematic desensitization and implosive therapy in the treatment of snake phobia. Journal of Behavior Therapy and Experimental Psychiatry1971;2(2):85-94. ">Mealiea 1971</a> ; <a href="./references#MR000050-bbs2-0060" title="PeckCL .Desensitization for the treatment of fear in the high level adult retardate. Behaviour Research and Therapy1977;15(2):137-48. ">Peck 1976</a> ; <a href="./references#MR000050-bbs2-0062" title="PedletonMG , HigginsRL .A comparison of negative practice and systematic desensitization in the treatment of acrophobia. Journal of Behavior Therapy and Experimental Psychiatry1983;14(4):317-23. ">Pendleton 1983</a> ; <a href="./references#MR000050-bbs2-0065" title="PowersMB , SmitsJA , TelchMJ .Disentangling the effects of safety-behavior utilization and safety-behavior availability during exposure-based treatment: a placebo-controlled trial. Journal of Consulting and Clinical Psychology2004;72(3):448-54. ">Powers 2004</a> ; <a href="./references#MR000050-bbs2-0066" title="PowersMB , SmithsJA , WhitleyD , BystritskyA , TelchMJ .The effect of attributional processes concerning medication taking on return of fear. Journal of Consulting and Clinical Psychology2008;76(3):478-90. ">Powers 2008a</a> ; <a href="./references#MR000050-bbs2-0067" title="PowersMB , SmithsJA , WhitleyD , BystritskyA , TelchMJ .The effect of attributional processes concerning medication taking on return of fear. Journal of Consulting and Clinical Psychology2008;76(3):478-90. ">Powers 2008b</a> ; <a href="./references#MR000050-bbs2-0068" title="ProudfootJ , ClarkeJ , BirchMR , WhittonAE , ParkerG , ManicavasagarV , et al.Impact of a mobile phone and web program on symptom and functional outcomes for people with mild- to-moderate depression, anxiety and stress: a randomized controlled trial. BMC Psychiatry2013;13(312):1-12. ProudfootJ .Re: Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 26th of August 2019. ">Proudfoot 2013</a> ; <a href="./references#MR000050-bbs2-0071" title="RapeeR .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 29th of August 2019. RapeeRM , AbbottMJ , LynehamHJ .Bibliotherapy for children With anxiety disorders using written materials for parents: a randomized controlled trial. Journal of Consulting and Clinical Psychology2006;74(3):436-44. ">Rapee 2006</a> ; <a href="./references#MR000050-bbs2-0072" title="RapeeR .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 29th of August 2019. RapeeRM , AbbottMJ , BaillieAJ , GastonJE .Treatment of social phobia through pure self-help and therapist-augmented self-help. British Journal of Psychiatry2007;191:246-52. ">Rapee 2007</a> ; <a href="./references#MR000050-bbs2-0075" title="OlivaresJ .Program IAFS. Protocol for the treatment of social phobia in adolescents [Programa IAFS. Protocolo para el tratamiento de la fobia social enadolescentes]. Madrid: Pirámide2005;1. Rosa-AlcázarAI , Olivares-OlivaresPJ , OlivaresJ .The role of non-specific effects in the psychological treatment of adolescents with social phobia [Papel de los efectos inespecíficos en el tratamiento psicológico de adolescentes con fobia social]. Anuario de Psicologia2009;40(1):43-61. ">Rosa‐Alcatraz 2009</a> ; <a href="./references#MR000050-bbs2-0076" title="RosenGM , GlasgowRE , BarreraM .A controlled study to assess the clinical efficacy of totally self-administrated systematic desensitization. Journal of Consulting and Clinical Psychology1976;44(2):208-17. ">Rosen 1976</a> ; <a href="./references#MR000050-bbs2-0078" title="RupertPA , HolmesDS .Effects of multiple sessions of true and placebo heart rate biofeedback training on the heart rates and anxiety levels of anxious patients during and following treatment. Psychophysiology1978;15(6):582-90. ">Rupert 1978</a> ; <a href="./references#MR000050-bbs2-0084" title="SzymanskiJ , O'DonohueW .The potential role of state-dependent learning in cognitive therapy with spider phobics. Journal of Rational-Emotive &amp; Cognitive-Behavior Therapy1995;13(2):131-50. SzymanskiJ .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 20th of August 2019. ">Szymanski 1995</a> ; <a href="./references#MR000050-bbs2-0087" title="ToriC , WorellL .Reduction of human avoidant behavior. A comparison of counterconditioning, expectancy, and cognitive information approaches. Clinical Psychology1973;41(2):269-78. ">Tori 1973</a> ; <a href="./references#MR000050-bbs2-0088" title="Trexler, L.Rational-emotive therapy, placebo, and no-treatment effects on public-speaking anxiety. Doctoral dissertation, Temple University AnnArbor, Mich.: University Microfilms1971;71-31(063). TrexlerLD , KarstTO .Rational-emotive therapy, placebo, and no-treatment effects on public-speaking anxiety. Journal of Abnormal Psyhology1972;79(1):60-7. ">Trexler 1972</a> ; <a href="./references#MR000050-bbs2-0095" title="WolitzkyKB , TelchMJ .Augmenting in vivo exposure with fear antagonistic actions: a preliminary test. Behavior Therapy2009;40(1):57-71. ">Wolitzky 2009</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Autism spectrum disorder</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#MR000050-bbs2-0033" title="HowlinP , GordonKR , PascoG , WadeA , CharmanT .The effectiveness of picture exchange communication system (PECS) training for teachers of children with autism: a pragmatic,group randomised controlled trial. Journal of Child Psychology and Psychiatry2007;48(5):473-81. ">Howlin 2007</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Bulimia</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#MR000050-bbs2-0016" title="CarterJC , OlmstedMP , KaplanAS , McCabeRE , MillsJS , AimeA .Self-help for bulimia nervosa: a randomized controlled trial. American Journal of Psychiatry2003;160(5):973-8. ">Carter 2003</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Depression</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>16</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#MR000050-bbs2-0002" title="AllenJB .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to A Todorovac 28th of August 2019. AllenJJ , SchnyerRN , HittSK .The efficacy of acupuncture in the treatment of major depression in women. Psychological Science1998;9(5):397-401. ">Allen 1998</a> ; <a href="./references#MR000050-bbs2-0003" title="AllenJB .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 28th of August 2019. AllenJJ , SchnyerRN , ChambersAS , HittSK , MorenoFA , ManberR .Acupuncture for depression: a randomized controlled trial. Journal of Clinical Psychiatry2006;67(11):1665-73. ">Allen 2006</a> ; <a href="./references#MR000050-bbs2-0006" title="AyenI , HautzingerM .Cognitive behavior therapy for depression in menopausal women. A controlled, randomized treatment study [Kognitive Verhaltenstherapie bei Depressionen im Klimakterium: Eine kontrollierte, randomiserte Interventionsstudie]. Zeitschrift für Klinische Psychologie und Psychotherapie2004;33(4):290-9. AyenI .Inclusion of study in Cochrane Systematic Review (personal communication). Email to EG Faltinsen 9th of September 2019. ">Ayen 2004</a> ; <a href="./references#MR000050-bbs2-0027" title="FuchsCZ , RehnLP .A self-control behavior therapy program for depression. Journal of Consulting and Clinical Psychology1977;45(2):206-15. ">Fuchs 1977</a> ; <a href="./references#MR000050-bbs2-0035" title="KelleyJ .Inclusion of study in Cochrane Systematic Review (personal communication). Email to: A Todorovac 12th of August 2019. KelleyJM , KaptchukTJ , CusinC , LipkinS , FavaM .Open-label placebo for major depressive disorder: a pilot randomized controlled trial. Psychotherapy and Psychosomatics2012;81(5):312-4. ">Kelley 2012</a> ; <a href="./references#MR000050-bbs2-0039" title="KlermanGL , DimascioA , WeismannM , PrusoffB , PaykelES .Treatment of depression by drugs and psychotherapy. American Journal of Psychiatry1974;131(2):186-91. PaykelES , DimascioA , HaskellD , PrusoffBA .Effects of maintenance amitriptyline and psychotherapy on symptoms of depression. Psychological Medicine1975;5(1):67-77. PaykelES , DiMascioA , KlermanGL , PrusoffBA .Maintenance therapy of depression. Pharmakopsychiatrie, Neuro-Psychopharmakologie1976;9:127-39. PaykelES , WeissmanMM , PrusoffBA .Social maladjustment and severity of depression. Comprehensive Psychiatry1978;19(2):121-8. WeissmanMM , KlermanGL , PaykelES , PrusoffB .Treatment effects on the social adjustment of depressed patients. Archives of General Psychiatry1974;30:771-8. ">Klerman 1974a</a> ; <a href="./references#MR000050-bbs2-0040" title="KlermanGL , DimascioA , WeismannM , PrusoffB , PaykelES .Treatment of depression by drugs and psychotherapy. American Journal of Psychiatry1974;131(2):186-91. ">Klerman 1974b</a> ; <a href="./references#MR000050-bbs2-0047" title="LegrandF .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 14th of August 2019. LegrandFD , NeffEM .Efficacy of exercise as an adjunct treatment for clinically depressed inpatients during the initial stages of antidepressant pharmacotherapy: an open randomized controlled trial. Journal of Affective Disorders2016;191:139-44. ">Legrand 2016</a> ; <a href="./references#MR000050-bbs2-0050" title="LiddleB , SpenceSH .Cognitive-behaviour therapy with depressed primary school children: A cautionary note. Behavioural Psychotherapy1990;18(2):85-102. ">Liddle 1990</a> ; <a href="./references#MR000050-bbs2-0057" title="NandiDN , AjmanyS , GanguliH , BanerjeeG , BoralGC , GhoshA , et al.A clinical evaluation of depressives found in a rural survey in India. British Journal of Psychiatry1976;128:523-7. ">Nandi 1976</a> ; <a href="./references#MR000050-bbs2-0064" title="PolandRE , GertsikL , FavreauJT , SmithSI , MirochaJM , RaoU , et al.Open-label randomized parallel-group controlled clinical trial of massage for treatment of depression in HIV-infected subjects. Journal of Alternative and Complementary Medicine2013;19(4):334-40. ">Poland 2013</a> ; <a href="./references#MR000050-bbs2-0068" title="ProudfootJ , ClarkeJ , BirchMR , WhittonAE , ParkerG , ManicavasagarV , et al.Impact of a mobile phone and web program on symptom and functional outcomes for people with mild- to-moderate depression, anxiety and stress: a randomized controlled trial. BMC Psychiatry2013;13(312):1-12. ProudfootJ .Re: Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 26th of August 2019. ">Proudfoot 2013</a> ; <a href="./references#MR000050-bbs2-0070" title="LiebowitzM , QuitkinFM , StewartJW , McGrathPJ , HarrisonWM , MarkowitzJS , et al.Antidepressant efficacy in atypical depression. Archives of General Psychiatry1988;45(2):129-37. QuitkinFM , McGrathPJ , StewartJW , HarrisonW , WagerSG , NunesE , et al.Phenelzine and imipramine in mood reactive depressives: further delineation of the syndrome of atypical depression. Archives of General Psychiatry1989;46(9):787-93. RabkinJG , McGrathPJ , QuitkinFM , TricamoE , StewartJW , KleinDF .Effects of pill-giving on maintenance of placebo response in patients with chronic mild depression. American Journal of Psychiatry1990;147(12):1622-6. ">Rabkin 1990</a> ; <a href="./references#MR000050-bbs2-0085" title="TanSY , BruniJ .Cognitive-behavior therapy with adult patients with epilepsy: a controlled outcome study. Epilepsia1986;27(3):225-33. ">Tan 1986</a> ; <a href="./references#MR000050-bbs2-0086" title="TeriL , LogsdonRG , UomotoJ , McCurrySM .Behavioral treatment of depression in dementia patients: a controlled clinical trial. Journals of Gerontology. Series B, Psychological Sciences and Social Sciences1997;52(4):159-66. TeriL .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 26th of August 2019. ">Teri 1997</a> ; <a href="./references#MR000050-bbs2-0096" title="WollersheimJP , WilsonGL .Group treatment of unipolar depression: a comparison of coping, supportive, bibliotherapy, and delayed treatment groups. Professional Psychology: Research and Practice1991;22(6):496-502. ">Wollersheim 1991</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Encopresis</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#MR000050-bbs2-0007" title="BergI , ForsytheI , HoltP , WattsJ .A controlled trial of ‘Senokot’ in faecal soiling treated by behavioural methods. Journal of Child Psychology and Psychiatry1983;24(4):543-9. ">Berg 1983</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Erectile dysfunction</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#MR000050-bbs2-0037" title="KilmannPR , MilanRJ , BolandJP , NankinHR , DavidsonE , WestMO , et al.Group treatment of secondary erectile dysfunction. Journal of Sex &amp; Marital Therapy1987;13(3):168-82. KilmannPR , Milan RJ Jr, BolandJP , DavidsonE , WestMO , SablisRF , et al.The sexual interactions of men with secondary erectile dysfunction. Journal of Sex Education and Therapy1988;14(1):46-9. KilmannPR , Milan RJ Jr, BolandJP , NankinHR , SablisRF , WestMO , et al.The sexual interactions of men with secondary erectile dysfunction. Paper presented at the annual meeting of the American Psychological Association in Los Angeles1985;1:46-9. ">Kilmann 1987</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Intellectual disability</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#MR000050-bbs2-0012" title="BramstonP , SpenceSH .Behavioural versus cognitive social-skills training with intellectually-handicapped adults. Behaviour Research and Therapy1985;23(3):239-46. ">Bramston 1985</a> ; <a href="./references#MR000050-bbs2-0051" title="MatsonJL , MarchettiA , AdkinsJA .Comparison of operant- and independence-training procedures for mentally retarded adults. American Journal of Mental Deficiency1980;84(5):487-94. ">Matson 1980</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Learning disability</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#MR000050-bbs2-0028" title="GlogowskaM , RoulstoneS , EnderbyP , PetersTJ .Randomised controlled trial of community based speech and language therapy in preschool children. BMJ2000;321(7266):923-6. ">Glogowska 2000</a> ; <a href="./references#MR000050-bbs2-0055" title="MirandaA , ArlandisP , SorianoM .Instruction in strategies and attributional training: Effects on the problem-solving and self-concept of students’ with learning disabilities [Instrucción en estrategias y entrenamiento atribucional: efectos sobre la resolución de problemas y el autoconcepto de los estudiantes con dificultades en el aprendizaje]. Infancia y Aprendizaje1997;20(80):37-52. ">Miranda 1997</a> ; <a href="./references#MR000050-bbs2-0056" title="MitchellC , MansfieldD , RautenbachS .Coloured filters and reading accuracy, comprehension and rate: a placebo-controlled study. Perceptual and Motor Skills2008;106(2):517-32. ">Mitchell 2008</a> ) </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Neurodegenerative disease</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#MR000050-bbs2-0030" title="GoldwasserAN , AuerbachSM , HarkinsSW .Cognitive, affective, and behavioural effects of reminiscence group therapy on demented elderly. Aging and Human Development1987;25(3):209-22. ">Goldwasser 1987</a> ; <a href="./references#MR000050-bbs2-0043" title="KwanR .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 26th of August 2019. KwanRY , LeungMC , LaiCK .Acupressure for agitation in nursing home residents with dementia: study protocol for a randomized controlled trial. Trials2014;15(410):1-7. KwanRY , LeungMCP , LaiCK .A randomized controlled trial examining the effect of acupressure on agitation and salivary cortisol in nursing home residents with dementia. Dementia and Geriatric Cognitive Disorders2017;44(1-2):92-104. ">Kwan 2017</a> ; <a href="./references#MR000050-bbs2-0045" title="LaiCK , ChiI , Kayser-JonesJ .A randomized controlled trial of a specific reminiscence approach to promote the well-being of nursing home residents with dementia. International Psychogeriatrics2004;16(1):33-49. LaiK .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 6th of September 2019. ">Lai 2004</a> ; <a href="./references#MR000050-bbs2-0052" title="McLachlanDR , DaltonAJ , KruckTP , BellMY , SmithWL , KalowW , et al.Intramuscular desferrioxamine in patients with Alzheimer's disease. Lancet1991;337(8753):1304-8. McLachlanDRC , SmithWL , KruckTP .Desferrioxamine and Alzheimer’s disease: video home behavior assessment of clinical course and measures of brain aluminum. Therapeutic Drug Monitoring1993;15(6):602-7. ">McLachlan 1991</a> ; <a href="./references#MR000050-bbs2-0069" title="QuayhagenMP , QuayhagenM , CorbeilRR , RothPA , RodgersJA .A dyadic remediation program for care recipients with dementia. Nursing Research1995;44(3):153-9. ">Quayhagen 1995</a> ; <a href="./references#MR000050-bbs2-0086" title="TeriL , LogsdonRG , UomotoJ , McCurrySM .Behavioral treatment of depression in dementia patients: a controlled clinical trial. Journals of Gerontology. Series B, Psychological Sciences and Social Sciences1997;52(4):159-66. TeriL .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 26th of August 2019. ">Teri 1997</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Post‐Traumatic Stress‐Disorder (PTSD)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#MR000050-bbs2-0021" title="EhlersA , HackmannA , GreyN , WildJ , LinessS , AlbertI , et al.A randomized controlled trial of 7-day intensive and standard weekly cognitive therapy for PTSD and emotion-focused supportive therapy. American Journal of Psychiatry2014;171(3):294-304. ">Ehlers 2014</a> ; <a href="./references#MR000050-bbs2-0024" title="FoaEB , RothbaumBO , RiggsDS , MurdockTB .Treatment of posttraumatic stress disorder in rape victims: a comparison between cognitive-behavioral procedures and counselling. Journal of Consulting and Clinical Psychology1991;59(5):715-23. ">Foa 1991</a> ; <a href="./references#MR000050-bbs2-0025" title="FoaEB , McLeanCP , ZangY , RosenfieldD , YadinE , YarvisJS , et al.Effect of prolonged exposure therapy delivered over 2 weeks vs 8 weeks vs present-centered therapy on PTSD symptom severity in military personnel: a randomized clinical trial. JAMA2018;319(4):354-64. ">Foa 2018</a> ; <a href="./references#MR000050-bbs2-0079" title="ShalevAY , AnkriY , Isreali-ShalevY , PelegT , AdesskyR , FreedmanS .Prevention of posttraumatic stress disorder by early treatment. Archives of General Psychiatry2012;69(2):166-76. ">Shalev 2012</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Schizophrenia</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#MR000050-bbs2-0032" title="HippmanC , RingroseA , InglisA , CheekJ , AlbertAY , RemickR , et al.A pilot randomized clinical trial evaluating the impact of genetic counselling for serious mental illnesses. Journal of Clinical Psychiatry2016;77(2):e190-8. ">Hippman 2016</a> ; <a href="./references#MR000050-bbs2-0059" title="PearlD , Vander KampH , OlsenAL , GreenbergPD , ArmitageSG .The effects of reserpine on schizophrenic patients. American Journal of Psychiatry1956;112:198-204. ">Pearl 1956</a> ; <a href="./references#MR000050-bbs2-0081" title="SibilioJP , AndrewG , DartD , MooreKB , StehmanA .Treatment of chronic schizophrenia with promazine hydrochloride. AMA Archives of Neurology and Psychiatry1957;78(4):419-24. ">Sibilio 1957</a> ; <a href="./references#MR000050-bbs2-0092" title="WeingaertnerAH .Self-administered aversive stimulation with hallucinating hospitalized schizophrenics. Journal of Consulting and Clinical Psychology1971;36(3):422-29. ">Weingaertner 1971</a> ; <a href="./references#MR000050-bbs2-0093" title="WhittakerCB , HoyRM .Withdrawal of perphenazine in chronic schizophrenia. British Journal of Psychiatry1963;109:422-7. ">Whittaker 1963</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Sleep‐wake disorders (e.g. insomnia, sleep disturbance)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>11</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#MR000050-bbs2-0005" title="AscherLM , TurnerR .Paradoxical intention and insomnia: an experimental investigation. Behaviour Research and Therapy1979;17(4):408-11. ">Ascher 1979</a> ; <a href="./references#MR000050-bbs2-0009" title="BorkovecTD , KaloupekDG , SlamaKM .The facilitative effect of muscle tension-release in the relaxation treatment of sleep disturbance. Behavior Therapy1975;6(3):301-9. ">Borkovec 1975</a> ; <a href="./references#MR000050-bbs2-0010" title="BorkovecTD , WeertsTC .Effects of progressive relaxation on sleep disturbance: an electroencephalographic evaluation. Psychosomatic Medicine1976;38(3):173-80. ">Borkovec 1976</a> ; <a href="./references#MR000050-bbs2-0022" title="EspieCA , BrooksDN , LindsayWR .An evaluation of tailored psychological treatment of insomnia. Journal of Behavior Therapy and Experimental Psychiatry1989;20(2):143-53. EspieCA , LindsayWR , BrooksDN , HoodEM , TurveyT .A controlled comparative investigation of psychological treatments for chronic sleep-onset insomnia. Behaviour Research and Therapy1989;27(1):79-88. ">Espie 1989a</a> ; <a href="./references#MR000050-bbs2-0026" title="FreireAO , SugaiGC , ChrispinFS , TogeiroSM , YamamuraY , MelloLE , et al.Treatment of moderate obstructive sleep apnea syndrome with acupuncture: a randomised, placebo-controlled pilot trial. Sleep Medicine2007;8(1):43-50. ">Freire 2007</a> ; <a href="./references#MR000050-bbs2-0049" title="LickJR , HefflerD .Relaxation training and attention placebo in the treatment of severe insomnia. Journal of Consulting and Clinical Psychology1977;45(2):153-61. ">Lick 1977</a> ; <a href="./references#MR000050-bbs2-0058" title="NicassioP , BootzinR .A comparison of progressive relaxation and autogenic training as treatments for insomnia. Journal of Abnormal Psychology1974;83(3):253-60. ">Nicassio 1974</a> ; <a href="./references#MR000050-bbs2-0080" title="ShealyRC .The effectiveness of various treatment techniques on different degrees and durations of sleep-onset insomnia. Behaviour Research and Therapy1979;17(6):541-6. ">Shealy 1979</a> ; <a href="./references#MR000050-bbs2-0083" title="SteinmarkSW , BorkovecTD .Active and placebo treatment effects on moderate insomnia under counterdemand and positive demand instructions. Journal of Abnormal Psychology1974;83(2):157-63. ">Steinmark 1974</a> ; <a href="./references#MR000050-bbs2-0089" title="AscherML , TurnerRM .A comparison of two methods for the administration of paradoxical intention. Behaviour Research and Therapy1980;18(2):121-6. TurnerRM , AscherLM .Controlled comparison of progressive relaxation, stimulus control, and paradoxical intention therapies for insomnia. Journal of Consulting and Clinical Psychology1979;47(3):500-8. ">Turner 1979</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Substance use disorders of different kind (e.g. alcohol, cocaine)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#MR000050-bbs2-0004" title="AlvarezJR .The effects of anger management training on depression, anger, self-concept, and treatment responsibility in a sample of drug-dependent individuals in a therapeutic community. Dissertation Abstracts International: Section B: the Sciences and Engineering1997;58(4-B):2108. ">Alvarez 1997</a> ; <a href="./references#MR000050-bbs2-0011" title="BornovalovaM .Inclusion of study in Cochrane Systematic Review (personal communication). Email to A Todorovac. 21st of August 2019. BornovalovaMA .Distress tolerance treatment for inner-city drug users: a preliminary trial. Doctor’s Dissertation, University of Maryland2008. ">Bornovalova 2008</a> ; <a href="./references#MR000050-bbs2-0018" title="CrouchG , RobsonM , HallstromC .Benzodiazepine dependent patients and their psychological treatment. Progress in Neuro-psychopharmacology &amp; Biological Psychiatry1988;12(4):503-10. HallströmC , CrouchG , RobsenM , ShineP .The treatment of tranquillizer dependence by propranolol. Postgraduate Medical Journal1988;64(Suppl 2):40-4. ">Crouch 1988</a> ; <a href="./references#MR000050-bbs2-0054" title="MilbyJB , ClarkeC , ToroC , ThorntonS , RickertD .Effectiveness of urine surveillance as an adjunct to outpatient psychotherapy for drug abusers. International Journal of the Addictions1980;15(7):993-1001. ">Milby 1980</a> ; <a href="./references#MR000050-bbs2-0063" title="PetersonMA , PattersonB , PillmanBM , BattistaMA .Cognitive recovery following alcohol detoxification: a computerised remediation study. Neuropsychological Rehabilitation2002;12(1):63-74. PillmanBM .Computerized cognitive remediation with recently detoxified alcoholics. Dissertation, California School of Professional Psychology, Fresno Campus2000. ">Pillman 2001</a> ; <a href="./references#MR000050-bbs2-0074" title="RoehrichL , GoldmanMS .Experience-dependent neuropsychological recovery and the treatment of alcoholism. Journal of Consulting and Clinical Psychology1993;61(5):812-21. ">Roehrich 1993</a> ; <a href="./references#MR000050-bbs2-0091" title="WatzlH , RistF , OlbrichR , CohenR .Placebo injections and surveillance of alcohol intake during inpatient treatment of female alcoholics. Addictive Behaviors1988;13(2):197-200. ">Watzl 1988</a> ; <a href="./references#MR000050-bbs2-0094" title="WilsonA , DavidsonWJ , BlanchardR , WhiteJ .Disulfiram implantation. A placebo-controlled trial with two-year follow-up. Journal of Studies on Alcohol1978;39(5):809-19. WilsonA , DavidsonWJ , BlanchardR .Disulfiram implantation: a trial using placebo implants and two types of controls. Journal of Studies on Alcohol1980;41(5):429-36. ">Wilson 1980</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Other unspecified disorders</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#MR000050-bbs2-0013" title="BrillNQ , KoeglerRR , EpsteinLJ , ForgyEW .Controlled study of psychiatric outpatient treatment. Archives of General Psychiatry1964;10:581-95. BrillNQ .Results of psychotherapy. California Medicine1966;104(4):249-53. ">Brill 1964a</a> ; <a href="./references#MR000050-bbs2-0014" title="BrillNQ , KoeglerRR , EpsteinLJ , ForgyEW .Controlled study of psychiatric outpatient treatment. Archives of General Psychiatry1964;10:581-95. ">Brill 1964b</a> ; <a href="./references#MR000050-bbs2-0019" title="Doty, DW.Role playing and incentives in the modification of the social interaction of chronic psychiatric patients. Journal of Consulting and Clinical Psychology1975;43(5):676-82. ">Doty 1975</a> ; <a href="./references#MR000050-bbs2-0020" title="DoubleDB , WarrenGC , EvansM , RowlandsMP .Efficacy of maintenance use of anticholinergic agents. Acta Psychiatrica Scandinavica1993;88:381-4. ">Double 1993</a> ; <a href="./references#MR000050-bbs2-0044" title="LacyMK .The effect of short term autogenic training on the stress reactivity of hospitalized emotionally disturbed adolescents. ProQuest Dissertations Publishing, Oklahoma State University1996. ">Lacy 1990</a> ; <a href="./references#MR000050-bbs2-0073" title="RobinA .Rationing out-patients: a defence of the waiting list. British Journal of Psychiatry1976;129:138-41. ">Robin 1976</a> ; <a href="./references#MR000050-bbs2-0077" title="LorrM , McNairDM , WeinsteinGJ .Early effects of chlordiazepoxide (Librium) used with psychotherapy. Journal of Psychiatric Research1963;1:257-70. RothI , RhudickPJ , ShaskanDA , SlobinMS , WilkinsonAE , YoungHH .Long-term effects on psychotherapy of initial treatment conditions. Journal of Psychiatric Research1964;2:283-97. ">Roth 1964</a> ; <a href="./references#MR000050-bbs2-0082" title="SommernessMD , LuceroRJ , HamlonJS , EricksonJL , MatthewsR .A controlled study of reserpine on chronically disturbed patients. JAMA Archives of Neurology and Psychiatry1955;74(3):316-9. ">Sommerness 1955</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Duration of interventions</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Less than three<br/>months </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>74</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#MR000050-bbs2-0002" title="AllenJB .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to A Todorovac 28th of August 2019. AllenJJ , SchnyerRN , HittSK .The efficacy of acupuncture in the treatment of major depression in women. Psychological Science1998;9(5):397-401. ">Allen 1998</a> ; <a href="./references#MR000050-bbs2-0003" title="AllenJB .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 28th of August 2019. AllenJJ , SchnyerRN , ChambersAS , HittSK , MorenoFA , ManberR .Acupuncture for depression: a randomized controlled trial. Journal of Clinical Psychiatry2006;67(11):1665-73. ">Allen 2006</a> ; <a href="./references#MR000050-bbs2-0004" title="AlvarezJR .The effects of anger management training on depression, anger, self-concept, and treatment responsibility in a sample of drug-dependent individuals in a therapeutic community. Dissertation Abstracts International: Section B: the Sciences and Engineering1997;58(4-B):2108. ">Alvarez 1997</a> ; <a href="./references#MR000050-bbs2-0005" title="AscherLM , TurnerR .Paradoxical intention and insomnia: an experimental investigation. Behaviour Research and Therapy1979;17(4):408-11. ">Ascher 1979</a> ; <a href="./references#MR000050-bbs2-0009" title="BorkovecTD , KaloupekDG , SlamaKM .The facilitative effect of muscle tension-release in the relaxation treatment of sleep disturbance. Behavior Therapy1975;6(3):301-9. ">Borkovec 1975</a> ; <a href="./references#MR000050-bbs2-0010" title="BorkovecTD , WeertsTC .Effects of progressive relaxation on sleep disturbance: an electroencephalographic evaluation. Psychosomatic Medicine1976;38(3):173-80. ">Borkovec 1976</a> ; <a href="./references#MR000050-bbs2-0011" title="BornovalovaM .Inclusion of study in Cochrane Systematic Review (personal communication). Email to A Todorovac. 21st of August 2019. BornovalovaMA .Distress tolerance treatment for inner-city drug users: a preliminary trial. Doctor’s Dissertation, University of Maryland2008. ">Bornovalova 2008</a> ; <a href="./references#MR000050-bbs2-0012" title="BramstonP , SpenceSH .Behavioural versus cognitive social-skills training with intellectually-handicapped adults. Behaviour Research and Therapy1985;23(3):239-46. ">Bramston 1985</a> ; <a href="./references#MR000050-bbs2-0015" title="CarlsonCL , PelhamWE , MilichR , HozaB .ADHD boys’ performance and attributions following success and failure: drug effects and individual differences. Cognitive Therapy and Research1993;17:269-87. ">Carlson 1993</a> ; <a href="./references#MR000050-bbs2-0016" title="CarterJC , OlmstedMP , KaplanAS , McCabeRE , MillsJS , AimeA .Self-help for bulimia nervosa: a randomized controlled trial. American Journal of Psychiatry2003;160(5):973-8. ">Carter 2003</a> ; <a href="./references#MR000050-bbs2-0017" title="CrispAH , NortonK , GowersS , HalekC , BowyerC , YeldhamD , et al.A controlled study of the effect of therapies aimed at adolescent and family psychopathology in Anorexia Nervosa. British Journal of Psychiatry: the Journal of Mental Science1991;159:325-33. GowersS , NortonK , HalekC , CrispAH .Outcome of outpatient psychotherapy in a random allocation treatment study of anorexia nervosa. International Journal of Eating Disorders1994;15(2):165-77. GowersS , NortonK , YelshamD .The St George's prospective treatment study of anorexia nervosa: a discussion of methodological problems. International Journal of Eating Disorders1989;8:445-54. ">Crisp 1991</a> ; <a href="./references#MR000050-bbs2-0018" title="CrouchG , RobsonM , HallstromC .Benzodiazepine dependent patients and their psychological treatment. Progress in Neuro-psychopharmacology &amp; Biological Psychiatry1988;12(4):503-10. HallströmC , CrouchG , RobsenM , ShineP .The treatment of tranquillizer dependence by propranolol. Postgraduate Medical Journal1988;64(Suppl 2):40-4. ">Crouch 1988</a> ; <a href="./references#MR000050-bbs2-0019" title="Doty, DW.Role playing and incentives in the modification of the social interaction of chronic psychiatric patients. Journal of Consulting and Clinical Psychology1975;43(5):676-82. ">Doty 1975</a> ; <a href="./references#MR000050-bbs2-0020" title="DoubleDB , WarrenGC , EvansM , RowlandsMP .Efficacy of maintenance use of anticholinergic agents. Acta Psychiatrica Scandinavica1993;88:381-4. ">Double 1993</a> ; <a href="./references#MR000050-bbs2-0022" title="EspieCA , BrooksDN , LindsayWR .An evaluation of tailored psychological treatment of insomnia. Journal of Behavior Therapy and Experimental Psychiatry1989;20(2):143-53. EspieCA , LindsayWR , BrooksDN , HoodEM , TurveyT .A controlled comparative investigation of psychological treatments for chronic sleep-onset insomnia. Behaviour Research and Therapy1989;27(1):79-88. ">Espie 1989a</a> ; <a href="./references#MR000050-bbs2-0023" title="EtringerBD , CashTF , RimmDC .Behavioral, affective, and cognitive effects of participant modeling and an equally credible placebo. Behavior Therapy1982;13(4):476-85. ">Etringer 1982</a> ; <a href="./references#MR000050-bbs2-0024" title="FoaEB , RothbaumBO , RiggsDS , MurdockTB .Treatment of posttraumatic stress disorder in rape victims: a comparison between cognitive-behavioral procedures and counselling. Journal of Consulting and Clinical Psychology1991;59(5):715-23. ">Foa 1991</a> ; <a href="./references#MR000050-bbs2-0025" title="FoaEB , McLeanCP , ZangY , RosenfieldD , YadinE , YarvisJS , et al.Effect of prolonged exposure therapy delivered over 2 weeks vs 8 weeks vs present-centered therapy on PTSD symptom severity in military personnel: a randomized clinical trial. JAMA2018;319(4):354-64. ">Foa 2018</a> ; <a href="./references#MR000050-bbs2-0026" title="FreireAO , SugaiGC , ChrispinFS , TogeiroSM , YamamuraY , MelloLE , et al.Treatment of moderate obstructive sleep apnea syndrome with acupuncture: a randomised, placebo-controlled pilot trial. Sleep Medicine2007;8(1):43-50. ">Freire 2007</a> ; <a href="./references#MR000050-bbs2-0027" title="FuchsCZ , RehnLP .A self-control behavior therapy program for depression. Journal of Consulting and Clinical Psychology1977;45(2):206-15. ">Fuchs 1977</a> ; <a href="./references#MR000050-bbs2-0029" title="GoldsteinAJ , BeursE , Chambless Dl, WilsonKA .EMDR for panic disorder with agoraphobia: comparison with waiting list and credible attention-placebo control conditions. Journal of Consulting and Clinical Psychology2000;68(6):947-56. ">Goldstein 2000</a> ; <a href="./references#MR000050-bbs2-0030" title="GoldwasserAN , AuerbachSM , HarkinsSW .Cognitive, affective, and behavioural effects of reminiscence group therapy on demented elderly. Aging and Human Development1987;25(3):209-22. ">Goldwasser 1987</a> ; <a href="./references#MR000050-bbs2-0031" title="HekmatH , LubitzR , DealR .Semantic desensitization: a paradigmatic intervention approach to anxiety disorders. Journal of Clinical Psychology1984;40(2):463-6. ">Hekmat 1984</a> ; <a href="./references#MR000050-bbs2-0033" title="HowlinP , GordonKR , PascoG , WadeA , CharmanT .The effectiveness of picture exchange communication system (PECS) training for teachers of children with autism: a pragmatic,group randomised controlled trial. Journal of Child Psychology and Psychiatry2007;48(5):473-81. ">Howlin 2007</a> ; <a href="./references#MR000050-bbs2-0034" title="KarstM , WinterhalterM , MünteS , FranckiB , HondronikosA , EckardtA , et al.Auricular acupuncture for dental anxiety: a randomized controlled trial. Anesthesia and Analgesia2007;104(2):295-300. KarstM .Inclusion of study in Cochrane Systematic Review (personal communication). Email to: EG Faltinsen 5th of September 2019. ">Karst 2007</a> ; <a href="./references#MR000050-bbs2-0035" title="KelleyJ .Inclusion of study in Cochrane Systematic Review (personal communication). Email to: A Todorovac 12th of August 2019. KelleyJM , KaptchukTJ , CusinC , LipkinS , FavaM .Open-label placebo for major depressive disorder: a pilot randomized controlled trial. Psychotherapy and Psychosomatics2012;81(5):312-4. ">Kelley 2012</a> ; <a href="./references#MR000050-bbs2-0037" title="KilmannPR , MilanRJ , BolandJP , NankinHR , DavidsonE , WestMO , et al.Group treatment of secondary erectile dysfunction. Journal of Sex &amp; Marital Therapy1987;13(3):168-82. KilmannPR , Milan RJ Jr, BolandJP , DavidsonE , WestMO , SablisRF , et al.The sexual interactions of men with secondary erectile dysfunction. Journal of Sex Education and Therapy1988;14(1):46-9. KilmannPR , Milan RJ Jr, BolandJP , NankinHR , SablisRF , WestMO , et al.The sexual interactions of men with secondary erectile dysfunction. Paper presented at the annual meeting of the American Psychological Association in Los Angeles1985;1:46-9. ">Kilmann 1987</a> ; <a href="./references#MR000050-bbs2-0038" title="KleinSA , DeffenbacherJL .Relaxation and exercise for hyperactive impulsive children. Perceptual and Motor Skills1977;45:1159-62. ">Klein 1977</a> ; <a href="./references#MR000050-bbs2-0042" title="KrapflJE , NawasMM .Differential ordering of stimulus presentation in systematic desensitization. Journal of Abnormal Psychology1970;75(3):333-7. ">Krapfl 1970</a> ; <a href="./references#MR000050-bbs2-0043" title="KwanR .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 26th of August 2019. KwanRY , LeungMC , LaiCK .Acupressure for agitation in nursing home residents with dementia: study protocol for a randomized controlled trial. Trials2014;15(410):1-7. KwanRY , LeungMCP , LaiCK .A randomized controlled trial examining the effect of acupressure on agitation and salivary cortisol in nursing home residents with dementia. Dementia and Geriatric Cognitive Disorders2017;44(1-2):92-104. ">Kwan 2017</a> ; <a href="./references#MR000050-bbs2-0045" title="LaiCK , ChiI , Kayser-JonesJ .A randomized controlled trial of a specific reminiscence approach to promote the well-being of nursing home residents with dementia. International Psychogeriatrics2004;16(1):33-49. LaiK .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 6th of September 2019. ">Lai 2004</a> ; <a href="./references#MR000050-bbs2-0046" title="LangOJ , LazovikAD .Experimental desensitization of a phobia. Journal of Abnormal and Social Psychology1963;66:519-25. LangPJ , LazovikAD , ReynoldsDJ .Desensitization, suggestibility, and pseudotherapy. Journal of Abnormal Psychology1965;70(6):395-402. ">Lang 1965</a> ; <a href="./references#MR000050-bbs2-0047" title="LegrandF .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 14th of August 2019. LegrandFD , NeffEM .Efficacy of exercise as an adjunct treatment for clinically depressed inpatients during the initial stages of antidepressant pharmacotherapy: an open randomized controlled trial. Journal of Affective Disorders2016;191:139-44. ">Legrand 2016</a> ; <a href="./references#MR000050-bbs2-0048" title="LickJ .Expectancy, false galvanic skin response feedback, and systematic desensitization in the modification of phobic behavior. Journal of Consulting and Clinical Psychology1975;43(4):557-67. ">Lick 1975</a> ; <a href="./references#MR000050-bbs2-0049" title="LickJR , HefflerD .Relaxation training and attention placebo in the treatment of severe insomnia. Journal of Consulting and Clinical Psychology1977;45(2):153-61. ">Lick 1977</a> ; <a href="./references#MR000050-bbs2-0050" title="LiddleB , SpenceSH .Cognitive-behaviour therapy with depressed primary school children: A cautionary note. Behavioural Psychotherapy1990;18(2):85-102. ">Liddle 1990</a> ; <a href="./references#MR000050-bbs2-0051" title="MatsonJL , MarchettiA , AdkinsJA .Comparison of operant- and independence-training procedures for mentally retarded adults. American Journal of Mental Deficiency1980;84(5):487-94. ">Matson 1980</a> ; <a href="./references#MR000050-bbs2-0053" title="MealieaWL , NawasMM .The comparative effectiveness of systematic desensitization and implosive therapy in the treatment of snake phobia. Journal of Behavior Therapy and Experimental Psychiatry1971;2(2):85-94. ">Mealiea 1971</a> ; <a href="./references#MR000050-bbs2-0054" title="MilbyJB , ClarkeC , ToroC , ThorntonS , RickertD .Effectiveness of urine surveillance as an adjunct to outpatient psychotherapy for drug abusers. International Journal of the Addictions1980;15(7):993-1001. ">Milby 1980</a> ; <a href="./references#MR000050-bbs2-0055" title="MirandaA , ArlandisP , SorianoM .Instruction in strategies and attributional training: Effects on the problem-solving and self-concept of students’ with learning disabilities [Instrucción en estrategias y entrenamiento atribucional: efectos sobre la resolución de problemas y el autoconcepto de los estudiantes con dificultades en el aprendizaje]. Infancia y Aprendizaje1997;20(80):37-52. ">Miranda 1997</a> ; <a href="./references#MR000050-bbs2-0056" title="MitchellC , MansfieldD , RautenbachS .Coloured filters and reading accuracy, comprehension and rate: a placebo-controlled study. Perceptual and Motor Skills2008;106(2):517-32. ">Mitchell 2008</a> ; <a href="./references#MR000050-bbs2-0057" title="NandiDN , AjmanyS , GanguliH , BanerjeeG , BoralGC , GhoshA , et al.A clinical evaluation of depressives found in a rural survey in India. British Journal of Psychiatry1976;128:523-7. ">Nandi 1976</a> ; <a href="./references#MR000050-bbs2-0058" title="NicassioP , BootzinR .A comparison of progressive relaxation and autogenic training as treatments for insomnia. Journal of Abnormal Psychology1974;83(3):253-60. ">Nicassio 1974</a> ; <a href="./references#MR000050-bbs2-0059" title="PearlD , Vander KampH , OlsenAL , GreenbergPD , ArmitageSG .The effects of reserpine on schizophrenic patients. American Journal of Psychiatry1956;112:198-204. ">Pearl 1956</a> ; <a href="./references#MR000050-bbs2-0060" title="PeckCL .Desensitization for the treatment of fear in the high level adult retardate. Behaviour Research and Therapy1977;15(2):137-48. ">Peck 1976</a> ; <a href="./references#MR000050-bbs2-0061" title="MilichR , CarlsonCL , Pelham WE Jr, LichtBG .Effects of methylphenidate on the persistence of ADHD boys following failure experiences. Journal of Abnormal Child Psychology1991;19(5):519-36. PelhamWE , MurphyDA , VannattaK , MilichR , LichtBG , GnagyEM , et al.Methylphenidate and attributions in boys with attention-deficit hyperactivity disorder. Journal of Consulting and Clinical Psychology1992;60(2):282-92. ">Pelham 1992</a> ; <a href="./references#MR000050-bbs2-0062" title="PedletonMG , HigginsRL .A comparison of negative practice and systematic desensitization in the treatment of acrophobia. Journal of Behavior Therapy and Experimental Psychiatry1983;14(4):317-23. ">Pendleton 1983</a> ; <a href="./references#MR000050-bbs2-0063" title="PetersonMA , PattersonB , PillmanBM , BattistaMA .Cognitive recovery following alcohol detoxification: a computerised remediation study. Neuropsychological Rehabilitation2002;12(1):63-74. PillmanBM .Computerized cognitive remediation with recently detoxified alcoholics. Dissertation, California School of Professional Psychology, Fresno Campus2000. ">Pillman 2001</a> ; <a href="./references#MR000050-bbs2-0064" title="PolandRE , GertsikL , FavreauJT , SmithSI , MirochaJM , RaoU , et al.Open-label randomized parallel-group controlled clinical trial of massage for treatment of depression in HIV-infected subjects. Journal of Alternative and Complementary Medicine2013;19(4):334-40. ">Poland 2013</a> ; <a href="./references#MR000050-bbs2-0065" title="PowersMB , SmitsJA , TelchMJ .Disentangling the effects of safety-behavior utilization and safety-behavior availability during exposure-based treatment: a placebo-controlled trial. Journal of Consulting and Clinical Psychology2004;72(3):448-54. ">Powers 2004</a> ; <a href="./references#MR000050-bbs2-0066" title="PowersMB , SmithsJA , WhitleyD , BystritskyA , TelchMJ .The effect of attributional processes concerning medication taking on return of fear. Journal of Consulting and Clinical Psychology2008;76(3):478-90. ">Powers 2008a</a> ; <a href="./references#MR000050-bbs2-0067" title="PowersMB , SmithsJA , WhitleyD , BystritskyA , TelchMJ .The effect of attributional processes concerning medication taking on return of fear. Journal of Consulting and Clinical Psychology2008;76(3):478-90. ">Powers 2008b</a> ; <a href="./references#MR000050-bbs2-0068" title="ProudfootJ , ClarkeJ , BirchMR , WhittonAE , ParkerG , ManicavasagarV , et al.Impact of a mobile phone and web program on symptom and functional outcomes for people with mild- to-moderate depression, anxiety and stress: a randomized controlled trial. BMC Psychiatry2013;13(312):1-12. ProudfootJ .Re: Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 26th of August 2019. ">Proudfoot 2013</a> ; <a href="./references#MR000050-bbs2-0070" title="LiebowitzM , QuitkinFM , StewartJW , McGrathPJ , HarrisonWM , MarkowitzJS , et al.Antidepressant efficacy in atypical depression. Archives of General Psychiatry1988;45(2):129-37. QuitkinFM , McGrathPJ , StewartJW , HarrisonW , WagerSG , NunesE , et al.Phenelzine and imipramine in mood reactive depressives: further delineation of the syndrome of atypical depression. Archives of General Psychiatry1989;46(9):787-93. RabkinJG , McGrathPJ , QuitkinFM , TricamoE , StewartJW , KleinDF .Effects of pill-giving on maintenance of placebo response in patients with chronic mild depression. American Journal of Psychiatry1990;147(12):1622-6. ">Rabkin 1990</a> ; <a href="./references#MR000050-bbs2-0073" title="RobinA .Rationing out-patients: a defence of the waiting list. British Journal of Psychiatry1976;129:138-41. ">Robin 1976</a> ; <a href="./references#MR000050-bbs2-0074" title="RoehrichL , GoldmanMS .Experience-dependent neuropsychological recovery and the treatment of alcoholism. Journal of Consulting and Clinical Psychology1993;61(5):812-21. ">Roehrich 1993</a> ; <a href="./references#MR000050-bbs2-0076" title="RosenGM , GlasgowRE , BarreraM .A controlled study to assess the clinical efficacy of totally self-administrated systematic desensitization. Journal of Consulting and Clinical Psychology1976;44(2):208-17. ">Rosen 1976</a> ; <a href="./references#MR000050-bbs2-0077" title="LorrM , McNairDM , WeinsteinGJ .Early effects of chlordiazepoxide (Librium) used with psychotherapy. Journal of Psychiatric Research1963;1:257-70. RothI , RhudickPJ , ShaskanDA , SlobinMS , WilkinsonAE , YoungHH .Long-term effects on psychotherapy of initial treatment conditions. Journal of Psychiatric Research1964;2:283-97. ">Roth 1964</a> ; <a href="./references#MR000050-bbs2-0078" title="RupertPA , HolmesDS .Effects of multiple sessions of true and placebo heart rate biofeedback training on the heart rates and anxiety levels of anxious patients during and following treatment. Psychophysiology1978;15(6):582-90. ">Rupert 1978</a> ; <a href="./references#MR000050-bbs2-0080" title="ShealyRC .The effectiveness of various treatment techniques on different degrees and durations of sleep-onset insomnia. Behaviour Research and Therapy1979;17(6):541-6. ">Shealy 1979</a> ; <a href="./references#MR000050-bbs2-0081" title="SibilioJP , AndrewG , DartD , MooreKB , StehmanA .Treatment of chronic schizophrenia with promazine hydrochloride. AMA Archives of Neurology and Psychiatry1957;78(4):419-24. ">Sibilio 1957</a> ; <a href="./references#MR000050-bbs2-0083" title="SteinmarkSW , BorkovecTD .Active and placebo treatment effects on moderate insomnia under counterdemand and positive demand instructions. Journal of Abnormal Psychology1974;83(2):157-63. ">Steinmark 1974</a> ; <a href="./references#MR000050-bbs2-0084" title="SzymanskiJ , O'DonohueW .The potential role of state-dependent learning in cognitive therapy with spider phobics. Journal of Rational-Emotive &amp; Cognitive-Behavior Therapy1995;13(2):131-50. SzymanskiJ .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 20th of August 2019. ">Szymanski 1995</a> ; <a href="./references#MR000050-bbs2-0085" title="TanSY , BruniJ .Cognitive-behavior therapy with adult patients with epilepsy: a controlled outcome study. Epilepsia1986;27(3):225-33. ">Tan 1986</a> ; <a href="./references#MR000050-bbs2-0086" title="TeriL , LogsdonRG , UomotoJ , McCurrySM .Behavioral treatment of depression in dementia patients: a controlled clinical trial. Journals of Gerontology. Series B, Psychological Sciences and Social Sciences1997;52(4):159-66. TeriL .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 26th of August 2019. ">Teri 1997</a> ; <a href="./references#MR000050-bbs2-0087" title="ToriC , WorellL .Reduction of human avoidant behavior. A comparison of counterconditioning, expectancy, and cognitive information approaches. Clinical Psychology1973;41(2):269-78. ">Tori 1973</a> ; <a href="./references#MR000050-bbs2-0088" title="Trexler, L.Rational-emotive therapy, placebo, and no-treatment effects on public-speaking anxiety. Doctoral dissertation, Temple University AnnArbor, Mich.: University Microfilms1971;71-31(063). TrexlerLD , KarstTO .Rational-emotive therapy, placebo, and no-treatment effects on public-speaking anxiety. Journal of Abnormal Psyhology1972;79(1):60-7. ">Trexler 1972</a> ; <a href="./references#MR000050-bbs2-0089" title="AscherML , TurnerRM .A comparison of two methods for the administration of paradoxical intention. Behaviour Research and Therapy1980;18(2):121-6. TurnerRM , AscherLM .Controlled comparison of progressive relaxation, stimulus control, and paradoxical intention therapies for insomnia. Journal of Consulting and Clinical Psychology1979;47(3):500-8. ">Turner 1979</a> ; <a href="./references#MR000050-bbs2-0090" title="VanderplateC .Electromyograph biofeedback Treatment of sleep onset Insomnia: a controlled Investigation. Dissertation, University of Southern Mississippi1978. ">Vanderplate 1983</a> ; <a href="./references#MR000050-bbs2-0092" title="WeingaertnerAH .Self-administered aversive stimulation with hallucinating hospitalized schizophrenics. Journal of Consulting and Clinical Psychology1971;36(3):422-29. ">Weingaertner 1971</a> ; <a href="./references#MR000050-bbs2-0093" title="WhittakerCB , HoyRM .Withdrawal of perphenazine in chronic schizophrenia. British Journal of Psychiatry1963;109:422-7. ">Whittaker 1963</a> ; <a href="./references#MR000050-bbs2-0094" title="WilsonA , DavidsonWJ , BlanchardR , WhiteJ .Disulfiram implantation. A placebo-controlled trial with two-year follow-up. Journal of Studies on Alcohol1978;39(5):809-19. WilsonA , DavidsonWJ , BlanchardR .Disulfiram implantation: a trial using placebo implants and two types of controls. Journal of Studies on Alcohol1980;41(5):429-36. ">Wilson 1980</a> ; <a href="./references#MR000050-bbs2-0095" title="WolitzkyKB , TelchMJ .Augmenting in vivo exposure with fear antagonistic actions: a preliminary test. Behavior Therapy2009;40(1):57-71. ">Wolitzky 2009</a> ; <a href="./references#MR000050-bbs2-0096" title="WollersheimJP , WilsonGL .Group treatment of unipolar depression: a comparison of coping, supportive, bibliotherapy, and delayed treatment groups. Professional Psychology: Research and Practice1991;22(6):496-502. ">Wollersheim 1991</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>More than three months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>21</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#MR000050-bbs2-0001" title="AbikoffH , HechtmanL , KleinRG .Social functioning in children with ADHD treated with long-term methylphenidate and multimodal psychosocial treatment. Journal of the American Academy of Child and Adolescent Psychiatry2004;43(7):820-9. AbikoffH .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to A Todorovac 23rd of August 2019. KleinRG , AbikoffH , HechtmanL , WeissG .Design and rationale of controlled study of long-term methylphenidate and multimodal psychosocial treatment in children with ADHD. Journal of the American Academy of Child and Adolescent Psychiatry2004;43(7):792-801. ">Abikoff 2004</a> ; <a href="./references#MR000050-bbs2-0006" title="AyenI , HautzingerM .Cognitive behavior therapy for depression in menopausal women. A controlled, randomized treatment study [Kognitive Verhaltenstherapie bei Depressionen im Klimakterium: Eine kontrollierte, randomiserte Interventionsstudie]. Zeitschrift für Klinische Psychologie und Psychotherapie2004;33(4):290-9. AyenI .Inclusion of study in Cochrane Systematic Review (personal communication). Email to EG Faltinsen 9th of September 2019. ">Ayen 2004</a> ; <a href="./references#MR000050-bbs2-0007" title="BergI , ForsytheI , HoltP , WattsJ .A controlled trial of ‘Senokot’ in faecal soiling treated by behavioural methods. Journal of Child Psychology and Psychiatry1983;24(4):543-9. ">Berg 1983</a> ; <a href="./references#MR000050-bbs2-0008" title="Borden, KA.Attributional Outcomes: the Subtle Messages of Treatments for Attention Deficit Disorder. Dissertation, University of Illinois at Urbana-Champaign1986. BordenKA , BrownRT .Attributional outcomes: The subtle messages of treatments for attention deficit disorder. Cognitive Therapy and Research1989;13(2):147-60. ">Borden 1986</a> ; <a href="./references#MR000050-bbs2-0013" title="BrillNQ , KoeglerRR , EpsteinLJ , ForgyEW .Controlled study of psychiatric outpatient treatment. Archives of General Psychiatry1964;10:581-95. BrillNQ .Results of psychotherapy. California Medicine1966;104(4):249-53. ">Brill 1964a</a> ; <a href="./references#MR000050-bbs2-0014" title="BrillNQ , KoeglerRR , EpsteinLJ , ForgyEW .Controlled study of psychiatric outpatient treatment. Archives of General Psychiatry1964;10:581-95. ">Brill 1964b</a> ; <a href="./references#MR000050-bbs2-0021" title="EhlersA , HackmannA , GreyN , WildJ , LinessS , AlbertI , et al.A randomized controlled trial of 7-day intensive and standard weekly cognitive therapy for PTSD and emotion-focused supportive therapy. American Journal of Psychiatry2014;171(3):294-304. ">Ehlers 2014</a> ; <a href="./references#MR000050-bbs2-0028" title="GlogowskaM , RoulstoneS , EnderbyP , PetersTJ .Randomised controlled trial of community based speech and language therapy in preschool children. BMJ2000;321(7266):923-6. ">Glogowska 2000</a> ; <a href="./references#MR000050-bbs2-0036" title="KennedyTD , KimuraHK .Transfer, behavioral improvement, and anxiety reduction in systematic desensitization. Journal of Consulting and Clinical Psychology1974;42(5):720-8. ">Kennedy 1974</a> ; <a href="./references#MR000050-bbs2-0039" title="KlermanGL , DimascioA , WeismannM , PrusoffB , PaykelES .Treatment of depression by drugs and psychotherapy. American Journal of Psychiatry1974;131(2):186-91. PaykelES , DimascioA , HaskellD , PrusoffBA .Effects of maintenance amitriptyline and psychotherapy on symptoms of depression. Psychological Medicine1975;5(1):67-77. PaykelES , DiMascioA , KlermanGL , PrusoffBA .Maintenance therapy of depression. Pharmakopsychiatrie, Neuro-Psychopharmakologie1976;9:127-39. PaykelES , WeissmanMM , PrusoffBA .Social maladjustment and severity of depression. Comprehensive Psychiatry1978;19(2):121-8. WeissmanMM , KlermanGL , PaykelES , PrusoffB .Treatment effects on the social adjustment of depressed patients. Archives of General Psychiatry1974;30:771-8. ">Klerman 1974a</a> ; <a href="./references#MR000050-bbs2-0040" title="KlermanGL , DimascioA , WeismannM , PrusoffB , PaykelES .Treatment of depression by drugs and psychotherapy. American Journal of Psychiatry1974;131(2):186-91. ">Klerman 1974b</a> ; <a href="./references#MR000050-bbs2-0041" title="KloskoJS , BarlowDH , TassinariR , CernyJA .A comparison of alprazolam and behavior therapy in treatment of panic disorder: correction. Journal of Psychotherapy Practice and Research1994;3(2):163-79. KloskoJS , BarlowDH , TassinariR , CernyJA .A comparison of alprazolam and behavior therapy in treatment of panic disorder. Journal of Consulting and Clinical Psychology1990;58(1):77-84. ">Klosko 1990</a> ; <a href="./references#MR000050-bbs2-0044" title="LacyMK .The effect of short term autogenic training on the stress reactivity of hospitalized emotionally disturbed adolescents. ProQuest Dissertations Publishing, Oklahoma State University1996. ">Lacy 1990</a> ; <a href="./references#MR000050-bbs2-0052" title="McLachlanDR , DaltonAJ , KruckTP , BellMY , SmithWL , KalowW , et al.Intramuscular desferrioxamine in patients with Alzheimer's disease. Lancet1991;337(8753):1304-8. McLachlanDRC , SmithWL , KruckTP .Desferrioxamine and Alzheimer’s disease: video home behavior assessment of clinical course and measures of brain aluminum. Therapeutic Drug Monitoring1993;15(6):602-7. ">McLachlan 1991</a> ; <a href="./references#MR000050-bbs2-0069" title="QuayhagenMP , QuayhagenM , CorbeilRR , RothPA , RodgersJA .A dyadic remediation program for care recipients with dementia. Nursing Research1995;44(3):153-9. ">Quayhagen 1995</a> ; <a href="./references#MR000050-bbs2-0071" title="RapeeR .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 29th of August 2019. RapeeRM , AbbottMJ , LynehamHJ .Bibliotherapy for children With anxiety disorders using written materials for parents: a randomized controlled trial. Journal of Consulting and Clinical Psychology2006;74(3):436-44. ">Rapee 2006</a> ; <a href="./references#MR000050-bbs2-0072" title="RapeeR .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 29th of August 2019. RapeeRM , AbbottMJ , BaillieAJ , GastonJE .Treatment of social phobia through pure self-help and therapist-augmented self-help. British Journal of Psychiatry2007;191:246-52. ">Rapee 2007</a> ; <a href="./references#MR000050-bbs2-0075" title="OlivaresJ .Program IAFS. Protocol for the treatment of social phobia in adolescents [Programa IAFS. Protocolo para el tratamiento de la fobia social enadolescentes]. Madrid: Pirámide2005;1. Rosa-AlcázarAI , Olivares-OlivaresPJ , OlivaresJ .The role of non-specific effects in the psychological treatment of adolescents with social phobia [Papel de los efectos inespecíficos en el tratamiento psicológico de adolescentes con fobia social]. Anuario de Psicologia2009;40(1):43-61. ">Rosa‐Alcatraz 2009</a> ; <a href="./references#MR000050-bbs2-0079" title="ShalevAY , AnkriY , Isreali-ShalevY , PelegT , AdesskyR , FreedmanS .Prevention of posttraumatic stress disorder by early treatment. Archives of General Psychiatry2012;69(2):166-76. ">Shalev 2012</a> ; <a href="./references#MR000050-bbs2-0082" title="SommernessMD , LuceroRJ , HamlonJS , EricksonJL , MatthewsR .A controlled study of reserpine on chronically disturbed patients. JAMA Archives of Neurology and Psychiatry1955;74(3):316-9. ">Sommerness 1955</a> ; <a href="./references#MR000050-bbs2-0091" title="WatzlH , RistF , OlbrichR , CohenR .Placebo injections and surveillance of alcohol intake during inpatient treatment of female alcoholics. Addictive Behaviors1988;13(2):197-200. ">Watzl 1988</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not reported</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#MR000050-bbs2-0032" title="HippmanC , RingroseA , InglisA , CheekJ , AlbertAY , RemickR , et al.A pilot randomized clinical trial evaluating the impact of genetic counselling for serious mental illnesses. Journal of Clinical Psychiatry2016;77(2):e190-8. ">Hippman 2016</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Formats of interventions</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Individual treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>25</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#MR000050-bbs2-0005" title="AscherLM , TurnerR .Paradoxical intention and insomnia: an experimental investigation. Behaviour Research and Therapy1979;17(4):408-11. ">Ascher 1979</a> ; <a href="./references#MR000050-bbs2-0011" title="BornovalovaM .Inclusion of study in Cochrane Systematic Review (personal communication). Email to A Todorovac. 21st of August 2019. BornovalovaMA .Distress tolerance treatment for inner-city drug users: a preliminary trial. Doctor’s Dissertation, University of Maryland2008. ">Bornovalova 2008</a> ; <a href="./references#MR000050-bbs2-0013" title="BrillNQ , KoeglerRR , EpsteinLJ , ForgyEW .Controlled study of psychiatric outpatient treatment. Archives of General Psychiatry1964;10:581-95. BrillNQ .Results of psychotherapy. California Medicine1966;104(4):249-53. ">Brill 1964a</a> ; <a href="./references#MR000050-bbs2-0016" title="CarterJC , OlmstedMP , KaplanAS , McCabeRE , MillsJS , AimeA .Self-help for bulimia nervosa: a randomized controlled trial. American Journal of Psychiatry2003;160(5):973-8. ">Carter 2003</a> ; <a href="./references#MR000050-bbs2-0021" title="EhlersA , HackmannA , GreyN , WildJ , LinessS , AlbertI , et al.A randomized controlled trial of 7-day intensive and standard weekly cognitive therapy for PTSD and emotion-focused supportive therapy. American Journal of Psychiatry2014;171(3):294-304. ">Ehlers 2014</a> ; <a href="./references#MR000050-bbs2-0022" title="EspieCA , BrooksDN , LindsayWR .An evaluation of tailored psychological treatment of insomnia. Journal of Behavior Therapy and Experimental Psychiatry1989;20(2):143-53. EspieCA , LindsayWR , BrooksDN , HoodEM , TurveyT .A controlled comparative investigation of psychological treatments for chronic sleep-onset insomnia. Behaviour Research and Therapy1989;27(1):79-88. ">Espie 1989a</a> ; <a href="./references#MR000050-bbs2-0024" title="FoaEB , RothbaumBO , RiggsDS , MurdockTB .Treatment of posttraumatic stress disorder in rape victims: a comparison between cognitive-behavioral procedures and counselling. Journal of Consulting and Clinical Psychology1991;59(5):715-23. ">Foa 1991</a> ; <a href="./references#MR000050-bbs2-0025" title="FoaEB , McLeanCP , ZangY , RosenfieldD , YadinE , YarvisJS , et al.Effect of prolonged exposure therapy delivered over 2 weeks vs 8 weeks vs present-centered therapy on PTSD symptom severity in military personnel: a randomized clinical trial. JAMA2018;319(4):354-64. ">Foa 2018</a> ; <a href="./references#MR000050-bbs2-0028" title="GlogowskaM , RoulstoneS , EnderbyP , PetersTJ .Randomised controlled trial of community based speech and language therapy in preschool children. BMJ2000;321(7266):923-6. ">Glogowska 2000</a> ; <a href="./references#MR000050-bbs2-0029" title="GoldsteinAJ , BeursE , Chambless Dl, WilsonKA .EMDR for panic disorder with agoraphobia: comparison with waiting list and credible attention-placebo control conditions. Journal of Consulting and Clinical Psychology2000;68(6):947-56. ">Goldstein 2000</a> ; <a href="./references#MR000050-bbs2-0031" title="HekmatH , LubitzR , DealR .Semantic desensitization: a paradigmatic intervention approach to anxiety disorders. Journal of Clinical Psychology1984;40(2):463-6. ">Hekmat 1984</a> ; <a href="./references#MR000050-bbs2-0032" title="HippmanC , RingroseA , InglisA , CheekJ , AlbertAY , RemickR , et al.A pilot randomized clinical trial evaluating the impact of genetic counselling for serious mental illnesses. Journal of Clinical Psychiatry2016;77(2):e190-8. ">Hippman 2016</a> ; <a href="./references#MR000050-bbs2-0036" title="KennedyTD , KimuraHK .Transfer, behavioral improvement, and anxiety reduction in systematic desensitization. Journal of Consulting and Clinical Psychology1974;42(5):720-8. ">Kennedy 1974</a> ; <a href="./references#MR000050-bbs2-0045" title="LaiCK , ChiI , Kayser-JonesJ .A randomized controlled trial of a specific reminiscence approach to promote the well-being of nursing home residents with dementia. International Psychogeriatrics2004;16(1):33-49. LaiK .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 6th of September 2019. ">Lai 2004</a> ; <a href="./references#MR000050-bbs2-0046" title="LangOJ , LazovikAD .Experimental desensitization of a phobia. Journal of Abnormal and Social Psychology1963;66:519-25. LangPJ , LazovikAD , ReynoldsDJ .Desensitization, suggestibility, and pseudotherapy. Journal of Abnormal Psychology1965;70(6):395-402. ">Lang 1965</a> ; <a href="./references#MR000050-bbs2-0048" title="LickJ .Expectancy, false galvanic skin response feedback, and systematic desensitization in the modification of phobic behavior. Journal of Consulting and Clinical Psychology1975;43(4):557-67. ">Lick 1975</a> ; <a href="./references#MR000050-bbs2-0051" title="MatsonJL , MarchettiA , AdkinsJA .Comparison of operant- and independence-training procedures for mentally retarded adults. American Journal of Mental Deficiency1980;84(5):487-94. ">Matson 1980</a> ; <a href="./references#MR000050-bbs2-0065" title="PowersMB , SmitsJA , TelchMJ .Disentangling the effects of safety-behavior utilization and safety-behavior availability during exposure-based treatment: a placebo-controlled trial. Journal of Consulting and Clinical Psychology2004;72(3):448-54. ">Powers 2004</a> ; <a href="./references#MR000050-bbs2-0066" title="PowersMB , SmithsJA , WhitleyD , BystritskyA , TelchMJ .The effect of attributional processes concerning medication taking on return of fear. Journal of Consulting and Clinical Psychology2008;76(3):478-90. ">Powers 2008a</a> ; <a href="./references#MR000050-bbs2-0068" title="ProudfootJ , ClarkeJ , BirchMR , WhittonAE , ParkerG , ManicavasagarV , et al.Impact of a mobile phone and web program on symptom and functional outcomes for people with mild- to-moderate depression, anxiety and stress: a randomized controlled trial. BMC Psychiatry2013;13(312):1-12. ProudfootJ .Re: Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 26th of August 2019. ">Proudfoot 2013</a> ; <a href="./references#MR000050-bbs2-0069" title="QuayhagenMP , QuayhagenM , CorbeilRR , RothPA , RodgersJA .A dyadic remediation program for care recipients with dementia. Nursing Research1995;44(3):153-9. ">Quayhagen 1995</a> ; <a href="./references#MR000050-bbs2-0074" title="RoehrichL , GoldmanMS .Experience-dependent neuropsychological recovery and the treatment of alcoholism. Journal of Consulting and Clinical Psychology1993;61(5):812-21. ">Roehrich 1993</a> ; <a href="./references#MR000050-bbs2-0076" title="RosenGM , GlasgowRE , BarreraM .A controlled study to assess the clinical efficacy of totally self-administrated systematic desensitization. Journal of Consulting and Clinical Psychology1976;44(2):208-17. ">Rosen 1976</a> ; <a href="./references#MR000050-bbs2-0086" title="TeriL , LogsdonRG , UomotoJ , McCurrySM .Behavioral treatment of depression in dementia patients: a controlled clinical trial. Journals of Gerontology. Series B, Psychological Sciences and Social Sciences1997;52(4):159-66. TeriL .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 26th of August 2019. ">Teri 1997</a> ; <a href="./references#MR000050-bbs2-0089" title="AscherML , TurnerRM .A comparison of two methods for the administration of paradoxical intention. Behaviour Research and Therapy1980;18(2):121-6. TurnerRM , AscherLM .Controlled comparison of progressive relaxation, stimulus control, and paradoxical intention therapies for insomnia. Journal of Consulting and Clinical Psychology1979;47(3):500-8. ">Turner 1979</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Group treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>18</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#MR000050-bbs2-0004" title="AlvarezJR .The effects of anger management training on depression, anger, self-concept, and treatment responsibility in a sample of drug-dependent individuals in a therapeutic community. Dissertation Abstracts International: Section B: the Sciences and Engineering1997;58(4-B):2108. ">Alvarez 1997</a> ; <a href="./references#MR000050-bbs2-0006" title="AyenI , HautzingerM .Cognitive behavior therapy for depression in menopausal women. A controlled, randomized treatment study [Kognitive Verhaltenstherapie bei Depressionen im Klimakterium: Eine kontrollierte, randomiserte Interventionsstudie]. Zeitschrift für Klinische Psychologie und Psychotherapie2004;33(4):290-9. AyenI .Inclusion of study in Cochrane Systematic Review (personal communication). Email to EG Faltinsen 9th of September 2019. ">Ayen 2004</a> ; <a href="./references#MR000050-bbs2-0012" title="BramstonP , SpenceSH .Behavioural versus cognitive social-skills training with intellectually-handicapped adults. Behaviour Research and Therapy1985;23(3):239-46. ">Bramston 1985</a> ; <a href="./references#MR000050-bbs2-0019" title="Doty, DW.Role playing and incentives in the modification of the social interaction of chronic psychiatric patients. Journal of Consulting and Clinical Psychology1975;43(5):676-82. ">Doty 1975</a> ; <a href="./references#MR000050-bbs2-0027" title="FuchsCZ , RehnLP .A self-control behavior therapy program for depression. Journal of Consulting and Clinical Psychology1977;45(2):206-15. ">Fuchs 1977</a> ; <a href="./references#MR000050-bbs2-0030" title="GoldwasserAN , AuerbachSM , HarkinsSW .Cognitive, affective, and behavioural effects of reminiscence group therapy on demented elderly. Aging and Human Development1987;25(3):209-22. ">Goldwasser 1987</a> ; <a href="./references#MR000050-bbs2-0037" title="KilmannPR , MilanRJ , BolandJP , NankinHR , DavidsonE , WestMO , et al.Group treatment of secondary erectile dysfunction. Journal of Sex &amp; Marital Therapy1987;13(3):168-82. KilmannPR , Milan RJ Jr, BolandJP , DavidsonE , WestMO , SablisRF , et al.The sexual interactions of men with secondary erectile dysfunction. Journal of Sex Education and Therapy1988;14(1):46-9. KilmannPR , Milan RJ Jr, BolandJP , NankinHR , SablisRF , WestMO , et al.The sexual interactions of men with secondary erectile dysfunction. Paper presented at the annual meeting of the American Psychological Association in Los Angeles1985;1:46-9. ">Kilmann 1987</a> ; <a href="./references#MR000050-bbs2-0050" title="LiddleB , SpenceSH .Cognitive-behaviour therapy with depressed primary school children: A cautionary note. Behavioural Psychotherapy1990;18(2):85-102. ">Liddle 1990</a> ; <a href="./references#MR000050-bbs2-0055" title="MirandaA , ArlandisP , SorianoM .Instruction in strategies and attributional training: Effects on the problem-solving and self-concept of students’ with learning disabilities [Instrucción en estrategias y entrenamiento atribucional: efectos sobre la resolución de problemas y el autoconcepto de los estudiantes con dificultades en el aprendizaje]. Infancia y Aprendizaje1997;20(80):37-52. ">Miranda 1997</a> ; <a href="./references#MR000050-bbs2-0062" title="PedletonMG , HigginsRL .A comparison of negative practice and systematic desensitization in the treatment of acrophobia. Journal of Behavior Therapy and Experimental Psychiatry1983;14(4):317-23. ">Pendleton 1983</a> ; <a href="./references#MR000050-bbs2-0071" title="RapeeR .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 29th of August 2019. RapeeRM , AbbottMJ , LynehamHJ .Bibliotherapy for children With anxiety disorders using written materials for parents: a randomized controlled trial. Journal of Consulting and Clinical Psychology2006;74(3):436-44. ">Rapee 2006</a> ; <a href="./references#MR000050-bbs2-0072" title="RapeeR .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 29th of August 2019. RapeeRM , AbbottMJ , BaillieAJ , GastonJE .Treatment of social phobia through pure self-help and therapist-augmented self-help. British Journal of Psychiatry2007;191:246-52. ">Rapee 2007</a> ; <a href="./references#MR000050-bbs2-0075" title="OlivaresJ .Program IAFS. Protocol for the treatment of social phobia in adolescents [Programa IAFS. Protocolo para el tratamiento de la fobia social enadolescentes]. Madrid: Pirámide2005;1. Rosa-AlcázarAI , Olivares-OlivaresPJ , OlivaresJ .The role of non-specific effects in the psychological treatment of adolescents with social phobia [Papel de los efectos inespecíficos en el tratamiento psicológico de adolescentes con fobia social]. Anuario de Psicologia2009;40(1):43-61. ">Rosa‐Alcatraz 2009</a> ; <a href="./references#MR000050-bbs2-0083" title="SteinmarkSW , BorkovecTD .Active and placebo treatment effects on moderate insomnia under counterdemand and positive demand instructions. Journal of Abnormal Psychology1974;83(2):157-63. ">Steinmark 1974</a> ; <a href="./references#MR000050-bbs2-0084" title="SzymanskiJ , O'DonohueW .The potential role of state-dependent learning in cognitive therapy with spider phobics. Journal of Rational-Emotive &amp; Cognitive-Behavior Therapy1995;13(2):131-50. SzymanskiJ .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 20th of August 2019. ">Szymanski 1995</a> ; <a href="./references#MR000050-bbs2-0085" title="TanSY , BruniJ .Cognitive-behavior therapy with adult patients with epilepsy: a controlled outcome study. Epilepsia1986;27(3):225-33. ">Tan 1986</a> ; <a href="./references#MR000050-bbs2-0088" title="Trexler, L.Rational-emotive therapy, placebo, and no-treatment effects on public-speaking anxiety. Doctoral dissertation, Temple University AnnArbor, Mich.: University Microfilms1971;71-31(063). TrexlerLD , KarstTO .Rational-emotive therapy, placebo, and no-treatment effects on public-speaking anxiety. Journal of Abnormal Psyhology1972;79(1):60-7. ">Trexler 1972</a> ; <a href="./references#MR000050-bbs2-0096" title="WollersheimJP , WilsonGL .Group treatment of unipolar depression: a comparison of coping, supportive, bibliotherapy, and delayed treatment groups. Professional Psychology: Research and Practice1991;22(6):496-502. ">Wollersheim 1991</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Combined treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#MR000050-bbs2-0001" title="AbikoffH , HechtmanL , KleinRG .Social functioning in children with ADHD treated with long-term methylphenidate and multimodal psychosocial treatment. Journal of the American Academy of Child and Adolescent Psychiatry2004;43(7):820-9. AbikoffH .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to A Todorovac 23rd of August 2019. KleinRG , AbikoffH , HechtmanL , WeissG .Design and rationale of controlled study of long-term methylphenidate and multimodal psychosocial treatment in children with ADHD. Journal of the American Academy of Child and Adolescent Psychiatry2004;43(7):792-801. ">Abikoff 2004</a> ; <a href="./references#MR000050-bbs2-0009" title="BorkovecTD , KaloupekDG , SlamaKM .The facilitative effect of muscle tension-release in the relaxation treatment of sleep disturbance. Behavior Therapy1975;6(3):301-9. ">Borkovec 1975</a> ; <a href="./references#MR000050-bbs2-0010" title="BorkovecTD , WeertsTC .Effects of progressive relaxation on sleep disturbance: an electroencephalographic evaluation. Psychosomatic Medicine1976;38(3):173-80. ">Borkovec 1976</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Types of interventions</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Types of psychological placebos</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Interactional component in psychological placebo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>19</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#MR000050-bbs2-0001" title="AbikoffH , HechtmanL , KleinRG .Social functioning in children with ADHD treated with long-term methylphenidate and multimodal psychosocial treatment. Journal of the American Academy of Child and Adolescent Psychiatry2004;43(7):820-9. AbikoffH .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to A Todorovac 23rd of August 2019. KleinRG , AbikoffH , HechtmanL , WeissG .Design and rationale of controlled study of long-term methylphenidate and multimodal psychosocial treatment in children with ADHD. Journal of the American Academy of Child and Adolescent Psychiatry2004;43(7):792-801. ">Abikoff 2004</a> ; <a href="./references#MR000050-bbs2-0006" title="AyenI , HautzingerM .Cognitive behavior therapy for depression in menopausal women. A controlled, randomized treatment study [Kognitive Verhaltenstherapie bei Depressionen im Klimakterium: Eine kontrollierte, randomiserte Interventionsstudie]. Zeitschrift für Klinische Psychologie und Psychotherapie2004;33(4):290-9. AyenI .Inclusion of study in Cochrane Systematic Review (personal communication). Email to EG Faltinsen 9th of September 2019. ">Ayen 2004</a> ; <a href="./references#MR000050-bbs2-0012" title="BramstonP , SpenceSH .Behavioural versus cognitive social-skills training with intellectually-handicapped adults. Behaviour Research and Therapy1985;23(3):239-46. ">Bramston 1985</a> ; <a href="./references#MR000050-bbs2-0019" title="Doty, DW.Role playing and incentives in the modification of the social interaction of chronic psychiatric patients. Journal of Consulting and Clinical Psychology1975;43(5):676-82. ">Doty 1975</a> ; <a href="./references#MR000050-bbs2-0021" title="EhlersA , HackmannA , GreyN , WildJ , LinessS , AlbertI , et al.A randomized controlled trial of 7-day intensive and standard weekly cognitive therapy for PTSD and emotion-focused supportive therapy. American Journal of Psychiatry2014;171(3):294-304. ">Ehlers 2014</a> ; <a href="./references#MR000050-bbs2-0024" title="FoaEB , RothbaumBO , RiggsDS , MurdockTB .Treatment of posttraumatic stress disorder in rape victims: a comparison between cognitive-behavioral procedures and counselling. Journal of Consulting and Clinical Psychology1991;59(5):715-23. ">Foa 1991</a> ; <a href="./references#MR000050-bbs2-0025" title="FoaEB , McLeanCP , ZangY , RosenfieldD , YadinE , YarvisJS , et al.Effect of prolonged exposure therapy delivered over 2 weeks vs 8 weeks vs present-centered therapy on PTSD symptom severity in military personnel: a randomized clinical trial. JAMA2018;319(4):354-64. ">Foa 2018</a> ; <a href="./references#MR000050-bbs2-0027" title="FuchsCZ , RehnLP .A self-control behavior therapy program for depression. Journal of Consulting and Clinical Psychology1977;45(2):206-15. ">Fuchs 1977</a> ; <a href="./references#MR000050-bbs2-0030" title="GoldwasserAN , AuerbachSM , HarkinsSW .Cognitive, affective, and behavioural effects of reminiscence group therapy on demented elderly. Aging and Human Development1987;25(3):209-22. ">Goldwasser 1987</a> ; <a href="./references#MR000050-bbs2-0031" title="HekmatH , LubitzR , DealR .Semantic desensitization: a paradigmatic intervention approach to anxiety disorders. Journal of Clinical Psychology1984;40(2):463-6. ">Hekmat 1984</a> ; <a href="./references#MR000050-bbs2-0037" title="KilmannPR , MilanRJ , BolandJP , NankinHR , DavidsonE , WestMO , et al.Group treatment of secondary erectile dysfunction. Journal of Sex &amp; Marital Therapy1987;13(3):168-82. KilmannPR , Milan RJ Jr, BolandJP , DavidsonE , WestMO , SablisRF , et al.The sexual interactions of men with secondary erectile dysfunction. Journal of Sex Education and Therapy1988;14(1):46-9. KilmannPR , Milan RJ Jr, BolandJP , NankinHR , SablisRF , WestMO , et al.The sexual interactions of men with secondary erectile dysfunction. Paper presented at the annual meeting of the American Psychological Association in Los Angeles1985;1:46-9. ">Kilmann 1987</a> ; <a href="./references#MR000050-bbs2-0038" title="KleinSA , DeffenbacherJL .Relaxation and exercise for hyperactive impulsive children. Perceptual and Motor Skills1977;45:1159-62. ">Klein 1977</a> ; <a href="./references#MR000050-bbs2-0045" title="LaiCK , ChiI , Kayser-JonesJ .A randomized controlled trial of a specific reminiscence approach to promote the well-being of nursing home residents with dementia. International Psychogeriatrics2004;16(1):33-49. LaiK .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 6th of September 2019. ">Lai 2004</a> ; <a href="./references#MR000050-bbs2-0046" title="LangOJ , LazovikAD .Experimental desensitization of a phobia. Journal of Abnormal and Social Psychology1963;66:519-25. LangPJ , LazovikAD , ReynoldsDJ .Desensitization, suggestibility, and pseudotherapy. Journal of Abnormal Psychology1965;70(6):395-402. ">Lang 1965</a> ; <a href="./references#MR000050-bbs2-0068" title="ProudfootJ , ClarkeJ , BirchMR , WhittonAE , ParkerG , ManicavasagarV , et al.Impact of a mobile phone and web program on symptom and functional outcomes for people with mild- to-moderate depression, anxiety and stress: a randomized controlled trial. BMC Psychiatry2013;13(312):1-12. ProudfootJ .Re: Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 26th of August 2019. ">Proudfoot 2013</a> ; <a href="./references#MR000050-bbs2-0069" title="QuayhagenMP , QuayhagenM , CorbeilRR , RothPA , RodgersJA .A dyadic remediation program for care recipients with dementia. Nursing Research1995;44(3):153-9. ">Quayhagen 1995</a> ; <a href="./references#MR000050-bbs2-0075" title="OlivaresJ .Program IAFS. Protocol for the treatment of social phobia in adolescents [Programa IAFS. Protocolo para el tratamiento de la fobia social enadolescentes]. Madrid: Pirámide2005;1. Rosa-AlcázarAI , Olivares-OlivaresPJ , OlivaresJ .The role of non-specific effects in the psychological treatment of adolescents with social phobia [Papel de los efectos inespecíficos en el tratamiento psicológico de adolescentes con fobia social]. Anuario de Psicologia2009;40(1):43-61. ">Rosa‐Alcatraz 2009</a> ; <a href="./references#MR000050-bbs2-0080" title="ShealyRC .The effectiveness of various treatment techniques on different degrees and durations of sleep-onset insomnia. Behaviour Research and Therapy1979;17(6):541-6. ">Shealy 1979</a> ; <a href="./references#MR000050-bbs2-0085" title="TanSY , BruniJ .Cognitive-behavior therapy with adult patients with epilepsy: a controlled outcome study. Epilepsia1986;27(3):225-33. ">Tan 1986</a> ; <a href="./references#MR000050-bbs2-0096" title="WollersheimJP , WilsonGL .Group treatment of unipolar depression: a comparison of coping, supportive, bibliotherapy, and delayed treatment groups. Professional Psychology: Research and Practice1991;22(6):496-502. ">Wollersheim 1991</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Psychoeducational component in psychological placebo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#MR000050-bbs2-0004" title="AlvarezJR .The effects of anger management training on depression, anger, self-concept, and treatment responsibility in a sample of drug-dependent individuals in a therapeutic community. Dissertation Abstracts International: Section B: the Sciences and Engineering1997;58(4-B):2108. ">Alvarez 1997</a> ; <a href="./references#MR000050-bbs2-0011" title="BornovalovaM .Inclusion of study in Cochrane Systematic Review (personal communication). Email to A Todorovac. 21st of August 2019. BornovalovaMA .Distress tolerance treatment for inner-city drug users: a preliminary trial. Doctor’s Dissertation, University of Maryland2008. ">Bornovalova 2008</a> ; <a href="./references#MR000050-bbs2-0016" title="CarterJC , OlmstedMP , KaplanAS , McCabeRE , MillsJS , AimeA .Self-help for bulimia nervosa: a randomized controlled trial. American Journal of Psychiatry2003;160(5):973-8. ">Carter 2003</a> ; <a href="./references#MR000050-bbs2-0032" title="HippmanC , RingroseA , InglisA , CheekJ , AlbertAY , RemickR , et al.A pilot randomized clinical trial evaluating the impact of genetic counselling for serious mental illnesses. Journal of Clinical Psychiatry2016;77(2):e190-8. ">Hippman 2016</a> ; <a href="./references#MR000050-bbs2-0050" title="LiddleB , SpenceSH .Cognitive-behaviour therapy with depressed primary school children: A cautionary note. Behavioural Psychotherapy1990;18(2):85-102. ">Liddle 1990</a> ; <a href="./references#MR000050-bbs2-0055" title="MirandaA , ArlandisP , SorianoM .Instruction in strategies and attributional training: Effects on the problem-solving and self-concept of students’ with learning disabilities [Instrucción en estrategias y entrenamiento atribucional: efectos sobre la resolución de problemas y el autoconcepto de los estudiantes con dificultades en el aprendizaje]. Infancia y Aprendizaje1997;20(80):37-52. ">Miranda 1997</a> ; <a href="./references#MR000050-bbs2-0074" title="RoehrichL , GoldmanMS .Experience-dependent neuropsychological recovery and the treatment of alcoholism. Journal of Consulting and Clinical Psychology1993;61(5):812-21. ">Roehrich 1993</a> ; <a href="./references#MR000050-bbs2-0076" title="RosenGM , GlasgowRE , BarreraM .A controlled study to assess the clinical efficacy of totally self-administrated systematic desensitization. Journal of Consulting and Clinical Psychology1976;44(2):208-17. ">Rosen 1976</a> ; <a href="./references#MR000050-bbs2-0084" title="SzymanskiJ , O'DonohueW .The potential role of state-dependent learning in cognitive therapy with spider phobics. Journal of Rational-Emotive &amp; Cognitive-Behavior Therapy1995;13(2):131-50. SzymanskiJ .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 20th of August 2019. ">Szymanski 1995</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Exposure component in psychological placebo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>16</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#MR000050-bbs2-0005" title="AscherLM , TurnerR .Paradoxical intention and insomnia: an experimental investigation. Behaviour Research and Therapy1979;17(4):408-11. ">Ascher 1979</a> ; <a href="./references#MR000050-bbs2-0009" title="BorkovecTD , KaloupekDG , SlamaKM .The facilitative effect of muscle tension-release in the relaxation treatment of sleep disturbance. Behavior Therapy1975;6(3):301-9. ">Borkovec 1975</a> ; <a href="./references#MR000050-bbs2-0010" title="BorkovecTD , WeertsTC .Effects of progressive relaxation on sleep disturbance: an electroencephalographic evaluation. Psychosomatic Medicine1976;38(3):173-80. ">Borkovec 1976</a> ; <a href="./references#MR000050-bbs2-0022" title="EspieCA , BrooksDN , LindsayWR .An evaluation of tailored psychological treatment of insomnia. Journal of Behavior Therapy and Experimental Psychiatry1989;20(2):143-53. EspieCA , LindsayWR , BrooksDN , HoodEM , TurveyT .A controlled comparative investigation of psychological treatments for chronic sleep-onset insomnia. Behaviour Research and Therapy1989;27(1):79-88. ">Espie 1989a</a> ; <a href="./references#MR000050-bbs2-0023" title="EtringerBD , CashTF , RimmDC .Behavioral, affective, and cognitive effects of participant modeling and an equally credible placebo. Behavior Therapy1982;13(4):476-85. ">Etringer 1982</a> ; <a href="./references#MR000050-bbs2-0029" title="GoldsteinAJ , BeursE , Chambless Dl, WilsonKA .EMDR for panic disorder with agoraphobia: comparison with waiting list and credible attention-placebo control conditions. Journal of Consulting and Clinical Psychology2000;68(6):947-56. ">Goldstein 2000</a> ; <a href="./references#MR000050-bbs2-0036" title="KennedyTD , KimuraHK .Transfer, behavioral improvement, and anxiety reduction in systematic desensitization. Journal of Consulting and Clinical Psychology1974;42(5):720-8. ">Kennedy 1974</a> ; <a href="./references#MR000050-bbs2-0042" title="KrapflJE , NawasMM .Differential ordering of stimulus presentation in systematic desensitization. Journal of Abnormal Psychology1970;75(3):333-7. ">Krapfl 1970</a> ; <a href="./references#MR000050-bbs2-0048" title="LickJ .Expectancy, false galvanic skin response feedback, and systematic desensitization in the modification of phobic behavior. Journal of Consulting and Clinical Psychology1975;43(4):557-67. ">Lick 1975</a> ; <a href="./references#MR000050-bbs2-0053" title="MealieaWL , NawasMM .The comparative effectiveness of systematic desensitization and implosive therapy in the treatment of snake phobia. Journal of Behavior Therapy and Experimental Psychiatry1971;2(2):85-94. ">Mealiea 1971</a> ; <a href="./references#MR000050-bbs2-0062" title="PedletonMG , HigginsRL .A comparison of negative practice and systematic desensitization in the treatment of acrophobia. Journal of Behavior Therapy and Experimental Psychiatry1983;14(4):317-23. ">Pendleton 1983</a> ; <a href="./references#MR000050-bbs2-0065" title="PowersMB , SmitsJA , TelchMJ .Disentangling the effects of safety-behavior utilization and safety-behavior availability during exposure-based treatment: a placebo-controlled trial. Journal of Consulting and Clinical Psychology2004;72(3):448-54. ">Powers 2004</a> ; <a href="./references#MR000050-bbs2-0066" title="PowersMB , SmithsJA , WhitleyD , BystritskyA , TelchMJ .The effect of attributional processes concerning medication taking on return of fear. Journal of Consulting and Clinical Psychology2008;76(3):478-90. ">Powers 2008a</a> ; <a href="./references#MR000050-bbs2-0083" title="SteinmarkSW , BorkovecTD .Active and placebo treatment effects on moderate insomnia under counterdemand and positive demand instructions. Journal of Abnormal Psychology1974;83(2):157-63. ">Steinmark 1974</a> ; <a href="./references#MR000050-bbs2-0088" title="Trexler, L.Rational-emotive therapy, placebo, and no-treatment effects on public-speaking anxiety. Doctoral dissertation, Temple University AnnArbor, Mich.: University Microfilms1971;71-31(063). TrexlerLD , KarstTO .Rational-emotive therapy, placebo, and no-treatment effects on public-speaking anxiety. Journal of Abnormal Psyhology1972;79(1):60-7. ">Trexler 1972</a> ; <a href="./references#MR000050-bbs2-0089" title="AscherML , TurnerRM .A comparison of two methods for the administration of paradoxical intention. Behaviour Research and Therapy1980;18(2):121-6. TurnerRM , AscherLM .Controlled comparison of progressive relaxation, stimulus control, and paradoxical intention therapies for insomnia. Journal of Consulting and Clinical Psychology1979;47(3):500-8. ">Turner 1979</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Labels for psychological placebo</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Attention placebo control</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#MR000050-bbs2-0001" title="AbikoffH , HechtmanL , KleinRG .Social functioning in children with ADHD treated with long-term methylphenidate and multimodal psychosocial treatment. Journal of the American Academy of Child and Adolescent Psychiatry2004;43(7):820-9. AbikoffH .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to A Todorovac 23rd of August 2019. KleinRG , AbikoffH , HechtmanL , WeissG .Design and rationale of controlled study of long-term methylphenidate and multimodal psychosocial treatment in children with ADHD. Journal of the American Academy of Child and Adolescent Psychiatry2004;43(7):792-801. ">Abikoff 2004</a> ; <a href="./references#MR000050-bbs2-0004" title="AlvarezJR .The effects of anger management training on depression, anger, self-concept, and treatment responsibility in a sample of drug-dependent individuals in a therapeutic community. Dissertation Abstracts International: Section B: the Sciences and Engineering1997;58(4-B):2108. ">Alvarez 1997</a> ; <a href="./references#MR000050-bbs2-0012" title="BramstonP , SpenceSH .Behavioural versus cognitive social-skills training with intellectually-handicapped adults. Behaviour Research and Therapy1985;23(3):239-46. ">Bramston 1985</a> ; <a href="./references#MR000050-bbs2-0029" title="GoldsteinAJ , BeursE , Chambless Dl, WilsonKA .EMDR for panic disorder with agoraphobia: comparison with waiting list and credible attention-placebo control conditions. Journal of Consulting and Clinical Psychology2000;68(6):947-56. ">Goldstein 2000</a> ; <a href="./references#MR000050-bbs2-0030" title="GoldwasserAN , AuerbachSM , HarkinsSW .Cognitive, affective, and behavioural effects of reminiscence group therapy on demented elderly. Aging and Human Development1987;25(3):209-22. ">Goldwasser 1987</a> ; <a href="./references#MR000050-bbs2-0031" title="HekmatH , LubitzR , DealR .Semantic desensitization: a paradigmatic intervention approach to anxiety disorders. Journal of Clinical Psychology1984;40(2):463-6. ">Hekmat 1984</a> ; <a href="./references#MR000050-bbs2-0037" title="KilmannPR , MilanRJ , BolandJP , NankinHR , DavidsonE , WestMO , et al.Group treatment of secondary erectile dysfunction. Journal of Sex &amp; Marital Therapy1987;13(3):168-82. KilmannPR , Milan RJ Jr, BolandJP , DavidsonE , WestMO , SablisRF , et al.The sexual interactions of men with secondary erectile dysfunction. Journal of Sex Education and Therapy1988;14(1):46-9. KilmannPR , Milan RJ Jr, BolandJP , NankinHR , SablisRF , WestMO , et al.The sexual interactions of men with secondary erectile dysfunction. Paper presented at the annual meeting of the American Psychological Association in Los Angeles1985;1:46-9. ">Kilmann 1987</a> ; <a href="./references#MR000050-bbs2-0038" title="KleinSA , DeffenbacherJL .Relaxation and exercise for hyperactive impulsive children. Perceptual and Motor Skills1977;45:1159-62. ">Klein 1977</a> ; <a href="./references#MR000050-bbs2-0050" title="LiddleB , SpenceSH .Cognitive-behaviour therapy with depressed primary school children: A cautionary note. Behavioural Psychotherapy1990;18(2):85-102. ">Liddle 1990</a> ; <a href="./references#MR000050-bbs2-0060" title="PeckCL .Desensitization for the treatment of fear in the high level adult retardate. Behaviour Research and Therapy1977;15(2):137-48. ">Peck 1976</a> ; <a href="./references#MR000050-bbs2-0085" title="TanSY , BruniJ .Cognitive-behavior therapy with adult patients with epilepsy: a controlled outcome study. Epilepsia1986;27(3):225-33. ">Tan 1986</a> ; <a href="./references#MR000050-bbs2-0088" title="Trexler, L.Rational-emotive therapy, placebo, and no-treatment effects on public-speaking anxiety. Doctoral dissertation, Temple University AnnArbor, Mich.: University Microfilms1971;71-31(063). TrexlerLD , KarstTO .Rational-emotive therapy, placebo, and no-treatment effects on public-speaking anxiety. Journal of Abnormal Psyhology1972;79(1):60-7. ">Trexler 1972</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Non‐specific placebo counselling or treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>11</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#MR000050-bbs2-0006" title="AyenI , HautzingerM .Cognitive behavior therapy for depression in menopausal women. A controlled, randomized treatment study [Kognitive Verhaltenstherapie bei Depressionen im Klimakterium: Eine kontrollierte, randomiserte Interventionsstudie]. Zeitschrift für Klinische Psychologie und Psychotherapie2004;33(4):290-9. AyenI .Inclusion of study in Cochrane Systematic Review (personal communication). Email to EG Faltinsen 9th of September 2019. ">Ayen 2004</a> ; <a href="./references#MR000050-bbs2-0011" title="BornovalovaM .Inclusion of study in Cochrane Systematic Review (personal communication). Email to A Todorovac. 21st of August 2019. BornovalovaMA .Distress tolerance treatment for inner-city drug users: a preliminary trial. Doctor’s Dissertation, University of Maryland2008. ">Bornovalova 2008</a> ; <a href="./references#MR000050-bbs2-0019" title="Doty, DW.Role playing and incentives in the modification of the social interaction of chronic psychiatric patients. Journal of Consulting and Clinical Psychology1975;43(5):676-82. ">Doty 1975</a> ; <a href="./references#MR000050-bbs2-0024" title="FoaEB , RothbaumBO , RiggsDS , MurdockTB .Treatment of posttraumatic stress disorder in rape victims: a comparison between cognitive-behavioral procedures and counselling. Journal of Consulting and Clinical Psychology1991;59(5):715-23. ">Foa 1991</a> ; <a href="./references#MR000050-bbs2-0027" title="FuchsCZ , RehnLP .A self-control behavior therapy program for depression. Journal of Consulting and Clinical Psychology1977;45(2):206-15. ">Fuchs 1977</a> ; <a href="./references#MR000050-bbs2-0045" title="LaiCK , ChiI , Kayser-JonesJ .A randomized controlled trial of a specific reminiscence approach to promote the well-being of nursing home residents with dementia. International Psychogeriatrics2004;16(1):33-49. LaiK .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 6th of September 2019. ">Lai 2004</a> ; <a href="./references#MR000050-bbs2-0046" title="LangOJ , LazovikAD .Experimental desensitization of a phobia. Journal of Abnormal and Social Psychology1963;66:519-25. LangPJ , LazovikAD , ReynoldsDJ .Desensitization, suggestibility, and pseudotherapy. Journal of Abnormal Psychology1965;70(6):395-402. ">Lang 1965</a> ; <a href="./references#MR000050-bbs2-0053" title="MealieaWL , NawasMM .The comparative effectiveness of systematic desensitization and implosive therapy in the treatment of snake phobia. Journal of Behavior Therapy and Experimental Psychiatry1971;2(2):85-94. ">Mealiea 1971</a> ; <a href="./references#MR000050-bbs2-0062" title="PedletonMG , HigginsRL .A comparison of negative practice and systematic desensitization in the treatment of acrophobia. Journal of Behavior Therapy and Experimental Psychiatry1983;14(4):317-23. ">Pendleton 1983</a> ; <a href="./references#MR000050-bbs2-0076" title="RosenGM , GlasgowRE , BarreraM .A controlled study to assess the clinical efficacy of totally self-administrated systematic desensitization. Journal of Consulting and Clinical Psychology1976;44(2):208-17. ">Rosen 1976</a> ; <a href="./references#MR000050-bbs2-0096" title="WollersheimJP , WilsonGL .Group treatment of unipolar depression: a comparison of coping, supportive, bibliotherapy, and delayed treatment groups. Professional Psychology: Research and Practice1991;22(6):496-502. ">Wollersheim 1991</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Non‐specific educational placebo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#MR000050-bbs2-0016" title="CarterJC , OlmstedMP , KaplanAS , McCabeRE , MillsJS , AimeA .Self-help for bulimia nervosa: a randomized controlled trial. American Journal of Psychiatry2003;160(5):973-8. ">Carter 2003</a> ; <a href="./references#MR000050-bbs2-0032" title="HippmanC , RingroseA , InglisA , CheekJ , AlbertAY , RemickR , et al.A pilot randomized clinical trial evaluating the impact of genetic counselling for serious mental illnesses. Journal of Clinical Psychiatry2016;77(2):e190-8. ">Hippman 2016</a> ; <a href="./references#MR000050-bbs2-0074" title="RoehrichL , GoldmanMS .Experience-dependent neuropsychological recovery and the treatment of alcoholism. Journal of Consulting and Clinical Psychology1993;61(5):812-21. ">Roehrich 1993</a> ; <a href="./references#MR000050-bbs2-0084" title="SzymanskiJ , O'DonohueW .The potential role of state-dependent learning in cognitive therapy with spider phobics. Journal of Rational-Emotive &amp; Cognitive-Behavior Therapy1995;13(2):131-50. SzymanskiJ .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 20th of August 2019. ">Szymanski 1995</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Quasi‐desensitization placebo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#MR000050-bbs2-0005" title="AscherLM , TurnerR .Paradoxical intention and insomnia: an experimental investigation. Behaviour Research and Therapy1979;17(4):408-11. ">Ascher 1979</a> ; <a href="./references#MR000050-bbs2-0009" title="BorkovecTD , KaloupekDG , SlamaKM .The facilitative effect of muscle tension-release in the relaxation treatment of sleep disturbance. Behavior Therapy1975;6(3):301-9. ">Borkovec 1975</a> ; <a href="./references#MR000050-bbs2-0010" title="BorkovecTD , WeertsTC .Effects of progressive relaxation on sleep disturbance: an electroencephalographic evaluation. Psychosomatic Medicine1976;38(3):173-80. ">Borkovec 1976</a> ; <a href="./references#MR000050-bbs2-0036" title="KennedyTD , KimuraHK .Transfer, behavioral improvement, and anxiety reduction in systematic desensitization. Journal of Consulting and Clinical Psychology1974;42(5):720-8. ">Kennedy 1974</a> ; <a href="./references#MR000050-bbs2-0042" title="KrapflJE , NawasMM .Differential ordering of stimulus presentation in systematic desensitization. Journal of Abnormal Psychology1970;75(3):333-7. ">Krapfl 1970</a> ; <a href="./references#MR000050-bbs2-0083" title="SteinmarkSW , BorkovecTD .Active and placebo treatment effects on moderate insomnia under counterdemand and positive demand instructions. Journal of Abnormal Psychology1974;83(2):157-63. ">Steinmark 1974</a> ; <a href="./references#MR000050-bbs2-0089" title="AscherML , TurnerRM .A comparison of two methods for the administration of paradoxical intention. Behaviour Research and Therapy1980;18(2):121-6. TurnerRM , AscherLM .Controlled comparison of progressive relaxation, stimulus control, and paradoxical intention therapies for insomnia. Journal of Consulting and Clinical Psychology1979;47(3):500-8. ">Turner 1979</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Standarised psychological placebo (e.g. present‐centred therapy or emotion‐focused supportive therapy) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#MR000050-bbs2-0021" title="EhlersA , HackmannA , GreyN , WildJ , LinessS , AlbertI , et al.A randomized controlled trial of 7-day intensive and standard weekly cognitive therapy for PTSD and emotion-focused supportive therapy. American Journal of Psychiatry2014;171(3):294-304. ">Ehlers 2014</a> ; <a href="./references#MR000050-bbs2-0025" title="FoaEB , McLeanCP , ZangY , RosenfieldD , YadinE , YarvisJS , et al.Effect of prolonged exposure therapy delivered over 2 weeks vs 8 weeks vs present-centered therapy on PTSD symptom severity in military personnel: a randomized clinical trial. JAMA2018;319(4):354-64. ">Foa 2018</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Credible placebos or imagery relief placebo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#MR000050-bbs2-0023" title="EtringerBD , CashTF , RimmDC .Behavioral, affective, and cognitive effects of participant modeling and an equally credible placebo. Behavior Therapy1982;13(4):476-85. ">Etringer 1982</a> ; <a href="./references#MR000050-bbs2-0048" title="LickJ .Expectancy, false galvanic skin response feedback, and systematic desensitization in the modification of phobic behavior. Journal of Consulting and Clinical Psychology1975;43(4):557-67. ">Lick 1975</a> ; <a href="./references#MR000050-bbs2-0055" title="MirandaA , ArlandisP , SorianoM .Instruction in strategies and attributional training: Effects on the problem-solving and self-concept of students’ with learning disabilities [Instrucción en estrategias y entrenamiento atribucional: efectos sobre la resolución de problemas y el autoconcepto de los estudiantes con dificultades en el aprendizaje]. Infancia y Aprendizaje1997;20(80):37-52. ">Miranda 1997</a> ; <a href="./references#MR000050-bbs2-0065" title="PowersMB , SmitsJA , TelchMJ .Disentangling the effects of safety-behavior utilization and safety-behavior availability during exposure-based treatment: a placebo-controlled trial. Journal of Consulting and Clinical Psychology2004;72(3):448-54. ">Powers 2004</a> ; <a href="./references#MR000050-bbs2-0066" title="PowersMB , SmithsJA , WhitleyD , BystritskyA , TelchMJ .The effect of attributional processes concerning medication taking on return of fear. Journal of Consulting and Clinical Psychology2008;76(3):478-90. ">Powers 2008a</a> ; <a href="./references#MR000050-bbs2-0069" title="QuayhagenMP , QuayhagenM , CorbeilRR , RothPA , RodgersJA .A dyadic remediation program for care recipients with dementia. Nursing Research1995;44(3):153-9. ">Quayhagen 1995</a> ; <a href="./references#MR000050-bbs2-0075" title="OlivaresJ .Program IAFS. Protocol for the treatment of social phobia in adolescents [Programa IAFS. Protocolo para el tratamiento de la fobia social enadolescentes]. Madrid: Pirámide2005;1. Rosa-AlcázarAI , Olivares-OlivaresPJ , OlivaresJ .The role of non-specific effects in the psychological treatment of adolescents with social phobia [Papel de los efectos inespecíficos en el tratamiento psicológico de adolescentes con fobia social]. Anuario de Psicologia2009;40(1):43-61. ">Rosa‐Alcatraz 2009</a> ; <a href="./references#MR000050-bbs2-0080" title="ShealyRC .The effectiveness of various treatment techniques on different degrees and durations of sleep-onset insomnia. Behaviour Research and Therapy1979;17(6):541-6. ">Shealy 1979</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Labels for pharmacological placebos</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Placebo pill</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>16</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#MR000050-bbs2-0008" title="Borden, KA.Attributional Outcomes: the Subtle Messages of Treatments for Attention Deficit Disorder. Dissertation, University of Illinois at Urbana-Champaign1986. BordenKA , BrownRT .Attributional outcomes: The subtle messages of treatments for attention deficit disorder. Cognitive Therapy and Research1989;13(2):147-60. ">Borden 1986</a> ; <a href="./references#MR000050-bbs2-0013" title="BrillNQ , KoeglerRR , EpsteinLJ , ForgyEW .Controlled study of psychiatric outpatient treatment. Archives of General Psychiatry1964;10:581-95. BrillNQ .Results of psychotherapy. California Medicine1966;104(4):249-53. ">Brill 1964a</a> ; <a href="./references#MR000050-bbs2-0015" title="CarlsonCL , PelhamWE , MilichR , HozaB .ADHD boys’ performance and attributions following success and failure: drug effects and individual differences. Cognitive Therapy and Research1993;17:269-87. ">Carlson 1993</a> ; <a href="./references#MR000050-bbs2-0018" title="CrouchG , RobsonM , HallstromC .Benzodiazepine dependent patients and their psychological treatment. Progress in Neuro-psychopharmacology &amp; Biological Psychiatry1988;12(4):503-10. HallströmC , CrouchG , RobsenM , ShineP .The treatment of tranquillizer dependence by propranolol. Postgraduate Medical Journal1988;64(Suppl 2):40-4. ">Crouch 1988</a> ; <a href="./references#MR000050-bbs2-0020" title="DoubleDB , WarrenGC , EvansM , RowlandsMP .Efficacy of maintenance use of anticholinergic agents. Acta Psychiatrica Scandinavica1993;88:381-4. ">Double 1993</a> ; <a href="./references#MR000050-bbs2-0035" title="KelleyJ .Inclusion of study in Cochrane Systematic Review (personal communication). Email to: A Todorovac 12th of August 2019. KelleyJM , KaptchukTJ , CusinC , LipkinS , FavaM .Open-label placebo for major depressive disorder: a pilot randomized controlled trial. Psychotherapy and Psychosomatics2012;81(5):312-4. ">Kelley 2012</a> ; <a href="./references#MR000050-bbs2-0041" title="KloskoJS , BarlowDH , TassinariR , CernyJA .A comparison of alprazolam and behavior therapy in treatment of panic disorder: correction. Journal of Psychotherapy Practice and Research1994;3(2):163-79. KloskoJS , BarlowDH , TassinariR , CernyJA .A comparison of alprazolam and behavior therapy in treatment of panic disorder. Journal of Consulting and Clinical Psychology1990;58(1):77-84. ">Klosko 1990</a> ; <a href="./references#MR000050-bbs2-0052" title="McLachlanDR , DaltonAJ , KruckTP , BellMY , SmithWL , KalowW , et al.Intramuscular desferrioxamine in patients with Alzheimer's disease. Lancet1991;337(8753):1304-8. McLachlanDRC , SmithWL , KruckTP .Desferrioxamine and Alzheimer’s disease: video home behavior assessment of clinical course and measures of brain aluminum. Therapeutic Drug Monitoring1993;15(6):602-7. ">McLachlan 1991</a> ; <a href="./references#MR000050-bbs2-0057" title="NandiDN , AjmanyS , GanguliH , BanerjeeG , BoralGC , GhoshA , et al.A clinical evaluation of depressives found in a rural survey in India. British Journal of Psychiatry1976;128:523-7. ">Nandi 1976</a> ; <a href="./references#MR000050-bbs2-0061" title="MilichR , CarlsonCL , Pelham WE Jr, LichtBG .Effects of methylphenidate on the persistence of ADHD boys following failure experiences. Journal of Abnormal Child Psychology1991;19(5):519-36. PelhamWE , MurphyDA , VannattaK , MilichR , LichtBG , GnagyEM , et al.Methylphenidate and attributions in boys with attention-deficit hyperactivity disorder. Journal of Consulting and Clinical Psychology1992;60(2):282-92. ">Pelham 1992</a> ; <a href="./references#MR000050-bbs2-0070" title="LiebowitzM , QuitkinFM , StewartJW , McGrathPJ , HarrisonWM , MarkowitzJS , et al.Antidepressant efficacy in atypical depression. Archives of General Psychiatry1988;45(2):129-37. QuitkinFM , McGrathPJ , StewartJW , HarrisonW , WagerSG , NunesE , et al.Phenelzine and imipramine in mood reactive depressives: further delineation of the syndrome of atypical depression. Archives of General Psychiatry1989;46(9):787-93. RabkinJG , McGrathPJ , QuitkinFM , TricamoE , StewartJW , KleinDF .Effects of pill-giving on maintenance of placebo response in patients with chronic mild depression. American Journal of Psychiatry1990;147(12):1622-6. ">Rabkin 1990</a> ; <a href="./references#MR000050-bbs2-0077" title="LorrM , McNairDM , WeinsteinGJ .Early effects of chlordiazepoxide (Librium) used with psychotherapy. Journal of Psychiatric Research1963;1:257-70. RothI , RhudickPJ , ShaskanDA , SlobinMS , WilkinsonAE , YoungHH .Long-term effects on psychotherapy of initial treatment conditions. Journal of Psychiatric Research1964;2:283-97. ">Roth 1964</a> ; <a href="./references#MR000050-bbs2-0079" title="ShalevAY , AnkriY , Isreali-ShalevY , PelegT , AdesskyR , FreedmanS .Prevention of posttraumatic stress disorder by early treatment. Archives of General Psychiatry2012;69(2):166-76. ">Shalev 2012</a> ; <a href="./references#MR000050-bbs2-0081" title="SibilioJP , AndrewG , DartD , MooreKB , StehmanA .Treatment of chronic schizophrenia with promazine hydrochloride. AMA Archives of Neurology and Psychiatry1957;78(4):419-24. ">Sibilio 1957</a> ; <a href="./references#MR000050-bbs2-0082" title="SommernessMD , LuceroRJ , HamlonJS , EricksonJL , MatthewsR .A controlled study of reserpine on chronically disturbed patients. JAMA Archives of Neurology and Psychiatry1955;74(3):316-9. ">Sommerness 1955</a> ; <a href="./references#MR000050-bbs2-0093" title="WhittakerCB , HoyRM .Withdrawal of perphenazine in chronic schizophrenia. British Journal of Psychiatry1963;109:422-7. ">Whittaker 1963</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Implants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#MR000050-bbs2-0094" title="WilsonA , DavidsonWJ , BlanchardR , WhiteJ .Disulfiram implantation. A placebo-controlled trial with two-year follow-up. Journal of Studies on Alcohol1978;39(5):809-19. WilsonA , DavidsonWJ , BlanchardR .Disulfiram implantation: a trial using placebo implants and two types of controls. Journal of Studies on Alcohol1980;41(5):429-36. ">Wilson 1980</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Injection</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#MR000050-bbs2-0091" title="WatzlH , RistF , OlbrichR , CohenR .Placebo injections and surveillance of alcohol intake during inpatient treatment of female alcoholics. Addictive Behaviors1988;13(2):197-200. ">Watzl 1988</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Psychological treatment and pharmacological placebo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#MR000050-bbs2-0007" title="BergI , ForsytheI , HoltP , WattsJ .A controlled trial of ‘Senokot’ in faecal soiling treated by behavioural methods. Journal of Child Psychology and Psychiatry1983;24(4):543-9. ">Berg 1983</a> ; <a href="./references#MR000050-bbs2-0039" title="KlermanGL , DimascioA , WeismannM , PrusoffB , PaykelES .Treatment of depression by drugs and psychotherapy. American Journal of Psychiatry1974;131(2):186-91. PaykelES , DimascioA , HaskellD , PrusoffBA .Effects of maintenance amitriptyline and psychotherapy on symptoms of depression. Psychological Medicine1975;5(1):67-77. PaykelES , DiMascioA , KlermanGL , PrusoffBA .Maintenance therapy of depression. Pharmakopsychiatrie, Neuro-Psychopharmakologie1976;9:127-39. PaykelES , WeissmanMM , PrusoffBA .Social maladjustment and severity of depression. Comprehensive Psychiatry1978;19(2):121-8. WeissmanMM , KlermanGL , PaykelES , PrusoffB .Treatment effects on the social adjustment of depressed patients. Archives of General Psychiatry1974;30:771-8. ">Klerman 1974a</a> ; <a href="./references#MR000050-bbs2-0040" title="KlermanGL , DimascioA , WeismannM , PrusoffB , PaykelES .Treatment of depression by drugs and psychotherapy. American Journal of Psychiatry1974;131(2):186-91. ">Klerman 1974b</a> ; <a href="./references#MR000050-bbs2-0067" title="PowersMB , SmithsJA , WhitleyD , BystritskyA , TelchMJ .The effect of attributional processes concerning medication taking on return of fear. Journal of Consulting and Clinical Psychology2008;76(3):478-90. ">Powers 2008b</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Labels for physical placebos</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Acupuncture or acupressure</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#MR000050-bbs2-0002" title="AllenJB .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to A Todorovac 28th of August 2019. AllenJJ , SchnyerRN , HittSK .The efficacy of acupuncture in the treatment of major depression in women. Psychological Science1998;9(5):397-401. ">Allen 1998</a> ; <a href="./references#MR000050-bbs2-0003" title="AllenJB .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 28th of August 2019. AllenJJ , SchnyerRN , ChambersAS , HittSK , MorenoFA , ManberR .Acupuncture for depression: a randomized controlled trial. Journal of Clinical Psychiatry2006;67(11):1665-73. ">Allen 2006</a> ; <a href="./references#MR000050-bbs2-0026" title="FreireAO , SugaiGC , ChrispinFS , TogeiroSM , YamamuraY , MelloLE , et al.Treatment of moderate obstructive sleep apnea syndrome with acupuncture: a randomised, placebo-controlled pilot trial. Sleep Medicine2007;8(1):43-50. ">Freire 2007</a> ; <a href="./references#MR000050-bbs2-0034" title="KarstM , WinterhalterM , MünteS , FranckiB , HondronikosA , EckardtA , et al.Auricular acupuncture for dental anxiety: a randomized controlled trial. Anesthesia and Analgesia2007;104(2):295-300. KarstM .Inclusion of study in Cochrane Systematic Review (personal communication). Email to: EG Faltinsen 5th of September 2019. ">Karst 2007</a> ; <a href="./references#MR000050-bbs2-0043" title="KwanR .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 26th of August 2019. KwanRY , LeungMC , LaiCK .Acupressure for agitation in nursing home residents with dementia: study protocol for a randomized controlled trial. Trials2014;15(410):1-7. KwanRY , LeungMCP , LaiCK .A randomized controlled trial examining the effect of acupressure on agitation and salivary cortisol in nursing home residents with dementia. Dementia and Geriatric Cognitive Disorders2017;44(1-2):92-104. ">Kwan 2017</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Electromagnetic stimulation</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#MR000050-bbs2-0048" title="LickJ .Expectancy, false galvanic skin response feedback, and systematic desensitization in the modification of phobic behavior. Journal of Consulting and Clinical Psychology1975;43(4):557-67. ">Lick 1975</a> ; <a href="./references#MR000050-bbs2-0092" title="WeingaertnerAH .Self-administered aversive stimulation with hallucinating hospitalized schizophrenics. Journal of Consulting and Clinical Psychology1971;36(3):422-29. ">Weingaertner 1971</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Exercise and relaxation</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#MR000050-bbs2-0044" title="LacyMK .The effect of short term autogenic training on the stress reactivity of hospitalized emotionally disturbed adolescents. ProQuest Dissertations Publishing, Oklahoma State University1996. ">Lacy 1990</a> ; <a href="./references#MR000050-bbs2-0047" title="LegrandF .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 14th of August 2019. LegrandFD , NeffEM .Efficacy of exercise as an adjunct treatment for clinically depressed inpatients during the initial stages of antidepressant pharmacotherapy: an open randomized controlled trial. Journal of Affective Disorders2016;191:139-44. ">Legrand 2016</a> ; <a href="./references#MR000050-bbs2-0058" title="NicassioP , BootzinR .A comparison of progressive relaxation and autogenic training as treatments for insomnia. Journal of Abnormal Psychology1974;83(3):253-60. ">Nicassio 1974</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Technical device</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#MR000050-bbs2-0056" title="MitchellC , MansfieldD , RautenbachS .Coloured filters and reading accuracy, comprehension and rate: a placebo-controlled study. Perceptual and Motor Skills2008;106(2):517-32. ">Mitchell 2008</a> ; <a href="./references#MR000050-bbs2-0063" title="PetersonMA , PattersonB , PillmanBM , BattistaMA .Cognitive recovery following alcohol detoxification: a computerised remediation study. Neuropsychological Rehabilitation2002;12(1):63-74. PillmanBM .Computerized cognitive remediation with recently detoxified alcoholics. Dissertation, California School of Professional Psychology, Fresno Campus2000. ">Pillman 2001</a> ; <a href="./references#MR000050-bbs2-0078" title="RupertPA , HolmesDS .Effects of multiple sessions of true and placebo heart rate biofeedback training on the heart rates and anxiety levels of anxious patients during and following treatment. Psychophysiology1978;15(6):582-90. ">Rupert 1978</a> ; <a href="./references#MR000050-bbs2-0087" title="ToriC , WorellL .Reduction of human avoidant behavior. A comparison of counterconditioning, expectancy, and cognitive information approaches. Clinical Psychology1973;41(2):269-78. ">Tori 1973</a> ; <a href="./references#MR000050-bbs2-0090" title="VanderplateC .Electromyograph biofeedback Treatment of sleep onset Insomnia: a controlled Investigation. Dissertation, University of Southern Mississippi1978. ">Vanderplate 1983</a> ; <a href="./references#MR000050-bbs2-0095" title="WolitzkyKB , TelchMJ .Augmenting in vivo exposure with fear antagonistic actions: a preliminary test. Behavior Therapy2009;40(1):57-71. ">Wolitzky 2009</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Labels for usual care</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Standard treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#MR000050-bbs2-0051" title="MatsonJL , MarchettiA , AdkinsJA .Comparison of operant- and independence-training procedures for mentally retarded adults. American Journal of Mental Deficiency1980;84(5):487-94. ">Matson 1980</a> ; <a href="./references#MR000050-bbs2-0071" title="RapeeR .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 29th of August 2019. RapeeRM , AbbottMJ , LynehamHJ .Bibliotherapy for children With anxiety disorders using written materials for parents: a randomized controlled trial. Journal of Consulting and Clinical Psychology2006;74(3):436-44. ">Rapee 2006</a> ; <a href="./references#MR000050-bbs2-0072" title="RapeeR .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 29th of August 2019. RapeeRM , AbbottMJ , BaillieAJ , GastonJE .Treatment of social phobia through pure self-help and therapist-augmented self-help. British Journal of Psychiatry2007;191:246-52. ">Rapee 2007</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Community based therapy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#MR000050-bbs2-0028" title="GlogowskaM , RoulstoneS , EnderbyP , PetersTJ .Randomised controlled trial of community based speech and language therapy in preschool children. BMJ2000;321(7266):923-6. ">Glogowska 2000</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Typical care control</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#MR000050-bbs2-0086" title="TeriL , LogsdonRG , UomotoJ , McCurrySM .Behavioral treatment of depression in dementia patients: a controlled clinical trial. Journals of Gerontology. Series B, Psychological Sciences and Social Sciences1997;52(4):159-66. TeriL .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 26th of August 2019. ">Teri 1997</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Outpatient psychotherapy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#MR000050-bbs2-0014" title="BrillNQ , KoeglerRR , EpsteinLJ , ForgyEW .Controlled study of psychiatric outpatient treatment. Archives of General Psychiatry1964;10:581-95. ">Brill 1964b</a> ; <a href="./references#MR000050-bbs2-0017" title="CrispAH , NortonK , GowersS , HalekC , BowyerC , YeldhamD , et al.A controlled study of the effect of therapies aimed at adolescent and family psychopathology in Anorexia Nervosa. British Journal of Psychiatry: the Journal of Mental Science1991;159:325-33. GowersS , NortonK , HalekC , CrispAH .Outcome of outpatient psychotherapy in a random allocation treatment study of anorexia nervosa. International Journal of Eating Disorders1994;15(2):165-77. GowersS , NortonK , YelshamD .The St George's prospective treatment study of anorexia nervosa: a discussion of methodological problems. International Journal of Eating Disorders1989;8:445-54. ">Crisp 1991</a> ; <a href="./references#MR000050-bbs2-0054" title="MilbyJB , ClarkeC , ToroC , ThorntonS , RickertD .Effectiveness of urine surveillance as an adjunct to outpatient psychotherapy for drug abusers. International Journal of the Addictions1980;15(7):993-1001. ">Milby 1980</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Other</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#MR000050-bbs2-0073" title="RobinA .Rationing out-patients: a defence of the waiting list. British Journal of Psychiatry1976;129:138-41. ">Robin 1976</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Concomitant treatment</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Allowed the participant to receive a concomitant psychotherapy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>18</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#MR000050-bbs2-0008" title="Borden, KA.Attributional Outcomes: the Subtle Messages of Treatments for Attention Deficit Disorder. Dissertation, University of Illinois at Urbana-Champaign1986. BordenKA , BrownRT .Attributional outcomes: The subtle messages of treatments for attention deficit disorder. Cognitive Therapy and Research1989;13(2):147-60. ">Borden 1986</a> ; <a href="./references#MR000050-bbs2-0011" title="BornovalovaM .Inclusion of study in Cochrane Systematic Review (personal communication). Email to A Todorovac. 21st of August 2019. BornovalovaMA .Distress tolerance treatment for inner-city drug users: a preliminary trial. Doctor’s Dissertation, University of Maryland2008. ">Bornovalova 2008</a> ; <a href="./references#MR000050-bbs2-0015" title="CarlsonCL , PelhamWE , MilichR , HozaB .ADHD boys’ performance and attributions following success and failure: drug effects and individual differences. Cognitive Therapy and Research1993;17:269-87. ">Carlson 1993</a> ; <a href="./references#MR000050-bbs2-0018" title="CrouchG , RobsonM , HallstromC .Benzodiazepine dependent patients and their psychological treatment. Progress in Neuro-psychopharmacology &amp; Biological Psychiatry1988;12(4):503-10. HallströmC , CrouchG , RobsenM , ShineP .The treatment of tranquillizer dependence by propranolol. Postgraduate Medical Journal1988;64(Suppl 2):40-4. ">Crouch 1988</a> ; <a href="./references#MR000050-bbs2-0021" title="EhlersA , HackmannA , GreyN , WildJ , LinessS , AlbertI , et al.A randomized controlled trial of 7-day intensive and standard weekly cognitive therapy for PTSD and emotion-focused supportive therapy. American Journal of Psychiatry2014;171(3):294-304. ">Ehlers 2014</a> ; <a href="./references#MR000050-bbs2-0043" title="KwanR .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 26th of August 2019. KwanRY , LeungMC , LaiCK .Acupressure for agitation in nursing home residents with dementia: study protocol for a randomized controlled trial. Trials2014;15(410):1-7. KwanRY , LeungMCP , LaiCK .A randomized controlled trial examining the effect of acupressure on agitation and salivary cortisol in nursing home residents with dementia. Dementia and Geriatric Cognitive Disorders2017;44(1-2):92-104. ">Kwan 2017</a> ; <a href="./references#MR000050-bbs2-0044" title="LacyMK .The effect of short term autogenic training on the stress reactivity of hospitalized emotionally disturbed adolescents. ProQuest Dissertations Publishing, Oklahoma State University1996. ">Lacy 1990</a> ; <a href="./references#MR000050-bbs2-0045" title="LaiCK , ChiI , Kayser-JonesJ .A randomized controlled trial of a specific reminiscence approach to promote the well-being of nursing home residents with dementia. International Psychogeriatrics2004;16(1):33-49. LaiK .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 6th of September 2019. ">Lai 2004</a> ; <a href="./references#MR000050-bbs2-0052" title="McLachlanDR , DaltonAJ , KruckTP , BellMY , SmithWL , KalowW , et al.Intramuscular desferrioxamine in patients with Alzheimer's disease. Lancet1991;337(8753):1304-8. McLachlanDRC , SmithWL , KruckTP .Desferrioxamine and Alzheimer’s disease: video home behavior assessment of clinical course and measures of brain aluminum. Therapeutic Drug Monitoring1993;15(6):602-7. ">McLachlan 1991</a> ; <a href="./references#MR000050-bbs2-0061" title="MilichR , CarlsonCL , Pelham WE Jr, LichtBG .Effects of methylphenidate on the persistence of ADHD boys following failure experiences. Journal of Abnormal Child Psychology1991;19(5):519-36. PelhamWE , MurphyDA , VannattaK , MilichR , LichtBG , GnagyEM , et al.Methylphenidate and attributions in boys with attention-deficit hyperactivity disorder. Journal of Consulting and Clinical Psychology1992;60(2):282-92. ">Pelham 1992</a> ; <a href="./references#MR000050-bbs2-0071" title="RapeeR .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 29th of August 2019. RapeeRM , AbbottMJ , LynehamHJ .Bibliotherapy for children With anxiety disorders using written materials for parents: a randomized controlled trial. Journal of Consulting and Clinical Psychology2006;74(3):436-44. ">Rapee 2006</a> ; <a href="./references#MR000050-bbs2-0072" title="RapeeR .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 29th of August 2019. RapeeRM , AbbottMJ , BaillieAJ , GastonJE .Treatment of social phobia through pure self-help and therapist-augmented self-help. British Journal of Psychiatry2007;191:246-52. ">Rapee 2007</a> ; <a href="./references#MR000050-bbs2-0077" title="LorrM , McNairDM , WeinsteinGJ .Early effects of chlordiazepoxide (Librium) used with psychotherapy. Journal of Psychiatric Research1963;1:257-70. RothI , RhudickPJ , ShaskanDA , SlobinMS , WilkinsonAE , YoungHH .Long-term effects on psychotherapy of initial treatment conditions. Journal of Psychiatric Research1964;2:283-97. ">Roth 1964</a> ; <a href="./references#MR000050-bbs2-0082" title="SommernessMD , LuceroRJ , HamlonJS , EricksonJL , MatthewsR .A controlled study of reserpine on chronically disturbed patients. JAMA Archives of Neurology and Psychiatry1955;74(3):316-9. ">Sommerness 1955</a> ; <a href="./references#MR000050-bbs2-0085" title="TanSY , BruniJ .Cognitive-behavior therapy with adult patients with epilepsy: a controlled outcome study. Epilepsia1986;27(3):225-33. ">Tan 1986</a> ; <a href="./references#MR000050-bbs2-0086" title="TeriL , LogsdonRG , UomotoJ , McCurrySM .Behavioral treatment of depression in dementia patients: a controlled clinical trial. Journals of Gerontology. Series B, Psychological Sciences and Social Sciences1997;52(4):159-66. TeriL .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 26th of August 2019. ">Teri 1997</a> ; <a href="./references#MR000050-bbs2-0091" title="WatzlH , RistF , OlbrichR , CohenR .Placebo injections and surveillance of alcohol intake during inpatient treatment of female alcoholics. Addictive Behaviors1988;13(2):197-200. ">Watzl 1988</a> ; <a href="./references#MR000050-bbs2-0093" title="WhittakerCB , HoyRM .Withdrawal of perphenazine in chronic schizophrenia. British Journal of Psychiatry1963;109:422-7. ">Whittaker 1963</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Did not allow the participant to receive a concomitant psychotherapy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>20</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#MR000050-bbs2-0002" title="AllenJB .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to A Todorovac 28th of August 2019. AllenJJ , SchnyerRN , HittSK .The efficacy of acupuncture in the treatment of major depression in women. Psychological Science1998;9(5):397-401. ">Allen 1998</a> ; <a href="./references#MR000050-bbs2-0003" title="AllenJB .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 28th of August 2019. AllenJJ , SchnyerRN , ChambersAS , HittSK , MorenoFA , ManberR .Acupuncture for depression: a randomized controlled trial. Journal of Clinical Psychiatry2006;67(11):1665-73. ">Allen 2006</a> ; <a href="./references#MR000050-bbs2-0010" title="BorkovecTD , WeertsTC .Effects of progressive relaxation on sleep disturbance: an electroencephalographic evaluation. Psychosomatic Medicine1976;38(3):173-80. ">Borkovec 1976</a> ; <a href="./references#MR000050-bbs2-0019" title="Doty, DW.Role playing and incentives in the modification of the social interaction of chronic psychiatric patients. Journal of Consulting and Clinical Psychology1975;43(5):676-82. ">Doty 1975</a> ; <a href="./references#MR000050-bbs2-0027" title="FuchsCZ , RehnLP .A self-control behavior therapy program for depression. Journal of Consulting and Clinical Psychology1977;45(2):206-15. ">Fuchs 1977</a> ; <a href="./references#MR000050-bbs2-0029" title="GoldsteinAJ , BeursE , Chambless Dl, WilsonKA .EMDR for panic disorder with agoraphobia: comparison with waiting list and credible attention-placebo control conditions. Journal of Consulting and Clinical Psychology2000;68(6):947-56. ">Goldstein 2000</a> ; <a href="./references#MR000050-bbs2-0035" title="KelleyJ .Inclusion of study in Cochrane Systematic Review (personal communication). Email to: A Todorovac 12th of August 2019. KelleyJM , KaptchukTJ , CusinC , LipkinS , FavaM .Open-label placebo for major depressive disorder: a pilot randomized controlled trial. Psychotherapy and Psychosomatics2012;81(5):312-4. ">Kelley 2012</a> ; <a href="./references#MR000050-bbs2-0039" title="KlermanGL , DimascioA , WeismannM , PrusoffB , PaykelES .Treatment of depression by drugs and psychotherapy. American Journal of Psychiatry1974;131(2):186-91. PaykelES , DimascioA , HaskellD , PrusoffBA .Effects of maintenance amitriptyline and psychotherapy on symptoms of depression. Psychological Medicine1975;5(1):67-77. PaykelES , DiMascioA , KlermanGL , PrusoffBA .Maintenance therapy of depression. Pharmakopsychiatrie, Neuro-Psychopharmakologie1976;9:127-39. PaykelES , WeissmanMM , PrusoffBA .Social maladjustment and severity of depression. Comprehensive Psychiatry1978;19(2):121-8. WeissmanMM , KlermanGL , PaykelES , PrusoffB .Treatment effects on the social adjustment of depressed patients. Archives of General Psychiatry1974;30:771-8. ">Klerman 1974a</a> ; <a href="./references#MR000050-bbs2-0040" title="KlermanGL , DimascioA , WeismannM , PrusoffB , PaykelES .Treatment of depression by drugs and psychotherapy. American Journal of Psychiatry1974;131(2):186-91. ">Klerman 1974b</a> ; <a href="./references#MR000050-bbs2-0041" title="KloskoJS , BarlowDH , TassinariR , CernyJA .A comparison of alprazolam and behavior therapy in treatment of panic disorder: correction. Journal of Psychotherapy Practice and Research1994;3(2):163-79. KloskoJS , BarlowDH , TassinariR , CernyJA .A comparison of alprazolam and behavior therapy in treatment of panic disorder. Journal of Consulting and Clinical Psychology1990;58(1):77-84. ">Klosko 1990</a> ; <a href="./references#MR000050-bbs2-0042" title="KrapflJE , NawasMM .Differential ordering of stimulus presentation in systematic desensitization. Journal of Abnormal Psychology1970;75(3):333-7. ">Krapfl 1970</a> ; <a href="./references#MR000050-bbs2-0046" title="LangOJ , LazovikAD .Experimental desensitization of a phobia. Journal of Abnormal and Social Psychology1963;66:519-25. LangPJ , LazovikAD , ReynoldsDJ .Desensitization, suggestibility, and pseudotherapy. Journal of Abnormal Psychology1965;70(6):395-402. ">Lang 1965</a> ; <a href="./references#MR000050-bbs2-0047" title="LegrandF .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 14th of August 2019. LegrandFD , NeffEM .Efficacy of exercise as an adjunct treatment for clinically depressed inpatients during the initial stages of antidepressant pharmacotherapy: an open randomized controlled trial. Journal of Affective Disorders2016;191:139-44. ">Legrand 2016</a> ; <a href="./references#MR000050-bbs2-0054" title="MilbyJB , ClarkeC , ToroC , ThorntonS , RickertD .Effectiveness of urine surveillance as an adjunct to outpatient psychotherapy for drug abusers. International Journal of the Addictions1980;15(7):993-1001. ">Milby 1980</a> ; <a href="./references#MR000050-bbs2-0076" title="RosenGM , GlasgowRE , BarreraM .A controlled study to assess the clinical efficacy of totally self-administrated systematic desensitization. Journal of Consulting and Clinical Psychology1976;44(2):208-17. ">Rosen 1976</a> ; <a href="./references#MR000050-bbs2-0080" title="ShealyRC .The effectiveness of various treatment techniques on different degrees and durations of sleep-onset insomnia. Behaviour Research and Therapy1979;17(6):541-6. ">Shealy 1979</a> ; <a href="./references#MR000050-bbs2-0081" title="SibilioJP , AndrewG , DartD , MooreKB , StehmanA .Treatment of chronic schizophrenia with promazine hydrochloride. AMA Archives of Neurology and Psychiatry1957;78(4):419-24. ">Sibilio 1957</a> ; <a href="./references#MR000050-bbs2-0083" title="SteinmarkSW , BorkovecTD .Active and placebo treatment effects on moderate insomnia under counterdemand and positive demand instructions. Journal of Abnormal Psychology1974;83(2):157-63. ">Steinmark 1974</a> ; <a href="./references#MR000050-bbs2-0084" title="SzymanskiJ , O'DonohueW .The potential role of state-dependent learning in cognitive therapy with spider phobics. Journal of Rational-Emotive &amp; Cognitive-Behavior Therapy1995;13(2):131-50. SzymanskiJ .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 20th of August 2019. ">Szymanski 1995</a> ; <a href="./references#MR000050-bbs2-0090" title="VanderplateC .Electromyograph biofeedback Treatment of sleep onset Insomnia: a controlled Investigation. Dissertation, University of Southern Mississippi1978. ">Vanderplate 1983</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Allowed the participants to receive a concomitant pharmacotherapy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>29</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#MR000050-bbs2-0001" title="AbikoffH , HechtmanL , KleinRG .Social functioning in children with ADHD treated with long-term methylphenidate and multimodal psychosocial treatment. Journal of the American Academy of Child and Adolescent Psychiatry2004;43(7):820-9. AbikoffH .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to A Todorovac 23rd of August 2019. KleinRG , AbikoffH , HechtmanL , WeissG .Design and rationale of controlled study of long-term methylphenidate and multimodal psychosocial treatment in children with ADHD. Journal of the American Academy of Child and Adolescent Psychiatry2004;43(7):792-801. ">Abikoff 2004</a> ; <a href="./references#MR000050-bbs2-0004" title="AlvarezJR .The effects of anger management training on depression, anger, self-concept, and treatment responsibility in a sample of drug-dependent individuals in a therapeutic community. Dissertation Abstracts International: Section B: the Sciences and Engineering1997;58(4-B):2108. ">Alvarez 1997</a> ; <a href="./references#MR000050-bbs2-0006" title="AyenI , HautzingerM .Cognitive behavior therapy for depression in menopausal women. A controlled, randomized treatment study [Kognitive Verhaltenstherapie bei Depressionen im Klimakterium: Eine kontrollierte, randomiserte Interventionsstudie]. Zeitschrift für Klinische Psychologie und Psychotherapie2004;33(4):290-9. AyenI .Inclusion of study in Cochrane Systematic Review (personal communication). Email to EG Faltinsen 9th of September 2019. ">Ayen 2004</a> ; <a href="./references#MR000050-bbs2-0011" title="BornovalovaM .Inclusion of study in Cochrane Systematic Review (personal communication). Email to A Todorovac. 21st of August 2019. BornovalovaMA .Distress tolerance treatment for inner-city drug users: a preliminary trial. Doctor’s Dissertation, University of Maryland2008. ">Bornovalova 2008</a> ; <a href="./references#MR000050-bbs2-0012" title="BramstonP , SpenceSH .Behavioural versus cognitive social-skills training with intellectually-handicapped adults. Behaviour Research and Therapy1985;23(3):239-46. ">Bramston 1985</a> ; <a href="./references#MR000050-bbs2-0016" title="CarterJC , OlmstedMP , KaplanAS , McCabeRE , MillsJS , AimeA .Self-help for bulimia nervosa: a randomized controlled trial. American Journal of Psychiatry2003;160(5):973-8. ">Carter 2003</a> ; <a href="./references#MR000050-bbs2-0018" title="CrouchG , RobsonM , HallstromC .Benzodiazepine dependent patients and their psychological treatment. Progress in Neuro-psychopharmacology &amp; Biological Psychiatry1988;12(4):503-10. HallströmC , CrouchG , RobsenM , ShineP .The treatment of tranquillizer dependence by propranolol. Postgraduate Medical Journal1988;64(Suppl 2):40-4. ">Crouch 1988</a> ; <a href="./references#MR000050-bbs2-0019" title="Doty, DW.Role playing and incentives in the modification of the social interaction of chronic psychiatric patients. Journal of Consulting and Clinical Psychology1975;43(5):676-82. ">Doty 1975</a> ; <a href="./references#MR000050-bbs2-0020" title="DoubleDB , WarrenGC , EvansM , RowlandsMP .Efficacy of maintenance use of anticholinergic agents. Acta Psychiatrica Scandinavica1993;88:381-4. ">Double 1993</a> ; <a href="./references#MR000050-bbs2-0021" title="EhlersA , HackmannA , GreyN , WildJ , LinessS , AlbertI , et al.A randomized controlled trial of 7-day intensive and standard weekly cognitive therapy for PTSD and emotion-focused supportive therapy. American Journal of Psychiatry2014;171(3):294-304. ">Ehlers 2014</a> ; <a href="./references#MR000050-bbs2-0022" title="EspieCA , BrooksDN , LindsayWR .An evaluation of tailored psychological treatment of insomnia. Journal of Behavior Therapy and Experimental Psychiatry1989;20(2):143-53. EspieCA , LindsayWR , BrooksDN , HoodEM , TurveyT .A controlled comparative investigation of psychological treatments for chronic sleep-onset insomnia. Behaviour Research and Therapy1989;27(1):79-88. ">Espie 1989a</a> ; <a href="./references#MR000050-bbs2-0025" title="FoaEB , McLeanCP , ZangY , RosenfieldD , YadinE , YarvisJS , et al.Effect of prolonged exposure therapy delivered over 2 weeks vs 8 weeks vs present-centered therapy on PTSD symptom severity in military personnel: a randomized clinical trial. JAMA2018;319(4):354-64. ">Foa 2018</a> ; <a href="./references#MR000050-bbs2-0037" title="KilmannPR , MilanRJ , BolandJP , NankinHR , DavidsonE , WestMO , et al.Group treatment of secondary erectile dysfunction. Journal of Sex &amp; Marital Therapy1987;13(3):168-82. KilmannPR , Milan RJ Jr, BolandJP , DavidsonE , WestMO , SablisRF , et al.The sexual interactions of men with secondary erectile dysfunction. Journal of Sex Education and Therapy1988;14(1):46-9. KilmannPR , Milan RJ Jr, BolandJP , NankinHR , SablisRF , WestMO , et al.The sexual interactions of men with secondary erectile dysfunction. Paper presented at the annual meeting of the American Psychological Association in Los Angeles1985;1:46-9. ">Kilmann 1987</a> ; <a href="./references#MR000050-bbs2-0041" title="KloskoJS , BarlowDH , TassinariR , CernyJA .A comparison of alprazolam and behavior therapy in treatment of panic disorder: correction. Journal of Psychotherapy Practice and Research1994;3(2):163-79. KloskoJS , BarlowDH , TassinariR , CernyJA .A comparison of alprazolam and behavior therapy in treatment of panic disorder. Journal of Consulting and Clinical Psychology1990;58(1):77-84. ">Klosko 1990</a> ; <a href="./references#MR000050-bbs2-0043" title="KwanR .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 26th of August 2019. KwanRY , LeungMC , LaiCK .Acupressure for agitation in nursing home residents with dementia: study protocol for a randomized controlled trial. Trials2014;15(410):1-7. KwanRY , LeungMCP , LaiCK .A randomized controlled trial examining the effect of acupressure on agitation and salivary cortisol in nursing home residents with dementia. Dementia and Geriatric Cognitive Disorders2017;44(1-2):92-104. ">Kwan 2017</a> ; <a href="./references#MR000050-bbs2-0045" title="LaiCK , ChiI , Kayser-JonesJ .A randomized controlled trial of a specific reminiscence approach to promote the well-being of nursing home residents with dementia. International Psychogeriatrics2004;16(1):33-49. LaiK .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 6th of September 2019. ">Lai 2004</a> ; <a href="./references#MR000050-bbs2-0047" title="LegrandF .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 14th of August 2019. LegrandFD , NeffEM .Efficacy of exercise as an adjunct treatment for clinically depressed inpatients during the initial stages of antidepressant pharmacotherapy: an open randomized controlled trial. Journal of Affective Disorders2016;191:139-44. ">Legrand 2016</a> ; <a href="./references#MR000050-bbs2-0049" title="LickJR , HefflerD .Relaxation training and attention placebo in the treatment of severe insomnia. Journal of Consulting and Clinical Psychology1977;45(2):153-61. ">Lick 1977</a> ; <a href="./references#MR000050-bbs2-0060" title="PeckCL .Desensitization for the treatment of fear in the high level adult retardate. Behaviour Research and Therapy1977;15(2):137-48. ">Peck 1976</a> ; <a href="./references#MR000050-bbs2-0061" title="MilichR , CarlsonCL , Pelham WE Jr, LichtBG .Effects of methylphenidate on the persistence of ADHD boys following failure experiences. Journal of Abnormal Child Psychology1991;19(5):519-36. PelhamWE , MurphyDA , VannattaK , MilichR , LichtBG , GnagyEM , et al.Methylphenidate and attributions in boys with attention-deficit hyperactivity disorder. Journal of Consulting and Clinical Psychology1992;60(2):282-92. ">Pelham 1992</a> ; <a href="./references#MR000050-bbs2-0064" title="PolandRE , GertsikL , FavreauJT , SmithSI , MirochaJM , RaoU , et al.Open-label randomized parallel-group controlled clinical trial of massage for treatment of depression in HIV-infected subjects. Journal of Alternative and Complementary Medicine2013;19(4):334-40. ">Poland 2013</a> ; <a href="./references#MR000050-bbs2-0068" title="ProudfootJ , ClarkeJ , BirchMR , WhittonAE , ParkerG , ManicavasagarV , et al.Impact of a mobile phone and web program on symptom and functional outcomes for people with mild- to-moderate depression, anxiety and stress: a randomized controlled trial. BMC Psychiatry2013;13(312):1-12. ProudfootJ .Re: Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 26th of August 2019. ">Proudfoot 2013</a> ; <a href="./references#MR000050-bbs2-0071" title="RapeeR .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 29th of August 2019. RapeeRM , AbbottMJ , LynehamHJ .Bibliotherapy for children With anxiety disorders using written materials for parents: a randomized controlled trial. Journal of Consulting and Clinical Psychology2006;74(3):436-44. ">Rapee 2006</a> ; <a href="./references#MR000050-bbs2-0072" title="RapeeR .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 29th of August 2019. RapeeRM , AbbottMJ , BaillieAJ , GastonJE .Treatment of social phobia through pure self-help and therapist-augmented self-help. British Journal of Psychiatry2007;191:246-52. ">Rapee 2007</a> ; <a href="./references#MR000050-bbs2-0078" title="RupertPA , HolmesDS .Effects of multiple sessions of true and placebo heart rate biofeedback training on the heart rates and anxiety levels of anxious patients during and following treatment. Psychophysiology1978;15(6):582-90. ">Rupert 1978</a> ; <a href="./references#MR000050-bbs2-0082" title="SommernessMD , LuceroRJ , HamlonJS , EricksonJL , MatthewsR .A controlled study of reserpine on chronically disturbed patients. JAMA Archives of Neurology and Psychiatry1955;74(3):316-9. ">Sommerness 1955</a> ; <a href="./references#MR000050-bbs2-0085" title="TanSY , BruniJ .Cognitive-behavior therapy with adult patients with epilepsy: a controlled outcome study. Epilepsia1986;27(3):225-33. ">Tan 1986</a> ; <a href="./references#MR000050-bbs2-0086" title="TeriL , LogsdonRG , UomotoJ , McCurrySM .Behavioral treatment of depression in dementia patients: a controlled clinical trial. Journals of Gerontology. Series B, Psychological Sciences and Social Sciences1997;52(4):159-66. TeriL .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 26th of August 2019. ">Teri 1997</a> ; <a href="./references#MR000050-bbs2-0093" title="WhittakerCB , HoyRM .Withdrawal of perphenazine in chronic schizophrenia. British Journal of Psychiatry1963;109:422-7. ">Whittaker 1963</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Did not allow the participant to receive a concomitant pharmacotherapy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>19</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#MR000050-bbs2-0002" title="AllenJB .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to A Todorovac 28th of August 2019. AllenJJ , SchnyerRN , HittSK .The efficacy of acupuncture in the treatment of major depression in women. Psychological Science1998;9(5):397-401. ">Allen 1998</a> ; <a href="./references#MR000050-bbs2-0003" title="AllenJB .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 28th of August 2019. AllenJJ , SchnyerRN , ChambersAS , HittSK , MorenoFA , ManberR .Acupuncture for depression: a randomized controlled trial. Journal of Clinical Psychiatry2006;67(11):1665-73. ">Allen 2006</a> ; <a href="./references#MR000050-bbs2-0010" title="BorkovecTD , WeertsTC .Effects of progressive relaxation on sleep disturbance: an electroencephalographic evaluation. Psychosomatic Medicine1976;38(3):173-80. ">Borkovec 1976</a> ; <a href="./references#MR000050-bbs2-0017" title="CrispAH , NortonK , GowersS , HalekC , BowyerC , YeldhamD , et al.A controlled study of the effect of therapies aimed at adolescent and family psychopathology in Anorexia Nervosa. British Journal of Psychiatry: the Journal of Mental Science1991;159:325-33. GowersS , NortonK , HalekC , CrispAH .Outcome of outpatient psychotherapy in a random allocation treatment study of anorexia nervosa. International Journal of Eating Disorders1994;15(2):165-77. GowersS , NortonK , YelshamD .The St George's prospective treatment study of anorexia nervosa: a discussion of methodological problems. International Journal of Eating Disorders1989;8:445-54. ">Crisp 1991</a> ; <a href="./references#MR000050-bbs2-0026" title="FreireAO , SugaiGC , ChrispinFS , TogeiroSM , YamamuraY , MelloLE , et al.Treatment of moderate obstructive sleep apnea syndrome with acupuncture: a randomised, placebo-controlled pilot trial. Sleep Medicine2007;8(1):43-50. ">Freire 2007</a> ; <a href="./references#MR000050-bbs2-0029" title="GoldsteinAJ , BeursE , Chambless Dl, WilsonKA .EMDR for panic disorder with agoraphobia: comparison with waiting list and credible attention-placebo control conditions. Journal of Consulting and Clinical Psychology2000;68(6):947-56. ">Goldstein 2000</a> ; <a href="./references#MR000050-bbs2-0035" title="KelleyJ .Inclusion of study in Cochrane Systematic Review (personal communication). Email to: A Todorovac 12th of August 2019. KelleyJM , KaptchukTJ , CusinC , LipkinS , FavaM .Open-label placebo for major depressive disorder: a pilot randomized controlled trial. Psychotherapy and Psychosomatics2012;81(5):312-4. ">Kelley 2012</a> ; <a href="./references#MR000050-bbs2-0044" title="LacyMK .The effect of short term autogenic training on the stress reactivity of hospitalized emotionally disturbed adolescents. ProQuest Dissertations Publishing, Oklahoma State University1996. ">Lacy 1990</a> ; <a href="./references#MR000050-bbs2-0058" title="NicassioP , BootzinR .A comparison of progressive relaxation and autogenic training as treatments for insomnia. Journal of Abnormal Psychology1974;83(3):253-60. ">Nicassio 1974</a> ; <a href="./references#MR000050-bbs2-0069" title="QuayhagenMP , QuayhagenM , CorbeilRR , RothPA , RodgersJA .A dyadic remediation program for care recipients with dementia. Nursing Research1995;44(3):153-9. ">Quayhagen 1995</a> ; <a href="./references#MR000050-bbs2-0074" title="RoehrichL , GoldmanMS .Experience-dependent neuropsychological recovery and the treatment of alcoholism. Journal of Consulting and Clinical Psychology1993;61(5):812-21. ">Roehrich 1993</a> ; <a href="./references#MR000050-bbs2-0076" title="RosenGM , GlasgowRE , BarreraM .A controlled study to assess the clinical efficacy of totally self-administrated systematic desensitization. Journal of Consulting and Clinical Psychology1976;44(2):208-17. ">Rosen 1976</a> ; <a href="./references#MR000050-bbs2-0077" title="LorrM , McNairDM , WeinsteinGJ .Early effects of chlordiazepoxide (Librium) used with psychotherapy. Journal of Psychiatric Research1963;1:257-70. RothI , RhudickPJ , ShaskanDA , SlobinMS , WilkinsonAE , YoungHH .Long-term effects on psychotherapy of initial treatment conditions. Journal of Psychiatric Research1964;2:283-97. ">Roth 1964</a> ; <a href="./references#MR000050-bbs2-0080" title="ShealyRC .The effectiveness of various treatment techniques on different degrees and durations of sleep-onset insomnia. Behaviour Research and Therapy1979;17(6):541-6. ">Shealy 1979</a> ; <a href="./references#MR000050-bbs2-0083" title="SteinmarkSW , BorkovecTD .Active and placebo treatment effects on moderate insomnia under counterdemand and positive demand instructions. Journal of Abnormal Psychology1974;83(2):157-63. ">Steinmark 1974</a> ; <a href="./references#MR000050-bbs2-0084" title="SzymanskiJ , O'DonohueW .The potential role of state-dependent learning in cognitive therapy with spider phobics. Journal of Rational-Emotive &amp; Cognitive-Behavior Therapy1995;13(2):131-50. SzymanskiJ .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 20th of August 2019. ">Szymanski 1995</a> ; <a href="./references#MR000050-bbs2-0090" title="VanderplateC .Electromyograph biofeedback Treatment of sleep onset Insomnia: a controlled Investigation. Dissertation, University of Southern Mississippi1978. ">Vanderplate 1983</a> ; <a href="./references#MR000050-bbs2-0092" title="WeingaertnerAH .Self-administered aversive stimulation with hallucinating hospitalized schizophrenics. Journal of Consulting and Clinical Psychology1971;36(3):422-29. ">Weingaertner 1971</a> ; <a href="./references#MR000050-bbs2-0096" title="WollersheimJP , WilsonGL .Group treatment of unipolar depression: a comparison of coping, supportive, bibliotherapy, and delayed treatment groups. Professional Psychology: Research and Practice1991;22(6):496-502. ">Wollersheim 1991</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Comparators</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Wait‐list control interventions</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>39</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#MR000050-bbs2-0002" title="AllenJB .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to A Todorovac 28th of August 2019. AllenJJ , SchnyerRN , HittSK .The efficacy of acupuncture in the treatment of major depression in women. Psychological Science1998;9(5):397-401. ">Allen 1998</a> ; <a href="./references#MR000050-bbs2-0003" title="AllenJB .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 28th of August 2019. AllenJJ , SchnyerRN , ChambersAS , HittSK , MorenoFA , ManberR .Acupuncture for depression: a randomized controlled trial. Journal of Clinical Psychiatry2006;67(11):1665-73. ">Allen 2006</a> ; <a href="./references#MR000050-bbs2-0005" title="AscherLM , TurnerR .Paradoxical intention and insomnia: an experimental investigation. Behaviour Research and Therapy1979;17(4):408-11. ">Ascher 1979</a> ; <a href="./references#MR000050-bbs2-0006" title="AyenI , HautzingerM .Cognitive behavior therapy for depression in menopausal women. A controlled, randomized treatment study [Kognitive Verhaltenstherapie bei Depressionen im Klimakterium: Eine kontrollierte, randomiserte Interventionsstudie]. Zeitschrift für Klinische Psychologie und Psychotherapie2004;33(4):290-9. AyenI .Inclusion of study in Cochrane Systematic Review (personal communication). Email to EG Faltinsen 9th of September 2019. ">Ayen 2004</a> ; <a href="./references#MR000050-bbs2-0009" title="BorkovecTD , KaloupekDG , SlamaKM .The facilitative effect of muscle tension-release in the relaxation treatment of sleep disturbance. Behavior Therapy1975;6(3):301-9. ">Borkovec 1975</a> ; <a href="./references#MR000050-bbs2-0010" title="BorkovecTD , WeertsTC .Effects of progressive relaxation on sleep disturbance: an electroencephalographic evaluation. Psychosomatic Medicine1976;38(3):173-80. ">Borkovec 1976</a> ; <a href="./references#MR000050-bbs2-0012" title="BramstonP , SpenceSH .Behavioural versus cognitive social-skills training with intellectually-handicapped adults. Behaviour Research and Therapy1985;23(3):239-46. ">Bramston 1985</a> ; <a href="./references#MR000050-bbs2-0013" title="BrillNQ , KoeglerRR , EpsteinLJ , ForgyEW .Controlled study of psychiatric outpatient treatment. Archives of General Psychiatry1964;10:581-95. BrillNQ .Results of psychotherapy. California Medicine1966;104(4):249-53. ">Brill 1964a</a> ; <a href="./references#MR000050-bbs2-0014" title="BrillNQ , KoeglerRR , EpsteinLJ , ForgyEW .Controlled study of psychiatric outpatient treatment. Archives of General Psychiatry1964;10:581-95. ">Brill 1964b</a> ; <a href="./references#MR000050-bbs2-0021" title="EhlersA , HackmannA , GreyN , WildJ , LinessS , AlbertI , et al.A randomized controlled trial of 7-day intensive and standard weekly cognitive therapy for PTSD and emotion-focused supportive therapy. American Journal of Psychiatry2014;171(3):294-304. ">Ehlers 2014</a> ; <a href="./references#MR000050-bbs2-0022" title="EspieCA , BrooksDN , LindsayWR .An evaluation of tailored psychological treatment of insomnia. Journal of Behavior Therapy and Experimental Psychiatry1989;20(2):143-53. EspieCA , LindsayWR , BrooksDN , HoodEM , TurveyT .A controlled comparative investigation of psychological treatments for chronic sleep-onset insomnia. Behaviour Research and Therapy1989;27(1):79-88. ">Espie 1989a</a> ; <a href="./references#MR000050-bbs2-0024" title="FoaEB , RothbaumBO , RiggsDS , MurdockTB .Treatment of posttraumatic stress disorder in rape victims: a comparison between cognitive-behavioral procedures and counselling. Journal of Consulting and Clinical Psychology1991;59(5):715-23. ">Foa 1991</a> ; <a href="./references#MR000050-bbs2-0025" title="FoaEB , McLeanCP , ZangY , RosenfieldD , YadinE , YarvisJS , et al.Effect of prolonged exposure therapy delivered over 2 weeks vs 8 weeks vs present-centered therapy on PTSD symptom severity in military personnel: a randomized clinical trial. JAMA2018;319(4):354-64. ">Foa 2018</a> ; <a href="./references#MR000050-bbs2-0027" title="FuchsCZ , RehnLP .A self-control behavior therapy program for depression. Journal of Consulting and Clinical Psychology1977;45(2):206-15. ">Fuchs 1977</a> ; <a href="./references#MR000050-bbs2-0028" title="GlogowskaM , RoulstoneS , EnderbyP , PetersTJ .Randomised controlled trial of community based speech and language therapy in preschool children. BMJ2000;321(7266):923-6. ">Glogowska 2000</a> ; <a href="./references#MR000050-bbs2-0029" title="GoldsteinAJ , BeursE , Chambless Dl, WilsonKA .EMDR for panic disorder with agoraphobia: comparison with waiting list and credible attention-placebo control conditions. Journal of Consulting and Clinical Psychology2000;68(6):947-56. ">Goldstein 2000</a> ; <a href="./references#MR000050-bbs2-0035" title="KelleyJ .Inclusion of study in Cochrane Systematic Review (personal communication). Email to: A Todorovac 12th of August 2019. KelleyJM , KaptchukTJ , CusinC , LipkinS , FavaM .Open-label placebo for major depressive disorder: a pilot randomized controlled trial. Psychotherapy and Psychosomatics2012;81(5):312-4. ">Kelley 2012</a> ; <a href="./references#MR000050-bbs2-0037" title="KilmannPR , MilanRJ , BolandJP , NankinHR , DavidsonE , WestMO , et al.Group treatment of secondary erectile dysfunction. Journal of Sex &amp; Marital Therapy1987;13(3):168-82. KilmannPR , Milan RJ Jr, BolandJP , DavidsonE , WestMO , SablisRF , et al.The sexual interactions of men with secondary erectile dysfunction. Journal of Sex Education and Therapy1988;14(1):46-9. KilmannPR , Milan RJ Jr, BolandJP , NankinHR , SablisRF , WestMO , et al.The sexual interactions of men with secondary erectile dysfunction. Paper presented at the annual meeting of the American Psychological Association in Los Angeles1985;1:46-9. ">Kilmann 1987</a> ; <a href="./references#MR000050-bbs2-0043" title="KwanR .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 26th of August 2019. KwanRY , LeungMC , LaiCK .Acupressure for agitation in nursing home residents with dementia: study protocol for a randomized controlled trial. Trials2014;15(410):1-7. KwanRY , LeungMCP , LaiCK .A randomized controlled trial examining the effect of acupressure on agitation and salivary cortisol in nursing home residents with dementia. Dementia and Geriatric Cognitive Disorders2017;44(1-2):92-104. ">Kwan 2017</a> ; <a href="./references#MR000050-bbs2-0044" title="LacyMK .The effect of short term autogenic training on the stress reactivity of hospitalized emotionally disturbed adolescents. ProQuest Dissertations Publishing, Oklahoma State University1996. ">Lacy 1990</a> ; <a href="./references#MR000050-bbs2-0048" title="LickJ .Expectancy, false galvanic skin response feedback, and systematic desensitization in the modification of phobic behavior. Journal of Consulting and Clinical Psychology1975;43(4):557-67. ">Lick 1975</a> ; <a href="./references#MR000050-bbs2-0054" title="MilbyJB , ClarkeC , ToroC , ThorntonS , RickertD .Effectiveness of urine surveillance as an adjunct to outpatient psychotherapy for drug abusers. International Journal of the Addictions1980;15(7):993-1001. ">Milby 1980</a> ; <a href="./references#MR000050-bbs2-0062" title="PedletonMG , HigginsRL .A comparison of negative practice and systematic desensitization in the treatment of acrophobia. Journal of Behavior Therapy and Experimental Psychiatry1983;14(4):317-23. ">Pendleton 1983</a> ; <a href="./references#MR000050-bbs2-0065" title="PowersMB , SmitsJA , TelchMJ .Disentangling the effects of safety-behavior utilization and safety-behavior availability during exposure-based treatment: a placebo-controlled trial. Journal of Consulting and Clinical Psychology2004;72(3):448-54. ">Powers 2004</a> ; <a href="./references#MR000050-bbs2-0066" title="PowersMB , SmithsJA , WhitleyD , BystritskyA , TelchMJ .The effect of attributional processes concerning medication taking on return of fear. Journal of Consulting and Clinical Psychology2008;76(3):478-90. ">Powers 2008a</a> ; <a href="./references#MR000050-bbs2-0068" title="ProudfootJ , ClarkeJ , BirchMR , WhittonAE , ParkerG , ManicavasagarV , et al.Impact of a mobile phone and web program on symptom and functional outcomes for people with mild- to-moderate depression, anxiety and stress: a randomized controlled trial. BMC Psychiatry2013;13(312):1-12. ProudfootJ .Re: Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 26th of August 2019. ">Proudfoot 2013</a> ; <a href="./references#MR000050-bbs2-0069" title="QuayhagenMP , QuayhagenM , CorbeilRR , RothPA , RodgersJA .A dyadic remediation program for care recipients with dementia. Nursing Research1995;44(3):153-9. ">Quayhagen 1995</a> ; <a href="./references#MR000050-bbs2-0071" title="RapeeR .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 29th of August 2019. RapeeRM , AbbottMJ , LynehamHJ .Bibliotherapy for children With anxiety disorders using written materials for parents: a randomized controlled trial. Journal of Consulting and Clinical Psychology2006;74(3):436-44. ">Rapee 2006</a> ; <a href="./references#MR000050-bbs2-0072" title="RapeeR .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 29th of August 2019. RapeeRM , AbbottMJ , BaillieAJ , GastonJE .Treatment of social phobia through pure self-help and therapist-augmented self-help. British Journal of Psychiatry2007;191:246-52. ">Rapee 2007</a> ; <a href="./references#MR000050-bbs2-0073" title="RobinA .Rationing out-patients: a defence of the waiting list. British Journal of Psychiatry1976;129:138-41. ">Robin 1976</a> ; <a href="./references#MR000050-bbs2-0075" title="OlivaresJ .Program IAFS. Protocol for the treatment of social phobia in adolescents [Programa IAFS. Protocolo para el tratamiento de la fobia social enadolescentes]. Madrid: Pirámide2005;1. Rosa-AlcázarAI , Olivares-OlivaresPJ , OlivaresJ .The role of non-specific effects in the psychological treatment of adolescents with social phobia [Papel de los efectos inespecíficos en el tratamiento psicológico de adolescentes con fobia social]. Anuario de Psicologia2009;40(1):43-61. ">Rosa‐Alcatraz 2009</a> ; <a href="./references#MR000050-bbs2-0076" title="RosenGM , GlasgowRE , BarreraM .A controlled study to assess the clinical efficacy of totally self-administrated systematic desensitization. Journal of Consulting and Clinical Psychology1976;44(2):208-17. ">Rosen 1976</a> ; <a href="./references#MR000050-bbs2-0080" title="ShealyRC .The effectiveness of various treatment techniques on different degrees and durations of sleep-onset insomnia. Behaviour Research and Therapy1979;17(6):541-6. ">Shealy 1979</a> ; <a href="./references#MR000050-bbs2-0083" title="SteinmarkSW , BorkovecTD .Active and placebo treatment effects on moderate insomnia under counterdemand and positive demand instructions. Journal of Abnormal Psychology1974;83(2):157-63. ">Steinmark 1974</a> ; <a href="./references#MR000050-bbs2-0088" title="Trexler, L.Rational-emotive therapy, placebo, and no-treatment effects on public-speaking anxiety. Doctoral dissertation, Temple University AnnArbor, Mich.: University Microfilms1971;71-31(063). TrexlerLD , KarstTO .Rational-emotive therapy, placebo, and no-treatment effects on public-speaking anxiety. Journal of Abnormal Psyhology1972;79(1):60-7. ">Trexler 1972</a> ; <a href="./references#MR000050-bbs2-0089" title="AscherML , TurnerRM .A comparison of two methods for the administration of paradoxical intention. Behaviour Research and Therapy1980;18(2):121-6. TurnerRM , AscherLM .Controlled comparison of progressive relaxation, stimulus control, and paradoxical intention therapies for insomnia. Journal of Consulting and Clinical Psychology1979;47(3):500-8. ">Turner 1979</a> ; <a href="./references#MR000050-bbs2-0090" title="VanderplateC .Electromyograph biofeedback Treatment of sleep onset Insomnia: a controlled Investigation. Dissertation, University of Southern Mississippi1978. ">Vanderplate 1983</a> ; <a href="./references#MR000050-bbs2-0095" title="WolitzkyKB , TelchMJ .Augmenting in vivo exposure with fear antagonistic actions: a preliminary test. Behavior Therapy2009;40(1):57-71. ">Wolitzky 2009</a> ; <a href="./references#MR000050-bbs2-0096" title="WollersheimJP , WilsonGL .Group treatment of unipolar depression: a comparison of coping, supportive, bibliotherapy, and delayed treatment groups. Professional Psychology: Research and Practice1991;22(6):496-502. ">Wollersheim 1991</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No‐treatment control interventions</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>56</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#MR000050-bbs2-0001" title="AbikoffH , HechtmanL , KleinRG .Social functioning in children with ADHD treated with long-term methylphenidate and multimodal psychosocial treatment. Journal of the American Academy of Child and Adolescent Psychiatry2004;43(7):820-9. AbikoffH .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to A Todorovac 23rd of August 2019. KleinRG , AbikoffH , HechtmanL , WeissG .Design and rationale of controlled study of long-term methylphenidate and multimodal psychosocial treatment in children with ADHD. Journal of the American Academy of Child and Adolescent Psychiatry2004;43(7):792-801. ">Abikoff 2004</a> ; <a href="./references#MR000050-bbs2-0004" title="AlvarezJR .The effects of anger management training on depression, anger, self-concept, and treatment responsibility in a sample of drug-dependent individuals in a therapeutic community. Dissertation Abstracts International: Section B: the Sciences and Engineering1997;58(4-B):2108. ">Alvarez 1997</a> ; <a href="./references#MR000050-bbs2-0007" title="BergI , ForsytheI , HoltP , WattsJ .A controlled trial of ‘Senokot’ in faecal soiling treated by behavioural methods. Journal of Child Psychology and Psychiatry1983;24(4):543-9. ">Berg 1983</a> ; <a href="./references#MR000050-bbs2-0008" title="Borden, KA.Attributional Outcomes: the Subtle Messages of Treatments for Attention Deficit Disorder. Dissertation, University of Illinois at Urbana-Champaign1986. BordenKA , BrownRT .Attributional outcomes: The subtle messages of treatments for attention deficit disorder. Cognitive Therapy and Research1989;13(2):147-60. ">Borden 1986</a> ; <a href="./references#MR000050-bbs2-0011" title="BornovalovaM .Inclusion of study in Cochrane Systematic Review (personal communication). Email to A Todorovac. 21st of August 2019. BornovalovaMA .Distress tolerance treatment for inner-city drug users: a preliminary trial. Doctor’s Dissertation, University of Maryland2008. ">Bornovalova 2008</a> ; <a href="./references#MR000050-bbs2-0015" title="CarlsonCL , PelhamWE , MilichR , HozaB .ADHD boys’ performance and attributions following success and failure: drug effects and individual differences. Cognitive Therapy and Research1993;17:269-87. ">Carlson 1993</a> ; <a href="./references#MR000050-bbs2-0016" title="CarterJC , OlmstedMP , KaplanAS , McCabeRE , MillsJS , AimeA .Self-help for bulimia nervosa: a randomized controlled trial. American Journal of Psychiatry2003;160(5):973-8. ">Carter 2003</a> ; <a href="./references#MR000050-bbs2-0017" title="CrispAH , NortonK , GowersS , HalekC , BowyerC , YeldhamD , et al.A controlled study of the effect of therapies aimed at adolescent and family psychopathology in Anorexia Nervosa. British Journal of Psychiatry: the Journal of Mental Science1991;159:325-33. GowersS , NortonK , HalekC , CrispAH .Outcome of outpatient psychotherapy in a random allocation treatment study of anorexia nervosa. International Journal of Eating Disorders1994;15(2):165-77. GowersS , NortonK , YelshamD .The St George's prospective treatment study of anorexia nervosa: a discussion of methodological problems. International Journal of Eating Disorders1989;8:445-54. ">Crisp 1991</a> ; <a href="./references#MR000050-bbs2-0018" title="CrouchG , RobsonM , HallstromC .Benzodiazepine dependent patients and their psychological treatment. Progress in Neuro-psychopharmacology &amp; Biological Psychiatry1988;12(4):503-10. HallströmC , CrouchG , RobsenM , ShineP .The treatment of tranquillizer dependence by propranolol. Postgraduate Medical Journal1988;64(Suppl 2):40-4. ">Crouch 1988</a> ; <a href="./references#MR000050-bbs2-0019" title="Doty, DW.Role playing and incentives in the modification of the social interaction of chronic psychiatric patients. Journal of Consulting and Clinical Psychology1975;43(5):676-82. ">Doty 1975</a> ; <a href="./references#MR000050-bbs2-0020" title="DoubleDB , WarrenGC , EvansM , RowlandsMP .Efficacy of maintenance use of anticholinergic agents. Acta Psychiatrica Scandinavica1993;88:381-4. ">Double 1993</a> ; <a href="./references#MR000050-bbs2-0023" title="EtringerBD , CashTF , RimmDC .Behavioral, affective, and cognitive effects of participant modeling and an equally credible placebo. Behavior Therapy1982;13(4):476-85. ">Etringer 1982</a> ; <a href="./references#MR000050-bbs2-0026" title="FreireAO , SugaiGC , ChrispinFS , TogeiroSM , YamamuraY , MelloLE , et al.Treatment of moderate obstructive sleep apnea syndrome with acupuncture: a randomised, placebo-controlled pilot trial. Sleep Medicine2007;8(1):43-50. ">Freire 2007</a> ; <a href="./references#MR000050-bbs2-0030" title="GoldwasserAN , AuerbachSM , HarkinsSW .Cognitive, affective, and behavioural effects of reminiscence group therapy on demented elderly. Aging and Human Development1987;25(3):209-22. ">Goldwasser 1987</a> ; <a href="./references#MR000050-bbs2-0031" title="HekmatH , LubitzR , DealR .Semantic desensitization: a paradigmatic intervention approach to anxiety disorders. Journal of Clinical Psychology1984;40(2):463-6. ">Hekmat 1984</a> ; <a href="./references#MR000050-bbs2-0032" title="HippmanC , RingroseA , InglisA , CheekJ , AlbertAY , RemickR , et al.A pilot randomized clinical trial evaluating the impact of genetic counselling for serious mental illnesses. Journal of Clinical Psychiatry2016;77(2):e190-8. ">Hippman 2016</a> ; <a href="./references#MR000050-bbs2-0034" title="KarstM , WinterhalterM , MünteS , FranckiB , HondronikosA , EckardtA , et al.Auricular acupuncture for dental anxiety: a randomized controlled trial. Anesthesia and Analgesia2007;104(2):295-300. KarstM .Inclusion of study in Cochrane Systematic Review (personal communication). Email to: EG Faltinsen 5th of September 2019. ">Karst 2007</a> ; <a href="./references#MR000050-bbs2-0036" title="KennedyTD , KimuraHK .Transfer, behavioral improvement, and anxiety reduction in systematic desensitization. Journal of Consulting and Clinical Psychology1974;42(5):720-8. ">Kennedy 1974</a> ; <a href="./references#MR000050-bbs2-0038" title="KleinSA , DeffenbacherJL .Relaxation and exercise for hyperactive impulsive children. Perceptual and Motor Skills1977;45:1159-62. ">Klein 1977</a> ; <a href="./references#MR000050-bbs2-0039" title="KlermanGL , DimascioA , WeismannM , PrusoffB , PaykelES .Treatment of depression by drugs and psychotherapy. American Journal of Psychiatry1974;131(2):186-91. PaykelES , DimascioA , HaskellD , PrusoffBA .Effects of maintenance amitriptyline and psychotherapy on symptoms of depression. Psychological Medicine1975;5(1):67-77. PaykelES , DiMascioA , KlermanGL , PrusoffBA .Maintenance therapy of depression. Pharmakopsychiatrie, Neuro-Psychopharmakologie1976;9:127-39. PaykelES , WeissmanMM , PrusoffBA .Social maladjustment and severity of depression. Comprehensive Psychiatry1978;19(2):121-8. WeissmanMM , KlermanGL , PaykelES , PrusoffB .Treatment effects on the social adjustment of depressed patients. Archives of General Psychiatry1974;30:771-8. ">Klerman 1974a</a> ; <a href="./references#MR000050-bbs2-0040" title="KlermanGL , DimascioA , WeismannM , PrusoffB , PaykelES .Treatment of depression by drugs and psychotherapy. American Journal of Psychiatry1974;131(2):186-91. ">Klerman 1974b</a> ; <a href="./references#MR000050-bbs2-0041" title="KloskoJS , BarlowDH , TassinariR , CernyJA .A comparison of alprazolam and behavior therapy in treatment of panic disorder: correction. Journal of Psychotherapy Practice and Research1994;3(2):163-79. KloskoJS , BarlowDH , TassinariR , CernyJA .A comparison of alprazolam and behavior therapy in treatment of panic disorder. Journal of Consulting and Clinical Psychology1990;58(1):77-84. ">Klosko 1990</a> ; <a href="./references#MR000050-bbs2-0042" title="KrapflJE , NawasMM .Differential ordering of stimulus presentation in systematic desensitization. Journal of Abnormal Psychology1970;75(3):333-7. ">Krapfl 1970</a> ; <a href="./references#MR000050-bbs2-0045" title="LaiCK , ChiI , Kayser-JonesJ .A randomized controlled trial of a specific reminiscence approach to promote the well-being of nursing home residents with dementia. International Psychogeriatrics2004;16(1):33-49. LaiK .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 6th of September 2019. ">Lai 2004</a> ; <a href="./references#MR000050-bbs2-0046" title="LangOJ , LazovikAD .Experimental desensitization of a phobia. Journal of Abnormal and Social Psychology1963;66:519-25. LangPJ , LazovikAD , ReynoldsDJ .Desensitization, suggestibility, and pseudotherapy. Journal of Abnormal Psychology1965;70(6):395-402. ">Lang 1965</a> ; <a href="./references#MR000050-bbs2-0047" title="LegrandF .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 14th of August 2019. LegrandFD , NeffEM .Efficacy of exercise as an adjunct treatment for clinically depressed inpatients during the initial stages of antidepressant pharmacotherapy: an open randomized controlled trial. Journal of Affective Disorders2016;191:139-44. ">Legrand 2016</a> ; <a href="./references#MR000050-bbs2-0049" title="LickJR , HefflerD .Relaxation training and attention placebo in the treatment of severe insomnia. Journal of Consulting and Clinical Psychology1977;45(2):153-61. ">Lick 1977</a> ; <a href="./references#MR000050-bbs2-0050" title="LiddleB , SpenceSH .Cognitive-behaviour therapy with depressed primary school children: A cautionary note. Behavioural Psychotherapy1990;18(2):85-102. ">Liddle 1990</a> ; <a href="./references#MR000050-bbs2-0051" title="MatsonJL , MarchettiA , AdkinsJA .Comparison of operant- and independence-training procedures for mentally retarded adults. American Journal of Mental Deficiency1980;84(5):487-94. ">Matson 1980</a> ; <a href="./references#MR000050-bbs2-0052" title="McLachlanDR , DaltonAJ , KruckTP , BellMY , SmithWL , KalowW , et al.Intramuscular desferrioxamine in patients with Alzheimer's disease. Lancet1991;337(8753):1304-8. McLachlanDRC , SmithWL , KruckTP .Desferrioxamine and Alzheimer’s disease: video home behavior assessment of clinical course and measures of brain aluminum. Therapeutic Drug Monitoring1993;15(6):602-7. ">McLachlan 1991</a> ; <a href="./references#MR000050-bbs2-0053" title="MealieaWL , NawasMM .The comparative effectiveness of systematic desensitization and implosive therapy in the treatment of snake phobia. Journal of Behavior Therapy and Experimental Psychiatry1971;2(2):85-94. ">Mealiea 1971</a> ; <a href="./references#MR000050-bbs2-0055" title="MirandaA , ArlandisP , SorianoM .Instruction in strategies and attributional training: Effects on the problem-solving and self-concept of students’ with learning disabilities [Instrucción en estrategias y entrenamiento atribucional: efectos sobre la resolución de problemas y el autoconcepto de los estudiantes con dificultades en el aprendizaje]. Infancia y Aprendizaje1997;20(80):37-52. ">Miranda 1997</a> ; <a href="./references#MR000050-bbs2-0056" title="MitchellC , MansfieldD , RautenbachS .Coloured filters and reading accuracy, comprehension and rate: a placebo-controlled study. Perceptual and Motor Skills2008;106(2):517-32. ">Mitchell 2008</a> ; <a href="./references#MR000050-bbs2-0057" title="NandiDN , AjmanyS , GanguliH , BanerjeeG , BoralGC , GhoshA , et al.A clinical evaluation of depressives found in a rural survey in India. British Journal of Psychiatry1976;128:523-7. ">Nandi 1976</a> ; <a href="./references#MR000050-bbs2-0058" title="NicassioP , BootzinR .A comparison of progressive relaxation and autogenic training as treatments for insomnia. Journal of Abnormal Psychology1974;83(3):253-60. ">Nicassio 1974</a> ; <a href="./references#MR000050-bbs2-0059" title="PearlD , Vander KampH , OlsenAL , GreenbergPD , ArmitageSG .The effects of reserpine on schizophrenic patients. American Journal of Psychiatry1956;112:198-204. ">Pearl 1956</a> ; <a href="./references#MR000050-bbs2-0060" title="PeckCL .Desensitization for the treatment of fear in the high level adult retardate. Behaviour Research and Therapy1977;15(2):137-48. ">Peck 1976</a> ; <a href="./references#MR000050-bbs2-0061" title="MilichR , CarlsonCL , Pelham WE Jr, LichtBG .Effects of methylphenidate on the persistence of ADHD boys following failure experiences. Journal of Abnormal Child Psychology1991;19(5):519-36. PelhamWE , MurphyDA , VannattaK , MilichR , LichtBG , GnagyEM , et al.Methylphenidate and attributions in boys with attention-deficit hyperactivity disorder. Journal of Consulting and Clinical Psychology1992;60(2):282-92. ">Pelham 1992</a> ; <a href="./references#MR000050-bbs2-0063" title="PetersonMA , PattersonB , PillmanBM , BattistaMA .Cognitive recovery following alcohol detoxification: a computerised remediation study. Neuropsychological Rehabilitation2002;12(1):63-74. PillmanBM .Computerized cognitive remediation with recently detoxified alcoholics. Dissertation, California School of Professional Psychology, Fresno Campus2000. ">Pillman 2001</a> ; <a href="./references#MR000050-bbs2-0064" title="PolandRE , GertsikL , FavreauJT , SmithSI , MirochaJM , RaoU , et al.Open-label randomized parallel-group controlled clinical trial of massage for treatment of depression in HIV-infected subjects. Journal of Alternative and Complementary Medicine2013;19(4):334-40. ">Poland 2013</a> ; <a href="./references#MR000050-bbs2-0067" title="PowersMB , SmithsJA , WhitleyD , BystritskyA , TelchMJ .The effect of attributional processes concerning medication taking on return of fear. Journal of Consulting and Clinical Psychology2008;76(3):478-90. ">Powers 2008b</a> ; <a href="./references#MR000050-bbs2-0070" title="LiebowitzM , QuitkinFM , StewartJW , McGrathPJ , HarrisonWM , MarkowitzJS , et al.Antidepressant efficacy in atypical depression. Archives of General Psychiatry1988;45(2):129-37. QuitkinFM , McGrathPJ , StewartJW , HarrisonW , WagerSG , NunesE , et al.Phenelzine and imipramine in mood reactive depressives: further delineation of the syndrome of atypical depression. Archives of General Psychiatry1989;46(9):787-93. RabkinJG , McGrathPJ , QuitkinFM , TricamoE , StewartJW , KleinDF .Effects of pill-giving on maintenance of placebo response in patients with chronic mild depression. American Journal of Psychiatry1990;147(12):1622-6. ">Rabkin 1990</a> ; <a href="./references#MR000050-bbs2-0074" title="RoehrichL , GoldmanMS .Experience-dependent neuropsychological recovery and the treatment of alcoholism. Journal of Consulting and Clinical Psychology1993;61(5):812-21. ">Roehrich 1993</a> ; <a href="./references#MR000050-bbs2-0077" title="LorrM , McNairDM , WeinsteinGJ .Early effects of chlordiazepoxide (Librium) used with psychotherapy. Journal of Psychiatric Research1963;1:257-70. RothI , RhudickPJ , ShaskanDA , SlobinMS , WilkinsonAE , YoungHH .Long-term effects on psychotherapy of initial treatment conditions. Journal of Psychiatric Research1964;2:283-97. ">Roth 1964</a> ; <a href="./references#MR000050-bbs2-0078" title="RupertPA , HolmesDS .Effects of multiple sessions of true and placebo heart rate biofeedback training on the heart rates and anxiety levels of anxious patients during and following treatment. Psychophysiology1978;15(6):582-90. ">Rupert 1978</a> ; <a href="./references#MR000050-bbs2-0079" title="ShalevAY , AnkriY , Isreali-ShalevY , PelegT , AdesskyR , FreedmanS .Prevention of posttraumatic stress disorder by early treatment. Archives of General Psychiatry2012;69(2):166-76. ">Shalev 2012</a> ; <a href="./references#MR000050-bbs2-0081" title="SibilioJP , AndrewG , DartD , MooreKB , StehmanA .Treatment of chronic schizophrenia with promazine hydrochloride. AMA Archives of Neurology and Psychiatry1957;78(4):419-24. ">Sibilio 1957</a> ; <a href="./references#MR000050-bbs2-0082" title="SommernessMD , LuceroRJ , HamlonJS , EricksonJL , MatthewsR .A controlled study of reserpine on chronically disturbed patients. JAMA Archives of Neurology and Psychiatry1955;74(3):316-9. ">Sommerness 1955</a> ; <a href="./references#MR000050-bbs2-0084" title="SzymanskiJ , O'DonohueW .The potential role of state-dependent learning in cognitive therapy with spider phobics. Journal of Rational-Emotive &amp; Cognitive-Behavior Therapy1995;13(2):131-50. SzymanskiJ .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 20th of August 2019. ">Szymanski 1995</a> ; <a href="./references#MR000050-bbs2-0085" title="TanSY , BruniJ .Cognitive-behavior therapy with adult patients with epilepsy: a controlled outcome study. Epilepsia1986;27(3):225-33. ">Tan 1986</a> ; <a href="./references#MR000050-bbs2-0086" title="TeriL , LogsdonRG , UomotoJ , McCurrySM .Behavioral treatment of depression in dementia patients: a controlled clinical trial. Journals of Gerontology. Series B, Psychological Sciences and Social Sciences1997;52(4):159-66. TeriL .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 26th of August 2019. ">Teri 1997</a> ; <a href="./references#MR000050-bbs2-0087" title="ToriC , WorellL .Reduction of human avoidant behavior. A comparison of counterconditioning, expectancy, and cognitive information approaches. Clinical Psychology1973;41(2):269-78. ">Tori 1973</a> ; <a href="./references#MR000050-bbs2-0091" title="WatzlH , RistF , OlbrichR , CohenR .Placebo injections and surveillance of alcohol intake during inpatient treatment of female alcoholics. Addictive Behaviors1988;13(2):197-200. ">Watzl 1988</a> ; <a href="./references#MR000050-bbs2-0092" title="WeingaertnerAH .Self-administered aversive stimulation with hallucinating hospitalized schizophrenics. Journal of Consulting and Clinical Psychology1971;36(3):422-29. ">Weingaertner 1971</a> ; <a href="./references#MR000050-bbs2-0093" title="WhittakerCB , HoyRM .Withdrawal of perphenazine in chronic schizophrenia. British Journal of Psychiatry1963;109:422-7. ">Whittaker 1963</a> ; <a href="./references#MR000050-bbs2-0094" title="WilsonA , DavidsonWJ , BlanchardR , WhiteJ .Disulfiram implantation. A placebo-controlled trial with two-year follow-up. Journal of Studies on Alcohol1978;39(5):809-19. WilsonA , DavidsonWJ , BlanchardR .Disulfiram implantation: a trial using placebo implants and two types of controls. Journal of Studies on Alcohol1980;41(5):429-36. ">Wilson 1980</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Labelled wait‐list control intervention but the description is a no‐treatment control intervention </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>10</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#MR000050-bbs2-0005" title="AscherLM , TurnerR .Paradoxical intention and insomnia: an experimental investigation. Behaviour Research and Therapy1979;17(4):408-11. ">Ascher 1979</a> ; <a href="./references#MR000050-bbs2-0009" title="BorkovecTD , KaloupekDG , SlamaKM .The facilitative effect of muscle tension-release in the relaxation treatment of sleep disturbance. Behavior Therapy1975;6(3):301-9. ">Borkovec 1975</a> ; <a href="./references#MR000050-bbs2-0010" title="BorkovecTD , WeertsTC .Effects of progressive relaxation on sleep disturbance: an electroencephalographic evaluation. Psychosomatic Medicine1976;38(3):173-80. ">Borkovec 1976</a> ; <a href="./references#MR000050-bbs2-0012" title="BramstonP , SpenceSH .Behavioural versus cognitive social-skills training with intellectually-handicapped adults. Behaviour Research and Therapy1985;23(3):239-46. ">Bramston 1985</a> ; <a href="./references#MR000050-bbs2-0022" title="EspieCA , BrooksDN , LindsayWR .An evaluation of tailored psychological treatment of insomnia. Journal of Behavior Therapy and Experimental Psychiatry1989;20(2):143-53. EspieCA , LindsayWR , BrooksDN , HoodEM , TurveyT .A controlled comparative investigation of psychological treatments for chronic sleep-onset insomnia. Behaviour Research and Therapy1989;27(1):79-88. ">Espie 1989a</a> ; <a href="./references#MR000050-bbs2-0037" title="KilmannPR , MilanRJ , BolandJP , NankinHR , DavidsonE , WestMO , et al.Group treatment of secondary erectile dysfunction. Journal of Sex &amp; Marital Therapy1987;13(3):168-82. KilmannPR , Milan RJ Jr, BolandJP , DavidsonE , WestMO , SablisRF , et al.The sexual interactions of men with secondary erectile dysfunction. Journal of Sex Education and Therapy1988;14(1):46-9. KilmannPR , Milan RJ Jr, BolandJP , NankinHR , SablisRF , WestMO , et al.The sexual interactions of men with secondary erectile dysfunction. Paper presented at the annual meeting of the American Psychological Association in Los Angeles1985;1:46-9. ">Kilmann 1987</a> ; <a href="./references#MR000050-bbs2-0048" title="LickJ .Expectancy, false galvanic skin response feedback, and systematic desensitization in the modification of phobic behavior. Journal of Consulting and Clinical Psychology1975;43(4):557-67. ">Lick 1975</a> ; <a href="./references#MR000050-bbs2-0076" title="RosenGM , GlasgowRE , BarreraM .A controlled study to assess the clinical efficacy of totally self-administrated systematic desensitization. Journal of Consulting and Clinical Psychology1976;44(2):208-17. ">Rosen 1976</a> ; <a href="./references#MR000050-bbs2-0088" title="Trexler, L.Rational-emotive therapy, placebo, and no-treatment effects on public-speaking anxiety. Doctoral dissertation, Temple University AnnArbor, Mich.: University Microfilms1971;71-31(063). TrexlerLD , KarstTO .Rational-emotive therapy, placebo, and no-treatment effects on public-speaking anxiety. Journal of Abnormal Psyhology1972;79(1):60-7. ">Trexler 1972</a> ; <a href="./references#MR000050-bbs2-0089" title="AscherML , TurnerRM .A comparison of two methods for the administration of paradoxical intention. Behaviour Research and Therapy1980;18(2):121-6. TurnerRM , AscherLM .Controlled comparison of progressive relaxation, stimulus control, and paradoxical intention therapies for insomnia. Journal of Consulting and Clinical Psychology1979;47(3):500-8. ">Turner 1979</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Labelled no‐treatment control intervention but the description is a wait‐list control intervention </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#MR000050-bbs2-0016" title="CarterJC , OlmstedMP , KaplanAS , McCabeRE , MillsJS , AimeA .Self-help for bulimia nervosa: a randomized controlled trial. American Journal of Psychiatry2003;160(5):973-8. ">Carter 2003</a> ; <a href="./references#MR000050-bbs2-0031" title="HekmatH , LubitzR , DealR .Semantic desensitization: a paradigmatic intervention approach to anxiety disorders. Journal of Clinical Psychology1984;40(2):463-6. ">Hekmat 1984</a> ; <a href="./references#MR000050-bbs2-0032" title="HippmanC , RingroseA , InglisA , CheekJ , AlbertAY , RemickR , et al.A pilot randomized clinical trial evaluating the impact of genetic counselling for serious mental illnesses. Journal of Clinical Psychiatry2016;77(2):e190-8. ">Hippman 2016</a> ; <a href="./references#MR000050-bbs2-0086" title="TeriL , LogsdonRG , UomotoJ , McCurrySM .Behavioral treatment of depression in dementia patients: a controlled clinical trial. Journals of Gerontology. Series B, Psychological Sciences and Social Sciences1997;52(4):159-66. TeriL .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 26th of August 2019. ">Teri 1997</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Labelled as 'Minimal contact group' but description is a wait‐list control intervention</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#MR000050-bbs2-0025" title="FoaEB , McLeanCP , ZangY , RosenfieldD , YadinE , YarvisJS , et al.Effect of prolonged exposure therapy delivered over 2 weeks vs 8 weeks vs present-centered therapy on PTSD symptom severity in military personnel: a randomized clinical trial. JAMA2018;319(4):354-64. ">Foa 2018</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Labelled as 'Delayed treatment group' but description is a wait‐list control intervention</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#MR000050-bbs2-0033" title="HowlinP , GordonKR , PascoG , WadeA , CharmanT .The effectiveness of picture exchange communication system (PECS) training for teachers of children with autism: a pragmatic,group randomised controlled trial. Journal of Child Psychology and Psychiatry2007;48(5):473-81. ">Howlin 2007</a> ; <a href="./references#MR000050-bbs2-0073" title="RobinA .Rationing out-patients: a defence of the waiting list. British Journal of Psychiatry1976;129:138-41. ">Robin 1976</a> ; <a href="./references#MR000050-bbs2-0096" title="WollersheimJP , WilsonGL .Group treatment of unipolar depression: a comparison of coping, supportive, bibliotherapy, and delayed treatment groups. Professional Psychology: Research and Practice1991;22(6):496-502. ">Wollersheim 1991</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Add‐on drug treatment to each group</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#MR000050-bbs2-0001" title="AbikoffH , HechtmanL , KleinRG .Social functioning in children with ADHD treated with long-term methylphenidate and multimodal psychosocial treatment. Journal of the American Academy of Child and Adolescent Psychiatry2004;43(7):820-9. AbikoffH .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to A Todorovac 23rd of August 2019. KleinRG , AbikoffH , HechtmanL , WeissG .Design and rationale of controlled study of long-term methylphenidate and multimodal psychosocial treatment in children with ADHD. Journal of the American Academy of Child and Adolescent Psychiatry2004;43(7):792-801. ">Abikoff 2004</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Add‐on psychotherapeutic treatment on each group</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#MR000050-bbs2-0007" title="BergI , ForsytheI , HoltP , WattsJ .A controlled trial of ‘Senokot’ in faecal soiling treated by behavioural methods. Journal of Child Psychology and Psychiatry1983;24(4):543-9. ">Berg 1983</a> ; <a href="./references#MR000050-bbs2-0039" title="KlermanGL , DimascioA , WeismannM , PrusoffB , PaykelES .Treatment of depression by drugs and psychotherapy. American Journal of Psychiatry1974;131(2):186-91. PaykelES , DimascioA , HaskellD , PrusoffBA .Effects of maintenance amitriptyline and psychotherapy on symptoms of depression. Psychological Medicine1975;5(1):67-77. PaykelES , DiMascioA , KlermanGL , PrusoffBA .Maintenance therapy of depression. Pharmakopsychiatrie, Neuro-Psychopharmakologie1976;9:127-39. PaykelES , WeissmanMM , PrusoffBA .Social maladjustment and severity of depression. Comprehensive Psychiatry1978;19(2):121-8. WeissmanMM , KlermanGL , PaykelES , PrusoffB .Treatment effects on the social adjustment of depressed patients. Archives of General Psychiatry1974;30:771-8. ">Klerman 1974a</a> ; <a href="./references#MR000050-bbs2-0040" title="KlermanGL , DimascioA , WeismannM , PrusoffB , PaykelES .Treatment of depression by drugs and psychotherapy. American Journal of Psychiatry1974;131(2):186-91. ">Klerman 1974b</a> ; <a href="./references#MR000050-bbs2-0067" title="PowersMB , SmithsJA , WhitleyD , BystritskyA , TelchMJ .The effect of attributional processes concerning medication taking on return of fear. Journal of Consulting and Clinical Psychology2008;76(3):478-90. ">Powers 2008b</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Outcomes (four or more trials)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Behavioral Avoidance Test (BAT)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#MR000050-bbs2-0023" title="EtringerBD , CashTF , RimmDC .Behavioral, affective, and cognitive effects of participant modeling and an equally credible placebo. Behavior Therapy1982;13(4):476-85. ">Etringer 1982</a> ; <a href="./references#MR000050-bbs2-0036" title="KennedyTD , KimuraHK .Transfer, behavioral improvement, and anxiety reduction in systematic desensitization. Journal of Consulting and Clinical Psychology1974;42(5):720-8. ">Kennedy 1974</a> ; <a href="./references#MR000050-bbs2-0042" title="KrapflJE , NawasMM .Differential ordering of stimulus presentation in systematic desensitization. Journal of Abnormal Psychology1970;75(3):333-7. ">Krapfl 1970</a> ; <a href="./references#MR000050-bbs2-0046" title="LangOJ , LazovikAD .Experimental desensitization of a phobia. Journal of Abnormal and Social Psychology1963;66:519-25. LangPJ , LazovikAD , ReynoldsDJ .Desensitization, suggestibility, and pseudotherapy. Journal of Abnormal Psychology1965;70(6):395-402. ">Lang 1965</a> ; <a href="./references#MR000050-bbs2-0060" title="PeckCL .Desensitization for the treatment of fear in the high level adult retardate. Behaviour Research and Therapy1977;15(2):137-48. ">Peck 1976</a> ; <a href="./references#MR000050-bbs2-0076" title="RosenGM , GlasgowRE , BarreraM .A controlled study to assess the clinical efficacy of totally self-administrated systematic desensitization. Journal of Consulting and Clinical Psychology1976;44(2):208-17. ">Rosen 1976</a> ; <a href="./references#MR000050-bbs2-0084" title="SzymanskiJ , O'DonohueW .The potential role of state-dependent learning in cognitive therapy with spider phobics. Journal of Rational-Emotive &amp; Cognitive-Behavior Therapy1995;13(2):131-50. SzymanskiJ .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 20th of August 2019. ">Szymanski 1995</a> ; <a href="./references#MR000050-bbs2-0095" title="WolitzkyKB , TelchMJ .Augmenting in vivo exposure with fear antagonistic actions: a preliminary test. Behavior Therapy2009;40(1):57-71. ">Wolitzky 2009</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Daily Sleep Questionnaire (DSQ)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#MR000050-bbs2-0005" title="AscherLM , TurnerR .Paradoxical intention and insomnia: an experimental investigation. Behaviour Research and Therapy1979;17(4):408-11. ">Ascher 1979</a> ; <a href="./references#MR000050-bbs2-0009" title="BorkovecTD , KaloupekDG , SlamaKM .The facilitative effect of muscle tension-release in the relaxation treatment of sleep disturbance. Behavior Therapy1975;6(3):301-9. ">Borkovec 1975</a> ; <a href="./references#MR000050-bbs2-0022" title="EspieCA , BrooksDN , LindsayWR .An evaluation of tailored psychological treatment of insomnia. Journal of Behavior Therapy and Experimental Psychiatry1989;20(2):143-53. EspieCA , LindsayWR , BrooksDN , HoodEM , TurveyT .A controlled comparative investigation of psychological treatments for chronic sleep-onset insomnia. Behaviour Research and Therapy1989;27(1):79-88. ">Espie 1989a</a> ; <a href="./references#MR000050-bbs2-0083" title="SteinmarkSW , BorkovecTD .Active and placebo treatment effects on moderate insomnia under counterdemand and positive demand instructions. Journal of Abnormal Psychology1974;83(2):157-63. ">Steinmark 1974</a> ; <a href="./references#MR000050-bbs2-0088" title="Trexler, L.Rational-emotive therapy, placebo, and no-treatment effects on public-speaking anxiety. Doctoral dissertation, Temple University AnnArbor, Mich.: University Microfilms1971;71-31(063). TrexlerLD , KarstTO .Rational-emotive therapy, placebo, and no-treatment effects on public-speaking anxiety. Journal of Abnormal Psyhology1972;79(1):60-7. ">Trexler 1972</a> ; <a href="./references#MR000050-bbs2-0090" title="VanderplateC .Electromyograph biofeedback Treatment of sleep onset Insomnia: a controlled Investigation. Dissertation, University of Southern Mississippi1978. ">Vanderplate 1983</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Beck Depression Inventory (BDI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#MR000050-bbs2-0006" title="AyenI , HautzingerM .Cognitive behavior therapy for depression in menopausal women. A controlled, randomized treatment study [Kognitive Verhaltenstherapie bei Depressionen im Klimakterium: Eine kontrollierte, randomiserte Interventionsstudie]. Zeitschrift für Klinische Psychologie und Psychotherapie2004;33(4):290-9. AyenI .Inclusion of study in Cochrane Systematic Review (personal communication). Email to EG Faltinsen 9th of September 2019. ">Ayen 2004</a> ; <a href="./references#MR000050-bbs2-0027" title="FuchsCZ , RehnLP .A self-control behavior therapy program for depression. Journal of Consulting and Clinical Psychology1977;45(2):206-15. ">Fuchs 1977</a> ; <a href="./references#MR000050-bbs2-0047" title="LegrandF .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 14th of August 2019. LegrandFD , NeffEM .Efficacy of exercise as an adjunct treatment for clinically depressed inpatients during the initial stages of antidepressant pharmacotherapy: an open randomized controlled trial. Journal of Affective Disorders2016;191:139-44. ">Legrand 2016</a> ; <a href="./references#MR000050-bbs2-0085" title="TanSY , BruniJ .Cognitive-behavior therapy with adult patients with epilepsy: a controlled outcome study. Epilepsia1986;27(3):225-33. ">Tan 1986</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Adverse events</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Serious adverse events</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>11</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#MR000050-bbs2-0021" title="EhlersA , HackmannA , GreyN , WildJ , LinessS , AlbertI , et al.A randomized controlled trial of 7-day intensive and standard weekly cognitive therapy for PTSD and emotion-focused supportive therapy. American Journal of Psychiatry2014;171(3):294-304. ">Ehlers 2014</a> ; <a href="./references#MR000050-bbs2-0025" title="FoaEB , McLeanCP , ZangY , RosenfieldD , YadinE , YarvisJS , et al.Effect of prolonged exposure therapy delivered over 2 weeks vs 8 weeks vs present-centered therapy on PTSD symptom severity in military personnel: a randomized clinical trial. JAMA2018;319(4):354-64. ">Foa 2018</a> ; <a href="./references#MR000050-bbs2-0026" title="FreireAO , SugaiGC , ChrispinFS , TogeiroSM , YamamuraY , MelloLE , et al.Treatment of moderate obstructive sleep apnea syndrome with acupuncture: a randomised, placebo-controlled pilot trial. Sleep Medicine2007;8(1):43-50. ">Freire 2007</a> ; <a href="./references#MR000050-bbs2-0034" title="KarstM , WinterhalterM , MünteS , FranckiB , HondronikosA , EckardtA , et al.Auricular acupuncture for dental anxiety: a randomized controlled trial. Anesthesia and Analgesia2007;104(2):295-300. KarstM .Inclusion of study in Cochrane Systematic Review (personal communication). Email to: EG Faltinsen 5th of September 2019. ">Karst 2007</a> ; <a href="./references#MR000050-bbs2-0041" title="KloskoJS , BarlowDH , TassinariR , CernyJA .A comparison of alprazolam and behavior therapy in treatment of panic disorder: correction. Journal of Psychotherapy Practice and Research1994;3(2):163-79. KloskoJS , BarlowDH , TassinariR , CernyJA .A comparison of alprazolam and behavior therapy in treatment of panic disorder. Journal of Consulting and Clinical Psychology1990;58(1):77-84. ">Klosko 1990</a> ; <a href="./references#MR000050-bbs2-0043" title="KwanR .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 26th of August 2019. KwanRY , LeungMC , LaiCK .Acupressure for agitation in nursing home residents with dementia: study protocol for a randomized controlled trial. Trials2014;15(410):1-7. KwanRY , LeungMCP , LaiCK .A randomized controlled trial examining the effect of acupressure on agitation and salivary cortisol in nursing home residents with dementia. Dementia and Geriatric Cognitive Disorders2017;44(1-2):92-104. ">Kwan 2017</a> ; <a href="./references#MR000050-bbs2-0044" title="LacyMK .The effect of short term autogenic training on the stress reactivity of hospitalized emotionally disturbed adolescents. ProQuest Dissertations Publishing, Oklahoma State University1996. ">Lacy 1990</a> ; <a href="./references#MR000050-bbs2-0047" title="LegrandF .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 14th of August 2019. LegrandFD , NeffEM .Efficacy of exercise as an adjunct treatment for clinically depressed inpatients during the initial stages of antidepressant pharmacotherapy: an open randomized controlled trial. Journal of Affective Disorders2016;191:139-44. ">Legrand 2016</a> ; <a href="./references#MR000050-bbs2-0052" title="McLachlanDR , DaltonAJ , KruckTP , BellMY , SmithWL , KalowW , et al.Intramuscular desferrioxamine in patients with Alzheimer's disease. Lancet1991;337(8753):1304-8. McLachlanDRC , SmithWL , KruckTP .Desferrioxamine and Alzheimer’s disease: video home behavior assessment of clinical course and measures of brain aluminum. Therapeutic Drug Monitoring1993;15(6):602-7. ">McLachlan 1991</a> ; <a href="./references#MR000050-bbs2-0057" title="NandiDN , AjmanyS , GanguliH , BanerjeeG , BoralGC , GhoshA , et al.A clinical evaluation of depressives found in a rural survey in India. British Journal of Psychiatry1976;128:523-7. ">Nandi 1976</a> ; <a href="./references#MR000050-bbs2-0094" title="WilsonA , DavidsonWJ , BlanchardR , WhiteJ .Disulfiram implantation. A placebo-controlled trial with two-year follow-up. Journal of Studies on Alcohol1978;39(5):809-19. WilsonA , DavidsonWJ , BlanchardR .Disulfiram implantation: a trial using placebo implants and two types of controls. Journal of Studies on Alcohol1980;41(5):429-36. ">Wilson 1980</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Non‐serious adverse events</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>14</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#MR000050-bbs2-0006" title="AyenI , HautzingerM .Cognitive behavior therapy for depression in menopausal women. A controlled, randomized treatment study [Kognitive Verhaltenstherapie bei Depressionen im Klimakterium: Eine kontrollierte, randomiserte Interventionsstudie]. Zeitschrift für Klinische Psychologie und Psychotherapie2004;33(4):290-9. AyenI .Inclusion of study in Cochrane Systematic Review (personal communication). Email to EG Faltinsen 9th of September 2019. ">Ayen 2004</a> ; <a href="./references#MR000050-bbs2-0021" title="EhlersA , HackmannA , GreyN , WildJ , LinessS , AlbertI , et al.A randomized controlled trial of 7-day intensive and standard weekly cognitive therapy for PTSD and emotion-focused supportive therapy. American Journal of Psychiatry2014;171(3):294-304. ">Ehlers 2014</a> ; <a href="./references#MR000050-bbs2-0025" title="FoaEB , McLeanCP , ZangY , RosenfieldD , YadinE , YarvisJS , et al.Effect of prolonged exposure therapy delivered over 2 weeks vs 8 weeks vs present-centered therapy on PTSD symptom severity in military personnel: a randomized clinical trial. JAMA2018;319(4):354-64. ">Foa 2018</a> ; <a href="./references#MR000050-bbs2-0026" title="FreireAO , SugaiGC , ChrispinFS , TogeiroSM , YamamuraY , MelloLE , et al.Treatment of moderate obstructive sleep apnea syndrome with acupuncture: a randomised, placebo-controlled pilot trial. Sleep Medicine2007;8(1):43-50. ">Freire 2007</a> ; <a href="./references#MR000050-bbs2-0029" title="GoldsteinAJ , BeursE , Chambless Dl, WilsonKA .EMDR for panic disorder with agoraphobia: comparison with waiting list and credible attention-placebo control conditions. Journal of Consulting and Clinical Psychology2000;68(6):947-56. ">Goldstein 2000</a> ; <a href="./references#MR000050-bbs2-0034" title="KarstM , WinterhalterM , MünteS , FranckiB , HondronikosA , EckardtA , et al.Auricular acupuncture for dental anxiety: a randomized controlled trial. Anesthesia and Analgesia2007;104(2):295-300. KarstM .Inclusion of study in Cochrane Systematic Review (personal communication). Email to: EG Faltinsen 5th of September 2019. ">Karst 2007</a> ; <a href="./references#MR000050-bbs2-0041" title="KloskoJS , BarlowDH , TassinariR , CernyJA .A comparison of alprazolam and behavior therapy in treatment of panic disorder: correction. Journal of Psychotherapy Practice and Research1994;3(2):163-79. KloskoJS , BarlowDH , TassinariR , CernyJA .A comparison of alprazolam and behavior therapy in treatment of panic disorder. Journal of Consulting and Clinical Psychology1990;58(1):77-84. ">Klosko 1990</a> ; <a href="./references#MR000050-bbs2-0043" title="KwanR .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 26th of August 2019. KwanRY , LeungMC , LaiCK .Acupressure for agitation in nursing home residents with dementia: study protocol for a randomized controlled trial. Trials2014;15(410):1-7. KwanRY , LeungMCP , LaiCK .A randomized controlled trial examining the effect of acupressure on agitation and salivary cortisol in nursing home residents with dementia. Dementia and Geriatric Cognitive Disorders2017;44(1-2):92-104. ">Kwan 2017</a> ; <a href="./references#MR000050-bbs2-0044" title="LacyMK .The effect of short term autogenic training on the stress reactivity of hospitalized emotionally disturbed adolescents. ProQuest Dissertations Publishing, Oklahoma State University1996. ">Lacy 1990</a> ; <a href="./references#MR000050-bbs2-0047" title="LegrandF .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 14th of August 2019. LegrandFD , NeffEM .Efficacy of exercise as an adjunct treatment for clinically depressed inpatients during the initial stages of antidepressant pharmacotherapy: an open randomized controlled trial. Journal of Affective Disorders2016;191:139-44. ">Legrand 2016</a> ; <a href="./references#MR000050-bbs2-0052" title="McLachlanDR , DaltonAJ , KruckTP , BellMY , SmithWL , KalowW , et al.Intramuscular desferrioxamine in patients with Alzheimer's disease. Lancet1991;337(8753):1304-8. McLachlanDRC , SmithWL , KruckTP .Desferrioxamine and Alzheimer’s disease: video home behavior assessment of clinical course and measures of brain aluminum. Therapeutic Drug Monitoring1993;15(6):602-7. ">McLachlan 1991</a> ; <a href="./references#MR000050-bbs2-0057" title="NandiDN , AjmanyS , GanguliH , BanerjeeG , BoralGC , GhoshA , et al.A clinical evaluation of depressives found in a rural survey in India. British Journal of Psychiatry1976;128:523-7. ">Nandi 1976</a> ; <a href="./references#MR000050-bbs2-0094" title="WilsonA , DavidsonWJ , BlanchardR , WhiteJ .Disulfiram implantation. A placebo-controlled trial with two-year follow-up. Journal of Studies on Alcohol1978;39(5):809-19. WilsonA , DavidsonWJ , BlanchardR .Disulfiram implantation: a trial using placebo implants and two types of controls. Journal of Studies on Alcohol1980;41(5):429-36. ">Wilson 1980</a> ; <a href="./references#MR000050-bbs2-0096" title="WollersheimJP , WilsonGL .Group treatment of unipolar depression: a comparison of coping, supportive, bibliotherapy, and delayed treatment groups. Professional Psychology: Research and Practice1991;22(6):496-502. ">Wollersheim 1991</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Type of adverse events</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Complaint list</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#MR000050-bbs2-0006" title="AyenI , HautzingerM .Cognitive behavior therapy for depression in menopausal women. A controlled, randomized treatment study [Kognitive Verhaltenstherapie bei Depressionen im Klimakterium: Eine kontrollierte, randomiserte Interventionsstudie]. Zeitschrift für Klinische Psychologie und Psychotherapie2004;33(4):290-9. AyenI .Inclusion of study in Cochrane Systematic Review (personal communication). Email to EG Faltinsen 9th of September 2019. ">Ayen 2004</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Clinician‐administered posttraumatic stress disorder (PTSD) Scale for DSM‐5 (CAPS‐5)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#MR000050-bbs2-0021" title="EhlersA , HackmannA , GreyN , WildJ , LinessS , AlbertI , et al.A randomized controlled trial of 7-day intensive and standard weekly cognitive therapy for PTSD and emotion-focused supportive therapy. American Journal of Psychiatry2014;171(3):294-304. ">Ehlers 2014</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Disulfiram‐ethanol reaction (DER)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#MR000050-bbs2-0094" title="WilsonA , DavidsonWJ , BlanchardR , WhiteJ .Disulfiram implantation. A placebo-controlled trial with two-year follow-up. Journal of Studies on Alcohol1978;39(5):809-19. WilsonA , DavidsonWJ , BlanchardR .Disulfiram implantation: a trial using placebo implants and two types of controls. Journal of Studies on Alcohol1980;41(5):429-36. ">Wilson 1980</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Spontaneous reporting</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>11</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#MR000050-bbs2-0025" title="FoaEB , McLeanCP , ZangY , RosenfieldD , YadinE , YarvisJS , et al.Effect of prolonged exposure therapy delivered over 2 weeks vs 8 weeks vs present-centered therapy on PTSD symptom severity in military personnel: a randomized clinical trial. JAMA2018;319(4):354-64. ">Foa 2018</a> ; <a href="./references#MR000050-bbs2-0026" title="FreireAO , SugaiGC , ChrispinFS , TogeiroSM , YamamuraY , MelloLE , et al.Treatment of moderate obstructive sleep apnea syndrome with acupuncture: a randomised, placebo-controlled pilot trial. Sleep Medicine2007;8(1):43-50. ">Freire 2007</a> ; <a href="./references#MR000050-bbs2-0029" title="GoldsteinAJ , BeursE , Chambless Dl, WilsonKA .EMDR for panic disorder with agoraphobia: comparison with waiting list and credible attention-placebo control conditions. Journal of Consulting and Clinical Psychology2000;68(6):947-56. ">Goldstein 2000</a> ; <a href="./references#MR000050-bbs2-0034" title="KarstM , WinterhalterM , MünteS , FranckiB , HondronikosA , EckardtA , et al.Auricular acupuncture for dental anxiety: a randomized controlled trial. Anesthesia and Analgesia2007;104(2):295-300. KarstM .Inclusion of study in Cochrane Systematic Review (personal communication). Email to: EG Faltinsen 5th of September 2019. ">Karst 2007</a> ; <a href="./references#MR000050-bbs2-0041" title="KloskoJS , BarlowDH , TassinariR , CernyJA .A comparison of alprazolam and behavior therapy in treatment of panic disorder: correction. Journal of Psychotherapy Practice and Research1994;3(2):163-79. KloskoJS , BarlowDH , TassinariR , CernyJA .A comparison of alprazolam and behavior therapy in treatment of panic disorder. Journal of Consulting and Clinical Psychology1990;58(1):77-84. ">Klosko 1990</a> ; <a href="./references#MR000050-bbs2-0043" title="KwanR .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 26th of August 2019. KwanRY , LeungMC , LaiCK .Acupressure for agitation in nursing home residents with dementia: study protocol for a randomized controlled trial. Trials2014;15(410):1-7. KwanRY , LeungMCP , LaiCK .A randomized controlled trial examining the effect of acupressure on agitation and salivary cortisol in nursing home residents with dementia. Dementia and Geriatric Cognitive Disorders2017;44(1-2):92-104. ">Kwan 2017</a> ; <a href="./references#MR000050-bbs2-0044" title="LacyMK .The effect of short term autogenic training on the stress reactivity of hospitalized emotionally disturbed adolescents. ProQuest Dissertations Publishing, Oklahoma State University1996. ">Lacy 1990</a> ; <a href="./references#MR000050-bbs2-0047" title="LegrandF .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 14th of August 2019. LegrandFD , NeffEM .Efficacy of exercise as an adjunct treatment for clinically depressed inpatients during the initial stages of antidepressant pharmacotherapy: an open randomized controlled trial. Journal of Affective Disorders2016;191:139-44. ">Legrand 2016</a> ; <a href="./references#MR000050-bbs2-0052" title="McLachlanDR , DaltonAJ , KruckTP , BellMY , SmithWL , KalowW , et al.Intramuscular desferrioxamine in patients with Alzheimer's disease. Lancet1991;337(8753):1304-8. McLachlanDRC , SmithWL , KruckTP .Desferrioxamine and Alzheimer’s disease: video home behavior assessment of clinical course and measures of brain aluminum. Therapeutic Drug Monitoring1993;15(6):602-7. ">McLachlan 1991</a> ; <a href="./references#MR000050-bbs2-0057" title="NandiDN , AjmanyS , GanguliH , BanerjeeG , BoralGC , GhoshA , et al.A clinical evaluation of depressives found in a rural survey in India. British Journal of Psychiatry1976;128:523-7. ">Nandi 1976</a> ; <a href="./references#MR000050-bbs2-0096" title="WollersheimJP , WilsonGL .Group treatment of unipolar depression: a comparison of coping, supportive, bibliotherapy, and delayed treatment groups. Professional Psychology: Research and Practice1991;22(6):496-502. ">Wollersheim 1991</a> </p> </td> </tr> </tbody> </table> </div> </section> </section> <section id="MR000050-sec-0050"> <h4 class="title">Included studies</h4> <p>Here we summarise the key characteristics of the 96 included trials. Further detail can also be found in <a href="./references#MR000050-sec-0149" title="">Characteristics of included studies</a>. </p> <section id="MR000050-sec-0051"> <h5 class="title">Design</h5> <p>We included 96 trials (94 parallel‐group trials, one cluster‐randomised trial, and one cross‐over trial). The only cross‐over trial did not provide any usable data (<a href="./references#MR000050-bbs2-0081" title="SibilioJP , AndrewG , DartD , MooreKB , StehmanA .Treatment of chronic schizophrenia with promazine hydrochloride. AMA Archives of Neurology and Psychiatry1957;78(4):419-24. ">Sibilio 1957</a>). Only one trial compared wait‐list with no‐treatment (<a href="./references#MR000050-bbs2-0033" title="HowlinP , GordonKR , PascoG , WadeA , CharmanT .The effectiveness of picture exchange communication system (PECS) training for teachers of children with autism: a pragmatic,group randomised controlled trial. Journal of Child Psychology and Psychiatry2007;48(5):473-81. ">Howlin 2007</a>). This was the only cluster‐randomised trial identified. Nine trials compared usual care versus either wait‐list or no‐treatment (<a href="./references#MR000050-bbs2-0014" title="BrillNQ , KoeglerRR , EpsteinLJ , ForgyEW .Controlled study of psychiatric outpatient treatment. Archives of General Psychiatry1964;10:581-95. ">Brill 1964b</a>; <a href="./references#MR000050-bbs2-0017" title="CrispAH , NortonK , GowersS , HalekC , BowyerC , YeldhamD , et al.A controlled study of the effect of therapies aimed at adolescent and family psychopathology in Anorexia Nervosa. British Journal of Psychiatry: the Journal of Mental Science1991;159:325-33. GowersS , NortonK , HalekC , CrispAH .Outcome of outpatient psychotherapy in a random allocation treatment study of anorexia nervosa. International Journal of Eating Disorders1994;15(2):165-77. GowersS , NortonK , YelshamD .The St George's prospective treatment study of anorexia nervosa: a discussion of methodological problems. International Journal of Eating Disorders1989;8:445-54. ">Crisp 1991</a>; <a href="./references#MR000050-bbs2-0028" title="GlogowskaM , RoulstoneS , EnderbyP , PetersTJ .Randomised controlled trial of community based speech and language therapy in preschool children. BMJ2000;321(7266):923-6. ">Glogowska 2000</a>; <a href="./references#MR000050-bbs2-0051" title="MatsonJL , MarchettiA , AdkinsJA .Comparison of operant- and independence-training procedures for mentally retarded adults. American Journal of Mental Deficiency1980;84(5):487-94. ">Matson 1980</a>; <a href="./references#MR000050-bbs2-0054" title="MilbyJB , ClarkeC , ToroC , ThorntonS , RickertD .Effectiveness of urine surveillance as an adjunct to outpatient psychotherapy for drug abusers. International Journal of the Addictions1980;15(7):993-1001. ">Milby 1980</a>; <a href="./references#MR000050-bbs2-0071" title="RapeeR .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 29th of August 2019. RapeeRM , AbbottMJ , LynehamHJ .Bibliotherapy for children With anxiety disorders using written materials for parents: a randomized controlled trial. Journal of Consulting and Clinical Psychology2006;74(3):436-44. ">Rapee 2006</a>; <a href="./references#MR000050-bbs2-0072" title="RapeeR .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 29th of August 2019. RapeeRM , AbbottMJ , BaillieAJ , GastonJE .Treatment of social phobia through pure self-help and therapist-augmented self-help. British Journal of Psychiatry2007;191:246-52. ">Rapee 2007</a>; <a href="./references#MR000050-bbs2-0073" title="RobinA .Rationing out-patients: a defence of the waiting list. British Journal of Psychiatry1976;129:138-41. ">Robin 1976</a>; <a href="./references#MR000050-bbs2-0086" title="TeriL , LogsdonRG , UomotoJ , McCurrySM .Behavioral treatment of depression in dementia patients: a controlled clinical trial. Journals of Gerontology. Series B, Psychological Sciences and Social Sciences1997;52(4):159-66. TeriL .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 26th of August 2019. ">Teri 1997</a>). We included 45 trials on psychological placebos, 23 trials on pharmacological placebos and 17 trials on physical placebos. </p> <p>One parallel‐group trial compared a pooled group of psychological and pharmacological placebo with no‐treatment (<a href="./references#MR000050-bbs2-0060" title="PeckCL .Desensitization for the treatment of fear in the high level adult retardate. Behaviour Research and Therapy1977;15(2):137-48. ">Peck 1976</a>). One trial included three control groups (wait‐list, usual care and pharmacological placebo) and was split into two trials ( <a href="./references#MR000050-bbs2-0013" title="BrillNQ , KoeglerRR , EpsteinLJ , ForgyEW .Controlled study of psychiatric outpatient treatment. Archives of General Psychiatry1964;10:581-95. BrillNQ .Results of psychotherapy. California Medicine1966;104(4):249-53. ">Brill 1964a</a>; <a href="./references#MR000050-bbs2-0014" title="BrillNQ , KoeglerRR , EpsteinLJ , ForgyEW .Controlled study of psychiatric outpatient treatment. Archives of General Psychiatry1964;10:581-95. ">Brill 1964b</a>). </p> </section> <section id="MR000050-sec-0052"> <h5 class="title">Settings</h5> <p>Seventy‐four trials were conducted in outpatient settings and 20 trials were conducted in inpatient settings. Two trials were conducted combining inpatient and outpatient settings (<a href="#MR000050-tbl-0006">Table 3</a>). </p> </section> <section id="MR000050-sec-0053"> <h5 class="title">Sample sizes</h5> <p>There was considerable variation in sample sizes between the trials. The total number of participants ranged from eight participants ( <a href="./references#MR000050-bbs2-0037" title="KilmannPR , MilanRJ , BolandJP , NankinHR , DavidsonE , WestMO , et al.Group treatment of secondary erectile dysfunction. Journal of Sex &amp; Marital Therapy1987;13(3):168-82. KilmannPR , Milan RJ Jr, BolandJP , DavidsonE , WestMO , SablisRF , et al.The sexual interactions of men with secondary erectile dysfunction. Journal of Sex Education and Therapy1988;14(1):46-9. KilmannPR , Milan RJ Jr, BolandJP , NankinHR , SablisRF , WestMO , et al.The sexual interactions of men with secondary erectile dysfunction. Paper presented at the annual meeting of the American Psychological Association in Los Angeles1985;1:46-9. ">Kilmann 1987</a>; <a href="./references#MR000050-bbs2-0060" title="PeckCL .Desensitization for the treatment of fear in the high level adult retardate. Behaviour Research and Therapy1977;15(2):137-48. ">Peck 1976</a>) to 393 participants (<a href="./references#MR000050-bbs2-0068" title="ProudfootJ , ClarkeJ , BirchMR , WhittonAE , ParkerG , ManicavasagarV , et al.Impact of a mobile phone and web program on symptom and functional outcomes for people with mild- to-moderate depression, anxiety and stress: a randomized controlled trial. BMC Psychiatry2013;13(312):1-12. ProudfootJ .Re: Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 26th of August 2019. ">Proudfoot 2013</a>). Only five trials included more than 100 participants (<a href="#MR000050-tbl-0006">Table 3</a>). </p> </section> <section id="MR000050-sec-0054"> <h5 class="title">Participants</h5> <p>The 96 trials included a total of 4200 participants but 586 participants could not be included due to missing data. The mean age ranged from 2.9 years (<a href="./references#MR000050-bbs2-0028" title="GlogowskaM , RoulstoneS , EnderbyP , PetersTJ .Randomised controlled trial of community based speech and language therapy in preschool children. BMJ2000;321(7266):923-6. ">Glogowska 2000</a>) to 86.5 years (<a href="./references#MR000050-bbs2-0043" title="KwanR .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 26th of August 2019. KwanRY , LeungMC , LaiCK .Acupressure for agitation in nursing home residents with dementia: study protocol for a randomized controlled trial. Trials2014;15(410):1-7. KwanRY , LeungMCP , LaiCK .A randomized controlled trial examining the effect of acupressure on agitation and salivary cortisol in nursing home residents with dementia. Dementia and Geriatric Cognitive Disorders2017;44(1-2):92-104. ">Kwan 2017</a>). Nineteen trials only included females, and 14 trials only included males. Seven trials did not state the sex of the participants (<a href="#MR000050-tbl-0006">Table 3</a>). All remaining trials included both sexes. </p> <section id="MR000050-sec-0055"> <h6 class="title">Diagnostic criteria</h6> <p>Participants were diagnosed as having a formal mental health disorder according to DSM‐II (two trials), DSM‐III (four trials), DSM‐III‐R (eight trials), DSM‐IV (15 trials), DSM‐IV‐TR (three trials) and ICD 9th edition (one trial) (<a href="#MR000050-tbl-0006">Table 3</a>). The most commonly used assessment instrument was Structured Clinical Interview for DSM (SCID; <a href="./references#MR000050-bbs2-0273" title="SpitzerRL , WilliamJBW , GibbonM , FirstMB .Structured Clinical Interview for DSM-III-R Personality Disorders (SCID-II). 1989: Biometrics Research Department, New York State Psychiatric Institute, 1989.">Spitzer 1989</a>), which was used by eight trials. Twenty‐four trials fulfilled the symptoms of a mental health disorder from the available diagnostic classifications system at the time of the trial, but did not report a classification system. Thirty‐five trials reported a population classified as having a mental health disorder, but full diagnostic criteria were not reported (for more information see <a href="#MR000050-tbl-0006">Table 3</a>). </p> </section> <section id="MR000050-sec-0056"> <h6 class="title">Diagnoses</h6> <p>The 96 trials included participants with the following 15 diagnoses: different forms of anxiety disorders (such as specific anxiety, social anxiety, or panic disorder, 25 trials); depression (16 trials); sleep‐wake disorders (11 trials); substance use disorders of different kind such as cocaine and alcohol dependency (eight trials); other unspecified disorders mentioned as 'psychiatric patients' only (eight trials); neurodegenerative diseases (six trials); schizophrenia (five trials); attention deficit hyperactivity disorder (ADHD) or attention deficit disorder (ADD) (five trials); post traumatic stress disorder (PTSD) (four trials); learning disability (three trials); intellectual disability (two trials); and one trial each for anorexia, autism, bulimia, encopresis, and erectile dysfunction (<a href="#MR000050-tbl-0006">Table 3</a>). </p> </section> </section> <section id="MR000050-sec-0057"> <h5 class="title">Experimental interventions</h5> <p>In the original trials, the placebo groups were all control interventions. We turned these control interventions into our experimental interventions in this systematic review. </p> <section id="MR000050-sec-0058"> <h6 class="title">Types of interventions</h6> <p>Only one trial (cluster‐randomised) compared a wait‐list intervention versus a no‐treatment intervention. </p> <p>Three trials included usual care as a standard treatment, three trials included it as a form of outpatient psychotherapy, one trial as community‐based therapy, one trial as typical care control, and one trial did not specify its format (<a href="./references#MR000050-bbs2-0073" title="RobinA .Rationing out-patients: a defence of the waiting list. British Journal of Psychiatry1976;129:138-41. ">Robin 1976</a>). </p> <p>The 44 trials with psychological placebo included seven different labels for the psychological placebos. Thirteen trials used the term attention placebo control, 11 trials used non‐specific placebo counselling or treatment; seven trials used a quasi‐desensitisation placebo; four trials used a non‐specific educational placebo; two trials used a form of active treatment such as present‐centred therapy (<a href="./references#MR000050-bbs2-0025" title="FoaEB , McLeanCP , ZangY , RosenfieldD , YadinE , YarvisJS , et al.Effect of prolonged exposure therapy delivered over 2 weeks vs 8 weeks vs present-centered therapy on PTSD symptom severity in military personnel: a randomized clinical trial. JAMA2018;319(4):354-64. ">Foa 2018</a>), or emotion‐focused supportive therapy (<a href="./references#MR000050-bbs2-0021" title="EhlersA , HackmannA , GreyN , WildJ , LinessS , AlbertI , et al.A randomized controlled trial of 7-day intensive and standard weekly cognitive therapy for PTSD and emotion-focused supportive therapy. American Journal of Psychiatry2014;171(3):294-304. ">Ehlers 2014</a>). The other trials used different variations of placebo definitions, such as credible placebo or imagery relief placebo (<a href="#MR000050-tbl-0006">Table 3</a>). </p> <p>Twenty trials used a psychological placebo with an interactive component; 16 trials included a psychological placebo with an exposure component; nine trials had a psychoeducational character (<a href="#MR000050-tbl-0006">Table 3</a>); and one trial combined psychological and pharmacological placebo (<a href="./references#MR000050-bbs2-0060" title="PeckCL .Desensitization for the treatment of fear in the high level adult retardate. Behaviour Research and Therapy1977;15(2):137-48. ">Peck 1976</a> ). </p> <p>Sixteen trials provided pharmacological placebos in pill form, one trial used implants, and one trial used injection (<a href="#MR000050-tbl-0006">Table 3</a>). </p> <p>Four trials used a pharmacological placebo with psychological treatment as an add‐on treatment. Six trials provided a physical placebo as a technical device, five trials as either acupuncture or acupressure, three trials as exercise and relaxation, and two trials as electromagnetic stimulation (<a href="#MR000050-tbl-0006">Table 3</a>). </p> </section> <section id="MR000050-sec-0059"> <h6 class="title">Format of interventions</h6> <p>Twenty‐five trials administered psychological placebos individually, whereas 18 trials administered them in groups. Three trials used a combination of individual and group administration of psychological placebos (<a href="#MR000050-tbl-0006">Table 3</a>). All pharmacological and physical treatments were provided on an individual basis, except for one trial that combined a pharmacological treatment with group psychological treatment (<a href="./references#MR000050-bbs2-0018" title="CrouchG , RobsonM , HallstromC .Benzodiazepine dependent patients and their psychological treatment. Progress in Neuro-psychopharmacology &amp; Biological Psychiatry1988;12(4):503-10. HallströmC , CrouchG , RobsenM , ShineP .The treatment of tranquillizer dependence by propranolol. Postgraduate Medical Journal1988;64(Suppl 2):40-4. ">Crouch 1988</a>). </p> </section> <section id="MR000050-sec-0060"> <h6 class="title">Duration of interventions</h6> <p>Seventy‐four trials had a duration of less than three months, while 21 had a duration of three months or more (<a href="#MR000050-tbl-0006">Table 3</a>). One trial did report the duration of the interventions (<a href="./references#MR000050-bbs2-0032" title="HippmanC , RingroseA , InglisA , CheekJ , AlbertAY , RemickR , et al.A pilot randomized clinical trial evaluating the impact of genetic counselling for serious mental illnesses. Journal of Clinical Psychiatry2016;77(2):e190-8. ">Hippman 2016</a>). Where reported, the duration of treatment ranged from a single session (<a href="./references#MR000050-bbs2-0023" title="EtringerBD , CashTF , RimmDC .Behavioral, affective, and cognitive effects of participant modeling and an equally credible placebo. Behavior Therapy1982;13(4):476-85. ">Etringer 1982</a>; <a href="./references#MR000050-bbs2-0034" title="KarstM , WinterhalterM , MünteS , FranckiB , HondronikosA , EckardtA , et al.Auricular acupuncture for dental anxiety: a randomized controlled trial. Anesthesia and Analgesia2007;104(2):295-300. KarstM .Inclusion of study in Cochrane Systematic Review (personal communication). Email to: EG Faltinsen 5th of September 2019. ">Karst 2007</a>; <a href="./references#MR000050-bbs2-0065" title="PowersMB , SmitsJA , TelchMJ .Disentangling the effects of safety-behavior utilization and safety-behavior availability during exposure-based treatment: a placebo-controlled trial. Journal of Consulting and Clinical Psychology2004;72(3):448-54. ">Powers 2004</a>; <a href="./references#MR000050-bbs2-0066" title="PowersMB , SmithsJA , WhitleyD , BystritskyA , TelchMJ .The effect of attributional processes concerning medication taking on return of fear. Journal of Consulting and Clinical Psychology2008;76(3):478-90. ">Powers 2008a</a>; <a href="./references#MR000050-bbs2-0067" title="PowersMB , SmithsJA , WhitleyD , BystritskyA , TelchMJ .The effect of attributional processes concerning medication taking on return of fear. Journal of Consulting and Clinical Psychology2008;76(3):478-90. ">Powers 2008b</a>; <a href="./references#MR000050-bbs2-0094" title="WilsonA , DavidsonWJ , BlanchardR , WhiteJ .Disulfiram implantation. A placebo-controlled trial with two-year follow-up. Journal of Studies on Alcohol1978;39(5):809-19. WilsonA , DavidsonWJ , BlanchardR .Disulfiram implantation: a trial using placebo implants and two types of controls. Journal of Studies on Alcohol1980;41(5):429-36. ">Wilson 1980</a>; <a href="./references#MR000050-bbs2-0095" title="WolitzkyKB , TelchMJ .Augmenting in vivo exposure with fear antagonistic actions: a preliminary test. Behavior Therapy2009;40(1):57-71. ">Wolitzky 2009</a>) to two years of treatment (<a href="./references#MR000050-bbs2-0052" title="McLachlanDR , DaltonAJ , KruckTP , BellMY , SmithWL , KalowW , et al.Intramuscular desferrioxamine in patients with Alzheimer's disease. Lancet1991;337(8753):1304-8. McLachlanDRC , SmithWL , KruckTP .Desferrioxamine and Alzheimer’s disease: video home behavior assessment of clinical course and measures of brain aluminum. Therapeutic Drug Monitoring1993;15(6):602-7. ">McLachlan 1991</a>). </p> </section> </section> <section id="MR000050-sec-0061"> <h5 class="title">Control comparators</h5> <p>Fifty‐six trials included a no‐treatment control and 39 trials used a wait‐list control intervention. Ten trials labelled their comparator as a wait‐list intervention, but their description and definition of it led us to classify it as a no‐treatment control intervention. Four trials labelled their comparator as no‐treatment, but their description and definition led us to classify it as a wait‐list control intervention, and four trials received an add‐on psychotherapeutic treatment to the wait‐list group. One trial labelled their wait‐list as a 'minimal contact group', three trials labelled their wait‐list as a 'delayed treatment group', and one trial received an add‐on drug treatment (<a href="#MR000050-tbl-0006">Table 3</a>). </p> <section id="MR000050-sec-0062"> <h6 class="title">Concomitant treatment</h6> <p>Twenty trials did not allow concomitant psychotherapy to the placebo, treatment as usual, no‐intervention, or wait‐list groups, and 18 trials allowed the participant to receive a concomitant psychotherapy to the placebo, treatment as usual, no‐intervention, or wait‐list groups, (<a href="#MR000050-tbl-0006">Table 3</a>). The remaining trials did not report any information about concomitant treatments. </p> <p>Twenty‐nine trials allowed the participants to receive a concomitant pharmacotherapy to the placebo, treatment as usual, no‐intervention or wait‐list groups, while 19 trials did not allow any sort of concomitant pharmacotherapy (<a href="#MR000050-tbl-0006">Table 3</a>). The other trials did not report any information about concomitant treatments. </p> </section> </section> <section id="MR000050-sec-0063"> <h5 class="title">Outcomes</h5> <section id="MR000050-sec-0064"> <h6 class="title">Benefits</h6> <p>We followed our hierarchy for selecting outcomes measuring potential benefits (see <a href="#MR000050-sec-0021">Types of outcome measures</a>). For more information for the individual trials, see <a href="./references#MR000050-sec-0149" title="">Characteristics of included studies</a> . We included 59 different outcomes for the placebo analyses (see <a href="./references#MR000050-sec-0149" title="">Characteristics of included studies</a>). The most common outcomes were Behavioral Avoidance Test (BAT) in eight trials, Daily Sleep Questionnaire (DSQ) in six trials, and Beck Depression Inventory (BDI) in four trials (<a href="#MR000050-tbl-0006">Table 3</a>). All outcomes included in the usual care analysis were different. The outcome in the cluster‐randomised trial of wait‐list versus no‐treatment included an outcome that was not used in any of the other analyses. </p> </section> <section id="MR000050-sec-0065"> <h6 class="title">Adverse events</h6> <p>Only 11 trials reported serious adverse events, and only 14 trials reported non‐serious adverse events (<a href="#MR000050-tbl-0006">Table 3</a>). This was reported in the following ways: one trial used a complaint list ( <a href="./references#MR000050-bbs2-0006" title="AyenI , HautzingerM .Cognitive behavior therapy for depression in menopausal women. A controlled, randomized treatment study [Kognitive Verhaltenstherapie bei Depressionen im Klimakterium: Eine kontrollierte, randomiserte Interventionsstudie]. Zeitschrift für Klinische Psychologie und Psychotherapie2004;33(4):290-9. AyenI .Inclusion of study in Cochrane Systematic Review (personal communication). Email to EG Faltinsen 9th of September 2019. ">Ayen 2004</a> ), another trial used an assessment with clinician‐administered posttraumatic stress disorder (PTSD) Scale for DSM‐5 (CAPS‐5), a third trial used a disulfiram‐ethanol reaction (DER), and the remaining 11 trials reported adverse events as a spontaneous reporting. </p> </section> </section> </section> <section id="MR000050-sec-0066"> <h4 class="title">Excluded studies</h4> <p>In total, we excluded 1121 full‐text reports. Of the excluded full‐text reports, 159 were not a randomised trial, 840 did not compare a placebo or usual care control intervention versus either wait‐list or no‐treatment intervention. One hundred and three studies were excluded because the participants did not belong to a psychiatric population. Lastly, nine duplicates were identified in the full‐text screening and excluded (<a href="#MR000050-fig-0001">Figure 1</a>). Thirty‐three excluded studies were close enough to the inclusion criteria to be listed in <a href="./references#MR000050-sec-0150" title="">Characteristics of excluded studies</a>. </p> <p><b>Studies awaiting classification</b> </p> <p>Six full reports are awaiting classification due to difficulties in retrieving them (<a href="./references#MR000050-bbs1-0003" title="">Studies awaiting classification</a>). We were not able to locate the full text for these trials. Three were reported as an abstract (<a href="./references#MR000050-bbs2-0130" title="">Bommert 1978</a>; <a href="./references#MR000050-bbs2-0132" title="">McLachlan 1993</a>; <a href="./references#MR000050-bbs2-0135" title="">Trianes Torres 1991</a>), and three were only reported as a title ( <a href="./references#MR000050-bbs2-0131" title="">Brandes 2010</a>; <a href="./references#MR000050-bbs2-0133" title="">Newton‐Cross 2017</a>; <a href="./references#MR000050-bbs2-0134" title="">Schwarzler 1999</a>). We tried to contact the authors of the most recent studies (<a href="./references#MR000050-bbs2-0131" title="">Brandes 2010</a> ; <a href="./references#MR000050-bbs2-0133" title="">Newton‐Cross 2017</a>), but did not receive any response. After two attempts, we terminated our correspondence. </p> <p><b>Ongoing studies</b> </p> <p>We identified four ongoing studies that assessed different type of placebos or usual care versus wait‐list or no‐treatment (<a href="./references#MR000050-bbs2-0136" title="Internet-based attentional bias modification training as add-on to regular treatment in alcohol and cannabis dependent outpatients: a study protocol of a randomised control trial. Ongoing study. 18/05/2015. Contact author for more information.">Heitman 2017</a>; <a href="./references#MR000050-bbs2-0137" title="Standardised stress management mental health training: does it have a beneficial effect?. Ongoing study. 06/09/2010. Contact author for more information.">ISRCTN21392756</a>; <a href="./references#MR000050-bbs2-0138" title="Cognitive training with non-invasive brain stimulation to treat binge eating disorder. Ongoing study. 03/05/2018. Contact author for more information.">ISRCTN35717198</a>; <a href="./references#MR000050-bbs2-0139" title="Combined behavioral/pharmacologicaltTherapy for insomnia. Ongoing study. 05/09/2002. Contact author for more information.">NCT00044629</a>) (<a href="./references#MR000050-sec-0152" title="">Characteristics of ongoing studies</a>). </p> </section> </section> <section id="MR000050-sec-0067"> <h3 class="title">Risk of bias in included studies</h3> <p><a href="#MR000050-fig-0002">Figure 2</a> and <a href="#MR000050-fig-0003">Figure 3</a> show our assessment of the risk of bias for each included study (see also <a href="./references#MR000050-sec-0149" title="">Characteristics of included studies</a>). </p> <div class="figure" id="MR000050-fig-0002"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 2</div> </div> <hr class="top"/><img alt="Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies." data-id="MR000050-fig-0002" src="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/image_n/nMR000050-FIG-02.svg"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies. </p> </div> </div> </div> <div class="figure" id="MR000050-fig-0003"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 3</div> </div> <hr class="top"/><img alt="Risk of bias summary: review authors' judgements about each risk of bias item for each included study." data-id="MR000050-fig-0003" src="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/image_n/nMR000050-FIG-03.svg"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Risk of bias summary: review authors' judgements about each risk of bias item for each included study. </p> </div> </div> </div> <p>We judged all trials to be at high risk of bias overall. All trials were rated at high risk of bias on blinding of participants and personnel because of the difficulties with blinding a trial with a no‐treatment or wait‐list comparator. However, the remaining risk of bias domains also had a large proportion of unclear risk of biases. We used all eligible trials in the meta‐analysis, as recommended in the Cochrane Handbook for Systematic Reviews of Interventions when all trials are assigned the same risk of bias ( <a href="./references#MR000050-bbs2-0205" title="HigginJP , GreenS , editors.Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0. The Cochrane Collaboration, 2011. [Available from handbook.cochrane.org.]">Higgins 2011</a>; <a href="./references#MR000050-bbs2-0207" title="HigginJP , ThomasJ , ChandlerJ , CumpstonM , LiT , PageMJ , et al (editors).Cochrane Handbook for Systematic Reviews of Interventions Version 6.0 (updated July 2019). Cochrane, 2019.. Available from www.training.cochrane.org/handbook.">Higgins 2019</a>). We incorporated our risk of bias assessment when considering the quality of the evidence using the GRADE approach (<a href="./references#MR000050-bbs2-0205" title="HigginJP , GreenS , editors.Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0. The Cochrane Collaboration, 2011. [Available from handbook.cochrane.org.]">Higgins 2011</a>). Below is a breakdown of how the included trials scored on each risk of bias domain. </p> <section id="MR000050-sec-0068"> <h4 class="title">Allocation</h4> <section id="MR000050-sec-0069"> <h5 class="title">Random sequence generation</h5> <p>Evidence suggests that trials which lack sufficient reporting of randomisation processes are more likely to present larger effect estimates for beneficial outcomes (<a href="./references#MR000050-bbs2-0167" title="ChalmersTC , CelanoP , SacksHS , Smith H Jr.Bias in treatment assignment in controlled clinical trials. New England Journal of Medicine1983;309(22):1358-61.">Chalmers 1983</a>; <a href="./references#MR000050-bbs2-0270" title="SchulzKF , ChalmersI , HayesRJ , AltmanDG .Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials. JAMA1995;273:408-12.">Schulz 1995</a>; <a href="./references#MR000050-bbs2-0230" title="KjaergardLL , VillumsenJ , GluudC .Reported methodologic quality and discrepancies between large and small randomized trials in meta-analyses. Annals of Internal Medicine2001;135(11):982.">Kjaergard 2001</a>; <a href="./references#MR000050-bbs2-0267" title="SavovićJ , JonesH , AltmanD , HarrisR , JüniP , PildalJ , et al.Influence of reported study design characteristics on intervention effect estimates from randomised controlled trials: combined analysis of meta-epidemiological studies. Health Technology Assessment2012;16(35):1-82.">Savović 2012</a>; <a href="./references#MR000050-bbs2-0268" title="SavovicJ , TurnerRM , MawdsleyD , JonesHE , BeynonR , HigginsJP , et al.Association between Risk-of-Bias assessments and results of randomized trials in Cochrane reviews: the ROBES meta-epidemiologic study. American Journal of Epidemiology2018;187(5):1113-22.">Savovic 2018</a>; <a href="./references#MR000050-bbs2-0303" title="WoodL , EggerM , GluudLL , SchulzKF , JüniP , AltmanDG , et al.Empirical evidence of bias in treatment effect estimates in controlled trials with different interventions and outcomes: meta-epidemiological study. BMJ2008;336(7644):601. [DOI: 10.1136/bmj.39465.451748.AD]">Wood 2008</a>). Trials were regarded as low risk of bias if they provided detailed description of their randomisation process such as stratification methods rather than just stating that it was randomised. Twenty‐seven trials provided sufficient information on how the randomisation sequence had been generated, and were rated at low risk of bias. The random sequence generation was rated at high risk of bias in four trials (<a href="#MR000050-tbl-0007">Table 4</a>). Examples included patients being randomised according to when they entered the treatment program (<a href="./references#MR000050-bbs2-0064" title="PolandRE , GertsikL , FavreauJT , SmithSI , MirochaJM , RaoU , et al.Open-label randomized parallel-group controlled clinical trial of massage for treatment of depression in HIV-infected subjects. Journal of Alternative and Complementary Medicine2013;19(4):334-40. ">Poland 2013</a>) or allowing participants to decline up to two treatments arms (<a href="./references#MR000050-bbs2-0079" title="ShalevAY , AnkriY , Isreali-ShalevY , PelegT , AdesskyR , FreedmanS .Prevention of posttraumatic stress disorder by early treatment. Archives of General Psychiatry2012;69(2):166-76. ">Shalev 2012</a>). The remaining 65 trials did not provide sufficient information on how the treatment allocation had been conducted and were assessed as unclear risk of bias. </p> <div class="table" id="MR000050-tbl-0007"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 4.</span> <span class="table-title">Risk of bias in included studies</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Category</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Study</b> <b>frequency</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Study ID</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Random sequence generation</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Low risk of bias</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>27</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#MR000050-bbs2-0002" title="AllenJB .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to A Todorovac 28th of August 2019. AllenJJ , SchnyerRN , HittSK .The efficacy of acupuncture in the treatment of major depression in women. Psychological Science1998;9(5):397-401. ">Allen 1998</a> ; <a href="./references#MR000050-bbs2-0003" title="AllenJB .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 28th of August 2019. AllenJJ , SchnyerRN , ChambersAS , HittSK , MorenoFA , ManberR .Acupuncture for depression: a randomized controlled trial. Journal of Clinical Psychiatry2006;67(11):1665-73. ">Allen 2006</a> ; <a href="./references#MR000050-bbs2-0011" title="BornovalovaM .Inclusion of study in Cochrane Systematic Review (personal communication). Email to A Todorovac. 21st of August 2019. BornovalovaMA .Distress tolerance treatment for inner-city drug users: a preliminary trial. Doctor’s Dissertation, University of Maryland2008. ">Bornovalova 2008</a> ; <a href="./references#MR000050-bbs2-0016" title="CarterJC , OlmstedMP , KaplanAS , McCabeRE , MillsJS , AimeA .Self-help for bulimia nervosa: a randomized controlled trial. American Journal of Psychiatry2003;160(5):973-8. ">Carter 2003</a> ; <a href="./references#MR000050-bbs2-0019" title="Doty, DW.Role playing and incentives in the modification of the social interaction of chronic psychiatric patients. Journal of Consulting and Clinical Psychology1975;43(5):676-82. ">Doty 1975</a> ; <a href="./references#MR000050-bbs2-0021" title="EhlersA , HackmannA , GreyN , WildJ , LinessS , AlbertI , et al.A randomized controlled trial of 7-day intensive and standard weekly cognitive therapy for PTSD and emotion-focused supportive therapy. American Journal of Psychiatry2014;171(3):294-304. ">Ehlers 2014</a> ; <a href="./references#MR000050-bbs2-0025" title="FoaEB , McLeanCP , ZangY , RosenfieldD , YadinE , YarvisJS , et al.Effect of prolonged exposure therapy delivered over 2 weeks vs 8 weeks vs present-centered therapy on PTSD symptom severity in military personnel: a randomized clinical trial. JAMA2018;319(4):354-64. ">Foa 2018</a> ; <a href="./references#MR000050-bbs2-0026" title="FreireAO , SugaiGC , ChrispinFS , TogeiroSM , YamamuraY , MelloLE , et al.Treatment of moderate obstructive sleep apnea syndrome with acupuncture: a randomised, placebo-controlled pilot trial. Sleep Medicine2007;8(1):43-50. ">Freire 2007</a> ; <a href="./references#MR000050-bbs2-0032" title="HippmanC , RingroseA , InglisA , CheekJ , AlbertAY , RemickR , et al.A pilot randomized clinical trial evaluating the impact of genetic counselling for serious mental illnesses. Journal of Clinical Psychiatry2016;77(2):e190-8. ">Hippman 2016</a> ; <a href="./references#MR000050-bbs2-0033" title="HowlinP , GordonKR , PascoG , WadeA , CharmanT .The effectiveness of picture exchange communication system (PECS) training for teachers of children with autism: a pragmatic,group randomised controlled trial. Journal of Child Psychology and Psychiatry2007;48(5):473-81. ">Howlin 2007</a> ; <a href="./references#MR000050-bbs2-0034" title="KarstM , WinterhalterM , MünteS , FranckiB , HondronikosA , EckardtA , et al.Auricular acupuncture for dental anxiety: a randomized controlled trial. Anesthesia and Analgesia2007;104(2):295-300. KarstM .Inclusion of study in Cochrane Systematic Review (personal communication). Email to: EG Faltinsen 5th of September 2019. ">Karst 2007</a> ; <a href="./references#MR000050-bbs2-0035" title="KelleyJ .Inclusion of study in Cochrane Systematic Review (personal communication). Email to: A Todorovac 12th of August 2019. KelleyJM , KaptchukTJ , CusinC , LipkinS , FavaM .Open-label placebo for major depressive disorder: a pilot randomized controlled trial. Psychotherapy and Psychosomatics2012;81(5):312-4. ">Kelley 2012</a> ; <a href="./references#MR000050-bbs2-0037" title="KilmannPR , MilanRJ , BolandJP , NankinHR , DavidsonE , WestMO , et al.Group treatment of secondary erectile dysfunction. Journal of Sex &amp; Marital Therapy1987;13(3):168-82. KilmannPR , Milan RJ Jr, BolandJP , DavidsonE , WestMO , SablisRF , et al.The sexual interactions of men with secondary erectile dysfunction. Journal of Sex Education and Therapy1988;14(1):46-9. KilmannPR , Milan RJ Jr, BolandJP , NankinHR , SablisRF , WestMO , et al.The sexual interactions of men with secondary erectile dysfunction. Paper presented at the annual meeting of the American Psychological Association in Los Angeles1985;1:46-9. ">Kilmann 1987</a> ; <a href="./references#MR000050-bbs2-0043" title="KwanR .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 26th of August 2019. KwanRY , LeungMC , LaiCK .Acupressure for agitation in nursing home residents with dementia: study protocol for a randomized controlled trial. Trials2014;15(410):1-7. KwanRY , LeungMCP , LaiCK .A randomized controlled trial examining the effect of acupressure on agitation and salivary cortisol in nursing home residents with dementia. Dementia and Geriatric Cognitive Disorders2017;44(1-2):92-104. ">Kwan 2017</a> ; <a href="./references#MR000050-bbs2-0047" title="LegrandF .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 14th of August 2019. LegrandFD , NeffEM .Efficacy of exercise as an adjunct treatment for clinically depressed inpatients during the initial stages of antidepressant pharmacotherapy: an open randomized controlled trial. Journal of Affective Disorders2016;191:139-44. ">Legrand 2016</a> ; <a href="./references#MR000050-bbs2-0052" title="McLachlanDR , DaltonAJ , KruckTP , BellMY , SmithWL , KalowW , et al.Intramuscular desferrioxamine in patients with Alzheimer's disease. Lancet1991;337(8753):1304-8. McLachlanDRC , SmithWL , KruckTP .Desferrioxamine and Alzheimer’s disease: video home behavior assessment of clinical course and measures of brain aluminum. Therapeutic Drug Monitoring1993;15(6):602-7. ">McLachlan 1991</a> ; <a href="./references#MR000050-bbs2-0064" title="PolandRE , GertsikL , FavreauJT , SmithSI , MirochaJM , RaoU , et al.Open-label randomized parallel-group controlled clinical trial of massage for treatment of depression in HIV-infected subjects. Journal of Alternative and Complementary Medicine2013;19(4):334-40. ">Poland 2013</a> ; <a href="./references#MR000050-bbs2-0066" title="PowersMB , SmithsJA , WhitleyD , BystritskyA , TelchMJ .The effect of attributional processes concerning medication taking on return of fear. Journal of Consulting and Clinical Psychology2008;76(3):478-90. ">Powers 2008a</a> ; <a href="./references#MR000050-bbs2-0067" title="PowersMB , SmithsJA , WhitleyD , BystritskyA , TelchMJ .The effect of attributional processes concerning medication taking on return of fear. Journal of Consulting and Clinical Psychology2008;76(3):478-90. ">Powers 2008b</a> ; <a href="./references#MR000050-bbs2-0068" title="ProudfootJ , ClarkeJ , BirchMR , WhittonAE , ParkerG , ManicavasagarV , et al.Impact of a mobile phone and web program on symptom and functional outcomes for people with mild- to-moderate depression, anxiety and stress: a randomized controlled trial. BMC Psychiatry2013;13(312):1-12. ProudfootJ .Re: Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 26th of August 2019. ">Proudfoot 2013</a> ; <a href="./references#MR000050-bbs2-0070" title="LiebowitzM , QuitkinFM , StewartJW , McGrathPJ , HarrisonWM , MarkowitzJS , et al.Antidepressant efficacy in atypical depression. Archives of General Psychiatry1988;45(2):129-37. QuitkinFM , McGrathPJ , StewartJW , HarrisonW , WagerSG , NunesE , et al.Phenelzine and imipramine in mood reactive depressives: further delineation of the syndrome of atypical depression. Archives of General Psychiatry1989;46(9):787-93. RabkinJG , McGrathPJ , QuitkinFM , TricamoE , StewartJW , KleinDF .Effects of pill-giving on maintenance of placebo response in patients with chronic mild depression. American Journal of Psychiatry1990;147(12):1622-6. ">Rabkin 1990</a> ; <a href="./references#MR000050-bbs2-0071" title="RapeeR .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 29th of August 2019. RapeeRM , AbbottMJ , LynehamHJ .Bibliotherapy for children With anxiety disorders using written materials for parents: a randomized controlled trial. Journal of Consulting and Clinical Psychology2006;74(3):436-44. ">Rapee 2006</a> ; <a href="./references#MR000050-bbs2-0072" title="RapeeR .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 29th of August 2019. RapeeRM , AbbottMJ , BaillieAJ , GastonJE .Treatment of social phobia through pure self-help and therapist-augmented self-help. British Journal of Psychiatry2007;191:246-52. ">Rapee 2007</a> ; <a href="./references#MR000050-bbs2-0076" title="RosenGM , GlasgowRE , BarreraM .A controlled study to assess the clinical efficacy of totally self-administrated systematic desensitization. Journal of Consulting and Clinical Psychology1976;44(2):208-17. ">Rosen 1976</a> ; <a href="./references#MR000050-bbs2-0082" title="SommernessMD , LuceroRJ , HamlonJS , EricksonJL , MatthewsR .A controlled study of reserpine on chronically disturbed patients. JAMA Archives of Neurology and Psychiatry1955;74(3):316-9. ">Sommerness 1955</a> ; <a href="./references#MR000050-bbs2-0084" title="SzymanskiJ , O'DonohueW .The potential role of state-dependent learning in cognitive therapy with spider phobics. Journal of Rational-Emotive &amp; Cognitive-Behavior Therapy1995;13(2):131-50. SzymanskiJ .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 20th of August 2019. ">Szymanski 1995</a> ; <a href="./references#MR000050-bbs2-0086" title="TeriL , LogsdonRG , UomotoJ , McCurrySM .Behavioral treatment of depression in dementia patients: a controlled clinical trial. Journals of Gerontology. Series B, Psychological Sciences and Social Sciences1997;52(4):159-66. TeriL .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 26th of August 2019. ">Teri 1997</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>High risk of bias</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#MR000050-bbs2-0045" title="LaiCK , ChiI , Kayser-JonesJ .A randomized controlled trial of a specific reminiscence approach to promote the well-being of nursing home residents with dementia. International Psychogeriatrics2004;16(1):33-49. LaiK .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 6th of September 2019. ">Lai 2004</a> ; <a href="./references#MR000050-bbs2-0063" title="PetersonMA , PattersonB , PillmanBM , BattistaMA .Cognitive recovery following alcohol detoxification: a computerised remediation study. Neuropsychological Rehabilitation2002;12(1):63-74. PillmanBM .Computerized cognitive remediation with recently detoxified alcoholics. Dissertation, California School of Professional Psychology, Fresno Campus2000. ">Pillman 2001</a> ; <a href="./references#MR000050-bbs2-0073" title="RobinA .Rationing out-patients: a defence of the waiting list. British Journal of Psychiatry1976;129:138-41. ">Robin 1976</a> ; <a href="./references#MR000050-bbs2-0079" title="ShalevAY , AnkriY , Isreali-ShalevY , PelegT , AdesskyR , FreedmanS .Prevention of posttraumatic stress disorder by early treatment. Archives of General Psychiatry2012;69(2):166-76. ">Shalev 2012</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Unclear risk of bias</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>65</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#MR000050-bbs2-0001" title="AbikoffH , HechtmanL , KleinRG .Social functioning in children with ADHD treated with long-term methylphenidate and multimodal psychosocial treatment. Journal of the American Academy of Child and Adolescent Psychiatry2004;43(7):820-9. AbikoffH .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to A Todorovac 23rd of August 2019. KleinRG , AbikoffH , HechtmanL , WeissG .Design and rationale of controlled study of long-term methylphenidate and multimodal psychosocial treatment in children with ADHD. Journal of the American Academy of Child and Adolescent Psychiatry2004;43(7):792-801. ">Abikoff 2004</a> ; <a href="./references#MR000050-bbs2-0004" title="AlvarezJR .The effects of anger management training on depression, anger, self-concept, and treatment responsibility in a sample of drug-dependent individuals in a therapeutic community. Dissertation Abstracts International: Section B: the Sciences and Engineering1997;58(4-B):2108. ">Alvarez 1997</a> ; <a href="./references#MR000050-bbs2-0005" title="AscherLM , TurnerR .Paradoxical intention and insomnia: an experimental investigation. Behaviour Research and Therapy1979;17(4):408-11. ">Ascher 1979</a> ; <a href="./references#MR000050-bbs2-0006" title="AyenI , HautzingerM .Cognitive behavior therapy for depression in menopausal women. A controlled, randomized treatment study [Kognitive Verhaltenstherapie bei Depressionen im Klimakterium: Eine kontrollierte, randomiserte Interventionsstudie]. Zeitschrift für Klinische Psychologie und Psychotherapie2004;33(4):290-9. AyenI .Inclusion of study in Cochrane Systematic Review (personal communication). Email to EG Faltinsen 9th of September 2019. ">Ayen 2004</a> ; <a href="./references#MR000050-bbs2-0007" title="BergI , ForsytheI , HoltP , WattsJ .A controlled trial of ‘Senokot’ in faecal soiling treated by behavioural methods. Journal of Child Psychology and Psychiatry1983;24(4):543-9. ">Berg 1983</a> ; <a href="./references#MR000050-bbs2-0008" title="Borden, KA.Attributional Outcomes: the Subtle Messages of Treatments for Attention Deficit Disorder. Dissertation, University of Illinois at Urbana-Champaign1986. BordenKA , BrownRT .Attributional outcomes: The subtle messages of treatments for attention deficit disorder. Cognitive Therapy and Research1989;13(2):147-60. ">Borden 1986</a> ; <a href="./references#MR000050-bbs2-0009" title="BorkovecTD , KaloupekDG , SlamaKM .The facilitative effect of muscle tension-release in the relaxation treatment of sleep disturbance. Behavior Therapy1975;6(3):301-9. ">Borkovec 1975</a> ; <a href="./references#MR000050-bbs2-0010" title="BorkovecTD , WeertsTC .Effects of progressive relaxation on sleep disturbance: an electroencephalographic evaluation. Psychosomatic Medicine1976;38(3):173-80. ">Borkovec 1976</a> ; <a href="./references#MR000050-bbs2-0012" title="BramstonP , SpenceSH .Behavioural versus cognitive social-skills training with intellectually-handicapped adults. Behaviour Research and Therapy1985;23(3):239-46. ">Bramston 1985</a> ; <a href="./references#MR000050-bbs2-0013" title="BrillNQ , KoeglerRR , EpsteinLJ , ForgyEW .Controlled study of psychiatric outpatient treatment. Archives of General Psychiatry1964;10:581-95. BrillNQ .Results of psychotherapy. California Medicine1966;104(4):249-53. ">Brill 1964a</a> ; <a href="./references#MR000050-bbs2-0014" title="BrillNQ , KoeglerRR , EpsteinLJ , ForgyEW .Controlled study of psychiatric outpatient treatment. Archives of General Psychiatry1964;10:581-95. ">Brill 1964b</a> ; <a href="./references#MR000050-bbs2-0015" title="CarlsonCL , PelhamWE , MilichR , HozaB .ADHD boys’ performance and attributions following success and failure: drug effects and individual differences. Cognitive Therapy and Research1993;17:269-87. ">Carlson 1993</a> ; <a href="./references#MR000050-bbs2-0017" title="CrispAH , NortonK , GowersS , HalekC , BowyerC , YeldhamD , et al.A controlled study of the effect of therapies aimed at adolescent and family psychopathology in Anorexia Nervosa. British Journal of Psychiatry: the Journal of Mental Science1991;159:325-33. GowersS , NortonK , HalekC , CrispAH .Outcome of outpatient psychotherapy in a random allocation treatment study of anorexia nervosa. International Journal of Eating Disorders1994;15(2):165-77. GowersS , NortonK , YelshamD .The St George's prospective treatment study of anorexia nervosa: a discussion of methodological problems. International Journal of Eating Disorders1989;8:445-54. ">Crisp 1991</a> ; <a href="./references#MR000050-bbs2-0018" title="CrouchG , RobsonM , HallstromC .Benzodiazepine dependent patients and their psychological treatment. Progress in Neuro-psychopharmacology &amp; Biological Psychiatry1988;12(4):503-10. HallströmC , CrouchG , RobsenM , ShineP .The treatment of tranquillizer dependence by propranolol. Postgraduate Medical Journal1988;64(Suppl 2):40-4. ">Crouch 1988</a> ; <a href="./references#MR000050-bbs2-0020" title="DoubleDB , WarrenGC , EvansM , RowlandsMP .Efficacy of maintenance use of anticholinergic agents. Acta Psychiatrica Scandinavica1993;88:381-4. ">Double 1993</a> ; <a href="./references#MR000050-bbs2-0022" title="EspieCA , BrooksDN , LindsayWR .An evaluation of tailored psychological treatment of insomnia. Journal of Behavior Therapy and Experimental Psychiatry1989;20(2):143-53. EspieCA , LindsayWR , BrooksDN , HoodEM , TurveyT .A controlled comparative investigation of psychological treatments for chronic sleep-onset insomnia. Behaviour Research and Therapy1989;27(1):79-88. ">Espie 1989a</a> ; <a href="./references#MR000050-bbs2-0023" title="EtringerBD , CashTF , RimmDC .Behavioral, affective, and cognitive effects of participant modeling and an equally credible placebo. Behavior Therapy1982;13(4):476-85. ">Etringer 1982</a> ; <a href="./references#MR000050-bbs2-0024" title="FoaEB , RothbaumBO , RiggsDS , MurdockTB .Treatment of posttraumatic stress disorder in rape victims: a comparison between cognitive-behavioral procedures and counselling. Journal of Consulting and Clinical Psychology1991;59(5):715-23. ">Foa 1991</a> ; <a href="./references#MR000050-bbs2-0027" title="FuchsCZ , RehnLP .A self-control behavior therapy program for depression. Journal of Consulting and Clinical Psychology1977;45(2):206-15. ">Fuchs 1977</a> ; <a href="./references#MR000050-bbs2-0028" title="GlogowskaM , RoulstoneS , EnderbyP , PetersTJ .Randomised controlled trial of community based speech and language therapy in preschool children. BMJ2000;321(7266):923-6. ">Glogowska 2000</a> ; <a href="./references#MR000050-bbs2-0029" title="GoldsteinAJ , BeursE , Chambless Dl, WilsonKA .EMDR for panic disorder with agoraphobia: comparison with waiting list and credible attention-placebo control conditions. Journal of Consulting and Clinical Psychology2000;68(6):947-56. ">Goldstein 2000</a> ; <a href="./references#MR000050-bbs2-0030" title="GoldwasserAN , AuerbachSM , HarkinsSW .Cognitive, affective, and behavioural effects of reminiscence group therapy on demented elderly. Aging and Human Development1987;25(3):209-22. ">Goldwasser 1987</a> ; <a href="./references#MR000050-bbs2-0031" title="HekmatH , LubitzR , DealR .Semantic desensitization: a paradigmatic intervention approach to anxiety disorders. Journal of Clinical Psychology1984;40(2):463-6. ">Hekmat 1984</a> ; <a href="./references#MR000050-bbs2-0036" title="KennedyTD , KimuraHK .Transfer, behavioral improvement, and anxiety reduction in systematic desensitization. Journal of Consulting and Clinical Psychology1974;42(5):720-8. ">Kennedy 1974</a> ; <a href="./references#MR000050-bbs2-0038" title="KleinSA , DeffenbacherJL .Relaxation and exercise for hyperactive impulsive children. Perceptual and Motor Skills1977;45:1159-62. ">Klein 1977</a> ; <a href="./references#MR000050-bbs2-0039" title="KlermanGL , DimascioA , WeismannM , PrusoffB , PaykelES .Treatment of depression by drugs and psychotherapy. American Journal of Psychiatry1974;131(2):186-91. PaykelES , DimascioA , HaskellD , PrusoffBA .Effects of maintenance amitriptyline and psychotherapy on symptoms of depression. Psychological Medicine1975;5(1):67-77. PaykelES , DiMascioA , KlermanGL , PrusoffBA .Maintenance therapy of depression. Pharmakopsychiatrie, Neuro-Psychopharmakologie1976;9:127-39. PaykelES , WeissmanMM , PrusoffBA .Social maladjustment and severity of depression. Comprehensive Psychiatry1978;19(2):121-8. WeissmanMM , KlermanGL , PaykelES , PrusoffB .Treatment effects on the social adjustment of depressed patients. Archives of General Psychiatry1974;30:771-8. ">Klerman 1974a</a> ; <a href="./references#MR000050-bbs2-0040" title="KlermanGL , DimascioA , WeismannM , PrusoffB , PaykelES .Treatment of depression by drugs and psychotherapy. American Journal of Psychiatry1974;131(2):186-91. ">Klerman 1974b</a> ; <a href="./references#MR000050-bbs2-0041" title="KloskoJS , BarlowDH , TassinariR , CernyJA .A comparison of alprazolam and behavior therapy in treatment of panic disorder: correction. Journal of Psychotherapy Practice and Research1994;3(2):163-79. KloskoJS , BarlowDH , TassinariR , CernyJA .A comparison of alprazolam and behavior therapy in treatment of panic disorder. Journal of Consulting and Clinical Psychology1990;58(1):77-84. ">Klosko 1990</a> ; <a href="./references#MR000050-bbs2-0042" title="KrapflJE , NawasMM .Differential ordering of stimulus presentation in systematic desensitization. Journal of Abnormal Psychology1970;75(3):333-7. ">Krapfl 1970</a> ; <a href="./references#MR000050-bbs2-0044" title="LacyMK .The effect of short term autogenic training on the stress reactivity of hospitalized emotionally disturbed adolescents. ProQuest Dissertations Publishing, Oklahoma State University1996. ">Lacy 1990</a> ; <a href="./references#MR000050-bbs2-0046" title="LangOJ , LazovikAD .Experimental desensitization of a phobia. Journal of Abnormal and Social Psychology1963;66:519-25. LangPJ , LazovikAD , ReynoldsDJ .Desensitization, suggestibility, and pseudotherapy. Journal of Abnormal Psychology1965;70(6):395-402. ">Lang 1965</a> ; <a href="./references#MR000050-bbs2-0048" title="LickJ .Expectancy, false galvanic skin response feedback, and systematic desensitization in the modification of phobic behavior. Journal of Consulting and Clinical Psychology1975;43(4):557-67. ">Lick 1975</a> ; <a href="./references#MR000050-bbs2-0049" title="LickJR , HefflerD .Relaxation training and attention placebo in the treatment of severe insomnia. Journal of Consulting and Clinical Psychology1977;45(2):153-61. ">Lick 1977</a> ; <a href="./references#MR000050-bbs2-0050" title="LiddleB , SpenceSH .Cognitive-behaviour therapy with depressed primary school children: A cautionary note. Behavioural Psychotherapy1990;18(2):85-102. ">Liddle 1990</a> ; <a href="./references#MR000050-bbs2-0051" title="MatsonJL , MarchettiA , AdkinsJA .Comparison of operant- and independence-training procedures for mentally retarded adults. American Journal of Mental Deficiency1980;84(5):487-94. ">Matson 1980</a> ; <a href="./references#MR000050-bbs2-0053" title="MealieaWL , NawasMM .The comparative effectiveness of systematic desensitization and implosive therapy in the treatment of snake phobia. Journal of Behavior Therapy and Experimental Psychiatry1971;2(2):85-94. ">Mealiea 1971</a> ; <a href="./references#MR000050-bbs2-0054" title="MilbyJB , ClarkeC , ToroC , ThorntonS , RickertD .Effectiveness of urine surveillance as an adjunct to outpatient psychotherapy for drug abusers. International Journal of the Addictions1980;15(7):993-1001. ">Milby 1980</a> ; <a href="./references#MR000050-bbs2-0055" title="MirandaA , ArlandisP , SorianoM .Instruction in strategies and attributional training: Effects on the problem-solving and self-concept of students’ with learning disabilities [Instrucción en estrategias y entrenamiento atribucional: efectos sobre la resolución de problemas y el autoconcepto de los estudiantes con dificultades en el aprendizaje]. Infancia y Aprendizaje1997;20(80):37-52. ">Miranda 1997</a> ; <a href="./references#MR000050-bbs2-0056" title="MitchellC , MansfieldD , RautenbachS .Coloured filters and reading accuracy, comprehension and rate: a placebo-controlled study. Perceptual and Motor Skills2008;106(2):517-32. ">Mitchell 2008</a> ; <a href="./references#MR000050-bbs2-0057" title="NandiDN , AjmanyS , GanguliH , BanerjeeG , BoralGC , GhoshA , et al.A clinical evaluation of depressives found in a rural survey in India. British Journal of Psychiatry1976;128:523-7. ">Nandi 1976</a> ; <a href="./references#MR000050-bbs2-0058" title="NicassioP , BootzinR .A comparison of progressive relaxation and autogenic training as treatments for insomnia. Journal of Abnormal Psychology1974;83(3):253-60. ">Nicassio 1974</a> ; <a href="./references#MR000050-bbs2-0060" title="PeckCL .Desensitization for the treatment of fear in the high level adult retardate. Behaviour Research and Therapy1977;15(2):137-48. ">Peck 1976</a> ; <a href="./references#MR000050-bbs2-0059" title="PearlD , Vander KampH , OlsenAL , GreenbergPD , ArmitageSG .The effects of reserpine on schizophrenic patients. American Journal of Psychiatry1956;112:198-204. ">Pearl 1956</a> ; <a href="./references#MR000050-bbs2-0061" title="MilichR , CarlsonCL , Pelham WE Jr, LichtBG .Effects of methylphenidate on the persistence of ADHD boys following failure experiences. Journal of Abnormal Child Psychology1991;19(5):519-36. PelhamWE , MurphyDA , VannattaK , MilichR , LichtBG , GnagyEM , et al.Methylphenidate and attributions in boys with attention-deficit hyperactivity disorder. Journal of Consulting and Clinical Psychology1992;60(2):282-92. ">Pelham 1992</a> ; <a href="./references#MR000050-bbs2-0062" title="PedletonMG , HigginsRL .A comparison of negative practice and systematic desensitization in the treatment of acrophobia. Journal of Behavior Therapy and Experimental Psychiatry1983;14(4):317-23. ">Pendleton 1983</a> ; <a href="./references#MR000050-bbs2-0065" title="PowersMB , SmitsJA , TelchMJ .Disentangling the effects of safety-behavior utilization and safety-behavior availability during exposure-based treatment: a placebo-controlled trial. Journal of Consulting and Clinical Psychology2004;72(3):448-54. ">Powers 2004</a> ; <a href="./references#MR000050-bbs2-0069" title="QuayhagenMP , QuayhagenM , CorbeilRR , RothPA , RodgersJA .A dyadic remediation program for care recipients with dementia. Nursing Research1995;44(3):153-9. ">Quayhagen 1995</a> ; <a href="./references#MR000050-bbs2-0074" title="RoehrichL , GoldmanMS .Experience-dependent neuropsychological recovery and the treatment of alcoholism. Journal of Consulting and Clinical Psychology1993;61(5):812-21. ">Roehrich 1993</a> ; <a href="./references#MR000050-bbs2-0075" title="OlivaresJ .Program IAFS. Protocol for the treatment of social phobia in adolescents [Programa IAFS. Protocolo para el tratamiento de la fobia social enadolescentes]. Madrid: Pirámide2005;1. Rosa-AlcázarAI , Olivares-OlivaresPJ , OlivaresJ .The role of non-specific effects in the psychological treatment of adolescents with social phobia [Papel de los efectos inespecíficos en el tratamiento psicológico de adolescentes con fobia social]. Anuario de Psicologia2009;40(1):43-61. ">Rosa‐Alcatraz 2009</a> ; <a href="./references#MR000050-bbs2-0077" title="LorrM , McNairDM , WeinsteinGJ .Early effects of chlordiazepoxide (Librium) used with psychotherapy. Journal of Psychiatric Research1963;1:257-70. RothI , RhudickPJ , ShaskanDA , SlobinMS , WilkinsonAE , YoungHH .Long-term effects on psychotherapy of initial treatment conditions. Journal of Psychiatric Research1964;2:283-97. ">Roth 1964</a> ; <a href="./references#MR000050-bbs2-0078" title="RupertPA , HolmesDS .Effects of multiple sessions of true and placebo heart rate biofeedback training on the heart rates and anxiety levels of anxious patients during and following treatment. Psychophysiology1978;15(6):582-90. ">Rupert 1978</a> ; <a href="./references#MR000050-bbs2-0080" title="ShealyRC .The effectiveness of various treatment techniques on different degrees and durations of sleep-onset insomnia. Behaviour Research and Therapy1979;17(6):541-6. ">Shealy 1979</a> ; <a href="./references#MR000050-bbs2-0081" title="SibilioJP , AndrewG , DartD , MooreKB , StehmanA .Treatment of chronic schizophrenia with promazine hydrochloride. AMA Archives of Neurology and Psychiatry1957;78(4):419-24. ">Sibilio 1957</a> ; <a href="./references#MR000050-bbs2-0083" title="SteinmarkSW , BorkovecTD .Active and placebo treatment effects on moderate insomnia under counterdemand and positive demand instructions. Journal of Abnormal Psychology1974;83(2):157-63. ">Steinmark 1974</a> ; <a href="./references#MR000050-bbs2-0085" title="TanSY , BruniJ .Cognitive-behavior therapy with adult patients with epilepsy: a controlled outcome study. Epilepsia1986;27(3):225-33. ">Tan 1986</a> ; <a href="./references#MR000050-bbs2-0087" title="ToriC , WorellL .Reduction of human avoidant behavior. A comparison of counterconditioning, expectancy, and cognitive information approaches. Clinical Psychology1973;41(2):269-78. ">Tori 1973</a> ; <a href="./references#MR000050-bbs2-0088" title="Trexler, L.Rational-emotive therapy, placebo, and no-treatment effects on public-speaking anxiety. Doctoral dissertation, Temple University AnnArbor, Mich.: University Microfilms1971;71-31(063). TrexlerLD , KarstTO .Rational-emotive therapy, placebo, and no-treatment effects on public-speaking anxiety. Journal of Abnormal Psyhology1972;79(1):60-7. ">Trexler 1972</a> ; <a href="./references#MR000050-bbs2-0089" title="AscherML , TurnerRM .A comparison of two methods for the administration of paradoxical intention. Behaviour Research and Therapy1980;18(2):121-6. TurnerRM , AscherLM .Controlled comparison of progressive relaxation, stimulus control, and paradoxical intention therapies for insomnia. Journal of Consulting and Clinical Psychology1979;47(3):500-8. ">Turner 1979</a> ; <a href="./references#MR000050-bbs2-0090" title="VanderplateC .Electromyograph biofeedback Treatment of sleep onset Insomnia: a controlled Investigation. Dissertation, University of Southern Mississippi1978. ">Vanderplate 1983</a> ; <a href="./references#MR000050-bbs2-0091" title="WatzlH , RistF , OlbrichR , CohenR .Placebo injections and surveillance of alcohol intake during inpatient treatment of female alcoholics. Addictive Behaviors1988;13(2):197-200. ">Watzl 1988</a> ; <a href="./references#MR000050-bbs2-0092" title="WeingaertnerAH .Self-administered aversive stimulation with hallucinating hospitalized schizophrenics. Journal of Consulting and Clinical Psychology1971;36(3):422-29. ">Weingaertner 1971</a> ; <a href="./references#MR000050-bbs2-0093" title="WhittakerCB , HoyRM .Withdrawal of perphenazine in chronic schizophrenia. British Journal of Psychiatry1963;109:422-7. ">Whittaker 1963</a> ; <a href="./references#MR000050-bbs2-0094" title="WilsonA , DavidsonWJ , BlanchardR , WhiteJ .Disulfiram implantation. A placebo-controlled trial with two-year follow-up. Journal of Studies on Alcohol1978;39(5):809-19. WilsonA , DavidsonWJ , BlanchardR .Disulfiram implantation: a trial using placebo implants and two types of controls. Journal of Studies on Alcohol1980;41(5):429-36. ">Wilson 1980</a> ; <a href="./references#MR000050-bbs2-0095" title="WolitzkyKB , TelchMJ .Augmenting in vivo exposure with fear antagonistic actions: a preliminary test. Behavior Therapy2009;40(1):57-71. ">Wolitzky 2009</a> ; <a href="./references#MR000050-bbs2-0096" title="WollersheimJP , WilsonGL .Group treatment of unipolar depression: a comparison of coping, supportive, bibliotherapy, and delayed treatment groups. Professional Psychology: Research and Practice1991;22(6):496-502. ">Wollersheim 1991</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Allocation concealment</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Low risk of bias</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>18</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#MR000050-bbs2-0002" title="AllenJB .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to A Todorovac 28th of August 2019. AllenJJ , SchnyerRN , HittSK .The efficacy of acupuncture in the treatment of major depression in women. Psychological Science1998;9(5):397-401. ">Allen 1998</a> ; <a href="./references#MR000050-bbs2-0003" title="AllenJB .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 28th of August 2019. AllenJJ , SchnyerRN , ChambersAS , HittSK , MorenoFA , ManberR .Acupuncture for depression: a randomized controlled trial. Journal of Clinical Psychiatry2006;67(11):1665-73. ">Allen 2006</a> ; <a href="./references#MR000050-bbs2-0011" title="BornovalovaM .Inclusion of study in Cochrane Systematic Review (personal communication). Email to A Todorovac. 21st of August 2019. BornovalovaMA .Distress tolerance treatment for inner-city drug users: a preliminary trial. Doctor’s Dissertation, University of Maryland2008. ">Bornovalova 2008</a> ; <a href="./references#MR000050-bbs2-0021" title="EhlersA , HackmannA , GreyN , WildJ , LinessS , AlbertI , et al.A randomized controlled trial of 7-day intensive and standard weekly cognitive therapy for PTSD and emotion-focused supportive therapy. American Journal of Psychiatry2014;171(3):294-304. ">Ehlers 2014</a> ; <a href="./references#MR000050-bbs2-0026" title="FreireAO , SugaiGC , ChrispinFS , TogeiroSM , YamamuraY , MelloLE , et al.Treatment of moderate obstructive sleep apnea syndrome with acupuncture: a randomised, placebo-controlled pilot trial. Sleep Medicine2007;8(1):43-50. ">Freire 2007</a> ; <a href="./references#MR000050-bbs2-0028" title="GlogowskaM , RoulstoneS , EnderbyP , PetersTJ .Randomised controlled trial of community based speech and language therapy in preschool children. BMJ2000;321(7266):923-6. ">Glogowska 2000</a> ; <a href="./references#MR000050-bbs2-0034" title="KarstM , WinterhalterM , MünteS , FranckiB , HondronikosA , EckardtA , et al.Auricular acupuncture for dental anxiety: a randomized controlled trial. Anesthesia and Analgesia2007;104(2):295-300. KarstM .Inclusion of study in Cochrane Systematic Review (personal communication). Email to: EG Faltinsen 5th of September 2019. ">Karst 2007</a> ; <a href="./references#MR000050-bbs2-0035" title="KelleyJ .Inclusion of study in Cochrane Systematic Review (personal communication). Email to: A Todorovac 12th of August 2019. KelleyJM , KaptchukTJ , CusinC , LipkinS , FavaM .Open-label placebo for major depressive disorder: a pilot randomized controlled trial. Psychotherapy and Psychosomatics2012;81(5):312-4. ">Kelley 2012</a> ; <a href="./references#MR000050-bbs2-0043" title="KwanR .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 26th of August 2019. KwanRY , LeungMC , LaiCK .Acupressure for agitation in nursing home residents with dementia: study protocol for a randomized controlled trial. Trials2014;15(410):1-7. KwanRY , LeungMCP , LaiCK .A randomized controlled trial examining the effect of acupressure on agitation and salivary cortisol in nursing home residents with dementia. Dementia and Geriatric Cognitive Disorders2017;44(1-2):92-104. ">Kwan 2017</a> ; <a href="./references#MR000050-bbs2-0047" title="LegrandF .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 14th of August 2019. LegrandFD , NeffEM .Efficacy of exercise as an adjunct treatment for clinically depressed inpatients during the initial stages of antidepressant pharmacotherapy: an open randomized controlled trial. Journal of Affective Disorders2016;191:139-44. ">Legrand 2016</a> ; <a href="./references#MR000050-bbs2-0064" title="PolandRE , GertsikL , FavreauJT , SmithSI , MirochaJM , RaoU , et al.Open-label randomized parallel-group controlled clinical trial of massage for treatment of depression in HIV-infected subjects. Journal of Alternative and Complementary Medicine2013;19(4):334-40. ">Poland 2013</a> ; <a href="./references#MR000050-bbs2-0068" title="ProudfootJ , ClarkeJ , BirchMR , WhittonAE , ParkerG , ManicavasagarV , et al.Impact of a mobile phone and web program on symptom and functional outcomes for people with mild- to-moderate depression, anxiety and stress: a randomized controlled trial. BMC Psychiatry2013;13(312):1-12. ProudfootJ .Re: Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 26th of August 2019. ">Proudfoot 2013</a> ; <a href="./references#MR000050-bbs2-0071" title="RapeeR .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 29th of August 2019. RapeeRM , AbbottMJ , LynehamHJ .Bibliotherapy for children With anxiety disorders using written materials for parents: a randomized controlled trial. Journal of Consulting and Clinical Psychology2006;74(3):436-44. ">Rapee 2006</a> ; <a href="./references#MR000050-bbs2-0077" title="LorrM , McNairDM , WeinsteinGJ .Early effects of chlordiazepoxide (Librium) used with psychotherapy. Journal of Psychiatric Research1963;1:257-70. RothI , RhudickPJ , ShaskanDA , SlobinMS , WilkinsonAE , YoungHH .Long-term effects on psychotherapy of initial treatment conditions. Journal of Psychiatric Research1964;2:283-97. ">Roth 1964</a> ; <a href="./references#MR000050-bbs2-0081" title="SibilioJP , AndrewG , DartD , MooreKB , StehmanA .Treatment of chronic schizophrenia with promazine hydrochloride. AMA Archives of Neurology and Psychiatry1957;78(4):419-24. ">Sibilio 1957</a> ; <a href="./references#MR000050-bbs2-0082" title="SommernessMD , LuceroRJ , HamlonJS , EricksonJL , MatthewsR .A controlled study of reserpine on chronically disturbed patients. JAMA Archives of Neurology and Psychiatry1955;74(3):316-9. ">Sommerness 1955</a> ; <a href="./references#MR000050-bbs2-0086" title="TeriL , LogsdonRG , UomotoJ , McCurrySM .Behavioral treatment of depression in dementia patients: a controlled clinical trial. Journals of Gerontology. Series B, Psychological Sciences and Social Sciences1997;52(4):159-66. TeriL .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 26th of August 2019. ">Teri 1997</a> ; <a href="./references#MR000050-bbs2-0093" title="WhittakerCB , HoyRM .Withdrawal of perphenazine in chronic schizophrenia. British Journal of Psychiatry1963;109:422-7. ">Whittaker 1963</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Unclear risk of bias</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>78</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#MR000050-bbs2-0001" title="AbikoffH , HechtmanL , KleinRG .Social functioning in children with ADHD treated with long-term methylphenidate and multimodal psychosocial treatment. Journal of the American Academy of Child and Adolescent Psychiatry2004;43(7):820-9. AbikoffH .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to A Todorovac 23rd of August 2019. KleinRG , AbikoffH , HechtmanL , WeissG .Design and rationale of controlled study of long-term methylphenidate and multimodal psychosocial treatment in children with ADHD. Journal of the American Academy of Child and Adolescent Psychiatry2004;43(7):792-801. ">Abikoff 2004</a> ; <a href="./references#MR000050-bbs2-0004" title="AlvarezJR .The effects of anger management training on depression, anger, self-concept, and treatment responsibility in a sample of drug-dependent individuals in a therapeutic community. Dissertation Abstracts International: Section B: the Sciences and Engineering1997;58(4-B):2108. ">Alvarez 1997</a> ; <a href="./references#MR000050-bbs2-0005" title="AscherLM , TurnerR .Paradoxical intention and insomnia: an experimental investigation. Behaviour Research and Therapy1979;17(4):408-11. ">Ascher 1979</a> ; <a href="./references#MR000050-bbs2-0006" title="AyenI , HautzingerM .Cognitive behavior therapy for depression in menopausal women. A controlled, randomized treatment study [Kognitive Verhaltenstherapie bei Depressionen im Klimakterium: Eine kontrollierte, randomiserte Interventionsstudie]. Zeitschrift für Klinische Psychologie und Psychotherapie2004;33(4):290-9. AyenI .Inclusion of study in Cochrane Systematic Review (personal communication). Email to EG Faltinsen 9th of September 2019. ">Ayen 2004</a> ; <a href="./references#MR000050-bbs2-0007" title="BergI , ForsytheI , HoltP , WattsJ .A controlled trial of ‘Senokot’ in faecal soiling treated by behavioural methods. Journal of Child Psychology and Psychiatry1983;24(4):543-9. ">Berg 1983</a> ; <a href="./references#MR000050-bbs2-0008" title="Borden, KA.Attributional Outcomes: the Subtle Messages of Treatments for Attention Deficit Disorder. Dissertation, University of Illinois at Urbana-Champaign1986. BordenKA , BrownRT .Attributional outcomes: The subtle messages of treatments for attention deficit disorder. Cognitive Therapy and Research1989;13(2):147-60. ">Borden 1986</a> ; <a href="./references#MR000050-bbs2-0009" title="BorkovecTD , KaloupekDG , SlamaKM .The facilitative effect of muscle tension-release in the relaxation treatment of sleep disturbance. Behavior Therapy1975;6(3):301-9. ">Borkovec 1975</a> ; <a href="./references#MR000050-bbs2-0010" title="BorkovecTD , WeertsTC .Effects of progressive relaxation on sleep disturbance: an electroencephalographic evaluation. Psychosomatic Medicine1976;38(3):173-80. ">Borkovec 1976</a> ; <a href="./references#MR000050-bbs2-0012" title="BramstonP , SpenceSH .Behavioural versus cognitive social-skills training with intellectually-handicapped adults. Behaviour Research and Therapy1985;23(3):239-46. ">Bramston 1985</a> ; <a href="./references#MR000050-bbs2-0013" title="BrillNQ , KoeglerRR , EpsteinLJ , ForgyEW .Controlled study of psychiatric outpatient treatment. Archives of General Psychiatry1964;10:581-95. BrillNQ .Results of psychotherapy. California Medicine1966;104(4):249-53. ">Brill 1964a</a> ; <a href="./references#MR000050-bbs2-0014" title="BrillNQ , KoeglerRR , EpsteinLJ , ForgyEW .Controlled study of psychiatric outpatient treatment. Archives of General Psychiatry1964;10:581-95. ">Brill 1964b</a> ; <a href="./references#MR000050-bbs2-0015" title="CarlsonCL , PelhamWE , MilichR , HozaB .ADHD boys’ performance and attributions following success and failure: drug effects and individual differences. Cognitive Therapy and Research1993;17:269-87. ">Carlson 1993</a> ; <a href="./references#MR000050-bbs2-0016" title="CarterJC , OlmstedMP , KaplanAS , McCabeRE , MillsJS , AimeA .Self-help for bulimia nervosa: a randomized controlled trial. American Journal of Psychiatry2003;160(5):973-8. ">Carter 2003</a> ; <a href="./references#MR000050-bbs2-0017" title="CrispAH , NortonK , GowersS , HalekC , BowyerC , YeldhamD , et al.A controlled study of the effect of therapies aimed at adolescent and family psychopathology in Anorexia Nervosa. British Journal of Psychiatry: the Journal of Mental Science1991;159:325-33. GowersS , NortonK , HalekC , CrispAH .Outcome of outpatient psychotherapy in a random allocation treatment study of anorexia nervosa. International Journal of Eating Disorders1994;15(2):165-77. GowersS , NortonK , YelshamD .The St George's prospective treatment study of anorexia nervosa: a discussion of methodological problems. International Journal of Eating Disorders1989;8:445-54. ">Crisp 1991</a> ; <a href="./references#MR000050-bbs2-0018" title="CrouchG , RobsonM , HallstromC .Benzodiazepine dependent patients and their psychological treatment. Progress in Neuro-psychopharmacology &amp; Biological Psychiatry1988;12(4):503-10. HallströmC , CrouchG , RobsenM , ShineP .The treatment of tranquillizer dependence by propranolol. Postgraduate Medical Journal1988;64(Suppl 2):40-4. ">Crouch 1988</a> ; <a href="./references#MR000050-bbs2-0019" title="Doty, DW.Role playing and incentives in the modification of the social interaction of chronic psychiatric patients. Journal of Consulting and Clinical Psychology1975;43(5):676-82. ">Doty 1975</a> ; <a href="./references#MR000050-bbs2-0020" title="DoubleDB , WarrenGC , EvansM , RowlandsMP .Efficacy of maintenance use of anticholinergic agents. Acta Psychiatrica Scandinavica1993;88:381-4. ">Double 1993</a> ; <a href="./references#MR000050-bbs2-0022" title="EspieCA , BrooksDN , LindsayWR .An evaluation of tailored psychological treatment of insomnia. Journal of Behavior Therapy and Experimental Psychiatry1989;20(2):143-53. EspieCA , LindsayWR , BrooksDN , HoodEM , TurveyT .A controlled comparative investigation of psychological treatments for chronic sleep-onset insomnia. Behaviour Research and Therapy1989;27(1):79-88. ">Espie 1989a</a> ; <a href="./references#MR000050-bbs2-0023" title="EtringerBD , CashTF , RimmDC .Behavioral, affective, and cognitive effects of participant modeling and an equally credible placebo. Behavior Therapy1982;13(4):476-85. ">Etringer 1982</a> ; <a href="./references#MR000050-bbs2-0024" title="FoaEB , RothbaumBO , RiggsDS , MurdockTB .Treatment of posttraumatic stress disorder in rape victims: a comparison between cognitive-behavioral procedures and counselling. Journal of Consulting and Clinical Psychology1991;59(5):715-23. ">Foa 1991</a> ; <a href="./references#MR000050-bbs2-0025" title="FoaEB , McLeanCP , ZangY , RosenfieldD , YadinE , YarvisJS , et al.Effect of prolonged exposure therapy delivered over 2 weeks vs 8 weeks vs present-centered therapy on PTSD symptom severity in military personnel: a randomized clinical trial. JAMA2018;319(4):354-64. ">Foa 2018</a> ; <a href="./references#MR000050-bbs2-0027" title="FuchsCZ , RehnLP .A self-control behavior therapy program for depression. Journal of Consulting and Clinical Psychology1977;45(2):206-15. ">Fuchs 1977</a> ; <a href="./references#MR000050-bbs2-0029" title="GoldsteinAJ , BeursE , Chambless Dl, WilsonKA .EMDR for panic disorder with agoraphobia: comparison with waiting list and credible attention-placebo control conditions. Journal of Consulting and Clinical Psychology2000;68(6):947-56. ">Goldstein 2000</a> ; <a href="./references#MR000050-bbs2-0030" title="GoldwasserAN , AuerbachSM , HarkinsSW .Cognitive, affective, and behavioural effects of reminiscence group therapy on demented elderly. Aging and Human Development1987;25(3):209-22. ">Goldwasser 1987</a> ; <a href="./references#MR000050-bbs2-0031" title="HekmatH , LubitzR , DealR .Semantic desensitization: a paradigmatic intervention approach to anxiety disorders. Journal of Clinical Psychology1984;40(2):463-6. ">Hekmat 1984</a> ; <a href="./references#MR000050-bbs2-0032" title="HippmanC , RingroseA , InglisA , CheekJ , AlbertAY , RemickR , et al.A pilot randomized clinical trial evaluating the impact of genetic counselling for serious mental illnesses. Journal of Clinical Psychiatry2016;77(2):e190-8. ">Hippman 2016</a> ; <a href="./references#MR000050-bbs2-0033" title="HowlinP , GordonKR , PascoG , WadeA , CharmanT .The effectiveness of picture exchange communication system (PECS) training for teachers of children with autism: a pragmatic,group randomised controlled trial. Journal of Child Psychology and Psychiatry2007;48(5):473-81. ">Howlin 2007</a> ; <a href="./references#MR000050-bbs2-0036" title="KennedyTD , KimuraHK .Transfer, behavioral improvement, and anxiety reduction in systematic desensitization. Journal of Consulting and Clinical Psychology1974;42(5):720-8. ">Kennedy 1974</a> ; <a href="./references#MR000050-bbs2-0037" title="KilmannPR , MilanRJ , BolandJP , NankinHR , DavidsonE , WestMO , et al.Group treatment of secondary erectile dysfunction. Journal of Sex &amp; Marital Therapy1987;13(3):168-82. KilmannPR , Milan RJ Jr, BolandJP , DavidsonE , WestMO , SablisRF , et al.The sexual interactions of men with secondary erectile dysfunction. Journal of Sex Education and Therapy1988;14(1):46-9. KilmannPR , Milan RJ Jr, BolandJP , NankinHR , SablisRF , WestMO , et al.The sexual interactions of men with secondary erectile dysfunction. Paper presented at the annual meeting of the American Psychological Association in Los Angeles1985;1:46-9. ">Kilmann 1987</a> ; <a href="./references#MR000050-bbs2-0038" title="KleinSA , DeffenbacherJL .Relaxation and exercise for hyperactive impulsive children. Perceptual and Motor Skills1977;45:1159-62. ">Klein 1977</a> ; <a href="./references#MR000050-bbs2-0039" title="KlermanGL , DimascioA , WeismannM , PrusoffB , PaykelES .Treatment of depression by drugs and psychotherapy. American Journal of Psychiatry1974;131(2):186-91. PaykelES , DimascioA , HaskellD , PrusoffBA .Effects of maintenance amitriptyline and psychotherapy on symptoms of depression. Psychological Medicine1975;5(1):67-77. PaykelES , DiMascioA , KlermanGL , PrusoffBA .Maintenance therapy of depression. Pharmakopsychiatrie, Neuro-Psychopharmakologie1976;9:127-39. PaykelES , WeissmanMM , PrusoffBA .Social maladjustment and severity of depression. Comprehensive Psychiatry1978;19(2):121-8. WeissmanMM , KlermanGL , PaykelES , PrusoffB .Treatment effects on the social adjustment of depressed patients. Archives of General Psychiatry1974;30:771-8. ">Klerman 1974a</a> ; <a href="./references#MR000050-bbs2-0040" title="KlermanGL , DimascioA , WeismannM , PrusoffB , PaykelES .Treatment of depression by drugs and psychotherapy. American Journal of Psychiatry1974;131(2):186-91. ">Klerman 1974b</a> ; <a href="./references#MR000050-bbs2-0041" title="KloskoJS , BarlowDH , TassinariR , CernyJA .A comparison of alprazolam and behavior therapy in treatment of panic disorder: correction. Journal of Psychotherapy Practice and Research1994;3(2):163-79. KloskoJS , BarlowDH , TassinariR , CernyJA .A comparison of alprazolam and behavior therapy in treatment of panic disorder. Journal of Consulting and Clinical Psychology1990;58(1):77-84. ">Klosko 1990</a> ; <a href="./references#MR000050-bbs2-0042" title="KrapflJE , NawasMM .Differential ordering of stimulus presentation in systematic desensitization. Journal of Abnormal Psychology1970;75(3):333-7. ">Krapfl 1970</a> ; <a href="./references#MR000050-bbs2-0044" title="LacyMK .The effect of short term autogenic training on the stress reactivity of hospitalized emotionally disturbed adolescents. ProQuest Dissertations Publishing, Oklahoma State University1996. ">Lacy 1990</a> ; <a href="./references#MR000050-bbs2-0045" title="LaiCK , ChiI , Kayser-JonesJ .A randomized controlled trial of a specific reminiscence approach to promote the well-being of nursing home residents with dementia. International Psychogeriatrics2004;16(1):33-49. LaiK .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 6th of September 2019. ">Lai 2004</a> ; <a href="./references#MR000050-bbs2-0046" title="LangOJ , LazovikAD .Experimental desensitization of a phobia. Journal of Abnormal and Social Psychology1963;66:519-25. LangPJ , LazovikAD , ReynoldsDJ .Desensitization, suggestibility, and pseudotherapy. Journal of Abnormal Psychology1965;70(6):395-402. ">Lang 1965</a> ; <a href="./references#MR000050-bbs2-0048" title="LickJ .Expectancy, false galvanic skin response feedback, and systematic desensitization in the modification of phobic behavior. Journal of Consulting and Clinical Psychology1975;43(4):557-67. ">Lick 1975</a> ; <a href="./references#MR000050-bbs2-0049" title="LickJR , HefflerD .Relaxation training and attention placebo in the treatment of severe insomnia. Journal of Consulting and Clinical Psychology1977;45(2):153-61. ">Lick 1977</a> ; <a href="./references#MR000050-bbs2-0050" title="LiddleB , SpenceSH .Cognitive-behaviour therapy with depressed primary school children: A cautionary note. Behavioural Psychotherapy1990;18(2):85-102. ">Liddle 1990</a> ; <a href="./references#MR000050-bbs2-0051" title="MatsonJL , MarchettiA , AdkinsJA .Comparison of operant- and independence-training procedures for mentally retarded adults. American Journal of Mental Deficiency1980;84(5):487-94. ">Matson 1980</a> ; <a href="./references#MR000050-bbs2-0052" title="McLachlanDR , DaltonAJ , KruckTP , BellMY , SmithWL , KalowW , et al.Intramuscular desferrioxamine in patients with Alzheimer's disease. Lancet1991;337(8753):1304-8. McLachlanDRC , SmithWL , KruckTP .Desferrioxamine and Alzheimer’s disease: video home behavior assessment of clinical course and measures of brain aluminum. Therapeutic Drug Monitoring1993;15(6):602-7. ">McLachlan 1991</a> ; <a href="./references#MR000050-bbs2-0053" title="MealieaWL , NawasMM .The comparative effectiveness of systematic desensitization and implosive therapy in the treatment of snake phobia. Journal of Behavior Therapy and Experimental Psychiatry1971;2(2):85-94. ">Mealiea 1971</a> ; <a href="./references#MR000050-bbs2-0054" title="MilbyJB , ClarkeC , ToroC , ThorntonS , RickertD .Effectiveness of urine surveillance as an adjunct to outpatient psychotherapy for drug abusers. International Journal of the Addictions1980;15(7):993-1001. ">Milby 1980</a> ; <a href="./references#MR000050-bbs2-0055" title="MirandaA , ArlandisP , SorianoM .Instruction in strategies and attributional training: Effects on the problem-solving and self-concept of students’ with learning disabilities [Instrucción en estrategias y entrenamiento atribucional: efectos sobre la resolución de problemas y el autoconcepto de los estudiantes con dificultades en el aprendizaje]. Infancia y Aprendizaje1997;20(80):37-52. ">Miranda 1997</a> ; <a href="./references#MR000050-bbs2-0056" title="MitchellC , MansfieldD , RautenbachS .Coloured filters and reading accuracy, comprehension and rate: a placebo-controlled study. Perceptual and Motor Skills2008;106(2):517-32. ">Mitchell 2008</a> ; <a href="./references#MR000050-bbs2-0057" title="NandiDN , AjmanyS , GanguliH , BanerjeeG , BoralGC , GhoshA , et al.A clinical evaluation of depressives found in a rural survey in India. British Journal of Psychiatry1976;128:523-7. ">Nandi 1976</a> ; <a href="./references#MR000050-bbs2-0058" title="NicassioP , BootzinR .A comparison of progressive relaxation and autogenic training as treatments for insomnia. Journal of Abnormal Psychology1974;83(3):253-60. ">Nicassio 1974</a> ; <a href="./references#MR000050-bbs2-0059" title="PearlD , Vander KampH , OlsenAL , GreenbergPD , ArmitageSG .The effects of reserpine on schizophrenic patients. American Journal of Psychiatry1956;112:198-204. ">Pearl 1956</a> ; <a href="./references#MR000050-bbs2-0060" title="PeckCL .Desensitization for the treatment of fear in the high level adult retardate. Behaviour Research and Therapy1977;15(2):137-48. ">Peck 1976</a> ; <a href="./references#MR000050-bbs2-0061" title="MilichR , CarlsonCL , Pelham WE Jr, LichtBG .Effects of methylphenidate on the persistence of ADHD boys following failure experiences. Journal of Abnormal Child Psychology1991;19(5):519-36. PelhamWE , MurphyDA , VannattaK , MilichR , LichtBG , GnagyEM , et al.Methylphenidate and attributions in boys with attention-deficit hyperactivity disorder. Journal of Consulting and Clinical Psychology1992;60(2):282-92. ">Pelham 1992</a> ; <a href="./references#MR000050-bbs2-0062" title="PedletonMG , HigginsRL .A comparison of negative practice and systematic desensitization in the treatment of acrophobia. Journal of Behavior Therapy and Experimental Psychiatry1983;14(4):317-23. ">Pendleton 1983</a> ; <a href="./references#MR000050-bbs2-0063" title="PetersonMA , PattersonB , PillmanBM , BattistaMA .Cognitive recovery following alcohol detoxification: a computerised remediation study. Neuropsychological Rehabilitation2002;12(1):63-74. PillmanBM .Computerized cognitive remediation with recently detoxified alcoholics. Dissertation, California School of Professional Psychology, Fresno Campus2000. ">Pillman 2001</a> ; <a href="./references#MR000050-bbs2-0065" title="PowersMB , SmitsJA , TelchMJ .Disentangling the effects of safety-behavior utilization and safety-behavior availability during exposure-based treatment: a placebo-controlled trial. Journal of Consulting and Clinical Psychology2004;72(3):448-54. ">Powers 2004</a> ; <a href="./references#MR000050-bbs2-0066" title="PowersMB , SmithsJA , WhitleyD , BystritskyA , TelchMJ .The effect of attributional processes concerning medication taking on return of fear. Journal of Consulting and Clinical Psychology2008;76(3):478-90. ">Powers 2008a</a> ; <a href="./references#MR000050-bbs2-0067" title="PowersMB , SmithsJA , WhitleyD , BystritskyA , TelchMJ .The effect of attributional processes concerning medication taking on return of fear. Journal of Consulting and Clinical Psychology2008;76(3):478-90. ">Powers 2008b</a> ; <a href="./references#MR000050-bbs2-0069" title="QuayhagenMP , QuayhagenM , CorbeilRR , RothPA , RodgersJA .A dyadic remediation program for care recipients with dementia. Nursing Research1995;44(3):153-9. ">Quayhagen 1995</a> ; <a href="./references#MR000050-bbs2-0070" title="LiebowitzM , QuitkinFM , StewartJW , McGrathPJ , HarrisonWM , MarkowitzJS , et al.Antidepressant efficacy in atypical depression. Archives of General Psychiatry1988;45(2):129-37. QuitkinFM , McGrathPJ , StewartJW , HarrisonW , WagerSG , NunesE , et al.Phenelzine and imipramine in mood reactive depressives: further delineation of the syndrome of atypical depression. Archives of General Psychiatry1989;46(9):787-93. RabkinJG , McGrathPJ , QuitkinFM , TricamoE , StewartJW , KleinDF .Effects of pill-giving on maintenance of placebo response in patients with chronic mild depression. American Journal of Psychiatry1990;147(12):1622-6. ">Rabkin 1990</a> ; <a href="./references#MR000050-bbs2-0072" title="RapeeR .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 29th of August 2019. RapeeRM , AbbottMJ , BaillieAJ , GastonJE .Treatment of social phobia through pure self-help and therapist-augmented self-help. British Journal of Psychiatry2007;191:246-52. ">Rapee 2007</a> ; <a href="./references#MR000050-bbs2-0073" title="RobinA .Rationing out-patients: a defence of the waiting list. British Journal of Psychiatry1976;129:138-41. ">Robin 1976</a> ; <a href="./references#MR000050-bbs2-0074" title="RoehrichL , GoldmanMS .Experience-dependent neuropsychological recovery and the treatment of alcoholism. Journal of Consulting and Clinical Psychology1993;61(5):812-21. ">Roehrich 1993</a> ; <a href="./references#MR000050-bbs2-0075" title="OlivaresJ .Program IAFS. Protocol for the treatment of social phobia in adolescents [Programa IAFS. Protocolo para el tratamiento de la fobia social enadolescentes]. Madrid: Pirámide2005;1. Rosa-AlcázarAI , Olivares-OlivaresPJ , OlivaresJ .The role of non-specific effects in the psychological treatment of adolescents with social phobia [Papel de los efectos inespecíficos en el tratamiento psicológico de adolescentes con fobia social]. Anuario de Psicologia2009;40(1):43-61. ">Rosa‐Alcatraz 2009</a> ; <a href="./references#MR000050-bbs2-0076" title="RosenGM , GlasgowRE , BarreraM .A controlled study to assess the clinical efficacy of totally self-administrated systematic desensitization. Journal of Consulting and Clinical Psychology1976;44(2):208-17. ">Rosen 1976</a> ; <a href="./references#MR000050-bbs2-0078" title="RupertPA , HolmesDS .Effects of multiple sessions of true and placebo heart rate biofeedback training on the heart rates and anxiety levels of anxious patients during and following treatment. Psychophysiology1978;15(6):582-90. ">Rupert 1978</a> ; <a href="./references#MR000050-bbs2-0079" title="ShalevAY , AnkriY , Isreali-ShalevY , PelegT , AdesskyR , FreedmanS .Prevention of posttraumatic stress disorder by early treatment. Archives of General Psychiatry2012;69(2):166-76. ">Shalev 2012</a> ; <a href="./references#MR000050-bbs2-0080" title="ShealyRC .The effectiveness of various treatment techniques on different degrees and durations of sleep-onset insomnia. Behaviour Research and Therapy1979;17(6):541-6. ">Shealy 1979</a> ; <a href="./references#MR000050-bbs2-0083" title="SteinmarkSW , BorkovecTD .Active and placebo treatment effects on moderate insomnia under counterdemand and positive demand instructions. Journal of Abnormal Psychology1974;83(2):157-63. ">Steinmark 1974</a> ; <a href="./references#MR000050-bbs2-0084" title="SzymanskiJ , O'DonohueW .The potential role of state-dependent learning in cognitive therapy with spider phobics. Journal of Rational-Emotive &amp; Cognitive-Behavior Therapy1995;13(2):131-50. SzymanskiJ .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 20th of August 2019. ">Szymanski 1995</a> ; <a href="./references#MR000050-bbs2-0085" title="TanSY , BruniJ .Cognitive-behavior therapy with adult patients with epilepsy: a controlled outcome study. Epilepsia1986;27(3):225-33. ">Tan 1986</a> ; <a href="./references#MR000050-bbs2-0087" title="ToriC , WorellL .Reduction of human avoidant behavior. A comparison of counterconditioning, expectancy, and cognitive information approaches. Clinical Psychology1973;41(2):269-78. ">Tori 1973</a> ; <a href="./references#MR000050-bbs2-0088" title="Trexler, L.Rational-emotive therapy, placebo, and no-treatment effects on public-speaking anxiety. Doctoral dissertation, Temple University AnnArbor, Mich.: University Microfilms1971;71-31(063). TrexlerLD , KarstTO .Rational-emotive therapy, placebo, and no-treatment effects on public-speaking anxiety. Journal of Abnormal Psyhology1972;79(1):60-7. ">Trexler 1972</a> ; <a href="./references#MR000050-bbs2-0089" title="AscherML , TurnerRM .A comparison of two methods for the administration of paradoxical intention. Behaviour Research and Therapy1980;18(2):121-6. TurnerRM , AscherLM .Controlled comparison of progressive relaxation, stimulus control, and paradoxical intention therapies for insomnia. Journal of Consulting and Clinical Psychology1979;47(3):500-8. ">Turner 1979</a> ; <a href="./references#MR000050-bbs2-0090" title="VanderplateC .Electromyograph biofeedback Treatment of sleep onset Insomnia: a controlled Investigation. Dissertation, University of Southern Mississippi1978. ">Vanderplate 1983</a> ; <a href="./references#MR000050-bbs2-0091" title="WatzlH , RistF , OlbrichR , CohenR .Placebo injections and surveillance of alcohol intake during inpatient treatment of female alcoholics. Addictive Behaviors1988;13(2):197-200. ">Watzl 1988</a> ; <a href="./references#MR000050-bbs2-0092" title="WeingaertnerAH .Self-administered aversive stimulation with hallucinating hospitalized schizophrenics. Journal of Consulting and Clinical Psychology1971;36(3):422-29. ">Weingaertner 1971</a> ; <a href="./references#MR000050-bbs2-0094" title="WilsonA , DavidsonWJ , BlanchardR , WhiteJ .Disulfiram implantation. A placebo-controlled trial with two-year follow-up. Journal of Studies on Alcohol1978;39(5):809-19. WilsonA , DavidsonWJ , BlanchardR .Disulfiram implantation: a trial using placebo implants and two types of controls. Journal of Studies on Alcohol1980;41(5):429-36. ">Wilson 1980</a> ; <a href="./references#MR000050-bbs2-0095" title="WolitzkyKB , TelchMJ .Augmenting in vivo exposure with fear antagonistic actions: a preliminary test. Behavior Therapy2009;40(1):57-71. ">Wolitzky 2009</a> ; <a href="./references#MR000050-bbs2-0096" title="WollersheimJP , WilsonGL .Group treatment of unipolar depression: a comparison of coping, supportive, bibliotherapy, and delayed treatment groups. Professional Psychology: Research and Practice1991;22(6):496-502. ">Wollersheim 1991</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Blinding of outcome assessors</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Low risk of bias</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>45</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#MR000050-bbs2-0002" title="AllenJB .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to A Todorovac 28th of August 2019. AllenJJ , SchnyerRN , HittSK .The efficacy of acupuncture in the treatment of major depression in women. Psychological Science1998;9(5):397-401. ">Allen 1998</a> ; <a href="./references#MR000050-bbs2-0003" title="AllenJB .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 28th of August 2019. AllenJJ , SchnyerRN , ChambersAS , HittSK , MorenoFA , ManberR .Acupuncture for depression: a randomized controlled trial. Journal of Clinical Psychiatry2006;67(11):1665-73. ">Allen 2006</a> ; <a href="./references#MR000050-bbs2-0008" title="Borden, KA.Attributional Outcomes: the Subtle Messages of Treatments for Attention Deficit Disorder. Dissertation, University of Illinois at Urbana-Champaign1986. BordenKA , BrownRT .Attributional outcomes: The subtle messages of treatments for attention deficit disorder. Cognitive Therapy and Research1989;13(2):147-60. ">Borden 1986</a> ; <a href="./references#MR000050-bbs2-0010" title="BorkovecTD , WeertsTC .Effects of progressive relaxation on sleep disturbance: an electroencephalographic evaluation. Psychosomatic Medicine1976;38(3):173-80. ">Borkovec 1976</a> ; <a href="./references#MR000050-bbs2-0012" title="BramstonP , SpenceSH .Behavioural versus cognitive social-skills training with intellectually-handicapped adults. Behaviour Research and Therapy1985;23(3):239-46. ">Bramston 1985</a> ; <a href="./references#MR000050-bbs2-0015" title="CarlsonCL , PelhamWE , MilichR , HozaB .ADHD boys’ performance and attributions following success and failure: drug effects and individual differences. Cognitive Therapy and Research1993;17:269-87. ">Carlson 1993</a> ; <a href="./references#MR000050-bbs2-0019" title="Doty, DW.Role playing and incentives in the modification of the social interaction of chronic psychiatric patients. Journal of Consulting and Clinical Psychology1975;43(5):676-82. ">Doty 1975</a> ; <a href="./references#MR000050-bbs2-0020" title="DoubleDB , WarrenGC , EvansM , RowlandsMP .Efficacy of maintenance use of anticholinergic agents. Acta Psychiatrica Scandinavica1993;88:381-4. ">Double 1993</a> ; <a href="./references#MR000050-bbs2-0021" title="EhlersA , HackmannA , GreyN , WildJ , LinessS , AlbertI , et al.A randomized controlled trial of 7-day intensive and standard weekly cognitive therapy for PTSD and emotion-focused supportive therapy. American Journal of Psychiatry2014;171(3):294-304. ">Ehlers 2014</a> ; <a href="./references#MR000050-bbs2-0023" title="EtringerBD , CashTF , RimmDC .Behavioral, affective, and cognitive effects of participant modeling and an equally credible placebo. Behavior Therapy1982;13(4):476-85. ">Etringer 1982</a> ; <a href="./references#MR000050-bbs2-0024" title="FoaEB , RothbaumBO , RiggsDS , MurdockTB .Treatment of posttraumatic stress disorder in rape victims: a comparison between cognitive-behavioral procedures and counselling. Journal of Consulting and Clinical Psychology1991;59(5):715-23. ">Foa 1991</a> ; <a href="./references#MR000050-bbs2-0025" title="FoaEB , McLeanCP , ZangY , RosenfieldD , YadinE , YarvisJS , et al.Effect of prolonged exposure therapy delivered over 2 weeks vs 8 weeks vs present-centered therapy on PTSD symptom severity in military personnel: a randomized clinical trial. JAMA2018;319(4):354-64. ">Foa 2018</a> ; <a href="./references#MR000050-bbs2-0026" title="FreireAO , SugaiGC , ChrispinFS , TogeiroSM , YamamuraY , MelloLE , et al.Treatment of moderate obstructive sleep apnea syndrome with acupuncture: a randomised, placebo-controlled pilot trial. Sleep Medicine2007;8(1):43-50. ">Freire 2007</a> ; <a href="./references#MR000050-bbs2-0028" title="GlogowskaM , RoulstoneS , EnderbyP , PetersTJ .Randomised controlled trial of community based speech and language therapy in preschool children. BMJ2000;321(7266):923-6. ">Glogowska 2000</a> ; <a href="./references#MR000050-bbs2-0031" title="HekmatH , LubitzR , DealR .Semantic desensitization: a paradigmatic intervention approach to anxiety disorders. Journal of Clinical Psychology1984;40(2):463-6. ">Hekmat 1984</a> ; <a href="./references#MR000050-bbs2-0034" title="KarstM , WinterhalterM , MünteS , FranckiB , HondronikosA , EckardtA , et al.Auricular acupuncture for dental anxiety: a randomized controlled trial. Anesthesia and Analgesia2007;104(2):295-300. KarstM .Inclusion of study in Cochrane Systematic Review (personal communication). Email to: EG Faltinsen 5th of September 2019. ">Karst 2007</a> ; <a href="./references#MR000050-bbs2-0035" title="KelleyJ .Inclusion of study in Cochrane Systematic Review (personal communication). Email to: A Todorovac 12th of August 2019. KelleyJM , KaptchukTJ , CusinC , LipkinS , FavaM .Open-label placebo for major depressive disorder: a pilot randomized controlled trial. Psychotherapy and Psychosomatics2012;81(5):312-4. ">Kelley 2012</a> ; <a href="./references#MR000050-bbs2-0036" title="KennedyTD , KimuraHK .Transfer, behavioral improvement, and anxiety reduction in systematic desensitization. Journal of Consulting and Clinical Psychology1974;42(5):720-8. ">Kennedy 1974</a> ; <a href="./references#MR000050-bbs2-0038" title="KleinSA , DeffenbacherJL .Relaxation and exercise for hyperactive impulsive children. Perceptual and Motor Skills1977;45:1159-62. ">Klein 1977</a> ; <a href="./references#MR000050-bbs2-0041" title="KloskoJS , BarlowDH , TassinariR , CernyJA .A comparison of alprazolam and behavior therapy in treatment of panic disorder: correction. Journal of Psychotherapy Practice and Research1994;3(2):163-79. KloskoJS , BarlowDH , TassinariR , CernyJA .A comparison of alprazolam and behavior therapy in treatment of panic disorder. Journal of Consulting and Clinical Psychology1990;58(1):77-84. ">Klosko 1990</a> ; <a href="./references#MR000050-bbs2-0043" title="KwanR .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 26th of August 2019. KwanRY , LeungMC , LaiCK .Acupressure for agitation in nursing home residents with dementia: study protocol for a randomized controlled trial. Trials2014;15(410):1-7. KwanRY , LeungMCP , LaiCK .A randomized controlled trial examining the effect of acupressure on agitation and salivary cortisol in nursing home residents with dementia. Dementia and Geriatric Cognitive Disorders2017;44(1-2):92-104. ">Kwan 2017</a> ; <a href="./references#MR000050-bbs2-0045" title="LaiCK , ChiI , Kayser-JonesJ .A randomized controlled trial of a specific reminiscence approach to promote the well-being of nursing home residents with dementia. International Psychogeriatrics2004;16(1):33-49. LaiK .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 6th of September 2019. ">Lai 2004</a> ; <a href="./references#MR000050-bbs2-0048" title="LickJ .Expectancy, false galvanic skin response feedback, and systematic desensitization in the modification of phobic behavior. Journal of Consulting and Clinical Psychology1975;43(4):557-67. ">Lick 1975</a> ; <a href="./references#MR000050-bbs2-0051" title="MatsonJL , MarchettiA , AdkinsJA .Comparison of operant- and independence-training procedures for mentally retarded adults. American Journal of Mental Deficiency1980;84(5):487-94. ">Matson 1980</a> ; <a href="./references#MR000050-bbs2-0052" title="McLachlanDR , DaltonAJ , KruckTP , BellMY , SmithWL , KalowW , et al.Intramuscular desferrioxamine in patients with Alzheimer's disease. Lancet1991;337(8753):1304-8. McLachlanDRC , SmithWL , KruckTP .Desferrioxamine and Alzheimer’s disease: video home behavior assessment of clinical course and measures of brain aluminum. Therapeutic Drug Monitoring1993;15(6):602-7. ">McLachlan 1991</a> ; <a href="./references#MR000050-bbs2-0053" title="MealieaWL , NawasMM .The comparative effectiveness of systematic desensitization and implosive therapy in the treatment of snake phobia. Journal of Behavior Therapy and Experimental Psychiatry1971;2(2):85-94. ">Mealiea 1971</a> ; <a href="./references#MR000050-bbs2-0057" title="NandiDN , AjmanyS , GanguliH , BanerjeeG , BoralGC , GhoshA , et al.A clinical evaluation of depressives found in a rural survey in India. British Journal of Psychiatry1976;128:523-7. ">Nandi 1976</a> ; <a href="./references#MR000050-bbs2-0062" title="PedletonMG , HigginsRL .A comparison of negative practice and systematic desensitization in the treatment of acrophobia. Journal of Behavior Therapy and Experimental Psychiatry1983;14(4):317-23. ">Pendleton 1983</a> ; <a href="./references#MR000050-bbs2-0063" title="PetersonMA , PattersonB , PillmanBM , BattistaMA .Cognitive recovery following alcohol detoxification: a computerised remediation study. Neuropsychological Rehabilitation2002;12(1):63-74. PillmanBM .Computerized cognitive remediation with recently detoxified alcoholics. Dissertation, California School of Professional Psychology, Fresno Campus2000. ">Pillman 2001</a> ; <a href="./references#MR000050-bbs2-0070" title="LiebowitzM , QuitkinFM , StewartJW , McGrathPJ , HarrisonWM , MarkowitzJS , et al.Antidepressant efficacy in atypical depression. Archives of General Psychiatry1988;45(2):129-37. QuitkinFM , McGrathPJ , StewartJW , HarrisonW , WagerSG , NunesE , et al.Phenelzine and imipramine in mood reactive depressives: further delineation of the syndrome of atypical depression. Archives of General Psychiatry1989;46(9):787-93. RabkinJG , McGrathPJ , QuitkinFM , TricamoE , StewartJW , KleinDF .Effects of pill-giving on maintenance of placebo response in patients with chronic mild depression. American Journal of Psychiatry1990;147(12):1622-6. ">Rabkin 1990</a> ; <a href="./references#MR000050-bbs2-0071" title="RapeeR .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 29th of August 2019. RapeeRM , AbbottMJ , LynehamHJ .Bibliotherapy for children With anxiety disorders using written materials for parents: a randomized controlled trial. Journal of Consulting and Clinical Psychology2006;74(3):436-44. ">Rapee 2006</a> ; <a href="./references#MR000050-bbs2-0072" title="RapeeR .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 29th of August 2019. RapeeRM , AbbottMJ , BaillieAJ , GastonJE .Treatment of social phobia through pure self-help and therapist-augmented self-help. British Journal of Psychiatry2007;191:246-52. ">Rapee 2007</a> ; <a href="./references#MR000050-bbs2-0073" title="RobinA .Rationing out-patients: a defence of the waiting list. British Journal of Psychiatry1976;129:138-41. ">Robin 1976</a> ; <a href="./references#MR000050-bbs2-0075" title="OlivaresJ .Program IAFS. Protocol for the treatment of social phobia in adolescents [Programa IAFS. Protocolo para el tratamiento de la fobia social enadolescentes]. Madrid: Pirámide2005;1. Rosa-AlcázarAI , Olivares-OlivaresPJ , OlivaresJ .The role of non-specific effects in the psychological treatment of adolescents with social phobia [Papel de los efectos inespecíficos en el tratamiento psicológico de adolescentes con fobia social]. Anuario de Psicologia2009;40(1):43-61. ">Rosa‐Alcatraz 2009</a> ; <a href="./references#MR000050-bbs2-0076" title="RosenGM , GlasgowRE , BarreraM .A controlled study to assess the clinical efficacy of totally self-administrated systematic desensitization. Journal of Consulting and Clinical Psychology1976;44(2):208-17. ">Rosen 1976</a> ; <a href="./references#MR000050-bbs2-0077" title="LorrM , McNairDM , WeinsteinGJ .Early effects of chlordiazepoxide (Librium) used with psychotherapy. Journal of Psychiatric Research1963;1:257-70. RothI , RhudickPJ , ShaskanDA , SlobinMS , WilkinsonAE , YoungHH .Long-term effects on psychotherapy of initial treatment conditions. Journal of Psychiatric Research1964;2:283-97. ">Roth 1964</a> ; <a href="./references#MR000050-bbs2-0079" title="ShalevAY , AnkriY , Isreali-ShalevY , PelegT , AdesskyR , FreedmanS .Prevention of posttraumatic stress disorder by early treatment. Archives of General Psychiatry2012;69(2):166-76. ">Shalev 2012</a> ; <a href="./references#MR000050-bbs2-0081" title="SibilioJP , AndrewG , DartD , MooreKB , StehmanA .Treatment of chronic schizophrenia with promazine hydrochloride. AMA Archives of Neurology and Psychiatry1957;78(4):419-24. ">Sibilio 1957</a> ; <a href="./references#MR000050-bbs2-0082" title="SommernessMD , LuceroRJ , HamlonJS , EricksonJL , MatthewsR .A controlled study of reserpine on chronically disturbed patients. JAMA Archives of Neurology and Psychiatry1955;74(3):316-9. ">Sommerness 1955</a> ; <a href="./references#MR000050-bbs2-0084" title="SzymanskiJ , O'DonohueW .The potential role of state-dependent learning in cognitive therapy with spider phobics. Journal of Rational-Emotive &amp; Cognitive-Behavior Therapy1995;13(2):131-50. SzymanskiJ .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 20th of August 2019. ">Szymanski 1995</a> ; <a href="./references#MR000050-bbs2-0086" title="TeriL , LogsdonRG , UomotoJ , McCurrySM .Behavioral treatment of depression in dementia patients: a controlled clinical trial. Journals of Gerontology. Series B, Psychological Sciences and Social Sciences1997;52(4):159-66. TeriL .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 26th of August 2019. ">Teri 1997</a> ; <a href="./references#MR000050-bbs2-0087" title="ToriC , WorellL .Reduction of human avoidant behavior. A comparison of counterconditioning, expectancy, and cognitive information approaches. Clinical Psychology1973;41(2):269-78. ">Tori 1973</a> ; <a href="./references#MR000050-bbs2-0088" title="Trexler, L.Rational-emotive therapy, placebo, and no-treatment effects on public-speaking anxiety. Doctoral dissertation, Temple University AnnArbor, Mich.: University Microfilms1971;71-31(063). TrexlerLD , KarstTO .Rational-emotive therapy, placebo, and no-treatment effects on public-speaking anxiety. Journal of Abnormal Psyhology1972;79(1):60-7. ">Trexler 1972</a> ; <a href="./references#MR000050-bbs2-0092" title="WeingaertnerAH .Self-administered aversive stimulation with hallucinating hospitalized schizophrenics. Journal of Consulting and Clinical Psychology1971;36(3):422-29. ">Weingaertner 1971</a> ; <a href="./references#MR000050-bbs2-0095" title="WolitzkyKB , TelchMJ .Augmenting in vivo exposure with fear antagonistic actions: a preliminary test. Behavior Therapy2009;40(1):57-71. ">Wolitzky 2009</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>High risk of bias</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>32</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#MR000050-bbs2-0001" title="AbikoffH , HechtmanL , KleinRG .Social functioning in children with ADHD treated with long-term methylphenidate and multimodal psychosocial treatment. Journal of the American Academy of Child and Adolescent Psychiatry2004;43(7):820-9. AbikoffH .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to A Todorovac 23rd of August 2019. KleinRG , AbikoffH , HechtmanL , WeissG .Design and rationale of controlled study of long-term methylphenidate and multimodal psychosocial treatment in children with ADHD. Journal of the American Academy of Child and Adolescent Psychiatry2004;43(7):792-801. ">Abikoff 2004</a> ; <a href="./references#MR000050-bbs2-0004" title="AlvarezJR .The effects of anger management training on depression, anger, self-concept, and treatment responsibility in a sample of drug-dependent individuals in a therapeutic community. Dissertation Abstracts International: Section B: the Sciences and Engineering1997;58(4-B):2108. ">Alvarez 1997</a> ; <a href="./references#MR000050-bbs2-0005" title="AscherLM , TurnerR .Paradoxical intention and insomnia: an experimental investigation. Behaviour Research and Therapy1979;17(4):408-11. ">Ascher 1979</a> ; <a href="./references#MR000050-bbs2-0006" title="AyenI , HautzingerM .Cognitive behavior therapy for depression in menopausal women. A controlled, randomized treatment study [Kognitive Verhaltenstherapie bei Depressionen im Klimakterium: Eine kontrollierte, randomiserte Interventionsstudie]. Zeitschrift für Klinische Psychologie und Psychotherapie2004;33(4):290-9. AyenI .Inclusion of study in Cochrane Systematic Review (personal communication). Email to EG Faltinsen 9th of September 2019. ">Ayen 2004</a> ; <a href="./references#MR000050-bbs2-0007" title="BergI , ForsytheI , HoltP , WattsJ .A controlled trial of ‘Senokot’ in faecal soiling treated by behavioural methods. Journal of Child Psychology and Psychiatry1983;24(4):543-9. ">Berg 1983</a> ; <a href="./references#MR000050-bbs2-0009" title="BorkovecTD , KaloupekDG , SlamaKM .The facilitative effect of muscle tension-release in the relaxation treatment of sleep disturbance. Behavior Therapy1975;6(3):301-9. ">Borkovec 1975</a> ; <a href="./references#MR000050-bbs2-0011" title="BornovalovaM .Inclusion of study in Cochrane Systematic Review (personal communication). Email to A Todorovac. 21st of August 2019. BornovalovaMA .Distress tolerance treatment for inner-city drug users: a preliminary trial. Doctor’s Dissertation, University of Maryland2008. ">Bornovalova 2008</a> ; <a href="./references#MR000050-bbs2-0016" title="CarterJC , OlmstedMP , KaplanAS , McCabeRE , MillsJS , AimeA .Self-help for bulimia nervosa: a randomized controlled trial. American Journal of Psychiatry2003;160(5):973-8. ">Carter 2003</a> ; <a href="./references#MR000050-bbs2-0017" title="CrispAH , NortonK , GowersS , HalekC , BowyerC , YeldhamD , et al.A controlled study of the effect of therapies aimed at adolescent and family psychopathology in Anorexia Nervosa. British Journal of Psychiatry: the Journal of Mental Science1991;159:325-33. GowersS , NortonK , HalekC , CrispAH .Outcome of outpatient psychotherapy in a random allocation treatment study of anorexia nervosa. International Journal of Eating Disorders1994;15(2):165-77. GowersS , NortonK , YelshamD .The St George's prospective treatment study of anorexia nervosa: a discussion of methodological problems. International Journal of Eating Disorders1989;8:445-54. ">Crisp 1991</a> ; <a href="./references#MR000050-bbs2-0018" title="CrouchG , RobsonM , HallstromC .Benzodiazepine dependent patients and their psychological treatment. Progress in Neuro-psychopharmacology &amp; Biological Psychiatry1988;12(4):503-10. HallströmC , CrouchG , RobsenM , ShineP .The treatment of tranquillizer dependence by propranolol. Postgraduate Medical Journal1988;64(Suppl 2):40-4. ">Crouch 1988</a> ; <a href="./references#MR000050-bbs2-0022" title="EspieCA , BrooksDN , LindsayWR .An evaluation of tailored psychological treatment of insomnia. Journal of Behavior Therapy and Experimental Psychiatry1989;20(2):143-53. EspieCA , LindsayWR , BrooksDN , HoodEM , TurveyT .A controlled comparative investigation of psychological treatments for chronic sleep-onset insomnia. Behaviour Research and Therapy1989;27(1):79-88. ">Espie 1989a</a> ; <a href="./references#MR000050-bbs2-0027" title="FuchsCZ , RehnLP .A self-control behavior therapy program for depression. Journal of Consulting and Clinical Psychology1977;45(2):206-15. ">Fuchs 1977</a> ; <a href="./references#MR000050-bbs2-0029" title="GoldsteinAJ , BeursE , Chambless Dl, WilsonKA .EMDR for panic disorder with agoraphobia: comparison with waiting list and credible attention-placebo control conditions. Journal of Consulting and Clinical Psychology2000;68(6):947-56. ">Goldstein 2000</a> ; <a href="./references#MR000050-bbs2-0032" title="HippmanC , RingroseA , InglisA , CheekJ , AlbertAY , RemickR , et al.A pilot randomized clinical trial evaluating the impact of genetic counselling for serious mental illnesses. Journal of Clinical Psychiatry2016;77(2):e190-8. ">Hippman 2016</a> ; <a href="./references#MR000050-bbs2-0033" title="HowlinP , GordonKR , PascoG , WadeA , CharmanT .The effectiveness of picture exchange communication system (PECS) training for teachers of children with autism: a pragmatic,group randomised controlled trial. Journal of Child Psychology and Psychiatry2007;48(5):473-81. ">Howlin 2007</a> ; <a href="./references#MR000050-bbs2-0037" title="KilmannPR , MilanRJ , BolandJP , NankinHR , DavidsonE , WestMO , et al.Group treatment of secondary erectile dysfunction. Journal of Sex &amp; Marital Therapy1987;13(3):168-82. KilmannPR , Milan RJ Jr, BolandJP , DavidsonE , WestMO , SablisRF , et al.The sexual interactions of men with secondary erectile dysfunction. Journal of Sex Education and Therapy1988;14(1):46-9. KilmannPR , Milan RJ Jr, BolandJP , NankinHR , SablisRF , WestMO , et al.The sexual interactions of men with secondary erectile dysfunction. Paper presented at the annual meeting of the American Psychological Association in Los Angeles1985;1:46-9. ">Kilmann 1987</a> ; <a href="./references#MR000050-bbs2-0047" title="LegrandF .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 14th of August 2019. LegrandFD , NeffEM .Efficacy of exercise as an adjunct treatment for clinically depressed inpatients during the initial stages of antidepressant pharmacotherapy: an open randomized controlled trial. Journal of Affective Disorders2016;191:139-44. ">Legrand 2016</a> ; <a href="./references#MR000050-bbs2-0049" title="LickJR , HefflerD .Relaxation training and attention placebo in the treatment of severe insomnia. Journal of Consulting and Clinical Psychology1977;45(2):153-61. ">Lick 1977</a> ; <a href="./references#MR000050-bbs2-0050" title="LiddleB , SpenceSH .Cognitive-behaviour therapy with depressed primary school children: A cautionary note. Behavioural Psychotherapy1990;18(2):85-102. ">Liddle 1990</a> ; <a href="./references#MR000050-bbs2-0058" title="NicassioP , BootzinR .A comparison of progressive relaxation and autogenic training as treatments for insomnia. Journal of Abnormal Psychology1974;83(3):253-60. ">Nicassio 1974</a> ; <a href="./references#MR000050-bbs2-0061" title="MilichR , CarlsonCL , Pelham WE Jr, LichtBG .Effects of methylphenidate on the persistence of ADHD boys following failure experiences. Journal of Abnormal Child Psychology1991;19(5):519-36. PelhamWE , MurphyDA , VannattaK , MilichR , LichtBG , GnagyEM , et al.Methylphenidate and attributions in boys with attention-deficit hyperactivity disorder. Journal of Consulting and Clinical Psychology1992;60(2):282-92. ">Pelham 1992</a> ; <a href="./references#MR000050-bbs2-0065" title="PowersMB , SmitsJA , TelchMJ .Disentangling the effects of safety-behavior utilization and safety-behavior availability during exposure-based treatment: a placebo-controlled trial. Journal of Consulting and Clinical Psychology2004;72(3):448-54. ">Powers 2004</a> ; <a href="./references#MR000050-bbs2-0066" title="PowersMB , SmithsJA , WhitleyD , BystritskyA , TelchMJ .The effect of attributional processes concerning medication taking on return of fear. Journal of Consulting and Clinical Psychology2008;76(3):478-90. ">Powers 2008a</a> ; <a href="./references#MR000050-bbs2-0067" title="PowersMB , SmithsJA , WhitleyD , BystritskyA , TelchMJ .The effect of attributional processes concerning medication taking on return of fear. Journal of Consulting and Clinical Psychology2008;76(3):478-90. ">Powers 2008b</a> ; <a href="./references#MR000050-bbs2-0068" title="ProudfootJ , ClarkeJ , BirchMR , WhittonAE , ParkerG , ManicavasagarV , et al.Impact of a mobile phone and web program on symptom and functional outcomes for people with mild- to-moderate depression, anxiety and stress: a randomized controlled trial. BMC Psychiatry2013;13(312):1-12. ProudfootJ .Re: Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 26th of August 2019. ">Proudfoot 2013</a> ; <a href="./references#MR000050-bbs2-0080" title="ShealyRC .The effectiveness of various treatment techniques on different degrees and durations of sleep-onset insomnia. Behaviour Research and Therapy1979;17(6):541-6. ">Shealy 1979</a> ; <a href="./references#MR000050-bbs2-0083" title="SteinmarkSW , BorkovecTD .Active and placebo treatment effects on moderate insomnia under counterdemand and positive demand instructions. Journal of Abnormal Psychology1974;83(2):157-63. ">Steinmark 1974</a> ; <a href="./references#MR000050-bbs2-0085" title="TanSY , BruniJ .Cognitive-behavior therapy with adult patients with epilepsy: a controlled outcome study. Epilepsia1986;27(3):225-33. ">Tan 1986</a> ; <a href="./references#MR000050-bbs2-0089" title="AscherML , TurnerRM .A comparison of two methods for the administration of paradoxical intention. Behaviour Research and Therapy1980;18(2):121-6. TurnerRM , AscherLM .Controlled comparison of progressive relaxation, stimulus control, and paradoxical intention therapies for insomnia. Journal of Consulting and Clinical Psychology1979;47(3):500-8. ">Turner 1979</a> ; <a href="./references#MR000050-bbs2-0090" title="VanderplateC .Electromyograph biofeedback Treatment of sleep onset Insomnia: a controlled Investigation. Dissertation, University of Southern Mississippi1978. ">Vanderplate 1983</a> ; <a href="./references#MR000050-bbs2-0093" title="WhittakerCB , HoyRM .Withdrawal of perphenazine in chronic schizophrenia. British Journal of Psychiatry1963;109:422-7. ">Whittaker 1963</a> ; <a href="./references#MR000050-bbs2-0094" title="WilsonA , DavidsonWJ , BlanchardR , WhiteJ .Disulfiram implantation. A placebo-controlled trial with two-year follow-up. Journal of Studies on Alcohol1978;39(5):809-19. WilsonA , DavidsonWJ , BlanchardR .Disulfiram implantation: a trial using placebo implants and two types of controls. Journal of Studies on Alcohol1980;41(5):429-36. ">Wilson 1980</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Unclear risk of bias</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>19</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#MR000050-bbs2-0013" title="BrillNQ , KoeglerRR , EpsteinLJ , ForgyEW .Controlled study of psychiatric outpatient treatment. Archives of General Psychiatry1964;10:581-95. BrillNQ .Results of psychotherapy. California Medicine1966;104(4):249-53. ">Brill 1964a</a> ; <a href="./references#MR000050-bbs2-0014" title="BrillNQ , KoeglerRR , EpsteinLJ , ForgyEW .Controlled study of psychiatric outpatient treatment. Archives of General Psychiatry1964;10:581-95. ">Brill 1964b</a> ; <a href="./references#MR000050-bbs2-0030" title="GoldwasserAN , AuerbachSM , HarkinsSW .Cognitive, affective, and behavioural effects of reminiscence group therapy on demented elderly. Aging and Human Development1987;25(3):209-22. ">Goldwasser 1987</a> ; <a href="./references#MR000050-bbs2-0039" title="KlermanGL , DimascioA , WeismannM , PrusoffB , PaykelES .Treatment of depression by drugs and psychotherapy. American Journal of Psychiatry1974;131(2):186-91. PaykelES , DimascioA , HaskellD , PrusoffBA .Effects of maintenance amitriptyline and psychotherapy on symptoms of depression. Psychological Medicine1975;5(1):67-77. PaykelES , DiMascioA , KlermanGL , PrusoffBA .Maintenance therapy of depression. Pharmakopsychiatrie, Neuro-Psychopharmakologie1976;9:127-39. PaykelES , WeissmanMM , PrusoffBA .Social maladjustment and severity of depression. Comprehensive Psychiatry1978;19(2):121-8. WeissmanMM , KlermanGL , PaykelES , PrusoffB .Treatment effects on the social adjustment of depressed patients. Archives of General Psychiatry1974;30:771-8. ">Klerman 1974a</a> ; <a href="./references#MR000050-bbs2-0040" title="KlermanGL , DimascioA , WeismannM , PrusoffB , PaykelES .Treatment of depression by drugs and psychotherapy. American Journal of Psychiatry1974;131(2):186-91. ">Klerman 1974b</a> ; <a href="./references#MR000050-bbs2-0042" title="KrapflJE , NawasMM .Differential ordering of stimulus presentation in systematic desensitization. Journal of Abnormal Psychology1970;75(3):333-7. ">Krapfl 1970</a> ; <a href="./references#MR000050-bbs2-0044" title="LacyMK .The effect of short term autogenic training on the stress reactivity of hospitalized emotionally disturbed adolescents. ProQuest Dissertations Publishing, Oklahoma State University1996. ">Lacy 1990</a> ; <a href="./references#MR000050-bbs2-0046" title="LangOJ , LazovikAD .Experimental desensitization of a phobia. Journal of Abnormal and Social Psychology1963;66:519-25. LangPJ , LazovikAD , ReynoldsDJ .Desensitization, suggestibility, and pseudotherapy. Journal of Abnormal Psychology1965;70(6):395-402. ">Lang 1965</a> ; <a href="./references#MR000050-bbs2-0054" title="MilbyJB , ClarkeC , ToroC , ThorntonS , RickertD .Effectiveness of urine surveillance as an adjunct to outpatient psychotherapy for drug abusers. International Journal of the Addictions1980;15(7):993-1001. ">Milby 1980</a> ; <a href="./references#MR000050-bbs2-0055" title="MirandaA , ArlandisP , SorianoM .Instruction in strategies and attributional training: Effects on the problem-solving and self-concept of students’ with learning disabilities [Instrucción en estrategias y entrenamiento atribucional: efectos sobre la resolución de problemas y el autoconcepto de los estudiantes con dificultades en el aprendizaje]. Infancia y Aprendizaje1997;20(80):37-52. ">Miranda 1997</a> ; <a href="./references#MR000050-bbs2-0056" title="MitchellC , MansfieldD , RautenbachS .Coloured filters and reading accuracy, comprehension and rate: a placebo-controlled study. Perceptual and Motor Skills2008;106(2):517-32. ">Mitchell 2008</a> ; <a href="./references#MR000050-bbs2-0059" title="PearlD , Vander KampH , OlsenAL , GreenbergPD , ArmitageSG .The effects of reserpine on schizophrenic patients. American Journal of Psychiatry1956;112:198-204. ">Pearl 1956</a> ; <a href="./references#MR000050-bbs2-0060" title="PeckCL .Desensitization for the treatment of fear in the high level adult retardate. Behaviour Research and Therapy1977;15(2):137-48. ">Peck 1976</a> ; <a href="./references#MR000050-bbs2-0064" title="PolandRE , GertsikL , FavreauJT , SmithSI , MirochaJM , RaoU , et al.Open-label randomized parallel-group controlled clinical trial of massage for treatment of depression in HIV-infected subjects. Journal of Alternative and Complementary Medicine2013;19(4):334-40. ">Poland 2013</a> ; <a href="./references#MR000050-bbs2-0069" title="QuayhagenMP , QuayhagenM , CorbeilRR , RothPA , RodgersJA .A dyadic remediation program for care recipients with dementia. Nursing Research1995;44(3):153-9. ">Quayhagen 1995</a> ; <a href="./references#MR000050-bbs2-0074" title="RoehrichL , GoldmanMS .Experience-dependent neuropsychological recovery and the treatment of alcoholism. Journal of Consulting and Clinical Psychology1993;61(5):812-21. ">Roehrich 1993</a> ; <a href="./references#MR000050-bbs2-0078" title="RupertPA , HolmesDS .Effects of multiple sessions of true and placebo heart rate biofeedback training on the heart rates and anxiety levels of anxious patients during and following treatment. Psychophysiology1978;15(6):582-90. ">Rupert 1978</a> ; <a href="./references#MR000050-bbs2-0091" title="WatzlH , RistF , OlbrichR , CohenR .Placebo injections and surveillance of alcohol intake during inpatient treatment of female alcoholics. Addictive Behaviors1988;13(2):197-200. ">Watzl 1988</a> ; <a href="./references#MR000050-bbs2-0096" title="WollersheimJP , WilsonGL .Group treatment of unipolar depression: a comparison of coping, supportive, bibliotherapy, and delayed treatment groups. Professional Psychology: Research and Practice1991;22(6):496-502. ">Wollersheim 1991</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Blinding of participants and personnel</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>High risk of bias</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>96</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#MR000050-bbs2-0001" title="AbikoffH , HechtmanL , KleinRG .Social functioning in children with ADHD treated with long-term methylphenidate and multimodal psychosocial treatment. Journal of the American Academy of Child and Adolescent Psychiatry2004;43(7):820-9. AbikoffH .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to A Todorovac 23rd of August 2019. KleinRG , AbikoffH , HechtmanL , WeissG .Design and rationale of controlled study of long-term methylphenidate and multimodal psychosocial treatment in children with ADHD. Journal of the American Academy of Child and Adolescent Psychiatry2004;43(7):792-801. ">Abikoff 2004</a> ; <a href="./references#MR000050-bbs2-0002" title="AllenJB .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to A Todorovac 28th of August 2019. AllenJJ , SchnyerRN , HittSK .The efficacy of acupuncture in the treatment of major depression in women. Psychological Science1998;9(5):397-401. ">Allen 1998</a> ; <a href="./references#MR000050-bbs2-0003" title="AllenJB .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 28th of August 2019. AllenJJ , SchnyerRN , ChambersAS , HittSK , MorenoFA , ManberR .Acupuncture for depression: a randomized controlled trial. Journal of Clinical Psychiatry2006;67(11):1665-73. ">Allen 2006</a> ; <a href="./references#MR000050-bbs2-0004" title="AlvarezJR .The effects of anger management training on depression, anger, self-concept, and treatment responsibility in a sample of drug-dependent individuals in a therapeutic community. Dissertation Abstracts International: Section B: the Sciences and Engineering1997;58(4-B):2108. ">Alvarez 1997</a> ; <a href="./references#MR000050-bbs2-0005" title="AscherLM , TurnerR .Paradoxical intention and insomnia: an experimental investigation. Behaviour Research and Therapy1979;17(4):408-11. ">Ascher 1979</a> ; <a href="./references#MR000050-bbs2-0006" title="AyenI , HautzingerM .Cognitive behavior therapy for depression in menopausal women. A controlled, randomized treatment study [Kognitive Verhaltenstherapie bei Depressionen im Klimakterium: Eine kontrollierte, randomiserte Interventionsstudie]. Zeitschrift für Klinische Psychologie und Psychotherapie2004;33(4):290-9. AyenI .Inclusion of study in Cochrane Systematic Review (personal communication). Email to EG Faltinsen 9th of September 2019. ">Ayen 2004</a> ; <a href="./references#MR000050-bbs2-0007" title="BergI , ForsytheI , HoltP , WattsJ .A controlled trial of ‘Senokot’ in faecal soiling treated by behavioural methods. Journal of Child Psychology and Psychiatry1983;24(4):543-9. ">Berg 1983</a> ; <a href="./references#MR000050-bbs2-0008" title="Borden, KA.Attributional Outcomes: the Subtle Messages of Treatments for Attention Deficit Disorder. Dissertation, University of Illinois at Urbana-Champaign1986. BordenKA , BrownRT .Attributional outcomes: The subtle messages of treatments for attention deficit disorder. Cognitive Therapy and Research1989;13(2):147-60. ">Borden 1986</a> ; <a href="./references#MR000050-bbs2-0009" title="BorkovecTD , KaloupekDG , SlamaKM .The facilitative effect of muscle tension-release in the relaxation treatment of sleep disturbance. Behavior Therapy1975;6(3):301-9. ">Borkovec 1975</a> ; <a href="./references#MR000050-bbs2-0010" title="BorkovecTD , WeertsTC .Effects of progressive relaxation on sleep disturbance: an electroencephalographic evaluation. Psychosomatic Medicine1976;38(3):173-80. ">Borkovec 1976</a> ; <a href="./references#MR000050-bbs2-0011" title="BornovalovaM .Inclusion of study in Cochrane Systematic Review (personal communication). Email to A Todorovac. 21st of August 2019. BornovalovaMA .Distress tolerance treatment for inner-city drug users: a preliminary trial. Doctor’s Dissertation, University of Maryland2008. ">Bornovalova 2008</a> ; <a href="./references#MR000050-bbs2-0012" title="BramstonP , SpenceSH .Behavioural versus cognitive social-skills training with intellectually-handicapped adults. Behaviour Research and Therapy1985;23(3):239-46. ">Bramston 1985</a> ; <a href="./references#MR000050-bbs2-0013" title="BrillNQ , KoeglerRR , EpsteinLJ , ForgyEW .Controlled study of psychiatric outpatient treatment. Archives of General Psychiatry1964;10:581-95. BrillNQ .Results of psychotherapy. California Medicine1966;104(4):249-53. ">Brill 1964a</a> ; <a href="./references#MR000050-bbs2-0014" title="BrillNQ , KoeglerRR , EpsteinLJ , ForgyEW .Controlled study of psychiatric outpatient treatment. Archives of General Psychiatry1964;10:581-95. ">Brill 1964b</a> ; <a href="./references#MR000050-bbs2-0015" title="CarlsonCL , PelhamWE , MilichR , HozaB .ADHD boys’ performance and attributions following success and failure: drug effects and individual differences. Cognitive Therapy and Research1993;17:269-87. ">Carlson 1993</a> ; <a href="./references#MR000050-bbs2-0016" title="CarterJC , OlmstedMP , KaplanAS , McCabeRE , MillsJS , AimeA .Self-help for bulimia nervosa: a randomized controlled trial. American Journal of Psychiatry2003;160(5):973-8. ">Carter 2003</a> ; <a href="./references#MR000050-bbs2-0017" title="CrispAH , NortonK , GowersS , HalekC , BowyerC , YeldhamD , et al.A controlled study of the effect of therapies aimed at adolescent and family psychopathology in Anorexia Nervosa. British Journal of Psychiatry: the Journal of Mental Science1991;159:325-33. GowersS , NortonK , HalekC , CrispAH .Outcome of outpatient psychotherapy in a random allocation treatment study of anorexia nervosa. International Journal of Eating Disorders1994;15(2):165-77. GowersS , NortonK , YelshamD .The St George's prospective treatment study of anorexia nervosa: a discussion of methodological problems. International Journal of Eating Disorders1989;8:445-54. ">Crisp 1991</a> ; <a href="./references#MR000050-bbs2-0018" title="CrouchG , RobsonM , HallstromC .Benzodiazepine dependent patients and their psychological treatment. Progress in Neuro-psychopharmacology &amp; Biological Psychiatry1988;12(4):503-10. HallströmC , CrouchG , RobsenM , ShineP .The treatment of tranquillizer dependence by propranolol. Postgraduate Medical Journal1988;64(Suppl 2):40-4. ">Crouch 1988</a> ; <a href="./references#MR000050-bbs2-0019" title="Doty, DW.Role playing and incentives in the modification of the social interaction of chronic psychiatric patients. Journal of Consulting and Clinical Psychology1975;43(5):676-82. ">Doty 1975</a> ; <a href="./references#MR000050-bbs2-0020" title="DoubleDB , WarrenGC , EvansM , RowlandsMP .Efficacy of maintenance use of anticholinergic agents. Acta Psychiatrica Scandinavica1993;88:381-4. ">Double 1993</a> ; <a href="./references#MR000050-bbs2-0021" title="EhlersA , HackmannA , GreyN , WildJ , LinessS , AlbertI , et al.A randomized controlled trial of 7-day intensive and standard weekly cognitive therapy for PTSD and emotion-focused supportive therapy. American Journal of Psychiatry2014;171(3):294-304. ">Ehlers 2014</a> ; <a href="./references#MR000050-bbs2-0022" title="EspieCA , BrooksDN , LindsayWR .An evaluation of tailored psychological treatment of insomnia. Journal of Behavior Therapy and Experimental Psychiatry1989;20(2):143-53. EspieCA , LindsayWR , BrooksDN , HoodEM , TurveyT .A controlled comparative investigation of psychological treatments for chronic sleep-onset insomnia. Behaviour Research and Therapy1989;27(1):79-88. ">Espie 1989a</a> ; <a href="./references#MR000050-bbs2-0023" title="EtringerBD , CashTF , RimmDC .Behavioral, affective, and cognitive effects of participant modeling and an equally credible placebo. Behavior Therapy1982;13(4):476-85. ">Etringer 1982</a> ; <a href="./references#MR000050-bbs2-0024" title="FoaEB , RothbaumBO , RiggsDS , MurdockTB .Treatment of posttraumatic stress disorder in rape victims: a comparison between cognitive-behavioral procedures and counselling. Journal of Consulting and Clinical Psychology1991;59(5):715-23. ">Foa 1991</a> ; <a href="./references#MR000050-bbs2-0025" title="FoaEB , McLeanCP , ZangY , RosenfieldD , YadinE , YarvisJS , et al.Effect of prolonged exposure therapy delivered over 2 weeks vs 8 weeks vs present-centered therapy on PTSD symptom severity in military personnel: a randomized clinical trial. JAMA2018;319(4):354-64. ">Foa 2018</a> ; <a href="./references#MR000050-bbs2-0026" title="FreireAO , SugaiGC , ChrispinFS , TogeiroSM , YamamuraY , MelloLE , et al.Treatment of moderate obstructive sleep apnea syndrome with acupuncture: a randomised, placebo-controlled pilot trial. Sleep Medicine2007;8(1):43-50. ">Freire 2007</a> ; <a href="./references#MR000050-bbs2-0027" title="FuchsCZ , RehnLP .A self-control behavior therapy program for depression. Journal of Consulting and Clinical Psychology1977;45(2):206-15. ">Fuchs 1977</a> ; <a href="./references#MR000050-bbs2-0028" title="GlogowskaM , RoulstoneS , EnderbyP , PetersTJ .Randomised controlled trial of community based speech and language therapy in preschool children. BMJ2000;321(7266):923-6. ">Glogowska 2000</a> ; <a href="./references#MR000050-bbs2-0029" title="GoldsteinAJ , BeursE , Chambless Dl, WilsonKA .EMDR for panic disorder with agoraphobia: comparison with waiting list and credible attention-placebo control conditions. Journal of Consulting and Clinical Psychology2000;68(6):947-56. ">Goldstein 2000</a> ; <a href="./references#MR000050-bbs2-0030" title="GoldwasserAN , AuerbachSM , HarkinsSW .Cognitive, affective, and behavioural effects of reminiscence group therapy on demented elderly. Aging and Human Development1987;25(3):209-22. ">Goldwasser 1987</a> ; <a href="./references#MR000050-bbs2-0031" title="HekmatH , LubitzR , DealR .Semantic desensitization: a paradigmatic intervention approach to anxiety disorders. Journal of Clinical Psychology1984;40(2):463-6. ">Hekmat 1984</a> ; <a href="./references#MR000050-bbs2-0032" title="HippmanC , RingroseA , InglisA , CheekJ , AlbertAY , RemickR , et al.A pilot randomized clinical trial evaluating the impact of genetic counselling for serious mental illnesses. Journal of Clinical Psychiatry2016;77(2):e190-8. ">Hippman 2016</a> ; <a href="./references#MR000050-bbs2-0033" title="HowlinP , GordonKR , PascoG , WadeA , CharmanT .The effectiveness of picture exchange communication system (PECS) training for teachers of children with autism: a pragmatic,group randomised controlled trial. Journal of Child Psychology and Psychiatry2007;48(5):473-81. ">Howlin 2007</a> ; <a href="./references#MR000050-bbs2-0034" title="KarstM , WinterhalterM , MünteS , FranckiB , HondronikosA , EckardtA , et al.Auricular acupuncture for dental anxiety: a randomized controlled trial. Anesthesia and Analgesia2007;104(2):295-300. KarstM .Inclusion of study in Cochrane Systematic Review (personal communication). Email to: EG Faltinsen 5th of September 2019. ">Karst 2007</a> ; <a href="./references#MR000050-bbs2-0035" title="KelleyJ .Inclusion of study in Cochrane Systematic Review (personal communication). Email to: A Todorovac 12th of August 2019. KelleyJM , KaptchukTJ , CusinC , LipkinS , FavaM .Open-label placebo for major depressive disorder: a pilot randomized controlled trial. Psychotherapy and Psychosomatics2012;81(5):312-4. ">Kelley 2012</a> ; <a href="./references#MR000050-bbs2-0036" title="KennedyTD , KimuraHK .Transfer, behavioral improvement, and anxiety reduction in systematic desensitization. Journal of Consulting and Clinical Psychology1974;42(5):720-8. ">Kennedy 1974</a> ; <a href="./references#MR000050-bbs2-0037" title="KilmannPR , MilanRJ , BolandJP , NankinHR , DavidsonE , WestMO , et al.Group treatment of secondary erectile dysfunction. Journal of Sex &amp; Marital Therapy1987;13(3):168-82. KilmannPR , Milan RJ Jr, BolandJP , DavidsonE , WestMO , SablisRF , et al.The sexual interactions of men with secondary erectile dysfunction. Journal of Sex Education and Therapy1988;14(1):46-9. KilmannPR , Milan RJ Jr, BolandJP , NankinHR , SablisRF , WestMO , et al.The sexual interactions of men with secondary erectile dysfunction. Paper presented at the annual meeting of the American Psychological Association in Los Angeles1985;1:46-9. ">Kilmann 1987</a> ; <a href="./references#MR000050-bbs2-0038" title="KleinSA , DeffenbacherJL .Relaxation and exercise for hyperactive impulsive children. Perceptual and Motor Skills1977;45:1159-62. ">Klein 1977</a> ; <a href="./references#MR000050-bbs2-0039" title="KlermanGL , DimascioA , WeismannM , PrusoffB , PaykelES .Treatment of depression by drugs and psychotherapy. American Journal of Psychiatry1974;131(2):186-91. PaykelES , DimascioA , HaskellD , PrusoffBA .Effects of maintenance amitriptyline and psychotherapy on symptoms of depression. Psychological Medicine1975;5(1):67-77. PaykelES , DiMascioA , KlermanGL , PrusoffBA .Maintenance therapy of depression. Pharmakopsychiatrie, Neuro-Psychopharmakologie1976;9:127-39. PaykelES , WeissmanMM , PrusoffBA .Social maladjustment and severity of depression. Comprehensive Psychiatry1978;19(2):121-8. WeissmanMM , KlermanGL , PaykelES , PrusoffB .Treatment effects on the social adjustment of depressed patients. Archives of General Psychiatry1974;30:771-8. ">Klerman 1974a</a> ; <a href="./references#MR000050-bbs2-0040" title="KlermanGL , DimascioA , WeismannM , PrusoffB , PaykelES .Treatment of depression by drugs and psychotherapy. American Journal of Psychiatry1974;131(2):186-91. ">Klerman 1974b</a> ; <a href="./references#MR000050-bbs2-0041" title="KloskoJS , BarlowDH , TassinariR , CernyJA .A comparison of alprazolam and behavior therapy in treatment of panic disorder: correction. Journal of Psychotherapy Practice and Research1994;3(2):163-79. KloskoJS , BarlowDH , TassinariR , CernyJA .A comparison of alprazolam and behavior therapy in treatment of panic disorder. Journal of Consulting and Clinical Psychology1990;58(1):77-84. ">Klosko 1990</a> ; <a href="./references#MR000050-bbs2-0042" title="KrapflJE , NawasMM .Differential ordering of stimulus presentation in systematic desensitization. Journal of Abnormal Psychology1970;75(3):333-7. ">Krapfl 1970</a> ; <a href="./references#MR000050-bbs2-0043" title="KwanR .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 26th of August 2019. KwanRY , LeungMC , LaiCK .Acupressure for agitation in nursing home residents with dementia: study protocol for a randomized controlled trial. Trials2014;15(410):1-7. KwanRY , LeungMCP , LaiCK .A randomized controlled trial examining the effect of acupressure on agitation and salivary cortisol in nursing home residents with dementia. Dementia and Geriatric Cognitive Disorders2017;44(1-2):92-104. ">Kwan 2017</a> ; <a href="./references#MR000050-bbs2-0044" title="LacyMK .The effect of short term autogenic training on the stress reactivity of hospitalized emotionally disturbed adolescents. ProQuest Dissertations Publishing, Oklahoma State University1996. ">Lacy 1990</a> ; <a href="./references#MR000050-bbs2-0045" title="LaiCK , ChiI , Kayser-JonesJ .A randomized controlled trial of a specific reminiscence approach to promote the well-being of nursing home residents with dementia. International Psychogeriatrics2004;16(1):33-49. LaiK .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 6th of September 2019. ">Lai 2004</a> ; <a href="./references#MR000050-bbs2-0046" title="LangOJ , LazovikAD .Experimental desensitization of a phobia. Journal of Abnormal and Social Psychology1963;66:519-25. LangPJ , LazovikAD , ReynoldsDJ .Desensitization, suggestibility, and pseudotherapy. Journal of Abnormal Psychology1965;70(6):395-402. ">Lang 1965</a> ; <a href="./references#MR000050-bbs2-0047" title="LegrandF .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 14th of August 2019. LegrandFD , NeffEM .Efficacy of exercise as an adjunct treatment for clinically depressed inpatients during the initial stages of antidepressant pharmacotherapy: an open randomized controlled trial. Journal of Affective Disorders2016;191:139-44. ">Legrand 2016</a> ; <a href="./references#MR000050-bbs2-0048" title="LickJ .Expectancy, false galvanic skin response feedback, and systematic desensitization in the modification of phobic behavior. Journal of Consulting and Clinical Psychology1975;43(4):557-67. ">Lick 1975</a> ; <a href="./references#MR000050-bbs2-0049" title="LickJR , HefflerD .Relaxation training and attention placebo in the treatment of severe insomnia. Journal of Consulting and Clinical Psychology1977;45(2):153-61. ">Lick 1977</a> ; <a href="./references#MR000050-bbs2-0050" title="LiddleB , SpenceSH .Cognitive-behaviour therapy with depressed primary school children: A cautionary note. Behavioural Psychotherapy1990;18(2):85-102. ">Liddle 1990</a> ; <a href="./references#MR000050-bbs2-0051" title="MatsonJL , MarchettiA , AdkinsJA .Comparison of operant- and independence-training procedures for mentally retarded adults. American Journal of Mental Deficiency1980;84(5):487-94. ">Matson 1980</a> ; <a href="./references#MR000050-bbs2-0052" title="McLachlanDR , DaltonAJ , KruckTP , BellMY , SmithWL , KalowW , et al.Intramuscular desferrioxamine in patients with Alzheimer's disease. Lancet1991;337(8753):1304-8. McLachlanDRC , SmithWL , KruckTP .Desferrioxamine and Alzheimer’s disease: video home behavior assessment of clinical course and measures of brain aluminum. Therapeutic Drug Monitoring1993;15(6):602-7. ">McLachlan 1991</a> ; <a href="./references#MR000050-bbs2-0053" title="MealieaWL , NawasMM .The comparative effectiveness of systematic desensitization and implosive therapy in the treatment of snake phobia. Journal of Behavior Therapy and Experimental Psychiatry1971;2(2):85-94. ">Mealiea 1971</a> ; <a href="./references#MR000050-bbs2-0054" title="MilbyJB , ClarkeC , ToroC , ThorntonS , RickertD .Effectiveness of urine surveillance as an adjunct to outpatient psychotherapy for drug abusers. International Journal of the Addictions1980;15(7):993-1001. ">Milby 1980</a> ; <a href="./references#MR000050-bbs2-0055" title="MirandaA , ArlandisP , SorianoM .Instruction in strategies and attributional training: Effects on the problem-solving and self-concept of students’ with learning disabilities [Instrucción en estrategias y entrenamiento atribucional: efectos sobre la resolución de problemas y el autoconcepto de los estudiantes con dificultades en el aprendizaje]. Infancia y Aprendizaje1997;20(80):37-52. ">Miranda 1997</a> ; <a href="./references#MR000050-bbs2-0056" title="MitchellC , MansfieldD , RautenbachS .Coloured filters and reading accuracy, comprehension and rate: a placebo-controlled study. Perceptual and Motor Skills2008;106(2):517-32. ">Mitchell 2008</a> ; <a href="./references#MR000050-bbs2-0057" title="NandiDN , AjmanyS , GanguliH , BanerjeeG , BoralGC , GhoshA , et al.A clinical evaluation of depressives found in a rural survey in India. British Journal of Psychiatry1976;128:523-7. ">Nandi 1976</a> ; <a href="./references#MR000050-bbs2-0058" title="NicassioP , BootzinR .A comparison of progressive relaxation and autogenic training as treatments for insomnia. Journal of Abnormal Psychology1974;83(3):253-60. ">Nicassio 1974</a> ; <a href="./references#MR000050-bbs2-0059" title="PearlD , Vander KampH , OlsenAL , GreenbergPD , ArmitageSG .The effects of reserpine on schizophrenic patients. American Journal of Psychiatry1956;112:198-204. ">Pearl 1956</a> ; <a href="./references#MR000050-bbs2-0060" title="PeckCL .Desensitization for the treatment of fear in the high level adult retardate. Behaviour Research and Therapy1977;15(2):137-48. ">Peck 1976</a> ; <a href="./references#MR000050-bbs2-0061" title="MilichR , CarlsonCL , Pelham WE Jr, LichtBG .Effects of methylphenidate on the persistence of ADHD boys following failure experiences. Journal of Abnormal Child Psychology1991;19(5):519-36. PelhamWE , MurphyDA , VannattaK , MilichR , LichtBG , GnagyEM , et al.Methylphenidate and attributions in boys with attention-deficit hyperactivity disorder. Journal of Consulting and Clinical Psychology1992;60(2):282-92. ">Pelham 1992</a> ; <a href="./references#MR000050-bbs2-0062" title="PedletonMG , HigginsRL .A comparison of negative practice and systematic desensitization in the treatment of acrophobia. Journal of Behavior Therapy and Experimental Psychiatry1983;14(4):317-23. ">Pendleton 1983</a> ; <a href="./references#MR000050-bbs2-0063" title="PetersonMA , PattersonB , PillmanBM , BattistaMA .Cognitive recovery following alcohol detoxification: a computerised remediation study. Neuropsychological Rehabilitation2002;12(1):63-74. PillmanBM .Computerized cognitive remediation with recently detoxified alcoholics. Dissertation, California School of Professional Psychology, Fresno Campus2000. ">Pillman 2001</a> ; <a href="./references#MR000050-bbs2-0064" title="PolandRE , GertsikL , FavreauJT , SmithSI , MirochaJM , RaoU , et al.Open-label randomized parallel-group controlled clinical trial of massage for treatment of depression in HIV-infected subjects. Journal of Alternative and Complementary Medicine2013;19(4):334-40. ">Poland 2013</a> ; <a href="./references#MR000050-bbs2-0065" title="PowersMB , SmitsJA , TelchMJ .Disentangling the effects of safety-behavior utilization and safety-behavior availability during exposure-based treatment: a placebo-controlled trial. Journal of Consulting and Clinical Psychology2004;72(3):448-54. ">Powers 2004</a> ; <a href="./references#MR000050-bbs2-0066" title="PowersMB , SmithsJA , WhitleyD , BystritskyA , TelchMJ .The effect of attributional processes concerning medication taking on return of fear. Journal of Consulting and Clinical Psychology2008;76(3):478-90. ">Powers 2008a</a> ; <a href="./references#MR000050-bbs2-0067" title="PowersMB , SmithsJA , WhitleyD , BystritskyA , TelchMJ .The effect of attributional processes concerning medication taking on return of fear. Journal of Consulting and Clinical Psychology2008;76(3):478-90. ">Powers 2008b</a> ; <a href="./references#MR000050-bbs2-0068" title="ProudfootJ , ClarkeJ , BirchMR , WhittonAE , ParkerG , ManicavasagarV , et al.Impact of a mobile phone and web program on symptom and functional outcomes for people with mild- to-moderate depression, anxiety and stress: a randomized controlled trial. BMC Psychiatry2013;13(312):1-12. ProudfootJ .Re: Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 26th of August 2019. ">Proudfoot 2013</a> ; <a href="./references#MR000050-bbs2-0069" title="QuayhagenMP , QuayhagenM , CorbeilRR , RothPA , RodgersJA .A dyadic remediation program for care recipients with dementia. Nursing Research1995;44(3):153-9. ">Quayhagen 1995</a> ; <a href="./references#MR000050-bbs2-0070" title="LiebowitzM , QuitkinFM , StewartJW , McGrathPJ , HarrisonWM , MarkowitzJS , et al.Antidepressant efficacy in atypical depression. Archives of General Psychiatry1988;45(2):129-37. QuitkinFM , McGrathPJ , StewartJW , HarrisonW , WagerSG , NunesE , et al.Phenelzine and imipramine in mood reactive depressives: further delineation of the syndrome of atypical depression. Archives of General Psychiatry1989;46(9):787-93. RabkinJG , McGrathPJ , QuitkinFM , TricamoE , StewartJW , KleinDF .Effects of pill-giving on maintenance of placebo response in patients with chronic mild depression. American Journal of Psychiatry1990;147(12):1622-6. ">Rabkin 1990</a> ; <a href="./references#MR000050-bbs2-0071" title="RapeeR .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 29th of August 2019. RapeeRM , AbbottMJ , LynehamHJ .Bibliotherapy for children With anxiety disorders using written materials for parents: a randomized controlled trial. Journal of Consulting and Clinical Psychology2006;74(3):436-44. ">Rapee 2006</a> ; <a href="./references#MR000050-bbs2-0072" title="RapeeR .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 29th of August 2019. RapeeRM , AbbottMJ , BaillieAJ , GastonJE .Treatment of social phobia through pure self-help and therapist-augmented self-help. British Journal of Psychiatry2007;191:246-52. ">Rapee 2007</a> ; <a href="./references#MR000050-bbs2-0073" title="RobinA .Rationing out-patients: a defence of the waiting list. British Journal of Psychiatry1976;129:138-41. ">Robin 1976</a> ; <a href="./references#MR000050-bbs2-0074" title="RoehrichL , GoldmanMS .Experience-dependent neuropsychological recovery and the treatment of alcoholism. Journal of Consulting and Clinical Psychology1993;61(5):812-21. ">Roehrich 1993</a> ; <a href="./references#MR000050-bbs2-0075" title="OlivaresJ .Program IAFS. Protocol for the treatment of social phobia in adolescents [Programa IAFS. Protocolo para el tratamiento de la fobia social enadolescentes]. Madrid: Pirámide2005;1. Rosa-AlcázarAI , Olivares-OlivaresPJ , OlivaresJ .The role of non-specific effects in the psychological treatment of adolescents with social phobia [Papel de los efectos inespecíficos en el tratamiento psicológico de adolescentes con fobia social]. Anuario de Psicologia2009;40(1):43-61. ">Rosa‐Alcatraz 2009</a> ; <a href="./references#MR000050-bbs2-0076" title="RosenGM , GlasgowRE , BarreraM .A controlled study to assess the clinical efficacy of totally self-administrated systematic desensitization. Journal of Consulting and Clinical Psychology1976;44(2):208-17. ">Rosen 1976</a> ; <a href="./references#MR000050-bbs2-0077" title="LorrM , McNairDM , WeinsteinGJ .Early effects of chlordiazepoxide (Librium) used with psychotherapy. Journal of Psychiatric Research1963;1:257-70. RothI , RhudickPJ , ShaskanDA , SlobinMS , WilkinsonAE , YoungHH .Long-term effects on psychotherapy of initial treatment conditions. Journal of Psychiatric Research1964;2:283-97. ">Roth 1964</a> ; <a href="./references#MR000050-bbs2-0078" title="RupertPA , HolmesDS .Effects of multiple sessions of true and placebo heart rate biofeedback training on the heart rates and anxiety levels of anxious patients during and following treatment. Psychophysiology1978;15(6):582-90. ">Rupert 1978</a> ; <a href="./references#MR000050-bbs2-0079" title="ShalevAY , AnkriY , Isreali-ShalevY , PelegT , AdesskyR , FreedmanS .Prevention of posttraumatic stress disorder by early treatment. Archives of General Psychiatry2012;69(2):166-76. ">Shalev 2012</a> ; <a href="./references#MR000050-bbs2-0080" title="ShealyRC .The effectiveness of various treatment techniques on different degrees and durations of sleep-onset insomnia. Behaviour Research and Therapy1979;17(6):541-6. ">Shealy 1979</a> ; <a href="./references#MR000050-bbs2-0081" title="SibilioJP , AndrewG , DartD , MooreKB , StehmanA .Treatment of chronic schizophrenia with promazine hydrochloride. AMA Archives of Neurology and Psychiatry1957;78(4):419-24. ">Sibilio 1957</a> ; <a href="./references#MR000050-bbs2-0082" title="SommernessMD , LuceroRJ , HamlonJS , EricksonJL , MatthewsR .A controlled study of reserpine on chronically disturbed patients. JAMA Archives of Neurology and Psychiatry1955;74(3):316-9. ">Sommerness 1955</a> ; <a href="./references#MR000050-bbs2-0083" title="SteinmarkSW , BorkovecTD .Active and placebo treatment effects on moderate insomnia under counterdemand and positive demand instructions. Journal of Abnormal Psychology1974;83(2):157-63. ">Steinmark 1974</a> ; <a href="./references#MR000050-bbs2-0084" title="SzymanskiJ , O'DonohueW .The potential role of state-dependent learning in cognitive therapy with spider phobics. Journal of Rational-Emotive &amp; Cognitive-Behavior Therapy1995;13(2):131-50. SzymanskiJ .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 20th of August 2019. ">Szymanski 1995</a> ; <a href="./references#MR000050-bbs2-0085" title="TanSY , BruniJ .Cognitive-behavior therapy with adult patients with epilepsy: a controlled outcome study. Epilepsia1986;27(3):225-33. ">Tan 1986</a> ; <a href="./references#MR000050-bbs2-0086" title="TeriL , LogsdonRG , UomotoJ , McCurrySM .Behavioral treatment of depression in dementia patients: a controlled clinical trial. Journals of Gerontology. Series B, Psychological Sciences and Social Sciences1997;52(4):159-66. TeriL .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 26th of August 2019. ">Teri 1997</a> ; <a href="./references#MR000050-bbs2-0087" title="ToriC , WorellL .Reduction of human avoidant behavior. A comparison of counterconditioning, expectancy, and cognitive information approaches. Clinical Psychology1973;41(2):269-78. ">Tori 1973</a> ; <a href="./references#MR000050-bbs2-0088" title="Trexler, L.Rational-emotive therapy, placebo, and no-treatment effects on public-speaking anxiety. Doctoral dissertation, Temple University AnnArbor, Mich.: University Microfilms1971;71-31(063). TrexlerLD , KarstTO .Rational-emotive therapy, placebo, and no-treatment effects on public-speaking anxiety. Journal of Abnormal Psyhology1972;79(1):60-7. ">Trexler 1972</a> ; <a href="./references#MR000050-bbs2-0089" title="AscherML , TurnerRM .A comparison of two methods for the administration of paradoxical intention. Behaviour Research and Therapy1980;18(2):121-6. TurnerRM , AscherLM .Controlled comparison of progressive relaxation, stimulus control, and paradoxical intention therapies for insomnia. Journal of Consulting and Clinical Psychology1979;47(3):500-8. ">Turner 1979</a> ; <a href="./references#MR000050-bbs2-0090" title="VanderplateC .Electromyograph biofeedback Treatment of sleep onset Insomnia: a controlled Investigation. Dissertation, University of Southern Mississippi1978. ">Vanderplate 1983</a> ; <a href="./references#MR000050-bbs2-0091" title="WatzlH , RistF , OlbrichR , CohenR .Placebo injections and surveillance of alcohol intake during inpatient treatment of female alcoholics. Addictive Behaviors1988;13(2):197-200. ">Watzl 1988</a> ; <a href="./references#MR000050-bbs2-0092" title="WeingaertnerAH .Self-administered aversive stimulation with hallucinating hospitalized schizophrenics. Journal of Consulting and Clinical Psychology1971;36(3):422-29. ">Weingaertner 1971</a> ; <a href="./references#MR000050-bbs2-0093" title="WhittakerCB , HoyRM .Withdrawal of perphenazine in chronic schizophrenia. British Journal of Psychiatry1963;109:422-7. ">Whittaker 1963</a> ; <a href="./references#MR000050-bbs2-0094" title="WilsonA , DavidsonWJ , BlanchardR , WhiteJ .Disulfiram implantation. A placebo-controlled trial with two-year follow-up. Journal of Studies on Alcohol1978;39(5):809-19. WilsonA , DavidsonWJ , BlanchardR .Disulfiram implantation: a trial using placebo implants and two types of controls. Journal of Studies on Alcohol1980;41(5):429-36. ">Wilson 1980</a> ; <a href="./references#MR000050-bbs2-0095" title="WolitzkyKB , TelchMJ .Augmenting in vivo exposure with fear antagonistic actions: a preliminary test. Behavior Therapy2009;40(1):57-71. ">Wolitzky 2009</a> ; <a href="./references#MR000050-bbs2-0096" title="WollersheimJP , WilsonGL .Group treatment of unipolar depression: a comparison of coping, supportive, bibliotherapy, and delayed treatment groups. Professional Psychology: Research and Practice1991;22(6):496-502. ">Wollersheim 1991</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Incomplete outcome data</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Low risk of bias</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>41</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#MR000050-bbs2-0002" title="AllenJB .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to A Todorovac 28th of August 2019. AllenJJ , SchnyerRN , HittSK .The efficacy of acupuncture in the treatment of major depression in women. Psychological Science1998;9(5):397-401. ">Allen 1998</a> ; <a href="./references#MR000050-bbs2-0003" title="AllenJB .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 28th of August 2019. AllenJJ , SchnyerRN , ChambersAS , HittSK , MorenoFA , ManberR .Acupuncture for depression: a randomized controlled trial. Journal of Clinical Psychiatry2006;67(11):1665-73. ">Allen 2006</a> ; <a href="./references#MR000050-bbs2-0006" title="AyenI , HautzingerM .Cognitive behavior therapy for depression in menopausal women. A controlled, randomized treatment study [Kognitive Verhaltenstherapie bei Depressionen im Klimakterium: Eine kontrollierte, randomiserte Interventionsstudie]. Zeitschrift für Klinische Psychologie und Psychotherapie2004;33(4):290-9. AyenI .Inclusion of study in Cochrane Systematic Review (personal communication). Email to EG Faltinsen 9th of September 2019. ">Ayen 2004</a> ; <a href="./references#MR000050-bbs2-0007" title="BergI , ForsytheI , HoltP , WattsJ .A controlled trial of ‘Senokot’ in faecal soiling treated by behavioural methods. Journal of Child Psychology and Psychiatry1983;24(4):543-9. ">Berg 1983</a> ; <a href="./references#MR000050-bbs2-0010" title="BorkovecTD , WeertsTC .Effects of progressive relaxation on sleep disturbance: an electroencephalographic evaluation. Psychosomatic Medicine1976;38(3):173-80. ">Borkovec 1976</a> ; <a href="./references#MR000050-bbs2-0012" title="BramstonP , SpenceSH .Behavioural versus cognitive social-skills training with intellectually-handicapped adults. Behaviour Research and Therapy1985;23(3):239-46. ">Bramston 1985</a> ; <a href="./references#MR000050-bbs2-0021" title="EhlersA , HackmannA , GreyN , WildJ , LinessS , AlbertI , et al.A randomized controlled trial of 7-day intensive and standard weekly cognitive therapy for PTSD and emotion-focused supportive therapy. American Journal of Psychiatry2014;171(3):294-304. ">Ehlers 2014</a> ; <a href="./references#MR000050-bbs2-0028" title="GlogowskaM , RoulstoneS , EnderbyP , PetersTJ .Randomised controlled trial of community based speech and language therapy in preschool children. BMJ2000;321(7266):923-6. ">Glogowska 2000</a> ; <a href="./references#MR000050-bbs2-0029" title="GoldsteinAJ , BeursE , Chambless Dl, WilsonKA .EMDR for panic disorder with agoraphobia: comparison with waiting list and credible attention-placebo control conditions. Journal of Consulting and Clinical Psychology2000;68(6):947-56. ">Goldstein 2000</a> ; <a href="./references#MR000050-bbs2-0032" title="HippmanC , RingroseA , InglisA , CheekJ , AlbertAY , RemickR , et al.A pilot randomized clinical trial evaluating the impact of genetic counselling for serious mental illnesses. Journal of Clinical Psychiatry2016;77(2):e190-8. ">Hippman 2016</a> ; <a href="./references#MR000050-bbs2-0033" title="HowlinP , GordonKR , PascoG , WadeA , CharmanT .The effectiveness of picture exchange communication system (PECS) training for teachers of children with autism: a pragmatic,group randomised controlled trial. Journal of Child Psychology and Psychiatry2007;48(5):473-81. ">Howlin 2007</a> ; <a href="./references#MR000050-bbs2-0034" title="KarstM , WinterhalterM , MünteS , FranckiB , HondronikosA , EckardtA , et al.Auricular acupuncture for dental anxiety: a randomized controlled trial. Anesthesia and Analgesia2007;104(2):295-300. KarstM .Inclusion of study in Cochrane Systematic Review (personal communication). Email to: EG Faltinsen 5th of September 2019. ">Karst 2007</a> ; <a href="./references#MR000050-bbs2-0037" title="KilmannPR , MilanRJ , BolandJP , NankinHR , DavidsonE , WestMO , et al.Group treatment of secondary erectile dysfunction. Journal of Sex &amp; Marital Therapy1987;13(3):168-82. KilmannPR , Milan RJ Jr, BolandJP , DavidsonE , WestMO , SablisRF , et al.The sexual interactions of men with secondary erectile dysfunction. Journal of Sex Education and Therapy1988;14(1):46-9. KilmannPR , Milan RJ Jr, BolandJP , NankinHR , SablisRF , WestMO , et al.The sexual interactions of men with secondary erectile dysfunction. Paper presented at the annual meeting of the American Psychological Association in Los Angeles1985;1:46-9. ">Kilmann 1987</a> ; <a href="./references#MR000050-bbs2-0039" title="KlermanGL , DimascioA , WeismannM , PrusoffB , PaykelES .Treatment of depression by drugs and psychotherapy. American Journal of Psychiatry1974;131(2):186-91. PaykelES , DimascioA , HaskellD , PrusoffBA .Effects of maintenance amitriptyline and psychotherapy on symptoms of depression. Psychological Medicine1975;5(1):67-77. PaykelES , DiMascioA , KlermanGL , PrusoffBA .Maintenance therapy of depression. Pharmakopsychiatrie, Neuro-Psychopharmakologie1976;9:127-39. PaykelES , WeissmanMM , PrusoffBA .Social maladjustment and severity of depression. Comprehensive Psychiatry1978;19(2):121-8. WeissmanMM , KlermanGL , PaykelES , PrusoffB .Treatment effects on the social adjustment of depressed patients. Archives of General Psychiatry1974;30:771-8. ">Klerman 1974a</a> ; <a href="./references#MR000050-bbs2-0040" title="KlermanGL , DimascioA , WeismannM , PrusoffB , PaykelES .Treatment of depression by drugs and psychotherapy. American Journal of Psychiatry1974;131(2):186-91. ">Klerman 1974b</a> ; <a href="./references#MR000050-bbs2-0043" title="KwanR .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 26th of August 2019. KwanRY , LeungMC , LaiCK .Acupressure for agitation in nursing home residents with dementia: study protocol for a randomized controlled trial. Trials2014;15(410):1-7. KwanRY , LeungMCP , LaiCK .A randomized controlled trial examining the effect of acupressure on agitation and salivary cortisol in nursing home residents with dementia. Dementia and Geriatric Cognitive Disorders2017;44(1-2):92-104. ">Kwan 2017</a> ; <a href="./references#MR000050-bbs2-0044" title="LacyMK .The effect of short term autogenic training on the stress reactivity of hospitalized emotionally disturbed adolescents. ProQuest Dissertations Publishing, Oklahoma State University1996. ">Lacy 1990</a> ; <a href="./references#MR000050-bbs2-0045" title="LaiCK , ChiI , Kayser-JonesJ .A randomized controlled trial of a specific reminiscence approach to promote the well-being of nursing home residents with dementia. International Psychogeriatrics2004;16(1):33-49. LaiK .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 6th of September 2019. ">Lai 2004</a> ; <a href="./references#MR000050-bbs2-0046" title="LangOJ , LazovikAD .Experimental desensitization of a phobia. Journal of Abnormal and Social Psychology1963;66:519-25. LangPJ , LazovikAD , ReynoldsDJ .Desensitization, suggestibility, and pseudotherapy. Journal of Abnormal Psychology1965;70(6):395-402. ">Lang 1965</a> ; <a href="./references#MR000050-bbs2-0047" title="LegrandF .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 14th of August 2019. LegrandFD , NeffEM .Efficacy of exercise as an adjunct treatment for clinically depressed inpatients during the initial stages of antidepressant pharmacotherapy: an open randomized controlled trial. Journal of Affective Disorders2016;191:139-44. ">Legrand 2016</a> ; <a href="./references#MR000050-bbs2-0049" title="LickJR , HefflerD .Relaxation training and attention placebo in the treatment of severe insomnia. Journal of Consulting and Clinical Psychology1977;45(2):153-61. ">Lick 1977</a> ; <a href="./references#MR000050-bbs2-0050" title="LiddleB , SpenceSH .Cognitive-behaviour therapy with depressed primary school children: A cautionary note. Behavioural Psychotherapy1990;18(2):85-102. ">Liddle 1990</a> ; <a href="./references#MR000050-bbs2-0051" title="MatsonJL , MarchettiA , AdkinsJA .Comparison of operant- and independence-training procedures for mentally retarded adults. American Journal of Mental Deficiency1980;84(5):487-94. ">Matson 1980</a> ; <a href="./references#MR000050-bbs2-0053" title="MealieaWL , NawasMM .The comparative effectiveness of systematic desensitization and implosive therapy in the treatment of snake phobia. Journal of Behavior Therapy and Experimental Psychiatry1971;2(2):85-94. ">Mealiea 1971</a> ; <a href="./references#MR000050-bbs2-0055" title="MirandaA , ArlandisP , SorianoM .Instruction in strategies and attributional training: Effects on the problem-solving and self-concept of students’ with learning disabilities [Instrucción en estrategias y entrenamiento atribucional: efectos sobre la resolución de problemas y el autoconcepto de los estudiantes con dificultades en el aprendizaje]. Infancia y Aprendizaje1997;20(80):37-52. ">Miranda 1997</a> ; <a href="./references#MR000050-bbs2-0056" title="MitchellC , MansfieldD , RautenbachS .Coloured filters and reading accuracy, comprehension and rate: a placebo-controlled study. Perceptual and Motor Skills2008;106(2):517-32. ">Mitchell 2008</a> ; <a href="./references#MR000050-bbs2-0058" title="NicassioP , BootzinR .A comparison of progressive relaxation and autogenic training as treatments for insomnia. Journal of Abnormal Psychology1974;83(3):253-60. ">Nicassio 1974</a> ; <a href="./references#MR000050-bbs2-0061" title="MilichR , CarlsonCL , Pelham WE Jr, LichtBG .Effects of methylphenidate on the persistence of ADHD boys following failure experiences. Journal of Abnormal Child Psychology1991;19(5):519-36. PelhamWE , MurphyDA , VannattaK , MilichR , LichtBG , GnagyEM , et al.Methylphenidate and attributions in boys with attention-deficit hyperactivity disorder. Journal of Consulting and Clinical Psychology1992;60(2):282-92. ">Pelham 1992</a> ; <a href="./references#MR000050-bbs2-0062" title="PedletonMG , HigginsRL .A comparison of negative practice and systematic desensitization in the treatment of acrophobia. Journal of Behavior Therapy and Experimental Psychiatry1983;14(4):317-23. ">Pendleton 1983</a> ; <a href="./references#MR000050-bbs2-0065" title="PowersMB , SmitsJA , TelchMJ .Disentangling the effects of safety-behavior utilization and safety-behavior availability during exposure-based treatment: a placebo-controlled trial. Journal of Consulting and Clinical Psychology2004;72(3):448-54. ">Powers 2004</a> ; <a href="./references#MR000050-bbs2-0066" title="PowersMB , SmithsJA , WhitleyD , BystritskyA , TelchMJ .The effect of attributional processes concerning medication taking on return of fear. Journal of Consulting and Clinical Psychology2008;76(3):478-90. ">Powers 2008a</a> ; <a href="./references#MR000050-bbs2-0067" title="PowersMB , SmithsJA , WhitleyD , BystritskyA , TelchMJ .The effect of attributional processes concerning medication taking on return of fear. Journal of Consulting and Clinical Psychology2008;76(3):478-90. ">Powers 2008b</a> ; <a href="./references#MR000050-bbs2-0070" title="LiebowitzM , QuitkinFM , StewartJW , McGrathPJ , HarrisonWM , MarkowitzJS , et al.Antidepressant efficacy in atypical depression. Archives of General Psychiatry1988;45(2):129-37. QuitkinFM , McGrathPJ , StewartJW , HarrisonW , WagerSG , NunesE , et al.Phenelzine and imipramine in mood reactive depressives: further delineation of the syndrome of atypical depression. Archives of General Psychiatry1989;46(9):787-93. RabkinJG , McGrathPJ , QuitkinFM , TricamoE , StewartJW , KleinDF .Effects of pill-giving on maintenance of placebo response in patients with chronic mild depression. American Journal of Psychiatry1990;147(12):1622-6. ">Rabkin 1990</a> ; <a href="./references#MR000050-bbs2-0073" title="RobinA .Rationing out-patients: a defence of the waiting list. British Journal of Psychiatry1976;129:138-41. ">Robin 1976</a> ; <a href="./references#MR000050-bbs2-0075" title="OlivaresJ .Program IAFS. Protocol for the treatment of social phobia in adolescents [Programa IAFS. Protocolo para el tratamiento de la fobia social enadolescentes]. Madrid: Pirámide2005;1. Rosa-AlcázarAI , Olivares-OlivaresPJ , OlivaresJ .The role of non-specific effects in the psychological treatment of adolescents with social phobia [Papel de los efectos inespecíficos en el tratamiento psicológico de adolescentes con fobia social]. Anuario de Psicologia2009;40(1):43-61. ">Rosa‐Alcatraz 2009</a> ; <a href="./references#MR000050-bbs2-0079" title="ShalevAY , AnkriY , Isreali-ShalevY , PelegT , AdesskyR , FreedmanS .Prevention of posttraumatic stress disorder by early treatment. Archives of General Psychiatry2012;69(2):166-76. ">Shalev 2012</a> ; <a href="./references#MR000050-bbs2-0083" title="SteinmarkSW , BorkovecTD .Active and placebo treatment effects on moderate insomnia under counterdemand and positive demand instructions. Journal of Abnormal Psychology1974;83(2):157-63. ">Steinmark 1974</a> ; <a href="./references#MR000050-bbs2-0085" title="TanSY , BruniJ .Cognitive-behavior therapy with adult patients with epilepsy: a controlled outcome study. Epilepsia1986;27(3):225-33. ">Tan 1986</a> ; <a href="./references#MR000050-bbs2-0089" title="AscherML , TurnerRM .A comparison of two methods for the administration of paradoxical intention. Behaviour Research and Therapy1980;18(2):121-6. TurnerRM , AscherLM .Controlled comparison of progressive relaxation, stimulus control, and paradoxical intention therapies for insomnia. Journal of Consulting and Clinical Psychology1979;47(3):500-8. ">Turner 1979</a> ; <a href="./references#MR000050-bbs2-0091" title="WatzlH , RistF , OlbrichR , CohenR .Placebo injections and surveillance of alcohol intake during inpatient treatment of female alcoholics. Addictive Behaviors1988;13(2):197-200. ">Watzl 1988</a> ; <a href="./references#MR000050-bbs2-0095" title="WolitzkyKB , TelchMJ .Augmenting in vivo exposure with fear antagonistic actions: a preliminary test. Behavior Therapy2009;40(1):57-71. ">Wolitzky 2009</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>High risk of bias</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>29</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#MR000050-bbs2-0001" title="AbikoffH , HechtmanL , KleinRG .Social functioning in children with ADHD treated with long-term methylphenidate and multimodal psychosocial treatment. Journal of the American Academy of Child and Adolescent Psychiatry2004;43(7):820-9. AbikoffH .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to A Todorovac 23rd of August 2019. KleinRG , AbikoffH , HechtmanL , WeissG .Design and rationale of controlled study of long-term methylphenidate and multimodal psychosocial treatment in children with ADHD. Journal of the American Academy of Child and Adolescent Psychiatry2004;43(7):792-801. ">Abikoff 2004</a> ; <a href="./references#MR000050-bbs2-0004" title="AlvarezJR .The effects of anger management training on depression, anger, self-concept, and treatment responsibility in a sample of drug-dependent individuals in a therapeutic community. Dissertation Abstracts International: Section B: the Sciences and Engineering1997;58(4-B):2108. ">Alvarez 1997</a> ; <a href="./references#MR000050-bbs2-0009" title="BorkovecTD , KaloupekDG , SlamaKM .The facilitative effect of muscle tension-release in the relaxation treatment of sleep disturbance. Behavior Therapy1975;6(3):301-9. ">Borkovec 1975</a> ; <a href="./references#MR000050-bbs2-0011" title="BornovalovaM .Inclusion of study in Cochrane Systematic Review (personal communication). Email to A Todorovac. 21st of August 2019. BornovalovaMA .Distress tolerance treatment for inner-city drug users: a preliminary trial. Doctor’s Dissertation, University of Maryland2008. ">Bornovalova 2008</a> ; <a href="./references#MR000050-bbs2-0013" title="BrillNQ , KoeglerRR , EpsteinLJ , ForgyEW .Controlled study of psychiatric outpatient treatment. Archives of General Psychiatry1964;10:581-95. BrillNQ .Results of psychotherapy. California Medicine1966;104(4):249-53. ">Brill 1964a</a> ; <a href="./references#MR000050-bbs2-0014" title="BrillNQ , KoeglerRR , EpsteinLJ , ForgyEW .Controlled study of psychiatric outpatient treatment. Archives of General Psychiatry1964;10:581-95. ">Brill 1964b</a> ; <a href="./references#MR000050-bbs2-0017" title="CrispAH , NortonK , GowersS , HalekC , BowyerC , YeldhamD , et al.A controlled study of the effect of therapies aimed at adolescent and family psychopathology in Anorexia Nervosa. British Journal of Psychiatry: the Journal of Mental Science1991;159:325-33. GowersS , NortonK , HalekC , CrispAH .Outcome of outpatient psychotherapy in a random allocation treatment study of anorexia nervosa. International Journal of Eating Disorders1994;15(2):165-77. GowersS , NortonK , YelshamD .The St George's prospective treatment study of anorexia nervosa: a discussion of methodological problems. International Journal of Eating Disorders1989;8:445-54. ">Crisp 1991</a> ; <a href="./references#MR000050-bbs2-0018" title="CrouchG , RobsonM , HallstromC .Benzodiazepine dependent patients and their psychological treatment. Progress in Neuro-psychopharmacology &amp; Biological Psychiatry1988;12(4):503-10. HallströmC , CrouchG , RobsenM , ShineP .The treatment of tranquillizer dependence by propranolol. Postgraduate Medical Journal1988;64(Suppl 2):40-4. ">Crouch 1988</a> ; <a href="./references#MR000050-bbs2-0019" title="Doty, DW.Role playing and incentives in the modification of the social interaction of chronic psychiatric patients. Journal of Consulting and Clinical Psychology1975;43(5):676-82. ">Doty 1975</a> ; <a href="./references#MR000050-bbs2-0020" title="DoubleDB , WarrenGC , EvansM , RowlandsMP .Efficacy of maintenance use of anticholinergic agents. Acta Psychiatrica Scandinavica1993;88:381-4. ">Double 1993</a> ; <a href="./references#MR000050-bbs2-0022" title="EspieCA , BrooksDN , LindsayWR .An evaluation of tailored psychological treatment of insomnia. Journal of Behavior Therapy and Experimental Psychiatry1989;20(2):143-53. EspieCA , LindsayWR , BrooksDN , HoodEM , TurveyT .A controlled comparative investigation of psychological treatments for chronic sleep-onset insomnia. Behaviour Research and Therapy1989;27(1):79-88. ">Espie 1989a</a> ; <a href="./references#MR000050-bbs2-0024" title="FoaEB , RothbaumBO , RiggsDS , MurdockTB .Treatment of posttraumatic stress disorder in rape victims: a comparison between cognitive-behavioral procedures and counselling. Journal of Consulting and Clinical Psychology1991;59(5):715-23. ">Foa 1991</a> ; <a href="./references#MR000050-bbs2-0026" title="FreireAO , SugaiGC , ChrispinFS , TogeiroSM , YamamuraY , MelloLE , et al.Treatment of moderate obstructive sleep apnea syndrome with acupuncture: a randomised, placebo-controlled pilot trial. Sleep Medicine2007;8(1):43-50. ">Freire 2007</a> ; <a href="./references#MR000050-bbs2-0027" title="FuchsCZ , RehnLP .A self-control behavior therapy program for depression. Journal of Consulting and Clinical Psychology1977;45(2):206-15. ">Fuchs 1977</a> ; <a href="./references#MR000050-bbs2-0036" title="KennedyTD , KimuraHK .Transfer, behavioral improvement, and anxiety reduction in systematic desensitization. Journal of Consulting and Clinical Psychology1974;42(5):720-8. ">Kennedy 1974</a> ; <a href="./references#MR000050-bbs2-0041" title="KloskoJS , BarlowDH , TassinariR , CernyJA .A comparison of alprazolam and behavior therapy in treatment of panic disorder: correction. Journal of Psychotherapy Practice and Research1994;3(2):163-79. KloskoJS , BarlowDH , TassinariR , CernyJA .A comparison of alprazolam and behavior therapy in treatment of panic disorder. Journal of Consulting and Clinical Psychology1990;58(1):77-84. ">Klosko 1990</a> ; <a href="./references#MR000050-bbs2-0052" title="McLachlanDR , DaltonAJ , KruckTP , BellMY , SmithWL , KalowW , et al.Intramuscular desferrioxamine in patients with Alzheimer's disease. Lancet1991;337(8753):1304-8. McLachlanDRC , SmithWL , KruckTP .Desferrioxamine and Alzheimer’s disease: video home behavior assessment of clinical course and measures of brain aluminum. Therapeutic Drug Monitoring1993;15(6):602-7. ">McLachlan 1991</a> ; <a href="./references#MR000050-bbs2-0057" title="NandiDN , AjmanyS , GanguliH , BanerjeeG , BoralGC , GhoshA , et al.A clinical evaluation of depressives found in a rural survey in India. British Journal of Psychiatry1976;128:523-7. ">Nandi 1976</a> ; <a href="./references#MR000050-bbs2-0063" title="PetersonMA , PattersonB , PillmanBM , BattistaMA .Cognitive recovery following alcohol detoxification: a computerised remediation study. Neuropsychological Rehabilitation2002;12(1):63-74. PillmanBM .Computerized cognitive remediation with recently detoxified alcoholics. Dissertation, California School of Professional Psychology, Fresno Campus2000. ">Pillman 2001</a> ; <a href="./references#MR000050-bbs2-0064" title="PolandRE , GertsikL , FavreauJT , SmithSI , MirochaJM , RaoU , et al.Open-label randomized parallel-group controlled clinical trial of massage for treatment of depression in HIV-infected subjects. Journal of Alternative and Complementary Medicine2013;19(4):334-40. ">Poland 2013</a> ; <a href="./references#MR000050-bbs2-0069" title="QuayhagenMP , QuayhagenM , CorbeilRR , RothPA , RodgersJA .A dyadic remediation program for care recipients with dementia. Nursing Research1995;44(3):153-9. ">Quayhagen 1995</a> ; <a href="./references#MR000050-bbs2-0071" title="RapeeR .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 29th of August 2019. RapeeRM , AbbottMJ , LynehamHJ .Bibliotherapy for children With anxiety disorders using written materials for parents: a randomized controlled trial. Journal of Consulting and Clinical Psychology2006;74(3):436-44. ">Rapee 2006</a> ; <a href="./references#MR000050-bbs2-0074" title="RoehrichL , GoldmanMS .Experience-dependent neuropsychological recovery and the treatment of alcoholism. Journal of Consulting and Clinical Psychology1993;61(5):812-21. ">Roehrich 1993</a> ; <a href="./references#MR000050-bbs2-0076" title="RosenGM , GlasgowRE , BarreraM .A controlled study to assess the clinical efficacy of totally self-administrated systematic desensitization. Journal of Consulting and Clinical Psychology1976;44(2):208-17. ">Rosen 1976</a> ; <a href="./references#MR000050-bbs2-0077" title="LorrM , McNairDM , WeinsteinGJ .Early effects of chlordiazepoxide (Librium) used with psychotherapy. Journal of Psychiatric Research1963;1:257-70. RothI , RhudickPJ , ShaskanDA , SlobinMS , WilkinsonAE , YoungHH .Long-term effects on psychotherapy of initial treatment conditions. Journal of Psychiatric Research1964;2:283-97. ">Roth 1964</a> ; <a href="./references#MR000050-bbs2-0084" title="SzymanskiJ , O'DonohueW .The potential role of state-dependent learning in cognitive therapy with spider phobics. Journal of Rational-Emotive &amp; Cognitive-Behavior Therapy1995;13(2):131-50. SzymanskiJ .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 20th of August 2019. ">Szymanski 1995</a> ; <a href="./references#MR000050-bbs2-0086" title="TeriL , LogsdonRG , UomotoJ , McCurrySM .Behavioral treatment of depression in dementia patients: a controlled clinical trial. Journals of Gerontology. Series B, Psychological Sciences and Social Sciences1997;52(4):159-66. TeriL .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 26th of August 2019. ">Teri 1997</a> ; <a href="./references#MR000050-bbs2-0090" title="VanderplateC .Electromyograph biofeedback Treatment of sleep onset Insomnia: a controlled Investigation. Dissertation, University of Southern Mississippi1978. ">Vanderplate 1983</a> ; <a href="./references#MR000050-bbs2-0096" title="WollersheimJP , WilsonGL .Group treatment of unipolar depression: a comparison of coping, supportive, bibliotherapy, and delayed treatment groups. Professional Psychology: Research and Practice1991;22(6):496-502. ">Wollersheim 1991</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Unclear risk of bias</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>26</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#MR000050-bbs2-0005" title="AscherLM , TurnerR .Paradoxical intention and insomnia: an experimental investigation. Behaviour Research and Therapy1979;17(4):408-11. ">Ascher 1979</a> ; <a href="./references#MR000050-bbs2-0008" title="Borden, KA.Attributional Outcomes: the Subtle Messages of Treatments for Attention Deficit Disorder. Dissertation, University of Illinois at Urbana-Champaign1986. BordenKA , BrownRT .Attributional outcomes: The subtle messages of treatments for attention deficit disorder. Cognitive Therapy and Research1989;13(2):147-60. ">Borden 1986</a> ; <a href="./references#MR000050-bbs2-0015" title="CarlsonCL , PelhamWE , MilichR , HozaB .ADHD boys’ performance and attributions following success and failure: drug effects and individual differences. Cognitive Therapy and Research1993;17:269-87. ">Carlson 1993</a> ; <a href="./references#MR000050-bbs2-0016" title="CarterJC , OlmstedMP , KaplanAS , McCabeRE , MillsJS , AimeA .Self-help for bulimia nervosa: a randomized controlled trial. American Journal of Psychiatry2003;160(5):973-8. ">Carter 2003</a> ; <a href="./references#MR000050-bbs2-0023" title="EtringerBD , CashTF , RimmDC .Behavioral, affective, and cognitive effects of participant modeling and an equally credible placebo. Behavior Therapy1982;13(4):476-85. ">Etringer 1982</a> ; <a href="./references#MR000050-bbs2-0025" title="FoaEB , McLeanCP , ZangY , RosenfieldD , YadinE , YarvisJS , et al.Effect of prolonged exposure therapy delivered over 2 weeks vs 8 weeks vs present-centered therapy on PTSD symptom severity in military personnel: a randomized clinical trial. JAMA2018;319(4):354-64. ">Foa 2018</a> ; <a href="./references#MR000050-bbs2-0030" title="GoldwasserAN , AuerbachSM , HarkinsSW .Cognitive, affective, and behavioural effects of reminiscence group therapy on demented elderly. Aging and Human Development1987;25(3):209-22. ">Goldwasser 1987</a> ; <a href="./references#MR000050-bbs2-0031" title="HekmatH , LubitzR , DealR .Semantic desensitization: a paradigmatic intervention approach to anxiety disorders. Journal of Clinical Psychology1984;40(2):463-6. ">Hekmat 1984</a> ; <a href="./references#MR000050-bbs2-0035" title="KelleyJ .Inclusion of study in Cochrane Systematic Review (personal communication). Email to: A Todorovac 12th of August 2019. KelleyJM , KaptchukTJ , CusinC , LipkinS , FavaM .Open-label placebo for major depressive disorder: a pilot randomized controlled trial. Psychotherapy and Psychosomatics2012;81(5):312-4. ">Kelley 2012</a> ; <a href="./references#MR000050-bbs2-0038" title="KleinSA , DeffenbacherJL .Relaxation and exercise for hyperactive impulsive children. Perceptual and Motor Skills1977;45:1159-62. ">Klein 1977</a> ; <a href="./references#MR000050-bbs2-0042" title="KrapflJE , NawasMM .Differential ordering of stimulus presentation in systematic desensitization. Journal of Abnormal Psychology1970;75(3):333-7. ">Krapfl 1970</a> ; <a href="./references#MR000050-bbs2-0048" title="LickJ .Expectancy, false galvanic skin response feedback, and systematic desensitization in the modification of phobic behavior. Journal of Consulting and Clinical Psychology1975;43(4):557-67. ">Lick 1975</a> ; <a href="./references#MR000050-bbs2-0054" title="MilbyJB , ClarkeC , ToroC , ThorntonS , RickertD .Effectiveness of urine surveillance as an adjunct to outpatient psychotherapy for drug abusers. International Journal of the Addictions1980;15(7):993-1001. ">Milby 1980</a> ; <a href="./references#MR000050-bbs2-0060" title="PeckCL .Desensitization for the treatment of fear in the high level adult retardate. Behaviour Research and Therapy1977;15(2):137-48. ">Peck 1976</a> ; <a href="./references#MR000050-bbs2-0068" title="ProudfootJ , ClarkeJ , BirchMR , WhittonAE , ParkerG , ManicavasagarV , et al.Impact of a mobile phone and web program on symptom and functional outcomes for people with mild- to-moderate depression, anxiety and stress: a randomized controlled trial. BMC Psychiatry2013;13(312):1-12. ProudfootJ .Re: Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 26th of August 2019. ">Proudfoot 2013</a> ; <a href="./references#MR000050-bbs2-0072" title="RapeeR .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 29th of August 2019. RapeeRM , AbbottMJ , BaillieAJ , GastonJE .Treatment of social phobia through pure self-help and therapist-augmented self-help. British Journal of Psychiatry2007;191:246-52. ">Rapee 2007</a> ; <a href="./references#MR000050-bbs2-0078" title="RupertPA , HolmesDS .Effects of multiple sessions of true and placebo heart rate biofeedback training on the heart rates and anxiety levels of anxious patients during and following treatment. Psychophysiology1978;15(6):582-90. ">Rupert 1978</a> ; <a href="./references#MR000050-bbs2-0059" title="PearlD , Vander KampH , OlsenAL , GreenbergPD , ArmitageSG .The effects of reserpine on schizophrenic patients. American Journal of Psychiatry1956;112:198-204. ">Pearl 1956</a> ; <a href="./references#MR000050-bbs2-0080" title="ShealyRC .The effectiveness of various treatment techniques on different degrees and durations of sleep-onset insomnia. Behaviour Research and Therapy1979;17(6):541-6. ">Shealy 1979</a> ; <a href="./references#MR000050-bbs2-0081" title="SibilioJP , AndrewG , DartD , MooreKB , StehmanA .Treatment of chronic schizophrenia with promazine hydrochloride. AMA Archives of Neurology and Psychiatry1957;78(4):419-24. ">Sibilio 1957</a> ; <a href="./references#MR000050-bbs2-0082" title="SommernessMD , LuceroRJ , HamlonJS , EricksonJL , MatthewsR .A controlled study of reserpine on chronically disturbed patients. JAMA Archives of Neurology and Psychiatry1955;74(3):316-9. ">Sommerness 1955</a> ; <a href="./references#MR000050-bbs2-0087" title="ToriC , WorellL .Reduction of human avoidant behavior. A comparison of counterconditioning, expectancy, and cognitive information approaches. Clinical Psychology1973;41(2):269-78. ">Tori 1973</a> ; <a href="./references#MR000050-bbs2-0088" title="Trexler, L.Rational-emotive therapy, placebo, and no-treatment effects on public-speaking anxiety. Doctoral dissertation, Temple University AnnArbor, Mich.: University Microfilms1971;71-31(063). TrexlerLD , KarstTO .Rational-emotive therapy, placebo, and no-treatment effects on public-speaking anxiety. Journal of Abnormal Psyhology1972;79(1):60-7. ">Trexler 1972</a> ; <a href="./references#MR000050-bbs2-0092" title="WeingaertnerAH .Self-administered aversive stimulation with hallucinating hospitalized schizophrenics. Journal of Consulting and Clinical Psychology1971;36(3):422-29. ">Weingaertner 1971</a> ; <a href="./references#MR000050-bbs2-0093" title="WhittakerCB , HoyRM .Withdrawal of perphenazine in chronic schizophrenia. British Journal of Psychiatry1963;109:422-7. ">Whittaker 1963</a> ; <a href="./references#MR000050-bbs2-0094" title="WilsonA , DavidsonWJ , BlanchardR , WhiteJ .Disulfiram implantation. A placebo-controlled trial with two-year follow-up. Journal of Studies on Alcohol1978;39(5):809-19. WilsonA , DavidsonWJ , BlanchardR .Disulfiram implantation: a trial using placebo implants and two types of controls. Journal of Studies on Alcohol1980;41(5):429-36. ">Wilson 1980</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Selective reporting</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Low risk of bias</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#MR000050-bbs2-0003" title="AllenJB .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 28th of August 2019. AllenJJ , SchnyerRN , ChambersAS , HittSK , MorenoFA , ManberR .Acupuncture for depression: a randomized controlled trial. Journal of Clinical Psychiatry2006;67(11):1665-73. ">Allen 2006</a> ; <a href="./references#MR000050-bbs2-0021" title="EhlersA , HackmannA , GreyN , WildJ , LinessS , AlbertI , et al.A randomized controlled trial of 7-day intensive and standard weekly cognitive therapy for PTSD and emotion-focused supportive therapy. American Journal of Psychiatry2014;171(3):294-304. ">Ehlers 2014</a> ; <a href="./references#MR000050-bbs2-0032" title="HippmanC , RingroseA , InglisA , CheekJ , AlbertAY , RemickR , et al.A pilot randomized clinical trial evaluating the impact of genetic counselling for serious mental illnesses. Journal of Clinical Psychiatry2016;77(2):e190-8. ">Hippman 2016</a> ; <a href="./references#MR000050-bbs2-0043" title="KwanR .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 26th of August 2019. KwanRY , LeungMC , LaiCK .Acupressure for agitation in nursing home residents with dementia: study protocol for a randomized controlled trial. Trials2014;15(410):1-7. KwanRY , LeungMCP , LaiCK .A randomized controlled trial examining the effect of acupressure on agitation and salivary cortisol in nursing home residents with dementia. Dementia and Geriatric Cognitive Disorders2017;44(1-2):92-104. ">Kwan 2017</a> ; <a href="./references#MR000050-bbs2-0047" title="LegrandF .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 14th of August 2019. LegrandFD , NeffEM .Efficacy of exercise as an adjunct treatment for clinically depressed inpatients during the initial stages of antidepressant pharmacotherapy: an open randomized controlled trial. Journal of Affective Disorders2016;191:139-44. ">Legrand 2016</a> ; <a href="./references#MR000050-bbs2-0079" title="ShalevAY , AnkriY , Isreali-ShalevY , PelegT , AdesskyR , FreedmanS .Prevention of posttraumatic stress disorder by early treatment. Archives of General Psychiatry2012;69(2):166-76. ">Shalev 2012</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>High risk of bias</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#MR000050-bbs2-0001" title="AbikoffH , HechtmanL , KleinRG .Social functioning in children with ADHD treated with long-term methylphenidate and multimodal psychosocial treatment. Journal of the American Academy of Child and Adolescent Psychiatry2004;43(7):820-9. AbikoffH .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to A Todorovac 23rd of August 2019. KleinRG , AbikoffH , HechtmanL , WeissG .Design and rationale of controlled study of long-term methylphenidate and multimodal psychosocial treatment in children with ADHD. Journal of the American Academy of Child and Adolescent Psychiatry2004;43(7):792-801. ">Abikoff 2004</a> ; <a href="./references#MR000050-bbs2-0011" title="BornovalovaM .Inclusion of study in Cochrane Systematic Review (personal communication). Email to A Todorovac. 21st of August 2019. BornovalovaMA .Distress tolerance treatment for inner-city drug users: a preliminary trial. Doctor’s Dissertation, University of Maryland2008. ">Bornovalova 2008</a> ; <a href="./references#MR000050-bbs2-0025" title="FoaEB , McLeanCP , ZangY , RosenfieldD , YadinE , YarvisJS , et al.Effect of prolonged exposure therapy delivered over 2 weeks vs 8 weeks vs present-centered therapy on PTSD symptom severity in military personnel: a randomized clinical trial. JAMA2018;319(4):354-64. ">Foa 2018</a> ; <a href="./references#MR000050-bbs2-0035" title="KelleyJ .Inclusion of study in Cochrane Systematic Review (personal communication). Email to: A Todorovac 12th of August 2019. KelleyJM , KaptchukTJ , CusinC , LipkinS , FavaM .Open-label placebo for major depressive disorder: a pilot randomized controlled trial. Psychotherapy and Psychosomatics2012;81(5):312-4. ">Kelley 2012</a> ; <a href="./references#MR000050-bbs2-0068" title="ProudfootJ , ClarkeJ , BirchMR , WhittonAE , ParkerG , ManicavasagarV , et al.Impact of a mobile phone and web program on symptom and functional outcomes for people with mild- to-moderate depression, anxiety and stress: a randomized controlled trial. BMC Psychiatry2013;13(312):1-12. ProudfootJ .Re: Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 26th of August 2019. ">Proudfoot 2013</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Unclear risk of bias</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>85</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#MR000050-bbs2-0002" title="AllenJB .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to A Todorovac 28th of August 2019. AllenJJ , SchnyerRN , HittSK .The efficacy of acupuncture in the treatment of major depression in women. Psychological Science1998;9(5):397-401. ">Allen 1998</a> ; <a href="./references#MR000050-bbs2-0004" title="AlvarezJR .The effects of anger management training on depression, anger, self-concept, and treatment responsibility in a sample of drug-dependent individuals in a therapeutic community. Dissertation Abstracts International: Section B: the Sciences and Engineering1997;58(4-B):2108. ">Alvarez 1997</a> ; <a href="./references#MR000050-bbs2-0005" title="AscherLM , TurnerR .Paradoxical intention and insomnia: an experimental investigation. Behaviour Research and Therapy1979;17(4):408-11. ">Ascher 1979</a> ; <a href="./references#MR000050-bbs2-0006" title="AyenI , HautzingerM .Cognitive behavior therapy for depression in menopausal women. A controlled, randomized treatment study [Kognitive Verhaltenstherapie bei Depressionen im Klimakterium: Eine kontrollierte, randomiserte Interventionsstudie]. Zeitschrift für Klinische Psychologie und Psychotherapie2004;33(4):290-9. AyenI .Inclusion of study in Cochrane Systematic Review (personal communication). Email to EG Faltinsen 9th of September 2019. ">Ayen 2004</a> ; <a href="./references#MR000050-bbs2-0007" title="BergI , ForsytheI , HoltP , WattsJ .A controlled trial of ‘Senokot’ in faecal soiling treated by behavioural methods. Journal of Child Psychology and Psychiatry1983;24(4):543-9. ">Berg 1983</a> ; <a href="./references#MR000050-bbs2-0008" title="Borden, KA.Attributional Outcomes: the Subtle Messages of Treatments for Attention Deficit Disorder. Dissertation, University of Illinois at Urbana-Champaign1986. BordenKA , BrownRT .Attributional outcomes: The subtle messages of treatments for attention deficit disorder. Cognitive Therapy and Research1989;13(2):147-60. ">Borden 1986</a> ; <a href="./references#MR000050-bbs2-0009" title="BorkovecTD , KaloupekDG , SlamaKM .The facilitative effect of muscle tension-release in the relaxation treatment of sleep disturbance. Behavior Therapy1975;6(3):301-9. ">Borkovec 1975</a> ; <a href="./references#MR000050-bbs2-0010" title="BorkovecTD , WeertsTC .Effects of progressive relaxation on sleep disturbance: an electroencephalographic evaluation. Psychosomatic Medicine1976;38(3):173-80. ">Borkovec 1976</a> ; <a href="./references#MR000050-bbs2-0012" title="BramstonP , SpenceSH .Behavioural versus cognitive social-skills training with intellectually-handicapped adults. Behaviour Research and Therapy1985;23(3):239-46. ">Bramston 1985</a> ; <a href="./references#MR000050-bbs2-0013" title="BrillNQ , KoeglerRR , EpsteinLJ , ForgyEW .Controlled study of psychiatric outpatient treatment. Archives of General Psychiatry1964;10:581-95. BrillNQ .Results of psychotherapy. California Medicine1966;104(4):249-53. ">Brill 1964a</a> ; <a href="./references#MR000050-bbs2-0014" title="BrillNQ , KoeglerRR , EpsteinLJ , ForgyEW .Controlled study of psychiatric outpatient treatment. Archives of General Psychiatry1964;10:581-95. ">Brill 1964b</a> ; <a href="./references#MR000050-bbs2-0015" title="CarlsonCL , PelhamWE , MilichR , HozaB .ADHD boys’ performance and attributions following success and failure: drug effects and individual differences. Cognitive Therapy and Research1993;17:269-87. ">Carlson 1993</a> ; <a href="./references#MR000050-bbs2-0016" title="CarterJC , OlmstedMP , KaplanAS , McCabeRE , MillsJS , AimeA .Self-help for bulimia nervosa: a randomized controlled trial. American Journal of Psychiatry2003;160(5):973-8. ">Carter 2003</a> ; <a href="./references#MR000050-bbs2-0017" title="CrispAH , NortonK , GowersS , HalekC , BowyerC , YeldhamD , et al.A controlled study of the effect of therapies aimed at adolescent and family psychopathology in Anorexia Nervosa. British Journal of Psychiatry: the Journal of Mental Science1991;159:325-33. GowersS , NortonK , HalekC , CrispAH .Outcome of outpatient psychotherapy in a random allocation treatment study of anorexia nervosa. International Journal of Eating Disorders1994;15(2):165-77. GowersS , NortonK , YelshamD .The St George's prospective treatment study of anorexia nervosa: a discussion of methodological problems. International Journal of Eating Disorders1989;8:445-54. ">Crisp 1991</a> ; <a href="./references#MR000050-bbs2-0018" title="CrouchG , RobsonM , HallstromC .Benzodiazepine dependent patients and their psychological treatment. Progress in Neuro-psychopharmacology &amp; Biological Psychiatry1988;12(4):503-10. HallströmC , CrouchG , RobsenM , ShineP .The treatment of tranquillizer dependence by propranolol. Postgraduate Medical Journal1988;64(Suppl 2):40-4. ">Crouch 1988</a> ; <a href="./references#MR000050-bbs2-0019" title="Doty, DW.Role playing and incentives in the modification of the social interaction of chronic psychiatric patients. Journal of Consulting and Clinical Psychology1975;43(5):676-82. ">Doty 1975</a> ; <a href="./references#MR000050-bbs2-0020" title="DoubleDB , WarrenGC , EvansM , RowlandsMP .Efficacy of maintenance use of anticholinergic agents. Acta Psychiatrica Scandinavica1993;88:381-4. ">Double 1993</a> ; <a href="./references#MR000050-bbs2-0022" title="EspieCA , BrooksDN , LindsayWR .An evaluation of tailored psychological treatment of insomnia. Journal of Behavior Therapy and Experimental Psychiatry1989;20(2):143-53. EspieCA , LindsayWR , BrooksDN , HoodEM , TurveyT .A controlled comparative investigation of psychological treatments for chronic sleep-onset insomnia. Behaviour Research and Therapy1989;27(1):79-88. ">Espie 1989a</a> ; <a href="./references#MR000050-bbs2-0023" title="EtringerBD , CashTF , RimmDC .Behavioral, affective, and cognitive effects of participant modeling and an equally credible placebo. Behavior Therapy1982;13(4):476-85. ">Etringer 1982</a> ; <a href="./references#MR000050-bbs2-0024" title="FoaEB , RothbaumBO , RiggsDS , MurdockTB .Treatment of posttraumatic stress disorder in rape victims: a comparison between cognitive-behavioral procedures and counselling. Journal of Consulting and Clinical Psychology1991;59(5):715-23. ">Foa 1991</a> ; <a href="./references#MR000050-bbs2-0026" title="FreireAO , SugaiGC , ChrispinFS , TogeiroSM , YamamuraY , MelloLE , et al.Treatment of moderate obstructive sleep apnea syndrome with acupuncture: a randomised, placebo-controlled pilot trial. Sleep Medicine2007;8(1):43-50. ">Freire 2007</a> ; <a href="./references#MR000050-bbs2-0027" title="FuchsCZ , RehnLP .A self-control behavior therapy program for depression. Journal of Consulting and Clinical Psychology1977;45(2):206-15. ">Fuchs 1977</a> ; <a href="./references#MR000050-bbs2-0028" title="GlogowskaM , RoulstoneS , EnderbyP , PetersTJ .Randomised controlled trial of community based speech and language therapy in preschool children. BMJ2000;321(7266):923-6. ">Glogowska 2000</a> ; <a href="./references#MR000050-bbs2-0029" title="GoldsteinAJ , BeursE , Chambless Dl, WilsonKA .EMDR for panic disorder with agoraphobia: comparison with waiting list and credible attention-placebo control conditions. Journal of Consulting and Clinical Psychology2000;68(6):947-56. ">Goldstein 2000</a> ; <a href="./references#MR000050-bbs2-0030" title="GoldwasserAN , AuerbachSM , HarkinsSW .Cognitive, affective, and behavioural effects of reminiscence group therapy on demented elderly. Aging and Human Development1987;25(3):209-22. ">Goldwasser 1987</a> ; <a href="./references#MR000050-bbs2-0031" title="HekmatH , LubitzR , DealR .Semantic desensitization: a paradigmatic intervention approach to anxiety disorders. Journal of Clinical Psychology1984;40(2):463-6. ">Hekmat 1984</a> ; <a href="./references#MR000050-bbs2-0033" title="HowlinP , GordonKR , PascoG , WadeA , CharmanT .The effectiveness of picture exchange communication system (PECS) training for teachers of children with autism: a pragmatic,group randomised controlled trial. Journal of Child Psychology and Psychiatry2007;48(5):473-81. ">Howlin 2007</a> ; <a href="./references#MR000050-bbs2-0034" title="KarstM , WinterhalterM , MünteS , FranckiB , HondronikosA , EckardtA , et al.Auricular acupuncture for dental anxiety: a randomized controlled trial. Anesthesia and Analgesia2007;104(2):295-300. KarstM .Inclusion of study in Cochrane Systematic Review (personal communication). Email to: EG Faltinsen 5th of September 2019. ">Karst 2007</a> ; <a href="./references#MR000050-bbs2-0036" title="KennedyTD , KimuraHK .Transfer, behavioral improvement, and anxiety reduction in systematic desensitization. Journal of Consulting and Clinical Psychology1974;42(5):720-8. ">Kennedy 1974</a> ; <a href="./references#MR000050-bbs2-0037" title="KilmannPR , MilanRJ , BolandJP , NankinHR , DavidsonE , WestMO , et al.Group treatment of secondary erectile dysfunction. Journal of Sex &amp; Marital Therapy1987;13(3):168-82. KilmannPR , Milan RJ Jr, BolandJP , DavidsonE , WestMO , SablisRF , et al.The sexual interactions of men with secondary erectile dysfunction. Journal of Sex Education and Therapy1988;14(1):46-9. KilmannPR , Milan RJ Jr, BolandJP , NankinHR , SablisRF , WestMO , et al.The sexual interactions of men with secondary erectile dysfunction. Paper presented at the annual meeting of the American Psychological Association in Los Angeles1985;1:46-9. ">Kilmann 1987</a> ; <a href="./references#MR000050-bbs2-0038" title="KleinSA , DeffenbacherJL .Relaxation and exercise for hyperactive impulsive children. Perceptual and Motor Skills1977;45:1159-62. ">Klein 1977</a> ; <a href="./references#MR000050-bbs2-0039" title="KlermanGL , DimascioA , WeismannM , PrusoffB , PaykelES .Treatment of depression by drugs and psychotherapy. American Journal of Psychiatry1974;131(2):186-91. PaykelES , DimascioA , HaskellD , PrusoffBA .Effects of maintenance amitriptyline and psychotherapy on symptoms of depression. Psychological Medicine1975;5(1):67-77. PaykelES , DiMascioA , KlermanGL , PrusoffBA .Maintenance therapy of depression. Pharmakopsychiatrie, Neuro-Psychopharmakologie1976;9:127-39. PaykelES , WeissmanMM , PrusoffBA .Social maladjustment and severity of depression. Comprehensive Psychiatry1978;19(2):121-8. WeissmanMM , KlermanGL , PaykelES , PrusoffB .Treatment effects on the social adjustment of depressed patients. Archives of General Psychiatry1974;30:771-8. ">Klerman 1974a</a> ; <a href="./references#MR000050-bbs2-0040" title="KlermanGL , DimascioA , WeismannM , PrusoffB , PaykelES .Treatment of depression by drugs and psychotherapy. American Journal of Psychiatry1974;131(2):186-91. ">Klerman 1974b</a> ; <a href="./references#MR000050-bbs2-0041" title="KloskoJS , BarlowDH , TassinariR , CernyJA .A comparison of alprazolam and behavior therapy in treatment of panic disorder: correction. Journal of Psychotherapy Practice and Research1994;3(2):163-79. KloskoJS , BarlowDH , TassinariR , CernyJA .A comparison of alprazolam and behavior therapy in treatment of panic disorder. Journal of Consulting and Clinical Psychology1990;58(1):77-84. ">Klosko 1990</a> ; <a href="./references#MR000050-bbs2-0042" title="KrapflJE , NawasMM .Differential ordering of stimulus presentation in systematic desensitization. Journal of Abnormal Psychology1970;75(3):333-7. ">Krapfl 1970</a> ; <a href="./references#MR000050-bbs2-0044" title="LacyMK .The effect of short term autogenic training on the stress reactivity of hospitalized emotionally disturbed adolescents. ProQuest Dissertations Publishing, Oklahoma State University1996. ">Lacy 1990</a> ; <a href="./references#MR000050-bbs2-0045" title="LaiCK , ChiI , Kayser-JonesJ .A randomized controlled trial of a specific reminiscence approach to promote the well-being of nursing home residents with dementia. International Psychogeriatrics2004;16(1):33-49. LaiK .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 6th of September 2019. ">Lai 2004</a> ; <a href="./references#MR000050-bbs2-0046" title="LangOJ , LazovikAD .Experimental desensitization of a phobia. Journal of Abnormal and Social Psychology1963;66:519-25. LangPJ , LazovikAD , ReynoldsDJ .Desensitization, suggestibility, and pseudotherapy. Journal of Abnormal Psychology1965;70(6):395-402. ">Lang 1965</a> ; <a href="./references#MR000050-bbs2-0048" title="LickJ .Expectancy, false galvanic skin response feedback, and systematic desensitization in the modification of phobic behavior. Journal of Consulting and Clinical Psychology1975;43(4):557-67. ">Lick 1975</a> ; <a href="./references#MR000050-bbs2-0049" title="LickJR , HefflerD .Relaxation training and attention placebo in the treatment of severe insomnia. Journal of Consulting and Clinical Psychology1977;45(2):153-61. ">Lick 1977</a> ; <a href="./references#MR000050-bbs2-0050" title="LiddleB , SpenceSH .Cognitive-behaviour therapy with depressed primary school children: A cautionary note. Behavioural Psychotherapy1990;18(2):85-102. ">Liddle 1990</a> ; <a href="./references#MR000050-bbs2-0051" title="MatsonJL , MarchettiA , AdkinsJA .Comparison of operant- and independence-training procedures for mentally retarded adults. American Journal of Mental Deficiency1980;84(5):487-94. ">Matson 1980</a> ; <a href="./references#MR000050-bbs2-0052" title="McLachlanDR , DaltonAJ , KruckTP , BellMY , SmithWL , KalowW , et al.Intramuscular desferrioxamine in patients with Alzheimer's disease. Lancet1991;337(8753):1304-8. McLachlanDRC , SmithWL , KruckTP .Desferrioxamine and Alzheimer’s disease: video home behavior assessment of clinical course and measures of brain aluminum. Therapeutic Drug Monitoring1993;15(6):602-7. ">McLachlan 1991</a> ; <a href="./references#MR000050-bbs2-0053" title="MealieaWL , NawasMM .The comparative effectiveness of systematic desensitization and implosive therapy in the treatment of snake phobia. Journal of Behavior Therapy and Experimental Psychiatry1971;2(2):85-94. ">Mealiea 1971</a> ; <a href="./references#MR000050-bbs2-0054" title="MilbyJB , ClarkeC , ToroC , ThorntonS , RickertD .Effectiveness of urine surveillance as an adjunct to outpatient psychotherapy for drug abusers. International Journal of the Addictions1980;15(7):993-1001. ">Milby 1980</a> ; <a href="./references#MR000050-bbs2-0055" title="MirandaA , ArlandisP , SorianoM .Instruction in strategies and attributional training: Effects on the problem-solving and self-concept of students’ with learning disabilities [Instrucción en estrategias y entrenamiento atribucional: efectos sobre la resolución de problemas y el autoconcepto de los estudiantes con dificultades en el aprendizaje]. Infancia y Aprendizaje1997;20(80):37-52. ">Miranda 1997</a> ; <a href="./references#MR000050-bbs2-0056" title="MitchellC , MansfieldD , RautenbachS .Coloured filters and reading accuracy, comprehension and rate: a placebo-controlled study. Perceptual and Motor Skills2008;106(2):517-32. ">Mitchell 2008</a> ; <a href="./references#MR000050-bbs2-0057" title="NandiDN , AjmanyS , GanguliH , BanerjeeG , BoralGC , GhoshA , et al.A clinical evaluation of depressives found in a rural survey in India. British Journal of Psychiatry1976;128:523-7. ">Nandi 1976</a> ; <a href="./references#MR000050-bbs2-0058" title="NicassioP , BootzinR .A comparison of progressive relaxation and autogenic training as treatments for insomnia. Journal of Abnormal Psychology1974;83(3):253-60. ">Nicassio 1974</a> ; <a href="./references#MR000050-bbs2-0059" title="PearlD , Vander KampH , OlsenAL , GreenbergPD , ArmitageSG .The effects of reserpine on schizophrenic patients. American Journal of Psychiatry1956;112:198-204. ">Pearl 1956</a> ; <a href="./references#MR000050-bbs2-0060" title="PeckCL .Desensitization for the treatment of fear in the high level adult retardate. Behaviour Research and Therapy1977;15(2):137-48. ">Peck 1976</a> ; <a href="./references#MR000050-bbs2-0061" title="MilichR , CarlsonCL , Pelham WE Jr, LichtBG .Effects of methylphenidate on the persistence of ADHD boys following failure experiences. Journal of Abnormal Child Psychology1991;19(5):519-36. PelhamWE , MurphyDA , VannattaK , MilichR , LichtBG , GnagyEM , et al.Methylphenidate and attributions in boys with attention-deficit hyperactivity disorder. Journal of Consulting and Clinical Psychology1992;60(2):282-92. ">Pelham 1992</a> ; <a href="./references#MR000050-bbs2-0062" title="PedletonMG , HigginsRL .A comparison of negative practice and systematic desensitization in the treatment of acrophobia. Journal of Behavior Therapy and Experimental Psychiatry1983;14(4):317-23. ">Pendleton 1983</a> ; <a href="./references#MR000050-bbs2-0063" title="PetersonMA , PattersonB , PillmanBM , BattistaMA .Cognitive recovery following alcohol detoxification: a computerised remediation study. Neuropsychological Rehabilitation2002;12(1):63-74. PillmanBM .Computerized cognitive remediation with recently detoxified alcoholics. Dissertation, California School of Professional Psychology, Fresno Campus2000. ">Pillman 2001</a> ; <a href="./references#MR000050-bbs2-0064" title="PolandRE , GertsikL , FavreauJT , SmithSI , MirochaJM , RaoU , et al.Open-label randomized parallel-group controlled clinical trial of massage for treatment of depression in HIV-infected subjects. Journal of Alternative and Complementary Medicine2013;19(4):334-40. ">Poland 2013</a> ; <a href="./references#MR000050-bbs2-0065" title="PowersMB , SmitsJA , TelchMJ .Disentangling the effects of safety-behavior utilization and safety-behavior availability during exposure-based treatment: a placebo-controlled trial. Journal of Consulting and Clinical Psychology2004;72(3):448-54. ">Powers 2004</a> ; <a href="./references#MR000050-bbs2-0066" title="PowersMB , SmithsJA , WhitleyD , BystritskyA , TelchMJ .The effect of attributional processes concerning medication taking on return of fear. Journal of Consulting and Clinical Psychology2008;76(3):478-90. ">Powers 2008a</a> ; <a href="./references#MR000050-bbs2-0067" title="PowersMB , SmithsJA , WhitleyD , BystritskyA , TelchMJ .The effect of attributional processes concerning medication taking on return of fear. Journal of Consulting and Clinical Psychology2008;76(3):478-90. ">Powers 2008b</a> ; <a href="./references#MR000050-bbs2-0069" title="QuayhagenMP , QuayhagenM , CorbeilRR , RothPA , RodgersJA .A dyadic remediation program for care recipients with dementia. Nursing Research1995;44(3):153-9. ">Quayhagen 1995</a> ; <a href="./references#MR000050-bbs2-0070" title="LiebowitzM , QuitkinFM , StewartJW , McGrathPJ , HarrisonWM , MarkowitzJS , et al.Antidepressant efficacy in atypical depression. Archives of General Psychiatry1988;45(2):129-37. QuitkinFM , McGrathPJ , StewartJW , HarrisonW , WagerSG , NunesE , et al.Phenelzine and imipramine in mood reactive depressives: further delineation of the syndrome of atypical depression. Archives of General Psychiatry1989;46(9):787-93. RabkinJG , McGrathPJ , QuitkinFM , TricamoE , StewartJW , KleinDF .Effects of pill-giving on maintenance of placebo response in patients with chronic mild depression. American Journal of Psychiatry1990;147(12):1622-6. ">Rabkin 1990</a> ; <a href="./references#MR000050-bbs2-0071" title="RapeeR .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 29th of August 2019. RapeeRM , AbbottMJ , LynehamHJ .Bibliotherapy for children With anxiety disorders using written materials for parents: a randomized controlled trial. Journal of Consulting and Clinical Psychology2006;74(3):436-44. ">Rapee 2006</a> ; <a href="./references#MR000050-bbs2-0072" title="RapeeR .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 29th of August 2019. RapeeRM , AbbottMJ , BaillieAJ , GastonJE .Treatment of social phobia through pure self-help and therapist-augmented self-help. British Journal of Psychiatry2007;191:246-52. ">Rapee 2007</a> ; <a href="./references#MR000050-bbs2-0073" title="RobinA .Rationing out-patients: a defence of the waiting list. British Journal of Psychiatry1976;129:138-41. ">Robin 1976</a> ; <a href="./references#MR000050-bbs2-0074" title="RoehrichL , GoldmanMS .Experience-dependent neuropsychological recovery and the treatment of alcoholism. Journal of Consulting and Clinical Psychology1993;61(5):812-21. ">Roehrich 1993</a> ; <a href="./references#MR000050-bbs2-0075" title="OlivaresJ .Program IAFS. Protocol for the treatment of social phobia in adolescents [Programa IAFS. Protocolo para el tratamiento de la fobia social enadolescentes]. Madrid: Pirámide2005;1. Rosa-AlcázarAI , Olivares-OlivaresPJ , OlivaresJ .The role of non-specific effects in the psychological treatment of adolescents with social phobia [Papel de los efectos inespecíficos en el tratamiento psicológico de adolescentes con fobia social]. Anuario de Psicologia2009;40(1):43-61. ">Rosa‐Alcatraz 2009</a> ; <a href="./references#MR000050-bbs2-0076" title="RosenGM , GlasgowRE , BarreraM .A controlled study to assess the clinical efficacy of totally self-administrated systematic desensitization. Journal of Consulting and Clinical Psychology1976;44(2):208-17. ">Rosen 1976</a> ; <a href="./references#MR000050-bbs2-0077" title="LorrM , McNairDM , WeinsteinGJ .Early effects of chlordiazepoxide (Librium) used with psychotherapy. Journal of Psychiatric Research1963;1:257-70. RothI , RhudickPJ , ShaskanDA , SlobinMS , WilkinsonAE , YoungHH .Long-term effects on psychotherapy of initial treatment conditions. Journal of Psychiatric Research1964;2:283-97. ">Roth 1964</a> ; <a href="./references#MR000050-bbs2-0078" title="RupertPA , HolmesDS .Effects of multiple sessions of true and placebo heart rate biofeedback training on the heart rates and anxiety levels of anxious patients during and following treatment. Psychophysiology1978;15(6):582-90. ">Rupert 1978</a> ; <a href="./references#MR000050-bbs2-0080" title="ShealyRC .The effectiveness of various treatment techniques on different degrees and durations of sleep-onset insomnia. Behaviour Research and Therapy1979;17(6):541-6. ">Shealy 1979</a> ; <a href="./references#MR000050-bbs2-0081" title="SibilioJP , AndrewG , DartD , MooreKB , StehmanA .Treatment of chronic schizophrenia with promazine hydrochloride. AMA Archives of Neurology and Psychiatry1957;78(4):419-24. ">Sibilio 1957</a> ; <a href="./references#MR000050-bbs2-0082" title="SommernessMD , LuceroRJ , HamlonJS , EricksonJL , MatthewsR .A controlled study of reserpine on chronically disturbed patients. JAMA Archives of Neurology and Psychiatry1955;74(3):316-9. ">Sommerness 1955</a> ; <a href="./references#MR000050-bbs2-0083" title="SteinmarkSW , BorkovecTD .Active and placebo treatment effects on moderate insomnia under counterdemand and positive demand instructions. Journal of Abnormal Psychology1974;83(2):157-63. ">Steinmark 1974</a> ; <a href="./references#MR000050-bbs2-0084" title="SzymanskiJ , O'DonohueW .The potential role of state-dependent learning in cognitive therapy with spider phobics. Journal of Rational-Emotive &amp; Cognitive-Behavior Therapy1995;13(2):131-50. SzymanskiJ .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 20th of August 2019. ">Szymanski 1995</a> ; <a href="./references#MR000050-bbs2-0085" title="TanSY , BruniJ .Cognitive-behavior therapy with adult patients with epilepsy: a controlled outcome study. Epilepsia1986;27(3):225-33. ">Tan 1986</a> ; <a href="./references#MR000050-bbs2-0086" title="TeriL , LogsdonRG , UomotoJ , McCurrySM .Behavioral treatment of depression in dementia patients: a controlled clinical trial. Journals of Gerontology. Series B, Psychological Sciences and Social Sciences1997;52(4):159-66. TeriL .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 26th of August 2019. ">Teri 1997</a> ; <a href="./references#MR000050-bbs2-0087" title="ToriC , WorellL .Reduction of human avoidant behavior. A comparison of counterconditioning, expectancy, and cognitive information approaches. Clinical Psychology1973;41(2):269-78. ">Tori 1973</a> ; <a href="./references#MR000050-bbs2-0088" title="Trexler, L.Rational-emotive therapy, placebo, and no-treatment effects on public-speaking anxiety. Doctoral dissertation, Temple University AnnArbor, Mich.: University Microfilms1971;71-31(063). TrexlerLD , KarstTO .Rational-emotive therapy, placebo, and no-treatment effects on public-speaking anxiety. Journal of Abnormal Psyhology1972;79(1):60-7. ">Trexler 1972</a> ; <a href="./references#MR000050-bbs2-0089" title="AscherML , TurnerRM .A comparison of two methods for the administration of paradoxical intention. Behaviour Research and Therapy1980;18(2):121-6. TurnerRM , AscherLM .Controlled comparison of progressive relaxation, stimulus control, and paradoxical intention therapies for insomnia. Journal of Consulting and Clinical Psychology1979;47(3):500-8. ">Turner 1979</a> ; <a href="./references#MR000050-bbs2-0090" title="VanderplateC .Electromyograph biofeedback Treatment of sleep onset Insomnia: a controlled Investigation. Dissertation, University of Southern Mississippi1978. ">Vanderplate 1983</a> ; <a href="./references#MR000050-bbs2-0091" title="WatzlH , RistF , OlbrichR , CohenR .Placebo injections and surveillance of alcohol intake during inpatient treatment of female alcoholics. Addictive Behaviors1988;13(2):197-200. ">Watzl 1988</a> ; <a href="./references#MR000050-bbs2-0092" title="WeingaertnerAH .Self-administered aversive stimulation with hallucinating hospitalized schizophrenics. Journal of Consulting and Clinical Psychology1971;36(3):422-29. ">Weingaertner 1971</a> ; <a href="./references#MR000050-bbs2-0093" title="WhittakerCB , HoyRM .Withdrawal of perphenazine in chronic schizophrenia. British Journal of Psychiatry1963;109:422-7. ">Whittaker 1963</a> ; <a href="./references#MR000050-bbs2-0094" title="WilsonA , DavidsonWJ , BlanchardR , WhiteJ .Disulfiram implantation. A placebo-controlled trial with two-year follow-up. Journal of Studies on Alcohol1978;39(5):809-19. WilsonA , DavidsonWJ , BlanchardR .Disulfiram implantation: a trial using placebo implants and two types of controls. Journal of Studies on Alcohol1980;41(5):429-36. ">Wilson 1980</a> ; <a href="./references#MR000050-bbs2-0095" title="WolitzkyKB , TelchMJ .Augmenting in vivo exposure with fear antagonistic actions: a preliminary test. Behavior Therapy2009;40(1):57-71. ">Wolitzky 2009</a> ; <a href="./references#MR000050-bbs2-0096" title="WollersheimJP , WilsonGL .Group treatment of unipolar depression: a comparison of coping, supportive, bibliotherapy, and delayed treatment groups. Professional Psychology: Research and Practice1991;22(6):496-502. ">Wollersheim 1991</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Other potential sources of bias</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Low risk of bias</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>87</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#MR000050-bbs2-0001" title="AbikoffH , HechtmanL , KleinRG .Social functioning in children with ADHD treated with long-term methylphenidate and multimodal psychosocial treatment. Journal of the American Academy of Child and Adolescent Psychiatry2004;43(7):820-9. AbikoffH .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to A Todorovac 23rd of August 2019. KleinRG , AbikoffH , HechtmanL , WeissG .Design and rationale of controlled study of long-term methylphenidate and multimodal psychosocial treatment in children with ADHD. Journal of the American Academy of Child and Adolescent Psychiatry2004;43(7):792-801. ">Abikoff 2004</a> ; <a href="./references#MR000050-bbs2-0002" title="AllenJB .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to A Todorovac 28th of August 2019. AllenJJ , SchnyerRN , HittSK .The efficacy of acupuncture in the treatment of major depression in women. Psychological Science1998;9(5):397-401. ">Allen 1998</a> ; <a href="./references#MR000050-bbs2-0003" title="AllenJB .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 28th of August 2019. AllenJJ , SchnyerRN , ChambersAS , HittSK , MorenoFA , ManberR .Acupuncture for depression: a randomized controlled trial. Journal of Clinical Psychiatry2006;67(11):1665-73. ">Allen 2006</a> ; <a href="./references#MR000050-bbs2-0004" title="AlvarezJR .The effects of anger management training on depression, anger, self-concept, and treatment responsibility in a sample of drug-dependent individuals in a therapeutic community. Dissertation Abstracts International: Section B: the Sciences and Engineering1997;58(4-B):2108. ">Alvarez 1997</a> ; <a href="./references#MR000050-bbs2-0005" title="AscherLM , TurnerR .Paradoxical intention and insomnia: an experimental investigation. Behaviour Research and Therapy1979;17(4):408-11. ">Ascher 1979</a> ; <a href="./references#MR000050-bbs2-0006" title="AyenI , HautzingerM .Cognitive behavior therapy for depression in menopausal women. A controlled, randomized treatment study [Kognitive Verhaltenstherapie bei Depressionen im Klimakterium: Eine kontrollierte, randomiserte Interventionsstudie]. Zeitschrift für Klinische Psychologie und Psychotherapie2004;33(4):290-9. AyenI .Inclusion of study in Cochrane Systematic Review (personal communication). Email to EG Faltinsen 9th of September 2019. ">Ayen 2004</a> ; <a href="./references#MR000050-bbs2-0007" title="BergI , ForsytheI , HoltP , WattsJ .A controlled trial of ‘Senokot’ in faecal soiling treated by behavioural methods. Journal of Child Psychology and Psychiatry1983;24(4):543-9. ">Berg 1983</a> ; <a href="./references#MR000050-bbs2-0008" title="Borden, KA.Attributional Outcomes: the Subtle Messages of Treatments for Attention Deficit Disorder. Dissertation, University of Illinois at Urbana-Champaign1986. BordenKA , BrownRT .Attributional outcomes: The subtle messages of treatments for attention deficit disorder. Cognitive Therapy and Research1989;13(2):147-60. ">Borden 1986</a> ; <a href="./references#MR000050-bbs2-0009" title="BorkovecTD , KaloupekDG , SlamaKM .The facilitative effect of muscle tension-release in the relaxation treatment of sleep disturbance. Behavior Therapy1975;6(3):301-9. ">Borkovec 1975</a> ; <a href="./references#MR000050-bbs2-0010" title="BorkovecTD , WeertsTC .Effects of progressive relaxation on sleep disturbance: an electroencephalographic evaluation. Psychosomatic Medicine1976;38(3):173-80. ">Borkovec 1976</a> ; <a href="./references#MR000050-bbs2-0011" title="BornovalovaM .Inclusion of study in Cochrane Systematic Review (personal communication). Email to A Todorovac. 21st of August 2019. BornovalovaMA .Distress tolerance treatment for inner-city drug users: a preliminary trial. Doctor’s Dissertation, University of Maryland2008. ">Bornovalova 2008</a> ; <a href="./references#MR000050-bbs2-0012" title="BramstonP , SpenceSH .Behavioural versus cognitive social-skills training with intellectually-handicapped adults. Behaviour Research and Therapy1985;23(3):239-46. ">Bramston 1985</a> ; <a href="./references#MR000050-bbs2-0013" title="BrillNQ , KoeglerRR , EpsteinLJ , ForgyEW .Controlled study of psychiatric outpatient treatment. Archives of General Psychiatry1964;10:581-95. BrillNQ .Results of psychotherapy. California Medicine1966;104(4):249-53. ">Brill 1964a</a> ; <a href="./references#MR000050-bbs2-0014" title="BrillNQ , KoeglerRR , EpsteinLJ , ForgyEW .Controlled study of psychiatric outpatient treatment. Archives of General Psychiatry1964;10:581-95. ">Brill 1964b</a> ; <a href="./references#MR000050-bbs2-0015" title="CarlsonCL , PelhamWE , MilichR , HozaB .ADHD boys’ performance and attributions following success and failure: drug effects and individual differences. Cognitive Therapy and Research1993;17:269-87. ">Carlson 1993</a> ; <a href="./references#MR000050-bbs2-0016" title="CarterJC , OlmstedMP , KaplanAS , McCabeRE , MillsJS , AimeA .Self-help for bulimia nervosa: a randomized controlled trial. American Journal of Psychiatry2003;160(5):973-8. ">Carter 2003</a> ; <a href="./references#MR000050-bbs2-0017" title="CrispAH , NortonK , GowersS , HalekC , BowyerC , YeldhamD , et al.A controlled study of the effect of therapies aimed at adolescent and family psychopathology in Anorexia Nervosa. British Journal of Psychiatry: the Journal of Mental Science1991;159:325-33. GowersS , NortonK , HalekC , CrispAH .Outcome of outpatient psychotherapy in a random allocation treatment study of anorexia nervosa. International Journal of Eating Disorders1994;15(2):165-77. GowersS , NortonK , YelshamD .The St George's prospective treatment study of anorexia nervosa: a discussion of methodological problems. International Journal of Eating Disorders1989;8:445-54. ">Crisp 1991</a> ; <a href="./references#MR000050-bbs2-0018" title="CrouchG , RobsonM , HallstromC .Benzodiazepine dependent patients and their psychological treatment. Progress in Neuro-psychopharmacology &amp; Biological Psychiatry1988;12(4):503-10. HallströmC , CrouchG , RobsenM , ShineP .The treatment of tranquillizer dependence by propranolol. Postgraduate Medical Journal1988;64(Suppl 2):40-4. ">Crouch 1988</a> ; <a href="./references#MR000050-bbs2-0019" title="Doty, DW.Role playing and incentives in the modification of the social interaction of chronic psychiatric patients. Journal of Consulting and Clinical Psychology1975;43(5):676-82. ">Doty 1975</a> ; <a href="./references#MR000050-bbs2-0020" title="DoubleDB , WarrenGC , EvansM , RowlandsMP .Efficacy of maintenance use of anticholinergic agents. Acta Psychiatrica Scandinavica1993;88:381-4. ">Double 1993</a> ; <a href="./references#MR000050-bbs2-0021" title="EhlersA , HackmannA , GreyN , WildJ , LinessS , AlbertI , et al.A randomized controlled trial of 7-day intensive and standard weekly cognitive therapy for PTSD and emotion-focused supportive therapy. American Journal of Psychiatry2014;171(3):294-304. ">Ehlers 2014</a> ; <a href="./references#MR000050-bbs2-0022" title="EspieCA , BrooksDN , LindsayWR .An evaluation of tailored psychological treatment of insomnia. Journal of Behavior Therapy and Experimental Psychiatry1989;20(2):143-53. EspieCA , LindsayWR , BrooksDN , HoodEM , TurveyT .A controlled comparative investigation of psychological treatments for chronic sleep-onset insomnia. Behaviour Research and Therapy1989;27(1):79-88. ">Espie 1989a</a> ; <a href="./references#MR000050-bbs2-0023" title="EtringerBD , CashTF , RimmDC .Behavioral, affective, and cognitive effects of participant modeling and an equally credible placebo. Behavior Therapy1982;13(4):476-85. ">Etringer 1982</a> ; <a href="./references#MR000050-bbs2-0024" title="FoaEB , RothbaumBO , RiggsDS , MurdockTB .Treatment of posttraumatic stress disorder in rape victims: a comparison between cognitive-behavioral procedures and counselling. Journal of Consulting and Clinical Psychology1991;59(5):715-23. ">Foa 1991</a> ; <a href="./references#MR000050-bbs2-0025" title="FoaEB , McLeanCP , ZangY , RosenfieldD , YadinE , YarvisJS , et al.Effect of prolonged exposure therapy delivered over 2 weeks vs 8 weeks vs present-centered therapy on PTSD symptom severity in military personnel: a randomized clinical trial. JAMA2018;319(4):354-64. ">Foa 2018</a> ; <a href="./references#MR000050-bbs2-0026" title="FreireAO , SugaiGC , ChrispinFS , TogeiroSM , YamamuraY , MelloLE , et al.Treatment of moderate obstructive sleep apnea syndrome with acupuncture: a randomised, placebo-controlled pilot trial. Sleep Medicine2007;8(1):43-50. ">Freire 2007</a> ; <a href="./references#MR000050-bbs2-0027" title="FuchsCZ , RehnLP .A self-control behavior therapy program for depression. Journal of Consulting and Clinical Psychology1977;45(2):206-15. ">Fuchs 1977</a> ; <a href="./references#MR000050-bbs2-0028" title="GlogowskaM , RoulstoneS , EnderbyP , PetersTJ .Randomised controlled trial of community based speech and language therapy in preschool children. BMJ2000;321(7266):923-6. ">Glogowska 2000</a> ; <a href="./references#MR000050-bbs2-0029" title="GoldsteinAJ , BeursE , Chambless Dl, WilsonKA .EMDR for panic disorder with agoraphobia: comparison with waiting list and credible attention-placebo control conditions. Journal of Consulting and Clinical Psychology2000;68(6):947-56. ">Goldstein 2000</a> ; <a href="./references#MR000050-bbs2-0030" title="GoldwasserAN , AuerbachSM , HarkinsSW .Cognitive, affective, and behavioural effects of reminiscence group therapy on demented elderly. Aging and Human Development1987;25(3):209-22. ">Goldwasser 1987</a> ; <a href="./references#MR000050-bbs2-0031" title="HekmatH , LubitzR , DealR .Semantic desensitization: a paradigmatic intervention approach to anxiety disorders. Journal of Clinical Psychology1984;40(2):463-6. ">Hekmat 1984</a> ; <a href="./references#MR000050-bbs2-0032" title="HippmanC , RingroseA , InglisA , CheekJ , AlbertAY , RemickR , et al.A pilot randomized clinical trial evaluating the impact of genetic counselling for serious mental illnesses. Journal of Clinical Psychiatry2016;77(2):e190-8. ">Hippman 2016</a> ; <a href="./references#MR000050-bbs2-0033" title="HowlinP , GordonKR , PascoG , WadeA , CharmanT .The effectiveness of picture exchange communication system (PECS) training for teachers of children with autism: a pragmatic,group randomised controlled trial. Journal of Child Psychology and Psychiatry2007;48(5):473-81. ">Howlin 2007</a> ; <a href="./references#MR000050-bbs2-0034" title="KarstM , WinterhalterM , MünteS , FranckiB , HondronikosA , EckardtA , et al.Auricular acupuncture for dental anxiety: a randomized controlled trial. Anesthesia and Analgesia2007;104(2):295-300. KarstM .Inclusion of study in Cochrane Systematic Review (personal communication). Email to: EG Faltinsen 5th of September 2019. ">Karst 2007</a> ; <a href="./references#MR000050-bbs2-0035" title="KelleyJ .Inclusion of study in Cochrane Systematic Review (personal communication). Email to: A Todorovac 12th of August 2019. KelleyJM , KaptchukTJ , CusinC , LipkinS , FavaM .Open-label placebo for major depressive disorder: a pilot randomized controlled trial. Psychotherapy and Psychosomatics2012;81(5):312-4. ">Kelley 2012</a> ; <a href="./references#MR000050-bbs2-0036" title="KennedyTD , KimuraHK .Transfer, behavioral improvement, and anxiety reduction in systematic desensitization. Journal of Consulting and Clinical Psychology1974;42(5):720-8. ">Kennedy 1974</a> ; <a href="./references#MR000050-bbs2-0037" title="KilmannPR , MilanRJ , BolandJP , NankinHR , DavidsonE , WestMO , et al.Group treatment of secondary erectile dysfunction. Journal of Sex &amp; Marital Therapy1987;13(3):168-82. KilmannPR , Milan RJ Jr, BolandJP , DavidsonE , WestMO , SablisRF , et al.The sexual interactions of men with secondary erectile dysfunction. Journal of Sex Education and Therapy1988;14(1):46-9. KilmannPR , Milan RJ Jr, BolandJP , NankinHR , SablisRF , WestMO , et al.The sexual interactions of men with secondary erectile dysfunction. Paper presented at the annual meeting of the American Psychological Association in Los Angeles1985;1:46-9. ">Kilmann 1987</a> ; <a href="./references#MR000050-bbs2-0038" title="KleinSA , DeffenbacherJL .Relaxation and exercise for hyperactive impulsive children. Perceptual and Motor Skills1977;45:1159-62. ">Klein 1977</a> ; <a href="./references#MR000050-bbs2-0039" title="KlermanGL , DimascioA , WeismannM , PrusoffB , PaykelES .Treatment of depression by drugs and psychotherapy. American Journal of Psychiatry1974;131(2):186-91. PaykelES , DimascioA , HaskellD , PrusoffBA .Effects of maintenance amitriptyline and psychotherapy on symptoms of depression. Psychological Medicine1975;5(1):67-77. PaykelES , DiMascioA , KlermanGL , PrusoffBA .Maintenance therapy of depression. Pharmakopsychiatrie, Neuro-Psychopharmakologie1976;9:127-39. PaykelES , WeissmanMM , PrusoffBA .Social maladjustment and severity of depression. Comprehensive Psychiatry1978;19(2):121-8. WeissmanMM , KlermanGL , PaykelES , PrusoffB .Treatment effects on the social adjustment of depressed patients. Archives of General Psychiatry1974;30:771-8. ">Klerman 1974a</a> ; <a href="./references#MR000050-bbs2-0040" title="KlermanGL , DimascioA , WeismannM , PrusoffB , PaykelES .Treatment of depression by drugs and psychotherapy. American Journal of Psychiatry1974;131(2):186-91. ">Klerman 1974b</a> ; <a href="./references#MR000050-bbs2-0041" title="KloskoJS , BarlowDH , TassinariR , CernyJA .A comparison of alprazolam and behavior therapy in treatment of panic disorder: correction. Journal of Psychotherapy Practice and Research1994;3(2):163-79. KloskoJS , BarlowDH , TassinariR , CernyJA .A comparison of alprazolam and behavior therapy in treatment of panic disorder. Journal of Consulting and Clinical Psychology1990;58(1):77-84. ">Klosko 1990</a> ; <a href="./references#MR000050-bbs2-0042" title="KrapflJE , NawasMM .Differential ordering of stimulus presentation in systematic desensitization. Journal of Abnormal Psychology1970;75(3):333-7. ">Krapfl 1970</a> ; <a href="./references#MR000050-bbs2-0043" title="KwanR .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 26th of August 2019. KwanRY , LeungMC , LaiCK .Acupressure for agitation in nursing home residents with dementia: study protocol for a randomized controlled trial. Trials2014;15(410):1-7. KwanRY , LeungMCP , LaiCK .A randomized controlled trial examining the effect of acupressure on agitation and salivary cortisol in nursing home residents with dementia. Dementia and Geriatric Cognitive Disorders2017;44(1-2):92-104. ">Kwan 2017</a> ; <a href="./references#MR000050-bbs2-0044" title="LacyMK .The effect of short term autogenic training on the stress reactivity of hospitalized emotionally disturbed adolescents. ProQuest Dissertations Publishing, Oklahoma State University1996. ">Lacy 1990</a> ; <a href="./references#MR000050-bbs2-0046" title="LangOJ , LazovikAD .Experimental desensitization of a phobia. Journal of Abnormal and Social Psychology1963;66:519-25. LangPJ , LazovikAD , ReynoldsDJ .Desensitization, suggestibility, and pseudotherapy. Journal of Abnormal Psychology1965;70(6):395-402. ">Lang 1965</a> ; <a href="./references#MR000050-bbs2-0047" title="LegrandF .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 14th of August 2019. LegrandFD , NeffEM .Efficacy of exercise as an adjunct treatment for clinically depressed inpatients during the initial stages of antidepressant pharmacotherapy: an open randomized controlled trial. Journal of Affective Disorders2016;191:139-44. ">Legrand 2016</a> ; <a href="./references#MR000050-bbs2-0048" title="LickJ .Expectancy, false galvanic skin response feedback, and systematic desensitization in the modification of phobic behavior. Journal of Consulting and Clinical Psychology1975;43(4):557-67. ">Lick 1975</a> ; <a href="./references#MR000050-bbs2-0050" title="LiddleB , SpenceSH .Cognitive-behaviour therapy with depressed primary school children: A cautionary note. Behavioural Psychotherapy1990;18(2):85-102. ">Liddle 1990</a> ; <a href="./references#MR000050-bbs2-0051" title="MatsonJL , MarchettiA , AdkinsJA .Comparison of operant- and independence-training procedures for mentally retarded adults. American Journal of Mental Deficiency1980;84(5):487-94. ">Matson 1980</a> ; <a href="./references#MR000050-bbs2-0052" title="McLachlanDR , DaltonAJ , KruckTP , BellMY , SmithWL , KalowW , et al.Intramuscular desferrioxamine in patients with Alzheimer's disease. Lancet1991;337(8753):1304-8. McLachlanDRC , SmithWL , KruckTP .Desferrioxamine and Alzheimer’s disease: video home behavior assessment of clinical course and measures of brain aluminum. Therapeutic Drug Monitoring1993;15(6):602-7. ">McLachlan 1991</a> ; <a href="./references#MR000050-bbs2-0053" title="MealieaWL , NawasMM .The comparative effectiveness of systematic desensitization and implosive therapy in the treatment of snake phobia. Journal of Behavior Therapy and Experimental Psychiatry1971;2(2):85-94. ">Mealiea 1971</a> ; <a href="./references#MR000050-bbs2-0054" title="MilbyJB , ClarkeC , ToroC , ThorntonS , RickertD .Effectiveness of urine surveillance as an adjunct to outpatient psychotherapy for drug abusers. International Journal of the Addictions1980;15(7):993-1001. ">Milby 1980</a> ; <a href="./references#MR000050-bbs2-0055" title="MirandaA , ArlandisP , SorianoM .Instruction in strategies and attributional training: Effects on the problem-solving and self-concept of students’ with learning disabilities [Instrucción en estrategias y entrenamiento atribucional: efectos sobre la resolución de problemas y el autoconcepto de los estudiantes con dificultades en el aprendizaje]. Infancia y Aprendizaje1997;20(80):37-52. ">Miranda 1997</a> ; <a href="./references#MR000050-bbs2-0057" title="NandiDN , AjmanyS , GanguliH , BanerjeeG , BoralGC , GhoshA , et al.A clinical evaluation of depressives found in a rural survey in India. British Journal of Psychiatry1976;128:523-7. ">Nandi 1976</a> ; <a href="./references#MR000050-bbs2-0058" title="NicassioP , BootzinR .A comparison of progressive relaxation and autogenic training as treatments for insomnia. Journal of Abnormal Psychology1974;83(3):253-60. ">Nicassio 1974</a> ; <a href="./references#MR000050-bbs2-0059" title="PearlD , Vander KampH , OlsenAL , GreenbergPD , ArmitageSG .The effects of reserpine on schizophrenic patients. American Journal of Psychiatry1956;112:198-204. ">Pearl 1956</a> ; <a href="./references#MR000050-bbs2-0060" title="PeckCL .Desensitization for the treatment of fear in the high level adult retardate. Behaviour Research and Therapy1977;15(2):137-48. ">Peck 1976</a> ; <a href="./references#MR000050-bbs2-0062" title="PedletonMG , HigginsRL .A comparison of negative practice and systematic desensitization in the treatment of acrophobia. Journal of Behavior Therapy and Experimental Psychiatry1983;14(4):317-23. ">Pendleton 1983</a> ; <a href="./references#MR000050-bbs2-0063" title="PetersonMA , PattersonB , PillmanBM , BattistaMA .Cognitive recovery following alcohol detoxification: a computerised remediation study. Neuropsychological Rehabilitation2002;12(1):63-74. PillmanBM .Computerized cognitive remediation with recently detoxified alcoholics. Dissertation, California School of Professional Psychology, Fresno Campus2000. ">Pillman 2001</a> ; <a href="./references#MR000050-bbs2-0064" title="PolandRE , GertsikL , FavreauJT , SmithSI , MirochaJM , RaoU , et al.Open-label randomized parallel-group controlled clinical trial of massage for treatment of depression in HIV-infected subjects. Journal of Alternative and Complementary Medicine2013;19(4):334-40. ">Poland 2013</a> ; <a href="./references#MR000050-bbs2-0065" title="PowersMB , SmitsJA , TelchMJ .Disentangling the effects of safety-behavior utilization and safety-behavior availability during exposure-based treatment: a placebo-controlled trial. Journal of Consulting and Clinical Psychology2004;72(3):448-54. ">Powers 2004</a> ; <a href="./references#MR000050-bbs2-0066" title="PowersMB , SmithsJA , WhitleyD , BystritskyA , TelchMJ .The effect of attributional processes concerning medication taking on return of fear. Journal of Consulting and Clinical Psychology2008;76(3):478-90. ">Powers 2008a</a> ; <a href="./references#MR000050-bbs2-0067" title="PowersMB , SmithsJA , WhitleyD , BystritskyA , TelchMJ .The effect of attributional processes concerning medication taking on return of fear. Journal of Consulting and Clinical Psychology2008;76(3):478-90. ">Powers 2008b</a> ; <a href="./references#MR000050-bbs2-0068" title="ProudfootJ , ClarkeJ , BirchMR , WhittonAE , ParkerG , ManicavasagarV , et al.Impact of a mobile phone and web program on symptom and functional outcomes for people with mild- to-moderate depression, anxiety and stress: a randomized controlled trial. BMC Psychiatry2013;13(312):1-12. ProudfootJ .Re: Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 26th of August 2019. ">Proudfoot 2013</a> ; <a href="./references#MR000050-bbs2-0070" title="LiebowitzM , QuitkinFM , StewartJW , McGrathPJ , HarrisonWM , MarkowitzJS , et al.Antidepressant efficacy in atypical depression. Archives of General Psychiatry1988;45(2):129-37. QuitkinFM , McGrathPJ , StewartJW , HarrisonW , WagerSG , NunesE , et al.Phenelzine and imipramine in mood reactive depressives: further delineation of the syndrome of atypical depression. Archives of General Psychiatry1989;46(9):787-93. RabkinJG , McGrathPJ , QuitkinFM , TricamoE , StewartJW , KleinDF .Effects of pill-giving on maintenance of placebo response in patients with chronic mild depression. American Journal of Psychiatry1990;147(12):1622-6. ">Rabkin 1990</a> ; <a href="./references#MR000050-bbs2-0071" title="RapeeR .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 29th of August 2019. RapeeRM , AbbottMJ , LynehamHJ .Bibliotherapy for children With anxiety disorders using written materials for parents: a randomized controlled trial. Journal of Consulting and Clinical Psychology2006;74(3):436-44. ">Rapee 2006</a> ; <a href="./references#MR000050-bbs2-0072" title="RapeeR .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 29th of August 2019. RapeeRM , AbbottMJ , BaillieAJ , GastonJE .Treatment of social phobia through pure self-help and therapist-augmented self-help. British Journal of Psychiatry2007;191:246-52. ">Rapee 2007</a> ; <a href="./references#MR000050-bbs2-0074" title="RoehrichL , GoldmanMS .Experience-dependent neuropsychological recovery and the treatment of alcoholism. Journal of Consulting and Clinical Psychology1993;61(5):812-21. ">Roehrich 1993</a> ; <a href="./references#MR000050-bbs2-0075" title="OlivaresJ .Program IAFS. Protocol for the treatment of social phobia in adolescents [Programa IAFS. Protocolo para el tratamiento de la fobia social enadolescentes]. Madrid: Pirámide2005;1. Rosa-AlcázarAI , Olivares-OlivaresPJ , OlivaresJ .The role of non-specific effects in the psychological treatment of adolescents with social phobia [Papel de los efectos inespecíficos en el tratamiento psicológico de adolescentes con fobia social]. Anuario de Psicologia2009;40(1):43-61. ">Rosa‐Alcatraz 2009</a> ; <a href="./references#MR000050-bbs2-0076" title="RosenGM , GlasgowRE , BarreraM .A controlled study to assess the clinical efficacy of totally self-administrated systematic desensitization. Journal of Consulting and Clinical Psychology1976;44(2):208-17. ">Rosen 1976</a> ; <a href="./references#MR000050-bbs2-0077" title="LorrM , McNairDM , WeinsteinGJ .Early effects of chlordiazepoxide (Librium) used with psychotherapy. Journal of Psychiatric Research1963;1:257-70. RothI , RhudickPJ , ShaskanDA , SlobinMS , WilkinsonAE , YoungHH .Long-term effects on psychotherapy of initial treatment conditions. Journal of Psychiatric Research1964;2:283-97. ">Roth 1964</a> ; <a href="./references#MR000050-bbs2-0078" title="RupertPA , HolmesDS .Effects of multiple sessions of true and placebo heart rate biofeedback training on the heart rates and anxiety levels of anxious patients during and following treatment. Psychophysiology1978;15(6):582-90. ">Rupert 1978</a> ; <a href="./references#MR000050-bbs2-0079" title="ShalevAY , AnkriY , Isreali-ShalevY , PelegT , AdesskyR , FreedmanS .Prevention of posttraumatic stress disorder by early treatment. Archives of General Psychiatry2012;69(2):166-76. ">Shalev 2012</a> ; <a href="./references#MR000050-bbs2-0080" title="ShealyRC .The effectiveness of various treatment techniques on different degrees and durations of sleep-onset insomnia. Behaviour Research and Therapy1979;17(6):541-6. ">Shealy 1979</a> ; <a href="./references#MR000050-bbs2-0081" title="SibilioJP , AndrewG , DartD , MooreKB , StehmanA .Treatment of chronic schizophrenia with promazine hydrochloride. AMA Archives of Neurology and Psychiatry1957;78(4):419-24. ">Sibilio 1957</a> ; <a href="./references#MR000050-bbs2-0082" title="SommernessMD , LuceroRJ , HamlonJS , EricksonJL , MatthewsR .A controlled study of reserpine on chronically disturbed patients. JAMA Archives of Neurology and Psychiatry1955;74(3):316-9. ">Sommerness 1955</a> ; <a href="./references#MR000050-bbs2-0084" title="SzymanskiJ , O'DonohueW .The potential role of state-dependent learning in cognitive therapy with spider phobics. Journal of Rational-Emotive &amp; Cognitive-Behavior Therapy1995;13(2):131-50. SzymanskiJ .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 20th of August 2019. ">Szymanski 1995</a> ; <a href="./references#MR000050-bbs2-0085" title="TanSY , BruniJ .Cognitive-behavior therapy with adult patients with epilepsy: a controlled outcome study. Epilepsia1986;27(3):225-33. ">Tan 1986</a> ; <a href="./references#MR000050-bbs2-0086" title="TeriL , LogsdonRG , UomotoJ , McCurrySM .Behavioral treatment of depression in dementia patients: a controlled clinical trial. Journals of Gerontology. Series B, Psychological Sciences and Social Sciences1997;52(4):159-66. TeriL .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 26th of August 2019. ">Teri 1997</a> ; <a href="./references#MR000050-bbs2-0087" title="ToriC , WorellL .Reduction of human avoidant behavior. A comparison of counterconditioning, expectancy, and cognitive information approaches. Clinical Psychology1973;41(2):269-78. ">Tori 1973</a> ; <a href="./references#MR000050-bbs2-0090" title="VanderplateC .Electromyograph biofeedback Treatment of sleep onset Insomnia: a controlled Investigation. Dissertation, University of Southern Mississippi1978. ">Vanderplate 1983</a> ; <a href="./references#MR000050-bbs2-0091" title="WatzlH , RistF , OlbrichR , CohenR .Placebo injections and surveillance of alcohol intake during inpatient treatment of female alcoholics. Addictive Behaviors1988;13(2):197-200. ">Watzl 1988</a> ; <a href="./references#MR000050-bbs2-0092" title="WeingaertnerAH .Self-administered aversive stimulation with hallucinating hospitalized schizophrenics. Journal of Consulting and Clinical Psychology1971;36(3):422-29. ">Weingaertner 1971</a> ; <a href="./references#MR000050-bbs2-0093" title="WhittakerCB , HoyRM .Withdrawal of perphenazine in chronic schizophrenia. British Journal of Psychiatry1963;109:422-7. ">Whittaker 1963</a> ; <a href="./references#MR000050-bbs2-0094" title="WilsonA , DavidsonWJ , BlanchardR , WhiteJ .Disulfiram implantation. A placebo-controlled trial with two-year follow-up. Journal of Studies on Alcohol1978;39(5):809-19. WilsonA , DavidsonWJ , BlanchardR .Disulfiram implantation: a trial using placebo implants and two types of controls. Journal of Studies on Alcohol1980;41(5):429-36. ">Wilson 1980</a> ; <a href="./references#MR000050-bbs2-0095" title="WolitzkyKB , TelchMJ .Augmenting in vivo exposure with fear antagonistic actions: a preliminary test. Behavior Therapy2009;40(1):57-71. ">Wolitzky 2009</a> ; <a href="./references#MR000050-bbs2-0096" title="WollersheimJP , WilsonGL .Group treatment of unipolar depression: a comparison of coping, supportive, bibliotherapy, and delayed treatment groups. Professional Psychology: Research and Practice1991;22(6):496-502. ">Wollersheim 1991</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>High risk of bias</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#MR000050-bbs2-0048" title="LickJ .Expectancy, false galvanic skin response feedback, and systematic desensitization in the modification of phobic behavior. Journal of Consulting and Clinical Psychology1975;43(4):557-67. ">Lick 1975</a> ; <a href="./references#MR000050-bbs2-0056" title="MitchellC , MansfieldD , RautenbachS .Coloured filters and reading accuracy, comprehension and rate: a placebo-controlled study. Perceptual and Motor Skills2008;106(2):517-32. ">Mitchell 2008</a> ; <a href="./references#MR000050-bbs2-0061" title="MilichR , CarlsonCL , Pelham WE Jr, LichtBG .Effects of methylphenidate on the persistence of ADHD boys following failure experiences. Journal of Abnormal Child Psychology1991;19(5):519-36. PelhamWE , MurphyDA , VannattaK , MilichR , LichtBG , GnagyEM , et al.Methylphenidate and attributions in boys with attention-deficit hyperactivity disorder. Journal of Consulting and Clinical Psychology1992;60(2):282-92. ">Pelham 1992</a> ; <a href="./references#MR000050-bbs2-0069" title="QuayhagenMP , QuayhagenM , CorbeilRR , RothPA , RodgersJA .A dyadic remediation program for care recipients with dementia. Nursing Research1995;44(3):153-9. ">Quayhagen 1995</a> ; <a href="./references#MR000050-bbs2-0073" title="RobinA .Rationing out-patients: a defence of the waiting list. British Journal of Psychiatry1976;129:138-41. ">Robin 1976</a> ; <a href="./references#MR000050-bbs2-0083" title="SteinmarkSW , BorkovecTD .Active and placebo treatment effects on moderate insomnia under counterdemand and positive demand instructions. Journal of Abnormal Psychology1974;83(2):157-63. ">Steinmark 1974</a> ; <a href="./references#MR000050-bbs2-0088" title="Trexler, L.Rational-emotive therapy, placebo, and no-treatment effects on public-speaking anxiety. Doctoral dissertation, Temple University AnnArbor, Mich.: University Microfilms1971;71-31(063). TrexlerLD , KarstTO .Rational-emotive therapy, placebo, and no-treatment effects on public-speaking anxiety. Journal of Abnormal Psyhology1972;79(1):60-7. ">Trexler 1972</a> ; <a href="./references#MR000050-bbs2-0089" title="AscherML , TurnerRM .A comparison of two methods for the administration of paradoxical intention. Behaviour Research and Therapy1980;18(2):121-6. TurnerRM , AscherLM .Controlled comparison of progressive relaxation, stimulus control, and paradoxical intention therapies for insomnia. Journal of Consulting and Clinical Psychology1979;47(3):500-8. ">Turner 1979</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Unclear risk of bias</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#MR000050-bbs2-0045" title="LaiCK , ChiI , Kayser-JonesJ .A randomized controlled trial of a specific reminiscence approach to promote the well-being of nursing home residents with dementia. International Psychogeriatrics2004;16(1):33-49. LaiK .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 6th of September 2019. ">Lai 2004</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><i>Researchers or authors provided the treatment</i> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#MR000050-bbs2-0048" title="LickJ .Expectancy, false galvanic skin response feedback, and systematic desensitization in the modification of phobic behavior. Journal of Consulting and Clinical Psychology1975;43(4):557-67. ">Lick 1975</a> ; <a href="./references#MR000050-bbs2-0083" title="SteinmarkSW , BorkovecTD .Active and placebo treatment effects on moderate insomnia under counterdemand and positive demand instructions. Journal of Abnormal Psychology1974;83(2):157-63. ">Steinmark 1974</a> ; <a href="./references#MR000050-bbs2-0088" title="Trexler, L.Rational-emotive therapy, placebo, and no-treatment effects on public-speaking anxiety. Doctoral dissertation, Temple University AnnArbor, Mich.: University Microfilms1971;71-31(063). TrexlerLD , KarstTO .Rational-emotive therapy, placebo, and no-treatment effects on public-speaking anxiety. Journal of Abnormal Psyhology1972;79(1):60-7. ">Trexler 1972</a> ; <a href="./references#MR000050-bbs2-0089" title="AscherML , TurnerRM .A comparison of two methods for the administration of paradoxical intention. Behaviour Research and Therapy1980;18(2):121-6. TurnerRM , AscherLM .Controlled comparison of progressive relaxation, stimulus control, and paradoxical intention therapies for insomnia. Journal of Consulting and Clinical Psychology1979;47(3):500-8. ">Turner 1979</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><i>Attention bias or differences in duration of treatment</i> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#MR000050-bbs2-0056" title="MitchellC , MansfieldD , RautenbachS .Coloured filters and reading accuracy, comprehension and rate: a placebo-controlled study. Perceptual and Motor Skills2008;106(2):517-32. ">Mitchell 2008</a> ; <a href="./references#MR000050-bbs2-0073" title="RobinA .Rationing out-patients: a defence of the waiting list. British Journal of Psychiatry1976;129:138-41. ">Robin 1976</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><i>Carry‐over effects</i> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#MR000050-bbs2-0061" title="MilichR , CarlsonCL , Pelham WE Jr, LichtBG .Effects of methylphenidate on the persistence of ADHD boys following failure experiences. Journal of Abnormal Child Psychology1991;19(5):519-36. PelhamWE , MurphyDA , VannattaK , MilichR , LichtBG , GnagyEM , et al.Methylphenidate and attributions in boys with attention-deficit hyperactivity disorder. Journal of Consulting and Clinical Psychology1992;60(2):282-92. ">Pelham 1992</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><i>Exceed the passivity of placebo</i> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#MR000050-bbs2-0069" title="QuayhagenMP , QuayhagenM , CorbeilRR , RothPA , RodgersJA .A dyadic remediation program for care recipients with dementia. Nursing Research1995;44(3):153-9. ">Quayhagen 1995</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><i>Time bias or assessment at different point for the groups</i> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#MR000050-bbs2-0073" title="RobinA .Rationing out-patients: a defence of the waiting list. British Journal of Psychiatry1976;129:138-41. ">Robin 1976</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Affiliation bias (allegiance or industry bias)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Low risk of bias</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>90</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#MR000050-bbs2-0002" title="AllenJB .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to A Todorovac 28th of August 2019. AllenJJ , SchnyerRN , HittSK .The efficacy of acupuncture in the treatment of major depression in women. Psychological Science1998;9(5):397-401. ">Allen 1998</a> ; <a href="./references#MR000050-bbs2-0003" title="AllenJB .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 28th of August 2019. AllenJJ , SchnyerRN , ChambersAS , HittSK , MorenoFA , ManberR .Acupuncture for depression: a randomized controlled trial. Journal of Clinical Psychiatry2006;67(11):1665-73. ">Allen 2006</a> ; <a href="./references#MR000050-bbs2-0004" title="AlvarezJR .The effects of anger management training on depression, anger, self-concept, and treatment responsibility in a sample of drug-dependent individuals in a therapeutic community. Dissertation Abstracts International: Section B: the Sciences and Engineering1997;58(4-B):2108. ">Alvarez 1997</a> ; <a href="./references#MR000050-bbs2-0005" title="AscherLM , TurnerR .Paradoxical intention and insomnia: an experimental investigation. Behaviour Research and Therapy1979;17(4):408-11. ">Ascher 1979</a> ; <a href="./references#MR000050-bbs2-0006" title="AyenI , HautzingerM .Cognitive behavior therapy for depression in menopausal women. A controlled, randomized treatment study [Kognitive Verhaltenstherapie bei Depressionen im Klimakterium: Eine kontrollierte, randomiserte Interventionsstudie]. Zeitschrift für Klinische Psychologie und Psychotherapie2004;33(4):290-9. AyenI .Inclusion of study in Cochrane Systematic Review (personal communication). Email to EG Faltinsen 9th of September 2019. ">Ayen 2004</a> ; <a href="./references#MR000050-bbs2-0007" title="BergI , ForsytheI , HoltP , WattsJ .A controlled trial of ‘Senokot’ in faecal soiling treated by behavioural methods. Journal of Child Psychology and Psychiatry1983;24(4):543-9. ">Berg 1983</a> ; <a href="./references#MR000050-bbs2-0008" title="Borden, KA.Attributional Outcomes: the Subtle Messages of Treatments for Attention Deficit Disorder. Dissertation, University of Illinois at Urbana-Champaign1986. BordenKA , BrownRT .Attributional outcomes: The subtle messages of treatments for attention deficit disorder. Cognitive Therapy and Research1989;13(2):147-60. ">Borden 1986</a> ; <a href="./references#MR000050-bbs2-0009" title="BorkovecTD , KaloupekDG , SlamaKM .The facilitative effect of muscle tension-release in the relaxation treatment of sleep disturbance. Behavior Therapy1975;6(3):301-9. ">Borkovec 1975</a> ; <a href="./references#MR000050-bbs2-0010" title="BorkovecTD , WeertsTC .Effects of progressive relaxation on sleep disturbance: an electroencephalographic evaluation. Psychosomatic Medicine1976;38(3):173-80. ">Borkovec 1976</a> ; <a href="./references#MR000050-bbs2-0012" title="BramstonP , SpenceSH .Behavioural versus cognitive social-skills training with intellectually-handicapped adults. Behaviour Research and Therapy1985;23(3):239-46. ">Bramston 1985</a> ; <a href="./references#MR000050-bbs2-0013" title="BrillNQ , KoeglerRR , EpsteinLJ , ForgyEW .Controlled study of psychiatric outpatient treatment. Archives of General Psychiatry1964;10:581-95. BrillNQ .Results of psychotherapy. California Medicine1966;104(4):249-53. ">Brill 1964a</a> ; <a href="./references#MR000050-bbs2-0014" title="BrillNQ , KoeglerRR , EpsteinLJ , ForgyEW .Controlled study of psychiatric outpatient treatment. Archives of General Psychiatry1964;10:581-95. ">Brill 1964b</a> ; <a href="./references#MR000050-bbs2-0015" title="CarlsonCL , PelhamWE , MilichR , HozaB .ADHD boys’ performance and attributions following success and failure: drug effects and individual differences. Cognitive Therapy and Research1993;17:269-87. ">Carlson 1993</a> ; <a href="./references#MR000050-bbs2-0016" title="CarterJC , OlmstedMP , KaplanAS , McCabeRE , MillsJS , AimeA .Self-help for bulimia nervosa: a randomized controlled trial. American Journal of Psychiatry2003;160(5):973-8. ">Carter 2003</a> ; <a href="./references#MR000050-bbs2-0017" title="CrispAH , NortonK , GowersS , HalekC , BowyerC , YeldhamD , et al.A controlled study of the effect of therapies aimed at adolescent and family psychopathology in Anorexia Nervosa. British Journal of Psychiatry: the Journal of Mental Science1991;159:325-33. GowersS , NortonK , HalekC , CrispAH .Outcome of outpatient psychotherapy in a random allocation treatment study of anorexia nervosa. International Journal of Eating Disorders1994;15(2):165-77. GowersS , NortonK , YelshamD .The St George's prospective treatment study of anorexia nervosa: a discussion of methodological problems. International Journal of Eating Disorders1989;8:445-54. ">Crisp 1991</a> ; <a href="./references#MR000050-bbs2-0018" title="CrouchG , RobsonM , HallstromC .Benzodiazepine dependent patients and their psychological treatment. Progress in Neuro-psychopharmacology &amp; Biological Psychiatry1988;12(4):503-10. HallströmC , CrouchG , RobsenM , ShineP .The treatment of tranquillizer dependence by propranolol. Postgraduate Medical Journal1988;64(Suppl 2):40-4. ">Crouch 1988</a> ; <a href="./references#MR000050-bbs2-0019" title="Doty, DW.Role playing and incentives in the modification of the social interaction of chronic psychiatric patients. Journal of Consulting and Clinical Psychology1975;43(5):676-82. ">Doty 1975</a> ; <a href="./references#MR000050-bbs2-0020" title="DoubleDB , WarrenGC , EvansM , RowlandsMP .Efficacy of maintenance use of anticholinergic agents. Acta Psychiatrica Scandinavica1993;88:381-4. ">Double 1993</a> ; <a href="./references#MR000050-bbs2-0022" title="EspieCA , BrooksDN , LindsayWR .An evaluation of tailored psychological treatment of insomnia. Journal of Behavior Therapy and Experimental Psychiatry1989;20(2):143-53. EspieCA , LindsayWR , BrooksDN , HoodEM , TurveyT .A controlled comparative investigation of psychological treatments for chronic sleep-onset insomnia. Behaviour Research and Therapy1989;27(1):79-88. ">Espie 1989a</a> ; <a href="./references#MR000050-bbs2-0023" title="EtringerBD , CashTF , RimmDC .Behavioral, affective, and cognitive effects of participant modeling and an equally credible placebo. Behavior Therapy1982;13(4):476-85. ">Etringer 1982</a> ; <a href="./references#MR000050-bbs2-0026" title="FreireAO , SugaiGC , ChrispinFS , TogeiroSM , YamamuraY , MelloLE , et al.Treatment of moderate obstructive sleep apnea syndrome with acupuncture: a randomised, placebo-controlled pilot trial. Sleep Medicine2007;8(1):43-50. ">Freire 2007</a> ; <a href="./references#MR000050-bbs2-0028" title="GlogowskaM , RoulstoneS , EnderbyP , PetersTJ .Randomised controlled trial of community based speech and language therapy in preschool children. BMJ2000;321(7266):923-6. ">Glogowska 2000</a> ; <a href="./references#MR000050-bbs2-0029" title="GoldsteinAJ , BeursE , Chambless Dl, WilsonKA .EMDR for panic disorder with agoraphobia: comparison with waiting list and credible attention-placebo control conditions. Journal of Consulting and Clinical Psychology2000;68(6):947-56. ">Goldstein 2000</a> ; <a href="./references#MR000050-bbs2-0030" title="GoldwasserAN , AuerbachSM , HarkinsSW .Cognitive, affective, and behavioural effects of reminiscence group therapy on demented elderly. Aging and Human Development1987;25(3):209-22. ">Goldwasser 1987</a> ; <a href="./references#MR000050-bbs2-0031" title="HekmatH , LubitzR , DealR .Semantic desensitization: a paradigmatic intervention approach to anxiety disorders. Journal of Clinical Psychology1984;40(2):463-6. ">Hekmat 1984</a> ; <a href="./references#MR000050-bbs2-0032" title="HippmanC , RingroseA , InglisA , CheekJ , AlbertAY , RemickR , et al.A pilot randomized clinical trial evaluating the impact of genetic counselling for serious mental illnesses. Journal of Clinical Psychiatry2016;77(2):e190-8. ">Hippman 2016</a> ; <a href="./references#MR000050-bbs2-0033" title="HowlinP , GordonKR , PascoG , WadeA , CharmanT .The effectiveness of picture exchange communication system (PECS) training for teachers of children with autism: a pragmatic,group randomised controlled trial. Journal of Child Psychology and Psychiatry2007;48(5):473-81. ">Howlin 2007</a> ; <a href="./references#MR000050-bbs2-0034" title="KarstM , WinterhalterM , MünteS , FranckiB , HondronikosA , EckardtA , et al.Auricular acupuncture for dental anxiety: a randomized controlled trial. Anesthesia and Analgesia2007;104(2):295-300. KarstM .Inclusion of study in Cochrane Systematic Review (personal communication). Email to: EG Faltinsen 5th of September 2019. ">Karst 2007</a> ; <a href="./references#MR000050-bbs2-0035" title="KelleyJ .Inclusion of study in Cochrane Systematic Review (personal communication). Email to: A Todorovac 12th of August 2019. KelleyJM , KaptchukTJ , CusinC , LipkinS , FavaM .Open-label placebo for major depressive disorder: a pilot randomized controlled trial. Psychotherapy and Psychosomatics2012;81(5):312-4. ">Kelley 2012</a> ; <a href="./references#MR000050-bbs2-0036" title="KennedyTD , KimuraHK .Transfer, behavioral improvement, and anxiety reduction in systematic desensitization. Journal of Consulting and Clinical Psychology1974;42(5):720-8. ">Kennedy 1974</a> ; <a href="./references#MR000050-bbs2-0037" title="KilmannPR , MilanRJ , BolandJP , NankinHR , DavidsonE , WestMO , et al.Group treatment of secondary erectile dysfunction. Journal of Sex &amp; Marital Therapy1987;13(3):168-82. KilmannPR , Milan RJ Jr, BolandJP , DavidsonE , WestMO , SablisRF , et al.The sexual interactions of men with secondary erectile dysfunction. Journal of Sex Education and Therapy1988;14(1):46-9. KilmannPR , Milan RJ Jr, BolandJP , NankinHR , SablisRF , WestMO , et al.The sexual interactions of men with secondary erectile dysfunction. Paper presented at the annual meeting of the American Psychological Association in Los Angeles1985;1:46-9. ">Kilmann 1987</a> ; <a href="./references#MR000050-bbs2-0038" title="KleinSA , DeffenbacherJL .Relaxation and exercise for hyperactive impulsive children. Perceptual and Motor Skills1977;45:1159-62. ">Klein 1977</a> ; <a href="./references#MR000050-bbs2-0039" title="KlermanGL , DimascioA , WeismannM , PrusoffB , PaykelES .Treatment of depression by drugs and psychotherapy. American Journal of Psychiatry1974;131(2):186-91. PaykelES , DimascioA , HaskellD , PrusoffBA .Effects of maintenance amitriptyline and psychotherapy on symptoms of depression. Psychological Medicine1975;5(1):67-77. PaykelES , DiMascioA , KlermanGL , PrusoffBA .Maintenance therapy of depression. Pharmakopsychiatrie, Neuro-Psychopharmakologie1976;9:127-39. PaykelES , WeissmanMM , PrusoffBA .Social maladjustment and severity of depression. Comprehensive Psychiatry1978;19(2):121-8. WeissmanMM , KlermanGL , PaykelES , PrusoffB .Treatment effects on the social adjustment of depressed patients. Archives of General Psychiatry1974;30:771-8. ">Klerman 1974a</a> ; <a href="./references#MR000050-bbs2-0040" title="KlermanGL , DimascioA , WeismannM , PrusoffB , PaykelES .Treatment of depression by drugs and psychotherapy. American Journal of Psychiatry1974;131(2):186-91. ">Klerman 1974b</a> ; <a href="./references#MR000050-bbs2-0041" title="KloskoJS , BarlowDH , TassinariR , CernyJA .A comparison of alprazolam and behavior therapy in treatment of panic disorder: correction. Journal of Psychotherapy Practice and Research1994;3(2):163-79. KloskoJS , BarlowDH , TassinariR , CernyJA .A comparison of alprazolam and behavior therapy in treatment of panic disorder. Journal of Consulting and Clinical Psychology1990;58(1):77-84. ">Klosko 1990</a> ; <a href="./references#MR000050-bbs2-0042" title="KrapflJE , NawasMM .Differential ordering of stimulus presentation in systematic desensitization. Journal of Abnormal Psychology1970;75(3):333-7. ">Krapfl 1970</a> ; <a href="./references#MR000050-bbs2-0043" title="KwanR .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 26th of August 2019. KwanRY , LeungMC , LaiCK .Acupressure for agitation in nursing home residents with dementia: study protocol for a randomized controlled trial. Trials2014;15(410):1-7. KwanRY , LeungMCP , LaiCK .A randomized controlled trial examining the effect of acupressure on agitation and salivary cortisol in nursing home residents with dementia. Dementia and Geriatric Cognitive Disorders2017;44(1-2):92-104. ">Kwan 2017</a> ; <a href="./references#MR000050-bbs2-0044" title="LacyMK .The effect of short term autogenic training on the stress reactivity of hospitalized emotionally disturbed adolescents. ProQuest Dissertations Publishing, Oklahoma State University1996. ">Lacy 1990</a> ; <a href="./references#MR000050-bbs2-0045" title="LaiCK , ChiI , Kayser-JonesJ .A randomized controlled trial of a specific reminiscence approach to promote the well-being of nursing home residents with dementia. International Psychogeriatrics2004;16(1):33-49. LaiK .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 6th of September 2019. ">Lai 2004</a> ; <a href="./references#MR000050-bbs2-0046" title="LangOJ , LazovikAD .Experimental desensitization of a phobia. Journal of Abnormal and Social Psychology1963;66:519-25. LangPJ , LazovikAD , ReynoldsDJ .Desensitization, suggestibility, and pseudotherapy. Journal of Abnormal Psychology1965;70(6):395-402. ">Lang 1965</a> ; <a href="./references#MR000050-bbs2-0047" title="LegrandF .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 14th of August 2019. LegrandFD , NeffEM .Efficacy of exercise as an adjunct treatment for clinically depressed inpatients during the initial stages of antidepressant pharmacotherapy: an open randomized controlled trial. Journal of Affective Disorders2016;191:139-44. ">Legrand 2016</a> ; <a href="./references#MR000050-bbs2-0048" title="LickJ .Expectancy, false galvanic skin response feedback, and systematic desensitization in the modification of phobic behavior. Journal of Consulting and Clinical Psychology1975;43(4):557-67. ">Lick 1975</a> ; <a href="./references#MR000050-bbs2-0049" title="LickJR , HefflerD .Relaxation training and attention placebo in the treatment of severe insomnia. Journal of Consulting and Clinical Psychology1977;45(2):153-61. ">Lick 1977</a> ; <a href="./references#MR000050-bbs2-0050" title="LiddleB , SpenceSH .Cognitive-behaviour therapy with depressed primary school children: A cautionary note. Behavioural Psychotherapy1990;18(2):85-102. ">Liddle 1990</a> ; <a href="./references#MR000050-bbs2-0051" title="MatsonJL , MarchettiA , AdkinsJA .Comparison of operant- and independence-training procedures for mentally retarded adults. American Journal of Mental Deficiency1980;84(5):487-94. ">Matson 1980</a> ; <a href="./references#MR000050-bbs2-0052" title="McLachlanDR , DaltonAJ , KruckTP , BellMY , SmithWL , KalowW , et al.Intramuscular desferrioxamine in patients with Alzheimer's disease. Lancet1991;337(8753):1304-8. McLachlanDRC , SmithWL , KruckTP .Desferrioxamine and Alzheimer’s disease: video home behavior assessment of clinical course and measures of brain aluminum. Therapeutic Drug Monitoring1993;15(6):602-7. ">McLachlan 1991</a> ; <a href="./references#MR000050-bbs2-0053" title="MealieaWL , NawasMM .The comparative effectiveness of systematic desensitization and implosive therapy in the treatment of snake phobia. Journal of Behavior Therapy and Experimental Psychiatry1971;2(2):85-94. ">Mealiea 1971</a> ; <a href="./references#MR000050-bbs2-0054" title="MilbyJB , ClarkeC , ToroC , ThorntonS , RickertD .Effectiveness of urine surveillance as an adjunct to outpatient psychotherapy for drug abusers. International Journal of the Addictions1980;15(7):993-1001. ">Milby 1980</a> ; <a href="./references#MR000050-bbs2-0055" title="MirandaA , ArlandisP , SorianoM .Instruction in strategies and attributional training: Effects on the problem-solving and self-concept of students’ with learning disabilities [Instrucción en estrategias y entrenamiento atribucional: efectos sobre la resolución de problemas y el autoconcepto de los estudiantes con dificultades en el aprendizaje]. Infancia y Aprendizaje1997;20(80):37-52. ">Miranda 1997</a> ; <a href="./references#MR000050-bbs2-0056" title="MitchellC , MansfieldD , RautenbachS .Coloured filters and reading accuracy, comprehension and rate: a placebo-controlled study. Perceptual and Motor Skills2008;106(2):517-32. ">Mitchell 2008</a> ; <a href="./references#MR000050-bbs2-0057" title="NandiDN , AjmanyS , GanguliH , BanerjeeG , BoralGC , GhoshA , et al.A clinical evaluation of depressives found in a rural survey in India. British Journal of Psychiatry1976;128:523-7. ">Nandi 1976</a> ; <a href="./references#MR000050-bbs2-0058" title="NicassioP , BootzinR .A comparison of progressive relaxation and autogenic training as treatments for insomnia. Journal of Abnormal Psychology1974;83(3):253-60. ">Nicassio 1974</a> ; <a href="./references#MR000050-bbs2-0059" title="PearlD , Vander KampH , OlsenAL , GreenbergPD , ArmitageSG .The effects of reserpine on schizophrenic patients. American Journal of Psychiatry1956;112:198-204. ">Pearl 1956</a> ; <a href="./references#MR000050-bbs2-0060" title="PeckCL .Desensitization for the treatment of fear in the high level adult retardate. Behaviour Research and Therapy1977;15(2):137-48. ">Peck 1976</a> ; <a href="./references#MR000050-bbs2-0061" title="MilichR , CarlsonCL , Pelham WE Jr, LichtBG .Effects of methylphenidate on the persistence of ADHD boys following failure experiences. Journal of Abnormal Child Psychology1991;19(5):519-36. PelhamWE , MurphyDA , VannattaK , MilichR , LichtBG , GnagyEM , et al.Methylphenidate and attributions in boys with attention-deficit hyperactivity disorder. Journal of Consulting and Clinical Psychology1992;60(2):282-92. ">Pelham 1992</a> ; <a href="./references#MR000050-bbs2-0062" title="PedletonMG , HigginsRL .A comparison of negative practice and systematic desensitization in the treatment of acrophobia. Journal of Behavior Therapy and Experimental Psychiatry1983;14(4):317-23. ">Pendleton 1983</a> ; <a href="./references#MR000050-bbs2-0063" title="PetersonMA , PattersonB , PillmanBM , BattistaMA .Cognitive recovery following alcohol detoxification: a computerised remediation study. Neuropsychological Rehabilitation2002;12(1):63-74. PillmanBM .Computerized cognitive remediation with recently detoxified alcoholics. Dissertation, California School of Professional Psychology, Fresno Campus2000. ">Pillman 2001</a> ; <a href="./references#MR000050-bbs2-0064" title="PolandRE , GertsikL , FavreauJT , SmithSI , MirochaJM , RaoU , et al.Open-label randomized parallel-group controlled clinical trial of massage for treatment of depression in HIV-infected subjects. Journal of Alternative and Complementary Medicine2013;19(4):334-40. ">Poland 2013</a> ; <a href="./references#MR000050-bbs2-0065" title="PowersMB , SmitsJA , TelchMJ .Disentangling the effects of safety-behavior utilization and safety-behavior availability during exposure-based treatment: a placebo-controlled trial. Journal of Consulting and Clinical Psychology2004;72(3):448-54. ">Powers 2004</a> ; <a href="./references#MR000050-bbs2-0066" title="PowersMB , SmithsJA , WhitleyD , BystritskyA , TelchMJ .The effect of attributional processes concerning medication taking on return of fear. Journal of Consulting and Clinical Psychology2008;76(3):478-90. ">Powers 2008a</a> ; <a href="./references#MR000050-bbs2-0067" title="PowersMB , SmithsJA , WhitleyD , BystritskyA , TelchMJ .The effect of attributional processes concerning medication taking on return of fear. Journal of Consulting and Clinical Psychology2008;76(3):478-90. ">Powers 2008b</a> ; <a href="./references#MR000050-bbs2-0068" title="ProudfootJ , ClarkeJ , BirchMR , WhittonAE , ParkerG , ManicavasagarV , et al.Impact of a mobile phone and web program on symptom and functional outcomes for people with mild- to-moderate depression, anxiety and stress: a randomized controlled trial. BMC Psychiatry2013;13(312):1-12. ProudfootJ .Re: Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 26th of August 2019. ">Proudfoot 2013</a> ; <a href="./references#MR000050-bbs2-0069" title="QuayhagenMP , QuayhagenM , CorbeilRR , RothPA , RodgersJA .A dyadic remediation program for care recipients with dementia. Nursing Research1995;44(3):153-9. ">Quayhagen 1995</a> ; <a href="./references#MR000050-bbs2-0070" title="LiebowitzM , QuitkinFM , StewartJW , McGrathPJ , HarrisonWM , MarkowitzJS , et al.Antidepressant efficacy in atypical depression. Archives of General Psychiatry1988;45(2):129-37. QuitkinFM , McGrathPJ , StewartJW , HarrisonW , WagerSG , NunesE , et al.Phenelzine and imipramine in mood reactive depressives: further delineation of the syndrome of atypical depression. Archives of General Psychiatry1989;46(9):787-93. RabkinJG , McGrathPJ , QuitkinFM , TricamoE , StewartJW , KleinDF .Effects of pill-giving on maintenance of placebo response in patients with chronic mild depression. American Journal of Psychiatry1990;147(12):1622-6. ">Rabkin 1990</a> ; <a href="./references#MR000050-bbs2-0071" title="RapeeR .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 29th of August 2019. RapeeRM , AbbottMJ , LynehamHJ .Bibliotherapy for children With anxiety disorders using written materials for parents: a randomized controlled trial. Journal of Consulting and Clinical Psychology2006;74(3):436-44. ">Rapee 2006</a> ; <a href="./references#MR000050-bbs2-0072" title="RapeeR .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 29th of August 2019. RapeeRM , AbbottMJ , BaillieAJ , GastonJE .Treatment of social phobia through pure self-help and therapist-augmented self-help. British Journal of Psychiatry2007;191:246-52. ">Rapee 2007</a> ; <a href="./references#MR000050-bbs2-0073" title="RobinA .Rationing out-patients: a defence of the waiting list. British Journal of Psychiatry1976;129:138-41. ">Robin 1976</a> ; <a href="./references#MR000050-bbs2-0074" title="RoehrichL , GoldmanMS .Experience-dependent neuropsychological recovery and the treatment of alcoholism. Journal of Consulting and Clinical Psychology1993;61(5):812-21. ">Roehrich 1993</a> ; <a href="./references#MR000050-bbs2-0075" title="OlivaresJ .Program IAFS. Protocol for the treatment of social phobia in adolescents [Programa IAFS. Protocolo para el tratamiento de la fobia social enadolescentes]. Madrid: Pirámide2005;1. Rosa-AlcázarAI , Olivares-OlivaresPJ , OlivaresJ .The role of non-specific effects in the psychological treatment of adolescents with social phobia [Papel de los efectos inespecíficos en el tratamiento psicológico de adolescentes con fobia social]. Anuario de Psicologia2009;40(1):43-61. ">Rosa‐Alcatraz 2009</a> ; <a href="./references#MR000050-bbs2-0076" title="RosenGM , GlasgowRE , BarreraM .A controlled study to assess the clinical efficacy of totally self-administrated systematic desensitization. Journal of Consulting and Clinical Psychology1976;44(2):208-17. ">Rosen 1976</a> ; <a href="./references#MR000050-bbs2-0077" title="LorrM , McNairDM , WeinsteinGJ .Early effects of chlordiazepoxide (Librium) used with psychotherapy. Journal of Psychiatric Research1963;1:257-70. RothI , RhudickPJ , ShaskanDA , SlobinMS , WilkinsonAE , YoungHH .Long-term effects on psychotherapy of initial treatment conditions. Journal of Psychiatric Research1964;2:283-97. ">Roth 1964</a> ; <a href="./references#MR000050-bbs2-0078" title="RupertPA , HolmesDS .Effects of multiple sessions of true and placebo heart rate biofeedback training on the heart rates and anxiety levels of anxious patients during and following treatment. Psychophysiology1978;15(6):582-90. ">Rupert 1978</a> ; <a href="./references#MR000050-bbs2-0079" title="ShalevAY , AnkriY , Isreali-ShalevY , PelegT , AdesskyR , FreedmanS .Prevention of posttraumatic stress disorder by early treatment. Archives of General Psychiatry2012;69(2):166-76. ">Shalev 2012</a> ; <a href="./references#MR000050-bbs2-0080" title="ShealyRC .The effectiveness of various treatment techniques on different degrees and durations of sleep-onset insomnia. Behaviour Research and Therapy1979;17(6):541-6. ">Shealy 1979</a> ; <a href="./references#MR000050-bbs2-0081" title="SibilioJP , AndrewG , DartD , MooreKB , StehmanA .Treatment of chronic schizophrenia with promazine hydrochloride. AMA Archives of Neurology and Psychiatry1957;78(4):419-24. ">Sibilio 1957</a> ; <a href="./references#MR000050-bbs2-0082" title="SommernessMD , LuceroRJ , HamlonJS , EricksonJL , MatthewsR .A controlled study of reserpine on chronically disturbed patients. JAMA Archives of Neurology and Psychiatry1955;74(3):316-9. ">Sommerness 1955</a> ; <a href="./references#MR000050-bbs2-0083" title="SteinmarkSW , BorkovecTD .Active and placebo treatment effects on moderate insomnia under counterdemand and positive demand instructions. Journal of Abnormal Psychology1974;83(2):157-63. ">Steinmark 1974</a> ; <a href="./references#MR000050-bbs2-0084" title="SzymanskiJ , O'DonohueW .The potential role of state-dependent learning in cognitive therapy with spider phobics. Journal of Rational-Emotive &amp; Cognitive-Behavior Therapy1995;13(2):131-50. SzymanskiJ .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 20th of August 2019. ">Szymanski 1995</a> ; <a href="./references#MR000050-bbs2-0085" title="TanSY , BruniJ .Cognitive-behavior therapy with adult patients with epilepsy: a controlled outcome study. Epilepsia1986;27(3):225-33. ">Tan 1986</a> ; <a href="./references#MR000050-bbs2-0086" title="TeriL , LogsdonRG , UomotoJ , McCurrySM .Behavioral treatment of depression in dementia patients: a controlled clinical trial. Journals of Gerontology. Series B, Psychological Sciences and Social Sciences1997;52(4):159-66. TeriL .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 26th of August 2019. ">Teri 1997</a> ; <a href="./references#MR000050-bbs2-0087" title="ToriC , WorellL .Reduction of human avoidant behavior. A comparison of counterconditioning, expectancy, and cognitive information approaches. Clinical Psychology1973;41(2):269-78. ">Tori 1973</a> ; <a href="./references#MR000050-bbs2-0088" title="Trexler, L.Rational-emotive therapy, placebo, and no-treatment effects on public-speaking anxiety. Doctoral dissertation, Temple University AnnArbor, Mich.: University Microfilms1971;71-31(063). TrexlerLD , KarstTO .Rational-emotive therapy, placebo, and no-treatment effects on public-speaking anxiety. Journal of Abnormal Psyhology1972;79(1):60-7. ">Trexler 1972</a> ; <a href="./references#MR000050-bbs2-0089" title="AscherML , TurnerRM .A comparison of two methods for the administration of paradoxical intention. Behaviour Research and Therapy1980;18(2):121-6. TurnerRM , AscherLM .Controlled comparison of progressive relaxation, stimulus control, and paradoxical intention therapies for insomnia. Journal of Consulting and Clinical Psychology1979;47(3):500-8. ">Turner 1979</a> ; <a href="./references#MR000050-bbs2-0090" title="VanderplateC .Electromyograph biofeedback Treatment of sleep onset Insomnia: a controlled Investigation. Dissertation, University of Southern Mississippi1978. ">Vanderplate 1983</a> ; <a href="./references#MR000050-bbs2-0091" title="WatzlH , RistF , OlbrichR , CohenR .Placebo injections and surveillance of alcohol intake during inpatient treatment of female alcoholics. Addictive Behaviors1988;13(2):197-200. ">Watzl 1988</a> ; <a href="./references#MR000050-bbs2-0092" title="WeingaertnerAH .Self-administered aversive stimulation with hallucinating hospitalized schizophrenics. Journal of Consulting and Clinical Psychology1971;36(3):422-29. ">Weingaertner 1971</a> ; <a href="./references#MR000050-bbs2-0093" title="WhittakerCB , HoyRM .Withdrawal of perphenazine in chronic schizophrenia. British Journal of Psychiatry1963;109:422-7. ">Whittaker 1963</a> ; <a href="./references#MR000050-bbs2-0094" title="WilsonA , DavidsonWJ , BlanchardR , WhiteJ .Disulfiram implantation. A placebo-controlled trial with two-year follow-up. Journal of Studies on Alcohol1978;39(5):809-19. WilsonA , DavidsonWJ , BlanchardR .Disulfiram implantation: a trial using placebo implants and two types of controls. Journal of Studies on Alcohol1980;41(5):429-36. ">Wilson 1980</a> ; <a href="./references#MR000050-bbs2-0095" title="WolitzkyKB , TelchMJ .Augmenting in vivo exposure with fear antagonistic actions: a preliminary test. Behavior Therapy2009;40(1):57-71. ">Wolitzky 2009</a> ; <a href="./references#MR000050-bbs2-0096" title="WollersheimJP , WilsonGL .Group treatment of unipolar depression: a comparison of coping, supportive, bibliotherapy, and delayed treatment groups. Professional Psychology: Research and Practice1991;22(6):496-502. ">Wollersheim 1991</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>High risk of bias</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#MR000050-bbs2-0001" title="AbikoffH , HechtmanL , KleinRG .Social functioning in children with ADHD treated with long-term methylphenidate and multimodal psychosocial treatment. Journal of the American Academy of Child and Adolescent Psychiatry2004;43(7):820-9. AbikoffH .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to A Todorovac 23rd of August 2019. KleinRG , AbikoffH , HechtmanL , WeissG .Design and rationale of controlled study of long-term methylphenidate and multimodal psychosocial treatment in children with ADHD. Journal of the American Academy of Child and Adolescent Psychiatry2004;43(7):792-801. ">Abikoff 2004</a> ; <a href="./references#MR000050-bbs2-0011" title="BornovalovaM .Inclusion of study in Cochrane Systematic Review (personal communication). Email to A Todorovac. 21st of August 2019. BornovalovaMA .Distress tolerance treatment for inner-city drug users: a preliminary trial. Doctor’s Dissertation, University of Maryland2008. ">Bornovalova 2008</a> ; <a href="./references#MR000050-bbs2-0021" title="EhlersA , HackmannA , GreyN , WildJ , LinessS , AlbertI , et al.A randomized controlled trial of 7-day intensive and standard weekly cognitive therapy for PTSD and emotion-focused supportive therapy. American Journal of Psychiatry2014;171(3):294-304. ">Ehlers 2014</a> ; <a href="./references#MR000050-bbs2-0024" title="FoaEB , RothbaumBO , RiggsDS , MurdockTB .Treatment of posttraumatic stress disorder in rape victims: a comparison between cognitive-behavioral procedures and counselling. Journal of Consulting and Clinical Psychology1991;59(5):715-23. ">Foa 1991</a> ; <a href="./references#MR000050-bbs2-0025" title="FoaEB , McLeanCP , ZangY , RosenfieldD , YadinE , YarvisJS , et al.Effect of prolonged exposure therapy delivered over 2 weeks vs 8 weeks vs present-centered therapy on PTSD symptom severity in military personnel: a randomized clinical trial. JAMA2018;319(4):354-64. ">Foa 2018</a> ; <a href="./references#MR000050-bbs2-0027" title="FuchsCZ , RehnLP .A self-control behavior therapy program for depression. Journal of Consulting and Clinical Psychology1977;45(2):206-15. ">Fuchs 1977</a> </p> </td> </tr> </tbody> </table> </div> </section> <section id="MR000050-sec-0070"> <h5 class="title">Allocation concealment</h5> <p>We classified trials as low risk of bias if the allocation was conducted off‐site (centralised) by computer software or by an independent research coordinator not involved in delivering the therapy. Eighteen trials provided information about how the allocation was concealed and were therefore rated at low risk of bias. The other 78 trials did not provide any information regarding allocation concealment and were assessed as unclear risk of bias (<a href="#MR000050-tbl-0007">Table 4</a>) </p> </section> </section> <section id="MR000050-sec-0071"> <h4 class="title">Blinding</h4> <section id="MR000050-sec-0072"> <h5 class="title">Blinding of outcome assessors</h5> <p>Forty‐five trials that reported that outcomes assessors were kept blind to treatment allocation were rated as low risk of bias. Thirty‐two trials were rated as high risk of bias due to reporting of inadequate blinding of outcomes assessors. The remaining 19 trials were assessed as unclear risk of bias due to a lack of sufficient information (<a href="#MR000050-tbl-0007">Table 4</a>). </p> </section> <section id="MR000050-sec-0073"> <h5 class="title">Blinding of participants and personnel</h5> <p>We judged all trials as high risk of bias in this domain because the participants would be aware of whether they received treatment or not (e.g. allocated to either placebo or wait‐list). </p> </section> </section> <section id="MR000050-sec-0074"> <h4 class="title">Incomplete outcome data</h4> <section id="MR000050-sec-0075"> <h5 class="title">Incomplete outcome data</h5> <p>Forty‐one trials were assessed as low risk of bias, due to the use of appropriate methods for handling missing data, such as intention‐to‐treat (ITT) analyses. Twenty‐nine trials either reported data on completers only or did not address the missing data and were considered as high risk of bias. The other trials did not report adequately information regarding missing data, and were therefore assessed as unclear risk of bias (<a href="#MR000050-tbl-0007">Table 4</a>). </p> </section> </section> <section id="MR000050-sec-0076"> <h4 class="title">Selective reporting</h4> <p>Most trials (n = 85) did not have a published protocol prior to initiation or did not provide sufficient information in the report to judge reporting bias and were considered as unclear risk of reporting bias. Six trials had a prior published protocol that provided sufficient information about all outcomes and did not exclude any of these in the full report. These trials were rated as low risk of biased reporting. Five trials published a protocol before the start of the trial, but we found discrepancies such as missing outcomes or an addition of outcomes and we rated them as high risk of bias. </p> </section> <section id="MR000050-sec-0077"> <h4 class="title">Other potential sources of bias</h4> <p>Eighty‐seven trials were rated as low risk of other biases, eight trials were rated as high risk of bias in other potential sources of bias. These included four trials with researchers or authors who provided the treatment, two trials with attention bias or differences in duration of treatment, one trial with potential carry‐over effects, one trial that exceeded the passivity of placebo, and one trial with a time bias or assessment at different point for the groups. One trial was rated as unclear risk of others bias because of confounding differences between groups on the number of medical diagnoses other than dementia among participants (<a href="#MR000050-tbl-0007">Table 4</a>). </p> </section> <section id="MR000050-sec-0078"> <h4 class="title">Conflicts of interest</h4> <p>We assessed six trials to be at risk of bias because of conflicts of interest. This could be a non‐financial affiliation bias, for instance if one of the investigators had developed a treatment evaluated in the trial, or bias from trials funded by a company manufacturing one of the interventions. We included subgroup analyses to test the difference between trials judged to be at risk of affiliation bias and those judged not to be at this risk (<a href="./references#MR000050-fig-0057" title="">Analysis 16.17</a>). </p> </section> </section> <section id="MR000050-sec-0079"> <h3 class="title" id="MR000050-sec-0079">Effect of methods</h3> <section id="MR000050-sec-0080"> <h4 class="title">Effects of interventions for all mental health disorders</h4> <p>Here, we present the results for each of the primary and secondary outcomes for the 19 comparisons. Seventy‐one trials reported data as continuous and 11 trials reported dichotomous data, whereas 13 trials did not report usable data. It was only possible to generate missing data for nine trials. For more information see <a href="#MR000050-tbl-0005">Table 2</a> . </p> <section id="MR000050-sec-0081"> <h5 class="title">Wait‐list versus no‐treatment</h5> <p>We included a single cluster‐randomised trial that compared a wait‐list intervention versus a no‐treatment intervention (<a href="./references#MR000050-bbs2-0033" title="HowlinP , GordonKR , PascoG , WadeA , CharmanT .The effectiveness of picture exchange communication system (PECS) training for teachers of children with autism: a pragmatic,group randomised controlled trial. Journal of Child Psychology and Psychiatry2007;48(5):473-81. ">Howlin 2007</a>). However, no usable data were provided in the full report and the trial authors did not respond to our request for additional data. In this trial, 84 elementary school children with autism spectrum disorder were randomised to either immediate treatment, delayed treatment (wait‐list) or no‐treatment. The study's conclusion was that Picture Exchange Communication System (PECS) training showed modest effectiveness for these children. In general, there were no differences across outcome measures between the wait‐list and the no‐treatment intervention groups. </p> </section> <section id="MR000050-sec-0082"> <h5 class="title">Outcomes measuring benefits for usual care versus wait‐list or no‐treatment</h5> <p>Nine trials compared usual care versus wait‐list or no‐treatment. Two of these did not report usable data (<a href="#MR000050-tbl-0008">Table 5</a>). Five trials reported continuous data and two trials reported dichotomous data. </p> <div class="table" id="MR000050-tbl-0008"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 5.</span> <span class="table-title">Effects of methods</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Category</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Study frequency</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Study ID</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Beneficial outcome data</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Dichotomous data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>11</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#MR000050-bbs2-0007" title="BergI , ForsytheI , HoltP , WattsJ .A controlled trial of ‘Senokot’ in faecal soiling treated by behavioural methods. Journal of Child Psychology and Psychiatry1983;24(4):543-9. ">Berg 1983</a> ; <a href="./references#MR000050-bbs2-0020" title="DoubleDB , WarrenGC , EvansM , RowlandsMP .Efficacy of maintenance use of anticholinergic agents. Acta Psychiatrica Scandinavica1993;88:381-4. ">Double 1993</a> ; <a href="./references#MR000050-bbs2-0039" title="KlermanGL , DimascioA , WeismannM , PrusoffB , PaykelES .Treatment of depression by drugs and psychotherapy. American Journal of Psychiatry1974;131(2):186-91. PaykelES , DimascioA , HaskellD , PrusoffBA .Effects of maintenance amitriptyline and psychotherapy on symptoms of depression. Psychological Medicine1975;5(1):67-77. PaykelES , DiMascioA , KlermanGL , PrusoffBA .Maintenance therapy of depression. Pharmakopsychiatrie, Neuro-Psychopharmakologie1976;9:127-39. PaykelES , WeissmanMM , PrusoffBA .Social maladjustment and severity of depression. Comprehensive Psychiatry1978;19(2):121-8. WeissmanMM , KlermanGL , PaykelES , PrusoffB .Treatment effects on the social adjustment of depressed patients. Archives of General Psychiatry1974;30:771-8. ">Klerman 1974a</a> ; <a href="./references#MR000050-bbs2-0040" title="KlermanGL , DimascioA , WeismannM , PrusoffB , PaykelES .Treatment of depression by drugs and psychotherapy. American Journal of Psychiatry1974;131(2):186-91. ">Klerman 1974b</a> ; <a href="./references#MR000050-bbs2-0053" title="MealieaWL , NawasMM .The comparative effectiveness of systematic desensitization and implosive therapy in the treatment of snake phobia. Journal of Behavior Therapy and Experimental Psychiatry1971;2(2):85-94. ">Mealiea 1971</a> ; <a href="./references#MR000050-bbs2-0054" title="MilbyJB , ClarkeC , ToroC , ThorntonS , RickertD .Effectiveness of urine surveillance as an adjunct to outpatient psychotherapy for drug abusers. International Journal of the Addictions1980;15(7):993-1001. ">Milby 1980</a> ; <a href="./references#MR000050-bbs2-0070" title="LiebowitzM , QuitkinFM , StewartJW , McGrathPJ , HarrisonWM , MarkowitzJS , et al.Antidepressant efficacy in atypical depression. Archives of General Psychiatry1988;45(2):129-37. QuitkinFM , McGrathPJ , StewartJW , HarrisonW , WagerSG , NunesE , et al.Phenelzine and imipramine in mood reactive depressives: further delineation of the syndrome of atypical depression. Archives of General Psychiatry1989;46(9):787-93. RabkinJG , McGrathPJ , QuitkinFM , TricamoE , StewartJW , KleinDF .Effects of pill-giving on maintenance of placebo response in patients with chronic mild depression. American Journal of Psychiatry1990;147(12):1622-6. ">Rabkin 1990</a> ; <a href="./references#MR000050-bbs2-0073" title="RobinA .Rationing out-patients: a defence of the waiting list. British Journal of Psychiatry1976;129:138-41. ">Robin 1976</a> ; <a href="./references#MR000050-bbs2-0091" title="WatzlH , RistF , OlbrichR , CohenR .Placebo injections and surveillance of alcohol intake during inpatient treatment of female alcoholics. Addictive Behaviors1988;13(2):197-200. ">Watzl 1988</a> ; <a href="./references#MR000050-bbs2-0093" title="WhittakerCB , HoyRM .Withdrawal of perphenazine in chronic schizophrenia. British Journal of Psychiatry1963;109:422-7. ">Whittaker 1963</a> ; <a href="./references#MR000050-bbs2-0096" title="WollersheimJP , WilsonGL .Group treatment of unipolar depression: a comparison of coping, supportive, bibliotherapy, and delayed treatment groups. Professional Psychology: Research and Practice1991;22(6):496-502. ">Wollersheim 1991</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Continuous data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>71</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#MR000050-bbs2-0001" title="AbikoffH , HechtmanL , KleinRG .Social functioning in children with ADHD treated with long-term methylphenidate and multimodal psychosocial treatment. Journal of the American Academy of Child and Adolescent Psychiatry2004;43(7):820-9. AbikoffH .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to A Todorovac 23rd of August 2019. KleinRG , AbikoffH , HechtmanL , WeissG .Design and rationale of controlled study of long-term methylphenidate and multimodal psychosocial treatment in children with ADHD. Journal of the American Academy of Child and Adolescent Psychiatry2004;43(7):792-801. ">Abikoff 2004</a> ; <a href="./references#MR000050-bbs2-0002" title="AllenJB .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to A Todorovac 28th of August 2019. AllenJJ , SchnyerRN , HittSK .The efficacy of acupuncture in the treatment of major depression in women. Psychological Science1998;9(5):397-401. ">Allen 1998</a> ; <a href="./references#MR000050-bbs2-0003" title="AllenJB .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 28th of August 2019. AllenJJ , SchnyerRN , ChambersAS , HittSK , MorenoFA , ManberR .Acupuncture for depression: a randomized controlled trial. Journal of Clinical Psychiatry2006;67(11):1665-73. ">Allen 2006</a> ; <a href="./references#MR000050-bbs2-0004" title="AlvarezJR .The effects of anger management training on depression, anger, self-concept, and treatment responsibility in a sample of drug-dependent individuals in a therapeutic community. Dissertation Abstracts International: Section B: the Sciences and Engineering1997;58(4-B):2108. ">Alvarez 1997</a> ; <a href="./references#MR000050-bbs2-0005" title="AscherLM , TurnerR .Paradoxical intention and insomnia: an experimental investigation. Behaviour Research and Therapy1979;17(4):408-11. ">Ascher 1979</a> ; <a href="./references#MR000050-bbs2-0006" title="AyenI , HautzingerM .Cognitive behavior therapy for depression in menopausal women. A controlled, randomized treatment study [Kognitive Verhaltenstherapie bei Depressionen im Klimakterium: Eine kontrollierte, randomiserte Interventionsstudie]. Zeitschrift für Klinische Psychologie und Psychotherapie2004;33(4):290-9. AyenI .Inclusion of study in Cochrane Systematic Review (personal communication). Email to EG Faltinsen 9th of September 2019. ">Ayen 2004</a> ; <a href="./references#MR000050-bbs2-0008" title="Borden, KA.Attributional Outcomes: the Subtle Messages of Treatments for Attention Deficit Disorder. Dissertation, University of Illinois at Urbana-Champaign1986. BordenKA , BrownRT .Attributional outcomes: The subtle messages of treatments for attention deficit disorder. Cognitive Therapy and Research1989;13(2):147-60. ">Borden 1986</a> ; <a href="./references#MR000050-bbs2-0009" title="BorkovecTD , KaloupekDG , SlamaKM .The facilitative effect of muscle tension-release in the relaxation treatment of sleep disturbance. Behavior Therapy1975;6(3):301-9. ">Borkovec 1975</a> ; <a href="./references#MR000050-bbs2-0010" title="BorkovecTD , WeertsTC .Effects of progressive relaxation on sleep disturbance: an electroencephalographic evaluation. Psychosomatic Medicine1976;38(3):173-80. ">Borkovec 1976</a> ; <a href="./references#MR000050-bbs2-0011" title="BornovalovaM .Inclusion of study in Cochrane Systematic Review (personal communication). Email to A Todorovac. 21st of August 2019. BornovalovaMA .Distress tolerance treatment for inner-city drug users: a preliminary trial. Doctor’s Dissertation, University of Maryland2008. ">Bornovalova 2008</a> ; <a href="./references#MR000050-bbs2-0012" title="BramstonP , SpenceSH .Behavioural versus cognitive social-skills training with intellectually-handicapped adults. Behaviour Research and Therapy1985;23(3):239-46. ">Bramston 1985</a> ; <a href="./references#MR000050-bbs2-0015" title="CarlsonCL , PelhamWE , MilichR , HozaB .ADHD boys’ performance and attributions following success and failure: drug effects and individual differences. Cognitive Therapy and Research1993;17:269-87. ">Carlson 1993</a> ; <a href="./references#MR000050-bbs2-0016" title="CarterJC , OlmstedMP , KaplanAS , McCabeRE , MillsJS , AimeA .Self-help for bulimia nervosa: a randomized controlled trial. American Journal of Psychiatry2003;160(5):973-8. ">Carter 2003</a> ; <a href="./references#MR000050-bbs2-0017" title="CrispAH , NortonK , GowersS , HalekC , BowyerC , YeldhamD , et al.A controlled study of the effect of therapies aimed at adolescent and family psychopathology in Anorexia Nervosa. British Journal of Psychiatry: the Journal of Mental Science1991;159:325-33. GowersS , NortonK , HalekC , CrispAH .Outcome of outpatient psychotherapy in a random allocation treatment study of anorexia nervosa. International Journal of Eating Disorders1994;15(2):165-77. GowersS , NortonK , YelshamD .The St George's prospective treatment study of anorexia nervosa: a discussion of methodological problems. International Journal of Eating Disorders1989;8:445-54. ">Crisp 1991</a> ; <a href="./references#MR000050-bbs2-0021" title="EhlersA , HackmannA , GreyN , WildJ , LinessS , AlbertI , et al.A randomized controlled trial of 7-day intensive and standard weekly cognitive therapy for PTSD and emotion-focused supportive therapy. American Journal of Psychiatry2014;171(3):294-304. ">Ehlers 2014</a> ; <a href="./references#MR000050-bbs2-0022" title="EspieCA , BrooksDN , LindsayWR .An evaluation of tailored psychological treatment of insomnia. Journal of Behavior Therapy and Experimental Psychiatry1989;20(2):143-53. EspieCA , LindsayWR , BrooksDN , HoodEM , TurveyT .A controlled comparative investigation of psychological treatments for chronic sleep-onset insomnia. Behaviour Research and Therapy1989;27(1):79-88. ">Espie 1989a</a> ; <a href="./references#MR000050-bbs2-0023" title="EtringerBD , CashTF , RimmDC .Behavioral, affective, and cognitive effects of participant modeling and an equally credible placebo. Behavior Therapy1982;13(4):476-85. ">Etringer 1982</a> ; <a href="./references#MR000050-bbs2-0024" title="FoaEB , RothbaumBO , RiggsDS , MurdockTB .Treatment of posttraumatic stress disorder in rape victims: a comparison between cognitive-behavioral procedures and counselling. Journal of Consulting and Clinical Psychology1991;59(5):715-23. ">Foa 1991</a> ; <a href="./references#MR000050-bbs2-0025" title="FoaEB , McLeanCP , ZangY , RosenfieldD , YadinE , YarvisJS , et al.Effect of prolonged exposure therapy delivered over 2 weeks vs 8 weeks vs present-centered therapy on PTSD symptom severity in military personnel: a randomized clinical trial. JAMA2018;319(4):354-64. ">Foa 2018</a> ; <a href="./references#MR000050-bbs2-0026" title="FreireAO , SugaiGC , ChrispinFS , TogeiroSM , YamamuraY , MelloLE , et al.Treatment of moderate obstructive sleep apnea syndrome with acupuncture: a randomised, placebo-controlled pilot trial. Sleep Medicine2007;8(1):43-50. ">Freire 2007</a> ; <a href="./references#MR000050-bbs2-0027" title="FuchsCZ , RehnLP .A self-control behavior therapy program for depression. Journal of Consulting and Clinical Psychology1977;45(2):206-15. ">Fuchs 1977</a> ; <a href="./references#MR000050-bbs2-0028" title="GlogowskaM , RoulstoneS , EnderbyP , PetersTJ .Randomised controlled trial of community based speech and language therapy in preschool children. BMJ2000;321(7266):923-6. ">Glogowska 2000</a> ; <a href="./references#MR000050-bbs2-0029" title="GoldsteinAJ , BeursE , Chambless Dl, WilsonKA .EMDR for panic disorder with agoraphobia: comparison with waiting list and credible attention-placebo control conditions. Journal of Consulting and Clinical Psychology2000;68(6):947-56. ">Goldstein 2000</a> ; <a href="./references#MR000050-bbs2-0032" title="HippmanC , RingroseA , InglisA , CheekJ , AlbertAY , RemickR , et al.A pilot randomized clinical trial evaluating the impact of genetic counselling for serious mental illnesses. Journal of Clinical Psychiatry2016;77(2):e190-8. ">Hippman 2016</a> ; <a href="./references#MR000050-bbs2-0034" title="KarstM , WinterhalterM , MünteS , FranckiB , HondronikosA , EckardtA , et al.Auricular acupuncture for dental anxiety: a randomized controlled trial. Anesthesia and Analgesia2007;104(2):295-300. KarstM .Inclusion of study in Cochrane Systematic Review (personal communication). Email to: EG Faltinsen 5th of September 2019. ">Karst 2007</a> ; <a href="./references#MR000050-bbs2-0035" title="KelleyJ .Inclusion of study in Cochrane Systematic Review (personal communication). Email to: A Todorovac 12th of August 2019. KelleyJM , KaptchukTJ , CusinC , LipkinS , FavaM .Open-label placebo for major depressive disorder: a pilot randomized controlled trial. Psychotherapy and Psychosomatics2012;81(5):312-4. ">Kelley 2012</a> ; <a href="./references#MR000050-bbs2-0036" title="KennedyTD , KimuraHK .Transfer, behavioral improvement, and anxiety reduction in systematic desensitization. Journal of Consulting and Clinical Psychology1974;42(5):720-8. ">Kennedy 1974</a> ; <a href="./references#MR000050-bbs2-0037" title="KilmannPR , MilanRJ , BolandJP , NankinHR , DavidsonE , WestMO , et al.Group treatment of secondary erectile dysfunction. Journal of Sex &amp; Marital Therapy1987;13(3):168-82. KilmannPR , Milan RJ Jr, BolandJP , DavidsonE , WestMO , SablisRF , et al.The sexual interactions of men with secondary erectile dysfunction. Journal of Sex Education and Therapy1988;14(1):46-9. KilmannPR , Milan RJ Jr, BolandJP , NankinHR , SablisRF , WestMO , et al.The sexual interactions of men with secondary erectile dysfunction. Paper presented at the annual meeting of the American Psychological Association in Los Angeles1985;1:46-9. ">Kilmann 1987</a> ; <a href="./references#MR000050-bbs2-0038" title="KleinSA , DeffenbacherJL .Relaxation and exercise for hyperactive impulsive children. Perceptual and Motor Skills1977;45:1159-62. ">Klein 1977</a> ; <a href="./references#MR000050-bbs2-0041" title="KloskoJS , BarlowDH , TassinariR , CernyJA .A comparison of alprazolam and behavior therapy in treatment of panic disorder: correction. Journal of Psychotherapy Practice and Research1994;3(2):163-79. KloskoJS , BarlowDH , TassinariR , CernyJA .A comparison of alprazolam and behavior therapy in treatment of panic disorder. Journal of Consulting and Clinical Psychology1990;58(1):77-84. ">Klosko 1990</a> ; <a href="./references#MR000050-bbs2-0042" title="KrapflJE , NawasMM .Differential ordering of stimulus presentation in systematic desensitization. Journal of Abnormal Psychology1970;75(3):333-7. ">Krapfl 1970</a> ; <a href="./references#MR000050-bbs2-0043" title="KwanR .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 26th of August 2019. KwanRY , LeungMC , LaiCK .Acupressure for agitation in nursing home residents with dementia: study protocol for a randomized controlled trial. Trials2014;15(410):1-7. KwanRY , LeungMCP , LaiCK .A randomized controlled trial examining the effect of acupressure on agitation and salivary cortisol in nursing home residents with dementia. Dementia and Geriatric Cognitive Disorders2017;44(1-2):92-104. ">Kwan 2017</a> ; <a href="./references#MR000050-bbs2-0044" title="LacyMK .The effect of short term autogenic training on the stress reactivity of hospitalized emotionally disturbed adolescents. ProQuest Dissertations Publishing, Oklahoma State University1996. ">Lacy 1990</a> ; <a href="./references#MR000050-bbs2-0045" title="LaiCK , ChiI , Kayser-JonesJ .A randomized controlled trial of a specific reminiscence approach to promote the well-being of nursing home residents with dementia. International Psychogeriatrics2004;16(1):33-49. LaiK .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 6th of September 2019. ">Lai 2004</a> ; <a href="./references#MR000050-bbs2-0047" title="LegrandF .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 14th of August 2019. LegrandFD , NeffEM .Efficacy of exercise as an adjunct treatment for clinically depressed inpatients during the initial stages of antidepressant pharmacotherapy: an open randomized controlled trial. Journal of Affective Disorders2016;191:139-44. ">Legrand 2016</a> ; <a href="./references#MR000050-bbs2-0048" title="LickJ .Expectancy, false galvanic skin response feedback, and systematic desensitization in the modification of phobic behavior. Journal of Consulting and Clinical Psychology1975;43(4):557-67. ">Lick 1975</a> ; <a href="./references#MR000050-bbs2-0049" title="LickJR , HefflerD .Relaxation training and attention placebo in the treatment of severe insomnia. Journal of Consulting and Clinical Psychology1977;45(2):153-61. ">Lick 1977</a> ; <a href="./references#MR000050-bbs2-0050" title="LiddleB , SpenceSH .Cognitive-behaviour therapy with depressed primary school children: A cautionary note. Behavioural Psychotherapy1990;18(2):85-102. ">Liddle 1990</a> ; <a href="./references#MR000050-bbs2-0051" title="MatsonJL , MarchettiA , AdkinsJA .Comparison of operant- and independence-training procedures for mentally retarded adults. American Journal of Mental Deficiency1980;84(5):487-94. ">Matson 1980</a> ; <a href="./references#MR000050-bbs2-0052" title="McLachlanDR , DaltonAJ , KruckTP , BellMY , SmithWL , KalowW , et al.Intramuscular desferrioxamine in patients with Alzheimer's disease. Lancet1991;337(8753):1304-8. McLachlanDRC , SmithWL , KruckTP .Desferrioxamine and Alzheimer’s disease: video home behavior assessment of clinical course and measures of brain aluminum. Therapeutic Drug Monitoring1993;15(6):602-7. ">McLachlan 1991</a> ; <a href="./references#MR000050-bbs2-0055" title="MirandaA , ArlandisP , SorianoM .Instruction in strategies and attributional training: Effects on the problem-solving and self-concept of students’ with learning disabilities [Instrucción en estrategias y entrenamiento atribucional: efectos sobre la resolución de problemas y el autoconcepto de los estudiantes con dificultades en el aprendizaje]. Infancia y Aprendizaje1997;20(80):37-52. ">Miranda 1997</a> ; <a href="./references#MR000050-bbs2-0056" title="MitchellC , MansfieldD , RautenbachS .Coloured filters and reading accuracy, comprehension and rate: a placebo-controlled study. Perceptual and Motor Skills2008;106(2):517-32. ">Mitchell 2008</a> ; <a href="./references#MR000050-bbs2-0057" title="NandiDN , AjmanyS , GanguliH , BanerjeeG , BoralGC , GhoshA , et al.A clinical evaluation of depressives found in a rural survey in India. British Journal of Psychiatry1976;128:523-7. ">Nandi 1976</a> ; <a href="./references#MR000050-bbs2-0058" title="NicassioP , BootzinR .A comparison of progressive relaxation and autogenic training as treatments for insomnia. Journal of Abnormal Psychology1974;83(3):253-60. ">Nicassio 1974</a> ; <a href="./references#MR000050-bbs2-0060" title="PeckCL .Desensitization for the treatment of fear in the high level adult retardate. Behaviour Research and Therapy1977;15(2):137-48. ">Peck 1976</a> ; <a href="./references#MR000050-bbs2-0061" title="MilichR , CarlsonCL , Pelham WE Jr, LichtBG .Effects of methylphenidate on the persistence of ADHD boys following failure experiences. Journal of Abnormal Child Psychology1991;19(5):519-36. PelhamWE , MurphyDA , VannattaK , MilichR , LichtBG , GnagyEM , et al.Methylphenidate and attributions in boys with attention-deficit hyperactivity disorder. Journal of Consulting and Clinical Psychology1992;60(2):282-92. ">Pelham 1992</a> ; <a href="./references#MR000050-bbs2-0062" title="PedletonMG , HigginsRL .A comparison of negative practice and systematic desensitization in the treatment of acrophobia. Journal of Behavior Therapy and Experimental Psychiatry1983;14(4):317-23. ">Pendleton 1983</a> ; <a href="./references#MR000050-bbs2-0063" title="PetersonMA , PattersonB , PillmanBM , BattistaMA .Cognitive recovery following alcohol detoxification: a computerised remediation study. Neuropsychological Rehabilitation2002;12(1):63-74. PillmanBM .Computerized cognitive remediation with recently detoxified alcoholics. Dissertation, California School of Professional Psychology, Fresno Campus2000. ">Pillman 2001</a> ; <a href="./references#MR000050-bbs2-0064" title="PolandRE , GertsikL , FavreauJT , SmithSI , MirochaJM , RaoU , et al.Open-label randomized parallel-group controlled clinical trial of massage for treatment of depression in HIV-infected subjects. Journal of Alternative and Complementary Medicine2013;19(4):334-40. ">Poland 2013</a> ; <a href="./references#MR000050-bbs2-0065" title="PowersMB , SmitsJA , TelchMJ .Disentangling the effects of safety-behavior utilization and safety-behavior availability during exposure-based treatment: a placebo-controlled trial. Journal of Consulting and Clinical Psychology2004;72(3):448-54. ">Powers 2004</a> ; <a href="./references#MR000050-bbs2-0066" title="PowersMB , SmithsJA , WhitleyD , BystritskyA , TelchMJ .The effect of attributional processes concerning medication taking on return of fear. Journal of Consulting and Clinical Psychology2008;76(3):478-90. ">Powers 2008a</a> ; <a href="./references#MR000050-bbs2-0067" title="PowersMB , SmithsJA , WhitleyD , BystritskyA , TelchMJ .The effect of attributional processes concerning medication taking on return of fear. Journal of Consulting and Clinical Psychology2008;76(3):478-90. ">Powers 2008b</a> ; <a href="./references#MR000050-bbs2-0068" title="ProudfootJ , ClarkeJ , BirchMR , WhittonAE , ParkerG , ManicavasagarV , et al.Impact of a mobile phone and web program on symptom and functional outcomes for people with mild- to-moderate depression, anxiety and stress: a randomized controlled trial. BMC Psychiatry2013;13(312):1-12. ProudfootJ .Re: Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 26th of August 2019. ">Proudfoot 2013</a> ; <a href="./references#MR000050-bbs2-0069" title="QuayhagenMP , QuayhagenM , CorbeilRR , RothPA , RodgersJA .A dyadic remediation program for care recipients with dementia. Nursing Research1995;44(3):153-9. ">Quayhagen 1995</a> ; <a href="./references#MR000050-bbs2-0071" title="RapeeR .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 29th of August 2019. RapeeRM , AbbottMJ , LynehamHJ .Bibliotherapy for children With anxiety disorders using written materials for parents: a randomized controlled trial. Journal of Consulting and Clinical Psychology2006;74(3):436-44. ">Rapee 2006</a> ; <a href="./references#MR000050-bbs2-0072" title="RapeeR .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 29th of August 2019. RapeeRM , AbbottMJ , BaillieAJ , GastonJE .Treatment of social phobia through pure self-help and therapist-augmented self-help. British Journal of Psychiatry2007;191:246-52. ">Rapee 2007</a> ; <a href="./references#MR000050-bbs2-0074" title="RoehrichL , GoldmanMS .Experience-dependent neuropsychological recovery and the treatment of alcoholism. Journal of Consulting and Clinical Psychology1993;61(5):812-21. ">Roehrich 1993</a> ; <a href="./references#MR000050-bbs2-0075" title="OlivaresJ .Program IAFS. Protocol for the treatment of social phobia in adolescents [Programa IAFS. Protocolo para el tratamiento de la fobia social enadolescentes]. Madrid: Pirámide2005;1. Rosa-AlcázarAI , Olivares-OlivaresPJ , OlivaresJ .The role of non-specific effects in the psychological treatment of adolescents with social phobia [Papel de los efectos inespecíficos en el tratamiento psicológico de adolescentes con fobia social]. Anuario de Psicologia2009;40(1):43-61. ">Rosa‐Alcatraz 2009</a> ; <a href="./references#MR000050-bbs2-0076" title="RosenGM , GlasgowRE , BarreraM .A controlled study to assess the clinical efficacy of totally self-administrated systematic desensitization. Journal of Consulting and Clinical Psychology1976;44(2):208-17. ">Rosen 1976</a> ; <a href="./references#MR000050-bbs2-0079" title="ShalevAY , AnkriY , Isreali-ShalevY , PelegT , AdesskyR , FreedmanS .Prevention of posttraumatic stress disorder by early treatment. Archives of General Psychiatry2012;69(2):166-76. ">Shalev 2012</a> ; <a href="./references#MR000050-bbs2-0080" title="ShealyRC .The effectiveness of various treatment techniques on different degrees and durations of sleep-onset insomnia. Behaviour Research and Therapy1979;17(6):541-6. ">Shealy 1979</a> ; <a href="./references#MR000050-bbs2-0083" title="SteinmarkSW , BorkovecTD .Active and placebo treatment effects on moderate insomnia under counterdemand and positive demand instructions. Journal of Abnormal Psychology1974;83(2):157-63. ">Steinmark 1974</a> ; <a href="./references#MR000050-bbs2-0084" title="SzymanskiJ , O'DonohueW .The potential role of state-dependent learning in cognitive therapy with spider phobics. Journal of Rational-Emotive &amp; Cognitive-Behavior Therapy1995;13(2):131-50. SzymanskiJ .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 20th of August 2019. ">Szymanski 1995</a> ; <a href="./references#MR000050-bbs2-0085" title="TanSY , BruniJ .Cognitive-behavior therapy with adult patients with epilepsy: a controlled outcome study. Epilepsia1986;27(3):225-33. ">Tan 1986</a> ; <a href="./references#MR000050-bbs2-0086" title="TeriL , LogsdonRG , UomotoJ , McCurrySM .Behavioral treatment of depression in dementia patients: a controlled clinical trial. Journals of Gerontology. Series B, Psychological Sciences and Social Sciences1997;52(4):159-66. TeriL .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 26th of August 2019. ">Teri 1997</a> ; <a href="./references#MR000050-bbs2-0087" title="ToriC , WorellL .Reduction of human avoidant behavior. A comparison of counterconditioning, expectancy, and cognitive information approaches. Clinical Psychology1973;41(2):269-78. ">Tori 1973</a> ; <a href="./references#MR000050-bbs2-0089" title="AscherML , TurnerRM .A comparison of two methods for the administration of paradoxical intention. Behaviour Research and Therapy1980;18(2):121-6. TurnerRM , AscherLM .Controlled comparison of progressive relaxation, stimulus control, and paradoxical intention therapies for insomnia. Journal of Consulting and Clinical Psychology1979;47(3):500-8. ">Turner 1979</a> ; <a href="./references#MR000050-bbs2-0090" title="VanderplateC .Electromyograph biofeedback Treatment of sleep onset Insomnia: a controlled Investigation. Dissertation, University of Southern Mississippi1978. ">Vanderplate 1983</a> ; <a href="./references#MR000050-bbs2-0092" title="WeingaertnerAH .Self-administered aversive stimulation with hallucinating hospitalized schizophrenics. Journal of Consulting and Clinical Psychology1971;36(3):422-29. ">Weingaertner 1971</a> ; <a href="./references#MR000050-bbs2-0094" title="WilsonA , DavidsonWJ , BlanchardR , WhiteJ .Disulfiram implantation. A placebo-controlled trial with two-year follow-up. Journal of Studies on Alcohol1978;39(5):809-19. WilsonA , DavidsonWJ , BlanchardR .Disulfiram implantation: a trial using placebo implants and two types of controls. Journal of Studies on Alcohol1980;41(5):429-36. ">Wilson 1980</a> ; <a href="./references#MR000050-bbs2-0095" title="WolitzkyKB , TelchMJ .Augmenting in vivo exposure with fear antagonistic actions: a preliminary test. Behavior Therapy2009;40(1):57-71. ">Wolitzky 2009</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Did not report usable data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>14(13)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#MR000050-bbs2-0013" title="BrillNQ , KoeglerRR , EpsteinLJ , ForgyEW .Controlled study of psychiatric outpatient treatment. Archives of General Psychiatry1964;10:581-95. BrillNQ .Results of psychotherapy. California Medicine1966;104(4):249-53. ">Brill 1964a</a> ; <a href="./references#MR000050-bbs2-0014" title="BrillNQ , KoeglerRR , EpsteinLJ , ForgyEW .Controlled study of psychiatric outpatient treatment. Archives of General Psychiatry1964;10:581-95. ">Brill 1964b</a> ; <a href="./references#MR000050-bbs2-0018" title="CrouchG , RobsonM , HallstromC .Benzodiazepine dependent patients and their psychological treatment. Progress in Neuro-psychopharmacology &amp; Biological Psychiatry1988;12(4):503-10. HallströmC , CrouchG , RobsenM , ShineP .The treatment of tranquillizer dependence by propranolol. Postgraduate Medical Journal1988;64(Suppl 2):40-4. ">Crouch 1988</a> ; <a href="./references#MR000050-bbs2-0019" title="Doty, DW.Role playing and incentives in the modification of the social interaction of chronic psychiatric patients. Journal of Consulting and Clinical Psychology1975;43(5):676-82. ">Doty 1975</a> ; <a href="./references#MR000050-bbs2-0030" title="GoldwasserAN , AuerbachSM , HarkinsSW .Cognitive, affective, and behavioural effects of reminiscence group therapy on demented elderly. Aging and Human Development1987;25(3):209-22. ">Goldwasser 1987</a> ; <a href="./references#MR000050-bbs2-0031" title="HekmatH , LubitzR , DealR .Semantic desensitization: a paradigmatic intervention approach to anxiety disorders. Journal of Clinical Psychology1984;40(2):463-6. ">Hekmat 1984</a> ; <a href="./references#MR000050-bbs2-0046" title="LangOJ , LazovikAD .Experimental desensitization of a phobia. Journal of Abnormal and Social Psychology1963;66:519-25. LangPJ , LazovikAD , ReynoldsDJ .Desensitization, suggestibility, and pseudotherapy. Journal of Abnormal Psychology1965;70(6):395-402. ">Lang 1965</a> ; <a href="./references#MR000050-bbs2-0059" title="PearlD , Vander KampH , OlsenAL , GreenbergPD , ArmitageSG .The effects of reserpine on schizophrenic patients. American Journal of Psychiatry1956;112:198-204. ">Pearl 1956</a> ; <a href="./references#MR000050-bbs2-0077" title="LorrM , McNairDM , WeinsteinGJ .Early effects of chlordiazepoxide (Librium) used with psychotherapy. Journal of Psychiatric Research1963;1:257-70. RothI , RhudickPJ , ShaskanDA , SlobinMS , WilkinsonAE , YoungHH .Long-term effects on psychotherapy of initial treatment conditions. Journal of Psychiatric Research1964;2:283-97. ">Roth 1964</a> ; <a href="./references#MR000050-bbs2-0078" title="RupertPA , HolmesDS .Effects of multiple sessions of true and placebo heart rate biofeedback training on the heart rates and anxiety levels of anxious patients during and following treatment. Psychophysiology1978;15(6):582-90. ">Rupert 1978</a> ; <a href="./references#MR000050-bbs2-0081" title="SibilioJP , AndrewG , DartD , MooreKB , StehmanA .Treatment of chronic schizophrenia with promazine hydrochloride. AMA Archives of Neurology and Psychiatry1957;78(4):419-24. ">Sibilio 1957</a> ; <a href="./references#MR000050-bbs2-0082" title="SommernessMD , LuceroRJ , HamlonJS , EricksonJL , MatthewsR .A controlled study of reserpine on chronically disturbed patients. JAMA Archives of Neurology and Psychiatry1955;74(3):316-9. ">Sommerness 1955</a> ; <a href="./references#MR000050-bbs2-0088" title="Trexler, L.Rational-emotive therapy, placebo, and no-treatment effects on public-speaking anxiety. Doctoral dissertation, Temple University AnnArbor, Mich.: University Microfilms1971;71-31(063). TrexlerLD , KarstTO .Rational-emotive therapy, placebo, and no-treatment effects on public-speaking anxiety. Journal of Abnormal Psyhology1972;79(1):60-7. ">Trexler 1972</a> ; <a href="./references#MR000050-bbs2-0051" title="MatsonJL , MarchettiA , AdkinsJA .Comparison of operant- and independence-training procedures for mentally retarded adults. American Journal of Mental Deficiency1980;84(5):487-94. ">Matson 1980</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Efficacy of all placebos</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Reported dichotomous data on a outcome for efficacy of placebo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#MR000050-bbs2-0007" title="BergI , ForsytheI , HoltP , WattsJ .A controlled trial of ‘Senokot’ in faecal soiling treated by behavioural methods. Journal of Child Psychology and Psychiatry1983;24(4):543-9. ">Berg 1983</a> ; <a href="./references#MR000050-bbs2-0020" title="DoubleDB , WarrenGC , EvansM , RowlandsMP .Efficacy of maintenance use of anticholinergic agents. Acta Psychiatrica Scandinavica1993;88:381-4. ">Double 1993</a> ; <a href="./references#MR000050-bbs2-0039" title="KlermanGL , DimascioA , WeismannM , PrusoffB , PaykelES .Treatment of depression by drugs and psychotherapy. American Journal of Psychiatry1974;131(2):186-91. PaykelES , DimascioA , HaskellD , PrusoffBA .Effects of maintenance amitriptyline and psychotherapy on symptoms of depression. Psychological Medicine1975;5(1):67-77. PaykelES , DiMascioA , KlermanGL , PrusoffBA .Maintenance therapy of depression. Pharmakopsychiatrie, Neuro-Psychopharmakologie1976;9:127-39. PaykelES , WeissmanMM , PrusoffBA .Social maladjustment and severity of depression. Comprehensive Psychiatry1978;19(2):121-8. WeissmanMM , KlermanGL , PaykelES , PrusoffB .Treatment effects on the social adjustment of depressed patients. Archives of General Psychiatry1974;30:771-8. ">Klerman 1974a</a> ; <a href="./references#MR000050-bbs2-0040" title="KlermanGL , DimascioA , WeismannM , PrusoffB , PaykelES .Treatment of depression by drugs and psychotherapy. American Journal of Psychiatry1974;131(2):186-91. ">Klerman 1974b</a> ; <a href="./references#MR000050-bbs2-0053" title="MealieaWL , NawasMM .The comparative effectiveness of systematic desensitization and implosive therapy in the treatment of snake phobia. Journal of Behavior Therapy and Experimental Psychiatry1971;2(2):85-94. ">Mealiea 1971</a> ; <a href="./references#MR000050-bbs2-0070" title="LiebowitzM , QuitkinFM , StewartJW , McGrathPJ , HarrisonWM , MarkowitzJS , et al.Antidepressant efficacy in atypical depression. Archives of General Psychiatry1988;45(2):129-37. QuitkinFM , McGrathPJ , StewartJW , HarrisonW , WagerSG , NunesE , et al.Phenelzine and imipramine in mood reactive depressives: further delineation of the syndrome of atypical depression. Archives of General Psychiatry1989;46(9):787-93. RabkinJG , McGrathPJ , QuitkinFM , TricamoE , StewartJW , KleinDF .Effects of pill-giving on maintenance of placebo response in patients with chronic mild depression. American Journal of Psychiatry1990;147(12):1622-6. ">Rabkin 1990</a> ; <a href="./references#MR000050-bbs2-0091" title="WatzlH , RistF , OlbrichR , CohenR .Placebo injections and surveillance of alcohol intake during inpatient treatment of female alcoholics. Addictive Behaviors1988;13(2):197-200. ">Watzl 1988</a> ; <a href="./references#MR000050-bbs2-0093" title="WhittakerCB , HoyRM .Withdrawal of perphenazine in chronic schizophrenia. British Journal of Psychiatry1963;109:422-7. ">Whittaker 1963</a> ; <a href="./references#MR000050-bbs2-0094" title="WilsonA , DavidsonWJ , BlanchardR , WhiteJ .Disulfiram implantation. A placebo-controlled trial with two-year follow-up. Journal of Studies on Alcohol1978;39(5):809-19. WilsonA , DavidsonWJ , BlanchardR .Disulfiram implantation: a trial using placebo implants and two types of controls. Journal of Studies on Alcohol1980;41(5):429-36. ">Wilson 1980</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Reported continuous data on a outcome for efficacy of placebo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>65</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#MR000050-bbs2-0001" title="AbikoffH , HechtmanL , KleinRG .Social functioning in children with ADHD treated with long-term methylphenidate and multimodal psychosocial treatment. Journal of the American Academy of Child and Adolescent Psychiatry2004;43(7):820-9. AbikoffH .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to A Todorovac 23rd of August 2019. KleinRG , AbikoffH , HechtmanL , WeissG .Design and rationale of controlled study of long-term methylphenidate and multimodal psychosocial treatment in children with ADHD. Journal of the American Academy of Child and Adolescent Psychiatry2004;43(7):792-801. ">Abikoff 2004</a> ; <a href="./references#MR000050-bbs2-0002" title="AllenJB .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to A Todorovac 28th of August 2019. AllenJJ , SchnyerRN , HittSK .The efficacy of acupuncture in the treatment of major depression in women. Psychological Science1998;9(5):397-401. ">Allen 1998</a> ; <a href="./references#MR000050-bbs2-0003" title="AllenJB .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 28th of August 2019. AllenJJ , SchnyerRN , ChambersAS , HittSK , MorenoFA , ManberR .Acupuncture for depression: a randomized controlled trial. Journal of Clinical Psychiatry2006;67(11):1665-73. ">Allen 2006</a> ; <a href="./references#MR000050-bbs2-0004" title="AlvarezJR .The effects of anger management training on depression, anger, self-concept, and treatment responsibility in a sample of drug-dependent individuals in a therapeutic community. Dissertation Abstracts International: Section B: the Sciences and Engineering1997;58(4-B):2108. ">Alvarez 1997</a> ; <a href="./references#MR000050-bbs2-0005" title="AscherLM , TurnerR .Paradoxical intention and insomnia: an experimental investigation. Behaviour Research and Therapy1979;17(4):408-11. ">Ascher 1979</a> ; <a href="./references#MR000050-bbs2-0006" title="AyenI , HautzingerM .Cognitive behavior therapy for depression in menopausal women. A controlled, randomized treatment study [Kognitive Verhaltenstherapie bei Depressionen im Klimakterium: Eine kontrollierte, randomiserte Interventionsstudie]. Zeitschrift für Klinische Psychologie und Psychotherapie2004;33(4):290-9. AyenI .Inclusion of study in Cochrane Systematic Review (personal communication). Email to EG Faltinsen 9th of September 2019. ">Ayen 2004</a> ; <a href="./references#MR000050-bbs2-0008" title="Borden, KA.Attributional Outcomes: the Subtle Messages of Treatments for Attention Deficit Disorder. Dissertation, University of Illinois at Urbana-Champaign1986. BordenKA , BrownRT .Attributional outcomes: The subtle messages of treatments for attention deficit disorder. Cognitive Therapy and Research1989;13(2):147-60. ">Borden 1986</a> ; <a href="./references#MR000050-bbs2-0009" title="BorkovecTD , KaloupekDG , SlamaKM .The facilitative effect of muscle tension-release in the relaxation treatment of sleep disturbance. Behavior Therapy1975;6(3):301-9. ">Borkovec 1975</a> ; <a href="./references#MR000050-bbs2-0010" title="BorkovecTD , WeertsTC .Effects of progressive relaxation on sleep disturbance: an electroencephalographic evaluation. Psychosomatic Medicine1976;38(3):173-80. ">Borkovec 1976</a> ; <a href="./references#MR000050-bbs2-0011" title="BornovalovaM .Inclusion of study in Cochrane Systematic Review (personal communication). Email to A Todorovac. 21st of August 2019. BornovalovaMA .Distress tolerance treatment for inner-city drug users: a preliminary trial. Doctor’s Dissertation, University of Maryland2008. ">Bornovalova 2008</a> ; <a href="./references#MR000050-bbs2-0012" title="BramstonP , SpenceSH .Behavioural versus cognitive social-skills training with intellectually-handicapped adults. Behaviour Research and Therapy1985;23(3):239-46. ">Bramston 1985</a> ; <a href="./references#MR000050-bbs2-0015" title="CarlsonCL , PelhamWE , MilichR , HozaB .ADHD boys’ performance and attributions following success and failure: drug effects and individual differences. Cognitive Therapy and Research1993;17:269-87. ">Carlson 1993</a> ; <a href="./references#MR000050-bbs2-0016" title="CarterJC , OlmstedMP , KaplanAS , McCabeRE , MillsJS , AimeA .Self-help for bulimia nervosa: a randomized controlled trial. American Journal of Psychiatry2003;160(5):973-8. ">Carter 2003</a> ; <a href="./references#MR000050-bbs2-0018" title="CrouchG , RobsonM , HallstromC .Benzodiazepine dependent patients and their psychological treatment. Progress in Neuro-psychopharmacology &amp; Biological Psychiatry1988;12(4):503-10. HallströmC , CrouchG , RobsenM , ShineP .The treatment of tranquillizer dependence by propranolol. Postgraduate Medical Journal1988;64(Suppl 2):40-4. ">Crouch 1988</a> ; <a href="./references#MR000050-bbs2-0021" title="EhlersA , HackmannA , GreyN , WildJ , LinessS , AlbertI , et al.A randomized controlled trial of 7-day intensive and standard weekly cognitive therapy for PTSD and emotion-focused supportive therapy. American Journal of Psychiatry2014;171(3):294-304. ">Ehlers 2014</a> ; <a href="./references#MR000050-bbs2-0022" title="EspieCA , BrooksDN , LindsayWR .An evaluation of tailored psychological treatment of insomnia. Journal of Behavior Therapy and Experimental Psychiatry1989;20(2):143-53. EspieCA , LindsayWR , BrooksDN , HoodEM , TurveyT .A controlled comparative investigation of psychological treatments for chronic sleep-onset insomnia. Behaviour Research and Therapy1989;27(1):79-88. ">Espie 1989a</a> ; <a href="./references#MR000050-bbs2-0023" title="EtringerBD , CashTF , RimmDC .Behavioral, affective, and cognitive effects of participant modeling and an equally credible placebo. Behavior Therapy1982;13(4):476-85. ">Etringer 1982</a> ; <a href="./references#MR000050-bbs2-0024" title="FoaEB , RothbaumBO , RiggsDS , MurdockTB .Treatment of posttraumatic stress disorder in rape victims: a comparison between cognitive-behavioral procedures and counselling. Journal of Consulting and Clinical Psychology1991;59(5):715-23. ">Foa 1991</a> ; <a href="./references#MR000050-bbs2-0025" title="FoaEB , McLeanCP , ZangY , RosenfieldD , YadinE , YarvisJS , et al.Effect of prolonged exposure therapy delivered over 2 weeks vs 8 weeks vs present-centered therapy on PTSD symptom severity in military personnel: a randomized clinical trial. JAMA2018;319(4):354-64. ">Foa 2018</a> ; <a href="./references#MR000050-bbs2-0026" title="FreireAO , SugaiGC , ChrispinFS , TogeiroSM , YamamuraY , MelloLE , et al.Treatment of moderate obstructive sleep apnea syndrome with acupuncture: a randomised, placebo-controlled pilot trial. Sleep Medicine2007;8(1):43-50. ">Freire 2007</a> ; <a href="./references#MR000050-bbs2-0027" title="FuchsCZ , RehnLP .A self-control behavior therapy program for depression. Journal of Consulting and Clinical Psychology1977;45(2):206-15. ">Fuchs 1977</a> ; <a href="./references#MR000050-bbs2-0028" title="GlogowskaM , RoulstoneS , EnderbyP , PetersTJ .Randomised controlled trial of community based speech and language therapy in preschool children. BMJ2000;321(7266):923-6. ">Glogowska 2000</a> ; <a href="./references#MR000050-bbs2-0032" title="HippmanC , RingroseA , InglisA , CheekJ , AlbertAY , RemickR , et al.A pilot randomized clinical trial evaluating the impact of genetic counselling for serious mental illnesses. Journal of Clinical Psychiatry2016;77(2):e190-8. ">Hippman 2016</a> ; <a href="./references#MR000050-bbs2-0034" title="KarstM , WinterhalterM , MünteS , FranckiB , HondronikosA , EckardtA , et al.Auricular acupuncture for dental anxiety: a randomized controlled trial. Anesthesia and Analgesia2007;104(2):295-300. KarstM .Inclusion of study in Cochrane Systematic Review (personal communication). Email to: EG Faltinsen 5th of September 2019. ">Karst 2007</a> ; <a href="./references#MR000050-bbs2-0035" title="KelleyJ .Inclusion of study in Cochrane Systematic Review (personal communication). Email to: A Todorovac 12th of August 2019. KelleyJM , KaptchukTJ , CusinC , LipkinS , FavaM .Open-label placebo for major depressive disorder: a pilot randomized controlled trial. Psychotherapy and Psychosomatics2012;81(5):312-4. ">Kelley 2012</a> ; <a href="./references#MR000050-bbs2-0036" title="KennedyTD , KimuraHK .Transfer, behavioral improvement, and anxiety reduction in systematic desensitization. Journal of Consulting and Clinical Psychology1974;42(5):720-8. ">Kennedy 1974</a> ; <a href="./references#MR000050-bbs2-0037" title="KilmannPR , MilanRJ , BolandJP , NankinHR , DavidsonE , WestMO , et al.Group treatment of secondary erectile dysfunction. Journal of Sex &amp; Marital Therapy1987;13(3):168-82. KilmannPR , Milan RJ Jr, BolandJP , DavidsonE , WestMO , SablisRF , et al.The sexual interactions of men with secondary erectile dysfunction. Journal of Sex Education and Therapy1988;14(1):46-9. KilmannPR , Milan RJ Jr, BolandJP , NankinHR , SablisRF , WestMO , et al.The sexual interactions of men with secondary erectile dysfunction. Paper presented at the annual meeting of the American Psychological Association in Los Angeles1985;1:46-9. ">Kilmann 1987</a> ; <a href="./references#MR000050-bbs2-0038" title="KleinSA , DeffenbacherJL .Relaxation and exercise for hyperactive impulsive children. Perceptual and Motor Skills1977;45:1159-62. ">Klein 1977</a> ; <a href="./references#MR000050-bbs2-0041" title="KloskoJS , BarlowDH , TassinariR , CernyJA .A comparison of alprazolam and behavior therapy in treatment of panic disorder: correction. Journal of Psychotherapy Practice and Research1994;3(2):163-79. KloskoJS , BarlowDH , TassinariR , CernyJA .A comparison of alprazolam and behavior therapy in treatment of panic disorder. Journal of Consulting and Clinical Psychology1990;58(1):77-84. ">Klosko 1990</a> ; <a href="./references#MR000050-bbs2-0042" title="KrapflJE , NawasMM .Differential ordering of stimulus presentation in systematic desensitization. Journal of Abnormal Psychology1970;75(3):333-7. ">Krapfl 1970</a> ; <a href="./references#MR000050-bbs2-0043" title="KwanR .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 26th of August 2019. KwanRY , LeungMC , LaiCK .Acupressure for agitation in nursing home residents with dementia: study protocol for a randomized controlled trial. Trials2014;15(410):1-7. KwanRY , LeungMCP , LaiCK .A randomized controlled trial examining the effect of acupressure on agitation and salivary cortisol in nursing home residents with dementia. Dementia and Geriatric Cognitive Disorders2017;44(1-2):92-104. ">Kwan 2017</a> ; <a href="./references#MR000050-bbs2-0044" title="LacyMK .The effect of short term autogenic training on the stress reactivity of hospitalized emotionally disturbed adolescents. ProQuest Dissertations Publishing, Oklahoma State University1996. ">Lacy 1990</a> ; <a href="./references#MR000050-bbs2-0045" title="LaiCK , ChiI , Kayser-JonesJ .A randomized controlled trial of a specific reminiscence approach to promote the well-being of nursing home residents with dementia. International Psychogeriatrics2004;16(1):33-49. LaiK .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 6th of September 2019. ">Lai 2004</a> ; <a href="./references#MR000050-bbs2-0047" title="LegrandF .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 14th of August 2019. LegrandFD , NeffEM .Efficacy of exercise as an adjunct treatment for clinically depressed inpatients during the initial stages of antidepressant pharmacotherapy: an open randomized controlled trial. Journal of Affective Disorders2016;191:139-44. ">Legrand 2016</a> ; <a href="./references#MR000050-bbs2-0048" title="LickJ .Expectancy, false galvanic skin response feedback, and systematic desensitization in the modification of phobic behavior. Journal of Consulting and Clinical Psychology1975;43(4):557-67. ">Lick 1975</a> ; <a href="./references#MR000050-bbs2-0049" title="LickJR , HefflerD .Relaxation training and attention placebo in the treatment of severe insomnia. Journal of Consulting and Clinical Psychology1977;45(2):153-61. ">Lick 1977</a> ; <a href="./references#MR000050-bbs2-0050" title="LiddleB , SpenceSH .Cognitive-behaviour therapy with depressed primary school children: A cautionary note. Behavioural Psychotherapy1990;18(2):85-102. ">Liddle 1990</a> ; <a href="./references#MR000050-bbs2-0052" title="McLachlanDR , DaltonAJ , KruckTP , BellMY , SmithWL , KalowW , et al.Intramuscular desferrioxamine in patients with Alzheimer's disease. Lancet1991;337(8753):1304-8. McLachlanDRC , SmithWL , KruckTP .Desferrioxamine and Alzheimer’s disease: video home behavior assessment of clinical course and measures of brain aluminum. Therapeutic Drug Monitoring1993;15(6):602-7. ">McLachlan 1991</a> ; <a href="./references#MR000050-bbs2-0055" title="MirandaA , ArlandisP , SorianoM .Instruction in strategies and attributional training: Effects on the problem-solving and self-concept of students’ with learning disabilities [Instrucción en estrategias y entrenamiento atribucional: efectos sobre la resolución de problemas y el autoconcepto de los estudiantes con dificultades en el aprendizaje]. Infancia y Aprendizaje1997;20(80):37-52. ">Miranda 1997</a> ; <a href="./references#MR000050-bbs2-0056" title="MitchellC , MansfieldD , RautenbachS .Coloured filters and reading accuracy, comprehension and rate: a placebo-controlled study. Perceptual and Motor Skills2008;106(2):517-32. ">Mitchell 2008</a> ; <a href="./references#MR000050-bbs2-0057" title="NandiDN , AjmanyS , GanguliH , BanerjeeG , BoralGC , GhoshA , et al.A clinical evaluation of depressives found in a rural survey in India. British Journal of Psychiatry1976;128:523-7. ">Nandi 1976</a> ; <a href="./references#MR000050-bbs2-0058" title="NicassioP , BootzinR .A comparison of progressive relaxation and autogenic training as treatments for insomnia. Journal of Abnormal Psychology1974;83(3):253-60. ">Nicassio 1974</a> ; <a href="./references#MR000050-bbs2-0060" title="PeckCL .Desensitization for the treatment of fear in the high level adult retardate. Behaviour Research and Therapy1977;15(2):137-48. ">Peck 1976</a> ; <a href="./references#MR000050-bbs2-0061" title="MilichR , CarlsonCL , Pelham WE Jr, LichtBG .Effects of methylphenidate on the persistence of ADHD boys following failure experiences. Journal of Abnormal Child Psychology1991;19(5):519-36. PelhamWE , MurphyDA , VannattaK , MilichR , LichtBG , GnagyEM , et al.Methylphenidate and attributions in boys with attention-deficit hyperactivity disorder. Journal of Consulting and Clinical Psychology1992;60(2):282-92. ">Pelham 1992</a> ; <a href="./references#MR000050-bbs2-0062" title="PedletonMG , HigginsRL .A comparison of negative practice and systematic desensitization in the treatment of acrophobia. Journal of Behavior Therapy and Experimental Psychiatry1983;14(4):317-23. ">Pendleton 1983</a> ; <a href="./references#MR000050-bbs2-0063" title="PetersonMA , PattersonB , PillmanBM , BattistaMA .Cognitive recovery following alcohol detoxification: a computerised remediation study. Neuropsychological Rehabilitation2002;12(1):63-74. PillmanBM .Computerized cognitive remediation with recently detoxified alcoholics. Dissertation, California School of Professional Psychology, Fresno Campus2000. ">Pillman 2001</a> ; <a href="./references#MR000050-bbs2-0064" title="PolandRE , GertsikL , FavreauJT , SmithSI , MirochaJM , RaoU , et al.Open-label randomized parallel-group controlled clinical trial of massage for treatment of depression in HIV-infected subjects. Journal of Alternative and Complementary Medicine2013;19(4):334-40. ">Poland 2013</a> ; <a href="./references#MR000050-bbs2-0065" title="PowersMB , SmitsJA , TelchMJ .Disentangling the effects of safety-behavior utilization and safety-behavior availability during exposure-based treatment: a placebo-controlled trial. Journal of Consulting and Clinical Psychology2004;72(3):448-54. ">Powers 2004</a> ; <a href="./references#MR000050-bbs2-0066" title="PowersMB , SmithsJA , WhitleyD , BystritskyA , TelchMJ .The effect of attributional processes concerning medication taking on return of fear. Journal of Consulting and Clinical Psychology2008;76(3):478-90. ">Powers 2008a</a> ; <a href="./references#MR000050-bbs2-0067" title="PowersMB , SmithsJA , WhitleyD , BystritskyA , TelchMJ .The effect of attributional processes concerning medication taking on return of fear. Journal of Consulting and Clinical Psychology2008;76(3):478-90. ">Powers 2008b</a> ; <a href="./references#MR000050-bbs2-0068" title="ProudfootJ , ClarkeJ , BirchMR , WhittonAE , ParkerG , ManicavasagarV , et al.Impact of a mobile phone and web program on symptom and functional outcomes for people with mild- to-moderate depression, anxiety and stress: a randomized controlled trial. BMC Psychiatry2013;13(312):1-12. ProudfootJ .Re: Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 26th of August 2019. ">Proudfoot 2013</a> ; <a href="./references#MR000050-bbs2-0069" title="QuayhagenMP , QuayhagenM , CorbeilRR , RothPA , RodgersJA .A dyadic remediation program for care recipients with dementia. Nursing Research1995;44(3):153-9. ">Quayhagen 1995</a> ; <a href="./references#MR000050-bbs2-0075" title="OlivaresJ .Program IAFS. Protocol for the treatment of social phobia in adolescents [Programa IAFS. Protocolo para el tratamiento de la fobia social enadolescentes]. Madrid: Pirámide2005;1. Rosa-AlcázarAI , Olivares-OlivaresPJ , OlivaresJ .The role of non-specific effects in the psychological treatment of adolescents with social phobia [Papel de los efectos inespecíficos en el tratamiento psicológico de adolescentes con fobia social]. Anuario de Psicologia2009;40(1):43-61. ">Rosa‐Alcatraz 2009</a> ; <a href="./references#MR000050-bbs2-0076" title="RosenGM , GlasgowRE , BarreraM .A controlled study to assess the clinical efficacy of totally self-administrated systematic desensitization. Journal of Consulting and Clinical Psychology1976;44(2):208-17. ">Rosen 1976</a> ; <a href="./references#MR000050-bbs2-0079" title="ShalevAY , AnkriY , Isreali-ShalevY , PelegT , AdesskyR , FreedmanS .Prevention of posttraumatic stress disorder by early treatment. Archives of General Psychiatry2012;69(2):166-76. ">Shalev 2012</a> ; <a href="./references#MR000050-bbs2-0080" title="ShealyRC .The effectiveness of various treatment techniques on different degrees and durations of sleep-onset insomnia. Behaviour Research and Therapy1979;17(6):541-6. ">Shealy 1979</a> ; <a href="./references#MR000050-bbs2-0083" title="SteinmarkSW , BorkovecTD .Active and placebo treatment effects on moderate insomnia under counterdemand and positive demand instructions. Journal of Abnormal Psychology1974;83(2):157-63. ">Steinmark 1974</a> ; <a href="./references#MR000050-bbs2-0084" title="SzymanskiJ , O'DonohueW .The potential role of state-dependent learning in cognitive therapy with spider phobics. Journal of Rational-Emotive &amp; Cognitive-Behavior Therapy1995;13(2):131-50. SzymanskiJ .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 20th of August 2019. ">Szymanski 1995</a> ; <a href="./references#MR000050-bbs2-0085" title="TanSY , BruniJ .Cognitive-behavior therapy with adult patients with epilepsy: a controlled outcome study. Epilepsia1986;27(3):225-33. ">Tan 1986</a> ; <a href="./references#MR000050-bbs2-0087" title="ToriC , WorellL .Reduction of human avoidant behavior. A comparison of counterconditioning, expectancy, and cognitive information approaches. Clinical Psychology1973;41(2):269-78. ">Tori 1973</a> ; <a href="./references#MR000050-bbs2-0089" title="AscherML , TurnerRM .A comparison of two methods for the administration of paradoxical intention. Behaviour Research and Therapy1980;18(2):121-6. TurnerRM , AscherLM .Controlled comparison of progressive relaxation, stimulus control, and paradoxical intention therapies for insomnia. Journal of Consulting and Clinical Psychology1979;47(3):500-8. ">Turner 1979</a> ; <a href="./references#MR000050-bbs2-0090" title="VanderplateC .Electromyograph biofeedback Treatment of sleep onset Insomnia: a controlled Investigation. Dissertation, University of Southern Mississippi1978. ">Vanderplate 1983</a> ; <a href="./references#MR000050-bbs2-0092" title="WeingaertnerAH .Self-administered aversive stimulation with hallucinating hospitalized schizophrenics. Journal of Consulting and Clinical Psychology1971;36(3):422-29. ">Weingaertner 1971</a> ; <a href="./references#MR000050-bbs2-0095" title="WolitzkyKB , TelchMJ .Augmenting in vivo exposure with fear antagonistic actions: a preliminary test. Behavior Therapy2009;40(1):57-71. ">Wolitzky 2009</a> ; <a href="./references#MR000050-bbs2-0096" title="WollersheimJP , WilsonGL .Group treatment of unipolar depression: a comparison of coping, supportive, bibliotherapy, and delayed treatment groups. Professional Psychology: Research and Practice1991;22(6):496-502. ">Wollersheim 1991</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Did not report usable data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#MR000050-bbs2-0013" title="BrillNQ , KoeglerRR , EpsteinLJ , ForgyEW .Controlled study of psychiatric outpatient treatment. Archives of General Psychiatry1964;10:581-95. BrillNQ .Results of psychotherapy. California Medicine1966;104(4):249-53. ">Brill 1964a</a> ; <a href="./references#MR000050-bbs2-0018" title="CrouchG , RobsonM , HallstromC .Benzodiazepine dependent patients and their psychological treatment. Progress in Neuro-psychopharmacology &amp; Biological Psychiatry1988;12(4):503-10. HallströmC , CrouchG , RobsenM , ShineP .The treatment of tranquillizer dependence by propranolol. Postgraduate Medical Journal1988;64(Suppl 2):40-4. ">Crouch 1988</a> ; <a href="./references#MR000050-bbs2-0019" title="Doty, DW.Role playing and incentives in the modification of the social interaction of chronic psychiatric patients. Journal of Consulting and Clinical Psychology1975;43(5):676-82. ">Doty 1975</a> ; <a href="./references#MR000050-bbs2-0030" title="GoldwasserAN , AuerbachSM , HarkinsSW .Cognitive, affective, and behavioural effects of reminiscence group therapy on demented elderly. Aging and Human Development1987;25(3):209-22. ">Goldwasser 1987</a> ; <a href="./references#MR000050-bbs2-0031" title="HekmatH , LubitzR , DealR .Semantic desensitization: a paradigmatic intervention approach to anxiety disorders. Journal of Clinical Psychology1984;40(2):463-6. ">Hekmat 1984</a> ; <a href="./references#MR000050-bbs2-0046" title="LangOJ , LazovikAD .Experimental desensitization of a phobia. Journal of Abnormal and Social Psychology1963;66:519-25. LangPJ , LazovikAD , ReynoldsDJ .Desensitization, suggestibility, and pseudotherapy. Journal of Abnormal Psychology1965;70(6):395-402. ">Lang 1965</a> ; <a href="./references#MR000050-bbs2-0077" title="LorrM , McNairDM , WeinsteinGJ .Early effects of chlordiazepoxide (Librium) used with psychotherapy. Journal of Psychiatric Research1963;1:257-70. RothI , RhudickPJ , ShaskanDA , SlobinMS , WilkinsonAE , YoungHH .Long-term effects on psychotherapy of initial treatment conditions. Journal of Psychiatric Research1964;2:283-97. ">Roth 1964</a> ; <a href="./references#MR000050-bbs2-0078" title="RupertPA , HolmesDS .Effects of multiple sessions of true and placebo heart rate biofeedback training on the heart rates and anxiety levels of anxious patients during and following treatment. Psychophysiology1978;15(6):582-90. ">Rupert 1978</a> ; <a href="./references#MR000050-bbs2-0059" title="PearlD , Vander KampH , OlsenAL , GreenbergPD , ArmitageSG .The effects of reserpine on schizophrenic patients. American Journal of Psychiatry1956;112:198-204. ">Pearl 1956</a> ; <a href="./references#MR000050-bbs2-0081" title="SibilioJP , AndrewG , DartD , MooreKB , StehmanA .Treatment of chronic schizophrenia with promazine hydrochloride. AMA Archives of Neurology and Psychiatry1957;78(4):419-24. ">Sibilio 1957</a> ; <a href="./references#MR000050-bbs2-0082" title="SommernessMD , LuceroRJ , HamlonJS , EricksonJL , MatthewsR .A controlled study of reserpine on chronically disturbed patients. JAMA Archives of Neurology and Psychiatry1955;74(3):316-9. ">Sommerness 1955</a> ; <a href="./references#MR000050-bbs2-0088" title="Trexler, L.Rational-emotive therapy, placebo, and no-treatment effects on public-speaking anxiety. Doctoral dissertation, Temple University AnnArbor, Mich.: University Microfilms1971;71-31(063). TrexlerLD , KarstTO .Rational-emotive therapy, placebo, and no-treatment effects on public-speaking anxiety. Journal of Abnormal Psyhology1972;79(1):60-7. ">Trexler 1972</a> . </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Efficacy of psychological placebos</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Reported dichotomous data on a outcome for efficacy of placebo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#MR000050-bbs2-0053" title="MealieaWL , NawasMM .The comparative effectiveness of systematic desensitization and implosive therapy in the treatment of snake phobia. Journal of Behavior Therapy and Experimental Psychiatry1971;2(2):85-94. ">Mealiea 1971</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Reported continuous data on a outcome for efficacy of placebo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>38</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#MR000050-bbs2-0001" title="AbikoffH , HechtmanL , KleinRG .Social functioning in children with ADHD treated with long-term methylphenidate and multimodal psychosocial treatment. Journal of the American Academy of Child and Adolescent Psychiatry2004;43(7):820-9. AbikoffH .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to A Todorovac 23rd of August 2019. KleinRG , AbikoffH , HechtmanL , WeissG .Design and rationale of controlled study of long-term methylphenidate and multimodal psychosocial treatment in children with ADHD. Journal of the American Academy of Child and Adolescent Psychiatry2004;43(7):792-801. ">Abikoff 2004</a> ; <a href="./references#MR000050-bbs2-0004" title="AlvarezJR .The effects of anger management training on depression, anger, self-concept, and treatment responsibility in a sample of drug-dependent individuals in a therapeutic community. Dissertation Abstracts International: Section B: the Sciences and Engineering1997;58(4-B):2108. ">Alvarez 1997</a> ; <a href="./references#MR000050-bbs2-0005" title="AscherLM , TurnerR .Paradoxical intention and insomnia: an experimental investigation. Behaviour Research and Therapy1979;17(4):408-11. ">Ascher 1979</a> ; <a href="./references#MR000050-bbs2-0006" title="AyenI , HautzingerM .Cognitive behavior therapy for depression in menopausal women. A controlled, randomized treatment study [Kognitive Verhaltenstherapie bei Depressionen im Klimakterium: Eine kontrollierte, randomiserte Interventionsstudie]. Zeitschrift für Klinische Psychologie und Psychotherapie2004;33(4):290-9. AyenI .Inclusion of study in Cochrane Systematic Review (personal communication). Email to EG Faltinsen 9th of September 2019. ">Ayen 2004</a> ; <a href="./references#MR000050-bbs2-0009" title="BorkovecTD , KaloupekDG , SlamaKM .The facilitative effect of muscle tension-release in the relaxation treatment of sleep disturbance. Behavior Therapy1975;6(3):301-9. ">Borkovec 1975</a> ; <a href="./references#MR000050-bbs2-0010" title="BorkovecTD , WeertsTC .Effects of progressive relaxation on sleep disturbance: an electroencephalographic evaluation. Psychosomatic Medicine1976;38(3):173-80. ">Borkovec 1976</a> ; <a href="./references#MR000050-bbs2-0011" title="BornovalovaM .Inclusion of study in Cochrane Systematic Review (personal communication). Email to A Todorovac. 21st of August 2019. BornovalovaMA .Distress tolerance treatment for inner-city drug users: a preliminary trial. Doctor’s Dissertation, University of Maryland2008. ">Bornovalova 2008</a> ; <a href="./references#MR000050-bbs2-0012" title="BramstonP , SpenceSH .Behavioural versus cognitive social-skills training with intellectually-handicapped adults. Behaviour Research and Therapy1985;23(3):239-46. ">Bramston 1985</a> ; <a href="./references#MR000050-bbs2-0016" title="CarterJC , OlmstedMP , KaplanAS , McCabeRE , MillsJS , AimeA .Self-help for bulimia nervosa: a randomized controlled trial. American Journal of Psychiatry2003;160(5):973-8. ">Carter 2003</a> ; <a href="./references#MR000050-bbs2-0021" title="EhlersA , HackmannA , GreyN , WildJ , LinessS , AlbertI , et al.A randomized controlled trial of 7-day intensive and standard weekly cognitive therapy for PTSD and emotion-focused supportive therapy. American Journal of Psychiatry2014;171(3):294-304. ">Ehlers 2014</a> ; <a href="./references#MR000050-bbs2-0022" title="EspieCA , BrooksDN , LindsayWR .An evaluation of tailored psychological treatment of insomnia. Journal of Behavior Therapy and Experimental Psychiatry1989;20(2):143-53. EspieCA , LindsayWR , BrooksDN , HoodEM , TurveyT .A controlled comparative investigation of psychological treatments for chronic sleep-onset insomnia. Behaviour Research and Therapy1989;27(1):79-88. ">Espie 1989a</a> ; <a href="./references#MR000050-bbs2-0023" title="EtringerBD , CashTF , RimmDC .Behavioral, affective, and cognitive effects of participant modeling and an equally credible placebo. Behavior Therapy1982;13(4):476-85. ">Etringer 1982</a> ; <a href="./references#MR000050-bbs2-0024" title="FoaEB , RothbaumBO , RiggsDS , MurdockTB .Treatment of posttraumatic stress disorder in rape victims: a comparison between cognitive-behavioral procedures and counselling. Journal of Consulting and Clinical Psychology1991;59(5):715-23. ">Foa 1991</a> ; <a href="./references#MR000050-bbs2-0025" title="FoaEB , McLeanCP , ZangY , RosenfieldD , YadinE , YarvisJS , et al.Effect of prolonged exposure therapy delivered over 2 weeks vs 8 weeks vs present-centered therapy on PTSD symptom severity in military personnel: a randomized clinical trial. JAMA2018;319(4):354-64. ">Foa 2018</a> ; <a href="./references#MR000050-bbs2-0027" title="FuchsCZ , RehnLP .A self-control behavior therapy program for depression. Journal of Consulting and Clinical Psychology1977;45(2):206-15. ">Fuchs 1977</a> ; <a href="./references#MR000050-bbs2-0029" title="GoldsteinAJ , BeursE , Chambless Dl, WilsonKA .EMDR for panic disorder with agoraphobia: comparison with waiting list and credible attention-placebo control conditions. Journal of Consulting and Clinical Psychology2000;68(6):947-56. ">Goldstein 2000</a> ; <a href="./references#MR000050-bbs2-0032" title="HippmanC , RingroseA , InglisA , CheekJ , AlbertAY , RemickR , et al.A pilot randomized clinical trial evaluating the impact of genetic counselling for serious mental illnesses. Journal of Clinical Psychiatry2016;77(2):e190-8. ">Hippman 2016</a> ; <a href="./references#MR000050-bbs2-0036" title="KennedyTD , KimuraHK .Transfer, behavioral improvement, and anxiety reduction in systematic desensitization. Journal of Consulting and Clinical Psychology1974;42(5):720-8. ">Kennedy 1974</a> ; <a href="./references#MR000050-bbs2-0037" title="KilmannPR , MilanRJ , BolandJP , NankinHR , DavidsonE , WestMO , et al.Group treatment of secondary erectile dysfunction. Journal of Sex &amp; Marital Therapy1987;13(3):168-82. KilmannPR , Milan RJ Jr, BolandJP , DavidsonE , WestMO , SablisRF , et al.The sexual interactions of men with secondary erectile dysfunction. Journal of Sex Education and Therapy1988;14(1):46-9. KilmannPR , Milan RJ Jr, BolandJP , NankinHR , SablisRF , WestMO , et al.The sexual interactions of men with secondary erectile dysfunction. Paper presented at the annual meeting of the American Psychological Association in Los Angeles1985;1:46-9. ">Kilmann 1987</a> ; <a href="./references#MR000050-bbs2-0038" title="KleinSA , DeffenbacherJL .Relaxation and exercise for hyperactive impulsive children. Perceptual and Motor Skills1977;45:1159-62. ">Klein 1977</a> ; <a href="./references#MR000050-bbs2-0042" title="KrapflJE , NawasMM .Differential ordering of stimulus presentation in systematic desensitization. Journal of Abnormal Psychology1970;75(3):333-7. ">Krapfl 1970</a> ; <a href="./references#MR000050-bbs2-0045" title="LaiCK , ChiI , Kayser-JonesJ .A randomized controlled trial of a specific reminiscence approach to promote the well-being of nursing home residents with dementia. International Psychogeriatrics2004;16(1):33-49. LaiK .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 6th of September 2019. ">Lai 2004</a> ; <a href="./references#MR000050-bbs2-0048" title="LickJ .Expectancy, false galvanic skin response feedback, and systematic desensitization in the modification of phobic behavior. Journal of Consulting and Clinical Psychology1975;43(4):557-67. ">Lick 1975</a> ; <a href="./references#MR000050-bbs2-0050" title="LiddleB , SpenceSH .Cognitive-behaviour therapy with depressed primary school children: A cautionary note. Behavioural Psychotherapy1990;18(2):85-102. ">Liddle 1990</a> ; <a href="./references#MR000050-bbs2-0055" title="MirandaA , ArlandisP , SorianoM .Instruction in strategies and attributional training: Effects on the problem-solving and self-concept of students’ with learning disabilities [Instrucción en estrategias y entrenamiento atribucional: efectos sobre la resolución de problemas y el autoconcepto de los estudiantes con dificultades en el aprendizaje]. Infancia y Aprendizaje1997;20(80):37-52. ">Miranda 1997</a> ; <a href="./references#MR000050-bbs2-0062" title="PedletonMG , HigginsRL .A comparison of negative practice and systematic desensitization in the treatment of acrophobia. Journal of Behavior Therapy and Experimental Psychiatry1983;14(4):317-23. ">Pendleton 1983</a> ; <a href="./references#MR000050-bbs2-0065" title="PowersMB , SmitsJA , TelchMJ .Disentangling the effects of safety-behavior utilization and safety-behavior availability during exposure-based treatment: a placebo-controlled trial. Journal of Consulting and Clinical Psychology2004;72(3):448-54. ">Powers 2004</a> ; <a href="./references#MR000050-bbs2-0066" title="PowersMB , SmithsJA , WhitleyD , BystritskyA , TelchMJ .The effect of attributional processes concerning medication taking on return of fear. Journal of Consulting and Clinical Psychology2008;76(3):478-90. ">Powers 2008a</a> ; <a href="./references#MR000050-bbs2-0069" title="QuayhagenMP , QuayhagenM , CorbeilRR , RothPA , RodgersJA .A dyadic remediation program for care recipients with dementia. Nursing Research1995;44(3):153-9. ">Quayhagen 1995</a> ; <a href="./references#MR000050-bbs2-0074" title="RoehrichL , GoldmanMS .Experience-dependent neuropsychological recovery and the treatment of alcoholism. Journal of Consulting and Clinical Psychology1993;61(5):812-21. ">Roehrich 1993</a> ; <a href="./references#MR000050-bbs2-0075" title="OlivaresJ .Program IAFS. Protocol for the treatment of social phobia in adolescents [Programa IAFS. Protocolo para el tratamiento de la fobia social enadolescentes]. Madrid: Pirámide2005;1. Rosa-AlcázarAI , Olivares-OlivaresPJ , OlivaresJ .The role of non-specific effects in the psychological treatment of adolescents with social phobia [Papel de los efectos inespecíficos en el tratamiento psicológico de adolescentes con fobia social]. Anuario de Psicologia2009;40(1):43-61. ">Rosa‐Alcatraz 2009</a> ; <a href="./references#MR000050-bbs2-0076" title="RosenGM , GlasgowRE , BarreraM .A controlled study to assess the clinical efficacy of totally self-administrated systematic desensitization. Journal of Consulting and Clinical Psychology1976;44(2):208-17. ">Rosen 1976</a> ; <a href="./references#MR000050-bbs2-0080" title="ShealyRC .The effectiveness of various treatment techniques on different degrees and durations of sleep-onset insomnia. Behaviour Research and Therapy1979;17(6):541-6. ">Shealy 1979</a> ; <a href="./references#MR000050-bbs2-0083" title="SteinmarkSW , BorkovecTD .Active and placebo treatment effects on moderate insomnia under counterdemand and positive demand instructions. Journal of Abnormal Psychology1974;83(2):157-63. ">Steinmark 1974</a> ; <a href="./references#MR000050-bbs2-0084" title="SzymanskiJ , O'DonohueW .The potential role of state-dependent learning in cognitive therapy with spider phobics. Journal of Rational-Emotive &amp; Cognitive-Behavior Therapy1995;13(2):131-50. SzymanskiJ .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 20th of August 2019. ">Szymanski 1995</a> ; <a href="./references#MR000050-bbs2-0085" title="TanSY , BruniJ .Cognitive-behavior therapy with adult patients with epilepsy: a controlled outcome study. Epilepsia1986;27(3):225-33. ">Tan 1986</a> ; <a href="./references#MR000050-bbs2-0089" title="AscherML , TurnerRM .A comparison of two methods for the administration of paradoxical intention. Behaviour Research and Therapy1980;18(2):121-6. TurnerRM , AscherLM .Controlled comparison of progressive relaxation, stimulus control, and paradoxical intention therapies for insomnia. Journal of Consulting and Clinical Psychology1979;47(3):500-8. ">Turner 1979</a> ; <a href="./references#MR000050-bbs2-0096" title="WollersheimJP , WilsonGL .Group treatment of unipolar depression: a comparison of coping, supportive, bibliotherapy, and delayed treatment groups. Professional Psychology: Research and Practice1991;22(6):496-502. ">Wollersheim 1991</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Did not report usable data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#MR000050-bbs2-0019" title="Doty, DW.Role playing and incentives in the modification of the social interaction of chronic psychiatric patients. Journal of Consulting and Clinical Psychology1975;43(5):676-82. ">Doty 1975</a> ; <a href="./references#MR000050-bbs2-0030" title="GoldwasserAN , AuerbachSM , HarkinsSW .Cognitive, affective, and behavioural effects of reminiscence group therapy on demented elderly. Aging and Human Development1987;25(3):209-22. ">Goldwasser 1987</a> ; <a href="./references#MR000050-bbs2-0031" title="HekmatH , LubitzR , DealR .Semantic desensitization: a paradigmatic intervention approach to anxiety disorders. Journal of Clinical Psychology1984;40(2):463-6. ">Hekmat 1984</a> ; <a href="./references#MR000050-bbs2-0046" title="LangOJ , LazovikAD .Experimental desensitization of a phobia. Journal of Abnormal and Social Psychology1963;66:519-25. LangPJ , LazovikAD , ReynoldsDJ .Desensitization, suggestibility, and pseudotherapy. Journal of Abnormal Psychology1965;70(6):395-402. ">Lang 1965</a> ; <a href="./references#MR000050-bbs2-0088" title="Trexler, L.Rational-emotive therapy, placebo, and no-treatment effects on public-speaking anxiety. Doctoral dissertation, Temple University AnnArbor, Mich.: University Microfilms1971;71-31(063). TrexlerLD , KarstTO .Rational-emotive therapy, placebo, and no-treatment effects on public-speaking anxiety. Journal of Abnormal Psyhology1972;79(1):60-7. ">Trexler 1972</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Efficacy of pharmacological placebos</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Reported dichotomous data on a outcome for efficacy of placebo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#MR000050-bbs2-0007" title="BergI , ForsytheI , HoltP , WattsJ .A controlled trial of ‘Senokot’ in faecal soiling treated by behavioural methods. Journal of Child Psychology and Psychiatry1983;24(4):543-9. ">Berg 1983</a> ; <a href="./references#MR000050-bbs2-0020" title="DoubleDB , WarrenGC , EvansM , RowlandsMP .Efficacy of maintenance use of anticholinergic agents. Acta Psychiatrica Scandinavica1993;88:381-4. ">Double 1993</a> ; <a href="./references#MR000050-bbs2-0039" title="KlermanGL , DimascioA , WeismannM , PrusoffB , PaykelES .Treatment of depression by drugs and psychotherapy. American Journal of Psychiatry1974;131(2):186-91. PaykelES , DimascioA , HaskellD , PrusoffBA .Effects of maintenance amitriptyline and psychotherapy on symptoms of depression. Psychological Medicine1975;5(1):67-77. PaykelES , DiMascioA , KlermanGL , PrusoffBA .Maintenance therapy of depression. Pharmakopsychiatrie, Neuro-Psychopharmakologie1976;9:127-39. PaykelES , WeissmanMM , PrusoffBA .Social maladjustment and severity of depression. Comprehensive Psychiatry1978;19(2):121-8. WeissmanMM , KlermanGL , PaykelES , PrusoffB .Treatment effects on the social adjustment of depressed patients. Archives of General Psychiatry1974;30:771-8. ">Klerman 1974a</a> ; <a href="./references#MR000050-bbs2-0040" title="KlermanGL , DimascioA , WeismannM , PrusoffB , PaykelES .Treatment of depression by drugs and psychotherapy. American Journal of Psychiatry1974;131(2):186-91. ">Klerman 1974b</a> ; <a href="./references#MR000050-bbs2-0070" title="LiebowitzM , QuitkinFM , StewartJW , McGrathPJ , HarrisonWM , MarkowitzJS , et al.Antidepressant efficacy in atypical depression. Archives of General Psychiatry1988;45(2):129-37. QuitkinFM , McGrathPJ , StewartJW , HarrisonW , WagerSG , NunesE , et al.Phenelzine and imipramine in mood reactive depressives: further delineation of the syndrome of atypical depression. Archives of General Psychiatry1989;46(9):787-93. RabkinJG , McGrathPJ , QuitkinFM , TricamoE , StewartJW , KleinDF .Effects of pill-giving on maintenance of placebo response in patients with chronic mild depression. American Journal of Psychiatry1990;147(12):1622-6. ">Rabkin 1990</a> ; <a href="./references#MR000050-bbs2-0091" title="WatzlH , RistF , OlbrichR , CohenR .Placebo injections and surveillance of alcohol intake during inpatient treatment of female alcoholics. Addictive Behaviors1988;13(2):197-200. ">Watzl 1988</a> ; <a href="./references#MR000050-bbs2-0093" title="WhittakerCB , HoyRM .Withdrawal of perphenazine in chronic schizophrenia. British Journal of Psychiatry1963;109:422-7. ">Whittaker 1963</a> ; <a href="./references#MR000050-bbs2-0094" title="WilsonA , DavidsonWJ , BlanchardR , WhiteJ .Disulfiram implantation. A placebo-controlled trial with two-year follow-up. Journal of Studies on Alcohol1978;39(5):809-19. WilsonA , DavidsonWJ , BlanchardR .Disulfiram implantation: a trial using placebo implants and two types of controls. Journal of Studies on Alcohol1980;41(5):429-36. ">Wilson 1980</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Reported continuous data on a outcome for efficacy of placebo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#MR000050-bbs2-0008" title="Borden, KA.Attributional Outcomes: the Subtle Messages of Treatments for Attention Deficit Disorder. Dissertation, University of Illinois at Urbana-Champaign1986. BordenKA , BrownRT .Attributional outcomes: The subtle messages of treatments for attention deficit disorder. Cognitive Therapy and Research1989;13(2):147-60. ">Borden 1986</a> ; <a href="./references#MR000050-bbs2-0015" title="CarlsonCL , PelhamWE , MilichR , HozaB .ADHD boys’ performance and attributions following success and failure: drug effects and individual differences. Cognitive Therapy and Research1993;17:269-87. ">Carlson 1993</a> ; <a href="./references#MR000050-bbs2-0035" title="KelleyJ .Inclusion of study in Cochrane Systematic Review (personal communication). Email to: A Todorovac 12th of August 2019. KelleyJM , KaptchukTJ , CusinC , LipkinS , FavaM .Open-label placebo for major depressive disorder: a pilot randomized controlled trial. Psychotherapy and Psychosomatics2012;81(5):312-4. ">Kelley 2012</a> ; <a href="./references#MR000050-bbs2-0041" title="KloskoJS , BarlowDH , TassinariR , CernyJA .A comparison of alprazolam and behavior therapy in treatment of panic disorder: correction. Journal of Psychotherapy Practice and Research1994;3(2):163-79. KloskoJS , BarlowDH , TassinariR , CernyJA .A comparison of alprazolam and behavior therapy in treatment of panic disorder. Journal of Consulting and Clinical Psychology1990;58(1):77-84. ">Klosko 1990</a> ; <a href="./references#MR000050-bbs2-0052" title="McLachlanDR , DaltonAJ , KruckTP , BellMY , SmithWL , KalowW , et al.Intramuscular desferrioxamine in patients with Alzheimer's disease. Lancet1991;337(8753):1304-8. McLachlanDRC , SmithWL , KruckTP .Desferrioxamine and Alzheimer’s disease: video home behavior assessment of clinical course and measures of brain aluminum. Therapeutic Drug Monitoring1993;15(6):602-7. ">McLachlan 1991</a> ; <a href="./references#MR000050-bbs2-0057" title="NandiDN , AjmanyS , GanguliH , BanerjeeG , BoralGC , GhoshA , et al.A clinical evaluation of depressives found in a rural survey in India. British Journal of Psychiatry1976;128:523-7. ">Nandi 1976</a> ; <a href="./references#MR000050-bbs2-0061" title="MilichR , CarlsonCL , Pelham WE Jr, LichtBG .Effects of methylphenidate on the persistence of ADHD boys following failure experiences. Journal of Abnormal Child Psychology1991;19(5):519-36. PelhamWE , MurphyDA , VannattaK , MilichR , LichtBG , GnagyEM , et al.Methylphenidate and attributions in boys with attention-deficit hyperactivity disorder. Journal of Consulting and Clinical Psychology1992;60(2):282-92. ">Pelham 1992</a> ; <a href="./references#MR000050-bbs2-0067" title="PowersMB , SmithsJA , WhitleyD , BystritskyA , TelchMJ .The effect of attributional processes concerning medication taking on return of fear. Journal of Consulting and Clinical Psychology2008;76(3):478-90. ">Powers 2008b</a> ; <a href="./references#MR000050-bbs2-0079" title="ShalevAY , AnkriY , Isreali-ShalevY , PelegT , AdesskyR , FreedmanS .Prevention of posttraumatic stress disorder by early treatment. Archives of General Psychiatry2012;69(2):166-76. ">Shalev 2012</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Did not report usable data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#MR000050-bbs2-0013" title="BrillNQ , KoeglerRR , EpsteinLJ , ForgyEW .Controlled study of psychiatric outpatient treatment. Archives of General Psychiatry1964;10:581-95. BrillNQ .Results of psychotherapy. California Medicine1966;104(4):249-53. ">Brill 1964a</a> ; <a href="./references#MR000050-bbs2-0018" title="CrouchG , RobsonM , HallstromC .Benzodiazepine dependent patients and their psychological treatment. Progress in Neuro-psychopharmacology &amp; Biological Psychiatry1988;12(4):503-10. HallströmC , CrouchG , RobsenM , ShineP .The treatment of tranquillizer dependence by propranolol. Postgraduate Medical Journal1988;64(Suppl 2):40-4. ">Crouch 1988</a> ; <a href="./references#MR000050-bbs2-0077" title="LorrM , McNairDM , WeinsteinGJ .Early effects of chlordiazepoxide (Librium) used with psychotherapy. Journal of Psychiatric Research1963;1:257-70. RothI , RhudickPJ , ShaskanDA , SlobinMS , WilkinsonAE , YoungHH .Long-term effects on psychotherapy of initial treatment conditions. Journal of Psychiatric Research1964;2:283-97. ">Roth 1964</a> ; <a href="./references#MR000050-bbs2-0059" title="PearlD , Vander KampH , OlsenAL , GreenbergPD , ArmitageSG .The effects of reserpine on schizophrenic patients. American Journal of Psychiatry1956;112:198-204. ">Pearl 1956</a> ; <a href="./references#MR000050-bbs2-0081" title="SibilioJP , AndrewG , DartD , MooreKB , StehmanA .Treatment of chronic schizophrenia with promazine hydrochloride. AMA Archives of Neurology and Psychiatry1957;78(4):419-24. ">Sibilio 1957</a> ; <a href="./references#MR000050-bbs2-0082" title="SommernessMD , LuceroRJ , HamlonJS , EricksonJL , MatthewsR .A controlled study of reserpine on chronically disturbed patients. JAMA Archives of Neurology and Psychiatry1955;74(3):316-9. ">Sommerness 1955</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Efficacy of physical placebos</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Reported dichotomous data on a outcome for efficacy of placebo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Reported continuous data on a outcome for efficacy of placebo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>16</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#MR000050-bbs2-0002" title="AllenJB .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to A Todorovac 28th of August 2019. AllenJJ , SchnyerRN , HittSK .The efficacy of acupuncture in the treatment of major depression in women. Psychological Science1998;9(5):397-401. ">Allen 1998</a> ; <a href="./references#MR000050-bbs2-0003" title="AllenJB .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 28th of August 2019. AllenJJ , SchnyerRN , ChambersAS , HittSK , MorenoFA , ManberR .Acupuncture for depression: a randomized controlled trial. Journal of Clinical Psychiatry2006;67(11):1665-73. ">Allen 2006</a> ; <a href="./references#MR000050-bbs2-0026" title="FreireAO , SugaiGC , ChrispinFS , TogeiroSM , YamamuraY , MelloLE , et al.Treatment of moderate obstructive sleep apnea syndrome with acupuncture: a randomised, placebo-controlled pilot trial. Sleep Medicine2007;8(1):43-50. ">Freire 2007</a> ; <a href="./references#MR000050-bbs2-0034" title="KarstM , WinterhalterM , MünteS , FranckiB , HondronikosA , EckardtA , et al.Auricular acupuncture for dental anxiety: a randomized controlled trial. Anesthesia and Analgesia2007;104(2):295-300. KarstM .Inclusion of study in Cochrane Systematic Review (personal communication). Email to: EG Faltinsen 5th of September 2019. ">Karst 2007</a> ; <a href="./references#MR000050-bbs2-0043" title="KwanR .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 26th of August 2019. KwanRY , LeungMC , LaiCK .Acupressure for agitation in nursing home residents with dementia: study protocol for a randomized controlled trial. Trials2014;15(410):1-7. KwanRY , LeungMCP , LaiCK .A randomized controlled trial examining the effect of acupressure on agitation and salivary cortisol in nursing home residents with dementia. Dementia and Geriatric Cognitive Disorders2017;44(1-2):92-104. ">Kwan 2017</a> ; <a href="./references#MR000050-bbs2-0044" title="LacyMK .The effect of short term autogenic training on the stress reactivity of hospitalized emotionally disturbed adolescents. ProQuest Dissertations Publishing, Oklahoma State University1996. ">Lacy 1990</a> ; <a href="./references#MR000050-bbs2-0047" title="LegrandF .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 14th of August 2019. LegrandFD , NeffEM .Efficacy of exercise as an adjunct treatment for clinically depressed inpatients during the initial stages of antidepressant pharmacotherapy: an open randomized controlled trial. Journal of Affective Disorders2016;191:139-44. ">Legrand 2016</a> ; <a href="./references#MR000050-bbs2-0049" title="LickJR , HefflerD .Relaxation training and attention placebo in the treatment of severe insomnia. Journal of Consulting and Clinical Psychology1977;45(2):153-61. ">Lick 1977</a> ; <a href="./references#MR000050-bbs2-0056" title="MitchellC , MansfieldD , RautenbachS .Coloured filters and reading accuracy, comprehension and rate: a placebo-controlled study. Perceptual and Motor Skills2008;106(2):517-32. ">Mitchell 2008</a> ; <a href="./references#MR000050-bbs2-0058" title="NicassioP , BootzinR .A comparison of progressive relaxation and autogenic training as treatments for insomnia. Journal of Abnormal Psychology1974;83(3):253-60. ">Nicassio 1974</a> ; <a href="./references#MR000050-bbs2-0063" title="PetersonMA , PattersonB , PillmanBM , BattistaMA .Cognitive recovery following alcohol detoxification: a computerised remediation study. Neuropsychological Rehabilitation2002;12(1):63-74. PillmanBM .Computerized cognitive remediation with recently detoxified alcoholics. Dissertation, California School of Professional Psychology, Fresno Campus2000. ">Pillman 2001</a> ; <a href="./references#MR000050-bbs2-0064" title="PolandRE , GertsikL , FavreauJT , SmithSI , MirochaJM , RaoU , et al.Open-label randomized parallel-group controlled clinical trial of massage for treatment of depression in HIV-infected subjects. Journal of Alternative and Complementary Medicine2013;19(4):334-40. ">Poland 2013</a> ; <a href="./references#MR000050-bbs2-0087" title="ToriC , WorellL .Reduction of human avoidant behavior. A comparison of counterconditioning, expectancy, and cognitive information approaches. Clinical Psychology1973;41(2):269-78. ">Tori 1973</a> ; <a href="./references#MR000050-bbs2-0090" title="VanderplateC .Electromyograph biofeedback Treatment of sleep onset Insomnia: a controlled Investigation. Dissertation, University of Southern Mississippi1978. ">Vanderplate 1983</a> ; <a href="./references#MR000050-bbs2-0092" title="WeingaertnerAH .Self-administered aversive stimulation with hallucinating hospitalized schizophrenics. Journal of Consulting and Clinical Psychology1971;36(3):422-29. ">Weingaertner 1971</a> ; <a href="./references#MR000050-bbs2-0095" title="WolitzkyKB , TelchMJ .Augmenting in vivo exposure with fear antagonistic actions: a preliminary test. Behavior Therapy2009;40(1):57-71. ">Wolitzky 2009</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Did not report usable data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#MR000050-bbs2-0078" title="RupertPA , HolmesDS .Effects of multiple sessions of true and placebo heart rate biofeedback training on the heart rates and anxiety levels of anxious patients during and following treatment. Psychophysiology1978;15(6):582-90. ">Rupert 1978</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Efficacy of Usual care</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Reported dichotomous data on a outcome for efficacy of usual care</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#MR000050-bbs2-0054" title="MilbyJB , ClarkeC , ToroC , ThorntonS , RickertD .Effectiveness of urine surveillance as an adjunct to outpatient psychotherapy for drug abusers. International Journal of the Addictions1980;15(7):993-1001. ">Milby 1980</a> ; <a href="./references#MR000050-bbs2-0073" title="RobinA .Rationing out-patients: a defence of the waiting list. British Journal of Psychiatry1976;129:138-41. ">Robin 1976</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Reported continuous data on a outcome for efficacy of usual care</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#MR000050-bbs2-0017" title="CrispAH , NortonK , GowersS , HalekC , BowyerC , YeldhamD , et al.A controlled study of the effect of therapies aimed at adolescent and family psychopathology in Anorexia Nervosa. British Journal of Psychiatry: the Journal of Mental Science1991;159:325-33. GowersS , NortonK , HalekC , CrispAH .Outcome of outpatient psychotherapy in a random allocation treatment study of anorexia nervosa. International Journal of Eating Disorders1994;15(2):165-77. GowersS , NortonK , YelshamD .The St George's prospective treatment study of anorexia nervosa: a discussion of methodological problems. International Journal of Eating Disorders1989;8:445-54. ">Crisp 1991</a> ; <a href="./references#MR000050-bbs2-0028" title="GlogowskaM , RoulstoneS , EnderbyP , PetersTJ .Randomised controlled trial of community based speech and language therapy in preschool children. BMJ2000;321(7266):923-6. ">Glogowska 2000</a> ; <a href="./references#MR000050-bbs2-0071" title="RapeeR .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 29th of August 2019. RapeeRM , AbbottMJ , LynehamHJ .Bibliotherapy for children With anxiety disorders using written materials for parents: a randomized controlled trial. Journal of Consulting and Clinical Psychology2006;74(3):436-44. ">Rapee 2006</a> ; <a href="./references#MR000050-bbs2-0072" title="RapeeR .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 29th of August 2019. RapeeRM , AbbottMJ , BaillieAJ , GastonJE .Treatment of social phobia through pure self-help and therapist-augmented self-help. British Journal of Psychiatry2007;191:246-52. ">Rapee 2007</a> ; <a href="./references#MR000050-bbs2-0086" title="TeriL , LogsdonRG , UomotoJ , McCurrySM .Behavioral treatment of depression in dementia patients: a controlled clinical trial. Journals of Gerontology. Series B, Psychological Sciences and Social Sciences1997;52(4):159-66. TeriL .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 26th of August 2019. ">Teri 1997</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Did not report usable data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#MR000050-bbs2-0014" title="BrillNQ , KoeglerRR , EpsteinLJ , ForgyEW .Controlled study of psychiatric outpatient treatment. Archives of General Psychiatry1964;10:581-95. ">Brill 1964b</a> ; <a href="./references#MR000050-bbs2-0051" title="MatsonJL , MarchettiA , AdkinsJA .Comparison of operant- and independence-training procedures for mentally retarded adults. American Journal of Mental Deficiency1980;84(5):487-94. ">Matson 1980</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Reported serious adverse events</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>All placebos</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>11</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#MR000050-bbs2-0021" title="EhlersA , HackmannA , GreyN , WildJ , LinessS , AlbertI , et al.A randomized controlled trial of 7-day intensive and standard weekly cognitive therapy for PTSD and emotion-focused supportive therapy. American Journal of Psychiatry2014;171(3):294-304. ">Ehlers 2014</a> ; <a href="./references#MR000050-bbs2-0025" title="FoaEB , McLeanCP , ZangY , RosenfieldD , YadinE , YarvisJS , et al.Effect of prolonged exposure therapy delivered over 2 weeks vs 8 weeks vs present-centered therapy on PTSD symptom severity in military personnel: a randomized clinical trial. JAMA2018;319(4):354-64. ">Foa 2018</a> ; <a href="./references#MR000050-bbs2-0026" title="FreireAO , SugaiGC , ChrispinFS , TogeiroSM , YamamuraY , MelloLE , et al.Treatment of moderate obstructive sleep apnea syndrome with acupuncture: a randomised, placebo-controlled pilot trial. Sleep Medicine2007;8(1):43-50. ">Freire 2007</a> ; <a href="./references#MR000050-bbs2-0034" title="KarstM , WinterhalterM , MünteS , FranckiB , HondronikosA , EckardtA , et al.Auricular acupuncture for dental anxiety: a randomized controlled trial. Anesthesia and Analgesia2007;104(2):295-300. KarstM .Inclusion of study in Cochrane Systematic Review (personal communication). Email to: EG Faltinsen 5th of September 2019. ">Karst 2007</a> ; <a href="./references#MR000050-bbs2-0041" title="KloskoJS , BarlowDH , TassinariR , CernyJA .A comparison of alprazolam and behavior therapy in treatment of panic disorder: correction. Journal of Psychotherapy Practice and Research1994;3(2):163-79. KloskoJS , BarlowDH , TassinariR , CernyJA .A comparison of alprazolam and behavior therapy in treatment of panic disorder. Journal of Consulting and Clinical Psychology1990;58(1):77-84. ">Klosko 1990</a> ; <a href="./references#MR000050-bbs2-0043" title="KwanR .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 26th of August 2019. KwanRY , LeungMC , LaiCK .Acupressure for agitation in nursing home residents with dementia: study protocol for a randomized controlled trial. Trials2014;15(410):1-7. KwanRY , LeungMCP , LaiCK .A randomized controlled trial examining the effect of acupressure on agitation and salivary cortisol in nursing home residents with dementia. Dementia and Geriatric Cognitive Disorders2017;44(1-2):92-104. ">Kwan 2017</a> ; <a href="./references#MR000050-bbs2-0044" title="LacyMK .The effect of short term autogenic training on the stress reactivity of hospitalized emotionally disturbed adolescents. ProQuest Dissertations Publishing, Oklahoma State University1996. ">Lacy 1990</a> ; <a href="./references#MR000050-bbs2-0047" title="LegrandF .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 14th of August 2019. LegrandFD , NeffEM .Efficacy of exercise as an adjunct treatment for clinically depressed inpatients during the initial stages of antidepressant pharmacotherapy: an open randomized controlled trial. Journal of Affective Disorders2016;191:139-44. ">Legrand 2016</a> ; <a href="./references#MR000050-bbs2-0052" title="McLachlanDR , DaltonAJ , KruckTP , BellMY , SmithWL , KalowW , et al.Intramuscular desferrioxamine in patients with Alzheimer's disease. Lancet1991;337(8753):1304-8. McLachlanDRC , SmithWL , KruckTP .Desferrioxamine and Alzheimer’s disease: video home behavior assessment of clinical course and measures of brain aluminum. Therapeutic Drug Monitoring1993;15(6):602-7. ">McLachlan 1991</a> ; <a href="./references#MR000050-bbs2-0057" title="NandiDN , AjmanyS , GanguliH , BanerjeeG , BoralGC , GhoshA , et al.A clinical evaluation of depressives found in a rural survey in India. British Journal of Psychiatry1976;128:523-7. ">Nandi 1976</a> ; <a href="./references#MR000050-bbs2-0094" title="WilsonA , DavidsonWJ , BlanchardR , WhiteJ .Disulfiram implantation. A placebo-controlled trial with two-year follow-up. Journal of Studies on Alcohol1978;39(5):809-19. WilsonA , DavidsonWJ , BlanchardR .Disulfiram implantation: a trial using placebo implants and two types of controls. Journal of Studies on Alcohol1980;41(5):429-36. ">Wilson 1980</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Psychological placebos</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#MR000050-bbs2-0021" title="EhlersA , HackmannA , GreyN , WildJ , LinessS , AlbertI , et al.A randomized controlled trial of 7-day intensive and standard weekly cognitive therapy for PTSD and emotion-focused supportive therapy. American Journal of Psychiatry2014;171(3):294-304. ">Ehlers 2014</a> ; <a href="./references#MR000050-bbs2-0025" title="FoaEB , McLeanCP , ZangY , RosenfieldD , YadinE , YarvisJS , et al.Effect of prolonged exposure therapy delivered over 2 weeks vs 8 weeks vs present-centered therapy on PTSD symptom severity in military personnel: a randomized clinical trial. JAMA2018;319(4):354-64. ">Foa 2018</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Pharmacologica placebos</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#MR000050-bbs2-0041" title="KloskoJS , BarlowDH , TassinariR , CernyJA .A comparison of alprazolam and behavior therapy in treatment of panic disorder: correction. Journal of Psychotherapy Practice and Research1994;3(2):163-79. KloskoJS , BarlowDH , TassinariR , CernyJA .A comparison of alprazolam and behavior therapy in treatment of panic disorder. Journal of Consulting and Clinical Psychology1990;58(1):77-84. ">Klosko 1990</a> ; <a href="./references#MR000050-bbs2-0052" title="McLachlanDR , DaltonAJ , KruckTP , BellMY , SmithWL , KalowW , et al.Intramuscular desferrioxamine in patients with Alzheimer's disease. Lancet1991;337(8753):1304-8. McLachlanDRC , SmithWL , KruckTP .Desferrioxamine and Alzheimer’s disease: video home behavior assessment of clinical course and measures of brain aluminum. Therapeutic Drug Monitoring1993;15(6):602-7. ">McLachlan 1991</a> ; <a href="./references#MR000050-bbs2-0057" title="NandiDN , AjmanyS , GanguliH , BanerjeeG , BoralGC , GhoshA , et al.A clinical evaluation of depressives found in a rural survey in India. British Journal of Psychiatry1976;128:523-7. ">Nandi 1976</a> ; <a href="./references#MR000050-bbs2-0094" title="WilsonA , DavidsonWJ , BlanchardR , WhiteJ .Disulfiram implantation. A placebo-controlled trial with two-year follow-up. Journal of Studies on Alcohol1978;39(5):809-19. WilsonA , DavidsonWJ , BlanchardR .Disulfiram implantation: a trial using placebo implants and two types of controls. Journal of Studies on Alcohol1980;41(5):429-36. ">Wilson 1980</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Physical placebos</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#MR000050-bbs2-0026" title="FreireAO , SugaiGC , ChrispinFS , TogeiroSM , YamamuraY , MelloLE , et al.Treatment of moderate obstructive sleep apnea syndrome with acupuncture: a randomised, placebo-controlled pilot trial. Sleep Medicine2007;8(1):43-50. ">Freire 2007</a> ; <a href="./references#MR000050-bbs2-0034" title="KarstM , WinterhalterM , MünteS , FranckiB , HondronikosA , EckardtA , et al.Auricular acupuncture for dental anxiety: a randomized controlled trial. Anesthesia and Analgesia2007;104(2):295-300. KarstM .Inclusion of study in Cochrane Systematic Review (personal communication). Email to: EG Faltinsen 5th of September 2019. ">Karst 2007</a> ; <a href="./references#MR000050-bbs2-0043" title="KwanR .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 26th of August 2019. KwanRY , LeungMC , LaiCK .Acupressure for agitation in nursing home residents with dementia: study protocol for a randomized controlled trial. Trials2014;15(410):1-7. KwanRY , LeungMCP , LaiCK .A randomized controlled trial examining the effect of acupressure on agitation and salivary cortisol in nursing home residents with dementia. Dementia and Geriatric Cognitive Disorders2017;44(1-2):92-104. ">Kwan 2017</a> ; <a href="./references#MR000050-bbs2-0044" title="LacyMK .The effect of short term autogenic training on the stress reactivity of hospitalized emotionally disturbed adolescents. ProQuest Dissertations Publishing, Oklahoma State University1996. ">Lacy 1990</a> ; <a href="./references#MR000050-bbs2-0047" title="LegrandF .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 14th of August 2019. LegrandFD , NeffEM .Efficacy of exercise as an adjunct treatment for clinically depressed inpatients during the initial stages of antidepressant pharmacotherapy: an open randomized controlled trial. Journal of Affective Disorders2016;191:139-44. ">Legrand 2016</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Usual care</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Reported data on specific mental health diagnoses for all placebos (three or more trials)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Attention Deficit Hyperactivity Disorder (ADHD) or Attention Deficit Disorder (ADD)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#MR000050-bbs2-0001" title="AbikoffH , HechtmanL , KleinRG .Social functioning in children with ADHD treated with long-term methylphenidate and multimodal psychosocial treatment. Journal of the American Academy of Child and Adolescent Psychiatry2004;43(7):820-9. AbikoffH .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to A Todorovac 23rd of August 2019. KleinRG , AbikoffH , HechtmanL , WeissG .Design and rationale of controlled study of long-term methylphenidate and multimodal psychosocial treatment in children with ADHD. Journal of the American Academy of Child and Adolescent Psychiatry2004;43(7):792-801. ">Abikoff 2004</a> ; <a href="./references#MR000050-bbs2-0008" title="Borden, KA.Attributional Outcomes: the Subtle Messages of Treatments for Attention Deficit Disorder. Dissertation, University of Illinois at Urbana-Champaign1986. BordenKA , BrownRT .Attributional outcomes: The subtle messages of treatments for attention deficit disorder. Cognitive Therapy and Research1989;13(2):147-60. ">Borden 1986</a> ; <a href="./references#MR000050-bbs2-0015" title="CarlsonCL , PelhamWE , MilichR , HozaB .ADHD boys’ performance and attributions following success and failure: drug effects and individual differences. Cognitive Therapy and Research1993;17:269-87. ">Carlson 1993</a> ; <a href="./references#MR000050-bbs2-0038" title="KleinSA , DeffenbacherJL .Relaxation and exercise for hyperactive impulsive children. Perceptual and Motor Skills1977;45:1159-62. ">Klein 1977</a> ; <a href="./references#MR000050-bbs2-0061" title="MilichR , CarlsonCL , Pelham WE Jr, LichtBG .Effects of methylphenidate on the persistence of ADHD boys following failure experiences. Journal of Abnormal Child Psychology1991;19(5):519-36. PelhamWE , MurphyDA , VannattaK , MilichR , LichtBG , GnagyEM , et al.Methylphenidate and attributions in boys with attention-deficit hyperactivity disorder. Journal of Consulting and Clinical Psychology1992;60(2):282-92. ">Pelham 1992</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Anxiety disorders of different kind (e.g. specific anxiety, social anxiety, panic disorder) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>16</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#MR000050-bbs2-0023" title="EtringerBD , CashTF , RimmDC .Behavioral, affective, and cognitive effects of participant modeling and an equally credible placebo. Behavior Therapy1982;13(4):476-85. ">Etringer 1982</a> ; <a href="./references#MR000050-bbs2-0029" title="GoldsteinAJ , BeursE , Chambless Dl, WilsonKA .EMDR for panic disorder with agoraphobia: comparison with waiting list and credible attention-placebo control conditions. Journal of Consulting and Clinical Psychology2000;68(6):947-56. ">Goldstein 2000</a> ; <a href="./references#MR000050-bbs2-0034" title="KarstM , WinterhalterM , MünteS , FranckiB , HondronikosA , EckardtA , et al.Auricular acupuncture for dental anxiety: a randomized controlled trial. Anesthesia and Analgesia2007;104(2):295-300. KarstM .Inclusion of study in Cochrane Systematic Review (personal communication). Email to: EG Faltinsen 5th of September 2019. ">Karst 2007</a> ; <a href="./references#MR000050-bbs2-0041" title="KloskoJS , BarlowDH , TassinariR , CernyJA .A comparison of alprazolam and behavior therapy in treatment of panic disorder: correction. Journal of Psychotherapy Practice and Research1994;3(2):163-79. KloskoJS , BarlowDH , TassinariR , CernyJA .A comparison of alprazolam and behavior therapy in treatment of panic disorder. Journal of Consulting and Clinical Psychology1990;58(1):77-84. ">Klosko 1990</a> ; <a href="./references#MR000050-bbs2-0042" title="KrapflJE , NawasMM .Differential ordering of stimulus presentation in systematic desensitization. Journal of Abnormal Psychology1970;75(3):333-7. ">Krapfl 1970</a> ; <a href="./references#MR000050-bbs2-0048" title="LickJ .Expectancy, false galvanic skin response feedback, and systematic desensitization in the modification of phobic behavior. Journal of Consulting and Clinical Psychology1975;43(4):557-67. ">Lick 1975</a> ; <a href="./references#MR000050-bbs2-0055" title="MirandaA , ArlandisP , SorianoM .Instruction in strategies and attributional training: Effects on the problem-solving and self-concept of students’ with learning disabilities [Instrucción en estrategias y entrenamiento atribucional: efectos sobre la resolución de problemas y el autoconcepto de los estudiantes con dificultades en el aprendizaje]. Infancia y Aprendizaje1997;20(80):37-52. ">Miranda 1997</a> ; <a href="./references#MR000050-bbs2-0062" title="PedletonMG , HigginsRL .A comparison of negative practice and systematic desensitization in the treatment of acrophobia. Journal of Behavior Therapy and Experimental Psychiatry1983;14(4):317-23. ">Pendleton 1983</a> ; <a href="./references#MR000050-bbs2-0065" title="PowersMB , SmitsJA , TelchMJ .Disentangling the effects of safety-behavior utilization and safety-behavior availability during exposure-based treatment: a placebo-controlled trial. Journal of Consulting and Clinical Psychology2004;72(3):448-54. ">Powers 2004</a> ; <a href="./references#MR000050-bbs2-0066" title="PowersMB , SmithsJA , WhitleyD , BystritskyA , TelchMJ .The effect of attributional processes concerning medication taking on return of fear. Journal of Consulting and Clinical Psychology2008;76(3):478-90. ">Powers 2008a</a> ; <a href="./references#MR000050-bbs2-0067" title="PowersMB , SmithsJA , WhitleyD , BystritskyA , TelchMJ .The effect of attributional processes concerning medication taking on return of fear. Journal of Consulting and Clinical Psychology2008;76(3):478-90. ">Powers 2008b</a> ; <a href="./references#MR000050-bbs2-0075" title="OlivaresJ .Program IAFS. Protocol for the treatment of social phobia in adolescents [Programa IAFS. Protocolo para el tratamiento de la fobia social enadolescentes]. Madrid: Pirámide2005;1. Rosa-AlcázarAI , Olivares-OlivaresPJ , OlivaresJ .The role of non-specific effects in the psychological treatment of adolescents with social phobia [Papel de los efectos inespecíficos en el tratamiento psicológico de adolescentes con fobia social]. Anuario de Psicologia2009;40(1):43-61. ">Rosa‐Alcatraz 2009</a> ; <a href="./references#MR000050-bbs2-0076" title="RosenGM , GlasgowRE , BarreraM .A controlled study to assess the clinical efficacy of totally self-administrated systematic desensitization. Journal of Consulting and Clinical Psychology1976;44(2):208-17. ">Rosen 1976</a> ; <a href="./references#MR000050-bbs2-0084" title="SzymanskiJ , O'DonohueW .The potential role of state-dependent learning in cognitive therapy with spider phobics. Journal of Rational-Emotive &amp; Cognitive-Behavior Therapy1995;13(2):131-50. SzymanskiJ .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 20th of August 2019. ">Szymanski 1995</a> ; <a href="./references#MR000050-bbs2-0087" title="ToriC , WorellL .Reduction of human avoidant behavior. A comparison of counterconditioning, expectancy, and cognitive information approaches. Clinical Psychology1973;41(2):269-78. ">Tori 1973</a> ; <a href="./references#MR000050-bbs2-0095" title="WolitzkyKB , TelchMJ .Augmenting in vivo exposure with fear antagonistic actions: a preliminary test. Behavior Therapy2009;40(1):57-71. ">Wolitzky 2009</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Depression</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>10</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#MR000050-bbs2-0002" title="AllenJB .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to A Todorovac 28th of August 2019. AllenJJ , SchnyerRN , HittSK .The efficacy of acupuncture in the treatment of major depression in women. Psychological Science1998;9(5):397-401. ">Allen 1998</a> ; <a href="./references#MR000050-bbs2-0003" title="AllenJB .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 28th of August 2019. AllenJJ , SchnyerRN , ChambersAS , HittSK , MorenoFA , ManberR .Acupuncture for depression: a randomized controlled trial. Journal of Clinical Psychiatry2006;67(11):1665-73. ">Allen 2006</a> ; <a href="./references#MR000050-bbs2-0006" title="AyenI , HautzingerM .Cognitive behavior therapy for depression in menopausal women. A controlled, randomized treatment study [Kognitive Verhaltenstherapie bei Depressionen im Klimakterium: Eine kontrollierte, randomiserte Interventionsstudie]. Zeitschrift für Klinische Psychologie und Psychotherapie2004;33(4):290-9. AyenI .Inclusion of study in Cochrane Systematic Review (personal communication). Email to EG Faltinsen 9th of September 2019. ">Ayen 2004</a> ; <a href="./references#MR000050-bbs2-0027" title="FuchsCZ , RehnLP .A self-control behavior therapy program for depression. Journal of Consulting and Clinical Psychology1977;45(2):206-15. ">Fuchs 1977</a> ; <a href="./references#MR000050-bbs2-0035" title="KelleyJ .Inclusion of study in Cochrane Systematic Review (personal communication). Email to: A Todorovac 12th of August 2019. KelleyJM , KaptchukTJ , CusinC , LipkinS , FavaM .Open-label placebo for major depressive disorder: a pilot randomized controlled trial. Psychotherapy and Psychosomatics2012;81(5):312-4. ">Kelley 2012</a> ; <a href="./references#MR000050-bbs2-0047" title="LegrandF .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 14th of August 2019. LegrandFD , NeffEM .Efficacy of exercise as an adjunct treatment for clinically depressed inpatients during the initial stages of antidepressant pharmacotherapy: an open randomized controlled trial. Journal of Affective Disorders2016;191:139-44. ">Legrand 2016</a> ; <a href="./references#MR000050-bbs2-0050" title="LiddleB , SpenceSH .Cognitive-behaviour therapy with depressed primary school children: A cautionary note. Behavioural Psychotherapy1990;18(2):85-102. ">Liddle 1990</a> ; <a href="./references#MR000050-bbs2-0057" title="NandiDN , AjmanyS , GanguliH , BanerjeeG , BoralGC , GhoshA , et al.A clinical evaluation of depressives found in a rural survey in India. British Journal of Psychiatry1976;128:523-7. ">Nandi 1976</a> ; <a href="./references#MR000050-bbs2-0064" title="PolandRE , GertsikL , FavreauJT , SmithSI , MirochaJM , RaoU , et al.Open-label randomized parallel-group controlled clinical trial of massage for treatment of depression in HIV-infected subjects. Journal of Alternative and Complementary Medicine2013;19(4):334-40. ">Poland 2013</a> ; <a href="./references#MR000050-bbs2-0096" title="WollersheimJP , WilsonGL .Group treatment of unipolar depression: a comparison of coping, supportive, bibliotherapy, and delayed treatment groups. Professional Psychology: Research and Practice1991;22(6):496-502. ">Wollersheim 1991</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Neurodegenerative disease</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#MR000050-bbs2-0043" title="KwanR .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 26th of August 2019. KwanRY , LeungMC , LaiCK .Acupressure for agitation in nursing home residents with dementia: study protocol for a randomized controlled trial. Trials2014;15(410):1-7. KwanRY , LeungMCP , LaiCK .A randomized controlled trial examining the effect of acupressure on agitation and salivary cortisol in nursing home residents with dementia. Dementia and Geriatric Cognitive Disorders2017;44(1-2):92-104. ">Kwan 2017</a> ; <a href="./references#MR000050-bbs2-0045" title="LaiCK , ChiI , Kayser-JonesJ .A randomized controlled trial of a specific reminiscence approach to promote the well-being of nursing home residents with dementia. International Psychogeriatrics2004;16(1):33-49. LaiK .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 6th of September 2019. ">Lai 2004</a> ; <a href="./references#MR000050-bbs2-0056" title="MitchellC , MansfieldD , RautenbachS .Coloured filters and reading accuracy, comprehension and rate: a placebo-controlled study. Perceptual and Motor Skills2008;106(2):517-32. ">Mitchell 2008</a> ; <a href="./references#MR000050-bbs2-0069" title="QuayhagenMP , QuayhagenM , CorbeilRR , RothPA , RodgersJA .A dyadic remediation program for care recipients with dementia. Nursing Research1995;44(3):153-9. ">Quayhagen 1995</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Post‐Traumatic Stress‐Disorder (PTSD)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#MR000050-bbs2-0021" title="EhlersA , HackmannA , GreyN , WildJ , LinessS , AlbertI , et al.A randomized controlled trial of 7-day intensive and standard weekly cognitive therapy for PTSD and emotion-focused supportive therapy. American Journal of Psychiatry2014;171(3):294-304. ">Ehlers 2014</a> ; <a href="./references#MR000050-bbs2-0024" title="FoaEB , RothbaumBO , RiggsDS , MurdockTB .Treatment of posttraumatic stress disorder in rape victims: a comparison between cognitive-behavioral procedures and counselling. Journal of Consulting and Clinical Psychology1991;59(5):715-23. ">Foa 1991</a> ; <a href="./references#MR000050-bbs2-0025" title="FoaEB , McLeanCP , ZangY , RosenfieldD , YadinE , YarvisJS , et al.Effect of prolonged exposure therapy delivered over 2 weeks vs 8 weeks vs present-centered therapy on PTSD symptom severity in military personnel: a randomized clinical trial. JAMA2018;319(4):354-64. ">Foa 2018</a> ; <a href="./references#MR000050-bbs2-0079" title="ShalevAY , AnkriY , Isreali-ShalevY , PelegT , AdesskyR , FreedmanS .Prevention of posttraumatic stress disorder by early treatment. Archives of General Psychiatry2012;69(2):166-76. ">Shalev 2012</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Sleep‐wake disorders (e.g. insomnia, sleep disturbance)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>11</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#MR000050-bbs2-0005" title="AscherLM , TurnerR .Paradoxical intention and insomnia: an experimental investigation. Behaviour Research and Therapy1979;17(4):408-11. ">Ascher 1979</a> ; <a href="./references#MR000050-bbs2-0009" title="BorkovecTD , KaloupekDG , SlamaKM .The facilitative effect of muscle tension-release in the relaxation treatment of sleep disturbance. Behavior Therapy1975;6(3):301-9. ">Borkovec 1975</a> ; <a href="./references#MR000050-bbs2-0010" title="BorkovecTD , WeertsTC .Effects of progressive relaxation on sleep disturbance: an electroencephalographic evaluation. Psychosomatic Medicine1976;38(3):173-80. ">Borkovec 1976</a> ; <a href="./references#MR000050-bbs2-0022" title="EspieCA , BrooksDN , LindsayWR .An evaluation of tailored psychological treatment of insomnia. Journal of Behavior Therapy and Experimental Psychiatry1989;20(2):143-53. EspieCA , LindsayWR , BrooksDN , HoodEM , TurveyT .A controlled comparative investigation of psychological treatments for chronic sleep-onset insomnia. Behaviour Research and Therapy1989;27(1):79-88. ">Espie 1989a</a> ; <a href="./references#MR000050-bbs2-0026" title="FreireAO , SugaiGC , ChrispinFS , TogeiroSM , YamamuraY , MelloLE , et al.Treatment of moderate obstructive sleep apnea syndrome with acupuncture: a randomised, placebo-controlled pilot trial. Sleep Medicine2007;8(1):43-50. ">Freire 2007</a> ; <a href="./references#MR000050-bbs2-0049" title="LickJR , HefflerD .Relaxation training and attention placebo in the treatment of severe insomnia. Journal of Consulting and Clinical Psychology1977;45(2):153-61. ">Lick 1977</a> ; <a href="./references#MR000050-bbs2-0058" title="NicassioP , BootzinR .A comparison of progressive relaxation and autogenic training as treatments for insomnia. Journal of Abnormal Psychology1974;83(3):253-60. ">Nicassio 1974</a> ; <a href="./references#MR000050-bbs2-0080" title="ShealyRC .The effectiveness of various treatment techniques on different degrees and durations of sleep-onset insomnia. Behaviour Research and Therapy1979;17(6):541-6. ">Shealy 1979</a> ; <a href="./references#MR000050-bbs2-0083" title="SteinmarkSW , BorkovecTD .Active and placebo treatment effects on moderate insomnia under counterdemand and positive demand instructions. Journal of Abnormal Psychology1974;83(2):157-63. ">Steinmark 1974</a> ; <a href="./references#MR000050-bbs2-0089" title="AscherML , TurnerRM .A comparison of two methods for the administration of paradoxical intention. Behaviour Research and Therapy1980;18(2):121-6. TurnerRM , AscherLM .Controlled comparison of progressive relaxation, stimulus control, and paradoxical intention therapies for insomnia. Journal of Consulting and Clinical Psychology1979;47(3):500-8. ">Turner 1979</a> ; <a href="./references#MR000050-bbs2-0090" title="VanderplateC .Electromyograph biofeedback Treatment of sleep onset Insomnia: a controlled Investigation. Dissertation, University of Southern Mississippi1978. ">Vanderplate 1983</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Substance use disorders of different kind (e.g. alcohol, cocaine)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#MR000050-bbs2-0004" title="AlvarezJR .The effects of anger management training on depression, anger, self-concept, and treatment responsibility in a sample of drug-dependent individuals in a therapeutic community. Dissertation Abstracts International: Section B: the Sciences and Engineering1997;58(4-B):2108. ">Alvarez 1997</a> ; <a href="./references#MR000050-bbs2-0011" title="BornovalovaM .Inclusion of study in Cochrane Systematic Review (personal communication). Email to A Todorovac. 21st of August 2019. BornovalovaMA .Distress tolerance treatment for inner-city drug users: a preliminary trial. Doctor’s Dissertation, University of Maryland2008. ">Bornovalova 2008</a> ; <a href="./references#MR000050-bbs2-0063" title="PetersonMA , PattersonB , PillmanBM , BattistaMA .Cognitive recovery following alcohol detoxification: a computerised remediation study. Neuropsychological Rehabilitation2002;12(1):63-74. PillmanBM .Computerized cognitive remediation with recently detoxified alcoholics. Dissertation, California School of Professional Psychology, Fresno Campus2000. ">Pillman 2001</a> ; <a href="./references#MR000050-bbs2-0074" title="RoehrichL , GoldmanMS .Experience-dependent neuropsychological recovery and the treatment of alcoholism. Journal of Consulting and Clinical Psychology1993;61(5):812-21. ">Roehrich 1993</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Reported data on specific mental health diagnoses for psychological placebos (three or more trials)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Anxiety disorders of different kind (e.g. specific anxiety, social anxiety, panic disorder) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>11</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#MR000050-bbs2-0023" title="EtringerBD , CashTF , RimmDC .Behavioral, affective, and cognitive effects of participant modeling and an equally credible placebo. Behavior Therapy1982;13(4):476-85. ">Etringer 1982</a> ; <a href="./references#MR000050-bbs2-0029" title="GoldsteinAJ , BeursE , Chambless Dl, WilsonKA .EMDR for panic disorder with agoraphobia: comparison with waiting list and credible attention-placebo control conditions. Journal of Consulting and Clinical Psychology2000;68(6):947-56. ">Goldstein 2000</a> ; <a href="./references#MR000050-bbs2-0042" title="KrapflJE , NawasMM .Differential ordering of stimulus presentation in systematic desensitization. Journal of Abnormal Psychology1970;75(3):333-7. ">Krapfl 1970</a> ; <a href="./references#MR000050-bbs2-0048" title="LickJ .Expectancy, false galvanic skin response feedback, and systematic desensitization in the modification of phobic behavior. Journal of Consulting and Clinical Psychology1975;43(4):557-67. ">Lick 1975</a> ; <a href="./references#MR000050-bbs2-0055" title="MirandaA , ArlandisP , SorianoM .Instruction in strategies and attributional training: Effects on the problem-solving and self-concept of students’ with learning disabilities [Instrucción en estrategias y entrenamiento atribucional: efectos sobre la resolución de problemas y el autoconcepto de los estudiantes con dificultades en el aprendizaje]. Infancia y Aprendizaje1997;20(80):37-52. ">Miranda 1997</a> ; <a href="./references#MR000050-bbs2-0062" title="PedletonMG , HigginsRL .A comparison of negative practice and systematic desensitization in the treatment of acrophobia. Journal of Behavior Therapy and Experimental Psychiatry1983;14(4):317-23. ">Pendleton 1983</a> ; <a href="./references#MR000050-bbs2-0065" title="PowersMB , SmitsJA , TelchMJ .Disentangling the effects of safety-behavior utilization and safety-behavior availability during exposure-based treatment: a placebo-controlled trial. Journal of Consulting and Clinical Psychology2004;72(3):448-54. ">Powers 2004</a> ; <a href="./references#MR000050-bbs2-0066" title="PowersMB , SmithsJA , WhitleyD , BystritskyA , TelchMJ .The effect of attributional processes concerning medication taking on return of fear. Journal of Consulting and Clinical Psychology2008;76(3):478-90. ">Powers 2008a</a> ; <a href="./references#MR000050-bbs2-0075" title="OlivaresJ .Program IAFS. Protocol for the treatment of social phobia in adolescents [Programa IAFS. Protocolo para el tratamiento de la fobia social enadolescentes]. Madrid: Pirámide2005;1. Rosa-AlcázarAI , Olivares-OlivaresPJ , OlivaresJ .The role of non-specific effects in the psychological treatment of adolescents with social phobia [Papel de los efectos inespecíficos en el tratamiento psicológico de adolescentes con fobia social]. Anuario de Psicologia2009;40(1):43-61. ">Rosa‐Alcatraz 2009</a> ; <a href="./references#MR000050-bbs2-0076" title="RosenGM , GlasgowRE , BarreraM .A controlled study to assess the clinical efficacy of totally self-administrated systematic desensitization. Journal of Consulting and Clinical Psychology1976;44(2):208-17. ">Rosen 1976</a> ; <a href="./references#MR000050-bbs2-0084" title="SzymanskiJ , O'DonohueW .The potential role of state-dependent learning in cognitive therapy with spider phobics. Journal of Rational-Emotive &amp; Cognitive-Behavior Therapy1995;13(2):131-50. SzymanskiJ .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 20th of August 2019. ">Szymanski 1995</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Depression</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#MR000050-bbs2-0006" title="AyenI , HautzingerM .Cognitive behavior therapy for depression in menopausal women. A controlled, randomized treatment study [Kognitive Verhaltenstherapie bei Depressionen im Klimakterium: Eine kontrollierte, randomiserte Interventionsstudie]. Zeitschrift für Klinische Psychologie und Psychotherapie2004;33(4):290-9. AyenI .Inclusion of study in Cochrane Systematic Review (personal communication). Email to EG Faltinsen 9th of September 2019. ">Ayen 2004</a> ; <a href="./references#MR000050-bbs2-0027" title="FuchsCZ , RehnLP .A self-control behavior therapy program for depression. Journal of Consulting and Clinical Psychology1977;45(2):206-15. ">Fuchs 1977</a> ; <a href="./references#MR000050-bbs2-0050" title="LiddleB , SpenceSH .Cognitive-behaviour therapy with depressed primary school children: A cautionary note. Behavioural Psychotherapy1990;18(2):85-102. ">Liddle 1990</a> ; <a href="./references#MR000050-bbs2-0096" title="WollersheimJP , WilsonGL .Group treatment of unipolar depression: a comparison of coping, supportive, bibliotherapy, and delayed treatment groups. Professional Psychology: Research and Practice1991;22(6):496-502. ">Wollersheim 1991</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Post‐Traumatic Stress‐Disorder (PTSD)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#MR000050-bbs2-0021" title="EhlersA , HackmannA , GreyN , WildJ , LinessS , AlbertI , et al.A randomized controlled trial of 7-day intensive and standard weekly cognitive therapy for PTSD and emotion-focused supportive therapy. American Journal of Psychiatry2014;171(3):294-304. ">Ehlers 2014</a> ; <a href="./references#MR000050-bbs2-0024" title="FoaEB , RothbaumBO , RiggsDS , MurdockTB .Treatment of posttraumatic stress disorder in rape victims: a comparison between cognitive-behavioral procedures and counselling. Journal of Consulting and Clinical Psychology1991;59(5):715-23. ">Foa 1991</a> ; <a href="./references#MR000050-bbs2-0025" title="FoaEB , McLeanCP , ZangY , RosenfieldD , YadinE , YarvisJS , et al.Effect of prolonged exposure therapy delivered over 2 weeks vs 8 weeks vs present-centered therapy on PTSD symptom severity in military personnel: a randomized clinical trial. JAMA2018;319(4):354-64. ">Foa 2018</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Sleep‐wake disorders (e.g. insomnia, sleep disturbance)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#MR000050-bbs2-0005" title="AscherLM , TurnerR .Paradoxical intention and insomnia: an experimental investigation. Behaviour Research and Therapy1979;17(4):408-11. ">Ascher 1979</a> ; <a href="./references#MR000050-bbs2-0009" title="BorkovecTD , KaloupekDG , SlamaKM .The facilitative effect of muscle tension-release in the relaxation treatment of sleep disturbance. Behavior Therapy1975;6(3):301-9. ">Borkovec 1975</a> ; <a href="./references#MR000050-bbs2-0010" title="BorkovecTD , WeertsTC .Effects of progressive relaxation on sleep disturbance: an electroencephalographic evaluation. Psychosomatic Medicine1976;38(3):173-80. ">Borkovec 1976</a> ; <a href="./references#MR000050-bbs2-0022" title="EspieCA , BrooksDN , LindsayWR .An evaluation of tailored psychological treatment of insomnia. Journal of Behavior Therapy and Experimental Psychiatry1989;20(2):143-53. EspieCA , LindsayWR , BrooksDN , HoodEM , TurveyT .A controlled comparative investigation of psychological treatments for chronic sleep-onset insomnia. Behaviour Research and Therapy1989;27(1):79-88. ">Espie 1989a</a> ; <a href="./references#MR000050-bbs2-0080" title="ShealyRC .The effectiveness of various treatment techniques on different degrees and durations of sleep-onset insomnia. Behaviour Research and Therapy1979;17(6):541-6. ">Shealy 1979</a> ; <a href="./references#MR000050-bbs2-0083" title="SteinmarkSW , BorkovecTD .Active and placebo treatment effects on moderate insomnia under counterdemand and positive demand instructions. Journal of Abnormal Psychology1974;83(2):157-63. ">Steinmark 1974</a> ; <a href="./references#MR000050-bbs2-0089" title="AscherML , TurnerRM .A comparison of two methods for the administration of paradoxical intention. Behaviour Research and Therapy1980;18(2):121-6. TurnerRM , AscherLM .Controlled comparison of progressive relaxation, stimulus control, and paradoxical intention therapies for insomnia. Journal of Consulting and Clinical Psychology1979;47(3):500-8. ">Turner 1979</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Substance use disorders of different kind (e.g. alcohol, cocaine)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#MR000050-bbs2-0004" title="AlvarezJR .The effects of anger management training on depression, anger, self-concept, and treatment responsibility in a sample of drug-dependent individuals in a therapeutic community. Dissertation Abstracts International: Section B: the Sciences and Engineering1997;58(4-B):2108. ">Alvarez 1997</a> ; <a href="./references#MR000050-bbs2-0011" title="BornovalovaM .Inclusion of study in Cochrane Systematic Review (personal communication). Email to A Todorovac. 21st of August 2019. BornovalovaMA .Distress tolerance treatment for inner-city drug users: a preliminary trial. Doctor’s Dissertation, University of Maryland2008. ">Bornovalova 2008</a> ; <a href="./references#MR000050-bbs2-0074" title="RoehrichL , GoldmanMS .Experience-dependent neuropsychological recovery and the treatment of alcoholism. Journal of Consulting and Clinical Psychology1993;61(5):812-21. ">Roehrich 1993</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Reported data on specific mental health diagnoses for pharmacological placebos (three or more trials)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Attention Deficit Hyperactivity Disorder (ADHD) or Attention Deficit Disorder (ADD)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#MR000050-bbs2-0008" title="Borden, KA.Attributional Outcomes: the Subtle Messages of Treatments for Attention Deficit Disorder. Dissertation, University of Illinois at Urbana-Champaign1986. BordenKA , BrownRT .Attributional outcomes: The subtle messages of treatments for attention deficit disorder. Cognitive Therapy and Research1989;13(2):147-60. ">Borden 1986</a> ; <a href="./references#MR000050-bbs2-0015" title="CarlsonCL , PelhamWE , MilichR , HozaB .ADHD boys’ performance and attributions following success and failure: drug effects and individual differences. Cognitive Therapy and Research1993;17:269-87. ">Carlson 1993</a> ; <a href="./references#MR000050-bbs2-0061" title="MilichR , CarlsonCL , Pelham WE Jr, LichtBG .Effects of methylphenidate on the persistence of ADHD boys following failure experiences. Journal of Abnormal Child Psychology1991;19(5):519-36. PelhamWE , MurphyDA , VannattaK , MilichR , LichtBG , GnagyEM , et al.Methylphenidate and attributions in boys with attention-deficit hyperactivity disorder. Journal of Consulting and Clinical Psychology1992;60(2):282-92. ">Pelham 1992</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Reported data on specific mental health diagnoses for physical placebos (three or more trials)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Anxiety disorders of different kind (e.g. specific anxiety, social anxiety, panic disorder) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#MR000050-bbs2-0034" title="KarstM , WinterhalterM , MünteS , FranckiB , HondronikosA , EckardtA , et al.Auricular acupuncture for dental anxiety: a randomized controlled trial. Anesthesia and Analgesia2007;104(2):295-300. KarstM .Inclusion of study in Cochrane Systematic Review (personal communication). Email to: EG Faltinsen 5th of September 2019. ">Karst 2007</a> ; <a href="./references#MR000050-bbs2-0087" title="ToriC , WorellL .Reduction of human avoidant behavior. A comparison of counterconditioning, expectancy, and cognitive information approaches. Clinical Psychology1973;41(2):269-78. ">Tori 1973</a> ; <a href="./references#MR000050-bbs2-0095" title="WolitzkyKB , TelchMJ .Augmenting in vivo exposure with fear antagonistic actions: a preliminary test. Behavior Therapy2009;40(1):57-71. ">Wolitzky 2009</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Depression</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#MR000050-bbs2-0002" title="AllenJB .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to A Todorovac 28th of August 2019. AllenJJ , SchnyerRN , HittSK .The efficacy of acupuncture in the treatment of major depression in women. Psychological Science1998;9(5):397-401. ">Allen 1998</a> ; <a href="./references#MR000050-bbs2-0003" title="AllenJB .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 28th of August 2019. AllenJJ , SchnyerRN , ChambersAS , HittSK , MorenoFA , ManberR .Acupuncture for depression: a randomized controlled trial. Journal of Clinical Psychiatry2006;67(11):1665-73. ">Allen 2006</a> ; <a href="./references#MR000050-bbs2-0047" title="LegrandF .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 14th of August 2019. LegrandFD , NeffEM .Efficacy of exercise as an adjunct treatment for clinically depressed inpatients during the initial stages of antidepressant pharmacotherapy: an open randomized controlled trial. Journal of Affective Disorders2016;191:139-44. ">Legrand 2016</a> ; <a href="./references#MR000050-bbs2-0064" title="PolandRE , GertsikL , FavreauJT , SmithSI , MirochaJM , RaoU , et al.Open-label randomized parallel-group controlled clinical trial of massage for treatment of depression in HIV-infected subjects. Journal of Alternative and Complementary Medicine2013;19(4):334-40. ">Poland 2013</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Sleep‐wake disorders (e.g. insomnia, sleep disturbance)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#MR000050-bbs2-0026" title="FreireAO , SugaiGC , ChrispinFS , TogeiroSM , YamamuraY , MelloLE , et al.Treatment of moderate obstructive sleep apnea syndrome with acupuncture: a randomised, placebo-controlled pilot trial. Sleep Medicine2007;8(1):43-50. ">Freire 2007</a> ; <a href="./references#MR000050-bbs2-0049" title="LickJR , HefflerD .Relaxation training and attention placebo in the treatment of severe insomnia. Journal of Consulting and Clinical Psychology1977;45(2):153-61. ">Lick 1977</a> ; <a href="./references#MR000050-bbs2-0058" title="NicassioP , BootzinR .A comparison of progressive relaxation and autogenic training as treatments for insomnia. Journal of Abnormal Psychology1974;83(3):253-60. ">Nicassio 1974</a> ; <a href="./references#MR000050-bbs2-0090" title="VanderplateC .Electromyograph biofeedback Treatment of sleep onset Insomnia: a controlled Investigation. Dissertation, University of Southern Mississippi1978. ">Vanderplate 1983</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Reported non‐serious adverse events</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>All placebos</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>14</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#MR000050-bbs2-0006" title="AyenI , HautzingerM .Cognitive behavior therapy for depression in menopausal women. A controlled, randomized treatment study [Kognitive Verhaltenstherapie bei Depressionen im Klimakterium: Eine kontrollierte, randomiserte Interventionsstudie]. Zeitschrift für Klinische Psychologie und Psychotherapie2004;33(4):290-9. AyenI .Inclusion of study in Cochrane Systematic Review (personal communication). Email to EG Faltinsen 9th of September 2019. ">Ayen 2004</a> ; <a href="./references#MR000050-bbs2-0021" title="EhlersA , HackmannA , GreyN , WildJ , LinessS , AlbertI , et al.A randomized controlled trial of 7-day intensive and standard weekly cognitive therapy for PTSD and emotion-focused supportive therapy. American Journal of Psychiatry2014;171(3):294-304. ">Ehlers 2014</a> ; <a href="./references#MR000050-bbs2-0025" title="FoaEB , McLeanCP , ZangY , RosenfieldD , YadinE , YarvisJS , et al.Effect of prolonged exposure therapy delivered over 2 weeks vs 8 weeks vs present-centered therapy on PTSD symptom severity in military personnel: a randomized clinical trial. JAMA2018;319(4):354-64. ">Foa 2018</a> ; <a href="./references#MR000050-bbs2-0026" title="FreireAO , SugaiGC , ChrispinFS , TogeiroSM , YamamuraY , MelloLE , et al.Treatment of moderate obstructive sleep apnea syndrome with acupuncture: a randomised, placebo-controlled pilot trial. Sleep Medicine2007;8(1):43-50. ">Freire 2007</a> ; <a href="./references#MR000050-bbs2-0029" title="GoldsteinAJ , BeursE , Chambless Dl, WilsonKA .EMDR for panic disorder with agoraphobia: comparison with waiting list and credible attention-placebo control conditions. Journal of Consulting and Clinical Psychology2000;68(6):947-56. ">Goldstein 2000</a> ; <a href="./references#MR000050-bbs2-0034" title="KarstM , WinterhalterM , MünteS , FranckiB , HondronikosA , EckardtA , et al.Auricular acupuncture for dental anxiety: a randomized controlled trial. Anesthesia and Analgesia2007;104(2):295-300. KarstM .Inclusion of study in Cochrane Systematic Review (personal communication). Email to: EG Faltinsen 5th of September 2019. ">Karst 2007</a> ; <a href="./references#MR000050-bbs2-0041" title="KloskoJS , BarlowDH , TassinariR , CernyJA .A comparison of alprazolam and behavior therapy in treatment of panic disorder: correction. Journal of Psychotherapy Practice and Research1994;3(2):163-79. KloskoJS , BarlowDH , TassinariR , CernyJA .A comparison of alprazolam and behavior therapy in treatment of panic disorder. Journal of Consulting and Clinical Psychology1990;58(1):77-84. ">Klosko 1990</a> ; <a href="./references#MR000050-bbs2-0043" title="KwanR .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 26th of August 2019. KwanRY , LeungMC , LaiCK .Acupressure for agitation in nursing home residents with dementia: study protocol for a randomized controlled trial. Trials2014;15(410):1-7. KwanRY , LeungMCP , LaiCK .A randomized controlled trial examining the effect of acupressure on agitation and salivary cortisol in nursing home residents with dementia. Dementia and Geriatric Cognitive Disorders2017;44(1-2):92-104. ">Kwan 2017</a> ; <a href="./references#MR000050-bbs2-0044" title="LacyMK .The effect of short term autogenic training on the stress reactivity of hospitalized emotionally disturbed adolescents. ProQuest Dissertations Publishing, Oklahoma State University1996. ">Lacy 1990</a> ; <a href="./references#MR000050-bbs2-0047" title="LegrandF .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 14th of August 2019. LegrandFD , NeffEM .Efficacy of exercise as an adjunct treatment for clinically depressed inpatients during the initial stages of antidepressant pharmacotherapy: an open randomized controlled trial. Journal of Affective Disorders2016;191:139-44. ">Legrand 2016</a> ; <a href="./references#MR000050-bbs2-0052" title="McLachlanDR , DaltonAJ , KruckTP , BellMY , SmithWL , KalowW , et al.Intramuscular desferrioxamine in patients with Alzheimer's disease. Lancet1991;337(8753):1304-8. McLachlanDRC , SmithWL , KruckTP .Desferrioxamine and Alzheimer’s disease: video home behavior assessment of clinical course and measures of brain aluminum. Therapeutic Drug Monitoring1993;15(6):602-7. ">McLachlan 1991</a> ; <a href="./references#MR000050-bbs2-0057" title="NandiDN , AjmanyS , GanguliH , BanerjeeG , BoralGC , GhoshA , et al.A clinical evaluation of depressives found in a rural survey in India. British Journal of Psychiatry1976;128:523-7. ">Nandi 1976</a> ; <a href="./references#MR000050-bbs2-0094" title="WilsonA , DavidsonWJ , BlanchardR , WhiteJ .Disulfiram implantation. A placebo-controlled trial with two-year follow-up. Journal of Studies on Alcohol1978;39(5):809-19. WilsonA , DavidsonWJ , BlanchardR .Disulfiram implantation: a trial using placebo implants and two types of controls. Journal of Studies on Alcohol1980;41(5):429-36. ">Wilson 1980</a> ; <a href="./references#MR000050-bbs2-0096" title="WollersheimJP , WilsonGL .Group treatment of unipolar depression: a comparison of coping, supportive, bibliotherapy, and delayed treatment groups. Professional Psychology: Research and Practice1991;22(6):496-502. ">Wollersheim 1991</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Psychological placebos</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#MR000050-bbs2-0006" title="AyenI , HautzingerM .Cognitive behavior therapy for depression in menopausal women. A controlled, randomized treatment study [Kognitive Verhaltenstherapie bei Depressionen im Klimakterium: Eine kontrollierte, randomiserte Interventionsstudie]. Zeitschrift für Klinische Psychologie und Psychotherapie2004;33(4):290-9. AyenI .Inclusion of study in Cochrane Systematic Review (personal communication). Email to EG Faltinsen 9th of September 2019. ">Ayen 2004</a> ; <a href="./references#MR000050-bbs2-0021" title="EhlersA , HackmannA , GreyN , WildJ , LinessS , AlbertI , et al.A randomized controlled trial of 7-day intensive and standard weekly cognitive therapy for PTSD and emotion-focused supportive therapy. American Journal of Psychiatry2014;171(3):294-304. ">Ehlers 2014</a> ; <a href="./references#MR000050-bbs2-0025" title="FoaEB , McLeanCP , ZangY , RosenfieldD , YadinE , YarvisJS , et al.Effect of prolonged exposure therapy delivered over 2 weeks vs 8 weeks vs present-centered therapy on PTSD symptom severity in military personnel: a randomized clinical trial. JAMA2018;319(4):354-64. ">Foa 2018</a> ; <a href="./references#MR000050-bbs2-0029" title="GoldsteinAJ , BeursE , Chambless Dl, WilsonKA .EMDR for panic disorder with agoraphobia: comparison with waiting list and credible attention-placebo control conditions. Journal of Consulting and Clinical Psychology2000;68(6):947-56. ">Goldstein 2000</a> ; <a href="./references#MR000050-bbs2-0096" title="WollersheimJP , WilsonGL .Group treatment of unipolar depression: a comparison of coping, supportive, bibliotherapy, and delayed treatment groups. Professional Psychology: Research and Practice1991;22(6):496-502. ">Wollersheim 1991</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Pharmacologica placebos</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#MR000050-bbs2-0041" title="KloskoJS , BarlowDH , TassinariR , CernyJA .A comparison of alprazolam and behavior therapy in treatment of panic disorder: correction. Journal of Psychotherapy Practice and Research1994;3(2):163-79. KloskoJS , BarlowDH , TassinariR , CernyJA .A comparison of alprazolam and behavior therapy in treatment of panic disorder. Journal of Consulting and Clinical Psychology1990;58(1):77-84. ">Klosko 1990</a> ; <a href="./references#MR000050-bbs2-0052" title="McLachlanDR , DaltonAJ , KruckTP , BellMY , SmithWL , KalowW , et al.Intramuscular desferrioxamine in patients with Alzheimer's disease. Lancet1991;337(8753):1304-8. McLachlanDRC , SmithWL , KruckTP .Desferrioxamine and Alzheimer’s disease: video home behavior assessment of clinical course and measures of brain aluminum. Therapeutic Drug Monitoring1993;15(6):602-7. ">McLachlan 1991</a> ; <a href="./references#MR000050-bbs2-0057" title="NandiDN , AjmanyS , GanguliH , BanerjeeG , BoralGC , GhoshA , et al.A clinical evaluation of depressives found in a rural survey in India. British Journal of Psychiatry1976;128:523-7. ">Nandi 1976</a> ; <a href="./references#MR000050-bbs2-0094" title="WilsonA , DavidsonWJ , BlanchardR , WhiteJ .Disulfiram implantation. A placebo-controlled trial with two-year follow-up. Journal of Studies on Alcohol1978;39(5):809-19. WilsonA , DavidsonWJ , BlanchardR .Disulfiram implantation: a trial using placebo implants and two types of controls. Journal of Studies on Alcohol1980;41(5):429-36. ">Wilson 1980</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Physical placebos</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#MR000050-bbs2-0026" title="FreireAO , SugaiGC , ChrispinFS , TogeiroSM , YamamuraY , MelloLE , et al.Treatment of moderate obstructive sleep apnea syndrome with acupuncture: a randomised, placebo-controlled pilot trial. Sleep Medicine2007;8(1):43-50. ">Freire 2007</a> ; <a href="./references#MR000050-bbs2-0034" title="KarstM , WinterhalterM , MünteS , FranckiB , HondronikosA , EckardtA , et al.Auricular acupuncture for dental anxiety: a randomized controlled trial. Anesthesia and Analgesia2007;104(2):295-300. KarstM .Inclusion of study in Cochrane Systematic Review (personal communication). Email to: EG Faltinsen 5th of September 2019. ">Karst 2007</a> ; <a href="./references#MR000050-bbs2-0043" title="KwanR .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 26th of August 2019. KwanRY , LeungMC , LaiCK .Acupressure for agitation in nursing home residents with dementia: study protocol for a randomized controlled trial. Trials2014;15(410):1-7. KwanRY , LeungMCP , LaiCK .A randomized controlled trial examining the effect of acupressure on agitation and salivary cortisol in nursing home residents with dementia. Dementia and Geriatric Cognitive Disorders2017;44(1-2):92-104. ">Kwan 2017</a> ; <a href="./references#MR000050-bbs2-0044" title="LacyMK .The effect of short term autogenic training on the stress reactivity of hospitalized emotionally disturbed adolescents. ProQuest Dissertations Publishing, Oklahoma State University1996. ">Lacy 1990</a> ; <a href="./references#MR000050-bbs2-0047" title="LegrandF .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 14th of August 2019. LegrandFD , NeffEM .Efficacy of exercise as an adjunct treatment for clinically depressed inpatients during the initial stages of antidepressant pharmacotherapy: an open randomized controlled trial. Journal of Affective Disorders2016;191:139-44. ">Legrand 2016</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Usual care</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> </tbody> </table> </div> <p><b>Usual care versus wait‐list or no‐treatment (continuous data)</b> </p> <p>No differences were found for beneficial effects comparing usual care versus wait‐list or no‐treatment when using a random‐effects model (standardised mean difference (SMD) −0.33, 95% confidence interval (CI) −0.83 to 0.16; 5 trials, 523 participants; P = 0.13; I <sup>2</sup> = 86% ; very low‐quality evidence; <a href="./references#MR000050-fig-0008" title="">Analysis 2.1</a>). No differences were found between the subgroups: usual care versus wait‐list (SMD −0.53, 95% CI −1.17 to 0.10; 3 trials, 443 participants; P = 0.10; I <sup>2</sup> = 91%), and usual care versus no‐treatment (SMD 0.08, 95% CI −0.38 to 0.53; 2 trials, 80 participants; P = 0.74; I <sup>2</sup> = 0%). Test for subgroup difference: Chi <sup>2</sup> = 2.33, df = 1, P = 0.13, I <sup>2</sup> = 57.1%. </p> <p>When using a fixed‐effect model, usual care had a beneficial effect compared with wait‐list or no‐treatment (SMD −0.45, 95% CI −0.62 to −0.27; 5 trials, 523 participants; P = 0.01; I <sup>2</sup> = 83.3%; <a href="./references#MR000050-fig-0128" title="">Analysis 25.1</a>), and there were differences between the subgroups: usual care versus wait‐list (SMD −0.54, 95% CI −0.73 to −0.35; 3 trials, 443 participants; P &lt; 0.00001; I <sup>2</sup> = 91%) and usual care versus no‐treatment (SMD 0.08, 95% CI −0.38 to 0.53; 2 trials, 80 participants; P = 0.74; I <sup>2</sup> = 0%). Test for subgroup differences: Chi <sup>2</sup> = 5.99, df = 1; P = 0.01; I <sup>2</sup> = 83.3%. </p> <p>The TSA showed the cumulated Z curve enters the futility area, and therefore the anticipated intervention effect can be rejected (TSA‐adjusted confidence interval −2.32 to 1.15) (see <a href="#MR000050-fig-0004">Figure 4</a>). Inspection of the funnel plot and Egger's test were not possible due to insufficient data. </p> <div class="figure" id="MR000050-fig-0004"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 4</div> </div> <hr class="top"/><img alt="When we compared usual care with wait‐list and no‐treatment, we performed trial sequential analysis (TSA) on the primary outcome. The analysis shows that the required information size was not reached. See Figure 4 above. MIREDIF: Minimum relevant difference" data-id="MR000050-fig-0004" src="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/image_n/nMR000050-FIG-04.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>When we compared usual care with wait‐list and no‐treatment, we performed trial sequential analysis (TSA) on the primary outcome. The analysis shows that the required information size was not reached. See Figure 4 above. MIREDIF: Minimum relevant difference </p> </div> </div> </div> <p><b>Usual care versus wait‐list or no‐treatment (dichotomous data)</b> </p> <p>No differences were found for beneficial effects comparing usual care versus wait‐list or no‐treatment (RR 0.93, 95% CI 0.34 to 2.57; 2 trials, 260 participants; P = 0.89; I <sup>2</sup> = 79%; very low‐quality evidence; <a href="./references#MR000050-fig-0009" title="">Analysis 2.2</a>). Tests for subgroup differences were not done because both these trials were versus wait‐list. </p> </section> <section id="MR000050-sec-0083"> <h5 class="title">Serious adverse events of usual care versus wait‐list or no‐treatment</h5> <p>None of the trials in this comparison reported data on serious adverse events.</p> </section> <section id="MR000050-sec-0084"> <h5 class="title">Non‐serious adverse events of usual care versus wait‐list or no‐treatment</h5> <p>None of the trials in this comparison reported data on non‐serious adverse events.</p> </section> <section id="MR000050-sec-0085"> <h5 class="title">Outcomes measuring benefits for all placebos versus wait‐list or no‐treatment</h5> <p>86 trials compared all placebos versus wait‐list or no‐treatment. 12 of these did not report usable data (<a href="#MR000050-tbl-0008">Table 5</a>). </p> <p><b>All placebos versus wait‐list or no‐treatment (continuous data)</b> </p> <p>All placebo interventions showed beneficial effect compared with wait‐list or no‐treatment (SMD −0.37, 95% CI −0.49 to −0.25; 65 trials, 2446 participants; P &lt; 0.00001, I <sup>2</sup> = 41% ; low‐quality evidence; <a href="./references#MR000050-fig-0010" title="">Analysis 6.1</a>) <b>.</b> Differences were identified between subgroups: all placebos versus wait‐list (SMD −0.55, 95% CI −0.76 to −0.35; 31 trials, 1410 participants; P &lt; 0.00001; I <sup>2</sup> = 62%), and all placebos versus no‐treatment (SMD −0.18, 95% CI −0.30 to −0.05; 34 trials, 1036 participants; P = 0.005; I <sup>2</sup> = 0%). Test for subgroup differences: Chi <sup>2</sup> = 9.63, df = 1 ; P = 0.002; I <sup>2</sup> = 89.6%). </p> <p>The Trial Sequential Analysis (TSA) showed that the required information size (RIS) was reached (n = 397) and that there was no risk of type 1 error (TSA adjusted confidence interval −1.85 to −0.84) (see Figure 5 in <a href="./appendices#MR000050-sec-0116">Appendix 4</a>). Inspection of the funnel plot (see Figure 6 in <a href="./appendices#MR000050-sec-0116">Appendix 4</a>) suggested a small potential bias (asymmetry), but we found no evidence of possible publication bias: Egger’s regression intercept (bias) −0.699 (two tailed, P = 0.087). </p> <p><b>All placebos versus wait‐list or no‐treatment (dichotomous data)</b> </p> <p>We found no differences for beneficial effect comparing all placebos versus wait‐list or no‐treatment (risk ratio (RR) 1.05, 95% CI 0.74 to 1.48; 9 trials, 385 participants; P = 0.79; I <sup>2</sup> = 58%; very low‐quality evidence; <a href="./references#MR000050-fig-0011" title="">Analysis 6.2</a>) <b>.</b> Tests for subgroup differences were not done because all these trials were versus no‐treatment. </p> </section> <section id="MR000050-sec-0086"> <h5 class="title">Serious adverse events of all placebos versus wait‐list or no‐treatment</h5> <p>Eleven trials compared versus placebos with wait‐list or no‐treatment and reported serious adverse events (<a href="#MR000050-tbl-0008">Table 5</a>). </p> <p><b>All placebos versus wait‐list or no‐treatment (dichotomous data)</b> </p> <p>We found no differences for serious adverse events comparing all placebos versus wait‐list or no‐treatment (risk difference (RD) −0.00, 95% CI −0.03 to 0.03; 11 trials, 517 participants; P = 0.89; I <sup>2</sup> = 0%; very low‐quality evidence; <a href="./references#MR000050-fig-0012" title="">Analysis 7.1</a>) </p> <p>It was not possible to construct a TSA‐figure on serious adverse events due to insufficient data. Inspection of the funnel plot (Figure 7 in <a href="./appendices#MR000050-sec-0116">Appendix 4</a> ) suggested no potential bias (asymmetry). We found no evidence of possible publication bias: Egger’s regression intercept (bias) −1.192 (two tailed, P = 0.408). </p> <p><b>Psychological placebos versus wait‐list (dichotomous data)</b> </p> <p>We found no differences for serious adverse events comparing psychological placebos versus wait‐list (RD −0.01, 95% CI −0.07 to 0.04; 2 trials, 207 participants; P = 0.68; I <sup>2</sup> = 0%; very low‐quality evidence; <a href="./references#MR000050-fig-0013" title="">Analysis 7.2</a>) </p> <p><b>Pharmacological placebos versus no‐treatment (dichotomous data)</b> </p> <p>We found no differences for serious adverse events comparing pharmacological placebos versus no‐treatment (RD 0.01, 95% CI −0.08 to 0.09; 4 trials, 125 participants; P = 0.89; I <sup>2</sup> = 0%; very low‐quality evidence; <a href="./references#MR000050-fig-0014" title="">Analysis 7.3</a>) </p> <p><b>Physical placebos versus wait‐list or no‐treatment (dichotomous data)</b> </p> <p>We found no differences for serious adverse events comparing physical placebos versus wait‐list or no‐treatment (RD 0.00, 95% CI −0.04 to 0.04; 5 trials, 185 participants; P = 1.00; I <sup>2</sup> = 0%; very low‐quality evidence; <a href="./references#MR000050-fig-0015" title="">Analysis 7.4</a>) </p> </section> <section id="MR000050-sec-0087"> <h5 class="title">Non‐serious adverse events of all placebos versus wait‐list or no‐treatment</h5> <p>Fourteen trials compared all placebos versus wait‐list or no‐treatment and reported non‐serious adverse events (<a href="#MR000050-tbl-0008">Table 5</a>). </p> <p><b>All placebos compared with wait‐list or no‐treatment (dichotomous data)</b> </p> <p>We found no differences for non‐serious adverse events comparing all placebos versus wait‐list or no‐treatment (RD 0.03, 95% CI −0.02 to 0.08; 14 trials, 590 participants; P = 0.27; I <sup>2</sup> = 33% ; very low‐quality evidence; <a href="./references#MR000050-fig-0016" title="">Analysis 8.1</a>). </p> <p><b>Psychological placebos versus wait‐list or no‐treatment (dichotomous data)</b> </p> <p>We found no differences for non‐serious adverse events comparing psychological placebos versus wait‐list or no‐treatment (RD 0.01, 95% CI −0.18 to 0.19; 5 trials, 280 participants; P = 0.96; I <sup>2</sup> = 66%; very low‐quality evidence; <a href="./references#MR000050-fig-0017" title="">Analysis 8.2</a>). </p> <p><b>Pharmacological placebos versus wait‐list or no‐treatment (dichotomous data)</b> </p> <p>We found no differences for non‐serious adverse events comparing pharmacological placebos versus no‐treatment (RD 0.08, 95% CI −0.04 to 0.21; 4 trials, 125 participants; P = 0.18; I <sup>2</sup> = 46%; very low‐quality evidence; <a href="./references#MR000050-fig-0018" title="">Analysis 8.3</a>). </p> <p><b>Physical placebos versus wait‐list or no‐treatment (dichotomous data)</b> </p> <p>We found no differences for non‐serious adverse events comparing physical placebos versus wait‐list or no‐treatment (RD 0.00, 95% CI −0.04 to 0.04; 5 trials, 185 participants; P = 1.00; I <sup>2</sup> = 0%; very low‐quality evidence; <a href="./references#MR000050-fig-0019" title="">Analysis 8.4</a>). </p> </section> <section id="MR000050-sec-0088"> <h5 class="title">Outcomes measuring benefits for psychological placebos versus wait‐list or no‐treatment</h5> <p>Forty‐four trials compared psychological placebos versus wait‐list or no‐treatment. Five trials did not report usable data.(<a href="#MR000050-tbl-0008">Table 5</a>). One trial reported dichotomous data and 39 trials reported continuous data. </p> <p><b>Psychological placebos versus wait‐list or no‐treatment (continuous data)</b> </p> <p>Psychological placebos showed a beneficial effect compared with wait‐list or no‐treatment interventions (SMD −0.49, 95% CI −0.64 to −0.30; 38 trials, 1656 participants; P &lt; 0.00001; I <sup>2</sup> = 56%; low‐quality evidence; <a href="./references#MR000050-fig-0020" title="">Analysis 9.1</a>). Differences were identified between subgroups: psychological placebos versus wait‐list (SMD −0.66, 95% CI −0.92 to −0.40; 23 trials, 721 participants; P &lt; 0.00001; I <sup>2</sup> = 41%), and psychological placebos versus no‐treatment (SMD −0.21, 95% CI −0.38 to −0.04; 15 trials, 542 participants; P = 0.02; I <sup>2</sup> = 0%). Test for subgroup difference: Chi <sup>2</sup> = 8.03, df = 1, P = 0.005; I <sup>2</sup> = 87.5%. </p> <p>The TSA showed that the RIS was reached (n = 454), and that there was no risk of type 1 error (TSA‐adjusted confidence interval −2.54 to −1.02) (Figure 8 in <a href="./appendices#MR000050-sec-0116">Appendix 4</a>). Inspection of the funnel plot (Figure 9 in <a href="./appendices#MR000050-sec-0116">Appendix 4</a>) suggested no potential bias (asymmetry), and we found no evidence of possible publication bias: Egger’s regression intercept (bias) −0.915 (two tailed, P = 0.259). </p> <p><b>Psychological placebos versus wait‐list or no‐treatment (dichotomous data)</b> </p> <p>No data were applicable; <a href="./references#MR000050-fig-0021" title="">Analysis 9.2</a> . </p> </section> <section id="MR000050-sec-0089"> <h5 class="title">Outcomes measuring benefits for pharmacological placebos versus wait‐list or no‐treatment</h5> <p>Twenty‐three trials compared pharmacological placebos versus wait‐list or no‐treatment. Six trials did not report usable data (<a href="#MR000050-tbl-0008">Table 5</a>). Nine trials reported continuous data and eight trials reported dichotomous data. </p> <p><b>Pharmacological placebos versus wait‐list or no‐treatment (continuous data)</b> </p> <p>We found no differences for beneficial effect comparing pharmacological placebos versus wait‐list or no‐treatment (SMD −0.14, 95% CI −0.39 to 0.11; 9 trials, 279 participants; P = 0.28; I <sup>2</sup> = 0%; very low‐quality evidence; <a href="./references#MR000050-fig-0022" title="">Analysis 10.1</a>) No differences were identified between subgroups: pharmacological placebos versus wait‐list (SMD −0.51, 95% CI −1.41 to 0.38; 1 trial, 20 participants; P = 0.26; I <sup>2</sup> = not applicable), and pharmacological placebos versus no‐treatment (SMD −0.11, 95% CI −0.37 to 0.16; 8 trials, 259 participants; P = 0.43; I <sup>2</sup> = 0%). Test for subgroup differences: Chi <sup>2</sup> = 0.73, df = 1, P = 0.39; I <sup>2</sup> = 0%. </p> <p>The TSA shows that the cumulated Z curve enters the futility area, and therefore the anticipated intervention effect can be rejected (TSA adjusted confidence interval −9.43 to 6.15) (Figure 10 in <a href="./appendices#MR000050-sec-0116">Appendix 4</a>). Inspection of the funnel plot was not possible due to insufficient data. We found no evidence of possible publication bias: Egger’s regression intercept (bias) −1.192 (two tailed, P = 0.408). </p> <p><b>Pharmacological placebos versus wait‐list or no‐treatment (dichotomous data)</b> </p> <p>We found no differences for beneficial effect comparing pharmacological placebos versus wait‐list or no‐treatment (RR 1.05, 95% CI 0.74 to 1.48; 8 trials, 366 participants; P = 0.79; I <sup>2</sup> = 58%; very low‐quality evidence; <a href="./references#MR000050-fig-0023" title="">Analysis 10.2</a> ). Test for subgroup differences: not applicable. </p> </section> <section id="MR000050-sec-0090"> <h5 class="title">Outcomes measuring benefits for physical placebos versus wait‐list or no‐treatment</h5> <p>17 trials compared physical placebos versus wait‐list or no‐treatment. One of these did not report usable data (Table 5 in <a href="./appendices#MR000050-sec-0116">Appendix 4</a>). </p> <p><b>Physical placebos compared with wait‐list or no‐treatment for continuous data</b> </p> <p>Physical placebos had a beneficial effect compared with wait‐list or no‐treatment (SMD −0.21, 95% CI −0.35 to −0.08; 17 trials, 896 participants; P = 0.002; I <sup>2</sup> = 0%; low‐quality evidence; <a href="./references#MR000050-fig-0024" title="">Analysis 11.1</a>). No differences were found between subgroups: physical placebos versus wait‐list (SMD −0.30, 95% CI −0.54 to −0.06; 7 trials, 669 participants; P = 0.02; I <sup>2</sup> = 37%), and physical placebos versus no‐treatment (SMD −0.15, 95% CI −0.42 to 0.11; 10 trials, 227 participants; P = 0.26; I <sup>2</sup> = 0%). Test for subgroup differences: Chi <sup>2</sup> = 0.64, df = 1, P = 0.42, I <sup>2</sup> = 0%. </p> <p>The TSA showed that the RIS was reached (n = 194), and that there was no risk of type 1 error (TSA‐adjusted confidence interval −3.64 to −0.49) (Figure 11 in <a href="./appendices#MR000050-sec-0116">Appendix 4</a>). Inspection of the funnel plot (Figure 12 in <a href="./appendices#MR000050-sec-0116">Appendix 4</a>) suggested no potential bias (asymmetry), and we found no evidence of possible publication bias: Egger’s regression intercept (bias) −0.078 (two tailed, P = 0.860). </p> </section> </section> <section id="MR000050-sec-0091"> <h4 class="title">Subgroup analyses</h4> <p>We found significant subgroup differences between using wait‐list or no‐treatment as comparators in the analyses on all placebos and psychological placebos (<a href="./appendices#MR000050-sec-0117">Appendix 5</a>). We found larger differences in favour of all placebos or psychological placebos when comparing them with wait‐list rather than no‐treatment. </p> <p>For specific mental health disorders: on all placebos versus wait‐list or no‐treatment, we found differences in favour of placebos for sleep‐wake disorders (SMD −0.34, 95% CI −0.60 to −0.07, I <sup>2</sup> = 0%), depression (SMD −0.42, 95% CI −0.78 to −0.05, I <sup>2</sup> = 51%), post‐traumatic stress disorder (SMD −0.54, 95% CI −1.06 to −0.02, I <sup>2</sup> = 74%), and anxiety disorders (SMD −0.57, 95% CI −0.93 to −0.21, I <sup>2</sup> = 66%) . However, sparse data in these analyses made the results imprecise. Psychological placebos showed a beneficial effect for patients with sleep‐wake disorders (SMD −0.44, 95% CI −0.76 to −0.12, I <sup>2</sup> = 0%) and for patients with post‐traumatic stress disorder (SMD −0.75, 95% CI −1.23 to −0.27, I <sup>2</sup> = 55%) versus wait‐list or no‐treatment. </p> <p>In the other subgroup analyses, we only found significant differences in the analyses comparing non‐blinded observer‐reported outcomes with blinded observer‐rated and patient‐reported outcomes. We also conducted a post‐hoc subgroup analysis on types of psychological placebos: those with an interactional component (e.g. talking to a counsellor in a non‐directive manner), psychological placebos with a psychoeducational component and those with an exposure element. For this subgroup analysis, we found that interactional placebos yielded significantly higher effects than the other two types of psychological placebo. </p> <p>There were no significant differences in the other subgroup analyses (see <a href="./appendices#MR000050-sec-0117">Appendix 5</a> for all the estimates of the subgroup analyses). </p> </section> <section id="MR000050-sec-0092"> <h4 class="title">Sensitivity analyses</h4> <p>Due to a lack of sufficient data, it was not possible to conduct some of our predefined sensitivity analyses (see <a href="#MR000050-tbl-0009">Table 6</a>). We used both the fixed‐effect and the random‐effects models in all meta‐analyses. Statistical significance did not change when we applied a fixed‐effect model to analyses regarding all placebos, psychological placebos, pharmacological placebos and physical placebos. However, the statistical significance did change for usual care versus no‐treatment or wait‐list (<a href="./references#MR000050-fig-0128" title="">Analysis 25.1</a>). We therefore report the results of the random‐effects model for placebo interventions versus wait‐list or no treatment, and both the random‐effects and fixed‐effect models for usual care versus wait‐list or no treatment. </p> <div class="table" id="MR000050-tbl-0009"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 6.</span> <span class="table-title">Differences from protocol and review</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Section</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Protocol</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Review</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Pooling of placebos</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>We planned to pool psychological, pharmacological, and physical placebos into one placebo for the first primary outcome. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>We pooled psychological, pharmacological, and physical placebos into a group called 'all placebos' for all outcomes. This was done to increase the power of the analysis regarding adverse events and specific mental health diagnosis. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Dealing with missing data</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>We planned to contact study authors for relevant missing data on our prImary and secondary outcomes. If the authors dId not respond after two attempts to contact them, we planned to stop communications. If we are not able to obtain missing data, we will use the available data (incomplete data) in the analyses. If data are not reported in a usable way, we will consult a statistician to explore its transformation. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>We contacted study authors for relevant missing data. However, we made a pragmatic decision not to contact authors from studies before 1990. This was due to lack of probability that these data would have been preserved. </p> <p>In trials that did not report standard deviation (SD), we created an artificially SD from trials with the same population, outcome, experimental and control intervention. </p> <p>Furthermore, if trials did not report the amount of participants included in each group, and the total amount of participant could be equally divided, we expected the groups to have the same amount of participants in each group. However, if the number could not be equally divided, we anticipated that the active interventions and active control interventions included more. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Subgroup analysis and investigation of heterogeneity</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>We planned to conduct subgroup analyses to make hypotheses about the subgroups mentioned below. </p> <p> <ol id="MR000050-list-0015"> <li> <p>Type of active intervention: i) psychological intervention, ii) pharmacological intervention, iii) physical intervention, or iv) other intervention. </p> </li> <li> <p>Overall risk of bias: i) high risk of bias or ii) low risk of bias.</p> </li> <li> <p>Type of outcome domain: i) blinded observer‐reported, ii) non‐blinded observer‐reported, or iii) patient‐reported. </p> </li> <li> <p>Type of comparator intervention: i) wait‐list or ii) no‐treatment.</p> </li> <li> <p>Awareness of placebo intervention: i) participants were aware that they might receive a placebo, or ii) participants were not aware of such. </p> </li> <li> <p>The trial objective: i) a trial’s objective is clearly to assess the effects of placebo, usual care, or wait‐list interventions, or ii) no such objectives are stated. </p> </li> <li> <p>Mean age of participants: i) &lt; 18 years, ii) 18 to 50 years, or iii) &gt; 50 years.</p> </li> <li> <p>Duration of intervention: i) three months or above or ii) below three months.</p> </li> <li> <p>Type of usual care: i) pharmacological, ii) psychological, iii) physical, or iv) other.</p> </li> <li> <p>Standardised usual care: i) the usual care intervention was intentionally standardised or manualised, or ii) no standardisation or manualisation. </p> </li> <li> <p>Mode of psychological treatment in usual care and psychological placebo: i) individual psychological treatment, or ii) group psychological treatment. </p> </li> </ol> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>We added four post‐hoc subgroup analyses:</p> <p> <ol id="MR000050-list-0016"> <li> <p>Mental health diagnoses: i) formal diagnosis according to DSM/ICD, ii) fulfil symptoms of disorder ICD/DSM while not stating classifications systems, and iii) population is classified as having a mental disorder, but full diagnostic criteria not reported. </p> </li> <li> <p>Type of psychological placebo: i) interaction placebo, ii) educational placebo, and iii) exposure placebo. </p> </li> <li> <p>Type of physical placebo: i) acupuncture or acupressure placebo, ii) exercise and relaxation placebo, iii) technical device placebo, and iv) electromagnetic stimulation placebo. </p> </li> <li> <p>Affiliation bias: i) Risk of affiliation, industry, allegiance bias, and ii) no risk of affiliation, industry, allegiance bias ( <a href="./references#MR000050-bbs2-0237" title="LeichsenringF , SteinertC , IoannidisJPA .Toward a paradigm shift in treatment and research of mental disorders. Psychological Medicine2019;49(13):2111-7.">Leichsenring 2019</a> ) </p> </li> </ol> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Sensitivity analysis</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Studies contributing to heterogeneity (‘outliers’) was planned to be removed to evaluate the impact of their statistical heterogeneity on the overall pooled effect estimate. We will remove outliers one by one and assess the impact on the overall outcome. We will conduct sensitivity analyses to determine whether findings are sensitive to the following decisions made during the review process. </p> <p> <ol id="MR000050-list-0017"> <li> <p>Our assessment of the level of clinical heterogeneity.</p> </li> <li> <p>Analytical technique (e.g. fixed‐effect and random‐effects models).</p> </li> <li> <p>Type of data collection (e.g. different ways to measure adverse events).</p> </li> <li> <p>Imputed data (comparing the analyses with available outcome data with those following the ITT principle). </p> </li> <li> <p>Combination of data in continuous outcomes (end of intervention or change scores).</p> </li> <li> <p>Use of cluster‐randomised trials.</p> </li> <li> <p>Impact of non‐normally distributed data.</p> </li> </ol> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>We were only able to perform the analyses 2, 3, 4, and 5 due to a lack of sufficient data. </p> <p>Furthermore, we included a test for imprecision, as assessed by GRADE, by conducting Trial Sequential Analysis (TSA) on our primary outcomes included in the <a href="./full#MR000050-tbl-0003">summary of findings Table 3</a> . </p> <p>We also included these two sensitivity analyses:</p> <p> <ol id="MR000050-list-0018"> <li> <p>The impact of including wait‐list interventions described as no‐intervention</p> </li> <li> <p>The impact of including no‐interventions described as wait‐list interventions</p> </li> </ol> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Meta‐regression</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>It was planned that we would conduct supplementary meta‐regression analyses on continuous outcome, based on the findings from the subgroup analyses. We planned to choose covariates based on relevant subgroup analyses, such as type of intervention, risk of bias, type of outcome domain, mean participant age and duration of interventions. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Due to a lack of data, meta‐regression analyses were not possible to conduct.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Selections of studies (participants)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>All patients in each included trial was required to have a formal diagnosis of a mental health disorder, according to the Diagnostic and Statistical Manual of Mental Disorders (DSM), First Edition (DSM‐I;APA 1952), SecondEdition (DSM‐II;APA 1968),Third Edition (DSM‐III; APA 1980), Third Edition Revised (DSM‐IIIR; APA 1987), Fourth Edition (DSM‐IV; APA 1994), Fourth Edition Text Revision (DSM‐IV‐TR; APA 2000), and Fifth Edition (DSM‐5; APA 2013), or according to the International Classification ofDiseases andRelatedHealth Problems (ICD), Sixth Edition (ICD‐6; WHO 1949), Seventh Edition (ICD‐7; WHO 1955), Eighth Edition (ICD‐8; WHO 1967), Ninth Edition (ICD‐9; WHO 1975), 10th Edition (ICD‐10; WHO 1993), or 11th Edition (ICD‐11; WHO 2018). </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>During the inclusion phase we identified trials, where patients fulfilled the symptoms of the disorder according to ICD or DSM, but where the trial did not explicitly state a classification system. Moreover, trials were also identified where the populations was classified as having a mental health disorder, but full diagnostic symptoms were not reported. We chose to include these in our analyses, and included a post‐hoc subgroup analysis testing the difference </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Decision hierarchy of outcomes</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>We used the following decision hierarchy to select the outcomes measuring effect.</p> <p> <ol id="MR000050-list-0019"> <li> <p>We first included the outcome indicated as the primary outcome in the trial report. This could for instance be the one used for the sample size calculation. We preferred data from end of treatment over follow‐up data. </p> </li> <li> <p>If the trial did not differentiate between primary and secondary outcomes or if more than one primary outcome was stated, we preferred continuous to dichotomous outcomes. </p> </li> <li> <p>If there were multiple continuous outcomes, we preferred observer‐reported to patient‐reported outcomes, and blinded to non‐blinded outcomes. </p> </li> </ol> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>During the extraction phase, we had to extend our decision hierarchy due to the fact that the pre‐defined hierarchy proved not to be sufficient. We added: </p> <p> <ol id="MR000050-list-0020"> <li> <p>If trials reported several observer‐reported outcomes, we included the outcomes that best captured the core symptoms of the mental health population being treated. Here, we preferred global scores over sub‐scores. </p> </li> <li> <p>We then identified the outcome measure with the best psychometric properties (e.g. validity and reliability). </p> </li> <li> <p>If still undecided, the final outcome measure was randomly decided.</p> </li> </ol> </p> </td> </tr> </tbody> </table> </div> <p>We also tested if different type of data collection (e.g. measures of adverse events) impacted our results and found no differences. For another sensitivity analysis, for outcomes at the end of intervention, we removed change scores to see if it affected the results. No statistical significant differences were detected. </p> <p>We performed Trial Sequential Analysis (TSA) on all relevant primary outcomes included in <a href="./full#MR000050-tbl-0002">summary of findings Table 2</a> and <a href="./full#MR000050-tbl-0003">summary of findings Table 3</a> . The required information size (RIS) was reached for all placebos, psychological, and physical placebos compared with wait‐list and no‐treatment. It was not reached for pharmacological placebos, where the cumulated Z curve entered the futility area, and therefore the anticipated intervention effect could be rejected. The RIS was also not reached for usual care compared with wait‐list or no‐treatment. It was not possible to calculate TSA on serious adverse events and non‐serious adverse events because of insufficient information. We also tested whether removing the trials named by trial authors as wait‐list or no‐treatment but fitting our criteria for no‐treatment or wait‐list respectively would change the subgroup analysis between these two groups and found no significant differences. </p> </section> <section id="MR000050-sec-0093"> <h4 class="title">Summary of findings tables</h4> <p>We did not assess the quality of evidence and report effect estimates in <a href="./full#MR000050-tbl-0001">summary of findings Table 1</a> because it only included one study. In the second table, on usual care versus no‐treatment or wait‐list, we rated the quality of evidence as low using GRADE (<a href="./full#MR000050-tbl-0002">summary of findings Table 2</a>). In the third table on placebo interventions, we included six comparisons and the quality of evidence was rated low to very low (<a href="./full#MR000050-tbl-0003">summary of findings Table 3</a>). </p> </section> </section> </section> </section> <section class="discussion"> <div class="section-header section-collapse-header" id="MR000050-sec-0094" lang="en"> <h2 class="title section-collapse-title"> Discussion <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="discussion" lang="en"> <div class="section-header" id="MR000050-sec-0094"></div> <section id="MR000050-sec-0095"> <h3 class="title" id="MR000050-sec-0095">Summary of main results</h3> <p>This review includes 96 randomised trials, out of which 83 trials provided usable data (3614/4200 participants or 86%). The trials included 15 different mental health disorders. We only found one trial that compared wait‐list versus no‐treatment directly and the authors were not able to provide usable data for this comparison. The comparison on usual care versus wait‐list or no‐treatment was not significant with an standardised mean difference (SMD) of ‐0.33 (95% confidence interval (CI) ‐0.83 to 0.16, I² = 86%, 5 trials, 523 participants), although a sensitivity analysis showed significant differences when using a fixed‐effect instead of a random‐effect model with an SMD of ‐0.46 (95% CI ‐0.64 to ‐0.28). We found significant differences between all placebo interventions combined versus wait‐list and no‐treatment with an SMD of ‐0.37 (95% CI ‐0.49 to ‐0.25, I²= 41%, 65 trials, 2446 participants), but there was evidence of some asymmetry in the funnel plot and almost all the trials were small. We found a moderate effect in favour of psychological placebos (SMD ‐0.49, 95% CI ‐0.64 to ‐0.30, I² = 53%, 39 trials, 1656 participants) and small effects in favour of pharmacological placebos (SMD ‐0.14, 95% CI ‐0.39 to 0.11, I² = 0%, 9 trials, 279 participants) and physical placebos (SMD ‐0.21, 95% CI ‐0.35 to ‐0.08, I² = 0%, 17 trials, 896 participants). There were significant differences in favour of all placebos in the comparisons on specific mental disorders, but the analyses suffered from sparse data. No differences were found on harms in any of the analyses. </p> <p>The present systematic review has many strengths. We developed a protocol for this review (<a href="./references#MR000050-bbs2-0306" title="FaltinsenE , TodorovacA , HróbjartssonA , GluudC , KongerslevMT , SimonsenE , StorebøOJ .Placebo, usual care and wait‐list interventions for all mental health disorders.. Cochrane Database of Systematic Reviews2019, Issue 1. Art. No: MR000050. [DOI: 10.1002/14651858.MR000050]">Faltinsen 2019</a>) in accordance with the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#MR000050-bbs2-0207" title="HigginJP , ThomasJ , ChandlerJ , CumpstonM , LiT , PageMJ , et al (editors).Cochrane Handbook for Systematic Reviews of Interventions Version 6.0 (updated July 2019). Cochrane, 2019.. Available from www.training.cochrane.org/handbook.">Higgins 2019</a> ). We conducted extensive searches in relevant databases, with no restrictions to language, publication year, or publication type. Two independent review authors selected trials, extracted data, assessed the risk of bias, and graded the quality of the evidence. Disagreements were resolved by discussion. We used Trial Sequential Analysis (TSA) to estimate the required Information Size (RIS) needed to either accept or reject a certain intervention effect. Another strength of the review is the large number of included trials and the fact that we could make direct comparisons between the different control interventions. This enabled a comprehensive assessment of the effect of the included controls. </p> <p>The results of this review are affected by the statistical heterogeneity in the analyses, which may be due in part to methodological and clinical heterogeneity in variables such as the included mental health populations, outcome domains, and the contents of the control interventions. To investigate some of the heterogeneity stemming from the pooled mental health populations in the first primary outcome, we conducted comparisons on specific mental health disorders. However, out of the 15 different identified diagnoses across the included trials, we were only able to run comparisons on seven mental health disorders, and these analyses were limited by sparse data, which made the results imprecise. The majority of the review’s meta‐analyses are therefore conducted across all included mental disorders. </p> <p>Another example of methodological heterogeneity is the large variability in the contents of the included psychological placebos, which is a much‐discussed issue in the literature on mental health control interventions (<a href="./references#MR000050-bbs2-0172" title="ComerJS , KendallPC .Methodology, design, and evaluation in psychotherapy research. In: LambertMJ , editors(s). Bergin and Garfields’s Handbook of Psychotherapy and Behavior Change. 6th edition. New York: Wiley, 2013:21-48.">Comer 2013</a>; <a href="./references#MR000050-bbs2-0224" title="KazdinAE .Treatment as usual and routine care in research and clinical practice. Clinical Psychology Review2015;42:168.">Kazdin 2015</a>; <a href="./references#MR000050-bbs2-0159" title="BorkovecTD , SibravaNJ .Problems with the use of placebo conditions in psychotherapy research, suggested alternatives, and some strategies for the pursuit of the placebo phenomenon. Journal of Clinical Psychology2005;61(7):805-18.">Borkovec 2005</a>; <a href="./references#MR000050-bbs2-0216" title="HróbjartssonA , MillerFG .Placebo in nonpharmacological randomized trials. In: BoutronI , RavaudP , MoherD , editors(s). Randomized Clincial Trials of Nonpharmacological Treatments. Taylor &amp; Francis Group, LLC, 2012:11-26.">Hróbjartsson 2012</a>). It is in part difficult to properly design a psychological placebo because of the issue of targeting hypothesised specific factors of complex psychological treatments <a href="./references#MR000050-bbs2-0159" title="BorkovecTD , SibravaNJ .Problems with the use of placebo conditions in psychotherapy research, suggested alternatives, and some strategies for the pursuit of the placebo phenomenon. Journal of Clinical Psychology2005;61(7):805-18.">Borkovec 2005</a>; <a href="./references#MR000050-bbs2-0216" title="HróbjartssonA , MillerFG .Placebo in nonpharmacological randomized trials. In: BoutronI , RavaudP , MoherD , editors(s). Randomized Clincial Trials of Nonpharmacological Treatments. Taylor &amp; Francis Group, LLC, 2012:11-26.">Hróbjartsson 2012</a>; <a href="./references#MR000050-bbs2-0252" title="MohrDC , HoJ , HartTL , BaronKG , BerendsenM , BecknerV , et al.Control condition design and implementation features in controlled trials: a meta-analysis of trials evaluating psychotherapy for depression. Translational Behavioral Medicine2014;4(4):407-23.">Mohr 2014</a>). Out of the three types of placebo interventions, psychological placebos showed the largest reported difference compared with wait‐list and no‐treatment for all included mental health populations (SMD ‐0.49, 95% CI ‐0.65 to ‐0.30). In an attempt to further investigate the methodological heterogeneity within this control intervention, we conducted a post‐hoc subgroup analysis on psychological placebos and divided them into three separate groups: interactional, psychological placebos with a psychoeducational component, and those with an exposure element (<a href="./references#MR000050-fig-0067" title="">Analysis 17.8</a>). The term interactional placebo referred in this case to psychological placebos that control for human interaction variables in treatments such as psychotherapy. We found that interactional placebos yielded significantly higher effects than the other two groups, which may indicate that control interventions that involve a human interaction element yield higher effect sizes compared to no‐treatment or wait‐list. This is in line with previous frameworks on the shared factors of psychological treatments (<a href="./references#MR000050-bbs2-0286" title="WampoldBE , ImielZE .Great Psychotherapy Debate (Counseling and Psychotherapy) - The Evidence for What Makes Psychotherapy Work. 2 edition. Taylor &amp; Francis Inc, 2010.">Wampold 2010</a>; <a href="./references#MR000050-bbs2-0202" title="HafliðadóttirSH , JuhlCB , NielsenSM , HenriksenM , HarrisIA , BliddalH , et al.Placebo response and effect in randomized clinical trials: meta-research with focus on contextual effects. Trials2021;22(1):493.">Hafliðadóttir 2021</a>), although it is not possible to draw strong conclusions on this matter with this exploratory subgroup analysis. Rather, it points to the fact that the psychological placebos as an intervention are methodologically heterogeneous in their contents.<br/>  </p> </section> <section id="MR000050-sec-0096"> <h3 class="title" id="MR000050-sec-0096">Overall completeness and applicability of evidence</h3> <p>We were able to include data from 83 of 96 trials or 3614 participants out of 4200 in total (86% of the total participant pool). In order to include a sufficient number of trials and give a global estimate of efficacy, we combined different outcomes across the included trials. More specifically, one outcome was chosen from each trial based on our predetermined outcome hierarchy. We included 66 different outcomes, which is a source of methodological heterogeneity (<a href="./references#MR000050-bbs2-0207" title="HigginJP , ThomasJ , ChandlerJ , CumpstonM , LiT , PageMJ , et al (editors).Cochrane Handbook for Systematic Reviews of Interventions Version 6.0 (updated July 2019). Cochrane, 2019.. Available from www.training.cochrane.org/handbook.">Higgins 2019</a>). When we looked at specific mental health disorders, the outcome measures were often more similar. For instance, for depression, the outcome was often a depression inventory to rate symptoms (see <a href="#MR000050-tbl-0006">Table 3</a>). </p> </section> <section id="MR000050-sec-0097"> <h3 class="title" id="MR000050-sec-0097">Quality of the evidence</h3> <p>We assessed all included trials as high risk of bias, partly due to lack of blinding of participants and personnel. It is not possible to maintain blinding when comparing a control intervention where participants receive some form of treatment with a control intervention where no treatment is provided (wait‐list or no‐treatment). This is because the participants and often the personnel will know what treatment is provided to whom, which makes the results prone to bias and systematic errors (<a href="./references#MR000050-bbs2-0207" title="HigginJP , ThomasJ , ChandlerJ , CumpstonM , LiT , PageMJ , et al (editors).Cochrane Handbook for Systematic Reviews of Interventions Version 6.0 (updated July 2019). Cochrane, 2019.. Available from www.training.cochrane.org/handbook.">Higgins 2019</a>). However, the trials also suffered from other forms of risk of bias. In fact, only three trials (<a href="./references#MR000050-bbs2-0003" title="AllenJB .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 28th of August 2019. AllenJJ , SchnyerRN , ChambersAS , HittSK , MorenoFA , ManberR .Acupuncture for depression: a randomized controlled trial. Journal of Clinical Psychiatry2006;67(11):1665-73. ">Allen 2006</a>; <a href="./references#MR000050-bbs2-0021" title="EhlersA , HackmannA , GreyN , WildJ , LinessS , AlbertI , et al.A randomized controlled trial of 7-day intensive and standard weekly cognitive therapy for PTSD and emotion-focused supportive therapy. American Journal of Psychiatry2014;171(3):294-304. ">Ehlers 2014</a>; <a href="./references#MR000050-bbs2-0043" title="KwanR .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 26th of August 2019. KwanRY , LeungMC , LaiCK .Acupressure for agitation in nursing home residents with dementia: study protocol for a randomized controlled trial. Trials2014;15(410):1-7. KwanRY , LeungMCP , LaiCK .A randomized controlled trial examining the effect of acupressure on agitation and salivary cortisol in nursing home residents with dementia. Dementia and Geriatric Cognitive Disorders2017;44(1-2):92-104. ">Kwan 2017</a>) would have been rated at low risk of bias if the blinding of the participants and personnel rating were excluded from the risk of bias assessment. Blinding of participants and personnel is a persistent issue in randomised trials with psychosocial interventions (<a href="./references#MR000050-bbs2-0191" title="GuidiJ , BrakemeierEL , BocktingCL , CosciF , CuijpersP , JarrettRB , et al.Methodological recommendations for trials of psychological interventions. Psychotherapy and Psychosomatics2019;87(5):276-84.">Guidi 2018</a>; <a href="./references#MR000050-bbs2-0221" title="JuulS , GluudC , SimonsenS , FrandsenFW , IrvingK , JakobsenJC .Blinding in randomised clinical trials of psychological interventions: a retrospective study of published trial reports. BMJ Evidence-Based Medicine Online First: 30 September 2020. [DOI: doi: 10.1136/bmjebm-2020-111407]">Juul 2020</a>) and there is a need to consider how to address the specific methodological challenges relevant to these types of trials (<a href="./references#MR000050-bbs2-0191" title="GuidiJ , BrakemeierEL , BocktingCL , CosciF , CuijpersP , JarrettRB , et al.Methodological recommendations for trials of psychological interventions. Psychotherapy and Psychosomatics2019;87(5):276-84.">Guidi 2018</a>; <a href="./references#MR000050-bbs2-0254" title="MunderT , BarthJ .Cochrane’s risk of bias tool in the context of psychotherapy outcome research. Psychotherapy Research2018;28(3):347-55.">Munder 2018</a>). We also conducted a post‐hoc subgroup analysis and found no differences between the trials at low, unclear and high risk of bias, when we removed the blinding of participants and personnel from the assessment (<a href="./references#MR000050-fig-0058" title="">Analysis 16.18</a> , test for subgroup differences P = 0.26, I <sup>2</sup> = 26%). However, this analysis was exploratory and many of the trials provided insufficient information on the bias domains, which makes it difficult to judge the overall true extent of systematic bias in the included studies. The reader should take these factors into consideration when evaluating the review's risk of bias profile and its impact on the quality of the evidence. </p> <p>We intended for this review to provide support for an empirical and methodological reflection of the benefits and harms of control interventions in mental health intervention research. Realising that the subject matter is complex, one may look at the low to very low quality of evidence as a reflection of the state of control intervention design rather than a criticism of the interpretability of our review. Although the included trials were rated as low to very low quality of evidence, this is a reflection of the heterogeneous objectives of this review and to some extent the fact that blinding of participants is not possible with the included designs. As a consequence, we chose to report an alternative risk of bias profile where we excluded the blinding domains (see <a href="#MR000050-fig-0005">Figure 5</a>; <a href="#MR000050-fig-0006">Figure 6</a> ) in addition to the conventional risk of bias assessment. However, this did not change the overall quality of evidence. </p> <div class="figure" id="MR000050-fig-0005"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 5</div> </div> <hr class="top"/><img alt="Alternative Risk of bias graph" data-id="MR000050-fig-0005" src="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/image_n/nMR000050-FIG-13.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Alternative Risk of bias graph</p> </div> </div> </div> <div class="figure" id="MR000050-fig-0006"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 6</div> </div> <hr class="top"/><img alt="Alternative Risk of bias summary" data-id="MR000050-fig-0006" src="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/image_n/nMR000050-FIG-14.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Alternative Risk of bias summary</p> </div> </div> </div> <p>Many trials had small sample sizes which led to imprecise estimates. The funnel plot for the comparison on all placebos was somewhat asymmetrical, which may reflect poor methodological quality, true heterogeneity, or selection bias (<a href="./references#MR000050-bbs2-0207" title="HigginJP , ThomasJ , ChandlerJ , CumpstonM , LiT , PageMJ , et al (editors).Cochrane Handbook for Systematic Reviews of Interventions Version 6.0 (updated July 2019). Cochrane, 2019.. Available from www.training.cochrane.org/handbook.">Higgins 2019</a>). Upon visual inspection, the funnel plot indicated that some data points might be missing on the lower right corner of the plot, and this could have important implications for the interpretability of the data. The results in this comparison may be sensitive to trial size and should be interpreted with caution. </p> <p>Almost all the included trials had three arms (interventions) with one experimental arm. Potential conflicts of interest when the researches had vested interests in the experimental intervention, financially or non‐financially, may have produced bias and threatened the validity of the results (<a href="./references#MR000050-bbs2-0243" title="LundhA , LexchinJ , MintzesB , SchrollJB , BeroL .Industry sponsorship and research outcome. Cochrane Database of Systematic Reviews2017, Issue 2. Art. No: MR000033. [DOI: 10.1002/14651858.MR000033.pub3]">Lundh 2017</a>; <a href="./references#MR000050-bbs2-0161" title="BoutronI , PageMJ , HigginsJP , AltmanDG , LundhA , HróbjartssonA .Chapter 7: Considering bias and conflicts of interest among the included studies. In: HigginsJP , ThomasJ , ChandlerJ , CumpstonM , LiT , PageMJ , et al, editors(s). Cochrane Handbook for Systematic Reviews of Interventions version 6.2. Cochrane, 2021.">Boutron 2021</a>). We conducted a post‐hoc analysis to test conflicts of interest, but found no significant differences, but the data in the subgroup analysis were sparse. We should therefore not rule out the possibility of conflicts of interest towards the experimental intervention in some of the trials having impacted effect estimates. We graded all the overall results as either very low or low quality of evidence according to GRADE based on risk of bias, inconsistency of the evidence, and imprecision (<a href="./references#MR000050-bbs2-0192" title="GuyattG , OxmanAD , AklEA , KunzR , VistG , BrozekJ , et al.GRADE guidelines: 1. Introduction - GRADE evidence profiles and summary of findings tables. Journal of Clinical Epidemiology2011;64(4):383-94.">Guyatt 2011a</a>). </p> <p>There are also many potential issues with reporting in the included trials. For instance, usual care, wait‐list and no‐treatment can vary in their contents and trial authors do not always specify how their control interventions were designed (<a href="./references#MR000050-bbs2-0176" title="CuijpersP , QueroS , PapolaD , CristeaIA , KaryotakiE .Care-as-usual control groups across different settings in randomized trials on psychotherapy for adult depression: a meta-analysis. Psychological Medicine2021;51(4):634–44.">Cuijpers 2021</a>; <a href="./references#MR000050-bbs2-0288" title="WattsSE , TurnellA , KladnitskiN , NewbyJM , AndrewsG .Treatment-as-usual (TAU) is anything but usual: a meta-analysis of CBT versus TAU for anxiety and depression. Journal of Affective Disorders2015;175:152–67.">Watts 2015</a>), which makes it hard to determine how much overlap there is between the controls in the review. This should not, however, be an argument against the use of controls such as psychological placebos in trials with mental health populations because they may be methodologically useful for differentiating the active and non‐active factors in psychological treatments (<a href="./references#MR000050-bbs2-0251" title="MohrDC , SpringB , FreedlandKE , BecknerV , AreanP , HollonSD , et al.The selection and design of control conditions for randomized controlled trials of psychological interventions. Psychotherapy and Psychosomatics2009;78(5):275-84.">Mohr 2009</a>). Instead, controls such as psychological placebos should arguably be designed to control for everything but the hypothesised mechanism of causality in a psychological treatment (<a href="./references#MR000050-bbs2-0216" title="HróbjartssonA , MillerFG .Placebo in nonpharmacological randomized trials. In: BoutronI , RavaudP , MoherD , editors(s). Randomized Clincial Trials of Nonpharmacological Treatments. Taylor &amp; Francis Group, LLC, 2012:11-26.">Hróbjartsson 2012</a>; <a href="./references#MR000050-bbs2-0240" title="LocherC , GaabJ , BleaseC .When a placebo is not a placebo: problems and solutions to the gold standard in psychotherapy research. Frontiers in Psychology2018;9:2317.">Locher 2018</a>). Another potential issue is with the diagnostic classification systems used in the included studies, as some studies used older versions of the Diagnostic and Statistical Manual of Mental Disorders (DSM), which are not necessarily comparable to current versions. </p> </section> <section id="MR000050-sec-0098"> <h3 class="title" id="MR000050-sec-0098">Potential biases in the review process</h3> <p>Because of the large amount of records to screen, we chose to single‐screen records. This may have affected the selection of results and produced bias. It is very challenging to locate accurately all relevant records with such as broad search strategy (two control interventions in a three‐arm randomised trial with any mental health disorder), and we may have missed relevant trials. However, for the placebo interventions, we did include 50 more trials for mental health disorders than <a href="./references#MR000050-bbs2-0215" title="HróbjartssonA , GötzschePC .Placebo interventions for all clinical conditions. Cochrane Database of Systematic Reviews2010, Issue 1. Art. No: CD003974. [DOI: 10.1002/14651858.CD003974.pub3]">Hróbjartsson 2010</a> reported in an earlier review on placebos for all medical conditions. </p> <p>During the inclusion phase, we identified trials where patients fulfilled the symptoms of a mental health disorder according to International Classification of Diseases (ICD) or DSM, but where the trial did not explicitly state what classification system was used. In some instances we also included trials where the population was classified as having a mental health disorder but the full diagnostic symptoms were not reported. We chose to include these trials in our analyses, and included a post‐hoc subgroup analysis to investigate potential differences. </p> <p>There were some more minor changes from the protocol to the final report and these are all listed in <a href="#MR000050-sec-0147">Differences between protocol and review</a> and <a href="#MR000050-tbl-0009">Table 6</a>. </p> </section> <section id="MR000050-sec-0099"> <h3 class="title" id="MR000050-sec-0099">Agreements and disagreements with other studies or reviews</h3> <p>The earlier reviews by Hróbjartsson and Gøtzche (<a href="./references#MR000050-bbs2-0212" title="HróbjartssonA , GøtzschePC .Is the placebo powerless? An analysis of clinical trials comparing placebo with no treatment. New England Journal of Medicine2001;344:1594-602.">Hróbjartsson 2001</a>; <a href="./references#MR000050-bbs2-0213" title="HróbjartssonA , GötzschePC .Placebo treatment versus no treatment. Cochrane Database of Systematic Reviews2002, Issue 4. Art. No: CD003974. [DOI: 10.1002/14651858.CD003974]">Hróbjartsson 2002</a>; <a href="./references#MR000050-bbs2-0214" title="HróbjartssonA , GötzschePC .Placebo interventions for all clinical conditions. Cochrane Database of Systematic Reviews2004, Issue 2. Art. No: CD003974. [DOI: 10.1002/14651858.CD003974.pub2]">Hróbjartsson 2004</a>; <a href="./references#MR000050-bbs2-0215" title="HróbjartssonA , GötzschePC .Placebo interventions for all clinical conditions. Cochrane Database of Systematic Reviews2010, Issue 1. Art. No: CD003974. [DOI: 10.1002/14651858.CD003974.pub3]">Hróbjartsson 2010</a>) found that the efficacy of their included placebo interventions yielded, on average, a small to moderate effect and that placebos may influence patient‐reported outcomes. Our analysis on all placebo types combined for continuous outcomes yielded an SMD of ‐0.37 (95% CI ‐0.49 to ‐0.25), which is not considerably different from the results found in Hróbjartsson and Gøtzsche's work (SMD ‐0.23, 95% CI ‐0.28 to ‐0.17) for all placebos combined on continuous outcomes. Both these effect estimates are small to moderate. They also found moderate statistical heterogeneity present in both the binary and continuous outcomes and funnel plot asymmetry in the analyses on continuous outcomes, which is similar to the findings in the present review. </p> <p>We found some indication of funnel plot asymmetry in the comparison on all placebos, moderate heterogeneity in most analyses and high variability between effect sizes. In this review, psychological and physical placebos showed larger differences compared with no‐treatment or wait‐list than pharmacological placebos, which is also similar to what was found in <a href="./references#MR000050-bbs2-0215" title="HróbjartssonA , GötzschePC .Placebo interventions for all clinical conditions. Cochrane Database of Systematic Reviews2010, Issue 1. Art. No: CD003974. [DOI: 10.1002/14651858.CD003974.pub3]">Hróbjartsson 2010</a> . It could be true that placebo interventions yield larger differences compared with wait‐list or no‐treatment in randomised trials with mental health populations, perhaps because they involve more subjective outcome measures or that mental health disorders are more prone to be affected by placebo administration ( <a href="./references#MR000050-bbs2-0290" title="WeimerK , CollocaL , EnckP .Placebo effects in psychiatry: mediators and moderators. Lancet Psychiatry2015;2(3):246-57.">Weimer 2015</a> ). Our subgroup analyses for all placebos combined indicated that blinded and non‐blinded observer‐reported outcomes provided a higher placebo effect size compared with patient‐reported outcomes. <a href="./references#MR000050-bbs2-0215" title="HróbjartssonA , GötzschePC .Placebo interventions for all clinical conditions. Cochrane Database of Systematic Reviews2010, Issue 1. Art. No: CD003974. [DOI: 10.1002/14651858.CD003974.pub3]">Hróbjartsson 2010</a> found the opposite: a higher placebo effect for patient‐reported outcomes over observer‐reported. Here it should be noted that the observer‐reported outcomes in <a href="./references#MR000050-bbs2-0215" title="HróbjartssonA , GötzschePC .Placebo interventions for all clinical conditions. Cochrane Database of Systematic Reviews2010, Issue 1. Art. No: CD003974. [DOI: 10.1002/14651858.CD003974.pub3]">Hróbjartsson 2010</a> often measured a somatic variable, whereas observer‐reported outcomes in the present review were often psychometric instruments rated by an observer. Thus, the conflicting results from the reviews may not be directly comparable.<br/><br/>Placebo and usual care control groups compared with wait‐list controls were found to yield higher effect estimates than compared with no‐treatment controls. The findings were only significant for all placebos combined and for psychological placebos. Our review found similarities to the work of Mohr and colleagues (<a href="./references#MR000050-bbs2-0252" title="MohrDC , HoJ , HartTL , BaronKG , BerendsenM , BecknerV , et al.Control condition design and implementation features in controlled trials: a meta-analysis of trials evaluating psychotherapy for depression. Translational Behavioral Medicine2014;4(4):407-23.">Mohr 2014</a>). In their meta‐analysis focusing on studies on depression, they found significant differences in effect sizes generated across different control interventions. Another recent network meta‐analysis that assessed control intervention's influence on effect estimates of active psychotherapies for depression found weaker effect estimates for wait‐list and no‐treatment than psychological and pharmacological placebos (<a href="./references#MR000050-bbs2-0245" title="MichopoulosI , FurukawaTA , NomaH , KishimotoS , OnishiA , OstinelliEG , et al.Different control conditions can produce different effect estimates in psychotherapy trials for depression. Journal of Clinical Epidemiology2021;132:59–70.">Michopoulos 2021</a>). Our review supports these findings and the importance of considering the type of control intervention in a randomised trial with mental health populations because it can drastically influence reported effect estimates. Cuijpers and Cristea has also proposed that to ensure a higher effect estimate of the active treatment in a randomised trial, a wait‐list intervention should be preferred (<a href="./references#MR000050-bbs2-0175" title="CuijpersP , CristeaIA .How to prove that your therapy is effective, even when it is not: a guideline. Epidemiology and Psychiatric Sciences2016;25(5):428-35.">Cuijpers 2016</a>). Wait‐list control interventions might bias the true effect of different active treatments and therefore potentially produce a skewed view of the effect of those treatments, but we are not able to make conclusions about this based on the results in this review. </p> <p>Little research has been done on the harms of psychological treatments (<a href="./references#MR000050-bbs2-0238" title="LilienfeldSO .Psychological treatments that cause harm. Perspectives on Psychological Science2007;2(1):53-70.">Lilienfeld 2007</a>; <a href="./references#MR000050-bbs2-0239" title="LindenM , Schermuly-HauptM .Definition, assessment and rate of psychotherapy side effects. World Psychiatry2014;13(3):306-9.">Linden 2014</a>; <a href="./references#MR000050-bbs2-0258" title="PagsbergAK , JeppesenP , KlauberDG , JensenKG , RudåD , Stentebjerg-OlesonM , et al.Quetiapine extended release versus aripiprazole in children and adolescents with first-episode psychosis: the multicentre, double-blind, randomised tolerability and efficacy of antipsychotics (TEA) trial. Lancet Psychiatry2017;4(8):605-18.">Pagsberg 2017</a>; <a href="./references#MR000050-bbs2-0274" title="StorebøOJ , PedersenN , RamstadE , KielsholmML , NielsenSS , KroghHB , et al.Methylphenidate for attention deficit hyperactivity disorder (ADHD) in children and adolescents – assessment of adverse events in non-randomised studies. Cochrane Database of Systematic Reviews2018, Issue 5. Art. No: CD012069. [DOI: 10.1002/14651858.CD012069.pub2]">Storebø 2018</a>). We did not find indications of wait‐list or no‐treatment interventions being more harmful than any placebos. In the case of usual care, no trials reported or mentioned adverse events, and we are only able to give anecdotal evidence on adverse events here. Usual care is a highly heterogeneous control intervention and very few of our included trials accurately reported its contents because the researchers are often unaware of this themselves. Furukawa and colleagues previously speculated that wait‐list interventions could lead to negative effects in patients from waiting for an experimental treatment after the study period (<a href="./references#MR000050-bbs2-0187" title="FurukawaTA , NomaH , CaldwellDM , HonyashikiM , ShinoharaK , ImaiH , et al.Waiting list may be a nocebo condition in psychotherapy trials: a contribution from network meta-analysis. Acta Psychiatrica Scandinavica2014;130(3):181-92.">Furukawa 2014</a>), but our review was not able to confirm this because of sparse adverse event data. It should be a priority to identify whether wait‐list interventions might produce unfavourable harms in randomised trials with participants with mental health diagnoses in future research. </p> <p>It has previously been argued that a decision framework should be put in place for how to properly choose a control intervention in trials with patients with mental health disorders, and that such a framework should take into account factors like trial phase, participation risk and available levels of resources (<a href="./references#MR000050-bbs2-0188" title="GoldSM , EnckP , HasselmannH , FriedeT , HegerlU , MohrDC , et al.Control conditions for randomised trials of behavioural interventions in psychiatry: a decision framework. Lancet Psychiatry2018;4(9):725-32.">Gold 2018</a>). It is evident from this review that the effect sizes in trials with patients with mental health disorders may vary widely depending on what control intervention is used, and it seems reasonable, therefore, to demand methodological standards for when it is appropriate to use a particular control in a trial. It may for instance be recommended that wait‐list or no‐treatment controls should only be used in the early stages of testing a new behavioural treatment, seeing that they often produce high effect sizes in favour of experimental interventions, which may give a misguided impression of the intervention’s effectiveness. Overall, it seems important that a control intervention should be properly designed and tailored to the specific objectives under investigation, and that there should be some agreement among researchers on when a type of control design is appropriate in a mental health trial and when it is not (<a href="./references#MR000050-bbs2-0251" title="MohrDC , SpringB , FreedlandKE , BecknerV , AreanP , HollonSD , et al.The selection and design of control conditions for randomized controlled trials of psychological interventions. Psychotherapy and Psychosomatics2009;78(5):275-84.">Mohr 2009</a>; <a href="./references#MR000050-bbs2-0252" title="MohrDC , HoJ , HartTL , BaronKG , BerendsenM , BecknerV , et al.Control condition design and implementation features in controlled trials: a meta-analysis of trials evaluating psychotherapy for depression. Translational Behavioral Medicine2014;4(4):407-23.">Mohr 2014</a>). </p> </section> </section> </section> <div class="figures-list"> <div class="figure" id="MR000050-fig-0001"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/urn:x-wiley:14651858:media:MR000050:MR000050-FIG-01" target="_blank"><b></b></a></p> </div><img alt='Study flow diagram.* Powers 2008 was included in both psychological and pharmacological placebo" Brill 1964 was included in both pharmacological placebo and usual care&lt; Klerman 1974 was divided into two different trials‐: Peck 1974 was included only in all placebos analyses due to that the placebo group was a mix of psychological and pharmacological placebo' data-id="MR000050-fig-0001" src="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/image_n/nMR000050-FIG-01.png"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/image_t/tMR000050-FIG-01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 1</div> <div class="figure-caption"> <p>Study flow diagram.</p> <p>* Powers 2008 was included in both psychological and pharmacological placebo</p> <p>" Brill 1964 was included in both pharmacological placebo and usual care</p> <p>&lt; Klerman 1974 was divided into two different trials</p> <p>‐: Peck 1974 was included only in all placebos analyses due to that the placebo group was a mix of psychological and pharmacological placebo </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/full#MR000050-fig-0001">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/image_n/nMR000050-FIG-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="MR000050-fig-0002"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/urn:x-wiley:14651858:media:MR000050:MR000050-FIG-02" target="_blank"><b></b></a></p> </div><img alt="Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies." data-id="MR000050-fig-0002" src="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/image_n/nMR000050-FIG-02.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/image_t/tMR000050-FIG-02.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 2</div> <div class="figure-caption"> <p>Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/full#MR000050-fig-0002">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/image_n/nMR000050-FIG-02.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="MR000050-fig-0003"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/urn:x-wiley:14651858:media:MR000050:MR000050-FIG-03" target="_blank"><b></b></a></p> </div><img alt="Risk of bias summary: review authors' judgements about each risk of bias item for each included study." data-id="MR000050-fig-0003" src="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/image_n/nMR000050-FIG-03.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/image_t/tMR000050-FIG-03.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 3</div> <div class="figure-caption"> <p>Risk of bias summary: review authors' judgements about each risk of bias item for each included study. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/full#MR000050-fig-0003">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/image_n/nMR000050-FIG-03.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="MR000050-fig-0004"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/urn:x-wiley:14651858:media:MR000050:MR000050-FIG-04" target="_blank"><b></b></a></p> </div><img alt="When we compared usual care with wait‐list and no‐treatment, we performed trial sequential analysis (TSA) on the primary outcome. The analysis shows that the required information size was not reached. See Figure 4 above. MIREDIF: Minimum relevant difference" data-id="MR000050-fig-0004" src="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/image_n/nMR000050-FIG-04.png"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/image_t/tMR000050-FIG-04.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 4</div> <div class="figure-caption"> <p>When we compared usual care with wait‐list and no‐treatment, we performed trial sequential analysis (TSA) on the primary outcome. The analysis shows that the required information size was not reached. See Figure 4 above. MIREDIF: Minimum relevant difference </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/full#MR000050-fig-0004">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/image_n/nMR000050-FIG-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="MR000050-fig-0005"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/urn:x-wiley:14651858:media:MR000050:MR000050-FIG-13" target="_blank"><b></b></a></p> </div><img alt="Alternative Risk of bias graph" data-id="MR000050-fig-0005" src="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/image_n/nMR000050-FIG-13.png"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/image_t/tMR000050-FIG-13.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 5</div> <div class="figure-caption"> <p>Alternative Risk of bias graph</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/full#MR000050-fig-0005">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/image_n/nMR000050-FIG-13.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="MR000050-fig-0006"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/urn:x-wiley:14651858:media:MR000050:MR000050-FIG-14" target="_blank"><b></b></a></p> </div><img alt="Alternative Risk of bias summary" data-id="MR000050-fig-0006" src="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/image_n/nMR000050-FIG-14.png"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/image_t/tMR000050-FIG-14.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 6</div> <div class="figure-caption"> <p>Alternative Risk of bias summary</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/full#MR000050-fig-0006">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/image_n/nMR000050-FIG-14.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="MR000050-fig-0132"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/urn:x-wiley:14651858:media:MR000050:MR000050-FIG-05" target="_blank"><b></b></a></p> </div><img alt="When comparing all placebos with wait‐list and no‐treatment on beneficial effects, we performed a trial sequential analysis on the primary outcome. The analysis shows that the required information size was reached. See Figure 5 above. MIREDIF: Minimum relevant difference" data-id="MR000050-fig-0132" src="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/image_n/nMR000050-FIG-05.png"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/image_t/tMR000050-FIG-05.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 7</div> <div class="figure-caption"> <p>When comparing all placebos with wait‐list and no‐treatment on beneficial effects, we performed a trial sequential analysis on the primary outcome. The analysis shows that the required information size was reached. See Figure 5 above. MIREDIF: Minimum relevant difference </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/appendices#MR000050-fig-0132">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/image_n/nMR000050-FIG-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="MR000050-fig-0133"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/urn:x-wiley:14651858:media:MR000050:MR000050-FIG-06" target="_blank"><b></b></a></p> </div><img alt="Funnel plot of comparison: 6.1. Efficacy of all placebos compared with wait‐list/no‐treatment for continuous data." data-id="MR000050-fig-0133" src="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/image_n/nMR000050-FIG-06.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/image_t/tMR000050-FIG-06.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 8</div> <div class="figure-caption"> <p>Funnel plot of comparison: 6.1. Efficacy of all placebos compared with wait‐list/no‐treatment for continuous data. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/appendices#MR000050-fig-0133">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/image_n/nMR000050-FIG-06.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="MR000050-fig-0134"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/urn:x-wiley:14651858:media:MR000050:MR000050-FIG-07" target="_blank"><b></b></a></p> </div><img alt="Funnel plot of comparison: 7.1 Serious adverse events of all placebos compared with wait‐list/no‐treatment for dichotomous data." data-id="MR000050-fig-0134" src="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/image_n/nMR000050-FIG-07.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/image_t/tMR000050-FIG-07.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 9</div> <div class="figure-caption"> <p>Funnel plot of comparison: 7.1 Serious adverse events of all placebos compared with wait‐list/no‐treatment for dichotomous data. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/appendices#MR000050-fig-0134">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/image_n/nMR000050-FIG-07.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="MR000050-fig-0135"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/urn:x-wiley:14651858:media:MR000050:MR000050-FIG-08" target="_blank"><b></b></a></p> </div><img alt="We performed a trial sequential analysis on the primary outcome for efficacy of psychological placebos compared with wait‐list and no‐treatment. The analysis shows that the required information size was reached. See Figure 8 above. MIREDIF: Minimum relevant difference" data-id="MR000050-fig-0135" src="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/image_n/nMR000050-FIG-08.png"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/image_t/tMR000050-FIG-08.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 10</div> <div class="figure-caption"> <p>We performed a trial sequential analysis on the primary outcome for efficacy of psychological placebos compared with wait‐list and no‐treatment. The analysis shows that the required information size was reached. See Figure 8 above. MIREDIF: Minimum relevant difference </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/appendices#MR000050-fig-0135">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/image_n/nMR000050-FIG-08.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="MR000050-fig-0136"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/urn:x-wiley:14651858:media:MR000050:MR000050-FIG-09" target="_blank"><b></b></a></p> </div><img alt="Funnel plot of comparison: 9.1. Efficacy psychological placebos compared with wait‐list/no‐treatment for continuous data." data-id="MR000050-fig-0136" src="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/image_n/nMR000050-FIG-09.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/image_t/tMR000050-FIG-09.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 11</div> <div class="figure-caption"> <p>Funnel plot of comparison: 9.1. Efficacy psychological placebos compared with wait‐list/no‐treatment for continuous data. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/appendices#MR000050-fig-0136">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/image_n/nMR000050-FIG-09.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="MR000050-fig-0137"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/urn:x-wiley:14651858:media:MR000050:MR000050-FIG-10" target="_blank"><b></b></a></p> </div><img alt="We performed a trial sequential analysis on the primary outcome for efficacy of pharmacological placebos compared with wait‐list and no‐treatment. The TSA showed the cumulated Z curve enters the futility area. See Figure 10 above. MIREDIF: Minimum relevant difference" data-id="MR000050-fig-0137" src="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/image_n/nMR000050-FIG-10.png"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/image_t/tMR000050-FIG-10.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 12</div> <div class="figure-caption"> <p>We performed a trial sequential analysis on the primary outcome for efficacy of pharmacological placebos compared with wait‐list and no‐treatment. The TSA showed the cumulated Z curve enters the futility area. See Figure 10 above. MIREDIF: Minimum relevant difference </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/appendices#MR000050-fig-0137">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/image_n/nMR000050-FIG-10.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="MR000050-fig-0138"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/urn:x-wiley:14651858:media:MR000050:MR000050-FIG-11" target="_blank"><b></b></a></p> </div><img alt="We performed a trial sequential analysis on the primary outcome for efficacy of physical placebos compared with wait‐list and no‐treatment. The analysis shows that the required information size was reached. See Figure 11 above. MIREDIF: Minimum relevant difference" data-id="MR000050-fig-0138" src="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/image_n/nMR000050-FIG-11.png"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/image_t/tMR000050-FIG-11.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 13</div> <div class="figure-caption"> <p>We performed a trial sequential analysis on the primary outcome for efficacy of physical placebos compared with wait‐list and no‐treatment. The analysis shows that the required information size was reached. See Figure 11 above. MIREDIF: Minimum relevant difference </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/appendices#MR000050-fig-0138">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/image_n/nMR000050-FIG-11.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="MR000050-fig-0139"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/urn:x-wiley:14651858:media:MR000050:MR000050-FIG-12" target="_blank"><b></b></a></p> </div><img alt="Funnel plot of comparison: 11.1 Efficacy of physical placebos compared with wait‐list/no‐treatment for continuous data." data-id="MR000050-fig-0139" src="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/image_n/nMR000050-FIG-12.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/image_t/tMR000050-FIG-12.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 14</div> <div class="figure-caption"> <p>Funnel plot of comparison: 11.1 Efficacy of physical placebos compared with wait‐list/no‐treatment for continuous data. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/appendices#MR000050-fig-0139">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/image_n/nMR000050-FIG-12.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="MR000050-fig-0007"> <p> <div class="table" id="MR000050-tblf-0001"> <table> <div class="table-heading"><span class="table-title"></span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="2" rowspan="1" valign=""> <p>Wait‐list versus no‐treatment for people with mental health disorder</p> </td> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Study</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Heading 1</b> </p> </th> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Howlin 2007</b> </p> </th> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Only one cluster‐randomised trial compared a wait‐list intervention to a no‐treatment intervention was included ( <a href="./references#MR000050-bbs2-0033" title="HowlinP , GordonKR , PascoG , WadeA , CharmanT .The effectiveness of picture exchange communication system (PECS) training for teachers of children with autism: a pragmatic,group randomised controlled trial. Journal of Child Psychology and Psychiatry2007;48(5):473-81. ">Howlin 2007</a> ). However, no usable data was provided in the full report, and the authors did engage in correspondence. 84 elementary school children with a autism spectrum disorder was randomised to either, i) immediate treatment, ii) delayed treatment (wait‐list), and iii) no‐treatment. Conclusion were that Picture Exchange Communication System (PECS) training indicated modest effectiveness for children with autism spectrum disorder. In general there were no differences on across outcome measures between the wait‐list and no‐treatment intervention groups. </p> </td> </tr> </tbody> </table> </div> </p> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.1</div> <div class="figure-caption"> <p>Comparison 1: Wait‐list versus no‐treatment for people with mental health disorder, Outcome 1: Wait‐list versus no‐treatment for people with mental health disorder </p> </div> </div> <div class="tools"><a class="figureList" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/references#MR000050-fig-0007">Navigate to figure in review</a></div> </div> <div class="figure" id="MR000050-fig-0008"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/urn:x-wiley:14651858:media:MR000050:MR000050-CMP-002.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: Usual care versus wait‐list or no‐treatment for all mental health disorders, Outcome 1: Usual care compared with wait‐list/no‐treatment for continuous data" data-id="MR000050-fig-0008" src="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/image_n/nMR000050-CMP-002.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/image_t/tMR000050-CMP-002.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.1</div> <div class="figure-caption"> <p>Comparison 2: Usual care versus wait‐list or no‐treatment for all mental health disorders, Outcome 1: Usual care compared with wait‐list/no‐treatment for continuous data </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/references#MR000050-fig-0008">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/image_n/nMR000050-CMP-002.01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="MR000050-fig-0009"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/urn:x-wiley:14651858:media:MR000050:MR000050-CMP-002.02" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: Usual care versus wait‐list or no‐treatment for all mental health disorders, Outcome 2: Usual care compared with wait‐list/no‐treatment for dichotomous data" data-id="MR000050-fig-0009" src="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/image_n/nMR000050-CMP-002.02.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/image_t/tMR000050-CMP-002.02.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.2</div> <div class="figure-caption"> <p>Comparison 2: Usual care versus wait‐list or no‐treatment for all mental health disorders, Outcome 2: Usual care compared with wait‐list/no‐treatment for dichotomous data </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/references#MR000050-fig-0009">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/image_n/nMR000050-CMP-002.02.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="MR000050-fig-0010"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/urn:x-wiley:14651858:media:MR000050:MR000050-CMP-006.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 6: All placebos versus waitl‐list or no‐treatment for people with mental health disorders, Outcome 1: All placebos compared with wait‐list/no‐treatment for continuous data" data-id="MR000050-fig-0010" src="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/image_n/nMR000050-CMP-006.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/image_t/tMR000050-CMP-006.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.1</div> <div class="figure-caption"> <p>Comparison 6: All placebos versus waitl‐list or no‐treatment for people with mental health disorders, Outcome 1: All placebos compared with wait‐list/no‐treatment for continuous data </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/references#MR000050-fig-0010">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/image_n/nMR000050-CMP-006.01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="MR000050-fig-0011"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/urn:x-wiley:14651858:media:MR000050:MR000050-CMP-006.02" target="_blank"><b></b></a></p> </div><img alt="Comparison 6: All placebos versus waitl‐list or no‐treatment for people with mental health disorders, Outcome 2: All placebos compared with wait‐list/no‐treatment for dichotomous data" data-id="MR000050-fig-0011" src="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/image_n/nMR000050-CMP-006.02.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/image_t/tMR000050-CMP-006.02.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.2</div> <div class="figure-caption"> <p>Comparison 6: All placebos versus waitl‐list or no‐treatment for people with mental health disorders, Outcome 2: All placebos compared with wait‐list/no‐treatment for dichotomous data </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/references#MR000050-fig-0011">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/image_n/nMR000050-CMP-006.02.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="MR000050-fig-0012"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/urn:x-wiley:14651858:media:MR000050:MR000050-CMP-007.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 7: Serious adverse events of placebos versus wait‐list or no‐treatment for people with mental health disorders, Outcome 1: All placebos compared with wait‐list/no‐treatment for dichotomous data" data-id="MR000050-fig-0012" src="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/image_n/nMR000050-CMP-007.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/image_t/tMR000050-CMP-007.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 7.1</div> <div class="figure-caption"> <p>Comparison 7: Serious adverse events of placebos versus wait‐list or no‐treatment for people with mental health disorders, Outcome 1: All placebos compared with wait‐list/no‐treatment for dichotomous data </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/references#MR000050-fig-0012">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/image_n/nMR000050-CMP-007.01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="MR000050-fig-0013"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/urn:x-wiley:14651858:media:MR000050:MR000050-CMP-007.02" target="_blank"><b></b></a></p> </div><img alt="Comparison 7: Serious adverse events of placebos versus wait‐list or no‐treatment for people with mental health disorders, Outcome 2: Psychological placebos compared with wait‐list/no‐treatment for dichotomous data" data-id="MR000050-fig-0013" src="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/image_n/nMR000050-CMP-007.02.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/image_t/tMR000050-CMP-007.02.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 7.2</div> <div class="figure-caption"> <p>Comparison 7: Serious adverse events of placebos versus wait‐list or no‐treatment for people with mental health disorders, Outcome 2: Psychological placebos compared with wait‐list/no‐treatment for dichotomous data </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/references#MR000050-fig-0013">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/image_n/nMR000050-CMP-007.02.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="MR000050-fig-0014"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/urn:x-wiley:14651858:media:MR000050:MR000050-CMP-007.03" target="_blank"><b></b></a></p> </div><img alt="Comparison 7: Serious adverse events of placebos versus wait‐list or no‐treatment for people with mental health disorders, Outcome 3: Pharmacological placebos compared with wait‐list/no‐treatment for dichotomous data" data-id="MR000050-fig-0014" src="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/image_n/nMR000050-CMP-007.03.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/image_t/tMR000050-CMP-007.03.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 7.3</div> <div class="figure-caption"> <p>Comparison 7: Serious adverse events of placebos versus wait‐list or no‐treatment for people with mental health disorders, Outcome 3: Pharmacological placebos compared with wait‐list/no‐treatment for dichotomous data </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/references#MR000050-fig-0014">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/image_n/nMR000050-CMP-007.03.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="MR000050-fig-0015"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/urn:x-wiley:14651858:media:MR000050:MR000050-CMP-007.04" target="_blank"><b></b></a></p> </div><img alt="Comparison 7: Serious adverse events of placebos versus wait‐list or no‐treatment for people with mental health disorders, Outcome 4: Physical placebos compared with wait‐list/no‐treatment for dichotomous data" data-id="MR000050-fig-0015" src="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/image_n/nMR000050-CMP-007.04.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/image_t/tMR000050-CMP-007.04.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 7.4</div> <div class="figure-caption"> <p>Comparison 7: Serious adverse events of placebos versus wait‐list or no‐treatment for people with mental health disorders, Outcome 4: Physical placebos compared with wait‐list/no‐treatment for dichotomous data </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/references#MR000050-fig-0015">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/image_n/nMR000050-CMP-007.04.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="MR000050-fig-0016"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/urn:x-wiley:14651858:media:MR000050:MR000050-CMP-008.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 8: Non‐serious adverse events of all placebos versus wait‐list or no‐ treatment for people with mental health disorders, Outcome 1: All placebos compared with wait‐list/no‐treatment for dichotomous data" data-id="MR000050-fig-0016" src="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/image_n/nMR000050-CMP-008.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/image_t/tMR000050-CMP-008.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 8.1</div> <div class="figure-caption"> <p>Comparison 8: Non‐serious adverse events of all placebos versus wait‐list or no‐ treatment for people with mental health disorders, Outcome 1: All placebos compared with wait‐list/no‐treatment for dichotomous data </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/references#MR000050-fig-0016">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/image_n/nMR000050-CMP-008.01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="MR000050-fig-0017"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/urn:x-wiley:14651858:media:MR000050:MR000050-CMP-008.02" target="_blank"><b></b></a></p> </div><img alt="Comparison 8: Non‐serious adverse events of all placebos versus wait‐list or no‐ treatment for people with mental health disorders, Outcome 2: Psychological placebos compared with wait‐list/no‐treatment for dichotomous data" data-id="MR000050-fig-0017" src="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/image_n/nMR000050-CMP-008.02.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/image_t/tMR000050-CMP-008.02.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 8.2</div> <div class="figure-caption"> <p>Comparison 8: Non‐serious adverse events of all placebos versus wait‐list or no‐ treatment for people with mental health disorders, Outcome 2: Psychological placebos compared with wait‐list/no‐treatment for dichotomous data </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/references#MR000050-fig-0017">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/image_n/nMR000050-CMP-008.02.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="MR000050-fig-0018"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/urn:x-wiley:14651858:media:MR000050:MR000050-CMP-008.03" target="_blank"><b></b></a></p> </div><img alt="Comparison 8: Non‐serious adverse events of all placebos versus wait‐list or no‐ treatment for people with mental health disorders, Outcome 3: Pharmacological placebos compared with wait‐list/no‐treatment for dichotomous data" data-id="MR000050-fig-0018" src="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/image_n/nMR000050-CMP-008.03.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/image_t/tMR000050-CMP-008.03.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 8.3</div> <div class="figure-caption"> <p>Comparison 8: Non‐serious adverse events of all placebos versus wait‐list or no‐ treatment for people with mental health disorders, Outcome 3: Pharmacological placebos compared with wait‐list/no‐treatment for dichotomous data </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/references#MR000050-fig-0018">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/image_n/nMR000050-CMP-008.03.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="MR000050-fig-0019"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/urn:x-wiley:14651858:media:MR000050:MR000050-CMP-008.04" target="_blank"><b></b></a></p> </div><img alt="Comparison 8: Non‐serious adverse events of all placebos versus wait‐list or no‐ treatment for people with mental health disorders, Outcome 4: Physical placebos compared with wait‐list/no‐treatment for dichotomous data" data-id="MR000050-fig-0019" src="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/image_n/nMR000050-CMP-008.04.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/image_t/tMR000050-CMP-008.04.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 8.4</div> <div class="figure-caption"> <p>Comparison 8: Non‐serious adverse events of all placebos versus wait‐list or no‐ treatment for people with mental health disorders, Outcome 4: Physical placebos compared with wait‐list/no‐treatment for dichotomous data </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/references#MR000050-fig-0019">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/image_n/nMR000050-CMP-008.04.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="MR000050-fig-0020"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/urn:x-wiley:14651858:media:MR000050:MR000050-CMP-009.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 9: Psychological placebos versus wait‐list or no‐treatment for people with mental health disorders, Outcome 1: Psychological placebos compared with wait‐list/no‐treatment for continuous data" data-id="MR000050-fig-0020" src="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/image_n/nMR000050-CMP-009.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/image_t/tMR000050-CMP-009.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 9.1</div> <div class="figure-caption"> <p>Comparison 9: Psychological placebos versus wait‐list or no‐treatment for people with mental health disorders, Outcome 1: Psychological placebos compared with wait‐list/no‐treatment for continuous data </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/references#MR000050-fig-0020">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/image_n/nMR000050-CMP-009.01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="MR000050-fig-0021"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/urn:x-wiley:14651858:media:MR000050:MR000050-CMP-009.02" target="_blank"><b></b></a></p> </div><img alt="Comparison 9: Psychological placebos versus wait‐list or no‐treatment for people with mental health disorders, Outcome 2: Psychological placebos compared with wait‐list/no‐treatment for dichotomous data" data-id="MR000050-fig-0021" src="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/image_n/nMR000050-CMP-009.02.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/image_t/tMR000050-CMP-009.02.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 9.2</div> <div class="figure-caption"> <p>Comparison 9: Psychological placebos versus wait‐list or no‐treatment for people with mental health disorders, Outcome 2: Psychological placebos compared with wait‐list/no‐treatment for dichotomous data </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/references#MR000050-fig-0021">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/image_n/nMR000050-CMP-009.02.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="MR000050-fig-0022"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/urn:x-wiley:14651858:media:MR000050:MR000050-CMP-010.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 10: Pharmacological placebos versus wait‐list or no‐treatment for people with mental health disorders, Outcome 1: Pharmacological placebos compared with wait‐list/no‐treatment for continuous data" data-id="MR000050-fig-0022" src="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/image_n/nMR000050-CMP-010.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/image_t/tMR000050-CMP-010.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 10.1</div> <div class="figure-caption"> <p>Comparison 10: Pharmacological placebos versus wait‐list or no‐treatment for people with mental health disorders, Outcome 1: Pharmacological placebos compared with wait‐list/no‐treatment for continuous data </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/references#MR000050-fig-0022">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/image_n/nMR000050-CMP-010.01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="MR000050-fig-0023"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/urn:x-wiley:14651858:media:MR000050:MR000050-CMP-010.02" target="_blank"><b></b></a></p> </div><img alt="Comparison 10: Pharmacological placebos versus wait‐list or no‐treatment for people with mental health disorders, Outcome 2: Pharmacological placebos compared with no‐treatment for continuous data" data-id="MR000050-fig-0023" src="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/image_n/nMR000050-CMP-010.02.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/image_t/tMR000050-CMP-010.02.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 10.2</div> <div class="figure-caption"> <p>Comparison 10: Pharmacological placebos versus wait‐list or no‐treatment for people with mental health disorders, Outcome 2: Pharmacological placebos compared with no‐treatment for continuous data </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/references#MR000050-fig-0023">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/image_n/nMR000050-CMP-010.02.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="MR000050-fig-0024"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/urn:x-wiley:14651858:media:MR000050:MR000050-CMP-011.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 11: Physical placebo versus wait‐list or no‐treatment for people with mental health disorders, Outcome 1: Physical placebos compared with wait‐list/no‐treatment for continuous data" data-id="MR000050-fig-0024" src="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/image_n/nMR000050-CMP-011.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/image_t/tMR000050-CMP-011.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 11.1</div> <div class="figure-caption"> <p>Comparison 11: Physical placebo versus wait‐list or no‐treatment for people with mental health disorders, Outcome 1: Physical placebos compared with wait‐list/no‐treatment for continuous data </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/references#MR000050-fig-0024">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/image_n/nMR000050-CMP-011.01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="MR000050-fig-0025"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/urn:x-wiley:14651858:media:MR000050:MR000050-CMP-012.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 12: All placebos versus wait‐list or no‐treatment for people with specific mental health disorders for continuous data, Outcome 1: Efficacy of all placebos for people with substance use disorders" data-id="MR000050-fig-0025" src="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/image_n/nMR000050-CMP-012.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/image_t/tMR000050-CMP-012.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 12.1</div> <div class="figure-caption"> <p>Comparison 12: All placebos versus wait‐list or no‐treatment for people with specific mental health disorders for continuous data, Outcome 1: Efficacy of all placebos for people with substance use disorders </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/references#MR000050-fig-0025">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/image_n/nMR000050-CMP-012.01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="MR000050-fig-0026"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/urn:x-wiley:14651858:media:MR000050:MR000050-CMP-012.02" target="_blank"><b></b></a></p> </div><img alt="Comparison 12: All placebos versus wait‐list or no‐treatment for people with specific mental health disorders for continuous data, Outcome 2: Efficacy of all placebos for people with sleep‐wake disorders" data-id="MR000050-fig-0026" src="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/image_n/nMR000050-CMP-012.02.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/image_t/tMR000050-CMP-012.02.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 12.2</div> <div class="figure-caption"> <p>Comparison 12: All placebos versus wait‐list or no‐treatment for people with specific mental health disorders for continuous data, Outcome 2: Efficacy of all placebos for people with sleep‐wake disorders </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/references#MR000050-fig-0026">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/image_n/nMR000050-CMP-012.02.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="MR000050-fig-0027"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/urn:x-wiley:14651858:media:MR000050:MR000050-CMP-012.03" target="_blank"><b></b></a></p> </div><img alt="Comparison 12: All placebos versus wait‐list or no‐treatment for people with specific mental health disorders for continuous data, Outcome 3: Efficacy of all placebos for people with depression" data-id="MR000050-fig-0027" src="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/image_n/nMR000050-CMP-012.03.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/image_t/tMR000050-CMP-012.03.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 12.3</div> <div class="figure-caption"> <p>Comparison 12: All placebos versus wait‐list or no‐treatment for people with specific mental health disorders for continuous data, Outcome 3: Efficacy of all placebos for people with depression </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/references#MR000050-fig-0027">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/image_n/nMR000050-CMP-012.03.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="MR000050-fig-0028"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/urn:x-wiley:14651858:media:MR000050:MR000050-CMP-012.04" target="_blank"><b></b></a></p> </div><img alt="Comparison 12: All placebos versus wait‐list or no‐treatment for people with specific mental health disorders for continuous data, Outcome 4: Efficacy of all placebos for people with post‐traumatic stress disorder (PTSD)" data-id="MR000050-fig-0028" src="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/image_n/nMR000050-CMP-012.04.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/image_t/tMR000050-CMP-012.04.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 12.4</div> <div class="figure-caption"> <p>Comparison 12: All placebos versus wait‐list or no‐treatment for people with specific mental health disorders for continuous data, Outcome 4: Efficacy of all placebos for people with post‐traumatic stress disorder (PTSD) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/references#MR000050-fig-0028">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/image_n/nMR000050-CMP-012.04.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="MR000050-fig-0029"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/urn:x-wiley:14651858:media:MR000050:MR000050-CMP-012.05" target="_blank"><b></b></a></p> </div><img alt="Comparison 12: All placebos versus wait‐list or no‐treatment for people with specific mental health disorders for continuous data, Outcome 5: Efficacy of all placebos for people with anxiety disorders" data-id="MR000050-fig-0029" src="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/image_n/nMR000050-CMP-012.05.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/image_t/tMR000050-CMP-012.05.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 12.5</div> <div class="figure-caption"> <p>Comparison 12: All placebos versus wait‐list or no‐treatment for people with specific mental health disorders for continuous data, Outcome 5: Efficacy of all placebos for people with anxiety disorders </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/references#MR000050-fig-0029">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/image_n/nMR000050-CMP-012.05.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="MR000050-fig-0030"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/urn:x-wiley:14651858:media:MR000050:MR000050-CMP-012.06" target="_blank"><b></b></a></p> </div><img alt="Comparison 12: All placebos versus wait‐list or no‐treatment for people with specific mental health disorders for continuous data, Outcome 6: Efficacy of all placebos for people with attention deficit hyperactivity disorder (ADHD) or attention deficit disorder (ADD)" data-id="MR000050-fig-0030" src="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/image_n/nMR000050-CMP-012.06.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/image_t/tMR000050-CMP-012.06.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 12.6</div> <div class="figure-caption"> <p>Comparison 12: All placebos versus wait‐list or no‐treatment for people with specific mental health disorders for continuous data, Outcome 6: Efficacy of all placebos for people with attention deficit hyperactivity disorder (ADHD) or attention deficit disorder (ADD) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/references#MR000050-fig-0030">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/image_n/nMR000050-CMP-012.06.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="MR000050-fig-0031"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/urn:x-wiley:14651858:media:MR000050:MR000050-CMP-012.07" target="_blank"><b></b></a></p> </div><img alt="Comparison 12: All placebos versus wait‐list or no‐treatment for people with specific mental health disorders for continuous data, Outcome 7: Efficacy of all placebos for people with neurodegenerative disorders" data-id="MR000050-fig-0031" src="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/image_n/nMR000050-CMP-012.07.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/image_t/tMR000050-CMP-012.07.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 12.7</div> <div class="figure-caption"> <p>Comparison 12: All placebos versus wait‐list or no‐treatment for people with specific mental health disorders for continuous data, Outcome 7: Efficacy of all placebos for people with neurodegenerative disorders </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/references#MR000050-fig-0031">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/image_n/nMR000050-CMP-012.07.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="MR000050-fig-0032"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/urn:x-wiley:14651858:media:MR000050:MR000050-CMP-013.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 13: Psychological placebos versus wait‐list or no‐treatment for people with specific mental health disorders continuous data, Outcome 1: Efficacy of all placebos for people with substance use disorders" data-id="MR000050-fig-0032" src="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/image_n/nMR000050-CMP-013.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/image_t/tMR000050-CMP-013.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 13.1</div> <div class="figure-caption"> <p>Comparison 13: Psychological placebos versus wait‐list or no‐treatment for people with specific mental health disorders continuous data, Outcome 1: Efficacy of all placebos for people with substance use disorders </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/references#MR000050-fig-0032">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/image_n/nMR000050-CMP-013.01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="MR000050-fig-0033"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/urn:x-wiley:14651858:media:MR000050:MR000050-CMP-013.02" target="_blank"><b></b></a></p> </div><img alt="Comparison 13: Psychological placebos versus wait‐list or no‐treatment for people with specific mental health disorders continuous data, Outcome 2: Efficacy of all placebos for people with sleep‐wake disorders" data-id="MR000050-fig-0033" src="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/image_n/nMR000050-CMP-013.02.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/image_t/tMR000050-CMP-013.02.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 13.2</div> <div class="figure-caption"> <p>Comparison 13: Psychological placebos versus wait‐list or no‐treatment for people with specific mental health disorders continuous data, Outcome 2: Efficacy of all placebos for people with sleep‐wake disorders </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/references#MR000050-fig-0033">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/image_n/nMR000050-CMP-013.02.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="MR000050-fig-0034"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/urn:x-wiley:14651858:media:MR000050:MR000050-CMP-013.03" target="_blank"><b></b></a></p> </div><img alt="Comparison 13: Psychological placebos versus wait‐list or no‐treatment for people with specific mental health disorders continuous data, Outcome 3: Efficacy of all placebos for people with depression" data-id="MR000050-fig-0034" src="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/image_n/nMR000050-CMP-013.03.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/image_t/tMR000050-CMP-013.03.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 13.3</div> <div class="figure-caption"> <p>Comparison 13: Psychological placebos versus wait‐list or no‐treatment for people with specific mental health disorders continuous data, Outcome 3: Efficacy of all placebos for people with depression </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/references#MR000050-fig-0034">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/image_n/nMR000050-CMP-013.03.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="MR000050-fig-0035"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/urn:x-wiley:14651858:media:MR000050:MR000050-CMP-013.04" target="_blank"><b></b></a></p> </div><img alt="Comparison 13: Psychological placebos versus wait‐list or no‐treatment for people with specific mental health disorders continuous data, Outcome 4: Efficacy of all placebos for people with post‐traumatic stress disorder (PTSD)" data-id="MR000050-fig-0035" src="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/image_n/nMR000050-CMP-013.04.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/image_t/tMR000050-CMP-013.04.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 13.4</div> <div class="figure-caption"> <p>Comparison 13: Psychological placebos versus wait‐list or no‐treatment for people with specific mental health disorders continuous data, Outcome 4: Efficacy of all placebos for people with post‐traumatic stress disorder (PTSD) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/references#MR000050-fig-0035">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/image_n/nMR000050-CMP-013.04.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="MR000050-fig-0036"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/urn:x-wiley:14651858:media:MR000050:MR000050-CMP-013.05" target="_blank"><b></b></a></p> </div><img alt="Comparison 13: Psychological placebos versus wait‐list or no‐treatment for people with specific mental health disorders continuous data, Outcome 5: Efficacy of all placebos for people with anxiety disorders" data-id="MR000050-fig-0036" src="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/image_n/nMR000050-CMP-013.05.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/image_t/tMR000050-CMP-013.05.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 13.5</div> <div class="figure-caption"> <p>Comparison 13: Psychological placebos versus wait‐list or no‐treatment for people with specific mental health disorders continuous data, Outcome 5: Efficacy of all placebos for people with anxiety disorders </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/references#MR000050-fig-0036">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/image_n/nMR000050-CMP-013.05.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="MR000050-fig-0037"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/urn:x-wiley:14651858:media:MR000050:MR000050-CMP-014.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 14: Pharmacological placebos versus wait‐list or no‐treatment for people with specific mental health disorders continuous data, Outcome 1: Efficacy of all placebos for people with attention deficit hyperactivity disorder (ADHD) or attention deficit disorder (ADD)" data-id="MR000050-fig-0037" src="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/image_n/nMR000050-CMP-014.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/image_t/tMR000050-CMP-014.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 14.1</div> <div class="figure-caption"> <p>Comparison 14: Pharmacological placebos versus wait‐list or no‐treatment for people with specific mental health disorders continuous data, Outcome 1: Efficacy of all placebos for people with attention deficit hyperactivity disorder (ADHD) or attention deficit disorder (ADD) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/references#MR000050-fig-0037">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/image_n/nMR000050-CMP-014.01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="MR000050-fig-0038"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/urn:x-wiley:14651858:media:MR000050:MR000050-CMP-015.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 15: Physical placebos versus wait‐list or no‐treatment for people with specific mental health disorders continuous data, Outcome 1: Efficacy of all placebos for people with sleep‐wake disorders" data-id="MR000050-fig-0038" src="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/image_n/nMR000050-CMP-015.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/image_t/tMR000050-CMP-015.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 15.1</div> <div class="figure-caption"> <p>Comparison 15: Physical placebos versus wait‐list or no‐treatment for people with specific mental health disorders continuous data, Outcome 1: Efficacy of all placebos for people with sleep‐wake disorders </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/references#MR000050-fig-0038">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/image_n/nMR000050-CMP-015.01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="MR000050-fig-0039"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/urn:x-wiley:14651858:media:MR000050:MR000050-CMP-015.02" target="_blank"><b></b></a></p> </div><img alt="Comparison 15: Physical placebos versus wait‐list or no‐treatment for people with specific mental health disorders continuous data, Outcome 2: Efficacy of all placebos for people with depression" data-id="MR000050-fig-0039" src="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/image_n/nMR000050-CMP-015.02.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/image_t/tMR000050-CMP-015.02.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 15.2</div> <div class="figure-caption"> <p>Comparison 15: Physical placebos versus wait‐list or no‐treatment for people with specific mental health disorders continuous data, Outcome 2: Efficacy of all placebos for people with depression </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/references#MR000050-fig-0039">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/image_n/nMR000050-CMP-015.02.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="MR000050-fig-0040"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/urn:x-wiley:14651858:media:MR000050:MR000050-CMP-015.03" target="_blank"><b></b></a></p> </div><img alt="Comparison 15: Physical placebos versus wait‐list or no‐treatment for people with specific mental health disorders continuous data, Outcome 3: Efficacy of all placebos for people with anxiety disorders" data-id="MR000050-fig-0040" src="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/image_n/nMR000050-CMP-015.03.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/image_t/tMR000050-CMP-015.03.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 15.3</div> <div class="figure-caption"> <p>Comparison 15: Physical placebos versus wait‐list or no‐treatment for people with specific mental health disorders continuous data, Outcome 3: Efficacy of all placebos for people with anxiety disorders </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/references#MR000050-fig-0040">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/image_n/nMR000050-CMP-015.03.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="MR000050-fig-0041"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/urn:x-wiley:14651858:media:MR000050:MR000050-CMP-016.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 16: Subgroup analyses for all placebos compared with wait‐list or no‐treatment for continuous data, Outcome 1: Type of active intervention" data-id="MR000050-fig-0041" src="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/image_n/nMR000050-CMP-016.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/image_t/tMR000050-CMP-016.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 16.1</div> <div class="figure-caption"> <p>Comparison 16: Subgroup analyses for all placebos compared with wait‐list or no‐treatment for continuous data, Outcome 1: Type of active intervention </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/references#MR000050-fig-0041">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/image_n/nMR000050-CMP-016.01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="MR000050-fig-0042"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/urn:x-wiley:14651858:media:MR000050:MR000050-CMP-016.02" target="_blank"><b></b></a></p> </div><img alt="Comparison 16: Subgroup analyses for all placebos compared with wait‐list or no‐treatment for continuous data, Outcome 2: Type of active intervention" data-id="MR000050-fig-0042" src="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/image_n/nMR000050-CMP-016.02.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/image_t/tMR000050-CMP-016.02.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 16.2</div> <div class="figure-caption"> <p>Comparison 16: Subgroup analyses for all placebos compared with wait‐list or no‐treatment for continuous data, Outcome 2: Type of active intervention </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/references#MR000050-fig-0042">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/image_n/nMR000050-CMP-016.02.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="MR000050-fig-0043"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/urn:x-wiley:14651858:media:MR000050:MR000050-CMP-016.03" target="_blank"><b></b></a></p> </div><img alt="Comparison 16: Subgroup analyses for all placebos compared with wait‐list or no‐treatment for continuous data, Outcome 3: Risk of bias" data-id="MR000050-fig-0043" src="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/image_n/nMR000050-CMP-016.03.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/image_t/tMR000050-CMP-016.03.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 16.3</div> <div class="figure-caption"> <p>Comparison 16: Subgroup analyses for all placebos compared with wait‐list or no‐treatment for continuous data, Outcome 3: Risk of bias </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/references#MR000050-fig-0043">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/image_n/nMR000050-CMP-016.03.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="MR000050-fig-0044"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/urn:x-wiley:14651858:media:MR000050:MR000050-CMP-016.04" target="_blank"><b></b></a></p> </div><img alt="Comparison 16: Subgroup analyses for all placebos compared with wait‐list or no‐treatment for continuous data, Outcome 4: Risk of bias" data-id="MR000050-fig-0044" src="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/image_n/nMR000050-CMP-016.04.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/image_t/tMR000050-CMP-016.04.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 16.4</div> <div class="figure-caption"> <p>Comparison 16: Subgroup analyses for all placebos compared with wait‐list or no‐treatment for continuous data, Outcome 4: Risk of bias </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/references#MR000050-fig-0044">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/image_n/nMR000050-CMP-016.04.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="MR000050-fig-0045"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/urn:x-wiley:14651858:media:MR000050:MR000050-CMP-016.05" target="_blank"><b></b></a></p> </div><img alt="Comparison 16: Subgroup analyses for all placebos compared with wait‐list or no‐treatment for continuous data, Outcome 5: Type of outcome domain" data-id="MR000050-fig-0045" src="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/image_n/nMR000050-CMP-016.05.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/image_t/tMR000050-CMP-016.05.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 16.5</div> <div class="figure-caption"> <p>Comparison 16: Subgroup analyses for all placebos compared with wait‐list or no‐treatment for continuous data, Outcome 5: Type of outcome domain </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/references#MR000050-fig-0045">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/image_n/nMR000050-CMP-016.05.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="MR000050-fig-0046"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/urn:x-wiley:14651858:media:MR000050:MR000050-CMP-016.06" target="_blank"><b></b></a></p> </div><img alt="Comparison 16: Subgroup analyses for all placebos compared with wait‐list or no‐treatment for continuous data, Outcome 6: Type of outcome domain" data-id="MR000050-fig-0046" src="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/image_n/nMR000050-CMP-016.06.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/image_t/tMR000050-CMP-016.06.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 16.6</div> <div class="figure-caption"> <p>Comparison 16: Subgroup analyses for all placebos compared with wait‐list or no‐treatment for continuous data, Outcome 6: Type of outcome domain </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/references#MR000050-fig-0046">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/image_n/nMR000050-CMP-016.06.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="MR000050-fig-0047"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/urn:x-wiley:14651858:media:MR000050:MR000050-CMP-016.07" target="_blank"><b></b></a></p> </div><img alt="Comparison 16: Subgroup analyses for all placebos compared with wait‐list or no‐treatment for continuous data, Outcome 7: Awareness of placebo intervention" data-id="MR000050-fig-0047" src="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/image_n/nMR000050-CMP-016.07.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/image_t/tMR000050-CMP-016.07.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 16.7</div> <div class="figure-caption"> <p>Comparison 16: Subgroup analyses for all placebos compared with wait‐list or no‐treatment for continuous data, Outcome 7: Awareness of placebo intervention </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/references#MR000050-fig-0047">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/image_n/nMR000050-CMP-016.07.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="MR000050-fig-0048"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/urn:x-wiley:14651858:media:MR000050:MR000050-CMP-016.08" target="_blank"><b></b></a></p> </div><img alt="Comparison 16: Subgroup analyses for all placebos compared with wait‐list or no‐treatment for continuous data, Outcome 8: Awareness of placebo intervention" data-id="MR000050-fig-0048" src="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/image_n/nMR000050-CMP-016.08.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/image_t/tMR000050-CMP-016.08.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 16.8</div> <div class="figure-caption"> <p>Comparison 16: Subgroup analyses for all placebos compared with wait‐list or no‐treatment for continuous data, Outcome 8: Awareness of placebo intervention </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/references#MR000050-fig-0048">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/image_n/nMR000050-CMP-016.08.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="MR000050-fig-0049"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/urn:x-wiley:14651858:media:MR000050:MR000050-CMP-016.09" target="_blank"><b></b></a></p> </div><img alt="Comparison 16: Subgroup analyses for all placebos compared with wait‐list or no‐treatment for continuous data, Outcome 9: The trial objective" data-id="MR000050-fig-0049" src="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/image_n/nMR000050-CMP-016.09.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/image_t/tMR000050-CMP-016.09.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 16.9</div> <div class="figure-caption"> <p>Comparison 16: Subgroup analyses for all placebos compared with wait‐list or no‐treatment for continuous data, Outcome 9: The trial objective </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/references#MR000050-fig-0049">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/image_n/nMR000050-CMP-016.09.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="MR000050-fig-0050"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/urn:x-wiley:14651858:media:MR000050:MR000050-CMP-016.10" target="_blank"><b></b></a></p> </div><img alt="Comparison 16: Subgroup analyses for all placebos compared with wait‐list or no‐treatment for continuous data, Outcome 10: The trial objective" data-id="MR000050-fig-0050" src="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/image_n/nMR000050-CMP-016.10.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/image_t/tMR000050-CMP-016.10.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 16.10</div> <div class="figure-caption"> <p>Comparison 16: Subgroup analyses for all placebos compared with wait‐list or no‐treatment for continuous data, Outcome 10: The trial objective </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/references#MR000050-fig-0050">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/image_n/nMR000050-CMP-016.10.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="MR000050-fig-0051"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/urn:x-wiley:14651858:media:MR000050:MR000050-CMP-016.11" target="_blank"><b></b></a></p> </div><img alt="Comparison 16: Subgroup analyses for all placebos compared with wait‐list or no‐treatment for continuous data, Outcome 11: Mean age of participants" data-id="MR000050-fig-0051" src="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/image_n/nMR000050-CMP-016.11.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/image_t/tMR000050-CMP-016.11.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 16.11</div> <div class="figure-caption"> <p>Comparison 16: Subgroup analyses for all placebos compared with wait‐list or no‐treatment for continuous data, Outcome 11: Mean age of participants </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/references#MR000050-fig-0051">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/image_n/nMR000050-CMP-016.11.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="MR000050-fig-0052"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/urn:x-wiley:14651858:media:MR000050:MR000050-CMP-016.12" target="_blank"><b></b></a></p> </div><img alt="Comparison 16: Subgroup analyses for all placebos compared with wait‐list or no‐treatment for continuous data, Outcome 12: Mean age of participants" data-id="MR000050-fig-0052" src="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/image_n/nMR000050-CMP-016.12.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/image_t/tMR000050-CMP-016.12.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 16.12</div> <div class="figure-caption"> <p>Comparison 16: Subgroup analyses for all placebos compared with wait‐list or no‐treatment for continuous data, Outcome 12: Mean age of participants </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/references#MR000050-fig-0052">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/image_n/nMR000050-CMP-016.12.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="MR000050-fig-0053"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/urn:x-wiley:14651858:media:MR000050:MR000050-CMP-016.13" target="_blank"><b></b></a></p> </div><img alt="Comparison 16: Subgroup analyses for all placebos compared with wait‐list or no‐treatment for continuous data, Outcome 13: Duration of treatment" data-id="MR000050-fig-0053" src="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/image_n/nMR000050-CMP-016.13.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/image_t/tMR000050-CMP-016.13.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 16.13</div> <div class="figure-caption"> <p>Comparison 16: Subgroup analyses for all placebos compared with wait‐list or no‐treatment for continuous data, Outcome 13: Duration of treatment </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/references#MR000050-fig-0053">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/image_n/nMR000050-CMP-016.13.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="MR000050-fig-0054"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/urn:x-wiley:14651858:media:MR000050:MR000050-CMP-016.14" target="_blank"><b></b></a></p> </div><img alt="Comparison 16: Subgroup analyses for all placebos compared with wait‐list or no‐treatment for continuous data, Outcome 14: Duration of treatment" data-id="MR000050-fig-0054" src="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/image_n/nMR000050-CMP-016.14.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/image_t/tMR000050-CMP-016.14.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 16.14</div> <div class="figure-caption"> <p>Comparison 16: Subgroup analyses for all placebos compared with wait‐list or no‐treatment for continuous data, Outcome 14: Duration of treatment </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/references#MR000050-fig-0054">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/image_n/nMR000050-CMP-016.14.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="MR000050-fig-0055"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/urn:x-wiley:14651858:media:MR000050:MR000050-CMP-016.15" target="_blank"><b></b></a></p> </div><img alt="Comparison 16: Subgroup analyses for all placebos compared with wait‐list or no‐treatment for continuous data, Outcome 15: Mental health diagnoses" data-id="MR000050-fig-0055" src="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/image_n/nMR000050-CMP-016.15.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/image_t/tMR000050-CMP-016.15.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 16.15</div> <div class="figure-caption"> <p>Comparison 16: Subgroup analyses for all placebos compared with wait‐list or no‐treatment for continuous data, Outcome 15: Mental health diagnoses </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/references#MR000050-fig-0055">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/image_n/nMR000050-CMP-016.15.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="MR000050-fig-0056"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/urn:x-wiley:14651858:media:MR000050:MR000050-CMP-016.16" target="_blank"><b></b></a></p> </div><img alt="Comparison 16: Subgroup analyses for all placebos compared with wait‐list or no‐treatment for continuous data, Outcome 16: Mental health diagnoses" data-id="MR000050-fig-0056" src="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/image_n/nMR000050-CMP-016.16.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/image_t/tMR000050-CMP-016.16.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 16.16</div> <div class="figure-caption"> <p>Comparison 16: Subgroup analyses for all placebos compared with wait‐list or no‐treatment for continuous data, Outcome 16: Mental health diagnoses </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/references#MR000050-fig-0056">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/image_n/nMR000050-CMP-016.16.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="MR000050-fig-0057"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/urn:x-wiley:14651858:media:MR000050:MR000050-CMP-016.17" target="_blank"><b></b></a></p> </div><img alt="Comparison 16: Subgroup analyses for all placebos compared with wait‐list or no‐treatment for continuous data, Outcome 17: Affiliation bias" data-id="MR000050-fig-0057" src="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/image_n/nMR000050-CMP-016.17.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/image_t/tMR000050-CMP-016.17.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 16.17</div> <div class="figure-caption"> <p>Comparison 16: Subgroup analyses for all placebos compared with wait‐list or no‐treatment for continuous data, Outcome 17: Affiliation bias </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/references#MR000050-fig-0057">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/image_n/nMR000050-CMP-016.17.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="MR000050-fig-0058"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/urn:x-wiley:14651858:media:MR000050:MR000050-CMP-016.18" target="_blank"><b></b></a></p> </div><img alt="Comparison 16: Subgroup analyses for all placebos compared with wait‐list or no‐treatment for continuous data, Outcome 18: Risk of bias (participants and personnel excluded)" data-id="MR000050-fig-0058" src="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/image_n/nMR000050-CMP-016.18.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/image_t/tMR000050-CMP-016.18.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 16.18</div> <div class="figure-caption"> <p>Comparison 16: Subgroup analyses for all placebos compared with wait‐list or no‐treatment for continuous data, Outcome 18: Risk of bias (participants and personnel excluded) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/references#MR000050-fig-0058">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/image_n/nMR000050-CMP-016.18.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="MR000050-fig-0059"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/urn:x-wiley:14651858:media:MR000050:MR000050-CMP-016.19" target="_blank"><b></b></a></p> </div><img alt="Comparison 16: Subgroup analyses for all placebos compared with wait‐list or no‐treatment for continuous data, Outcome 19: Imputed data" data-id="MR000050-fig-0059" src="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/image_n/nMR000050-CMP-016.19.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/image_t/tMR000050-CMP-016.19.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 16.19</div> <div class="figure-caption"> <p>Comparison 16: Subgroup analyses for all placebos compared with wait‐list or no‐treatment for continuous data, Outcome 19: Imputed data </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/references#MR000050-fig-0059">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/image_n/nMR000050-CMP-016.19.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="MR000050-fig-0060"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/urn:x-wiley:14651858:media:MR000050:MR000050-CMP-017.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 17: Subgroup analyses for psychological placebos compared with wait‐list or no‐treatment for continuous data, Outcome 1: Type of active intervention" data-id="MR000050-fig-0060" src="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/image_n/nMR000050-CMP-017.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/image_t/tMR000050-CMP-017.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 17.1</div> <div class="figure-caption"> <p>Comparison 17: Subgroup analyses for psychological placebos compared with wait‐list or no‐treatment for continuous data, Outcome 1: Type of active intervention </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/references#MR000050-fig-0060">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/image_n/nMR000050-CMP-017.01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="MR000050-fig-0061"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/urn:x-wiley:14651858:media:MR000050:MR000050-CMP-017.02" target="_blank"><b></b></a></p> </div><img alt="Comparison 17: Subgroup analyses for psychological placebos compared with wait‐list or no‐treatment for continuous data, Outcome 2: Risk of bias" data-id="MR000050-fig-0061" src="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/image_n/nMR000050-CMP-017.02.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/image_t/tMR000050-CMP-017.02.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 17.2</div> <div class="figure-caption"> <p>Comparison 17: Subgroup analyses for psychological placebos compared with wait‐list or no‐treatment for continuous data, Outcome 2: Risk of bias </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/references#MR000050-fig-0061">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/image_n/nMR000050-CMP-017.02.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="MR000050-fig-0062"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/urn:x-wiley:14651858:media:MR000050:MR000050-CMP-017.03" target="_blank"><b></b></a></p> </div><img alt="Comparison 17: Subgroup analyses for psychological placebos compared with wait‐list or no‐treatment for continuous data, Outcome 3: Type of outcome domain" data-id="MR000050-fig-0062" src="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/image_n/nMR000050-CMP-017.03.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/image_t/tMR000050-CMP-017.03.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 17.3</div> <div class="figure-caption"> <p>Comparison 17: Subgroup analyses for psychological placebos compared with wait‐list or no‐treatment for continuous data, Outcome 3: Type of outcome domain </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/references#MR000050-fig-0062">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/image_n/nMR000050-CMP-017.03.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="MR000050-fig-0063"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/urn:x-wiley:14651858:media:MR000050:MR000050-CMP-017.04" target="_blank"><b></b></a></p> </div><img alt="Comparison 17: Subgroup analyses for psychological placebos compared with wait‐list or no‐treatment for continuous data, Outcome 4: Awareness of placebo intervention" data-id="MR000050-fig-0063" src="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/image_n/nMR000050-CMP-017.04.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/image_t/tMR000050-CMP-017.04.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 17.4</div> <div class="figure-caption"> <p>Comparison 17: Subgroup analyses for psychological placebos compared with wait‐list or no‐treatment for continuous data, Outcome 4: Awareness of placebo intervention </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/references#MR000050-fig-0063">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/image_n/nMR000050-CMP-017.04.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="MR000050-fig-0064"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/urn:x-wiley:14651858:media:MR000050:MR000050-CMP-017.05" target="_blank"><b></b></a></p> </div><img alt="Comparison 17: Subgroup analyses for psychological placebos compared with wait‐list or no‐treatment for continuous data, Outcome 5: The trial objective" data-id="MR000050-fig-0064" src="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/image_n/nMR000050-CMP-017.05.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/image_t/tMR000050-CMP-017.05.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 17.5</div> <div class="figure-caption"> <p>Comparison 17: Subgroup analyses for psychological placebos compared with wait‐list or no‐treatment for continuous data, Outcome 5: The trial objective </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/references#MR000050-fig-0064">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/image_n/nMR000050-CMP-017.05.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="MR000050-fig-0065"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/urn:x-wiley:14651858:media:MR000050:MR000050-CMP-017.06" target="_blank"><b></b></a></p> </div><img alt="Comparison 17: Subgroup analyses for psychological placebos compared with wait‐list or no‐treatment for continuous data, Outcome 6: Mean age of participants" data-id="MR000050-fig-0065" src="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/image_n/nMR000050-CMP-017.06.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/image_t/tMR000050-CMP-017.06.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 17.6</div> <div class="figure-caption"> <p>Comparison 17: Subgroup analyses for psychological placebos compared with wait‐list or no‐treatment for continuous data, Outcome 6: Mean age of participants </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/references#MR000050-fig-0065">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/image_n/nMR000050-CMP-017.06.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="MR000050-fig-0066"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/urn:x-wiley:14651858:media:MR000050:MR000050-CMP-017.07" target="_blank"><b></b></a></p> </div><img alt="Comparison 17: Subgroup analyses for psychological placebos compared with wait‐list or no‐treatment for continuous data, Outcome 7: Duration of treatment" data-id="MR000050-fig-0066" src="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/image_n/nMR000050-CMP-017.07.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/image_t/tMR000050-CMP-017.07.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 17.7</div> <div class="figure-caption"> <p>Comparison 17: Subgroup analyses for psychological placebos compared with wait‐list or no‐treatment for continuous data, Outcome 7: Duration of treatment </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/references#MR000050-fig-0066">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/image_n/nMR000050-CMP-017.07.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="MR000050-fig-0067"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/urn:x-wiley:14651858:media:MR000050:MR000050-CMP-017.08" target="_blank"><b></b></a></p> </div><img alt="Comparison 17: Subgroup analyses for psychological placebos compared with wait‐list or no‐treatment for continuous data, Outcome 8: Type of psychological placebo" data-id="MR000050-fig-0067" src="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/image_n/nMR000050-CMP-017.08.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/image_t/tMR000050-CMP-017.08.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 17.8</div> <div class="figure-caption"> <p>Comparison 17: Subgroup analyses for psychological placebos compared with wait‐list or no‐treatment for continuous data, Outcome 8: Type of psychological placebo </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/references#MR000050-fig-0067">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/image_n/nMR000050-CMP-017.08.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="MR000050-fig-0068"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/urn:x-wiley:14651858:media:MR000050:MR000050-CMP-017.09" target="_blank"><b></b></a></p> </div><img alt="Comparison 17: Subgroup analyses for psychological placebos compared with wait‐list or no‐treatment for continuous data, Outcome 9: Mode of psychological placebo" data-id="MR000050-fig-0068" src="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/image_n/nMR000050-CMP-017.09.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/image_t/tMR000050-CMP-017.09.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 17.9</div> <div class="figure-caption"> <p>Comparison 17: Subgroup analyses for psychological placebos compared with wait‐list or no‐treatment for continuous data, Outcome 9: Mode of psychological placebo </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/references#MR000050-fig-0068">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/image_n/nMR000050-CMP-017.09.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="MR000050-fig-0069"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/urn:x-wiley:14651858:media:MR000050:MR000050-CMP-017.10" target="_blank"><b></b></a></p> </div><img alt="Comparison 17: Subgroup analyses for psychological placebos compared with wait‐list or no‐treatment for continuous data, Outcome 10: Mental health diagnoses" data-id="MR000050-fig-0069" src="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/image_n/nMR000050-CMP-017.10.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/image_t/tMR000050-CMP-017.10.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 17.10</div> <div class="figure-caption"> <p>Comparison 17: Subgroup analyses for psychological placebos compared with wait‐list or no‐treatment for continuous data, Outcome 10: Mental health diagnoses </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/references#MR000050-fig-0069">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/image_n/nMR000050-CMP-017.10.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="MR000050-fig-0070"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/urn:x-wiley:14651858:media:MR000050:MR000050-CMP-017.11" target="_blank"><b></b></a></p> </div><img alt="Comparison 17: Subgroup analyses for psychological placebos compared with wait‐list or no‐treatment for continuous data, Outcome 11: Affiliation bias" data-id="MR000050-fig-0070" src="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/image_n/nMR000050-CMP-017.11.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/image_t/tMR000050-CMP-017.11.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 17.11</div> <div class="figure-caption"> <p>Comparison 17: Subgroup analyses for psychological placebos compared with wait‐list or no‐treatment for continuous data, Outcome 11: Affiliation bias </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/references#MR000050-fig-0070">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/image_n/nMR000050-CMP-017.11.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="MR000050-fig-0071"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/urn:x-wiley:14651858:media:MR000050:MR000050-CMP-017.12" target="_blank"><b></b></a></p> </div><img alt="Comparison 17: Subgroup analyses for psychological placebos compared with wait‐list or no‐treatment for continuous data, Outcome 12: Imputed data" data-id="MR000050-fig-0071" src="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/image_n/nMR000050-CMP-017.12.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/image_t/tMR000050-CMP-017.12.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 17.12</div> <div class="figure-caption"> <p>Comparison 17: Subgroup analyses for psychological placebos compared with wait‐list or no‐treatment for continuous data, Outcome 12: Imputed data </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/references#MR000050-fig-0071">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/image_n/nMR000050-CMP-017.12.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="MR000050-fig-0072"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/urn:x-wiley:14651858:media:MR000050:MR000050-CMP-018.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 18: Subgroup analyses for pharmacological placebos compared with wait‐list or no‐treatment for continuous data, Outcome 1: Type of active intervention" data-id="MR000050-fig-0072" src="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/image_n/nMR000050-CMP-018.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/image_t/tMR000050-CMP-018.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 18.1</div> <div class="figure-caption"> <p>Comparison 18: Subgroup analyses for pharmacological placebos compared with wait‐list or no‐treatment for continuous data, Outcome 1: Type of active intervention </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/references#MR000050-fig-0072">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/image_n/nMR000050-CMP-018.01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="MR000050-fig-0073"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/urn:x-wiley:14651858:media:MR000050:MR000050-CMP-018.02" target="_blank"><b></b></a></p> </div><img alt="Comparison 18: Subgroup analyses for pharmacological placebos compared with wait‐list or no‐treatment for continuous data, Outcome 2: Type of active intervention" data-id="MR000050-fig-0073" src="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/image_n/nMR000050-CMP-018.02.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/image_t/tMR000050-CMP-018.02.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 18.2</div> <div class="figure-caption"> <p>Comparison 18: Subgroup analyses for pharmacological placebos compared with wait‐list or no‐treatment for continuous data, Outcome 2: Type of active intervention </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/references#MR000050-fig-0073">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/image_n/nMR000050-CMP-018.02.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="MR000050-fig-0074"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/urn:x-wiley:14651858:media:MR000050:MR000050-CMP-018.03" target="_blank"><b></b></a></p> </div><img alt="Comparison 18: Subgroup analyses for pharmacological placebos compared with wait‐list or no‐treatment for continuous data, Outcome 3: Risk of bias" data-id="MR000050-fig-0074" src="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/image_n/nMR000050-CMP-018.03.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/image_t/tMR000050-CMP-018.03.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 18.3</div> <div class="figure-caption"> <p>Comparison 18: Subgroup analyses for pharmacological placebos compared with wait‐list or no‐treatment for continuous data, Outcome 3: Risk of bias </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/references#MR000050-fig-0074">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/image_n/nMR000050-CMP-018.03.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="MR000050-fig-0075"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/urn:x-wiley:14651858:media:MR000050:MR000050-CMP-018.04" target="_blank"><b></b></a></p> </div><img alt="Comparison 18: Subgroup analyses for pharmacological placebos compared with wait‐list or no‐treatment for continuous data, Outcome 4: Risk of bias" data-id="MR000050-fig-0075" src="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/image_n/nMR000050-CMP-018.04.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/image_t/tMR000050-CMP-018.04.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 18.4</div> <div class="figure-caption"> <p>Comparison 18: Subgroup analyses for pharmacological placebos compared with wait‐list or no‐treatment for continuous data, Outcome 4: Risk of bias </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/references#MR000050-fig-0075">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/image_n/nMR000050-CMP-018.04.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="MR000050-fig-0076"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/urn:x-wiley:14651858:media:MR000050:MR000050-CMP-018.05" target="_blank"><b></b></a></p> </div><img alt="Comparison 18: Subgroup analyses for pharmacological placebos compared with wait‐list or no‐treatment for continuous data, Outcome 5: Type of outcome domain" data-id="MR000050-fig-0076" src="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/image_n/nMR000050-CMP-018.05.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/image_t/tMR000050-CMP-018.05.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 18.5</div> <div class="figure-caption"> <p>Comparison 18: Subgroup analyses for pharmacological placebos compared with wait‐list or no‐treatment for continuous data, Outcome 5: Type of outcome domain </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/references#MR000050-fig-0076">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/image_n/nMR000050-CMP-018.05.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="MR000050-fig-0077"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/urn:x-wiley:14651858:media:MR000050:MR000050-CMP-018.06" target="_blank"><b></b></a></p> </div><img alt="Comparison 18: Subgroup analyses for pharmacological placebos compared with wait‐list or no‐treatment for continuous data, Outcome 6: Type of outcome domain" data-id="MR000050-fig-0077" src="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/image_n/nMR000050-CMP-018.06.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/image_t/tMR000050-CMP-018.06.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 18.6</div> <div class="figure-caption"> <p>Comparison 18: Subgroup analyses for pharmacological placebos compared with wait‐list or no‐treatment for continuous data, Outcome 6: Type of outcome domain </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/references#MR000050-fig-0077">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/image_n/nMR000050-CMP-018.06.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="MR000050-fig-0078"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/urn:x-wiley:14651858:media:MR000050:MR000050-CMP-018.07" target="_blank"><b></b></a></p> </div><img alt="Comparison 18: Subgroup analyses for pharmacological placebos compared with wait‐list or no‐treatment for continuous data, Outcome 7: Awareness of placebo intervention" data-id="MR000050-fig-0078" src="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/image_n/nMR000050-CMP-018.07.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/image_t/tMR000050-CMP-018.07.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 18.7</div> <div class="figure-caption"> <p>Comparison 18: Subgroup analyses for pharmacological placebos compared with wait‐list or no‐treatment for continuous data, Outcome 7: Awareness of placebo intervention </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/references#MR000050-fig-0078">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/image_n/nMR000050-CMP-018.07.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="MR000050-fig-0079"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/urn:x-wiley:14651858:media:MR000050:MR000050-CMP-018.08" target="_blank"><b></b></a></p> </div><img alt="Comparison 18: Subgroup analyses for pharmacological placebos compared with wait‐list or no‐treatment for continuous data, Outcome 8: Awareness of placebo intervention" data-id="MR000050-fig-0079" src="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/image_n/nMR000050-CMP-018.08.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/image_t/tMR000050-CMP-018.08.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 18.8</div> <div class="figure-caption"> <p>Comparison 18: Subgroup analyses for pharmacological placebos compared with wait‐list or no‐treatment for continuous data, Outcome 8: Awareness of placebo intervention </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/references#MR000050-fig-0079">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/image_n/nMR000050-CMP-018.08.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="MR000050-fig-0080"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/urn:x-wiley:14651858:media:MR000050:MR000050-CMP-018.09" target="_blank"><b></b></a></p> </div><img alt="Comparison 18: Subgroup analyses for pharmacological placebos compared with wait‐list or no‐treatment for continuous data, Outcome 9: The trial objective" data-id="MR000050-fig-0080" src="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/image_n/nMR000050-CMP-018.09.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/image_t/tMR000050-CMP-018.09.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 18.9</div> <div class="figure-caption"> <p>Comparison 18: Subgroup analyses for pharmacological placebos compared with wait‐list or no‐treatment for continuous data, Outcome 9: The trial objective </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/references#MR000050-fig-0080">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/image_n/nMR000050-CMP-018.09.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="MR000050-fig-0081"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/urn:x-wiley:14651858:media:MR000050:MR000050-CMP-018.10" target="_blank"><b></b></a></p> </div><img alt="Comparison 18: Subgroup analyses for pharmacological placebos compared with wait‐list or no‐treatment for continuous data, Outcome 10: The trial objective" data-id="MR000050-fig-0081" src="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/image_n/nMR000050-CMP-018.10.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/image_t/tMR000050-CMP-018.10.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 18.10</div> <div class="figure-caption"> <p>Comparison 18: Subgroup analyses for pharmacological placebos compared with wait‐list or no‐treatment for continuous data, Outcome 10: The trial objective </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/references#MR000050-fig-0081">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/image_n/nMR000050-CMP-018.10.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="MR000050-fig-0082"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/urn:x-wiley:14651858:media:MR000050:MR000050-CMP-018.11" target="_blank"><b></b></a></p> </div><img alt="Comparison 18: Subgroup analyses for pharmacological placebos compared with wait‐list or no‐treatment for continuous data, Outcome 11: Mean age of participants" data-id="MR000050-fig-0082" src="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/image_n/nMR000050-CMP-018.11.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/image_t/tMR000050-CMP-018.11.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 18.11</div> <div class="figure-caption"> <p>Comparison 18: Subgroup analyses for pharmacological placebos compared with wait‐list or no‐treatment for continuous data, Outcome 11: Mean age of participants </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/references#MR000050-fig-0082">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/image_n/nMR000050-CMP-018.11.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="MR000050-fig-0083"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/urn:x-wiley:14651858:media:MR000050:MR000050-CMP-018.12" target="_blank"><b></b></a></p> </div><img alt="Comparison 18: Subgroup analyses for pharmacological placebos compared with wait‐list or no‐treatment for continuous data, Outcome 12: Mean age of participants" data-id="MR000050-fig-0083" src="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/image_n/nMR000050-CMP-018.12.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/image_t/tMR000050-CMP-018.12.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 18.12</div> <div class="figure-caption"> <p>Comparison 18: Subgroup analyses for pharmacological placebos compared with wait‐list or no‐treatment for continuous data, Outcome 12: Mean age of participants </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/references#MR000050-fig-0083">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/image_n/nMR000050-CMP-018.12.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="MR000050-fig-0084"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/urn:x-wiley:14651858:media:MR000050:MR000050-CMP-018.13" target="_blank"><b></b></a></p> </div><img alt="Comparison 18: Subgroup analyses for pharmacological placebos compared with wait‐list or no‐treatment for continuous data, Outcome 13: Duration of treatment" data-id="MR000050-fig-0084" src="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/image_n/nMR000050-CMP-018.13.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/image_t/tMR000050-CMP-018.13.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 18.13</div> <div class="figure-caption"> <p>Comparison 18: Subgroup analyses for pharmacological placebos compared with wait‐list or no‐treatment for continuous data, Outcome 13: Duration of treatment </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/references#MR000050-fig-0084">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/image_n/nMR000050-CMP-018.13.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="MR000050-fig-0085"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/urn:x-wiley:14651858:media:MR000050:MR000050-CMP-018.14" target="_blank"><b></b></a></p> </div><img alt="Comparison 18: Subgroup analyses for pharmacological placebos compared with wait‐list or no‐treatment for continuous data, Outcome 14: Duration of treatment" data-id="MR000050-fig-0085" src="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/image_n/nMR000050-CMP-018.14.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/image_t/tMR000050-CMP-018.14.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 18.14</div> <div class="figure-caption"> <p>Comparison 18: Subgroup analyses for pharmacological placebos compared with wait‐list or no‐treatment for continuous data, Outcome 14: Duration of treatment </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/references#MR000050-fig-0085">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/image_n/nMR000050-CMP-018.14.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="MR000050-fig-0086"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/urn:x-wiley:14651858:media:MR000050:MR000050-CMP-018.15" target="_blank"><b></b></a></p> </div><img alt="Comparison 18: Subgroup analyses for pharmacological placebos compared with wait‐list or no‐treatment for continuous data, Outcome 15: Mental health diagnoses" data-id="MR000050-fig-0086" src="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/image_n/nMR000050-CMP-018.15.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/image_t/tMR000050-CMP-018.15.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 18.15</div> <div class="figure-caption"> <p>Comparison 18: Subgroup analyses for pharmacological placebos compared with wait‐list or no‐treatment for continuous data, Outcome 15: Mental health diagnoses </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/references#MR000050-fig-0086">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/image_n/nMR000050-CMP-018.15.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="MR000050-fig-0087"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/urn:x-wiley:14651858:media:MR000050:MR000050-CMP-018.16" target="_blank"><b></b></a></p> </div><img alt="Comparison 18: Subgroup analyses for pharmacological placebos compared with wait‐list or no‐treatment for continuous data, Outcome 16: Mental health diagnoses" data-id="MR000050-fig-0087" src="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/image_n/nMR000050-CMP-018.16.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/image_t/tMR000050-CMP-018.16.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 18.16</div> <div class="figure-caption"> <p>Comparison 18: Subgroup analyses for pharmacological placebos compared with wait‐list or no‐treatment for continuous data, Outcome 16: Mental health diagnoses </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/references#MR000050-fig-0087">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/image_n/nMR000050-CMP-018.16.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="MR000050-fig-0088"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/urn:x-wiley:14651858:media:MR000050:MR000050-CMP-018.17" target="_blank"><b></b></a></p> </div><img alt="Comparison 18: Subgroup analyses for pharmacological placebos compared with wait‐list or no‐treatment for continuous data, Outcome 17: Imputed data" data-id="MR000050-fig-0088" src="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/image_n/nMR000050-CMP-018.17.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/image_t/tMR000050-CMP-018.17.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 18.17</div> <div class="figure-caption"> <p>Comparison 18: Subgroup analyses for pharmacological placebos compared with wait‐list or no‐treatment for continuous data, Outcome 17: Imputed data </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/references#MR000050-fig-0088">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/image_n/nMR000050-CMP-018.17.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="MR000050-fig-0089"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/urn:x-wiley:14651858:media:MR000050:MR000050-CMP-019.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 19: Subgroup analyses for physical placebos compared with wait‐list or no‐treatment for continuous data, Outcome 1: Type of active intervention" data-id="MR000050-fig-0089" src="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/image_n/nMR000050-CMP-019.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/image_t/tMR000050-CMP-019.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 19.1</div> <div class="figure-caption"> <p>Comparison 19: Subgroup analyses for physical placebos compared with wait‐list or no‐treatment for continuous data, Outcome 1: Type of active intervention </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/references#MR000050-fig-0089">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/image_n/nMR000050-CMP-019.01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="MR000050-fig-0090"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/urn:x-wiley:14651858:media:MR000050:MR000050-CMP-019.02" target="_blank"><b></b></a></p> </div><img alt="Comparison 19: Subgroup analyses for physical placebos compared with wait‐list or no‐treatment for continuous data, Outcome 2: Risk of bias" data-id="MR000050-fig-0090" src="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/image_n/nMR000050-CMP-019.02.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/image_t/tMR000050-CMP-019.02.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 19.2</div> <div class="figure-caption"> <p>Comparison 19: Subgroup analyses for physical placebos compared with wait‐list or no‐treatment for continuous data, Outcome 2: Risk of bias </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/references#MR000050-fig-0090">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/image_n/nMR000050-CMP-019.02.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="MR000050-fig-0091"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/urn:x-wiley:14651858:media:MR000050:MR000050-CMP-019.03" target="_blank"><b></b></a></p> </div><img alt="Comparison 19: Subgroup analyses for physical placebos compared with wait‐list or no‐treatment for continuous data, Outcome 3: Type of outcome domain" data-id="MR000050-fig-0091" src="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/image_n/nMR000050-CMP-019.03.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/image_t/tMR000050-CMP-019.03.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 19.3</div> <div class="figure-caption"> <p>Comparison 19: Subgroup analyses for physical placebos compared with wait‐list or no‐treatment for continuous data, Outcome 3: Type of outcome domain </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/references#MR000050-fig-0091">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/image_n/nMR000050-CMP-019.03.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="MR000050-fig-0092"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/urn:x-wiley:14651858:media:MR000050:MR000050-CMP-019.04" target="_blank"><b></b></a></p> </div><img alt="Comparison 19: Subgroup analyses for physical placebos compared with wait‐list or no‐treatment for continuous data, Outcome 4: Awareness of placebo intervention" data-id="MR000050-fig-0092" src="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/image_n/nMR000050-CMP-019.04.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/image_t/tMR000050-CMP-019.04.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 19.4</div> <div class="figure-caption"> <p>Comparison 19: Subgroup analyses for physical placebos compared with wait‐list or no‐treatment for continuous data, Outcome 4: Awareness of placebo intervention </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/references#MR000050-fig-0092">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/image_n/nMR000050-CMP-019.04.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="MR000050-fig-0093"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/urn:x-wiley:14651858:media:MR000050:MR000050-CMP-019.05" target="_blank"><b></b></a></p> </div><img alt="Comparison 19: Subgroup analyses for physical placebos compared with wait‐list or no‐treatment for continuous data, Outcome 5: The trial objective" data-id="MR000050-fig-0093" src="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/image_n/nMR000050-CMP-019.05.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/image_t/tMR000050-CMP-019.05.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 19.5</div> <div class="figure-caption"> <p>Comparison 19: Subgroup analyses for physical placebos compared with wait‐list or no‐treatment for continuous data, Outcome 5: The trial objective </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/references#MR000050-fig-0093">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/image_n/nMR000050-CMP-019.05.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="MR000050-fig-0094"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/urn:x-wiley:14651858:media:MR000050:MR000050-CMP-019.06" target="_blank"><b></b></a></p> </div><img alt="Comparison 19: Subgroup analyses for physical placebos compared with wait‐list or no‐treatment for continuous data, Outcome 6: Mean age of participants" data-id="MR000050-fig-0094" src="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/image_n/nMR000050-CMP-019.06.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/image_t/tMR000050-CMP-019.06.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 19.6</div> <div class="figure-caption"> <p>Comparison 19: Subgroup analyses for physical placebos compared with wait‐list or no‐treatment for continuous data, Outcome 6: Mean age of participants </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/references#MR000050-fig-0094">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/image_n/nMR000050-CMP-019.06.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="MR000050-fig-0095"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/urn:x-wiley:14651858:media:MR000050:MR000050-CMP-019.07" target="_blank"><b></b></a></p> </div><img alt="Comparison 19: Subgroup analyses for physical placebos compared with wait‐list or no‐treatment for continuous data, Outcome 7: Duration of treatment" data-id="MR000050-fig-0095" src="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/image_n/nMR000050-CMP-019.07.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/image_t/tMR000050-CMP-019.07.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 19.7</div> <div class="figure-caption"> <p>Comparison 19: Subgroup analyses for physical placebos compared with wait‐list or no‐treatment for continuous data, Outcome 7: Duration of treatment </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/references#MR000050-fig-0095">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/image_n/nMR000050-CMP-019.07.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="MR000050-fig-0096"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/urn:x-wiley:14651858:media:MR000050:MR000050-CMP-019.08" target="_blank"><b></b></a></p> </div><img alt="Comparison 19: Subgroup analyses for physical placebos compared with wait‐list or no‐treatment for continuous data, Outcome 8: Type of physical placebo" data-id="MR000050-fig-0096" src="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/image_n/nMR000050-CMP-019.08.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/image_t/tMR000050-CMP-019.08.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 19.8</div> <div class="figure-caption"> <p>Comparison 19: Subgroup analyses for physical placebos compared with wait‐list or no‐treatment for continuous data, Outcome 8: Type of physical placebo </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/references#MR000050-fig-0096">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/image_n/nMR000050-CMP-019.08.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="MR000050-fig-0097"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/urn:x-wiley:14651858:media:MR000050:MR000050-CMP-019.09" target="_blank"><b></b></a></p> </div><img alt="Comparison 19: Subgroup analyses for physical placebos compared with wait‐list or no‐treatment for continuous data, Outcome 9: Mental health diagnoses" data-id="MR000050-fig-0097" src="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/image_n/nMR000050-CMP-019.09.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/image_t/tMR000050-CMP-019.09.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 19.9</div> <div class="figure-caption"> <p>Comparison 19: Subgroup analyses for physical placebos compared with wait‐list or no‐treatment for continuous data, Outcome 9: Mental health diagnoses </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/references#MR000050-fig-0097">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/image_n/nMR000050-CMP-019.09.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="MR000050-fig-0098"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/urn:x-wiley:14651858:media:MR000050:MR000050-CMP-019.10" target="_blank"><b></b></a></p> </div><img alt="Comparison 19: Subgroup analyses for physical placebos compared with wait‐list or no‐treatment for continuous data, Outcome 10: Imputed data" data-id="MR000050-fig-0098" src="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/image_n/nMR000050-CMP-019.10.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/image_t/tMR000050-CMP-019.10.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 19.10</div> <div class="figure-caption"> <p>Comparison 19: Subgroup analyses for physical placebos compared with wait‐list or no‐treatment for continuous data, Outcome 10: Imputed data </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/references#MR000050-fig-0098">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/image_n/nMR000050-CMP-019.10.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="MR000050-fig-0099"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/urn:x-wiley:14651858:media:MR000050:MR000050-CMP-020.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 20: Subgroup analyses for usual care compared with wait‐list or no‐treatment for continuous data, Outcome 1: Type of active intervention" data-id="MR000050-fig-0099" src="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/image_n/nMR000050-CMP-020.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/image_t/tMR000050-CMP-020.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 20.1</div> <div class="figure-caption"> <p>Comparison 20: Subgroup analyses for usual care compared with wait‐list or no‐treatment for continuous data, Outcome 1: Type of active intervention </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/references#MR000050-fig-0099">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/image_n/nMR000050-CMP-020.01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="MR000050-fig-0100"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/urn:x-wiley:14651858:media:MR000050:MR000050-CMP-020.02" target="_blank"><b></b></a></p> </div><img alt="Comparison 20: Subgroup analyses for usual care compared with wait‐list or no‐treatment for continuous data, Outcome 2: Type of active intervention" data-id="MR000050-fig-0100" src="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/image_n/nMR000050-CMP-020.02.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/image_t/tMR000050-CMP-020.02.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 20.2</div> <div class="figure-caption"> <p>Comparison 20: Subgroup analyses for usual care compared with wait‐list or no‐treatment for continuous data, Outcome 2: Type of active intervention </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/references#MR000050-fig-0100">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/image_n/nMR000050-CMP-020.02.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="MR000050-fig-0101"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/urn:x-wiley:14651858:media:MR000050:MR000050-CMP-020.03" target="_blank"><b></b></a></p> </div><img alt="Comparison 20: Subgroup analyses for usual care compared with wait‐list or no‐treatment for continuous data, Outcome 3: Risk of bias" data-id="MR000050-fig-0101" src="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/image_n/nMR000050-CMP-020.03.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/image_t/tMR000050-CMP-020.03.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 20.3</div> <div class="figure-caption"> <p>Comparison 20: Subgroup analyses for usual care compared with wait‐list or no‐treatment for continuous data, Outcome 3: Risk of bias </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/references#MR000050-fig-0101">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/image_n/nMR000050-CMP-020.03.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="MR000050-fig-0102"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/urn:x-wiley:14651858:media:MR000050:MR000050-CMP-020.04" target="_blank"><b></b></a></p> </div><img alt="Comparison 20: Subgroup analyses for usual care compared with wait‐list or no‐treatment for continuous data, Outcome 4: Risk of bias" data-id="MR000050-fig-0102" src="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/image_n/nMR000050-CMP-020.04.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/image_t/tMR000050-CMP-020.04.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 20.4</div> <div class="figure-caption"> <p>Comparison 20: Subgroup analyses for usual care compared with wait‐list or no‐treatment for continuous data, Outcome 4: Risk of bias </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/references#MR000050-fig-0102">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/image_n/nMR000050-CMP-020.04.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="MR000050-fig-0103"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/urn:x-wiley:14651858:media:MR000050:MR000050-CMP-020.05" target="_blank"><b></b></a></p> </div><img alt="Comparison 20: Subgroup analyses for usual care compared with wait‐list or no‐treatment for continuous data, Outcome 5: Type of outcome domain" data-id="MR000050-fig-0103" src="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/image_n/nMR000050-CMP-020.05.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/image_t/tMR000050-CMP-020.05.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 20.5</div> <div class="figure-caption"> <p>Comparison 20: Subgroup analyses for usual care compared with wait‐list or no‐treatment for continuous data, Outcome 5: Type of outcome domain </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/references#MR000050-fig-0103">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/image_n/nMR000050-CMP-020.05.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="MR000050-fig-0104"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/urn:x-wiley:14651858:media:MR000050:MR000050-CMP-020.06" target="_blank"><b></b></a></p> </div><img alt="Comparison 20: Subgroup analyses for usual care compared with wait‐list or no‐treatment for continuous data, Outcome 6: Mean age of participants" data-id="MR000050-fig-0104" src="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/image_n/nMR000050-CMP-020.06.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/image_t/tMR000050-CMP-020.06.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 20.6</div> <div class="figure-caption"> <p>Comparison 20: Subgroup analyses for usual care compared with wait‐list or no‐treatment for continuous data, Outcome 6: Mean age of participants </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/references#MR000050-fig-0104">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/image_n/nMR000050-CMP-020.06.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="MR000050-fig-0105"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/urn:x-wiley:14651858:media:MR000050:MR000050-CMP-020.07" target="_blank"><b></b></a></p> </div><img alt="Comparison 20: Subgroup analyses for usual care compared with wait‐list or no‐treatment for continuous data, Outcome 7: Duration of treatment" data-id="MR000050-fig-0105" src="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/image_n/nMR000050-CMP-020.07.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/image_t/tMR000050-CMP-020.07.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 20.7</div> <div class="figure-caption"> <p>Comparison 20: Subgroup analyses for usual care compared with wait‐list or no‐treatment for continuous data, Outcome 7: Duration of treatment </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/references#MR000050-fig-0105">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/image_n/nMR000050-CMP-020.07.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="MR000050-fig-0106"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/urn:x-wiley:14651858:media:MR000050:MR000050-CMP-020.08" target="_blank"><b></b></a></p> </div><img alt="Comparison 20: Subgroup analyses for usual care compared with wait‐list or no‐treatment for continuous data, Outcome 8: Duration of treatment" data-id="MR000050-fig-0106" src="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/image_n/nMR000050-CMP-020.08.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/image_t/tMR000050-CMP-020.08.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 20.8</div> <div class="figure-caption"> <p>Comparison 20: Subgroup analyses for usual care compared with wait‐list or no‐treatment for continuous data, Outcome 8: Duration of treatment </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/references#MR000050-fig-0106">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/image_n/nMR000050-CMP-020.08.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="MR000050-fig-0107"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/urn:x-wiley:14651858:media:MR000050:MR000050-CMP-020.09" target="_blank"><b></b></a></p> </div><img alt="Comparison 20: Subgroup analyses for usual care compared with wait‐list or no‐treatment for continuous data, Outcome 9: Type of usual care" data-id="MR000050-fig-0107" src="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/image_n/nMR000050-CMP-020.09.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/image_t/tMR000050-CMP-020.09.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 20.9</div> <div class="figure-caption"> <p>Comparison 20: Subgroup analyses for usual care compared with wait‐list or no‐treatment for continuous data, Outcome 9: Type of usual care </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/references#MR000050-fig-0107">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/image_n/nMR000050-CMP-020.09.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="MR000050-fig-0108"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/urn:x-wiley:14651858:media:MR000050:MR000050-CMP-020.10" target="_blank"><b></b></a></p> </div><img alt="Comparison 20: Subgroup analyses for usual care compared with wait‐list or no‐treatment for continuous data, Outcome 10: Type of usual care" data-id="MR000050-fig-0108" src="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/image_n/nMR000050-CMP-020.10.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/image_t/tMR000050-CMP-020.10.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 20.10</div> <div class="figure-caption"> <p>Comparison 20: Subgroup analyses for usual care compared with wait‐list or no‐treatment for continuous data, Outcome 10: Type of usual care </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/references#MR000050-fig-0108">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/image_n/nMR000050-CMP-020.10.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="MR000050-fig-0109"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/urn:x-wiley:14651858:media:MR000050:MR000050-CMP-020.11" target="_blank"><b></b></a></p> </div><img alt="Comparison 20: Subgroup analyses for usual care compared with wait‐list or no‐treatment for continuous data, Outcome 11: Standarised usual care" data-id="MR000050-fig-0109" src="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/image_n/nMR000050-CMP-020.11.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/image_t/tMR000050-CMP-020.11.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 20.11</div> <div class="figure-caption"> <p>Comparison 20: Subgroup analyses for usual care compared with wait‐list or no‐treatment for continuous data, Outcome 11: Standarised usual care </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/references#MR000050-fig-0109">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/image_n/nMR000050-CMP-020.11.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="MR000050-fig-0110"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/urn:x-wiley:14651858:media:MR000050:MR000050-CMP-020.12" target="_blank"><b></b></a></p> </div><img alt="Comparison 20: Subgroup analyses for usual care compared with wait‐list or no‐treatment for continuous data, Outcome 12: Standarised usual care" data-id="MR000050-fig-0110" src="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/image_n/nMR000050-CMP-020.12.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/image_t/tMR000050-CMP-020.12.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 20.12</div> <div class="figure-caption"> <p>Comparison 20: Subgroup analyses for usual care compared with wait‐list or no‐treatment for continuous data, Outcome 12: Standarised usual care </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/references#MR000050-fig-0110">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/image_n/nMR000050-CMP-020.12.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="MR000050-fig-0111"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/urn:x-wiley:14651858:media:MR000050:MR000050-CMP-020.13" target="_blank"><b></b></a></p> </div><img alt="Comparison 20: Subgroup analyses for usual care compared with wait‐list or no‐treatment for continuous data, Outcome 13: Mode of psychological treatment in usual care" data-id="MR000050-fig-0111" src="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/image_n/nMR000050-CMP-020.13.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/image_t/tMR000050-CMP-020.13.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 20.13</div> <div class="figure-caption"> <p>Comparison 20: Subgroup analyses for usual care compared with wait‐list or no‐treatment for continuous data, Outcome 13: Mode of psychological treatment in usual care </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/references#MR000050-fig-0111">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/image_n/nMR000050-CMP-020.13.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="MR000050-fig-0112"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/urn:x-wiley:14651858:media:MR000050:MR000050-CMP-020.14" target="_blank"><b></b></a></p> </div><img alt="Comparison 20: Subgroup analyses for usual care compared with wait‐list or no‐treatment for continuous data, Outcome 14: Imputed data" data-id="MR000050-fig-0112" src="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/image_n/nMR000050-CMP-020.14.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/image_t/tMR000050-CMP-020.14.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 20.14</div> <div class="figure-caption"> <p>Comparison 20: Subgroup analyses for usual care compared with wait‐list or no‐treatment for continuous data, Outcome 14: Imputed data </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/references#MR000050-fig-0112">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/image_n/nMR000050-CMP-020.14.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="MR000050-fig-0113"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/urn:x-wiley:14651858:media:MR000050:MR000050-CMP-021.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 21: Sensitivity analyses for all placebos compared with wait‐list or no‐treatment, Outcome 1: Fixed effects" data-id="MR000050-fig-0113" src="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/image_n/nMR000050-CMP-021.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/image_t/tMR000050-CMP-021.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 21.1</div> <div class="figure-caption"> <p>Comparison 21: Sensitivity analyses for all placebos compared with wait‐list or no‐treatment, Outcome 1: Fixed effects </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/references#MR000050-fig-0113">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/image_n/nMR000050-CMP-021.01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="MR000050-fig-0114"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/urn:x-wiley:14651858:media:MR000050:MR000050-CMP-021.02" target="_blank"><b></b></a></p> </div><img alt="Comparison 21: Sensitivity analyses for all placebos compared with wait‐list or no‐treatment, Outcome 2: Fixed effects" data-id="MR000050-fig-0114" src="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/image_n/nMR000050-CMP-021.02.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/image_t/tMR000050-CMP-021.02.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 21.2</div> <div class="figure-caption"> <p>Comparison 21: Sensitivity analyses for all placebos compared with wait‐list or no‐treatment, Outcome 2: Fixed effects </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/references#MR000050-fig-0114">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/image_n/nMR000050-CMP-021.02.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="MR000050-fig-0115"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/urn:x-wiley:14651858:media:MR000050:MR000050-CMP-021.03" target="_blank"><b></b></a></p> </div><img alt="Comparison 21: Sensitivity analyses for all placebos compared with wait‐list or no‐treatment, Outcome 3: End of intervention (post‐treatment scores, changes scores excluded)" data-id="MR000050-fig-0115" src="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/image_n/nMR000050-CMP-021.03.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/image_t/tMR000050-CMP-021.03.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 21.3</div> <div class="figure-caption"> <p>Comparison 21: Sensitivity analyses for all placebos compared with wait‐list or no‐treatment, Outcome 3: End of intervention (post‐treatment scores, changes scores excluded) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/references#MR000050-fig-0115">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/image_n/nMR000050-CMP-021.03.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="MR000050-fig-0116"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/urn:x-wiley:14651858:media:MR000050:MR000050-CMP-021.04" target="_blank"><b></b></a></p> </div><img alt="Comparison 21: Sensitivity analyses for all placebos compared with wait‐list or no‐treatment, Outcome 4: Type of data collection" data-id="MR000050-fig-0116" src="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/image_n/nMR000050-CMP-021.04.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/image_t/tMR000050-CMP-021.04.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 21.4</div> <div class="figure-caption"> <p>Comparison 21: Sensitivity analyses for all placebos compared with wait‐list or no‐treatment, Outcome 4: Type of data collection </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/references#MR000050-fig-0116">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/image_n/nMR000050-CMP-021.04.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="MR000050-fig-0117"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/urn:x-wiley:14651858:media:MR000050:MR000050-CMP-021.05" target="_blank"><b></b></a></p> </div><img alt="Comparison 21: Sensitivity analyses for all placebos compared with wait‐list or no‐treatment, Outcome 5: Transformed data for TSA analysis" data-id="MR000050-fig-0117" src="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/image_n/nMR000050-CMP-021.05.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/image_t/tMR000050-CMP-021.05.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 21.5</div> <div class="figure-caption"> <p>Comparison 21: Sensitivity analyses for all placebos compared with wait‐list or no‐treatment, Outcome 5: Transformed data for TSA analysis </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/references#MR000050-fig-0117">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/image_n/nMR000050-CMP-021.05.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="MR000050-fig-0118"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/urn:x-wiley:14651858:media:MR000050:MR000050-CMP-022.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 22: Sensitivity analyses for psychological placebo compared with wait‐list or no‐treatment, Outcome 1: Fixed effects" data-id="MR000050-fig-0118" src="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/image_n/nMR000050-CMP-022.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/image_t/tMR000050-CMP-022.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 22.1</div> <div class="figure-caption"> <p>Comparison 22: Sensitivity analyses for psychological placebo compared with wait‐list or no‐treatment, Outcome 1: Fixed effects </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/references#MR000050-fig-0118">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/image_n/nMR000050-CMP-022.01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="MR000050-fig-0119"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/urn:x-wiley:14651858:media:MR000050:MR000050-CMP-022.02" target="_blank"><b></b></a></p> </div><img alt="Comparison 22: Sensitivity analyses for psychological placebo compared with wait‐list or no‐treatment, Outcome 2: End of intervention (post‐treatment scores)" data-id="MR000050-fig-0119" src="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/image_n/nMR000050-CMP-022.02.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/image_t/tMR000050-CMP-022.02.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 22.2</div> <div class="figure-caption"> <p>Comparison 22: Sensitivity analyses for psychological placebo compared with wait‐list or no‐treatment, Outcome 2: End of intervention (post‐treatment scores) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/references#MR000050-fig-0119">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/image_n/nMR000050-CMP-022.02.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="MR000050-fig-0120"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/urn:x-wiley:14651858:media:MR000050:MR000050-CMP-022.03" target="_blank"><b></b></a></p> </div><img alt="Comparison 22: Sensitivity analyses for psychological placebo compared with wait‐list or no‐treatment, Outcome 3: Transformed data for TSA analysis" data-id="MR000050-fig-0120" src="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/image_n/nMR000050-CMP-022.03.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/image_t/tMR000050-CMP-022.03.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 22.3</div> <div class="figure-caption"> <p>Comparison 22: Sensitivity analyses for psychological placebo compared with wait‐list or no‐treatment, Outcome 3: Transformed data for TSA analysis </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/references#MR000050-fig-0120">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/image_n/nMR000050-CMP-022.03.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="MR000050-fig-0121"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/urn:x-wiley:14651858:media:MR000050:MR000050-CMP-023.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 23: Sensitivity analyses for pharmacological placebo compared with wait‐list or no‐treatment, Outcome 1: Fixed effects" data-id="MR000050-fig-0121" src="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/image_n/nMR000050-CMP-023.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/image_t/tMR000050-CMP-023.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 23.1</div> <div class="figure-caption"> <p>Comparison 23: Sensitivity analyses for pharmacological placebo compared with wait‐list or no‐treatment, Outcome 1: Fixed effects </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/references#MR000050-fig-0121">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/image_n/nMR000050-CMP-023.01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="MR000050-fig-0122"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/urn:x-wiley:14651858:media:MR000050:MR000050-CMP-023.02" target="_blank"><b></b></a></p> </div><img alt="Comparison 23: Sensitivity analyses for pharmacological placebo compared with wait‐list or no‐treatment, Outcome 2: Fixed effects" data-id="MR000050-fig-0122" src="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/image_n/nMR000050-CMP-023.02.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/image_t/tMR000050-CMP-023.02.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 23.2</div> <div class="figure-caption"> <p>Comparison 23: Sensitivity analyses for pharmacological placebo compared with wait‐list or no‐treatment, Outcome 2: Fixed effects </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/references#MR000050-fig-0122">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/image_n/nMR000050-CMP-023.02.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="MR000050-fig-0123"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/urn:x-wiley:14651858:media:MR000050:MR000050-CMP-023.03" target="_blank"><b></b></a></p> </div><img alt="Comparison 23: Sensitivity analyses for pharmacological placebo compared with wait‐list or no‐treatment, Outcome 3: End of intervention (post‐treatment scores)" data-id="MR000050-fig-0123" src="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/image_n/nMR000050-CMP-023.03.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/image_t/tMR000050-CMP-023.03.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 23.3</div> <div class="figure-caption"> <p>Comparison 23: Sensitivity analyses for pharmacological placebo compared with wait‐list or no‐treatment, Outcome 3: End of intervention (post‐treatment scores) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/references#MR000050-fig-0123">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/image_n/nMR000050-CMP-023.03.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="MR000050-fig-0124"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/urn:x-wiley:14651858:media:MR000050:MR000050-CMP-023.04" target="_blank"><b></b></a></p> </div><img alt="Comparison 23: Sensitivity analyses for pharmacological placebo compared with wait‐list or no‐treatment, Outcome 4: Transformed data for TSA analysis" data-id="MR000050-fig-0124" src="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/image_n/nMR000050-CMP-023.04.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/image_t/tMR000050-CMP-023.04.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 23.4</div> <div class="figure-caption"> <p>Comparison 23: Sensitivity analyses for pharmacological placebo compared with wait‐list or no‐treatment, Outcome 4: Transformed data for TSA analysis </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/references#MR000050-fig-0124">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/image_n/nMR000050-CMP-023.04.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="MR000050-fig-0125"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/urn:x-wiley:14651858:media:MR000050:MR000050-CMP-024.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 24: Sensitivity analyses for physical placebo compared with wait‐list or no‐treatment, Outcome 1: Fixed effects" data-id="MR000050-fig-0125" src="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/image_n/nMR000050-CMP-024.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/image_t/tMR000050-CMP-024.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 24.1</div> <div class="figure-caption"> <p>Comparison 24: Sensitivity analyses for physical placebo compared with wait‐list or no‐treatment, Outcome 1: Fixed effects </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/references#MR000050-fig-0125">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/image_n/nMR000050-CMP-024.01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="MR000050-fig-0126"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/urn:x-wiley:14651858:media:MR000050:MR000050-CMP-024.02" target="_blank"><b></b></a></p> </div><img alt="Comparison 24: Sensitivity analyses for physical placebo compared with wait‐list or no‐treatment, Outcome 2: End of intervention (post‐treatment scores)" data-id="MR000050-fig-0126" src="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/image_n/nMR000050-CMP-024.02.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/image_t/tMR000050-CMP-024.02.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 24.2</div> <div class="figure-caption"> <p>Comparison 24: Sensitivity analyses for physical placebo compared with wait‐list or no‐treatment, Outcome 2: End of intervention (post‐treatment scores) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/references#MR000050-fig-0126">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/image_n/nMR000050-CMP-024.02.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="MR000050-fig-0127"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/urn:x-wiley:14651858:media:MR000050:MR000050-CMP-024.03" target="_blank"><b></b></a></p> </div><img alt="Comparison 24: Sensitivity analyses for physical placebo compared with wait‐list or no‐treatment, Outcome 3: Transformed data for TSA analysis" data-id="MR000050-fig-0127" src="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/image_n/nMR000050-CMP-024.03.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/image_t/tMR000050-CMP-024.03.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 24.3</div> <div class="figure-caption"> <p>Comparison 24: Sensitivity analyses for physical placebo compared with wait‐list or no‐treatment, Outcome 3: Transformed data for TSA analysis </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/references#MR000050-fig-0127">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/image_n/nMR000050-CMP-024.03.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="MR000050-fig-0128"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/urn:x-wiley:14651858:media:MR000050:MR000050-CMP-025.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 25: Sensitivity analyses for usual care compared with wait‐list or no‐treatment, Outcome 1: Fixed effects" data-id="MR000050-fig-0128" src="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/image_n/nMR000050-CMP-025.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/image_t/tMR000050-CMP-025.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 25.1</div> <div class="figure-caption"> <p>Comparison 25: Sensitivity analyses for usual care compared with wait‐list or no‐treatment, Outcome 1: Fixed effects </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/references#MR000050-fig-0128">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/image_n/nMR000050-CMP-025.01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="MR000050-fig-0129"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/urn:x-wiley:14651858:media:MR000050:MR000050-CMP-025.02" target="_blank"><b></b></a></p> </div><img alt="Comparison 25: Sensitivity analyses for usual care compared with wait‐list or no‐treatment, Outcome 2: Transformed data for TSA analysis" data-id="MR000050-fig-0129" src="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/image_n/nMR000050-CMP-025.02.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/image_t/tMR000050-CMP-025.02.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 25.2</div> <div class="figure-caption"> <p>Comparison 25: Sensitivity analyses for usual care compared with wait‐list or no‐treatment, Outcome 2: Transformed data for TSA analysis </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/references#MR000050-fig-0129">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/image_n/nMR000050-CMP-025.02.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="MR000050-fig-0130"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/urn:x-wiley:14651858:media:MR000050:MR000050-CMP-026.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 26: Sensitivity analysis for serious adverse events of placebos, Outcome 1: Data in RR for TSA analysis" data-id="MR000050-fig-0130" src="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/image_n/nMR000050-CMP-026.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/image_t/tMR000050-CMP-026.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 26.1</div> <div class="figure-caption"> <p>Comparison 26: Sensitivity analysis for serious adverse events of placebos, Outcome 1: Data in RR for TSA analysis </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/references#MR000050-fig-0130">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/image_n/nMR000050-CMP-026.01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="MR000050-fig-0131"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/urn:x-wiley:14651858:media:MR000050:MR000050-CMP-027.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 27: Sensitivity analysis for non‐serious adverse events of placebos, Outcome 1: Data in RR for TSA analysis" data-id="MR000050-fig-0131" src="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/image_n/nMR000050-CMP-027.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/image_t/tMR000050-CMP-027.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 27.1</div> <div class="figure-caption"> <p>Comparison 27: Sensitivity analysis for non‐serious adverse events of placebos, Outcome 1: Data in RR for TSA analysis </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/references#MR000050-fig-0131">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/media/CDSR/MR000050/image_n/nMR000050-CMP-027.01.svg" target="_blank">Open in new tab</a></div> </div> </div> <div class="tables-list"> <div class="table"> <table class="summary-of-findings framed" data-id="MR000050-tbl-0001"> <div class="table-heading"><span class="table-label">Summary of findings 1.</span> <span class="table-title">Summary of findings</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Benefits and harms of wait‐list compared with no‐treatment for mental health disorders</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population:</b> patients with mental health disorders </p> <p><b>Settings:</b> inpatient and outpatient </p> <p><b>Intervention:</b> wait‐list </p> <p><b>Comparison:</b> no‐treatment </p> </td> </tr> <tr class="separated"> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>Outcomes</b> </p> </th> <th align="" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>Relative effect<br/>(95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>No of Participants<br/>(studies)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>Quality of the evidence<br/>(GRADE)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>Comments</b> </p> </th> </tr> <tr class="separated"> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Assumed risk</b> </p> </th> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Corresponding risk</b> </p> </th> </tr> <tr class="separated"> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Wait‐list/no‐treatment</b> </p> </th> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Usual care</b> </p> </th> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Wait‐list compared with no‐treatment</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""></td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Only one cluster‐randomised trial compared a wait‐list intervention to a no‐treatment intervention was included (<a href="./references#MR000050-bbs2-0033" title="HowlinP , GordonKR , PascoG , WadeA , CharmanT .The effectiveness of picture exchange communication system (PECS) training for teachers of children with autism: a pragmatic,group randomised controlled trial. Journal of Child Psychology and Psychiatry2007;48(5):473-81. ">Howlin 2007</a>). However, no usable data were provided in the full report, and the authors did engage in correspondence. Eighty‐four elementary school children with a autism spectrum disorder were randomised to either, i) immediate treatment, ii) delayed treatment (wait‐list), and iii) no‐treatment. Conclusions were that Picture Exchange Communication System (PECS) training indicated modest effectiveness for children with autism spectrum disorder. In general there were no differences on across outcome measures between the wait‐list and no‐treatment intervention groups. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/><b>CI:</b> Confidence interval; <b>RR:</b> Risk Ratio; <b>RD:</b> Risk Difference; <b>RCT:</b> Randomised clinical trial </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/><b>High quality:</b> further research is very unlikely to change our confidence in the estimate of effect.<br/><b>Moderate quality:</b> further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/><b>Low quality:</b> further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/><b>Very low quality:</b> we are very uncertain about the estimate. </p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 1.</span> <span class="table-title">Summary of findings</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/full#MR000050-tbl-0001">Navigate to table in review</a></div> </div> <div class="table"> <table class="summary-of-findings framed" data-id="MR000050-tbl-0002"> <div class="table-heading"><span class="table-label">Summary of findings 2.</span> <span class="table-title">Summary of findings</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Benefits and harms of usual care compared with wait‐list or no‐treatment for mental health disorders</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population:</b> patients with mental health disorders </p> <p><b>Settings:</b> inpatient and outpatient </p> <p><b>Intervention:</b> usual care </p> <p><b>Comparison:</b> wait‐list or no‐treatment </p> </td> </tr> <tr class="separated"> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>Outcomes</b> </p> </th> <th align="" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>Relative effect<br/>(95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>No of Participants<br/>(studies)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>Quality of the evidence<br/>(GRADE)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>Comments</b> </p> </th> </tr> <tr class="separated"> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Assumed risk</b> </p> </th> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Corresponding risk</b> </p> </th> </tr> <tr class="separated"> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Wait‐list/no‐treatment</b> </p> </th> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Usual care</b> </p> </th> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Usual care compared with wait‐list/no‐treatment</b> </p> <p>(Variety of continuous outcome)</p> <p>(Post‐treatment)</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""></td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>The mean score in the usual care group was <b>0.33 points lower</b> (0.83 lower to 0.16 higher) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>523</p> <p>(5 RCTs)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>⊕⊝⊝⊝<br/><b>very low <sup>a,b,c</sup> </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>TSA adjusted CI = ‐2.32 to 1.15</p> <p>TSA RIS = 1536</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Serious adverse events for all placebos</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""></td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No data</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Non‐serious adverse events for all placebos</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""></td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No data</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/><b>CI:</b> confidence interval; <b>RR:</b> risk ratio; <b>RD:</b> risk difference; <b>RCT:</b> randomised clinical trial; <b>TSA:</b> Trial Sequential Analysis </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/><b>High quality:</b> further research is very unlikely to change our confidence in the estimate of effect.<br/><b>Moderate quality:</b> further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/><b>Low quality:</b> further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/><b>Very low quality:</b> we are very uncertain about the estimate. </p> <p><sup>a</sup> We downgraded the quality of evidence by one level due to risk of bias </p> <p><sup>b</sup> We downgraded the quality of evidence by one level due to inconsistency (in terms of either clinical and methodological heterogeneity) </p> <p><sup>c</sup> We downgraded the quality of evidence by one level due to imprecision (wide confidence intervals) </p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 2.</span> <span class="table-title">Summary of findings</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/full#MR000050-tbl-0002">Navigate to table in review</a></div> </div> <div class="table"> <table class="summary-of-findings framed" data-id="MR000050-tbl-0003"> <div class="table-heading"><span class="table-label">Summary of findings 3.</span> <span class="table-title">Summary of findings</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Benefits and harms of placebos compared with wait‐list or no‐treatment for mental health disorders</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population:</b> patients with mental health disorders </p> <p><b>Settings:</b> inpatient and outpatient </p> <p><b>Intervention:</b> all placebos combined, psychological, pharmacological and physical placebos </p> <p><b>Comparison:</b> wait‐list or no‐treatment </p> </td> </tr> <tr class="separated"> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>Outcomes</b> </p> </th> <th align="" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>Relative effect<br/>(95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>No of Participants<br/>(studies)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>Quality of the evidence<br/>(GRADE)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>Comments</b> </p> </th> </tr> <tr class="separated"> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Assumed risk</b> </p> </th> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Corresponding risk</b> </p> </th> </tr> <tr class="separated"> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Wait‐list/no‐treatment</b> </p> </th> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Placebos</b> </p> </th> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>All placebos compared with wait‐list or no‐treatment</b> </p> <p>(Variety of continuous outcome)</p> <p>(Post‐treatment)</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"></td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean score in the placebo group was <b>0.37 points lower</b> (0.49 lower to 0.25 lower) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2446</p> <p>(65 RCTs)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/><b>low <sup>a,b</sup> </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>TSA adjusted<br/>Cl = −1.85 to<br/>−0.84<br/>TSA RIS = 397 </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Psychological placebos compared with wait‐list or no‐treatment</b> </p> <p>(Variety of continuous outcome)</p> <p>(Post‐treatment)</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""></td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>The mean score in the placebo group was <b>0.49 points lower</b> (0.66 lower to 0.31 lower) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1263</p> <p>(38 RCTs)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>⊕⊕⊝⊝<br/><b>low <sup>a,b</sup> </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>TSA adjusted<br/>Cl = −2.54 to<br/>−1.02<br/>TSA RIS = 454 </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Pharmacological placebos compared with wait‐list or no‐treatment</b> </p> <p>(Variety of continuous outcome)</p> <p>(Post‐treatment)</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""></td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>The mean score in the placebo group was <b>0.14 points lower</b> (0.39 lower to 0.11 higher) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>279</p> <p>(9 RCTs)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>⊕⊝⊝⊝<br/><b>very low <sup>a,b,c</sup> </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>TSA adjusted<br/>Cl = −9.43 to<br/>6.15<br/>TSA RIS = 229 </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Physical placebos compared with wait‐list or no‐treatment</b> </p> <p>(Variety of continuous outcome)</p> <p>(Post‐treatment)</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""></td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>The mean score in the placebo group was <b>0.21 points lower</b> (0.35 lower to 0.08 lower) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>896</p> <p>(17 RCTs)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>⊕⊕⊝⊝<br/><b>low <sup>a,b</sup> </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>TSA adjusted<br/>Cl = −3.64 to<br/>−0.49<br/>TSA RIS = 194 </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Serious adverse events for all placebos compared with wait‐list or no treatment</b> </p> <p>(Spontaneous reporting of dichotomous outcomes)</p> <p>(Post‐treatment)</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p><b>43 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p><b>27 per 1000 (95% CI 32 fewer to 23 higher)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>RD ‐0.00</b> </p> <p>(95% CI ‐0.03 to 0.03)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>517</p> <p>(11 RCTs)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><sub>⊕⊝⊝⊝</sub><br/><b><sub>very low a,b,c</sub> </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not possible to calculate TSA on serious adverse events due to too little information use </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Non‐serious adverse events for all placebos compared with wait‐list or no treatment</b> </p> <p>(Spontaneous reporting of dichotomous outcomes)</p> <p>(Post‐treatment)</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p><b>93 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p><b>96 per 1000</b> </p> <p><b>(95% CI 2 fewer to 7 higher)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>RD 0.03</b> </p> <p>(95% CI ‐0.02 to 0.08)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>590</p> <p>(14 trials)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><sub>⊕⊝⊝⊝</sub><br/><b><sub>very low a,b,c</sub> </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not possible to calculate TSA on serious adverse events due to too little information use </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/><b>CI:</b> Confidence interval; <b>RR:</b> Risk Ratio; <b>RD:</b> Risk Difference; <b>RCT:</b> Randomised clinical trial; <b>RIS:</b> required information size; <b>TSA:</b> trial sequential analysis </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>GRADE Working Group grades of evidence</b> <br/><b>High quality:</b> further research is very unlikely to change our confidence in the estimate of effect.<br/><b>Moderate quality:</b> further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/><b>Low quality:</b> further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/><b>Very low quality:</b> we are very uncertain about the estimate. </p> <p><sup>a</sup> We downgraded the quality of evidence by one level due to risk of bias </p> <p><sup>b</sup> We downgraded the quality of evidence by one level due to inconsistency (in terms of either clinical and methodological heterogeneity) </p> <p><sup>c</sup> We downgraded the quality of evidence by one level due to imprecision (wide confidence intervals) </p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 3.</span> <span class="table-title">Summary of findings</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/full#MR000050-tbl-0003">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="MR000050-tbl-0004"> <div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Description of experimental interventions</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Name of intervention</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Other common names reported in the literature</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Definition</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Examples</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Psychological placebo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Attention placebo, credible placebo, common‐factor treatment control, sham intervention, pseudo control </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Psychological placebos target the non‐specific or shared components of psychological treatments, such as human interaction variables, attending sessions, and patient expectations </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>In an example from Tan 1986, the psychological placebo participants were exposed to sessions of supportive group counselling, which were thought to represent the non‐specific component of the active intervention, which was cognitive behavioural therapy </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Pharmacological placebo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Pill placebo, placebo tablet, dummy pill</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Pharmacological placebos are inert substances, typically in pill or liquid form, which do not contain the active ingredients of a given drug treatment </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Participants typically receive a pill containing starch, sugar, or lactose (Double 1993; Meissner 2011b). </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Physical placebo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Sham intervention, credible placebo, pseudo control</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="middle"> <p>Physical placebos target the inert components of a given physical treatment (such as acupuncture, needle injection, exercise regimens, surgery, or electromagnetic stimulation) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>This could be sham acupuncture where the needles are blunted ( <a href="./references#MR000050-bbs2-0282" title="ToughEA , WhiteAR , RichardsSH , LordB , CampbellJL .Developing and validating a sham acupuncture needle. Acupuncture in Medicine2009;27(3):118-22.">Tough 2009</a> ), or sham electromagnetic stimulation, where the machine is not turned on or electrodes are attached to inactive sites ( <a href="./references#MR000050-bbs2-0272" title="SommerJ , JansenA , DrägerB , SteinsträterO , BreitensteinC , DeppeM , et al.Transcranial magnetic stimulation - a sandwich coil design for a better sham. Clinical Neurophysiology2006;117(2):440-6.">Sommer 2006</a> ) </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Usual care</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Treatment as usual (TAU), standard care, outpatient care, standard practice, support as usual, clinical care, routine care, existing‐practice control </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Usual care reflects locally accepted treatment practices for a given mental health disorder. It is provided either by private or public practitioners and may involve both pharmacological and psychological treatment. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Patients allocated to usual care might receive a large variety of therapies with a theoretical blend of psychodynamic, humanistic and behavioural approaches ( <a href="./references#MR000050-bbs2-0158" title="BorduinCM , SchaefferCM , HeiblumN .A randomized clinical trial of multisystemic therapy with juvenile sexual offenders: effects on youth social ecology and criminal activity. Journal of Consulting and Clinical Psychology2009;77(1):26-37.">Borduin 2009</a> ) </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Wait‐list</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Minimal contact control, delayed treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Wait‐list participants are assessed on repeated occasions, but are promised the "active" intervention after the trial has ended </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>In Ertl 2011, participants allocated to the wait‐list group were reassessed at baseline and follow‐up, and subsequently offered the active treatment, which was narrative exposure therapy </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No‐treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Minimal contact control</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No‐treatment participants are assessed on repeated occasions without receiving the active treatment intervention. Unlike wait‐list interventions, no‐treatment participants are not promised the "active" intervention after trial completion </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No‐treatment participants in <a href="./references#MR000050-bbs2-0248" title="MirandaJ , ChungJY , GreenBL , KrupnickJ , SiddiqueJ , RevickiDA , et al.Treating depression in predominantly low-income young minority women: a randomized controlled trial. JAMA2003;290(1):57-65.">Miranda 2003</a> did not receive any mental‐health related treatment, and were not promised the active intervention (antidepressants or psychotherapy) after trial completion </p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Description of experimental interventions</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/full#MR000050-tbl-0004">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="MR000050-tbl-0005"> <div class="table-heading"><span class="table-label">Table 2.</span> <span class="table-title">Description of trials with missing data</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Trial ID</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Missing data</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Methods of data generation</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#MR000050-bbs2-0008" title="Borden, KA.Attributional Outcomes: the Subtle Messages of Treatments for Attention Deficit Disorder. Dissertation, University of Illinois at Urbana-Champaign1986. BordenKA , BrownRT .Attributional outcomes: The subtle messages of treatments for attention deficit disorder. Cognitive Therapy and Research1989;13(2):147-60. ">Borden 1986</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Missing information regarding how many participants randomised to each group</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Since 30 patients was included in total, we assumed due to randomisation that there was an equal distribution of patients in each group. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#MR000050-bbs2-0009" title="BorkovecTD , KaloupekDG , SlamaKM .The facilitative effect of muscle tension-release in the relaxation treatment of sleep disturbance. Behavior Therapy1975;6(3):301-9. ">Borkovec 1975</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>The standard deviation (SD) was not reported on the Daily Sleep Questionnaire (DSQ) – Subscale difficulty experienced in falling asleep </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>An artificial SD was imported from <a href="./references#MR000050-bbs2-0083" title="SteinmarkSW , BorkovecTD .Active and placebo treatment effects on moderate insomnia under counterdemand and positive demand instructions. Journal of Abnormal Psychology1974;83(2):157-63. ">Steinmark 1974</a> due to similar outcome, population, and control interventions </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#MR000050-bbs2-0013" title="BrillNQ , KoeglerRR , EpsteinLJ , ForgyEW .Controlled study of psychiatric outpatient treatment. Archives of General Psychiatry1964;10:581-95. BrillNQ .Results of psychotherapy. California Medicine1966;104(4):249-53. ">Brill 1964a</a> ; <a href="./references#MR000050-bbs2-0014" title="BrillNQ , KoeglerRR , EpsteinLJ , ForgyEW .Controlled study of psychiatric outpatient treatment. Archives of General Psychiatry1964;10:581-95. ">Brill 1964b</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No usable data reported</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not possible to generate data</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#MR000050-bbs2-0015" title="CarlsonCL , PelhamWE , MilichR , HozaB .ADHD boys’ performance and attributions following success and failure: drug effects and individual differences. Cognitive Therapy and Research1993;17:269-87. ">Carlson 1993</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Missing information regarding how many participants randomised to each group</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Since 28 patients was included in total, we assumed due to randomisation and ethical principles that the active arm (in this case methylphenidate) included an additional patient compared with the placebo and no‐treatment group </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#MR000050-bbs2-0018" title="CrouchG , RobsonM , HallstromC .Benzodiazepine dependent patients and their psychological treatment. Progress in Neuro-psychopharmacology &amp; Biological Psychiatry1988;12(4):503-10. HallströmC , CrouchG , RobsenM , ShineP .The treatment of tranquillizer dependence by propranolol. Postgraduate Medical Journal1988;64(Suppl 2):40-4. ">Crouch 1988</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No usable data reported</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not possible to generate data, and could not get in contact with authors</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#MR000050-bbs2-0019" title="Doty, DW.Role playing and incentives in the modification of the social interaction of chronic psychiatric patients. Journal of Consulting and Clinical Psychology1975;43(5):676-82. ">Doty 1975</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No usable data reported</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not possible to generate data</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#MR000050-bbs2-0027" title="FuchsCZ , RehnLP .A self-control behavior therapy program for depression. Journal of Consulting and Clinical Psychology1977;45(2):206-15. ">Fuchs 1977</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>The standard deviation (SD) on the improvement of the mean on Beck Depression Inventory was not reported. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>The SD was calculated from a F‐test statistic</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#MR000050-bbs2-0030" title="GoldwasserAN , AuerbachSM , HarkinsSW .Cognitive, affective, and behavioural effects of reminiscence group therapy on demented elderly. Aging and Human Development1987;25(3):209-22. ">Goldwasser 1987</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>The SD was not reported on the Mini‐Mental State (MMS)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not possible to generate data</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#MR000050-bbs2-0031" title="HekmatH , LubitzR , DealR .Semantic desensitization: a paradigmatic intervention approach to anxiety disorders. Journal of Clinical Psychology1984;40(2):463-6. ">Hekmat 1984</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>The SD was not reported on the Timed Behavior Checklist (BCL)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not possible to generate data</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#MR000050-bbs2-0033" title="HowlinP , GordonKR , PascoG , WadeA , CharmanT .The effectiveness of picture exchange communication system (PECS) training for teachers of children with autism: a pragmatic,group randomised controlled trial. Journal of Child Psychology and Psychiatry2007;48(5):473-81. ">Howlin 2007</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No usable data reported</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not possible to generate data, and could not get in contact with authors</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#MR000050-bbs2-0042" title="KrapflJE , NawasMM .Differential ordering of stimulus presentation in systematic desensitization. Journal of Abnormal Psychology1970;75(3):333-7. ">Krapfl 1970</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Mean was only reported in a figure, and the SD on the Behavioral Avoidance Test (BAT) was not reported </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Mean value was generated from figure 1, and the SD was generated from <a href="./references#MR000050-bbs2-0023" title="EtringerBD , CashTF , RimmDC .Behavioral, affective, and cognitive effects of participant modeling and an equally credible placebo. Behavior Therapy1982;13(4):476-85. ">Etringer 1982</a> ; <a href="./references#MR000050-bbs2-0076" title="RosenGM , GlasgowRE , BarreraM .A controlled study to assess the clinical efficacy of totally self-administrated systematic desensitization. Journal of Consulting and Clinical Psychology1976;44(2):208-17. ">Rosen 1976</a> , due to that both trials included similar outcome, population, and control interventions </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#MR000050-bbs2-0046" title="LangOJ , LazovikAD .Experimental desensitization of a phobia. Journal of Abnormal and Social Psychology1963;66:519-25. LangPJ , LazovikAD , ReynoldsDJ .Desensitization, suggestibility, and pseudotherapy. Journal of Abnormal Psychology1965;70(6):395-402. ">Lang 1965</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No usable data reported</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not possible to generate data</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#MR000050-bbs2-0061" title="MilichR , CarlsonCL , Pelham WE Jr, LichtBG .Effects of methylphenidate on the persistence of ADHD boys following failure experiences. Journal of Abnormal Child Psychology1991;19(5):519-36. PelhamWE , MurphyDA , VannattaK , MilichR , LichtBG , GnagyEM , et al.Methylphenidate and attributions in boys with attention-deficit hyperactivity disorder. Journal of Consulting and Clinical Psychology1992;60(2):282-92. ">Pelham 1992</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Missing information regarding how many participants randomised to each group</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Since 38 patients was included in total, we assumed due to randomisation and ethical principles that the active arm (methylphenidate) and placebo included an additional patient each </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#MR000050-bbs2-0062" title="PedletonMG , HigginsRL .A comparison of negative practice and systematic desensitization in the treatment of acrophobia. Journal of Behavior Therapy and Experimental Psychiatry1983;14(4):317-23. ">Pendleton 1983</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Missing information regarding how many participants randomised to each group</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Since 62 patients was included in total, we assumed due to randomisation and ethical principles that the two active arms (Negative practice and Desensitization) included an additional patient each </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#MR000050-bbs2-0077" title="LorrM , McNairDM , WeinsteinGJ .Early effects of chlordiazepoxide (Librium) used with psychotherapy. Journal of Psychiatric Research1963;1:257-70. RothI , RhudickPJ , ShaskanDA , SlobinMS , WilkinsonAE , YoungHH .Long-term effects on psychotherapy of initial treatment conditions. Journal of Psychiatric Research1964;2:283-97. ">Roth 1964</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>The standard deviation (SD) was not reported on either Global estimate of the severity of the patient’s illness and a global measure of over‐all improvement </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not possible to generate data</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#MR000050-bbs2-0078" title="RupertPA , HolmesDS .Effects of multiple sessions of true and placebo heart rate biofeedback training on the heart rates and anxiety levels of anxious patients during and following treatment. Psychophysiology1978;15(6):582-90. ">Rupert 1978</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No usable data reported</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not possible to generate data</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#MR000050-bbs2-0080" title="ShealyRC .The effectiveness of various treatment techniques on different degrees and durations of sleep-onset insomnia. Behaviour Research and Therapy1979;17(6):541-6. ">Shealy 1979</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Separate means missing mild to moderate group.</p> <p>The standard deviation (SD) was not reported on the Daily Sleep and Relaxation Practice Questionnaire (DSRQ) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>We pooled the means from mild and moderate due to no information of patients in each group. A mean score was generated from the two groups. SDs was generated from <a href="./references#MR000050-bbs2-0005" title="AscherLM , TurnerR .Paradoxical intention and insomnia: an experimental investigation. Behaviour Research and Therapy1979;17(4):408-11. ">Ascher 1979</a> ; <a href="./references#MR000050-bbs2-0083" title="SteinmarkSW , BorkovecTD .Active and placebo treatment effects on moderate insomnia under counterdemand and positive demand instructions. Journal of Abnormal Psychology1974;83(2):157-63. ">Steinmark 1974</a> due to that these trials hade the same outcomes and population </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#MR000050-bbs2-0081" title="SibilioJP , AndrewG , DartD , MooreKB , StehmanA .Treatment of chronic schizophrenia with promazine hydrochloride. AMA Archives of Neurology and Psychiatry1957;78(4):419-24. ">Sibilio 1957</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No usable data reported</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not possible to generate data</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#MR000050-bbs2-0082" title="SommernessMD , LuceroRJ , HamlonJS , EricksonJL , MatthewsR .A controlled study of reserpine on chronically disturbed patients. JAMA Archives of Neurology and Psychiatry1955;74(3):316-9. ">Sommerness 1955</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No usable data reported</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not possible to generate data</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#MR000050-bbs2-0085" title="TanSY , BruniJ .Cognitive-behavior therapy with adult patients with epilepsy: a controlled outcome study. Epilepsia1986;27(3):225-33. ">Tan 1986</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>The standard deviation (SD) on the improvement of the mean on Beck Depression Inventory was not reported </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>The SD was imported from <a href="./references#MR000050-bbs2-0027" title="FuchsCZ , RehnLP .A self-control behavior therapy program for depression. Journal of Consulting and Clinical Psychology1977;45(2):206-15. ">Fuchs 1977</a> due to similar outcome and population </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#MR000050-bbs2-0088" title="Trexler, L.Rational-emotive therapy, placebo, and no-treatment effects on public-speaking anxiety. Doctoral dissertation, Temple University AnnArbor, Mich.: University Microfilms1971;71-31(063). TrexlerLD , KarstTO .Rational-emotive therapy, placebo, and no-treatment effects on public-speaking anxiety. Journal of Abnormal Psyhology1972;79(1):60-7. ">Trexler 1972</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>The standard deviation (SD) was not reported on the Behavioral Checklist</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not possible to generate data</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#MR000050-bbs2-0051" title="MatsonJL , MarchettiA , AdkinsJA .Comparison of operant- and independence-training procedures for mentally retarded adults. American Journal of Mental Deficiency1980;84(5):487-94. ">Matson 1980</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No usable data reported</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not possible to generate data, and could not get in contact with authors</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#MR000050-bbs2-0059" title="PearlD , Vander KampH , OlsenAL , GreenbergPD , ArmitageSG .The effects of reserpine on schizophrenic patients. American Journal of Psychiatry1956;112:198-204. ">Pearl 1956</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No usable data reported</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not possible to generate data, and could not get in contact with authors</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 2.</span> <span class="table-title">Description of trials with missing data</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/full#MR000050-tbl-0005">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="MR000050-tbl-0006"> <div class="table-heading"><span class="table-label">Table 3.</span> <span class="table-title">Key demographic characteristics of the included studies</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Category</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Study</b> <b>frequency</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Study ID</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Author correspondence</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Contacted</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>35</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#MR000050-bbs2-0001" title="AbikoffH , HechtmanL , KleinRG .Social functioning in children with ADHD treated with long-term methylphenidate and multimodal psychosocial treatment. Journal of the American Academy of Child and Adolescent Psychiatry2004;43(7):820-9. AbikoffH .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to A Todorovac 23rd of August 2019. KleinRG , AbikoffH , HechtmanL , WeissG .Design and rationale of controlled study of long-term methylphenidate and multimodal psychosocial treatment in children with ADHD. Journal of the American Academy of Child and Adolescent Psychiatry2004;43(7):792-801. ">Abikoff 2004</a> ; <a href="./references#MR000050-bbs2-0002" title="AllenJB .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to A Todorovac 28th of August 2019. AllenJJ , SchnyerRN , HittSK .The efficacy of acupuncture in the treatment of major depression in women. Psychological Science1998;9(5):397-401. ">Allen 1998</a> ; <a href="./references#MR000050-bbs2-0003" title="AllenJB .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 28th of August 2019. AllenJJ , SchnyerRN , ChambersAS , HittSK , MorenoFA , ManberR .Acupuncture for depression: a randomized controlled trial. Journal of Clinical Psychiatry2006;67(11):1665-73. ">Allen 2006</a> ; <a href="./references#MR000050-bbs2-0006" title="AyenI , HautzingerM .Cognitive behavior therapy for depression in menopausal women. A controlled, randomized treatment study [Kognitive Verhaltenstherapie bei Depressionen im Klimakterium: Eine kontrollierte, randomiserte Interventionsstudie]. Zeitschrift für Klinische Psychologie und Psychotherapie2004;33(4):290-9. AyenI .Inclusion of study in Cochrane Systematic Review (personal communication). Email to EG Faltinsen 9th of September 2019. ">Ayen 2004</a> ; <a href="./references#MR000050-bbs2-0011" title="BornovalovaM .Inclusion of study in Cochrane Systematic Review (personal communication). Email to A Todorovac. 21st of August 2019. BornovalovaMA .Distress tolerance treatment for inner-city drug users: a preliminary trial. Doctor’s Dissertation, University of Maryland2008. ">Bornovalova 2008</a> ; <a href="./references#MR000050-bbs2-0015" title="CarlsonCL , PelhamWE , MilichR , HozaB .ADHD boys’ performance and attributions following success and failure: drug effects and individual differences. Cognitive Therapy and Research1993;17:269-87. ">Carlson 1993</a> ; <a href="./references#MR000050-bbs2-0016" title="CarterJC , OlmstedMP , KaplanAS , McCabeRE , MillsJS , AimeA .Self-help for bulimia nervosa: a randomized controlled trial. American Journal of Psychiatry2003;160(5):973-8. ">Carter 2003</a> ; <a href="./references#MR000050-bbs2-0018" title="CrouchG , RobsonM , HallstromC .Benzodiazepine dependent patients and their psychological treatment. Progress in Neuro-psychopharmacology &amp; Biological Psychiatry1988;12(4):503-10. HallströmC , CrouchG , RobsenM , ShineP .The treatment of tranquillizer dependence by propranolol. Postgraduate Medical Journal1988;64(Suppl 2):40-4. ">Crouch 1988</a> ; <a href="./references#MR000050-bbs2-0024" title="FoaEB , RothbaumBO , RiggsDS , MurdockTB .Treatment of posttraumatic stress disorder in rape victims: a comparison between cognitive-behavioral procedures and counselling. Journal of Consulting and Clinical Psychology1991;59(5):715-23. ">Foa 1991</a> ; <a href="./references#MR000050-bbs2-0025" title="FoaEB , McLeanCP , ZangY , RosenfieldD , YadinE , YarvisJS , et al.Effect of prolonged exposure therapy delivered over 2 weeks vs 8 weeks vs present-centered therapy on PTSD symptom severity in military personnel: a randomized clinical trial. JAMA2018;319(4):354-64. ">Foa 2018</a> ; <a href="./references#MR000050-bbs2-0026" title="FreireAO , SugaiGC , ChrispinFS , TogeiroSM , YamamuraY , MelloLE , et al.Treatment of moderate obstructive sleep apnea syndrome with acupuncture: a randomised, placebo-controlled pilot trial. Sleep Medicine2007;8(1):43-50. ">Freire 2007</a> ; <a href="./references#MR000050-bbs2-0028" title="GlogowskaM , RoulstoneS , EnderbyP , PetersTJ .Randomised controlled trial of community based speech and language therapy in preschool children. BMJ2000;321(7266):923-6. ">Glogowska 2000</a> ; <a href="./references#MR000050-bbs2-0029" title="GoldsteinAJ , BeursE , Chambless Dl, WilsonKA .EMDR for panic disorder with agoraphobia: comparison with waiting list and credible attention-placebo control conditions. Journal of Consulting and Clinical Psychology2000;68(6):947-56. ">Goldstein 2000</a> ; <a href="./references#MR000050-bbs2-0032" title="HippmanC , RingroseA , InglisA , CheekJ , AlbertAY , RemickR , et al.A pilot randomized clinical trial evaluating the impact of genetic counselling for serious mental illnesses. Journal of Clinical Psychiatry2016;77(2):e190-8. ">Hippman 2016</a> ; <a href="./references#MR000050-bbs2-0034" title="KarstM , WinterhalterM , MünteS , FranckiB , HondronikosA , EckardtA , et al.Auricular acupuncture for dental anxiety: a randomized controlled trial. Anesthesia and Analgesia2007;104(2):295-300. KarstM .Inclusion of study in Cochrane Systematic Review (personal communication). Email to: EG Faltinsen 5th of September 2019. ">Karst 2007</a> ; <a href="./references#MR000050-bbs2-0035" title="KelleyJ .Inclusion of study in Cochrane Systematic Review (personal communication). Email to: A Todorovac 12th of August 2019. KelleyJM , KaptchukTJ , CusinC , LipkinS , FavaM .Open-label placebo for major depressive disorder: a pilot randomized controlled trial. Psychotherapy and Psychosomatics2012;81(5):312-4. ">Kelley 2012</a> ; <a href="./references#MR000050-bbs2-0043" title="KwanR .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 26th of August 2019. KwanRY , LeungMC , LaiCK .Acupressure for agitation in nursing home residents with dementia: study protocol for a randomized controlled trial. Trials2014;15(410):1-7. KwanRY , LeungMCP , LaiCK .A randomized controlled trial examining the effect of acupressure on agitation and salivary cortisol in nursing home residents with dementia. Dementia and Geriatric Cognitive Disorders2017;44(1-2):92-104. ">Kwan 2017</a> ; <a href="./references#MR000050-bbs2-0045" title="LaiCK , ChiI , Kayser-JonesJ .A randomized controlled trial of a specific reminiscence approach to promote the well-being of nursing home residents with dementia. International Psychogeriatrics2004;16(1):33-49. LaiK .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 6th of September 2019. ">Lai 2004</a> ; <a href="./references#MR000050-bbs2-0047" title="LegrandF .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 14th of August 2019. LegrandFD , NeffEM .Efficacy of exercise as an adjunct treatment for clinically depressed inpatients during the initial stages of antidepressant pharmacotherapy: an open randomized controlled trial. Journal of Affective Disorders2016;191:139-44. ">Legrand 2016</a> ; <a href="./references#MR000050-bbs2-0055" title="MirandaA , ArlandisP , SorianoM .Instruction in strategies and attributional training: Effects on the problem-solving and self-concept of students’ with learning disabilities [Instrucción en estrategias y entrenamiento atribucional: efectos sobre la resolución de problemas y el autoconcepto de los estudiantes con dificultades en el aprendizaje]. Infancia y Aprendizaje1997;20(80):37-52. ">Miranda 1997</a> ; <a href="./references#MR000050-bbs2-0056" title="MitchellC , MansfieldD , RautenbachS .Coloured filters and reading accuracy, comprehension and rate: a placebo-controlled study. Perceptual and Motor Skills2008;106(2):517-32. ">Mitchell 2008</a> ; <a href="./references#MR000050-bbs2-0061" title="MilichR , CarlsonCL , Pelham WE Jr, LichtBG .Effects of methylphenidate on the persistence of ADHD boys following failure experiences. Journal of Abnormal Child Psychology1991;19(5):519-36. PelhamWE , MurphyDA , VannattaK , MilichR , LichtBG , GnagyEM , et al.Methylphenidate and attributions in boys with attention-deficit hyperactivity disorder. Journal of Consulting and Clinical Psychology1992;60(2):282-92. ">Pelham 1992</a> ; <a href="./references#MR000050-bbs2-0064" title="PolandRE , GertsikL , FavreauJT , SmithSI , MirochaJM , RaoU , et al.Open-label randomized parallel-group controlled clinical trial of massage for treatment of depression in HIV-infected subjects. Journal of Alternative and Complementary Medicine2013;19(4):334-40. ">Poland 2013</a> ; <a href="./references#MR000050-bbs2-0065" title="PowersMB , SmitsJA , TelchMJ .Disentangling the effects of safety-behavior utilization and safety-behavior availability during exposure-based treatment: a placebo-controlled trial. Journal of Consulting and Clinical Psychology2004;72(3):448-54. ">Powers 2004</a> ; <a href="./references#MR000050-bbs2-0066" title="PowersMB , SmithsJA , WhitleyD , BystritskyA , TelchMJ .The effect of attributional processes concerning medication taking on return of fear. Journal of Consulting and Clinical Psychology2008;76(3):478-90. ">Powers 2008a</a> ; <a href="./references#MR000050-bbs2-0067" title="PowersMB , SmithsJA , WhitleyD , BystritskyA , TelchMJ .The effect of attributional processes concerning medication taking on return of fear. Journal of Consulting and Clinical Psychology2008;76(3):478-90. ">Powers 2008b</a> ; <a href="./references#MR000050-bbs2-0068" title="ProudfootJ , ClarkeJ , BirchMR , WhittonAE , ParkerG , ManicavasagarV , et al.Impact of a mobile phone and web program on symptom and functional outcomes for people with mild- to-moderate depression, anxiety and stress: a randomized controlled trial. BMC Psychiatry2013;13(312):1-12. ProudfootJ .Re: Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 26th of August 2019. ">Proudfoot 2013</a> ; <a href="./references#MR000050-bbs2-0070" title="LiebowitzM , QuitkinFM , StewartJW , McGrathPJ , HarrisonWM , MarkowitzJS , et al.Antidepressant efficacy in atypical depression. Archives of General Psychiatry1988;45(2):129-37. QuitkinFM , McGrathPJ , StewartJW , HarrisonW , WagerSG , NunesE , et al.Phenelzine and imipramine in mood reactive depressives: further delineation of the syndrome of atypical depression. Archives of General Psychiatry1989;46(9):787-93. RabkinJG , McGrathPJ , QuitkinFM , TricamoE , StewartJW , KleinDF .Effects of pill-giving on maintenance of placebo response in patients with chronic mild depression. American Journal of Psychiatry1990;147(12):1622-6. ">Rabkin 1990</a> ; <a href="./references#MR000050-bbs2-0071" title="RapeeR .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 29th of August 2019. RapeeRM , AbbottMJ , LynehamHJ .Bibliotherapy for children With anxiety disorders using written materials for parents: a randomized controlled trial. Journal of Consulting and Clinical Psychology2006;74(3):436-44. ">Rapee 2006</a> ; <a href="./references#MR000050-bbs2-0072" title="RapeeR .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 29th of August 2019. RapeeRM , AbbottMJ , BaillieAJ , GastonJE .Treatment of social phobia through pure self-help and therapist-augmented self-help. British Journal of Psychiatry2007;191:246-52. ">Rapee 2007</a> ; <a href="./references#MR000050-bbs2-0075" title="OlivaresJ .Program IAFS. Protocol for the treatment of social phobia in adolescents [Programa IAFS. Protocolo para el tratamiento de la fobia social enadolescentes]. Madrid: Pirámide2005;1. Rosa-AlcázarAI , Olivares-OlivaresPJ , OlivaresJ .The role of non-specific effects in the psychological treatment of adolescents with social phobia [Papel de los efectos inespecíficos en el tratamiento psicológico de adolescentes con fobia social]. Anuario de Psicologia2009;40(1):43-61. ">Rosa‐Alcatraz 2009</a> ; <a href="./references#MR000050-bbs2-0079" title="ShalevAY , AnkriY , Isreali-ShalevY , PelegT , AdesskyR , FreedmanS .Prevention of posttraumatic stress disorder by early treatment. Archives of General Psychiatry2012;69(2):166-76. ">Shalev 2012</a> ; <a href="./references#MR000050-bbs2-0084" title="SzymanskiJ , O'DonohueW .The potential role of state-dependent learning in cognitive therapy with spider phobics. Journal of Rational-Emotive &amp; Cognitive-Behavior Therapy1995;13(2):131-50. SzymanskiJ .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 20th of August 2019. ">Szymanski 1995</a> ; <a href="./references#MR000050-bbs2-0086" title="TeriL , LogsdonRG , UomotoJ , McCurrySM .Behavioral treatment of depression in dementia patients: a controlled clinical trial. Journals of Gerontology. Series B, Psychological Sciences and Social Sciences1997;52(4):159-66. TeriL .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 26th of August 2019. ">Teri 1997</a> ; <a href="./references#MR000050-bbs2-0095" title="WolitzkyKB , TelchMJ .Augmenting in vivo exposure with fear antagonistic actions: a preliminary test. Behavior Therapy2009;40(1):57-71. ">Wolitzky 2009</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Authors responded</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>16</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#MR000050-bbs2-0001" title="AbikoffH , HechtmanL , KleinRG .Social functioning in children with ADHD treated with long-term methylphenidate and multimodal psychosocial treatment. Journal of the American Academy of Child and Adolescent Psychiatry2004;43(7):820-9. AbikoffH .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to A Todorovac 23rd of August 2019. KleinRG , AbikoffH , HechtmanL , WeissG .Design and rationale of controlled study of long-term methylphenidate and multimodal psychosocial treatment in children with ADHD. Journal of the American Academy of Child and Adolescent Psychiatry2004;43(7):792-801. ">Abikoff 2004</a> ; <a href="./references#MR000050-bbs2-0140" title="AbikoffH .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 23rd of August 2019.">Abikoff 2004 (pers comm)</a> ; <a href="./references#MR000050-bbs2-0002" title="AllenJB .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to A Todorovac 28th of August 2019. AllenJJ , SchnyerRN , HittSK .The efficacy of acupuncture in the treatment of major depression in women. Psychological Science1998;9(5):397-401. ">Allen 1998</a> ; <a href="./references#MR000050-bbs2-0141" title="AllenJB .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 28th of August 2019.">Allen 1998 (pers comm)</a> ; <a href="./references#MR000050-bbs2-0003" title="AllenJB .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 28th of August 2019. AllenJJ , SchnyerRN , ChambersAS , HittSK , MorenoFA , ManberR .Acupuncture for depression: a randomized controlled trial. Journal of Clinical Psychiatry2006;67(11):1665-73. ">Allen 2006</a> ; <a href="./references#MR000050-bbs2-0142" title="AllenJB .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 28th of August 2019.">Allen 2006 (pers comm)</a> ; <a href="./references#MR000050-bbs2-0006" title="AyenI , HautzingerM .Cognitive behavior therapy for depression in menopausal women. A controlled, randomized treatment study [Kognitive Verhaltenstherapie bei Depressionen im Klimakterium: Eine kontrollierte, randomiserte Interventionsstudie]. Zeitschrift für Klinische Psychologie und Psychotherapie2004;33(4):290-9. AyenI .Inclusion of study in Cochrane Systematic Review (personal communication). Email to EG Faltinsen 9th of September 2019. ">Ayen 2004</a> ; <a href="./references#MR000050-bbs2-0153" title="AyenI .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: EG Faltinsen 9th of September 2019.">Ayen 2004 (pers comm)</a> ; <a href="./references#MR000050-bbs2-0011" title="BornovalovaM .Inclusion of study in Cochrane Systematic Review (personal communication). Email to A Todorovac. 21st of August 2019. BornovalovaMA .Distress tolerance treatment for inner-city drug users: a preliminary trial. Doctor’s Dissertation, University of Maryland2008. ">Bornovalova 2008</a> ; <a href="./references#MR000050-bbs2-0160" title="BornovalovaM .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 21st of August 2019.">Bornovalova 2008 (pers comm)</a> ; <a href="./references#MR000050-bbs2-0034" title="KarstM , WinterhalterM , MünteS , FranckiB , HondronikosA , EckardtA , et al.Auricular acupuncture for dental anxiety: a randomized controlled trial. Anesthesia and Analgesia2007;104(2):295-300. KarstM .Inclusion of study in Cochrane Systematic Review (personal communication). Email to: EG Faltinsen 5th of September 2019. ">Karst 2007</a> ; <a href="./references#MR000050-bbs2-0222" title="KarstM .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: EG Faltinsen 5th of September 2019.">Karst 2007 (pers comm)</a> ; <a href="./references#MR000050-bbs2-0035" title="KelleyJ .Inclusion of study in Cochrane Systematic Review (personal communication). Email to: A Todorovac 12th of August 2019. KelleyJM , KaptchukTJ , CusinC , LipkinS , FavaM .Open-label placebo for major depressive disorder: a pilot randomized controlled trial. Psychotherapy and Psychosomatics2012;81(5):312-4. ">Kelley 2012</a> ; <a href="./references#MR000050-bbs2-0226" title="KelleyJ .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 12th of August 2019.">Kelley 2012 (pers comm)</a> ; <a href="./references#MR000050-bbs2-0043" title="KwanR .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 26th of August 2019. KwanRY , LeungMC , LaiCK .Acupressure for agitation in nursing home residents with dementia: study protocol for a randomized controlled trial. Trials2014;15(410):1-7. KwanRY , LeungMCP , LaiCK .A randomized controlled trial examining the effect of acupressure on agitation and salivary cortisol in nursing home residents with dementia. Dementia and Geriatric Cognitive Disorders2017;44(1-2):92-104. ">Kwan 2017</a> ; <a href="./references#MR000050-bbs2-0234" title="KwanR .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 26th of August 2019.">Kwan 2017 (pers comm)</a> ; <a href="./references#MR000050-bbs2-0045" title="LaiCK , ChiI , Kayser-JonesJ .A randomized controlled trial of a specific reminiscence approach to promote the well-being of nursing home residents with dementia. International Psychogeriatrics2004;16(1):33-49. LaiK .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 6th of September 2019. ">Lai 2004</a> ; <a href="./references#MR000050-bbs2-0235" title="LaiK .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 6th of September 2019.">Lai 2004 (pers comm)</a> ; <a href="./references#MR000050-bbs2-0047" title="LegrandF .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 14th of August 2019. LegrandFD , NeffEM .Efficacy of exercise as an adjunct treatment for clinically depressed inpatients during the initial stages of antidepressant pharmacotherapy: an open randomized controlled trial. Journal of Affective Disorders2016;191:139-44. ">Legrand 2016</a> ; <a href="./references#MR000050-bbs2-0236" title="LegrandF .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 14th of August 2019.">Legrand 2016 (pers comm)</a> ; <a href="./references#MR000050-bbs2-0055" title="MirandaA , ArlandisP , SorianoM .Instruction in strategies and attributional training: Effects on the problem-solving and self-concept of students’ with learning disabilities [Instrucción en estrategias y entrenamiento atribucional: efectos sobre la resolución de problemas y el autoconcepto de los estudiantes con dificultades en el aprendizaje]. Infancia y Aprendizaje1997;20(80):37-52. ">Miranda 1997</a> ; <a href="./references#MR000050-bbs2-0247" title="MirandaJ .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: EG Faltinsen 9th of September 2019.">Miranda 1997 (pers comm)</a> ; <a href="./references#MR000050-bbs2-0068" title="ProudfootJ , ClarkeJ , BirchMR , WhittonAE , ParkerG , ManicavasagarV , et al.Impact of a mobile phone and web program on symptom and functional outcomes for people with mild- to-moderate depression, anxiety and stress: a randomized controlled trial. BMC Psychiatry2013;13(312):1-12. ProudfootJ .Re: Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 26th of August 2019. ">Proudfoot 2013</a> ; <a href="./references#MR000050-bbs2-0260" title="ProudfootJ .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 26th of August 2019.">Proudfoot 2013 (pers comm)</a> ; <a href="./references#MR000050-bbs2-0071" title="RapeeR .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 29th of August 2019. RapeeRM , AbbottMJ , LynehamHJ .Bibliotherapy for children With anxiety disorders using written materials for parents: a randomized controlled trial. Journal of Consulting and Clinical Psychology2006;74(3):436-44. ">Rapee 2006</a> ; <a href="./references#MR000050-bbs2-0261" title="RapeeR .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 29th of August 2019.">Rapee 2006 (pers comm)</a> ; <a href="./references#MR000050-bbs2-0072" title="RapeeR .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 29th of August 2019. RapeeRM , AbbottMJ , BaillieAJ , GastonJE .Treatment of social phobia through pure self-help and therapist-augmented self-help. British Journal of Psychiatry2007;191:246-52. ">Rapee 2007</a> ; <a href="./references#MR000050-bbs2-0262" title="RapeeR .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 29th of August 2019.">Rapee 2007 (pers comm)</a> ; <a href="./references#MR000050-bbs2-0084" title="SzymanskiJ , O'DonohueW .The potential role of state-dependent learning in cognitive therapy with spider phobics. Journal of Rational-Emotive &amp; Cognitive-Behavior Therapy1995;13(2):131-50. SzymanskiJ .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 20th of August 2019. ">Szymanski 1995</a> ; <a href="./references#MR000050-bbs2-0276" title="SzymanskiJ .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 20th of August 2019.">Szymanski 1995 (pers comm)</a> ; <a href="./references#MR000050-bbs2-0086" title="TeriL , LogsdonRG , UomotoJ , McCurrySM .Behavioral treatment of depression in dementia patients: a controlled clinical trial. Journals of Gerontology. Series B, Psychological Sciences and Social Sciences1997;52(4):159-66. TeriL .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 26th of August 2019. ">Teri 1997</a> ; <a href="./references#MR000050-bbs2-0278" title="TeriL .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 26th of August 2019.">Teri 1997 (pers comm)</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Setting</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Studies with outpatient settings</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>74</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#MR000050-bbs2-0001" title="AbikoffH , HechtmanL , KleinRG .Social functioning in children with ADHD treated with long-term methylphenidate and multimodal psychosocial treatment. Journal of the American Academy of Child and Adolescent Psychiatry2004;43(7):820-9. AbikoffH .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to A Todorovac 23rd of August 2019. KleinRG , AbikoffH , HechtmanL , WeissG .Design and rationale of controlled study of long-term methylphenidate and multimodal psychosocial treatment in children with ADHD. Journal of the American Academy of Child and Adolescent Psychiatry2004;43(7):792-801. ">Abikoff 2004</a> ; <a href="./references#MR000050-bbs2-0002" title="AllenJB .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to A Todorovac 28th of August 2019. AllenJJ , SchnyerRN , HittSK .The efficacy of acupuncture in the treatment of major depression in women. Psychological Science1998;9(5):397-401. ">Allen 1998</a> ; <a href="./references#MR000050-bbs2-0003" title="AllenJB .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 28th of August 2019. AllenJJ , SchnyerRN , ChambersAS , HittSK , MorenoFA , ManberR .Acupuncture for depression: a randomized controlled trial. Journal of Clinical Psychiatry2006;67(11):1665-73. ">Allen 2006</a> ; <a href="./references#MR000050-bbs2-0004" title="AlvarezJR .The effects of anger management training on depression, anger, self-concept, and treatment responsibility in a sample of drug-dependent individuals in a therapeutic community. Dissertation Abstracts International: Section B: the Sciences and Engineering1997;58(4-B):2108. ">Alvarez 1997</a> ; <a href="./references#MR000050-bbs2-0005" title="AscherLM , TurnerR .Paradoxical intention and insomnia: an experimental investigation. Behaviour Research and Therapy1979;17(4):408-11. ">Ascher 1979</a> ; <a href="./references#MR000050-bbs2-0006" title="AyenI , HautzingerM .Cognitive behavior therapy for depression in menopausal women. A controlled, randomized treatment study [Kognitive Verhaltenstherapie bei Depressionen im Klimakterium: Eine kontrollierte, randomiserte Interventionsstudie]. Zeitschrift für Klinische Psychologie und Psychotherapie2004;33(4):290-9. AyenI .Inclusion of study in Cochrane Systematic Review (personal communication). Email to EG Faltinsen 9th of September 2019. ">Ayen 2004</a> ; <a href="./references#MR000050-bbs2-0007" title="BergI , ForsytheI , HoltP , WattsJ .A controlled trial of ‘Senokot’ in faecal soiling treated by behavioural methods. Journal of Child Psychology and Psychiatry1983;24(4):543-9. ">Berg 1983</a> ; <a href="./references#MR000050-bbs2-0008" title="Borden, KA.Attributional Outcomes: the Subtle Messages of Treatments for Attention Deficit Disorder. Dissertation, University of Illinois at Urbana-Champaign1986. BordenKA , BrownRT .Attributional outcomes: The subtle messages of treatments for attention deficit disorder. Cognitive Therapy and Research1989;13(2):147-60. ">Borden 1986</a> ; <a href="./references#MR000050-bbs2-0009" title="BorkovecTD , KaloupekDG , SlamaKM .The facilitative effect of muscle tension-release in the relaxation treatment of sleep disturbance. Behavior Therapy1975;6(3):301-9. ">Borkovec 1975</a> ; <a href="./references#MR000050-bbs2-0010" title="BorkovecTD , WeertsTC .Effects of progressive relaxation on sleep disturbance: an electroencephalographic evaluation. Psychosomatic Medicine1976;38(3):173-80. ">Borkovec 1976</a> ; <a href="./references#MR000050-bbs2-0013" title="BrillNQ , KoeglerRR , EpsteinLJ , ForgyEW .Controlled study of psychiatric outpatient treatment. Archives of General Psychiatry1964;10:581-95. BrillNQ .Results of psychotherapy. California Medicine1966;104(4):249-53. ">Brill 1964a</a> ; <a href="./references#MR000050-bbs2-0014" title="BrillNQ , KoeglerRR , EpsteinLJ , ForgyEW .Controlled study of psychiatric outpatient treatment. Archives of General Psychiatry1964;10:581-95. ">Brill 1964b</a> ; <a href="./references#MR000050-bbs2-0015" title="CarlsonCL , PelhamWE , MilichR , HozaB .ADHD boys’ performance and attributions following success and failure: drug effects and individual differences. Cognitive Therapy and Research1993;17:269-87. ">Carlson 1993</a> ; <a href="./references#MR000050-bbs2-0018" title="CrouchG , RobsonM , HallstromC .Benzodiazepine dependent patients and their psychological treatment. Progress in Neuro-psychopharmacology &amp; Biological Psychiatry1988;12(4):503-10. HallströmC , CrouchG , RobsenM , ShineP .The treatment of tranquillizer dependence by propranolol. Postgraduate Medical Journal1988;64(Suppl 2):40-4. ">Crouch 1988</a> ; <a href="./references#MR000050-bbs2-0021" title="EhlersA , HackmannA , GreyN , WildJ , LinessS , AlbertI , et al.A randomized controlled trial of 7-day intensive and standard weekly cognitive therapy for PTSD and emotion-focused supportive therapy. American Journal of Psychiatry2014;171(3):294-304. ">Ehlers 2014</a> ; <a href="./references#MR000050-bbs2-0022" title="EspieCA , BrooksDN , LindsayWR .An evaluation of tailored psychological treatment of insomnia. Journal of Behavior Therapy and Experimental Psychiatry1989;20(2):143-53. EspieCA , LindsayWR , BrooksDN , HoodEM , TurveyT .A controlled comparative investigation of psychological treatments for chronic sleep-onset insomnia. Behaviour Research and Therapy1989;27(1):79-88. ">Espie 1989a</a> ; <a href="./references#MR000050-bbs2-0023" title="EtringerBD , CashTF , RimmDC .Behavioral, affective, and cognitive effects of participant modeling and an equally credible placebo. Behavior Therapy1982;13(4):476-85. ">Etringer 1982</a> ; <a href="./references#MR000050-bbs2-0024" title="FoaEB , RothbaumBO , RiggsDS , MurdockTB .Treatment of posttraumatic stress disorder in rape victims: a comparison between cognitive-behavioral procedures and counselling. Journal of Consulting and Clinical Psychology1991;59(5):715-23. ">Foa 1991</a> ; <a href="./references#MR000050-bbs2-0025" title="FoaEB , McLeanCP , ZangY , RosenfieldD , YadinE , YarvisJS , et al.Effect of prolonged exposure therapy delivered over 2 weeks vs 8 weeks vs present-centered therapy on PTSD symptom severity in military personnel: a randomized clinical trial. JAMA2018;319(4):354-64. ">Foa 2018</a> ; <a href="./references#MR000050-bbs2-0026" title="FreireAO , SugaiGC , ChrispinFS , TogeiroSM , YamamuraY , MelloLE , et al.Treatment of moderate obstructive sleep apnea syndrome with acupuncture: a randomised, placebo-controlled pilot trial. Sleep Medicine2007;8(1):43-50. ">Freire 2007</a> ; <a href="./references#MR000050-bbs2-0027" title="FuchsCZ , RehnLP .A self-control behavior therapy program for depression. Journal of Consulting and Clinical Psychology1977;45(2):206-15. ">Fuchs 1977</a> ; <a href="./references#MR000050-bbs2-0028" title="GlogowskaM , RoulstoneS , EnderbyP , PetersTJ .Randomised controlled trial of community based speech and language therapy in preschool children. BMJ2000;321(7266):923-6. ">Glogowska 2000</a> ; <a href="./references#MR000050-bbs2-0029" title="GoldsteinAJ , BeursE , Chambless Dl, WilsonKA .EMDR for panic disorder with agoraphobia: comparison with waiting list and credible attention-placebo control conditions. Journal of Consulting and Clinical Psychology2000;68(6):947-56. ">Goldstein 2000</a> ; <a href="./references#MR000050-bbs2-0031" title="HekmatH , LubitzR , DealR .Semantic desensitization: a paradigmatic intervention approach to anxiety disorders. Journal of Clinical Psychology1984;40(2):463-6. ">Hekmat 1984</a> ; <a href="./references#MR000050-bbs2-0033" title="HowlinP , GordonKR , PascoG , WadeA , CharmanT .The effectiveness of picture exchange communication system (PECS) training for teachers of children with autism: a pragmatic,group randomised controlled trial. Journal of Child Psychology and Psychiatry2007;48(5):473-81. ">Howlin 2007</a> ; <a href="./references#MR000050-bbs2-0034" title="KarstM , WinterhalterM , MünteS , FranckiB , HondronikosA , EckardtA , et al.Auricular acupuncture for dental anxiety: a randomized controlled trial. Anesthesia and Analgesia2007;104(2):295-300. KarstM .Inclusion of study in Cochrane Systematic Review (personal communication). Email to: EG Faltinsen 5th of September 2019. ">Karst 2007</a> ; <a href="./references#MR000050-bbs2-0035" title="KelleyJ .Inclusion of study in Cochrane Systematic Review (personal communication). Email to: A Todorovac 12th of August 2019. KelleyJM , KaptchukTJ , CusinC , LipkinS , FavaM .Open-label placebo for major depressive disorder: a pilot randomized controlled trial. Psychotherapy and Psychosomatics2012;81(5):312-4. ">Kelley 2012</a> ; <a href="./references#MR000050-bbs2-0036" title="KennedyTD , KimuraHK .Transfer, behavioral improvement, and anxiety reduction in systematic desensitization. Journal of Consulting and Clinical Psychology1974;42(5):720-8. ">Kennedy 1974</a> ; <a href="./references#MR000050-bbs2-0037" title="KilmannPR , MilanRJ , BolandJP , NankinHR , DavidsonE , WestMO , et al.Group treatment of secondary erectile dysfunction. Journal of Sex &amp; Marital Therapy1987;13(3):168-82. KilmannPR , Milan RJ Jr, BolandJP , DavidsonE , WestMO , SablisRF , et al.The sexual interactions of men with secondary erectile dysfunction. Journal of Sex Education and Therapy1988;14(1):46-9. KilmannPR , Milan RJ Jr, BolandJP , NankinHR , SablisRF , WestMO , et al.The sexual interactions of men with secondary erectile dysfunction. Paper presented at the annual meeting of the American Psychological Association in Los Angeles1985;1:46-9. ">Kilmann 1987</a> ; <a href="./references#MR000050-bbs2-0038" title="KleinSA , DeffenbacherJL .Relaxation and exercise for hyperactive impulsive children. Perceptual and Motor Skills1977;45:1159-62. ">Klein 1977</a> ; <a href="./references#MR000050-bbs2-0039" title="KlermanGL , DimascioA , WeismannM , PrusoffB , PaykelES .Treatment of depression by drugs and psychotherapy. American Journal of Psychiatry1974;131(2):186-91. PaykelES , DimascioA , HaskellD , PrusoffBA .Effects of maintenance amitriptyline and psychotherapy on symptoms of depression. Psychological Medicine1975;5(1):67-77. PaykelES , DiMascioA , KlermanGL , PrusoffBA .Maintenance therapy of depression. Pharmakopsychiatrie, Neuro-Psychopharmakologie1976;9:127-39. PaykelES , WeissmanMM , PrusoffBA .Social maladjustment and severity of depression. Comprehensive Psychiatry1978;19(2):121-8. WeissmanMM , KlermanGL , PaykelES , PrusoffB .Treatment effects on the social adjustment of depressed patients. Archives of General Psychiatry1974;30:771-8. ">Klerman 1974a</a> ; <a href="./references#MR000050-bbs2-0040" title="KlermanGL , DimascioA , WeismannM , PrusoffB , PaykelES .Treatment of depression by drugs and psychotherapy. American Journal of Psychiatry1974;131(2):186-91. ">Klerman 1974b</a> ; <a href="./references#MR000050-bbs2-0041" title="KloskoJS , BarlowDH , TassinariR , CernyJA .A comparison of alprazolam and behavior therapy in treatment of panic disorder: correction. Journal of Psychotherapy Practice and Research1994;3(2):163-79. KloskoJS , BarlowDH , TassinariR , CernyJA .A comparison of alprazolam and behavior therapy in treatment of panic disorder. Journal of Consulting and Clinical Psychology1990;58(1):77-84. ">Klosko 1990</a> ; <a href="./references#MR000050-bbs2-0042" title="KrapflJE , NawasMM .Differential ordering of stimulus presentation in systematic desensitization. Journal of Abnormal Psychology1970;75(3):333-7. ">Krapfl 1970</a> ; <a href="./references#MR000050-bbs2-0043" title="KwanR .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 26th of August 2019. KwanRY , LeungMC , LaiCK .Acupressure for agitation in nursing home residents with dementia: study protocol for a randomized controlled trial. Trials2014;15(410):1-7. KwanRY , LeungMCP , LaiCK .A randomized controlled trial examining the effect of acupressure on agitation and salivary cortisol in nursing home residents with dementia. Dementia and Geriatric Cognitive Disorders2017;44(1-2):92-104. ">Kwan 2017</a> ; <a href="./references#MR000050-bbs2-0046" title="LangOJ , LazovikAD .Experimental desensitization of a phobia. Journal of Abnormal and Social Psychology1963;66:519-25. LangPJ , LazovikAD , ReynoldsDJ .Desensitization, suggestibility, and pseudotherapy. Journal of Abnormal Psychology1965;70(6):395-402. ">Lang 1965</a> ; <a href="./references#MR000050-bbs2-0048" title="LickJ .Expectancy, false galvanic skin response feedback, and systematic desensitization in the modification of phobic behavior. Journal of Consulting and Clinical Psychology1975;43(4):557-67. ">Lick 1975</a> ; <a href="./references#MR000050-bbs2-0049" title="LickJR , HefflerD .Relaxation training and attention placebo in the treatment of severe insomnia. Journal of Consulting and Clinical Psychology1977;45(2):153-61. ">Lick 1977</a> ; <a href="./references#MR000050-bbs2-0050" title="LiddleB , SpenceSH .Cognitive-behaviour therapy with depressed primary school children: A cautionary note. Behavioural Psychotherapy1990;18(2):85-102. ">Liddle 1990</a> ; <a href="./references#MR000050-bbs2-0051" title="MatsonJL , MarchettiA , AdkinsJA .Comparison of operant- and independence-training procedures for mentally retarded adults. American Journal of Mental Deficiency1980;84(5):487-94. ">Matson 1980</a> ; <a href="./references#MR000050-bbs2-0053" title="MealieaWL , NawasMM .The comparative effectiveness of systematic desensitization and implosive therapy in the treatment of snake phobia. Journal of Behavior Therapy and Experimental Psychiatry1971;2(2):85-94. ">Mealiea 1971</a> ; <a href="./references#MR000050-bbs2-0054" title="MilbyJB , ClarkeC , ToroC , ThorntonS , RickertD .Effectiveness of urine surveillance as an adjunct to outpatient psychotherapy for drug abusers. International Journal of the Addictions1980;15(7):993-1001. ">Milby 1980</a> ; <a href="./references#MR000050-bbs2-0055" title="MirandaA , ArlandisP , SorianoM .Instruction in strategies and attributional training: Effects on the problem-solving and self-concept of students’ with learning disabilities [Instrucción en estrategias y entrenamiento atribucional: efectos sobre la resolución de problemas y el autoconcepto de los estudiantes con dificultades en el aprendizaje]. Infancia y Aprendizaje1997;20(80):37-52. ">Miranda 1997</a> ; <a href="./references#MR000050-bbs2-0056" title="MitchellC , MansfieldD , RautenbachS .Coloured filters and reading accuracy, comprehension and rate: a placebo-controlled study. Perceptual and Motor Skills2008;106(2):517-32. ">Mitchell 2008</a> ; <a href="./references#MR000050-bbs2-0057" title="NandiDN , AjmanyS , GanguliH , BanerjeeG , BoralGC , GhoshA , et al.A clinical evaluation of depressives found in a rural survey in India. British Journal of Psychiatry1976;128:523-7. ">Nandi 1976</a> ; <a href="./references#MR000050-bbs2-0058" title="NicassioP , BootzinR .A comparison of progressive relaxation and autogenic training as treatments for insomnia. Journal of Abnormal Psychology1974;83(3):253-60. ">Nicassio 1974</a> ; <a href="./references#MR000050-bbs2-0061" title="MilichR , CarlsonCL , Pelham WE Jr, LichtBG .Effects of methylphenidate on the persistence of ADHD boys following failure experiences. Journal of Abnormal Child Psychology1991;19(5):519-36. PelhamWE , MurphyDA , VannattaK , MilichR , LichtBG , GnagyEM , et al.Methylphenidate and attributions in boys with attention-deficit hyperactivity disorder. Journal of Consulting and Clinical Psychology1992;60(2):282-92. ">Pelham 1992</a> ; <a href="./references#MR000050-bbs2-0062" title="PedletonMG , HigginsRL .A comparison of negative practice and systematic desensitization in the treatment of acrophobia. Journal of Behavior Therapy and Experimental Psychiatry1983;14(4):317-23. ">Pendleton 1983</a> ; <a href="./references#MR000050-bbs2-0064" title="PolandRE , GertsikL , FavreauJT , SmithSI , MirochaJM , RaoU , et al.Open-label randomized parallel-group controlled clinical trial of massage for treatment of depression in HIV-infected subjects. Journal of Alternative and Complementary Medicine2013;19(4):334-40. ">Poland 2013</a> ; <a href="./references#MR000050-bbs2-0065" title="PowersMB , SmitsJA , TelchMJ .Disentangling the effects of safety-behavior utilization and safety-behavior availability during exposure-based treatment: a placebo-controlled trial. Journal of Consulting and Clinical Psychology2004;72(3):448-54. ">Powers 2004</a> ; <a href="./references#MR000050-bbs2-0066" title="PowersMB , SmithsJA , WhitleyD , BystritskyA , TelchMJ .The effect of attributional processes concerning medication taking on return of fear. Journal of Consulting and Clinical Psychology2008;76(3):478-90. ">Powers 2008a</a> ; <a href="./references#MR000050-bbs2-0067" title="PowersMB , SmithsJA , WhitleyD , BystritskyA , TelchMJ .The effect of attributional processes concerning medication taking on return of fear. Journal of Consulting and Clinical Psychology2008;76(3):478-90. ">Powers 2008b</a> ; <a href="./references#MR000050-bbs2-0068" title="ProudfootJ , ClarkeJ , BirchMR , WhittonAE , ParkerG , ManicavasagarV , et al.Impact of a mobile phone and web program on symptom and functional outcomes for people with mild- to-moderate depression, anxiety and stress: a randomized controlled trial. BMC Psychiatry2013;13(312):1-12. ProudfootJ .Re: Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 26th of August 2019. ">Proudfoot 2013</a> ; <a href="./references#MR000050-bbs2-0069" title="QuayhagenMP , QuayhagenM , CorbeilRR , RothPA , RodgersJA .A dyadic remediation program for care recipients with dementia. Nursing Research1995;44(3):153-9. ">Quayhagen 1995</a> ; <a href="./references#MR000050-bbs2-0070" title="LiebowitzM , QuitkinFM , StewartJW , McGrathPJ , HarrisonWM , MarkowitzJS , et al.Antidepressant efficacy in atypical depression. Archives of General Psychiatry1988;45(2):129-37. QuitkinFM , McGrathPJ , StewartJW , HarrisonW , WagerSG , NunesE , et al.Phenelzine and imipramine in mood reactive depressives: further delineation of the syndrome of atypical depression. Archives of General Psychiatry1989;46(9):787-93. RabkinJG , McGrathPJ , QuitkinFM , TricamoE , StewartJW , KleinDF .Effects of pill-giving on maintenance of placebo response in patients with chronic mild depression. American Journal of Psychiatry1990;147(12):1622-6. ">Rabkin 1990</a> ; <a href="./references#MR000050-bbs2-0071" title="RapeeR .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 29th of August 2019. RapeeRM , AbbottMJ , LynehamHJ .Bibliotherapy for children With anxiety disorders using written materials for parents: a randomized controlled trial. Journal of Consulting and Clinical Psychology2006;74(3):436-44. ">Rapee 2006</a> ; <a href="./references#MR000050-bbs2-0072" title="RapeeR .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 29th of August 2019. RapeeRM , AbbottMJ , BaillieAJ , GastonJE .Treatment of social phobia through pure self-help and therapist-augmented self-help. British Journal of Psychiatry2007;191:246-52. ">Rapee 2007</a> ; <a href="./references#MR000050-bbs2-0073" title="RobinA .Rationing out-patients: a defence of the waiting list. British Journal of Psychiatry1976;129:138-41. ">Robin 1976</a> ; <a href="./references#MR000050-bbs2-0075" title="OlivaresJ .Program IAFS. Protocol for the treatment of social phobia in adolescents [Programa IAFS. Protocolo para el tratamiento de la fobia social enadolescentes]. Madrid: Pirámide2005;1. Rosa-AlcázarAI , Olivares-OlivaresPJ , OlivaresJ .The role of non-specific effects in the psychological treatment of adolescents with social phobia [Papel de los efectos inespecíficos en el tratamiento psicológico de adolescentes con fobia social]. Anuario de Psicologia2009;40(1):43-61. ">Rosa‐Alcatraz 2009</a> ; <a href="./references#MR000050-bbs2-0076" title="RosenGM , GlasgowRE , BarreraM .A controlled study to assess the clinical efficacy of totally self-administrated systematic desensitization. Journal of Consulting and Clinical Psychology1976;44(2):208-17. ">Rosen 1976</a> ; <a href="./references#MR000050-bbs2-0077" title="LorrM , McNairDM , WeinsteinGJ .Early effects of chlordiazepoxide (Librium) used with psychotherapy. Journal of Psychiatric Research1963;1:257-70. RothI , RhudickPJ , ShaskanDA , SlobinMS , WilkinsonAE , YoungHH .Long-term effects on psychotherapy of initial treatment conditions. Journal of Psychiatric Research1964;2:283-97. ">Roth 1964</a> ; <a href="./references#MR000050-bbs2-0079" title="ShalevAY , AnkriY , Isreali-ShalevY , PelegT , AdesskyR , FreedmanS .Prevention of posttraumatic stress disorder by early treatment. Archives of General Psychiatry2012;69(2):166-76. ">Shalev 2012</a> ; <a href="./references#MR000050-bbs2-0080" title="ShealyRC .The effectiveness of various treatment techniques on different degrees and durations of sleep-onset insomnia. Behaviour Research and Therapy1979;17(6):541-6. ">Shealy 1979</a> ; <a href="./references#MR000050-bbs2-0083" title="SteinmarkSW , BorkovecTD .Active and placebo treatment effects on moderate insomnia under counterdemand and positive demand instructions. Journal of Abnormal Psychology1974;83(2):157-63. ">Steinmark 1974</a> ; <a href="./references#MR000050-bbs2-0084" title="SzymanskiJ , O'DonohueW .The potential role of state-dependent learning in cognitive therapy with spider phobics. Journal of Rational-Emotive &amp; Cognitive-Behavior Therapy1995;13(2):131-50. SzymanskiJ .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 20th of August 2019. ">Szymanski 1995</a> ; <a href="./references#MR000050-bbs2-0085" title="TanSY , BruniJ .Cognitive-behavior therapy with adult patients with epilepsy: a controlled outcome study. Epilepsia1986;27(3):225-33. ">Tan 1986</a> ; <a href="./references#MR000050-bbs2-0086" title="TeriL , LogsdonRG , UomotoJ , McCurrySM .Behavioral treatment of depression in dementia patients: a controlled clinical trial. Journals of Gerontology. Series B, Psychological Sciences and Social Sciences1997;52(4):159-66. TeriL .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 26th of August 2019. ">Teri 1997</a> ; <a href="./references#MR000050-bbs2-0087" title="ToriC , WorellL .Reduction of human avoidant behavior. A comparison of counterconditioning, expectancy, and cognitive information approaches. Clinical Psychology1973;41(2):269-78. ">Tori 1973</a> ; <a href="./references#MR000050-bbs2-0088" title="Trexler, L.Rational-emotive therapy, placebo, and no-treatment effects on public-speaking anxiety. Doctoral dissertation, Temple University AnnArbor, Mich.: University Microfilms1971;71-31(063). TrexlerLD , KarstTO .Rational-emotive therapy, placebo, and no-treatment effects on public-speaking anxiety. Journal of Abnormal Psyhology1972;79(1):60-7. ">Trexler 1972</a> ; <a href="./references#MR000050-bbs2-0089" title="AscherML , TurnerRM .A comparison of two methods for the administration of paradoxical intention. Behaviour Research and Therapy1980;18(2):121-6. TurnerRM , AscherLM .Controlled comparison of progressive relaxation, stimulus control, and paradoxical intention therapies for insomnia. Journal of Consulting and Clinical Psychology1979;47(3):500-8. ">Turner 1979</a> ; <a href="./references#MR000050-bbs2-0090" title="VanderplateC .Electromyograph biofeedback Treatment of sleep onset Insomnia: a controlled Investigation. Dissertation, University of Southern Mississippi1978. ">Vanderplate 1983</a> ; <a href="./references#MR000050-bbs2-0094" title="WilsonA , DavidsonWJ , BlanchardR , WhiteJ .Disulfiram implantation. A placebo-controlled trial with two-year follow-up. Journal of Studies on Alcohol1978;39(5):809-19. WilsonA , DavidsonWJ , BlanchardR .Disulfiram implantation: a trial using placebo implants and two types of controls. Journal of Studies on Alcohol1980;41(5):429-36. ">Wilson 1980</a> ; <a href="./references#MR000050-bbs2-0095" title="WolitzkyKB , TelchMJ .Augmenting in vivo exposure with fear antagonistic actions: a preliminary test. Behavior Therapy2009;40(1):57-71. ">Wolitzky 2009</a> ; <a href="./references#MR000050-bbs2-0096" title="WollersheimJP , WilsonGL .Group treatment of unipolar depression: a comparison of coping, supportive, bibliotherapy, and delayed treatment groups. Professional Psychology: Research and Practice1991;22(6):496-502. ">Wollersheim 1991</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Studies with inpatient<br/>settings </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>20</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#MR000050-bbs2-0011" title="BornovalovaM .Inclusion of study in Cochrane Systematic Review (personal communication). Email to A Todorovac. 21st of August 2019. BornovalovaMA .Distress tolerance treatment for inner-city drug users: a preliminary trial. Doctor’s Dissertation, University of Maryland2008. ">Bornovalova 2008</a> ; <a href="./references#MR000050-bbs2-0012" title="BramstonP , SpenceSH .Behavioural versus cognitive social-skills training with intellectually-handicapped adults. Behaviour Research and Therapy1985;23(3):239-46. ">Bramston 1985</a> ; <a href="./references#MR000050-bbs2-0016" title="CarterJC , OlmstedMP , KaplanAS , McCabeRE , MillsJS , AimeA .Self-help for bulimia nervosa: a randomized controlled trial. American Journal of Psychiatry2003;160(5):973-8. ">Carter 2003</a> ; <a href="./references#MR000050-bbs2-0019" title="Doty, DW.Role playing and incentives in the modification of the social interaction of chronic psychiatric patients. Journal of Consulting and Clinical Psychology1975;43(5):676-82. ">Doty 1975</a> ; <a href="./references#MR000050-bbs2-0020" title="DoubleDB , WarrenGC , EvansM , RowlandsMP .Efficacy of maintenance use of anticholinergic agents. Acta Psychiatrica Scandinavica1993;88:381-4. ">Double 1993</a> ; <a href="./references#MR000050-bbs2-0030" title="GoldwasserAN , AuerbachSM , HarkinsSW .Cognitive, affective, and behavioural effects of reminiscence group therapy on demented elderly. Aging and Human Development1987;25(3):209-22. ">Goldwasser 1987</a> ; <a href="./references#MR000050-bbs2-0044" title="LacyMK .The effect of short term autogenic training on the stress reactivity of hospitalized emotionally disturbed adolescents. ProQuest Dissertations Publishing, Oklahoma State University1996. ">Lacy 1990</a> ; <a href="./references#MR000050-bbs2-0045" title="LaiCK , ChiI , Kayser-JonesJ .A randomized controlled trial of a specific reminiscence approach to promote the well-being of nursing home residents with dementia. International Psychogeriatrics2004;16(1):33-49. LaiK .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 6th of September 2019. ">Lai 2004</a> ; <a href="./references#MR000050-bbs2-0047" title="LegrandF .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 14th of August 2019. LegrandFD , NeffEM .Efficacy of exercise as an adjunct treatment for clinically depressed inpatients during the initial stages of antidepressant pharmacotherapy: an open randomized controlled trial. Journal of Affective Disorders2016;191:139-44. ">Legrand 2016</a> ; <a href="./references#MR000050-bbs2-0052" title="McLachlanDR , DaltonAJ , KruckTP , BellMY , SmithWL , KalowW , et al.Intramuscular desferrioxamine in patients with Alzheimer's disease. Lancet1991;337(8753):1304-8. McLachlanDRC , SmithWL , KruckTP .Desferrioxamine and Alzheimer’s disease: video home behavior assessment of clinical course and measures of brain aluminum. Therapeutic Drug Monitoring1993;15(6):602-7. ">McLachlan 1991</a> ; <a href="./references#MR000050-bbs2-0060" title="PeckCL .Desensitization for the treatment of fear in the high level adult retardate. Behaviour Research and Therapy1977;15(2):137-48. ">Peck 1976</a> ; <a href="./references#MR000050-bbs2-0059" title="PearlD , Vander KampH , OlsenAL , GreenbergPD , ArmitageSG .The effects of reserpine on schizophrenic patients. American Journal of Psychiatry1956;112:198-204. ">Pearl 1956</a> ; <a href="./references#MR000050-bbs2-0063" title="PetersonMA , PattersonB , PillmanBM , BattistaMA .Cognitive recovery following alcohol detoxification: a computerised remediation study. Neuropsychological Rehabilitation2002;12(1):63-74. PillmanBM .Computerized cognitive remediation with recently detoxified alcoholics. Dissertation, California School of Professional Psychology, Fresno Campus2000. ">Pillman 2001</a> ; <a href="./references#MR000050-bbs2-0074" title="RoehrichL , GoldmanMS .Experience-dependent neuropsychological recovery and the treatment of alcoholism. Journal of Consulting and Clinical Psychology1993;61(5):812-21. ">Roehrich 1993</a> ; <a href="./references#MR000050-bbs2-0078" title="RupertPA , HolmesDS .Effects of multiple sessions of true and placebo heart rate biofeedback training on the heart rates and anxiety levels of anxious patients during and following treatment. Psychophysiology1978;15(6):582-90. ">Rupert 1978</a> ; <a href="./references#MR000050-bbs2-0081" title="SibilioJP , AndrewG , DartD , MooreKB , StehmanA .Treatment of chronic schizophrenia with promazine hydrochloride. AMA Archives of Neurology and Psychiatry1957;78(4):419-24. ">Sibilio 1957</a> ; <a href="./references#MR000050-bbs2-0082" title="SommernessMD , LuceroRJ , HamlonJS , EricksonJL , MatthewsR .A controlled study of reserpine on chronically disturbed patients. JAMA Archives of Neurology and Psychiatry1955;74(3):316-9. ">Sommerness 1955</a> ; <a href="./references#MR000050-bbs2-0091" title="WatzlH , RistF , OlbrichR , CohenR .Placebo injections and surveillance of alcohol intake during inpatient treatment of female alcoholics. Addictive Behaviors1988;13(2):197-200. ">Watzl 1988</a> ; <a href="./references#MR000050-bbs2-0092" title="WeingaertnerAH .Self-administered aversive stimulation with hallucinating hospitalized schizophrenics. Journal of Consulting and Clinical Psychology1971;36(3):422-29. ">Weingaertner 1971</a> ; <a href="./references#MR000050-bbs2-0093" title="WhittakerCB , HoyRM .Withdrawal of perphenazine in chronic schizophrenia. British Journal of Psychiatry1963;109:422-7. ">Whittaker 1963</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Studies with both<br/>inpatient and outpatient<br/>settings </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#MR000050-bbs2-0017" title="CrispAH , NortonK , GowersS , HalekC , BowyerC , YeldhamD , et al.A controlled study of the effect of therapies aimed at adolescent and family psychopathology in Anorexia Nervosa. British Journal of Psychiatry: the Journal of Mental Science1991;159:325-33. GowersS , NortonK , HalekC , CrispAH .Outcome of outpatient psychotherapy in a random allocation treatment study of anorexia nervosa. International Journal of Eating Disorders1994;15(2):165-77. GowersS , NortonK , YelshamD .The St George's prospective treatment study of anorexia nervosa: a discussion of methodological problems. International Journal of Eating Disorders1989;8:445-54. ">Crisp 1991</a> ; <a href="./references#MR000050-bbs2-0032" title="HippmanC , RingroseA , InglisA , CheekJ , AlbertAY , RemickR , et al.A pilot randomized clinical trial evaluating the impact of genetic counselling for serious mental illnesses. Journal of Clinical Psychiatry2016;77(2):e190-8. ">Hippman 2016</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Sample size</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Sample size above<br/>100 participants </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#MR000050-bbs2-0025" title="FoaEB , McLeanCP , ZangY , RosenfieldD , YadinE , YarvisJS , et al.Effect of prolonged exposure therapy delivered over 2 weeks vs 8 weeks vs present-centered therapy on PTSD symptom severity in military personnel: a randomized clinical trial. JAMA2018;319(4):354-64. ">Foa 2018</a> ; <a href="./references#MR000050-bbs2-0028" title="GlogowskaM , RoulstoneS , EnderbyP , PetersTJ .Randomised controlled trial of community based speech and language therapy in preschool children. BMJ2000;321(7266):923-6. ">Glogowska 2000</a> ; <a href="./references#MR000050-bbs2-0068" title="ProudfootJ , ClarkeJ , BirchMR , WhittonAE , ParkerG , ManicavasagarV , et al.Impact of a mobile phone and web program on symptom and functional outcomes for people with mild- to-moderate depression, anxiety and stress: a randomized controlled trial. BMC Psychiatry2013;13(312):1-12. ProudfootJ .Re: Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 26th of August 2019. ">Proudfoot 2013</a> ; <a href="./references#MR000050-bbs2-0071" title="RapeeR .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 29th of August 2019. RapeeRM , AbbottMJ , LynehamHJ .Bibliotherapy for children With anxiety disorders using written materials for parents: a randomized controlled trial. Journal of Consulting and Clinical Psychology2006;74(3):436-44. ">Rapee 2006</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Gender</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Only females included</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>19</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#MR000050-bbs2-0002" title="AllenJB .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to A Todorovac 28th of August 2019. AllenJJ , SchnyerRN , HittSK .The efficacy of acupuncture in the treatment of major depression in women. Psychological Science1998;9(5):397-401. ">Allen 1998</a> ; <a href="./references#MR000050-bbs2-0006" title="AyenI , HautzingerM .Cognitive behavior therapy for depression in menopausal women. A controlled, randomized treatment study [Kognitive Verhaltenstherapie bei Depressionen im Klimakterium: Eine kontrollierte, randomiserte Interventionsstudie]. Zeitschrift für Klinische Psychologie und Psychotherapie2004;33(4):290-9. AyenI .Inclusion of study in Cochrane Systematic Review (personal communication). Email to EG Faltinsen 9th of September 2019. ">Ayen 2004</a> ; <a href="./references#MR000050-bbs2-0013" title="BrillNQ , KoeglerRR , EpsteinLJ , ForgyEW .Controlled study of psychiatric outpatient treatment. Archives of General Psychiatry1964;10:581-95. BrillNQ .Results of psychotherapy. California Medicine1966;104(4):249-53. ">Brill 1964a</a> ; <a href="./references#MR000050-bbs2-0014" title="BrillNQ , KoeglerRR , EpsteinLJ , ForgyEW .Controlled study of psychiatric outpatient treatment. Archives of General Psychiatry1964;10:581-95. ">Brill 1964b</a> ; <a href="./references#MR000050-bbs2-0016" title="CarterJC , OlmstedMP , KaplanAS , McCabeRE , MillsJS , AimeA .Self-help for bulimia nervosa: a randomized controlled trial. American Journal of Psychiatry2003;160(5):973-8. ">Carter 2003</a> ; <a href="./references#MR000050-bbs2-0017" title="CrispAH , NortonK , GowersS , HalekC , BowyerC , YeldhamD , et al.A controlled study of the effect of therapies aimed at adolescent and family psychopathology in Anorexia Nervosa. British Journal of Psychiatry: the Journal of Mental Science1991;159:325-33. GowersS , NortonK , HalekC , CrispAH .Outcome of outpatient psychotherapy in a random allocation treatment study of anorexia nervosa. International Journal of Eating Disorders1994;15(2):165-77. GowersS , NortonK , YelshamD .The St George's prospective treatment study of anorexia nervosa: a discussion of methodological problems. International Journal of Eating Disorders1989;8:445-54. ">Crisp 1991</a> ; <a href="./references#MR000050-bbs2-0021" title="EhlersA , HackmannA , GreyN , WildJ , LinessS , AlbertI , et al.A randomized controlled trial of 7-day intensive and standard weekly cognitive therapy for PTSD and emotion-focused supportive therapy. American Journal of Psychiatry2014;171(3):294-304. ">Ehlers 2014</a> ; <a href="./references#MR000050-bbs2-0024" title="FoaEB , RothbaumBO , RiggsDS , MurdockTB .Treatment of posttraumatic stress disorder in rape victims: a comparison between cognitive-behavioral procedures and counselling. Journal of Consulting and Clinical Psychology1991;59(5):715-23. ">Foa 1991</a> ; <a href="./references#MR000050-bbs2-0027" title="FuchsCZ , RehnLP .A self-control behavior therapy program for depression. Journal of Consulting and Clinical Psychology1977;45(2):206-15. ">Fuchs 1977</a> ; <a href="./references#MR000050-bbs2-0036" title="KennedyTD , KimuraHK .Transfer, behavioral improvement, and anxiety reduction in systematic desensitization. Journal of Consulting and Clinical Psychology1974;42(5):720-8. ">Kennedy 1974</a> ; <a href="./references#MR000050-bbs2-0039" title="KlermanGL , DimascioA , WeismannM , PrusoffB , PaykelES .Treatment of depression by drugs and psychotherapy. American Journal of Psychiatry1974;131(2):186-91. PaykelES , DimascioA , HaskellD , PrusoffBA .Effects of maintenance amitriptyline and psychotherapy on symptoms of depression. Psychological Medicine1975;5(1):67-77. PaykelES , DiMascioA , KlermanGL , PrusoffBA .Maintenance therapy of depression. Pharmakopsychiatrie, Neuro-Psychopharmakologie1976;9:127-39. PaykelES , WeissmanMM , PrusoffBA .Social maladjustment and severity of depression. Comprehensive Psychiatry1978;19(2):121-8. WeissmanMM , KlermanGL , PaykelES , PrusoffB .Treatment effects on the social adjustment of depressed patients. Archives of General Psychiatry1974;30:771-8. ">Klerman 1974a</a> ; <a href="./references#MR000050-bbs2-0040" title="KlermanGL , DimascioA , WeismannM , PrusoffB , PaykelES .Treatment of depression by drugs and psychotherapy. American Journal of Psychiatry1974;131(2):186-91. ">Klerman 1974b</a> ; <a href="./references#MR000050-bbs2-0042" title="KrapflJE , NawasMM .Differential ordering of stimulus presentation in systematic desensitization. Journal of Abnormal Psychology1970;75(3):333-7. ">Krapfl 1970</a> ; <a href="./references#MR000050-bbs2-0048" title="LickJ .Expectancy, false galvanic skin response feedback, and systematic desensitization in the modification of phobic behavior. Journal of Consulting and Clinical Psychology1975;43(4):557-67. ">Lick 1975</a> ; <a href="./references#MR000050-bbs2-0053" title="MealieaWL , NawasMM .The comparative effectiveness of systematic desensitization and implosive therapy in the treatment of snake phobia. Journal of Behavior Therapy and Experimental Psychiatry1971;2(2):85-94. ">Mealiea 1971</a> ; <a href="./references#MR000050-bbs2-0080" title="ShealyRC .The effectiveness of various treatment techniques on different degrees and durations of sleep-onset insomnia. Behaviour Research and Therapy1979;17(6):541-6. ">Shealy 1979</a> ; <a href="./references#MR000050-bbs2-0081" title="SibilioJP , AndrewG , DartD , MooreKB , StehmanA .Treatment of chronic schizophrenia with promazine hydrochloride. AMA Archives of Neurology and Psychiatry1957;78(4):419-24. ">Sibilio 1957</a> ; <a href="./references#MR000050-bbs2-0090" title="VanderplateC .Electromyograph biofeedback Treatment of sleep onset Insomnia: a controlled Investigation. Dissertation, University of Southern Mississippi1978. ">Vanderplate 1983</a> ; <a href="./references#MR000050-bbs2-0091" title="WatzlH , RistF , OlbrichR , CohenR .Placebo injections and surveillance of alcohol intake during inpatient treatment of female alcoholics. Addictive Behaviors1988;13(2):197-200. ">Watzl 1988</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Only males included</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>14</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#MR000050-bbs2-0015" title="CarlsonCL , PelhamWE , MilichR , HozaB .ADHD boys’ performance and attributions following success and failure: drug effects and individual differences. Cognitive Therapy and Research1993;17:269-87. ">Carlson 1993</a> ; <a href="./references#MR000050-bbs2-0019" title="Doty, DW.Role playing and incentives in the modification of the social interaction of chronic psychiatric patients. Journal of Consulting and Clinical Psychology1975;43(5):676-82. ">Doty 1975</a> ; <a href="./references#MR000050-bbs2-0037" title="KilmannPR , MilanRJ , BolandJP , NankinHR , DavidsonE , WestMO , et al.Group treatment of secondary erectile dysfunction. Journal of Sex &amp; Marital Therapy1987;13(3):168-82. KilmannPR , Milan RJ Jr, BolandJP , DavidsonE , WestMO , SablisRF , et al.The sexual interactions of men with secondary erectile dysfunction. Journal of Sex Education and Therapy1988;14(1):46-9. KilmannPR , Milan RJ Jr, BolandJP , NankinHR , SablisRF , WestMO , et al.The sexual interactions of men with secondary erectile dysfunction. Paper presented at the annual meeting of the American Psychological Association in Los Angeles1985;1:46-9. ">Kilmann 1987</a> ; <a href="./references#MR000050-bbs2-0038" title="KleinSA , DeffenbacherJL .Relaxation and exercise for hyperactive impulsive children. Perceptual and Motor Skills1977;45:1159-62. ">Klein 1977</a> ; <a href="./references#MR000050-bbs2-0059" title="PearlD , Vander KampH , OlsenAL , GreenbergPD , ArmitageSG .The effects of reserpine on schizophrenic patients. American Journal of Psychiatry1956;112:198-204. ">Pearl 1956</a> ; <a href="./references#MR000050-bbs2-0061" title="MilichR , CarlsonCL , Pelham WE Jr, LichtBG .Effects of methylphenidate on the persistence of ADHD boys following failure experiences. Journal of Abnormal Child Psychology1991;19(5):519-36. PelhamWE , MurphyDA , VannattaK , MilichR , LichtBG , GnagyEM , et al.Methylphenidate and attributions in boys with attention-deficit hyperactivity disorder. Journal of Consulting and Clinical Psychology1992;60(2):282-92. ">Pelham 1992</a> ; <a href="./references#MR000050-bbs2-0063" title="PetersonMA , PattersonB , PillmanBM , BattistaMA .Cognitive recovery following alcohol detoxification: a computerised remediation study. Neuropsychological Rehabilitation2002;12(1):63-74. PillmanBM .Computerized cognitive remediation with recently detoxified alcoholics. Dissertation, California School of Professional Psychology, Fresno Campus2000. ">Pillman 2001</a> ; <a href="./references#MR000050-bbs2-0064" title="PolandRE , GertsikL , FavreauJT , SmithSI , MirochaJM , RaoU , et al.Open-label randomized parallel-group controlled clinical trial of massage for treatment of depression in HIV-infected subjects. Journal of Alternative and Complementary Medicine2013;19(4):334-40. ">Poland 2013</a> ; <a href="./references#MR000050-bbs2-0074" title="RoehrichL , GoldmanMS .Experience-dependent neuropsychological recovery and the treatment of alcoholism. Journal of Consulting and Clinical Psychology1993;61(5):812-21. ">Roehrich 1993</a> ; <a href="./references#MR000050-bbs2-0077" title="LorrM , McNairDM , WeinsteinGJ .Early effects of chlordiazepoxide (Librium) used with psychotherapy. Journal of Psychiatric Research1963;1:257-70. RothI , RhudickPJ , ShaskanDA , SlobinMS , WilkinsonAE , YoungHH .Long-term effects on psychotherapy of initial treatment conditions. Journal of Psychiatric Research1964;2:283-97. ">Roth 1964</a> ; <a href="./references#MR000050-bbs2-0078" title="RupertPA , HolmesDS .Effects of multiple sessions of true and placebo heart rate biofeedback training on the heart rates and anxiety levels of anxious patients during and following treatment. Psychophysiology1978;15(6):582-90. ">Rupert 1978</a> ; <a href="./references#MR000050-bbs2-0082" title="SommernessMD , LuceroRJ , HamlonJS , EricksonJL , MatthewsR .A controlled study of reserpine on chronically disturbed patients. JAMA Archives of Neurology and Psychiatry1955;74(3):316-9. ">Sommerness 1955</a> ; <a href="./references#MR000050-bbs2-0092" title="WeingaertnerAH .Self-administered aversive stimulation with hallucinating hospitalized schizophrenics. Journal of Consulting and Clinical Psychology1971;36(3):422-29. ">Weingaertner 1971</a> ; <a href="./references#MR000050-bbs2-0093" title="WhittakerCB , HoyRM .Withdrawal of perphenazine in chronic schizophrenia. British Journal of Psychiatry1963;109:422-7. ">Whittaker 1963</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Diagnostic classification</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>DSM‐II diagnosis</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#MR000050-bbs2-0039" title="KlermanGL , DimascioA , WeismannM , PrusoffB , PaykelES .Treatment of depression by drugs and psychotherapy. American Journal of Psychiatry1974;131(2):186-91. PaykelES , DimascioA , HaskellD , PrusoffBA .Effects of maintenance amitriptyline and psychotherapy on symptoms of depression. Psychological Medicine1975;5(1):67-77. PaykelES , DiMascioA , KlermanGL , PrusoffBA .Maintenance therapy of depression. Pharmakopsychiatrie, Neuro-Psychopharmakologie1976;9:127-39. PaykelES , WeissmanMM , PrusoffBA .Social maladjustment and severity of depression. Comprehensive Psychiatry1978;19(2):121-8. WeissmanMM , KlermanGL , PaykelES , PrusoffB .Treatment effects on the social adjustment of depressed patients. Archives of General Psychiatry1974;30:771-8. ">Klerman 1974a</a> ; <a href="./references#MR000050-bbs2-0040" title="KlermanGL , DimascioA , WeismannM , PrusoffB , PaykelES .Treatment of depression by drugs and psychotherapy. American Journal of Psychiatry1974;131(2):186-91. ">Klerman 1974b</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>DSM‐III diagnosis</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#MR000050-bbs2-0041" title="KloskoJS , BarlowDH , TassinariR , CernyJA .A comparison of alprazolam and behavior therapy in treatment of panic disorder: correction. Journal of Psychotherapy Practice and Research1994;3(2):163-79. KloskoJS , BarlowDH , TassinariR , CernyJA .A comparison of alprazolam and behavior therapy in treatment of panic disorder. Journal of Consulting and Clinical Psychology1990;58(1):77-84. ">Klosko 1990</a> ; <a href="./references#MR000050-bbs2-0050" title="LiddleB , SpenceSH .Cognitive-behaviour therapy with depressed primary school children: A cautionary note. Behavioural Psychotherapy1990;18(2):85-102. ">Liddle 1990</a> ; <a href="./references#MR000050-bbs2-0070" title="LiebowitzM , QuitkinFM , StewartJW , McGrathPJ , HarrisonWM , MarkowitzJS , et al.Antidepressant efficacy in atypical depression. Archives of General Psychiatry1988;45(2):129-37. QuitkinFM , McGrathPJ , StewartJW , HarrisonW , WagerSG , NunesE , et al.Phenelzine and imipramine in mood reactive depressives: further delineation of the syndrome of atypical depression. Archives of General Psychiatry1989;46(9):787-93. RabkinJG , McGrathPJ , QuitkinFM , TricamoE , StewartJW , KleinDF .Effects of pill-giving on maintenance of placebo response in patients with chronic mild depression. American Journal of Psychiatry1990;147(12):1622-6. ">Rabkin 1990</a> ; <a href="./references#MR000050-bbs2-0074" title="RoehrichL , GoldmanMS .Experience-dependent neuropsychological recovery and the treatment of alcoholism. Journal of Consulting and Clinical Psychology1993;61(5):812-21. ">Roehrich 1993</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>DSM‐III‐R diagnosis</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#MR000050-bbs2-0001" title="AbikoffH , HechtmanL , KleinRG .Social functioning in children with ADHD treated with long-term methylphenidate and multimodal psychosocial treatment. Journal of the American Academy of Child and Adolescent Psychiatry2004;43(7):820-9. AbikoffH .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to A Todorovac 23rd of August 2019. KleinRG , AbikoffH , HechtmanL , WeissG .Design and rationale of controlled study of long-term methylphenidate and multimodal psychosocial treatment in children with ADHD. Journal of the American Academy of Child and Adolescent Psychiatry2004;43(7):792-801. ">Abikoff 2004</a> ; <a href="./references#MR000050-bbs2-0015" title="CarlsonCL , PelhamWE , MilichR , HozaB .ADHD boys’ performance and attributions following success and failure: drug effects and individual differences. Cognitive Therapy and Research1993;17:269-87. ">Carlson 1993</a> ; <a href="./references#MR000050-bbs2-0017" title="CrispAH , NortonK , GowersS , HalekC , BowyerC , YeldhamD , et al.A controlled study of the effect of therapies aimed at adolescent and family psychopathology in Anorexia Nervosa. British Journal of Psychiatry: the Journal of Mental Science1991;159:325-33. GowersS , NortonK , HalekC , CrispAH .Outcome of outpatient psychotherapy in a random allocation treatment study of anorexia nervosa. International Journal of Eating Disorders1994;15(2):165-77. GowersS , NortonK , YelshamD .The St George's prospective treatment study of anorexia nervosa: a discussion of methodological problems. International Journal of Eating Disorders1989;8:445-54. ">Crisp 1991</a> ; <a href="./references#MR000050-bbs2-0024" title="FoaEB , RothbaumBO , RiggsDS , MurdockTB .Treatment of posttraumatic stress disorder in rape victims: a comparison between cognitive-behavioral procedures and counselling. Journal of Consulting and Clinical Psychology1991;59(5):715-23. ">Foa 1991</a> ; <a href="./references#MR000050-bbs2-0061" title="MilichR , CarlsonCL , Pelham WE Jr, LichtBG .Effects of methylphenidate on the persistence of ADHD boys following failure experiences. Journal of Abnormal Child Psychology1991;19(5):519-36. PelhamWE , MurphyDA , VannattaK , MilichR , LichtBG , GnagyEM , et al.Methylphenidate and attributions in boys with attention-deficit hyperactivity disorder. Journal of Consulting and Clinical Psychology1992;60(2):282-92. ">Pelham 1992</a> ; <a href="./references#MR000050-bbs2-0084" title="SzymanskiJ , O'DonohueW .The potential role of state-dependent learning in cognitive therapy with spider phobics. Journal of Rational-Emotive &amp; Cognitive-Behavior Therapy1995;13(2):131-50. SzymanskiJ .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 20th of August 2019. ">Szymanski 1995</a> ; <a href="./references#MR000050-bbs2-0086" title="TeriL , LogsdonRG , UomotoJ , McCurrySM .Behavioral treatment of depression in dementia patients: a controlled clinical trial. Journals of Gerontology. Series B, Psychological Sciences and Social Sciences1997;52(4):159-66. TeriL .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 26th of August 2019. ">Teri 1997</a> ; <a href="./references#MR000050-bbs2-0096" title="WollersheimJP , WilsonGL .Group treatment of unipolar depression: a comparison of coping, supportive, bibliotherapy, and delayed treatment groups. Professional Psychology: Research and Practice1991;22(6):496-502. ">Wollersheim 1991</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>DSM‐IV diagnosis</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>15</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#MR000050-bbs2-0002" title="AllenJB .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to A Todorovac 28th of August 2019. AllenJJ , SchnyerRN , HittSK .The efficacy of acupuncture in the treatment of major depression in women. Psychological Science1998;9(5):397-401. ">Allen 1998</a> ; <a href="./references#MR000050-bbs2-0003" title="AllenJB .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 28th of August 2019. AllenJJ , SchnyerRN , ChambersAS , HittSK , MorenoFA , ManberR .Acupuncture for depression: a randomized controlled trial. Journal of Clinical Psychiatry2006;67(11):1665-73. ">Allen 2006</a> ; <a href="./references#MR000050-bbs2-0004" title="AlvarezJR .The effects of anger management training on depression, anger, self-concept, and treatment responsibility in a sample of drug-dependent individuals in a therapeutic community. Dissertation Abstracts International: Section B: the Sciences and Engineering1997;58(4-B):2108. ">Alvarez 1997</a> ; <a href="./references#MR000050-bbs2-0006" title="AyenI , HautzingerM .Cognitive behavior therapy for depression in menopausal women. A controlled, randomized treatment study [Kognitive Verhaltenstherapie bei Depressionen im Klimakterium: Eine kontrollierte, randomiserte Interventionsstudie]. Zeitschrift für Klinische Psychologie und Psychotherapie2004;33(4):290-9. AyenI .Inclusion of study in Cochrane Systematic Review (personal communication). Email to EG Faltinsen 9th of September 2019. ">Ayen 2004</a> ; <a href="./references#MR000050-bbs2-0016" title="CarterJC , OlmstedMP , KaplanAS , McCabeRE , MillsJS , AimeA .Self-help for bulimia nervosa: a randomized controlled trial. American Journal of Psychiatry2003;160(5):973-8. ">Carter 2003</a> ; <a href="./references#MR000050-bbs2-0029" title="GoldsteinAJ , BeursE , Chambless Dl, WilsonKA .EMDR for panic disorder with agoraphobia: comparison with waiting list and credible attention-placebo control conditions. Journal of Consulting and Clinical Psychology2000;68(6):947-56. ">Goldstein 2000</a> ; <a href="./references#MR000050-bbs2-0032" title="HippmanC , RingroseA , InglisA , CheekJ , AlbertAY , RemickR , et al.A pilot randomized clinical trial evaluating the impact of genetic counselling for serious mental illnesses. Journal of Clinical Psychiatry2016;77(2):e190-8. ">Hippman 2016</a> ; <a href="./references#MR000050-bbs2-0035" title="KelleyJ .Inclusion of study in Cochrane Systematic Review (personal communication). Email to: A Todorovac 12th of August 2019. KelleyJM , KaptchukTJ , CusinC , LipkinS , FavaM .Open-label placebo for major depressive disorder: a pilot randomized controlled trial. Psychotherapy and Psychosomatics2012;81(5):312-4. ">Kelley 2012</a> ; <a href="./references#MR000050-bbs2-0045" title="LaiCK , ChiI , Kayser-JonesJ .A randomized controlled trial of a specific reminiscence approach to promote the well-being of nursing home residents with dementia. International Psychogeriatrics2004;16(1):33-49. LaiK .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 6th of September 2019. ">Lai 2004</a> ; <a href="./references#MR000050-bbs2-0063" title="PetersonMA , PattersonB , PillmanBM , BattistaMA .Cognitive recovery following alcohol detoxification: a computerised remediation study. Neuropsychological Rehabilitation2002;12(1):63-74. PillmanBM .Computerized cognitive remediation with recently detoxified alcoholics. Dissertation, California School of Professional Psychology, Fresno Campus2000. ">Pillman 2001</a> ; <a href="./references#MR000050-bbs2-0064" title="PolandRE , GertsikL , FavreauJT , SmithSI , MirochaJM , RaoU , et al.Open-label randomized parallel-group controlled clinical trial of massage for treatment of depression in HIV-infected subjects. Journal of Alternative and Complementary Medicine2013;19(4):334-40. ">Poland 2013</a> ; <a href="./references#MR000050-bbs2-0071" title="RapeeR .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 29th of August 2019. RapeeRM , AbbottMJ , LynehamHJ .Bibliotherapy for children With anxiety disorders using written materials for parents: a randomized controlled trial. Journal of Consulting and Clinical Psychology2006;74(3):436-44. ">Rapee 2006</a> ; <a href="./references#MR000050-bbs2-0072" title="RapeeR .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 29th of August 2019. RapeeRM , AbbottMJ , BaillieAJ , GastonJE .Treatment of social phobia through pure self-help and therapist-augmented self-help. British Journal of Psychiatry2007;191:246-52. ">Rapee 2007</a> ; <a href="./references#MR000050-bbs2-0079" title="ShalevAY , AnkriY , Isreali-ShalevY , PelegT , AdesskyR , FreedmanS .Prevention of posttraumatic stress disorder by early treatment. Archives of General Psychiatry2012;69(2):166-76. ">Shalev 2012</a> ; <a href="./references#MR000050-bbs2-0095" title="WolitzkyKB , TelchMJ .Augmenting in vivo exposure with fear antagonistic actions: a preliminary test. Behavior Therapy2009;40(1):57-71. ">Wolitzky 2009</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>DSM‐IV‐TR diagnosis</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#MR000050-bbs2-0024" title="FoaEB , RothbaumBO , RiggsDS , MurdockTB .Treatment of posttraumatic stress disorder in rape victims: a comparison between cognitive-behavioral procedures and counselling. Journal of Consulting and Clinical Psychology1991;59(5):715-23. ">Foa 1991</a> ; <a href="./references#MR000050-bbs2-0043" title="KwanR .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 26th of August 2019. KwanRY , LeungMC , LaiCK .Acupressure for agitation in nursing home residents with dementia: study protocol for a randomized controlled trial. Trials2014;15(410):1-7. KwanRY , LeungMCP , LaiCK .A randomized controlled trial examining the effect of acupressure on agitation and salivary cortisol in nursing home residents with dementia. Dementia and Geriatric Cognitive Disorders2017;44(1-2):92-104. ">Kwan 2017</a> ; <a href="./references#MR000050-bbs2-0075" title="OlivaresJ .Program IAFS. Protocol for the treatment of social phobia in adolescents [Programa IAFS. Protocolo para el tratamiento de la fobia social enadolescentes]. Madrid: Pirámide2005;1. Rosa-AlcázarAI , Olivares-OlivaresPJ , OlivaresJ .The role of non-specific effects in the psychological treatment of adolescents with social phobia [Papel de los efectos inespecíficos en el tratamiento psicológico de adolescentes con fobia social]. Anuario de Psicologia2009;40(1):43-61. ">Rosa‐Alcatraz 2009</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>ICD‐9 diagnosis</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#MR000050-bbs2-0091" title="WatzlH , RistF , OlbrichR , CohenR .Placebo injections and surveillance of alcohol intake during inpatient treatment of female alcoholics. Addictive Behaviors1988;13(2):197-200. ">Watzl 1988</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>The most commonly assessment instrument was Structured Clinical Interview for DSM (SCID; <a href="./references#MR000050-bbs2-0273" title="SpitzerRL , WilliamJBW , GibbonM , FirstMB .Structured Clinical Interview for DSM-III-R Personality Disorders (SCID-II). 1989: Biometrics Research Department, New York State Psychiatric Institute, 1989.">Spitzer 1989</a> ) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#MR000050-bbs2-0002" title="AllenJB .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to A Todorovac 28th of August 2019. AllenJJ , SchnyerRN , HittSK .The efficacy of acupuncture in the treatment of major depression in women. Psychological Science1998;9(5):397-401. ">Allen 1998</a> ; <a href="./references#MR000050-bbs2-0003" title="AllenJB .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 28th of August 2019. AllenJJ , SchnyerRN , ChambersAS , HittSK , MorenoFA , ManberR .Acupuncture for depression: a randomized controlled trial. Journal of Clinical Psychiatry2006;67(11):1665-73. ">Allen 2006</a> ; <a href="./references#MR000050-bbs2-0006" title="AyenI , HautzingerM .Cognitive behavior therapy for depression in menopausal women. A controlled, randomized treatment study [Kognitive Verhaltenstherapie bei Depressionen im Klimakterium: Eine kontrollierte, randomiserte Interventionsstudie]. Zeitschrift für Klinische Psychologie und Psychotherapie2004;33(4):290-9. AyenI .Inclusion of study in Cochrane Systematic Review (personal communication). Email to EG Faltinsen 9th of September 2019. ">Ayen 2004</a> ; <a href="./references#MR000050-bbs2-0021" title="EhlersA , HackmannA , GreyN , WildJ , LinessS , AlbertI , et al.A randomized controlled trial of 7-day intensive and standard weekly cognitive therapy for PTSD and emotion-focused supportive therapy. American Journal of Psychiatry2014;171(3):294-304. ">Ehlers 2014</a> ; <a href="./references#MR000050-bbs2-0029" title="GoldsteinAJ , BeursE , Chambless Dl, WilsonKA .EMDR for panic disorder with agoraphobia: comparison with waiting list and credible attention-placebo control conditions. Journal of Consulting and Clinical Psychology2000;68(6):947-56. ">Goldstein 2000</a> ; <a href="./references#MR000050-bbs2-0032" title="HippmanC , RingroseA , InglisA , CheekJ , AlbertAY , RemickR , et al.A pilot randomized clinical trial evaluating the impact of genetic counselling for serious mental illnesses. Journal of Clinical Psychiatry2016;77(2):e190-8. ">Hippman 2016</a> ; <a href="./references#MR000050-bbs2-0035" title="KelleyJ .Inclusion of study in Cochrane Systematic Review (personal communication). Email to: A Todorovac 12th of August 2019. KelleyJM , KaptchukTJ , CusinC , LipkinS , FavaM .Open-label placebo for major depressive disorder: a pilot randomized controlled trial. Psychotherapy and Psychosomatics2012;81(5):312-4. ">Kelley 2012</a> ; <a href="./references#MR000050-bbs2-0064" title="PolandRE , GertsikL , FavreauJT , SmithSI , MirochaJM , RaoU , et al.Open-label randomized parallel-group controlled clinical trial of massage for treatment of depression in HIV-infected subjects. Journal of Alternative and Complementary Medicine2013;19(4):334-40. ">Poland 2013</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Trials fulfilled the symptoms of a mental health disorder from the available diagnostic classifications system at the time of the trial, but did not report classification system </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>24</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#MR000050-bbs2-0005" title="AscherLM , TurnerR .Paradoxical intention and insomnia: an experimental investigation. Behaviour Research and Therapy1979;17(4):408-11. ">Ascher 1979</a> ; <a href="./references#MR000050-bbs2-0007" title="BergI , ForsytheI , HoltP , WattsJ .A controlled trial of ‘Senokot’ in faecal soiling treated by behavioural methods. Journal of Child Psychology and Psychiatry1983;24(4):543-9. ">Berg 1983</a> ; <a href="./references#MR000050-bbs2-0008" title="Borden, KA.Attributional Outcomes: the Subtle Messages of Treatments for Attention Deficit Disorder. Dissertation, University of Illinois at Urbana-Champaign1986. BordenKA , BrownRT .Attributional outcomes: The subtle messages of treatments for attention deficit disorder. Cognitive Therapy and Research1989;13(2):147-60. ">Borden 1986</a> ; <a href="./references#MR000050-bbs2-0012" title="BramstonP , SpenceSH .Behavioural versus cognitive social-skills training with intellectually-handicapped adults. Behaviour Research and Therapy1985;23(3):239-46. ">Bramston 1985</a> ; <a href="./references#MR000050-bbs2-0013" title="BrillNQ , KoeglerRR , EpsteinLJ , ForgyEW .Controlled study of psychiatric outpatient treatment. Archives of General Psychiatry1964;10:581-95. BrillNQ .Results of psychotherapy. California Medicine1966;104(4):249-53. ">Brill 1964a</a> ; <a href="./references#MR000050-bbs2-0014" title="BrillNQ , KoeglerRR , EpsteinLJ , ForgyEW .Controlled study of psychiatric outpatient treatment. Archives of General Psychiatry1964;10:581-95. ">Brill 1964b</a> ; <a href="./references#MR000050-bbs2-0020" title="DoubleDB , WarrenGC , EvansM , RowlandsMP .Efficacy of maintenance use of anticholinergic agents. Acta Psychiatrica Scandinavica1993;88:381-4. ">Double 1993</a> ; <a href="./references#MR000050-bbs2-0022" title="EspieCA , BrooksDN , LindsayWR .An evaluation of tailored psychological treatment of insomnia. Journal of Behavior Therapy and Experimental Psychiatry1989;20(2):143-53. EspieCA , LindsayWR , BrooksDN , HoodEM , TurveyT .A controlled comparative investigation of psychological treatments for chronic sleep-onset insomnia. Behaviour Research and Therapy1989;27(1):79-88. ">Espie 1989a</a> ; <a href="./references#MR000050-bbs2-0030" title="GoldwasserAN , AuerbachSM , HarkinsSW .Cognitive, affective, and behavioural effects of reminiscence group therapy on demented elderly. Aging and Human Development1987;25(3):209-22. ">Goldwasser 1987</a> ; <a href="./references#MR000050-bbs2-0033" title="HowlinP , GordonKR , PascoG , WadeA , CharmanT .The effectiveness of picture exchange communication system (PECS) training for teachers of children with autism: a pragmatic,group randomised controlled trial. Journal of Child Psychology and Psychiatry2007;48(5):473-81. ">Howlin 2007</a> ; <a href="./references#MR000050-bbs2-0037" title="KilmannPR , MilanRJ , BolandJP , NankinHR , DavidsonE , WestMO , et al.Group treatment of secondary erectile dysfunction. Journal of Sex &amp; Marital Therapy1987;13(3):168-82. KilmannPR , Milan RJ Jr, BolandJP , DavidsonE , WestMO , SablisRF , et al.The sexual interactions of men with secondary erectile dysfunction. Journal of Sex Education and Therapy1988;14(1):46-9. KilmannPR , Milan RJ Jr, BolandJP , NankinHR , SablisRF , WestMO , et al.The sexual interactions of men with secondary erectile dysfunction. Paper presented at the annual meeting of the American Psychological Association in Los Angeles1985;1:46-9. ">Kilmann 1987</a> ; <a href="./references#MR000050-bbs2-0049" title="LickJR , HefflerD .Relaxation training and attention placebo in the treatment of severe insomnia. Journal of Consulting and Clinical Psychology1977;45(2):153-61. ">Lick 1977</a> ; <a href="./references#MR000050-bbs2-0051" title="MatsonJL , MarchettiA , AdkinsJA .Comparison of operant- and independence-training procedures for mentally retarded adults. American Journal of Mental Deficiency1980;84(5):487-94. ">Matson 1980</a> ; <a href="./references#MR000050-bbs2-0052" title="McLachlanDR , DaltonAJ , KruckTP , BellMY , SmithWL , KalowW , et al.Intramuscular desferrioxamine in patients with Alzheimer's disease. Lancet1991;337(8753):1304-8. McLachlanDRC , SmithWL , KruckTP .Desferrioxamine and Alzheimer’s disease: video home behavior assessment of clinical course and measures of brain aluminum. Therapeutic Drug Monitoring1993;15(6):602-7. ">McLachlan 1991</a> ; <a href="./references#MR000050-bbs2-0069" title="QuayhagenMP , QuayhagenM , CorbeilRR , RothPA , RodgersJA .A dyadic remediation program for care recipients with dementia. Nursing Research1995;44(3):153-9. ">Quayhagen 1995</a> ; <a href="./references#MR000050-bbs2-0073" title="RobinA .Rationing out-patients: a defence of the waiting list. British Journal of Psychiatry1976;129:138-41. ">Robin 1976</a> ; <a href="./references#MR000050-bbs2-0076" title="RosenGM , GlasgowRE , BarreraM .A controlled study to assess the clinical efficacy of totally self-administrated systematic desensitization. Journal of Consulting and Clinical Psychology1976;44(2):208-17. ">Rosen 1976</a> ; <a href="./references#MR000050-bbs2-0077" title="LorrM , McNairDM , WeinsteinGJ .Early effects of chlordiazepoxide (Librium) used with psychotherapy. Journal of Psychiatric Research1963;1:257-70. RothI , RhudickPJ , ShaskanDA , SlobinMS , WilkinsonAE , YoungHH .Long-term effects on psychotherapy of initial treatment conditions. Journal of Psychiatric Research1964;2:283-97. ">Roth 1964</a> ; <a href="./references#MR000050-bbs2-0080" title="ShealyRC .The effectiveness of various treatment techniques on different degrees and durations of sleep-onset insomnia. Behaviour Research and Therapy1979;17(6):541-6. ">Shealy 1979</a> ; <a href="./references#MR000050-bbs2-0083" title="SteinmarkSW , BorkovecTD .Active and placebo treatment effects on moderate insomnia under counterdemand and positive demand instructions. Journal of Abnormal Psychology1974;83(2):157-63. ">Steinmark 1974</a> ; <a href="./references#MR000050-bbs2-0089" title="AscherML , TurnerRM .A comparison of two methods for the administration of paradoxical intention. Behaviour Research and Therapy1980;18(2):121-6. TurnerRM , AscherLM .Controlled comparison of progressive relaxation, stimulus control, and paradoxical intention therapies for insomnia. Journal of Consulting and Clinical Psychology1979;47(3):500-8. ">Turner 1979</a> ; <a href="./references#MR000050-bbs2-0090" title="VanderplateC .Electromyograph biofeedback Treatment of sleep onset Insomnia: a controlled Investigation. Dissertation, University of Southern Mississippi1978. ">Vanderplate 1983</a> ; <a href="./references#MR000050-bbs2-0092" title="WeingaertnerAH .Self-administered aversive stimulation with hallucinating hospitalized schizophrenics. Journal of Consulting and Clinical Psychology1971;36(3):422-29. ">Weingaertner 1971</a> ; <a href="./references#MR000050-bbs2-0093" title="WhittakerCB , HoyRM .Withdrawal of perphenazine in chronic schizophrenia. British Journal of Psychiatry1963;109:422-7. ">Whittaker 1963</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Trials reported a population classified as having a mental health disorder, but full diagnostic criteria was not reported </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>35</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#MR000050-bbs2-0009" title="BorkovecTD , KaloupekDG , SlamaKM .The facilitative effect of muscle tension-release in the relaxation treatment of sleep disturbance. Behavior Therapy1975;6(3):301-9. ">Borkovec 1975</a> ; <a href="./references#MR000050-bbs2-0010" title="BorkovecTD , WeertsTC .Effects of progressive relaxation on sleep disturbance: an electroencephalographic evaluation. Psychosomatic Medicine1976;38(3):173-80. ">Borkovec 1976</a> ; <a href="./references#MR000050-bbs2-0011" title="BornovalovaM .Inclusion of study in Cochrane Systematic Review (personal communication). Email to A Todorovac. 21st of August 2019. BornovalovaMA .Distress tolerance treatment for inner-city drug users: a preliminary trial. Doctor’s Dissertation, University of Maryland2008. ">Bornovalova 2008</a> ; <a href="./references#MR000050-bbs2-0018" title="CrouchG , RobsonM , HallstromC .Benzodiazepine dependent patients and their psychological treatment. Progress in Neuro-psychopharmacology &amp; Biological Psychiatry1988;12(4):503-10. HallströmC , CrouchG , RobsenM , ShineP .The treatment of tranquillizer dependence by propranolol. Postgraduate Medical Journal1988;64(Suppl 2):40-4. ">Crouch 1988</a> ; <a href="./references#MR000050-bbs2-0019" title="Doty, DW.Role playing and incentives in the modification of the social interaction of chronic psychiatric patients. Journal of Consulting and Clinical Psychology1975;43(5):676-82. ">Doty 1975</a> ; <a href="./references#MR000050-bbs2-0023" title="EtringerBD , CashTF , RimmDC .Behavioral, affective, and cognitive effects of participant modeling and an equally credible placebo. Behavior Therapy1982;13(4):476-85. ">Etringer 1982</a> ; <a href="./references#MR000050-bbs2-0026" title="FreireAO , SugaiGC , ChrispinFS , TogeiroSM , YamamuraY , MelloLE , et al.Treatment of moderate obstructive sleep apnea syndrome with acupuncture: a randomised, placebo-controlled pilot trial. Sleep Medicine2007;8(1):43-50. ">Freire 2007</a> ; <a href="./references#MR000050-bbs2-0027" title="FuchsCZ , RehnLP .A self-control behavior therapy program for depression. Journal of Consulting and Clinical Psychology1977;45(2):206-15. ">Fuchs 1977</a> ; <a href="./references#MR000050-bbs2-0028" title="GlogowskaM , RoulstoneS , EnderbyP , PetersTJ .Randomised controlled trial of community based speech and language therapy in preschool children. BMJ2000;321(7266):923-6. ">Glogowska 2000</a> ; <a href="./references#MR000050-bbs2-0031" title="HekmatH , LubitzR , DealR .Semantic desensitization: a paradigmatic intervention approach to anxiety disorders. Journal of Clinical Psychology1984;40(2):463-6. ">Hekmat 1984</a> ; <a href="./references#MR000050-bbs2-0034" title="KarstM , WinterhalterM , MünteS , FranckiB , HondronikosA , EckardtA , et al.Auricular acupuncture for dental anxiety: a randomized controlled trial. Anesthesia and Analgesia2007;104(2):295-300. KarstM .Inclusion of study in Cochrane Systematic Review (personal communication). Email to: EG Faltinsen 5th of September 2019. ">Karst 2007</a> ; <a href="./references#MR000050-bbs2-0036" title="KennedyTD , KimuraHK .Transfer, behavioral improvement, and anxiety reduction in systematic desensitization. Journal of Consulting and Clinical Psychology1974;42(5):720-8. ">Kennedy 1974</a> ; <a href="./references#MR000050-bbs2-0038" title="KleinSA , DeffenbacherJL .Relaxation and exercise for hyperactive impulsive children. Perceptual and Motor Skills1977;45:1159-62. ">Klein 1977</a> ; <a href="./references#MR000050-bbs2-0042" title="KrapflJE , NawasMM .Differential ordering of stimulus presentation in systematic desensitization. Journal of Abnormal Psychology1970;75(3):333-7. ">Krapfl 1970</a> ; <a href="./references#MR000050-bbs2-0044" title="LacyMK .The effect of short term autogenic training on the stress reactivity of hospitalized emotionally disturbed adolescents. ProQuest Dissertations Publishing, Oklahoma State University1996. ">Lacy 1990</a> ; <a href="./references#MR000050-bbs2-0046" title="LangOJ , LazovikAD .Experimental desensitization of a phobia. Journal of Abnormal and Social Psychology1963;66:519-25. LangPJ , LazovikAD , ReynoldsDJ .Desensitization, suggestibility, and pseudotherapy. Journal of Abnormal Psychology1965;70(6):395-402. ">Lang 1965</a> ; <a href="./references#MR000050-bbs2-0048" title="LickJ .Expectancy, false galvanic skin response feedback, and systematic desensitization in the modification of phobic behavior. Journal of Consulting and Clinical Psychology1975;43(4):557-67. ">Lick 1975</a> ; <a href="./references#MR000050-bbs2-0053" title="MealieaWL , NawasMM .The comparative effectiveness of systematic desensitization and implosive therapy in the treatment of snake phobia. Journal of Behavior Therapy and Experimental Psychiatry1971;2(2):85-94. ">Mealiea 1971</a> ; <a href="./references#MR000050-bbs2-0054" title="MilbyJB , ClarkeC , ToroC , ThorntonS , RickertD .Effectiveness of urine surveillance as an adjunct to outpatient psychotherapy for drug abusers. International Journal of the Addictions1980;15(7):993-1001. ">Milby 1980</a> ; <a href="./references#MR000050-bbs2-0055" title="MirandaA , ArlandisP , SorianoM .Instruction in strategies and attributional training: Effects on the problem-solving and self-concept of students’ with learning disabilities [Instrucción en estrategias y entrenamiento atribucional: efectos sobre la resolución de problemas y el autoconcepto de los estudiantes con dificultades en el aprendizaje]. Infancia y Aprendizaje1997;20(80):37-52. ">Miranda 1997</a> ; <a href="./references#MR000050-bbs2-0056" title="MitchellC , MansfieldD , RautenbachS .Coloured filters and reading accuracy, comprehension and rate: a placebo-controlled study. Perceptual and Motor Skills2008;106(2):517-32. ">Mitchell 2008</a> ; <a href="./references#MR000050-bbs2-0057" title="NandiDN , AjmanyS , GanguliH , BanerjeeG , BoralGC , GhoshA , et al.A clinical evaluation of depressives found in a rural survey in India. British Journal of Psychiatry1976;128:523-7. ">Nandi 1976</a> ; <a href="./references#MR000050-bbs2-0058" title="NicassioP , BootzinR .A comparison of progressive relaxation and autogenic training as treatments for insomnia. Journal of Abnormal Psychology1974;83(3):253-60. ">Nicassio 1974</a> ; <a href="./references#MR000050-bbs2-0062" title="PedletonMG , HigginsRL .A comparison of negative practice and systematic desensitization in the treatment of acrophobia. Journal of Behavior Therapy and Experimental Psychiatry1983;14(4):317-23. ">Pendleton 1983</a> ; <a href="./references#MR000050-bbs2-0065" title="PowersMB , SmitsJA , TelchMJ .Disentangling the effects of safety-behavior utilization and safety-behavior availability during exposure-based treatment: a placebo-controlled trial. Journal of Consulting and Clinical Psychology2004;72(3):448-54. ">Powers 2004</a> ; <a href="./references#MR000050-bbs2-0066" title="PowersMB , SmithsJA , WhitleyD , BystritskyA , TelchMJ .The effect of attributional processes concerning medication taking on return of fear. Journal of Consulting and Clinical Psychology2008;76(3):478-90. ">Powers 2008a</a> ; <a href="./references#MR000050-bbs2-0067" title="PowersMB , SmithsJA , WhitleyD , BystritskyA , TelchMJ .The effect of attributional processes concerning medication taking on return of fear. Journal of Consulting and Clinical Psychology2008;76(3):478-90. ">Powers 2008b</a> ; <a href="./references#MR000050-bbs2-0068" title="ProudfootJ , ClarkeJ , BirchMR , WhittonAE , ParkerG , ManicavasagarV , et al.Impact of a mobile phone and web program on symptom and functional outcomes for people with mild- to-moderate depression, anxiety and stress: a randomized controlled trial. BMC Psychiatry2013;13(312):1-12. ProudfootJ .Re: Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 26th of August 2019. ">Proudfoot 2013</a> ; <a href="./references#MR000050-bbs2-0078" title="RupertPA , HolmesDS .Effects of multiple sessions of true and placebo heart rate biofeedback training on the heart rates and anxiety levels of anxious patients during and following treatment. Psychophysiology1978;15(6):582-90. ">Rupert 1978</a> ; <a href="./references#MR000050-bbs2-0081" title="SibilioJP , AndrewG , DartD , MooreKB , StehmanA .Treatment of chronic schizophrenia with promazine hydrochloride. AMA Archives of Neurology and Psychiatry1957;78(4):419-24. ">Sibilio 1957</a> ; <a href="./references#MR000050-bbs2-0082" title="SommernessMD , LuceroRJ , HamlonJS , EricksonJL , MatthewsR .A controlled study of reserpine on chronically disturbed patients. JAMA Archives of Neurology and Psychiatry1955;74(3):316-9. ">Sommerness 1955</a> ; <a href="./references#MR000050-bbs2-0085" title="TanSY , BruniJ .Cognitive-behavior therapy with adult patients with epilepsy: a controlled outcome study. Epilepsia1986;27(3):225-33. ">Tan 1986</a> ; <a href="./references#MR000050-bbs2-0087" title="ToriC , WorellL .Reduction of human avoidant behavior. A comparison of counterconditioning, expectancy, and cognitive information approaches. Clinical Psychology1973;41(2):269-78. ">Tori 1973</a> ; <a href="./references#MR000050-bbs2-0088" title="Trexler, L.Rational-emotive therapy, placebo, and no-treatment effects on public-speaking anxiety. Doctoral dissertation, Temple University AnnArbor, Mich.: University Microfilms1971;71-31(063). TrexlerLD , KarstTO .Rational-emotive therapy, placebo, and no-treatment effects on public-speaking anxiety. Journal of Abnormal Psyhology1972;79(1):60-7. ">Trexler 1972</a> ; <a href="./references#MR000050-bbs2-0094" title="WilsonA , DavidsonWJ , BlanchardR , WhiteJ .Disulfiram implantation. A placebo-controlled trial with two-year follow-up. Journal of Studies on Alcohol1978;39(5):809-19. WilsonA , DavidsonWJ , BlanchardR .Disulfiram implantation: a trial using placebo implants and two types of controls. Journal of Studies on Alcohol1980;41(5):429-36. ">Wilson 1980</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Diagnoses</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Attention Deficit Hyperactivity Disorder (ADHD) or Attention Deficit Disorder (ADD)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#MR000050-bbs2-0001" title="AbikoffH , HechtmanL , KleinRG .Social functioning in children with ADHD treated with long-term methylphenidate and multimodal psychosocial treatment. Journal of the American Academy of Child and Adolescent Psychiatry2004;43(7):820-9. AbikoffH .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to A Todorovac 23rd of August 2019. KleinRG , AbikoffH , HechtmanL , WeissG .Design and rationale of controlled study of long-term methylphenidate and multimodal psychosocial treatment in children with ADHD. Journal of the American Academy of Child and Adolescent Psychiatry2004;43(7):792-801. ">Abikoff 2004</a> ; <a href="./references#MR000050-bbs2-0008" title="Borden, KA.Attributional Outcomes: the Subtle Messages of Treatments for Attention Deficit Disorder. Dissertation, University of Illinois at Urbana-Champaign1986. BordenKA , BrownRT .Attributional outcomes: The subtle messages of treatments for attention deficit disorder. Cognitive Therapy and Research1989;13(2):147-60. ">Borden 1986</a> ; <a href="./references#MR000050-bbs2-0015" title="CarlsonCL , PelhamWE , MilichR , HozaB .ADHD boys’ performance and attributions following success and failure: drug effects and individual differences. Cognitive Therapy and Research1993;17:269-87. ">Carlson 1993</a> ; <a href="./references#MR000050-bbs2-0038" title="KleinSA , DeffenbacherJL .Relaxation and exercise for hyperactive impulsive children. Perceptual and Motor Skills1977;45:1159-62. ">Klein 1977</a> ; <a href="./references#MR000050-bbs2-0061" title="MilichR , CarlsonCL , Pelham WE Jr, LichtBG .Effects of methylphenidate on the persistence of ADHD boys following failure experiences. Journal of Abnormal Child Psychology1991;19(5):519-36. PelhamWE , MurphyDA , VannattaK , MilichR , LichtBG , GnagyEM , et al.Methylphenidate and attributions in boys with attention-deficit hyperactivity disorder. Journal of Consulting and Clinical Psychology1992;60(2):282-92. ">Pelham 1992</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Anorexia</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#MR000050-bbs2-0017" title="CrispAH , NortonK , GowersS , HalekC , BowyerC , YeldhamD , et al.A controlled study of the effect of therapies aimed at adolescent and family psychopathology in Anorexia Nervosa. British Journal of Psychiatry: the Journal of Mental Science1991;159:325-33. GowersS , NortonK , HalekC , CrispAH .Outcome of outpatient psychotherapy in a random allocation treatment study of anorexia nervosa. International Journal of Eating Disorders1994;15(2):165-77. GowersS , NortonK , YelshamD .The St George's prospective treatment study of anorexia nervosa: a discussion of methodological problems. International Journal of Eating Disorders1989;8:445-54. ">Crisp 1991</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Anxiety disorders of different kind (e.g. specific anxiety, social anxiety, panic disorder) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>25</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#MR000050-bbs2-0023" title="EtringerBD , CashTF , RimmDC .Behavioral, affective, and cognitive effects of participant modeling and an equally credible placebo. Behavior Therapy1982;13(4):476-85. ">Etringer 1982</a> ; <a href="./references#MR000050-bbs2-0029" title="GoldsteinAJ , BeursE , Chambless Dl, WilsonKA .EMDR for panic disorder with agoraphobia: comparison with waiting list and credible attention-placebo control conditions. Journal of Consulting and Clinical Psychology2000;68(6):947-56. ">Goldstein 2000</a> ; <a href="./references#MR000050-bbs2-0031" title="HekmatH , LubitzR , DealR .Semantic desensitization: a paradigmatic intervention approach to anxiety disorders. Journal of Clinical Psychology1984;40(2):463-6. ">Hekmat 1984</a> ; <a href="./references#MR000050-bbs2-0034" title="KarstM , WinterhalterM , MünteS , FranckiB , HondronikosA , EckardtA , et al.Auricular acupuncture for dental anxiety: a randomized controlled trial. Anesthesia and Analgesia2007;104(2):295-300. KarstM .Inclusion of study in Cochrane Systematic Review (personal communication). Email to: EG Faltinsen 5th of September 2019. ">Karst 2007</a> ; <a href="./references#MR000050-bbs2-0036" title="KennedyTD , KimuraHK .Transfer, behavioral improvement, and anxiety reduction in systematic desensitization. Journal of Consulting and Clinical Psychology1974;42(5):720-8. ">Kennedy 1974</a> ; <a href="./references#MR000050-bbs2-0041" title="KloskoJS , BarlowDH , TassinariR , CernyJA .A comparison of alprazolam and behavior therapy in treatment of panic disorder: correction. Journal of Psychotherapy Practice and Research1994;3(2):163-79. KloskoJS , BarlowDH , TassinariR , CernyJA .A comparison of alprazolam and behavior therapy in treatment of panic disorder. Journal of Consulting and Clinical Psychology1990;58(1):77-84. ">Klosko 1990</a> ; <a href="./references#MR000050-bbs2-0042" title="KrapflJE , NawasMM .Differential ordering of stimulus presentation in systematic desensitization. Journal of Abnormal Psychology1970;75(3):333-7. ">Krapfl 1970</a> ; <a href="./references#MR000050-bbs2-0046" title="LangOJ , LazovikAD .Experimental desensitization of a phobia. Journal of Abnormal and Social Psychology1963;66:519-25. LangPJ , LazovikAD , ReynoldsDJ .Desensitization, suggestibility, and pseudotherapy. Journal of Abnormal Psychology1965;70(6):395-402. ">Lang 1965</a> ; <a href="./references#MR000050-bbs2-0048" title="LickJ .Expectancy, false galvanic skin response feedback, and systematic desensitization in the modification of phobic behavior. Journal of Consulting and Clinical Psychology1975;43(4):557-67. ">Lick 1975</a> ; <a href="./references#MR000050-bbs2-0053" title="MealieaWL , NawasMM .The comparative effectiveness of systematic desensitization and implosive therapy in the treatment of snake phobia. Journal of Behavior Therapy and Experimental Psychiatry1971;2(2):85-94. ">Mealiea 1971</a> ; <a href="./references#MR000050-bbs2-0060" title="PeckCL .Desensitization for the treatment of fear in the high level adult retardate. Behaviour Research and Therapy1977;15(2):137-48. ">Peck 1976</a> ; <a href="./references#MR000050-bbs2-0062" title="PedletonMG , HigginsRL .A comparison of negative practice and systematic desensitization in the treatment of acrophobia. Journal of Behavior Therapy and Experimental Psychiatry1983;14(4):317-23. ">Pendleton 1983</a> ; <a href="./references#MR000050-bbs2-0065" title="PowersMB , SmitsJA , TelchMJ .Disentangling the effects of safety-behavior utilization and safety-behavior availability during exposure-based treatment: a placebo-controlled trial. Journal of Consulting and Clinical Psychology2004;72(3):448-54. ">Powers 2004</a> ; <a href="./references#MR000050-bbs2-0066" title="PowersMB , SmithsJA , WhitleyD , BystritskyA , TelchMJ .The effect of attributional processes concerning medication taking on return of fear. Journal of Consulting and Clinical Psychology2008;76(3):478-90. ">Powers 2008a</a> ; <a href="./references#MR000050-bbs2-0067" title="PowersMB , SmithsJA , WhitleyD , BystritskyA , TelchMJ .The effect of attributional processes concerning medication taking on return of fear. Journal of Consulting and Clinical Psychology2008;76(3):478-90. ">Powers 2008b</a> ; <a href="./references#MR000050-bbs2-0068" title="ProudfootJ , ClarkeJ , BirchMR , WhittonAE , ParkerG , ManicavasagarV , et al.Impact of a mobile phone and web program on symptom and functional outcomes for people with mild- to-moderate depression, anxiety and stress: a randomized controlled trial. BMC Psychiatry2013;13(312):1-12. ProudfootJ .Re: Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 26th of August 2019. ">Proudfoot 2013</a> ; <a href="./references#MR000050-bbs2-0071" title="RapeeR .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 29th of August 2019. RapeeRM , AbbottMJ , LynehamHJ .Bibliotherapy for children With anxiety disorders using written materials for parents: a randomized controlled trial. Journal of Consulting and Clinical Psychology2006;74(3):436-44. ">Rapee 2006</a> ; <a href="./references#MR000050-bbs2-0072" title="RapeeR .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 29th of August 2019. RapeeRM , AbbottMJ , BaillieAJ , GastonJE .Treatment of social phobia through pure self-help and therapist-augmented self-help. British Journal of Psychiatry2007;191:246-52. ">Rapee 2007</a> ; <a href="./references#MR000050-bbs2-0075" title="OlivaresJ .Program IAFS. Protocol for the treatment of social phobia in adolescents [Programa IAFS. Protocolo para el tratamiento de la fobia social enadolescentes]. Madrid: Pirámide2005;1. Rosa-AlcázarAI , Olivares-OlivaresPJ , OlivaresJ .The role of non-specific effects in the psychological treatment of adolescents with social phobia [Papel de los efectos inespecíficos en el tratamiento psicológico de adolescentes con fobia social]. Anuario de Psicologia2009;40(1):43-61. ">Rosa‐Alcatraz 2009</a> ; <a href="./references#MR000050-bbs2-0076" title="RosenGM , GlasgowRE , BarreraM .A controlled study to assess the clinical efficacy of totally self-administrated systematic desensitization. Journal of Consulting and Clinical Psychology1976;44(2):208-17. ">Rosen 1976</a> ; <a href="./references#MR000050-bbs2-0078" title="RupertPA , HolmesDS .Effects of multiple sessions of true and placebo heart rate biofeedback training on the heart rates and anxiety levels of anxious patients during and following treatment. Psychophysiology1978;15(6):582-90. ">Rupert 1978</a> ; <a href="./references#MR000050-bbs2-0084" title="SzymanskiJ , O'DonohueW .The potential role of state-dependent learning in cognitive therapy with spider phobics. Journal of Rational-Emotive &amp; Cognitive-Behavior Therapy1995;13(2):131-50. SzymanskiJ .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 20th of August 2019. ">Szymanski 1995</a> ; <a href="./references#MR000050-bbs2-0087" title="ToriC , WorellL .Reduction of human avoidant behavior. A comparison of counterconditioning, expectancy, and cognitive information approaches. Clinical Psychology1973;41(2):269-78. ">Tori 1973</a> ; <a href="./references#MR000050-bbs2-0088" title="Trexler, L.Rational-emotive therapy, placebo, and no-treatment effects on public-speaking anxiety. Doctoral dissertation, Temple University AnnArbor, Mich.: University Microfilms1971;71-31(063). TrexlerLD , KarstTO .Rational-emotive therapy, placebo, and no-treatment effects on public-speaking anxiety. Journal of Abnormal Psyhology1972;79(1):60-7. ">Trexler 1972</a> ; <a href="./references#MR000050-bbs2-0095" title="WolitzkyKB , TelchMJ .Augmenting in vivo exposure with fear antagonistic actions: a preliminary test. Behavior Therapy2009;40(1):57-71. ">Wolitzky 2009</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Autism spectrum disorder</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#MR000050-bbs2-0033" title="HowlinP , GordonKR , PascoG , WadeA , CharmanT .The effectiveness of picture exchange communication system (PECS) training for teachers of children with autism: a pragmatic,group randomised controlled trial. Journal of Child Psychology and Psychiatry2007;48(5):473-81. ">Howlin 2007</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Bulimia</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#MR000050-bbs2-0016" title="CarterJC , OlmstedMP , KaplanAS , McCabeRE , MillsJS , AimeA .Self-help for bulimia nervosa: a randomized controlled trial. American Journal of Psychiatry2003;160(5):973-8. ">Carter 2003</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Depression</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>16</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#MR000050-bbs2-0002" title="AllenJB .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to A Todorovac 28th of August 2019. AllenJJ , SchnyerRN , HittSK .The efficacy of acupuncture in the treatment of major depression in women. Psychological Science1998;9(5):397-401. ">Allen 1998</a> ; <a href="./references#MR000050-bbs2-0003" title="AllenJB .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 28th of August 2019. AllenJJ , SchnyerRN , ChambersAS , HittSK , MorenoFA , ManberR .Acupuncture for depression: a randomized controlled trial. Journal of Clinical Psychiatry2006;67(11):1665-73. ">Allen 2006</a> ; <a href="./references#MR000050-bbs2-0006" title="AyenI , HautzingerM .Cognitive behavior therapy for depression in menopausal women. A controlled, randomized treatment study [Kognitive Verhaltenstherapie bei Depressionen im Klimakterium: Eine kontrollierte, randomiserte Interventionsstudie]. Zeitschrift für Klinische Psychologie und Psychotherapie2004;33(4):290-9. AyenI .Inclusion of study in Cochrane Systematic Review (personal communication). Email to EG Faltinsen 9th of September 2019. ">Ayen 2004</a> ; <a href="./references#MR000050-bbs2-0027" title="FuchsCZ , RehnLP .A self-control behavior therapy program for depression. Journal of Consulting and Clinical Psychology1977;45(2):206-15. ">Fuchs 1977</a> ; <a href="./references#MR000050-bbs2-0035" title="KelleyJ .Inclusion of study in Cochrane Systematic Review (personal communication). Email to: A Todorovac 12th of August 2019. KelleyJM , KaptchukTJ , CusinC , LipkinS , FavaM .Open-label placebo for major depressive disorder: a pilot randomized controlled trial. Psychotherapy and Psychosomatics2012;81(5):312-4. ">Kelley 2012</a> ; <a href="./references#MR000050-bbs2-0039" title="KlermanGL , DimascioA , WeismannM , PrusoffB , PaykelES .Treatment of depression by drugs and psychotherapy. American Journal of Psychiatry1974;131(2):186-91. PaykelES , DimascioA , HaskellD , PrusoffBA .Effects of maintenance amitriptyline and psychotherapy on symptoms of depression. Psychological Medicine1975;5(1):67-77. PaykelES , DiMascioA , KlermanGL , PrusoffBA .Maintenance therapy of depression. Pharmakopsychiatrie, Neuro-Psychopharmakologie1976;9:127-39. PaykelES , WeissmanMM , PrusoffBA .Social maladjustment and severity of depression. Comprehensive Psychiatry1978;19(2):121-8. WeissmanMM , KlermanGL , PaykelES , PrusoffB .Treatment effects on the social adjustment of depressed patients. Archives of General Psychiatry1974;30:771-8. ">Klerman 1974a</a> ; <a href="./references#MR000050-bbs2-0040" title="KlermanGL , DimascioA , WeismannM , PrusoffB , PaykelES .Treatment of depression by drugs and psychotherapy. American Journal of Psychiatry1974;131(2):186-91. ">Klerman 1974b</a> ; <a href="./references#MR000050-bbs2-0047" title="LegrandF .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 14th of August 2019. LegrandFD , NeffEM .Efficacy of exercise as an adjunct treatment for clinically depressed inpatients during the initial stages of antidepressant pharmacotherapy: an open randomized controlled trial. Journal of Affective Disorders2016;191:139-44. ">Legrand 2016</a> ; <a href="./references#MR000050-bbs2-0050" title="LiddleB , SpenceSH .Cognitive-behaviour therapy with depressed primary school children: A cautionary note. Behavioural Psychotherapy1990;18(2):85-102. ">Liddle 1990</a> ; <a href="./references#MR000050-bbs2-0057" title="NandiDN , AjmanyS , GanguliH , BanerjeeG , BoralGC , GhoshA , et al.A clinical evaluation of depressives found in a rural survey in India. British Journal of Psychiatry1976;128:523-7. ">Nandi 1976</a> ; <a href="./references#MR000050-bbs2-0064" title="PolandRE , GertsikL , FavreauJT , SmithSI , MirochaJM , RaoU , et al.Open-label randomized parallel-group controlled clinical trial of massage for treatment of depression in HIV-infected subjects. Journal of Alternative and Complementary Medicine2013;19(4):334-40. ">Poland 2013</a> ; <a href="./references#MR000050-bbs2-0068" title="ProudfootJ , ClarkeJ , BirchMR , WhittonAE , ParkerG , ManicavasagarV , et al.Impact of a mobile phone and web program on symptom and functional outcomes for people with mild- to-moderate depression, anxiety and stress: a randomized controlled trial. BMC Psychiatry2013;13(312):1-12. ProudfootJ .Re: Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 26th of August 2019. ">Proudfoot 2013</a> ; <a href="./references#MR000050-bbs2-0070" title="LiebowitzM , QuitkinFM , StewartJW , McGrathPJ , HarrisonWM , MarkowitzJS , et al.Antidepressant efficacy in atypical depression. Archives of General Psychiatry1988;45(2):129-37. QuitkinFM , McGrathPJ , StewartJW , HarrisonW , WagerSG , NunesE , et al.Phenelzine and imipramine in mood reactive depressives: further delineation of the syndrome of atypical depression. Archives of General Psychiatry1989;46(9):787-93. RabkinJG , McGrathPJ , QuitkinFM , TricamoE , StewartJW , KleinDF .Effects of pill-giving on maintenance of placebo response in patients with chronic mild depression. American Journal of Psychiatry1990;147(12):1622-6. ">Rabkin 1990</a> ; <a href="./references#MR000050-bbs2-0085" title="TanSY , BruniJ .Cognitive-behavior therapy with adult patients with epilepsy: a controlled outcome study. Epilepsia1986;27(3):225-33. ">Tan 1986</a> ; <a href="./references#MR000050-bbs2-0086" title="TeriL , LogsdonRG , UomotoJ , McCurrySM .Behavioral treatment of depression in dementia patients: a controlled clinical trial. Journals of Gerontology. Series B, Psychological Sciences and Social Sciences1997;52(4):159-66. TeriL .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 26th of August 2019. ">Teri 1997</a> ; <a href="./references#MR000050-bbs2-0096" title="WollersheimJP , WilsonGL .Group treatment of unipolar depression: a comparison of coping, supportive, bibliotherapy, and delayed treatment groups. Professional Psychology: Research and Practice1991;22(6):496-502. ">Wollersheim 1991</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Encopresis</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#MR000050-bbs2-0007" title="BergI , ForsytheI , HoltP , WattsJ .A controlled trial of ‘Senokot’ in faecal soiling treated by behavioural methods. Journal of Child Psychology and Psychiatry1983;24(4):543-9. ">Berg 1983</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Erectile dysfunction</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#MR000050-bbs2-0037" title="KilmannPR , MilanRJ , BolandJP , NankinHR , DavidsonE , WestMO , et al.Group treatment of secondary erectile dysfunction. Journal of Sex &amp; Marital Therapy1987;13(3):168-82. KilmannPR , Milan RJ Jr, BolandJP , DavidsonE , WestMO , SablisRF , et al.The sexual interactions of men with secondary erectile dysfunction. Journal of Sex Education and Therapy1988;14(1):46-9. KilmannPR , Milan RJ Jr, BolandJP , NankinHR , SablisRF , WestMO , et al.The sexual interactions of men with secondary erectile dysfunction. Paper presented at the annual meeting of the American Psychological Association in Los Angeles1985;1:46-9. ">Kilmann 1987</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Intellectual disability</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#MR000050-bbs2-0012" title="BramstonP , SpenceSH .Behavioural versus cognitive social-skills training with intellectually-handicapped adults. Behaviour Research and Therapy1985;23(3):239-46. ">Bramston 1985</a> ; <a href="./references#MR000050-bbs2-0051" title="MatsonJL , MarchettiA , AdkinsJA .Comparison of operant- and independence-training procedures for mentally retarded adults. American Journal of Mental Deficiency1980;84(5):487-94. ">Matson 1980</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Learning disability</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#MR000050-bbs2-0028" title="GlogowskaM , RoulstoneS , EnderbyP , PetersTJ .Randomised controlled trial of community based speech and language therapy in preschool children. BMJ2000;321(7266):923-6. ">Glogowska 2000</a> ; <a href="./references#MR000050-bbs2-0055" title="MirandaA , ArlandisP , SorianoM .Instruction in strategies and attributional training: Effects on the problem-solving and self-concept of students’ with learning disabilities [Instrucción en estrategias y entrenamiento atribucional: efectos sobre la resolución de problemas y el autoconcepto de los estudiantes con dificultades en el aprendizaje]. Infancia y Aprendizaje1997;20(80):37-52. ">Miranda 1997</a> ; <a href="./references#MR000050-bbs2-0056" title="MitchellC , MansfieldD , RautenbachS .Coloured filters and reading accuracy, comprehension and rate: a placebo-controlled study. Perceptual and Motor Skills2008;106(2):517-32. ">Mitchell 2008</a> ) </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Neurodegenerative disease</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#MR000050-bbs2-0030" title="GoldwasserAN , AuerbachSM , HarkinsSW .Cognitive, affective, and behavioural effects of reminiscence group therapy on demented elderly. Aging and Human Development1987;25(3):209-22. ">Goldwasser 1987</a> ; <a href="./references#MR000050-bbs2-0043" title="KwanR .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 26th of August 2019. KwanRY , LeungMC , LaiCK .Acupressure for agitation in nursing home residents with dementia: study protocol for a randomized controlled trial. Trials2014;15(410):1-7. KwanRY , LeungMCP , LaiCK .A randomized controlled trial examining the effect of acupressure on agitation and salivary cortisol in nursing home residents with dementia. Dementia and Geriatric Cognitive Disorders2017;44(1-2):92-104. ">Kwan 2017</a> ; <a href="./references#MR000050-bbs2-0045" title="LaiCK , ChiI , Kayser-JonesJ .A randomized controlled trial of a specific reminiscence approach to promote the well-being of nursing home residents with dementia. International Psychogeriatrics2004;16(1):33-49. LaiK .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 6th of September 2019. ">Lai 2004</a> ; <a href="./references#MR000050-bbs2-0052" title="McLachlanDR , DaltonAJ , KruckTP , BellMY , SmithWL , KalowW , et al.Intramuscular desferrioxamine in patients with Alzheimer's disease. Lancet1991;337(8753):1304-8. McLachlanDRC , SmithWL , KruckTP .Desferrioxamine and Alzheimer’s disease: video home behavior assessment of clinical course and measures of brain aluminum. Therapeutic Drug Monitoring1993;15(6):602-7. ">McLachlan 1991</a> ; <a href="./references#MR000050-bbs2-0069" title="QuayhagenMP , QuayhagenM , CorbeilRR , RothPA , RodgersJA .A dyadic remediation program for care recipients with dementia. Nursing Research1995;44(3):153-9. ">Quayhagen 1995</a> ; <a href="./references#MR000050-bbs2-0086" title="TeriL , LogsdonRG , UomotoJ , McCurrySM .Behavioral treatment of depression in dementia patients: a controlled clinical trial. Journals of Gerontology. Series B, Psychological Sciences and Social Sciences1997;52(4):159-66. TeriL .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 26th of August 2019. ">Teri 1997</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Post‐Traumatic Stress‐Disorder (PTSD)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#MR000050-bbs2-0021" title="EhlersA , HackmannA , GreyN , WildJ , LinessS , AlbertI , et al.A randomized controlled trial of 7-day intensive and standard weekly cognitive therapy for PTSD and emotion-focused supportive therapy. American Journal of Psychiatry2014;171(3):294-304. ">Ehlers 2014</a> ; <a href="./references#MR000050-bbs2-0024" title="FoaEB , RothbaumBO , RiggsDS , MurdockTB .Treatment of posttraumatic stress disorder in rape victims: a comparison between cognitive-behavioral procedures and counselling. Journal of Consulting and Clinical Psychology1991;59(5):715-23. ">Foa 1991</a> ; <a href="./references#MR000050-bbs2-0025" title="FoaEB , McLeanCP , ZangY , RosenfieldD , YadinE , YarvisJS , et al.Effect of prolonged exposure therapy delivered over 2 weeks vs 8 weeks vs present-centered therapy on PTSD symptom severity in military personnel: a randomized clinical trial. JAMA2018;319(4):354-64. ">Foa 2018</a> ; <a href="./references#MR000050-bbs2-0079" title="ShalevAY , AnkriY , Isreali-ShalevY , PelegT , AdesskyR , FreedmanS .Prevention of posttraumatic stress disorder by early treatment. Archives of General Psychiatry2012;69(2):166-76. ">Shalev 2012</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Schizophrenia</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#MR000050-bbs2-0032" title="HippmanC , RingroseA , InglisA , CheekJ , AlbertAY , RemickR , et al.A pilot randomized clinical trial evaluating the impact of genetic counselling for serious mental illnesses. Journal of Clinical Psychiatry2016;77(2):e190-8. ">Hippman 2016</a> ; <a href="./references#MR000050-bbs2-0059" title="PearlD , Vander KampH , OlsenAL , GreenbergPD , ArmitageSG .The effects of reserpine on schizophrenic patients. American Journal of Psychiatry1956;112:198-204. ">Pearl 1956</a> ; <a href="./references#MR000050-bbs2-0081" title="SibilioJP , AndrewG , DartD , MooreKB , StehmanA .Treatment of chronic schizophrenia with promazine hydrochloride. AMA Archives of Neurology and Psychiatry1957;78(4):419-24. ">Sibilio 1957</a> ; <a href="./references#MR000050-bbs2-0092" title="WeingaertnerAH .Self-administered aversive stimulation with hallucinating hospitalized schizophrenics. Journal of Consulting and Clinical Psychology1971;36(3):422-29. ">Weingaertner 1971</a> ; <a href="./references#MR000050-bbs2-0093" title="WhittakerCB , HoyRM .Withdrawal of perphenazine in chronic schizophrenia. British Journal of Psychiatry1963;109:422-7. ">Whittaker 1963</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Sleep‐wake disorders (e.g. insomnia, sleep disturbance)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>11</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#MR000050-bbs2-0005" title="AscherLM , TurnerR .Paradoxical intention and insomnia: an experimental investigation. Behaviour Research and Therapy1979;17(4):408-11. ">Ascher 1979</a> ; <a href="./references#MR000050-bbs2-0009" title="BorkovecTD , KaloupekDG , SlamaKM .The facilitative effect of muscle tension-release in the relaxation treatment of sleep disturbance. Behavior Therapy1975;6(3):301-9. ">Borkovec 1975</a> ; <a href="./references#MR000050-bbs2-0010" title="BorkovecTD , WeertsTC .Effects of progressive relaxation on sleep disturbance: an electroencephalographic evaluation. Psychosomatic Medicine1976;38(3):173-80. ">Borkovec 1976</a> ; <a href="./references#MR000050-bbs2-0022" title="EspieCA , BrooksDN , LindsayWR .An evaluation of tailored psychological treatment of insomnia. Journal of Behavior Therapy and Experimental Psychiatry1989;20(2):143-53. EspieCA , LindsayWR , BrooksDN , HoodEM , TurveyT .A controlled comparative investigation of psychological treatments for chronic sleep-onset insomnia. Behaviour Research and Therapy1989;27(1):79-88. ">Espie 1989a</a> ; <a href="./references#MR000050-bbs2-0026" title="FreireAO , SugaiGC , ChrispinFS , TogeiroSM , YamamuraY , MelloLE , et al.Treatment of moderate obstructive sleep apnea syndrome with acupuncture: a randomised, placebo-controlled pilot trial. Sleep Medicine2007;8(1):43-50. ">Freire 2007</a> ; <a href="./references#MR000050-bbs2-0049" title="LickJR , HefflerD .Relaxation training and attention placebo in the treatment of severe insomnia. Journal of Consulting and Clinical Psychology1977;45(2):153-61. ">Lick 1977</a> ; <a href="./references#MR000050-bbs2-0058" title="NicassioP , BootzinR .A comparison of progressive relaxation and autogenic training as treatments for insomnia. Journal of Abnormal Psychology1974;83(3):253-60. ">Nicassio 1974</a> ; <a href="./references#MR000050-bbs2-0080" title="ShealyRC .The effectiveness of various treatment techniques on different degrees and durations of sleep-onset insomnia. Behaviour Research and Therapy1979;17(6):541-6. ">Shealy 1979</a> ; <a href="./references#MR000050-bbs2-0083" title="SteinmarkSW , BorkovecTD .Active and placebo treatment effects on moderate insomnia under counterdemand and positive demand instructions. Journal of Abnormal Psychology1974;83(2):157-63. ">Steinmark 1974</a> ; <a href="./references#MR000050-bbs2-0089" title="AscherML , TurnerRM .A comparison of two methods for the administration of paradoxical intention. Behaviour Research and Therapy1980;18(2):121-6. TurnerRM , AscherLM .Controlled comparison of progressive relaxation, stimulus control, and paradoxical intention therapies for insomnia. Journal of Consulting and Clinical Psychology1979;47(3):500-8. ">Turner 1979</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Substance use disorders of different kind (e.g. alcohol, cocaine)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#MR000050-bbs2-0004" title="AlvarezJR .The effects of anger management training on depression, anger, self-concept, and treatment responsibility in a sample of drug-dependent individuals in a therapeutic community. Dissertation Abstracts International: Section B: the Sciences and Engineering1997;58(4-B):2108. ">Alvarez 1997</a> ; <a href="./references#MR000050-bbs2-0011" title="BornovalovaM .Inclusion of study in Cochrane Systematic Review (personal communication). Email to A Todorovac. 21st of August 2019. BornovalovaMA .Distress tolerance treatment for inner-city drug users: a preliminary trial. Doctor’s Dissertation, University of Maryland2008. ">Bornovalova 2008</a> ; <a href="./references#MR000050-bbs2-0018" title="CrouchG , RobsonM , HallstromC .Benzodiazepine dependent patients and their psychological treatment. Progress in Neuro-psychopharmacology &amp; Biological Psychiatry1988;12(4):503-10. HallströmC , CrouchG , RobsenM , ShineP .The treatment of tranquillizer dependence by propranolol. Postgraduate Medical Journal1988;64(Suppl 2):40-4. ">Crouch 1988</a> ; <a href="./references#MR000050-bbs2-0054" title="MilbyJB , ClarkeC , ToroC , ThorntonS , RickertD .Effectiveness of urine surveillance as an adjunct to outpatient psychotherapy for drug abusers. International Journal of the Addictions1980;15(7):993-1001. ">Milby 1980</a> ; <a href="./references#MR000050-bbs2-0063" title="PetersonMA , PattersonB , PillmanBM , BattistaMA .Cognitive recovery following alcohol detoxification: a computerised remediation study. Neuropsychological Rehabilitation2002;12(1):63-74. PillmanBM .Computerized cognitive remediation with recently detoxified alcoholics. Dissertation, California School of Professional Psychology, Fresno Campus2000. ">Pillman 2001</a> ; <a href="./references#MR000050-bbs2-0074" title="RoehrichL , GoldmanMS .Experience-dependent neuropsychological recovery and the treatment of alcoholism. Journal of Consulting and Clinical Psychology1993;61(5):812-21. ">Roehrich 1993</a> ; <a href="./references#MR000050-bbs2-0091" title="WatzlH , RistF , OlbrichR , CohenR .Placebo injections and surveillance of alcohol intake during inpatient treatment of female alcoholics. Addictive Behaviors1988;13(2):197-200. ">Watzl 1988</a> ; <a href="./references#MR000050-bbs2-0094" title="WilsonA , DavidsonWJ , BlanchardR , WhiteJ .Disulfiram implantation. A placebo-controlled trial with two-year follow-up. Journal of Studies on Alcohol1978;39(5):809-19. WilsonA , DavidsonWJ , BlanchardR .Disulfiram implantation: a trial using placebo implants and two types of controls. Journal of Studies on Alcohol1980;41(5):429-36. ">Wilson 1980</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Other unspecified disorders</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#MR000050-bbs2-0013" title="BrillNQ , KoeglerRR , EpsteinLJ , ForgyEW .Controlled study of psychiatric outpatient treatment. Archives of General Psychiatry1964;10:581-95. BrillNQ .Results of psychotherapy. California Medicine1966;104(4):249-53. ">Brill 1964a</a> ; <a href="./references#MR000050-bbs2-0014" title="BrillNQ , KoeglerRR , EpsteinLJ , ForgyEW .Controlled study of psychiatric outpatient treatment. Archives of General Psychiatry1964;10:581-95. ">Brill 1964b</a> ; <a href="./references#MR000050-bbs2-0019" title="Doty, DW.Role playing and incentives in the modification of the social interaction of chronic psychiatric patients. Journal of Consulting and Clinical Psychology1975;43(5):676-82. ">Doty 1975</a> ; <a href="./references#MR000050-bbs2-0020" title="DoubleDB , WarrenGC , EvansM , RowlandsMP .Efficacy of maintenance use of anticholinergic agents. Acta Psychiatrica Scandinavica1993;88:381-4. ">Double 1993</a> ; <a href="./references#MR000050-bbs2-0044" title="LacyMK .The effect of short term autogenic training on the stress reactivity of hospitalized emotionally disturbed adolescents. ProQuest Dissertations Publishing, Oklahoma State University1996. ">Lacy 1990</a> ; <a href="./references#MR000050-bbs2-0073" title="RobinA .Rationing out-patients: a defence of the waiting list. British Journal of Psychiatry1976;129:138-41. ">Robin 1976</a> ; <a href="./references#MR000050-bbs2-0077" title="LorrM , McNairDM , WeinsteinGJ .Early effects of chlordiazepoxide (Librium) used with psychotherapy. Journal of Psychiatric Research1963;1:257-70. RothI , RhudickPJ , ShaskanDA , SlobinMS , WilkinsonAE , YoungHH .Long-term effects on psychotherapy of initial treatment conditions. Journal of Psychiatric Research1964;2:283-97. ">Roth 1964</a> ; <a href="./references#MR000050-bbs2-0082" title="SommernessMD , LuceroRJ , HamlonJS , EricksonJL , MatthewsR .A controlled study of reserpine on chronically disturbed patients. JAMA Archives of Neurology and Psychiatry1955;74(3):316-9. ">Sommerness 1955</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Duration of interventions</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Less than three<br/>months </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>74</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#MR000050-bbs2-0002" title="AllenJB .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to A Todorovac 28th of August 2019. AllenJJ , SchnyerRN , HittSK .The efficacy of acupuncture in the treatment of major depression in women. Psychological Science1998;9(5):397-401. ">Allen 1998</a> ; <a href="./references#MR000050-bbs2-0003" title="AllenJB .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 28th of August 2019. AllenJJ , SchnyerRN , ChambersAS , HittSK , MorenoFA , ManberR .Acupuncture for depression: a randomized controlled trial. Journal of Clinical Psychiatry2006;67(11):1665-73. ">Allen 2006</a> ; <a href="./references#MR000050-bbs2-0004" title="AlvarezJR .The effects of anger management training on depression, anger, self-concept, and treatment responsibility in a sample of drug-dependent individuals in a therapeutic community. Dissertation Abstracts International: Section B: the Sciences and Engineering1997;58(4-B):2108. ">Alvarez 1997</a> ; <a href="./references#MR000050-bbs2-0005" title="AscherLM , TurnerR .Paradoxical intention and insomnia: an experimental investigation. Behaviour Research and Therapy1979;17(4):408-11. ">Ascher 1979</a> ; <a href="./references#MR000050-bbs2-0009" title="BorkovecTD , KaloupekDG , SlamaKM .The facilitative effect of muscle tension-release in the relaxation treatment of sleep disturbance. Behavior Therapy1975;6(3):301-9. ">Borkovec 1975</a> ; <a href="./references#MR000050-bbs2-0010" title="BorkovecTD , WeertsTC .Effects of progressive relaxation on sleep disturbance: an electroencephalographic evaluation. Psychosomatic Medicine1976;38(3):173-80. ">Borkovec 1976</a> ; <a href="./references#MR000050-bbs2-0011" title="BornovalovaM .Inclusion of study in Cochrane Systematic Review (personal communication). Email to A Todorovac. 21st of August 2019. BornovalovaMA .Distress tolerance treatment for inner-city drug users: a preliminary trial. Doctor’s Dissertation, University of Maryland2008. ">Bornovalova 2008</a> ; <a href="./references#MR000050-bbs2-0012" title="BramstonP , SpenceSH .Behavioural versus cognitive social-skills training with intellectually-handicapped adults. Behaviour Research and Therapy1985;23(3):239-46. ">Bramston 1985</a> ; <a href="./references#MR000050-bbs2-0015" title="CarlsonCL , PelhamWE , MilichR , HozaB .ADHD boys’ performance and attributions following success and failure: drug effects and individual differences. Cognitive Therapy and Research1993;17:269-87. ">Carlson 1993</a> ; <a href="./references#MR000050-bbs2-0016" title="CarterJC , OlmstedMP , KaplanAS , McCabeRE , MillsJS , AimeA .Self-help for bulimia nervosa: a randomized controlled trial. American Journal of Psychiatry2003;160(5):973-8. ">Carter 2003</a> ; <a href="./references#MR000050-bbs2-0017" title="CrispAH , NortonK , GowersS , HalekC , BowyerC , YeldhamD , et al.A controlled study of the effect of therapies aimed at adolescent and family psychopathology in Anorexia Nervosa. British Journal of Psychiatry: the Journal of Mental Science1991;159:325-33. GowersS , NortonK , HalekC , CrispAH .Outcome of outpatient psychotherapy in a random allocation treatment study of anorexia nervosa. International Journal of Eating Disorders1994;15(2):165-77. GowersS , NortonK , YelshamD .The St George's prospective treatment study of anorexia nervosa: a discussion of methodological problems. International Journal of Eating Disorders1989;8:445-54. ">Crisp 1991</a> ; <a href="./references#MR000050-bbs2-0018" title="CrouchG , RobsonM , HallstromC .Benzodiazepine dependent patients and their psychological treatment. Progress in Neuro-psychopharmacology &amp; Biological Psychiatry1988;12(4):503-10. HallströmC , CrouchG , RobsenM , ShineP .The treatment of tranquillizer dependence by propranolol. Postgraduate Medical Journal1988;64(Suppl 2):40-4. ">Crouch 1988</a> ; <a href="./references#MR000050-bbs2-0019" title="Doty, DW.Role playing and incentives in the modification of the social interaction of chronic psychiatric patients. Journal of Consulting and Clinical Psychology1975;43(5):676-82. ">Doty 1975</a> ; <a href="./references#MR000050-bbs2-0020" title="DoubleDB , WarrenGC , EvansM , RowlandsMP .Efficacy of maintenance use of anticholinergic agents. Acta Psychiatrica Scandinavica1993;88:381-4. ">Double 1993</a> ; <a href="./references#MR000050-bbs2-0022" title="EspieCA , BrooksDN , LindsayWR .An evaluation of tailored psychological treatment of insomnia. Journal of Behavior Therapy and Experimental Psychiatry1989;20(2):143-53. EspieCA , LindsayWR , BrooksDN , HoodEM , TurveyT .A controlled comparative investigation of psychological treatments for chronic sleep-onset insomnia. Behaviour Research and Therapy1989;27(1):79-88. ">Espie 1989a</a> ; <a href="./references#MR000050-bbs2-0023" title="EtringerBD , CashTF , RimmDC .Behavioral, affective, and cognitive effects of participant modeling and an equally credible placebo. Behavior Therapy1982;13(4):476-85. ">Etringer 1982</a> ; <a href="./references#MR000050-bbs2-0024" title="FoaEB , RothbaumBO , RiggsDS , MurdockTB .Treatment of posttraumatic stress disorder in rape victims: a comparison between cognitive-behavioral procedures and counselling. Journal of Consulting and Clinical Psychology1991;59(5):715-23. ">Foa 1991</a> ; <a href="./references#MR000050-bbs2-0025" title="FoaEB , McLeanCP , ZangY , RosenfieldD , YadinE , YarvisJS , et al.Effect of prolonged exposure therapy delivered over 2 weeks vs 8 weeks vs present-centered therapy on PTSD symptom severity in military personnel: a randomized clinical trial. JAMA2018;319(4):354-64. ">Foa 2018</a> ; <a href="./references#MR000050-bbs2-0026" title="FreireAO , SugaiGC , ChrispinFS , TogeiroSM , YamamuraY , MelloLE , et al.Treatment of moderate obstructive sleep apnea syndrome with acupuncture: a randomised, placebo-controlled pilot trial. Sleep Medicine2007;8(1):43-50. ">Freire 2007</a> ; <a href="./references#MR000050-bbs2-0027" title="FuchsCZ , RehnLP .A self-control behavior therapy program for depression. Journal of Consulting and Clinical Psychology1977;45(2):206-15. ">Fuchs 1977</a> ; <a href="./references#MR000050-bbs2-0029" title="GoldsteinAJ , BeursE , Chambless Dl, WilsonKA .EMDR for panic disorder with agoraphobia: comparison with waiting list and credible attention-placebo control conditions. Journal of Consulting and Clinical Psychology2000;68(6):947-56. ">Goldstein 2000</a> ; <a href="./references#MR000050-bbs2-0030" title="GoldwasserAN , AuerbachSM , HarkinsSW .Cognitive, affective, and behavioural effects of reminiscence group therapy on demented elderly. Aging and Human Development1987;25(3):209-22. ">Goldwasser 1987</a> ; <a href="./references#MR000050-bbs2-0031" title="HekmatH , LubitzR , DealR .Semantic desensitization: a paradigmatic intervention approach to anxiety disorders. Journal of Clinical Psychology1984;40(2):463-6. ">Hekmat 1984</a> ; <a href="./references#MR000050-bbs2-0033" title="HowlinP , GordonKR , PascoG , WadeA , CharmanT .The effectiveness of picture exchange communication system (PECS) training for teachers of children with autism: a pragmatic,group randomised controlled trial. Journal of Child Psychology and Psychiatry2007;48(5):473-81. ">Howlin 2007</a> ; <a href="./references#MR000050-bbs2-0034" title="KarstM , WinterhalterM , MünteS , FranckiB , HondronikosA , EckardtA , et al.Auricular acupuncture for dental anxiety: a randomized controlled trial. Anesthesia and Analgesia2007;104(2):295-300. KarstM .Inclusion of study in Cochrane Systematic Review (personal communication). Email to: EG Faltinsen 5th of September 2019. ">Karst 2007</a> ; <a href="./references#MR000050-bbs2-0035" title="KelleyJ .Inclusion of study in Cochrane Systematic Review (personal communication). Email to: A Todorovac 12th of August 2019. KelleyJM , KaptchukTJ , CusinC , LipkinS , FavaM .Open-label placebo for major depressive disorder: a pilot randomized controlled trial. Psychotherapy and Psychosomatics2012;81(5):312-4. ">Kelley 2012</a> ; <a href="./references#MR000050-bbs2-0037" title="KilmannPR , MilanRJ , BolandJP , NankinHR , DavidsonE , WestMO , et al.Group treatment of secondary erectile dysfunction. Journal of Sex &amp; Marital Therapy1987;13(3):168-82. KilmannPR , Milan RJ Jr, BolandJP , DavidsonE , WestMO , SablisRF , et al.The sexual interactions of men with secondary erectile dysfunction. Journal of Sex Education and Therapy1988;14(1):46-9. KilmannPR , Milan RJ Jr, BolandJP , NankinHR , SablisRF , WestMO , et al.The sexual interactions of men with secondary erectile dysfunction. Paper presented at the annual meeting of the American Psychological Association in Los Angeles1985;1:46-9. ">Kilmann 1987</a> ; <a href="./references#MR000050-bbs2-0038" title="KleinSA , DeffenbacherJL .Relaxation and exercise for hyperactive impulsive children. Perceptual and Motor Skills1977;45:1159-62. ">Klein 1977</a> ; <a href="./references#MR000050-bbs2-0042" title="KrapflJE , NawasMM .Differential ordering of stimulus presentation in systematic desensitization. Journal of Abnormal Psychology1970;75(3):333-7. ">Krapfl 1970</a> ; <a href="./references#MR000050-bbs2-0043" title="KwanR .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 26th of August 2019. KwanRY , LeungMC , LaiCK .Acupressure for agitation in nursing home residents with dementia: study protocol for a randomized controlled trial. Trials2014;15(410):1-7. KwanRY , LeungMCP , LaiCK .A randomized controlled trial examining the effect of acupressure on agitation and salivary cortisol in nursing home residents with dementia. Dementia and Geriatric Cognitive Disorders2017;44(1-2):92-104. ">Kwan 2017</a> ; <a href="./references#MR000050-bbs2-0045" title="LaiCK , ChiI , Kayser-JonesJ .A randomized controlled trial of a specific reminiscence approach to promote the well-being of nursing home residents with dementia. International Psychogeriatrics2004;16(1):33-49. LaiK .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 6th of September 2019. ">Lai 2004</a> ; <a href="./references#MR000050-bbs2-0046" title="LangOJ , LazovikAD .Experimental desensitization of a phobia. Journal of Abnormal and Social Psychology1963;66:519-25. LangPJ , LazovikAD , ReynoldsDJ .Desensitization, suggestibility, and pseudotherapy. Journal of Abnormal Psychology1965;70(6):395-402. ">Lang 1965</a> ; <a href="./references#MR000050-bbs2-0047" title="LegrandF .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 14th of August 2019. LegrandFD , NeffEM .Efficacy of exercise as an adjunct treatment for clinically depressed inpatients during the initial stages of antidepressant pharmacotherapy: an open randomized controlled trial. Journal of Affective Disorders2016;191:139-44. ">Legrand 2016</a> ; <a href="./references#MR000050-bbs2-0048" title="LickJ .Expectancy, false galvanic skin response feedback, and systematic desensitization in the modification of phobic behavior. Journal of Consulting and Clinical Psychology1975;43(4):557-67. ">Lick 1975</a> ; <a href="./references#MR000050-bbs2-0049" title="LickJR , HefflerD .Relaxation training and attention placebo in the treatment of severe insomnia. Journal of Consulting and Clinical Psychology1977;45(2):153-61. ">Lick 1977</a> ; <a href="./references#MR000050-bbs2-0050" title="LiddleB , SpenceSH .Cognitive-behaviour therapy with depressed primary school children: A cautionary note. Behavioural Psychotherapy1990;18(2):85-102. ">Liddle 1990</a> ; <a href="./references#MR000050-bbs2-0051" title="MatsonJL , MarchettiA , AdkinsJA .Comparison of operant- and independence-training procedures for mentally retarded adults. American Journal of Mental Deficiency1980;84(5):487-94. ">Matson 1980</a> ; <a href="./references#MR000050-bbs2-0053" title="MealieaWL , NawasMM .The comparative effectiveness of systematic desensitization and implosive therapy in the treatment of snake phobia. Journal of Behavior Therapy and Experimental Psychiatry1971;2(2):85-94. ">Mealiea 1971</a> ; <a href="./references#MR000050-bbs2-0054" title="MilbyJB , ClarkeC , ToroC , ThorntonS , RickertD .Effectiveness of urine surveillance as an adjunct to outpatient psychotherapy for drug abusers. International Journal of the Addictions1980;15(7):993-1001. ">Milby 1980</a> ; <a href="./references#MR000050-bbs2-0055" title="MirandaA , ArlandisP , SorianoM .Instruction in strategies and attributional training: Effects on the problem-solving and self-concept of students’ with learning disabilities [Instrucción en estrategias y entrenamiento atribucional: efectos sobre la resolución de problemas y el autoconcepto de los estudiantes con dificultades en el aprendizaje]. Infancia y Aprendizaje1997;20(80):37-52. ">Miranda 1997</a> ; <a href="./references#MR000050-bbs2-0056" title="MitchellC , MansfieldD , RautenbachS .Coloured filters and reading accuracy, comprehension and rate: a placebo-controlled study. Perceptual and Motor Skills2008;106(2):517-32. ">Mitchell 2008</a> ; <a href="./references#MR000050-bbs2-0057" title="NandiDN , AjmanyS , GanguliH , BanerjeeG , BoralGC , GhoshA , et al.A clinical evaluation of depressives found in a rural survey in India. British Journal of Psychiatry1976;128:523-7. ">Nandi 1976</a> ; <a href="./references#MR000050-bbs2-0058" title="NicassioP , BootzinR .A comparison of progressive relaxation and autogenic training as treatments for insomnia. Journal of Abnormal Psychology1974;83(3):253-60. ">Nicassio 1974</a> ; <a href="./references#MR000050-bbs2-0059" title="PearlD , Vander KampH , OlsenAL , GreenbergPD , ArmitageSG .The effects of reserpine on schizophrenic patients. American Journal of Psychiatry1956;112:198-204. ">Pearl 1956</a> ; <a href="./references#MR000050-bbs2-0060" title="PeckCL .Desensitization for the treatment of fear in the high level adult retardate. Behaviour Research and Therapy1977;15(2):137-48. ">Peck 1976</a> ; <a href="./references#MR000050-bbs2-0061" title="MilichR , CarlsonCL , Pelham WE Jr, LichtBG .Effects of methylphenidate on the persistence of ADHD boys following failure experiences. Journal of Abnormal Child Psychology1991;19(5):519-36. PelhamWE , MurphyDA , VannattaK , MilichR , LichtBG , GnagyEM , et al.Methylphenidate and attributions in boys with attention-deficit hyperactivity disorder. Journal of Consulting and Clinical Psychology1992;60(2):282-92. ">Pelham 1992</a> ; <a href="./references#MR000050-bbs2-0062" title="PedletonMG , HigginsRL .A comparison of negative practice and systematic desensitization in the treatment of acrophobia. Journal of Behavior Therapy and Experimental Psychiatry1983;14(4):317-23. ">Pendleton 1983</a> ; <a href="./references#MR000050-bbs2-0063" title="PetersonMA , PattersonB , PillmanBM , BattistaMA .Cognitive recovery following alcohol detoxification: a computerised remediation study. Neuropsychological Rehabilitation2002;12(1):63-74. PillmanBM .Computerized cognitive remediation with recently detoxified alcoholics. Dissertation, California School of Professional Psychology, Fresno Campus2000. ">Pillman 2001</a> ; <a href="./references#MR000050-bbs2-0064" title="PolandRE , GertsikL , FavreauJT , SmithSI , MirochaJM , RaoU , et al.Open-label randomized parallel-group controlled clinical trial of massage for treatment of depression in HIV-infected subjects. Journal of Alternative and Complementary Medicine2013;19(4):334-40. ">Poland 2013</a> ; <a href="./references#MR000050-bbs2-0065" title="PowersMB , SmitsJA , TelchMJ .Disentangling the effects of safety-behavior utilization and safety-behavior availability during exposure-based treatment: a placebo-controlled trial. Journal of Consulting and Clinical Psychology2004;72(3):448-54. ">Powers 2004</a> ; <a href="./references#MR000050-bbs2-0066" title="PowersMB , SmithsJA , WhitleyD , BystritskyA , TelchMJ .The effect of attributional processes concerning medication taking on return of fear. Journal of Consulting and Clinical Psychology2008;76(3):478-90. ">Powers 2008a</a> ; <a href="./references#MR000050-bbs2-0067" title="PowersMB , SmithsJA , WhitleyD , BystritskyA , TelchMJ .The effect of attributional processes concerning medication taking on return of fear. Journal of Consulting and Clinical Psychology2008;76(3):478-90. ">Powers 2008b</a> ; <a href="./references#MR000050-bbs2-0068" title="ProudfootJ , ClarkeJ , BirchMR , WhittonAE , ParkerG , ManicavasagarV , et al.Impact of a mobile phone and web program on symptom and functional outcomes for people with mild- to-moderate depression, anxiety and stress: a randomized controlled trial. BMC Psychiatry2013;13(312):1-12. ProudfootJ .Re: Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 26th of August 2019. ">Proudfoot 2013</a> ; <a href="./references#MR000050-bbs2-0070" title="LiebowitzM , QuitkinFM , StewartJW , McGrathPJ , HarrisonWM , MarkowitzJS , et al.Antidepressant efficacy in atypical depression. Archives of General Psychiatry1988;45(2):129-37. QuitkinFM , McGrathPJ , StewartJW , HarrisonW , WagerSG , NunesE , et al.Phenelzine and imipramine in mood reactive depressives: further delineation of the syndrome of atypical depression. Archives of General Psychiatry1989;46(9):787-93. RabkinJG , McGrathPJ , QuitkinFM , TricamoE , StewartJW , KleinDF .Effects of pill-giving on maintenance of placebo response in patients with chronic mild depression. American Journal of Psychiatry1990;147(12):1622-6. ">Rabkin 1990</a> ; <a href="./references#MR000050-bbs2-0073" title="RobinA .Rationing out-patients: a defence of the waiting list. British Journal of Psychiatry1976;129:138-41. ">Robin 1976</a> ; <a href="./references#MR000050-bbs2-0074" title="RoehrichL , GoldmanMS .Experience-dependent neuropsychological recovery and the treatment of alcoholism. Journal of Consulting and Clinical Psychology1993;61(5):812-21. ">Roehrich 1993</a> ; <a href="./references#MR000050-bbs2-0076" title="RosenGM , GlasgowRE , BarreraM .A controlled study to assess the clinical efficacy of totally self-administrated systematic desensitization. Journal of Consulting and Clinical Psychology1976;44(2):208-17. ">Rosen 1976</a> ; <a href="./references#MR000050-bbs2-0077" title="LorrM , McNairDM , WeinsteinGJ .Early effects of chlordiazepoxide (Librium) used with psychotherapy. Journal of Psychiatric Research1963;1:257-70. RothI , RhudickPJ , ShaskanDA , SlobinMS , WilkinsonAE , YoungHH .Long-term effects on psychotherapy of initial treatment conditions. Journal of Psychiatric Research1964;2:283-97. ">Roth 1964</a> ; <a href="./references#MR000050-bbs2-0078" title="RupertPA , HolmesDS .Effects of multiple sessions of true and placebo heart rate biofeedback training on the heart rates and anxiety levels of anxious patients during and following treatment. Psychophysiology1978;15(6):582-90. ">Rupert 1978</a> ; <a href="./references#MR000050-bbs2-0080" title="ShealyRC .The effectiveness of various treatment techniques on different degrees and durations of sleep-onset insomnia. Behaviour Research and Therapy1979;17(6):541-6. ">Shealy 1979</a> ; <a href="./references#MR000050-bbs2-0081" title="SibilioJP , AndrewG , DartD , MooreKB , StehmanA .Treatment of chronic schizophrenia with promazine hydrochloride. AMA Archives of Neurology and Psychiatry1957;78(4):419-24. ">Sibilio 1957</a> ; <a href="./references#MR000050-bbs2-0083" title="SteinmarkSW , BorkovecTD .Active and placebo treatment effects on moderate insomnia under counterdemand and positive demand instructions. Journal of Abnormal Psychology1974;83(2):157-63. ">Steinmark 1974</a> ; <a href="./references#MR000050-bbs2-0084" title="SzymanskiJ , O'DonohueW .The potential role of state-dependent learning in cognitive therapy with spider phobics. Journal of Rational-Emotive &amp; Cognitive-Behavior Therapy1995;13(2):131-50. SzymanskiJ .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 20th of August 2019. ">Szymanski 1995</a> ; <a href="./references#MR000050-bbs2-0085" title="TanSY , BruniJ .Cognitive-behavior therapy with adult patients with epilepsy: a controlled outcome study. Epilepsia1986;27(3):225-33. ">Tan 1986</a> ; <a href="./references#MR000050-bbs2-0086" title="TeriL , LogsdonRG , UomotoJ , McCurrySM .Behavioral treatment of depression in dementia patients: a controlled clinical trial. Journals of Gerontology. Series B, Psychological Sciences and Social Sciences1997;52(4):159-66. TeriL .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 26th of August 2019. ">Teri 1997</a> ; <a href="./references#MR000050-bbs2-0087" title="ToriC , WorellL .Reduction of human avoidant behavior. A comparison of counterconditioning, expectancy, and cognitive information approaches. Clinical Psychology1973;41(2):269-78. ">Tori 1973</a> ; <a href="./references#MR000050-bbs2-0088" title="Trexler, L.Rational-emotive therapy, placebo, and no-treatment effects on public-speaking anxiety. Doctoral dissertation, Temple University AnnArbor, Mich.: University Microfilms1971;71-31(063). TrexlerLD , KarstTO .Rational-emotive therapy, placebo, and no-treatment effects on public-speaking anxiety. Journal of Abnormal Psyhology1972;79(1):60-7. ">Trexler 1972</a> ; <a href="./references#MR000050-bbs2-0089" title="AscherML , TurnerRM .A comparison of two methods for the administration of paradoxical intention. Behaviour Research and Therapy1980;18(2):121-6. TurnerRM , AscherLM .Controlled comparison of progressive relaxation, stimulus control, and paradoxical intention therapies for insomnia. Journal of Consulting and Clinical Psychology1979;47(3):500-8. ">Turner 1979</a> ; <a href="./references#MR000050-bbs2-0090" title="VanderplateC .Electromyograph biofeedback Treatment of sleep onset Insomnia: a controlled Investigation. Dissertation, University of Southern Mississippi1978. ">Vanderplate 1983</a> ; <a href="./references#MR000050-bbs2-0092" title="WeingaertnerAH .Self-administered aversive stimulation with hallucinating hospitalized schizophrenics. Journal of Consulting and Clinical Psychology1971;36(3):422-29. ">Weingaertner 1971</a> ; <a href="./references#MR000050-bbs2-0093" title="WhittakerCB , HoyRM .Withdrawal of perphenazine in chronic schizophrenia. British Journal of Psychiatry1963;109:422-7. ">Whittaker 1963</a> ; <a href="./references#MR000050-bbs2-0094" title="WilsonA , DavidsonWJ , BlanchardR , WhiteJ .Disulfiram implantation. A placebo-controlled trial with two-year follow-up. Journal of Studies on Alcohol1978;39(5):809-19. WilsonA , DavidsonWJ , BlanchardR .Disulfiram implantation: a trial using placebo implants and two types of controls. Journal of Studies on Alcohol1980;41(5):429-36. ">Wilson 1980</a> ; <a href="./references#MR000050-bbs2-0095" title="WolitzkyKB , TelchMJ .Augmenting in vivo exposure with fear antagonistic actions: a preliminary test. Behavior Therapy2009;40(1):57-71. ">Wolitzky 2009</a> ; <a href="./references#MR000050-bbs2-0096" title="WollersheimJP , WilsonGL .Group treatment of unipolar depression: a comparison of coping, supportive, bibliotherapy, and delayed treatment groups. Professional Psychology: Research and Practice1991;22(6):496-502. ">Wollersheim 1991</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>More than three months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>21</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#MR000050-bbs2-0001" title="AbikoffH , HechtmanL , KleinRG .Social functioning in children with ADHD treated with long-term methylphenidate and multimodal psychosocial treatment. Journal of the American Academy of Child and Adolescent Psychiatry2004;43(7):820-9. AbikoffH .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to A Todorovac 23rd of August 2019. KleinRG , AbikoffH , HechtmanL , WeissG .Design and rationale of controlled study of long-term methylphenidate and multimodal psychosocial treatment in children with ADHD. Journal of the American Academy of Child and Adolescent Psychiatry2004;43(7):792-801. ">Abikoff 2004</a> ; <a href="./references#MR000050-bbs2-0006" title="AyenI , HautzingerM .Cognitive behavior therapy for depression in menopausal women. A controlled, randomized treatment study [Kognitive Verhaltenstherapie bei Depressionen im Klimakterium: Eine kontrollierte, randomiserte Interventionsstudie]. Zeitschrift für Klinische Psychologie und Psychotherapie2004;33(4):290-9. AyenI .Inclusion of study in Cochrane Systematic Review (personal communication). Email to EG Faltinsen 9th of September 2019. ">Ayen 2004</a> ; <a href="./references#MR000050-bbs2-0007" title="BergI , ForsytheI , HoltP , WattsJ .A controlled trial of ‘Senokot’ in faecal soiling treated by behavioural methods. Journal of Child Psychology and Psychiatry1983;24(4):543-9. ">Berg 1983</a> ; <a href="./references#MR000050-bbs2-0008" title="Borden, KA.Attributional Outcomes: the Subtle Messages of Treatments for Attention Deficit Disorder. Dissertation, University of Illinois at Urbana-Champaign1986. BordenKA , BrownRT .Attributional outcomes: The subtle messages of treatments for attention deficit disorder. Cognitive Therapy and Research1989;13(2):147-60. ">Borden 1986</a> ; <a href="./references#MR000050-bbs2-0013" title="BrillNQ , KoeglerRR , EpsteinLJ , ForgyEW .Controlled study of psychiatric outpatient treatment. Archives of General Psychiatry1964;10:581-95. BrillNQ .Results of psychotherapy. California Medicine1966;104(4):249-53. ">Brill 1964a</a> ; <a href="./references#MR000050-bbs2-0014" title="BrillNQ , KoeglerRR , EpsteinLJ , ForgyEW .Controlled study of psychiatric outpatient treatment. Archives of General Psychiatry1964;10:581-95. ">Brill 1964b</a> ; <a href="./references#MR000050-bbs2-0021" title="EhlersA , HackmannA , GreyN , WildJ , LinessS , AlbertI , et al.A randomized controlled trial of 7-day intensive and standard weekly cognitive therapy for PTSD and emotion-focused supportive therapy. American Journal of Psychiatry2014;171(3):294-304. ">Ehlers 2014</a> ; <a href="./references#MR000050-bbs2-0028" title="GlogowskaM , RoulstoneS , EnderbyP , PetersTJ .Randomised controlled trial of community based speech and language therapy in preschool children. BMJ2000;321(7266):923-6. ">Glogowska 2000</a> ; <a href="./references#MR000050-bbs2-0036" title="KennedyTD , KimuraHK .Transfer, behavioral improvement, and anxiety reduction in systematic desensitization. Journal of Consulting and Clinical Psychology1974;42(5):720-8. ">Kennedy 1974</a> ; <a href="./references#MR000050-bbs2-0039" title="KlermanGL , DimascioA , WeismannM , PrusoffB , PaykelES .Treatment of depression by drugs and psychotherapy. American Journal of Psychiatry1974;131(2):186-91. PaykelES , DimascioA , HaskellD , PrusoffBA .Effects of maintenance amitriptyline and psychotherapy on symptoms of depression. Psychological Medicine1975;5(1):67-77. PaykelES , DiMascioA , KlermanGL , PrusoffBA .Maintenance therapy of depression. Pharmakopsychiatrie, Neuro-Psychopharmakologie1976;9:127-39. PaykelES , WeissmanMM , PrusoffBA .Social maladjustment and severity of depression. Comprehensive Psychiatry1978;19(2):121-8. WeissmanMM , KlermanGL , PaykelES , PrusoffB .Treatment effects on the social adjustment of depressed patients. Archives of General Psychiatry1974;30:771-8. ">Klerman 1974a</a> ; <a href="./references#MR000050-bbs2-0040" title="KlermanGL , DimascioA , WeismannM , PrusoffB , PaykelES .Treatment of depression by drugs and psychotherapy. American Journal of Psychiatry1974;131(2):186-91. ">Klerman 1974b</a> ; <a href="./references#MR000050-bbs2-0041" title="KloskoJS , BarlowDH , TassinariR , CernyJA .A comparison of alprazolam and behavior therapy in treatment of panic disorder: correction. Journal of Psychotherapy Practice and Research1994;3(2):163-79. KloskoJS , BarlowDH , TassinariR , CernyJA .A comparison of alprazolam and behavior therapy in treatment of panic disorder. Journal of Consulting and Clinical Psychology1990;58(1):77-84. ">Klosko 1990</a> ; <a href="./references#MR000050-bbs2-0044" title="LacyMK .The effect of short term autogenic training on the stress reactivity of hospitalized emotionally disturbed adolescents. ProQuest Dissertations Publishing, Oklahoma State University1996. ">Lacy 1990</a> ; <a href="./references#MR000050-bbs2-0052" title="McLachlanDR , DaltonAJ , KruckTP , BellMY , SmithWL , KalowW , et al.Intramuscular desferrioxamine in patients with Alzheimer's disease. Lancet1991;337(8753):1304-8. McLachlanDRC , SmithWL , KruckTP .Desferrioxamine and Alzheimer’s disease: video home behavior assessment of clinical course and measures of brain aluminum. Therapeutic Drug Monitoring1993;15(6):602-7. ">McLachlan 1991</a> ; <a href="./references#MR000050-bbs2-0069" title="QuayhagenMP , QuayhagenM , CorbeilRR , RothPA , RodgersJA .A dyadic remediation program for care recipients with dementia. Nursing Research1995;44(3):153-9. ">Quayhagen 1995</a> ; <a href="./references#MR000050-bbs2-0071" title="RapeeR .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 29th of August 2019. RapeeRM , AbbottMJ , LynehamHJ .Bibliotherapy for children With anxiety disorders using written materials for parents: a randomized controlled trial. Journal of Consulting and Clinical Psychology2006;74(3):436-44. ">Rapee 2006</a> ; <a href="./references#MR000050-bbs2-0072" title="RapeeR .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 29th of August 2019. RapeeRM , AbbottMJ , BaillieAJ , GastonJE .Treatment of social phobia through pure self-help and therapist-augmented self-help. British Journal of Psychiatry2007;191:246-52. ">Rapee 2007</a> ; <a href="./references#MR000050-bbs2-0075" title="OlivaresJ .Program IAFS. Protocol for the treatment of social phobia in adolescents [Programa IAFS. Protocolo para el tratamiento de la fobia social enadolescentes]. Madrid: Pirámide2005;1. Rosa-AlcázarAI , Olivares-OlivaresPJ , OlivaresJ .The role of non-specific effects in the psychological treatment of adolescents with social phobia [Papel de los efectos inespecíficos en el tratamiento psicológico de adolescentes con fobia social]. Anuario de Psicologia2009;40(1):43-61. ">Rosa‐Alcatraz 2009</a> ; <a href="./references#MR000050-bbs2-0079" title="ShalevAY , AnkriY , Isreali-ShalevY , PelegT , AdesskyR , FreedmanS .Prevention of posttraumatic stress disorder by early treatment. Archives of General Psychiatry2012;69(2):166-76. ">Shalev 2012</a> ; <a href="./references#MR000050-bbs2-0082" title="SommernessMD , LuceroRJ , HamlonJS , EricksonJL , MatthewsR .A controlled study of reserpine on chronically disturbed patients. JAMA Archives of Neurology and Psychiatry1955;74(3):316-9. ">Sommerness 1955</a> ; <a href="./references#MR000050-bbs2-0091" title="WatzlH , RistF , OlbrichR , CohenR .Placebo injections and surveillance of alcohol intake during inpatient treatment of female alcoholics. Addictive Behaviors1988;13(2):197-200. ">Watzl 1988</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not reported</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#MR000050-bbs2-0032" title="HippmanC , RingroseA , InglisA , CheekJ , AlbertAY , RemickR , et al.A pilot randomized clinical trial evaluating the impact of genetic counselling for serious mental illnesses. Journal of Clinical Psychiatry2016;77(2):e190-8. ">Hippman 2016</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Formats of interventions</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Individual treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>25</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#MR000050-bbs2-0005" title="AscherLM , TurnerR .Paradoxical intention and insomnia: an experimental investigation. Behaviour Research and Therapy1979;17(4):408-11. ">Ascher 1979</a> ; <a href="./references#MR000050-bbs2-0011" title="BornovalovaM .Inclusion of study in Cochrane Systematic Review (personal communication). Email to A Todorovac. 21st of August 2019. BornovalovaMA .Distress tolerance treatment for inner-city drug users: a preliminary trial. Doctor’s Dissertation, University of Maryland2008. ">Bornovalova 2008</a> ; <a href="./references#MR000050-bbs2-0013" title="BrillNQ , KoeglerRR , EpsteinLJ , ForgyEW .Controlled study of psychiatric outpatient treatment. Archives of General Psychiatry1964;10:581-95. BrillNQ .Results of psychotherapy. California Medicine1966;104(4):249-53. ">Brill 1964a</a> ; <a href="./references#MR000050-bbs2-0016" title="CarterJC , OlmstedMP , KaplanAS , McCabeRE , MillsJS , AimeA .Self-help for bulimia nervosa: a randomized controlled trial. American Journal of Psychiatry2003;160(5):973-8. ">Carter 2003</a> ; <a href="./references#MR000050-bbs2-0021" title="EhlersA , HackmannA , GreyN , WildJ , LinessS , AlbertI , et al.A randomized controlled trial of 7-day intensive and standard weekly cognitive therapy for PTSD and emotion-focused supportive therapy. American Journal of Psychiatry2014;171(3):294-304. ">Ehlers 2014</a> ; <a href="./references#MR000050-bbs2-0022" title="EspieCA , BrooksDN , LindsayWR .An evaluation of tailored psychological treatment of insomnia. Journal of Behavior Therapy and Experimental Psychiatry1989;20(2):143-53. EspieCA , LindsayWR , BrooksDN , HoodEM , TurveyT .A controlled comparative investigation of psychological treatments for chronic sleep-onset insomnia. Behaviour Research and Therapy1989;27(1):79-88. ">Espie 1989a</a> ; <a href="./references#MR000050-bbs2-0024" title="FoaEB , RothbaumBO , RiggsDS , MurdockTB .Treatment of posttraumatic stress disorder in rape victims: a comparison between cognitive-behavioral procedures and counselling. Journal of Consulting and Clinical Psychology1991;59(5):715-23. ">Foa 1991</a> ; <a href="./references#MR000050-bbs2-0025" title="FoaEB , McLeanCP , ZangY , RosenfieldD , YadinE , YarvisJS , et al.Effect of prolonged exposure therapy delivered over 2 weeks vs 8 weeks vs present-centered therapy on PTSD symptom severity in military personnel: a randomized clinical trial. JAMA2018;319(4):354-64. ">Foa 2018</a> ; <a href="./references#MR000050-bbs2-0028" title="GlogowskaM , RoulstoneS , EnderbyP , PetersTJ .Randomised controlled trial of community based speech and language therapy in preschool children. BMJ2000;321(7266):923-6. ">Glogowska 2000</a> ; <a href="./references#MR000050-bbs2-0029" title="GoldsteinAJ , BeursE , Chambless Dl, WilsonKA .EMDR for panic disorder with agoraphobia: comparison with waiting list and credible attention-placebo control conditions. Journal of Consulting and Clinical Psychology2000;68(6):947-56. ">Goldstein 2000</a> ; <a href="./references#MR000050-bbs2-0031" title="HekmatH , LubitzR , DealR .Semantic desensitization: a paradigmatic intervention approach to anxiety disorders. Journal of Clinical Psychology1984;40(2):463-6. ">Hekmat 1984</a> ; <a href="./references#MR000050-bbs2-0032" title="HippmanC , RingroseA , InglisA , CheekJ , AlbertAY , RemickR , et al.A pilot randomized clinical trial evaluating the impact of genetic counselling for serious mental illnesses. Journal of Clinical Psychiatry2016;77(2):e190-8. ">Hippman 2016</a> ; <a href="./references#MR000050-bbs2-0036" title="KennedyTD , KimuraHK .Transfer, behavioral improvement, and anxiety reduction in systematic desensitization. Journal of Consulting and Clinical Psychology1974;42(5):720-8. ">Kennedy 1974</a> ; <a href="./references#MR000050-bbs2-0045" title="LaiCK , ChiI , Kayser-JonesJ .A randomized controlled trial of a specific reminiscence approach to promote the well-being of nursing home residents with dementia. International Psychogeriatrics2004;16(1):33-49. LaiK .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 6th of September 2019. ">Lai 2004</a> ; <a href="./references#MR000050-bbs2-0046" title="LangOJ , LazovikAD .Experimental desensitization of a phobia. Journal of Abnormal and Social Psychology1963;66:519-25. LangPJ , LazovikAD , ReynoldsDJ .Desensitization, suggestibility, and pseudotherapy. Journal of Abnormal Psychology1965;70(6):395-402. ">Lang 1965</a> ; <a href="./references#MR000050-bbs2-0048" title="LickJ .Expectancy, false galvanic skin response feedback, and systematic desensitization in the modification of phobic behavior. Journal of Consulting and Clinical Psychology1975;43(4):557-67. ">Lick 1975</a> ; <a href="./references#MR000050-bbs2-0051" title="MatsonJL , MarchettiA , AdkinsJA .Comparison of operant- and independence-training procedures for mentally retarded adults. American Journal of Mental Deficiency1980;84(5):487-94. ">Matson 1980</a> ; <a href="./references#MR000050-bbs2-0065" title="PowersMB , SmitsJA , TelchMJ .Disentangling the effects of safety-behavior utilization and safety-behavior availability during exposure-based treatment: a placebo-controlled trial. Journal of Consulting and Clinical Psychology2004;72(3):448-54. ">Powers 2004</a> ; <a href="./references#MR000050-bbs2-0066" title="PowersMB , SmithsJA , WhitleyD , BystritskyA , TelchMJ .The effect of attributional processes concerning medication taking on return of fear. Journal of Consulting and Clinical Psychology2008;76(3):478-90. ">Powers 2008a</a> ; <a href="./references#MR000050-bbs2-0068" title="ProudfootJ , ClarkeJ , BirchMR , WhittonAE , ParkerG , ManicavasagarV , et al.Impact of a mobile phone and web program on symptom and functional outcomes for people with mild- to-moderate depression, anxiety and stress: a randomized controlled trial. BMC Psychiatry2013;13(312):1-12. ProudfootJ .Re: Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 26th of August 2019. ">Proudfoot 2013</a> ; <a href="./references#MR000050-bbs2-0069" title="QuayhagenMP , QuayhagenM , CorbeilRR , RothPA , RodgersJA .A dyadic remediation program for care recipients with dementia. Nursing Research1995;44(3):153-9. ">Quayhagen 1995</a> ; <a href="./references#MR000050-bbs2-0074" title="RoehrichL , GoldmanMS .Experience-dependent neuropsychological recovery and the treatment of alcoholism. Journal of Consulting and Clinical Psychology1993;61(5):812-21. ">Roehrich 1993</a> ; <a href="./references#MR000050-bbs2-0076" title="RosenGM , GlasgowRE , BarreraM .A controlled study to assess the clinical efficacy of totally self-administrated systematic desensitization. Journal of Consulting and Clinical Psychology1976;44(2):208-17. ">Rosen 1976</a> ; <a href="./references#MR000050-bbs2-0086" title="TeriL , LogsdonRG , UomotoJ , McCurrySM .Behavioral treatment of depression in dementia patients: a controlled clinical trial. Journals of Gerontology. Series B, Psychological Sciences and Social Sciences1997;52(4):159-66. TeriL .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 26th of August 2019. ">Teri 1997</a> ; <a href="./references#MR000050-bbs2-0089" title="AscherML , TurnerRM .A comparison of two methods for the administration of paradoxical intention. Behaviour Research and Therapy1980;18(2):121-6. TurnerRM , AscherLM .Controlled comparison of progressive relaxation, stimulus control, and paradoxical intention therapies for insomnia. Journal of Consulting and Clinical Psychology1979;47(3):500-8. ">Turner 1979</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Group treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>18</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#MR000050-bbs2-0004" title="AlvarezJR .The effects of anger management training on depression, anger, self-concept, and treatment responsibility in a sample of drug-dependent individuals in a therapeutic community. Dissertation Abstracts International: Section B: the Sciences and Engineering1997;58(4-B):2108. ">Alvarez 1997</a> ; <a href="./references#MR000050-bbs2-0006" title="AyenI , HautzingerM .Cognitive behavior therapy for depression in menopausal women. A controlled, randomized treatment study [Kognitive Verhaltenstherapie bei Depressionen im Klimakterium: Eine kontrollierte, randomiserte Interventionsstudie]. Zeitschrift für Klinische Psychologie und Psychotherapie2004;33(4):290-9. AyenI .Inclusion of study in Cochrane Systematic Review (personal communication). Email to EG Faltinsen 9th of September 2019. ">Ayen 2004</a> ; <a href="./references#MR000050-bbs2-0012" title="BramstonP , SpenceSH .Behavioural versus cognitive social-skills training with intellectually-handicapped adults. Behaviour Research and Therapy1985;23(3):239-46. ">Bramston 1985</a> ; <a href="./references#MR000050-bbs2-0019" title="Doty, DW.Role playing and incentives in the modification of the social interaction of chronic psychiatric patients. Journal of Consulting and Clinical Psychology1975;43(5):676-82. ">Doty 1975</a> ; <a href="./references#MR000050-bbs2-0027" title="FuchsCZ , RehnLP .A self-control behavior therapy program for depression. Journal of Consulting and Clinical Psychology1977;45(2):206-15. ">Fuchs 1977</a> ; <a href="./references#MR000050-bbs2-0030" title="GoldwasserAN , AuerbachSM , HarkinsSW .Cognitive, affective, and behavioural effects of reminiscence group therapy on demented elderly. Aging and Human Development1987;25(3):209-22. ">Goldwasser 1987</a> ; <a href="./references#MR000050-bbs2-0037" title="KilmannPR , MilanRJ , BolandJP , NankinHR , DavidsonE , WestMO , et al.Group treatment of secondary erectile dysfunction. Journal of Sex &amp; Marital Therapy1987;13(3):168-82. KilmannPR , Milan RJ Jr, BolandJP , DavidsonE , WestMO , SablisRF , et al.The sexual interactions of men with secondary erectile dysfunction. Journal of Sex Education and Therapy1988;14(1):46-9. KilmannPR , Milan RJ Jr, BolandJP , NankinHR , SablisRF , WestMO , et al.The sexual interactions of men with secondary erectile dysfunction. Paper presented at the annual meeting of the American Psychological Association in Los Angeles1985;1:46-9. ">Kilmann 1987</a> ; <a href="./references#MR000050-bbs2-0050" title="LiddleB , SpenceSH .Cognitive-behaviour therapy with depressed primary school children: A cautionary note. Behavioural Psychotherapy1990;18(2):85-102. ">Liddle 1990</a> ; <a href="./references#MR000050-bbs2-0055" title="MirandaA , ArlandisP , SorianoM .Instruction in strategies and attributional training: Effects on the problem-solving and self-concept of students’ with learning disabilities [Instrucción en estrategias y entrenamiento atribucional: efectos sobre la resolución de problemas y el autoconcepto de los estudiantes con dificultades en el aprendizaje]. Infancia y Aprendizaje1997;20(80):37-52. ">Miranda 1997</a> ; <a href="./references#MR000050-bbs2-0062" title="PedletonMG , HigginsRL .A comparison of negative practice and systematic desensitization in the treatment of acrophobia. Journal of Behavior Therapy and Experimental Psychiatry1983;14(4):317-23. ">Pendleton 1983</a> ; <a href="./references#MR000050-bbs2-0071" title="RapeeR .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 29th of August 2019. RapeeRM , AbbottMJ , LynehamHJ .Bibliotherapy for children With anxiety disorders using written materials for parents: a randomized controlled trial. Journal of Consulting and Clinical Psychology2006;74(3):436-44. ">Rapee 2006</a> ; <a href="./references#MR000050-bbs2-0072" title="RapeeR .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 29th of August 2019. RapeeRM , AbbottMJ , BaillieAJ , GastonJE .Treatment of social phobia through pure self-help and therapist-augmented self-help. British Journal of Psychiatry2007;191:246-52. ">Rapee 2007</a> ; <a href="./references#MR000050-bbs2-0075" title="OlivaresJ .Program IAFS. Protocol for the treatment of social phobia in adolescents [Programa IAFS. Protocolo para el tratamiento de la fobia social enadolescentes]. Madrid: Pirámide2005;1. Rosa-AlcázarAI , Olivares-OlivaresPJ , OlivaresJ .The role of non-specific effects in the psychological treatment of adolescents with social phobia [Papel de los efectos inespecíficos en el tratamiento psicológico de adolescentes con fobia social]. Anuario de Psicologia2009;40(1):43-61. ">Rosa‐Alcatraz 2009</a> ; <a href="./references#MR000050-bbs2-0083" title="SteinmarkSW , BorkovecTD .Active and placebo treatment effects on moderate insomnia under counterdemand and positive demand instructions. Journal of Abnormal Psychology1974;83(2):157-63. ">Steinmark 1974</a> ; <a href="./references#MR000050-bbs2-0084" title="SzymanskiJ , O'DonohueW .The potential role of state-dependent learning in cognitive therapy with spider phobics. Journal of Rational-Emotive &amp; Cognitive-Behavior Therapy1995;13(2):131-50. SzymanskiJ .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 20th of August 2019. ">Szymanski 1995</a> ; <a href="./references#MR000050-bbs2-0085" title="TanSY , BruniJ .Cognitive-behavior therapy with adult patients with epilepsy: a controlled outcome study. Epilepsia1986;27(3):225-33. ">Tan 1986</a> ; <a href="./references#MR000050-bbs2-0088" title="Trexler, L.Rational-emotive therapy, placebo, and no-treatment effects on public-speaking anxiety. Doctoral dissertation, Temple University AnnArbor, Mich.: University Microfilms1971;71-31(063). TrexlerLD , KarstTO .Rational-emotive therapy, placebo, and no-treatment effects on public-speaking anxiety. Journal of Abnormal Psyhology1972;79(1):60-7. ">Trexler 1972</a> ; <a href="./references#MR000050-bbs2-0096" title="WollersheimJP , WilsonGL .Group treatment of unipolar depression: a comparison of coping, supportive, bibliotherapy, and delayed treatment groups. Professional Psychology: Research and Practice1991;22(6):496-502. ">Wollersheim 1991</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Combined treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#MR000050-bbs2-0001" title="AbikoffH , HechtmanL , KleinRG .Social functioning in children with ADHD treated with long-term methylphenidate and multimodal psychosocial treatment. Journal of the American Academy of Child and Adolescent Psychiatry2004;43(7):820-9. AbikoffH .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to A Todorovac 23rd of August 2019. KleinRG , AbikoffH , HechtmanL , WeissG .Design and rationale of controlled study of long-term methylphenidate and multimodal psychosocial treatment in children with ADHD. Journal of the American Academy of Child and Adolescent Psychiatry2004;43(7):792-801. ">Abikoff 2004</a> ; <a href="./references#MR000050-bbs2-0009" title="BorkovecTD , KaloupekDG , SlamaKM .The facilitative effect of muscle tension-release in the relaxation treatment of sleep disturbance. Behavior Therapy1975;6(3):301-9. ">Borkovec 1975</a> ; <a href="./references#MR000050-bbs2-0010" title="BorkovecTD , WeertsTC .Effects of progressive relaxation on sleep disturbance: an electroencephalographic evaluation. Psychosomatic Medicine1976;38(3):173-80. ">Borkovec 1976</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Types of interventions</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Types of psychological placebos</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Interactional component in psychological placebo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>19</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#MR000050-bbs2-0001" title="AbikoffH , HechtmanL , KleinRG .Social functioning in children with ADHD treated with long-term methylphenidate and multimodal psychosocial treatment. Journal of the American Academy of Child and Adolescent Psychiatry2004;43(7):820-9. AbikoffH .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to A Todorovac 23rd of August 2019. KleinRG , AbikoffH , HechtmanL , WeissG .Design and rationale of controlled study of long-term methylphenidate and multimodal psychosocial treatment in children with ADHD. Journal of the American Academy of Child and Adolescent Psychiatry2004;43(7):792-801. ">Abikoff 2004</a> ; <a href="./references#MR000050-bbs2-0006" title="AyenI , HautzingerM .Cognitive behavior therapy for depression in menopausal women. A controlled, randomized treatment study [Kognitive Verhaltenstherapie bei Depressionen im Klimakterium: Eine kontrollierte, randomiserte Interventionsstudie]. Zeitschrift für Klinische Psychologie und Psychotherapie2004;33(4):290-9. AyenI .Inclusion of study in Cochrane Systematic Review (personal communication). Email to EG Faltinsen 9th of September 2019. ">Ayen 2004</a> ; <a href="./references#MR000050-bbs2-0012" title="BramstonP , SpenceSH .Behavioural versus cognitive social-skills training with intellectually-handicapped adults. Behaviour Research and Therapy1985;23(3):239-46. ">Bramston 1985</a> ; <a href="./references#MR000050-bbs2-0019" title="Doty, DW.Role playing and incentives in the modification of the social interaction of chronic psychiatric patients. Journal of Consulting and Clinical Psychology1975;43(5):676-82. ">Doty 1975</a> ; <a href="./references#MR000050-bbs2-0021" title="EhlersA , HackmannA , GreyN , WildJ , LinessS , AlbertI , et al.A randomized controlled trial of 7-day intensive and standard weekly cognitive therapy for PTSD and emotion-focused supportive therapy. American Journal of Psychiatry2014;171(3):294-304. ">Ehlers 2014</a> ; <a href="./references#MR000050-bbs2-0024" title="FoaEB , RothbaumBO , RiggsDS , MurdockTB .Treatment of posttraumatic stress disorder in rape victims: a comparison between cognitive-behavioral procedures and counselling. Journal of Consulting and Clinical Psychology1991;59(5):715-23. ">Foa 1991</a> ; <a href="./references#MR000050-bbs2-0025" title="FoaEB , McLeanCP , ZangY , RosenfieldD , YadinE , YarvisJS , et al.Effect of prolonged exposure therapy delivered over 2 weeks vs 8 weeks vs present-centered therapy on PTSD symptom severity in military personnel: a randomized clinical trial. JAMA2018;319(4):354-64. ">Foa 2018</a> ; <a href="./references#MR000050-bbs2-0027" title="FuchsCZ , RehnLP .A self-control behavior therapy program for depression. Journal of Consulting and Clinical Psychology1977;45(2):206-15. ">Fuchs 1977</a> ; <a href="./references#MR000050-bbs2-0030" title="GoldwasserAN , AuerbachSM , HarkinsSW .Cognitive, affective, and behavioural effects of reminiscence group therapy on demented elderly. Aging and Human Development1987;25(3):209-22. ">Goldwasser 1987</a> ; <a href="./references#MR000050-bbs2-0031" title="HekmatH , LubitzR , DealR .Semantic desensitization: a paradigmatic intervention approach to anxiety disorders. Journal of Clinical Psychology1984;40(2):463-6. ">Hekmat 1984</a> ; <a href="./references#MR000050-bbs2-0037" title="KilmannPR , MilanRJ , BolandJP , NankinHR , DavidsonE , WestMO , et al.Group treatment of secondary erectile dysfunction. Journal of Sex &amp; Marital Therapy1987;13(3):168-82. KilmannPR , Milan RJ Jr, BolandJP , DavidsonE , WestMO , SablisRF , et al.The sexual interactions of men with secondary erectile dysfunction. Journal of Sex Education and Therapy1988;14(1):46-9. KilmannPR , Milan RJ Jr, BolandJP , NankinHR , SablisRF , WestMO , et al.The sexual interactions of men with secondary erectile dysfunction. Paper presented at the annual meeting of the American Psychological Association in Los Angeles1985;1:46-9. ">Kilmann 1987</a> ; <a href="./references#MR000050-bbs2-0038" title="KleinSA , DeffenbacherJL .Relaxation and exercise for hyperactive impulsive children. Perceptual and Motor Skills1977;45:1159-62. ">Klein 1977</a> ; <a href="./references#MR000050-bbs2-0045" title="LaiCK , ChiI , Kayser-JonesJ .A randomized controlled trial of a specific reminiscence approach to promote the well-being of nursing home residents with dementia. International Psychogeriatrics2004;16(1):33-49. LaiK .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 6th of September 2019. ">Lai 2004</a> ; <a href="./references#MR000050-bbs2-0046" title="LangOJ , LazovikAD .Experimental desensitization of a phobia. Journal of Abnormal and Social Psychology1963;66:519-25. LangPJ , LazovikAD , ReynoldsDJ .Desensitization, suggestibility, and pseudotherapy. Journal of Abnormal Psychology1965;70(6):395-402. ">Lang 1965</a> ; <a href="./references#MR000050-bbs2-0068" title="ProudfootJ , ClarkeJ , BirchMR , WhittonAE , ParkerG , ManicavasagarV , et al.Impact of a mobile phone and web program on symptom and functional outcomes for people with mild- to-moderate depression, anxiety and stress: a randomized controlled trial. BMC Psychiatry2013;13(312):1-12. ProudfootJ .Re: Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 26th of August 2019. ">Proudfoot 2013</a> ; <a href="./references#MR000050-bbs2-0069" title="QuayhagenMP , QuayhagenM , CorbeilRR , RothPA , RodgersJA .A dyadic remediation program for care recipients with dementia. Nursing Research1995;44(3):153-9. ">Quayhagen 1995</a> ; <a href="./references#MR000050-bbs2-0075" title="OlivaresJ .Program IAFS. Protocol for the treatment of social phobia in adolescents [Programa IAFS. Protocolo para el tratamiento de la fobia social enadolescentes]. Madrid: Pirámide2005;1. Rosa-AlcázarAI , Olivares-OlivaresPJ , OlivaresJ .The role of non-specific effects in the psychological treatment of adolescents with social phobia [Papel de los efectos inespecíficos en el tratamiento psicológico de adolescentes con fobia social]. Anuario de Psicologia2009;40(1):43-61. ">Rosa‐Alcatraz 2009</a> ; <a href="./references#MR000050-bbs2-0080" title="ShealyRC .The effectiveness of various treatment techniques on different degrees and durations of sleep-onset insomnia. Behaviour Research and Therapy1979;17(6):541-6. ">Shealy 1979</a> ; <a href="./references#MR000050-bbs2-0085" title="TanSY , BruniJ .Cognitive-behavior therapy with adult patients with epilepsy: a controlled outcome study. Epilepsia1986;27(3):225-33. ">Tan 1986</a> ; <a href="./references#MR000050-bbs2-0096" title="WollersheimJP , WilsonGL .Group treatment of unipolar depression: a comparison of coping, supportive, bibliotherapy, and delayed treatment groups. Professional Psychology: Research and Practice1991;22(6):496-502. ">Wollersheim 1991</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Psychoeducational component in psychological placebo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#MR000050-bbs2-0004" title="AlvarezJR .The effects of anger management training on depression, anger, self-concept, and treatment responsibility in a sample of drug-dependent individuals in a therapeutic community. Dissertation Abstracts International: Section B: the Sciences and Engineering1997;58(4-B):2108. ">Alvarez 1997</a> ; <a href="./references#MR000050-bbs2-0011" title="BornovalovaM .Inclusion of study in Cochrane Systematic Review (personal communication). Email to A Todorovac. 21st of August 2019. BornovalovaMA .Distress tolerance treatment for inner-city drug users: a preliminary trial. Doctor’s Dissertation, University of Maryland2008. ">Bornovalova 2008</a> ; <a href="./references#MR000050-bbs2-0016" title="CarterJC , OlmstedMP , KaplanAS , McCabeRE , MillsJS , AimeA .Self-help for bulimia nervosa: a randomized controlled trial. American Journal of Psychiatry2003;160(5):973-8. ">Carter 2003</a> ; <a href="./references#MR000050-bbs2-0032" title="HippmanC , RingroseA , InglisA , CheekJ , AlbertAY , RemickR , et al.A pilot randomized clinical trial evaluating the impact of genetic counselling for serious mental illnesses. Journal of Clinical Psychiatry2016;77(2):e190-8. ">Hippman 2016</a> ; <a href="./references#MR000050-bbs2-0050" title="LiddleB , SpenceSH .Cognitive-behaviour therapy with depressed primary school children: A cautionary note. Behavioural Psychotherapy1990;18(2):85-102. ">Liddle 1990</a> ; <a href="./references#MR000050-bbs2-0055" title="MirandaA , ArlandisP , SorianoM .Instruction in strategies and attributional training: Effects on the problem-solving and self-concept of students’ with learning disabilities [Instrucción en estrategias y entrenamiento atribucional: efectos sobre la resolución de problemas y el autoconcepto de los estudiantes con dificultades en el aprendizaje]. Infancia y Aprendizaje1997;20(80):37-52. ">Miranda 1997</a> ; <a href="./references#MR000050-bbs2-0074" title="RoehrichL , GoldmanMS .Experience-dependent neuropsychological recovery and the treatment of alcoholism. Journal of Consulting and Clinical Psychology1993;61(5):812-21. ">Roehrich 1993</a> ; <a href="./references#MR000050-bbs2-0076" title="RosenGM , GlasgowRE , BarreraM .A controlled study to assess the clinical efficacy of totally self-administrated systematic desensitization. Journal of Consulting and Clinical Psychology1976;44(2):208-17. ">Rosen 1976</a> ; <a href="./references#MR000050-bbs2-0084" title="SzymanskiJ , O'DonohueW .The potential role of state-dependent learning in cognitive therapy with spider phobics. Journal of Rational-Emotive &amp; Cognitive-Behavior Therapy1995;13(2):131-50. SzymanskiJ .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 20th of August 2019. ">Szymanski 1995</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Exposure component in psychological placebo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>16</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#MR000050-bbs2-0005" title="AscherLM , TurnerR .Paradoxical intention and insomnia: an experimental investigation. Behaviour Research and Therapy1979;17(4):408-11. ">Ascher 1979</a> ; <a href="./references#MR000050-bbs2-0009" title="BorkovecTD , KaloupekDG , SlamaKM .The facilitative effect of muscle tension-release in the relaxation treatment of sleep disturbance. Behavior Therapy1975;6(3):301-9. ">Borkovec 1975</a> ; <a href="./references#MR000050-bbs2-0010" title="BorkovecTD , WeertsTC .Effects of progressive relaxation on sleep disturbance: an electroencephalographic evaluation. Psychosomatic Medicine1976;38(3):173-80. ">Borkovec 1976</a> ; <a href="./references#MR000050-bbs2-0022" title="EspieCA , BrooksDN , LindsayWR .An evaluation of tailored psychological treatment of insomnia. Journal of Behavior Therapy and Experimental Psychiatry1989;20(2):143-53. EspieCA , LindsayWR , BrooksDN , HoodEM , TurveyT .A controlled comparative investigation of psychological treatments for chronic sleep-onset insomnia. Behaviour Research and Therapy1989;27(1):79-88. ">Espie 1989a</a> ; <a href="./references#MR000050-bbs2-0023" title="EtringerBD , CashTF , RimmDC .Behavioral, affective, and cognitive effects of participant modeling and an equally credible placebo. Behavior Therapy1982;13(4):476-85. ">Etringer 1982</a> ; <a href="./references#MR000050-bbs2-0029" title="GoldsteinAJ , BeursE , Chambless Dl, WilsonKA .EMDR for panic disorder with agoraphobia: comparison with waiting list and credible attention-placebo control conditions. Journal of Consulting and Clinical Psychology2000;68(6):947-56. ">Goldstein 2000</a> ; <a href="./references#MR000050-bbs2-0036" title="KennedyTD , KimuraHK .Transfer, behavioral improvement, and anxiety reduction in systematic desensitization. Journal of Consulting and Clinical Psychology1974;42(5):720-8. ">Kennedy 1974</a> ; <a href="./references#MR000050-bbs2-0042" title="KrapflJE , NawasMM .Differential ordering of stimulus presentation in systematic desensitization. Journal of Abnormal Psychology1970;75(3):333-7. ">Krapfl 1970</a> ; <a href="./references#MR000050-bbs2-0048" title="LickJ .Expectancy, false galvanic skin response feedback, and systematic desensitization in the modification of phobic behavior. Journal of Consulting and Clinical Psychology1975;43(4):557-67. ">Lick 1975</a> ; <a href="./references#MR000050-bbs2-0053" title="MealieaWL , NawasMM .The comparative effectiveness of systematic desensitization and implosive therapy in the treatment of snake phobia. Journal of Behavior Therapy and Experimental Psychiatry1971;2(2):85-94. ">Mealiea 1971</a> ; <a href="./references#MR000050-bbs2-0062" title="PedletonMG , HigginsRL .A comparison of negative practice and systematic desensitization in the treatment of acrophobia. Journal of Behavior Therapy and Experimental Psychiatry1983;14(4):317-23. ">Pendleton 1983</a> ; <a href="./references#MR000050-bbs2-0065" title="PowersMB , SmitsJA , TelchMJ .Disentangling the effects of safety-behavior utilization and safety-behavior availability during exposure-based treatment: a placebo-controlled trial. Journal of Consulting and Clinical Psychology2004;72(3):448-54. ">Powers 2004</a> ; <a href="./references#MR000050-bbs2-0066" title="PowersMB , SmithsJA , WhitleyD , BystritskyA , TelchMJ .The effect of attributional processes concerning medication taking on return of fear. Journal of Consulting and Clinical Psychology2008;76(3):478-90. ">Powers 2008a</a> ; <a href="./references#MR000050-bbs2-0083" title="SteinmarkSW , BorkovecTD .Active and placebo treatment effects on moderate insomnia under counterdemand and positive demand instructions. Journal of Abnormal Psychology1974;83(2):157-63. ">Steinmark 1974</a> ; <a href="./references#MR000050-bbs2-0088" title="Trexler, L.Rational-emotive therapy, placebo, and no-treatment effects on public-speaking anxiety. Doctoral dissertation, Temple University AnnArbor, Mich.: University Microfilms1971;71-31(063). TrexlerLD , KarstTO .Rational-emotive therapy, placebo, and no-treatment effects on public-speaking anxiety. Journal of Abnormal Psyhology1972;79(1):60-7. ">Trexler 1972</a> ; <a href="./references#MR000050-bbs2-0089" title="AscherML , TurnerRM .A comparison of two methods for the administration of paradoxical intention. Behaviour Research and Therapy1980;18(2):121-6. TurnerRM , AscherLM .Controlled comparison of progressive relaxation, stimulus control, and paradoxical intention therapies for insomnia. Journal of Consulting and Clinical Psychology1979;47(3):500-8. ">Turner 1979</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Labels for psychological placebo</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Attention placebo control</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#MR000050-bbs2-0001" title="AbikoffH , HechtmanL , KleinRG .Social functioning in children with ADHD treated with long-term methylphenidate and multimodal psychosocial treatment. Journal of the American Academy of Child and Adolescent Psychiatry2004;43(7):820-9. AbikoffH .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to A Todorovac 23rd of August 2019. KleinRG , AbikoffH , HechtmanL , WeissG .Design and rationale of controlled study of long-term methylphenidate and multimodal psychosocial treatment in children with ADHD. Journal of the American Academy of Child and Adolescent Psychiatry2004;43(7):792-801. ">Abikoff 2004</a> ; <a href="./references#MR000050-bbs2-0004" title="AlvarezJR .The effects of anger management training on depression, anger, self-concept, and treatment responsibility in a sample of drug-dependent individuals in a therapeutic community. Dissertation Abstracts International: Section B: the Sciences and Engineering1997;58(4-B):2108. ">Alvarez 1997</a> ; <a href="./references#MR000050-bbs2-0012" title="BramstonP , SpenceSH .Behavioural versus cognitive social-skills training with intellectually-handicapped adults. Behaviour Research and Therapy1985;23(3):239-46. ">Bramston 1985</a> ; <a href="./references#MR000050-bbs2-0029" title="GoldsteinAJ , BeursE , Chambless Dl, WilsonKA .EMDR for panic disorder with agoraphobia: comparison with waiting list and credible attention-placebo control conditions. Journal of Consulting and Clinical Psychology2000;68(6):947-56. ">Goldstein 2000</a> ; <a href="./references#MR000050-bbs2-0030" title="GoldwasserAN , AuerbachSM , HarkinsSW .Cognitive, affective, and behavioural effects of reminiscence group therapy on demented elderly. Aging and Human Development1987;25(3):209-22. ">Goldwasser 1987</a> ; <a href="./references#MR000050-bbs2-0031" title="HekmatH , LubitzR , DealR .Semantic desensitization: a paradigmatic intervention approach to anxiety disorders. Journal of Clinical Psychology1984;40(2):463-6. ">Hekmat 1984</a> ; <a href="./references#MR000050-bbs2-0037" title="KilmannPR , MilanRJ , BolandJP , NankinHR , DavidsonE , WestMO , et al.Group treatment of secondary erectile dysfunction. Journal of Sex &amp; Marital Therapy1987;13(3):168-82. KilmannPR , Milan RJ Jr, BolandJP , DavidsonE , WestMO , SablisRF , et al.The sexual interactions of men with secondary erectile dysfunction. Journal of Sex Education and Therapy1988;14(1):46-9. KilmannPR , Milan RJ Jr, BolandJP , NankinHR , SablisRF , WestMO , et al.The sexual interactions of men with secondary erectile dysfunction. Paper presented at the annual meeting of the American Psychological Association in Los Angeles1985;1:46-9. ">Kilmann 1987</a> ; <a href="./references#MR000050-bbs2-0038" title="KleinSA , DeffenbacherJL .Relaxation and exercise for hyperactive impulsive children. Perceptual and Motor Skills1977;45:1159-62. ">Klein 1977</a> ; <a href="./references#MR000050-bbs2-0050" title="LiddleB , SpenceSH .Cognitive-behaviour therapy with depressed primary school children: A cautionary note. Behavioural Psychotherapy1990;18(2):85-102. ">Liddle 1990</a> ; <a href="./references#MR000050-bbs2-0060" title="PeckCL .Desensitization for the treatment of fear in the high level adult retardate. Behaviour Research and Therapy1977;15(2):137-48. ">Peck 1976</a> ; <a href="./references#MR000050-bbs2-0085" title="TanSY , BruniJ .Cognitive-behavior therapy with adult patients with epilepsy: a controlled outcome study. Epilepsia1986;27(3):225-33. ">Tan 1986</a> ; <a href="./references#MR000050-bbs2-0088" title="Trexler, L.Rational-emotive therapy, placebo, and no-treatment effects on public-speaking anxiety. Doctoral dissertation, Temple University AnnArbor, Mich.: University Microfilms1971;71-31(063). TrexlerLD , KarstTO .Rational-emotive therapy, placebo, and no-treatment effects on public-speaking anxiety. Journal of Abnormal Psyhology1972;79(1):60-7. ">Trexler 1972</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Non‐specific placebo counselling or treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>11</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#MR000050-bbs2-0006" title="AyenI , HautzingerM .Cognitive behavior therapy for depression in menopausal women. A controlled, randomized treatment study [Kognitive Verhaltenstherapie bei Depressionen im Klimakterium: Eine kontrollierte, randomiserte Interventionsstudie]. Zeitschrift für Klinische Psychologie und Psychotherapie2004;33(4):290-9. AyenI .Inclusion of study in Cochrane Systematic Review (personal communication). Email to EG Faltinsen 9th of September 2019. ">Ayen 2004</a> ; <a href="./references#MR000050-bbs2-0011" title="BornovalovaM .Inclusion of study in Cochrane Systematic Review (personal communication). Email to A Todorovac. 21st of August 2019. BornovalovaMA .Distress tolerance treatment for inner-city drug users: a preliminary trial. Doctor’s Dissertation, University of Maryland2008. ">Bornovalova 2008</a> ; <a href="./references#MR000050-bbs2-0019" title="Doty, DW.Role playing and incentives in the modification of the social interaction of chronic psychiatric patients. Journal of Consulting and Clinical Psychology1975;43(5):676-82. ">Doty 1975</a> ; <a href="./references#MR000050-bbs2-0024" title="FoaEB , RothbaumBO , RiggsDS , MurdockTB .Treatment of posttraumatic stress disorder in rape victims: a comparison between cognitive-behavioral procedures and counselling. Journal of Consulting and Clinical Psychology1991;59(5):715-23. ">Foa 1991</a> ; <a href="./references#MR000050-bbs2-0027" title="FuchsCZ , RehnLP .A self-control behavior therapy program for depression. Journal of Consulting and Clinical Psychology1977;45(2):206-15. ">Fuchs 1977</a> ; <a href="./references#MR000050-bbs2-0045" title="LaiCK , ChiI , Kayser-JonesJ .A randomized controlled trial of a specific reminiscence approach to promote the well-being of nursing home residents with dementia. International Psychogeriatrics2004;16(1):33-49. LaiK .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 6th of September 2019. ">Lai 2004</a> ; <a href="./references#MR000050-bbs2-0046" title="LangOJ , LazovikAD .Experimental desensitization of a phobia. Journal of Abnormal and Social Psychology1963;66:519-25. LangPJ , LazovikAD , ReynoldsDJ .Desensitization, suggestibility, and pseudotherapy. Journal of Abnormal Psychology1965;70(6):395-402. ">Lang 1965</a> ; <a href="./references#MR000050-bbs2-0053" title="MealieaWL , NawasMM .The comparative effectiveness of systematic desensitization and implosive therapy in the treatment of snake phobia. Journal of Behavior Therapy and Experimental Psychiatry1971;2(2):85-94. ">Mealiea 1971</a> ; <a href="./references#MR000050-bbs2-0062" title="PedletonMG , HigginsRL .A comparison of negative practice and systematic desensitization in the treatment of acrophobia. Journal of Behavior Therapy and Experimental Psychiatry1983;14(4):317-23. ">Pendleton 1983</a> ; <a href="./references#MR000050-bbs2-0076" title="RosenGM , GlasgowRE , BarreraM .A controlled study to assess the clinical efficacy of totally self-administrated systematic desensitization. Journal of Consulting and Clinical Psychology1976;44(2):208-17. ">Rosen 1976</a> ; <a href="./references#MR000050-bbs2-0096" title="WollersheimJP , WilsonGL .Group treatment of unipolar depression: a comparison of coping, supportive, bibliotherapy, and delayed treatment groups. Professional Psychology: Research and Practice1991;22(6):496-502. ">Wollersheim 1991</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Non‐specific educational placebo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#MR000050-bbs2-0016" title="CarterJC , OlmstedMP , KaplanAS , McCabeRE , MillsJS , AimeA .Self-help for bulimia nervosa: a randomized controlled trial. American Journal of Psychiatry2003;160(5):973-8. ">Carter 2003</a> ; <a href="./references#MR000050-bbs2-0032" title="HippmanC , RingroseA , InglisA , CheekJ , AlbertAY , RemickR , et al.A pilot randomized clinical trial evaluating the impact of genetic counselling for serious mental illnesses. Journal of Clinical Psychiatry2016;77(2):e190-8. ">Hippman 2016</a> ; <a href="./references#MR000050-bbs2-0074" title="RoehrichL , GoldmanMS .Experience-dependent neuropsychological recovery and the treatment of alcoholism. Journal of Consulting and Clinical Psychology1993;61(5):812-21. ">Roehrich 1993</a> ; <a href="./references#MR000050-bbs2-0084" title="SzymanskiJ , O'DonohueW .The potential role of state-dependent learning in cognitive therapy with spider phobics. Journal of Rational-Emotive &amp; Cognitive-Behavior Therapy1995;13(2):131-50. SzymanskiJ .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 20th of August 2019. ">Szymanski 1995</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Quasi‐desensitization placebo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#MR000050-bbs2-0005" title="AscherLM , TurnerR .Paradoxical intention and insomnia: an experimental investigation. Behaviour Research and Therapy1979;17(4):408-11. ">Ascher 1979</a> ; <a href="./references#MR000050-bbs2-0009" title="BorkovecTD , KaloupekDG , SlamaKM .The facilitative effect of muscle tension-release in the relaxation treatment of sleep disturbance. Behavior Therapy1975;6(3):301-9. ">Borkovec 1975</a> ; <a href="./references#MR000050-bbs2-0010" title="BorkovecTD , WeertsTC .Effects of progressive relaxation on sleep disturbance: an electroencephalographic evaluation. Psychosomatic Medicine1976;38(3):173-80. ">Borkovec 1976</a> ; <a href="./references#MR000050-bbs2-0036" title="KennedyTD , KimuraHK .Transfer, behavioral improvement, and anxiety reduction in systematic desensitization. Journal of Consulting and Clinical Psychology1974;42(5):720-8. ">Kennedy 1974</a> ; <a href="./references#MR000050-bbs2-0042" title="KrapflJE , NawasMM .Differential ordering of stimulus presentation in systematic desensitization. Journal of Abnormal Psychology1970;75(3):333-7. ">Krapfl 1970</a> ; <a href="./references#MR000050-bbs2-0083" title="SteinmarkSW , BorkovecTD .Active and placebo treatment effects on moderate insomnia under counterdemand and positive demand instructions. Journal of Abnormal Psychology1974;83(2):157-63. ">Steinmark 1974</a> ; <a href="./references#MR000050-bbs2-0089" title="AscherML , TurnerRM .A comparison of two methods for the administration of paradoxical intention. Behaviour Research and Therapy1980;18(2):121-6. TurnerRM , AscherLM .Controlled comparison of progressive relaxation, stimulus control, and paradoxical intention therapies for insomnia. Journal of Consulting and Clinical Psychology1979;47(3):500-8. ">Turner 1979</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Standarised psychological placebo (e.g. present‐centred therapy or emotion‐focused supportive therapy) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#MR000050-bbs2-0021" title="EhlersA , HackmannA , GreyN , WildJ , LinessS , AlbertI , et al.A randomized controlled trial of 7-day intensive and standard weekly cognitive therapy for PTSD and emotion-focused supportive therapy. American Journal of Psychiatry2014;171(3):294-304. ">Ehlers 2014</a> ; <a href="./references#MR000050-bbs2-0025" title="FoaEB , McLeanCP , ZangY , RosenfieldD , YadinE , YarvisJS , et al.Effect of prolonged exposure therapy delivered over 2 weeks vs 8 weeks vs present-centered therapy on PTSD symptom severity in military personnel: a randomized clinical trial. JAMA2018;319(4):354-64. ">Foa 2018</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Credible placebos or imagery relief placebo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#MR000050-bbs2-0023" title="EtringerBD , CashTF , RimmDC .Behavioral, affective, and cognitive effects of participant modeling and an equally credible placebo. Behavior Therapy1982;13(4):476-85. ">Etringer 1982</a> ; <a href="./references#MR000050-bbs2-0048" title="LickJ .Expectancy, false galvanic skin response feedback, and systematic desensitization in the modification of phobic behavior. Journal of Consulting and Clinical Psychology1975;43(4):557-67. ">Lick 1975</a> ; <a href="./references#MR000050-bbs2-0055" title="MirandaA , ArlandisP , SorianoM .Instruction in strategies and attributional training: Effects on the problem-solving and self-concept of students’ with learning disabilities [Instrucción en estrategias y entrenamiento atribucional: efectos sobre la resolución de problemas y el autoconcepto de los estudiantes con dificultades en el aprendizaje]. Infancia y Aprendizaje1997;20(80):37-52. ">Miranda 1997</a> ; <a href="./references#MR000050-bbs2-0065" title="PowersMB , SmitsJA , TelchMJ .Disentangling the effects of safety-behavior utilization and safety-behavior availability during exposure-based treatment: a placebo-controlled trial. Journal of Consulting and Clinical Psychology2004;72(3):448-54. ">Powers 2004</a> ; <a href="./references#MR000050-bbs2-0066" title="PowersMB , SmithsJA , WhitleyD , BystritskyA , TelchMJ .The effect of attributional processes concerning medication taking on return of fear. Journal of Consulting and Clinical Psychology2008;76(3):478-90. ">Powers 2008a</a> ; <a href="./references#MR000050-bbs2-0069" title="QuayhagenMP , QuayhagenM , CorbeilRR , RothPA , RodgersJA .A dyadic remediation program for care recipients with dementia. Nursing Research1995;44(3):153-9. ">Quayhagen 1995</a> ; <a href="./references#MR000050-bbs2-0075" title="OlivaresJ .Program IAFS. Protocol for the treatment of social phobia in adolescents [Programa IAFS. Protocolo para el tratamiento de la fobia social enadolescentes]. Madrid: Pirámide2005;1. Rosa-AlcázarAI , Olivares-OlivaresPJ , OlivaresJ .The role of non-specific effects in the psychological treatment of adolescents with social phobia [Papel de los efectos inespecíficos en el tratamiento psicológico de adolescentes con fobia social]. Anuario de Psicologia2009;40(1):43-61. ">Rosa‐Alcatraz 2009</a> ; <a href="./references#MR000050-bbs2-0080" title="ShealyRC .The effectiveness of various treatment techniques on different degrees and durations of sleep-onset insomnia. Behaviour Research and Therapy1979;17(6):541-6. ">Shealy 1979</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Labels for pharmacological placebos</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Placebo pill</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>16</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#MR000050-bbs2-0008" title="Borden, KA.Attributional Outcomes: the Subtle Messages of Treatments for Attention Deficit Disorder. Dissertation, University of Illinois at Urbana-Champaign1986. BordenKA , BrownRT .Attributional outcomes: The subtle messages of treatments for attention deficit disorder. Cognitive Therapy and Research1989;13(2):147-60. ">Borden 1986</a> ; <a href="./references#MR000050-bbs2-0013" title="BrillNQ , KoeglerRR , EpsteinLJ , ForgyEW .Controlled study of psychiatric outpatient treatment. Archives of General Psychiatry1964;10:581-95. BrillNQ .Results of psychotherapy. California Medicine1966;104(4):249-53. ">Brill 1964a</a> ; <a href="./references#MR000050-bbs2-0015" title="CarlsonCL , PelhamWE , MilichR , HozaB .ADHD boys’ performance and attributions following success and failure: drug effects and individual differences. Cognitive Therapy and Research1993;17:269-87. ">Carlson 1993</a> ; <a href="./references#MR000050-bbs2-0018" title="CrouchG , RobsonM , HallstromC .Benzodiazepine dependent patients and their psychological treatment. Progress in Neuro-psychopharmacology &amp; Biological Psychiatry1988;12(4):503-10. HallströmC , CrouchG , RobsenM , ShineP .The treatment of tranquillizer dependence by propranolol. Postgraduate Medical Journal1988;64(Suppl 2):40-4. ">Crouch 1988</a> ; <a href="./references#MR000050-bbs2-0020" title="DoubleDB , WarrenGC , EvansM , RowlandsMP .Efficacy of maintenance use of anticholinergic agents. Acta Psychiatrica Scandinavica1993;88:381-4. ">Double 1993</a> ; <a href="./references#MR000050-bbs2-0035" title="KelleyJ .Inclusion of study in Cochrane Systematic Review (personal communication). Email to: A Todorovac 12th of August 2019. KelleyJM , KaptchukTJ , CusinC , LipkinS , FavaM .Open-label placebo for major depressive disorder: a pilot randomized controlled trial. Psychotherapy and Psychosomatics2012;81(5):312-4. ">Kelley 2012</a> ; <a href="./references#MR000050-bbs2-0041" title="KloskoJS , BarlowDH , TassinariR , CernyJA .A comparison of alprazolam and behavior therapy in treatment of panic disorder: correction. Journal of Psychotherapy Practice and Research1994;3(2):163-79. KloskoJS , BarlowDH , TassinariR , CernyJA .A comparison of alprazolam and behavior therapy in treatment of panic disorder. Journal of Consulting and Clinical Psychology1990;58(1):77-84. ">Klosko 1990</a> ; <a href="./references#MR000050-bbs2-0052" title="McLachlanDR , DaltonAJ , KruckTP , BellMY , SmithWL , KalowW , et al.Intramuscular desferrioxamine in patients with Alzheimer's disease. Lancet1991;337(8753):1304-8. McLachlanDRC , SmithWL , KruckTP .Desferrioxamine and Alzheimer’s disease: video home behavior assessment of clinical course and measures of brain aluminum. Therapeutic Drug Monitoring1993;15(6):602-7. ">McLachlan 1991</a> ; <a href="./references#MR000050-bbs2-0057" title="NandiDN , AjmanyS , GanguliH , BanerjeeG , BoralGC , GhoshA , et al.A clinical evaluation of depressives found in a rural survey in India. British Journal of Psychiatry1976;128:523-7. ">Nandi 1976</a> ; <a href="./references#MR000050-bbs2-0061" title="MilichR , CarlsonCL , Pelham WE Jr, LichtBG .Effects of methylphenidate on the persistence of ADHD boys following failure experiences. Journal of Abnormal Child Psychology1991;19(5):519-36. PelhamWE , MurphyDA , VannattaK , MilichR , LichtBG , GnagyEM , et al.Methylphenidate and attributions in boys with attention-deficit hyperactivity disorder. Journal of Consulting and Clinical Psychology1992;60(2):282-92. ">Pelham 1992</a> ; <a href="./references#MR000050-bbs2-0070" title="LiebowitzM , QuitkinFM , StewartJW , McGrathPJ , HarrisonWM , MarkowitzJS , et al.Antidepressant efficacy in atypical depression. Archives of General Psychiatry1988;45(2):129-37. QuitkinFM , McGrathPJ , StewartJW , HarrisonW , WagerSG , NunesE , et al.Phenelzine and imipramine in mood reactive depressives: further delineation of the syndrome of atypical depression. Archives of General Psychiatry1989;46(9):787-93. RabkinJG , McGrathPJ , QuitkinFM , TricamoE , StewartJW , KleinDF .Effects of pill-giving on maintenance of placebo response in patients with chronic mild depression. American Journal of Psychiatry1990;147(12):1622-6. ">Rabkin 1990</a> ; <a href="./references#MR000050-bbs2-0077" title="LorrM , McNairDM , WeinsteinGJ .Early effects of chlordiazepoxide (Librium) used with psychotherapy. Journal of Psychiatric Research1963;1:257-70. RothI , RhudickPJ , ShaskanDA , SlobinMS , WilkinsonAE , YoungHH .Long-term effects on psychotherapy of initial treatment conditions. Journal of Psychiatric Research1964;2:283-97. ">Roth 1964</a> ; <a href="./references#MR000050-bbs2-0079" title="ShalevAY , AnkriY , Isreali-ShalevY , PelegT , AdesskyR , FreedmanS .Prevention of posttraumatic stress disorder by early treatment. Archives of General Psychiatry2012;69(2):166-76. ">Shalev 2012</a> ; <a href="./references#MR000050-bbs2-0081" title="SibilioJP , AndrewG , DartD , MooreKB , StehmanA .Treatment of chronic schizophrenia with promazine hydrochloride. AMA Archives of Neurology and Psychiatry1957;78(4):419-24. ">Sibilio 1957</a> ; <a href="./references#MR000050-bbs2-0082" title="SommernessMD , LuceroRJ , HamlonJS , EricksonJL , MatthewsR .A controlled study of reserpine on chronically disturbed patients. JAMA Archives of Neurology and Psychiatry1955;74(3):316-9. ">Sommerness 1955</a> ; <a href="./references#MR000050-bbs2-0093" title="WhittakerCB , HoyRM .Withdrawal of perphenazine in chronic schizophrenia. British Journal of Psychiatry1963;109:422-7. ">Whittaker 1963</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Implants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#MR000050-bbs2-0094" title="WilsonA , DavidsonWJ , BlanchardR , WhiteJ .Disulfiram implantation. A placebo-controlled trial with two-year follow-up. Journal of Studies on Alcohol1978;39(5):809-19. WilsonA , DavidsonWJ , BlanchardR .Disulfiram implantation: a trial using placebo implants and two types of controls. Journal of Studies on Alcohol1980;41(5):429-36. ">Wilson 1980</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Injection</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#MR000050-bbs2-0091" title="WatzlH , RistF , OlbrichR , CohenR .Placebo injections and surveillance of alcohol intake during inpatient treatment of female alcoholics. Addictive Behaviors1988;13(2):197-200. ">Watzl 1988</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Psychological treatment and pharmacological placebo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#MR000050-bbs2-0007" title="BergI , ForsytheI , HoltP , WattsJ .A controlled trial of ‘Senokot’ in faecal soiling treated by behavioural methods. Journal of Child Psychology and Psychiatry1983;24(4):543-9. ">Berg 1983</a> ; <a href="./references#MR000050-bbs2-0039" title="KlermanGL , DimascioA , WeismannM , PrusoffB , PaykelES .Treatment of depression by drugs and psychotherapy. American Journal of Psychiatry1974;131(2):186-91. PaykelES , DimascioA , HaskellD , PrusoffBA .Effects of maintenance amitriptyline and psychotherapy on symptoms of depression. Psychological Medicine1975;5(1):67-77. PaykelES , DiMascioA , KlermanGL , PrusoffBA .Maintenance therapy of depression. Pharmakopsychiatrie, Neuro-Psychopharmakologie1976;9:127-39. PaykelES , WeissmanMM , PrusoffBA .Social maladjustment and severity of depression. Comprehensive Psychiatry1978;19(2):121-8. WeissmanMM , KlermanGL , PaykelES , PrusoffB .Treatment effects on the social adjustment of depressed patients. Archives of General Psychiatry1974;30:771-8. ">Klerman 1974a</a> ; <a href="./references#MR000050-bbs2-0040" title="KlermanGL , DimascioA , WeismannM , PrusoffB , PaykelES .Treatment of depression by drugs and psychotherapy. American Journal of Psychiatry1974;131(2):186-91. ">Klerman 1974b</a> ; <a href="./references#MR000050-bbs2-0067" title="PowersMB , SmithsJA , WhitleyD , BystritskyA , TelchMJ .The effect of attributional processes concerning medication taking on return of fear. Journal of Consulting and Clinical Psychology2008;76(3):478-90. ">Powers 2008b</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Labels for physical placebos</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Acupuncture or acupressure</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#MR000050-bbs2-0002" title="AllenJB .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to A Todorovac 28th of August 2019. AllenJJ , SchnyerRN , HittSK .The efficacy of acupuncture in the treatment of major depression in women. Psychological Science1998;9(5):397-401. ">Allen 1998</a> ; <a href="./references#MR000050-bbs2-0003" title="AllenJB .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 28th of August 2019. AllenJJ , SchnyerRN , ChambersAS , HittSK , MorenoFA , ManberR .Acupuncture for depression: a randomized controlled trial. Journal of Clinical Psychiatry2006;67(11):1665-73. ">Allen 2006</a> ; <a href="./references#MR000050-bbs2-0026" title="FreireAO , SugaiGC , ChrispinFS , TogeiroSM , YamamuraY , MelloLE , et al.Treatment of moderate obstructive sleep apnea syndrome with acupuncture: a randomised, placebo-controlled pilot trial. Sleep Medicine2007;8(1):43-50. ">Freire 2007</a> ; <a href="./references#MR000050-bbs2-0034" title="KarstM , WinterhalterM , MünteS , FranckiB , HondronikosA , EckardtA , et al.Auricular acupuncture for dental anxiety: a randomized controlled trial. Anesthesia and Analgesia2007;104(2):295-300. KarstM .Inclusion of study in Cochrane Systematic Review (personal communication). Email to: EG Faltinsen 5th of September 2019. ">Karst 2007</a> ; <a href="./references#MR000050-bbs2-0043" title="KwanR .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 26th of August 2019. KwanRY , LeungMC , LaiCK .Acupressure for agitation in nursing home residents with dementia: study protocol for a randomized controlled trial. Trials2014;15(410):1-7. KwanRY , LeungMCP , LaiCK .A randomized controlled trial examining the effect of acupressure on agitation and salivary cortisol in nursing home residents with dementia. Dementia and Geriatric Cognitive Disorders2017;44(1-2):92-104. ">Kwan 2017</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Electromagnetic stimulation</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#MR000050-bbs2-0048" title="LickJ .Expectancy, false galvanic skin response feedback, and systematic desensitization in the modification of phobic behavior. Journal of Consulting and Clinical Psychology1975;43(4):557-67. ">Lick 1975</a> ; <a href="./references#MR000050-bbs2-0092" title="WeingaertnerAH .Self-administered aversive stimulation with hallucinating hospitalized schizophrenics. Journal of Consulting and Clinical Psychology1971;36(3):422-29. ">Weingaertner 1971</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Exercise and relaxation</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#MR000050-bbs2-0044" title="LacyMK .The effect of short term autogenic training on the stress reactivity of hospitalized emotionally disturbed adolescents. ProQuest Dissertations Publishing, Oklahoma State University1996. ">Lacy 1990</a> ; <a href="./references#MR000050-bbs2-0047" title="LegrandF .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 14th of August 2019. LegrandFD , NeffEM .Efficacy of exercise as an adjunct treatment for clinically depressed inpatients during the initial stages of antidepressant pharmacotherapy: an open randomized controlled trial. Journal of Affective Disorders2016;191:139-44. ">Legrand 2016</a> ; <a href="./references#MR000050-bbs2-0058" title="NicassioP , BootzinR .A comparison of progressive relaxation and autogenic training as treatments for insomnia. Journal of Abnormal Psychology1974;83(3):253-60. ">Nicassio 1974</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Technical device</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#MR000050-bbs2-0056" title="MitchellC , MansfieldD , RautenbachS .Coloured filters and reading accuracy, comprehension and rate: a placebo-controlled study. Perceptual and Motor Skills2008;106(2):517-32. ">Mitchell 2008</a> ; <a href="./references#MR000050-bbs2-0063" title="PetersonMA , PattersonB , PillmanBM , BattistaMA .Cognitive recovery following alcohol detoxification: a computerised remediation study. Neuropsychological Rehabilitation2002;12(1):63-74. PillmanBM .Computerized cognitive remediation with recently detoxified alcoholics. Dissertation, California School of Professional Psychology, Fresno Campus2000. ">Pillman 2001</a> ; <a href="./references#MR000050-bbs2-0078" title="RupertPA , HolmesDS .Effects of multiple sessions of true and placebo heart rate biofeedback training on the heart rates and anxiety levels of anxious patients during and following treatment. Psychophysiology1978;15(6):582-90. ">Rupert 1978</a> ; <a href="./references#MR000050-bbs2-0087" title="ToriC , WorellL .Reduction of human avoidant behavior. A comparison of counterconditioning, expectancy, and cognitive information approaches. Clinical Psychology1973;41(2):269-78. ">Tori 1973</a> ; <a href="./references#MR000050-bbs2-0090" title="VanderplateC .Electromyograph biofeedback Treatment of sleep onset Insomnia: a controlled Investigation. Dissertation, University of Southern Mississippi1978. ">Vanderplate 1983</a> ; <a href="./references#MR000050-bbs2-0095" title="WolitzkyKB , TelchMJ .Augmenting in vivo exposure with fear antagonistic actions: a preliminary test. Behavior Therapy2009;40(1):57-71. ">Wolitzky 2009</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Labels for usual care</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Standard treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#MR000050-bbs2-0051" title="MatsonJL , MarchettiA , AdkinsJA .Comparison of operant- and independence-training procedures for mentally retarded adults. American Journal of Mental Deficiency1980;84(5):487-94. ">Matson 1980</a> ; <a href="./references#MR000050-bbs2-0071" title="RapeeR .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 29th of August 2019. RapeeRM , AbbottMJ , LynehamHJ .Bibliotherapy for children With anxiety disorders using written materials for parents: a randomized controlled trial. Journal of Consulting and Clinical Psychology2006;74(3):436-44. ">Rapee 2006</a> ; <a href="./references#MR000050-bbs2-0072" title="RapeeR .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 29th of August 2019. RapeeRM , AbbottMJ , BaillieAJ , GastonJE .Treatment of social phobia through pure self-help and therapist-augmented self-help. British Journal of Psychiatry2007;191:246-52. ">Rapee 2007</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Community based therapy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#MR000050-bbs2-0028" title="GlogowskaM , RoulstoneS , EnderbyP , PetersTJ .Randomised controlled trial of community based speech and language therapy in preschool children. BMJ2000;321(7266):923-6. ">Glogowska 2000</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Typical care control</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#MR000050-bbs2-0086" title="TeriL , LogsdonRG , UomotoJ , McCurrySM .Behavioral treatment of depression in dementia patients: a controlled clinical trial. Journals of Gerontology. Series B, Psychological Sciences and Social Sciences1997;52(4):159-66. TeriL .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 26th of August 2019. ">Teri 1997</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Outpatient psychotherapy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#MR000050-bbs2-0014" title="BrillNQ , KoeglerRR , EpsteinLJ , ForgyEW .Controlled study of psychiatric outpatient treatment. Archives of General Psychiatry1964;10:581-95. ">Brill 1964b</a> ; <a href="./references#MR000050-bbs2-0017" title="CrispAH , NortonK , GowersS , HalekC , BowyerC , YeldhamD , et al.A controlled study of the effect of therapies aimed at adolescent and family psychopathology in Anorexia Nervosa. British Journal of Psychiatry: the Journal of Mental Science1991;159:325-33. GowersS , NortonK , HalekC , CrispAH .Outcome of outpatient psychotherapy in a random allocation treatment study of anorexia nervosa. International Journal of Eating Disorders1994;15(2):165-77. GowersS , NortonK , YelshamD .The St George's prospective treatment study of anorexia nervosa: a discussion of methodological problems. International Journal of Eating Disorders1989;8:445-54. ">Crisp 1991</a> ; <a href="./references#MR000050-bbs2-0054" title="MilbyJB , ClarkeC , ToroC , ThorntonS , RickertD .Effectiveness of urine surveillance as an adjunct to outpatient psychotherapy for drug abusers. International Journal of the Addictions1980;15(7):993-1001. ">Milby 1980</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Other</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#MR000050-bbs2-0073" title="RobinA .Rationing out-patients: a defence of the waiting list. British Journal of Psychiatry1976;129:138-41. ">Robin 1976</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Concomitant treatment</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Allowed the participant to receive a concomitant psychotherapy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>18</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#MR000050-bbs2-0008" title="Borden, KA.Attributional Outcomes: the Subtle Messages of Treatments for Attention Deficit Disorder. Dissertation, University of Illinois at Urbana-Champaign1986. BordenKA , BrownRT .Attributional outcomes: The subtle messages of treatments for attention deficit disorder. Cognitive Therapy and Research1989;13(2):147-60. ">Borden 1986</a> ; <a href="./references#MR000050-bbs2-0011" title="BornovalovaM .Inclusion of study in Cochrane Systematic Review (personal communication). Email to A Todorovac. 21st of August 2019. BornovalovaMA .Distress tolerance treatment for inner-city drug users: a preliminary trial. Doctor’s Dissertation, University of Maryland2008. ">Bornovalova 2008</a> ; <a href="./references#MR000050-bbs2-0015" title="CarlsonCL , PelhamWE , MilichR , HozaB .ADHD boys’ performance and attributions following success and failure: drug effects and individual differences. Cognitive Therapy and Research1993;17:269-87. ">Carlson 1993</a> ; <a href="./references#MR000050-bbs2-0018" title="CrouchG , RobsonM , HallstromC .Benzodiazepine dependent patients and their psychological treatment. Progress in Neuro-psychopharmacology &amp; Biological Psychiatry1988;12(4):503-10. HallströmC , CrouchG , RobsenM , ShineP .The treatment of tranquillizer dependence by propranolol. Postgraduate Medical Journal1988;64(Suppl 2):40-4. ">Crouch 1988</a> ; <a href="./references#MR000050-bbs2-0021" title="EhlersA , HackmannA , GreyN , WildJ , LinessS , AlbertI , et al.A randomized controlled trial of 7-day intensive and standard weekly cognitive therapy for PTSD and emotion-focused supportive therapy. American Journal of Psychiatry2014;171(3):294-304. ">Ehlers 2014</a> ; <a href="./references#MR000050-bbs2-0043" title="KwanR .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 26th of August 2019. KwanRY , LeungMC , LaiCK .Acupressure for agitation in nursing home residents with dementia: study protocol for a randomized controlled trial. Trials2014;15(410):1-7. KwanRY , LeungMCP , LaiCK .A randomized controlled trial examining the effect of acupressure on agitation and salivary cortisol in nursing home residents with dementia. Dementia and Geriatric Cognitive Disorders2017;44(1-2):92-104. ">Kwan 2017</a> ; <a href="./references#MR000050-bbs2-0044" title="LacyMK .The effect of short term autogenic training on the stress reactivity of hospitalized emotionally disturbed adolescents. ProQuest Dissertations Publishing, Oklahoma State University1996. ">Lacy 1990</a> ; <a href="./references#MR000050-bbs2-0045" title="LaiCK , ChiI , Kayser-JonesJ .A randomized controlled trial of a specific reminiscence approach to promote the well-being of nursing home residents with dementia. International Psychogeriatrics2004;16(1):33-49. LaiK .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 6th of September 2019. ">Lai 2004</a> ; <a href="./references#MR000050-bbs2-0052" title="McLachlanDR , DaltonAJ , KruckTP , BellMY , SmithWL , KalowW , et al.Intramuscular desferrioxamine in patients with Alzheimer's disease. Lancet1991;337(8753):1304-8. McLachlanDRC , SmithWL , KruckTP .Desferrioxamine and Alzheimer’s disease: video home behavior assessment of clinical course and measures of brain aluminum. Therapeutic Drug Monitoring1993;15(6):602-7. ">McLachlan 1991</a> ; <a href="./references#MR000050-bbs2-0061" title="MilichR , CarlsonCL , Pelham WE Jr, LichtBG .Effects of methylphenidate on the persistence of ADHD boys following failure experiences. Journal of Abnormal Child Psychology1991;19(5):519-36. PelhamWE , MurphyDA , VannattaK , MilichR , LichtBG , GnagyEM , et al.Methylphenidate and attributions in boys with attention-deficit hyperactivity disorder. Journal of Consulting and Clinical Psychology1992;60(2):282-92. ">Pelham 1992</a> ; <a href="./references#MR000050-bbs2-0071" title="RapeeR .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 29th of August 2019. RapeeRM , AbbottMJ , LynehamHJ .Bibliotherapy for children With anxiety disorders using written materials for parents: a randomized controlled trial. Journal of Consulting and Clinical Psychology2006;74(3):436-44. ">Rapee 2006</a> ; <a href="./references#MR000050-bbs2-0072" title="RapeeR .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 29th of August 2019. RapeeRM , AbbottMJ , BaillieAJ , GastonJE .Treatment of social phobia through pure self-help and therapist-augmented self-help. British Journal of Psychiatry2007;191:246-52. ">Rapee 2007</a> ; <a href="./references#MR000050-bbs2-0077" title="LorrM , McNairDM , WeinsteinGJ .Early effects of chlordiazepoxide (Librium) used with psychotherapy. Journal of Psychiatric Research1963;1:257-70. RothI , RhudickPJ , ShaskanDA , SlobinMS , WilkinsonAE , YoungHH .Long-term effects on psychotherapy of initial treatment conditions. Journal of Psychiatric Research1964;2:283-97. ">Roth 1964</a> ; <a href="./references#MR000050-bbs2-0082" title="SommernessMD , LuceroRJ , HamlonJS , EricksonJL , MatthewsR .A controlled study of reserpine on chronically disturbed patients. JAMA Archives of Neurology and Psychiatry1955;74(3):316-9. ">Sommerness 1955</a> ; <a href="./references#MR000050-bbs2-0085" title="TanSY , BruniJ .Cognitive-behavior therapy with adult patients with epilepsy: a controlled outcome study. Epilepsia1986;27(3):225-33. ">Tan 1986</a> ; <a href="./references#MR000050-bbs2-0086" title="TeriL , LogsdonRG , UomotoJ , McCurrySM .Behavioral treatment of depression in dementia patients: a controlled clinical trial. Journals of Gerontology. Series B, Psychological Sciences and Social Sciences1997;52(4):159-66. TeriL .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 26th of August 2019. ">Teri 1997</a> ; <a href="./references#MR000050-bbs2-0091" title="WatzlH , RistF , OlbrichR , CohenR .Placebo injections and surveillance of alcohol intake during inpatient treatment of female alcoholics. Addictive Behaviors1988;13(2):197-200. ">Watzl 1988</a> ; <a href="./references#MR000050-bbs2-0093" title="WhittakerCB , HoyRM .Withdrawal of perphenazine in chronic schizophrenia. British Journal of Psychiatry1963;109:422-7. ">Whittaker 1963</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Did not allow the participant to receive a concomitant psychotherapy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>20</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#MR000050-bbs2-0002" title="AllenJB .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to A Todorovac 28th of August 2019. AllenJJ , SchnyerRN , HittSK .The efficacy of acupuncture in the treatment of major depression in women. Psychological Science1998;9(5):397-401. ">Allen 1998</a> ; <a href="./references#MR000050-bbs2-0003" title="AllenJB .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 28th of August 2019. AllenJJ , SchnyerRN , ChambersAS , HittSK , MorenoFA , ManberR .Acupuncture for depression: a randomized controlled trial. Journal of Clinical Psychiatry2006;67(11):1665-73. ">Allen 2006</a> ; <a href="./references#MR000050-bbs2-0010" title="BorkovecTD , WeertsTC .Effects of progressive relaxation on sleep disturbance: an electroencephalographic evaluation. Psychosomatic Medicine1976;38(3):173-80. ">Borkovec 1976</a> ; <a href="./references#MR000050-bbs2-0019" title="Doty, DW.Role playing and incentives in the modification of the social interaction of chronic psychiatric patients. Journal of Consulting and Clinical Psychology1975;43(5):676-82. ">Doty 1975</a> ; <a href="./references#MR000050-bbs2-0027" title="FuchsCZ , RehnLP .A self-control behavior therapy program for depression. Journal of Consulting and Clinical Psychology1977;45(2):206-15. ">Fuchs 1977</a> ; <a href="./references#MR000050-bbs2-0029" title="GoldsteinAJ , BeursE , Chambless Dl, WilsonKA .EMDR for panic disorder with agoraphobia: comparison with waiting list and credible attention-placebo control conditions. Journal of Consulting and Clinical Psychology2000;68(6):947-56. ">Goldstein 2000</a> ; <a href="./references#MR000050-bbs2-0035" title="KelleyJ .Inclusion of study in Cochrane Systematic Review (personal communication). Email to: A Todorovac 12th of August 2019. KelleyJM , KaptchukTJ , CusinC , LipkinS , FavaM .Open-label placebo for major depressive disorder: a pilot randomized controlled trial. Psychotherapy and Psychosomatics2012;81(5):312-4. ">Kelley 2012</a> ; <a href="./references#MR000050-bbs2-0039" title="KlermanGL , DimascioA , WeismannM , PrusoffB , PaykelES .Treatment of depression by drugs and psychotherapy. American Journal of Psychiatry1974;131(2):186-91. PaykelES , DimascioA , HaskellD , PrusoffBA .Effects of maintenance amitriptyline and psychotherapy on symptoms of depression. Psychological Medicine1975;5(1):67-77. PaykelES , DiMascioA , KlermanGL , PrusoffBA .Maintenance therapy of depression. Pharmakopsychiatrie, Neuro-Psychopharmakologie1976;9:127-39. PaykelES , WeissmanMM , PrusoffBA .Social maladjustment and severity of depression. Comprehensive Psychiatry1978;19(2):121-8. WeissmanMM , KlermanGL , PaykelES , PrusoffB .Treatment effects on the social adjustment of depressed patients. Archives of General Psychiatry1974;30:771-8. ">Klerman 1974a</a> ; <a href="./references#MR000050-bbs2-0040" title="KlermanGL , DimascioA , WeismannM , PrusoffB , PaykelES .Treatment of depression by drugs and psychotherapy. American Journal of Psychiatry1974;131(2):186-91. ">Klerman 1974b</a> ; <a href="./references#MR000050-bbs2-0041" title="KloskoJS , BarlowDH , TassinariR , CernyJA .A comparison of alprazolam and behavior therapy in treatment of panic disorder: correction. Journal of Psychotherapy Practice and Research1994;3(2):163-79. KloskoJS , BarlowDH , TassinariR , CernyJA .A comparison of alprazolam and behavior therapy in treatment of panic disorder. Journal of Consulting and Clinical Psychology1990;58(1):77-84. ">Klosko 1990</a> ; <a href="./references#MR000050-bbs2-0042" title="KrapflJE , NawasMM .Differential ordering of stimulus presentation in systematic desensitization. Journal of Abnormal Psychology1970;75(3):333-7. ">Krapfl 1970</a> ; <a href="./references#MR000050-bbs2-0046" title="LangOJ , LazovikAD .Experimental desensitization of a phobia. Journal of Abnormal and Social Psychology1963;66:519-25. LangPJ , LazovikAD , ReynoldsDJ .Desensitization, suggestibility, and pseudotherapy. Journal of Abnormal Psychology1965;70(6):395-402. ">Lang 1965</a> ; <a href="./references#MR000050-bbs2-0047" title="LegrandF .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 14th of August 2019. LegrandFD , NeffEM .Efficacy of exercise as an adjunct treatment for clinically depressed inpatients during the initial stages of antidepressant pharmacotherapy: an open randomized controlled trial. Journal of Affective Disorders2016;191:139-44. ">Legrand 2016</a> ; <a href="./references#MR000050-bbs2-0054" title="MilbyJB , ClarkeC , ToroC , ThorntonS , RickertD .Effectiveness of urine surveillance as an adjunct to outpatient psychotherapy for drug abusers. International Journal of the Addictions1980;15(7):993-1001. ">Milby 1980</a> ; <a href="./references#MR000050-bbs2-0076" title="RosenGM , GlasgowRE , BarreraM .A controlled study to assess the clinical efficacy of totally self-administrated systematic desensitization. Journal of Consulting and Clinical Psychology1976;44(2):208-17. ">Rosen 1976</a> ; <a href="./references#MR000050-bbs2-0080" title="ShealyRC .The effectiveness of various treatment techniques on different degrees and durations of sleep-onset insomnia. Behaviour Research and Therapy1979;17(6):541-6. ">Shealy 1979</a> ; <a href="./references#MR000050-bbs2-0081" title="SibilioJP , AndrewG , DartD , MooreKB , StehmanA .Treatment of chronic schizophrenia with promazine hydrochloride. AMA Archives of Neurology and Psychiatry1957;78(4):419-24. ">Sibilio 1957</a> ; <a href="./references#MR000050-bbs2-0083" title="SteinmarkSW , BorkovecTD .Active and placebo treatment effects on moderate insomnia under counterdemand and positive demand instructions. Journal of Abnormal Psychology1974;83(2):157-63. ">Steinmark 1974</a> ; <a href="./references#MR000050-bbs2-0084" title="SzymanskiJ , O'DonohueW .The potential role of state-dependent learning in cognitive therapy with spider phobics. Journal of Rational-Emotive &amp; Cognitive-Behavior Therapy1995;13(2):131-50. SzymanskiJ .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 20th of August 2019. ">Szymanski 1995</a> ; <a href="./references#MR000050-bbs2-0090" title="VanderplateC .Electromyograph biofeedback Treatment of sleep onset Insomnia: a controlled Investigation. Dissertation, University of Southern Mississippi1978. ">Vanderplate 1983</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Allowed the participants to receive a concomitant pharmacotherapy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>29</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#MR000050-bbs2-0001" title="AbikoffH , HechtmanL , KleinRG .Social functioning in children with ADHD treated with long-term methylphenidate and multimodal psychosocial treatment. Journal of the American Academy of Child and Adolescent Psychiatry2004;43(7):820-9. AbikoffH .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to A Todorovac 23rd of August 2019. KleinRG , AbikoffH , HechtmanL , WeissG .Design and rationale of controlled study of long-term methylphenidate and multimodal psychosocial treatment in children with ADHD. Journal of the American Academy of Child and Adolescent Psychiatry2004;43(7):792-801. ">Abikoff 2004</a> ; <a href="./references#MR000050-bbs2-0004" title="AlvarezJR .The effects of anger management training on depression, anger, self-concept, and treatment responsibility in a sample of drug-dependent individuals in a therapeutic community. Dissertation Abstracts International: Section B: the Sciences and Engineering1997;58(4-B):2108. ">Alvarez 1997</a> ; <a href="./references#MR000050-bbs2-0006" title="AyenI , HautzingerM .Cognitive behavior therapy for depression in menopausal women. A controlled, randomized treatment study [Kognitive Verhaltenstherapie bei Depressionen im Klimakterium: Eine kontrollierte, randomiserte Interventionsstudie]. Zeitschrift für Klinische Psychologie und Psychotherapie2004;33(4):290-9. AyenI .Inclusion of study in Cochrane Systematic Review (personal communication). Email to EG Faltinsen 9th of September 2019. ">Ayen 2004</a> ; <a href="./references#MR000050-bbs2-0011" title="BornovalovaM .Inclusion of study in Cochrane Systematic Review (personal communication). Email to A Todorovac. 21st of August 2019. BornovalovaMA .Distress tolerance treatment for inner-city drug users: a preliminary trial. Doctor’s Dissertation, University of Maryland2008. ">Bornovalova 2008</a> ; <a href="./references#MR000050-bbs2-0012" title="BramstonP , SpenceSH .Behavioural versus cognitive social-skills training with intellectually-handicapped adults. Behaviour Research and Therapy1985;23(3):239-46. ">Bramston 1985</a> ; <a href="./references#MR000050-bbs2-0016" title="CarterJC , OlmstedMP , KaplanAS , McCabeRE , MillsJS , AimeA .Self-help for bulimia nervosa: a randomized controlled trial. American Journal of Psychiatry2003;160(5):973-8. ">Carter 2003</a> ; <a href="./references#MR000050-bbs2-0018" title="CrouchG , RobsonM , HallstromC .Benzodiazepine dependent patients and their psychological treatment. Progress in Neuro-psychopharmacology &amp; Biological Psychiatry1988;12(4):503-10. HallströmC , CrouchG , RobsenM , ShineP .The treatment of tranquillizer dependence by propranolol. Postgraduate Medical Journal1988;64(Suppl 2):40-4. ">Crouch 1988</a> ; <a href="./references#MR000050-bbs2-0019" title="Doty, DW.Role playing and incentives in the modification of the social interaction of chronic psychiatric patients. Journal of Consulting and Clinical Psychology1975;43(5):676-82. ">Doty 1975</a> ; <a href="./references#MR000050-bbs2-0020" title="DoubleDB , WarrenGC , EvansM , RowlandsMP .Efficacy of maintenance use of anticholinergic agents. Acta Psychiatrica Scandinavica1993;88:381-4. ">Double 1993</a> ; <a href="./references#MR000050-bbs2-0021" title="EhlersA , HackmannA , GreyN , WildJ , LinessS , AlbertI , et al.A randomized controlled trial of 7-day intensive and standard weekly cognitive therapy for PTSD and emotion-focused supportive therapy. American Journal of Psychiatry2014;171(3):294-304. ">Ehlers 2014</a> ; <a href="./references#MR000050-bbs2-0022" title="EspieCA , BrooksDN , LindsayWR .An evaluation of tailored psychological treatment of insomnia. Journal of Behavior Therapy and Experimental Psychiatry1989;20(2):143-53. EspieCA , LindsayWR , BrooksDN , HoodEM , TurveyT .A controlled comparative investigation of psychological treatments for chronic sleep-onset insomnia. Behaviour Research and Therapy1989;27(1):79-88. ">Espie 1989a</a> ; <a href="./references#MR000050-bbs2-0025" title="FoaEB , McLeanCP , ZangY , RosenfieldD , YadinE , YarvisJS , et al.Effect of prolonged exposure therapy delivered over 2 weeks vs 8 weeks vs present-centered therapy on PTSD symptom severity in military personnel: a randomized clinical trial. JAMA2018;319(4):354-64. ">Foa 2018</a> ; <a href="./references#MR000050-bbs2-0037" title="KilmannPR , MilanRJ , BolandJP , NankinHR , DavidsonE , WestMO , et al.Group treatment of secondary erectile dysfunction. Journal of Sex &amp; Marital Therapy1987;13(3):168-82. KilmannPR , Milan RJ Jr, BolandJP , DavidsonE , WestMO , SablisRF , et al.The sexual interactions of men with secondary erectile dysfunction. Journal of Sex Education and Therapy1988;14(1):46-9. KilmannPR , Milan RJ Jr, BolandJP , NankinHR , SablisRF , WestMO , et al.The sexual interactions of men with secondary erectile dysfunction. Paper presented at the annual meeting of the American Psychological Association in Los Angeles1985;1:46-9. ">Kilmann 1987</a> ; <a href="./references#MR000050-bbs2-0041" title="KloskoJS , BarlowDH , TassinariR , CernyJA .A comparison of alprazolam and behavior therapy in treatment of panic disorder: correction. Journal of Psychotherapy Practice and Research1994;3(2):163-79. KloskoJS , BarlowDH , TassinariR , CernyJA .A comparison of alprazolam and behavior therapy in treatment of panic disorder. Journal of Consulting and Clinical Psychology1990;58(1):77-84. ">Klosko 1990</a> ; <a href="./references#MR000050-bbs2-0043" title="KwanR .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 26th of August 2019. KwanRY , LeungMC , LaiCK .Acupressure for agitation in nursing home residents with dementia: study protocol for a randomized controlled trial. Trials2014;15(410):1-7. KwanRY , LeungMCP , LaiCK .A randomized controlled trial examining the effect of acupressure on agitation and salivary cortisol in nursing home residents with dementia. Dementia and Geriatric Cognitive Disorders2017;44(1-2):92-104. ">Kwan 2017</a> ; <a href="./references#MR000050-bbs2-0045" title="LaiCK , ChiI , Kayser-JonesJ .A randomized controlled trial of a specific reminiscence approach to promote the well-being of nursing home residents with dementia. International Psychogeriatrics2004;16(1):33-49. LaiK .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 6th of September 2019. ">Lai 2004</a> ; <a href="./references#MR000050-bbs2-0047" title="LegrandF .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 14th of August 2019. LegrandFD , NeffEM .Efficacy of exercise as an adjunct treatment for clinically depressed inpatients during the initial stages of antidepressant pharmacotherapy: an open randomized controlled trial. Journal of Affective Disorders2016;191:139-44. ">Legrand 2016</a> ; <a href="./references#MR000050-bbs2-0049" title="LickJR , HefflerD .Relaxation training and attention placebo in the treatment of severe insomnia. Journal of Consulting and Clinical Psychology1977;45(2):153-61. ">Lick 1977</a> ; <a href="./references#MR000050-bbs2-0060" title="PeckCL .Desensitization for the treatment of fear in the high level adult retardate. Behaviour Research and Therapy1977;15(2):137-48. ">Peck 1976</a> ; <a href="./references#MR000050-bbs2-0061" title="MilichR , CarlsonCL , Pelham WE Jr, LichtBG .Effects of methylphenidate on the persistence of ADHD boys following failure experiences. Journal of Abnormal Child Psychology1991;19(5):519-36. PelhamWE , MurphyDA , VannattaK , MilichR , LichtBG , GnagyEM , et al.Methylphenidate and attributions in boys with attention-deficit hyperactivity disorder. Journal of Consulting and Clinical Psychology1992;60(2):282-92. ">Pelham 1992</a> ; <a href="./references#MR000050-bbs2-0064" title="PolandRE , GertsikL , FavreauJT , SmithSI , MirochaJM , RaoU , et al.Open-label randomized parallel-group controlled clinical trial of massage for treatment of depression in HIV-infected subjects. Journal of Alternative and Complementary Medicine2013;19(4):334-40. ">Poland 2013</a> ; <a href="./references#MR000050-bbs2-0068" title="ProudfootJ , ClarkeJ , BirchMR , WhittonAE , ParkerG , ManicavasagarV , et al.Impact of a mobile phone and web program on symptom and functional outcomes for people with mild- to-moderate depression, anxiety and stress: a randomized controlled trial. BMC Psychiatry2013;13(312):1-12. ProudfootJ .Re: Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 26th of August 2019. ">Proudfoot 2013</a> ; <a href="./references#MR000050-bbs2-0071" title="RapeeR .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 29th of August 2019. RapeeRM , AbbottMJ , LynehamHJ .Bibliotherapy for children With anxiety disorders using written materials for parents: a randomized controlled trial. Journal of Consulting and Clinical Psychology2006;74(3):436-44. ">Rapee 2006</a> ; <a href="./references#MR000050-bbs2-0072" title="RapeeR .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 29th of August 2019. RapeeRM , AbbottMJ , BaillieAJ , GastonJE .Treatment of social phobia through pure self-help and therapist-augmented self-help. British Journal of Psychiatry2007;191:246-52. ">Rapee 2007</a> ; <a href="./references#MR000050-bbs2-0078" title="RupertPA , HolmesDS .Effects of multiple sessions of true and placebo heart rate biofeedback training on the heart rates and anxiety levels of anxious patients during and following treatment. Psychophysiology1978;15(6):582-90. ">Rupert 1978</a> ; <a href="./references#MR000050-bbs2-0082" title="SommernessMD , LuceroRJ , HamlonJS , EricksonJL , MatthewsR .A controlled study of reserpine on chronically disturbed patients. JAMA Archives of Neurology and Psychiatry1955;74(3):316-9. ">Sommerness 1955</a> ; <a href="./references#MR000050-bbs2-0085" title="TanSY , BruniJ .Cognitive-behavior therapy with adult patients with epilepsy: a controlled outcome study. Epilepsia1986;27(3):225-33. ">Tan 1986</a> ; <a href="./references#MR000050-bbs2-0086" title="TeriL , LogsdonRG , UomotoJ , McCurrySM .Behavioral treatment of depression in dementia patients: a controlled clinical trial. Journals of Gerontology. Series B, Psychological Sciences and Social Sciences1997;52(4):159-66. TeriL .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 26th of August 2019. ">Teri 1997</a> ; <a href="./references#MR000050-bbs2-0093" title="WhittakerCB , HoyRM .Withdrawal of perphenazine in chronic schizophrenia. British Journal of Psychiatry1963;109:422-7. ">Whittaker 1963</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Did not allow the participant to receive a concomitant pharmacotherapy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>19</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#MR000050-bbs2-0002" title="AllenJB .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to A Todorovac 28th of August 2019. AllenJJ , SchnyerRN , HittSK .The efficacy of acupuncture in the treatment of major depression in women. Psychological Science1998;9(5):397-401. ">Allen 1998</a> ; <a href="./references#MR000050-bbs2-0003" title="AllenJB .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 28th of August 2019. AllenJJ , SchnyerRN , ChambersAS , HittSK , MorenoFA , ManberR .Acupuncture for depression: a randomized controlled trial. Journal of Clinical Psychiatry2006;67(11):1665-73. ">Allen 2006</a> ; <a href="./references#MR000050-bbs2-0010" title="BorkovecTD , WeertsTC .Effects of progressive relaxation on sleep disturbance: an electroencephalographic evaluation. Psychosomatic Medicine1976;38(3):173-80. ">Borkovec 1976</a> ; <a href="./references#MR000050-bbs2-0017" title="CrispAH , NortonK , GowersS , HalekC , BowyerC , YeldhamD , et al.A controlled study of the effect of therapies aimed at adolescent and family psychopathology in Anorexia Nervosa. British Journal of Psychiatry: the Journal of Mental Science1991;159:325-33. GowersS , NortonK , HalekC , CrispAH .Outcome of outpatient psychotherapy in a random allocation treatment study of anorexia nervosa. International Journal of Eating Disorders1994;15(2):165-77. GowersS , NortonK , YelshamD .The St George's prospective treatment study of anorexia nervosa: a discussion of methodological problems. International Journal of Eating Disorders1989;8:445-54. ">Crisp 1991</a> ; <a href="./references#MR000050-bbs2-0026" title="FreireAO , SugaiGC , ChrispinFS , TogeiroSM , YamamuraY , MelloLE , et al.Treatment of moderate obstructive sleep apnea syndrome with acupuncture: a randomised, placebo-controlled pilot trial. Sleep Medicine2007;8(1):43-50. ">Freire 2007</a> ; <a href="./references#MR000050-bbs2-0029" title="GoldsteinAJ , BeursE , Chambless Dl, WilsonKA .EMDR for panic disorder with agoraphobia: comparison with waiting list and credible attention-placebo control conditions. Journal of Consulting and Clinical Psychology2000;68(6):947-56. ">Goldstein 2000</a> ; <a href="./references#MR000050-bbs2-0035" title="KelleyJ .Inclusion of study in Cochrane Systematic Review (personal communication). Email to: A Todorovac 12th of August 2019. KelleyJM , KaptchukTJ , CusinC , LipkinS , FavaM .Open-label placebo for major depressive disorder: a pilot randomized controlled trial. Psychotherapy and Psychosomatics2012;81(5):312-4. ">Kelley 2012</a> ; <a href="./references#MR000050-bbs2-0044" title="LacyMK .The effect of short term autogenic training on the stress reactivity of hospitalized emotionally disturbed adolescents. ProQuest Dissertations Publishing, Oklahoma State University1996. ">Lacy 1990</a> ; <a href="./references#MR000050-bbs2-0058" title="NicassioP , BootzinR .A comparison of progressive relaxation and autogenic training as treatments for insomnia. Journal of Abnormal Psychology1974;83(3):253-60. ">Nicassio 1974</a> ; <a href="./references#MR000050-bbs2-0069" title="QuayhagenMP , QuayhagenM , CorbeilRR , RothPA , RodgersJA .A dyadic remediation program for care recipients with dementia. Nursing Research1995;44(3):153-9. ">Quayhagen 1995</a> ; <a href="./references#MR000050-bbs2-0074" title="RoehrichL , GoldmanMS .Experience-dependent neuropsychological recovery and the treatment of alcoholism. Journal of Consulting and Clinical Psychology1993;61(5):812-21. ">Roehrich 1993</a> ; <a href="./references#MR000050-bbs2-0076" title="RosenGM , GlasgowRE , BarreraM .A controlled study to assess the clinical efficacy of totally self-administrated systematic desensitization. Journal of Consulting and Clinical Psychology1976;44(2):208-17. ">Rosen 1976</a> ; <a href="./references#MR000050-bbs2-0077" title="LorrM , McNairDM , WeinsteinGJ .Early effects of chlordiazepoxide (Librium) used with psychotherapy. Journal of Psychiatric Research1963;1:257-70. RothI , RhudickPJ , ShaskanDA , SlobinMS , WilkinsonAE , YoungHH .Long-term effects on psychotherapy of initial treatment conditions. Journal of Psychiatric Research1964;2:283-97. ">Roth 1964</a> ; <a href="./references#MR000050-bbs2-0080" title="ShealyRC .The effectiveness of various treatment techniques on different degrees and durations of sleep-onset insomnia. Behaviour Research and Therapy1979;17(6):541-6. ">Shealy 1979</a> ; <a href="./references#MR000050-bbs2-0083" title="SteinmarkSW , BorkovecTD .Active and placebo treatment effects on moderate insomnia under counterdemand and positive demand instructions. Journal of Abnormal Psychology1974;83(2):157-63. ">Steinmark 1974</a> ; <a href="./references#MR000050-bbs2-0084" title="SzymanskiJ , O'DonohueW .The potential role of state-dependent learning in cognitive therapy with spider phobics. Journal of Rational-Emotive &amp; Cognitive-Behavior Therapy1995;13(2):131-50. SzymanskiJ .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 20th of August 2019. ">Szymanski 1995</a> ; <a href="./references#MR000050-bbs2-0090" title="VanderplateC .Electromyograph biofeedback Treatment of sleep onset Insomnia: a controlled Investigation. Dissertation, University of Southern Mississippi1978. ">Vanderplate 1983</a> ; <a href="./references#MR000050-bbs2-0092" title="WeingaertnerAH .Self-administered aversive stimulation with hallucinating hospitalized schizophrenics. Journal of Consulting and Clinical Psychology1971;36(3):422-29. ">Weingaertner 1971</a> ; <a href="./references#MR000050-bbs2-0096" title="WollersheimJP , WilsonGL .Group treatment of unipolar depression: a comparison of coping, supportive, bibliotherapy, and delayed treatment groups. Professional Psychology: Research and Practice1991;22(6):496-502. ">Wollersheim 1991</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Comparators</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Wait‐list control interventions</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>39</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#MR000050-bbs2-0002" title="AllenJB .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to A Todorovac 28th of August 2019. AllenJJ , SchnyerRN , HittSK .The efficacy of acupuncture in the treatment of major depression in women. Psychological Science1998;9(5):397-401. ">Allen 1998</a> ; <a href="./references#MR000050-bbs2-0003" title="AllenJB .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 28th of August 2019. AllenJJ , SchnyerRN , ChambersAS , HittSK , MorenoFA , ManberR .Acupuncture for depression: a randomized controlled trial. Journal of Clinical Psychiatry2006;67(11):1665-73. ">Allen 2006</a> ; <a href="./references#MR000050-bbs2-0005" title="AscherLM , TurnerR .Paradoxical intention and insomnia: an experimental investigation. Behaviour Research and Therapy1979;17(4):408-11. ">Ascher 1979</a> ; <a href="./references#MR000050-bbs2-0006" title="AyenI , HautzingerM .Cognitive behavior therapy for depression in menopausal women. A controlled, randomized treatment study [Kognitive Verhaltenstherapie bei Depressionen im Klimakterium: Eine kontrollierte, randomiserte Interventionsstudie]. Zeitschrift für Klinische Psychologie und Psychotherapie2004;33(4):290-9. AyenI .Inclusion of study in Cochrane Systematic Review (personal communication). Email to EG Faltinsen 9th of September 2019. ">Ayen 2004</a> ; <a href="./references#MR000050-bbs2-0009" title="BorkovecTD , KaloupekDG , SlamaKM .The facilitative effect of muscle tension-release in the relaxation treatment of sleep disturbance. Behavior Therapy1975;6(3):301-9. ">Borkovec 1975</a> ; <a href="./references#MR000050-bbs2-0010" title="BorkovecTD , WeertsTC .Effects of progressive relaxation on sleep disturbance: an electroencephalographic evaluation. Psychosomatic Medicine1976;38(3):173-80. ">Borkovec 1976</a> ; <a href="./references#MR000050-bbs2-0012" title="BramstonP , SpenceSH .Behavioural versus cognitive social-skills training with intellectually-handicapped adults. Behaviour Research and Therapy1985;23(3):239-46. ">Bramston 1985</a> ; <a href="./references#MR000050-bbs2-0013" title="BrillNQ , KoeglerRR , EpsteinLJ , ForgyEW .Controlled study of psychiatric outpatient treatment. Archives of General Psychiatry1964;10:581-95. BrillNQ .Results of psychotherapy. California Medicine1966;104(4):249-53. ">Brill 1964a</a> ; <a href="./references#MR000050-bbs2-0014" title="BrillNQ , KoeglerRR , EpsteinLJ , ForgyEW .Controlled study of psychiatric outpatient treatment. Archives of General Psychiatry1964;10:581-95. ">Brill 1964b</a> ; <a href="./references#MR000050-bbs2-0021" title="EhlersA , HackmannA , GreyN , WildJ , LinessS , AlbertI , et al.A randomized controlled trial of 7-day intensive and standard weekly cognitive therapy for PTSD and emotion-focused supportive therapy. American Journal of Psychiatry2014;171(3):294-304. ">Ehlers 2014</a> ; <a href="./references#MR000050-bbs2-0022" title="EspieCA , BrooksDN , LindsayWR .An evaluation of tailored psychological treatment of insomnia. Journal of Behavior Therapy and Experimental Psychiatry1989;20(2):143-53. EspieCA , LindsayWR , BrooksDN , HoodEM , TurveyT .A controlled comparative investigation of psychological treatments for chronic sleep-onset insomnia. Behaviour Research and Therapy1989;27(1):79-88. ">Espie 1989a</a> ; <a href="./references#MR000050-bbs2-0024" title="FoaEB , RothbaumBO , RiggsDS , MurdockTB .Treatment of posttraumatic stress disorder in rape victims: a comparison between cognitive-behavioral procedures and counselling. Journal of Consulting and Clinical Psychology1991;59(5):715-23. ">Foa 1991</a> ; <a href="./references#MR000050-bbs2-0025" title="FoaEB , McLeanCP , ZangY , RosenfieldD , YadinE , YarvisJS , et al.Effect of prolonged exposure therapy delivered over 2 weeks vs 8 weeks vs present-centered therapy on PTSD symptom severity in military personnel: a randomized clinical trial. JAMA2018;319(4):354-64. ">Foa 2018</a> ; <a href="./references#MR000050-bbs2-0027" title="FuchsCZ , RehnLP .A self-control behavior therapy program for depression. Journal of Consulting and Clinical Psychology1977;45(2):206-15. ">Fuchs 1977</a> ; <a href="./references#MR000050-bbs2-0028" title="GlogowskaM , RoulstoneS , EnderbyP , PetersTJ .Randomised controlled trial of community based speech and language therapy in preschool children. BMJ2000;321(7266):923-6. ">Glogowska 2000</a> ; <a href="./references#MR000050-bbs2-0029" title="GoldsteinAJ , BeursE , Chambless Dl, WilsonKA .EMDR for panic disorder with agoraphobia: comparison with waiting list and credible attention-placebo control conditions. Journal of Consulting and Clinical Psychology2000;68(6):947-56. ">Goldstein 2000</a> ; <a href="./references#MR000050-bbs2-0035" title="KelleyJ .Inclusion of study in Cochrane Systematic Review (personal communication). Email to: A Todorovac 12th of August 2019. KelleyJM , KaptchukTJ , CusinC , LipkinS , FavaM .Open-label placebo for major depressive disorder: a pilot randomized controlled trial. Psychotherapy and Psychosomatics2012;81(5):312-4. ">Kelley 2012</a> ; <a href="./references#MR000050-bbs2-0037" title="KilmannPR , MilanRJ , BolandJP , NankinHR , DavidsonE , WestMO , et al.Group treatment of secondary erectile dysfunction. Journal of Sex &amp; Marital Therapy1987;13(3):168-82. KilmannPR , Milan RJ Jr, BolandJP , DavidsonE , WestMO , SablisRF , et al.The sexual interactions of men with secondary erectile dysfunction. Journal of Sex Education and Therapy1988;14(1):46-9. KilmannPR , Milan RJ Jr, BolandJP , NankinHR , SablisRF , WestMO , et al.The sexual interactions of men with secondary erectile dysfunction. Paper presented at the annual meeting of the American Psychological Association in Los Angeles1985;1:46-9. ">Kilmann 1987</a> ; <a href="./references#MR000050-bbs2-0043" title="KwanR .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 26th of August 2019. KwanRY , LeungMC , LaiCK .Acupressure for agitation in nursing home residents with dementia: study protocol for a randomized controlled trial. Trials2014;15(410):1-7. KwanRY , LeungMCP , LaiCK .A randomized controlled trial examining the effect of acupressure on agitation and salivary cortisol in nursing home residents with dementia. Dementia and Geriatric Cognitive Disorders2017;44(1-2):92-104. ">Kwan 2017</a> ; <a href="./references#MR000050-bbs2-0044" title="LacyMK .The effect of short term autogenic training on the stress reactivity of hospitalized emotionally disturbed adolescents. ProQuest Dissertations Publishing, Oklahoma State University1996. ">Lacy 1990</a> ; <a href="./references#MR000050-bbs2-0048" title="LickJ .Expectancy, false galvanic skin response feedback, and systematic desensitization in the modification of phobic behavior. Journal of Consulting and Clinical Psychology1975;43(4):557-67. ">Lick 1975</a> ; <a href="./references#MR000050-bbs2-0054" title="MilbyJB , ClarkeC , ToroC , ThorntonS , RickertD .Effectiveness of urine surveillance as an adjunct to outpatient psychotherapy for drug abusers. International Journal of the Addictions1980;15(7):993-1001. ">Milby 1980</a> ; <a href="./references#MR000050-bbs2-0062" title="PedletonMG , HigginsRL .A comparison of negative practice and systematic desensitization in the treatment of acrophobia. Journal of Behavior Therapy and Experimental Psychiatry1983;14(4):317-23. ">Pendleton 1983</a> ; <a href="./references#MR000050-bbs2-0065" title="PowersMB , SmitsJA , TelchMJ .Disentangling the effects of safety-behavior utilization and safety-behavior availability during exposure-based treatment: a placebo-controlled trial. Journal of Consulting and Clinical Psychology2004;72(3):448-54. ">Powers 2004</a> ; <a href="./references#MR000050-bbs2-0066" title="PowersMB , SmithsJA , WhitleyD , BystritskyA , TelchMJ .The effect of attributional processes concerning medication taking on return of fear. Journal of Consulting and Clinical Psychology2008;76(3):478-90. ">Powers 2008a</a> ; <a href="./references#MR000050-bbs2-0068" title="ProudfootJ , ClarkeJ , BirchMR , WhittonAE , ParkerG , ManicavasagarV , et al.Impact of a mobile phone and web program on symptom and functional outcomes for people with mild- to-moderate depression, anxiety and stress: a randomized controlled trial. BMC Psychiatry2013;13(312):1-12. ProudfootJ .Re: Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 26th of August 2019. ">Proudfoot 2013</a> ; <a href="./references#MR000050-bbs2-0069" title="QuayhagenMP , QuayhagenM , CorbeilRR , RothPA , RodgersJA .A dyadic remediation program for care recipients with dementia. Nursing Research1995;44(3):153-9. ">Quayhagen 1995</a> ; <a href="./references#MR000050-bbs2-0071" title="RapeeR .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 29th of August 2019. RapeeRM , AbbottMJ , LynehamHJ .Bibliotherapy for children With anxiety disorders using written materials for parents: a randomized controlled trial. Journal of Consulting and Clinical Psychology2006;74(3):436-44. ">Rapee 2006</a> ; <a href="./references#MR000050-bbs2-0072" title="RapeeR .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 29th of August 2019. RapeeRM , AbbottMJ , BaillieAJ , GastonJE .Treatment of social phobia through pure self-help and therapist-augmented self-help. British Journal of Psychiatry2007;191:246-52. ">Rapee 2007</a> ; <a href="./references#MR000050-bbs2-0073" title="RobinA .Rationing out-patients: a defence of the waiting list. British Journal of Psychiatry1976;129:138-41. ">Robin 1976</a> ; <a href="./references#MR000050-bbs2-0075" title="OlivaresJ .Program IAFS. Protocol for the treatment of social phobia in adolescents [Programa IAFS. Protocolo para el tratamiento de la fobia social enadolescentes]. Madrid: Pirámide2005;1. Rosa-AlcázarAI , Olivares-OlivaresPJ , OlivaresJ .The role of non-specific effects in the psychological treatment of adolescents with social phobia [Papel de los efectos inespecíficos en el tratamiento psicológico de adolescentes con fobia social]. Anuario de Psicologia2009;40(1):43-61. ">Rosa‐Alcatraz 2009</a> ; <a href="./references#MR000050-bbs2-0076" title="RosenGM , GlasgowRE , BarreraM .A controlled study to assess the clinical efficacy of totally self-administrated systematic desensitization. Journal of Consulting and Clinical Psychology1976;44(2):208-17. ">Rosen 1976</a> ; <a href="./references#MR000050-bbs2-0080" title="ShealyRC .The effectiveness of various treatment techniques on different degrees and durations of sleep-onset insomnia. Behaviour Research and Therapy1979;17(6):541-6. ">Shealy 1979</a> ; <a href="./references#MR000050-bbs2-0083" title="SteinmarkSW , BorkovecTD .Active and placebo treatment effects on moderate insomnia under counterdemand and positive demand instructions. Journal of Abnormal Psychology1974;83(2):157-63. ">Steinmark 1974</a> ; <a href="./references#MR000050-bbs2-0088" title="Trexler, L.Rational-emotive therapy, placebo, and no-treatment effects on public-speaking anxiety. Doctoral dissertation, Temple University AnnArbor, Mich.: University Microfilms1971;71-31(063). TrexlerLD , KarstTO .Rational-emotive therapy, placebo, and no-treatment effects on public-speaking anxiety. Journal of Abnormal Psyhology1972;79(1):60-7. ">Trexler 1972</a> ; <a href="./references#MR000050-bbs2-0089" title="AscherML , TurnerRM .A comparison of two methods for the administration of paradoxical intention. Behaviour Research and Therapy1980;18(2):121-6. TurnerRM , AscherLM .Controlled comparison of progressive relaxation, stimulus control, and paradoxical intention therapies for insomnia. Journal of Consulting and Clinical Psychology1979;47(3):500-8. ">Turner 1979</a> ; <a href="./references#MR000050-bbs2-0090" title="VanderplateC .Electromyograph biofeedback Treatment of sleep onset Insomnia: a controlled Investigation. Dissertation, University of Southern Mississippi1978. ">Vanderplate 1983</a> ; <a href="./references#MR000050-bbs2-0095" title="WolitzkyKB , TelchMJ .Augmenting in vivo exposure with fear antagonistic actions: a preliminary test. Behavior Therapy2009;40(1):57-71. ">Wolitzky 2009</a> ; <a href="./references#MR000050-bbs2-0096" title="WollersheimJP , WilsonGL .Group treatment of unipolar depression: a comparison of coping, supportive, bibliotherapy, and delayed treatment groups. Professional Psychology: Research and Practice1991;22(6):496-502. ">Wollersheim 1991</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No‐treatment control interventions</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>56</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#MR000050-bbs2-0001" title="AbikoffH , HechtmanL , KleinRG .Social functioning in children with ADHD treated with long-term methylphenidate and multimodal psychosocial treatment. Journal of the American Academy of Child and Adolescent Psychiatry2004;43(7):820-9. AbikoffH .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to A Todorovac 23rd of August 2019. KleinRG , AbikoffH , HechtmanL , WeissG .Design and rationale of controlled study of long-term methylphenidate and multimodal psychosocial treatment in children with ADHD. Journal of the American Academy of Child and Adolescent Psychiatry2004;43(7):792-801. ">Abikoff 2004</a> ; <a href="./references#MR000050-bbs2-0004" title="AlvarezJR .The effects of anger management training on depression, anger, self-concept, and treatment responsibility in a sample of drug-dependent individuals in a therapeutic community. Dissertation Abstracts International: Section B: the Sciences and Engineering1997;58(4-B):2108. ">Alvarez 1997</a> ; <a href="./references#MR000050-bbs2-0007" title="BergI , ForsytheI , HoltP , WattsJ .A controlled trial of ‘Senokot’ in faecal soiling treated by behavioural methods. Journal of Child Psychology and Psychiatry1983;24(4):543-9. ">Berg 1983</a> ; <a href="./references#MR000050-bbs2-0008" title="Borden, KA.Attributional Outcomes: the Subtle Messages of Treatments for Attention Deficit Disorder. Dissertation, University of Illinois at Urbana-Champaign1986. BordenKA , BrownRT .Attributional outcomes: The subtle messages of treatments for attention deficit disorder. Cognitive Therapy and Research1989;13(2):147-60. ">Borden 1986</a> ; <a href="./references#MR000050-bbs2-0011" title="BornovalovaM .Inclusion of study in Cochrane Systematic Review (personal communication). Email to A Todorovac. 21st of August 2019. BornovalovaMA .Distress tolerance treatment for inner-city drug users: a preliminary trial. Doctor’s Dissertation, University of Maryland2008. ">Bornovalova 2008</a> ; <a href="./references#MR000050-bbs2-0015" title="CarlsonCL , PelhamWE , MilichR , HozaB .ADHD boys’ performance and attributions following success and failure: drug effects and individual differences. Cognitive Therapy and Research1993;17:269-87. ">Carlson 1993</a> ; <a href="./references#MR000050-bbs2-0016" title="CarterJC , OlmstedMP , KaplanAS , McCabeRE , MillsJS , AimeA .Self-help for bulimia nervosa: a randomized controlled trial. American Journal of Psychiatry2003;160(5):973-8. ">Carter 2003</a> ; <a href="./references#MR000050-bbs2-0017" title="CrispAH , NortonK , GowersS , HalekC , BowyerC , YeldhamD , et al.A controlled study of the effect of therapies aimed at adolescent and family psychopathology in Anorexia Nervosa. British Journal of Psychiatry: the Journal of Mental Science1991;159:325-33. GowersS , NortonK , HalekC , CrispAH .Outcome of outpatient psychotherapy in a random allocation treatment study of anorexia nervosa. International Journal of Eating Disorders1994;15(2):165-77. GowersS , NortonK , YelshamD .The St George's prospective treatment study of anorexia nervosa: a discussion of methodological problems. International Journal of Eating Disorders1989;8:445-54. ">Crisp 1991</a> ; <a href="./references#MR000050-bbs2-0018" title="CrouchG , RobsonM , HallstromC .Benzodiazepine dependent patients and their psychological treatment. Progress in Neuro-psychopharmacology &amp; Biological Psychiatry1988;12(4):503-10. HallströmC , CrouchG , RobsenM , ShineP .The treatment of tranquillizer dependence by propranolol. Postgraduate Medical Journal1988;64(Suppl 2):40-4. ">Crouch 1988</a> ; <a href="./references#MR000050-bbs2-0019" title="Doty, DW.Role playing and incentives in the modification of the social interaction of chronic psychiatric patients. Journal of Consulting and Clinical Psychology1975;43(5):676-82. ">Doty 1975</a> ; <a href="./references#MR000050-bbs2-0020" title="DoubleDB , WarrenGC , EvansM , RowlandsMP .Efficacy of maintenance use of anticholinergic agents. Acta Psychiatrica Scandinavica1993;88:381-4. ">Double 1993</a> ; <a href="./references#MR000050-bbs2-0023" title="EtringerBD , CashTF , RimmDC .Behavioral, affective, and cognitive effects of participant modeling and an equally credible placebo. Behavior Therapy1982;13(4):476-85. ">Etringer 1982</a> ; <a href="./references#MR000050-bbs2-0026" title="FreireAO , SugaiGC , ChrispinFS , TogeiroSM , YamamuraY , MelloLE , et al.Treatment of moderate obstructive sleep apnea syndrome with acupuncture: a randomised, placebo-controlled pilot trial. Sleep Medicine2007;8(1):43-50. ">Freire 2007</a> ; <a href="./references#MR000050-bbs2-0030" title="GoldwasserAN , AuerbachSM , HarkinsSW .Cognitive, affective, and behavioural effects of reminiscence group therapy on demented elderly. Aging and Human Development1987;25(3):209-22. ">Goldwasser 1987</a> ; <a href="./references#MR000050-bbs2-0031" title="HekmatH , LubitzR , DealR .Semantic desensitization: a paradigmatic intervention approach to anxiety disorders. Journal of Clinical Psychology1984;40(2):463-6. ">Hekmat 1984</a> ; <a href="./references#MR000050-bbs2-0032" title="HippmanC , RingroseA , InglisA , CheekJ , AlbertAY , RemickR , et al.A pilot randomized clinical trial evaluating the impact of genetic counselling for serious mental illnesses. Journal of Clinical Psychiatry2016;77(2):e190-8. ">Hippman 2016</a> ; <a href="./references#MR000050-bbs2-0034" title="KarstM , WinterhalterM , MünteS , FranckiB , HondronikosA , EckardtA , et al.Auricular acupuncture for dental anxiety: a randomized controlled trial. Anesthesia and Analgesia2007;104(2):295-300. KarstM .Inclusion of study in Cochrane Systematic Review (personal communication). Email to: EG Faltinsen 5th of September 2019. ">Karst 2007</a> ; <a href="./references#MR000050-bbs2-0036" title="KennedyTD , KimuraHK .Transfer, behavioral improvement, and anxiety reduction in systematic desensitization. Journal of Consulting and Clinical Psychology1974;42(5):720-8. ">Kennedy 1974</a> ; <a href="./references#MR000050-bbs2-0038" title="KleinSA , DeffenbacherJL .Relaxation and exercise for hyperactive impulsive children. Perceptual and Motor Skills1977;45:1159-62. ">Klein 1977</a> ; <a href="./references#MR000050-bbs2-0039" title="KlermanGL , DimascioA , WeismannM , PrusoffB , PaykelES .Treatment of depression by drugs and psychotherapy. American Journal of Psychiatry1974;131(2):186-91. PaykelES , DimascioA , HaskellD , PrusoffBA .Effects of maintenance amitriptyline and psychotherapy on symptoms of depression. Psychological Medicine1975;5(1):67-77. PaykelES , DiMascioA , KlermanGL , PrusoffBA .Maintenance therapy of depression. Pharmakopsychiatrie, Neuro-Psychopharmakologie1976;9:127-39. PaykelES , WeissmanMM , PrusoffBA .Social maladjustment and severity of depression. Comprehensive Psychiatry1978;19(2):121-8. WeissmanMM , KlermanGL , PaykelES , PrusoffB .Treatment effects on the social adjustment of depressed patients. Archives of General Psychiatry1974;30:771-8. ">Klerman 1974a</a> ; <a href="./references#MR000050-bbs2-0040" title="KlermanGL , DimascioA , WeismannM , PrusoffB , PaykelES .Treatment of depression by drugs and psychotherapy. American Journal of Psychiatry1974;131(2):186-91. ">Klerman 1974b</a> ; <a href="./references#MR000050-bbs2-0041" title="KloskoJS , BarlowDH , TassinariR , CernyJA .A comparison of alprazolam and behavior therapy in treatment of panic disorder: correction. Journal of Psychotherapy Practice and Research1994;3(2):163-79. KloskoJS , BarlowDH , TassinariR , CernyJA .A comparison of alprazolam and behavior therapy in treatment of panic disorder. Journal of Consulting and Clinical Psychology1990;58(1):77-84. ">Klosko 1990</a> ; <a href="./references#MR000050-bbs2-0042" title="KrapflJE , NawasMM .Differential ordering of stimulus presentation in systematic desensitization. Journal of Abnormal Psychology1970;75(3):333-7. ">Krapfl 1970</a> ; <a href="./references#MR000050-bbs2-0045" title="LaiCK , ChiI , Kayser-JonesJ .A randomized controlled trial of a specific reminiscence approach to promote the well-being of nursing home residents with dementia. International Psychogeriatrics2004;16(1):33-49. LaiK .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 6th of September 2019. ">Lai 2004</a> ; <a href="./references#MR000050-bbs2-0046" title="LangOJ , LazovikAD .Experimental desensitization of a phobia. Journal of Abnormal and Social Psychology1963;66:519-25. LangPJ , LazovikAD , ReynoldsDJ .Desensitization, suggestibility, and pseudotherapy. Journal of Abnormal Psychology1965;70(6):395-402. ">Lang 1965</a> ; <a href="./references#MR000050-bbs2-0047" title="LegrandF .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 14th of August 2019. LegrandFD , NeffEM .Efficacy of exercise as an adjunct treatment for clinically depressed inpatients during the initial stages of antidepressant pharmacotherapy: an open randomized controlled trial. Journal of Affective Disorders2016;191:139-44. ">Legrand 2016</a> ; <a href="./references#MR000050-bbs2-0049" title="LickJR , HefflerD .Relaxation training and attention placebo in the treatment of severe insomnia. Journal of Consulting and Clinical Psychology1977;45(2):153-61. ">Lick 1977</a> ; <a href="./references#MR000050-bbs2-0050" title="LiddleB , SpenceSH .Cognitive-behaviour therapy with depressed primary school children: A cautionary note. Behavioural Psychotherapy1990;18(2):85-102. ">Liddle 1990</a> ; <a href="./references#MR000050-bbs2-0051" title="MatsonJL , MarchettiA , AdkinsJA .Comparison of operant- and independence-training procedures for mentally retarded adults. American Journal of Mental Deficiency1980;84(5):487-94. ">Matson 1980</a> ; <a href="./references#MR000050-bbs2-0052" title="McLachlanDR , DaltonAJ , KruckTP , BellMY , SmithWL , KalowW , et al.Intramuscular desferrioxamine in patients with Alzheimer's disease. Lancet1991;337(8753):1304-8. McLachlanDRC , SmithWL , KruckTP .Desferrioxamine and Alzheimer’s disease: video home behavior assessment of clinical course and measures of brain aluminum. Therapeutic Drug Monitoring1993;15(6):602-7. ">McLachlan 1991</a> ; <a href="./references#MR000050-bbs2-0053" title="MealieaWL , NawasMM .The comparative effectiveness of systematic desensitization and implosive therapy in the treatment of snake phobia. Journal of Behavior Therapy and Experimental Psychiatry1971;2(2):85-94. ">Mealiea 1971</a> ; <a href="./references#MR000050-bbs2-0055" title="MirandaA , ArlandisP , SorianoM .Instruction in strategies and attributional training: Effects on the problem-solving and self-concept of students’ with learning disabilities [Instrucción en estrategias y entrenamiento atribucional: efectos sobre la resolución de problemas y el autoconcepto de los estudiantes con dificultades en el aprendizaje]. Infancia y Aprendizaje1997;20(80):37-52. ">Miranda 1997</a> ; <a href="./references#MR000050-bbs2-0056" title="MitchellC , MansfieldD , RautenbachS .Coloured filters and reading accuracy, comprehension and rate: a placebo-controlled study. Perceptual and Motor Skills2008;106(2):517-32. ">Mitchell 2008</a> ; <a href="./references#MR000050-bbs2-0057" title="NandiDN , AjmanyS , GanguliH , BanerjeeG , BoralGC , GhoshA , et al.A clinical evaluation of depressives found in a rural survey in India. British Journal of Psychiatry1976;128:523-7. ">Nandi 1976</a> ; <a href="./references#MR000050-bbs2-0058" title="NicassioP , BootzinR .A comparison of progressive relaxation and autogenic training as treatments for insomnia. Journal of Abnormal Psychology1974;83(3):253-60. ">Nicassio 1974</a> ; <a href="./references#MR000050-bbs2-0059" title="PearlD , Vander KampH , OlsenAL , GreenbergPD , ArmitageSG .The effects of reserpine on schizophrenic patients. American Journal of Psychiatry1956;112:198-204. ">Pearl 1956</a> ; <a href="./references#MR000050-bbs2-0060" title="PeckCL .Desensitization for the treatment of fear in the high level adult retardate. Behaviour Research and Therapy1977;15(2):137-48. ">Peck 1976</a> ; <a href="./references#MR000050-bbs2-0061" title="MilichR , CarlsonCL , Pelham WE Jr, LichtBG .Effects of methylphenidate on the persistence of ADHD boys following failure experiences. Journal of Abnormal Child Psychology1991;19(5):519-36. PelhamWE , MurphyDA , VannattaK , MilichR , LichtBG , GnagyEM , et al.Methylphenidate and attributions in boys with attention-deficit hyperactivity disorder. Journal of Consulting and Clinical Psychology1992;60(2):282-92. ">Pelham 1992</a> ; <a href="./references#MR000050-bbs2-0063" title="PetersonMA , PattersonB , PillmanBM , BattistaMA .Cognitive recovery following alcohol detoxification: a computerised remediation study. Neuropsychological Rehabilitation2002;12(1):63-74. PillmanBM .Computerized cognitive remediation with recently detoxified alcoholics. Dissertation, California School of Professional Psychology, Fresno Campus2000. ">Pillman 2001</a> ; <a href="./references#MR000050-bbs2-0064" title="PolandRE , GertsikL , FavreauJT , SmithSI , MirochaJM , RaoU , et al.Open-label randomized parallel-group controlled clinical trial of massage for treatment of depression in HIV-infected subjects. Journal of Alternative and Complementary Medicine2013;19(4):334-40. ">Poland 2013</a> ; <a href="./references#MR000050-bbs2-0067" title="PowersMB , SmithsJA , WhitleyD , BystritskyA , TelchMJ .The effect of attributional processes concerning medication taking on return of fear. Journal of Consulting and Clinical Psychology2008;76(3):478-90. ">Powers 2008b</a> ; <a href="./references#MR000050-bbs2-0070" title="LiebowitzM , QuitkinFM , StewartJW , McGrathPJ , HarrisonWM , MarkowitzJS , et al.Antidepressant efficacy in atypical depression. Archives of General Psychiatry1988;45(2):129-37. QuitkinFM , McGrathPJ , StewartJW , HarrisonW , WagerSG , NunesE , et al.Phenelzine and imipramine in mood reactive depressives: further delineation of the syndrome of atypical depression. Archives of General Psychiatry1989;46(9):787-93. RabkinJG , McGrathPJ , QuitkinFM , TricamoE , StewartJW , KleinDF .Effects of pill-giving on maintenance of placebo response in patients with chronic mild depression. American Journal of Psychiatry1990;147(12):1622-6. ">Rabkin 1990</a> ; <a href="./references#MR000050-bbs2-0074" title="RoehrichL , GoldmanMS .Experience-dependent neuropsychological recovery and the treatment of alcoholism. Journal of Consulting and Clinical Psychology1993;61(5):812-21. ">Roehrich 1993</a> ; <a href="./references#MR000050-bbs2-0077" title="LorrM , McNairDM , WeinsteinGJ .Early effects of chlordiazepoxide (Librium) used with psychotherapy. Journal of Psychiatric Research1963;1:257-70. RothI , RhudickPJ , ShaskanDA , SlobinMS , WilkinsonAE , YoungHH .Long-term effects on psychotherapy of initial treatment conditions. Journal of Psychiatric Research1964;2:283-97. ">Roth 1964</a> ; <a href="./references#MR000050-bbs2-0078" title="RupertPA , HolmesDS .Effects of multiple sessions of true and placebo heart rate biofeedback training on the heart rates and anxiety levels of anxious patients during and following treatment. Psychophysiology1978;15(6):582-90. ">Rupert 1978</a> ; <a href="./references#MR000050-bbs2-0079" title="ShalevAY , AnkriY , Isreali-ShalevY , PelegT , AdesskyR , FreedmanS .Prevention of posttraumatic stress disorder by early treatment. Archives of General Psychiatry2012;69(2):166-76. ">Shalev 2012</a> ; <a href="./references#MR000050-bbs2-0081" title="SibilioJP , AndrewG , DartD , MooreKB , StehmanA .Treatment of chronic schizophrenia with promazine hydrochloride. AMA Archives of Neurology and Psychiatry1957;78(4):419-24. ">Sibilio 1957</a> ; <a href="./references#MR000050-bbs2-0082" title="SommernessMD , LuceroRJ , HamlonJS , EricksonJL , MatthewsR .A controlled study of reserpine on chronically disturbed patients. JAMA Archives of Neurology and Psychiatry1955;74(3):316-9. ">Sommerness 1955</a> ; <a href="./references#MR000050-bbs2-0084" title="SzymanskiJ , O'DonohueW .The potential role of state-dependent learning in cognitive therapy with spider phobics. Journal of Rational-Emotive &amp; Cognitive-Behavior Therapy1995;13(2):131-50. SzymanskiJ .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 20th of August 2019. ">Szymanski 1995</a> ; <a href="./references#MR000050-bbs2-0085" title="TanSY , BruniJ .Cognitive-behavior therapy with adult patients with epilepsy: a controlled outcome study. Epilepsia1986;27(3):225-33. ">Tan 1986</a> ; <a href="./references#MR000050-bbs2-0086" title="TeriL , LogsdonRG , UomotoJ , McCurrySM .Behavioral treatment of depression in dementia patients: a controlled clinical trial. Journals of Gerontology. Series B, Psychological Sciences and Social Sciences1997;52(4):159-66. TeriL .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 26th of August 2019. ">Teri 1997</a> ; <a href="./references#MR000050-bbs2-0087" title="ToriC , WorellL .Reduction of human avoidant behavior. A comparison of counterconditioning, expectancy, and cognitive information approaches. Clinical Psychology1973;41(2):269-78. ">Tori 1973</a> ; <a href="./references#MR000050-bbs2-0091" title="WatzlH , RistF , OlbrichR , CohenR .Placebo injections and surveillance of alcohol intake during inpatient treatment of female alcoholics. Addictive Behaviors1988;13(2):197-200. ">Watzl 1988</a> ; <a href="./references#MR000050-bbs2-0092" title="WeingaertnerAH .Self-administered aversive stimulation with hallucinating hospitalized schizophrenics. Journal of Consulting and Clinical Psychology1971;36(3):422-29. ">Weingaertner 1971</a> ; <a href="./references#MR000050-bbs2-0093" title="WhittakerCB , HoyRM .Withdrawal of perphenazine in chronic schizophrenia. British Journal of Psychiatry1963;109:422-7. ">Whittaker 1963</a> ; <a href="./references#MR000050-bbs2-0094" title="WilsonA , DavidsonWJ , BlanchardR , WhiteJ .Disulfiram implantation. A placebo-controlled trial with two-year follow-up. Journal of Studies on Alcohol1978;39(5):809-19. WilsonA , DavidsonWJ , BlanchardR .Disulfiram implantation: a trial using placebo implants and two types of controls. Journal of Studies on Alcohol1980;41(5):429-36. ">Wilson 1980</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Labelled wait‐list control intervention but the description is a no‐treatment control intervention </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>10</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#MR000050-bbs2-0005" title="AscherLM , TurnerR .Paradoxical intention and insomnia: an experimental investigation. Behaviour Research and Therapy1979;17(4):408-11. ">Ascher 1979</a> ; <a href="./references#MR000050-bbs2-0009" title="BorkovecTD , KaloupekDG , SlamaKM .The facilitative effect of muscle tension-release in the relaxation treatment of sleep disturbance. Behavior Therapy1975;6(3):301-9. ">Borkovec 1975</a> ; <a href="./references#MR000050-bbs2-0010" title="BorkovecTD , WeertsTC .Effects of progressive relaxation on sleep disturbance: an electroencephalographic evaluation. Psychosomatic Medicine1976;38(3):173-80. ">Borkovec 1976</a> ; <a href="./references#MR000050-bbs2-0012" title="BramstonP , SpenceSH .Behavioural versus cognitive social-skills training with intellectually-handicapped adults. Behaviour Research and Therapy1985;23(3):239-46. ">Bramston 1985</a> ; <a href="./references#MR000050-bbs2-0022" title="EspieCA , BrooksDN , LindsayWR .An evaluation of tailored psychological treatment of insomnia. Journal of Behavior Therapy and Experimental Psychiatry1989;20(2):143-53. EspieCA , LindsayWR , BrooksDN , HoodEM , TurveyT .A controlled comparative investigation of psychological treatments for chronic sleep-onset insomnia. Behaviour Research and Therapy1989;27(1):79-88. ">Espie 1989a</a> ; <a href="./references#MR000050-bbs2-0037" title="KilmannPR , MilanRJ , BolandJP , NankinHR , DavidsonE , WestMO , et al.Group treatment of secondary erectile dysfunction. Journal of Sex &amp; Marital Therapy1987;13(3):168-82. KilmannPR , Milan RJ Jr, BolandJP , DavidsonE , WestMO , SablisRF , et al.The sexual interactions of men with secondary erectile dysfunction. Journal of Sex Education and Therapy1988;14(1):46-9. KilmannPR , Milan RJ Jr, BolandJP , NankinHR , SablisRF , WestMO , et al.The sexual interactions of men with secondary erectile dysfunction. Paper presented at the annual meeting of the American Psychological Association in Los Angeles1985;1:46-9. ">Kilmann 1987</a> ; <a href="./references#MR000050-bbs2-0048" title="LickJ .Expectancy, false galvanic skin response feedback, and systematic desensitization in the modification of phobic behavior. Journal of Consulting and Clinical Psychology1975;43(4):557-67. ">Lick 1975</a> ; <a href="./references#MR000050-bbs2-0076" title="RosenGM , GlasgowRE , BarreraM .A controlled study to assess the clinical efficacy of totally self-administrated systematic desensitization. Journal of Consulting and Clinical Psychology1976;44(2):208-17. ">Rosen 1976</a> ; <a href="./references#MR000050-bbs2-0088" title="Trexler, L.Rational-emotive therapy, placebo, and no-treatment effects on public-speaking anxiety. Doctoral dissertation, Temple University AnnArbor, Mich.: University Microfilms1971;71-31(063). TrexlerLD , KarstTO .Rational-emotive therapy, placebo, and no-treatment effects on public-speaking anxiety. Journal of Abnormal Psyhology1972;79(1):60-7. ">Trexler 1972</a> ; <a href="./references#MR000050-bbs2-0089" title="AscherML , TurnerRM .A comparison of two methods for the administration of paradoxical intention. Behaviour Research and Therapy1980;18(2):121-6. TurnerRM , AscherLM .Controlled comparison of progressive relaxation, stimulus control, and paradoxical intention therapies for insomnia. Journal of Consulting and Clinical Psychology1979;47(3):500-8. ">Turner 1979</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Labelled no‐treatment control intervention but the description is a wait‐list control intervention </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#MR000050-bbs2-0016" title="CarterJC , OlmstedMP , KaplanAS , McCabeRE , MillsJS , AimeA .Self-help for bulimia nervosa: a randomized controlled trial. American Journal of Psychiatry2003;160(5):973-8. ">Carter 2003</a> ; <a href="./references#MR000050-bbs2-0031" title="HekmatH , LubitzR , DealR .Semantic desensitization: a paradigmatic intervention approach to anxiety disorders. Journal of Clinical Psychology1984;40(2):463-6. ">Hekmat 1984</a> ; <a href="./references#MR000050-bbs2-0032" title="HippmanC , RingroseA , InglisA , CheekJ , AlbertAY , RemickR , et al.A pilot randomized clinical trial evaluating the impact of genetic counselling for serious mental illnesses. Journal of Clinical Psychiatry2016;77(2):e190-8. ">Hippman 2016</a> ; <a href="./references#MR000050-bbs2-0086" title="TeriL , LogsdonRG , UomotoJ , McCurrySM .Behavioral treatment of depression in dementia patients: a controlled clinical trial. Journals of Gerontology. Series B, Psychological Sciences and Social Sciences1997;52(4):159-66. TeriL .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 26th of August 2019. ">Teri 1997</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Labelled as 'Minimal contact group' but description is a wait‐list control intervention</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#MR000050-bbs2-0025" title="FoaEB , McLeanCP , ZangY , RosenfieldD , YadinE , YarvisJS , et al.Effect of prolonged exposure therapy delivered over 2 weeks vs 8 weeks vs present-centered therapy on PTSD symptom severity in military personnel: a randomized clinical trial. JAMA2018;319(4):354-64. ">Foa 2018</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Labelled as 'Delayed treatment group' but description is a wait‐list control intervention</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#MR000050-bbs2-0033" title="HowlinP , GordonKR , PascoG , WadeA , CharmanT .The effectiveness of picture exchange communication system (PECS) training for teachers of children with autism: a pragmatic,group randomised controlled trial. Journal of Child Psychology and Psychiatry2007;48(5):473-81. ">Howlin 2007</a> ; <a href="./references#MR000050-bbs2-0073" title="RobinA .Rationing out-patients: a defence of the waiting list. British Journal of Psychiatry1976;129:138-41. ">Robin 1976</a> ; <a href="./references#MR000050-bbs2-0096" title="WollersheimJP , WilsonGL .Group treatment of unipolar depression: a comparison of coping, supportive, bibliotherapy, and delayed treatment groups. Professional Psychology: Research and Practice1991;22(6):496-502. ">Wollersheim 1991</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Add‐on drug treatment to each group</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#MR000050-bbs2-0001" title="AbikoffH , HechtmanL , KleinRG .Social functioning in children with ADHD treated with long-term methylphenidate and multimodal psychosocial treatment. Journal of the American Academy of Child and Adolescent Psychiatry2004;43(7):820-9. AbikoffH .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to A Todorovac 23rd of August 2019. KleinRG , AbikoffH , HechtmanL , WeissG .Design and rationale of controlled study of long-term methylphenidate and multimodal psychosocial treatment in children with ADHD. Journal of the American Academy of Child and Adolescent Psychiatry2004;43(7):792-801. ">Abikoff 2004</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Add‐on psychotherapeutic treatment on each group</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#MR000050-bbs2-0007" title="BergI , ForsytheI , HoltP , WattsJ .A controlled trial of ‘Senokot’ in faecal soiling treated by behavioural methods. Journal of Child Psychology and Psychiatry1983;24(4):543-9. ">Berg 1983</a> ; <a href="./references#MR000050-bbs2-0039" title="KlermanGL , DimascioA , WeismannM , PrusoffB , PaykelES .Treatment of depression by drugs and psychotherapy. American Journal of Psychiatry1974;131(2):186-91. PaykelES , DimascioA , HaskellD , PrusoffBA .Effects of maintenance amitriptyline and psychotherapy on symptoms of depression. Psychological Medicine1975;5(1):67-77. PaykelES , DiMascioA , KlermanGL , PrusoffBA .Maintenance therapy of depression. Pharmakopsychiatrie, Neuro-Psychopharmakologie1976;9:127-39. PaykelES , WeissmanMM , PrusoffBA .Social maladjustment and severity of depression. Comprehensive Psychiatry1978;19(2):121-8. WeissmanMM , KlermanGL , PaykelES , PrusoffB .Treatment effects on the social adjustment of depressed patients. Archives of General Psychiatry1974;30:771-8. ">Klerman 1974a</a> ; <a href="./references#MR000050-bbs2-0040" title="KlermanGL , DimascioA , WeismannM , PrusoffB , PaykelES .Treatment of depression by drugs and psychotherapy. American Journal of Psychiatry1974;131(2):186-91. ">Klerman 1974b</a> ; <a href="./references#MR000050-bbs2-0067" title="PowersMB , SmithsJA , WhitleyD , BystritskyA , TelchMJ .The effect of attributional processes concerning medication taking on return of fear. Journal of Consulting and Clinical Psychology2008;76(3):478-90. ">Powers 2008b</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Outcomes (four or more trials)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Behavioral Avoidance Test (BAT)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#MR000050-bbs2-0023" title="EtringerBD , CashTF , RimmDC .Behavioral, affective, and cognitive effects of participant modeling and an equally credible placebo. Behavior Therapy1982;13(4):476-85. ">Etringer 1982</a> ; <a href="./references#MR000050-bbs2-0036" title="KennedyTD , KimuraHK .Transfer, behavioral improvement, and anxiety reduction in systematic desensitization. Journal of Consulting and Clinical Psychology1974;42(5):720-8. ">Kennedy 1974</a> ; <a href="./references#MR000050-bbs2-0042" title="KrapflJE , NawasMM .Differential ordering of stimulus presentation in systematic desensitization. Journal of Abnormal Psychology1970;75(3):333-7. ">Krapfl 1970</a> ; <a href="./references#MR000050-bbs2-0046" title="LangOJ , LazovikAD .Experimental desensitization of a phobia. Journal of Abnormal and Social Psychology1963;66:519-25. LangPJ , LazovikAD , ReynoldsDJ .Desensitization, suggestibility, and pseudotherapy. Journal of Abnormal Psychology1965;70(6):395-402. ">Lang 1965</a> ; <a href="./references#MR000050-bbs2-0060" title="PeckCL .Desensitization for the treatment of fear in the high level adult retardate. Behaviour Research and Therapy1977;15(2):137-48. ">Peck 1976</a> ; <a href="./references#MR000050-bbs2-0076" title="RosenGM , GlasgowRE , BarreraM .A controlled study to assess the clinical efficacy of totally self-administrated systematic desensitization. Journal of Consulting and Clinical Psychology1976;44(2):208-17. ">Rosen 1976</a> ; <a href="./references#MR000050-bbs2-0084" title="SzymanskiJ , O'DonohueW .The potential role of state-dependent learning in cognitive therapy with spider phobics. Journal of Rational-Emotive &amp; Cognitive-Behavior Therapy1995;13(2):131-50. SzymanskiJ .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 20th of August 2019. ">Szymanski 1995</a> ; <a href="./references#MR000050-bbs2-0095" title="WolitzkyKB , TelchMJ .Augmenting in vivo exposure with fear antagonistic actions: a preliminary test. Behavior Therapy2009;40(1):57-71. ">Wolitzky 2009</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Daily Sleep Questionnaire (DSQ)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#MR000050-bbs2-0005" title="AscherLM , TurnerR .Paradoxical intention and insomnia: an experimental investigation. Behaviour Research and Therapy1979;17(4):408-11. ">Ascher 1979</a> ; <a href="./references#MR000050-bbs2-0009" title="BorkovecTD , KaloupekDG , SlamaKM .The facilitative effect of muscle tension-release in the relaxation treatment of sleep disturbance. Behavior Therapy1975;6(3):301-9. ">Borkovec 1975</a> ; <a href="./references#MR000050-bbs2-0022" title="EspieCA , BrooksDN , LindsayWR .An evaluation of tailored psychological treatment of insomnia. Journal of Behavior Therapy and Experimental Psychiatry1989;20(2):143-53. EspieCA , LindsayWR , BrooksDN , HoodEM , TurveyT .A controlled comparative investigation of psychological treatments for chronic sleep-onset insomnia. Behaviour Research and Therapy1989;27(1):79-88. ">Espie 1989a</a> ; <a href="./references#MR000050-bbs2-0083" title="SteinmarkSW , BorkovecTD .Active and placebo treatment effects on moderate insomnia under counterdemand and positive demand instructions. Journal of Abnormal Psychology1974;83(2):157-63. ">Steinmark 1974</a> ; <a href="./references#MR000050-bbs2-0088" title="Trexler, L.Rational-emotive therapy, placebo, and no-treatment effects on public-speaking anxiety. Doctoral dissertation, Temple University AnnArbor, Mich.: University Microfilms1971;71-31(063). TrexlerLD , KarstTO .Rational-emotive therapy, placebo, and no-treatment effects on public-speaking anxiety. Journal of Abnormal Psyhology1972;79(1):60-7. ">Trexler 1972</a> ; <a href="./references#MR000050-bbs2-0090" title="VanderplateC .Electromyograph biofeedback Treatment of sleep onset Insomnia: a controlled Investigation. Dissertation, University of Southern Mississippi1978. ">Vanderplate 1983</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Beck Depression Inventory (BDI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#MR000050-bbs2-0006" title="AyenI , HautzingerM .Cognitive behavior therapy for depression in menopausal women. A controlled, randomized treatment study [Kognitive Verhaltenstherapie bei Depressionen im Klimakterium: Eine kontrollierte, randomiserte Interventionsstudie]. Zeitschrift für Klinische Psychologie und Psychotherapie2004;33(4):290-9. AyenI .Inclusion of study in Cochrane Systematic Review (personal communication). Email to EG Faltinsen 9th of September 2019. ">Ayen 2004</a> ; <a href="./references#MR000050-bbs2-0027" title="FuchsCZ , RehnLP .A self-control behavior therapy program for depression. Journal of Consulting and Clinical Psychology1977;45(2):206-15. ">Fuchs 1977</a> ; <a href="./references#MR000050-bbs2-0047" title="LegrandF .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 14th of August 2019. LegrandFD , NeffEM .Efficacy of exercise as an adjunct treatment for clinically depressed inpatients during the initial stages of antidepressant pharmacotherapy: an open randomized controlled trial. Journal of Affective Disorders2016;191:139-44. ">Legrand 2016</a> ; <a href="./references#MR000050-bbs2-0085" title="TanSY , BruniJ .Cognitive-behavior therapy with adult patients with epilepsy: a controlled outcome study. Epilepsia1986;27(3):225-33. ">Tan 1986</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Adverse events</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Serious adverse events</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>11</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#MR000050-bbs2-0021" title="EhlersA , HackmannA , GreyN , WildJ , LinessS , AlbertI , et al.A randomized controlled trial of 7-day intensive and standard weekly cognitive therapy for PTSD and emotion-focused supportive therapy. American Journal of Psychiatry2014;171(3):294-304. ">Ehlers 2014</a> ; <a href="./references#MR000050-bbs2-0025" title="FoaEB , McLeanCP , ZangY , RosenfieldD , YadinE , YarvisJS , et al.Effect of prolonged exposure therapy delivered over 2 weeks vs 8 weeks vs present-centered therapy on PTSD symptom severity in military personnel: a randomized clinical trial. JAMA2018;319(4):354-64. ">Foa 2018</a> ; <a href="./references#MR000050-bbs2-0026" title="FreireAO , SugaiGC , ChrispinFS , TogeiroSM , YamamuraY , MelloLE , et al.Treatment of moderate obstructive sleep apnea syndrome with acupuncture: a randomised, placebo-controlled pilot trial. Sleep Medicine2007;8(1):43-50. ">Freire 2007</a> ; <a href="./references#MR000050-bbs2-0034" title="KarstM , WinterhalterM , MünteS , FranckiB , HondronikosA , EckardtA , et al.Auricular acupuncture for dental anxiety: a randomized controlled trial. Anesthesia and Analgesia2007;104(2):295-300. KarstM .Inclusion of study in Cochrane Systematic Review (personal communication). Email to: EG Faltinsen 5th of September 2019. ">Karst 2007</a> ; <a href="./references#MR000050-bbs2-0041" title="KloskoJS , BarlowDH , TassinariR , CernyJA .A comparison of alprazolam and behavior therapy in treatment of panic disorder: correction. Journal of Psychotherapy Practice and Research1994;3(2):163-79. KloskoJS , BarlowDH , TassinariR , CernyJA .A comparison of alprazolam and behavior therapy in treatment of panic disorder. Journal of Consulting and Clinical Psychology1990;58(1):77-84. ">Klosko 1990</a> ; <a href="./references#MR000050-bbs2-0043" title="KwanR .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 26th of August 2019. KwanRY , LeungMC , LaiCK .Acupressure for agitation in nursing home residents with dementia: study protocol for a randomized controlled trial. Trials2014;15(410):1-7. KwanRY , LeungMCP , LaiCK .A randomized controlled trial examining the effect of acupressure on agitation and salivary cortisol in nursing home residents with dementia. Dementia and Geriatric Cognitive Disorders2017;44(1-2):92-104. ">Kwan 2017</a> ; <a href="./references#MR000050-bbs2-0044" title="LacyMK .The effect of short term autogenic training on the stress reactivity of hospitalized emotionally disturbed adolescents. ProQuest Dissertations Publishing, Oklahoma State University1996. ">Lacy 1990</a> ; <a href="./references#MR000050-bbs2-0047" title="LegrandF .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 14th of August 2019. LegrandFD , NeffEM .Efficacy of exercise as an adjunct treatment for clinically depressed inpatients during the initial stages of antidepressant pharmacotherapy: an open randomized controlled trial. Journal of Affective Disorders2016;191:139-44. ">Legrand 2016</a> ; <a href="./references#MR000050-bbs2-0052" title="McLachlanDR , DaltonAJ , KruckTP , BellMY , SmithWL , KalowW , et al.Intramuscular desferrioxamine in patients with Alzheimer's disease. Lancet1991;337(8753):1304-8. McLachlanDRC , SmithWL , KruckTP .Desferrioxamine and Alzheimer’s disease: video home behavior assessment of clinical course and measures of brain aluminum. Therapeutic Drug Monitoring1993;15(6):602-7. ">McLachlan 1991</a> ; <a href="./references#MR000050-bbs2-0057" title="NandiDN , AjmanyS , GanguliH , BanerjeeG , BoralGC , GhoshA , et al.A clinical evaluation of depressives found in a rural survey in India. British Journal of Psychiatry1976;128:523-7. ">Nandi 1976</a> ; <a href="./references#MR000050-bbs2-0094" title="WilsonA , DavidsonWJ , BlanchardR , WhiteJ .Disulfiram implantation. A placebo-controlled trial with two-year follow-up. Journal of Studies on Alcohol1978;39(5):809-19. WilsonA , DavidsonWJ , BlanchardR .Disulfiram implantation: a trial using placebo implants and two types of controls. Journal of Studies on Alcohol1980;41(5):429-36. ">Wilson 1980</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Non‐serious adverse events</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>14</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#MR000050-bbs2-0006" title="AyenI , HautzingerM .Cognitive behavior therapy for depression in menopausal women. A controlled, randomized treatment study [Kognitive Verhaltenstherapie bei Depressionen im Klimakterium: Eine kontrollierte, randomiserte Interventionsstudie]. Zeitschrift für Klinische Psychologie und Psychotherapie2004;33(4):290-9. AyenI .Inclusion of study in Cochrane Systematic Review (personal communication). Email to EG Faltinsen 9th of September 2019. ">Ayen 2004</a> ; <a href="./references#MR000050-bbs2-0021" title="EhlersA , HackmannA , GreyN , WildJ , LinessS , AlbertI , et al.A randomized controlled trial of 7-day intensive and standard weekly cognitive therapy for PTSD and emotion-focused supportive therapy. American Journal of Psychiatry2014;171(3):294-304. ">Ehlers 2014</a> ; <a href="./references#MR000050-bbs2-0025" title="FoaEB , McLeanCP , ZangY , RosenfieldD , YadinE , YarvisJS , et al.Effect of prolonged exposure therapy delivered over 2 weeks vs 8 weeks vs present-centered therapy on PTSD symptom severity in military personnel: a randomized clinical trial. JAMA2018;319(4):354-64. ">Foa 2018</a> ; <a href="./references#MR000050-bbs2-0026" title="FreireAO , SugaiGC , ChrispinFS , TogeiroSM , YamamuraY , MelloLE , et al.Treatment of moderate obstructive sleep apnea syndrome with acupuncture: a randomised, placebo-controlled pilot trial. Sleep Medicine2007;8(1):43-50. ">Freire 2007</a> ; <a href="./references#MR000050-bbs2-0029" title="GoldsteinAJ , BeursE , Chambless Dl, WilsonKA .EMDR for panic disorder with agoraphobia: comparison with waiting list and credible attention-placebo control conditions. Journal of Consulting and Clinical Psychology2000;68(6):947-56. ">Goldstein 2000</a> ; <a href="./references#MR000050-bbs2-0034" title="KarstM , WinterhalterM , MünteS , FranckiB , HondronikosA , EckardtA , et al.Auricular acupuncture for dental anxiety: a randomized controlled trial. Anesthesia and Analgesia2007;104(2):295-300. KarstM .Inclusion of study in Cochrane Systematic Review (personal communication). Email to: EG Faltinsen 5th of September 2019. ">Karst 2007</a> ; <a href="./references#MR000050-bbs2-0041" title="KloskoJS , BarlowDH , TassinariR , CernyJA .A comparison of alprazolam and behavior therapy in treatment of panic disorder: correction. Journal of Psychotherapy Practice and Research1994;3(2):163-79. KloskoJS , BarlowDH , TassinariR , CernyJA .A comparison of alprazolam and behavior therapy in treatment of panic disorder. Journal of Consulting and Clinical Psychology1990;58(1):77-84. ">Klosko 1990</a> ; <a href="./references#MR000050-bbs2-0043" title="KwanR .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 26th of August 2019. KwanRY , LeungMC , LaiCK .Acupressure for agitation in nursing home residents with dementia: study protocol for a randomized controlled trial. Trials2014;15(410):1-7. KwanRY , LeungMCP , LaiCK .A randomized controlled trial examining the effect of acupressure on agitation and salivary cortisol in nursing home residents with dementia. Dementia and Geriatric Cognitive Disorders2017;44(1-2):92-104. ">Kwan 2017</a> ; <a href="./references#MR000050-bbs2-0044" title="LacyMK .The effect of short term autogenic training on the stress reactivity of hospitalized emotionally disturbed adolescents. ProQuest Dissertations Publishing, Oklahoma State University1996. ">Lacy 1990</a> ; <a href="./references#MR000050-bbs2-0047" title="LegrandF .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 14th of August 2019. LegrandFD , NeffEM .Efficacy of exercise as an adjunct treatment for clinically depressed inpatients during the initial stages of antidepressant pharmacotherapy: an open randomized controlled trial. Journal of Affective Disorders2016;191:139-44. ">Legrand 2016</a> ; <a href="./references#MR000050-bbs2-0052" title="McLachlanDR , DaltonAJ , KruckTP , BellMY , SmithWL , KalowW , et al.Intramuscular desferrioxamine in patients with Alzheimer's disease. Lancet1991;337(8753):1304-8. McLachlanDRC , SmithWL , KruckTP .Desferrioxamine and Alzheimer’s disease: video home behavior assessment of clinical course and measures of brain aluminum. Therapeutic Drug Monitoring1993;15(6):602-7. ">McLachlan 1991</a> ; <a href="./references#MR000050-bbs2-0057" title="NandiDN , AjmanyS , GanguliH , BanerjeeG , BoralGC , GhoshA , et al.A clinical evaluation of depressives found in a rural survey in India. British Journal of Psychiatry1976;128:523-7. ">Nandi 1976</a> ; <a href="./references#MR000050-bbs2-0094" title="WilsonA , DavidsonWJ , BlanchardR , WhiteJ .Disulfiram implantation. A placebo-controlled trial with two-year follow-up. Journal of Studies on Alcohol1978;39(5):809-19. WilsonA , DavidsonWJ , BlanchardR .Disulfiram implantation: a trial using placebo implants and two types of controls. Journal of Studies on Alcohol1980;41(5):429-36. ">Wilson 1980</a> ; <a href="./references#MR000050-bbs2-0096" title="WollersheimJP , WilsonGL .Group treatment of unipolar depression: a comparison of coping, supportive, bibliotherapy, and delayed treatment groups. Professional Psychology: Research and Practice1991;22(6):496-502. ">Wollersheim 1991</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Type of adverse events</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Complaint list</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#MR000050-bbs2-0006" title="AyenI , HautzingerM .Cognitive behavior therapy for depression in menopausal women. A controlled, randomized treatment study [Kognitive Verhaltenstherapie bei Depressionen im Klimakterium: Eine kontrollierte, randomiserte Interventionsstudie]. Zeitschrift für Klinische Psychologie und Psychotherapie2004;33(4):290-9. AyenI .Inclusion of study in Cochrane Systematic Review (personal communication). Email to EG Faltinsen 9th of September 2019. ">Ayen 2004</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Clinician‐administered posttraumatic stress disorder (PTSD) Scale for DSM‐5 (CAPS‐5)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#MR000050-bbs2-0021" title="EhlersA , HackmannA , GreyN , WildJ , LinessS , AlbertI , et al.A randomized controlled trial of 7-day intensive and standard weekly cognitive therapy for PTSD and emotion-focused supportive therapy. American Journal of Psychiatry2014;171(3):294-304. ">Ehlers 2014</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Disulfiram‐ethanol reaction (DER)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#MR000050-bbs2-0094" title="WilsonA , DavidsonWJ , BlanchardR , WhiteJ .Disulfiram implantation. A placebo-controlled trial with two-year follow-up. Journal of Studies on Alcohol1978;39(5):809-19. WilsonA , DavidsonWJ , BlanchardR .Disulfiram implantation: a trial using placebo implants and two types of controls. Journal of Studies on Alcohol1980;41(5):429-36. ">Wilson 1980</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Spontaneous reporting</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>11</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#MR000050-bbs2-0025" title="FoaEB , McLeanCP , ZangY , RosenfieldD , YadinE , YarvisJS , et al.Effect of prolonged exposure therapy delivered over 2 weeks vs 8 weeks vs present-centered therapy on PTSD symptom severity in military personnel: a randomized clinical trial. JAMA2018;319(4):354-64. ">Foa 2018</a> ; <a href="./references#MR000050-bbs2-0026" title="FreireAO , SugaiGC , ChrispinFS , TogeiroSM , YamamuraY , MelloLE , et al.Treatment of moderate obstructive sleep apnea syndrome with acupuncture: a randomised, placebo-controlled pilot trial. Sleep Medicine2007;8(1):43-50. ">Freire 2007</a> ; <a href="./references#MR000050-bbs2-0029" title="GoldsteinAJ , BeursE , Chambless Dl, WilsonKA .EMDR for panic disorder with agoraphobia: comparison with waiting list and credible attention-placebo control conditions. Journal of Consulting and Clinical Psychology2000;68(6):947-56. ">Goldstein 2000</a> ; <a href="./references#MR000050-bbs2-0034" title="KarstM , WinterhalterM , MünteS , FranckiB , HondronikosA , EckardtA , et al.Auricular acupuncture for dental anxiety: a randomized controlled trial. Anesthesia and Analgesia2007;104(2):295-300. KarstM .Inclusion of study in Cochrane Systematic Review (personal communication). Email to: EG Faltinsen 5th of September 2019. ">Karst 2007</a> ; <a href="./references#MR000050-bbs2-0041" title="KloskoJS , BarlowDH , TassinariR , CernyJA .A comparison of alprazolam and behavior therapy in treatment of panic disorder: correction. Journal of Psychotherapy Practice and Research1994;3(2):163-79. KloskoJS , BarlowDH , TassinariR , CernyJA .A comparison of alprazolam and behavior therapy in treatment of panic disorder. Journal of Consulting and Clinical Psychology1990;58(1):77-84. ">Klosko 1990</a> ; <a href="./references#MR000050-bbs2-0043" title="KwanR .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 26th of August 2019. KwanRY , LeungMC , LaiCK .Acupressure for agitation in nursing home residents with dementia: study protocol for a randomized controlled trial. Trials2014;15(410):1-7. KwanRY , LeungMCP , LaiCK .A randomized controlled trial examining the effect of acupressure on agitation and salivary cortisol in nursing home residents with dementia. Dementia and Geriatric Cognitive Disorders2017;44(1-2):92-104. ">Kwan 2017</a> ; <a href="./references#MR000050-bbs2-0044" title="LacyMK .The effect of short term autogenic training on the stress reactivity of hospitalized emotionally disturbed adolescents. ProQuest Dissertations Publishing, Oklahoma State University1996. ">Lacy 1990</a> ; <a href="./references#MR000050-bbs2-0047" title="LegrandF .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 14th of August 2019. LegrandFD , NeffEM .Efficacy of exercise as an adjunct treatment for clinically depressed inpatients during the initial stages of antidepressant pharmacotherapy: an open randomized controlled trial. Journal of Affective Disorders2016;191:139-44. ">Legrand 2016</a> ; <a href="./references#MR000050-bbs2-0052" title="McLachlanDR , DaltonAJ , KruckTP , BellMY , SmithWL , KalowW , et al.Intramuscular desferrioxamine in patients with Alzheimer's disease. Lancet1991;337(8753):1304-8. McLachlanDRC , SmithWL , KruckTP .Desferrioxamine and Alzheimer’s disease: video home behavior assessment of clinical course and measures of brain aluminum. Therapeutic Drug Monitoring1993;15(6):602-7. ">McLachlan 1991</a> ; <a href="./references#MR000050-bbs2-0057" title="NandiDN , AjmanyS , GanguliH , BanerjeeG , BoralGC , GhoshA , et al.A clinical evaluation of depressives found in a rural survey in India. British Journal of Psychiatry1976;128:523-7. ">Nandi 1976</a> ; <a href="./references#MR000050-bbs2-0096" title="WollersheimJP , WilsonGL .Group treatment of unipolar depression: a comparison of coping, supportive, bibliotherapy, and delayed treatment groups. Professional Psychology: Research and Practice1991;22(6):496-502. ">Wollersheim 1991</a> </p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 3.</span> <span class="table-title">Key demographic characteristics of the included studies</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/full#MR000050-tbl-0006">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="MR000050-tbl-0007"> <div class="table-heading"><span class="table-label">Table 4.</span> <span class="table-title">Risk of bias in included studies</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Category</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Study</b> <b>frequency</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Study ID</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Random sequence generation</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Low risk of bias</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>27</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#MR000050-bbs2-0002" title="AllenJB .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to A Todorovac 28th of August 2019. AllenJJ , SchnyerRN , HittSK .The efficacy of acupuncture in the treatment of major depression in women. Psychological Science1998;9(5):397-401. ">Allen 1998</a> ; <a href="./references#MR000050-bbs2-0003" title="AllenJB .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 28th of August 2019. AllenJJ , SchnyerRN , ChambersAS , HittSK , MorenoFA , ManberR .Acupuncture for depression: a randomized controlled trial. Journal of Clinical Psychiatry2006;67(11):1665-73. ">Allen 2006</a> ; <a href="./references#MR000050-bbs2-0011" title="BornovalovaM .Inclusion of study in Cochrane Systematic Review (personal communication). Email to A Todorovac. 21st of August 2019. BornovalovaMA .Distress tolerance treatment for inner-city drug users: a preliminary trial. Doctor’s Dissertation, University of Maryland2008. ">Bornovalova 2008</a> ; <a href="./references#MR000050-bbs2-0016" title="CarterJC , OlmstedMP , KaplanAS , McCabeRE , MillsJS , AimeA .Self-help for bulimia nervosa: a randomized controlled trial. American Journal of Psychiatry2003;160(5):973-8. ">Carter 2003</a> ; <a href="./references#MR000050-bbs2-0019" title="Doty, DW.Role playing and incentives in the modification of the social interaction of chronic psychiatric patients. Journal of Consulting and Clinical Psychology1975;43(5):676-82. ">Doty 1975</a> ; <a href="./references#MR000050-bbs2-0021" title="EhlersA , HackmannA , GreyN , WildJ , LinessS , AlbertI , et al.A randomized controlled trial of 7-day intensive and standard weekly cognitive therapy for PTSD and emotion-focused supportive therapy. American Journal of Psychiatry2014;171(3):294-304. ">Ehlers 2014</a> ; <a href="./references#MR000050-bbs2-0025" title="FoaEB , McLeanCP , ZangY , RosenfieldD , YadinE , YarvisJS , et al.Effect of prolonged exposure therapy delivered over 2 weeks vs 8 weeks vs present-centered therapy on PTSD symptom severity in military personnel: a randomized clinical trial. JAMA2018;319(4):354-64. ">Foa 2018</a> ; <a href="./references#MR000050-bbs2-0026" title="FreireAO , SugaiGC , ChrispinFS , TogeiroSM , YamamuraY , MelloLE , et al.Treatment of moderate obstructive sleep apnea syndrome with acupuncture: a randomised, placebo-controlled pilot trial. Sleep Medicine2007;8(1):43-50. ">Freire 2007</a> ; <a href="./references#MR000050-bbs2-0032" title="HippmanC , RingroseA , InglisA , CheekJ , AlbertAY , RemickR , et al.A pilot randomized clinical trial evaluating the impact of genetic counselling for serious mental illnesses. Journal of Clinical Psychiatry2016;77(2):e190-8. ">Hippman 2016</a> ; <a href="./references#MR000050-bbs2-0033" title="HowlinP , GordonKR , PascoG , WadeA , CharmanT .The effectiveness of picture exchange communication system (PECS) training for teachers of children with autism: a pragmatic,group randomised controlled trial. Journal of Child Psychology and Psychiatry2007;48(5):473-81. ">Howlin 2007</a> ; <a href="./references#MR000050-bbs2-0034" title="KarstM , WinterhalterM , MünteS , FranckiB , HondronikosA , EckardtA , et al.Auricular acupuncture for dental anxiety: a randomized controlled trial. Anesthesia and Analgesia2007;104(2):295-300. KarstM .Inclusion of study in Cochrane Systematic Review (personal communication). Email to: EG Faltinsen 5th of September 2019. ">Karst 2007</a> ; <a href="./references#MR000050-bbs2-0035" title="KelleyJ .Inclusion of study in Cochrane Systematic Review (personal communication). Email to: A Todorovac 12th of August 2019. KelleyJM , KaptchukTJ , CusinC , LipkinS , FavaM .Open-label placebo for major depressive disorder: a pilot randomized controlled trial. Psychotherapy and Psychosomatics2012;81(5):312-4. ">Kelley 2012</a> ; <a href="./references#MR000050-bbs2-0037" title="KilmannPR , MilanRJ , BolandJP , NankinHR , DavidsonE , WestMO , et al.Group treatment of secondary erectile dysfunction. Journal of Sex &amp; Marital Therapy1987;13(3):168-82. KilmannPR , Milan RJ Jr, BolandJP , DavidsonE , WestMO , SablisRF , et al.The sexual interactions of men with secondary erectile dysfunction. Journal of Sex Education and Therapy1988;14(1):46-9. KilmannPR , Milan RJ Jr, BolandJP , NankinHR , SablisRF , WestMO , et al.The sexual interactions of men with secondary erectile dysfunction. Paper presented at the annual meeting of the American Psychological Association in Los Angeles1985;1:46-9. ">Kilmann 1987</a> ; <a href="./references#MR000050-bbs2-0043" title="KwanR .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 26th of August 2019. KwanRY , LeungMC , LaiCK .Acupressure for agitation in nursing home residents with dementia: study protocol for a randomized controlled trial. Trials2014;15(410):1-7. KwanRY , LeungMCP , LaiCK .A randomized controlled trial examining the effect of acupressure on agitation and salivary cortisol in nursing home residents with dementia. Dementia and Geriatric Cognitive Disorders2017;44(1-2):92-104. ">Kwan 2017</a> ; <a href="./references#MR000050-bbs2-0047" title="LegrandF .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 14th of August 2019. LegrandFD , NeffEM .Efficacy of exercise as an adjunct treatment for clinically depressed inpatients during the initial stages of antidepressant pharmacotherapy: an open randomized controlled trial. Journal of Affective Disorders2016;191:139-44. ">Legrand 2016</a> ; <a href="./references#MR000050-bbs2-0052" title="McLachlanDR , DaltonAJ , KruckTP , BellMY , SmithWL , KalowW , et al.Intramuscular desferrioxamine in patients with Alzheimer's disease. Lancet1991;337(8753):1304-8. McLachlanDRC , SmithWL , KruckTP .Desferrioxamine and Alzheimer’s disease: video home behavior assessment of clinical course and measures of brain aluminum. Therapeutic Drug Monitoring1993;15(6):602-7. ">McLachlan 1991</a> ; <a href="./references#MR000050-bbs2-0064" title="PolandRE , GertsikL , FavreauJT , SmithSI , MirochaJM , RaoU , et al.Open-label randomized parallel-group controlled clinical trial of massage for treatment of depression in HIV-infected subjects. Journal of Alternative and Complementary Medicine2013;19(4):334-40. ">Poland 2013</a> ; <a href="./references#MR000050-bbs2-0066" title="PowersMB , SmithsJA , WhitleyD , BystritskyA , TelchMJ .The effect of attributional processes concerning medication taking on return of fear. Journal of Consulting and Clinical Psychology2008;76(3):478-90. ">Powers 2008a</a> ; <a href="./references#MR000050-bbs2-0067" title="PowersMB , SmithsJA , WhitleyD , BystritskyA , TelchMJ .The effect of attributional processes concerning medication taking on return of fear. Journal of Consulting and Clinical Psychology2008;76(3):478-90. ">Powers 2008b</a> ; <a href="./references#MR000050-bbs2-0068" title="ProudfootJ , ClarkeJ , BirchMR , WhittonAE , ParkerG , ManicavasagarV , et al.Impact of a mobile phone and web program on symptom and functional outcomes for people with mild- to-moderate depression, anxiety and stress: a randomized controlled trial. BMC Psychiatry2013;13(312):1-12. ProudfootJ .Re: Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 26th of August 2019. ">Proudfoot 2013</a> ; <a href="./references#MR000050-bbs2-0070" title="LiebowitzM , QuitkinFM , StewartJW , McGrathPJ , HarrisonWM , MarkowitzJS , et al.Antidepressant efficacy in atypical depression. Archives of General Psychiatry1988;45(2):129-37. QuitkinFM , McGrathPJ , StewartJW , HarrisonW , WagerSG , NunesE , et al.Phenelzine and imipramine in mood reactive depressives: further delineation of the syndrome of atypical depression. Archives of General Psychiatry1989;46(9):787-93. RabkinJG , McGrathPJ , QuitkinFM , TricamoE , StewartJW , KleinDF .Effects of pill-giving on maintenance of placebo response in patients with chronic mild depression. American Journal of Psychiatry1990;147(12):1622-6. ">Rabkin 1990</a> ; <a href="./references#MR000050-bbs2-0071" title="RapeeR .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 29th of August 2019. RapeeRM , AbbottMJ , LynehamHJ .Bibliotherapy for children With anxiety disorders using written materials for parents: a randomized controlled trial. Journal of Consulting and Clinical Psychology2006;74(3):436-44. ">Rapee 2006</a> ; <a href="./references#MR000050-bbs2-0072" title="RapeeR .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 29th of August 2019. RapeeRM , AbbottMJ , BaillieAJ , GastonJE .Treatment of social phobia through pure self-help and therapist-augmented self-help. British Journal of Psychiatry2007;191:246-52. ">Rapee 2007</a> ; <a href="./references#MR000050-bbs2-0076" title="RosenGM , GlasgowRE , BarreraM .A controlled study to assess the clinical efficacy of totally self-administrated systematic desensitization. Journal of Consulting and Clinical Psychology1976;44(2):208-17. ">Rosen 1976</a> ; <a href="./references#MR000050-bbs2-0082" title="SommernessMD , LuceroRJ , HamlonJS , EricksonJL , MatthewsR .A controlled study of reserpine on chronically disturbed patients. JAMA Archives of Neurology and Psychiatry1955;74(3):316-9. ">Sommerness 1955</a> ; <a href="./references#MR000050-bbs2-0084" title="SzymanskiJ , O'DonohueW .The potential role of state-dependent learning in cognitive therapy with spider phobics. Journal of Rational-Emotive &amp; Cognitive-Behavior Therapy1995;13(2):131-50. SzymanskiJ .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 20th of August 2019. ">Szymanski 1995</a> ; <a href="./references#MR000050-bbs2-0086" title="TeriL , LogsdonRG , UomotoJ , McCurrySM .Behavioral treatment of depression in dementia patients: a controlled clinical trial. Journals of Gerontology. Series B, Psychological Sciences and Social Sciences1997;52(4):159-66. TeriL .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 26th of August 2019. ">Teri 1997</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>High risk of bias</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#MR000050-bbs2-0045" title="LaiCK , ChiI , Kayser-JonesJ .A randomized controlled trial of a specific reminiscence approach to promote the well-being of nursing home residents with dementia. International Psychogeriatrics2004;16(1):33-49. LaiK .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 6th of September 2019. ">Lai 2004</a> ; <a href="./references#MR000050-bbs2-0063" title="PetersonMA , PattersonB , PillmanBM , BattistaMA .Cognitive recovery following alcohol detoxification: a computerised remediation study. Neuropsychological Rehabilitation2002;12(1):63-74. PillmanBM .Computerized cognitive remediation with recently detoxified alcoholics. Dissertation, California School of Professional Psychology, Fresno Campus2000. ">Pillman 2001</a> ; <a href="./references#MR000050-bbs2-0073" title="RobinA .Rationing out-patients: a defence of the waiting list. British Journal of Psychiatry1976;129:138-41. ">Robin 1976</a> ; <a href="./references#MR000050-bbs2-0079" title="ShalevAY , AnkriY , Isreali-ShalevY , PelegT , AdesskyR , FreedmanS .Prevention of posttraumatic stress disorder by early treatment. Archives of General Psychiatry2012;69(2):166-76. ">Shalev 2012</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Unclear risk of bias</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>65</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#MR000050-bbs2-0001" title="AbikoffH , HechtmanL , KleinRG .Social functioning in children with ADHD treated with long-term methylphenidate and multimodal psychosocial treatment. Journal of the American Academy of Child and Adolescent Psychiatry2004;43(7):820-9. AbikoffH .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to A Todorovac 23rd of August 2019. KleinRG , AbikoffH , HechtmanL , WeissG .Design and rationale of controlled study of long-term methylphenidate and multimodal psychosocial treatment in children with ADHD. Journal of the American Academy of Child and Adolescent Psychiatry2004;43(7):792-801. ">Abikoff 2004</a> ; <a href="./references#MR000050-bbs2-0004" title="AlvarezJR .The effects of anger management training on depression, anger, self-concept, and treatment responsibility in a sample of drug-dependent individuals in a therapeutic community. Dissertation Abstracts International: Section B: the Sciences and Engineering1997;58(4-B):2108. ">Alvarez 1997</a> ; <a href="./references#MR000050-bbs2-0005" title="AscherLM , TurnerR .Paradoxical intention and insomnia: an experimental investigation. Behaviour Research and Therapy1979;17(4):408-11. ">Ascher 1979</a> ; <a href="./references#MR000050-bbs2-0006" title="AyenI , HautzingerM .Cognitive behavior therapy for depression in menopausal women. A controlled, randomized treatment study [Kognitive Verhaltenstherapie bei Depressionen im Klimakterium: Eine kontrollierte, randomiserte Interventionsstudie]. Zeitschrift für Klinische Psychologie und Psychotherapie2004;33(4):290-9. AyenI .Inclusion of study in Cochrane Systematic Review (personal communication). Email to EG Faltinsen 9th of September 2019. ">Ayen 2004</a> ; <a href="./references#MR000050-bbs2-0007" title="BergI , ForsytheI , HoltP , WattsJ .A controlled trial of ‘Senokot’ in faecal soiling treated by behavioural methods. Journal of Child Psychology and Psychiatry1983;24(4):543-9. ">Berg 1983</a> ; <a href="./references#MR000050-bbs2-0008" title="Borden, KA.Attributional Outcomes: the Subtle Messages of Treatments for Attention Deficit Disorder. Dissertation, University of Illinois at Urbana-Champaign1986. BordenKA , BrownRT .Attributional outcomes: The subtle messages of treatments for attention deficit disorder. Cognitive Therapy and Research1989;13(2):147-60. ">Borden 1986</a> ; <a href="./references#MR000050-bbs2-0009" title="BorkovecTD , KaloupekDG , SlamaKM .The facilitative effect of muscle tension-release in the relaxation treatment of sleep disturbance. Behavior Therapy1975;6(3):301-9. ">Borkovec 1975</a> ; <a href="./references#MR000050-bbs2-0010" title="BorkovecTD , WeertsTC .Effects of progressive relaxation on sleep disturbance: an electroencephalographic evaluation. Psychosomatic Medicine1976;38(3):173-80. ">Borkovec 1976</a> ; <a href="./references#MR000050-bbs2-0012" title="BramstonP , SpenceSH .Behavioural versus cognitive social-skills training with intellectually-handicapped adults. Behaviour Research and Therapy1985;23(3):239-46. ">Bramston 1985</a> ; <a href="./references#MR000050-bbs2-0013" title="BrillNQ , KoeglerRR , EpsteinLJ , ForgyEW .Controlled study of psychiatric outpatient treatment. Archives of General Psychiatry1964;10:581-95. BrillNQ .Results of psychotherapy. California Medicine1966;104(4):249-53. ">Brill 1964a</a> ; <a href="./references#MR000050-bbs2-0014" title="BrillNQ , KoeglerRR , EpsteinLJ , ForgyEW .Controlled study of psychiatric outpatient treatment. Archives of General Psychiatry1964;10:581-95. ">Brill 1964b</a> ; <a href="./references#MR000050-bbs2-0015" title="CarlsonCL , PelhamWE , MilichR , HozaB .ADHD boys’ performance and attributions following success and failure: drug effects and individual differences. Cognitive Therapy and Research1993;17:269-87. ">Carlson 1993</a> ; <a href="./references#MR000050-bbs2-0017" title="CrispAH , NortonK , GowersS , HalekC , BowyerC , YeldhamD , et al.A controlled study of the effect of therapies aimed at adolescent and family psychopathology in Anorexia Nervosa. British Journal of Psychiatry: the Journal of Mental Science1991;159:325-33. GowersS , NortonK , HalekC , CrispAH .Outcome of outpatient psychotherapy in a random allocation treatment study of anorexia nervosa. International Journal of Eating Disorders1994;15(2):165-77. GowersS , NortonK , YelshamD .The St George's prospective treatment study of anorexia nervosa: a discussion of methodological problems. International Journal of Eating Disorders1989;8:445-54. ">Crisp 1991</a> ; <a href="./references#MR000050-bbs2-0018" title="CrouchG , RobsonM , HallstromC .Benzodiazepine dependent patients and their psychological treatment. Progress in Neuro-psychopharmacology &amp; Biological Psychiatry1988;12(4):503-10. HallströmC , CrouchG , RobsenM , ShineP .The treatment of tranquillizer dependence by propranolol. Postgraduate Medical Journal1988;64(Suppl 2):40-4. ">Crouch 1988</a> ; <a href="./references#MR000050-bbs2-0020" title="DoubleDB , WarrenGC , EvansM , RowlandsMP .Efficacy of maintenance use of anticholinergic agents. Acta Psychiatrica Scandinavica1993;88:381-4. ">Double 1993</a> ; <a href="./references#MR000050-bbs2-0022" title="EspieCA , BrooksDN , LindsayWR .An evaluation of tailored psychological treatment of insomnia. Journal of Behavior Therapy and Experimental Psychiatry1989;20(2):143-53. EspieCA , LindsayWR , BrooksDN , HoodEM , TurveyT .A controlled comparative investigation of psychological treatments for chronic sleep-onset insomnia. Behaviour Research and Therapy1989;27(1):79-88. ">Espie 1989a</a> ; <a href="./references#MR000050-bbs2-0023" title="EtringerBD , CashTF , RimmDC .Behavioral, affective, and cognitive effects of participant modeling and an equally credible placebo. Behavior Therapy1982;13(4):476-85. ">Etringer 1982</a> ; <a href="./references#MR000050-bbs2-0024" title="FoaEB , RothbaumBO , RiggsDS , MurdockTB .Treatment of posttraumatic stress disorder in rape victims: a comparison between cognitive-behavioral procedures and counselling. Journal of Consulting and Clinical Psychology1991;59(5):715-23. ">Foa 1991</a> ; <a href="./references#MR000050-bbs2-0027" title="FuchsCZ , RehnLP .A self-control behavior therapy program for depression. Journal of Consulting and Clinical Psychology1977;45(2):206-15. ">Fuchs 1977</a> ; <a href="./references#MR000050-bbs2-0028" title="GlogowskaM , RoulstoneS , EnderbyP , PetersTJ .Randomised controlled trial of community based speech and language therapy in preschool children. BMJ2000;321(7266):923-6. ">Glogowska 2000</a> ; <a href="./references#MR000050-bbs2-0029" title="GoldsteinAJ , BeursE , Chambless Dl, WilsonKA .EMDR for panic disorder with agoraphobia: comparison with waiting list and credible attention-placebo control conditions. Journal of Consulting and Clinical Psychology2000;68(6):947-56. ">Goldstein 2000</a> ; <a href="./references#MR000050-bbs2-0030" title="GoldwasserAN , AuerbachSM , HarkinsSW .Cognitive, affective, and behavioural effects of reminiscence group therapy on demented elderly. Aging and Human Development1987;25(3):209-22. ">Goldwasser 1987</a> ; <a href="./references#MR000050-bbs2-0031" title="HekmatH , LubitzR , DealR .Semantic desensitization: a paradigmatic intervention approach to anxiety disorders. Journal of Clinical Psychology1984;40(2):463-6. ">Hekmat 1984</a> ; <a href="./references#MR000050-bbs2-0036" title="KennedyTD , KimuraHK .Transfer, behavioral improvement, and anxiety reduction in systematic desensitization. Journal of Consulting and Clinical Psychology1974;42(5):720-8. ">Kennedy 1974</a> ; <a href="./references#MR000050-bbs2-0038" title="KleinSA , DeffenbacherJL .Relaxation and exercise for hyperactive impulsive children. Perceptual and Motor Skills1977;45:1159-62. ">Klein 1977</a> ; <a href="./references#MR000050-bbs2-0039" title="KlermanGL , DimascioA , WeismannM , PrusoffB , PaykelES .Treatment of depression by drugs and psychotherapy. American Journal of Psychiatry1974;131(2):186-91. PaykelES , DimascioA , HaskellD , PrusoffBA .Effects of maintenance amitriptyline and psychotherapy on symptoms of depression. Psychological Medicine1975;5(1):67-77. PaykelES , DiMascioA , KlermanGL , PrusoffBA .Maintenance therapy of depression. Pharmakopsychiatrie, Neuro-Psychopharmakologie1976;9:127-39. PaykelES , WeissmanMM , PrusoffBA .Social maladjustment and severity of depression. Comprehensive Psychiatry1978;19(2):121-8. WeissmanMM , KlermanGL , PaykelES , PrusoffB .Treatment effects on the social adjustment of depressed patients. Archives of General Psychiatry1974;30:771-8. ">Klerman 1974a</a> ; <a href="./references#MR000050-bbs2-0040" title="KlermanGL , DimascioA , WeismannM , PrusoffB , PaykelES .Treatment of depression by drugs and psychotherapy. American Journal of Psychiatry1974;131(2):186-91. ">Klerman 1974b</a> ; <a href="./references#MR000050-bbs2-0041" title="KloskoJS , BarlowDH , TassinariR , CernyJA .A comparison of alprazolam and behavior therapy in treatment of panic disorder: correction. Journal of Psychotherapy Practice and Research1994;3(2):163-79. KloskoJS , BarlowDH , TassinariR , CernyJA .A comparison of alprazolam and behavior therapy in treatment of panic disorder. Journal of Consulting and Clinical Psychology1990;58(1):77-84. ">Klosko 1990</a> ; <a href="./references#MR000050-bbs2-0042" title="KrapflJE , NawasMM .Differential ordering of stimulus presentation in systematic desensitization. Journal of Abnormal Psychology1970;75(3):333-7. ">Krapfl 1970</a> ; <a href="./references#MR000050-bbs2-0044" title="LacyMK .The effect of short term autogenic training on the stress reactivity of hospitalized emotionally disturbed adolescents. ProQuest Dissertations Publishing, Oklahoma State University1996. ">Lacy 1990</a> ; <a href="./references#MR000050-bbs2-0046" title="LangOJ , LazovikAD .Experimental desensitization of a phobia. Journal of Abnormal and Social Psychology1963;66:519-25. LangPJ , LazovikAD , ReynoldsDJ .Desensitization, suggestibility, and pseudotherapy. Journal of Abnormal Psychology1965;70(6):395-402. ">Lang 1965</a> ; <a href="./references#MR000050-bbs2-0048" title="LickJ .Expectancy, false galvanic skin response feedback, and systematic desensitization in the modification of phobic behavior. Journal of Consulting and Clinical Psychology1975;43(4):557-67. ">Lick 1975</a> ; <a href="./references#MR000050-bbs2-0049" title="LickJR , HefflerD .Relaxation training and attention placebo in the treatment of severe insomnia. Journal of Consulting and Clinical Psychology1977;45(2):153-61. ">Lick 1977</a> ; <a href="./references#MR000050-bbs2-0050" title="LiddleB , SpenceSH .Cognitive-behaviour therapy with depressed primary school children: A cautionary note. Behavioural Psychotherapy1990;18(2):85-102. ">Liddle 1990</a> ; <a href="./references#MR000050-bbs2-0051" title="MatsonJL , MarchettiA , AdkinsJA .Comparison of operant- and independence-training procedures for mentally retarded adults. American Journal of Mental Deficiency1980;84(5):487-94. ">Matson 1980</a> ; <a href="./references#MR000050-bbs2-0053" title="MealieaWL , NawasMM .The comparative effectiveness of systematic desensitization and implosive therapy in the treatment of snake phobia. Journal of Behavior Therapy and Experimental Psychiatry1971;2(2):85-94. ">Mealiea 1971</a> ; <a href="./references#MR000050-bbs2-0054" title="MilbyJB , ClarkeC , ToroC , ThorntonS , RickertD .Effectiveness of urine surveillance as an adjunct to outpatient psychotherapy for drug abusers. International Journal of the Addictions1980;15(7):993-1001. ">Milby 1980</a> ; <a href="./references#MR000050-bbs2-0055" title="MirandaA , ArlandisP , SorianoM .Instruction in strategies and attributional training: Effects on the problem-solving and self-concept of students’ with learning disabilities [Instrucción en estrategias y entrenamiento atribucional: efectos sobre la resolución de problemas y el autoconcepto de los estudiantes con dificultades en el aprendizaje]. Infancia y Aprendizaje1997;20(80):37-52. ">Miranda 1997</a> ; <a href="./references#MR000050-bbs2-0056" title="MitchellC , MansfieldD , RautenbachS .Coloured filters and reading accuracy, comprehension and rate: a placebo-controlled study. Perceptual and Motor Skills2008;106(2):517-32. ">Mitchell 2008</a> ; <a href="./references#MR000050-bbs2-0057" title="NandiDN , AjmanyS , GanguliH , BanerjeeG , BoralGC , GhoshA , et al.A clinical evaluation of depressives found in a rural survey in India. British Journal of Psychiatry1976;128:523-7. ">Nandi 1976</a> ; <a href="./references#MR000050-bbs2-0058" title="NicassioP , BootzinR .A comparison of progressive relaxation and autogenic training as treatments for insomnia. Journal of Abnormal Psychology1974;83(3):253-60. ">Nicassio 1974</a> ; <a href="./references#MR000050-bbs2-0060" title="PeckCL .Desensitization for the treatment of fear in the high level adult retardate. Behaviour Research and Therapy1977;15(2):137-48. ">Peck 1976</a> ; <a href="./references#MR000050-bbs2-0059" title="PearlD , Vander KampH , OlsenAL , GreenbergPD , ArmitageSG .The effects of reserpine on schizophrenic patients. American Journal of Psychiatry1956;112:198-204. ">Pearl 1956</a> ; <a href="./references#MR000050-bbs2-0061" title="MilichR , CarlsonCL , Pelham WE Jr, LichtBG .Effects of methylphenidate on the persistence of ADHD boys following failure experiences. Journal of Abnormal Child Psychology1991;19(5):519-36. PelhamWE , MurphyDA , VannattaK , MilichR , LichtBG , GnagyEM , et al.Methylphenidate and attributions in boys with attention-deficit hyperactivity disorder. Journal of Consulting and Clinical Psychology1992;60(2):282-92. ">Pelham 1992</a> ; <a href="./references#MR000050-bbs2-0062" title="PedletonMG , HigginsRL .A comparison of negative practice and systematic desensitization in the treatment of acrophobia. Journal of Behavior Therapy and Experimental Psychiatry1983;14(4):317-23. ">Pendleton 1983</a> ; <a href="./references#MR000050-bbs2-0065" title="PowersMB , SmitsJA , TelchMJ .Disentangling the effects of safety-behavior utilization and safety-behavior availability during exposure-based treatment: a placebo-controlled trial. Journal of Consulting and Clinical Psychology2004;72(3):448-54. ">Powers 2004</a> ; <a href="./references#MR000050-bbs2-0069" title="QuayhagenMP , QuayhagenM , CorbeilRR , RothPA , RodgersJA .A dyadic remediation program for care recipients with dementia. Nursing Research1995;44(3):153-9. ">Quayhagen 1995</a> ; <a href="./references#MR000050-bbs2-0074" title="RoehrichL , GoldmanMS .Experience-dependent neuropsychological recovery and the treatment of alcoholism. Journal of Consulting and Clinical Psychology1993;61(5):812-21. ">Roehrich 1993</a> ; <a href="./references#MR000050-bbs2-0075" title="OlivaresJ .Program IAFS. Protocol for the treatment of social phobia in adolescents [Programa IAFS. Protocolo para el tratamiento de la fobia social enadolescentes]. Madrid: Pirámide2005;1. Rosa-AlcázarAI , Olivares-OlivaresPJ , OlivaresJ .The role of non-specific effects in the psychological treatment of adolescents with social phobia [Papel de los efectos inespecíficos en el tratamiento psicológico de adolescentes con fobia social]. Anuario de Psicologia2009;40(1):43-61. ">Rosa‐Alcatraz 2009</a> ; <a href="./references#MR000050-bbs2-0077" title="LorrM , McNairDM , WeinsteinGJ .Early effects of chlordiazepoxide (Librium) used with psychotherapy. Journal of Psychiatric Research1963;1:257-70. RothI , RhudickPJ , ShaskanDA , SlobinMS , WilkinsonAE , YoungHH .Long-term effects on psychotherapy of initial treatment conditions. Journal of Psychiatric Research1964;2:283-97. ">Roth 1964</a> ; <a href="./references#MR000050-bbs2-0078" title="RupertPA , HolmesDS .Effects of multiple sessions of true and placebo heart rate biofeedback training on the heart rates and anxiety levels of anxious patients during and following treatment. Psychophysiology1978;15(6):582-90. ">Rupert 1978</a> ; <a href="./references#MR000050-bbs2-0080" title="ShealyRC .The effectiveness of various treatment techniques on different degrees and durations of sleep-onset insomnia. Behaviour Research and Therapy1979;17(6):541-6. ">Shealy 1979</a> ; <a href="./references#MR000050-bbs2-0081" title="SibilioJP , AndrewG , DartD , MooreKB , StehmanA .Treatment of chronic schizophrenia with promazine hydrochloride. AMA Archives of Neurology and Psychiatry1957;78(4):419-24. ">Sibilio 1957</a> ; <a href="./references#MR000050-bbs2-0083" title="SteinmarkSW , BorkovecTD .Active and placebo treatment effects on moderate insomnia under counterdemand and positive demand instructions. Journal of Abnormal Psychology1974;83(2):157-63. ">Steinmark 1974</a> ; <a href="./references#MR000050-bbs2-0085" title="TanSY , BruniJ .Cognitive-behavior therapy with adult patients with epilepsy: a controlled outcome study. Epilepsia1986;27(3):225-33. ">Tan 1986</a> ; <a href="./references#MR000050-bbs2-0087" title="ToriC , WorellL .Reduction of human avoidant behavior. A comparison of counterconditioning, expectancy, and cognitive information approaches. Clinical Psychology1973;41(2):269-78. ">Tori 1973</a> ; <a href="./references#MR000050-bbs2-0088" title="Trexler, L.Rational-emotive therapy, placebo, and no-treatment effects on public-speaking anxiety. Doctoral dissertation, Temple University AnnArbor, Mich.: University Microfilms1971;71-31(063). TrexlerLD , KarstTO .Rational-emotive therapy, placebo, and no-treatment effects on public-speaking anxiety. Journal of Abnormal Psyhology1972;79(1):60-7. ">Trexler 1972</a> ; <a href="./references#MR000050-bbs2-0089" title="AscherML , TurnerRM .A comparison of two methods for the administration of paradoxical intention. Behaviour Research and Therapy1980;18(2):121-6. TurnerRM , AscherLM .Controlled comparison of progressive relaxation, stimulus control, and paradoxical intention therapies for insomnia. Journal of Consulting and Clinical Psychology1979;47(3):500-8. ">Turner 1979</a> ; <a href="./references#MR000050-bbs2-0090" title="VanderplateC .Electromyograph biofeedback Treatment of sleep onset Insomnia: a controlled Investigation. Dissertation, University of Southern Mississippi1978. ">Vanderplate 1983</a> ; <a href="./references#MR000050-bbs2-0091" title="WatzlH , RistF , OlbrichR , CohenR .Placebo injections and surveillance of alcohol intake during inpatient treatment of female alcoholics. Addictive Behaviors1988;13(2):197-200. ">Watzl 1988</a> ; <a href="./references#MR000050-bbs2-0092" title="WeingaertnerAH .Self-administered aversive stimulation with hallucinating hospitalized schizophrenics. Journal of Consulting and Clinical Psychology1971;36(3):422-29. ">Weingaertner 1971</a> ; <a href="./references#MR000050-bbs2-0093" title="WhittakerCB , HoyRM .Withdrawal of perphenazine in chronic schizophrenia. British Journal of Psychiatry1963;109:422-7. ">Whittaker 1963</a> ; <a href="./references#MR000050-bbs2-0094" title="WilsonA , DavidsonWJ , BlanchardR , WhiteJ .Disulfiram implantation. A placebo-controlled trial with two-year follow-up. Journal of Studies on Alcohol1978;39(5):809-19. WilsonA , DavidsonWJ , BlanchardR .Disulfiram implantation: a trial using placebo implants and two types of controls. Journal of Studies on Alcohol1980;41(5):429-36. ">Wilson 1980</a> ; <a href="./references#MR000050-bbs2-0095" title="WolitzkyKB , TelchMJ .Augmenting in vivo exposure with fear antagonistic actions: a preliminary test. Behavior Therapy2009;40(1):57-71. ">Wolitzky 2009</a> ; <a href="./references#MR000050-bbs2-0096" title="WollersheimJP , WilsonGL .Group treatment of unipolar depression: a comparison of coping, supportive, bibliotherapy, and delayed treatment groups. Professional Psychology: Research and Practice1991;22(6):496-502. ">Wollersheim 1991</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Allocation concealment</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Low risk of bias</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>18</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#MR000050-bbs2-0002" title="AllenJB .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to A Todorovac 28th of August 2019. AllenJJ , SchnyerRN , HittSK .The efficacy of acupuncture in the treatment of major depression in women. Psychological Science1998;9(5):397-401. ">Allen 1998</a> ; <a href="./references#MR000050-bbs2-0003" title="AllenJB .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 28th of August 2019. AllenJJ , SchnyerRN , ChambersAS , HittSK , MorenoFA , ManberR .Acupuncture for depression: a randomized controlled trial. Journal of Clinical Psychiatry2006;67(11):1665-73. ">Allen 2006</a> ; <a href="./references#MR000050-bbs2-0011" title="BornovalovaM .Inclusion of study in Cochrane Systematic Review (personal communication). Email to A Todorovac. 21st of August 2019. BornovalovaMA .Distress tolerance treatment for inner-city drug users: a preliminary trial. Doctor’s Dissertation, University of Maryland2008. ">Bornovalova 2008</a> ; <a href="./references#MR000050-bbs2-0021" title="EhlersA , HackmannA , GreyN , WildJ , LinessS , AlbertI , et al.A randomized controlled trial of 7-day intensive and standard weekly cognitive therapy for PTSD and emotion-focused supportive therapy. American Journal of Psychiatry2014;171(3):294-304. ">Ehlers 2014</a> ; <a href="./references#MR000050-bbs2-0026" title="FreireAO , SugaiGC , ChrispinFS , TogeiroSM , YamamuraY , MelloLE , et al.Treatment of moderate obstructive sleep apnea syndrome with acupuncture: a randomised, placebo-controlled pilot trial. Sleep Medicine2007;8(1):43-50. ">Freire 2007</a> ; <a href="./references#MR000050-bbs2-0028" title="GlogowskaM , RoulstoneS , EnderbyP , PetersTJ .Randomised controlled trial of community based speech and language therapy in preschool children. BMJ2000;321(7266):923-6. ">Glogowska 2000</a> ; <a href="./references#MR000050-bbs2-0034" title="KarstM , WinterhalterM , MünteS , FranckiB , HondronikosA , EckardtA , et al.Auricular acupuncture for dental anxiety: a randomized controlled trial. Anesthesia and Analgesia2007;104(2):295-300. KarstM .Inclusion of study in Cochrane Systematic Review (personal communication). Email to: EG Faltinsen 5th of September 2019. ">Karst 2007</a> ; <a href="./references#MR000050-bbs2-0035" title="KelleyJ .Inclusion of study in Cochrane Systematic Review (personal communication). Email to: A Todorovac 12th of August 2019. KelleyJM , KaptchukTJ , CusinC , LipkinS , FavaM .Open-label placebo for major depressive disorder: a pilot randomized controlled trial. Psychotherapy and Psychosomatics2012;81(5):312-4. ">Kelley 2012</a> ; <a href="./references#MR000050-bbs2-0043" title="KwanR .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 26th of August 2019. KwanRY , LeungMC , LaiCK .Acupressure for agitation in nursing home residents with dementia: study protocol for a randomized controlled trial. Trials2014;15(410):1-7. KwanRY , LeungMCP , LaiCK .A randomized controlled trial examining the effect of acupressure on agitation and salivary cortisol in nursing home residents with dementia. Dementia and Geriatric Cognitive Disorders2017;44(1-2):92-104. ">Kwan 2017</a> ; <a href="./references#MR000050-bbs2-0047" title="LegrandF .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 14th of August 2019. LegrandFD , NeffEM .Efficacy of exercise as an adjunct treatment for clinically depressed inpatients during the initial stages of antidepressant pharmacotherapy: an open randomized controlled trial. Journal of Affective Disorders2016;191:139-44. ">Legrand 2016</a> ; <a href="./references#MR000050-bbs2-0064" title="PolandRE , GertsikL , FavreauJT , SmithSI , MirochaJM , RaoU , et al.Open-label randomized parallel-group controlled clinical trial of massage for treatment of depression in HIV-infected subjects. Journal of Alternative and Complementary Medicine2013;19(4):334-40. ">Poland 2013</a> ; <a href="./references#MR000050-bbs2-0068" title="ProudfootJ , ClarkeJ , BirchMR , WhittonAE , ParkerG , ManicavasagarV , et al.Impact of a mobile phone and web program on symptom and functional outcomes for people with mild- to-moderate depression, anxiety and stress: a randomized controlled trial. BMC Psychiatry2013;13(312):1-12. ProudfootJ .Re: Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 26th of August 2019. ">Proudfoot 2013</a> ; <a href="./references#MR000050-bbs2-0071" title="RapeeR .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 29th of August 2019. RapeeRM , AbbottMJ , LynehamHJ .Bibliotherapy for children With anxiety disorders using written materials for parents: a randomized controlled trial. Journal of Consulting and Clinical Psychology2006;74(3):436-44. ">Rapee 2006</a> ; <a href="./references#MR000050-bbs2-0077" title="LorrM , McNairDM , WeinsteinGJ .Early effects of chlordiazepoxide (Librium) used with psychotherapy. Journal of Psychiatric Research1963;1:257-70. RothI , RhudickPJ , ShaskanDA , SlobinMS , WilkinsonAE , YoungHH .Long-term effects on psychotherapy of initial treatment conditions. Journal of Psychiatric Research1964;2:283-97. ">Roth 1964</a> ; <a href="./references#MR000050-bbs2-0081" title="SibilioJP , AndrewG , DartD , MooreKB , StehmanA .Treatment of chronic schizophrenia with promazine hydrochloride. AMA Archives of Neurology and Psychiatry1957;78(4):419-24. ">Sibilio 1957</a> ; <a href="./references#MR000050-bbs2-0082" title="SommernessMD , LuceroRJ , HamlonJS , EricksonJL , MatthewsR .A controlled study of reserpine on chronically disturbed patients. JAMA Archives of Neurology and Psychiatry1955;74(3):316-9. ">Sommerness 1955</a> ; <a href="./references#MR000050-bbs2-0086" title="TeriL , LogsdonRG , UomotoJ , McCurrySM .Behavioral treatment of depression in dementia patients: a controlled clinical trial. Journals of Gerontology. Series B, Psychological Sciences and Social Sciences1997;52(4):159-66. TeriL .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 26th of August 2019. ">Teri 1997</a> ; <a href="./references#MR000050-bbs2-0093" title="WhittakerCB , HoyRM .Withdrawal of perphenazine in chronic schizophrenia. British Journal of Psychiatry1963;109:422-7. ">Whittaker 1963</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Unclear risk of bias</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>78</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#MR000050-bbs2-0001" title="AbikoffH , HechtmanL , KleinRG .Social functioning in children with ADHD treated with long-term methylphenidate and multimodal psychosocial treatment. Journal of the American Academy of Child and Adolescent Psychiatry2004;43(7):820-9. AbikoffH .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to A Todorovac 23rd of August 2019. KleinRG , AbikoffH , HechtmanL , WeissG .Design and rationale of controlled study of long-term methylphenidate and multimodal psychosocial treatment in children with ADHD. Journal of the American Academy of Child and Adolescent Psychiatry2004;43(7):792-801. ">Abikoff 2004</a> ; <a href="./references#MR000050-bbs2-0004" title="AlvarezJR .The effects of anger management training on depression, anger, self-concept, and treatment responsibility in a sample of drug-dependent individuals in a therapeutic community. Dissertation Abstracts International: Section B: the Sciences and Engineering1997;58(4-B):2108. ">Alvarez 1997</a> ; <a href="./references#MR000050-bbs2-0005" title="AscherLM , TurnerR .Paradoxical intention and insomnia: an experimental investigation. Behaviour Research and Therapy1979;17(4):408-11. ">Ascher 1979</a> ; <a href="./references#MR000050-bbs2-0006" title="AyenI , HautzingerM .Cognitive behavior therapy for depression in menopausal women. A controlled, randomized treatment study [Kognitive Verhaltenstherapie bei Depressionen im Klimakterium: Eine kontrollierte, randomiserte Interventionsstudie]. Zeitschrift für Klinische Psychologie und Psychotherapie2004;33(4):290-9. AyenI .Inclusion of study in Cochrane Systematic Review (personal communication). Email to EG Faltinsen 9th of September 2019. ">Ayen 2004</a> ; <a href="./references#MR000050-bbs2-0007" title="BergI , ForsytheI , HoltP , WattsJ .A controlled trial of ‘Senokot’ in faecal soiling treated by behavioural methods. Journal of Child Psychology and Psychiatry1983;24(4):543-9. ">Berg 1983</a> ; <a href="./references#MR000050-bbs2-0008" title="Borden, KA.Attributional Outcomes: the Subtle Messages of Treatments for Attention Deficit Disorder. Dissertation, University of Illinois at Urbana-Champaign1986. BordenKA , BrownRT .Attributional outcomes: The subtle messages of treatments for attention deficit disorder. Cognitive Therapy and Research1989;13(2):147-60. ">Borden 1986</a> ; <a href="./references#MR000050-bbs2-0009" title="BorkovecTD , KaloupekDG , SlamaKM .The facilitative effect of muscle tension-release in the relaxation treatment of sleep disturbance. Behavior Therapy1975;6(3):301-9. ">Borkovec 1975</a> ; <a href="./references#MR000050-bbs2-0010" title="BorkovecTD , WeertsTC .Effects of progressive relaxation on sleep disturbance: an electroencephalographic evaluation. Psychosomatic Medicine1976;38(3):173-80. ">Borkovec 1976</a> ; <a href="./references#MR000050-bbs2-0012" title="BramstonP , SpenceSH .Behavioural versus cognitive social-skills training with intellectually-handicapped adults. Behaviour Research and Therapy1985;23(3):239-46. ">Bramston 1985</a> ; <a href="./references#MR000050-bbs2-0013" title="BrillNQ , KoeglerRR , EpsteinLJ , ForgyEW .Controlled study of psychiatric outpatient treatment. Archives of General Psychiatry1964;10:581-95. BrillNQ .Results of psychotherapy. California Medicine1966;104(4):249-53. ">Brill 1964a</a> ; <a href="./references#MR000050-bbs2-0014" title="BrillNQ , KoeglerRR , EpsteinLJ , ForgyEW .Controlled study of psychiatric outpatient treatment. Archives of General Psychiatry1964;10:581-95. ">Brill 1964b</a> ; <a href="./references#MR000050-bbs2-0015" title="CarlsonCL , PelhamWE , MilichR , HozaB .ADHD boys’ performance and attributions following success and failure: drug effects and individual differences. Cognitive Therapy and Research1993;17:269-87. ">Carlson 1993</a> ; <a href="./references#MR000050-bbs2-0016" title="CarterJC , OlmstedMP , KaplanAS , McCabeRE , MillsJS , AimeA .Self-help for bulimia nervosa: a randomized controlled trial. American Journal of Psychiatry2003;160(5):973-8. ">Carter 2003</a> ; <a href="./references#MR000050-bbs2-0017" title="CrispAH , NortonK , GowersS , HalekC , BowyerC , YeldhamD , et al.A controlled study of the effect of therapies aimed at adolescent and family psychopathology in Anorexia Nervosa. British Journal of Psychiatry: the Journal of Mental Science1991;159:325-33. GowersS , NortonK , HalekC , CrispAH .Outcome of outpatient psychotherapy in a random allocation treatment study of anorexia nervosa. International Journal of Eating Disorders1994;15(2):165-77. GowersS , NortonK , YelshamD .The St George's prospective treatment study of anorexia nervosa: a discussion of methodological problems. International Journal of Eating Disorders1989;8:445-54. ">Crisp 1991</a> ; <a href="./references#MR000050-bbs2-0018" title="CrouchG , RobsonM , HallstromC .Benzodiazepine dependent patients and their psychological treatment. Progress in Neuro-psychopharmacology &amp; Biological Psychiatry1988;12(4):503-10. HallströmC , CrouchG , RobsenM , ShineP .The treatment of tranquillizer dependence by propranolol. Postgraduate Medical Journal1988;64(Suppl 2):40-4. ">Crouch 1988</a> ; <a href="./references#MR000050-bbs2-0019" title="Doty, DW.Role playing and incentives in the modification of the social interaction of chronic psychiatric patients. Journal of Consulting and Clinical Psychology1975;43(5):676-82. ">Doty 1975</a> ; <a href="./references#MR000050-bbs2-0020" title="DoubleDB , WarrenGC , EvansM , RowlandsMP .Efficacy of maintenance use of anticholinergic agents. Acta Psychiatrica Scandinavica1993;88:381-4. ">Double 1993</a> ; <a href="./references#MR000050-bbs2-0022" title="EspieCA , BrooksDN , LindsayWR .An evaluation of tailored psychological treatment of insomnia. Journal of Behavior Therapy and Experimental Psychiatry1989;20(2):143-53. EspieCA , LindsayWR , BrooksDN , HoodEM , TurveyT .A controlled comparative investigation of psychological treatments for chronic sleep-onset insomnia. Behaviour Research and Therapy1989;27(1):79-88. ">Espie 1989a</a> ; <a href="./references#MR000050-bbs2-0023" title="EtringerBD , CashTF , RimmDC .Behavioral, affective, and cognitive effects of participant modeling and an equally credible placebo. Behavior Therapy1982;13(4):476-85. ">Etringer 1982</a> ; <a href="./references#MR000050-bbs2-0024" title="FoaEB , RothbaumBO , RiggsDS , MurdockTB .Treatment of posttraumatic stress disorder in rape victims: a comparison between cognitive-behavioral procedures and counselling. Journal of Consulting and Clinical Psychology1991;59(5):715-23. ">Foa 1991</a> ; <a href="./references#MR000050-bbs2-0025" title="FoaEB , McLeanCP , ZangY , RosenfieldD , YadinE , YarvisJS , et al.Effect of prolonged exposure therapy delivered over 2 weeks vs 8 weeks vs present-centered therapy on PTSD symptom severity in military personnel: a randomized clinical trial. JAMA2018;319(4):354-64. ">Foa 2018</a> ; <a href="./references#MR000050-bbs2-0027" title="FuchsCZ , RehnLP .A self-control behavior therapy program for depression. Journal of Consulting and Clinical Psychology1977;45(2):206-15. ">Fuchs 1977</a> ; <a href="./references#MR000050-bbs2-0029" title="GoldsteinAJ , BeursE , Chambless Dl, WilsonKA .EMDR for panic disorder with agoraphobia: comparison with waiting list and credible attention-placebo control conditions. Journal of Consulting and Clinical Psychology2000;68(6):947-56. ">Goldstein 2000</a> ; <a href="./references#MR000050-bbs2-0030" title="GoldwasserAN , AuerbachSM , HarkinsSW .Cognitive, affective, and behavioural effects of reminiscence group therapy on demented elderly. Aging and Human Development1987;25(3):209-22. ">Goldwasser 1987</a> ; <a href="./references#MR000050-bbs2-0031" title="HekmatH , LubitzR , DealR .Semantic desensitization: a paradigmatic intervention approach to anxiety disorders. Journal of Clinical Psychology1984;40(2):463-6. ">Hekmat 1984</a> ; <a href="./references#MR000050-bbs2-0032" title="HippmanC , RingroseA , InglisA , CheekJ , AlbertAY , RemickR , et al.A pilot randomized clinical trial evaluating the impact of genetic counselling for serious mental illnesses. Journal of Clinical Psychiatry2016;77(2):e190-8. ">Hippman 2016</a> ; <a href="./references#MR000050-bbs2-0033" title="HowlinP , GordonKR , PascoG , WadeA , CharmanT .The effectiveness of picture exchange communication system (PECS) training for teachers of children with autism: a pragmatic,group randomised controlled trial. Journal of Child Psychology and Psychiatry2007;48(5):473-81. ">Howlin 2007</a> ; <a href="./references#MR000050-bbs2-0036" title="KennedyTD , KimuraHK .Transfer, behavioral improvement, and anxiety reduction in systematic desensitization. Journal of Consulting and Clinical Psychology1974;42(5):720-8. ">Kennedy 1974</a> ; <a href="./references#MR000050-bbs2-0037" title="KilmannPR , MilanRJ , BolandJP , NankinHR , DavidsonE , WestMO , et al.Group treatment of secondary erectile dysfunction. Journal of Sex &amp; Marital Therapy1987;13(3):168-82. KilmannPR , Milan RJ Jr, BolandJP , DavidsonE , WestMO , SablisRF , et al.The sexual interactions of men with secondary erectile dysfunction. Journal of Sex Education and Therapy1988;14(1):46-9. KilmannPR , Milan RJ Jr, BolandJP , NankinHR , SablisRF , WestMO , et al.The sexual interactions of men with secondary erectile dysfunction. Paper presented at the annual meeting of the American Psychological Association in Los Angeles1985;1:46-9. ">Kilmann 1987</a> ; <a href="./references#MR000050-bbs2-0038" title="KleinSA , DeffenbacherJL .Relaxation and exercise for hyperactive impulsive children. Perceptual and Motor Skills1977;45:1159-62. ">Klein 1977</a> ; <a href="./references#MR000050-bbs2-0039" title="KlermanGL , DimascioA , WeismannM , PrusoffB , PaykelES .Treatment of depression by drugs and psychotherapy. American Journal of Psychiatry1974;131(2):186-91. PaykelES , DimascioA , HaskellD , PrusoffBA .Effects of maintenance amitriptyline and psychotherapy on symptoms of depression. Psychological Medicine1975;5(1):67-77. PaykelES , DiMascioA , KlermanGL , PrusoffBA .Maintenance therapy of depression. Pharmakopsychiatrie, Neuro-Psychopharmakologie1976;9:127-39. PaykelES , WeissmanMM , PrusoffBA .Social maladjustment and severity of depression. Comprehensive Psychiatry1978;19(2):121-8. WeissmanMM , KlermanGL , PaykelES , PrusoffB .Treatment effects on the social adjustment of depressed patients. Archives of General Psychiatry1974;30:771-8. ">Klerman 1974a</a> ; <a href="./references#MR000050-bbs2-0040" title="KlermanGL , DimascioA , WeismannM , PrusoffB , PaykelES .Treatment of depression by drugs and psychotherapy. American Journal of Psychiatry1974;131(2):186-91. ">Klerman 1974b</a> ; <a href="./references#MR000050-bbs2-0041" title="KloskoJS , BarlowDH , TassinariR , CernyJA .A comparison of alprazolam and behavior therapy in treatment of panic disorder: correction. Journal of Psychotherapy Practice and Research1994;3(2):163-79. KloskoJS , BarlowDH , TassinariR , CernyJA .A comparison of alprazolam and behavior therapy in treatment of panic disorder. Journal of Consulting and Clinical Psychology1990;58(1):77-84. ">Klosko 1990</a> ; <a href="./references#MR000050-bbs2-0042" title="KrapflJE , NawasMM .Differential ordering of stimulus presentation in systematic desensitization. Journal of Abnormal Psychology1970;75(3):333-7. ">Krapfl 1970</a> ; <a href="./references#MR000050-bbs2-0044" title="LacyMK .The effect of short term autogenic training on the stress reactivity of hospitalized emotionally disturbed adolescents. ProQuest Dissertations Publishing, Oklahoma State University1996. ">Lacy 1990</a> ; <a href="./references#MR000050-bbs2-0045" title="LaiCK , ChiI , Kayser-JonesJ .A randomized controlled trial of a specific reminiscence approach to promote the well-being of nursing home residents with dementia. International Psychogeriatrics2004;16(1):33-49. LaiK .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 6th of September 2019. ">Lai 2004</a> ; <a href="./references#MR000050-bbs2-0046" title="LangOJ , LazovikAD .Experimental desensitization of a phobia. Journal of Abnormal and Social Psychology1963;66:519-25. LangPJ , LazovikAD , ReynoldsDJ .Desensitization, suggestibility, and pseudotherapy. Journal of Abnormal Psychology1965;70(6):395-402. ">Lang 1965</a> ; <a href="./references#MR000050-bbs2-0048" title="LickJ .Expectancy, false galvanic skin response feedback, and systematic desensitization in the modification of phobic behavior. Journal of Consulting and Clinical Psychology1975;43(4):557-67. ">Lick 1975</a> ; <a href="./references#MR000050-bbs2-0049" title="LickJR , HefflerD .Relaxation training and attention placebo in the treatment of severe insomnia. Journal of Consulting and Clinical Psychology1977;45(2):153-61. ">Lick 1977</a> ; <a href="./references#MR000050-bbs2-0050" title="LiddleB , SpenceSH .Cognitive-behaviour therapy with depressed primary school children: A cautionary note. Behavioural Psychotherapy1990;18(2):85-102. ">Liddle 1990</a> ; <a href="./references#MR000050-bbs2-0051" title="MatsonJL , MarchettiA , AdkinsJA .Comparison of operant- and independence-training procedures for mentally retarded adults. American Journal of Mental Deficiency1980;84(5):487-94. ">Matson 1980</a> ; <a href="./references#MR000050-bbs2-0052" title="McLachlanDR , DaltonAJ , KruckTP , BellMY , SmithWL , KalowW , et al.Intramuscular desferrioxamine in patients with Alzheimer's disease. Lancet1991;337(8753):1304-8. McLachlanDRC , SmithWL , KruckTP .Desferrioxamine and Alzheimer’s disease: video home behavior assessment of clinical course and measures of brain aluminum. Therapeutic Drug Monitoring1993;15(6):602-7. ">McLachlan 1991</a> ; <a href="./references#MR000050-bbs2-0053" title="MealieaWL , NawasMM .The comparative effectiveness of systematic desensitization and implosive therapy in the treatment of snake phobia. Journal of Behavior Therapy and Experimental Psychiatry1971;2(2):85-94. ">Mealiea 1971</a> ; <a href="./references#MR000050-bbs2-0054" title="MilbyJB , ClarkeC , ToroC , ThorntonS , RickertD .Effectiveness of urine surveillance as an adjunct to outpatient psychotherapy for drug abusers. International Journal of the Addictions1980;15(7):993-1001. ">Milby 1980</a> ; <a href="./references#MR000050-bbs2-0055" title="MirandaA , ArlandisP , SorianoM .Instruction in strategies and attributional training: Effects on the problem-solving and self-concept of students’ with learning disabilities [Instrucción en estrategias y entrenamiento atribucional: efectos sobre la resolución de problemas y el autoconcepto de los estudiantes con dificultades en el aprendizaje]. Infancia y Aprendizaje1997;20(80):37-52. ">Miranda 1997</a> ; <a href="./references#MR000050-bbs2-0056" title="MitchellC , MansfieldD , RautenbachS .Coloured filters and reading accuracy, comprehension and rate: a placebo-controlled study. Perceptual and Motor Skills2008;106(2):517-32. ">Mitchell 2008</a> ; <a href="./references#MR000050-bbs2-0057" title="NandiDN , AjmanyS , GanguliH , BanerjeeG , BoralGC , GhoshA , et al.A clinical evaluation of depressives found in a rural survey in India. British Journal of Psychiatry1976;128:523-7. ">Nandi 1976</a> ; <a href="./references#MR000050-bbs2-0058" title="NicassioP , BootzinR .A comparison of progressive relaxation and autogenic training as treatments for insomnia. Journal of Abnormal Psychology1974;83(3):253-60. ">Nicassio 1974</a> ; <a href="./references#MR000050-bbs2-0059" title="PearlD , Vander KampH , OlsenAL , GreenbergPD , ArmitageSG .The effects of reserpine on schizophrenic patients. American Journal of Psychiatry1956;112:198-204. ">Pearl 1956</a> ; <a href="./references#MR000050-bbs2-0060" title="PeckCL .Desensitization for the treatment of fear in the high level adult retardate. Behaviour Research and Therapy1977;15(2):137-48. ">Peck 1976</a> ; <a href="./references#MR000050-bbs2-0061" title="MilichR , CarlsonCL , Pelham WE Jr, LichtBG .Effects of methylphenidate on the persistence of ADHD boys following failure experiences. Journal of Abnormal Child Psychology1991;19(5):519-36. PelhamWE , MurphyDA , VannattaK , MilichR , LichtBG , GnagyEM , et al.Methylphenidate and attributions in boys with attention-deficit hyperactivity disorder. Journal of Consulting and Clinical Psychology1992;60(2):282-92. ">Pelham 1992</a> ; <a href="./references#MR000050-bbs2-0062" title="PedletonMG , HigginsRL .A comparison of negative practice and systematic desensitization in the treatment of acrophobia. Journal of Behavior Therapy and Experimental Psychiatry1983;14(4):317-23. ">Pendleton 1983</a> ; <a href="./references#MR000050-bbs2-0063" title="PetersonMA , PattersonB , PillmanBM , BattistaMA .Cognitive recovery following alcohol detoxification: a computerised remediation study. Neuropsychological Rehabilitation2002;12(1):63-74. PillmanBM .Computerized cognitive remediation with recently detoxified alcoholics. Dissertation, California School of Professional Psychology, Fresno Campus2000. ">Pillman 2001</a> ; <a href="./references#MR000050-bbs2-0065" title="PowersMB , SmitsJA , TelchMJ .Disentangling the effects of safety-behavior utilization and safety-behavior availability during exposure-based treatment: a placebo-controlled trial. Journal of Consulting and Clinical Psychology2004;72(3):448-54. ">Powers 2004</a> ; <a href="./references#MR000050-bbs2-0066" title="PowersMB , SmithsJA , WhitleyD , BystritskyA , TelchMJ .The effect of attributional processes concerning medication taking on return of fear. Journal of Consulting and Clinical Psychology2008;76(3):478-90. ">Powers 2008a</a> ; <a href="./references#MR000050-bbs2-0067" title="PowersMB , SmithsJA , WhitleyD , BystritskyA , TelchMJ .The effect of attributional processes concerning medication taking on return of fear. Journal of Consulting and Clinical Psychology2008;76(3):478-90. ">Powers 2008b</a> ; <a href="./references#MR000050-bbs2-0069" title="QuayhagenMP , QuayhagenM , CorbeilRR , RothPA , RodgersJA .A dyadic remediation program for care recipients with dementia. Nursing Research1995;44(3):153-9. ">Quayhagen 1995</a> ; <a href="./references#MR000050-bbs2-0070" title="LiebowitzM , QuitkinFM , StewartJW , McGrathPJ , HarrisonWM , MarkowitzJS , et al.Antidepressant efficacy in atypical depression. Archives of General Psychiatry1988;45(2):129-37. QuitkinFM , McGrathPJ , StewartJW , HarrisonW , WagerSG , NunesE , et al.Phenelzine and imipramine in mood reactive depressives: further delineation of the syndrome of atypical depression. Archives of General Psychiatry1989;46(9):787-93. RabkinJG , McGrathPJ , QuitkinFM , TricamoE , StewartJW , KleinDF .Effects of pill-giving on maintenance of placebo response in patients with chronic mild depression. American Journal of Psychiatry1990;147(12):1622-6. ">Rabkin 1990</a> ; <a href="./references#MR000050-bbs2-0072" title="RapeeR .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 29th of August 2019. RapeeRM , AbbottMJ , BaillieAJ , GastonJE .Treatment of social phobia through pure self-help and therapist-augmented self-help. British Journal of Psychiatry2007;191:246-52. ">Rapee 2007</a> ; <a href="./references#MR000050-bbs2-0073" title="RobinA .Rationing out-patients: a defence of the waiting list. British Journal of Psychiatry1976;129:138-41. ">Robin 1976</a> ; <a href="./references#MR000050-bbs2-0074" title="RoehrichL , GoldmanMS .Experience-dependent neuropsychological recovery and the treatment of alcoholism. Journal of Consulting and Clinical Psychology1993;61(5):812-21. ">Roehrich 1993</a> ; <a href="./references#MR000050-bbs2-0075" title="OlivaresJ .Program IAFS. Protocol for the treatment of social phobia in adolescents [Programa IAFS. Protocolo para el tratamiento de la fobia social enadolescentes]. Madrid: Pirámide2005;1. Rosa-AlcázarAI , Olivares-OlivaresPJ , OlivaresJ .The role of non-specific effects in the psychological treatment of adolescents with social phobia [Papel de los efectos inespecíficos en el tratamiento psicológico de adolescentes con fobia social]. Anuario de Psicologia2009;40(1):43-61. ">Rosa‐Alcatraz 2009</a> ; <a href="./references#MR000050-bbs2-0076" title="RosenGM , GlasgowRE , BarreraM .A controlled study to assess the clinical efficacy of totally self-administrated systematic desensitization. Journal of Consulting and Clinical Psychology1976;44(2):208-17. ">Rosen 1976</a> ; <a href="./references#MR000050-bbs2-0078" title="RupertPA , HolmesDS .Effects of multiple sessions of true and placebo heart rate biofeedback training on the heart rates and anxiety levels of anxious patients during and following treatment. Psychophysiology1978;15(6):582-90. ">Rupert 1978</a> ; <a href="./references#MR000050-bbs2-0079" title="ShalevAY , AnkriY , Isreali-ShalevY , PelegT , AdesskyR , FreedmanS .Prevention of posttraumatic stress disorder by early treatment. Archives of General Psychiatry2012;69(2):166-76. ">Shalev 2012</a> ; <a href="./references#MR000050-bbs2-0080" title="ShealyRC .The effectiveness of various treatment techniques on different degrees and durations of sleep-onset insomnia. Behaviour Research and Therapy1979;17(6):541-6. ">Shealy 1979</a> ; <a href="./references#MR000050-bbs2-0083" title="SteinmarkSW , BorkovecTD .Active and placebo treatment effects on moderate insomnia under counterdemand and positive demand instructions. Journal of Abnormal Psychology1974;83(2):157-63. ">Steinmark 1974</a> ; <a href="./references#MR000050-bbs2-0084" title="SzymanskiJ , O'DonohueW .The potential role of state-dependent learning in cognitive therapy with spider phobics. Journal of Rational-Emotive &amp; Cognitive-Behavior Therapy1995;13(2):131-50. SzymanskiJ .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 20th of August 2019. ">Szymanski 1995</a> ; <a href="./references#MR000050-bbs2-0085" title="TanSY , BruniJ .Cognitive-behavior therapy with adult patients with epilepsy: a controlled outcome study. Epilepsia1986;27(3):225-33. ">Tan 1986</a> ; <a href="./references#MR000050-bbs2-0087" title="ToriC , WorellL .Reduction of human avoidant behavior. A comparison of counterconditioning, expectancy, and cognitive information approaches. Clinical Psychology1973;41(2):269-78. ">Tori 1973</a> ; <a href="./references#MR000050-bbs2-0088" title="Trexler, L.Rational-emotive therapy, placebo, and no-treatment effects on public-speaking anxiety. Doctoral dissertation, Temple University AnnArbor, Mich.: University Microfilms1971;71-31(063). TrexlerLD , KarstTO .Rational-emotive therapy, placebo, and no-treatment effects on public-speaking anxiety. Journal of Abnormal Psyhology1972;79(1):60-7. ">Trexler 1972</a> ; <a href="./references#MR000050-bbs2-0089" title="AscherML , TurnerRM .A comparison of two methods for the administration of paradoxical intention. Behaviour Research and Therapy1980;18(2):121-6. TurnerRM , AscherLM .Controlled comparison of progressive relaxation, stimulus control, and paradoxical intention therapies for insomnia. Journal of Consulting and Clinical Psychology1979;47(3):500-8. ">Turner 1979</a> ; <a href="./references#MR000050-bbs2-0090" title="VanderplateC .Electromyograph biofeedback Treatment of sleep onset Insomnia: a controlled Investigation. Dissertation, University of Southern Mississippi1978. ">Vanderplate 1983</a> ; <a href="./references#MR000050-bbs2-0091" title="WatzlH , RistF , OlbrichR , CohenR .Placebo injections and surveillance of alcohol intake during inpatient treatment of female alcoholics. Addictive Behaviors1988;13(2):197-200. ">Watzl 1988</a> ; <a href="./references#MR000050-bbs2-0092" title="WeingaertnerAH .Self-administered aversive stimulation with hallucinating hospitalized schizophrenics. Journal of Consulting and Clinical Psychology1971;36(3):422-29. ">Weingaertner 1971</a> ; <a href="./references#MR000050-bbs2-0094" title="WilsonA , DavidsonWJ , BlanchardR , WhiteJ .Disulfiram implantation. A placebo-controlled trial with two-year follow-up. Journal of Studies on Alcohol1978;39(5):809-19. WilsonA , DavidsonWJ , BlanchardR .Disulfiram implantation: a trial using placebo implants and two types of controls. Journal of Studies on Alcohol1980;41(5):429-36. ">Wilson 1980</a> ; <a href="./references#MR000050-bbs2-0095" title="WolitzkyKB , TelchMJ .Augmenting in vivo exposure with fear antagonistic actions: a preliminary test. Behavior Therapy2009;40(1):57-71. ">Wolitzky 2009</a> ; <a href="./references#MR000050-bbs2-0096" title="WollersheimJP , WilsonGL .Group treatment of unipolar depression: a comparison of coping, supportive, bibliotherapy, and delayed treatment groups. Professional Psychology: Research and Practice1991;22(6):496-502. ">Wollersheim 1991</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Blinding of outcome assessors</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Low risk of bias</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>45</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#MR000050-bbs2-0002" title="AllenJB .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to A Todorovac 28th of August 2019. AllenJJ , SchnyerRN , HittSK .The efficacy of acupuncture in the treatment of major depression in women. Psychological Science1998;9(5):397-401. ">Allen 1998</a> ; <a href="./references#MR000050-bbs2-0003" title="AllenJB .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 28th of August 2019. AllenJJ , SchnyerRN , ChambersAS , HittSK , MorenoFA , ManberR .Acupuncture for depression: a randomized controlled trial. Journal of Clinical Psychiatry2006;67(11):1665-73. ">Allen 2006</a> ; <a href="./references#MR000050-bbs2-0008" title="Borden, KA.Attributional Outcomes: the Subtle Messages of Treatments for Attention Deficit Disorder. Dissertation, University of Illinois at Urbana-Champaign1986. BordenKA , BrownRT .Attributional outcomes: The subtle messages of treatments for attention deficit disorder. Cognitive Therapy and Research1989;13(2):147-60. ">Borden 1986</a> ; <a href="./references#MR000050-bbs2-0010" title="BorkovecTD , WeertsTC .Effects of progressive relaxation on sleep disturbance: an electroencephalographic evaluation. Psychosomatic Medicine1976;38(3):173-80. ">Borkovec 1976</a> ; <a href="./references#MR000050-bbs2-0012" title="BramstonP , SpenceSH .Behavioural versus cognitive social-skills training with intellectually-handicapped adults. Behaviour Research and Therapy1985;23(3):239-46. ">Bramston 1985</a> ; <a href="./references#MR000050-bbs2-0015" title="CarlsonCL , PelhamWE , MilichR , HozaB .ADHD boys’ performance and attributions following success and failure: drug effects and individual differences. Cognitive Therapy and Research1993;17:269-87. ">Carlson 1993</a> ; <a href="./references#MR000050-bbs2-0019" title="Doty, DW.Role playing and incentives in the modification of the social interaction of chronic psychiatric patients. Journal of Consulting and Clinical Psychology1975;43(5):676-82. ">Doty 1975</a> ; <a href="./references#MR000050-bbs2-0020" title="DoubleDB , WarrenGC , EvansM , RowlandsMP .Efficacy of maintenance use of anticholinergic agents. Acta Psychiatrica Scandinavica1993;88:381-4. ">Double 1993</a> ; <a href="./references#MR000050-bbs2-0021" title="EhlersA , HackmannA , GreyN , WildJ , LinessS , AlbertI , et al.A randomized controlled trial of 7-day intensive and standard weekly cognitive therapy for PTSD and emotion-focused supportive therapy. American Journal of Psychiatry2014;171(3):294-304. ">Ehlers 2014</a> ; <a href="./references#MR000050-bbs2-0023" title="EtringerBD , CashTF , RimmDC .Behavioral, affective, and cognitive effects of participant modeling and an equally credible placebo. Behavior Therapy1982;13(4):476-85. ">Etringer 1982</a> ; <a href="./references#MR000050-bbs2-0024" title="FoaEB , RothbaumBO , RiggsDS , MurdockTB .Treatment of posttraumatic stress disorder in rape victims: a comparison between cognitive-behavioral procedures and counselling. Journal of Consulting and Clinical Psychology1991;59(5):715-23. ">Foa 1991</a> ; <a href="./references#MR000050-bbs2-0025" title="FoaEB , McLeanCP , ZangY , RosenfieldD , YadinE , YarvisJS , et al.Effect of prolonged exposure therapy delivered over 2 weeks vs 8 weeks vs present-centered therapy on PTSD symptom severity in military personnel: a randomized clinical trial. JAMA2018;319(4):354-64. ">Foa 2018</a> ; <a href="./references#MR000050-bbs2-0026" title="FreireAO , SugaiGC , ChrispinFS , TogeiroSM , YamamuraY , MelloLE , et al.Treatment of moderate obstructive sleep apnea syndrome with acupuncture: a randomised, placebo-controlled pilot trial. Sleep Medicine2007;8(1):43-50. ">Freire 2007</a> ; <a href="./references#MR000050-bbs2-0028" title="GlogowskaM , RoulstoneS , EnderbyP , PetersTJ .Randomised controlled trial of community based speech and language therapy in preschool children. BMJ2000;321(7266):923-6. ">Glogowska 2000</a> ; <a href="./references#MR000050-bbs2-0031" title="HekmatH , LubitzR , DealR .Semantic desensitization: a paradigmatic intervention approach to anxiety disorders. Journal of Clinical Psychology1984;40(2):463-6. ">Hekmat 1984</a> ; <a href="./references#MR000050-bbs2-0034" title="KarstM , WinterhalterM , MünteS , FranckiB , HondronikosA , EckardtA , et al.Auricular acupuncture for dental anxiety: a randomized controlled trial. Anesthesia and Analgesia2007;104(2):295-300. KarstM .Inclusion of study in Cochrane Systematic Review (personal communication). Email to: EG Faltinsen 5th of September 2019. ">Karst 2007</a> ; <a href="./references#MR000050-bbs2-0035" title="KelleyJ .Inclusion of study in Cochrane Systematic Review (personal communication). Email to: A Todorovac 12th of August 2019. KelleyJM , KaptchukTJ , CusinC , LipkinS , FavaM .Open-label placebo for major depressive disorder: a pilot randomized controlled trial. Psychotherapy and Psychosomatics2012;81(5):312-4. ">Kelley 2012</a> ; <a href="./references#MR000050-bbs2-0036" title="KennedyTD , KimuraHK .Transfer, behavioral improvement, and anxiety reduction in systematic desensitization. Journal of Consulting and Clinical Psychology1974;42(5):720-8. ">Kennedy 1974</a> ; <a href="./references#MR000050-bbs2-0038" title="KleinSA , DeffenbacherJL .Relaxation and exercise for hyperactive impulsive children. Perceptual and Motor Skills1977;45:1159-62. ">Klein 1977</a> ; <a href="./references#MR000050-bbs2-0041" title="KloskoJS , BarlowDH , TassinariR , CernyJA .A comparison of alprazolam and behavior therapy in treatment of panic disorder: correction. Journal of Psychotherapy Practice and Research1994;3(2):163-79. KloskoJS , BarlowDH , TassinariR , CernyJA .A comparison of alprazolam and behavior therapy in treatment of panic disorder. Journal of Consulting and Clinical Psychology1990;58(1):77-84. ">Klosko 1990</a> ; <a href="./references#MR000050-bbs2-0043" title="KwanR .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 26th of August 2019. KwanRY , LeungMC , LaiCK .Acupressure for agitation in nursing home residents with dementia: study protocol for a randomized controlled trial. Trials2014;15(410):1-7. KwanRY , LeungMCP , LaiCK .A randomized controlled trial examining the effect of acupressure on agitation and salivary cortisol in nursing home residents with dementia. Dementia and Geriatric Cognitive Disorders2017;44(1-2):92-104. ">Kwan 2017</a> ; <a href="./references#MR000050-bbs2-0045" title="LaiCK , ChiI , Kayser-JonesJ .A randomized controlled trial of a specific reminiscence approach to promote the well-being of nursing home residents with dementia. International Psychogeriatrics2004;16(1):33-49. LaiK .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 6th of September 2019. ">Lai 2004</a> ; <a href="./references#MR000050-bbs2-0048" title="LickJ .Expectancy, false galvanic skin response feedback, and systematic desensitization in the modification of phobic behavior. Journal of Consulting and Clinical Psychology1975;43(4):557-67. ">Lick 1975</a> ; <a href="./references#MR000050-bbs2-0051" title="MatsonJL , MarchettiA , AdkinsJA .Comparison of operant- and independence-training procedures for mentally retarded adults. American Journal of Mental Deficiency1980;84(5):487-94. ">Matson 1980</a> ; <a href="./references#MR000050-bbs2-0052" title="McLachlanDR , DaltonAJ , KruckTP , BellMY , SmithWL , KalowW , et al.Intramuscular desferrioxamine in patients with Alzheimer's disease. Lancet1991;337(8753):1304-8. McLachlanDRC , SmithWL , KruckTP .Desferrioxamine and Alzheimer’s disease: video home behavior assessment of clinical course and measures of brain aluminum. Therapeutic Drug Monitoring1993;15(6):602-7. ">McLachlan 1991</a> ; <a href="./references#MR000050-bbs2-0053" title="MealieaWL , NawasMM .The comparative effectiveness of systematic desensitization and implosive therapy in the treatment of snake phobia. Journal of Behavior Therapy and Experimental Psychiatry1971;2(2):85-94. ">Mealiea 1971</a> ; <a href="./references#MR000050-bbs2-0057" title="NandiDN , AjmanyS , GanguliH , BanerjeeG , BoralGC , GhoshA , et al.A clinical evaluation of depressives found in a rural survey in India. British Journal of Psychiatry1976;128:523-7. ">Nandi 1976</a> ; <a href="./references#MR000050-bbs2-0062" title="PedletonMG , HigginsRL .A comparison of negative practice and systematic desensitization in the treatment of acrophobia. Journal of Behavior Therapy and Experimental Psychiatry1983;14(4):317-23. ">Pendleton 1983</a> ; <a href="./references#MR000050-bbs2-0063" title="PetersonMA , PattersonB , PillmanBM , BattistaMA .Cognitive recovery following alcohol detoxification: a computerised remediation study. Neuropsychological Rehabilitation2002;12(1):63-74. PillmanBM .Computerized cognitive remediation with recently detoxified alcoholics. Dissertation, California School of Professional Psychology, Fresno Campus2000. ">Pillman 2001</a> ; <a href="./references#MR000050-bbs2-0070" title="LiebowitzM , QuitkinFM , StewartJW , McGrathPJ , HarrisonWM , MarkowitzJS , et al.Antidepressant efficacy in atypical depression. Archives of General Psychiatry1988;45(2):129-37. QuitkinFM , McGrathPJ , StewartJW , HarrisonW , WagerSG , NunesE , et al.Phenelzine and imipramine in mood reactive depressives: further delineation of the syndrome of atypical depression. Archives of General Psychiatry1989;46(9):787-93. RabkinJG , McGrathPJ , QuitkinFM , TricamoE , StewartJW , KleinDF .Effects of pill-giving on maintenance of placebo response in patients with chronic mild depression. American Journal of Psychiatry1990;147(12):1622-6. ">Rabkin 1990</a> ; <a href="./references#MR000050-bbs2-0071" title="RapeeR .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 29th of August 2019. RapeeRM , AbbottMJ , LynehamHJ .Bibliotherapy for children With anxiety disorders using written materials for parents: a randomized controlled trial. Journal of Consulting and Clinical Psychology2006;74(3):436-44. ">Rapee 2006</a> ; <a href="./references#MR000050-bbs2-0072" title="RapeeR .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 29th of August 2019. RapeeRM , AbbottMJ , BaillieAJ , GastonJE .Treatment of social phobia through pure self-help and therapist-augmented self-help. British Journal of Psychiatry2007;191:246-52. ">Rapee 2007</a> ; <a href="./references#MR000050-bbs2-0073" title="RobinA .Rationing out-patients: a defence of the waiting list. British Journal of Psychiatry1976;129:138-41. ">Robin 1976</a> ; <a href="./references#MR000050-bbs2-0075" title="OlivaresJ .Program IAFS. Protocol for the treatment of social phobia in adolescents [Programa IAFS. Protocolo para el tratamiento de la fobia social enadolescentes]. Madrid: Pirámide2005;1. Rosa-AlcázarAI , Olivares-OlivaresPJ , OlivaresJ .The role of non-specific effects in the psychological treatment of adolescents with social phobia [Papel de los efectos inespecíficos en el tratamiento psicológico de adolescentes con fobia social]. Anuario de Psicologia2009;40(1):43-61. ">Rosa‐Alcatraz 2009</a> ; <a href="./references#MR000050-bbs2-0076" title="RosenGM , GlasgowRE , BarreraM .A controlled study to assess the clinical efficacy of totally self-administrated systematic desensitization. Journal of Consulting and Clinical Psychology1976;44(2):208-17. ">Rosen 1976</a> ; <a href="./references#MR000050-bbs2-0077" title="LorrM , McNairDM , WeinsteinGJ .Early effects of chlordiazepoxide (Librium) used with psychotherapy. Journal of Psychiatric Research1963;1:257-70. RothI , RhudickPJ , ShaskanDA , SlobinMS , WilkinsonAE , YoungHH .Long-term effects on psychotherapy of initial treatment conditions. Journal of Psychiatric Research1964;2:283-97. ">Roth 1964</a> ; <a href="./references#MR000050-bbs2-0079" title="ShalevAY , AnkriY , Isreali-ShalevY , PelegT , AdesskyR , FreedmanS .Prevention of posttraumatic stress disorder by early treatment. Archives of General Psychiatry2012;69(2):166-76. ">Shalev 2012</a> ; <a href="./references#MR000050-bbs2-0081" title="SibilioJP , AndrewG , DartD , MooreKB , StehmanA .Treatment of chronic schizophrenia with promazine hydrochloride. AMA Archives of Neurology and Psychiatry1957;78(4):419-24. ">Sibilio 1957</a> ; <a href="./references#MR000050-bbs2-0082" title="SommernessMD , LuceroRJ , HamlonJS , EricksonJL , MatthewsR .A controlled study of reserpine on chronically disturbed patients. JAMA Archives of Neurology and Psychiatry1955;74(3):316-9. ">Sommerness 1955</a> ; <a href="./references#MR000050-bbs2-0084" title="SzymanskiJ , O'DonohueW .The potential role of state-dependent learning in cognitive therapy with spider phobics. Journal of Rational-Emotive &amp; Cognitive-Behavior Therapy1995;13(2):131-50. SzymanskiJ .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 20th of August 2019. ">Szymanski 1995</a> ; <a href="./references#MR000050-bbs2-0086" title="TeriL , LogsdonRG , UomotoJ , McCurrySM .Behavioral treatment of depression in dementia patients: a controlled clinical trial. Journals of Gerontology. Series B, Psychological Sciences and Social Sciences1997;52(4):159-66. TeriL .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 26th of August 2019. ">Teri 1997</a> ; <a href="./references#MR000050-bbs2-0087" title="ToriC , WorellL .Reduction of human avoidant behavior. A comparison of counterconditioning, expectancy, and cognitive information approaches. Clinical Psychology1973;41(2):269-78. ">Tori 1973</a> ; <a href="./references#MR000050-bbs2-0088" title="Trexler, L.Rational-emotive therapy, placebo, and no-treatment effects on public-speaking anxiety. Doctoral dissertation, Temple University AnnArbor, Mich.: University Microfilms1971;71-31(063). TrexlerLD , KarstTO .Rational-emotive therapy, placebo, and no-treatment effects on public-speaking anxiety. Journal of Abnormal Psyhology1972;79(1):60-7. ">Trexler 1972</a> ; <a href="./references#MR000050-bbs2-0092" title="WeingaertnerAH .Self-administered aversive stimulation with hallucinating hospitalized schizophrenics. Journal of Consulting and Clinical Psychology1971;36(3):422-29. ">Weingaertner 1971</a> ; <a href="./references#MR000050-bbs2-0095" title="WolitzkyKB , TelchMJ .Augmenting in vivo exposure with fear antagonistic actions: a preliminary test. Behavior Therapy2009;40(1):57-71. ">Wolitzky 2009</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>High risk of bias</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>32</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#MR000050-bbs2-0001" title="AbikoffH , HechtmanL , KleinRG .Social functioning in children with ADHD treated with long-term methylphenidate and multimodal psychosocial treatment. Journal of the American Academy of Child and Adolescent Psychiatry2004;43(7):820-9. AbikoffH .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to A Todorovac 23rd of August 2019. KleinRG , AbikoffH , HechtmanL , WeissG .Design and rationale of controlled study of long-term methylphenidate and multimodal psychosocial treatment in children with ADHD. Journal of the American Academy of Child and Adolescent Psychiatry2004;43(7):792-801. ">Abikoff 2004</a> ; <a href="./references#MR000050-bbs2-0004" title="AlvarezJR .The effects of anger management training on depression, anger, self-concept, and treatment responsibility in a sample of drug-dependent individuals in a therapeutic community. Dissertation Abstracts International: Section B: the Sciences and Engineering1997;58(4-B):2108. ">Alvarez 1997</a> ; <a href="./references#MR000050-bbs2-0005" title="AscherLM , TurnerR .Paradoxical intention and insomnia: an experimental investigation. Behaviour Research and Therapy1979;17(4):408-11. ">Ascher 1979</a> ; <a href="./references#MR000050-bbs2-0006" title="AyenI , HautzingerM .Cognitive behavior therapy for depression in menopausal women. A controlled, randomized treatment study [Kognitive Verhaltenstherapie bei Depressionen im Klimakterium: Eine kontrollierte, randomiserte Interventionsstudie]. Zeitschrift für Klinische Psychologie und Psychotherapie2004;33(4):290-9. AyenI .Inclusion of study in Cochrane Systematic Review (personal communication). Email to EG Faltinsen 9th of September 2019. ">Ayen 2004</a> ; <a href="./references#MR000050-bbs2-0007" title="BergI , ForsytheI , HoltP , WattsJ .A controlled trial of ‘Senokot’ in faecal soiling treated by behavioural methods. Journal of Child Psychology and Psychiatry1983;24(4):543-9. ">Berg 1983</a> ; <a href="./references#MR000050-bbs2-0009" title="BorkovecTD , KaloupekDG , SlamaKM .The facilitative effect of muscle tension-release in the relaxation treatment of sleep disturbance. Behavior Therapy1975;6(3):301-9. ">Borkovec 1975</a> ; <a href="./references#MR000050-bbs2-0011" title="BornovalovaM .Inclusion of study in Cochrane Systematic Review (personal communication). Email to A Todorovac. 21st of August 2019. BornovalovaMA .Distress tolerance treatment for inner-city drug users: a preliminary trial. Doctor’s Dissertation, University of Maryland2008. ">Bornovalova 2008</a> ; <a href="./references#MR000050-bbs2-0016" title="CarterJC , OlmstedMP , KaplanAS , McCabeRE , MillsJS , AimeA .Self-help for bulimia nervosa: a randomized controlled trial. American Journal of Psychiatry2003;160(5):973-8. ">Carter 2003</a> ; <a href="./references#MR000050-bbs2-0017" title="CrispAH , NortonK , GowersS , HalekC , BowyerC , YeldhamD , et al.A controlled study of the effect of therapies aimed at adolescent and family psychopathology in Anorexia Nervosa. British Journal of Psychiatry: the Journal of Mental Science1991;159:325-33. GowersS , NortonK , HalekC , CrispAH .Outcome of outpatient psychotherapy in a random allocation treatment study of anorexia nervosa. International Journal of Eating Disorders1994;15(2):165-77. GowersS , NortonK , YelshamD .The St George's prospective treatment study of anorexia nervosa: a discussion of methodological problems. International Journal of Eating Disorders1989;8:445-54. ">Crisp 1991</a> ; <a href="./references#MR000050-bbs2-0018" title="CrouchG , RobsonM , HallstromC .Benzodiazepine dependent patients and their psychological treatment. Progress in Neuro-psychopharmacology &amp; Biological Psychiatry1988;12(4):503-10. HallströmC , CrouchG , RobsenM , ShineP .The treatment of tranquillizer dependence by propranolol. Postgraduate Medical Journal1988;64(Suppl 2):40-4. ">Crouch 1988</a> ; <a href="./references#MR000050-bbs2-0022" title="EspieCA , BrooksDN , LindsayWR .An evaluation of tailored psychological treatment of insomnia. Journal of Behavior Therapy and Experimental Psychiatry1989;20(2):143-53. EspieCA , LindsayWR , BrooksDN , HoodEM , TurveyT .A controlled comparative investigation of psychological treatments for chronic sleep-onset insomnia. Behaviour Research and Therapy1989;27(1):79-88. ">Espie 1989a</a> ; <a href="./references#MR000050-bbs2-0027" title="FuchsCZ , RehnLP .A self-control behavior therapy program for depression. Journal of Consulting and Clinical Psychology1977;45(2):206-15. ">Fuchs 1977</a> ; <a href="./references#MR000050-bbs2-0029" title="GoldsteinAJ , BeursE , Chambless Dl, WilsonKA .EMDR for panic disorder with agoraphobia: comparison with waiting list and credible attention-placebo control conditions. Journal of Consulting and Clinical Psychology2000;68(6):947-56. ">Goldstein 2000</a> ; <a href="./references#MR000050-bbs2-0032" title="HippmanC , RingroseA , InglisA , CheekJ , AlbertAY , RemickR , et al.A pilot randomized clinical trial evaluating the impact of genetic counselling for serious mental illnesses. Journal of Clinical Psychiatry2016;77(2):e190-8. ">Hippman 2016</a> ; <a href="./references#MR000050-bbs2-0033" title="HowlinP , GordonKR , PascoG , WadeA , CharmanT .The effectiveness of picture exchange communication system (PECS) training for teachers of children with autism: a pragmatic,group randomised controlled trial. Journal of Child Psychology and Psychiatry2007;48(5):473-81. ">Howlin 2007</a> ; <a href="./references#MR000050-bbs2-0037" title="KilmannPR , MilanRJ , BolandJP , NankinHR , DavidsonE , WestMO , et al.Group treatment of secondary erectile dysfunction. Journal of Sex &amp; Marital Therapy1987;13(3):168-82. KilmannPR , Milan RJ Jr, BolandJP , DavidsonE , WestMO , SablisRF , et al.The sexual interactions of men with secondary erectile dysfunction. Journal of Sex Education and Therapy1988;14(1):46-9. KilmannPR , Milan RJ Jr, BolandJP , NankinHR , SablisRF , WestMO , et al.The sexual interactions of men with secondary erectile dysfunction. Paper presented at the annual meeting of the American Psychological Association in Los Angeles1985;1:46-9. ">Kilmann 1987</a> ; <a href="./references#MR000050-bbs2-0047" title="LegrandF .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 14th of August 2019. LegrandFD , NeffEM .Efficacy of exercise as an adjunct treatment for clinically depressed inpatients during the initial stages of antidepressant pharmacotherapy: an open randomized controlled trial. Journal of Affective Disorders2016;191:139-44. ">Legrand 2016</a> ; <a href="./references#MR000050-bbs2-0049" title="LickJR , HefflerD .Relaxation training and attention placebo in the treatment of severe insomnia. Journal of Consulting and Clinical Psychology1977;45(2):153-61. ">Lick 1977</a> ; <a href="./references#MR000050-bbs2-0050" title="LiddleB , SpenceSH .Cognitive-behaviour therapy with depressed primary school children: A cautionary note. Behavioural Psychotherapy1990;18(2):85-102. ">Liddle 1990</a> ; <a href="./references#MR000050-bbs2-0058" title="NicassioP , BootzinR .A comparison of progressive relaxation and autogenic training as treatments for insomnia. Journal of Abnormal Psychology1974;83(3):253-60. ">Nicassio 1974</a> ; <a href="./references#MR000050-bbs2-0061" title="MilichR , CarlsonCL , Pelham WE Jr, LichtBG .Effects of methylphenidate on the persistence of ADHD boys following failure experiences. Journal of Abnormal Child Psychology1991;19(5):519-36. PelhamWE , MurphyDA , VannattaK , MilichR , LichtBG , GnagyEM , et al.Methylphenidate and attributions in boys with attention-deficit hyperactivity disorder. Journal of Consulting and Clinical Psychology1992;60(2):282-92. ">Pelham 1992</a> ; <a href="./references#MR000050-bbs2-0065" title="PowersMB , SmitsJA , TelchMJ .Disentangling the effects of safety-behavior utilization and safety-behavior availability during exposure-based treatment: a placebo-controlled trial. Journal of Consulting and Clinical Psychology2004;72(3):448-54. ">Powers 2004</a> ; <a href="./references#MR000050-bbs2-0066" title="PowersMB , SmithsJA , WhitleyD , BystritskyA , TelchMJ .The effect of attributional processes concerning medication taking on return of fear. Journal of Consulting and Clinical Psychology2008;76(3):478-90. ">Powers 2008a</a> ; <a href="./references#MR000050-bbs2-0067" title="PowersMB , SmithsJA , WhitleyD , BystritskyA , TelchMJ .The effect of attributional processes concerning medication taking on return of fear. Journal of Consulting and Clinical Psychology2008;76(3):478-90. ">Powers 2008b</a> ; <a href="./references#MR000050-bbs2-0068" title="ProudfootJ , ClarkeJ , BirchMR , WhittonAE , ParkerG , ManicavasagarV , et al.Impact of a mobile phone and web program on symptom and functional outcomes for people with mild- to-moderate depression, anxiety and stress: a randomized controlled trial. BMC Psychiatry2013;13(312):1-12. ProudfootJ .Re: Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 26th of August 2019. ">Proudfoot 2013</a> ; <a href="./references#MR000050-bbs2-0080" title="ShealyRC .The effectiveness of various treatment techniques on different degrees and durations of sleep-onset insomnia. Behaviour Research and Therapy1979;17(6):541-6. ">Shealy 1979</a> ; <a href="./references#MR000050-bbs2-0083" title="SteinmarkSW , BorkovecTD .Active and placebo treatment effects on moderate insomnia under counterdemand and positive demand instructions. Journal of Abnormal Psychology1974;83(2):157-63. ">Steinmark 1974</a> ; <a href="./references#MR000050-bbs2-0085" title="TanSY , BruniJ .Cognitive-behavior therapy with adult patients with epilepsy: a controlled outcome study. Epilepsia1986;27(3):225-33. ">Tan 1986</a> ; <a href="./references#MR000050-bbs2-0089" title="AscherML , TurnerRM .A comparison of two methods for the administration of paradoxical intention. Behaviour Research and Therapy1980;18(2):121-6. TurnerRM , AscherLM .Controlled comparison of progressive relaxation, stimulus control, and paradoxical intention therapies for insomnia. Journal of Consulting and Clinical Psychology1979;47(3):500-8. ">Turner 1979</a> ; <a href="./references#MR000050-bbs2-0090" title="VanderplateC .Electromyograph biofeedback Treatment of sleep onset Insomnia: a controlled Investigation. Dissertation, University of Southern Mississippi1978. ">Vanderplate 1983</a> ; <a href="./references#MR000050-bbs2-0093" title="WhittakerCB , HoyRM .Withdrawal of perphenazine in chronic schizophrenia. British Journal of Psychiatry1963;109:422-7. ">Whittaker 1963</a> ; <a href="./references#MR000050-bbs2-0094" title="WilsonA , DavidsonWJ , BlanchardR , WhiteJ .Disulfiram implantation. A placebo-controlled trial with two-year follow-up. Journal of Studies on Alcohol1978;39(5):809-19. WilsonA , DavidsonWJ , BlanchardR .Disulfiram implantation: a trial using placebo implants and two types of controls. Journal of Studies on Alcohol1980;41(5):429-36. ">Wilson 1980</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Unclear risk of bias</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>19</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#MR000050-bbs2-0013" title="BrillNQ , KoeglerRR , EpsteinLJ , ForgyEW .Controlled study of psychiatric outpatient treatment. Archives of General Psychiatry1964;10:581-95. BrillNQ .Results of psychotherapy. California Medicine1966;104(4):249-53. ">Brill 1964a</a> ; <a href="./references#MR000050-bbs2-0014" title="BrillNQ , KoeglerRR , EpsteinLJ , ForgyEW .Controlled study of psychiatric outpatient treatment. Archives of General Psychiatry1964;10:581-95. ">Brill 1964b</a> ; <a href="./references#MR000050-bbs2-0030" title="GoldwasserAN , AuerbachSM , HarkinsSW .Cognitive, affective, and behavioural effects of reminiscence group therapy on demented elderly. Aging and Human Development1987;25(3):209-22. ">Goldwasser 1987</a> ; <a href="./references#MR000050-bbs2-0039" title="KlermanGL , DimascioA , WeismannM , PrusoffB , PaykelES .Treatment of depression by drugs and psychotherapy. American Journal of Psychiatry1974;131(2):186-91. PaykelES , DimascioA , HaskellD , PrusoffBA .Effects of maintenance amitriptyline and psychotherapy on symptoms of depression. Psychological Medicine1975;5(1):67-77. PaykelES , DiMascioA , KlermanGL , PrusoffBA .Maintenance therapy of depression. Pharmakopsychiatrie, Neuro-Psychopharmakologie1976;9:127-39. PaykelES , WeissmanMM , PrusoffBA .Social maladjustment and severity of depression. Comprehensive Psychiatry1978;19(2):121-8. WeissmanMM , KlermanGL , PaykelES , PrusoffB .Treatment effects on the social adjustment of depressed patients. Archives of General Psychiatry1974;30:771-8. ">Klerman 1974a</a> ; <a href="./references#MR000050-bbs2-0040" title="KlermanGL , DimascioA , WeismannM , PrusoffB , PaykelES .Treatment of depression by drugs and psychotherapy. American Journal of Psychiatry1974;131(2):186-91. ">Klerman 1974b</a> ; <a href="./references#MR000050-bbs2-0042" title="KrapflJE , NawasMM .Differential ordering of stimulus presentation in systematic desensitization. Journal of Abnormal Psychology1970;75(3):333-7. ">Krapfl 1970</a> ; <a href="./references#MR000050-bbs2-0044" title="LacyMK .The effect of short term autogenic training on the stress reactivity of hospitalized emotionally disturbed adolescents. ProQuest Dissertations Publishing, Oklahoma State University1996. ">Lacy 1990</a> ; <a href="./references#MR000050-bbs2-0046" title="LangOJ , LazovikAD .Experimental desensitization of a phobia. Journal of Abnormal and Social Psychology1963;66:519-25. LangPJ , LazovikAD , ReynoldsDJ .Desensitization, suggestibility, and pseudotherapy. Journal of Abnormal Psychology1965;70(6):395-402. ">Lang 1965</a> ; <a href="./references#MR000050-bbs2-0054" title="MilbyJB , ClarkeC , ToroC , ThorntonS , RickertD .Effectiveness of urine surveillance as an adjunct to outpatient psychotherapy for drug abusers. International Journal of the Addictions1980;15(7):993-1001. ">Milby 1980</a> ; <a href="./references#MR000050-bbs2-0055" title="MirandaA , ArlandisP , SorianoM .Instruction in strategies and attributional training: Effects on the problem-solving and self-concept of students’ with learning disabilities [Instrucción en estrategias y entrenamiento atribucional: efectos sobre la resolución de problemas y el autoconcepto de los estudiantes con dificultades en el aprendizaje]. Infancia y Aprendizaje1997;20(80):37-52. ">Miranda 1997</a> ; <a href="./references#MR000050-bbs2-0056" title="MitchellC , MansfieldD , RautenbachS .Coloured filters and reading accuracy, comprehension and rate: a placebo-controlled study. Perceptual and Motor Skills2008;106(2):517-32. ">Mitchell 2008</a> ; <a href="./references#MR000050-bbs2-0059" title="PearlD , Vander KampH , OlsenAL , GreenbergPD , ArmitageSG .The effects of reserpine on schizophrenic patients. American Journal of Psychiatry1956;112:198-204. ">Pearl 1956</a> ; <a href="./references#MR000050-bbs2-0060" title="PeckCL .Desensitization for the treatment of fear in the high level adult retardate. Behaviour Research and Therapy1977;15(2):137-48. ">Peck 1976</a> ; <a href="./references#MR000050-bbs2-0064" title="PolandRE , GertsikL , FavreauJT , SmithSI , MirochaJM , RaoU , et al.Open-label randomized parallel-group controlled clinical trial of massage for treatment of depression in HIV-infected subjects. Journal of Alternative and Complementary Medicine2013;19(4):334-40. ">Poland 2013</a> ; <a href="./references#MR000050-bbs2-0069" title="QuayhagenMP , QuayhagenM , CorbeilRR , RothPA , RodgersJA .A dyadic remediation program for care recipients with dementia. Nursing Research1995;44(3):153-9. ">Quayhagen 1995</a> ; <a href="./references#MR000050-bbs2-0074" title="RoehrichL , GoldmanMS .Experience-dependent neuropsychological recovery and the treatment of alcoholism. Journal of Consulting and Clinical Psychology1993;61(5):812-21. ">Roehrich 1993</a> ; <a href="./references#MR000050-bbs2-0078" title="RupertPA , HolmesDS .Effects of multiple sessions of true and placebo heart rate biofeedback training on the heart rates and anxiety levels of anxious patients during and following treatment. Psychophysiology1978;15(6):582-90. ">Rupert 1978</a> ; <a href="./references#MR000050-bbs2-0091" title="WatzlH , RistF , OlbrichR , CohenR .Placebo injections and surveillance of alcohol intake during inpatient treatment of female alcoholics. Addictive Behaviors1988;13(2):197-200. ">Watzl 1988</a> ; <a href="./references#MR000050-bbs2-0096" title="WollersheimJP , WilsonGL .Group treatment of unipolar depression: a comparison of coping, supportive, bibliotherapy, and delayed treatment groups. Professional Psychology: Research and Practice1991;22(6):496-502. ">Wollersheim 1991</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Blinding of participants and personnel</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>High risk of bias</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>96</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#MR000050-bbs2-0001" title="AbikoffH , HechtmanL , KleinRG .Social functioning in children with ADHD treated with long-term methylphenidate and multimodal psychosocial treatment. Journal of the American Academy of Child and Adolescent Psychiatry2004;43(7):820-9. AbikoffH .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to A Todorovac 23rd of August 2019. KleinRG , AbikoffH , HechtmanL , WeissG .Design and rationale of controlled study of long-term methylphenidate and multimodal psychosocial treatment in children with ADHD. Journal of the American Academy of Child and Adolescent Psychiatry2004;43(7):792-801. ">Abikoff 2004</a> ; <a href="./references#MR000050-bbs2-0002" title="AllenJB .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to A Todorovac 28th of August 2019. AllenJJ , SchnyerRN , HittSK .The efficacy of acupuncture in the treatment of major depression in women. Psychological Science1998;9(5):397-401. ">Allen 1998</a> ; <a href="./references#MR000050-bbs2-0003" title="AllenJB .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 28th of August 2019. AllenJJ , SchnyerRN , ChambersAS , HittSK , MorenoFA , ManberR .Acupuncture for depression: a randomized controlled trial. Journal of Clinical Psychiatry2006;67(11):1665-73. ">Allen 2006</a> ; <a href="./references#MR000050-bbs2-0004" title="AlvarezJR .The effects of anger management training on depression, anger, self-concept, and treatment responsibility in a sample of drug-dependent individuals in a therapeutic community. Dissertation Abstracts International: Section B: the Sciences and Engineering1997;58(4-B):2108. ">Alvarez 1997</a> ; <a href="./references#MR000050-bbs2-0005" title="AscherLM , TurnerR .Paradoxical intention and insomnia: an experimental investigation. Behaviour Research and Therapy1979;17(4):408-11. ">Ascher 1979</a> ; <a href="./references#MR000050-bbs2-0006" title="AyenI , HautzingerM .Cognitive behavior therapy for depression in menopausal women. A controlled, randomized treatment study [Kognitive Verhaltenstherapie bei Depressionen im Klimakterium: Eine kontrollierte, randomiserte Interventionsstudie]. Zeitschrift für Klinische Psychologie und Psychotherapie2004;33(4):290-9. AyenI .Inclusion of study in Cochrane Systematic Review (personal communication). Email to EG Faltinsen 9th of September 2019. ">Ayen 2004</a> ; <a href="./references#MR000050-bbs2-0007" title="BergI , ForsytheI , HoltP , WattsJ .A controlled trial of ‘Senokot’ in faecal soiling treated by behavioural methods. Journal of Child Psychology and Psychiatry1983;24(4):543-9. ">Berg 1983</a> ; <a href="./references#MR000050-bbs2-0008" title="Borden, KA.Attributional Outcomes: the Subtle Messages of Treatments for Attention Deficit Disorder. Dissertation, University of Illinois at Urbana-Champaign1986. BordenKA , BrownRT .Attributional outcomes: The subtle messages of treatments for attention deficit disorder. Cognitive Therapy and Research1989;13(2):147-60. ">Borden 1986</a> ; <a href="./references#MR000050-bbs2-0009" title="BorkovecTD , KaloupekDG , SlamaKM .The facilitative effect of muscle tension-release in the relaxation treatment of sleep disturbance. Behavior Therapy1975;6(3):301-9. ">Borkovec 1975</a> ; <a href="./references#MR000050-bbs2-0010" title="BorkovecTD , WeertsTC .Effects of progressive relaxation on sleep disturbance: an electroencephalographic evaluation. Psychosomatic Medicine1976;38(3):173-80. ">Borkovec 1976</a> ; <a href="./references#MR000050-bbs2-0011" title="BornovalovaM .Inclusion of study in Cochrane Systematic Review (personal communication). Email to A Todorovac. 21st of August 2019. BornovalovaMA .Distress tolerance treatment for inner-city drug users: a preliminary trial. Doctor’s Dissertation, University of Maryland2008. ">Bornovalova 2008</a> ; <a href="./references#MR000050-bbs2-0012" title="BramstonP , SpenceSH .Behavioural versus cognitive social-skills training with intellectually-handicapped adults. Behaviour Research and Therapy1985;23(3):239-46. ">Bramston 1985</a> ; <a href="./references#MR000050-bbs2-0013" title="BrillNQ , KoeglerRR , EpsteinLJ , ForgyEW .Controlled study of psychiatric outpatient treatment. Archives of General Psychiatry1964;10:581-95. BrillNQ .Results of psychotherapy. California Medicine1966;104(4):249-53. ">Brill 1964a</a> ; <a href="./references#MR000050-bbs2-0014" title="BrillNQ , KoeglerRR , EpsteinLJ , ForgyEW .Controlled study of psychiatric outpatient treatment. Archives of General Psychiatry1964;10:581-95. ">Brill 1964b</a> ; <a href="./references#MR000050-bbs2-0015" title="CarlsonCL , PelhamWE , MilichR , HozaB .ADHD boys’ performance and attributions following success and failure: drug effects and individual differences. Cognitive Therapy and Research1993;17:269-87. ">Carlson 1993</a> ; <a href="./references#MR000050-bbs2-0016" title="CarterJC , OlmstedMP , KaplanAS , McCabeRE , MillsJS , AimeA .Self-help for bulimia nervosa: a randomized controlled trial. American Journal of Psychiatry2003;160(5):973-8. ">Carter 2003</a> ; <a href="./references#MR000050-bbs2-0017" title="CrispAH , NortonK , GowersS , HalekC , BowyerC , YeldhamD , et al.A controlled study of the effect of therapies aimed at adolescent and family psychopathology in Anorexia Nervosa. British Journal of Psychiatry: the Journal of Mental Science1991;159:325-33. GowersS , NortonK , HalekC , CrispAH .Outcome of outpatient psychotherapy in a random allocation treatment study of anorexia nervosa. International Journal of Eating Disorders1994;15(2):165-77. GowersS , NortonK , YelshamD .The St George's prospective treatment study of anorexia nervosa: a discussion of methodological problems. International Journal of Eating Disorders1989;8:445-54. ">Crisp 1991</a> ; <a href="./references#MR000050-bbs2-0018" title="CrouchG , RobsonM , HallstromC .Benzodiazepine dependent patients and their psychological treatment. Progress in Neuro-psychopharmacology &amp; Biological Psychiatry1988;12(4):503-10. HallströmC , CrouchG , RobsenM , ShineP .The treatment of tranquillizer dependence by propranolol. Postgraduate Medical Journal1988;64(Suppl 2):40-4. ">Crouch 1988</a> ; <a href="./references#MR000050-bbs2-0019" title="Doty, DW.Role playing and incentives in the modification of the social interaction of chronic psychiatric patients. Journal of Consulting and Clinical Psychology1975;43(5):676-82. ">Doty 1975</a> ; <a href="./references#MR000050-bbs2-0020" title="DoubleDB , WarrenGC , EvansM , RowlandsMP .Efficacy of maintenance use of anticholinergic agents. Acta Psychiatrica Scandinavica1993;88:381-4. ">Double 1993</a> ; <a href="./references#MR000050-bbs2-0021" title="EhlersA , HackmannA , GreyN , WildJ , LinessS , AlbertI , et al.A randomized controlled trial of 7-day intensive and standard weekly cognitive therapy for PTSD and emotion-focused supportive therapy. American Journal of Psychiatry2014;171(3):294-304. ">Ehlers 2014</a> ; <a href="./references#MR000050-bbs2-0022" title="EspieCA , BrooksDN , LindsayWR .An evaluation of tailored psychological treatment of insomnia. Journal of Behavior Therapy and Experimental Psychiatry1989;20(2):143-53. EspieCA , LindsayWR , BrooksDN , HoodEM , TurveyT .A controlled comparative investigation of psychological treatments for chronic sleep-onset insomnia. Behaviour Research and Therapy1989;27(1):79-88. ">Espie 1989a</a> ; <a href="./references#MR000050-bbs2-0023" title="EtringerBD , CashTF , RimmDC .Behavioral, affective, and cognitive effects of participant modeling and an equally credible placebo. Behavior Therapy1982;13(4):476-85. ">Etringer 1982</a> ; <a href="./references#MR000050-bbs2-0024" title="FoaEB , RothbaumBO , RiggsDS , MurdockTB .Treatment of posttraumatic stress disorder in rape victims: a comparison between cognitive-behavioral procedures and counselling. Journal of Consulting and Clinical Psychology1991;59(5):715-23. ">Foa 1991</a> ; <a href="./references#MR000050-bbs2-0025" title="FoaEB , McLeanCP , ZangY , RosenfieldD , YadinE , YarvisJS , et al.Effect of prolonged exposure therapy delivered over 2 weeks vs 8 weeks vs present-centered therapy on PTSD symptom severity in military personnel: a randomized clinical trial. JAMA2018;319(4):354-64. ">Foa 2018</a> ; <a href="./references#MR000050-bbs2-0026" title="FreireAO , SugaiGC , ChrispinFS , TogeiroSM , YamamuraY , MelloLE , et al.Treatment of moderate obstructive sleep apnea syndrome with acupuncture: a randomised, placebo-controlled pilot trial. Sleep Medicine2007;8(1):43-50. ">Freire 2007</a> ; <a href="./references#MR000050-bbs2-0027" title="FuchsCZ , RehnLP .A self-control behavior therapy program for depression. Journal of Consulting and Clinical Psychology1977;45(2):206-15. ">Fuchs 1977</a> ; <a href="./references#MR000050-bbs2-0028" title="GlogowskaM , RoulstoneS , EnderbyP , PetersTJ .Randomised controlled trial of community based speech and language therapy in preschool children. BMJ2000;321(7266):923-6. ">Glogowska 2000</a> ; <a href="./references#MR000050-bbs2-0029" title="GoldsteinAJ , BeursE , Chambless Dl, WilsonKA .EMDR for panic disorder with agoraphobia: comparison with waiting list and credible attention-placebo control conditions. Journal of Consulting and Clinical Psychology2000;68(6):947-56. ">Goldstein 2000</a> ; <a href="./references#MR000050-bbs2-0030" title="GoldwasserAN , AuerbachSM , HarkinsSW .Cognitive, affective, and behavioural effects of reminiscence group therapy on demented elderly. Aging and Human Development1987;25(3):209-22. ">Goldwasser 1987</a> ; <a href="./references#MR000050-bbs2-0031" title="HekmatH , LubitzR , DealR .Semantic desensitization: a paradigmatic intervention approach to anxiety disorders. Journal of Clinical Psychology1984;40(2):463-6. ">Hekmat 1984</a> ; <a href="./references#MR000050-bbs2-0032" title="HippmanC , RingroseA , InglisA , CheekJ , AlbertAY , RemickR , et al.A pilot randomized clinical trial evaluating the impact of genetic counselling for serious mental illnesses. Journal of Clinical Psychiatry2016;77(2):e190-8. ">Hippman 2016</a> ; <a href="./references#MR000050-bbs2-0033" title="HowlinP , GordonKR , PascoG , WadeA , CharmanT .The effectiveness of picture exchange communication system (PECS) training for teachers of children with autism: a pragmatic,group randomised controlled trial. Journal of Child Psychology and Psychiatry2007;48(5):473-81. ">Howlin 2007</a> ; <a href="./references#MR000050-bbs2-0034" title="KarstM , WinterhalterM , MünteS , FranckiB , HondronikosA , EckardtA , et al.Auricular acupuncture for dental anxiety: a randomized controlled trial. Anesthesia and Analgesia2007;104(2):295-300. KarstM .Inclusion of study in Cochrane Systematic Review (personal communication). Email to: EG Faltinsen 5th of September 2019. ">Karst 2007</a> ; <a href="./references#MR000050-bbs2-0035" title="KelleyJ .Inclusion of study in Cochrane Systematic Review (personal communication). Email to: A Todorovac 12th of August 2019. KelleyJM , KaptchukTJ , CusinC , LipkinS , FavaM .Open-label placebo for major depressive disorder: a pilot randomized controlled trial. Psychotherapy and Psychosomatics2012;81(5):312-4. ">Kelley 2012</a> ; <a href="./references#MR000050-bbs2-0036" title="KennedyTD , KimuraHK .Transfer, behavioral improvement, and anxiety reduction in systematic desensitization. Journal of Consulting and Clinical Psychology1974;42(5):720-8. ">Kennedy 1974</a> ; <a href="./references#MR000050-bbs2-0037" title="KilmannPR , MilanRJ , BolandJP , NankinHR , DavidsonE , WestMO , et al.Group treatment of secondary erectile dysfunction. Journal of Sex &amp; Marital Therapy1987;13(3):168-82. KilmannPR , Milan RJ Jr, BolandJP , DavidsonE , WestMO , SablisRF , et al.The sexual interactions of men with secondary erectile dysfunction. Journal of Sex Education and Therapy1988;14(1):46-9. KilmannPR , Milan RJ Jr, BolandJP , NankinHR , SablisRF , WestMO , et al.The sexual interactions of men with secondary erectile dysfunction. Paper presented at the annual meeting of the American Psychological Association in Los Angeles1985;1:46-9. ">Kilmann 1987</a> ; <a href="./references#MR000050-bbs2-0038" title="KleinSA , DeffenbacherJL .Relaxation and exercise for hyperactive impulsive children. Perceptual and Motor Skills1977;45:1159-62. ">Klein 1977</a> ; <a href="./references#MR000050-bbs2-0039" title="KlermanGL , DimascioA , WeismannM , PrusoffB , PaykelES .Treatment of depression by drugs and psychotherapy. American Journal of Psychiatry1974;131(2):186-91. PaykelES , DimascioA , HaskellD , PrusoffBA .Effects of maintenance amitriptyline and psychotherapy on symptoms of depression. Psychological Medicine1975;5(1):67-77. PaykelES , DiMascioA , KlermanGL , PrusoffBA .Maintenance therapy of depression. Pharmakopsychiatrie, Neuro-Psychopharmakologie1976;9:127-39. PaykelES , WeissmanMM , PrusoffBA .Social maladjustment and severity of depression. Comprehensive Psychiatry1978;19(2):121-8. WeissmanMM , KlermanGL , PaykelES , PrusoffB .Treatment effects on the social adjustment of depressed patients. Archives of General Psychiatry1974;30:771-8. ">Klerman 1974a</a> ; <a href="./references#MR000050-bbs2-0040" title="KlermanGL , DimascioA , WeismannM , PrusoffB , PaykelES .Treatment of depression by drugs and psychotherapy. American Journal of Psychiatry1974;131(2):186-91. ">Klerman 1974b</a> ; <a href="./references#MR000050-bbs2-0041" title="KloskoJS , BarlowDH , TassinariR , CernyJA .A comparison of alprazolam and behavior therapy in treatment of panic disorder: correction. Journal of Psychotherapy Practice and Research1994;3(2):163-79. KloskoJS , BarlowDH , TassinariR , CernyJA .A comparison of alprazolam and behavior therapy in treatment of panic disorder. Journal of Consulting and Clinical Psychology1990;58(1):77-84. ">Klosko 1990</a> ; <a href="./references#MR000050-bbs2-0042" title="KrapflJE , NawasMM .Differential ordering of stimulus presentation in systematic desensitization. Journal of Abnormal Psychology1970;75(3):333-7. ">Krapfl 1970</a> ; <a href="./references#MR000050-bbs2-0043" title="KwanR .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 26th of August 2019. KwanRY , LeungMC , LaiCK .Acupressure for agitation in nursing home residents with dementia: study protocol for a randomized controlled trial. Trials2014;15(410):1-7. KwanRY , LeungMCP , LaiCK .A randomized controlled trial examining the effect of acupressure on agitation and salivary cortisol in nursing home residents with dementia. Dementia and Geriatric Cognitive Disorders2017;44(1-2):92-104. ">Kwan 2017</a> ; <a href="./references#MR000050-bbs2-0044" title="LacyMK .The effect of short term autogenic training on the stress reactivity of hospitalized emotionally disturbed adolescents. ProQuest Dissertations Publishing, Oklahoma State University1996. ">Lacy 1990</a> ; <a href="./references#MR000050-bbs2-0045" title="LaiCK , ChiI , Kayser-JonesJ .A randomized controlled trial of a specific reminiscence approach to promote the well-being of nursing home residents with dementia. International Psychogeriatrics2004;16(1):33-49. LaiK .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 6th of September 2019. ">Lai 2004</a> ; <a href="./references#MR000050-bbs2-0046" title="LangOJ , LazovikAD .Experimental desensitization of a phobia. Journal of Abnormal and Social Psychology1963;66:519-25. LangPJ , LazovikAD , ReynoldsDJ .Desensitization, suggestibility, and pseudotherapy. Journal of Abnormal Psychology1965;70(6):395-402. ">Lang 1965</a> ; <a href="./references#MR000050-bbs2-0047" title="LegrandF .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 14th of August 2019. LegrandFD , NeffEM .Efficacy of exercise as an adjunct treatment for clinically depressed inpatients during the initial stages of antidepressant pharmacotherapy: an open randomized controlled trial. Journal of Affective Disorders2016;191:139-44. ">Legrand 2016</a> ; <a href="./references#MR000050-bbs2-0048" title="LickJ .Expectancy, false galvanic skin response feedback, and systematic desensitization in the modification of phobic behavior. Journal of Consulting and Clinical Psychology1975;43(4):557-67. ">Lick 1975</a> ; <a href="./references#MR000050-bbs2-0049" title="LickJR , HefflerD .Relaxation training and attention placebo in the treatment of severe insomnia. Journal of Consulting and Clinical Psychology1977;45(2):153-61. ">Lick 1977</a> ; <a href="./references#MR000050-bbs2-0050" title="LiddleB , SpenceSH .Cognitive-behaviour therapy with depressed primary school children: A cautionary note. Behavioural Psychotherapy1990;18(2):85-102. ">Liddle 1990</a> ; <a href="./references#MR000050-bbs2-0051" title="MatsonJL , MarchettiA , AdkinsJA .Comparison of operant- and independence-training procedures for mentally retarded adults. American Journal of Mental Deficiency1980;84(5):487-94. ">Matson 1980</a> ; <a href="./references#MR000050-bbs2-0052" title="McLachlanDR , DaltonAJ , KruckTP , BellMY , SmithWL , KalowW , et al.Intramuscular desferrioxamine in patients with Alzheimer's disease. Lancet1991;337(8753):1304-8. McLachlanDRC , SmithWL , KruckTP .Desferrioxamine and Alzheimer’s disease: video home behavior assessment of clinical course and measures of brain aluminum. Therapeutic Drug Monitoring1993;15(6):602-7. ">McLachlan 1991</a> ; <a href="./references#MR000050-bbs2-0053" title="MealieaWL , NawasMM .The comparative effectiveness of systematic desensitization and implosive therapy in the treatment of snake phobia. Journal of Behavior Therapy and Experimental Psychiatry1971;2(2):85-94. ">Mealiea 1971</a> ; <a href="./references#MR000050-bbs2-0054" title="MilbyJB , ClarkeC , ToroC , ThorntonS , RickertD .Effectiveness of urine surveillance as an adjunct to outpatient psychotherapy for drug abusers. International Journal of the Addictions1980;15(7):993-1001. ">Milby 1980</a> ; <a href="./references#MR000050-bbs2-0055" title="MirandaA , ArlandisP , SorianoM .Instruction in strategies and attributional training: Effects on the problem-solving and self-concept of students’ with learning disabilities [Instrucción en estrategias y entrenamiento atribucional: efectos sobre la resolución de problemas y el autoconcepto de los estudiantes con dificultades en el aprendizaje]. Infancia y Aprendizaje1997;20(80):37-52. ">Miranda 1997</a> ; <a href="./references#MR000050-bbs2-0056" title="MitchellC , MansfieldD , RautenbachS .Coloured filters and reading accuracy, comprehension and rate: a placebo-controlled study. Perceptual and Motor Skills2008;106(2):517-32. ">Mitchell 2008</a> ; <a href="./references#MR000050-bbs2-0057" title="NandiDN , AjmanyS , GanguliH , BanerjeeG , BoralGC , GhoshA , et al.A clinical evaluation of depressives found in a rural survey in India. British Journal of Psychiatry1976;128:523-7. ">Nandi 1976</a> ; <a href="./references#MR000050-bbs2-0058" title="NicassioP , BootzinR .A comparison of progressive relaxation and autogenic training as treatments for insomnia. Journal of Abnormal Psychology1974;83(3):253-60. ">Nicassio 1974</a> ; <a href="./references#MR000050-bbs2-0059" title="PearlD , Vander KampH , OlsenAL , GreenbergPD , ArmitageSG .The effects of reserpine on schizophrenic patients. American Journal of Psychiatry1956;112:198-204. ">Pearl 1956</a> ; <a href="./references#MR000050-bbs2-0060" title="PeckCL .Desensitization for the treatment of fear in the high level adult retardate. Behaviour Research and Therapy1977;15(2):137-48. ">Peck 1976</a> ; <a href="./references#MR000050-bbs2-0061" title="MilichR , CarlsonCL , Pelham WE Jr, LichtBG .Effects of methylphenidate on the persistence of ADHD boys following failure experiences. Journal of Abnormal Child Psychology1991;19(5):519-36. PelhamWE , MurphyDA , VannattaK , MilichR , LichtBG , GnagyEM , et al.Methylphenidate and attributions in boys with attention-deficit hyperactivity disorder. Journal of Consulting and Clinical Psychology1992;60(2):282-92. ">Pelham 1992</a> ; <a href="./references#MR000050-bbs2-0062" title="PedletonMG , HigginsRL .A comparison of negative practice and systematic desensitization in the treatment of acrophobia. Journal of Behavior Therapy and Experimental Psychiatry1983;14(4):317-23. ">Pendleton 1983</a> ; <a href="./references#MR000050-bbs2-0063" title="PetersonMA , PattersonB , PillmanBM , BattistaMA .Cognitive recovery following alcohol detoxification: a computerised remediation study. Neuropsychological Rehabilitation2002;12(1):63-74. PillmanBM .Computerized cognitive remediation with recently detoxified alcoholics. Dissertation, California School of Professional Psychology, Fresno Campus2000. ">Pillman 2001</a> ; <a href="./references#MR000050-bbs2-0064" title="PolandRE , GertsikL , FavreauJT , SmithSI , MirochaJM , RaoU , et al.Open-label randomized parallel-group controlled clinical trial of massage for treatment of depression in HIV-infected subjects. Journal of Alternative and Complementary Medicine2013;19(4):334-40. ">Poland 2013</a> ; <a href="./references#MR000050-bbs2-0065" title="PowersMB , SmitsJA , TelchMJ .Disentangling the effects of safety-behavior utilization and safety-behavior availability during exposure-based treatment: a placebo-controlled trial. Journal of Consulting and Clinical Psychology2004;72(3):448-54. ">Powers 2004</a> ; <a href="./references#MR000050-bbs2-0066" title="PowersMB , SmithsJA , WhitleyD , BystritskyA , TelchMJ .The effect of attributional processes concerning medication taking on return of fear. Journal of Consulting and Clinical Psychology2008;76(3):478-90. ">Powers 2008a</a> ; <a href="./references#MR000050-bbs2-0067" title="PowersMB , SmithsJA , WhitleyD , BystritskyA , TelchMJ .The effect of attributional processes concerning medication taking on return of fear. Journal of Consulting and Clinical Psychology2008;76(3):478-90. ">Powers 2008b</a> ; <a href="./references#MR000050-bbs2-0068" title="ProudfootJ , ClarkeJ , BirchMR , WhittonAE , ParkerG , ManicavasagarV , et al.Impact of a mobile phone and web program on symptom and functional outcomes for people with mild- to-moderate depression, anxiety and stress: a randomized controlled trial. BMC Psychiatry2013;13(312):1-12. ProudfootJ .Re: Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 26th of August 2019. ">Proudfoot 2013</a> ; <a href="./references#MR000050-bbs2-0069" title="QuayhagenMP , QuayhagenM , CorbeilRR , RothPA , RodgersJA .A dyadic remediation program for care recipients with dementia. Nursing Research1995;44(3):153-9. ">Quayhagen 1995</a> ; <a href="./references#MR000050-bbs2-0070" title="LiebowitzM , QuitkinFM , StewartJW , McGrathPJ , HarrisonWM , MarkowitzJS , et al.Antidepressant efficacy in atypical depression. Archives of General Psychiatry1988;45(2):129-37. QuitkinFM , McGrathPJ , StewartJW , HarrisonW , WagerSG , NunesE , et al.Phenelzine and imipramine in mood reactive depressives: further delineation of the syndrome of atypical depression. Archives of General Psychiatry1989;46(9):787-93. RabkinJG , McGrathPJ , QuitkinFM , TricamoE , StewartJW , KleinDF .Effects of pill-giving on maintenance of placebo response in patients with chronic mild depression. American Journal of Psychiatry1990;147(12):1622-6. ">Rabkin 1990</a> ; <a href="./references#MR000050-bbs2-0071" title="RapeeR .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 29th of August 2019. RapeeRM , AbbottMJ , LynehamHJ .Bibliotherapy for children With anxiety disorders using written materials for parents: a randomized controlled trial. Journal of Consulting and Clinical Psychology2006;74(3):436-44. ">Rapee 2006</a> ; <a href="./references#MR000050-bbs2-0072" title="RapeeR .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 29th of August 2019. RapeeRM , AbbottMJ , BaillieAJ , GastonJE .Treatment of social phobia through pure self-help and therapist-augmented self-help. British Journal of Psychiatry2007;191:246-52. ">Rapee 2007</a> ; <a href="./references#MR000050-bbs2-0073" title="RobinA .Rationing out-patients: a defence of the waiting list. British Journal of Psychiatry1976;129:138-41. ">Robin 1976</a> ; <a href="./references#MR000050-bbs2-0074" title="RoehrichL , GoldmanMS .Experience-dependent neuropsychological recovery and the treatment of alcoholism. Journal of Consulting and Clinical Psychology1993;61(5):812-21. ">Roehrich 1993</a> ; <a href="./references#MR000050-bbs2-0075" title="OlivaresJ .Program IAFS. Protocol for the treatment of social phobia in adolescents [Programa IAFS. Protocolo para el tratamiento de la fobia social enadolescentes]. Madrid: Pirámide2005;1. Rosa-AlcázarAI , Olivares-OlivaresPJ , OlivaresJ .The role of non-specific effects in the psychological treatment of adolescents with social phobia [Papel de los efectos inespecíficos en el tratamiento psicológico de adolescentes con fobia social]. Anuario de Psicologia2009;40(1):43-61. ">Rosa‐Alcatraz 2009</a> ; <a href="./references#MR000050-bbs2-0076" title="RosenGM , GlasgowRE , BarreraM .A controlled study to assess the clinical efficacy of totally self-administrated systematic desensitization. Journal of Consulting and Clinical Psychology1976;44(2):208-17. ">Rosen 1976</a> ; <a href="./references#MR000050-bbs2-0077" title="LorrM , McNairDM , WeinsteinGJ .Early effects of chlordiazepoxide (Librium) used with psychotherapy. Journal of Psychiatric Research1963;1:257-70. RothI , RhudickPJ , ShaskanDA , SlobinMS , WilkinsonAE , YoungHH .Long-term effects on psychotherapy of initial treatment conditions. Journal of Psychiatric Research1964;2:283-97. ">Roth 1964</a> ; <a href="./references#MR000050-bbs2-0078" title="RupertPA , HolmesDS .Effects of multiple sessions of true and placebo heart rate biofeedback training on the heart rates and anxiety levels of anxious patients during and following treatment. Psychophysiology1978;15(6):582-90. ">Rupert 1978</a> ; <a href="./references#MR000050-bbs2-0079" title="ShalevAY , AnkriY , Isreali-ShalevY , PelegT , AdesskyR , FreedmanS .Prevention of posttraumatic stress disorder by early treatment. Archives of General Psychiatry2012;69(2):166-76. ">Shalev 2012</a> ; <a href="./references#MR000050-bbs2-0080" title="ShealyRC .The effectiveness of various treatment techniques on different degrees and durations of sleep-onset insomnia. Behaviour Research and Therapy1979;17(6):541-6. ">Shealy 1979</a> ; <a href="./references#MR000050-bbs2-0081" title="SibilioJP , AndrewG , DartD , MooreKB , StehmanA .Treatment of chronic schizophrenia with promazine hydrochloride. AMA Archives of Neurology and Psychiatry1957;78(4):419-24. ">Sibilio 1957</a> ; <a href="./references#MR000050-bbs2-0082" title="SommernessMD , LuceroRJ , HamlonJS , EricksonJL , MatthewsR .A controlled study of reserpine on chronically disturbed patients. JAMA Archives of Neurology and Psychiatry1955;74(3):316-9. ">Sommerness 1955</a> ; <a href="./references#MR000050-bbs2-0083" title="SteinmarkSW , BorkovecTD .Active and placebo treatment effects on moderate insomnia under counterdemand and positive demand instructions. Journal of Abnormal Psychology1974;83(2):157-63. ">Steinmark 1974</a> ; <a href="./references#MR000050-bbs2-0084" title="SzymanskiJ , O'DonohueW .The potential role of state-dependent learning in cognitive therapy with spider phobics. Journal of Rational-Emotive &amp; Cognitive-Behavior Therapy1995;13(2):131-50. SzymanskiJ .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 20th of August 2019. ">Szymanski 1995</a> ; <a href="./references#MR000050-bbs2-0085" title="TanSY , BruniJ .Cognitive-behavior therapy with adult patients with epilepsy: a controlled outcome study. Epilepsia1986;27(3):225-33. ">Tan 1986</a> ; <a href="./references#MR000050-bbs2-0086" title="TeriL , LogsdonRG , UomotoJ , McCurrySM .Behavioral treatment of depression in dementia patients: a controlled clinical trial. Journals of Gerontology. Series B, Psychological Sciences and Social Sciences1997;52(4):159-66. TeriL .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 26th of August 2019. ">Teri 1997</a> ; <a href="./references#MR000050-bbs2-0087" title="ToriC , WorellL .Reduction of human avoidant behavior. A comparison of counterconditioning, expectancy, and cognitive information approaches. Clinical Psychology1973;41(2):269-78. ">Tori 1973</a> ; <a href="./references#MR000050-bbs2-0088" title="Trexler, L.Rational-emotive therapy, placebo, and no-treatment effects on public-speaking anxiety. Doctoral dissertation, Temple University AnnArbor, Mich.: University Microfilms1971;71-31(063). TrexlerLD , KarstTO .Rational-emotive therapy, placebo, and no-treatment effects on public-speaking anxiety. Journal of Abnormal Psyhology1972;79(1):60-7. ">Trexler 1972</a> ; <a href="./references#MR000050-bbs2-0089" title="AscherML , TurnerRM .A comparison of two methods for the administration of paradoxical intention. Behaviour Research and Therapy1980;18(2):121-6. TurnerRM , AscherLM .Controlled comparison of progressive relaxation, stimulus control, and paradoxical intention therapies for insomnia. Journal of Consulting and Clinical Psychology1979;47(3):500-8. ">Turner 1979</a> ; <a href="./references#MR000050-bbs2-0090" title="VanderplateC .Electromyograph biofeedback Treatment of sleep onset Insomnia: a controlled Investigation. Dissertation, University of Southern Mississippi1978. ">Vanderplate 1983</a> ; <a href="./references#MR000050-bbs2-0091" title="WatzlH , RistF , OlbrichR , CohenR .Placebo injections and surveillance of alcohol intake during inpatient treatment of female alcoholics. Addictive Behaviors1988;13(2):197-200. ">Watzl 1988</a> ; <a href="./references#MR000050-bbs2-0092" title="WeingaertnerAH .Self-administered aversive stimulation with hallucinating hospitalized schizophrenics. Journal of Consulting and Clinical Psychology1971;36(3):422-29. ">Weingaertner 1971</a> ; <a href="./references#MR000050-bbs2-0093" title="WhittakerCB , HoyRM .Withdrawal of perphenazine in chronic schizophrenia. British Journal of Psychiatry1963;109:422-7. ">Whittaker 1963</a> ; <a href="./references#MR000050-bbs2-0094" title="WilsonA , DavidsonWJ , BlanchardR , WhiteJ .Disulfiram implantation. A placebo-controlled trial with two-year follow-up. Journal of Studies on Alcohol1978;39(5):809-19. WilsonA , DavidsonWJ , BlanchardR .Disulfiram implantation: a trial using placebo implants and two types of controls. Journal of Studies on Alcohol1980;41(5):429-36. ">Wilson 1980</a> ; <a href="./references#MR000050-bbs2-0095" title="WolitzkyKB , TelchMJ .Augmenting in vivo exposure with fear antagonistic actions: a preliminary test. Behavior Therapy2009;40(1):57-71. ">Wolitzky 2009</a> ; <a href="./references#MR000050-bbs2-0096" title="WollersheimJP , WilsonGL .Group treatment of unipolar depression: a comparison of coping, supportive, bibliotherapy, and delayed treatment groups. Professional Psychology: Research and Practice1991;22(6):496-502. ">Wollersheim 1991</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Incomplete outcome data</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Low risk of bias</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>41</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#MR000050-bbs2-0002" title="AllenJB .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to A Todorovac 28th of August 2019. AllenJJ , SchnyerRN , HittSK .The efficacy of acupuncture in the treatment of major depression in women. Psychological Science1998;9(5):397-401. ">Allen 1998</a> ; <a href="./references#MR000050-bbs2-0003" title="AllenJB .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 28th of August 2019. AllenJJ , SchnyerRN , ChambersAS , HittSK , MorenoFA , ManberR .Acupuncture for depression: a randomized controlled trial. Journal of Clinical Psychiatry2006;67(11):1665-73. ">Allen 2006</a> ; <a href="./references#MR000050-bbs2-0006" title="AyenI , HautzingerM .Cognitive behavior therapy for depression in menopausal women. A controlled, randomized treatment study [Kognitive Verhaltenstherapie bei Depressionen im Klimakterium: Eine kontrollierte, randomiserte Interventionsstudie]. Zeitschrift für Klinische Psychologie und Psychotherapie2004;33(4):290-9. AyenI .Inclusion of study in Cochrane Systematic Review (personal communication). Email to EG Faltinsen 9th of September 2019. ">Ayen 2004</a> ; <a href="./references#MR000050-bbs2-0007" title="BergI , ForsytheI , HoltP , WattsJ .A controlled trial of ‘Senokot’ in faecal soiling treated by behavioural methods. Journal of Child Psychology and Psychiatry1983;24(4):543-9. ">Berg 1983</a> ; <a href="./references#MR000050-bbs2-0010" title="BorkovecTD , WeertsTC .Effects of progressive relaxation on sleep disturbance: an electroencephalographic evaluation. Psychosomatic Medicine1976;38(3):173-80. ">Borkovec 1976</a> ; <a href="./references#MR000050-bbs2-0012" title="BramstonP , SpenceSH .Behavioural versus cognitive social-skills training with intellectually-handicapped adults. Behaviour Research and Therapy1985;23(3):239-46. ">Bramston 1985</a> ; <a href="./references#MR000050-bbs2-0021" title="EhlersA , HackmannA , GreyN , WildJ , LinessS , AlbertI , et al.A randomized controlled trial of 7-day intensive and standard weekly cognitive therapy for PTSD and emotion-focused supportive therapy. American Journal of Psychiatry2014;171(3):294-304. ">Ehlers 2014</a> ; <a href="./references#MR000050-bbs2-0028" title="GlogowskaM , RoulstoneS , EnderbyP , PetersTJ .Randomised controlled trial of community based speech and language therapy in preschool children. BMJ2000;321(7266):923-6. ">Glogowska 2000</a> ; <a href="./references#MR000050-bbs2-0029" title="GoldsteinAJ , BeursE , Chambless Dl, WilsonKA .EMDR for panic disorder with agoraphobia: comparison with waiting list and credible attention-placebo control conditions. Journal of Consulting and Clinical Psychology2000;68(6):947-56. ">Goldstein 2000</a> ; <a href="./references#MR000050-bbs2-0032" title="HippmanC , RingroseA , InglisA , CheekJ , AlbertAY , RemickR , et al.A pilot randomized clinical trial evaluating the impact of genetic counselling for serious mental illnesses. Journal of Clinical Psychiatry2016;77(2):e190-8. ">Hippman 2016</a> ; <a href="./references#MR000050-bbs2-0033" title="HowlinP , GordonKR , PascoG , WadeA , CharmanT .The effectiveness of picture exchange communication system (PECS) training for teachers of children with autism: a pragmatic,group randomised controlled trial. Journal of Child Psychology and Psychiatry2007;48(5):473-81. ">Howlin 2007</a> ; <a href="./references#MR000050-bbs2-0034" title="KarstM , WinterhalterM , MünteS , FranckiB , HondronikosA , EckardtA , et al.Auricular acupuncture for dental anxiety: a randomized controlled trial. Anesthesia and Analgesia2007;104(2):295-300. KarstM .Inclusion of study in Cochrane Systematic Review (personal communication). Email to: EG Faltinsen 5th of September 2019. ">Karst 2007</a> ; <a href="./references#MR000050-bbs2-0037" title="KilmannPR , MilanRJ , BolandJP , NankinHR , DavidsonE , WestMO , et al.Group treatment of secondary erectile dysfunction. Journal of Sex &amp; Marital Therapy1987;13(3):168-82. KilmannPR , Milan RJ Jr, BolandJP , DavidsonE , WestMO , SablisRF , et al.The sexual interactions of men with secondary erectile dysfunction. Journal of Sex Education and Therapy1988;14(1):46-9. KilmannPR , Milan RJ Jr, BolandJP , NankinHR , SablisRF , WestMO , et al.The sexual interactions of men with secondary erectile dysfunction. Paper presented at the annual meeting of the American Psychological Association in Los Angeles1985;1:46-9. ">Kilmann 1987</a> ; <a href="./references#MR000050-bbs2-0039" title="KlermanGL , DimascioA , WeismannM , PrusoffB , PaykelES .Treatment of depression by drugs and psychotherapy. American Journal of Psychiatry1974;131(2):186-91. PaykelES , DimascioA , HaskellD , PrusoffBA .Effects of maintenance amitriptyline and psychotherapy on symptoms of depression. Psychological Medicine1975;5(1):67-77. PaykelES , DiMascioA , KlermanGL , PrusoffBA .Maintenance therapy of depression. Pharmakopsychiatrie, Neuro-Psychopharmakologie1976;9:127-39. PaykelES , WeissmanMM , PrusoffBA .Social maladjustment and severity of depression. Comprehensive Psychiatry1978;19(2):121-8. WeissmanMM , KlermanGL , PaykelES , PrusoffB .Treatment effects on the social adjustment of depressed patients. Archives of General Psychiatry1974;30:771-8. ">Klerman 1974a</a> ; <a href="./references#MR000050-bbs2-0040" title="KlermanGL , DimascioA , WeismannM , PrusoffB , PaykelES .Treatment of depression by drugs and psychotherapy. American Journal of Psychiatry1974;131(2):186-91. ">Klerman 1974b</a> ; <a href="./references#MR000050-bbs2-0043" title="KwanR .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 26th of August 2019. KwanRY , LeungMC , LaiCK .Acupressure for agitation in nursing home residents with dementia: study protocol for a randomized controlled trial. Trials2014;15(410):1-7. KwanRY , LeungMCP , LaiCK .A randomized controlled trial examining the effect of acupressure on agitation and salivary cortisol in nursing home residents with dementia. Dementia and Geriatric Cognitive Disorders2017;44(1-2):92-104. ">Kwan 2017</a> ; <a href="./references#MR000050-bbs2-0044" title="LacyMK .The effect of short term autogenic training on the stress reactivity of hospitalized emotionally disturbed adolescents. ProQuest Dissertations Publishing, Oklahoma State University1996. ">Lacy 1990</a> ; <a href="./references#MR000050-bbs2-0045" title="LaiCK , ChiI , Kayser-JonesJ .A randomized controlled trial of a specific reminiscence approach to promote the well-being of nursing home residents with dementia. International Psychogeriatrics2004;16(1):33-49. LaiK .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 6th of September 2019. ">Lai 2004</a> ; <a href="./references#MR000050-bbs2-0046" title="LangOJ , LazovikAD .Experimental desensitization of a phobia. Journal of Abnormal and Social Psychology1963;66:519-25. LangPJ , LazovikAD , ReynoldsDJ .Desensitization, suggestibility, and pseudotherapy. Journal of Abnormal Psychology1965;70(6):395-402. ">Lang 1965</a> ; <a href="./references#MR000050-bbs2-0047" title="LegrandF .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 14th of August 2019. LegrandFD , NeffEM .Efficacy of exercise as an adjunct treatment for clinically depressed inpatients during the initial stages of antidepressant pharmacotherapy: an open randomized controlled trial. Journal of Affective Disorders2016;191:139-44. ">Legrand 2016</a> ; <a href="./references#MR000050-bbs2-0049" title="LickJR , HefflerD .Relaxation training and attention placebo in the treatment of severe insomnia. Journal of Consulting and Clinical Psychology1977;45(2):153-61. ">Lick 1977</a> ; <a href="./references#MR000050-bbs2-0050" title="LiddleB , SpenceSH .Cognitive-behaviour therapy with depressed primary school children: A cautionary note. Behavioural Psychotherapy1990;18(2):85-102. ">Liddle 1990</a> ; <a href="./references#MR000050-bbs2-0051" title="MatsonJL , MarchettiA , AdkinsJA .Comparison of operant- and independence-training procedures for mentally retarded adults. American Journal of Mental Deficiency1980;84(5):487-94. ">Matson 1980</a> ; <a href="./references#MR000050-bbs2-0053" title="MealieaWL , NawasMM .The comparative effectiveness of systematic desensitization and implosive therapy in the treatment of snake phobia. Journal of Behavior Therapy and Experimental Psychiatry1971;2(2):85-94. ">Mealiea 1971</a> ; <a href="./references#MR000050-bbs2-0055" title="MirandaA , ArlandisP , SorianoM .Instruction in strategies and attributional training: Effects on the problem-solving and self-concept of students’ with learning disabilities [Instrucción en estrategias y entrenamiento atribucional: efectos sobre la resolución de problemas y el autoconcepto de los estudiantes con dificultades en el aprendizaje]. Infancia y Aprendizaje1997;20(80):37-52. ">Miranda 1997</a> ; <a href="./references#MR000050-bbs2-0056" title="MitchellC , MansfieldD , RautenbachS .Coloured filters and reading accuracy, comprehension and rate: a placebo-controlled study. Perceptual and Motor Skills2008;106(2):517-32. ">Mitchell 2008</a> ; <a href="./references#MR000050-bbs2-0058" title="NicassioP , BootzinR .A comparison of progressive relaxation and autogenic training as treatments for insomnia. Journal of Abnormal Psychology1974;83(3):253-60. ">Nicassio 1974</a> ; <a href="./references#MR000050-bbs2-0061" title="MilichR , CarlsonCL , Pelham WE Jr, LichtBG .Effects of methylphenidate on the persistence of ADHD boys following failure experiences. Journal of Abnormal Child Psychology1991;19(5):519-36. PelhamWE , MurphyDA , VannattaK , MilichR , LichtBG , GnagyEM , et al.Methylphenidate and attributions in boys with attention-deficit hyperactivity disorder. Journal of Consulting and Clinical Psychology1992;60(2):282-92. ">Pelham 1992</a> ; <a href="./references#MR000050-bbs2-0062" title="PedletonMG , HigginsRL .A comparison of negative practice and systematic desensitization in the treatment of acrophobia. Journal of Behavior Therapy and Experimental Psychiatry1983;14(4):317-23. ">Pendleton 1983</a> ; <a href="./references#MR000050-bbs2-0065" title="PowersMB , SmitsJA , TelchMJ .Disentangling the effects of safety-behavior utilization and safety-behavior availability during exposure-based treatment: a placebo-controlled trial. Journal of Consulting and Clinical Psychology2004;72(3):448-54. ">Powers 2004</a> ; <a href="./references#MR000050-bbs2-0066" title="PowersMB , SmithsJA , WhitleyD , BystritskyA , TelchMJ .The effect of attributional processes concerning medication taking on return of fear. Journal of Consulting and Clinical Psychology2008;76(3):478-90. ">Powers 2008a</a> ; <a href="./references#MR000050-bbs2-0067" title="PowersMB , SmithsJA , WhitleyD , BystritskyA , TelchMJ .The effect of attributional processes concerning medication taking on return of fear. Journal of Consulting and Clinical Psychology2008;76(3):478-90. ">Powers 2008b</a> ; <a href="./references#MR000050-bbs2-0070" title="LiebowitzM , QuitkinFM , StewartJW , McGrathPJ , HarrisonWM , MarkowitzJS , et al.Antidepressant efficacy in atypical depression. Archives of General Psychiatry1988;45(2):129-37. QuitkinFM , McGrathPJ , StewartJW , HarrisonW , WagerSG , NunesE , et al.Phenelzine and imipramine in mood reactive depressives: further delineation of the syndrome of atypical depression. Archives of General Psychiatry1989;46(9):787-93. RabkinJG , McGrathPJ , QuitkinFM , TricamoE , StewartJW , KleinDF .Effects of pill-giving on maintenance of placebo response in patients with chronic mild depression. American Journal of Psychiatry1990;147(12):1622-6. ">Rabkin 1990</a> ; <a href="./references#MR000050-bbs2-0073" title="RobinA .Rationing out-patients: a defence of the waiting list. British Journal of Psychiatry1976;129:138-41. ">Robin 1976</a> ; <a href="./references#MR000050-bbs2-0075" title="OlivaresJ .Program IAFS. Protocol for the treatment of social phobia in adolescents [Programa IAFS. Protocolo para el tratamiento de la fobia social enadolescentes]. Madrid: Pirámide2005;1. Rosa-AlcázarAI , Olivares-OlivaresPJ , OlivaresJ .The role of non-specific effects in the psychological treatment of adolescents with social phobia [Papel de los efectos inespecíficos en el tratamiento psicológico de adolescentes con fobia social]. Anuario de Psicologia2009;40(1):43-61. ">Rosa‐Alcatraz 2009</a> ; <a href="./references#MR000050-bbs2-0079" title="ShalevAY , AnkriY , Isreali-ShalevY , PelegT , AdesskyR , FreedmanS .Prevention of posttraumatic stress disorder by early treatment. Archives of General Psychiatry2012;69(2):166-76. ">Shalev 2012</a> ; <a href="./references#MR000050-bbs2-0083" title="SteinmarkSW , BorkovecTD .Active and placebo treatment effects on moderate insomnia under counterdemand and positive demand instructions. Journal of Abnormal Psychology1974;83(2):157-63. ">Steinmark 1974</a> ; <a href="./references#MR000050-bbs2-0085" title="TanSY , BruniJ .Cognitive-behavior therapy with adult patients with epilepsy: a controlled outcome study. Epilepsia1986;27(3):225-33. ">Tan 1986</a> ; <a href="./references#MR000050-bbs2-0089" title="AscherML , TurnerRM .A comparison of two methods for the administration of paradoxical intention. Behaviour Research and Therapy1980;18(2):121-6. TurnerRM , AscherLM .Controlled comparison of progressive relaxation, stimulus control, and paradoxical intention therapies for insomnia. Journal of Consulting and Clinical Psychology1979;47(3):500-8. ">Turner 1979</a> ; <a href="./references#MR000050-bbs2-0091" title="WatzlH , RistF , OlbrichR , CohenR .Placebo injections and surveillance of alcohol intake during inpatient treatment of female alcoholics. Addictive Behaviors1988;13(2):197-200. ">Watzl 1988</a> ; <a href="./references#MR000050-bbs2-0095" title="WolitzkyKB , TelchMJ .Augmenting in vivo exposure with fear antagonistic actions: a preliminary test. Behavior Therapy2009;40(1):57-71. ">Wolitzky 2009</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>High risk of bias</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>29</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#MR000050-bbs2-0001" title="AbikoffH , HechtmanL , KleinRG .Social functioning in children with ADHD treated with long-term methylphenidate and multimodal psychosocial treatment. Journal of the American Academy of Child and Adolescent Psychiatry2004;43(7):820-9. AbikoffH .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to A Todorovac 23rd of August 2019. KleinRG , AbikoffH , HechtmanL , WeissG .Design and rationale of controlled study of long-term methylphenidate and multimodal psychosocial treatment in children with ADHD. Journal of the American Academy of Child and Adolescent Psychiatry2004;43(7):792-801. ">Abikoff 2004</a> ; <a href="./references#MR000050-bbs2-0004" title="AlvarezJR .The effects of anger management training on depression, anger, self-concept, and treatment responsibility in a sample of drug-dependent individuals in a therapeutic community. Dissertation Abstracts International: Section B: the Sciences and Engineering1997;58(4-B):2108. ">Alvarez 1997</a> ; <a href="./references#MR000050-bbs2-0009" title="BorkovecTD , KaloupekDG , SlamaKM .The facilitative effect of muscle tension-release in the relaxation treatment of sleep disturbance. Behavior Therapy1975;6(3):301-9. ">Borkovec 1975</a> ; <a href="./references#MR000050-bbs2-0011" title="BornovalovaM .Inclusion of study in Cochrane Systematic Review (personal communication). Email to A Todorovac. 21st of August 2019. BornovalovaMA .Distress tolerance treatment for inner-city drug users: a preliminary trial. Doctor’s Dissertation, University of Maryland2008. ">Bornovalova 2008</a> ; <a href="./references#MR000050-bbs2-0013" title="BrillNQ , KoeglerRR , EpsteinLJ , ForgyEW .Controlled study of psychiatric outpatient treatment. Archives of General Psychiatry1964;10:581-95. BrillNQ .Results of psychotherapy. California Medicine1966;104(4):249-53. ">Brill 1964a</a> ; <a href="./references#MR000050-bbs2-0014" title="BrillNQ , KoeglerRR , EpsteinLJ , ForgyEW .Controlled study of psychiatric outpatient treatment. Archives of General Psychiatry1964;10:581-95. ">Brill 1964b</a> ; <a href="./references#MR000050-bbs2-0017" title="CrispAH , NortonK , GowersS , HalekC , BowyerC , YeldhamD , et al.A controlled study of the effect of therapies aimed at adolescent and family psychopathology in Anorexia Nervosa. British Journal of Psychiatry: the Journal of Mental Science1991;159:325-33. GowersS , NortonK , HalekC , CrispAH .Outcome of outpatient psychotherapy in a random allocation treatment study of anorexia nervosa. International Journal of Eating Disorders1994;15(2):165-77. GowersS , NortonK , YelshamD .The St George's prospective treatment study of anorexia nervosa: a discussion of methodological problems. International Journal of Eating Disorders1989;8:445-54. ">Crisp 1991</a> ; <a href="./references#MR000050-bbs2-0018" title="CrouchG , RobsonM , HallstromC .Benzodiazepine dependent patients and their psychological treatment. Progress in Neuro-psychopharmacology &amp; Biological Psychiatry1988;12(4):503-10. HallströmC , CrouchG , RobsenM , ShineP .The treatment of tranquillizer dependence by propranolol. Postgraduate Medical Journal1988;64(Suppl 2):40-4. ">Crouch 1988</a> ; <a href="./references#MR000050-bbs2-0019" title="Doty, DW.Role playing and incentives in the modification of the social interaction of chronic psychiatric patients. Journal of Consulting and Clinical Psychology1975;43(5):676-82. ">Doty 1975</a> ; <a href="./references#MR000050-bbs2-0020" title="DoubleDB , WarrenGC , EvansM , RowlandsMP .Efficacy of maintenance use of anticholinergic agents. Acta Psychiatrica Scandinavica1993;88:381-4. ">Double 1993</a> ; <a href="./references#MR000050-bbs2-0022" title="EspieCA , BrooksDN , LindsayWR .An evaluation of tailored psychological treatment of insomnia. Journal of Behavior Therapy and Experimental Psychiatry1989;20(2):143-53. EspieCA , LindsayWR , BrooksDN , HoodEM , TurveyT .A controlled comparative investigation of psychological treatments for chronic sleep-onset insomnia. Behaviour Research and Therapy1989;27(1):79-88. ">Espie 1989a</a> ; <a href="./references#MR000050-bbs2-0024" title="FoaEB , RothbaumBO , RiggsDS , MurdockTB .Treatment of posttraumatic stress disorder in rape victims: a comparison between cognitive-behavioral procedures and counselling. Journal of Consulting and Clinical Psychology1991;59(5):715-23. ">Foa 1991</a> ; <a href="./references#MR000050-bbs2-0026" title="FreireAO , SugaiGC , ChrispinFS , TogeiroSM , YamamuraY , MelloLE , et al.Treatment of moderate obstructive sleep apnea syndrome with acupuncture: a randomised, placebo-controlled pilot trial. Sleep Medicine2007;8(1):43-50. ">Freire 2007</a> ; <a href="./references#MR000050-bbs2-0027" title="FuchsCZ , RehnLP .A self-control behavior therapy program for depression. Journal of Consulting and Clinical Psychology1977;45(2):206-15. ">Fuchs 1977</a> ; <a href="./references#MR000050-bbs2-0036" title="KennedyTD , KimuraHK .Transfer, behavioral improvement, and anxiety reduction in systematic desensitization. Journal of Consulting and Clinical Psychology1974;42(5):720-8. ">Kennedy 1974</a> ; <a href="./references#MR000050-bbs2-0041" title="KloskoJS , BarlowDH , TassinariR , CernyJA .A comparison of alprazolam and behavior therapy in treatment of panic disorder: correction. Journal of Psychotherapy Practice and Research1994;3(2):163-79. KloskoJS , BarlowDH , TassinariR , CernyJA .A comparison of alprazolam and behavior therapy in treatment of panic disorder. Journal of Consulting and Clinical Psychology1990;58(1):77-84. ">Klosko 1990</a> ; <a href="./references#MR000050-bbs2-0052" title="McLachlanDR , DaltonAJ , KruckTP , BellMY , SmithWL , KalowW , et al.Intramuscular desferrioxamine in patients with Alzheimer's disease. Lancet1991;337(8753):1304-8. McLachlanDRC , SmithWL , KruckTP .Desferrioxamine and Alzheimer’s disease: video home behavior assessment of clinical course and measures of brain aluminum. Therapeutic Drug Monitoring1993;15(6):602-7. ">McLachlan 1991</a> ; <a href="./references#MR000050-bbs2-0057" title="NandiDN , AjmanyS , GanguliH , BanerjeeG , BoralGC , GhoshA , et al.A clinical evaluation of depressives found in a rural survey in India. British Journal of Psychiatry1976;128:523-7. ">Nandi 1976</a> ; <a href="./references#MR000050-bbs2-0063" title="PetersonMA , PattersonB , PillmanBM , BattistaMA .Cognitive recovery following alcohol detoxification: a computerised remediation study. Neuropsychological Rehabilitation2002;12(1):63-74. PillmanBM .Computerized cognitive remediation with recently detoxified alcoholics. Dissertation, California School of Professional Psychology, Fresno Campus2000. ">Pillman 2001</a> ; <a href="./references#MR000050-bbs2-0064" title="PolandRE , GertsikL , FavreauJT , SmithSI , MirochaJM , RaoU , et al.Open-label randomized parallel-group controlled clinical trial of massage for treatment of depression in HIV-infected subjects. Journal of Alternative and Complementary Medicine2013;19(4):334-40. ">Poland 2013</a> ; <a href="./references#MR000050-bbs2-0069" title="QuayhagenMP , QuayhagenM , CorbeilRR , RothPA , RodgersJA .A dyadic remediation program for care recipients with dementia. Nursing Research1995;44(3):153-9. ">Quayhagen 1995</a> ; <a href="./references#MR000050-bbs2-0071" title="RapeeR .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 29th of August 2019. RapeeRM , AbbottMJ , LynehamHJ .Bibliotherapy for children With anxiety disorders using written materials for parents: a randomized controlled trial. Journal of Consulting and Clinical Psychology2006;74(3):436-44. ">Rapee 2006</a> ; <a href="./references#MR000050-bbs2-0074" title="RoehrichL , GoldmanMS .Experience-dependent neuropsychological recovery and the treatment of alcoholism. Journal of Consulting and Clinical Psychology1993;61(5):812-21. ">Roehrich 1993</a> ; <a href="./references#MR000050-bbs2-0076" title="RosenGM , GlasgowRE , BarreraM .A controlled study to assess the clinical efficacy of totally self-administrated systematic desensitization. Journal of Consulting and Clinical Psychology1976;44(2):208-17. ">Rosen 1976</a> ; <a href="./references#MR000050-bbs2-0077" title="LorrM , McNairDM , WeinsteinGJ .Early effects of chlordiazepoxide (Librium) used with psychotherapy. Journal of Psychiatric Research1963;1:257-70. RothI , RhudickPJ , ShaskanDA , SlobinMS , WilkinsonAE , YoungHH .Long-term effects on psychotherapy of initial treatment conditions. Journal of Psychiatric Research1964;2:283-97. ">Roth 1964</a> ; <a href="./references#MR000050-bbs2-0084" title="SzymanskiJ , O'DonohueW .The potential role of state-dependent learning in cognitive therapy with spider phobics. Journal of Rational-Emotive &amp; Cognitive-Behavior Therapy1995;13(2):131-50. SzymanskiJ .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 20th of August 2019. ">Szymanski 1995</a> ; <a href="./references#MR000050-bbs2-0086" title="TeriL , LogsdonRG , UomotoJ , McCurrySM .Behavioral treatment of depression in dementia patients: a controlled clinical trial. Journals of Gerontology. Series B, Psychological Sciences and Social Sciences1997;52(4):159-66. TeriL .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 26th of August 2019. ">Teri 1997</a> ; <a href="./references#MR000050-bbs2-0090" title="VanderplateC .Electromyograph biofeedback Treatment of sleep onset Insomnia: a controlled Investigation. Dissertation, University of Southern Mississippi1978. ">Vanderplate 1983</a> ; <a href="./references#MR000050-bbs2-0096" title="WollersheimJP , WilsonGL .Group treatment of unipolar depression: a comparison of coping, supportive, bibliotherapy, and delayed treatment groups. Professional Psychology: Research and Practice1991;22(6):496-502. ">Wollersheim 1991</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Unclear risk of bias</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>26</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#MR000050-bbs2-0005" title="AscherLM , TurnerR .Paradoxical intention and insomnia: an experimental investigation. Behaviour Research and Therapy1979;17(4):408-11. ">Ascher 1979</a> ; <a href="./references#MR000050-bbs2-0008" title="Borden, KA.Attributional Outcomes: the Subtle Messages of Treatments for Attention Deficit Disorder. Dissertation, University of Illinois at Urbana-Champaign1986. BordenKA , BrownRT .Attributional outcomes: The subtle messages of treatments for attention deficit disorder. Cognitive Therapy and Research1989;13(2):147-60. ">Borden 1986</a> ; <a href="./references#MR000050-bbs2-0015" title="CarlsonCL , PelhamWE , MilichR , HozaB .ADHD boys’ performance and attributions following success and failure: drug effects and individual differences. Cognitive Therapy and Research1993;17:269-87. ">Carlson 1993</a> ; <a href="./references#MR000050-bbs2-0016" title="CarterJC , OlmstedMP , KaplanAS , McCabeRE , MillsJS , AimeA .Self-help for bulimia nervosa: a randomized controlled trial. American Journal of Psychiatry2003;160(5):973-8. ">Carter 2003</a> ; <a href="./references#MR000050-bbs2-0023" title="EtringerBD , CashTF , RimmDC .Behavioral, affective, and cognitive effects of participant modeling and an equally credible placebo. Behavior Therapy1982;13(4):476-85. ">Etringer 1982</a> ; <a href="./references#MR000050-bbs2-0025" title="FoaEB , McLeanCP , ZangY , RosenfieldD , YadinE , YarvisJS , et al.Effect of prolonged exposure therapy delivered over 2 weeks vs 8 weeks vs present-centered therapy on PTSD symptom severity in military personnel: a randomized clinical trial. JAMA2018;319(4):354-64. ">Foa 2018</a> ; <a href="./references#MR000050-bbs2-0030" title="GoldwasserAN , AuerbachSM , HarkinsSW .Cognitive, affective, and behavioural effects of reminiscence group therapy on demented elderly. Aging and Human Development1987;25(3):209-22. ">Goldwasser 1987</a> ; <a href="./references#MR000050-bbs2-0031" title="HekmatH , LubitzR , DealR .Semantic desensitization: a paradigmatic intervention approach to anxiety disorders. Journal of Clinical Psychology1984;40(2):463-6. ">Hekmat 1984</a> ; <a href="./references#MR000050-bbs2-0035" title="KelleyJ .Inclusion of study in Cochrane Systematic Review (personal communication). Email to: A Todorovac 12th of August 2019. KelleyJM , KaptchukTJ , CusinC , LipkinS , FavaM .Open-label placebo for major depressive disorder: a pilot randomized controlled trial. Psychotherapy and Psychosomatics2012;81(5):312-4. ">Kelley 2012</a> ; <a href="./references#MR000050-bbs2-0038" title="KleinSA , DeffenbacherJL .Relaxation and exercise for hyperactive impulsive children. Perceptual and Motor Skills1977;45:1159-62. ">Klein 1977</a> ; <a href="./references#MR000050-bbs2-0042" title="KrapflJE , NawasMM .Differential ordering of stimulus presentation in systematic desensitization. Journal of Abnormal Psychology1970;75(3):333-7. ">Krapfl 1970</a> ; <a href="./references#MR000050-bbs2-0048" title="LickJ .Expectancy, false galvanic skin response feedback, and systematic desensitization in the modification of phobic behavior. Journal of Consulting and Clinical Psychology1975;43(4):557-67. ">Lick 1975</a> ; <a href="./references#MR000050-bbs2-0054" title="MilbyJB , ClarkeC , ToroC , ThorntonS , RickertD .Effectiveness of urine surveillance as an adjunct to outpatient psychotherapy for drug abusers. International Journal of the Addictions1980;15(7):993-1001. ">Milby 1980</a> ; <a href="./references#MR000050-bbs2-0060" title="PeckCL .Desensitization for the treatment of fear in the high level adult retardate. Behaviour Research and Therapy1977;15(2):137-48. ">Peck 1976</a> ; <a href="./references#MR000050-bbs2-0068" title="ProudfootJ , ClarkeJ , BirchMR , WhittonAE , ParkerG , ManicavasagarV , et al.Impact of a mobile phone and web program on symptom and functional outcomes for people with mild- to-moderate depression, anxiety and stress: a randomized controlled trial. BMC Psychiatry2013;13(312):1-12. ProudfootJ .Re: Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 26th of August 2019. ">Proudfoot 2013</a> ; <a href="./references#MR000050-bbs2-0072" title="RapeeR .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 29th of August 2019. RapeeRM , AbbottMJ , BaillieAJ , GastonJE .Treatment of social phobia through pure self-help and therapist-augmented self-help. British Journal of Psychiatry2007;191:246-52. ">Rapee 2007</a> ; <a href="./references#MR000050-bbs2-0078" title="RupertPA , HolmesDS .Effects of multiple sessions of true and placebo heart rate biofeedback training on the heart rates and anxiety levels of anxious patients during and following treatment. Psychophysiology1978;15(6):582-90. ">Rupert 1978</a> ; <a href="./references#MR000050-bbs2-0059" title="PearlD , Vander KampH , OlsenAL , GreenbergPD , ArmitageSG .The effects of reserpine on schizophrenic patients. American Journal of Psychiatry1956;112:198-204. ">Pearl 1956</a> ; <a href="./references#MR000050-bbs2-0080" title="ShealyRC .The effectiveness of various treatment techniques on different degrees and durations of sleep-onset insomnia. Behaviour Research and Therapy1979;17(6):541-6. ">Shealy 1979</a> ; <a href="./references#MR000050-bbs2-0081" title="SibilioJP , AndrewG , DartD , MooreKB , StehmanA .Treatment of chronic schizophrenia with promazine hydrochloride. AMA Archives of Neurology and Psychiatry1957;78(4):419-24. ">Sibilio 1957</a> ; <a href="./references#MR000050-bbs2-0082" title="SommernessMD , LuceroRJ , HamlonJS , EricksonJL , MatthewsR .A controlled study of reserpine on chronically disturbed patients. JAMA Archives of Neurology and Psychiatry1955;74(3):316-9. ">Sommerness 1955</a> ; <a href="./references#MR000050-bbs2-0087" title="ToriC , WorellL .Reduction of human avoidant behavior. A comparison of counterconditioning, expectancy, and cognitive information approaches. Clinical Psychology1973;41(2):269-78. ">Tori 1973</a> ; <a href="./references#MR000050-bbs2-0088" title="Trexler, L.Rational-emotive therapy, placebo, and no-treatment effects on public-speaking anxiety. Doctoral dissertation, Temple University AnnArbor, Mich.: University Microfilms1971;71-31(063). TrexlerLD , KarstTO .Rational-emotive therapy, placebo, and no-treatment effects on public-speaking anxiety. Journal of Abnormal Psyhology1972;79(1):60-7. ">Trexler 1972</a> ; <a href="./references#MR000050-bbs2-0092" title="WeingaertnerAH .Self-administered aversive stimulation with hallucinating hospitalized schizophrenics. Journal of Consulting and Clinical Psychology1971;36(3):422-29. ">Weingaertner 1971</a> ; <a href="./references#MR000050-bbs2-0093" title="WhittakerCB , HoyRM .Withdrawal of perphenazine in chronic schizophrenia. British Journal of Psychiatry1963;109:422-7. ">Whittaker 1963</a> ; <a href="./references#MR000050-bbs2-0094" title="WilsonA , DavidsonWJ , BlanchardR , WhiteJ .Disulfiram implantation. A placebo-controlled trial with two-year follow-up. Journal of Studies on Alcohol1978;39(5):809-19. WilsonA , DavidsonWJ , BlanchardR .Disulfiram implantation: a trial using placebo implants and two types of controls. Journal of Studies on Alcohol1980;41(5):429-36. ">Wilson 1980</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Selective reporting</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Low risk of bias</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#MR000050-bbs2-0003" title="AllenJB .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 28th of August 2019. AllenJJ , SchnyerRN , ChambersAS , HittSK , MorenoFA , ManberR .Acupuncture for depression: a randomized controlled trial. Journal of Clinical Psychiatry2006;67(11):1665-73. ">Allen 2006</a> ; <a href="./references#MR000050-bbs2-0021" title="EhlersA , HackmannA , GreyN , WildJ , LinessS , AlbertI , et al.A randomized controlled trial of 7-day intensive and standard weekly cognitive therapy for PTSD and emotion-focused supportive therapy. American Journal of Psychiatry2014;171(3):294-304. ">Ehlers 2014</a> ; <a href="./references#MR000050-bbs2-0032" title="HippmanC , RingroseA , InglisA , CheekJ , AlbertAY , RemickR , et al.A pilot randomized clinical trial evaluating the impact of genetic counselling for serious mental illnesses. Journal of Clinical Psychiatry2016;77(2):e190-8. ">Hippman 2016</a> ; <a href="./references#MR000050-bbs2-0043" title="KwanR .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 26th of August 2019. KwanRY , LeungMC , LaiCK .Acupressure for agitation in nursing home residents with dementia: study protocol for a randomized controlled trial. Trials2014;15(410):1-7. KwanRY , LeungMCP , LaiCK .A randomized controlled trial examining the effect of acupressure on agitation and salivary cortisol in nursing home residents with dementia. Dementia and Geriatric Cognitive Disorders2017;44(1-2):92-104. ">Kwan 2017</a> ; <a href="./references#MR000050-bbs2-0047" title="LegrandF .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 14th of August 2019. LegrandFD , NeffEM .Efficacy of exercise as an adjunct treatment for clinically depressed inpatients during the initial stages of antidepressant pharmacotherapy: an open randomized controlled trial. Journal of Affective Disorders2016;191:139-44. ">Legrand 2016</a> ; <a href="./references#MR000050-bbs2-0079" title="ShalevAY , AnkriY , Isreali-ShalevY , PelegT , AdesskyR , FreedmanS .Prevention of posttraumatic stress disorder by early treatment. Archives of General Psychiatry2012;69(2):166-76. ">Shalev 2012</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>High risk of bias</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#MR000050-bbs2-0001" title="AbikoffH , HechtmanL , KleinRG .Social functioning in children with ADHD treated with long-term methylphenidate and multimodal psychosocial treatment. Journal of the American Academy of Child and Adolescent Psychiatry2004;43(7):820-9. AbikoffH .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to A Todorovac 23rd of August 2019. KleinRG , AbikoffH , HechtmanL , WeissG .Design and rationale of controlled study of long-term methylphenidate and multimodal psychosocial treatment in children with ADHD. Journal of the American Academy of Child and Adolescent Psychiatry2004;43(7):792-801. ">Abikoff 2004</a> ; <a href="./references#MR000050-bbs2-0011" title="BornovalovaM .Inclusion of study in Cochrane Systematic Review (personal communication). Email to A Todorovac. 21st of August 2019. BornovalovaMA .Distress tolerance treatment for inner-city drug users: a preliminary trial. Doctor’s Dissertation, University of Maryland2008. ">Bornovalova 2008</a> ; <a href="./references#MR000050-bbs2-0025" title="FoaEB , McLeanCP , ZangY , RosenfieldD , YadinE , YarvisJS , et al.Effect of prolonged exposure therapy delivered over 2 weeks vs 8 weeks vs present-centered therapy on PTSD symptom severity in military personnel: a randomized clinical trial. JAMA2018;319(4):354-64. ">Foa 2018</a> ; <a href="./references#MR000050-bbs2-0035" title="KelleyJ .Inclusion of study in Cochrane Systematic Review (personal communication). Email to: A Todorovac 12th of August 2019. KelleyJM , KaptchukTJ , CusinC , LipkinS , FavaM .Open-label placebo for major depressive disorder: a pilot randomized controlled trial. Psychotherapy and Psychosomatics2012;81(5):312-4. ">Kelley 2012</a> ; <a href="./references#MR000050-bbs2-0068" title="ProudfootJ , ClarkeJ , BirchMR , WhittonAE , ParkerG , ManicavasagarV , et al.Impact of a mobile phone and web program on symptom and functional outcomes for people with mild- to-moderate depression, anxiety and stress: a randomized controlled trial. BMC Psychiatry2013;13(312):1-12. ProudfootJ .Re: Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 26th of August 2019. ">Proudfoot 2013</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Unclear risk of bias</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>85</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#MR000050-bbs2-0002" title="AllenJB .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to A Todorovac 28th of August 2019. AllenJJ , SchnyerRN , HittSK .The efficacy of acupuncture in the treatment of major depression in women. Psychological Science1998;9(5):397-401. ">Allen 1998</a> ; <a href="./references#MR000050-bbs2-0004" title="AlvarezJR .The effects of anger management training on depression, anger, self-concept, and treatment responsibility in a sample of drug-dependent individuals in a therapeutic community. Dissertation Abstracts International: Section B: the Sciences and Engineering1997;58(4-B):2108. ">Alvarez 1997</a> ; <a href="./references#MR000050-bbs2-0005" title="AscherLM , TurnerR .Paradoxical intention and insomnia: an experimental investigation. Behaviour Research and Therapy1979;17(4):408-11. ">Ascher 1979</a> ; <a href="./references#MR000050-bbs2-0006" title="AyenI , HautzingerM .Cognitive behavior therapy for depression in menopausal women. A controlled, randomized treatment study [Kognitive Verhaltenstherapie bei Depressionen im Klimakterium: Eine kontrollierte, randomiserte Interventionsstudie]. Zeitschrift für Klinische Psychologie und Psychotherapie2004;33(4):290-9. AyenI .Inclusion of study in Cochrane Systematic Review (personal communication). Email to EG Faltinsen 9th of September 2019. ">Ayen 2004</a> ; <a href="./references#MR000050-bbs2-0007" title="BergI , ForsytheI , HoltP , WattsJ .A controlled trial of ‘Senokot’ in faecal soiling treated by behavioural methods. Journal of Child Psychology and Psychiatry1983;24(4):543-9. ">Berg 1983</a> ; <a href="./references#MR000050-bbs2-0008" title="Borden, KA.Attributional Outcomes: the Subtle Messages of Treatments for Attention Deficit Disorder. Dissertation, University of Illinois at Urbana-Champaign1986. BordenKA , BrownRT .Attributional outcomes: The subtle messages of treatments for attention deficit disorder. Cognitive Therapy and Research1989;13(2):147-60. ">Borden 1986</a> ; <a href="./references#MR000050-bbs2-0009" title="BorkovecTD , KaloupekDG , SlamaKM .The facilitative effect of muscle tension-release in the relaxation treatment of sleep disturbance. Behavior Therapy1975;6(3):301-9. ">Borkovec 1975</a> ; <a href="./references#MR000050-bbs2-0010" title="BorkovecTD , WeertsTC .Effects of progressive relaxation on sleep disturbance: an electroencephalographic evaluation. Psychosomatic Medicine1976;38(3):173-80. ">Borkovec 1976</a> ; <a href="./references#MR000050-bbs2-0012" title="BramstonP , SpenceSH .Behavioural versus cognitive social-skills training with intellectually-handicapped adults. Behaviour Research and Therapy1985;23(3):239-46. ">Bramston 1985</a> ; <a href="./references#MR000050-bbs2-0013" title="BrillNQ , KoeglerRR , EpsteinLJ , ForgyEW .Controlled study of psychiatric outpatient treatment. Archives of General Psychiatry1964;10:581-95. BrillNQ .Results of psychotherapy. California Medicine1966;104(4):249-53. ">Brill 1964a</a> ; <a href="./references#MR000050-bbs2-0014" title="BrillNQ , KoeglerRR , EpsteinLJ , ForgyEW .Controlled study of psychiatric outpatient treatment. Archives of General Psychiatry1964;10:581-95. ">Brill 1964b</a> ; <a href="./references#MR000050-bbs2-0015" title="CarlsonCL , PelhamWE , MilichR , HozaB .ADHD boys’ performance and attributions following success and failure: drug effects and individual differences. Cognitive Therapy and Research1993;17:269-87. ">Carlson 1993</a> ; <a href="./references#MR000050-bbs2-0016" title="CarterJC , OlmstedMP , KaplanAS , McCabeRE , MillsJS , AimeA .Self-help for bulimia nervosa: a randomized controlled trial. American Journal of Psychiatry2003;160(5):973-8. ">Carter 2003</a> ; <a href="./references#MR000050-bbs2-0017" title="CrispAH , NortonK , GowersS , HalekC , BowyerC , YeldhamD , et al.A controlled study of the effect of therapies aimed at adolescent and family psychopathology in Anorexia Nervosa. British Journal of Psychiatry: the Journal of Mental Science1991;159:325-33. GowersS , NortonK , HalekC , CrispAH .Outcome of outpatient psychotherapy in a random allocation treatment study of anorexia nervosa. International Journal of Eating Disorders1994;15(2):165-77. GowersS , NortonK , YelshamD .The St George's prospective treatment study of anorexia nervosa: a discussion of methodological problems. International Journal of Eating Disorders1989;8:445-54. ">Crisp 1991</a> ; <a href="./references#MR000050-bbs2-0018" title="CrouchG , RobsonM , HallstromC .Benzodiazepine dependent patients and their psychological treatment. Progress in Neuro-psychopharmacology &amp; Biological Psychiatry1988;12(4):503-10. HallströmC , CrouchG , RobsenM , ShineP .The treatment of tranquillizer dependence by propranolol. Postgraduate Medical Journal1988;64(Suppl 2):40-4. ">Crouch 1988</a> ; <a href="./references#MR000050-bbs2-0019" title="Doty, DW.Role playing and incentives in the modification of the social interaction of chronic psychiatric patients. Journal of Consulting and Clinical Psychology1975;43(5):676-82. ">Doty 1975</a> ; <a href="./references#MR000050-bbs2-0020" title="DoubleDB , WarrenGC , EvansM , RowlandsMP .Efficacy of maintenance use of anticholinergic agents. Acta Psychiatrica Scandinavica1993;88:381-4. ">Double 1993</a> ; <a href="./references#MR000050-bbs2-0022" title="EspieCA , BrooksDN , LindsayWR .An evaluation of tailored psychological treatment of insomnia. Journal of Behavior Therapy and Experimental Psychiatry1989;20(2):143-53. EspieCA , LindsayWR , BrooksDN , HoodEM , TurveyT .A controlled comparative investigation of psychological treatments for chronic sleep-onset insomnia. Behaviour Research and Therapy1989;27(1):79-88. ">Espie 1989a</a> ; <a href="./references#MR000050-bbs2-0023" title="EtringerBD , CashTF , RimmDC .Behavioral, affective, and cognitive effects of participant modeling and an equally credible placebo. Behavior Therapy1982;13(4):476-85. ">Etringer 1982</a> ; <a href="./references#MR000050-bbs2-0024" title="FoaEB , RothbaumBO , RiggsDS , MurdockTB .Treatment of posttraumatic stress disorder in rape victims: a comparison between cognitive-behavioral procedures and counselling. Journal of Consulting and Clinical Psychology1991;59(5):715-23. ">Foa 1991</a> ; <a href="./references#MR000050-bbs2-0026" title="FreireAO , SugaiGC , ChrispinFS , TogeiroSM , YamamuraY , MelloLE , et al.Treatment of moderate obstructive sleep apnea syndrome with acupuncture: a randomised, placebo-controlled pilot trial. Sleep Medicine2007;8(1):43-50. ">Freire 2007</a> ; <a href="./references#MR000050-bbs2-0027" title="FuchsCZ , RehnLP .A self-control behavior therapy program for depression. Journal of Consulting and Clinical Psychology1977;45(2):206-15. ">Fuchs 1977</a> ; <a href="./references#MR000050-bbs2-0028" title="GlogowskaM , RoulstoneS , EnderbyP , PetersTJ .Randomised controlled trial of community based speech and language therapy in preschool children. BMJ2000;321(7266):923-6. ">Glogowska 2000</a> ; <a href="./references#MR000050-bbs2-0029" title="GoldsteinAJ , BeursE , Chambless Dl, WilsonKA .EMDR for panic disorder with agoraphobia: comparison with waiting list and credible attention-placebo control conditions. Journal of Consulting and Clinical Psychology2000;68(6):947-56. ">Goldstein 2000</a> ; <a href="./references#MR000050-bbs2-0030" title="GoldwasserAN , AuerbachSM , HarkinsSW .Cognitive, affective, and behavioural effects of reminiscence group therapy on demented elderly. Aging and Human Development1987;25(3):209-22. ">Goldwasser 1987</a> ; <a href="./references#MR000050-bbs2-0031" title="HekmatH , LubitzR , DealR .Semantic desensitization: a paradigmatic intervention approach to anxiety disorders. Journal of Clinical Psychology1984;40(2):463-6. ">Hekmat 1984</a> ; <a href="./references#MR000050-bbs2-0033" title="HowlinP , GordonKR , PascoG , WadeA , CharmanT .The effectiveness of picture exchange communication system (PECS) training for teachers of children with autism: a pragmatic,group randomised controlled trial. Journal of Child Psychology and Psychiatry2007;48(5):473-81. ">Howlin 2007</a> ; <a href="./references#MR000050-bbs2-0034" title="KarstM , WinterhalterM , MünteS , FranckiB , HondronikosA , EckardtA , et al.Auricular acupuncture for dental anxiety: a randomized controlled trial. Anesthesia and Analgesia2007;104(2):295-300. KarstM .Inclusion of study in Cochrane Systematic Review (personal communication). Email to: EG Faltinsen 5th of September 2019. ">Karst 2007</a> ; <a href="./references#MR000050-bbs2-0036" title="KennedyTD , KimuraHK .Transfer, behavioral improvement, and anxiety reduction in systematic desensitization. Journal of Consulting and Clinical Psychology1974;42(5):720-8. ">Kennedy 1974</a> ; <a href="./references#MR000050-bbs2-0037" title="KilmannPR , MilanRJ , BolandJP , NankinHR , DavidsonE , WestMO , et al.Group treatment of secondary erectile dysfunction. Journal of Sex &amp; Marital Therapy1987;13(3):168-82. KilmannPR , Milan RJ Jr, BolandJP , DavidsonE , WestMO , SablisRF , et al.The sexual interactions of men with secondary erectile dysfunction. Journal of Sex Education and Therapy1988;14(1):46-9. KilmannPR , Milan RJ Jr, BolandJP , NankinHR , SablisRF , WestMO , et al.The sexual interactions of men with secondary erectile dysfunction. Paper presented at the annual meeting of the American Psychological Association in Los Angeles1985;1:46-9. ">Kilmann 1987</a> ; <a href="./references#MR000050-bbs2-0038" title="KleinSA , DeffenbacherJL .Relaxation and exercise for hyperactive impulsive children. Perceptual and Motor Skills1977;45:1159-62. ">Klein 1977</a> ; <a href="./references#MR000050-bbs2-0039" title="KlermanGL , DimascioA , WeismannM , PrusoffB , PaykelES .Treatment of depression by drugs and psychotherapy. American Journal of Psychiatry1974;131(2):186-91. PaykelES , DimascioA , HaskellD , PrusoffBA .Effects of maintenance amitriptyline and psychotherapy on symptoms of depression. Psychological Medicine1975;5(1):67-77. PaykelES , DiMascioA , KlermanGL , PrusoffBA .Maintenance therapy of depression. Pharmakopsychiatrie, Neuro-Psychopharmakologie1976;9:127-39. PaykelES , WeissmanMM , PrusoffBA .Social maladjustment and severity of depression. Comprehensive Psychiatry1978;19(2):121-8. WeissmanMM , KlermanGL , PaykelES , PrusoffB .Treatment effects on the social adjustment of depressed patients. Archives of General Psychiatry1974;30:771-8. ">Klerman 1974a</a> ; <a href="./references#MR000050-bbs2-0040" title="KlermanGL , DimascioA , WeismannM , PrusoffB , PaykelES .Treatment of depression by drugs and psychotherapy. American Journal of Psychiatry1974;131(2):186-91. ">Klerman 1974b</a> ; <a href="./references#MR000050-bbs2-0041" title="KloskoJS , BarlowDH , TassinariR , CernyJA .A comparison of alprazolam and behavior therapy in treatment of panic disorder: correction. Journal of Psychotherapy Practice and Research1994;3(2):163-79. KloskoJS , BarlowDH , TassinariR , CernyJA .A comparison of alprazolam and behavior therapy in treatment of panic disorder. Journal of Consulting and Clinical Psychology1990;58(1):77-84. ">Klosko 1990</a> ; <a href="./references#MR000050-bbs2-0042" title="KrapflJE , NawasMM .Differential ordering of stimulus presentation in systematic desensitization. Journal of Abnormal Psychology1970;75(3):333-7. ">Krapfl 1970</a> ; <a href="./references#MR000050-bbs2-0044" title="LacyMK .The effect of short term autogenic training on the stress reactivity of hospitalized emotionally disturbed adolescents. ProQuest Dissertations Publishing, Oklahoma State University1996. ">Lacy 1990</a> ; <a href="./references#MR000050-bbs2-0045" title="LaiCK , ChiI , Kayser-JonesJ .A randomized controlled trial of a specific reminiscence approach to promote the well-being of nursing home residents with dementia. International Psychogeriatrics2004;16(1):33-49. LaiK .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 6th of September 2019. ">Lai 2004</a> ; <a href="./references#MR000050-bbs2-0046" title="LangOJ , LazovikAD .Experimental desensitization of a phobia. Journal of Abnormal and Social Psychology1963;66:519-25. LangPJ , LazovikAD , ReynoldsDJ .Desensitization, suggestibility, and pseudotherapy. Journal of Abnormal Psychology1965;70(6):395-402. ">Lang 1965</a> ; <a href="./references#MR000050-bbs2-0048" title="LickJ .Expectancy, false galvanic skin response feedback, and systematic desensitization in the modification of phobic behavior. Journal of Consulting and Clinical Psychology1975;43(4):557-67. ">Lick 1975</a> ; <a href="./references#MR000050-bbs2-0049" title="LickJR , HefflerD .Relaxation training and attention placebo in the treatment of severe insomnia. Journal of Consulting and Clinical Psychology1977;45(2):153-61. ">Lick 1977</a> ; <a href="./references#MR000050-bbs2-0050" title="LiddleB , SpenceSH .Cognitive-behaviour therapy with depressed primary school children: A cautionary note. Behavioural Psychotherapy1990;18(2):85-102. ">Liddle 1990</a> ; <a href="./references#MR000050-bbs2-0051" title="MatsonJL , MarchettiA , AdkinsJA .Comparison of operant- and independence-training procedures for mentally retarded adults. American Journal of Mental Deficiency1980;84(5):487-94. ">Matson 1980</a> ; <a href="./references#MR000050-bbs2-0052" title="McLachlanDR , DaltonAJ , KruckTP , BellMY , SmithWL , KalowW , et al.Intramuscular desferrioxamine in patients with Alzheimer's disease. Lancet1991;337(8753):1304-8. McLachlanDRC , SmithWL , KruckTP .Desferrioxamine and Alzheimer’s disease: video home behavior assessment of clinical course and measures of brain aluminum. Therapeutic Drug Monitoring1993;15(6):602-7. ">McLachlan 1991</a> ; <a href="./references#MR000050-bbs2-0053" title="MealieaWL , NawasMM .The comparative effectiveness of systematic desensitization and implosive therapy in the treatment of snake phobia. Journal of Behavior Therapy and Experimental Psychiatry1971;2(2):85-94. ">Mealiea 1971</a> ; <a href="./references#MR000050-bbs2-0054" title="MilbyJB , ClarkeC , ToroC , ThorntonS , RickertD .Effectiveness of urine surveillance as an adjunct to outpatient psychotherapy for drug abusers. International Journal of the Addictions1980;15(7):993-1001. ">Milby 1980</a> ; <a href="./references#MR000050-bbs2-0055" title="MirandaA , ArlandisP , SorianoM .Instruction in strategies and attributional training: Effects on the problem-solving and self-concept of students’ with learning disabilities [Instrucción en estrategias y entrenamiento atribucional: efectos sobre la resolución de problemas y el autoconcepto de los estudiantes con dificultades en el aprendizaje]. Infancia y Aprendizaje1997;20(80):37-52. ">Miranda 1997</a> ; <a href="./references#MR000050-bbs2-0056" title="MitchellC , MansfieldD , RautenbachS .Coloured filters and reading accuracy, comprehension and rate: a placebo-controlled study. Perceptual and Motor Skills2008;106(2):517-32. ">Mitchell 2008</a> ; <a href="./references#MR000050-bbs2-0057" title="NandiDN , AjmanyS , GanguliH , BanerjeeG , BoralGC , GhoshA , et al.A clinical evaluation of depressives found in a rural survey in India. British Journal of Psychiatry1976;128:523-7. ">Nandi 1976</a> ; <a href="./references#MR000050-bbs2-0058" title="NicassioP , BootzinR .A comparison of progressive relaxation and autogenic training as treatments for insomnia. Journal of Abnormal Psychology1974;83(3):253-60. ">Nicassio 1974</a> ; <a href="./references#MR000050-bbs2-0059" title="PearlD , Vander KampH , OlsenAL , GreenbergPD , ArmitageSG .The effects of reserpine on schizophrenic patients. American Journal of Psychiatry1956;112:198-204. ">Pearl 1956</a> ; <a href="./references#MR000050-bbs2-0060" title="PeckCL .Desensitization for the treatment of fear in the high level adult retardate. Behaviour Research and Therapy1977;15(2):137-48. ">Peck 1976</a> ; <a href="./references#MR000050-bbs2-0061" title="MilichR , CarlsonCL , Pelham WE Jr, LichtBG .Effects of methylphenidate on the persistence of ADHD boys following failure experiences. Journal of Abnormal Child Psychology1991;19(5):519-36. PelhamWE , MurphyDA , VannattaK , MilichR , LichtBG , GnagyEM , et al.Methylphenidate and attributions in boys with attention-deficit hyperactivity disorder. Journal of Consulting and Clinical Psychology1992;60(2):282-92. ">Pelham 1992</a> ; <a href="./references#MR000050-bbs2-0062" title="PedletonMG , HigginsRL .A comparison of negative practice and systematic desensitization in the treatment of acrophobia. Journal of Behavior Therapy and Experimental Psychiatry1983;14(4):317-23. ">Pendleton 1983</a> ; <a href="./references#MR000050-bbs2-0063" title="PetersonMA , PattersonB , PillmanBM , BattistaMA .Cognitive recovery following alcohol detoxification: a computerised remediation study. Neuropsychological Rehabilitation2002;12(1):63-74. PillmanBM .Computerized cognitive remediation with recently detoxified alcoholics. Dissertation, California School of Professional Psychology, Fresno Campus2000. ">Pillman 2001</a> ; <a href="./references#MR000050-bbs2-0064" title="PolandRE , GertsikL , FavreauJT , SmithSI , MirochaJM , RaoU , et al.Open-label randomized parallel-group controlled clinical trial of massage for treatment of depression in HIV-infected subjects. Journal of Alternative and Complementary Medicine2013;19(4):334-40. ">Poland 2013</a> ; <a href="./references#MR000050-bbs2-0065" title="PowersMB , SmitsJA , TelchMJ .Disentangling the effects of safety-behavior utilization and safety-behavior availability during exposure-based treatment: a placebo-controlled trial. Journal of Consulting and Clinical Psychology2004;72(3):448-54. ">Powers 2004</a> ; <a href="./references#MR000050-bbs2-0066" title="PowersMB , SmithsJA , WhitleyD , BystritskyA , TelchMJ .The effect of attributional processes concerning medication taking on return of fear. Journal of Consulting and Clinical Psychology2008;76(3):478-90. ">Powers 2008a</a> ; <a href="./references#MR000050-bbs2-0067" title="PowersMB , SmithsJA , WhitleyD , BystritskyA , TelchMJ .The effect of attributional processes concerning medication taking on return of fear. Journal of Consulting and Clinical Psychology2008;76(3):478-90. ">Powers 2008b</a> ; <a href="./references#MR000050-bbs2-0069" title="QuayhagenMP , QuayhagenM , CorbeilRR , RothPA , RodgersJA .A dyadic remediation program for care recipients with dementia. Nursing Research1995;44(3):153-9. ">Quayhagen 1995</a> ; <a href="./references#MR000050-bbs2-0070" title="LiebowitzM , QuitkinFM , StewartJW , McGrathPJ , HarrisonWM , MarkowitzJS , et al.Antidepressant efficacy in atypical depression. Archives of General Psychiatry1988;45(2):129-37. QuitkinFM , McGrathPJ , StewartJW , HarrisonW , WagerSG , NunesE , et al.Phenelzine and imipramine in mood reactive depressives: further delineation of the syndrome of atypical depression. Archives of General Psychiatry1989;46(9):787-93. RabkinJG , McGrathPJ , QuitkinFM , TricamoE , StewartJW , KleinDF .Effects of pill-giving on maintenance of placebo response in patients with chronic mild depression. American Journal of Psychiatry1990;147(12):1622-6. ">Rabkin 1990</a> ; <a href="./references#MR000050-bbs2-0071" title="RapeeR .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 29th of August 2019. RapeeRM , AbbottMJ , LynehamHJ .Bibliotherapy for children With anxiety disorders using written materials for parents: a randomized controlled trial. Journal of Consulting and Clinical Psychology2006;74(3):436-44. ">Rapee 2006</a> ; <a href="./references#MR000050-bbs2-0072" title="RapeeR .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 29th of August 2019. RapeeRM , AbbottMJ , BaillieAJ , GastonJE .Treatment of social phobia through pure self-help and therapist-augmented self-help. British Journal of Psychiatry2007;191:246-52. ">Rapee 2007</a> ; <a href="./references#MR000050-bbs2-0073" title="RobinA .Rationing out-patients: a defence of the waiting list. British Journal of Psychiatry1976;129:138-41. ">Robin 1976</a> ; <a href="./references#MR000050-bbs2-0074" title="RoehrichL , GoldmanMS .Experience-dependent neuropsychological recovery and the treatment of alcoholism. Journal of Consulting and Clinical Psychology1993;61(5):812-21. ">Roehrich 1993</a> ; <a href="./references#MR000050-bbs2-0075" title="OlivaresJ .Program IAFS. Protocol for the treatment of social phobia in adolescents [Programa IAFS. Protocolo para el tratamiento de la fobia social enadolescentes]. Madrid: Pirámide2005;1. Rosa-AlcázarAI , Olivares-OlivaresPJ , OlivaresJ .The role of non-specific effects in the psychological treatment of adolescents with social phobia [Papel de los efectos inespecíficos en el tratamiento psicológico de adolescentes con fobia social]. Anuario de Psicologia2009;40(1):43-61. ">Rosa‐Alcatraz 2009</a> ; <a href="./references#MR000050-bbs2-0076" title="RosenGM , GlasgowRE , BarreraM .A controlled study to assess the clinical efficacy of totally self-administrated systematic desensitization. Journal of Consulting and Clinical Psychology1976;44(2):208-17. ">Rosen 1976</a> ; <a href="./references#MR000050-bbs2-0077" title="LorrM , McNairDM , WeinsteinGJ .Early effects of chlordiazepoxide (Librium) used with psychotherapy. Journal of Psychiatric Research1963;1:257-70. RothI , RhudickPJ , ShaskanDA , SlobinMS , WilkinsonAE , YoungHH .Long-term effects on psychotherapy of initial treatment conditions. Journal of Psychiatric Research1964;2:283-97. ">Roth 1964</a> ; <a href="./references#MR000050-bbs2-0078" title="RupertPA , HolmesDS .Effects of multiple sessions of true and placebo heart rate biofeedback training on the heart rates and anxiety levels of anxious patients during and following treatment. Psychophysiology1978;15(6):582-90. ">Rupert 1978</a> ; <a href="./references#MR000050-bbs2-0080" title="ShealyRC .The effectiveness of various treatment techniques on different degrees and durations of sleep-onset insomnia. Behaviour Research and Therapy1979;17(6):541-6. ">Shealy 1979</a> ; <a href="./references#MR000050-bbs2-0081" title="SibilioJP , AndrewG , DartD , MooreKB , StehmanA .Treatment of chronic schizophrenia with promazine hydrochloride. AMA Archives of Neurology and Psychiatry1957;78(4):419-24. ">Sibilio 1957</a> ; <a href="./references#MR000050-bbs2-0082" title="SommernessMD , LuceroRJ , HamlonJS , EricksonJL , MatthewsR .A controlled study of reserpine on chronically disturbed patients. JAMA Archives of Neurology and Psychiatry1955;74(3):316-9. ">Sommerness 1955</a> ; <a href="./references#MR000050-bbs2-0083" title="SteinmarkSW , BorkovecTD .Active and placebo treatment effects on moderate insomnia under counterdemand and positive demand instructions. Journal of Abnormal Psychology1974;83(2):157-63. ">Steinmark 1974</a> ; <a href="./references#MR000050-bbs2-0084" title="SzymanskiJ , O'DonohueW .The potential role of state-dependent learning in cognitive therapy with spider phobics. Journal of Rational-Emotive &amp; Cognitive-Behavior Therapy1995;13(2):131-50. SzymanskiJ .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 20th of August 2019. ">Szymanski 1995</a> ; <a href="./references#MR000050-bbs2-0085" title="TanSY , BruniJ .Cognitive-behavior therapy with adult patients with epilepsy: a controlled outcome study. Epilepsia1986;27(3):225-33. ">Tan 1986</a> ; <a href="./references#MR000050-bbs2-0086" title="TeriL , LogsdonRG , UomotoJ , McCurrySM .Behavioral treatment of depression in dementia patients: a controlled clinical trial. Journals of Gerontology. Series B, Psychological Sciences and Social Sciences1997;52(4):159-66. TeriL .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 26th of August 2019. ">Teri 1997</a> ; <a href="./references#MR000050-bbs2-0087" title="ToriC , WorellL .Reduction of human avoidant behavior. A comparison of counterconditioning, expectancy, and cognitive information approaches. Clinical Psychology1973;41(2):269-78. ">Tori 1973</a> ; <a href="./references#MR000050-bbs2-0088" title="Trexler, L.Rational-emotive therapy, placebo, and no-treatment effects on public-speaking anxiety. Doctoral dissertation, Temple University AnnArbor, Mich.: University Microfilms1971;71-31(063). TrexlerLD , KarstTO .Rational-emotive therapy, placebo, and no-treatment effects on public-speaking anxiety. Journal of Abnormal Psyhology1972;79(1):60-7. ">Trexler 1972</a> ; <a href="./references#MR000050-bbs2-0089" title="AscherML , TurnerRM .A comparison of two methods for the administration of paradoxical intention. Behaviour Research and Therapy1980;18(2):121-6. TurnerRM , AscherLM .Controlled comparison of progressive relaxation, stimulus control, and paradoxical intention therapies for insomnia. Journal of Consulting and Clinical Psychology1979;47(3):500-8. ">Turner 1979</a> ; <a href="./references#MR000050-bbs2-0090" title="VanderplateC .Electromyograph biofeedback Treatment of sleep onset Insomnia: a controlled Investigation. Dissertation, University of Southern Mississippi1978. ">Vanderplate 1983</a> ; <a href="./references#MR000050-bbs2-0091" title="WatzlH , RistF , OlbrichR , CohenR .Placebo injections and surveillance of alcohol intake during inpatient treatment of female alcoholics. Addictive Behaviors1988;13(2):197-200. ">Watzl 1988</a> ; <a href="./references#MR000050-bbs2-0092" title="WeingaertnerAH .Self-administered aversive stimulation with hallucinating hospitalized schizophrenics. Journal of Consulting and Clinical Psychology1971;36(3):422-29. ">Weingaertner 1971</a> ; <a href="./references#MR000050-bbs2-0093" title="WhittakerCB , HoyRM .Withdrawal of perphenazine in chronic schizophrenia. British Journal of Psychiatry1963;109:422-7. ">Whittaker 1963</a> ; <a href="./references#MR000050-bbs2-0094" title="WilsonA , DavidsonWJ , BlanchardR , WhiteJ .Disulfiram implantation. A placebo-controlled trial with two-year follow-up. Journal of Studies on Alcohol1978;39(5):809-19. WilsonA , DavidsonWJ , BlanchardR .Disulfiram implantation: a trial using placebo implants and two types of controls. Journal of Studies on Alcohol1980;41(5):429-36. ">Wilson 1980</a> ; <a href="./references#MR000050-bbs2-0095" title="WolitzkyKB , TelchMJ .Augmenting in vivo exposure with fear antagonistic actions: a preliminary test. Behavior Therapy2009;40(1):57-71. ">Wolitzky 2009</a> ; <a href="./references#MR000050-bbs2-0096" title="WollersheimJP , WilsonGL .Group treatment of unipolar depression: a comparison of coping, supportive, bibliotherapy, and delayed treatment groups. Professional Psychology: Research and Practice1991;22(6):496-502. ">Wollersheim 1991</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Other potential sources of bias</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Low risk of bias</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>87</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#MR000050-bbs2-0001" title="AbikoffH , HechtmanL , KleinRG .Social functioning in children with ADHD treated with long-term methylphenidate and multimodal psychosocial treatment. Journal of the American Academy of Child and Adolescent Psychiatry2004;43(7):820-9. AbikoffH .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to A Todorovac 23rd of August 2019. KleinRG , AbikoffH , HechtmanL , WeissG .Design and rationale of controlled study of long-term methylphenidate and multimodal psychosocial treatment in children with ADHD. Journal of the American Academy of Child and Adolescent Psychiatry2004;43(7):792-801. ">Abikoff 2004</a> ; <a href="./references#MR000050-bbs2-0002" title="AllenJB .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to A Todorovac 28th of August 2019. AllenJJ , SchnyerRN , HittSK .The efficacy of acupuncture in the treatment of major depression in women. Psychological Science1998;9(5):397-401. ">Allen 1998</a> ; <a href="./references#MR000050-bbs2-0003" title="AllenJB .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 28th of August 2019. AllenJJ , SchnyerRN , ChambersAS , HittSK , MorenoFA , ManberR .Acupuncture for depression: a randomized controlled trial. Journal of Clinical Psychiatry2006;67(11):1665-73. ">Allen 2006</a> ; <a href="./references#MR000050-bbs2-0004" title="AlvarezJR .The effects of anger management training on depression, anger, self-concept, and treatment responsibility in a sample of drug-dependent individuals in a therapeutic community. Dissertation Abstracts International: Section B: the Sciences and Engineering1997;58(4-B):2108. ">Alvarez 1997</a> ; <a href="./references#MR000050-bbs2-0005" title="AscherLM , TurnerR .Paradoxical intention and insomnia: an experimental investigation. Behaviour Research and Therapy1979;17(4):408-11. ">Ascher 1979</a> ; <a href="./references#MR000050-bbs2-0006" title="AyenI , HautzingerM .Cognitive behavior therapy for depression in menopausal women. A controlled, randomized treatment study [Kognitive Verhaltenstherapie bei Depressionen im Klimakterium: Eine kontrollierte, randomiserte Interventionsstudie]. Zeitschrift für Klinische Psychologie und Psychotherapie2004;33(4):290-9. AyenI .Inclusion of study in Cochrane Systematic Review (personal communication). Email to EG Faltinsen 9th of September 2019. ">Ayen 2004</a> ; <a href="./references#MR000050-bbs2-0007" title="BergI , ForsytheI , HoltP , WattsJ .A controlled trial of ‘Senokot’ in faecal soiling treated by behavioural methods. Journal of Child Psychology and Psychiatry1983;24(4):543-9. ">Berg 1983</a> ; <a href="./references#MR000050-bbs2-0008" title="Borden, KA.Attributional Outcomes: the Subtle Messages of Treatments for Attention Deficit Disorder. Dissertation, University of Illinois at Urbana-Champaign1986. BordenKA , BrownRT .Attributional outcomes: The subtle messages of treatments for attention deficit disorder. Cognitive Therapy and Research1989;13(2):147-60. ">Borden 1986</a> ; <a href="./references#MR000050-bbs2-0009" title="BorkovecTD , KaloupekDG , SlamaKM .The facilitative effect of muscle tension-release in the relaxation treatment of sleep disturbance. Behavior Therapy1975;6(3):301-9. ">Borkovec 1975</a> ; <a href="./references#MR000050-bbs2-0010" title="BorkovecTD , WeertsTC .Effects of progressive relaxation on sleep disturbance: an electroencephalographic evaluation. Psychosomatic Medicine1976;38(3):173-80. ">Borkovec 1976</a> ; <a href="./references#MR000050-bbs2-0011" title="BornovalovaM .Inclusion of study in Cochrane Systematic Review (personal communication). Email to A Todorovac. 21st of August 2019. BornovalovaMA .Distress tolerance treatment for inner-city drug users: a preliminary trial. Doctor’s Dissertation, University of Maryland2008. ">Bornovalova 2008</a> ; <a href="./references#MR000050-bbs2-0012" title="BramstonP , SpenceSH .Behavioural versus cognitive social-skills training with intellectually-handicapped adults. Behaviour Research and Therapy1985;23(3):239-46. ">Bramston 1985</a> ; <a href="./references#MR000050-bbs2-0013" title="BrillNQ , KoeglerRR , EpsteinLJ , ForgyEW .Controlled study of psychiatric outpatient treatment. Archives of General Psychiatry1964;10:581-95. BrillNQ .Results of psychotherapy. California Medicine1966;104(4):249-53. ">Brill 1964a</a> ; <a href="./references#MR000050-bbs2-0014" title="BrillNQ , KoeglerRR , EpsteinLJ , ForgyEW .Controlled study of psychiatric outpatient treatment. Archives of General Psychiatry1964;10:581-95. ">Brill 1964b</a> ; <a href="./references#MR000050-bbs2-0015" title="CarlsonCL , PelhamWE , MilichR , HozaB .ADHD boys’ performance and attributions following success and failure: drug effects and individual differences. Cognitive Therapy and Research1993;17:269-87. ">Carlson 1993</a> ; <a href="./references#MR000050-bbs2-0016" title="CarterJC , OlmstedMP , KaplanAS , McCabeRE , MillsJS , AimeA .Self-help for bulimia nervosa: a randomized controlled trial. American Journal of Psychiatry2003;160(5):973-8. ">Carter 2003</a> ; <a href="./references#MR000050-bbs2-0017" title="CrispAH , NortonK , GowersS , HalekC , BowyerC , YeldhamD , et al.A controlled study of the effect of therapies aimed at adolescent and family psychopathology in Anorexia Nervosa. British Journal of Psychiatry: the Journal of Mental Science1991;159:325-33. GowersS , NortonK , HalekC , CrispAH .Outcome of outpatient psychotherapy in a random allocation treatment study of anorexia nervosa. International Journal of Eating Disorders1994;15(2):165-77. GowersS , NortonK , YelshamD .The St George's prospective treatment study of anorexia nervosa: a discussion of methodological problems. International Journal of Eating Disorders1989;8:445-54. ">Crisp 1991</a> ; <a href="./references#MR000050-bbs2-0018" title="CrouchG , RobsonM , HallstromC .Benzodiazepine dependent patients and their psychological treatment. Progress in Neuro-psychopharmacology &amp; Biological Psychiatry1988;12(4):503-10. HallströmC , CrouchG , RobsenM , ShineP .The treatment of tranquillizer dependence by propranolol. Postgraduate Medical Journal1988;64(Suppl 2):40-4. ">Crouch 1988</a> ; <a href="./references#MR000050-bbs2-0019" title="Doty, DW.Role playing and incentives in the modification of the social interaction of chronic psychiatric patients. Journal of Consulting and Clinical Psychology1975;43(5):676-82. ">Doty 1975</a> ; <a href="./references#MR000050-bbs2-0020" title="DoubleDB , WarrenGC , EvansM , RowlandsMP .Efficacy of maintenance use of anticholinergic agents. Acta Psychiatrica Scandinavica1993;88:381-4. ">Double 1993</a> ; <a href="./references#MR000050-bbs2-0021" title="EhlersA , HackmannA , GreyN , WildJ , LinessS , AlbertI , et al.A randomized controlled trial of 7-day intensive and standard weekly cognitive therapy for PTSD and emotion-focused supportive therapy. American Journal of Psychiatry2014;171(3):294-304. ">Ehlers 2014</a> ; <a href="./references#MR000050-bbs2-0022" title="EspieCA , BrooksDN , LindsayWR .An evaluation of tailored psychological treatment of insomnia. Journal of Behavior Therapy and Experimental Psychiatry1989;20(2):143-53. EspieCA , LindsayWR , BrooksDN , HoodEM , TurveyT .A controlled comparative investigation of psychological treatments for chronic sleep-onset insomnia. Behaviour Research and Therapy1989;27(1):79-88. ">Espie 1989a</a> ; <a href="./references#MR000050-bbs2-0023" title="EtringerBD , CashTF , RimmDC .Behavioral, affective, and cognitive effects of participant modeling and an equally credible placebo. Behavior Therapy1982;13(4):476-85. ">Etringer 1982</a> ; <a href="./references#MR000050-bbs2-0024" title="FoaEB , RothbaumBO , RiggsDS , MurdockTB .Treatment of posttraumatic stress disorder in rape victims: a comparison between cognitive-behavioral procedures and counselling. Journal of Consulting and Clinical Psychology1991;59(5):715-23. ">Foa 1991</a> ; <a href="./references#MR000050-bbs2-0025" title="FoaEB , McLeanCP , ZangY , RosenfieldD , YadinE , YarvisJS , et al.Effect of prolonged exposure therapy delivered over 2 weeks vs 8 weeks vs present-centered therapy on PTSD symptom severity in military personnel: a randomized clinical trial. JAMA2018;319(4):354-64. ">Foa 2018</a> ; <a href="./references#MR000050-bbs2-0026" title="FreireAO , SugaiGC , ChrispinFS , TogeiroSM , YamamuraY , MelloLE , et al.Treatment of moderate obstructive sleep apnea syndrome with acupuncture: a randomised, placebo-controlled pilot trial. Sleep Medicine2007;8(1):43-50. ">Freire 2007</a> ; <a href="./references#MR000050-bbs2-0027" title="FuchsCZ , RehnLP .A self-control behavior therapy program for depression. Journal of Consulting and Clinical Psychology1977;45(2):206-15. ">Fuchs 1977</a> ; <a href="./references#MR000050-bbs2-0028" title="GlogowskaM , RoulstoneS , EnderbyP , PetersTJ .Randomised controlled trial of community based speech and language therapy in preschool children. BMJ2000;321(7266):923-6. ">Glogowska 2000</a> ; <a href="./references#MR000050-bbs2-0029" title="GoldsteinAJ , BeursE , Chambless Dl, WilsonKA .EMDR for panic disorder with agoraphobia: comparison with waiting list and credible attention-placebo control conditions. Journal of Consulting and Clinical Psychology2000;68(6):947-56. ">Goldstein 2000</a> ; <a href="./references#MR000050-bbs2-0030" title="GoldwasserAN , AuerbachSM , HarkinsSW .Cognitive, affective, and behavioural effects of reminiscence group therapy on demented elderly. Aging and Human Development1987;25(3):209-22. ">Goldwasser 1987</a> ; <a href="./references#MR000050-bbs2-0031" title="HekmatH , LubitzR , DealR .Semantic desensitization: a paradigmatic intervention approach to anxiety disorders. Journal of Clinical Psychology1984;40(2):463-6. ">Hekmat 1984</a> ; <a href="./references#MR000050-bbs2-0032" title="HippmanC , RingroseA , InglisA , CheekJ , AlbertAY , RemickR , et al.A pilot randomized clinical trial evaluating the impact of genetic counselling for serious mental illnesses. Journal of Clinical Psychiatry2016;77(2):e190-8. ">Hippman 2016</a> ; <a href="./references#MR000050-bbs2-0033" title="HowlinP , GordonKR , PascoG , WadeA , CharmanT .The effectiveness of picture exchange communication system (PECS) training for teachers of children with autism: a pragmatic,group randomised controlled trial. Journal of Child Psychology and Psychiatry2007;48(5):473-81. ">Howlin 2007</a> ; <a href="./references#MR000050-bbs2-0034" title="KarstM , WinterhalterM , MünteS , FranckiB , HondronikosA , EckardtA , et al.Auricular acupuncture for dental anxiety: a randomized controlled trial. Anesthesia and Analgesia2007;104(2):295-300. KarstM .Inclusion of study in Cochrane Systematic Review (personal communication). Email to: EG Faltinsen 5th of September 2019. ">Karst 2007</a> ; <a href="./references#MR000050-bbs2-0035" title="KelleyJ .Inclusion of study in Cochrane Systematic Review (personal communication). Email to: A Todorovac 12th of August 2019. KelleyJM , KaptchukTJ , CusinC , LipkinS , FavaM .Open-label placebo for major depressive disorder: a pilot randomized controlled trial. Psychotherapy and Psychosomatics2012;81(5):312-4. ">Kelley 2012</a> ; <a href="./references#MR000050-bbs2-0036" title="KennedyTD , KimuraHK .Transfer, behavioral improvement, and anxiety reduction in systematic desensitization. Journal of Consulting and Clinical Psychology1974;42(5):720-8. ">Kennedy 1974</a> ; <a href="./references#MR000050-bbs2-0037" title="KilmannPR , MilanRJ , BolandJP , NankinHR , DavidsonE , WestMO , et al.Group treatment of secondary erectile dysfunction. Journal of Sex &amp; Marital Therapy1987;13(3):168-82. KilmannPR , Milan RJ Jr, BolandJP , DavidsonE , WestMO , SablisRF , et al.The sexual interactions of men with secondary erectile dysfunction. Journal of Sex Education and Therapy1988;14(1):46-9. KilmannPR , Milan RJ Jr, BolandJP , NankinHR , SablisRF , WestMO , et al.The sexual interactions of men with secondary erectile dysfunction. Paper presented at the annual meeting of the American Psychological Association in Los Angeles1985;1:46-9. ">Kilmann 1987</a> ; <a href="./references#MR000050-bbs2-0038" title="KleinSA , DeffenbacherJL .Relaxation and exercise for hyperactive impulsive children. Perceptual and Motor Skills1977;45:1159-62. ">Klein 1977</a> ; <a href="./references#MR000050-bbs2-0039" title="KlermanGL , DimascioA , WeismannM , PrusoffB , PaykelES .Treatment of depression by drugs and psychotherapy. American Journal of Psychiatry1974;131(2):186-91. PaykelES , DimascioA , HaskellD , PrusoffBA .Effects of maintenance amitriptyline and psychotherapy on symptoms of depression. Psychological Medicine1975;5(1):67-77. PaykelES , DiMascioA , KlermanGL , PrusoffBA .Maintenance therapy of depression. Pharmakopsychiatrie, Neuro-Psychopharmakologie1976;9:127-39. PaykelES , WeissmanMM , PrusoffBA .Social maladjustment and severity of depression. Comprehensive Psychiatry1978;19(2):121-8. WeissmanMM , KlermanGL , PaykelES , PrusoffB .Treatment effects on the social adjustment of depressed patients. Archives of General Psychiatry1974;30:771-8. ">Klerman 1974a</a> ; <a href="./references#MR000050-bbs2-0040" title="KlermanGL , DimascioA , WeismannM , PrusoffB , PaykelES .Treatment of depression by drugs and psychotherapy. American Journal of Psychiatry1974;131(2):186-91. ">Klerman 1974b</a> ; <a href="./references#MR000050-bbs2-0041" title="KloskoJS , BarlowDH , TassinariR , CernyJA .A comparison of alprazolam and behavior therapy in treatment of panic disorder: correction. Journal of Psychotherapy Practice and Research1994;3(2):163-79. KloskoJS , BarlowDH , TassinariR , CernyJA .A comparison of alprazolam and behavior therapy in treatment of panic disorder. Journal of Consulting and Clinical Psychology1990;58(1):77-84. ">Klosko 1990</a> ; <a href="./references#MR000050-bbs2-0042" title="KrapflJE , NawasMM .Differential ordering of stimulus presentation in systematic desensitization. Journal of Abnormal Psychology1970;75(3):333-7. ">Krapfl 1970</a> ; <a href="./references#MR000050-bbs2-0043" title="KwanR .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 26th of August 2019. KwanRY , LeungMC , LaiCK .Acupressure for agitation in nursing home residents with dementia: study protocol for a randomized controlled trial. Trials2014;15(410):1-7. KwanRY , LeungMCP , LaiCK .A randomized controlled trial examining the effect of acupressure on agitation and salivary cortisol in nursing home residents with dementia. Dementia and Geriatric Cognitive Disorders2017;44(1-2):92-104. ">Kwan 2017</a> ; <a href="./references#MR000050-bbs2-0044" title="LacyMK .The effect of short term autogenic training on the stress reactivity of hospitalized emotionally disturbed adolescents. ProQuest Dissertations Publishing, Oklahoma State University1996. ">Lacy 1990</a> ; <a href="./references#MR000050-bbs2-0046" title="LangOJ , LazovikAD .Experimental desensitization of a phobia. Journal of Abnormal and Social Psychology1963;66:519-25. LangPJ , LazovikAD , ReynoldsDJ .Desensitization, suggestibility, and pseudotherapy. Journal of Abnormal Psychology1965;70(6):395-402. ">Lang 1965</a> ; <a href="./references#MR000050-bbs2-0047" title="LegrandF .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 14th of August 2019. LegrandFD , NeffEM .Efficacy of exercise as an adjunct treatment for clinically depressed inpatients during the initial stages of antidepressant pharmacotherapy: an open randomized controlled trial. Journal of Affective Disorders2016;191:139-44. ">Legrand 2016</a> ; <a href="./references#MR000050-bbs2-0048" title="LickJ .Expectancy, false galvanic skin response feedback, and systematic desensitization in the modification of phobic behavior. Journal of Consulting and Clinical Psychology1975;43(4):557-67. ">Lick 1975</a> ; <a href="./references#MR000050-bbs2-0050" title="LiddleB , SpenceSH .Cognitive-behaviour therapy with depressed primary school children: A cautionary note. Behavioural Psychotherapy1990;18(2):85-102. ">Liddle 1990</a> ; <a href="./references#MR000050-bbs2-0051" title="MatsonJL , MarchettiA , AdkinsJA .Comparison of operant- and independence-training procedures for mentally retarded adults. American Journal of Mental Deficiency1980;84(5):487-94. ">Matson 1980</a> ; <a href="./references#MR000050-bbs2-0052" title="McLachlanDR , DaltonAJ , KruckTP , BellMY , SmithWL , KalowW , et al.Intramuscular desferrioxamine in patients with Alzheimer's disease. Lancet1991;337(8753):1304-8. McLachlanDRC , SmithWL , KruckTP .Desferrioxamine and Alzheimer’s disease: video home behavior assessment of clinical course and measures of brain aluminum. Therapeutic Drug Monitoring1993;15(6):602-7. ">McLachlan 1991</a> ; <a href="./references#MR000050-bbs2-0053" title="MealieaWL , NawasMM .The comparative effectiveness of systematic desensitization and implosive therapy in the treatment of snake phobia. Journal of Behavior Therapy and Experimental Psychiatry1971;2(2):85-94. ">Mealiea 1971</a> ; <a href="./references#MR000050-bbs2-0054" title="MilbyJB , ClarkeC , ToroC , ThorntonS , RickertD .Effectiveness of urine surveillance as an adjunct to outpatient psychotherapy for drug abusers. International Journal of the Addictions1980;15(7):993-1001. ">Milby 1980</a> ; <a href="./references#MR000050-bbs2-0055" title="MirandaA , ArlandisP , SorianoM .Instruction in strategies and attributional training: Effects on the problem-solving and self-concept of students’ with learning disabilities [Instrucción en estrategias y entrenamiento atribucional: efectos sobre la resolución de problemas y el autoconcepto de los estudiantes con dificultades en el aprendizaje]. Infancia y Aprendizaje1997;20(80):37-52. ">Miranda 1997</a> ; <a href="./references#MR000050-bbs2-0057" title="NandiDN , AjmanyS , GanguliH , BanerjeeG , BoralGC , GhoshA , et al.A clinical evaluation of depressives found in a rural survey in India. British Journal of Psychiatry1976;128:523-7. ">Nandi 1976</a> ; <a href="./references#MR000050-bbs2-0058" title="NicassioP , BootzinR .A comparison of progressive relaxation and autogenic training as treatments for insomnia. Journal of Abnormal Psychology1974;83(3):253-60. ">Nicassio 1974</a> ; <a href="./references#MR000050-bbs2-0059" title="PearlD , Vander KampH , OlsenAL , GreenbergPD , ArmitageSG .The effects of reserpine on schizophrenic patients. American Journal of Psychiatry1956;112:198-204. ">Pearl 1956</a> ; <a href="./references#MR000050-bbs2-0060" title="PeckCL .Desensitization for the treatment of fear in the high level adult retardate. Behaviour Research and Therapy1977;15(2):137-48. ">Peck 1976</a> ; <a href="./references#MR000050-bbs2-0062" title="PedletonMG , HigginsRL .A comparison of negative practice and systematic desensitization in the treatment of acrophobia. Journal of Behavior Therapy and Experimental Psychiatry1983;14(4):317-23. ">Pendleton 1983</a> ; <a href="./references#MR000050-bbs2-0063" title="PetersonMA , PattersonB , PillmanBM , BattistaMA .Cognitive recovery following alcohol detoxification: a computerised remediation study. Neuropsychological Rehabilitation2002;12(1):63-74. PillmanBM .Computerized cognitive remediation with recently detoxified alcoholics. Dissertation, California School of Professional Psychology, Fresno Campus2000. ">Pillman 2001</a> ; <a href="./references#MR000050-bbs2-0064" title="PolandRE , GertsikL , FavreauJT , SmithSI , MirochaJM , RaoU , et al.Open-label randomized parallel-group controlled clinical trial of massage for treatment of depression in HIV-infected subjects. Journal of Alternative and Complementary Medicine2013;19(4):334-40. ">Poland 2013</a> ; <a href="./references#MR000050-bbs2-0065" title="PowersMB , SmitsJA , TelchMJ .Disentangling the effects of safety-behavior utilization and safety-behavior availability during exposure-based treatment: a placebo-controlled trial. Journal of Consulting and Clinical Psychology2004;72(3):448-54. ">Powers 2004</a> ; <a href="./references#MR000050-bbs2-0066" title="PowersMB , SmithsJA , WhitleyD , BystritskyA , TelchMJ .The effect of attributional processes concerning medication taking on return of fear. Journal of Consulting and Clinical Psychology2008;76(3):478-90. ">Powers 2008a</a> ; <a href="./references#MR000050-bbs2-0067" title="PowersMB , SmithsJA , WhitleyD , BystritskyA , TelchMJ .The effect of attributional processes concerning medication taking on return of fear. Journal of Consulting and Clinical Psychology2008;76(3):478-90. ">Powers 2008b</a> ; <a href="./references#MR000050-bbs2-0068" title="ProudfootJ , ClarkeJ , BirchMR , WhittonAE , ParkerG , ManicavasagarV , et al.Impact of a mobile phone and web program on symptom and functional outcomes for people with mild- to-moderate depression, anxiety and stress: a randomized controlled trial. BMC Psychiatry2013;13(312):1-12. ProudfootJ .Re: Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 26th of August 2019. ">Proudfoot 2013</a> ; <a href="./references#MR000050-bbs2-0070" title="LiebowitzM , QuitkinFM , StewartJW , McGrathPJ , HarrisonWM , MarkowitzJS , et al.Antidepressant efficacy in atypical depression. Archives of General Psychiatry1988;45(2):129-37. QuitkinFM , McGrathPJ , StewartJW , HarrisonW , WagerSG , NunesE , et al.Phenelzine and imipramine in mood reactive depressives: further delineation of the syndrome of atypical depression. Archives of General Psychiatry1989;46(9):787-93. RabkinJG , McGrathPJ , QuitkinFM , TricamoE , StewartJW , KleinDF .Effects of pill-giving on maintenance of placebo response in patients with chronic mild depression. American Journal of Psychiatry1990;147(12):1622-6. ">Rabkin 1990</a> ; <a href="./references#MR000050-bbs2-0071" title="RapeeR .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 29th of August 2019. RapeeRM , AbbottMJ , LynehamHJ .Bibliotherapy for children With anxiety disorders using written materials for parents: a randomized controlled trial. Journal of Consulting and Clinical Psychology2006;74(3):436-44. ">Rapee 2006</a> ; <a href="./references#MR000050-bbs2-0072" title="RapeeR .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 29th of August 2019. RapeeRM , AbbottMJ , BaillieAJ , GastonJE .Treatment of social phobia through pure self-help and therapist-augmented self-help. British Journal of Psychiatry2007;191:246-52. ">Rapee 2007</a> ; <a href="./references#MR000050-bbs2-0074" title="RoehrichL , GoldmanMS .Experience-dependent neuropsychological recovery and the treatment of alcoholism. Journal of Consulting and Clinical Psychology1993;61(5):812-21. ">Roehrich 1993</a> ; <a href="./references#MR000050-bbs2-0075" title="OlivaresJ .Program IAFS. Protocol for the treatment of social phobia in adolescents [Programa IAFS. Protocolo para el tratamiento de la fobia social enadolescentes]. Madrid: Pirámide2005;1. Rosa-AlcázarAI , Olivares-OlivaresPJ , OlivaresJ .The role of non-specific effects in the psychological treatment of adolescents with social phobia [Papel de los efectos inespecíficos en el tratamiento psicológico de adolescentes con fobia social]. Anuario de Psicologia2009;40(1):43-61. ">Rosa‐Alcatraz 2009</a> ; <a href="./references#MR000050-bbs2-0076" title="RosenGM , GlasgowRE , BarreraM .A controlled study to assess the clinical efficacy of totally self-administrated systematic desensitization. Journal of Consulting and Clinical Psychology1976;44(2):208-17. ">Rosen 1976</a> ; <a href="./references#MR000050-bbs2-0077" title="LorrM , McNairDM , WeinsteinGJ .Early effects of chlordiazepoxide (Librium) used with psychotherapy. Journal of Psychiatric Research1963;1:257-70. RothI , RhudickPJ , ShaskanDA , SlobinMS , WilkinsonAE , YoungHH .Long-term effects on psychotherapy of initial treatment conditions. Journal of Psychiatric Research1964;2:283-97. ">Roth 1964</a> ; <a href="./references#MR000050-bbs2-0078" title="RupertPA , HolmesDS .Effects of multiple sessions of true and placebo heart rate biofeedback training on the heart rates and anxiety levels of anxious patients during and following treatment. Psychophysiology1978;15(6):582-90. ">Rupert 1978</a> ; <a href="./references#MR000050-bbs2-0079" title="ShalevAY , AnkriY , Isreali-ShalevY , PelegT , AdesskyR , FreedmanS .Prevention of posttraumatic stress disorder by early treatment. Archives of General Psychiatry2012;69(2):166-76. ">Shalev 2012</a> ; <a href="./references#MR000050-bbs2-0080" title="ShealyRC .The effectiveness of various treatment techniques on different degrees and durations of sleep-onset insomnia. Behaviour Research and Therapy1979;17(6):541-6. ">Shealy 1979</a> ; <a href="./references#MR000050-bbs2-0081" title="SibilioJP , AndrewG , DartD , MooreKB , StehmanA .Treatment of chronic schizophrenia with promazine hydrochloride. AMA Archives of Neurology and Psychiatry1957;78(4):419-24. ">Sibilio 1957</a> ; <a href="./references#MR000050-bbs2-0082" title="SommernessMD , LuceroRJ , HamlonJS , EricksonJL , MatthewsR .A controlled study of reserpine on chronically disturbed patients. JAMA Archives of Neurology and Psychiatry1955;74(3):316-9. ">Sommerness 1955</a> ; <a href="./references#MR000050-bbs2-0084" title="SzymanskiJ , O'DonohueW .The potential role of state-dependent learning in cognitive therapy with spider phobics. Journal of Rational-Emotive &amp; Cognitive-Behavior Therapy1995;13(2):131-50. SzymanskiJ .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 20th of August 2019. ">Szymanski 1995</a> ; <a href="./references#MR000050-bbs2-0085" title="TanSY , BruniJ .Cognitive-behavior therapy with adult patients with epilepsy: a controlled outcome study. Epilepsia1986;27(3):225-33. ">Tan 1986</a> ; <a href="./references#MR000050-bbs2-0086" title="TeriL , LogsdonRG , UomotoJ , McCurrySM .Behavioral treatment of depression in dementia patients: a controlled clinical trial. Journals of Gerontology. Series B, Psychological Sciences and Social Sciences1997;52(4):159-66. TeriL .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 26th of August 2019. ">Teri 1997</a> ; <a href="./references#MR000050-bbs2-0087" title="ToriC , WorellL .Reduction of human avoidant behavior. A comparison of counterconditioning, expectancy, and cognitive information approaches. Clinical Psychology1973;41(2):269-78. ">Tori 1973</a> ; <a href="./references#MR000050-bbs2-0090" title="VanderplateC .Electromyograph biofeedback Treatment of sleep onset Insomnia: a controlled Investigation. Dissertation, University of Southern Mississippi1978. ">Vanderplate 1983</a> ; <a href="./references#MR000050-bbs2-0091" title="WatzlH , RistF , OlbrichR , CohenR .Placebo injections and surveillance of alcohol intake during inpatient treatment of female alcoholics. Addictive Behaviors1988;13(2):197-200. ">Watzl 1988</a> ; <a href="./references#MR000050-bbs2-0092" title="WeingaertnerAH .Self-administered aversive stimulation with hallucinating hospitalized schizophrenics. Journal of Consulting and Clinical Psychology1971;36(3):422-29. ">Weingaertner 1971</a> ; <a href="./references#MR000050-bbs2-0093" title="WhittakerCB , HoyRM .Withdrawal of perphenazine in chronic schizophrenia. British Journal of Psychiatry1963;109:422-7. ">Whittaker 1963</a> ; <a href="./references#MR000050-bbs2-0094" title="WilsonA , DavidsonWJ , BlanchardR , WhiteJ .Disulfiram implantation. A placebo-controlled trial with two-year follow-up. Journal of Studies on Alcohol1978;39(5):809-19. WilsonA , DavidsonWJ , BlanchardR .Disulfiram implantation: a trial using placebo implants and two types of controls. Journal of Studies on Alcohol1980;41(5):429-36. ">Wilson 1980</a> ; <a href="./references#MR000050-bbs2-0095" title="WolitzkyKB , TelchMJ .Augmenting in vivo exposure with fear antagonistic actions: a preliminary test. Behavior Therapy2009;40(1):57-71. ">Wolitzky 2009</a> ; <a href="./references#MR000050-bbs2-0096" title="WollersheimJP , WilsonGL .Group treatment of unipolar depression: a comparison of coping, supportive, bibliotherapy, and delayed treatment groups. Professional Psychology: Research and Practice1991;22(6):496-502. ">Wollersheim 1991</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>High risk of bias</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#MR000050-bbs2-0048" title="LickJ .Expectancy, false galvanic skin response feedback, and systematic desensitization in the modification of phobic behavior. Journal of Consulting and Clinical Psychology1975;43(4):557-67. ">Lick 1975</a> ; <a href="./references#MR000050-bbs2-0056" title="MitchellC , MansfieldD , RautenbachS .Coloured filters and reading accuracy, comprehension and rate: a placebo-controlled study. Perceptual and Motor Skills2008;106(2):517-32. ">Mitchell 2008</a> ; <a href="./references#MR000050-bbs2-0061" title="MilichR , CarlsonCL , Pelham WE Jr, LichtBG .Effects of methylphenidate on the persistence of ADHD boys following failure experiences. Journal of Abnormal Child Psychology1991;19(5):519-36. PelhamWE , MurphyDA , VannattaK , MilichR , LichtBG , GnagyEM , et al.Methylphenidate and attributions in boys with attention-deficit hyperactivity disorder. Journal of Consulting and Clinical Psychology1992;60(2):282-92. ">Pelham 1992</a> ; <a href="./references#MR000050-bbs2-0069" title="QuayhagenMP , QuayhagenM , CorbeilRR , RothPA , RodgersJA .A dyadic remediation program for care recipients with dementia. Nursing Research1995;44(3):153-9. ">Quayhagen 1995</a> ; <a href="./references#MR000050-bbs2-0073" title="RobinA .Rationing out-patients: a defence of the waiting list. British Journal of Psychiatry1976;129:138-41. ">Robin 1976</a> ; <a href="./references#MR000050-bbs2-0083" title="SteinmarkSW , BorkovecTD .Active and placebo treatment effects on moderate insomnia under counterdemand and positive demand instructions. Journal of Abnormal Psychology1974;83(2):157-63. ">Steinmark 1974</a> ; <a href="./references#MR000050-bbs2-0088" title="Trexler, L.Rational-emotive therapy, placebo, and no-treatment effects on public-speaking anxiety. Doctoral dissertation, Temple University AnnArbor, Mich.: University Microfilms1971;71-31(063). TrexlerLD , KarstTO .Rational-emotive therapy, placebo, and no-treatment effects on public-speaking anxiety. Journal of Abnormal Psyhology1972;79(1):60-7. ">Trexler 1972</a> ; <a href="./references#MR000050-bbs2-0089" title="AscherML , TurnerRM .A comparison of two methods for the administration of paradoxical intention. Behaviour Research and Therapy1980;18(2):121-6. TurnerRM , AscherLM .Controlled comparison of progressive relaxation, stimulus control, and paradoxical intention therapies for insomnia. Journal of Consulting and Clinical Psychology1979;47(3):500-8. ">Turner 1979</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Unclear risk of bias</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#MR000050-bbs2-0045" title="LaiCK , ChiI , Kayser-JonesJ .A randomized controlled trial of a specific reminiscence approach to promote the well-being of nursing home residents with dementia. International Psychogeriatrics2004;16(1):33-49. LaiK .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 6th of September 2019. ">Lai 2004</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><i>Researchers or authors provided the treatment</i> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#MR000050-bbs2-0048" title="LickJ .Expectancy, false galvanic skin response feedback, and systematic desensitization in the modification of phobic behavior. Journal of Consulting and Clinical Psychology1975;43(4):557-67. ">Lick 1975</a> ; <a href="./references#MR000050-bbs2-0083" title="SteinmarkSW , BorkovecTD .Active and placebo treatment effects on moderate insomnia under counterdemand and positive demand instructions. Journal of Abnormal Psychology1974;83(2):157-63. ">Steinmark 1974</a> ; <a href="./references#MR000050-bbs2-0088" title="Trexler, L.Rational-emotive therapy, placebo, and no-treatment effects on public-speaking anxiety. Doctoral dissertation, Temple University AnnArbor, Mich.: University Microfilms1971;71-31(063). TrexlerLD , KarstTO .Rational-emotive therapy, placebo, and no-treatment effects on public-speaking anxiety. Journal of Abnormal Psyhology1972;79(1):60-7. ">Trexler 1972</a> ; <a href="./references#MR000050-bbs2-0089" title="AscherML , TurnerRM .A comparison of two methods for the administration of paradoxical intention. Behaviour Research and Therapy1980;18(2):121-6. TurnerRM , AscherLM .Controlled comparison of progressive relaxation, stimulus control, and paradoxical intention therapies for insomnia. Journal of Consulting and Clinical Psychology1979;47(3):500-8. ">Turner 1979</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><i>Attention bias or differences in duration of treatment</i> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#MR000050-bbs2-0056" title="MitchellC , MansfieldD , RautenbachS .Coloured filters and reading accuracy, comprehension and rate: a placebo-controlled study. Perceptual and Motor Skills2008;106(2):517-32. ">Mitchell 2008</a> ; <a href="./references#MR000050-bbs2-0073" title="RobinA .Rationing out-patients: a defence of the waiting list. British Journal of Psychiatry1976;129:138-41. ">Robin 1976</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><i>Carry‐over effects</i> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#MR000050-bbs2-0061" title="MilichR , CarlsonCL , Pelham WE Jr, LichtBG .Effects of methylphenidate on the persistence of ADHD boys following failure experiences. Journal of Abnormal Child Psychology1991;19(5):519-36. PelhamWE , MurphyDA , VannattaK , MilichR , LichtBG , GnagyEM , et al.Methylphenidate and attributions in boys with attention-deficit hyperactivity disorder. Journal of Consulting and Clinical Psychology1992;60(2):282-92. ">Pelham 1992</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><i>Exceed the passivity of placebo</i> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#MR000050-bbs2-0069" title="QuayhagenMP , QuayhagenM , CorbeilRR , RothPA , RodgersJA .A dyadic remediation program for care recipients with dementia. Nursing Research1995;44(3):153-9. ">Quayhagen 1995</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><i>Time bias or assessment at different point for the groups</i> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#MR000050-bbs2-0073" title="RobinA .Rationing out-patients: a defence of the waiting list. British Journal of Psychiatry1976;129:138-41. ">Robin 1976</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Affiliation bias (allegiance or industry bias)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Low risk of bias</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>90</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#MR000050-bbs2-0002" title="AllenJB .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to A Todorovac 28th of August 2019. AllenJJ , SchnyerRN , HittSK .The efficacy of acupuncture in the treatment of major depression in women. Psychological Science1998;9(5):397-401. ">Allen 1998</a> ; <a href="./references#MR000050-bbs2-0003" title="AllenJB .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 28th of August 2019. AllenJJ , SchnyerRN , ChambersAS , HittSK , MorenoFA , ManberR .Acupuncture for depression: a randomized controlled trial. Journal of Clinical Psychiatry2006;67(11):1665-73. ">Allen 2006</a> ; <a href="./references#MR000050-bbs2-0004" title="AlvarezJR .The effects of anger management training on depression, anger, self-concept, and treatment responsibility in a sample of drug-dependent individuals in a therapeutic community. Dissertation Abstracts International: Section B: the Sciences and Engineering1997;58(4-B):2108. ">Alvarez 1997</a> ; <a href="./references#MR000050-bbs2-0005" title="AscherLM , TurnerR .Paradoxical intention and insomnia: an experimental investigation. Behaviour Research and Therapy1979;17(4):408-11. ">Ascher 1979</a> ; <a href="./references#MR000050-bbs2-0006" title="AyenI , HautzingerM .Cognitive behavior therapy for depression in menopausal women. A controlled, randomized treatment study [Kognitive Verhaltenstherapie bei Depressionen im Klimakterium: Eine kontrollierte, randomiserte Interventionsstudie]. Zeitschrift für Klinische Psychologie und Psychotherapie2004;33(4):290-9. AyenI .Inclusion of study in Cochrane Systematic Review (personal communication). Email to EG Faltinsen 9th of September 2019. ">Ayen 2004</a> ; <a href="./references#MR000050-bbs2-0007" title="BergI , ForsytheI , HoltP , WattsJ .A controlled trial of ‘Senokot’ in faecal soiling treated by behavioural methods. Journal of Child Psychology and Psychiatry1983;24(4):543-9. ">Berg 1983</a> ; <a href="./references#MR000050-bbs2-0008" title="Borden, KA.Attributional Outcomes: the Subtle Messages of Treatments for Attention Deficit Disorder. Dissertation, University of Illinois at Urbana-Champaign1986. BordenKA , BrownRT .Attributional outcomes: The subtle messages of treatments for attention deficit disorder. Cognitive Therapy and Research1989;13(2):147-60. ">Borden 1986</a> ; <a href="./references#MR000050-bbs2-0009" title="BorkovecTD , KaloupekDG , SlamaKM .The facilitative effect of muscle tension-release in the relaxation treatment of sleep disturbance. Behavior Therapy1975;6(3):301-9. ">Borkovec 1975</a> ; <a href="./references#MR000050-bbs2-0010" title="BorkovecTD , WeertsTC .Effects of progressive relaxation on sleep disturbance: an electroencephalographic evaluation. Psychosomatic Medicine1976;38(3):173-80. ">Borkovec 1976</a> ; <a href="./references#MR000050-bbs2-0012" title="BramstonP , SpenceSH .Behavioural versus cognitive social-skills training with intellectually-handicapped adults. Behaviour Research and Therapy1985;23(3):239-46. ">Bramston 1985</a> ; <a href="./references#MR000050-bbs2-0013" title="BrillNQ , KoeglerRR , EpsteinLJ , ForgyEW .Controlled study of psychiatric outpatient treatment. Archives of General Psychiatry1964;10:581-95. BrillNQ .Results of psychotherapy. California Medicine1966;104(4):249-53. ">Brill 1964a</a> ; <a href="./references#MR000050-bbs2-0014" title="BrillNQ , KoeglerRR , EpsteinLJ , ForgyEW .Controlled study of psychiatric outpatient treatment. Archives of General Psychiatry1964;10:581-95. ">Brill 1964b</a> ; <a href="./references#MR000050-bbs2-0015" title="CarlsonCL , PelhamWE , MilichR , HozaB .ADHD boys’ performance and attributions following success and failure: drug effects and individual differences. Cognitive Therapy and Research1993;17:269-87. ">Carlson 1993</a> ; <a href="./references#MR000050-bbs2-0016" title="CarterJC , OlmstedMP , KaplanAS , McCabeRE , MillsJS , AimeA .Self-help for bulimia nervosa: a randomized controlled trial. American Journal of Psychiatry2003;160(5):973-8. ">Carter 2003</a> ; <a href="./references#MR000050-bbs2-0017" title="CrispAH , NortonK , GowersS , HalekC , BowyerC , YeldhamD , et al.A controlled study of the effect of therapies aimed at adolescent and family psychopathology in Anorexia Nervosa. British Journal of Psychiatry: the Journal of Mental Science1991;159:325-33. GowersS , NortonK , HalekC , CrispAH .Outcome of outpatient psychotherapy in a random allocation treatment study of anorexia nervosa. International Journal of Eating Disorders1994;15(2):165-77. GowersS , NortonK , YelshamD .The St George's prospective treatment study of anorexia nervosa: a discussion of methodological problems. International Journal of Eating Disorders1989;8:445-54. ">Crisp 1991</a> ; <a href="./references#MR000050-bbs2-0018" title="CrouchG , RobsonM , HallstromC .Benzodiazepine dependent patients and their psychological treatment. Progress in Neuro-psychopharmacology &amp; Biological Psychiatry1988;12(4):503-10. HallströmC , CrouchG , RobsenM , ShineP .The treatment of tranquillizer dependence by propranolol. Postgraduate Medical Journal1988;64(Suppl 2):40-4. ">Crouch 1988</a> ; <a href="./references#MR000050-bbs2-0019" title="Doty, DW.Role playing and incentives in the modification of the social interaction of chronic psychiatric patients. Journal of Consulting and Clinical Psychology1975;43(5):676-82. ">Doty 1975</a> ; <a href="./references#MR000050-bbs2-0020" title="DoubleDB , WarrenGC , EvansM , RowlandsMP .Efficacy of maintenance use of anticholinergic agents. Acta Psychiatrica Scandinavica1993;88:381-4. ">Double 1993</a> ; <a href="./references#MR000050-bbs2-0022" title="EspieCA , BrooksDN , LindsayWR .An evaluation of tailored psychological treatment of insomnia. Journal of Behavior Therapy and Experimental Psychiatry1989;20(2):143-53. EspieCA , LindsayWR , BrooksDN , HoodEM , TurveyT .A controlled comparative investigation of psychological treatments for chronic sleep-onset insomnia. Behaviour Research and Therapy1989;27(1):79-88. ">Espie 1989a</a> ; <a href="./references#MR000050-bbs2-0023" title="EtringerBD , CashTF , RimmDC .Behavioral, affective, and cognitive effects of participant modeling and an equally credible placebo. Behavior Therapy1982;13(4):476-85. ">Etringer 1982</a> ; <a href="./references#MR000050-bbs2-0026" title="FreireAO , SugaiGC , ChrispinFS , TogeiroSM , YamamuraY , MelloLE , et al.Treatment of moderate obstructive sleep apnea syndrome with acupuncture: a randomised, placebo-controlled pilot trial. Sleep Medicine2007;8(1):43-50. ">Freire 2007</a> ; <a href="./references#MR000050-bbs2-0028" title="GlogowskaM , RoulstoneS , EnderbyP , PetersTJ .Randomised controlled trial of community based speech and language therapy in preschool children. BMJ2000;321(7266):923-6. ">Glogowska 2000</a> ; <a href="./references#MR000050-bbs2-0029" title="GoldsteinAJ , BeursE , Chambless Dl, WilsonKA .EMDR for panic disorder with agoraphobia: comparison with waiting list and credible attention-placebo control conditions. Journal of Consulting and Clinical Psychology2000;68(6):947-56. ">Goldstein 2000</a> ; <a href="./references#MR000050-bbs2-0030" title="GoldwasserAN , AuerbachSM , HarkinsSW .Cognitive, affective, and behavioural effects of reminiscence group therapy on demented elderly. Aging and Human Development1987;25(3):209-22. ">Goldwasser 1987</a> ; <a href="./references#MR000050-bbs2-0031" title="HekmatH , LubitzR , DealR .Semantic desensitization: a paradigmatic intervention approach to anxiety disorders. Journal of Clinical Psychology1984;40(2):463-6. ">Hekmat 1984</a> ; <a href="./references#MR000050-bbs2-0032" title="HippmanC , RingroseA , InglisA , CheekJ , AlbertAY , RemickR , et al.A pilot randomized clinical trial evaluating the impact of genetic counselling for serious mental illnesses. Journal of Clinical Psychiatry2016;77(2):e190-8. ">Hippman 2016</a> ; <a href="./references#MR000050-bbs2-0033" title="HowlinP , GordonKR , PascoG , WadeA , CharmanT .The effectiveness of picture exchange communication system (PECS) training for teachers of children with autism: a pragmatic,group randomised controlled trial. Journal of Child Psychology and Psychiatry2007;48(5):473-81. ">Howlin 2007</a> ; <a href="./references#MR000050-bbs2-0034" title="KarstM , WinterhalterM , MünteS , FranckiB , HondronikosA , EckardtA , et al.Auricular acupuncture for dental anxiety: a randomized controlled trial. Anesthesia and Analgesia2007;104(2):295-300. KarstM .Inclusion of study in Cochrane Systematic Review (personal communication). Email to: EG Faltinsen 5th of September 2019. ">Karst 2007</a> ; <a href="./references#MR000050-bbs2-0035" title="KelleyJ .Inclusion of study in Cochrane Systematic Review (personal communication). Email to: A Todorovac 12th of August 2019. KelleyJM , KaptchukTJ , CusinC , LipkinS , FavaM .Open-label placebo for major depressive disorder: a pilot randomized controlled trial. Psychotherapy and Psychosomatics2012;81(5):312-4. ">Kelley 2012</a> ; <a href="./references#MR000050-bbs2-0036" title="KennedyTD , KimuraHK .Transfer, behavioral improvement, and anxiety reduction in systematic desensitization. Journal of Consulting and Clinical Psychology1974;42(5):720-8. ">Kennedy 1974</a> ; <a href="./references#MR000050-bbs2-0037" title="KilmannPR , MilanRJ , BolandJP , NankinHR , DavidsonE , WestMO , et al.Group treatment of secondary erectile dysfunction. Journal of Sex &amp; Marital Therapy1987;13(3):168-82. KilmannPR , Milan RJ Jr, BolandJP , DavidsonE , WestMO , SablisRF , et al.The sexual interactions of men with secondary erectile dysfunction. Journal of Sex Education and Therapy1988;14(1):46-9. KilmannPR , Milan RJ Jr, BolandJP , NankinHR , SablisRF , WestMO , et al.The sexual interactions of men with secondary erectile dysfunction. Paper presented at the annual meeting of the American Psychological Association in Los Angeles1985;1:46-9. ">Kilmann 1987</a> ; <a href="./references#MR000050-bbs2-0038" title="KleinSA , DeffenbacherJL .Relaxation and exercise for hyperactive impulsive children. Perceptual and Motor Skills1977;45:1159-62. ">Klein 1977</a> ; <a href="./references#MR000050-bbs2-0039" title="KlermanGL , DimascioA , WeismannM , PrusoffB , PaykelES .Treatment of depression by drugs and psychotherapy. American Journal of Psychiatry1974;131(2):186-91. PaykelES , DimascioA , HaskellD , PrusoffBA .Effects of maintenance amitriptyline and psychotherapy on symptoms of depression. Psychological Medicine1975;5(1):67-77. PaykelES , DiMascioA , KlermanGL , PrusoffBA .Maintenance therapy of depression. Pharmakopsychiatrie, Neuro-Psychopharmakologie1976;9:127-39. PaykelES , WeissmanMM , PrusoffBA .Social maladjustment and severity of depression. Comprehensive Psychiatry1978;19(2):121-8. WeissmanMM , KlermanGL , PaykelES , PrusoffB .Treatment effects on the social adjustment of depressed patients. Archives of General Psychiatry1974;30:771-8. ">Klerman 1974a</a> ; <a href="./references#MR000050-bbs2-0040" title="KlermanGL , DimascioA , WeismannM , PrusoffB , PaykelES .Treatment of depression by drugs and psychotherapy. American Journal of Psychiatry1974;131(2):186-91. ">Klerman 1974b</a> ; <a href="./references#MR000050-bbs2-0041" title="KloskoJS , BarlowDH , TassinariR , CernyJA .A comparison of alprazolam and behavior therapy in treatment of panic disorder: correction. Journal of Psychotherapy Practice and Research1994;3(2):163-79. KloskoJS , BarlowDH , TassinariR , CernyJA .A comparison of alprazolam and behavior therapy in treatment of panic disorder. Journal of Consulting and Clinical Psychology1990;58(1):77-84. ">Klosko 1990</a> ; <a href="./references#MR000050-bbs2-0042" title="KrapflJE , NawasMM .Differential ordering of stimulus presentation in systematic desensitization. Journal of Abnormal Psychology1970;75(3):333-7. ">Krapfl 1970</a> ; <a href="./references#MR000050-bbs2-0043" title="KwanR .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 26th of August 2019. KwanRY , LeungMC , LaiCK .Acupressure for agitation in nursing home residents with dementia: study protocol for a randomized controlled trial. Trials2014;15(410):1-7. KwanRY , LeungMCP , LaiCK .A randomized controlled trial examining the effect of acupressure on agitation and salivary cortisol in nursing home residents with dementia. Dementia and Geriatric Cognitive Disorders2017;44(1-2):92-104. ">Kwan 2017</a> ; <a href="./references#MR000050-bbs2-0044" title="LacyMK .The effect of short term autogenic training on the stress reactivity of hospitalized emotionally disturbed adolescents. ProQuest Dissertations Publishing, Oklahoma State University1996. ">Lacy 1990</a> ; <a href="./references#MR000050-bbs2-0045" title="LaiCK , ChiI , Kayser-JonesJ .A randomized controlled trial of a specific reminiscence approach to promote the well-being of nursing home residents with dementia. International Psychogeriatrics2004;16(1):33-49. LaiK .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 6th of September 2019. ">Lai 2004</a> ; <a href="./references#MR000050-bbs2-0046" title="LangOJ , LazovikAD .Experimental desensitization of a phobia. Journal of Abnormal and Social Psychology1963;66:519-25. LangPJ , LazovikAD , ReynoldsDJ .Desensitization, suggestibility, and pseudotherapy. Journal of Abnormal Psychology1965;70(6):395-402. ">Lang 1965</a> ; <a href="./references#MR000050-bbs2-0047" title="LegrandF .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 14th of August 2019. LegrandFD , NeffEM .Efficacy of exercise as an adjunct treatment for clinically depressed inpatients during the initial stages of antidepressant pharmacotherapy: an open randomized controlled trial. Journal of Affective Disorders2016;191:139-44. ">Legrand 2016</a> ; <a href="./references#MR000050-bbs2-0048" title="LickJ .Expectancy, false galvanic skin response feedback, and systematic desensitization in the modification of phobic behavior. Journal of Consulting and Clinical Psychology1975;43(4):557-67. ">Lick 1975</a> ; <a href="./references#MR000050-bbs2-0049" title="LickJR , HefflerD .Relaxation training and attention placebo in the treatment of severe insomnia. Journal of Consulting and Clinical Psychology1977;45(2):153-61. ">Lick 1977</a> ; <a href="./references#MR000050-bbs2-0050" title="LiddleB , SpenceSH .Cognitive-behaviour therapy with depressed primary school children: A cautionary note. Behavioural Psychotherapy1990;18(2):85-102. ">Liddle 1990</a> ; <a href="./references#MR000050-bbs2-0051" title="MatsonJL , MarchettiA , AdkinsJA .Comparison of operant- and independence-training procedures for mentally retarded adults. American Journal of Mental Deficiency1980;84(5):487-94. ">Matson 1980</a> ; <a href="./references#MR000050-bbs2-0052" title="McLachlanDR , DaltonAJ , KruckTP , BellMY , SmithWL , KalowW , et al.Intramuscular desferrioxamine in patients with Alzheimer's disease. Lancet1991;337(8753):1304-8. McLachlanDRC , SmithWL , KruckTP .Desferrioxamine and Alzheimer’s disease: video home behavior assessment of clinical course and measures of brain aluminum. Therapeutic Drug Monitoring1993;15(6):602-7. ">McLachlan 1991</a> ; <a href="./references#MR000050-bbs2-0053" title="MealieaWL , NawasMM .The comparative effectiveness of systematic desensitization and implosive therapy in the treatment of snake phobia. Journal of Behavior Therapy and Experimental Psychiatry1971;2(2):85-94. ">Mealiea 1971</a> ; <a href="./references#MR000050-bbs2-0054" title="MilbyJB , ClarkeC , ToroC , ThorntonS , RickertD .Effectiveness of urine surveillance as an adjunct to outpatient psychotherapy for drug abusers. International Journal of the Addictions1980;15(7):993-1001. ">Milby 1980</a> ; <a href="./references#MR000050-bbs2-0055" title="MirandaA , ArlandisP , SorianoM .Instruction in strategies and attributional training: Effects on the problem-solving and self-concept of students’ with learning disabilities [Instrucción en estrategias y entrenamiento atribucional: efectos sobre la resolución de problemas y el autoconcepto de los estudiantes con dificultades en el aprendizaje]. Infancia y Aprendizaje1997;20(80):37-52. ">Miranda 1997</a> ; <a href="./references#MR000050-bbs2-0056" title="MitchellC , MansfieldD , RautenbachS .Coloured filters and reading accuracy, comprehension and rate: a placebo-controlled study. Perceptual and Motor Skills2008;106(2):517-32. ">Mitchell 2008</a> ; <a href="./references#MR000050-bbs2-0057" title="NandiDN , AjmanyS , GanguliH , BanerjeeG , BoralGC , GhoshA , et al.A clinical evaluation of depressives found in a rural survey in India. British Journal of Psychiatry1976;128:523-7. ">Nandi 1976</a> ; <a href="./references#MR000050-bbs2-0058" title="NicassioP , BootzinR .A comparison of progressive relaxation and autogenic training as treatments for insomnia. Journal of Abnormal Psychology1974;83(3):253-60. ">Nicassio 1974</a> ; <a href="./references#MR000050-bbs2-0059" title="PearlD , Vander KampH , OlsenAL , GreenbergPD , ArmitageSG .The effects of reserpine on schizophrenic patients. American Journal of Psychiatry1956;112:198-204. ">Pearl 1956</a> ; <a href="./references#MR000050-bbs2-0060" title="PeckCL .Desensitization for the treatment of fear in the high level adult retardate. Behaviour Research and Therapy1977;15(2):137-48. ">Peck 1976</a> ; <a href="./references#MR000050-bbs2-0061" title="MilichR , CarlsonCL , Pelham WE Jr, LichtBG .Effects of methylphenidate on the persistence of ADHD boys following failure experiences. Journal of Abnormal Child Psychology1991;19(5):519-36. PelhamWE , MurphyDA , VannattaK , MilichR , LichtBG , GnagyEM , et al.Methylphenidate and attributions in boys with attention-deficit hyperactivity disorder. Journal of Consulting and Clinical Psychology1992;60(2):282-92. ">Pelham 1992</a> ; <a href="./references#MR000050-bbs2-0062" title="PedletonMG , HigginsRL .A comparison of negative practice and systematic desensitization in the treatment of acrophobia. Journal of Behavior Therapy and Experimental Psychiatry1983;14(4):317-23. ">Pendleton 1983</a> ; <a href="./references#MR000050-bbs2-0063" title="PetersonMA , PattersonB , PillmanBM , BattistaMA .Cognitive recovery following alcohol detoxification: a computerised remediation study. Neuropsychological Rehabilitation2002;12(1):63-74. PillmanBM .Computerized cognitive remediation with recently detoxified alcoholics. Dissertation, California School of Professional Psychology, Fresno Campus2000. ">Pillman 2001</a> ; <a href="./references#MR000050-bbs2-0064" title="PolandRE , GertsikL , FavreauJT , SmithSI , MirochaJM , RaoU , et al.Open-label randomized parallel-group controlled clinical trial of massage for treatment of depression in HIV-infected subjects. Journal of Alternative and Complementary Medicine2013;19(4):334-40. ">Poland 2013</a> ; <a href="./references#MR000050-bbs2-0065" title="PowersMB , SmitsJA , TelchMJ .Disentangling the effects of safety-behavior utilization and safety-behavior availability during exposure-based treatment: a placebo-controlled trial. Journal of Consulting and Clinical Psychology2004;72(3):448-54. ">Powers 2004</a> ; <a href="./references#MR000050-bbs2-0066" title="PowersMB , SmithsJA , WhitleyD , BystritskyA , TelchMJ .The effect of attributional processes concerning medication taking on return of fear. Journal of Consulting and Clinical Psychology2008;76(3):478-90. ">Powers 2008a</a> ; <a href="./references#MR000050-bbs2-0067" title="PowersMB , SmithsJA , WhitleyD , BystritskyA , TelchMJ .The effect of attributional processes concerning medication taking on return of fear. Journal of Consulting and Clinical Psychology2008;76(3):478-90. ">Powers 2008b</a> ; <a href="./references#MR000050-bbs2-0068" title="ProudfootJ , ClarkeJ , BirchMR , WhittonAE , ParkerG , ManicavasagarV , et al.Impact of a mobile phone and web program on symptom and functional outcomes for people with mild- to-moderate depression, anxiety and stress: a randomized controlled trial. BMC Psychiatry2013;13(312):1-12. ProudfootJ .Re: Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 26th of August 2019. ">Proudfoot 2013</a> ; <a href="./references#MR000050-bbs2-0069" title="QuayhagenMP , QuayhagenM , CorbeilRR , RothPA , RodgersJA .A dyadic remediation program for care recipients with dementia. Nursing Research1995;44(3):153-9. ">Quayhagen 1995</a> ; <a href="./references#MR000050-bbs2-0070" title="LiebowitzM , QuitkinFM , StewartJW , McGrathPJ , HarrisonWM , MarkowitzJS , et al.Antidepressant efficacy in atypical depression. Archives of General Psychiatry1988;45(2):129-37. QuitkinFM , McGrathPJ , StewartJW , HarrisonW , WagerSG , NunesE , et al.Phenelzine and imipramine in mood reactive depressives: further delineation of the syndrome of atypical depression. Archives of General Psychiatry1989;46(9):787-93. RabkinJG , McGrathPJ , QuitkinFM , TricamoE , StewartJW , KleinDF .Effects of pill-giving on maintenance of placebo response in patients with chronic mild depression. American Journal of Psychiatry1990;147(12):1622-6. ">Rabkin 1990</a> ; <a href="./references#MR000050-bbs2-0071" title="RapeeR .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 29th of August 2019. RapeeRM , AbbottMJ , LynehamHJ .Bibliotherapy for children With anxiety disorders using written materials for parents: a randomized controlled trial. Journal of Consulting and Clinical Psychology2006;74(3):436-44. ">Rapee 2006</a> ; <a href="./references#MR000050-bbs2-0072" title="RapeeR .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 29th of August 2019. RapeeRM , AbbottMJ , BaillieAJ , GastonJE .Treatment of social phobia through pure self-help and therapist-augmented self-help. British Journal of Psychiatry2007;191:246-52. ">Rapee 2007</a> ; <a href="./references#MR000050-bbs2-0073" title="RobinA .Rationing out-patients: a defence of the waiting list. British Journal of Psychiatry1976;129:138-41. ">Robin 1976</a> ; <a href="./references#MR000050-bbs2-0074" title="RoehrichL , GoldmanMS .Experience-dependent neuropsychological recovery and the treatment of alcoholism. Journal of Consulting and Clinical Psychology1993;61(5):812-21. ">Roehrich 1993</a> ; <a href="./references#MR000050-bbs2-0075" title="OlivaresJ .Program IAFS. Protocol for the treatment of social phobia in adolescents [Programa IAFS. Protocolo para el tratamiento de la fobia social enadolescentes]. Madrid: Pirámide2005;1. Rosa-AlcázarAI , Olivares-OlivaresPJ , OlivaresJ .The role of non-specific effects in the psychological treatment of adolescents with social phobia [Papel de los efectos inespecíficos en el tratamiento psicológico de adolescentes con fobia social]. Anuario de Psicologia2009;40(1):43-61. ">Rosa‐Alcatraz 2009</a> ; <a href="./references#MR000050-bbs2-0076" title="RosenGM , GlasgowRE , BarreraM .A controlled study to assess the clinical efficacy of totally self-administrated systematic desensitization. Journal of Consulting and Clinical Psychology1976;44(2):208-17. ">Rosen 1976</a> ; <a href="./references#MR000050-bbs2-0077" title="LorrM , McNairDM , WeinsteinGJ .Early effects of chlordiazepoxide (Librium) used with psychotherapy. Journal of Psychiatric Research1963;1:257-70. RothI , RhudickPJ , ShaskanDA , SlobinMS , WilkinsonAE , YoungHH .Long-term effects on psychotherapy of initial treatment conditions. Journal of Psychiatric Research1964;2:283-97. ">Roth 1964</a> ; <a href="./references#MR000050-bbs2-0078" title="RupertPA , HolmesDS .Effects of multiple sessions of true and placebo heart rate biofeedback training on the heart rates and anxiety levels of anxious patients during and following treatment. Psychophysiology1978;15(6):582-90. ">Rupert 1978</a> ; <a href="./references#MR000050-bbs2-0079" title="ShalevAY , AnkriY , Isreali-ShalevY , PelegT , AdesskyR , FreedmanS .Prevention of posttraumatic stress disorder by early treatment. Archives of General Psychiatry2012;69(2):166-76. ">Shalev 2012</a> ; <a href="./references#MR000050-bbs2-0080" title="ShealyRC .The effectiveness of various treatment techniques on different degrees and durations of sleep-onset insomnia. Behaviour Research and Therapy1979;17(6):541-6. ">Shealy 1979</a> ; <a href="./references#MR000050-bbs2-0081" title="SibilioJP , AndrewG , DartD , MooreKB , StehmanA .Treatment of chronic schizophrenia with promazine hydrochloride. AMA Archives of Neurology and Psychiatry1957;78(4):419-24. ">Sibilio 1957</a> ; <a href="./references#MR000050-bbs2-0082" title="SommernessMD , LuceroRJ , HamlonJS , EricksonJL , MatthewsR .A controlled study of reserpine on chronically disturbed patients. JAMA Archives of Neurology and Psychiatry1955;74(3):316-9. ">Sommerness 1955</a> ; <a href="./references#MR000050-bbs2-0083" title="SteinmarkSW , BorkovecTD .Active and placebo treatment effects on moderate insomnia under counterdemand and positive demand instructions. Journal of Abnormal Psychology1974;83(2):157-63. ">Steinmark 1974</a> ; <a href="./references#MR000050-bbs2-0084" title="SzymanskiJ , O'DonohueW .The potential role of state-dependent learning in cognitive therapy with spider phobics. Journal of Rational-Emotive &amp; Cognitive-Behavior Therapy1995;13(2):131-50. SzymanskiJ .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 20th of August 2019. ">Szymanski 1995</a> ; <a href="./references#MR000050-bbs2-0085" title="TanSY , BruniJ .Cognitive-behavior therapy with adult patients with epilepsy: a controlled outcome study. Epilepsia1986;27(3):225-33. ">Tan 1986</a> ; <a href="./references#MR000050-bbs2-0086" title="TeriL , LogsdonRG , UomotoJ , McCurrySM .Behavioral treatment of depression in dementia patients: a controlled clinical trial. Journals of Gerontology. Series B, Psychological Sciences and Social Sciences1997;52(4):159-66. TeriL .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 26th of August 2019. ">Teri 1997</a> ; <a href="./references#MR000050-bbs2-0087" title="ToriC , WorellL .Reduction of human avoidant behavior. A comparison of counterconditioning, expectancy, and cognitive information approaches. Clinical Psychology1973;41(2):269-78. ">Tori 1973</a> ; <a href="./references#MR000050-bbs2-0088" title="Trexler, L.Rational-emotive therapy, placebo, and no-treatment effects on public-speaking anxiety. Doctoral dissertation, Temple University AnnArbor, Mich.: University Microfilms1971;71-31(063). TrexlerLD , KarstTO .Rational-emotive therapy, placebo, and no-treatment effects on public-speaking anxiety. Journal of Abnormal Psyhology1972;79(1):60-7. ">Trexler 1972</a> ; <a href="./references#MR000050-bbs2-0089" title="AscherML , TurnerRM .A comparison of two methods for the administration of paradoxical intention. Behaviour Research and Therapy1980;18(2):121-6. TurnerRM , AscherLM .Controlled comparison of progressive relaxation, stimulus control, and paradoxical intention therapies for insomnia. Journal of Consulting and Clinical Psychology1979;47(3):500-8. ">Turner 1979</a> ; <a href="./references#MR000050-bbs2-0090" title="VanderplateC .Electromyograph biofeedback Treatment of sleep onset Insomnia: a controlled Investigation. Dissertation, University of Southern Mississippi1978. ">Vanderplate 1983</a> ; <a href="./references#MR000050-bbs2-0091" title="WatzlH , RistF , OlbrichR , CohenR .Placebo injections and surveillance of alcohol intake during inpatient treatment of female alcoholics. Addictive Behaviors1988;13(2):197-200. ">Watzl 1988</a> ; <a href="./references#MR000050-bbs2-0092" title="WeingaertnerAH .Self-administered aversive stimulation with hallucinating hospitalized schizophrenics. Journal of Consulting and Clinical Psychology1971;36(3):422-29. ">Weingaertner 1971</a> ; <a href="./references#MR000050-bbs2-0093" title="WhittakerCB , HoyRM .Withdrawal of perphenazine in chronic schizophrenia. British Journal of Psychiatry1963;109:422-7. ">Whittaker 1963</a> ; <a href="./references#MR000050-bbs2-0094" title="WilsonA , DavidsonWJ , BlanchardR , WhiteJ .Disulfiram implantation. A placebo-controlled trial with two-year follow-up. Journal of Studies on Alcohol1978;39(5):809-19. WilsonA , DavidsonWJ , BlanchardR .Disulfiram implantation: a trial using placebo implants and two types of controls. Journal of Studies on Alcohol1980;41(5):429-36. ">Wilson 1980</a> ; <a href="./references#MR000050-bbs2-0095" title="WolitzkyKB , TelchMJ .Augmenting in vivo exposure with fear antagonistic actions: a preliminary test. Behavior Therapy2009;40(1):57-71. ">Wolitzky 2009</a> ; <a href="./references#MR000050-bbs2-0096" title="WollersheimJP , WilsonGL .Group treatment of unipolar depression: a comparison of coping, supportive, bibliotherapy, and delayed treatment groups. Professional Psychology: Research and Practice1991;22(6):496-502. ">Wollersheim 1991</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>High risk of bias</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#MR000050-bbs2-0001" title="AbikoffH , HechtmanL , KleinRG .Social functioning in children with ADHD treated with long-term methylphenidate and multimodal psychosocial treatment. Journal of the American Academy of Child and Adolescent Psychiatry2004;43(7):820-9. AbikoffH .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to A Todorovac 23rd of August 2019. KleinRG , AbikoffH , HechtmanL , WeissG .Design and rationale of controlled study of long-term methylphenidate and multimodal psychosocial treatment in children with ADHD. Journal of the American Academy of Child and Adolescent Psychiatry2004;43(7):792-801. ">Abikoff 2004</a> ; <a href="./references#MR000050-bbs2-0011" title="BornovalovaM .Inclusion of study in Cochrane Systematic Review (personal communication). Email to A Todorovac. 21st of August 2019. BornovalovaMA .Distress tolerance treatment for inner-city drug users: a preliminary trial. Doctor’s Dissertation, University of Maryland2008. ">Bornovalova 2008</a> ; <a href="./references#MR000050-bbs2-0021" title="EhlersA , HackmannA , GreyN , WildJ , LinessS , AlbertI , et al.A randomized controlled trial of 7-day intensive and standard weekly cognitive therapy for PTSD and emotion-focused supportive therapy. American Journal of Psychiatry2014;171(3):294-304. ">Ehlers 2014</a> ; <a href="./references#MR000050-bbs2-0024" title="FoaEB , RothbaumBO , RiggsDS , MurdockTB .Treatment of posttraumatic stress disorder in rape victims: a comparison between cognitive-behavioral procedures and counselling. Journal of Consulting and Clinical Psychology1991;59(5):715-23. ">Foa 1991</a> ; <a href="./references#MR000050-bbs2-0025" title="FoaEB , McLeanCP , ZangY , RosenfieldD , YadinE , YarvisJS , et al.Effect of prolonged exposure therapy delivered over 2 weeks vs 8 weeks vs present-centered therapy on PTSD symptom severity in military personnel: a randomized clinical trial. JAMA2018;319(4):354-64. ">Foa 2018</a> ; <a href="./references#MR000050-bbs2-0027" title="FuchsCZ , RehnLP .A self-control behavior therapy program for depression. Journal of Consulting and Clinical Psychology1977;45(2):206-15. ">Fuchs 1977</a> </p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 4.</span> <span class="table-title">Risk of bias in included studies</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/full#MR000050-tbl-0007">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="MR000050-tbl-0008"> <div class="table-heading"><span class="table-label">Table 5.</span> <span class="table-title">Effects of methods</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Category</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Study frequency</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Study ID</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Beneficial outcome data</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Dichotomous data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>11</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#MR000050-bbs2-0007" title="BergI , ForsytheI , HoltP , WattsJ .A controlled trial of ‘Senokot’ in faecal soiling treated by behavioural methods. Journal of Child Psychology and Psychiatry1983;24(4):543-9. ">Berg 1983</a> ; <a href="./references#MR000050-bbs2-0020" title="DoubleDB , WarrenGC , EvansM , RowlandsMP .Efficacy of maintenance use of anticholinergic agents. Acta Psychiatrica Scandinavica1993;88:381-4. ">Double 1993</a> ; <a href="./references#MR000050-bbs2-0039" title="KlermanGL , DimascioA , WeismannM , PrusoffB , PaykelES .Treatment of depression by drugs and psychotherapy. American Journal of Psychiatry1974;131(2):186-91. PaykelES , DimascioA , HaskellD , PrusoffBA .Effects of maintenance amitriptyline and psychotherapy on symptoms of depression. Psychological Medicine1975;5(1):67-77. PaykelES , DiMascioA , KlermanGL , PrusoffBA .Maintenance therapy of depression. Pharmakopsychiatrie, Neuro-Psychopharmakologie1976;9:127-39. PaykelES , WeissmanMM , PrusoffBA .Social maladjustment and severity of depression. Comprehensive Psychiatry1978;19(2):121-8. WeissmanMM , KlermanGL , PaykelES , PrusoffB .Treatment effects on the social adjustment of depressed patients. Archives of General Psychiatry1974;30:771-8. ">Klerman 1974a</a> ; <a href="./references#MR000050-bbs2-0040" title="KlermanGL , DimascioA , WeismannM , PrusoffB , PaykelES .Treatment of depression by drugs and psychotherapy. American Journal of Psychiatry1974;131(2):186-91. ">Klerman 1974b</a> ; <a href="./references#MR000050-bbs2-0053" title="MealieaWL , NawasMM .The comparative effectiveness of systematic desensitization and implosive therapy in the treatment of snake phobia. Journal of Behavior Therapy and Experimental Psychiatry1971;2(2):85-94. ">Mealiea 1971</a> ; <a href="./references#MR000050-bbs2-0054" title="MilbyJB , ClarkeC , ToroC , ThorntonS , RickertD .Effectiveness of urine surveillance as an adjunct to outpatient psychotherapy for drug abusers. International Journal of the Addictions1980;15(7):993-1001. ">Milby 1980</a> ; <a href="./references#MR000050-bbs2-0070" title="LiebowitzM , QuitkinFM , StewartJW , McGrathPJ , HarrisonWM , MarkowitzJS , et al.Antidepressant efficacy in atypical depression. Archives of General Psychiatry1988;45(2):129-37. QuitkinFM , McGrathPJ , StewartJW , HarrisonW , WagerSG , NunesE , et al.Phenelzine and imipramine in mood reactive depressives: further delineation of the syndrome of atypical depression. Archives of General Psychiatry1989;46(9):787-93. RabkinJG , McGrathPJ , QuitkinFM , TricamoE , StewartJW , KleinDF .Effects of pill-giving on maintenance of placebo response in patients with chronic mild depression. American Journal of Psychiatry1990;147(12):1622-6. ">Rabkin 1990</a> ; <a href="./references#MR000050-bbs2-0073" title="RobinA .Rationing out-patients: a defence of the waiting list. British Journal of Psychiatry1976;129:138-41. ">Robin 1976</a> ; <a href="./references#MR000050-bbs2-0091" title="WatzlH , RistF , OlbrichR , CohenR .Placebo injections and surveillance of alcohol intake during inpatient treatment of female alcoholics. Addictive Behaviors1988;13(2):197-200. ">Watzl 1988</a> ; <a href="./references#MR000050-bbs2-0093" title="WhittakerCB , HoyRM .Withdrawal of perphenazine in chronic schizophrenia. British Journal of Psychiatry1963;109:422-7. ">Whittaker 1963</a> ; <a href="./references#MR000050-bbs2-0096" title="WollersheimJP , WilsonGL .Group treatment of unipolar depression: a comparison of coping, supportive, bibliotherapy, and delayed treatment groups. Professional Psychology: Research and Practice1991;22(6):496-502. ">Wollersheim 1991</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Continuous data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>71</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#MR000050-bbs2-0001" title="AbikoffH , HechtmanL , KleinRG .Social functioning in children with ADHD treated with long-term methylphenidate and multimodal psychosocial treatment. Journal of the American Academy of Child and Adolescent Psychiatry2004;43(7):820-9. AbikoffH .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to A Todorovac 23rd of August 2019. KleinRG , AbikoffH , HechtmanL , WeissG .Design and rationale of controlled study of long-term methylphenidate and multimodal psychosocial treatment in children with ADHD. Journal of the American Academy of Child and Adolescent Psychiatry2004;43(7):792-801. ">Abikoff 2004</a> ; <a href="./references#MR000050-bbs2-0002" title="AllenJB .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to A Todorovac 28th of August 2019. AllenJJ , SchnyerRN , HittSK .The efficacy of acupuncture in the treatment of major depression in women. Psychological Science1998;9(5):397-401. ">Allen 1998</a> ; <a href="./references#MR000050-bbs2-0003" title="AllenJB .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 28th of August 2019. AllenJJ , SchnyerRN , ChambersAS , HittSK , MorenoFA , ManberR .Acupuncture for depression: a randomized controlled trial. Journal of Clinical Psychiatry2006;67(11):1665-73. ">Allen 2006</a> ; <a href="./references#MR000050-bbs2-0004" title="AlvarezJR .The effects of anger management training on depression, anger, self-concept, and treatment responsibility in a sample of drug-dependent individuals in a therapeutic community. Dissertation Abstracts International: Section B: the Sciences and Engineering1997;58(4-B):2108. ">Alvarez 1997</a> ; <a href="./references#MR000050-bbs2-0005" title="AscherLM , TurnerR .Paradoxical intention and insomnia: an experimental investigation. Behaviour Research and Therapy1979;17(4):408-11. ">Ascher 1979</a> ; <a href="./references#MR000050-bbs2-0006" title="AyenI , HautzingerM .Cognitive behavior therapy for depression in menopausal women. A controlled, randomized treatment study [Kognitive Verhaltenstherapie bei Depressionen im Klimakterium: Eine kontrollierte, randomiserte Interventionsstudie]. Zeitschrift für Klinische Psychologie und Psychotherapie2004;33(4):290-9. AyenI .Inclusion of study in Cochrane Systematic Review (personal communication). Email to EG Faltinsen 9th of September 2019. ">Ayen 2004</a> ; <a href="./references#MR000050-bbs2-0008" title="Borden, KA.Attributional Outcomes: the Subtle Messages of Treatments for Attention Deficit Disorder. Dissertation, University of Illinois at Urbana-Champaign1986. BordenKA , BrownRT .Attributional outcomes: The subtle messages of treatments for attention deficit disorder. Cognitive Therapy and Research1989;13(2):147-60. ">Borden 1986</a> ; <a href="./references#MR000050-bbs2-0009" title="BorkovecTD , KaloupekDG , SlamaKM .The facilitative effect of muscle tension-release in the relaxation treatment of sleep disturbance. Behavior Therapy1975;6(3):301-9. ">Borkovec 1975</a> ; <a href="./references#MR000050-bbs2-0010" title="BorkovecTD , WeertsTC .Effects of progressive relaxation on sleep disturbance: an electroencephalographic evaluation. Psychosomatic Medicine1976;38(3):173-80. ">Borkovec 1976</a> ; <a href="./references#MR000050-bbs2-0011" title="BornovalovaM .Inclusion of study in Cochrane Systematic Review (personal communication). Email to A Todorovac. 21st of August 2019. BornovalovaMA .Distress tolerance treatment for inner-city drug users: a preliminary trial. Doctor’s Dissertation, University of Maryland2008. ">Bornovalova 2008</a> ; <a href="./references#MR000050-bbs2-0012" title="BramstonP , SpenceSH .Behavioural versus cognitive social-skills training with intellectually-handicapped adults. Behaviour Research and Therapy1985;23(3):239-46. ">Bramston 1985</a> ; <a href="./references#MR000050-bbs2-0015" title="CarlsonCL , PelhamWE , MilichR , HozaB .ADHD boys’ performance and attributions following success and failure: drug effects and individual differences. Cognitive Therapy and Research1993;17:269-87. ">Carlson 1993</a> ; <a href="./references#MR000050-bbs2-0016" title="CarterJC , OlmstedMP , KaplanAS , McCabeRE , MillsJS , AimeA .Self-help for bulimia nervosa: a randomized controlled trial. American Journal of Psychiatry2003;160(5):973-8. ">Carter 2003</a> ; <a href="./references#MR000050-bbs2-0017" title="CrispAH , NortonK , GowersS , HalekC , BowyerC , YeldhamD , et al.A controlled study of the effect of therapies aimed at adolescent and family psychopathology in Anorexia Nervosa. British Journal of Psychiatry: the Journal of Mental Science1991;159:325-33. GowersS , NortonK , HalekC , CrispAH .Outcome of outpatient psychotherapy in a random allocation treatment study of anorexia nervosa. International Journal of Eating Disorders1994;15(2):165-77. GowersS , NortonK , YelshamD .The St George's prospective treatment study of anorexia nervosa: a discussion of methodological problems. International Journal of Eating Disorders1989;8:445-54. ">Crisp 1991</a> ; <a href="./references#MR000050-bbs2-0021" title="EhlersA , HackmannA , GreyN , WildJ , LinessS , AlbertI , et al.A randomized controlled trial of 7-day intensive and standard weekly cognitive therapy for PTSD and emotion-focused supportive therapy. American Journal of Psychiatry2014;171(3):294-304. ">Ehlers 2014</a> ; <a href="./references#MR000050-bbs2-0022" title="EspieCA , BrooksDN , LindsayWR .An evaluation of tailored psychological treatment of insomnia. Journal of Behavior Therapy and Experimental Psychiatry1989;20(2):143-53. EspieCA , LindsayWR , BrooksDN , HoodEM , TurveyT .A controlled comparative investigation of psychological treatments for chronic sleep-onset insomnia. Behaviour Research and Therapy1989;27(1):79-88. ">Espie 1989a</a> ; <a href="./references#MR000050-bbs2-0023" title="EtringerBD , CashTF , RimmDC .Behavioral, affective, and cognitive effects of participant modeling and an equally credible placebo. Behavior Therapy1982;13(4):476-85. ">Etringer 1982</a> ; <a href="./references#MR000050-bbs2-0024" title="FoaEB , RothbaumBO , RiggsDS , MurdockTB .Treatment of posttraumatic stress disorder in rape victims: a comparison between cognitive-behavioral procedures and counselling. Journal of Consulting and Clinical Psychology1991;59(5):715-23. ">Foa 1991</a> ; <a href="./references#MR000050-bbs2-0025" title="FoaEB , McLeanCP , ZangY , RosenfieldD , YadinE , YarvisJS , et al.Effect of prolonged exposure therapy delivered over 2 weeks vs 8 weeks vs present-centered therapy on PTSD symptom severity in military personnel: a randomized clinical trial. JAMA2018;319(4):354-64. ">Foa 2018</a> ; <a href="./references#MR000050-bbs2-0026" title="FreireAO , SugaiGC , ChrispinFS , TogeiroSM , YamamuraY , MelloLE , et al.Treatment of moderate obstructive sleep apnea syndrome with acupuncture: a randomised, placebo-controlled pilot trial. Sleep Medicine2007;8(1):43-50. ">Freire 2007</a> ; <a href="./references#MR000050-bbs2-0027" title="FuchsCZ , RehnLP .A self-control behavior therapy program for depression. Journal of Consulting and Clinical Psychology1977;45(2):206-15. ">Fuchs 1977</a> ; <a href="./references#MR000050-bbs2-0028" title="GlogowskaM , RoulstoneS , EnderbyP , PetersTJ .Randomised controlled trial of community based speech and language therapy in preschool children. BMJ2000;321(7266):923-6. ">Glogowska 2000</a> ; <a href="./references#MR000050-bbs2-0029" title="GoldsteinAJ , BeursE , Chambless Dl, WilsonKA .EMDR for panic disorder with agoraphobia: comparison with waiting list and credible attention-placebo control conditions. Journal of Consulting and Clinical Psychology2000;68(6):947-56. ">Goldstein 2000</a> ; <a href="./references#MR000050-bbs2-0032" title="HippmanC , RingroseA , InglisA , CheekJ , AlbertAY , RemickR , et al.A pilot randomized clinical trial evaluating the impact of genetic counselling for serious mental illnesses. Journal of Clinical Psychiatry2016;77(2):e190-8. ">Hippman 2016</a> ; <a href="./references#MR000050-bbs2-0034" title="KarstM , WinterhalterM , MünteS , FranckiB , HondronikosA , EckardtA , et al.Auricular acupuncture for dental anxiety: a randomized controlled trial. Anesthesia and Analgesia2007;104(2):295-300. KarstM .Inclusion of study in Cochrane Systematic Review (personal communication). Email to: EG Faltinsen 5th of September 2019. ">Karst 2007</a> ; <a href="./references#MR000050-bbs2-0035" title="KelleyJ .Inclusion of study in Cochrane Systematic Review (personal communication). Email to: A Todorovac 12th of August 2019. KelleyJM , KaptchukTJ , CusinC , LipkinS , FavaM .Open-label placebo for major depressive disorder: a pilot randomized controlled trial. Psychotherapy and Psychosomatics2012;81(5):312-4. ">Kelley 2012</a> ; <a href="./references#MR000050-bbs2-0036" title="KennedyTD , KimuraHK .Transfer, behavioral improvement, and anxiety reduction in systematic desensitization. Journal of Consulting and Clinical Psychology1974;42(5):720-8. ">Kennedy 1974</a> ; <a href="./references#MR000050-bbs2-0037" title="KilmannPR , MilanRJ , BolandJP , NankinHR , DavidsonE , WestMO , et al.Group treatment of secondary erectile dysfunction. Journal of Sex &amp; Marital Therapy1987;13(3):168-82. KilmannPR , Milan RJ Jr, BolandJP , DavidsonE , WestMO , SablisRF , et al.The sexual interactions of men with secondary erectile dysfunction. Journal of Sex Education and Therapy1988;14(1):46-9. KilmannPR , Milan RJ Jr, BolandJP , NankinHR , SablisRF , WestMO , et al.The sexual interactions of men with secondary erectile dysfunction. Paper presented at the annual meeting of the American Psychological Association in Los Angeles1985;1:46-9. ">Kilmann 1987</a> ; <a href="./references#MR000050-bbs2-0038" title="KleinSA , DeffenbacherJL .Relaxation and exercise for hyperactive impulsive children. Perceptual and Motor Skills1977;45:1159-62. ">Klein 1977</a> ; <a href="./references#MR000050-bbs2-0041" title="KloskoJS , BarlowDH , TassinariR , CernyJA .A comparison of alprazolam and behavior therapy in treatment of panic disorder: correction. Journal of Psychotherapy Practice and Research1994;3(2):163-79. KloskoJS , BarlowDH , TassinariR , CernyJA .A comparison of alprazolam and behavior therapy in treatment of panic disorder. Journal of Consulting and Clinical Psychology1990;58(1):77-84. ">Klosko 1990</a> ; <a href="./references#MR000050-bbs2-0042" title="KrapflJE , NawasMM .Differential ordering of stimulus presentation in systematic desensitization. Journal of Abnormal Psychology1970;75(3):333-7. ">Krapfl 1970</a> ; <a href="./references#MR000050-bbs2-0043" title="KwanR .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 26th of August 2019. KwanRY , LeungMC , LaiCK .Acupressure for agitation in nursing home residents with dementia: study protocol for a randomized controlled trial. Trials2014;15(410):1-7. KwanRY , LeungMCP , LaiCK .A randomized controlled trial examining the effect of acupressure on agitation and salivary cortisol in nursing home residents with dementia. Dementia and Geriatric Cognitive Disorders2017;44(1-2):92-104. ">Kwan 2017</a> ; <a href="./references#MR000050-bbs2-0044" title="LacyMK .The effect of short term autogenic training on the stress reactivity of hospitalized emotionally disturbed adolescents. ProQuest Dissertations Publishing, Oklahoma State University1996. ">Lacy 1990</a> ; <a href="./references#MR000050-bbs2-0045" title="LaiCK , ChiI , Kayser-JonesJ .A randomized controlled trial of a specific reminiscence approach to promote the well-being of nursing home residents with dementia. International Psychogeriatrics2004;16(1):33-49. LaiK .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 6th of September 2019. ">Lai 2004</a> ; <a href="./references#MR000050-bbs2-0047" title="LegrandF .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 14th of August 2019. LegrandFD , NeffEM .Efficacy of exercise as an adjunct treatment for clinically depressed inpatients during the initial stages of antidepressant pharmacotherapy: an open randomized controlled trial. Journal of Affective Disorders2016;191:139-44. ">Legrand 2016</a> ; <a href="./references#MR000050-bbs2-0048" title="LickJ .Expectancy, false galvanic skin response feedback, and systematic desensitization in the modification of phobic behavior. Journal of Consulting and Clinical Psychology1975;43(4):557-67. ">Lick 1975</a> ; <a href="./references#MR000050-bbs2-0049" title="LickJR , HefflerD .Relaxation training and attention placebo in the treatment of severe insomnia. Journal of Consulting and Clinical Psychology1977;45(2):153-61. ">Lick 1977</a> ; <a href="./references#MR000050-bbs2-0050" title="LiddleB , SpenceSH .Cognitive-behaviour therapy with depressed primary school children: A cautionary note. Behavioural Psychotherapy1990;18(2):85-102. ">Liddle 1990</a> ; <a href="./references#MR000050-bbs2-0051" title="MatsonJL , MarchettiA , AdkinsJA .Comparison of operant- and independence-training procedures for mentally retarded adults. American Journal of Mental Deficiency1980;84(5):487-94. ">Matson 1980</a> ; <a href="./references#MR000050-bbs2-0052" title="McLachlanDR , DaltonAJ , KruckTP , BellMY , SmithWL , KalowW , et al.Intramuscular desferrioxamine in patients with Alzheimer's disease. Lancet1991;337(8753):1304-8. McLachlanDRC , SmithWL , KruckTP .Desferrioxamine and Alzheimer’s disease: video home behavior assessment of clinical course and measures of brain aluminum. Therapeutic Drug Monitoring1993;15(6):602-7. ">McLachlan 1991</a> ; <a href="./references#MR000050-bbs2-0055" title="MirandaA , ArlandisP , SorianoM .Instruction in strategies and attributional training: Effects on the problem-solving and self-concept of students’ with learning disabilities [Instrucción en estrategias y entrenamiento atribucional: efectos sobre la resolución de problemas y el autoconcepto de los estudiantes con dificultades en el aprendizaje]. Infancia y Aprendizaje1997;20(80):37-52. ">Miranda 1997</a> ; <a href="./references#MR000050-bbs2-0056" title="MitchellC , MansfieldD , RautenbachS .Coloured filters and reading accuracy, comprehension and rate: a placebo-controlled study. Perceptual and Motor Skills2008;106(2):517-32. ">Mitchell 2008</a> ; <a href="./references#MR000050-bbs2-0057" title="NandiDN , AjmanyS , GanguliH , BanerjeeG , BoralGC , GhoshA , et al.A clinical evaluation of depressives found in a rural survey in India. British Journal of Psychiatry1976;128:523-7. ">Nandi 1976</a> ; <a href="./references#MR000050-bbs2-0058" title="NicassioP , BootzinR .A comparison of progressive relaxation and autogenic training as treatments for insomnia. Journal of Abnormal Psychology1974;83(3):253-60. ">Nicassio 1974</a> ; <a href="./references#MR000050-bbs2-0060" title="PeckCL .Desensitization for the treatment of fear in the high level adult retardate. Behaviour Research and Therapy1977;15(2):137-48. ">Peck 1976</a> ; <a href="./references#MR000050-bbs2-0061" title="MilichR , CarlsonCL , Pelham WE Jr, LichtBG .Effects of methylphenidate on the persistence of ADHD boys following failure experiences. Journal of Abnormal Child Psychology1991;19(5):519-36. PelhamWE , MurphyDA , VannattaK , MilichR , LichtBG , GnagyEM , et al.Methylphenidate and attributions in boys with attention-deficit hyperactivity disorder. Journal of Consulting and Clinical Psychology1992;60(2):282-92. ">Pelham 1992</a> ; <a href="./references#MR000050-bbs2-0062" title="PedletonMG , HigginsRL .A comparison of negative practice and systematic desensitization in the treatment of acrophobia. Journal of Behavior Therapy and Experimental Psychiatry1983;14(4):317-23. ">Pendleton 1983</a> ; <a href="./references#MR000050-bbs2-0063" title="PetersonMA , PattersonB , PillmanBM , BattistaMA .Cognitive recovery following alcohol detoxification: a computerised remediation study. Neuropsychological Rehabilitation2002;12(1):63-74. PillmanBM .Computerized cognitive remediation with recently detoxified alcoholics. Dissertation, California School of Professional Psychology, Fresno Campus2000. ">Pillman 2001</a> ; <a href="./references#MR000050-bbs2-0064" title="PolandRE , GertsikL , FavreauJT , SmithSI , MirochaJM , RaoU , et al.Open-label randomized parallel-group controlled clinical trial of massage for treatment of depression in HIV-infected subjects. Journal of Alternative and Complementary Medicine2013;19(4):334-40. ">Poland 2013</a> ; <a href="./references#MR000050-bbs2-0065" title="PowersMB , SmitsJA , TelchMJ .Disentangling the effects of safety-behavior utilization and safety-behavior availability during exposure-based treatment: a placebo-controlled trial. Journal of Consulting and Clinical Psychology2004;72(3):448-54. ">Powers 2004</a> ; <a href="./references#MR000050-bbs2-0066" title="PowersMB , SmithsJA , WhitleyD , BystritskyA , TelchMJ .The effect of attributional processes concerning medication taking on return of fear. Journal of Consulting and Clinical Psychology2008;76(3):478-90. ">Powers 2008a</a> ; <a href="./references#MR000050-bbs2-0067" title="PowersMB , SmithsJA , WhitleyD , BystritskyA , TelchMJ .The effect of attributional processes concerning medication taking on return of fear. Journal of Consulting and Clinical Psychology2008;76(3):478-90. ">Powers 2008b</a> ; <a href="./references#MR000050-bbs2-0068" title="ProudfootJ , ClarkeJ , BirchMR , WhittonAE , ParkerG , ManicavasagarV , et al.Impact of a mobile phone and web program on symptom and functional outcomes for people with mild- to-moderate depression, anxiety and stress: a randomized controlled trial. BMC Psychiatry2013;13(312):1-12. ProudfootJ .Re: Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 26th of August 2019. ">Proudfoot 2013</a> ; <a href="./references#MR000050-bbs2-0069" title="QuayhagenMP , QuayhagenM , CorbeilRR , RothPA , RodgersJA .A dyadic remediation program for care recipients with dementia. Nursing Research1995;44(3):153-9. ">Quayhagen 1995</a> ; <a href="./references#MR000050-bbs2-0071" title="RapeeR .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 29th of August 2019. RapeeRM , AbbottMJ , LynehamHJ .Bibliotherapy for children With anxiety disorders using written materials for parents: a randomized controlled trial. Journal of Consulting and Clinical Psychology2006;74(3):436-44. ">Rapee 2006</a> ; <a href="./references#MR000050-bbs2-0072" title="RapeeR .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 29th of August 2019. RapeeRM , AbbottMJ , BaillieAJ , GastonJE .Treatment of social phobia through pure self-help and therapist-augmented self-help. British Journal of Psychiatry2007;191:246-52. ">Rapee 2007</a> ; <a href="./references#MR000050-bbs2-0074" title="RoehrichL , GoldmanMS .Experience-dependent neuropsychological recovery and the treatment of alcoholism. Journal of Consulting and Clinical Psychology1993;61(5):812-21. ">Roehrich 1993</a> ; <a href="./references#MR000050-bbs2-0075" title="OlivaresJ .Program IAFS. Protocol for the treatment of social phobia in adolescents [Programa IAFS. Protocolo para el tratamiento de la fobia social enadolescentes]. Madrid: Pirámide2005;1. Rosa-AlcázarAI , Olivares-OlivaresPJ , OlivaresJ .The role of non-specific effects in the psychological treatment of adolescents with social phobia [Papel de los efectos inespecíficos en el tratamiento psicológico de adolescentes con fobia social]. Anuario de Psicologia2009;40(1):43-61. ">Rosa‐Alcatraz 2009</a> ; <a href="./references#MR000050-bbs2-0076" title="RosenGM , GlasgowRE , BarreraM .A controlled study to assess the clinical efficacy of totally self-administrated systematic desensitization. Journal of Consulting and Clinical Psychology1976;44(2):208-17. ">Rosen 1976</a> ; <a href="./references#MR000050-bbs2-0079" title="ShalevAY , AnkriY , Isreali-ShalevY , PelegT , AdesskyR , FreedmanS .Prevention of posttraumatic stress disorder by early treatment. Archives of General Psychiatry2012;69(2):166-76. ">Shalev 2012</a> ; <a href="./references#MR000050-bbs2-0080" title="ShealyRC .The effectiveness of various treatment techniques on different degrees and durations of sleep-onset insomnia. Behaviour Research and Therapy1979;17(6):541-6. ">Shealy 1979</a> ; <a href="./references#MR000050-bbs2-0083" title="SteinmarkSW , BorkovecTD .Active and placebo treatment effects on moderate insomnia under counterdemand and positive demand instructions. Journal of Abnormal Psychology1974;83(2):157-63. ">Steinmark 1974</a> ; <a href="./references#MR000050-bbs2-0084" title="SzymanskiJ , O'DonohueW .The potential role of state-dependent learning in cognitive therapy with spider phobics. Journal of Rational-Emotive &amp; Cognitive-Behavior Therapy1995;13(2):131-50. SzymanskiJ .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 20th of August 2019. ">Szymanski 1995</a> ; <a href="./references#MR000050-bbs2-0085" title="TanSY , BruniJ .Cognitive-behavior therapy with adult patients with epilepsy: a controlled outcome study. Epilepsia1986;27(3):225-33. ">Tan 1986</a> ; <a href="./references#MR000050-bbs2-0086" title="TeriL , LogsdonRG , UomotoJ , McCurrySM .Behavioral treatment of depression in dementia patients: a controlled clinical trial. Journals of Gerontology. Series B, Psychological Sciences and Social Sciences1997;52(4):159-66. TeriL .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 26th of August 2019. ">Teri 1997</a> ; <a href="./references#MR000050-bbs2-0087" title="ToriC , WorellL .Reduction of human avoidant behavior. A comparison of counterconditioning, expectancy, and cognitive information approaches. Clinical Psychology1973;41(2):269-78. ">Tori 1973</a> ; <a href="./references#MR000050-bbs2-0089" title="AscherML , TurnerRM .A comparison of two methods for the administration of paradoxical intention. Behaviour Research and Therapy1980;18(2):121-6. TurnerRM , AscherLM .Controlled comparison of progressive relaxation, stimulus control, and paradoxical intention therapies for insomnia. Journal of Consulting and Clinical Psychology1979;47(3):500-8. ">Turner 1979</a> ; <a href="./references#MR000050-bbs2-0090" title="VanderplateC .Electromyograph biofeedback Treatment of sleep onset Insomnia: a controlled Investigation. Dissertation, University of Southern Mississippi1978. ">Vanderplate 1983</a> ; <a href="./references#MR000050-bbs2-0092" title="WeingaertnerAH .Self-administered aversive stimulation with hallucinating hospitalized schizophrenics. Journal of Consulting and Clinical Psychology1971;36(3):422-29. ">Weingaertner 1971</a> ; <a href="./references#MR000050-bbs2-0094" title="WilsonA , DavidsonWJ , BlanchardR , WhiteJ .Disulfiram implantation. A placebo-controlled trial with two-year follow-up. Journal of Studies on Alcohol1978;39(5):809-19. WilsonA , DavidsonWJ , BlanchardR .Disulfiram implantation: a trial using placebo implants and two types of controls. Journal of Studies on Alcohol1980;41(5):429-36. ">Wilson 1980</a> ; <a href="./references#MR000050-bbs2-0095" title="WolitzkyKB , TelchMJ .Augmenting in vivo exposure with fear antagonistic actions: a preliminary test. Behavior Therapy2009;40(1):57-71. ">Wolitzky 2009</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Did not report usable data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>14(13)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#MR000050-bbs2-0013" title="BrillNQ , KoeglerRR , EpsteinLJ , ForgyEW .Controlled study of psychiatric outpatient treatment. Archives of General Psychiatry1964;10:581-95. BrillNQ .Results of psychotherapy. California Medicine1966;104(4):249-53. ">Brill 1964a</a> ; <a href="./references#MR000050-bbs2-0014" title="BrillNQ , KoeglerRR , EpsteinLJ , ForgyEW .Controlled study of psychiatric outpatient treatment. Archives of General Psychiatry1964;10:581-95. ">Brill 1964b</a> ; <a href="./references#MR000050-bbs2-0018" title="CrouchG , RobsonM , HallstromC .Benzodiazepine dependent patients and their psychological treatment. Progress in Neuro-psychopharmacology &amp; Biological Psychiatry1988;12(4):503-10. HallströmC , CrouchG , RobsenM , ShineP .The treatment of tranquillizer dependence by propranolol. Postgraduate Medical Journal1988;64(Suppl 2):40-4. ">Crouch 1988</a> ; <a href="./references#MR000050-bbs2-0019" title="Doty, DW.Role playing and incentives in the modification of the social interaction of chronic psychiatric patients. Journal of Consulting and Clinical Psychology1975;43(5):676-82. ">Doty 1975</a> ; <a href="./references#MR000050-bbs2-0030" title="GoldwasserAN , AuerbachSM , HarkinsSW .Cognitive, affective, and behavioural effects of reminiscence group therapy on demented elderly. Aging and Human Development1987;25(3):209-22. ">Goldwasser 1987</a> ; <a href="./references#MR000050-bbs2-0031" title="HekmatH , LubitzR , DealR .Semantic desensitization: a paradigmatic intervention approach to anxiety disorders. Journal of Clinical Psychology1984;40(2):463-6. ">Hekmat 1984</a> ; <a href="./references#MR000050-bbs2-0046" title="LangOJ , LazovikAD .Experimental desensitization of a phobia. Journal of Abnormal and Social Psychology1963;66:519-25. LangPJ , LazovikAD , ReynoldsDJ .Desensitization, suggestibility, and pseudotherapy. Journal of Abnormal Psychology1965;70(6):395-402. ">Lang 1965</a> ; <a href="./references#MR000050-bbs2-0059" title="PearlD , Vander KampH , OlsenAL , GreenbergPD , ArmitageSG .The effects of reserpine on schizophrenic patients. American Journal of Psychiatry1956;112:198-204. ">Pearl 1956</a> ; <a href="./references#MR000050-bbs2-0077" title="LorrM , McNairDM , WeinsteinGJ .Early effects of chlordiazepoxide (Librium) used with psychotherapy. Journal of Psychiatric Research1963;1:257-70. RothI , RhudickPJ , ShaskanDA , SlobinMS , WilkinsonAE , YoungHH .Long-term effects on psychotherapy of initial treatment conditions. Journal of Psychiatric Research1964;2:283-97. ">Roth 1964</a> ; <a href="./references#MR000050-bbs2-0078" title="RupertPA , HolmesDS .Effects of multiple sessions of true and placebo heart rate biofeedback training on the heart rates and anxiety levels of anxious patients during and following treatment. Psychophysiology1978;15(6):582-90. ">Rupert 1978</a> ; <a href="./references#MR000050-bbs2-0081" title="SibilioJP , AndrewG , DartD , MooreKB , StehmanA .Treatment of chronic schizophrenia with promazine hydrochloride. AMA Archives of Neurology and Psychiatry1957;78(4):419-24. ">Sibilio 1957</a> ; <a href="./references#MR000050-bbs2-0082" title="SommernessMD , LuceroRJ , HamlonJS , EricksonJL , MatthewsR .A controlled study of reserpine on chronically disturbed patients. JAMA Archives of Neurology and Psychiatry1955;74(3):316-9. ">Sommerness 1955</a> ; <a href="./references#MR000050-bbs2-0088" title="Trexler, L.Rational-emotive therapy, placebo, and no-treatment effects on public-speaking anxiety. Doctoral dissertation, Temple University AnnArbor, Mich.: University Microfilms1971;71-31(063). TrexlerLD , KarstTO .Rational-emotive therapy, placebo, and no-treatment effects on public-speaking anxiety. Journal of Abnormal Psyhology1972;79(1):60-7. ">Trexler 1972</a> ; <a href="./references#MR000050-bbs2-0051" title="MatsonJL , MarchettiA , AdkinsJA .Comparison of operant- and independence-training procedures for mentally retarded adults. American Journal of Mental Deficiency1980;84(5):487-94. ">Matson 1980</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Efficacy of all placebos</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Reported dichotomous data on a outcome for efficacy of placebo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#MR000050-bbs2-0007" title="BergI , ForsytheI , HoltP , WattsJ .A controlled trial of ‘Senokot’ in faecal soiling treated by behavioural methods. Journal of Child Psychology and Psychiatry1983;24(4):543-9. ">Berg 1983</a> ; <a href="./references#MR000050-bbs2-0020" title="DoubleDB , WarrenGC , EvansM , RowlandsMP .Efficacy of maintenance use of anticholinergic agents. Acta Psychiatrica Scandinavica1993;88:381-4. ">Double 1993</a> ; <a href="./references#MR000050-bbs2-0039" title="KlermanGL , DimascioA , WeismannM , PrusoffB , PaykelES .Treatment of depression by drugs and psychotherapy. American Journal of Psychiatry1974;131(2):186-91. PaykelES , DimascioA , HaskellD , PrusoffBA .Effects of maintenance amitriptyline and psychotherapy on symptoms of depression. Psychological Medicine1975;5(1):67-77. PaykelES , DiMascioA , KlermanGL , PrusoffBA .Maintenance therapy of depression. Pharmakopsychiatrie, Neuro-Psychopharmakologie1976;9:127-39. PaykelES , WeissmanMM , PrusoffBA .Social maladjustment and severity of depression. Comprehensive Psychiatry1978;19(2):121-8. WeissmanMM , KlermanGL , PaykelES , PrusoffB .Treatment effects on the social adjustment of depressed patients. Archives of General Psychiatry1974;30:771-8. ">Klerman 1974a</a> ; <a href="./references#MR000050-bbs2-0040" title="KlermanGL , DimascioA , WeismannM , PrusoffB , PaykelES .Treatment of depression by drugs and psychotherapy. American Journal of Psychiatry1974;131(2):186-91. ">Klerman 1974b</a> ; <a href="./references#MR000050-bbs2-0053" title="MealieaWL , NawasMM .The comparative effectiveness of systematic desensitization and implosive therapy in the treatment of snake phobia. Journal of Behavior Therapy and Experimental Psychiatry1971;2(2):85-94. ">Mealiea 1971</a> ; <a href="./references#MR000050-bbs2-0070" title="LiebowitzM , QuitkinFM , StewartJW , McGrathPJ , HarrisonWM , MarkowitzJS , et al.Antidepressant efficacy in atypical depression. Archives of General Psychiatry1988;45(2):129-37. QuitkinFM , McGrathPJ , StewartJW , HarrisonW , WagerSG , NunesE , et al.Phenelzine and imipramine in mood reactive depressives: further delineation of the syndrome of atypical depression. Archives of General Psychiatry1989;46(9):787-93. RabkinJG , McGrathPJ , QuitkinFM , TricamoE , StewartJW , KleinDF .Effects of pill-giving on maintenance of placebo response in patients with chronic mild depression. American Journal of Psychiatry1990;147(12):1622-6. ">Rabkin 1990</a> ; <a href="./references#MR000050-bbs2-0091" title="WatzlH , RistF , OlbrichR , CohenR .Placebo injections and surveillance of alcohol intake during inpatient treatment of female alcoholics. Addictive Behaviors1988;13(2):197-200. ">Watzl 1988</a> ; <a href="./references#MR000050-bbs2-0093" title="WhittakerCB , HoyRM .Withdrawal of perphenazine in chronic schizophrenia. British Journal of Psychiatry1963;109:422-7. ">Whittaker 1963</a> ; <a href="./references#MR000050-bbs2-0094" title="WilsonA , DavidsonWJ , BlanchardR , WhiteJ .Disulfiram implantation. A placebo-controlled trial with two-year follow-up. Journal of Studies on Alcohol1978;39(5):809-19. WilsonA , DavidsonWJ , BlanchardR .Disulfiram implantation: a trial using placebo implants and two types of controls. Journal of Studies on Alcohol1980;41(5):429-36. ">Wilson 1980</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Reported continuous data on a outcome for efficacy of placebo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>65</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#MR000050-bbs2-0001" title="AbikoffH , HechtmanL , KleinRG .Social functioning in children with ADHD treated with long-term methylphenidate and multimodal psychosocial treatment. Journal of the American Academy of Child and Adolescent Psychiatry2004;43(7):820-9. AbikoffH .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to A Todorovac 23rd of August 2019. KleinRG , AbikoffH , HechtmanL , WeissG .Design and rationale of controlled study of long-term methylphenidate and multimodal psychosocial treatment in children with ADHD. Journal of the American Academy of Child and Adolescent Psychiatry2004;43(7):792-801. ">Abikoff 2004</a> ; <a href="./references#MR000050-bbs2-0002" title="AllenJB .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to A Todorovac 28th of August 2019. AllenJJ , SchnyerRN , HittSK .The efficacy of acupuncture in the treatment of major depression in women. Psychological Science1998;9(5):397-401. ">Allen 1998</a> ; <a href="./references#MR000050-bbs2-0003" title="AllenJB .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 28th of August 2019. AllenJJ , SchnyerRN , ChambersAS , HittSK , MorenoFA , ManberR .Acupuncture for depression: a randomized controlled trial. Journal of Clinical Psychiatry2006;67(11):1665-73. ">Allen 2006</a> ; <a href="./references#MR000050-bbs2-0004" title="AlvarezJR .The effects of anger management training on depression, anger, self-concept, and treatment responsibility in a sample of drug-dependent individuals in a therapeutic community. Dissertation Abstracts International: Section B: the Sciences and Engineering1997;58(4-B):2108. ">Alvarez 1997</a> ; <a href="./references#MR000050-bbs2-0005" title="AscherLM , TurnerR .Paradoxical intention and insomnia: an experimental investigation. Behaviour Research and Therapy1979;17(4):408-11. ">Ascher 1979</a> ; <a href="./references#MR000050-bbs2-0006" title="AyenI , HautzingerM .Cognitive behavior therapy for depression in menopausal women. A controlled, randomized treatment study [Kognitive Verhaltenstherapie bei Depressionen im Klimakterium: Eine kontrollierte, randomiserte Interventionsstudie]. Zeitschrift für Klinische Psychologie und Psychotherapie2004;33(4):290-9. AyenI .Inclusion of study in Cochrane Systematic Review (personal communication). Email to EG Faltinsen 9th of September 2019. ">Ayen 2004</a> ; <a href="./references#MR000050-bbs2-0008" title="Borden, KA.Attributional Outcomes: the Subtle Messages of Treatments for Attention Deficit Disorder. Dissertation, University of Illinois at Urbana-Champaign1986. BordenKA , BrownRT .Attributional outcomes: The subtle messages of treatments for attention deficit disorder. Cognitive Therapy and Research1989;13(2):147-60. ">Borden 1986</a> ; <a href="./references#MR000050-bbs2-0009" title="BorkovecTD , KaloupekDG , SlamaKM .The facilitative effect of muscle tension-release in the relaxation treatment of sleep disturbance. Behavior Therapy1975;6(3):301-9. ">Borkovec 1975</a> ; <a href="./references#MR000050-bbs2-0010" title="BorkovecTD , WeertsTC .Effects of progressive relaxation on sleep disturbance: an electroencephalographic evaluation. Psychosomatic Medicine1976;38(3):173-80. ">Borkovec 1976</a> ; <a href="./references#MR000050-bbs2-0011" title="BornovalovaM .Inclusion of study in Cochrane Systematic Review (personal communication). Email to A Todorovac. 21st of August 2019. BornovalovaMA .Distress tolerance treatment for inner-city drug users: a preliminary trial. Doctor’s Dissertation, University of Maryland2008. ">Bornovalova 2008</a> ; <a href="./references#MR000050-bbs2-0012" title="BramstonP , SpenceSH .Behavioural versus cognitive social-skills training with intellectually-handicapped adults. Behaviour Research and Therapy1985;23(3):239-46. ">Bramston 1985</a> ; <a href="./references#MR000050-bbs2-0015" title="CarlsonCL , PelhamWE , MilichR , HozaB .ADHD boys’ performance and attributions following success and failure: drug effects and individual differences. Cognitive Therapy and Research1993;17:269-87. ">Carlson 1993</a> ; <a href="./references#MR000050-bbs2-0016" title="CarterJC , OlmstedMP , KaplanAS , McCabeRE , MillsJS , AimeA .Self-help for bulimia nervosa: a randomized controlled trial. American Journal of Psychiatry2003;160(5):973-8. ">Carter 2003</a> ; <a href="./references#MR000050-bbs2-0018" title="CrouchG , RobsonM , HallstromC .Benzodiazepine dependent patients and their psychological treatment. Progress in Neuro-psychopharmacology &amp; Biological Psychiatry1988;12(4):503-10. HallströmC , CrouchG , RobsenM , ShineP .The treatment of tranquillizer dependence by propranolol. Postgraduate Medical Journal1988;64(Suppl 2):40-4. ">Crouch 1988</a> ; <a href="./references#MR000050-bbs2-0021" title="EhlersA , HackmannA , GreyN , WildJ , LinessS , AlbertI , et al.A randomized controlled trial of 7-day intensive and standard weekly cognitive therapy for PTSD and emotion-focused supportive therapy. American Journal of Psychiatry2014;171(3):294-304. ">Ehlers 2014</a> ; <a href="./references#MR000050-bbs2-0022" title="EspieCA , BrooksDN , LindsayWR .An evaluation of tailored psychological treatment of insomnia. Journal of Behavior Therapy and Experimental Psychiatry1989;20(2):143-53. EspieCA , LindsayWR , BrooksDN , HoodEM , TurveyT .A controlled comparative investigation of psychological treatments for chronic sleep-onset insomnia. Behaviour Research and Therapy1989;27(1):79-88. ">Espie 1989a</a> ; <a href="./references#MR000050-bbs2-0023" title="EtringerBD , CashTF , RimmDC .Behavioral, affective, and cognitive effects of participant modeling and an equally credible placebo. Behavior Therapy1982;13(4):476-85. ">Etringer 1982</a> ; <a href="./references#MR000050-bbs2-0024" title="FoaEB , RothbaumBO , RiggsDS , MurdockTB .Treatment of posttraumatic stress disorder in rape victims: a comparison between cognitive-behavioral procedures and counselling. Journal of Consulting and Clinical Psychology1991;59(5):715-23. ">Foa 1991</a> ; <a href="./references#MR000050-bbs2-0025" title="FoaEB , McLeanCP , ZangY , RosenfieldD , YadinE , YarvisJS , et al.Effect of prolonged exposure therapy delivered over 2 weeks vs 8 weeks vs present-centered therapy on PTSD symptom severity in military personnel: a randomized clinical trial. JAMA2018;319(4):354-64. ">Foa 2018</a> ; <a href="./references#MR000050-bbs2-0026" title="FreireAO , SugaiGC , ChrispinFS , TogeiroSM , YamamuraY , MelloLE , et al.Treatment of moderate obstructive sleep apnea syndrome with acupuncture: a randomised, placebo-controlled pilot trial. Sleep Medicine2007;8(1):43-50. ">Freire 2007</a> ; <a href="./references#MR000050-bbs2-0027" title="FuchsCZ , RehnLP .A self-control behavior therapy program for depression. Journal of Consulting and Clinical Psychology1977;45(2):206-15. ">Fuchs 1977</a> ; <a href="./references#MR000050-bbs2-0028" title="GlogowskaM , RoulstoneS , EnderbyP , PetersTJ .Randomised controlled trial of community based speech and language therapy in preschool children. BMJ2000;321(7266):923-6. ">Glogowska 2000</a> ; <a href="./references#MR000050-bbs2-0032" title="HippmanC , RingroseA , InglisA , CheekJ , AlbertAY , RemickR , et al.A pilot randomized clinical trial evaluating the impact of genetic counselling for serious mental illnesses. Journal of Clinical Psychiatry2016;77(2):e190-8. ">Hippman 2016</a> ; <a href="./references#MR000050-bbs2-0034" title="KarstM , WinterhalterM , MünteS , FranckiB , HondronikosA , EckardtA , et al.Auricular acupuncture for dental anxiety: a randomized controlled trial. Anesthesia and Analgesia2007;104(2):295-300. KarstM .Inclusion of study in Cochrane Systematic Review (personal communication). Email to: EG Faltinsen 5th of September 2019. ">Karst 2007</a> ; <a href="./references#MR000050-bbs2-0035" title="KelleyJ .Inclusion of study in Cochrane Systematic Review (personal communication). Email to: A Todorovac 12th of August 2019. KelleyJM , KaptchukTJ , CusinC , LipkinS , FavaM .Open-label placebo for major depressive disorder: a pilot randomized controlled trial. Psychotherapy and Psychosomatics2012;81(5):312-4. ">Kelley 2012</a> ; <a href="./references#MR000050-bbs2-0036" title="KennedyTD , KimuraHK .Transfer, behavioral improvement, and anxiety reduction in systematic desensitization. Journal of Consulting and Clinical Psychology1974;42(5):720-8. ">Kennedy 1974</a> ; <a href="./references#MR000050-bbs2-0037" title="KilmannPR , MilanRJ , BolandJP , NankinHR , DavidsonE , WestMO , et al.Group treatment of secondary erectile dysfunction. Journal of Sex &amp; Marital Therapy1987;13(3):168-82. KilmannPR , Milan RJ Jr, BolandJP , DavidsonE , WestMO , SablisRF , et al.The sexual interactions of men with secondary erectile dysfunction. Journal of Sex Education and Therapy1988;14(1):46-9. KilmannPR , Milan RJ Jr, BolandJP , NankinHR , SablisRF , WestMO , et al.The sexual interactions of men with secondary erectile dysfunction. Paper presented at the annual meeting of the American Psychological Association in Los Angeles1985;1:46-9. ">Kilmann 1987</a> ; <a href="./references#MR000050-bbs2-0038" title="KleinSA , DeffenbacherJL .Relaxation and exercise for hyperactive impulsive children. Perceptual and Motor Skills1977;45:1159-62. ">Klein 1977</a> ; <a href="./references#MR000050-bbs2-0041" title="KloskoJS , BarlowDH , TassinariR , CernyJA .A comparison of alprazolam and behavior therapy in treatment of panic disorder: correction. Journal of Psychotherapy Practice and Research1994;3(2):163-79. KloskoJS , BarlowDH , TassinariR , CernyJA .A comparison of alprazolam and behavior therapy in treatment of panic disorder. Journal of Consulting and Clinical Psychology1990;58(1):77-84. ">Klosko 1990</a> ; <a href="./references#MR000050-bbs2-0042" title="KrapflJE , NawasMM .Differential ordering of stimulus presentation in systematic desensitization. Journal of Abnormal Psychology1970;75(3):333-7. ">Krapfl 1970</a> ; <a href="./references#MR000050-bbs2-0043" title="KwanR .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 26th of August 2019. KwanRY , LeungMC , LaiCK .Acupressure for agitation in nursing home residents with dementia: study protocol for a randomized controlled trial. Trials2014;15(410):1-7. KwanRY , LeungMCP , LaiCK .A randomized controlled trial examining the effect of acupressure on agitation and salivary cortisol in nursing home residents with dementia. Dementia and Geriatric Cognitive Disorders2017;44(1-2):92-104. ">Kwan 2017</a> ; <a href="./references#MR000050-bbs2-0044" title="LacyMK .The effect of short term autogenic training on the stress reactivity of hospitalized emotionally disturbed adolescents. ProQuest Dissertations Publishing, Oklahoma State University1996. ">Lacy 1990</a> ; <a href="./references#MR000050-bbs2-0045" title="LaiCK , ChiI , Kayser-JonesJ .A randomized controlled trial of a specific reminiscence approach to promote the well-being of nursing home residents with dementia. International Psychogeriatrics2004;16(1):33-49. LaiK .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 6th of September 2019. ">Lai 2004</a> ; <a href="./references#MR000050-bbs2-0047" title="LegrandF .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 14th of August 2019. LegrandFD , NeffEM .Efficacy of exercise as an adjunct treatment for clinically depressed inpatients during the initial stages of antidepressant pharmacotherapy: an open randomized controlled trial. Journal of Affective Disorders2016;191:139-44. ">Legrand 2016</a> ; <a href="./references#MR000050-bbs2-0048" title="LickJ .Expectancy, false galvanic skin response feedback, and systematic desensitization in the modification of phobic behavior. Journal of Consulting and Clinical Psychology1975;43(4):557-67. ">Lick 1975</a> ; <a href="./references#MR000050-bbs2-0049" title="LickJR , HefflerD .Relaxation training and attention placebo in the treatment of severe insomnia. Journal of Consulting and Clinical Psychology1977;45(2):153-61. ">Lick 1977</a> ; <a href="./references#MR000050-bbs2-0050" title="LiddleB , SpenceSH .Cognitive-behaviour therapy with depressed primary school children: A cautionary note. Behavioural Psychotherapy1990;18(2):85-102. ">Liddle 1990</a> ; <a href="./references#MR000050-bbs2-0052" title="McLachlanDR , DaltonAJ , KruckTP , BellMY , SmithWL , KalowW , et al.Intramuscular desferrioxamine in patients with Alzheimer's disease. Lancet1991;337(8753):1304-8. McLachlanDRC , SmithWL , KruckTP .Desferrioxamine and Alzheimer’s disease: video home behavior assessment of clinical course and measures of brain aluminum. Therapeutic Drug Monitoring1993;15(6):602-7. ">McLachlan 1991</a> ; <a href="./references#MR000050-bbs2-0055" title="MirandaA , ArlandisP , SorianoM .Instruction in strategies and attributional training: Effects on the problem-solving and self-concept of students’ with learning disabilities [Instrucción en estrategias y entrenamiento atribucional: efectos sobre la resolución de problemas y el autoconcepto de los estudiantes con dificultades en el aprendizaje]. Infancia y Aprendizaje1997;20(80):37-52. ">Miranda 1997</a> ; <a href="./references#MR000050-bbs2-0056" title="MitchellC , MansfieldD , RautenbachS .Coloured filters and reading accuracy, comprehension and rate: a placebo-controlled study. Perceptual and Motor Skills2008;106(2):517-32. ">Mitchell 2008</a> ; <a href="./references#MR000050-bbs2-0057" title="NandiDN , AjmanyS , GanguliH , BanerjeeG , BoralGC , GhoshA , et al.A clinical evaluation of depressives found in a rural survey in India. British Journal of Psychiatry1976;128:523-7. ">Nandi 1976</a> ; <a href="./references#MR000050-bbs2-0058" title="NicassioP , BootzinR .A comparison of progressive relaxation and autogenic training as treatments for insomnia. Journal of Abnormal Psychology1974;83(3):253-60. ">Nicassio 1974</a> ; <a href="./references#MR000050-bbs2-0060" title="PeckCL .Desensitization for the treatment of fear in the high level adult retardate. Behaviour Research and Therapy1977;15(2):137-48. ">Peck 1976</a> ; <a href="./references#MR000050-bbs2-0061" title="MilichR , CarlsonCL , Pelham WE Jr, LichtBG .Effects of methylphenidate on the persistence of ADHD boys following failure experiences. Journal of Abnormal Child Psychology1991;19(5):519-36. PelhamWE , MurphyDA , VannattaK , MilichR , LichtBG , GnagyEM , et al.Methylphenidate and attributions in boys with attention-deficit hyperactivity disorder. Journal of Consulting and Clinical Psychology1992;60(2):282-92. ">Pelham 1992</a> ; <a href="./references#MR000050-bbs2-0062" title="PedletonMG , HigginsRL .A comparison of negative practice and systematic desensitization in the treatment of acrophobia. Journal of Behavior Therapy and Experimental Psychiatry1983;14(4):317-23. ">Pendleton 1983</a> ; <a href="./references#MR000050-bbs2-0063" title="PetersonMA , PattersonB , PillmanBM , BattistaMA .Cognitive recovery following alcohol detoxification: a computerised remediation study. Neuropsychological Rehabilitation2002;12(1):63-74. PillmanBM .Computerized cognitive remediation with recently detoxified alcoholics. Dissertation, California School of Professional Psychology, Fresno Campus2000. ">Pillman 2001</a> ; <a href="./references#MR000050-bbs2-0064" title="PolandRE , GertsikL , FavreauJT , SmithSI , MirochaJM , RaoU , et al.Open-label randomized parallel-group controlled clinical trial of massage for treatment of depression in HIV-infected subjects. Journal of Alternative and Complementary Medicine2013;19(4):334-40. ">Poland 2013</a> ; <a href="./references#MR000050-bbs2-0065" title="PowersMB , SmitsJA , TelchMJ .Disentangling the effects of safety-behavior utilization and safety-behavior availability during exposure-based treatment: a placebo-controlled trial. Journal of Consulting and Clinical Psychology2004;72(3):448-54. ">Powers 2004</a> ; <a href="./references#MR000050-bbs2-0066" title="PowersMB , SmithsJA , WhitleyD , BystritskyA , TelchMJ .The effect of attributional processes concerning medication taking on return of fear. Journal of Consulting and Clinical Psychology2008;76(3):478-90. ">Powers 2008a</a> ; <a href="./references#MR000050-bbs2-0067" title="PowersMB , SmithsJA , WhitleyD , BystritskyA , TelchMJ .The effect of attributional processes concerning medication taking on return of fear. Journal of Consulting and Clinical Psychology2008;76(3):478-90. ">Powers 2008b</a> ; <a href="./references#MR000050-bbs2-0068" title="ProudfootJ , ClarkeJ , BirchMR , WhittonAE , ParkerG , ManicavasagarV , et al.Impact of a mobile phone and web program on symptom and functional outcomes for people with mild- to-moderate depression, anxiety and stress: a randomized controlled trial. BMC Psychiatry2013;13(312):1-12. ProudfootJ .Re: Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 26th of August 2019. ">Proudfoot 2013</a> ; <a href="./references#MR000050-bbs2-0069" title="QuayhagenMP , QuayhagenM , CorbeilRR , RothPA , RodgersJA .A dyadic remediation program for care recipients with dementia. Nursing Research1995;44(3):153-9. ">Quayhagen 1995</a> ; <a href="./references#MR000050-bbs2-0075" title="OlivaresJ .Program IAFS. Protocol for the treatment of social phobia in adolescents [Programa IAFS. Protocolo para el tratamiento de la fobia social enadolescentes]. Madrid: Pirámide2005;1. Rosa-AlcázarAI , Olivares-OlivaresPJ , OlivaresJ .The role of non-specific effects in the psychological treatment of adolescents with social phobia [Papel de los efectos inespecíficos en el tratamiento psicológico de adolescentes con fobia social]. Anuario de Psicologia2009;40(1):43-61. ">Rosa‐Alcatraz 2009</a> ; <a href="./references#MR000050-bbs2-0076" title="RosenGM , GlasgowRE , BarreraM .A controlled study to assess the clinical efficacy of totally self-administrated systematic desensitization. Journal of Consulting and Clinical Psychology1976;44(2):208-17. ">Rosen 1976</a> ; <a href="./references#MR000050-bbs2-0079" title="ShalevAY , AnkriY , Isreali-ShalevY , PelegT , AdesskyR , FreedmanS .Prevention of posttraumatic stress disorder by early treatment. Archives of General Psychiatry2012;69(2):166-76. ">Shalev 2012</a> ; <a href="./references#MR000050-bbs2-0080" title="ShealyRC .The effectiveness of various treatment techniques on different degrees and durations of sleep-onset insomnia. Behaviour Research and Therapy1979;17(6):541-6. ">Shealy 1979</a> ; <a href="./references#MR000050-bbs2-0083" title="SteinmarkSW , BorkovecTD .Active and placebo treatment effects on moderate insomnia under counterdemand and positive demand instructions. Journal of Abnormal Psychology1974;83(2):157-63. ">Steinmark 1974</a> ; <a href="./references#MR000050-bbs2-0084" title="SzymanskiJ , O'DonohueW .The potential role of state-dependent learning in cognitive therapy with spider phobics. Journal of Rational-Emotive &amp; Cognitive-Behavior Therapy1995;13(2):131-50. SzymanskiJ .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 20th of August 2019. ">Szymanski 1995</a> ; <a href="./references#MR000050-bbs2-0085" title="TanSY , BruniJ .Cognitive-behavior therapy with adult patients with epilepsy: a controlled outcome study. Epilepsia1986;27(3):225-33. ">Tan 1986</a> ; <a href="./references#MR000050-bbs2-0087" title="ToriC , WorellL .Reduction of human avoidant behavior. A comparison of counterconditioning, expectancy, and cognitive information approaches. Clinical Psychology1973;41(2):269-78. ">Tori 1973</a> ; <a href="./references#MR000050-bbs2-0089" title="AscherML , TurnerRM .A comparison of two methods for the administration of paradoxical intention. Behaviour Research and Therapy1980;18(2):121-6. TurnerRM , AscherLM .Controlled comparison of progressive relaxation, stimulus control, and paradoxical intention therapies for insomnia. Journal of Consulting and Clinical Psychology1979;47(3):500-8. ">Turner 1979</a> ; <a href="./references#MR000050-bbs2-0090" title="VanderplateC .Electromyograph biofeedback Treatment of sleep onset Insomnia: a controlled Investigation. Dissertation, University of Southern Mississippi1978. ">Vanderplate 1983</a> ; <a href="./references#MR000050-bbs2-0092" title="WeingaertnerAH .Self-administered aversive stimulation with hallucinating hospitalized schizophrenics. Journal of Consulting and Clinical Psychology1971;36(3):422-29. ">Weingaertner 1971</a> ; <a href="./references#MR000050-bbs2-0095" title="WolitzkyKB , TelchMJ .Augmenting in vivo exposure with fear antagonistic actions: a preliminary test. Behavior Therapy2009;40(1):57-71. ">Wolitzky 2009</a> ; <a href="./references#MR000050-bbs2-0096" title="WollersheimJP , WilsonGL .Group treatment of unipolar depression: a comparison of coping, supportive, bibliotherapy, and delayed treatment groups. Professional Psychology: Research and Practice1991;22(6):496-502. ">Wollersheim 1991</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Did not report usable data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#MR000050-bbs2-0013" title="BrillNQ , KoeglerRR , EpsteinLJ , ForgyEW .Controlled study of psychiatric outpatient treatment. Archives of General Psychiatry1964;10:581-95. BrillNQ .Results of psychotherapy. California Medicine1966;104(4):249-53. ">Brill 1964a</a> ; <a href="./references#MR000050-bbs2-0018" title="CrouchG , RobsonM , HallstromC .Benzodiazepine dependent patients and their psychological treatment. Progress in Neuro-psychopharmacology &amp; Biological Psychiatry1988;12(4):503-10. HallströmC , CrouchG , RobsenM , ShineP .The treatment of tranquillizer dependence by propranolol. Postgraduate Medical Journal1988;64(Suppl 2):40-4. ">Crouch 1988</a> ; <a href="./references#MR000050-bbs2-0019" title="Doty, DW.Role playing and incentives in the modification of the social interaction of chronic psychiatric patients. Journal of Consulting and Clinical Psychology1975;43(5):676-82. ">Doty 1975</a> ; <a href="./references#MR000050-bbs2-0030" title="GoldwasserAN , AuerbachSM , HarkinsSW .Cognitive, affective, and behavioural effects of reminiscence group therapy on demented elderly. Aging and Human Development1987;25(3):209-22. ">Goldwasser 1987</a> ; <a href="./references#MR000050-bbs2-0031" title="HekmatH , LubitzR , DealR .Semantic desensitization: a paradigmatic intervention approach to anxiety disorders. Journal of Clinical Psychology1984;40(2):463-6. ">Hekmat 1984</a> ; <a href="./references#MR000050-bbs2-0046" title="LangOJ , LazovikAD .Experimental desensitization of a phobia. Journal of Abnormal and Social Psychology1963;66:519-25. LangPJ , LazovikAD , ReynoldsDJ .Desensitization, suggestibility, and pseudotherapy. Journal of Abnormal Psychology1965;70(6):395-402. ">Lang 1965</a> ; <a href="./references#MR000050-bbs2-0077" title="LorrM , McNairDM , WeinsteinGJ .Early effects of chlordiazepoxide (Librium) used with psychotherapy. Journal of Psychiatric Research1963;1:257-70. RothI , RhudickPJ , ShaskanDA , SlobinMS , WilkinsonAE , YoungHH .Long-term effects on psychotherapy of initial treatment conditions. Journal of Psychiatric Research1964;2:283-97. ">Roth 1964</a> ; <a href="./references#MR000050-bbs2-0078" title="RupertPA , HolmesDS .Effects of multiple sessions of true and placebo heart rate biofeedback training on the heart rates and anxiety levels of anxious patients during and following treatment. Psychophysiology1978;15(6):582-90. ">Rupert 1978</a> ; <a href="./references#MR000050-bbs2-0059" title="PearlD , Vander KampH , OlsenAL , GreenbergPD , ArmitageSG .The effects of reserpine on schizophrenic patients. American Journal of Psychiatry1956;112:198-204. ">Pearl 1956</a> ; <a href="./references#MR000050-bbs2-0081" title="SibilioJP , AndrewG , DartD , MooreKB , StehmanA .Treatment of chronic schizophrenia with promazine hydrochloride. AMA Archives of Neurology and Psychiatry1957;78(4):419-24. ">Sibilio 1957</a> ; <a href="./references#MR000050-bbs2-0082" title="SommernessMD , LuceroRJ , HamlonJS , EricksonJL , MatthewsR .A controlled study of reserpine on chronically disturbed patients. JAMA Archives of Neurology and Psychiatry1955;74(3):316-9. ">Sommerness 1955</a> ; <a href="./references#MR000050-bbs2-0088" title="Trexler, L.Rational-emotive therapy, placebo, and no-treatment effects on public-speaking anxiety. Doctoral dissertation, Temple University AnnArbor, Mich.: University Microfilms1971;71-31(063). TrexlerLD , KarstTO .Rational-emotive therapy, placebo, and no-treatment effects on public-speaking anxiety. Journal of Abnormal Psyhology1972;79(1):60-7. ">Trexler 1972</a> . </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Efficacy of psychological placebos</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Reported dichotomous data on a outcome for efficacy of placebo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#MR000050-bbs2-0053" title="MealieaWL , NawasMM .The comparative effectiveness of systematic desensitization and implosive therapy in the treatment of snake phobia. Journal of Behavior Therapy and Experimental Psychiatry1971;2(2):85-94. ">Mealiea 1971</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Reported continuous data on a outcome for efficacy of placebo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>38</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#MR000050-bbs2-0001" title="AbikoffH , HechtmanL , KleinRG .Social functioning in children with ADHD treated with long-term methylphenidate and multimodal psychosocial treatment. Journal of the American Academy of Child and Adolescent Psychiatry2004;43(7):820-9. AbikoffH .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to A Todorovac 23rd of August 2019. KleinRG , AbikoffH , HechtmanL , WeissG .Design and rationale of controlled study of long-term methylphenidate and multimodal psychosocial treatment in children with ADHD. Journal of the American Academy of Child and Adolescent Psychiatry2004;43(7):792-801. ">Abikoff 2004</a> ; <a href="./references#MR000050-bbs2-0004" title="AlvarezJR .The effects of anger management training on depression, anger, self-concept, and treatment responsibility in a sample of drug-dependent individuals in a therapeutic community. Dissertation Abstracts International: Section B: the Sciences and Engineering1997;58(4-B):2108. ">Alvarez 1997</a> ; <a href="./references#MR000050-bbs2-0005" title="AscherLM , TurnerR .Paradoxical intention and insomnia: an experimental investigation. Behaviour Research and Therapy1979;17(4):408-11. ">Ascher 1979</a> ; <a href="./references#MR000050-bbs2-0006" title="AyenI , HautzingerM .Cognitive behavior therapy for depression in menopausal women. A controlled, randomized treatment study [Kognitive Verhaltenstherapie bei Depressionen im Klimakterium: Eine kontrollierte, randomiserte Interventionsstudie]. Zeitschrift für Klinische Psychologie und Psychotherapie2004;33(4):290-9. AyenI .Inclusion of study in Cochrane Systematic Review (personal communication). Email to EG Faltinsen 9th of September 2019. ">Ayen 2004</a> ; <a href="./references#MR000050-bbs2-0009" title="BorkovecTD , KaloupekDG , SlamaKM .The facilitative effect of muscle tension-release in the relaxation treatment of sleep disturbance. Behavior Therapy1975;6(3):301-9. ">Borkovec 1975</a> ; <a href="./references#MR000050-bbs2-0010" title="BorkovecTD , WeertsTC .Effects of progressive relaxation on sleep disturbance: an electroencephalographic evaluation. Psychosomatic Medicine1976;38(3):173-80. ">Borkovec 1976</a> ; <a href="./references#MR000050-bbs2-0011" title="BornovalovaM .Inclusion of study in Cochrane Systematic Review (personal communication). Email to A Todorovac. 21st of August 2019. BornovalovaMA .Distress tolerance treatment for inner-city drug users: a preliminary trial. Doctor’s Dissertation, University of Maryland2008. ">Bornovalova 2008</a> ; <a href="./references#MR000050-bbs2-0012" title="BramstonP , SpenceSH .Behavioural versus cognitive social-skills training with intellectually-handicapped adults. Behaviour Research and Therapy1985;23(3):239-46. ">Bramston 1985</a> ; <a href="./references#MR000050-bbs2-0016" title="CarterJC , OlmstedMP , KaplanAS , McCabeRE , MillsJS , AimeA .Self-help for bulimia nervosa: a randomized controlled trial. American Journal of Psychiatry2003;160(5):973-8. ">Carter 2003</a> ; <a href="./references#MR000050-bbs2-0021" title="EhlersA , HackmannA , GreyN , WildJ , LinessS , AlbertI , et al.A randomized controlled trial of 7-day intensive and standard weekly cognitive therapy for PTSD and emotion-focused supportive therapy. American Journal of Psychiatry2014;171(3):294-304. ">Ehlers 2014</a> ; <a href="./references#MR000050-bbs2-0022" title="EspieCA , BrooksDN , LindsayWR .An evaluation of tailored psychological treatment of insomnia. Journal of Behavior Therapy and Experimental Psychiatry1989;20(2):143-53. EspieCA , LindsayWR , BrooksDN , HoodEM , TurveyT .A controlled comparative investigation of psychological treatments for chronic sleep-onset insomnia. Behaviour Research and Therapy1989;27(1):79-88. ">Espie 1989a</a> ; <a href="./references#MR000050-bbs2-0023" title="EtringerBD , CashTF , RimmDC .Behavioral, affective, and cognitive effects of participant modeling and an equally credible placebo. Behavior Therapy1982;13(4):476-85. ">Etringer 1982</a> ; <a href="./references#MR000050-bbs2-0024" title="FoaEB , RothbaumBO , RiggsDS , MurdockTB .Treatment of posttraumatic stress disorder in rape victims: a comparison between cognitive-behavioral procedures and counselling. Journal of Consulting and Clinical Psychology1991;59(5):715-23. ">Foa 1991</a> ; <a href="./references#MR000050-bbs2-0025" title="FoaEB , McLeanCP , ZangY , RosenfieldD , YadinE , YarvisJS , et al.Effect of prolonged exposure therapy delivered over 2 weeks vs 8 weeks vs present-centered therapy on PTSD symptom severity in military personnel: a randomized clinical trial. JAMA2018;319(4):354-64. ">Foa 2018</a> ; <a href="./references#MR000050-bbs2-0027" title="FuchsCZ , RehnLP .A self-control behavior therapy program for depression. Journal of Consulting and Clinical Psychology1977;45(2):206-15. ">Fuchs 1977</a> ; <a href="./references#MR000050-bbs2-0029" title="GoldsteinAJ , BeursE , Chambless Dl, WilsonKA .EMDR for panic disorder with agoraphobia: comparison with waiting list and credible attention-placebo control conditions. Journal of Consulting and Clinical Psychology2000;68(6):947-56. ">Goldstein 2000</a> ; <a href="./references#MR000050-bbs2-0032" title="HippmanC , RingroseA , InglisA , CheekJ , AlbertAY , RemickR , et al.A pilot randomized clinical trial evaluating the impact of genetic counselling for serious mental illnesses. Journal of Clinical Psychiatry2016;77(2):e190-8. ">Hippman 2016</a> ; <a href="./references#MR000050-bbs2-0036" title="KennedyTD , KimuraHK .Transfer, behavioral improvement, and anxiety reduction in systematic desensitization. Journal of Consulting and Clinical Psychology1974;42(5):720-8. ">Kennedy 1974</a> ; <a href="./references#MR000050-bbs2-0037" title="KilmannPR , MilanRJ , BolandJP , NankinHR , DavidsonE , WestMO , et al.Group treatment of secondary erectile dysfunction. Journal of Sex &amp; Marital Therapy1987;13(3):168-82. KilmannPR , Milan RJ Jr, BolandJP , DavidsonE , WestMO , SablisRF , et al.The sexual interactions of men with secondary erectile dysfunction. Journal of Sex Education and Therapy1988;14(1):46-9. KilmannPR , Milan RJ Jr, BolandJP , NankinHR , SablisRF , WestMO , et al.The sexual interactions of men with secondary erectile dysfunction. Paper presented at the annual meeting of the American Psychological Association in Los Angeles1985;1:46-9. ">Kilmann 1987</a> ; <a href="./references#MR000050-bbs2-0038" title="KleinSA , DeffenbacherJL .Relaxation and exercise for hyperactive impulsive children. Perceptual and Motor Skills1977;45:1159-62. ">Klein 1977</a> ; <a href="./references#MR000050-bbs2-0042" title="KrapflJE , NawasMM .Differential ordering of stimulus presentation in systematic desensitization. Journal of Abnormal Psychology1970;75(3):333-7. ">Krapfl 1970</a> ; <a href="./references#MR000050-bbs2-0045" title="LaiCK , ChiI , Kayser-JonesJ .A randomized controlled trial of a specific reminiscence approach to promote the well-being of nursing home residents with dementia. International Psychogeriatrics2004;16(1):33-49. LaiK .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 6th of September 2019. ">Lai 2004</a> ; <a href="./references#MR000050-bbs2-0048" title="LickJ .Expectancy, false galvanic skin response feedback, and systematic desensitization in the modification of phobic behavior. Journal of Consulting and Clinical Psychology1975;43(4):557-67. ">Lick 1975</a> ; <a href="./references#MR000050-bbs2-0050" title="LiddleB , SpenceSH .Cognitive-behaviour therapy with depressed primary school children: A cautionary note. Behavioural Psychotherapy1990;18(2):85-102. ">Liddle 1990</a> ; <a href="./references#MR000050-bbs2-0055" title="MirandaA , ArlandisP , SorianoM .Instruction in strategies and attributional training: Effects on the problem-solving and self-concept of students’ with learning disabilities [Instrucción en estrategias y entrenamiento atribucional: efectos sobre la resolución de problemas y el autoconcepto de los estudiantes con dificultades en el aprendizaje]. Infancia y Aprendizaje1997;20(80):37-52. ">Miranda 1997</a> ; <a href="./references#MR000050-bbs2-0062" title="PedletonMG , HigginsRL .A comparison of negative practice and systematic desensitization in the treatment of acrophobia. Journal of Behavior Therapy and Experimental Psychiatry1983;14(4):317-23. ">Pendleton 1983</a> ; <a href="./references#MR000050-bbs2-0065" title="PowersMB , SmitsJA , TelchMJ .Disentangling the effects of safety-behavior utilization and safety-behavior availability during exposure-based treatment: a placebo-controlled trial. Journal of Consulting and Clinical Psychology2004;72(3):448-54. ">Powers 2004</a> ; <a href="./references#MR000050-bbs2-0066" title="PowersMB , SmithsJA , WhitleyD , BystritskyA , TelchMJ .The effect of attributional processes concerning medication taking on return of fear. Journal of Consulting and Clinical Psychology2008;76(3):478-90. ">Powers 2008a</a> ; <a href="./references#MR000050-bbs2-0069" title="QuayhagenMP , QuayhagenM , CorbeilRR , RothPA , RodgersJA .A dyadic remediation program for care recipients with dementia. Nursing Research1995;44(3):153-9. ">Quayhagen 1995</a> ; <a href="./references#MR000050-bbs2-0074" title="RoehrichL , GoldmanMS .Experience-dependent neuropsychological recovery and the treatment of alcoholism. Journal of Consulting and Clinical Psychology1993;61(5):812-21. ">Roehrich 1993</a> ; <a href="./references#MR000050-bbs2-0075" title="OlivaresJ .Program IAFS. Protocol for the treatment of social phobia in adolescents [Programa IAFS. Protocolo para el tratamiento de la fobia social enadolescentes]. Madrid: Pirámide2005;1. Rosa-AlcázarAI , Olivares-OlivaresPJ , OlivaresJ .The role of non-specific effects in the psychological treatment of adolescents with social phobia [Papel de los efectos inespecíficos en el tratamiento psicológico de adolescentes con fobia social]. Anuario de Psicologia2009;40(1):43-61. ">Rosa‐Alcatraz 2009</a> ; <a href="./references#MR000050-bbs2-0076" title="RosenGM , GlasgowRE , BarreraM .A controlled study to assess the clinical efficacy of totally self-administrated systematic desensitization. Journal of Consulting and Clinical Psychology1976;44(2):208-17. ">Rosen 1976</a> ; <a href="./references#MR000050-bbs2-0080" title="ShealyRC .The effectiveness of various treatment techniques on different degrees and durations of sleep-onset insomnia. Behaviour Research and Therapy1979;17(6):541-6. ">Shealy 1979</a> ; <a href="./references#MR000050-bbs2-0083" title="SteinmarkSW , BorkovecTD .Active and placebo treatment effects on moderate insomnia under counterdemand and positive demand instructions. Journal of Abnormal Psychology1974;83(2):157-63. ">Steinmark 1974</a> ; <a href="./references#MR000050-bbs2-0084" title="SzymanskiJ , O'DonohueW .The potential role of state-dependent learning in cognitive therapy with spider phobics. Journal of Rational-Emotive &amp; Cognitive-Behavior Therapy1995;13(2):131-50. SzymanskiJ .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 20th of August 2019. ">Szymanski 1995</a> ; <a href="./references#MR000050-bbs2-0085" title="TanSY , BruniJ .Cognitive-behavior therapy with adult patients with epilepsy: a controlled outcome study. Epilepsia1986;27(3):225-33. ">Tan 1986</a> ; <a href="./references#MR000050-bbs2-0089" title="AscherML , TurnerRM .A comparison of two methods for the administration of paradoxical intention. Behaviour Research and Therapy1980;18(2):121-6. TurnerRM , AscherLM .Controlled comparison of progressive relaxation, stimulus control, and paradoxical intention therapies for insomnia. Journal of Consulting and Clinical Psychology1979;47(3):500-8. ">Turner 1979</a> ; <a href="./references#MR000050-bbs2-0096" title="WollersheimJP , WilsonGL .Group treatment of unipolar depression: a comparison of coping, supportive, bibliotherapy, and delayed treatment groups. Professional Psychology: Research and Practice1991;22(6):496-502. ">Wollersheim 1991</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Did not report usable data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#MR000050-bbs2-0019" title="Doty, DW.Role playing and incentives in the modification of the social interaction of chronic psychiatric patients. Journal of Consulting and Clinical Psychology1975;43(5):676-82. ">Doty 1975</a> ; <a href="./references#MR000050-bbs2-0030" title="GoldwasserAN , AuerbachSM , HarkinsSW .Cognitive, affective, and behavioural effects of reminiscence group therapy on demented elderly. Aging and Human Development1987;25(3):209-22. ">Goldwasser 1987</a> ; <a href="./references#MR000050-bbs2-0031" title="HekmatH , LubitzR , DealR .Semantic desensitization: a paradigmatic intervention approach to anxiety disorders. Journal of Clinical Psychology1984;40(2):463-6. ">Hekmat 1984</a> ; <a href="./references#MR000050-bbs2-0046" title="LangOJ , LazovikAD .Experimental desensitization of a phobia. Journal of Abnormal and Social Psychology1963;66:519-25. LangPJ , LazovikAD , ReynoldsDJ .Desensitization, suggestibility, and pseudotherapy. Journal of Abnormal Psychology1965;70(6):395-402. ">Lang 1965</a> ; <a href="./references#MR000050-bbs2-0088" title="Trexler, L.Rational-emotive therapy, placebo, and no-treatment effects on public-speaking anxiety. Doctoral dissertation, Temple University AnnArbor, Mich.: University Microfilms1971;71-31(063). TrexlerLD , KarstTO .Rational-emotive therapy, placebo, and no-treatment effects on public-speaking anxiety. Journal of Abnormal Psyhology1972;79(1):60-7. ">Trexler 1972</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Efficacy of pharmacological placebos</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Reported dichotomous data on a outcome for efficacy of placebo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#MR000050-bbs2-0007" title="BergI , ForsytheI , HoltP , WattsJ .A controlled trial of ‘Senokot’ in faecal soiling treated by behavioural methods. Journal of Child Psychology and Psychiatry1983;24(4):543-9. ">Berg 1983</a> ; <a href="./references#MR000050-bbs2-0020" title="DoubleDB , WarrenGC , EvansM , RowlandsMP .Efficacy of maintenance use of anticholinergic agents. Acta Psychiatrica Scandinavica1993;88:381-4. ">Double 1993</a> ; <a href="./references#MR000050-bbs2-0039" title="KlermanGL , DimascioA , WeismannM , PrusoffB , PaykelES .Treatment of depression by drugs and psychotherapy. American Journal of Psychiatry1974;131(2):186-91. PaykelES , DimascioA , HaskellD , PrusoffBA .Effects of maintenance amitriptyline and psychotherapy on symptoms of depression. Psychological Medicine1975;5(1):67-77. PaykelES , DiMascioA , KlermanGL , PrusoffBA .Maintenance therapy of depression. Pharmakopsychiatrie, Neuro-Psychopharmakologie1976;9:127-39. PaykelES , WeissmanMM , PrusoffBA .Social maladjustment and severity of depression. Comprehensive Psychiatry1978;19(2):121-8. WeissmanMM , KlermanGL , PaykelES , PrusoffB .Treatment effects on the social adjustment of depressed patients. Archives of General Psychiatry1974;30:771-8. ">Klerman 1974a</a> ; <a href="./references#MR000050-bbs2-0040" title="KlermanGL , DimascioA , WeismannM , PrusoffB , PaykelES .Treatment of depression by drugs and psychotherapy. American Journal of Psychiatry1974;131(2):186-91. ">Klerman 1974b</a> ; <a href="./references#MR000050-bbs2-0070" title="LiebowitzM , QuitkinFM , StewartJW , McGrathPJ , HarrisonWM , MarkowitzJS , et al.Antidepressant efficacy in atypical depression. Archives of General Psychiatry1988;45(2):129-37. QuitkinFM , McGrathPJ , StewartJW , HarrisonW , WagerSG , NunesE , et al.Phenelzine and imipramine in mood reactive depressives: further delineation of the syndrome of atypical depression. Archives of General Psychiatry1989;46(9):787-93. RabkinJG , McGrathPJ , QuitkinFM , TricamoE , StewartJW , KleinDF .Effects of pill-giving on maintenance of placebo response in patients with chronic mild depression. American Journal of Psychiatry1990;147(12):1622-6. ">Rabkin 1990</a> ; <a href="./references#MR000050-bbs2-0091" title="WatzlH , RistF , OlbrichR , CohenR .Placebo injections and surveillance of alcohol intake during inpatient treatment of female alcoholics. Addictive Behaviors1988;13(2):197-200. ">Watzl 1988</a> ; <a href="./references#MR000050-bbs2-0093" title="WhittakerCB , HoyRM .Withdrawal of perphenazine in chronic schizophrenia. British Journal of Psychiatry1963;109:422-7. ">Whittaker 1963</a> ; <a href="./references#MR000050-bbs2-0094" title="WilsonA , DavidsonWJ , BlanchardR , WhiteJ .Disulfiram implantation. A placebo-controlled trial with two-year follow-up. Journal of Studies on Alcohol1978;39(5):809-19. WilsonA , DavidsonWJ , BlanchardR .Disulfiram implantation: a trial using placebo implants and two types of controls. Journal of Studies on Alcohol1980;41(5):429-36. ">Wilson 1980</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Reported continuous data on a outcome for efficacy of placebo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#MR000050-bbs2-0008" title="Borden, KA.Attributional Outcomes: the Subtle Messages of Treatments for Attention Deficit Disorder. Dissertation, University of Illinois at Urbana-Champaign1986. BordenKA , BrownRT .Attributional outcomes: The subtle messages of treatments for attention deficit disorder. Cognitive Therapy and Research1989;13(2):147-60. ">Borden 1986</a> ; <a href="./references#MR000050-bbs2-0015" title="CarlsonCL , PelhamWE , MilichR , HozaB .ADHD boys’ performance and attributions following success and failure: drug effects and individual differences. Cognitive Therapy and Research1993;17:269-87. ">Carlson 1993</a> ; <a href="./references#MR000050-bbs2-0035" title="KelleyJ .Inclusion of study in Cochrane Systematic Review (personal communication). Email to: A Todorovac 12th of August 2019. KelleyJM , KaptchukTJ , CusinC , LipkinS , FavaM .Open-label placebo for major depressive disorder: a pilot randomized controlled trial. Psychotherapy and Psychosomatics2012;81(5):312-4. ">Kelley 2012</a> ; <a href="./references#MR000050-bbs2-0041" title="KloskoJS , BarlowDH , TassinariR , CernyJA .A comparison of alprazolam and behavior therapy in treatment of panic disorder: correction. Journal of Psychotherapy Practice and Research1994;3(2):163-79. KloskoJS , BarlowDH , TassinariR , CernyJA .A comparison of alprazolam and behavior therapy in treatment of panic disorder. Journal of Consulting and Clinical Psychology1990;58(1):77-84. ">Klosko 1990</a> ; <a href="./references#MR000050-bbs2-0052" title="McLachlanDR , DaltonAJ , KruckTP , BellMY , SmithWL , KalowW , et al.Intramuscular desferrioxamine in patients with Alzheimer's disease. Lancet1991;337(8753):1304-8. McLachlanDRC , SmithWL , KruckTP .Desferrioxamine and Alzheimer’s disease: video home behavior assessment of clinical course and measures of brain aluminum. Therapeutic Drug Monitoring1993;15(6):602-7. ">McLachlan 1991</a> ; <a href="./references#MR000050-bbs2-0057" title="NandiDN , AjmanyS , GanguliH , BanerjeeG , BoralGC , GhoshA , et al.A clinical evaluation of depressives found in a rural survey in India. British Journal of Psychiatry1976;128:523-7. ">Nandi 1976</a> ; <a href="./references#MR000050-bbs2-0061" title="MilichR , CarlsonCL , Pelham WE Jr, LichtBG .Effects of methylphenidate on the persistence of ADHD boys following failure experiences. Journal of Abnormal Child Psychology1991;19(5):519-36. PelhamWE , MurphyDA , VannattaK , MilichR , LichtBG , GnagyEM , et al.Methylphenidate and attributions in boys with attention-deficit hyperactivity disorder. Journal of Consulting and Clinical Psychology1992;60(2):282-92. ">Pelham 1992</a> ; <a href="./references#MR000050-bbs2-0067" title="PowersMB , SmithsJA , WhitleyD , BystritskyA , TelchMJ .The effect of attributional processes concerning medication taking on return of fear. Journal of Consulting and Clinical Psychology2008;76(3):478-90. ">Powers 2008b</a> ; <a href="./references#MR000050-bbs2-0079" title="ShalevAY , AnkriY , Isreali-ShalevY , PelegT , AdesskyR , FreedmanS .Prevention of posttraumatic stress disorder by early treatment. Archives of General Psychiatry2012;69(2):166-76. ">Shalev 2012</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Did not report usable data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#MR000050-bbs2-0013" title="BrillNQ , KoeglerRR , EpsteinLJ , ForgyEW .Controlled study of psychiatric outpatient treatment. Archives of General Psychiatry1964;10:581-95. BrillNQ .Results of psychotherapy. California Medicine1966;104(4):249-53. ">Brill 1964a</a> ; <a href="./references#MR000050-bbs2-0018" title="CrouchG , RobsonM , HallstromC .Benzodiazepine dependent patients and their psychological treatment. Progress in Neuro-psychopharmacology &amp; Biological Psychiatry1988;12(4):503-10. HallströmC , CrouchG , RobsenM , ShineP .The treatment of tranquillizer dependence by propranolol. Postgraduate Medical Journal1988;64(Suppl 2):40-4. ">Crouch 1988</a> ; <a href="./references#MR000050-bbs2-0077" title="LorrM , McNairDM , WeinsteinGJ .Early effects of chlordiazepoxide (Librium) used with psychotherapy. Journal of Psychiatric Research1963;1:257-70. RothI , RhudickPJ , ShaskanDA , SlobinMS , WilkinsonAE , YoungHH .Long-term effects on psychotherapy of initial treatment conditions. Journal of Psychiatric Research1964;2:283-97. ">Roth 1964</a> ; <a href="./references#MR000050-bbs2-0059" title="PearlD , Vander KampH , OlsenAL , GreenbergPD , ArmitageSG .The effects of reserpine on schizophrenic patients. American Journal of Psychiatry1956;112:198-204. ">Pearl 1956</a> ; <a href="./references#MR000050-bbs2-0081" title="SibilioJP , AndrewG , DartD , MooreKB , StehmanA .Treatment of chronic schizophrenia with promazine hydrochloride. AMA Archives of Neurology and Psychiatry1957;78(4):419-24. ">Sibilio 1957</a> ; <a href="./references#MR000050-bbs2-0082" title="SommernessMD , LuceroRJ , HamlonJS , EricksonJL , MatthewsR .A controlled study of reserpine on chronically disturbed patients. JAMA Archives of Neurology and Psychiatry1955;74(3):316-9. ">Sommerness 1955</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Efficacy of physical placebos</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Reported dichotomous data on a outcome for efficacy of placebo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Reported continuous data on a outcome for efficacy of placebo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>16</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#MR000050-bbs2-0002" title="AllenJB .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to A Todorovac 28th of August 2019. AllenJJ , SchnyerRN , HittSK .The efficacy of acupuncture in the treatment of major depression in women. Psychological Science1998;9(5):397-401. ">Allen 1998</a> ; <a href="./references#MR000050-bbs2-0003" title="AllenJB .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 28th of August 2019. AllenJJ , SchnyerRN , ChambersAS , HittSK , MorenoFA , ManberR .Acupuncture for depression: a randomized controlled trial. Journal of Clinical Psychiatry2006;67(11):1665-73. ">Allen 2006</a> ; <a href="./references#MR000050-bbs2-0026" title="FreireAO , SugaiGC , ChrispinFS , TogeiroSM , YamamuraY , MelloLE , et al.Treatment of moderate obstructive sleep apnea syndrome with acupuncture: a randomised, placebo-controlled pilot trial. Sleep Medicine2007;8(1):43-50. ">Freire 2007</a> ; <a href="./references#MR000050-bbs2-0034" title="KarstM , WinterhalterM , MünteS , FranckiB , HondronikosA , EckardtA , et al.Auricular acupuncture for dental anxiety: a randomized controlled trial. Anesthesia and Analgesia2007;104(2):295-300. KarstM .Inclusion of study in Cochrane Systematic Review (personal communication). Email to: EG Faltinsen 5th of September 2019. ">Karst 2007</a> ; <a href="./references#MR000050-bbs2-0043" title="KwanR .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 26th of August 2019. KwanRY , LeungMC , LaiCK .Acupressure for agitation in nursing home residents with dementia: study protocol for a randomized controlled trial. Trials2014;15(410):1-7. KwanRY , LeungMCP , LaiCK .A randomized controlled trial examining the effect of acupressure on agitation and salivary cortisol in nursing home residents with dementia. Dementia and Geriatric Cognitive Disorders2017;44(1-2):92-104. ">Kwan 2017</a> ; <a href="./references#MR000050-bbs2-0044" title="LacyMK .The effect of short term autogenic training on the stress reactivity of hospitalized emotionally disturbed adolescents. ProQuest Dissertations Publishing, Oklahoma State University1996. ">Lacy 1990</a> ; <a href="./references#MR000050-bbs2-0047" title="LegrandF .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 14th of August 2019. LegrandFD , NeffEM .Efficacy of exercise as an adjunct treatment for clinically depressed inpatients during the initial stages of antidepressant pharmacotherapy: an open randomized controlled trial. Journal of Affective Disorders2016;191:139-44. ">Legrand 2016</a> ; <a href="./references#MR000050-bbs2-0049" title="LickJR , HefflerD .Relaxation training and attention placebo in the treatment of severe insomnia. Journal of Consulting and Clinical Psychology1977;45(2):153-61. ">Lick 1977</a> ; <a href="./references#MR000050-bbs2-0056" title="MitchellC , MansfieldD , RautenbachS .Coloured filters and reading accuracy, comprehension and rate: a placebo-controlled study. Perceptual and Motor Skills2008;106(2):517-32. ">Mitchell 2008</a> ; <a href="./references#MR000050-bbs2-0058" title="NicassioP , BootzinR .A comparison of progressive relaxation and autogenic training as treatments for insomnia. Journal of Abnormal Psychology1974;83(3):253-60. ">Nicassio 1974</a> ; <a href="./references#MR000050-bbs2-0063" title="PetersonMA , PattersonB , PillmanBM , BattistaMA .Cognitive recovery following alcohol detoxification: a computerised remediation study. Neuropsychological Rehabilitation2002;12(1):63-74. PillmanBM .Computerized cognitive remediation with recently detoxified alcoholics. Dissertation, California School of Professional Psychology, Fresno Campus2000. ">Pillman 2001</a> ; <a href="./references#MR000050-bbs2-0064" title="PolandRE , GertsikL , FavreauJT , SmithSI , MirochaJM , RaoU , et al.Open-label randomized parallel-group controlled clinical trial of massage for treatment of depression in HIV-infected subjects. Journal of Alternative and Complementary Medicine2013;19(4):334-40. ">Poland 2013</a> ; <a href="./references#MR000050-bbs2-0087" title="ToriC , WorellL .Reduction of human avoidant behavior. A comparison of counterconditioning, expectancy, and cognitive information approaches. Clinical Psychology1973;41(2):269-78. ">Tori 1973</a> ; <a href="./references#MR000050-bbs2-0090" title="VanderplateC .Electromyograph biofeedback Treatment of sleep onset Insomnia: a controlled Investigation. Dissertation, University of Southern Mississippi1978. ">Vanderplate 1983</a> ; <a href="./references#MR000050-bbs2-0092" title="WeingaertnerAH .Self-administered aversive stimulation with hallucinating hospitalized schizophrenics. Journal of Consulting and Clinical Psychology1971;36(3):422-29. ">Weingaertner 1971</a> ; <a href="./references#MR000050-bbs2-0095" title="WolitzkyKB , TelchMJ .Augmenting in vivo exposure with fear antagonistic actions: a preliminary test. Behavior Therapy2009;40(1):57-71. ">Wolitzky 2009</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Did not report usable data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#MR000050-bbs2-0078" title="RupertPA , HolmesDS .Effects of multiple sessions of true and placebo heart rate biofeedback training on the heart rates and anxiety levels of anxious patients during and following treatment. Psychophysiology1978;15(6):582-90. ">Rupert 1978</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Efficacy of Usual care</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Reported dichotomous data on a outcome for efficacy of usual care</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#MR000050-bbs2-0054" title="MilbyJB , ClarkeC , ToroC , ThorntonS , RickertD .Effectiveness of urine surveillance as an adjunct to outpatient psychotherapy for drug abusers. International Journal of the Addictions1980;15(7):993-1001. ">Milby 1980</a> ; <a href="./references#MR000050-bbs2-0073" title="RobinA .Rationing out-patients: a defence of the waiting list. British Journal of Psychiatry1976;129:138-41. ">Robin 1976</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Reported continuous data on a outcome for efficacy of usual care</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#MR000050-bbs2-0017" title="CrispAH , NortonK , GowersS , HalekC , BowyerC , YeldhamD , et al.A controlled study of the effect of therapies aimed at adolescent and family psychopathology in Anorexia Nervosa. British Journal of Psychiatry: the Journal of Mental Science1991;159:325-33. GowersS , NortonK , HalekC , CrispAH .Outcome of outpatient psychotherapy in a random allocation treatment study of anorexia nervosa. International Journal of Eating Disorders1994;15(2):165-77. GowersS , NortonK , YelshamD .The St George's prospective treatment study of anorexia nervosa: a discussion of methodological problems. International Journal of Eating Disorders1989;8:445-54. ">Crisp 1991</a> ; <a href="./references#MR000050-bbs2-0028" title="GlogowskaM , RoulstoneS , EnderbyP , PetersTJ .Randomised controlled trial of community based speech and language therapy in preschool children. BMJ2000;321(7266):923-6. ">Glogowska 2000</a> ; <a href="./references#MR000050-bbs2-0071" title="RapeeR .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 29th of August 2019. RapeeRM , AbbottMJ , LynehamHJ .Bibliotherapy for children With anxiety disorders using written materials for parents: a randomized controlled trial. Journal of Consulting and Clinical Psychology2006;74(3):436-44. ">Rapee 2006</a> ; <a href="./references#MR000050-bbs2-0072" title="RapeeR .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 29th of August 2019. RapeeRM , AbbottMJ , BaillieAJ , GastonJE .Treatment of social phobia through pure self-help and therapist-augmented self-help. British Journal of Psychiatry2007;191:246-52. ">Rapee 2007</a> ; <a href="./references#MR000050-bbs2-0086" title="TeriL , LogsdonRG , UomotoJ , McCurrySM .Behavioral treatment of depression in dementia patients: a controlled clinical trial. Journals of Gerontology. Series B, Psychological Sciences and Social Sciences1997;52(4):159-66. TeriL .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 26th of August 2019. ">Teri 1997</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Did not report usable data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#MR000050-bbs2-0014" title="BrillNQ , KoeglerRR , EpsteinLJ , ForgyEW .Controlled study of psychiatric outpatient treatment. Archives of General Psychiatry1964;10:581-95. ">Brill 1964b</a> ; <a href="./references#MR000050-bbs2-0051" title="MatsonJL , MarchettiA , AdkinsJA .Comparison of operant- and independence-training procedures for mentally retarded adults. American Journal of Mental Deficiency1980;84(5):487-94. ">Matson 1980</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Reported serious adverse events</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>All placebos</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>11</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#MR000050-bbs2-0021" title="EhlersA , HackmannA , GreyN , WildJ , LinessS , AlbertI , et al.A randomized controlled trial of 7-day intensive and standard weekly cognitive therapy for PTSD and emotion-focused supportive therapy. American Journal of Psychiatry2014;171(3):294-304. ">Ehlers 2014</a> ; <a href="./references#MR000050-bbs2-0025" title="FoaEB , McLeanCP , ZangY , RosenfieldD , YadinE , YarvisJS , et al.Effect of prolonged exposure therapy delivered over 2 weeks vs 8 weeks vs present-centered therapy on PTSD symptom severity in military personnel: a randomized clinical trial. JAMA2018;319(4):354-64. ">Foa 2018</a> ; <a href="./references#MR000050-bbs2-0026" title="FreireAO , SugaiGC , ChrispinFS , TogeiroSM , YamamuraY , MelloLE , et al.Treatment of moderate obstructive sleep apnea syndrome with acupuncture: a randomised, placebo-controlled pilot trial. Sleep Medicine2007;8(1):43-50. ">Freire 2007</a> ; <a href="./references#MR000050-bbs2-0034" title="KarstM , WinterhalterM , MünteS , FranckiB , HondronikosA , EckardtA , et al.Auricular acupuncture for dental anxiety: a randomized controlled trial. Anesthesia and Analgesia2007;104(2):295-300. KarstM .Inclusion of study in Cochrane Systematic Review (personal communication). Email to: EG Faltinsen 5th of September 2019. ">Karst 2007</a> ; <a href="./references#MR000050-bbs2-0041" title="KloskoJS , BarlowDH , TassinariR , CernyJA .A comparison of alprazolam and behavior therapy in treatment of panic disorder: correction. Journal of Psychotherapy Practice and Research1994;3(2):163-79. KloskoJS , BarlowDH , TassinariR , CernyJA .A comparison of alprazolam and behavior therapy in treatment of panic disorder. Journal of Consulting and Clinical Psychology1990;58(1):77-84. ">Klosko 1990</a> ; <a href="./references#MR000050-bbs2-0043" title="KwanR .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 26th of August 2019. KwanRY , LeungMC , LaiCK .Acupressure for agitation in nursing home residents with dementia: study protocol for a randomized controlled trial. Trials2014;15(410):1-7. KwanRY , LeungMCP , LaiCK .A randomized controlled trial examining the effect of acupressure on agitation and salivary cortisol in nursing home residents with dementia. Dementia and Geriatric Cognitive Disorders2017;44(1-2):92-104. ">Kwan 2017</a> ; <a href="./references#MR000050-bbs2-0044" title="LacyMK .The effect of short term autogenic training on the stress reactivity of hospitalized emotionally disturbed adolescents. ProQuest Dissertations Publishing, Oklahoma State University1996. ">Lacy 1990</a> ; <a href="./references#MR000050-bbs2-0047" title="LegrandF .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 14th of August 2019. LegrandFD , NeffEM .Efficacy of exercise as an adjunct treatment for clinically depressed inpatients during the initial stages of antidepressant pharmacotherapy: an open randomized controlled trial. Journal of Affective Disorders2016;191:139-44. ">Legrand 2016</a> ; <a href="./references#MR000050-bbs2-0052" title="McLachlanDR , DaltonAJ , KruckTP , BellMY , SmithWL , KalowW , et al.Intramuscular desferrioxamine in patients with Alzheimer's disease. Lancet1991;337(8753):1304-8. McLachlanDRC , SmithWL , KruckTP .Desferrioxamine and Alzheimer’s disease: video home behavior assessment of clinical course and measures of brain aluminum. Therapeutic Drug Monitoring1993;15(6):602-7. ">McLachlan 1991</a> ; <a href="./references#MR000050-bbs2-0057" title="NandiDN , AjmanyS , GanguliH , BanerjeeG , BoralGC , GhoshA , et al.A clinical evaluation of depressives found in a rural survey in India. British Journal of Psychiatry1976;128:523-7. ">Nandi 1976</a> ; <a href="./references#MR000050-bbs2-0094" title="WilsonA , DavidsonWJ , BlanchardR , WhiteJ .Disulfiram implantation. A placebo-controlled trial with two-year follow-up. Journal of Studies on Alcohol1978;39(5):809-19. WilsonA , DavidsonWJ , BlanchardR .Disulfiram implantation: a trial using placebo implants and two types of controls. Journal of Studies on Alcohol1980;41(5):429-36. ">Wilson 1980</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Psychological placebos</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#MR000050-bbs2-0021" title="EhlersA , HackmannA , GreyN , WildJ , LinessS , AlbertI , et al.A randomized controlled trial of 7-day intensive and standard weekly cognitive therapy for PTSD and emotion-focused supportive therapy. American Journal of Psychiatry2014;171(3):294-304. ">Ehlers 2014</a> ; <a href="./references#MR000050-bbs2-0025" title="FoaEB , McLeanCP , ZangY , RosenfieldD , YadinE , YarvisJS , et al.Effect of prolonged exposure therapy delivered over 2 weeks vs 8 weeks vs present-centered therapy on PTSD symptom severity in military personnel: a randomized clinical trial. JAMA2018;319(4):354-64. ">Foa 2018</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Pharmacologica placebos</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#MR000050-bbs2-0041" title="KloskoJS , BarlowDH , TassinariR , CernyJA .A comparison of alprazolam and behavior therapy in treatment of panic disorder: correction. Journal of Psychotherapy Practice and Research1994;3(2):163-79. KloskoJS , BarlowDH , TassinariR , CernyJA .A comparison of alprazolam and behavior therapy in treatment of panic disorder. Journal of Consulting and Clinical Psychology1990;58(1):77-84. ">Klosko 1990</a> ; <a href="./references#MR000050-bbs2-0052" title="McLachlanDR , DaltonAJ , KruckTP , BellMY , SmithWL , KalowW , et al.Intramuscular desferrioxamine in patients with Alzheimer's disease. Lancet1991;337(8753):1304-8. McLachlanDRC , SmithWL , KruckTP .Desferrioxamine and Alzheimer’s disease: video home behavior assessment of clinical course and measures of brain aluminum. Therapeutic Drug Monitoring1993;15(6):602-7. ">McLachlan 1991</a> ; <a href="./references#MR000050-bbs2-0057" title="NandiDN , AjmanyS , GanguliH , BanerjeeG , BoralGC , GhoshA , et al.A clinical evaluation of depressives found in a rural survey in India. British Journal of Psychiatry1976;128:523-7. ">Nandi 1976</a> ; <a href="./references#MR000050-bbs2-0094" title="WilsonA , DavidsonWJ , BlanchardR , WhiteJ .Disulfiram implantation. A placebo-controlled trial with two-year follow-up. Journal of Studies on Alcohol1978;39(5):809-19. WilsonA , DavidsonWJ , BlanchardR .Disulfiram implantation: a trial using placebo implants and two types of controls. Journal of Studies on Alcohol1980;41(5):429-36. ">Wilson 1980</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Physical placebos</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#MR000050-bbs2-0026" title="FreireAO , SugaiGC , ChrispinFS , TogeiroSM , YamamuraY , MelloLE , et al.Treatment of moderate obstructive sleep apnea syndrome with acupuncture: a randomised, placebo-controlled pilot trial. Sleep Medicine2007;8(1):43-50. ">Freire 2007</a> ; <a href="./references#MR000050-bbs2-0034" title="KarstM , WinterhalterM , MünteS , FranckiB , HondronikosA , EckardtA , et al.Auricular acupuncture for dental anxiety: a randomized controlled trial. Anesthesia and Analgesia2007;104(2):295-300. KarstM .Inclusion of study in Cochrane Systematic Review (personal communication). Email to: EG Faltinsen 5th of September 2019. ">Karst 2007</a> ; <a href="./references#MR000050-bbs2-0043" title="KwanR .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 26th of August 2019. KwanRY , LeungMC , LaiCK .Acupressure for agitation in nursing home residents with dementia: study protocol for a randomized controlled trial. Trials2014;15(410):1-7. KwanRY , LeungMCP , LaiCK .A randomized controlled trial examining the effect of acupressure on agitation and salivary cortisol in nursing home residents with dementia. Dementia and Geriatric Cognitive Disorders2017;44(1-2):92-104. ">Kwan 2017</a> ; <a href="./references#MR000050-bbs2-0044" title="LacyMK .The effect of short term autogenic training on the stress reactivity of hospitalized emotionally disturbed adolescents. ProQuest Dissertations Publishing, Oklahoma State University1996. ">Lacy 1990</a> ; <a href="./references#MR000050-bbs2-0047" title="LegrandF .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 14th of August 2019. LegrandFD , NeffEM .Efficacy of exercise as an adjunct treatment for clinically depressed inpatients during the initial stages of antidepressant pharmacotherapy: an open randomized controlled trial. Journal of Affective Disorders2016;191:139-44. ">Legrand 2016</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Usual care</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Reported data on specific mental health diagnoses for all placebos (three or more trials)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Attention Deficit Hyperactivity Disorder (ADHD) or Attention Deficit Disorder (ADD)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#MR000050-bbs2-0001" title="AbikoffH , HechtmanL , KleinRG .Social functioning in children with ADHD treated with long-term methylphenidate and multimodal psychosocial treatment. Journal of the American Academy of Child and Adolescent Psychiatry2004;43(7):820-9. AbikoffH .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to A Todorovac 23rd of August 2019. KleinRG , AbikoffH , HechtmanL , WeissG .Design and rationale of controlled study of long-term methylphenidate and multimodal psychosocial treatment in children with ADHD. Journal of the American Academy of Child and Adolescent Psychiatry2004;43(7):792-801. ">Abikoff 2004</a> ; <a href="./references#MR000050-bbs2-0008" title="Borden, KA.Attributional Outcomes: the Subtle Messages of Treatments for Attention Deficit Disorder. Dissertation, University of Illinois at Urbana-Champaign1986. BordenKA , BrownRT .Attributional outcomes: The subtle messages of treatments for attention deficit disorder. Cognitive Therapy and Research1989;13(2):147-60. ">Borden 1986</a> ; <a href="./references#MR000050-bbs2-0015" title="CarlsonCL , PelhamWE , MilichR , HozaB .ADHD boys’ performance and attributions following success and failure: drug effects and individual differences. Cognitive Therapy and Research1993;17:269-87. ">Carlson 1993</a> ; <a href="./references#MR000050-bbs2-0038" title="KleinSA , DeffenbacherJL .Relaxation and exercise for hyperactive impulsive children. Perceptual and Motor Skills1977;45:1159-62. ">Klein 1977</a> ; <a href="./references#MR000050-bbs2-0061" title="MilichR , CarlsonCL , Pelham WE Jr, LichtBG .Effects of methylphenidate on the persistence of ADHD boys following failure experiences. Journal of Abnormal Child Psychology1991;19(5):519-36. PelhamWE , MurphyDA , VannattaK , MilichR , LichtBG , GnagyEM , et al.Methylphenidate and attributions in boys with attention-deficit hyperactivity disorder. Journal of Consulting and Clinical Psychology1992;60(2):282-92. ">Pelham 1992</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Anxiety disorders of different kind (e.g. specific anxiety, social anxiety, panic disorder) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>16</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#MR000050-bbs2-0023" title="EtringerBD , CashTF , RimmDC .Behavioral, affective, and cognitive effects of participant modeling and an equally credible placebo. Behavior Therapy1982;13(4):476-85. ">Etringer 1982</a> ; <a href="./references#MR000050-bbs2-0029" title="GoldsteinAJ , BeursE , Chambless Dl, WilsonKA .EMDR for panic disorder with agoraphobia: comparison with waiting list and credible attention-placebo control conditions. Journal of Consulting and Clinical Psychology2000;68(6):947-56. ">Goldstein 2000</a> ; <a href="./references#MR000050-bbs2-0034" title="KarstM , WinterhalterM , MünteS , FranckiB , HondronikosA , EckardtA , et al.Auricular acupuncture for dental anxiety: a randomized controlled trial. Anesthesia and Analgesia2007;104(2):295-300. KarstM .Inclusion of study in Cochrane Systematic Review (personal communication). Email to: EG Faltinsen 5th of September 2019. ">Karst 2007</a> ; <a href="./references#MR000050-bbs2-0041" title="KloskoJS , BarlowDH , TassinariR , CernyJA .A comparison of alprazolam and behavior therapy in treatment of panic disorder: correction. Journal of Psychotherapy Practice and Research1994;3(2):163-79. KloskoJS , BarlowDH , TassinariR , CernyJA .A comparison of alprazolam and behavior therapy in treatment of panic disorder. Journal of Consulting and Clinical Psychology1990;58(1):77-84. ">Klosko 1990</a> ; <a href="./references#MR000050-bbs2-0042" title="KrapflJE , NawasMM .Differential ordering of stimulus presentation in systematic desensitization. Journal of Abnormal Psychology1970;75(3):333-7. ">Krapfl 1970</a> ; <a href="./references#MR000050-bbs2-0048" title="LickJ .Expectancy, false galvanic skin response feedback, and systematic desensitization in the modification of phobic behavior. Journal of Consulting and Clinical Psychology1975;43(4):557-67. ">Lick 1975</a> ; <a href="./references#MR000050-bbs2-0055" title="MirandaA , ArlandisP , SorianoM .Instruction in strategies and attributional training: Effects on the problem-solving and self-concept of students’ with learning disabilities [Instrucción en estrategias y entrenamiento atribucional: efectos sobre la resolución de problemas y el autoconcepto de los estudiantes con dificultades en el aprendizaje]. Infancia y Aprendizaje1997;20(80):37-52. ">Miranda 1997</a> ; <a href="./references#MR000050-bbs2-0062" title="PedletonMG , HigginsRL .A comparison of negative practice and systematic desensitization in the treatment of acrophobia. Journal of Behavior Therapy and Experimental Psychiatry1983;14(4):317-23. ">Pendleton 1983</a> ; <a href="./references#MR000050-bbs2-0065" title="PowersMB , SmitsJA , TelchMJ .Disentangling the effects of safety-behavior utilization and safety-behavior availability during exposure-based treatment: a placebo-controlled trial. Journal of Consulting and Clinical Psychology2004;72(3):448-54. ">Powers 2004</a> ; <a href="./references#MR000050-bbs2-0066" title="PowersMB , SmithsJA , WhitleyD , BystritskyA , TelchMJ .The effect of attributional processes concerning medication taking on return of fear. Journal of Consulting and Clinical Psychology2008;76(3):478-90. ">Powers 2008a</a> ; <a href="./references#MR000050-bbs2-0067" title="PowersMB , SmithsJA , WhitleyD , BystritskyA , TelchMJ .The effect of attributional processes concerning medication taking on return of fear. Journal of Consulting and Clinical Psychology2008;76(3):478-90. ">Powers 2008b</a> ; <a href="./references#MR000050-bbs2-0075" title="OlivaresJ .Program IAFS. Protocol for the treatment of social phobia in adolescents [Programa IAFS. Protocolo para el tratamiento de la fobia social enadolescentes]. Madrid: Pirámide2005;1. Rosa-AlcázarAI , Olivares-OlivaresPJ , OlivaresJ .The role of non-specific effects in the psychological treatment of adolescents with social phobia [Papel de los efectos inespecíficos en el tratamiento psicológico de adolescentes con fobia social]. Anuario de Psicologia2009;40(1):43-61. ">Rosa‐Alcatraz 2009</a> ; <a href="./references#MR000050-bbs2-0076" title="RosenGM , GlasgowRE , BarreraM .A controlled study to assess the clinical efficacy of totally self-administrated systematic desensitization. Journal of Consulting and Clinical Psychology1976;44(2):208-17. ">Rosen 1976</a> ; <a href="./references#MR000050-bbs2-0084" title="SzymanskiJ , O'DonohueW .The potential role of state-dependent learning in cognitive therapy with spider phobics. Journal of Rational-Emotive &amp; Cognitive-Behavior Therapy1995;13(2):131-50. SzymanskiJ .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 20th of August 2019. ">Szymanski 1995</a> ; <a href="./references#MR000050-bbs2-0087" title="ToriC , WorellL .Reduction of human avoidant behavior. A comparison of counterconditioning, expectancy, and cognitive information approaches. Clinical Psychology1973;41(2):269-78. ">Tori 1973</a> ; <a href="./references#MR000050-bbs2-0095" title="WolitzkyKB , TelchMJ .Augmenting in vivo exposure with fear antagonistic actions: a preliminary test. Behavior Therapy2009;40(1):57-71. ">Wolitzky 2009</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Depression</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>10</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#MR000050-bbs2-0002" title="AllenJB .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to A Todorovac 28th of August 2019. AllenJJ , SchnyerRN , HittSK .The efficacy of acupuncture in the treatment of major depression in women. Psychological Science1998;9(5):397-401. ">Allen 1998</a> ; <a href="./references#MR000050-bbs2-0003" title="AllenJB .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 28th of August 2019. AllenJJ , SchnyerRN , ChambersAS , HittSK , MorenoFA , ManberR .Acupuncture for depression: a randomized controlled trial. Journal of Clinical Psychiatry2006;67(11):1665-73. ">Allen 2006</a> ; <a href="./references#MR000050-bbs2-0006" title="AyenI , HautzingerM .Cognitive behavior therapy for depression in menopausal women. A controlled, randomized treatment study [Kognitive Verhaltenstherapie bei Depressionen im Klimakterium: Eine kontrollierte, randomiserte Interventionsstudie]. Zeitschrift für Klinische Psychologie und Psychotherapie2004;33(4):290-9. AyenI .Inclusion of study in Cochrane Systematic Review (personal communication). Email to EG Faltinsen 9th of September 2019. ">Ayen 2004</a> ; <a href="./references#MR000050-bbs2-0027" title="FuchsCZ , RehnLP .A self-control behavior therapy program for depression. Journal of Consulting and Clinical Psychology1977;45(2):206-15. ">Fuchs 1977</a> ; <a href="./references#MR000050-bbs2-0035" title="KelleyJ .Inclusion of study in Cochrane Systematic Review (personal communication). Email to: A Todorovac 12th of August 2019. KelleyJM , KaptchukTJ , CusinC , LipkinS , FavaM .Open-label placebo for major depressive disorder: a pilot randomized controlled trial. Psychotherapy and Psychosomatics2012;81(5):312-4. ">Kelley 2012</a> ; <a href="./references#MR000050-bbs2-0047" title="LegrandF .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 14th of August 2019. LegrandFD , NeffEM .Efficacy of exercise as an adjunct treatment for clinically depressed inpatients during the initial stages of antidepressant pharmacotherapy: an open randomized controlled trial. Journal of Affective Disorders2016;191:139-44. ">Legrand 2016</a> ; <a href="./references#MR000050-bbs2-0050" title="LiddleB , SpenceSH .Cognitive-behaviour therapy with depressed primary school children: A cautionary note. Behavioural Psychotherapy1990;18(2):85-102. ">Liddle 1990</a> ; <a href="./references#MR000050-bbs2-0057" title="NandiDN , AjmanyS , GanguliH , BanerjeeG , BoralGC , GhoshA , et al.A clinical evaluation of depressives found in a rural survey in India. British Journal of Psychiatry1976;128:523-7. ">Nandi 1976</a> ; <a href="./references#MR000050-bbs2-0064" title="PolandRE , GertsikL , FavreauJT , SmithSI , MirochaJM , RaoU , et al.Open-label randomized parallel-group controlled clinical trial of massage for treatment of depression in HIV-infected subjects. Journal of Alternative and Complementary Medicine2013;19(4):334-40. ">Poland 2013</a> ; <a href="./references#MR000050-bbs2-0096" title="WollersheimJP , WilsonGL .Group treatment of unipolar depression: a comparison of coping, supportive, bibliotherapy, and delayed treatment groups. Professional Psychology: Research and Practice1991;22(6):496-502. ">Wollersheim 1991</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Neurodegenerative disease</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#MR000050-bbs2-0043" title="KwanR .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 26th of August 2019. KwanRY , LeungMC , LaiCK .Acupressure for agitation in nursing home residents with dementia: study protocol for a randomized controlled trial. Trials2014;15(410):1-7. KwanRY , LeungMCP , LaiCK .A randomized controlled trial examining the effect of acupressure on agitation and salivary cortisol in nursing home residents with dementia. Dementia and Geriatric Cognitive Disorders2017;44(1-2):92-104. ">Kwan 2017</a> ; <a href="./references#MR000050-bbs2-0045" title="LaiCK , ChiI , Kayser-JonesJ .A randomized controlled trial of a specific reminiscence approach to promote the well-being of nursing home residents with dementia. International Psychogeriatrics2004;16(1):33-49. LaiK .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 6th of September 2019. ">Lai 2004</a> ; <a href="./references#MR000050-bbs2-0056" title="MitchellC , MansfieldD , RautenbachS .Coloured filters and reading accuracy, comprehension and rate: a placebo-controlled study. Perceptual and Motor Skills2008;106(2):517-32. ">Mitchell 2008</a> ; <a href="./references#MR000050-bbs2-0069" title="QuayhagenMP , QuayhagenM , CorbeilRR , RothPA , RodgersJA .A dyadic remediation program for care recipients with dementia. Nursing Research1995;44(3):153-9. ">Quayhagen 1995</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Post‐Traumatic Stress‐Disorder (PTSD)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#MR000050-bbs2-0021" title="EhlersA , HackmannA , GreyN , WildJ , LinessS , AlbertI , et al.A randomized controlled trial of 7-day intensive and standard weekly cognitive therapy for PTSD and emotion-focused supportive therapy. American Journal of Psychiatry2014;171(3):294-304. ">Ehlers 2014</a> ; <a href="./references#MR000050-bbs2-0024" title="FoaEB , RothbaumBO , RiggsDS , MurdockTB .Treatment of posttraumatic stress disorder in rape victims: a comparison between cognitive-behavioral procedures and counselling. Journal of Consulting and Clinical Psychology1991;59(5):715-23. ">Foa 1991</a> ; <a href="./references#MR000050-bbs2-0025" title="FoaEB , McLeanCP , ZangY , RosenfieldD , YadinE , YarvisJS , et al.Effect of prolonged exposure therapy delivered over 2 weeks vs 8 weeks vs present-centered therapy on PTSD symptom severity in military personnel: a randomized clinical trial. JAMA2018;319(4):354-64. ">Foa 2018</a> ; <a href="./references#MR000050-bbs2-0079" title="ShalevAY , AnkriY , Isreali-ShalevY , PelegT , AdesskyR , FreedmanS .Prevention of posttraumatic stress disorder by early treatment. Archives of General Psychiatry2012;69(2):166-76. ">Shalev 2012</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Sleep‐wake disorders (e.g. insomnia, sleep disturbance)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>11</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#MR000050-bbs2-0005" title="AscherLM , TurnerR .Paradoxical intention and insomnia: an experimental investigation. Behaviour Research and Therapy1979;17(4):408-11. ">Ascher 1979</a> ; <a href="./references#MR000050-bbs2-0009" title="BorkovecTD , KaloupekDG , SlamaKM .The facilitative effect of muscle tension-release in the relaxation treatment of sleep disturbance. Behavior Therapy1975;6(3):301-9. ">Borkovec 1975</a> ; <a href="./references#MR000050-bbs2-0010" title="BorkovecTD , WeertsTC .Effects of progressive relaxation on sleep disturbance: an electroencephalographic evaluation. Psychosomatic Medicine1976;38(3):173-80. ">Borkovec 1976</a> ; <a href="./references#MR000050-bbs2-0022" title="EspieCA , BrooksDN , LindsayWR .An evaluation of tailored psychological treatment of insomnia. Journal of Behavior Therapy and Experimental Psychiatry1989;20(2):143-53. EspieCA , LindsayWR , BrooksDN , HoodEM , TurveyT .A controlled comparative investigation of psychological treatments for chronic sleep-onset insomnia. Behaviour Research and Therapy1989;27(1):79-88. ">Espie 1989a</a> ; <a href="./references#MR000050-bbs2-0026" title="FreireAO , SugaiGC , ChrispinFS , TogeiroSM , YamamuraY , MelloLE , et al.Treatment of moderate obstructive sleep apnea syndrome with acupuncture: a randomised, placebo-controlled pilot trial. Sleep Medicine2007;8(1):43-50. ">Freire 2007</a> ; <a href="./references#MR000050-bbs2-0049" title="LickJR , HefflerD .Relaxation training and attention placebo in the treatment of severe insomnia. Journal of Consulting and Clinical Psychology1977;45(2):153-61. ">Lick 1977</a> ; <a href="./references#MR000050-bbs2-0058" title="NicassioP , BootzinR .A comparison of progressive relaxation and autogenic training as treatments for insomnia. Journal of Abnormal Psychology1974;83(3):253-60. ">Nicassio 1974</a> ; <a href="./references#MR000050-bbs2-0080" title="ShealyRC .The effectiveness of various treatment techniques on different degrees and durations of sleep-onset insomnia. Behaviour Research and Therapy1979;17(6):541-6. ">Shealy 1979</a> ; <a href="./references#MR000050-bbs2-0083" title="SteinmarkSW , BorkovecTD .Active and placebo treatment effects on moderate insomnia under counterdemand and positive demand instructions. Journal of Abnormal Psychology1974;83(2):157-63. ">Steinmark 1974</a> ; <a href="./references#MR000050-bbs2-0089" title="AscherML , TurnerRM .A comparison of two methods for the administration of paradoxical intention. Behaviour Research and Therapy1980;18(2):121-6. TurnerRM , AscherLM .Controlled comparison of progressive relaxation, stimulus control, and paradoxical intention therapies for insomnia. Journal of Consulting and Clinical Psychology1979;47(3):500-8. ">Turner 1979</a> ; <a href="./references#MR000050-bbs2-0090" title="VanderplateC .Electromyograph biofeedback Treatment of sleep onset Insomnia: a controlled Investigation. Dissertation, University of Southern Mississippi1978. ">Vanderplate 1983</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Substance use disorders of different kind (e.g. alcohol, cocaine)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#MR000050-bbs2-0004" title="AlvarezJR .The effects of anger management training on depression, anger, self-concept, and treatment responsibility in a sample of drug-dependent individuals in a therapeutic community. Dissertation Abstracts International: Section B: the Sciences and Engineering1997;58(4-B):2108. ">Alvarez 1997</a> ; <a href="./references#MR000050-bbs2-0011" title="BornovalovaM .Inclusion of study in Cochrane Systematic Review (personal communication). Email to A Todorovac. 21st of August 2019. BornovalovaMA .Distress tolerance treatment for inner-city drug users: a preliminary trial. Doctor’s Dissertation, University of Maryland2008. ">Bornovalova 2008</a> ; <a href="./references#MR000050-bbs2-0063" title="PetersonMA , PattersonB , PillmanBM , BattistaMA .Cognitive recovery following alcohol detoxification: a computerised remediation study. Neuropsychological Rehabilitation2002;12(1):63-74. PillmanBM .Computerized cognitive remediation with recently detoxified alcoholics. Dissertation, California School of Professional Psychology, Fresno Campus2000. ">Pillman 2001</a> ; <a href="./references#MR000050-bbs2-0074" title="RoehrichL , GoldmanMS .Experience-dependent neuropsychological recovery and the treatment of alcoholism. Journal of Consulting and Clinical Psychology1993;61(5):812-21. ">Roehrich 1993</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Reported data on specific mental health diagnoses for psychological placebos (three or more trials)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Anxiety disorders of different kind (e.g. specific anxiety, social anxiety, panic disorder) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>11</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#MR000050-bbs2-0023" title="EtringerBD , CashTF , RimmDC .Behavioral, affective, and cognitive effects of participant modeling and an equally credible placebo. Behavior Therapy1982;13(4):476-85. ">Etringer 1982</a> ; <a href="./references#MR000050-bbs2-0029" title="GoldsteinAJ , BeursE , Chambless Dl, WilsonKA .EMDR for panic disorder with agoraphobia: comparison with waiting list and credible attention-placebo control conditions. Journal of Consulting and Clinical Psychology2000;68(6):947-56. ">Goldstein 2000</a> ; <a href="./references#MR000050-bbs2-0042" title="KrapflJE , NawasMM .Differential ordering of stimulus presentation in systematic desensitization. Journal of Abnormal Psychology1970;75(3):333-7. ">Krapfl 1970</a> ; <a href="./references#MR000050-bbs2-0048" title="LickJ .Expectancy, false galvanic skin response feedback, and systematic desensitization in the modification of phobic behavior. Journal of Consulting and Clinical Psychology1975;43(4):557-67. ">Lick 1975</a> ; <a href="./references#MR000050-bbs2-0055" title="MirandaA , ArlandisP , SorianoM .Instruction in strategies and attributional training: Effects on the problem-solving and self-concept of students’ with learning disabilities [Instrucción en estrategias y entrenamiento atribucional: efectos sobre la resolución de problemas y el autoconcepto de los estudiantes con dificultades en el aprendizaje]. Infancia y Aprendizaje1997;20(80):37-52. ">Miranda 1997</a> ; <a href="./references#MR000050-bbs2-0062" title="PedletonMG , HigginsRL .A comparison of negative practice and systematic desensitization in the treatment of acrophobia. Journal of Behavior Therapy and Experimental Psychiatry1983;14(4):317-23. ">Pendleton 1983</a> ; <a href="./references#MR000050-bbs2-0065" title="PowersMB , SmitsJA , TelchMJ .Disentangling the effects of safety-behavior utilization and safety-behavior availability during exposure-based treatment: a placebo-controlled trial. Journal of Consulting and Clinical Psychology2004;72(3):448-54. ">Powers 2004</a> ; <a href="./references#MR000050-bbs2-0066" title="PowersMB , SmithsJA , WhitleyD , BystritskyA , TelchMJ .The effect of attributional processes concerning medication taking on return of fear. Journal of Consulting and Clinical Psychology2008;76(3):478-90. ">Powers 2008a</a> ; <a href="./references#MR000050-bbs2-0075" title="OlivaresJ .Program IAFS. Protocol for the treatment of social phobia in adolescents [Programa IAFS. Protocolo para el tratamiento de la fobia social enadolescentes]. Madrid: Pirámide2005;1. Rosa-AlcázarAI , Olivares-OlivaresPJ , OlivaresJ .The role of non-specific effects in the psychological treatment of adolescents with social phobia [Papel de los efectos inespecíficos en el tratamiento psicológico de adolescentes con fobia social]. Anuario de Psicologia2009;40(1):43-61. ">Rosa‐Alcatraz 2009</a> ; <a href="./references#MR000050-bbs2-0076" title="RosenGM , GlasgowRE , BarreraM .A controlled study to assess the clinical efficacy of totally self-administrated systematic desensitization. Journal of Consulting and Clinical Psychology1976;44(2):208-17. ">Rosen 1976</a> ; <a href="./references#MR000050-bbs2-0084" title="SzymanskiJ , O'DonohueW .The potential role of state-dependent learning in cognitive therapy with spider phobics. Journal of Rational-Emotive &amp; Cognitive-Behavior Therapy1995;13(2):131-50. SzymanskiJ .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 20th of August 2019. ">Szymanski 1995</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Depression</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#MR000050-bbs2-0006" title="AyenI , HautzingerM .Cognitive behavior therapy for depression in menopausal women. A controlled, randomized treatment study [Kognitive Verhaltenstherapie bei Depressionen im Klimakterium: Eine kontrollierte, randomiserte Interventionsstudie]. Zeitschrift für Klinische Psychologie und Psychotherapie2004;33(4):290-9. AyenI .Inclusion of study in Cochrane Systematic Review (personal communication). Email to EG Faltinsen 9th of September 2019. ">Ayen 2004</a> ; <a href="./references#MR000050-bbs2-0027" title="FuchsCZ , RehnLP .A self-control behavior therapy program for depression. Journal of Consulting and Clinical Psychology1977;45(2):206-15. ">Fuchs 1977</a> ; <a href="./references#MR000050-bbs2-0050" title="LiddleB , SpenceSH .Cognitive-behaviour therapy with depressed primary school children: A cautionary note. Behavioural Psychotherapy1990;18(2):85-102. ">Liddle 1990</a> ; <a href="./references#MR000050-bbs2-0096" title="WollersheimJP , WilsonGL .Group treatment of unipolar depression: a comparison of coping, supportive, bibliotherapy, and delayed treatment groups. Professional Psychology: Research and Practice1991;22(6):496-502. ">Wollersheim 1991</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Post‐Traumatic Stress‐Disorder (PTSD)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#MR000050-bbs2-0021" title="EhlersA , HackmannA , GreyN , WildJ , LinessS , AlbertI , et al.A randomized controlled trial of 7-day intensive and standard weekly cognitive therapy for PTSD and emotion-focused supportive therapy. American Journal of Psychiatry2014;171(3):294-304. ">Ehlers 2014</a> ; <a href="./references#MR000050-bbs2-0024" title="FoaEB , RothbaumBO , RiggsDS , MurdockTB .Treatment of posttraumatic stress disorder in rape victims: a comparison between cognitive-behavioral procedures and counselling. Journal of Consulting and Clinical Psychology1991;59(5):715-23. ">Foa 1991</a> ; <a href="./references#MR000050-bbs2-0025" title="FoaEB , McLeanCP , ZangY , RosenfieldD , YadinE , YarvisJS , et al.Effect of prolonged exposure therapy delivered over 2 weeks vs 8 weeks vs present-centered therapy on PTSD symptom severity in military personnel: a randomized clinical trial. JAMA2018;319(4):354-64. ">Foa 2018</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Sleep‐wake disorders (e.g. insomnia, sleep disturbance)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#MR000050-bbs2-0005" title="AscherLM , TurnerR .Paradoxical intention and insomnia: an experimental investigation. Behaviour Research and Therapy1979;17(4):408-11. ">Ascher 1979</a> ; <a href="./references#MR000050-bbs2-0009" title="BorkovecTD , KaloupekDG , SlamaKM .The facilitative effect of muscle tension-release in the relaxation treatment of sleep disturbance. Behavior Therapy1975;6(3):301-9. ">Borkovec 1975</a> ; <a href="./references#MR000050-bbs2-0010" title="BorkovecTD , WeertsTC .Effects of progressive relaxation on sleep disturbance: an electroencephalographic evaluation. Psychosomatic Medicine1976;38(3):173-80. ">Borkovec 1976</a> ; <a href="./references#MR000050-bbs2-0022" title="EspieCA , BrooksDN , LindsayWR .An evaluation of tailored psychological treatment of insomnia. Journal of Behavior Therapy and Experimental Psychiatry1989;20(2):143-53. EspieCA , LindsayWR , BrooksDN , HoodEM , TurveyT .A controlled comparative investigation of psychological treatments for chronic sleep-onset insomnia. Behaviour Research and Therapy1989;27(1):79-88. ">Espie 1989a</a> ; <a href="./references#MR000050-bbs2-0080" title="ShealyRC .The effectiveness of various treatment techniques on different degrees and durations of sleep-onset insomnia. Behaviour Research and Therapy1979;17(6):541-6. ">Shealy 1979</a> ; <a href="./references#MR000050-bbs2-0083" title="SteinmarkSW , BorkovecTD .Active and placebo treatment effects on moderate insomnia under counterdemand and positive demand instructions. Journal of Abnormal Psychology1974;83(2):157-63. ">Steinmark 1974</a> ; <a href="./references#MR000050-bbs2-0089" title="AscherML , TurnerRM .A comparison of two methods for the administration of paradoxical intention. Behaviour Research and Therapy1980;18(2):121-6. TurnerRM , AscherLM .Controlled comparison of progressive relaxation, stimulus control, and paradoxical intention therapies for insomnia. Journal of Consulting and Clinical Psychology1979;47(3):500-8. ">Turner 1979</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Substance use disorders of different kind (e.g. alcohol, cocaine)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#MR000050-bbs2-0004" title="AlvarezJR .The effects of anger management training on depression, anger, self-concept, and treatment responsibility in a sample of drug-dependent individuals in a therapeutic community. Dissertation Abstracts International: Section B: the Sciences and Engineering1997;58(4-B):2108. ">Alvarez 1997</a> ; <a href="./references#MR000050-bbs2-0011" title="BornovalovaM .Inclusion of study in Cochrane Systematic Review (personal communication). Email to A Todorovac. 21st of August 2019. BornovalovaMA .Distress tolerance treatment for inner-city drug users: a preliminary trial. Doctor’s Dissertation, University of Maryland2008. ">Bornovalova 2008</a> ; <a href="./references#MR000050-bbs2-0074" title="RoehrichL , GoldmanMS .Experience-dependent neuropsychological recovery and the treatment of alcoholism. Journal of Consulting and Clinical Psychology1993;61(5):812-21. ">Roehrich 1993</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Reported data on specific mental health diagnoses for pharmacological placebos (three or more trials)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Attention Deficit Hyperactivity Disorder (ADHD) or Attention Deficit Disorder (ADD)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#MR000050-bbs2-0008" title="Borden, KA.Attributional Outcomes: the Subtle Messages of Treatments for Attention Deficit Disorder. Dissertation, University of Illinois at Urbana-Champaign1986. BordenKA , BrownRT .Attributional outcomes: The subtle messages of treatments for attention deficit disorder. Cognitive Therapy and Research1989;13(2):147-60. ">Borden 1986</a> ; <a href="./references#MR000050-bbs2-0015" title="CarlsonCL , PelhamWE , MilichR , HozaB .ADHD boys’ performance and attributions following success and failure: drug effects and individual differences. Cognitive Therapy and Research1993;17:269-87. ">Carlson 1993</a> ; <a href="./references#MR000050-bbs2-0061" title="MilichR , CarlsonCL , Pelham WE Jr, LichtBG .Effects of methylphenidate on the persistence of ADHD boys following failure experiences. Journal of Abnormal Child Psychology1991;19(5):519-36. PelhamWE , MurphyDA , VannattaK , MilichR , LichtBG , GnagyEM , et al.Methylphenidate and attributions in boys with attention-deficit hyperactivity disorder. Journal of Consulting and Clinical Psychology1992;60(2):282-92. ">Pelham 1992</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Reported data on specific mental health diagnoses for physical placebos (three or more trials)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Anxiety disorders of different kind (e.g. specific anxiety, social anxiety, panic disorder) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#MR000050-bbs2-0034" title="KarstM , WinterhalterM , MünteS , FranckiB , HondronikosA , EckardtA , et al.Auricular acupuncture for dental anxiety: a randomized controlled trial. Anesthesia and Analgesia2007;104(2):295-300. KarstM .Inclusion of study in Cochrane Systematic Review (personal communication). Email to: EG Faltinsen 5th of September 2019. ">Karst 2007</a> ; <a href="./references#MR000050-bbs2-0087" title="ToriC , WorellL .Reduction of human avoidant behavior. A comparison of counterconditioning, expectancy, and cognitive information approaches. Clinical Psychology1973;41(2):269-78. ">Tori 1973</a> ; <a href="./references#MR000050-bbs2-0095" title="WolitzkyKB , TelchMJ .Augmenting in vivo exposure with fear antagonistic actions: a preliminary test. Behavior Therapy2009;40(1):57-71. ">Wolitzky 2009</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Depression</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#MR000050-bbs2-0002" title="AllenJB .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to A Todorovac 28th of August 2019. AllenJJ , SchnyerRN , HittSK .The efficacy of acupuncture in the treatment of major depression in women. Psychological Science1998;9(5):397-401. ">Allen 1998</a> ; <a href="./references#MR000050-bbs2-0003" title="AllenJB .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 28th of August 2019. AllenJJ , SchnyerRN , ChambersAS , HittSK , MorenoFA , ManberR .Acupuncture for depression: a randomized controlled trial. Journal of Clinical Psychiatry2006;67(11):1665-73. ">Allen 2006</a> ; <a href="./references#MR000050-bbs2-0047" title="LegrandF .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 14th of August 2019. LegrandFD , NeffEM .Efficacy of exercise as an adjunct treatment for clinically depressed inpatients during the initial stages of antidepressant pharmacotherapy: an open randomized controlled trial. Journal of Affective Disorders2016;191:139-44. ">Legrand 2016</a> ; <a href="./references#MR000050-bbs2-0064" title="PolandRE , GertsikL , FavreauJT , SmithSI , MirochaJM , RaoU , et al.Open-label randomized parallel-group controlled clinical trial of massage for treatment of depression in HIV-infected subjects. Journal of Alternative and Complementary Medicine2013;19(4):334-40. ">Poland 2013</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Sleep‐wake disorders (e.g. insomnia, sleep disturbance)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#MR000050-bbs2-0026" title="FreireAO , SugaiGC , ChrispinFS , TogeiroSM , YamamuraY , MelloLE , et al.Treatment of moderate obstructive sleep apnea syndrome with acupuncture: a randomised, placebo-controlled pilot trial. Sleep Medicine2007;8(1):43-50. ">Freire 2007</a> ; <a href="./references#MR000050-bbs2-0049" title="LickJR , HefflerD .Relaxation training and attention placebo in the treatment of severe insomnia. Journal of Consulting and Clinical Psychology1977;45(2):153-61. ">Lick 1977</a> ; <a href="./references#MR000050-bbs2-0058" title="NicassioP , BootzinR .A comparison of progressive relaxation and autogenic training as treatments for insomnia. Journal of Abnormal Psychology1974;83(3):253-60. ">Nicassio 1974</a> ; <a href="./references#MR000050-bbs2-0090" title="VanderplateC .Electromyograph biofeedback Treatment of sleep onset Insomnia: a controlled Investigation. Dissertation, University of Southern Mississippi1978. ">Vanderplate 1983</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Reported non‐serious adverse events</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>All placebos</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>14</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#MR000050-bbs2-0006" title="AyenI , HautzingerM .Cognitive behavior therapy for depression in menopausal women. A controlled, randomized treatment study [Kognitive Verhaltenstherapie bei Depressionen im Klimakterium: Eine kontrollierte, randomiserte Interventionsstudie]. Zeitschrift für Klinische Psychologie und Psychotherapie2004;33(4):290-9. AyenI .Inclusion of study in Cochrane Systematic Review (personal communication). Email to EG Faltinsen 9th of September 2019. ">Ayen 2004</a> ; <a href="./references#MR000050-bbs2-0021" title="EhlersA , HackmannA , GreyN , WildJ , LinessS , AlbertI , et al.A randomized controlled trial of 7-day intensive and standard weekly cognitive therapy for PTSD and emotion-focused supportive therapy. American Journal of Psychiatry2014;171(3):294-304. ">Ehlers 2014</a> ; <a href="./references#MR000050-bbs2-0025" title="FoaEB , McLeanCP , ZangY , RosenfieldD , YadinE , YarvisJS , et al.Effect of prolonged exposure therapy delivered over 2 weeks vs 8 weeks vs present-centered therapy on PTSD symptom severity in military personnel: a randomized clinical trial. JAMA2018;319(4):354-64. ">Foa 2018</a> ; <a href="./references#MR000050-bbs2-0026" title="FreireAO , SugaiGC , ChrispinFS , TogeiroSM , YamamuraY , MelloLE , et al.Treatment of moderate obstructive sleep apnea syndrome with acupuncture: a randomised, placebo-controlled pilot trial. Sleep Medicine2007;8(1):43-50. ">Freire 2007</a> ; <a href="./references#MR000050-bbs2-0029" title="GoldsteinAJ , BeursE , Chambless Dl, WilsonKA .EMDR for panic disorder with agoraphobia: comparison with waiting list and credible attention-placebo control conditions. Journal of Consulting and Clinical Psychology2000;68(6):947-56. ">Goldstein 2000</a> ; <a href="./references#MR000050-bbs2-0034" title="KarstM , WinterhalterM , MünteS , FranckiB , HondronikosA , EckardtA , et al.Auricular acupuncture for dental anxiety: a randomized controlled trial. Anesthesia and Analgesia2007;104(2):295-300. KarstM .Inclusion of study in Cochrane Systematic Review (personal communication). Email to: EG Faltinsen 5th of September 2019. ">Karst 2007</a> ; <a href="./references#MR000050-bbs2-0041" title="KloskoJS , BarlowDH , TassinariR , CernyJA .A comparison of alprazolam and behavior therapy in treatment of panic disorder: correction. Journal of Psychotherapy Practice and Research1994;3(2):163-79. KloskoJS , BarlowDH , TassinariR , CernyJA .A comparison of alprazolam and behavior therapy in treatment of panic disorder. Journal of Consulting and Clinical Psychology1990;58(1):77-84. ">Klosko 1990</a> ; <a href="./references#MR000050-bbs2-0043" title="KwanR .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 26th of August 2019. KwanRY , LeungMC , LaiCK .Acupressure for agitation in nursing home residents with dementia: study protocol for a randomized controlled trial. Trials2014;15(410):1-7. KwanRY , LeungMCP , LaiCK .A randomized controlled trial examining the effect of acupressure on agitation and salivary cortisol in nursing home residents with dementia. Dementia and Geriatric Cognitive Disorders2017;44(1-2):92-104. ">Kwan 2017</a> ; <a href="./references#MR000050-bbs2-0044" title="LacyMK .The effect of short term autogenic training on the stress reactivity of hospitalized emotionally disturbed adolescents. ProQuest Dissertations Publishing, Oklahoma State University1996. ">Lacy 1990</a> ; <a href="./references#MR000050-bbs2-0047" title="LegrandF .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 14th of August 2019. LegrandFD , NeffEM .Efficacy of exercise as an adjunct treatment for clinically depressed inpatients during the initial stages of antidepressant pharmacotherapy: an open randomized controlled trial. Journal of Affective Disorders2016;191:139-44. ">Legrand 2016</a> ; <a href="./references#MR000050-bbs2-0052" title="McLachlanDR , DaltonAJ , KruckTP , BellMY , SmithWL , KalowW , et al.Intramuscular desferrioxamine in patients with Alzheimer's disease. Lancet1991;337(8753):1304-8. McLachlanDRC , SmithWL , KruckTP .Desferrioxamine and Alzheimer’s disease: video home behavior assessment of clinical course and measures of brain aluminum. Therapeutic Drug Monitoring1993;15(6):602-7. ">McLachlan 1991</a> ; <a href="./references#MR000050-bbs2-0057" title="NandiDN , AjmanyS , GanguliH , BanerjeeG , BoralGC , GhoshA , et al.A clinical evaluation of depressives found in a rural survey in India. British Journal of Psychiatry1976;128:523-7. ">Nandi 1976</a> ; <a href="./references#MR000050-bbs2-0094" title="WilsonA , DavidsonWJ , BlanchardR , WhiteJ .Disulfiram implantation. A placebo-controlled trial with two-year follow-up. Journal of Studies on Alcohol1978;39(5):809-19. WilsonA , DavidsonWJ , BlanchardR .Disulfiram implantation: a trial using placebo implants and two types of controls. Journal of Studies on Alcohol1980;41(5):429-36. ">Wilson 1980</a> ; <a href="./references#MR000050-bbs2-0096" title="WollersheimJP , WilsonGL .Group treatment of unipolar depression: a comparison of coping, supportive, bibliotherapy, and delayed treatment groups. Professional Psychology: Research and Practice1991;22(6):496-502. ">Wollersheim 1991</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Psychological placebos</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#MR000050-bbs2-0006" title="AyenI , HautzingerM .Cognitive behavior therapy for depression in menopausal women. A controlled, randomized treatment study [Kognitive Verhaltenstherapie bei Depressionen im Klimakterium: Eine kontrollierte, randomiserte Interventionsstudie]. Zeitschrift für Klinische Psychologie und Psychotherapie2004;33(4):290-9. AyenI .Inclusion of study in Cochrane Systematic Review (personal communication). Email to EG Faltinsen 9th of September 2019. ">Ayen 2004</a> ; <a href="./references#MR000050-bbs2-0021" title="EhlersA , HackmannA , GreyN , WildJ , LinessS , AlbertI , et al.A randomized controlled trial of 7-day intensive and standard weekly cognitive therapy for PTSD and emotion-focused supportive therapy. American Journal of Psychiatry2014;171(3):294-304. ">Ehlers 2014</a> ; <a href="./references#MR000050-bbs2-0025" title="FoaEB , McLeanCP , ZangY , RosenfieldD , YadinE , YarvisJS , et al.Effect of prolonged exposure therapy delivered over 2 weeks vs 8 weeks vs present-centered therapy on PTSD symptom severity in military personnel: a randomized clinical trial. JAMA2018;319(4):354-64. ">Foa 2018</a> ; <a href="./references#MR000050-bbs2-0029" title="GoldsteinAJ , BeursE , Chambless Dl, WilsonKA .EMDR for panic disorder with agoraphobia: comparison with waiting list and credible attention-placebo control conditions. Journal of Consulting and Clinical Psychology2000;68(6):947-56. ">Goldstein 2000</a> ; <a href="./references#MR000050-bbs2-0096" title="WollersheimJP , WilsonGL .Group treatment of unipolar depression: a comparison of coping, supportive, bibliotherapy, and delayed treatment groups. Professional Psychology: Research and Practice1991;22(6):496-502. ">Wollersheim 1991</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Pharmacologica placebos</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#MR000050-bbs2-0041" title="KloskoJS , BarlowDH , TassinariR , CernyJA .A comparison of alprazolam and behavior therapy in treatment of panic disorder: correction. Journal of Psychotherapy Practice and Research1994;3(2):163-79. KloskoJS , BarlowDH , TassinariR , CernyJA .A comparison of alprazolam and behavior therapy in treatment of panic disorder. Journal of Consulting and Clinical Psychology1990;58(1):77-84. ">Klosko 1990</a> ; <a href="./references#MR000050-bbs2-0052" title="McLachlanDR , DaltonAJ , KruckTP , BellMY , SmithWL , KalowW , et al.Intramuscular desferrioxamine in patients with Alzheimer's disease. Lancet1991;337(8753):1304-8. McLachlanDRC , SmithWL , KruckTP .Desferrioxamine and Alzheimer’s disease: video home behavior assessment of clinical course and measures of brain aluminum. Therapeutic Drug Monitoring1993;15(6):602-7. ">McLachlan 1991</a> ; <a href="./references#MR000050-bbs2-0057" title="NandiDN , AjmanyS , GanguliH , BanerjeeG , BoralGC , GhoshA , et al.A clinical evaluation of depressives found in a rural survey in India. British Journal of Psychiatry1976;128:523-7. ">Nandi 1976</a> ; <a href="./references#MR000050-bbs2-0094" title="WilsonA , DavidsonWJ , BlanchardR , WhiteJ .Disulfiram implantation. A placebo-controlled trial with two-year follow-up. Journal of Studies on Alcohol1978;39(5):809-19. WilsonA , DavidsonWJ , BlanchardR .Disulfiram implantation: a trial using placebo implants and two types of controls. Journal of Studies on Alcohol1980;41(5):429-36. ">Wilson 1980</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Physical placebos</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#MR000050-bbs2-0026" title="FreireAO , SugaiGC , ChrispinFS , TogeiroSM , YamamuraY , MelloLE , et al.Treatment of moderate obstructive sleep apnea syndrome with acupuncture: a randomised, placebo-controlled pilot trial. Sleep Medicine2007;8(1):43-50. ">Freire 2007</a> ; <a href="./references#MR000050-bbs2-0034" title="KarstM , WinterhalterM , MünteS , FranckiB , HondronikosA , EckardtA , et al.Auricular acupuncture for dental anxiety: a randomized controlled trial. Anesthesia and Analgesia2007;104(2):295-300. KarstM .Inclusion of study in Cochrane Systematic Review (personal communication). Email to: EG Faltinsen 5th of September 2019. ">Karst 2007</a> ; <a href="./references#MR000050-bbs2-0043" title="KwanR .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 26th of August 2019. KwanRY , LeungMC , LaiCK .Acupressure for agitation in nursing home residents with dementia: study protocol for a randomized controlled trial. Trials2014;15(410):1-7. KwanRY , LeungMCP , LaiCK .A randomized controlled trial examining the effect of acupressure on agitation and salivary cortisol in nursing home residents with dementia. Dementia and Geriatric Cognitive Disorders2017;44(1-2):92-104. ">Kwan 2017</a> ; <a href="./references#MR000050-bbs2-0044" title="LacyMK .The effect of short term autogenic training on the stress reactivity of hospitalized emotionally disturbed adolescents. ProQuest Dissertations Publishing, Oklahoma State University1996. ">Lacy 1990</a> ; <a href="./references#MR000050-bbs2-0047" title="LegrandF .Inclusion of study in Cochrane Systematic Review [personal communication]. Email to: A Todorovac 14th of August 2019. LegrandFD , NeffEM .Efficacy of exercise as an adjunct treatment for clinically depressed inpatients during the initial stages of antidepressant pharmacotherapy: an open randomized controlled trial. Journal of Affective Disorders2016;191:139-44. ">Legrand 2016</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Usual care</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 5.</span> <span class="table-title">Effects of methods</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/full#MR000050-tbl-0008">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="MR000050-tbl-0009"> <div class="table-heading"><span class="table-label">Table 6.</span> <span class="table-title">Differences from protocol and review</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Section</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Protocol</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Review</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Pooling of placebos</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>We planned to pool psychological, pharmacological, and physical placebos into one placebo for the first primary outcome. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>We pooled psychological, pharmacological, and physical placebos into a group called 'all placebos' for all outcomes. This was done to increase the power of the analysis regarding adverse events and specific mental health diagnosis. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Dealing with missing data</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>We planned to contact study authors for relevant missing data on our prImary and secondary outcomes. If the authors dId not respond after two attempts to contact them, we planned to stop communications. If we are not able to obtain missing data, we will use the available data (incomplete data) in the analyses. If data are not reported in a usable way, we will consult a statistician to explore its transformation. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>We contacted study authors for relevant missing data. However, we made a pragmatic decision not to contact authors from studies before 1990. This was due to lack of probability that these data would have been preserved. </p> <p>In trials that did not report standard deviation (SD), we created an artificially SD from trials with the same population, outcome, experimental and control intervention. </p> <p>Furthermore, if trials did not report the amount of participants included in each group, and the total amount of participant could be equally divided, we expected the groups to have the same amount of participants in each group. However, if the number could not be equally divided, we anticipated that the active interventions and active control interventions included more. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Subgroup analysis and investigation of heterogeneity</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>We planned to conduct subgroup analyses to make hypotheses about the subgroups mentioned below. </p> <p> <ol id="MR000050-list-0015"> <li> <p>Type of active intervention: i) psychological intervention, ii) pharmacological intervention, iii) physical intervention, or iv) other intervention. </p> </li> <li> <p>Overall risk of bias: i) high risk of bias or ii) low risk of bias.</p> </li> <li> <p>Type of outcome domain: i) blinded observer‐reported, ii) non‐blinded observer‐reported, or iii) patient‐reported. </p> </li> <li> <p>Type of comparator intervention: i) wait‐list or ii) no‐treatment.</p> </li> <li> <p>Awareness of placebo intervention: i) participants were aware that they might receive a placebo, or ii) participants were not aware of such. </p> </li> <li> <p>The trial objective: i) a trial’s objective is clearly to assess the effects of placebo, usual care, or wait‐list interventions, or ii) no such objectives are stated. </p> </li> <li> <p>Mean age of participants: i) &lt; 18 years, ii) 18 to 50 years, or iii) &gt; 50 years.</p> </li> <li> <p>Duration of intervention: i) three months or above or ii) below three months.</p> </li> <li> <p>Type of usual care: i) pharmacological, ii) psychological, iii) physical, or iv) other.</p> </li> <li> <p>Standardised usual care: i) the usual care intervention was intentionally standardised or manualised, or ii) no standardisation or manualisation. </p> </li> <li> <p>Mode of psychological treatment in usual care and psychological placebo: i) individual psychological treatment, or ii) group psychological treatment. </p> </li> </ol> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>We added four post‐hoc subgroup analyses:</p> <p> <ol id="MR000050-list-0016"> <li> <p>Mental health diagnoses: i) formal diagnosis according to DSM/ICD, ii) fulfil symptoms of disorder ICD/DSM while not stating classifications systems, and iii) population is classified as having a mental disorder, but full diagnostic criteria not reported. </p> </li> <li> <p>Type of psychological placebo: i) interaction placebo, ii) educational placebo, and iii) exposure placebo. </p> </li> <li> <p>Type of physical placebo: i) acupuncture or acupressure placebo, ii) exercise and relaxation placebo, iii) technical device placebo, and iv) electromagnetic stimulation placebo. </p> </li> <li> <p>Affiliation bias: i) Risk of affiliation, industry, allegiance bias, and ii) no risk of affiliation, industry, allegiance bias ( <a href="./references#MR000050-bbs2-0237" title="LeichsenringF , SteinertC , IoannidisJPA .Toward a paradigm shift in treatment and research of mental disorders. Psychological Medicine2019;49(13):2111-7.">Leichsenring 2019</a> ) </p> </li> </ol> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Sensitivity analysis</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Studies contributing to heterogeneity (‘outliers’) was planned to be removed to evaluate the impact of their statistical heterogeneity on the overall pooled effect estimate. We will remove outliers one by one and assess the impact on the overall outcome. We will conduct sensitivity analyses to determine whether findings are sensitive to the following decisions made during the review process. </p> <p> <ol id="MR000050-list-0017"> <li> <p>Our assessment of the level of clinical heterogeneity.</p> </li> <li> <p>Analytical technique (e.g. fixed‐effect and random‐effects models).</p> </li> <li> <p>Type of data collection (e.g. different ways to measure adverse events).</p> </li> <li> <p>Imputed data (comparing the analyses with available outcome data with those following the ITT principle). </p> </li> <li> <p>Combination of data in continuous outcomes (end of intervention or change scores).</p> </li> <li> <p>Use of cluster‐randomised trials.</p> </li> <li> <p>Impact of non‐normally distributed data.</p> </li> </ol> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>We were only able to perform the analyses 2, 3, 4, and 5 due to a lack of sufficient data. </p> <p>Furthermore, we included a test for imprecision, as assessed by GRADE, by conducting Trial Sequential Analysis (TSA) on our primary outcomes included in the <a href="./full#MR000050-tbl-0003">summary of findings Table 3</a> . </p> <p>We also included these two sensitivity analyses:</p> <p> <ol id="MR000050-list-0018"> <li> <p>The impact of including wait‐list interventions described as no‐intervention</p> </li> <li> <p>The impact of including no‐interventions described as wait‐list interventions</p> </li> </ol> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Meta‐regression</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>It was planned that we would conduct supplementary meta‐regression analyses on continuous outcome, based on the findings from the subgroup analyses. We planned to choose covariates based on relevant subgroup analyses, such as type of intervention, risk of bias, type of outcome domain, mean participant age and duration of interventions. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Due to a lack of data, meta‐regression analyses were not possible to conduct.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Selections of studies (participants)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>All patients in each included trial was required to have a formal diagnosis of a mental health disorder, according to the Diagnostic and Statistical Manual of Mental Disorders (DSM), First Edition (DSM‐I;APA 1952), SecondEdition (DSM‐II;APA 1968),Third Edition (DSM‐III; APA 1980), Third Edition Revised (DSM‐IIIR; APA 1987), Fourth Edition (DSM‐IV; APA 1994), Fourth Edition Text Revision (DSM‐IV‐TR; APA 2000), and Fifth Edition (DSM‐5; APA 2013), or according to the International Classification ofDiseases andRelatedHealth Problems (ICD), Sixth Edition (ICD‐6; WHO 1949), Seventh Edition (ICD‐7; WHO 1955), Eighth Edition (ICD‐8; WHO 1967), Ninth Edition (ICD‐9; WHO 1975), 10th Edition (ICD‐10; WHO 1993), or 11th Edition (ICD‐11; WHO 2018). </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>During the inclusion phase we identified trials, where patients fulfilled the symptoms of the disorder according to ICD or DSM, but where the trial did not explicitly state a classification system. Moreover, trials were also identified where the populations was classified as having a mental health disorder, but full diagnostic symptoms were not reported. We chose to include these in our analyses, and included a post‐hoc subgroup analysis testing the difference </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Decision hierarchy of outcomes</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>We used the following decision hierarchy to select the outcomes measuring effect.</p> <p> <ol id="MR000050-list-0019"> <li> <p>We first included the outcome indicated as the primary outcome in the trial report. This could for instance be the one used for the sample size calculation. We preferred data from end of treatment over follow‐up data. </p> </li> <li> <p>If the trial did not differentiate between primary and secondary outcomes or if more than one primary outcome was stated, we preferred continuous to dichotomous outcomes. </p> </li> <li> <p>If there were multiple continuous outcomes, we preferred observer‐reported to patient‐reported outcomes, and blinded to non‐blinded outcomes. </p> </li> </ol> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>During the extraction phase, we had to extend our decision hierarchy due to the fact that the pre‐defined hierarchy proved not to be sufficient. We added: </p> <p> <ol id="MR000050-list-0020"> <li> <p>If trials reported several observer‐reported outcomes, we included the outcomes that best captured the core symptoms of the mental health population being treated. Here, we preferred global scores over sub‐scores. </p> </li> <li> <p>We then identified the outcome measure with the best psychometric properties (e.g. validity and reliability). </p> </li> <li> <p>If still undecided, the final outcome measure was randomly decided.</p> </li> </ol> </p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 6.</span> <span class="table-title">Differences from protocol and review</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/full#MR000050-tbl-0009">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="MR000050-tbl-0010"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Wait‐list versus no‐treatment for people with mental health disorder</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.1 Wait‐list versus no‐treatment for people with mental health disorder <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Wait‐list versus no‐treatment for people with mental health disorder</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/references#MR000050-tbl-0010">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="MR000050-tbl-0011"> <div class="table-heading"><span class="table-label">Comparison 2.</span> <span class="table-title">Usual care versus wait‐list or no‐treatment for all mental health disorders</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.1 Usual care compared with wait‐list/no‐treatment for continuous data <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>523</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.33 [‐0.83, 0.16]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1.1 Usual care compared with wait‐list</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>443</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.53 [‐1.17, 0.10]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1.2 Usual care compared with no‐treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>80</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.08 [‐0.38, 0.53]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.2 Usual care compared with wait‐list/no‐treatment for dichotomous data <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>260</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.93 [0.34, 2.57]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.2.1 Usual care compared with wait‐list</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>260</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.93 [0.34, 2.57]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.2.2 Usual care compared with no‐treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Not estimable</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 2.</span> <span class="table-title">Usual care versus wait‐list or no‐treatment for all mental health disorders</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/references#MR000050-tbl-0011">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="MR000050-tbl-0012"> <div class="table-heading"><span class="table-label">Comparison 6.</span> <span class="table-title">All placebos versus waitl‐list or no‐treatment for people with mental health disorders</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6.1 All placebos compared with wait‐list/no‐treatment for continuous data <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>65</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2446</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.37 [‐0.49, ‐0.25]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.1.1 All placebos compared with wait‐list</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>31</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1410</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.55 [‐0.76, ‐0.35]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.1.2 All placebos compared with no‐treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>34</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1036</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.18 [‐0.30, ‐0.05]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6.2 All placebos compared with wait‐list/no‐treatment for dichotomous data <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>385</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.05 [0.74, 1.48]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.2.1 All placebos compared with wait‐list</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Not estimable</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.2.2 All placebos compared with no‐treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>385</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.05 [0.74, 1.48]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 6.</span> <span class="table-title">All placebos versus waitl‐list or no‐treatment for people with mental health disorders</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/references#MR000050-tbl-0012">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="MR000050-tbl-0013"> <div class="table-heading"><span class="table-label">Comparison 7.</span> <span class="table-title">Serious adverse events of placebos versus wait‐list or no‐treatment for people with mental health disorders</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">7.1 All placebos compared with wait‐list/no‐treatment for dichotomous data <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>11</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>517</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.00 [‐0.03, 0.03]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">7.2 Psychological placebos compared with wait‐list/no‐treatment for dichotomous data <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>207</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.01 [‐0.07, 0.04]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">7.3 Pharmacological placebos compared with wait‐list/no‐treatment for dichotomous data <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>125</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Difference (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.01 [‐0.08, 0.09]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">7.4 Physical placebos compared with wait‐list/no‐treatment for dichotomous data <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>185</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Difference (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.00 [‐0.04, 0.04]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 7.</span> <span class="table-title">Serious adverse events of placebos versus wait‐list or no‐treatment for people with mental health disorders</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/references#MR000050-tbl-0013">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="MR000050-tbl-0014"> <div class="table-heading"><span class="table-label">Comparison 8.</span> <span class="table-title">Non‐serious adverse events of all placebos versus wait‐list or no‐ treatment for people with mental health disorders</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">8.1 All placebos compared with wait‐list/no‐treatment for dichotomous data <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>14</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.03 [‐0.02, 0.08]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>8.1.1 All placebos compared with wait‐list</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.02 [‐0.07, 0.10]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>8.1.2 All placebos compared with no‐treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.04 [‐0.03, 0.10]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">8.2 Psychological placebos compared with wait‐list/no‐treatment for dichotomous data <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.01 [‐0.18, 0.19]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>8.2.1 Psychological placebos compared with wait‐list</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.01 [‐0.18, 0.19]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>8.2.2 Psychological placebos compared with no‐treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Not estimable</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">8.3 Pharmacological placebos compared with wait‐list/no‐treatment for dichotomous data <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>125</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Difference (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.08 [‐0.04, 0.21]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>8.3.1 Pharmacological placebos compared with wait‐list</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Difference (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Not estimable</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>8.3.2 Pharmacological placebos compared with no‐treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>125</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Difference (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.08 [‐0.04, 0.21]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">8.4 Physical placebos compared with wait‐list/no‐treatment for dichotomous data <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>185</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Difference (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.00 [‐0.04, 0.04]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>8.4.1 Physical placebos compared with wait‐list</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>111</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Difference (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.00 [‐0.04, 0.04]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>8.4.2 Physical placebos compared with no‐treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>74</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Difference (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.00 [‐0.09, 0.09]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 8.</span> <span class="table-title">Non‐serious adverse events of all placebos versus wait‐list or no‐ treatment for people with mental health disorders</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/references#MR000050-tbl-0014">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="MR000050-tbl-0015"> <div class="table-heading"><span class="table-label">Comparison 9.</span> <span class="table-title">Psychological placebos versus wait‐list or no‐treatment for people with mental health disorders</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">9.1 Psychological placebos compared with wait‐list/no‐treatment for continuous data <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>38</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1263</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.49 [‐0.66, ‐0.31]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>9.1.1 Psychological placebos compared with wait‐list</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>23</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>721</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.66 [‐0.92, ‐0.40]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>9.1.2 Psychological placebos compared with no‐treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>15</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>542</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.21 [‐0.38, ‐0.04]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">9.2 Psychological placebos compared with wait‐list/no‐treatment for dichotomous data <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>19</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Not estimable</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>9.2.1 Psychological placebos compared with wait‐list</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Not estimable</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>9.2.2 Psychological placebos compared with no‐treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>19</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Not estimable</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 9.</span> <span class="table-title">Psychological placebos versus wait‐list or no‐treatment for people with mental health disorders</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/references#MR000050-tbl-0015">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="MR000050-tbl-0016"> <div class="table-heading"><span class="table-label">Comparison 10.</span> <span class="table-title">Pharmacological placebos versus wait‐list or no‐treatment for people with mental health disorders</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">10.1 Pharmacological placebos compared with wait‐list/no‐treatment for continuous data <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>279</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.14 [‐0.39, 0.11]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>10.1.1 Pharmacological placebos compared with wait‐list</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>20</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.51 [‐1.41, 0.38]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>10.1.2 Pharmacological placebos compared with no‐treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>259</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.11 [‐0.37, 0.16]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">10.2 Pharmacological placebos compared with no‐treatment for continuous data <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>366</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.05 [0.74, 1.48]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>10.2.1 Pharmacological placebos compared with wait‐list</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Not estimable</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>10.2.2 Pharmacological placebos compared with no‐treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>366</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.05 [0.74, 1.48]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 10.</span> <span class="table-title">Pharmacological placebos versus wait‐list or no‐treatment for people with mental health disorders</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/references#MR000050-tbl-0016">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="MR000050-tbl-0017"> <div class="table-heading"><span class="table-label">Comparison 11.</span> <span class="table-title">Physical placebo versus wait‐list or no‐treatment for people with mental health disorders</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">11.1 Physical placebos compared with wait‐list/no‐treatment for continuous data <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>17</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>896</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.21 [‐0.35, ‐0.08]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>11.1.1 Physical placebos compared with wait‐list</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>669</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.30 [‐0.54, ‐0.06]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>11.1.2 Physical placebos compared with no‐treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>10</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>227</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.15 [‐0.42, 0.11]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 11.</span> <span class="table-title">Physical placebo versus wait‐list or no‐treatment for people with mental health disorders</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/references#MR000050-tbl-0017">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="MR000050-tbl-0018"> <div class="table-heading"><span class="table-label">Comparison 12.</span> <span class="table-title">All placebos versus wait‐list or no‐treatment for people with specific mental health disorders for continuous data</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">12.1 Efficacy of all placebos for people with substance use disorders <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>136</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.15 [‐0.49, 0.19]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>12.1.1 All placebos compared with wait‐list</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Not estimable</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>12.1.2 All placebos compared with no‐treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>136</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.15 [‐0.49, 0.19]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">12.2 Efficacy of all placebos for people with sleep‐wake disorders <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>11</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>229</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.34 [‐0.60, ‐0.07]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>12.2.1 All placebos compared with wait‐list</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>70</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.58 [‐1.10, ‐0.05]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>12.2.2 All placebos compared with no‐treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>159</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.24 [‐0.55, 0.08]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">12.3 Efficacy of all placebos for people with depression <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>10</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>286</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.42 [‐0.78, ‐0.05]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>12.3.1 All placebos compared with wait‐list</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>197</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.65 [‐1.15, ‐0.15]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>12.3.2 All placebos compared with no‐treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>89</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.05 [‐0.47, 0.37]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">12.4 Efficacy of all placebos for people with post‐traumatic stress disorder (PTSD) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>329</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.54 [‐1.06, ‐0.02]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>12.4.1 All placebos compared with wait‐list</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>231</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.75 [‐1.23, ‐0.27]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>12.4.2 All placebos compared with no‐treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>98</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.08 [‐0.56, 0.40]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">12.5 Efficacy of all placebos for people with anxiety disorders <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>16</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>401</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.57 [‐0.93, ‐0.21]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>12.5.1 All placebos compared with wait‐list</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>181</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.81 [‐1.66, 0.05]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>12.5.2 All placebos compared with no‐treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>10</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>220</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.39 [‐0.66, ‐0.11]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">12.6 Efficacy of all placebos for people with attention deficit hyperactivity disorder (ADHD) or attention deficit disorder (ADD) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>145</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.31 [‐0.64, 0.02]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>12.6.1 All placebos compared with wait‐list</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Not estimable</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>12.6.2 All placebos compared with no‐treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>145</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.31 [‐0.64, 0.02]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">12.7 Efficacy of all placebos for people with neurodegenerative disorders <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>231</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.21 [‐0.47, 0.05]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>12.7.1 All placebos compared with wait‐list</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>134</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.33 [‐0.67, 0.01]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>12.7.2 All placebos compared with no‐treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>97</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.03 [‐0.43, 0.36]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 12.</span> <span class="table-title">All placebos versus wait‐list or no‐treatment for people with specific mental health disorders for continuous data</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/references#MR000050-tbl-0018">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="MR000050-tbl-0019"> <div class="table-heading"><span class="table-label">Comparison 13.</span> <span class="table-title">Psychological placebos versus wait‐list or no‐treatment for people with specific mental health disorders continuous data</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">13.1 Efficacy of all placebos for people with substance use disorders <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>122</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.19 [‐0.54, 0.17]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>13.1.1 Psychological placebos compared with wait‐list</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Not estimable</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>13.1.2 Psychological placebos compared with no‐treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>122</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.19 [‐0.54, 0.17]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">13.2 Efficacy of all placebos for people with sleep‐wake disorders <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>159</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.44 [‐0.76, ‐0.12]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>13.2.1 Psychological placebos compared with wait‐list</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>52</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.63 [‐1.49, 0.24]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>13.2.2 Psychological placebos compared with no‐treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>107</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.37 [‐0.75, 0.02]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">13.3 Efficacy of all placebos for people with depression <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>86</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.66 [‐1.56, 0.23]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>13.3.1 Psychological placebos compared with wait‐list</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>66</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐1.01 [‐1.82, ‐0.21]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>13.3.2 Psychological placebos compared with no‐treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>20</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.34 [‐0.55, 1.22]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">13.4 Efficacy of all placebos for people with post‐traumatic stress disorder (PTSD) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>231</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.75 [‐1.23, ‐0.27]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>13.4.1 Psychological placebos compared with wait‐list</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>231</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.75 [‐1.23, ‐0.27]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>13.4.2 Psychological placebos compared with no‐treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Not estimable</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">13.5 Efficacy of all placebos for people with anxiety disorders <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>11</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>258</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.71 [‐1.19, ‐0.22]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>13.5.1 Psychological placebos compared with wait‐list</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>157</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.94 [‐1.83, ‐0.05]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>13.5.2 Psychological placebos compared with no‐treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>101</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.43 [‐0.83, ‐0.04]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 13.</span> <span class="table-title">Psychological placebos versus wait‐list or no‐treatment for people with specific mental health disorders continuous data</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/references#MR000050-tbl-0019">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="MR000050-tbl-0020"> <div class="table-heading"><span class="table-label">Comparison 14.</span> <span class="table-title">Pharmacological placebos versus wait‐list or no‐treatment for people with specific mental health disorders continuous data</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">14.1 Efficacy of all placebos for people with attention deficit hyperactivity disorder (ADHD) or attention deficit disorder (ADD) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>64</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.10 [‐0.59, 0.39]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>14.1.1 Pharmacological placebos compared with wait‐list</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Not estimable</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>14.1.2 Pharmacological placebos compared with no‐treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>64</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.10 [‐0.59, 0.39]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 14.</span> <span class="table-title">Pharmacological placebos versus wait‐list or no‐treatment for people with specific mental health disorders continuous data</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/references#MR000050-tbl-0020">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="MR000050-tbl-0021"> <div class="table-heading"><span class="table-label">Comparison 15.</span> <span class="table-title">Physical placebos versus wait‐list or no‐treatment for people with specific mental health disorders continuous data</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">15.1 Efficacy of all placebos for people with sleep‐wake disorders <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>70</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.11 [‐0.58, 0.36]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>15.1.1 Physical placebos compared with wait‐list</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>18</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.52 [‐1.46, 0.43]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>15.1.2 Physical placebos compared with no‐treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>52</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.03 [‐0.52, 0.57]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">15.2 Efficacy of all placebos for people with depression <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>162</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.24 [‐0.73, 0.25]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>15.2.1 Physical placebos compared with wait‐list</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>111</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.27 [‐1.28, 0.75]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>15.2.2 Physical placebos compared with no‐treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>51</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.10 [‐0.65, 0.45]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">15.3 Efficacy of all placebos for people with anxiety disorders <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>84</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.36 [‐0.82, 0.09]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>15.3.1 Physical placebos compared with wait‐list</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>36</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.11 [‐0.82, 0.60]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>15.3.2 Physical placebos compared with no‐treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>48</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.54 [‐1.14, 0.06]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 15.</span> <span class="table-title">Physical placebos versus wait‐list or no‐treatment for people with specific mental health disorders continuous data</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/references#MR000050-tbl-0021">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="MR000050-tbl-0022"> <div class="table-heading"><span class="table-label">Comparison 16.</span> <span class="table-title">Subgroup analyses for all placebos compared with wait‐list or no‐treatment for continuous data</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">16.1 Type of active intervention <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>64</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2413</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.38 [‐0.50, ‐0.27]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>16.1.1 Psychological intervention</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>38</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1215</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.48 [‐0.66, ‐0.30]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>16.1.2 Pharmacological intervention</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>148</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.29 [‐0.62, 0.04]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>16.1.3 Physical intervention</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>13</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>798</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.21 [‐0.35, ‐0.07]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>16.1.4 Other or combination intervention</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>252</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.32 [‐0.59, ‐0.04]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">16.2 Type of active intervention <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>385</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.01 [0.76, 1.35]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>16.2.1 Psychological intervention</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>19</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Not estimable</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>16.2.2 Pharmacological intervention</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>316</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.04 [0.74, 1.48]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>16.2.3 Physical intervention</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Not estimable</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>16.2.4 Other or combination intervention</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>50</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.99 [0.58, 1.70]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">16.3 Risk of bias <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>65</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2446</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.37 [‐0.49, ‐0.25]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>16.3.1 Low risk of bias</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Not estimable</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>16.3.2 High risk of bias</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>65</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2446</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.37 [‐0.49, ‐0.25]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">16.4 Risk of bias <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>385</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.01 [0.76, 1.35]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>16.4.1 Low risk of bias</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Not estimable</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>16.4.2 High risk of bias</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>385</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.01 [0.76, 1.35]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">16.5 Type of outcome domain <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>56</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2205</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.38 [‐0.51, ‐0.24]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>16.5.1 Blinded observer‐reported</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>29</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1046</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.50 [‐0.70, ‐0.31]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>16.5.2 Non‐blinded observer‐reported</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>96</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.54 [‐0.95, ‐0.13]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>16.5.3 Patient‐reported</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>25</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1063</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.19 [‐0.35, ‐0.03]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">16.6 Type of outcome domain <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>189</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.94 [0.73, 1.21]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>16.6.1 Blinded observer‐reported</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>113</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.99 [0.60, 1.64]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>16.6.2 Non‐blinded observer‐reported</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Not estimable</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>16.6.3 Patient‐reported</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>76</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.00 [0.60, 1.65]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">16.7 Awareness of placebo intervention <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>65</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2446</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.37 [‐0.49, ‐0.25]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>16.7.1 Open placebo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>20</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.51 [‐1.41, 0.38]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>16.7.2 Closed placebo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>64</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2426</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.37 [‐0.49, ‐0.25]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">16.8 Awareness of placebo intervention <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>385</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.01 [0.76, 1.35]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>16.8.1 Open placebo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Not estimable</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>16.8.2 Closed placebo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>385</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.01 [0.76, 1.35]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">16.9 The trial objective <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>65</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2446</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.37 [‐0.49, ‐0.25]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>16.9.1 A trial’s objective is clearly to assess the effects of placebo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Not estimable</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>16.9.2 No such objectives are stated</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>65</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2446</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.37 [‐0.49, ‐0.25]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">16.10 The trial objective <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>385</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.01 [0.76, 1.35]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>16.10.1 A trial’s objective is clearly to assess the effects of placebo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Not estimable</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>16.10.2 No such objectives are stated</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>385</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.01 [0.76, 1.35]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">16.11 Mean age of participants <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>57</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2301</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.35 [‐0.47, ‐0.22]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>16.11.1 Below 18 years</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>274</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.47 [‐0.98, 0.04]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>16.11.2 18 to 50 years</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>40</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1735</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.31 [‐0.44, ‐0.18]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>16.11.3 Above 50 years</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>292</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.41 [‐0.75, ‐0.06]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">16.12 Mean age of participants <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>340</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.94 [0.70, 1.27]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>16.12.1 18 to 50 years</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>270</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.07 [0.70, 1.62]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>16.12.2 Above 50 years</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>70</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.73 [0.43, 1.27]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">16.13 Duration of treatment <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>64</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2366</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.38 [‐0.50, ‐0.26]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>16.13.1 Above 3 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>11</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>464</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.68 [‐1.09, ‐0.27]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>16.13.2 Below 3 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>53</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1902</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.32 [‐0.43, ‐0.20]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">16.14 Duration of treatment <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>366</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.01 [0.76, 1.35]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>16.14.1 Above 3 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>196</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.45 [0.84, 2.49]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>16.14.2 Below 3 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>170</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.82 [0.68, 0.98]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">16.15 Mental health diagnoses <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>65</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2446</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.37 [‐0.49, ‐0.25]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>16.15.1 Formal diagnosis according to DSM/ICD</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>29</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1256</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.42 [‐0.62, ‐0.21]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>16.15.2 Fulfil symptoms of disorder ICD/DSM while not stating systems</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>14</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>326</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.30 [‐0.52, ‐0.08]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>16.15.3 Population is classified as having a mental disorder, but full diagnostic criteria not reported </p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>22</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>864</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.27 [‐0.42, ‐0.12]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">16.16 Mental health diagnoses <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>385</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.01 [0.76, 1.35]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>16.16.1 Formal diagnosis according to DSM/ICD</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>220</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.31 [0.72, 2.37]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>16.16.2 Fulfill symptoms of disorder ICD/DSM while not stating systems</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>96</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.01 [0.62, 1.63]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>16.16.3 Population is classified as having a mental disorder, but full diagnostic criteria not reported </p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>69</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.80 [0.65, 0.99]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">16.17 Affiliation bias <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>65</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2446</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.37 [‐0.49, ‐0.25]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>16.17.1 Risk of affiliation, industry, and allegiance bias</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>363</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.61 [‐0.95, ‐0.26]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>16.17.2 No risk found of affiliation, industry, and allegiance bias</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>59</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2083</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.33 [‐0.45, ‐0.21]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">16.18 Risk of bias (participants and personnel excluded) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>65</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2446</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.37 [‐0.49, ‐0.25]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>16.18.1 Low risk of bias</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>230</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.58 [‐0.85, ‐0.32]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>16.18.2 Unclear risk of bias</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>51</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.12 [‐0.95, 0.71]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>16.18.3 High risk of bias</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>60</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2165</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.36 [‐0.48, ‐0.23]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">16.19 Imputed data <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>63</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2416</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.36 [‐0.48, ‐0.24]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>16.19.1 Available data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>45</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1236</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.39 [‐0.52, ‐0.25]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>16.19.2 Intent‐to‐treat</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>891</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.22 [‐0.44, ‐0.01]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>16.19.3 No attrition</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>289</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.50 [‐1.00, 0.00]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 16.</span> <span class="table-title">Subgroup analyses for all placebos compared with wait‐list or no‐treatment for continuous data</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/references#MR000050-tbl-0022">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="MR000050-tbl-0023"> <div class="table-heading"><span class="table-label">Comparison 17.</span> <span class="table-title">Subgroup analyses for psychological placebos compared with wait‐list or no‐treatment for continuous data</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">17.1 Type of active intervention <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>38</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1263</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.49 [‐0.66, ‐0.31]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>17.1.1 Psychological intervention</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>35</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1174</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.48 [‐0.67, ‐0.29]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>17.1.2 Pharmacological intervention</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Not estimable</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>17.1.3 Physical intervention</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Not estimable</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>17.1.4 Other or combination intervention</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>89</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.51 [‐0.94, ‐0.09]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">17.2 Risk of bias <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>38</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1263</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.49 [‐0.66, ‐0.31]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>17.2.1 Low risk of bias</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Not estimable</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>17.2.2 High risk of bias</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>38</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1263</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.49 [‐0.66, ‐0.31]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">17.3 Type of outcome domain <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>34</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1515</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.49 [‐0.68, ‐0.30]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>17.3.1 Blinded observer‐reported</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>14</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>512</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.72 [‐1.08, ‐0.36]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>17.3.2 Non‐blinded observer‐reported</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>96</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.54 [‐0.95, ‐0.13]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>17.3.3 Patient‐reported</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>18</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>907</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.27 [‐0.47, ‐0.08]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">17.4 Awareness of placebo intervention <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>38</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1263</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.49 [‐0.66, ‐0.31]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>17.4.1 Open placebo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Not estimable</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>17.4.2 Closed placebo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>38</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1263</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.49 [‐0.66, ‐0.31]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">17.5 The trial objective <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>38</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1263</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.49 [‐0.66, ‐0.31]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>17.5.1 A trial’s objective is clearly to assess the effects of placebo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Not estimable</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>17.5.2 No such objectives are stated</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>38</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1263</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.49 [‐0.66, ‐0.31]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">17.6 Mean age of participants <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>33</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1537</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.45 [‐0.64, ‐0.26]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>17.6.1 Below 18 years</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>148</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.85 [‐2.02, 0.32]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>17.6.2 18 to 50 years</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>25</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1233</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.38 [‐0.55, ‐0.21]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>17.6.3 Above 50 years</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>156</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.59 [‐1.33, 0.14]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">17.7 Duration of treatment <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>38</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1576</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.48 [‐0.66, ‐0.31]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>17.7.1 Above 3 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>270</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐1.02 [‐1.68, ‐0.36]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>17.7.2 Below 3 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>32</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1306</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.38 [‐0.53, ‐0.22]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">17.8 Type of psychological placebo <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>38</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1263</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.49 [‐0.66, ‐0.31]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>17.8.1 Interaction placebo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>15</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>613</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.70 [‐1.04, ‐0.36]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>17.8.2 Psychoeducational placebo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>329</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.14 [‐0.36, 0.07]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>17.8.3 Exposure placebo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>14</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>321</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.48 [‐0.71, ‐0.24]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">17.9 Mode of psychological placebo <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>35</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1571</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.48 [‐0.66, ‐0.30]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>17.9.1 Individual treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>19</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1151</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.31 [‐0.49, ‐0.12]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>17.9.2 Group treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>13</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>308</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.85 [‐1.30, ‐0.39]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>17.9.3 Combination of individual and group</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>112</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.45 [‐0.83, ‐0.08]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">17.10 Mental health diagnoses <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>39</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1656</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.47 [‐0.64, ‐0.30]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>17.10.1 Formal diagnosis according to DSM/ICD</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>16</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>767</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.53 [‐0.86, ‐0.21]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>17.10.2 Fulfill symptoms of disorder ICD/DSM while not stating systems</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>218</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.39 [‐0.66, ‐0.12]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>17.10.3 Population is classified as having a mental disorder, but full diagnostic criteria not reported </p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>14</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>671</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.37 [‐0.59, ‐0.15]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">17.11 Affiliation bias <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>65</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2446</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.37 [‐0.49, ‐0.25]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>17.11.1 Risk of affiliation, industry, allegiance bias</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>363</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.61 [‐0.95, ‐0.26]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>17.11.2 No risk of affiliation, industry, allegiance bias</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>59</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2083</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.33 [‐0.45, ‐0.21]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">17.12 Imputed data <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>37</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1626</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.46 [‐0.63, ‐0.29]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>17.12.1 Available data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>27</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>842</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.50 [‐0.68, ‐0.33]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>17.12.2 Intent‐to‐treat</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>682</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.18 [‐0.39, 0.03]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>17.12.3 No attrition</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>102</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.75 [‐2.11, 0.62]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 17.</span> <span class="table-title">Subgroup analyses for psychological placebos compared with wait‐list or no‐treatment for continuous data</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/references#MR000050-tbl-0023">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="MR000050-tbl-0024"> <div class="table-heading"><span class="table-label">Comparison 18.</span> <span class="table-title">Subgroup analyses for pharmacological placebos compared with wait‐list or no‐treatment for continuous data</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">18.1 Type of active intervention <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>279</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.14 [‐0.39, 0.11]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>18.1.1 Psychological intervention</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>33</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.44 [‐0.26, 1.13]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>18.1.2 Pharmacological intervention</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>148</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.29 [‐0.62, 0.04]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>18.1.3 Physical intervention</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Not estimable</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>18.1.4 Other or combination intervention</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>98</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.08 [‐0.56, 0.40]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">18.2 Type of active intervention <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>366</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.05 [0.74, 1.48]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>18.2.1 Psychological intervention</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Not estimable</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>18.2.2 Pharmacological intervention</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>316</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.09 [0.71, 1.67]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>18.2.3 Physical intervention</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Not estimable</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>18.2.4 Other or combination intervention</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>50</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.99 [0.58, 1.70]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">18.3 Risk of bias <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>279</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.14 [‐0.39, 0.11]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>18.3.1 Low risk of bias</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Not estimable</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>18.3.2 High risk of bias</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>279</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.14 [‐0.39, 0.11]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">18.4 Risk of bias <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>366</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.01 [0.76, 1.35]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>18.4.1 Low risk of bias</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Not estimable</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>18.4.2 High risk of bias</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>366</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.01 [0.76, 1.35]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">18.5 Type of outcome domain <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>279</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.14 [‐0.39, 0.11]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>18.5.1 Blinded observer‐reported</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>220</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.24 [‐0.53, 0.05]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>18.5.2 Non‐blinded observer‐reported</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Not estimable</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>18.5.3 Patient‐reported</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>59</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.18 [‐0.36, 0.73]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">18.6 Type of outcome domain <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>170</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.94 [0.73, 1.21]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>18.6.1 Blinded observer‐reported</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>94</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.99 [0.60, 1.64]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>18.6.2 Non‐blinded observer‐reported</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Not estimable</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>18.6.3 Patient‐reported</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>76</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.00 [0.60, 1.65]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">18.7 Awareness of placebo intervention <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>279</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.14 [‐0.39, 0.11]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>18.7.1 Open placebo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>20</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.51 [‐1.41, 0.38]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>18.7.2 Closed placebo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>259</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.11 [‐0.37, 0.16]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">18.8 Awareness of placebo intervention <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>385</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.01 [0.76, 1.35]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>18.8.1 Open placebo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Not estimable</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>18.8.2 Closed placebo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>385</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.01 [0.76, 1.35]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">18.9 The trial objective <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>279</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.14 [‐0.39, 0.11]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>18.9.1 A trial’s objective is clearly to assess the effects of placebo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Not estimable</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>18.9.2 No such objectives are stated</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>279</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.14 [‐0.39, 0.11]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">18.10 The trial objective <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>385</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.01 [0.76, 1.35]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>18.10.1 A trial’s objective is clearly to assess the effects of placebo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Not estimable</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>18.10.2 No such objectives are stated</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>385</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.01 [0.76, 1.35]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">18.11 Mean age of participants <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>241</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.13 [‐0.41, 0.14]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>18.11.1 Below 18 years</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>64</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.10 [‐0.59, 0.39]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>18.11.2 18 to 50 years</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>177</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.19 [‐0.68, 0.31]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>18.11.3 Above 50 years</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Not estimable</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">18.12 Mean age of participants <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>340</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.94 [0.70, 1.27]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>18.12.1 Below 18 years</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Not estimable</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>18.12.2 18 to 50 years</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>270</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.07 [0.70, 1.62]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>18.12.3 Above 50 years</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>70</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.73 [0.43, 1.27]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">18.13 Duration of treatment <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>279</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.14 [‐0.39, 0.11]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>18.13.1 Above 3 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>164</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.21 [‐0.56, 0.14]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>18.13.2 Below 3 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>115</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.06 [‐0.43, 0.31]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">18.14 Duration of treatment <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>366</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.01 [0.76, 1.35]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>18.14.1 Above 3 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>196</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.45 [0.84, 2.49]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>18.14.2 Below 3 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>170</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.82 [0.68, 0.98]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">18.15 Mental health diagnoses <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>279</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.14 [‐0.39, 0.11]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>18.15.1 Formal diagnosis according to DSM/ICD</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>188</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.25 [‐0.57, 0.06]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>18.15.2 Fulfill symptoms of disorder ICD/DSM while not stating systems</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>40</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.07 [‐0.69, 0.56]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>18.15.3 Population is classified as having a mental disorder, but full diagnostic criteria not reported </p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>51</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.12 [‐0.62, 0.86]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">18.16 Mental health diagnoses <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>316</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.12 [0.79, 1.59]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>18.16.1 Formal diagnosis according to DSM/ICD</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>220</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.31 [0.72, 2.37]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>18.16.2 Fulfill symptoms of disorder ICD/DSM while not stating systems</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>96</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.01 [0.62, 1.63]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>18.16.3 Population is classified as having a mental disorder, but full diagnostic criteria not reported </p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Not estimable</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">18.17 Imputed data <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>279</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.14 [‐0.39, 0.11]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>18.17.1 Available data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>155</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.17 [‐0.49, 0.16]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>18.17.2 Intent‐to‐treat</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>98</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.08 [‐0.56, 0.40]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>18.17.3 No attrition</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>26</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.12 [‐0.89, 0.65]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 18.</span> <span class="table-title">Subgroup analyses for pharmacological placebos compared with wait‐list or no‐treatment for continuous data</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/references#MR000050-tbl-0024">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="MR000050-tbl-0025"> <div class="table-heading"><span class="table-label">Comparison 19.</span> <span class="table-title">Subgroup analyses for physical placebos compared with wait‐list or no‐treatment for continuous data</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">19.1 Type of active intervention <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>17</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>896</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.21 [‐0.35, ‐0.08]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>19.1.1 Psychological intervention</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>33</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.26 [‐0.95, 0.43]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>19.1.2 Pharmacological intervention</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Not estimable</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>19.1.3 Physical intervention</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>13</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>798</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.21 [‐0.35, ‐0.07]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>19.1.4 Other or combination intervention</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>65</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.30 [‐0.82, 0.23]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">19.2 Risk of bias <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>17</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>896</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.21 [‐0.35, ‐0.08]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>19.2.1 Low risk of bias</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Not estimable</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>19.2.2 High risk of bias</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>17</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>896</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.21 [‐0.35, ‐0.08]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">19.3 Type of outcome domain <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>13</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>411</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.31 [‐0.51, ‐0.12]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>19.3.1 Blinded observer‐reported</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>314</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.42 [‐0.64, ‐0.19]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>19.3.2 Non‐blinded observer‐reported</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Not estimable</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>19.3.3 Patient‐reported</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>97</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.00 [‐0.40, 0.40]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">19.4 Awareness of placebo intervention <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>17</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>896</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.21 [‐0.35, ‐0.08]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>19.4.1 Open placebo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Not estimable</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>19.4.2 Closed placebo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>17</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>896</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.21 [‐0.35, ‐0.08]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">19.5 The trial objective <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>17</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>896</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.21 [‐0.35, ‐0.08]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>19.5.1 A trial’s objective is clearly to assess the effects of placebo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Not estimable</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>19.5.2 No such objectives are stated</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>17</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>896</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.21 [‐0.35, ‐0.08]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">19.6 Mean age of participants <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>16</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>503</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.30 [‐0.48, ‐0.12]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>19.6.1 Below 18 years</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>62</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.32 [‐0.82, 0.19]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>19.6.2 18 to 50 years</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>11</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>325</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.26 [‐0.48, ‐0.04]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>19.6.3 Above 50 years</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>116</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.40 [‐0.77, ‐0.03]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">19.7 Duration of treatment <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>17</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>926</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.22 [‐0.35, ‐0.09]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>19.7.1 Above 3 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>30</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.48 [‐1.21, 0.25]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>19.7.2 Below 3 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>17</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>896</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.21 [‐0.35, ‐0.08]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">19.8 Type of physical placebo <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>15</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>473</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.31 [‐0.50, ‐0.13]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>19.8.1 Acupuncture or acupressure placebo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>237</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.42 [‐0.73, ‐0.11]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>19.8.2 Excercise and relaxation placebo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>67</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.21 [‐0.70, 0.27]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>19.8.3 Technical device placebo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>119</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.23 [‐0.60, 0.14]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>19.8.4 Electromagnetic stimulation placebo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>50</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.02 [‐0.57, 0.54]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">19.9 Mental health diagnoses <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>16</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>503</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.30 [‐0.48, ‐0.12]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>19.9.1 Formal diagnosis according to DSM/ICD</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>293</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.29 [‐0.56, ‐0.02]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>19.9.2 Fulfill symptoms of disorder ICD/DSM while not stating systems</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>68</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.15 [‐0.62, 0.33]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>19.9.3 Population is classified as having a mental disorder, but full diagnostic criteria not reported </p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>142</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.32 [‐0.66, 0.02]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">19.10 Imputed data <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>16</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>503</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.30 [‐0.48, ‐0.12]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>19.10.1 Available data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>10</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>231</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.13 [‐0.40, 0.13]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>19.10.2 Intent‐to‐treat</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>111</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.27 [‐1.28, 0.75]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>19.10.3 No attrition</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>161</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.40 [‐0.71, ‐0.08]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 19.</span> <span class="table-title">Subgroup analyses for physical placebos compared with wait‐list or no‐treatment for continuous data</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/references#MR000050-tbl-0025">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="MR000050-tbl-0026"> <div class="table-heading"><span class="table-label">Comparison 20.</span> <span class="table-title">Subgroup analyses for usual care compared with wait‐list or no‐treatment for continuous data</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">20.1 Type of active intervention <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>523</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.33 [‐0.83, 0.16]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>20.1.1 Psychological intervention</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>346</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.14 [‐0.39, 0.10]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>20.1.2 Pharmacological intervention</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Not estimable</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>20.1.3 Physical intervention</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>177</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐1.10 [‐1.42, ‐0.79]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>20.1.4 Other or combination intervention</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Not estimable</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">20.2 Type of active intervention <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>260</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.93 [0.34, 2.55]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>20.2.1 Psychological intervention</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>260</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.93 [0.34, 2.55]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>20.2.2 Pharmacological intervention</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Not estimable</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>20.2.3 Physical intervention</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Not estimable</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>20.2.4 Other intervention</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Not estimable</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">20.3 Risk of bias <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>523</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.33 [‐0.83, 0.16]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>20.3.1 Low risk of bias</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Not estimable</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>20.3.2 High risk of bias</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>523</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.33 [‐0.83, 0.16]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">20.4 Risk of bias <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>260</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.93 [0.34, 2.55]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>20.4.1 Low risk of bias</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Not estimable</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>20.4.2 High risk of bias</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>260</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.93 [0.34, 2.55]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">20.5 Type of outcome domain <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>523</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.33 [‐0.83, 0.16]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>20.5.1 Blinded observer‐reported</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>473</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.44 [‐0.99, 0.10]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>20.5.2 Non‐blinded observer‐reported</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Not estimable</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>20.5.3 Patient‐reported</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>50</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.15 [‐0.41, 0.72]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">20.6 Mean age of participants <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>523</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.33 [‐0.83, 0.16]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>20.6.1 Below 18 years</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>177</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐1.10 [‐1.42, ‐0.79]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>20.6.2 18 to 50 years</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>316</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.15 [‐0.46, 0.17]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>20.6.3 Above 50 years</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>30</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.06 [‐0.82, 0.70]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">20.7 Duration of treatment <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>523</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.36 [‐0.84, 0.12]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>20.7.1 Above 3 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>443</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.53 [‐1.17, 0.10]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>20.7.2 Below 3 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>80</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.00 [‐0.46, 0.45]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">20.8 Duration of treatment <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>260</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.93 [0.34, 2.55]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>20.8.1 Above 3 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Not estimable</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>20.8.2 Below 3 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>260</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.93 [0.34, 2.55]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">20.9 Type of usual care <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>523</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.33 [‐0.83, 0.16]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>20.9.1 Psychological usual care</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>473</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.44 [‐0.99, 0.10]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>20.9.2 Pharmacological usual care</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Not estimable</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>20.9.3 Physical usual care</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Not estimable</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>20.9.4 Other or a combination usual care</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>50</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.15 [‐0.41, 0.72]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">20.10 Type of usual care <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>260</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.93 [0.34, 2.55]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>20.10.1 Psychological usual care</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>26</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.50 [0.20, 1.26]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>20.10.2 Pharmacological usual care</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Not estimable</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>20.10.3 Physical usual care</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Not estimable</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>20.10.4 Other or a combination usual care</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>234</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.42 [1.17, 1.73]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">20.11 Standarised usual care <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>523</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.33 [‐0.83, 0.16]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>20.11.1 The usual care intervention was intentionally standardised or manualised</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>493</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.38 [‐0.94, 0.18]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>20.11.2 No standardisation or manualisation</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>30</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.06 [‐0.82, 0.70]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">20.12 Standarised usual care <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>260</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.93 [0.34, 2.55]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>20.12.1 The usual care intervention was intentionally standardised or manualised</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Not estimable</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>20.12.2 No standardisation or manualisation</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>260</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.93 [0.34, 2.55]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">20.13 Mode of psychological treatment in usual care <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>473</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.44 [‐0.99, 0.10]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>20.13.1 Individual treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>185</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.06 [‐0.35, 0.23]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>20.13.2 Group treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>288</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.78 [‐1.43, ‐0.12]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>20.13.3 Combination of individual and group</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Not estimable</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">20.14 Imputed data <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>523</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.36 [‐0.84, 0.12]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>20.14.1 Available data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>80</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.00 [‐0.46, 0.45]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>20.14.2 Intent‐to‐treat</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>443</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.53 [‐1.17, 0.10]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 20.</span> <span class="table-title">Subgroup analyses for usual care compared with wait‐list or no‐treatment for continuous data</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/references#MR000050-tbl-0026">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="MR000050-tbl-0027"> <div class="table-heading"><span class="table-label">Comparison 21.</span> <span class="table-title">Sensitivity analyses for all placebos compared with wait‐list or no‐treatment</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">21.1 Fixed effects <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>65</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2446</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.33 [‐0.42, ‐0.25]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">21.2 Fixed effects <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>385</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.91 [0.77, 1.07]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">21.3 End of intervention (post‐treatment scores, changes scores excluded) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>65</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2446</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.37 [‐0.49, ‐0.25]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">21.4 Type of data collection <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>14</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.03 [‐0.02, 0.08]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>21.4.1 Structured list of reporting</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐1.54 [‐2.97, ‐0.11]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>21.4.2 Spontaneous reporting</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>13</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.03 [‐0.02, 0.07]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">21.5 Transformed data for TSA analysis <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>65</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2456</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.34 [‐0.44, ‐0.23]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 21.</span> <span class="table-title">Sensitivity analyses for all placebos compared with wait‐list or no‐treatment</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/references#MR000050-tbl-0027">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="MR000050-tbl-0028"> <div class="table-heading"><span class="table-label">Comparison 22.</span> <span class="table-title">Sensitivity analyses for psychological placebo compared with wait‐list or no‐treatment</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">22.1 Fixed effects <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>39</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1656</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.37 [‐0.47, ‐0.27]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">22.2 End of intervention (post‐treatment scores) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>39</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1656</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.47 [‐0.64, ‐0.30]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">22.3 Transformed data for TSA analysis <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>38</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1263</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.44 [‐0.59, ‐0.29]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 22.</span> <span class="table-title">Sensitivity analyses for psychological placebo compared with wait‐list or no‐treatment</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/references#MR000050-tbl-0028">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="MR000050-tbl-0029"> <div class="table-heading"><span class="table-label">Comparison 23.</span> <span class="table-title">Sensitivity analyses for pharmacological placebo compared with wait‐list or no‐treatment</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">23.1 Fixed effects <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>279</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.14 [‐0.39, 0.11]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">23.2 Fixed effects <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>366</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.91 [0.77, 1.07]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">23.3 End of intervention (post‐treatment scores) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>279</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.14 [‐0.39, 0.11]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">23.4 Transformed data for TSA analysis <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>279</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.08 [‐0.33, 0.17]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 23.</span> <span class="table-title">Sensitivity analyses for pharmacological placebo compared with wait‐list or no‐treatment</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/references#MR000050-tbl-0029">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="MR000050-tbl-0030"> <div class="table-heading"><span class="table-label">Comparison 24.</span> <span class="table-title">Sensitivity analyses for physical placebo compared with wait‐list or no‐treatment</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">24.1 Fixed effects <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>16</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>503</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.30 [‐0.48, ‐0.12]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">24.2 End of intervention (post‐treatment scores) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>16</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>503</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.30 [‐0.48, ‐0.12]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">24.3 Transformed data for TSA analysis <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>17</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>896</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.21 [‐0.34, ‐0.07]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 24.</span> <span class="table-title">Sensitivity analyses for physical placebo compared with wait‐list or no‐treatment</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/references#MR000050-tbl-0030">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="MR000050-tbl-0031"> <div class="table-heading"><span class="table-label">Comparison 25.</span> <span class="table-title">Sensitivity analyses for usual care compared with wait‐list or no‐treatment</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">25.1 Fixed effects <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>523</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.46 [‐0.64, ‐0.28]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">25.2 Transformed data for TSA analysis <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>523</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.32 [‐0.78, 0.14]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 25.</span> <span class="table-title">Sensitivity analyses for usual care compared with wait‐list or no‐treatment</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/references#MR000050-tbl-0031">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="MR000050-tbl-0032"> <div class="table-heading"><span class="table-label">Comparison 26.</span> <span class="table-title">Sensitivity analysis for serious adverse events of placebos</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">26.1 Data in RR for TSA analysis <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>11</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>517</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.62 [0.25, 1.53]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 26.</span> <span class="table-title">Sensitivity analysis for serious adverse events of placebos</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/references#MR000050-tbl-0032">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="MR000050-tbl-0033"> <div class="table-heading"><span class="table-label">Comparison 27.</span> <span class="table-title">Sensitivity analysis for non‐serious adverse events of placebos</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">27.1 Data in RR for TSA analysis <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>11</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>362</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.71 [0.27, 1.84]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 27.</span> <span class="table-title">Sensitivity analysis for non‐serious adverse events of placebos</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.MR000050.pub2/references#MR000050-tbl-0033">Navigate to table in review</a></div> </div> </div> <noscript> <img height="1" src="/scolaris-auth/report/nonjs/fulltexthtmlreg?doi=10.1002%2F14651858.MR000050.pub2&amp;rf=&amp;articleType=CDSR" style="display:none" width="1"> </img></noscript> <section class="translation-notes-modal" data-modal-class="translation-notes" data-modal-title="Translation notes" data-ok-btn-selector=".ok-btn" style="display: none"> <div class="translation-notes"> <div class="section-language-toggles"> <nav class="section-languages"> <ul> <li class="section-languages-legend">Available in</li> <li class="section-language"> <a class="" href="es#MR000050-note-0026">Español</a> </li> <li class="section-language"> <a class="" href="fa#MR000050-note-0020">فارسی</a> </li> <li class="section-language"> <a class="" href="fr#MR000050-note-0023">Français</a> </li> <li class="section-language"> <a class="" href="hr#MR000050-note-0017">Hrvatski</a> </li> <li class="section-language"> <a class="" href="ja#MR000050-note-0014">日本語</a> </li> <li class="section-language"> <a class="" href="ms#MR000050-note-0011">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="pt#MR000050-note-0010">Português</a> </li> <li class="section-language"> <a class="" href="th#MR000050-note-0009">ภาษาไทย</a> </li> <li class="section-language"> <a class="" href="zh_HANT#MR000050-note-0006">繁體中文</a> </li> </ul> </nav> </div> <section class="translation-notes-content"> </section> <button class="btn primary ok-btn pull-right" type="button">Close</button> </div> </section></article> </div> <div class="citation-modal" style="display: none"> <div class="export-citation-header"> <p class="inset-message" data-load-error="Unable to load citation data" id="citeProcText"></p> </div> <div class="export-citation-body row-fluid"> <div class="span12"> <div class="addthis_toolbox addthis_default_style addthis_16x16_style"> <nav class="inline-nav-list is-bordered"> <li> <h4 class="heading">Save citation to:</h4> </li> <li><a class="citation-btn-refworks at300b btn btn-link" href="#" id="refWorksCitationBtn"><span class="citation-icon refworks"></span>RefWorks</a></li> <li><a class="citation-btn-sciwheel at300b btn btn-link disabled" href="#" id="sciWheelCitationBtn" target="_blank"><span class="citation-icon sciwheel"></span>SciWheel</a></li> </nav> </div> </div> </div> <div class="row-fluid"> <div class="span12"> <div class="citation-format"> <h4>Copy or download citation</h4> <a href="/en/help/exporting-search-results" rel="noopener noreferrer" target="_blank">Export help</a> </div> <nav class="inline-nav-list has-dividers"> <li class="citation-option" data-option="plain"><button class="btn btn-link" type="button">Plain text</button></li> <li class="citation-option" data-option="endnote"><button class="btn btn-link" type="button">EndNote</button></li> <li class="citation-option" data-option="refmanager"><button class="btn btn-link" type="button">Reference Manager</button></li> <li class="citation-option" data-option="procite"><button class="btn btn-link" type="button">ProCite</button></li> <li class="citation-option" data-option="bibtex"><button class="btn btn-link" type="button">BibteX</button></li> <li class="citation-option" data-option="csv"><button class="btn btn-link" type="button">CSV (Excel)</button></li> </nav> <div class="citation-content"> <pre data-load-error="Unable to load citation data" id="citationContent" tabindex="0"></pre> </div> <div class="clearfix"> <form class="download-citation-form" data-citation-citeproc-url="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=citation-citeproc&amp;p_p_cacheability=cacheLevelPage&amp;p_p_col_id=column-1&amp;p_p_col_count=1" method="GET" target="citation-download-iframe"> <input id="siteId" name="siteId" type="hidden" value=""> <input id="downloadType" name="downloadType" type="hidden" value=""> <input id="style" name="style" type="hidden" value=""> <input id="articleId" name="articleId" type="hidden" value=""> <input name="p_p_id" type="hidden" value="scolariscontentdisplay_WAR_scolariscontentdisplay"><input name="p_p_lifecycle" type="hidden" value="2"><input name="p_p_state" type="hidden" value="normal"><input name="p_p_mode" type="hidden" value="view"/><input name="p_p_resource_id" type="hidden" value="citation-download"/><input name="p_p_cacheability" type="hidden" value="cacheLevelPage"/><input name="p_p_col_id" type="hidden" value="column-1"/><input name="p_p_col_count" type="hidden" value="1"/> <button class="btn primary wide pull-right" type="submit">Download</button> <div class="inline-checkbox pull-right"> <label title=" for=" withabstract"=""> <input checked="" class="checkbox" name="withAbstract" type="checkbox"/> <span class="checkbox-label">Include abstract</span> </label> </div> </input></input></input></input></input></input></input></form> <iframe aria-hidden="true" name="citation-download-iframe" src="" style="display: none; visibility: hidden" title="Citation download frame"></iframe> </div> </div> </div> </div> <div class="print-modal" data-modal-title="Print this review" style="display: none;"> <div class="print-options-wrapper"> <p><strong>All sections are selected by default</strong>, please select the sections you do not wish to print or use the select or deselect all button to add or remove sections.</p> <div class="print-options-controls"> <input checked="checked" class="print-options-select-all" title="Select/deselect all" type="checkbox"/> <span class="checkbox-label">Select/deselect all</span> </div> <ul class="print-options checkbox-list"> </ul> <button class="btn primary print-article pull-right"><i aria-hidden="true" class="fa fa-print"></i> Print</button> </div> </div> <div class="download-stats-data-modal" data-modal-title="Download data package" style="display: none;"> <div> <p> The data available are protected by copyright and may only be used in accordance with the <a class="external" href="/about/data-download" target="_blank">Terms and Conditions.</a> </p> <div class="hide-for-zip"> <p> <a class="external" href="https://revman.cochrane.org/#/rm5Converter" target="_blank">RevMan 5 files</a> can be converted to a <a class="external" href="https://links.cochrane.org/review-datapack-userguide" target="_blank">data package.</a> </p> </div> <p> Files in the data package can be imported to <a class="external" href="https://revman.cochrane.org/info" target="_blank">Review Manager software</a> or opened in other tools that support CSV and RIS. </p> <form class="download-stats-data-form" method="GET" target="_blank"> <input name="content-disposition" type="hidden" value="attachment"/> <input name="mime-type" type="hidden" value="application/octet-stream"/> <p class="print-options-controls"> <input aria-label="I agree to these terms and conditions" class="download-stats-data-toc-check-box" type="checkbox"/> <span aria-hidden="true" class="checkbox-label">I agree to these terms and conditions</span> <button class="btn primary download-stats-data pull-right" disabled=""><i aria-hidden="true" class="fa fa-download"></i> Download data</button> </p> </form> </div> </div> <div class="share-modal" data-modal-title="Share this review" style="display:none;"> </div> <div class="viewer-thumbnail-pane-html" style="display:none;"> <div class="figure-viewer-options"> <nav class="inline-nav-list"> <li class="figure-options-btn-container"><button class="btn btn-link" id="figureOptionBtn" type="button">Figures</button></li> <li class="table-options-btn-container"><button class="btn btn-link" id="tableOptionBtn" type="button">Tables</button></li> </nav> </div> <div class="figure-viewer-thumbnails"> <div class="figure-thumbnails is-visible" id="figureThumbnails"></div> <div class="table-thumbnails" id="tableThumbnails"></div> </div> </div> <div class="utilities-html" style="display:none;"> <div class="figure-viewer-utilities"> <a class="figure-viewer-menu-toggle" href="#"> <i class="fa fa-chevron-left"></i><span class="toggle-label" data-figure-hide-text="Hide thumbnails" data-figure-show-text="Show thumbnails" data-table-hide-text="Hide table list" data-table-show-text="Show table list">Hide thumbnails</span> </a> <a class="figure-viewer-navigateback" href="#"> <i class="fa fa-chevron-left"></i> </a> <a class="figure-viewer-rotate" href="#"> <i class="fa fa-undo"></i> </a> <a class="figure-viewer-download" href="#"> <i class="fa fa-download"></i> </a> <a class="figure-viewer-share" href="#"> <i class="fa fa-share-alt"></i> </a> <a class="figure-viewer-zoomin" href="#"> <i class="fa fa-plus"></i><span>zoom in</span> </a> <a class="figure-viewer-zoomout" href="#"> <i class="fa fa-minus"></i><span>zoom out</span> </a> </div> </div> <div class="controls-html" style="display:none;"> <div class="figure-viewer-navigation"> <a class="figure-viewer-nav previous" href="#"> <i class="fa fa-chevron-left"></i><span>left</span> </a> <a class="figure-viewer-nav next" href="#"> <i class="fa fa-chevron-right"></i><span>right</span> </a> </div> </div> <div class="mobile-thumbnail-selector-html" style="display:none;"> <div class="figure-viewer-mobile-thumbnails"> <select class="figure-selection"> <option>Figures</option> </select> <select class="table-selection"> <option>Tables</option> </select> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div>
<div class="portlet-boundary portlet-boundary_1_WAR_kaleodesignerportlet_ portlet-static portlet-static-end kaleo-designer-portlet" id="p_p_id_1_WAR_kaleodesignerportlet_">
<span id="p_1_WAR_kaleodesignerportlet"></span>
</div>
<form action="#" id="hrefFm" method="post" name="hrefFm">
<span></span>
</form>
</div>
<footer class="footer">
<div class="main-footer">
<div class="main-footer-wrapper container">
<div class="brand">
<p class="brand-name">Cochrane</p>
<a href="http://www.cochrane.org/" title="Cochrane logo">
<img alt="Cochrane logo" class="footer-logo logo-part-1" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-1.png"> <img alt="" class="footer-logo logo-part-2" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-2.png"> </img></img></a> </div> </div> </div> <div class="aux-footer"> <div class="aux-footer-nav-container container"> <nav class="aux-footer-nav"> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse Publications</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse by Subject</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/advertisers">Advertisers &amp; Agents</a></li> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Contact Us</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Help &amp; Support</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/terms-and-conditions">Terms &amp; Conditions</a></li> </ul> </nav> </div> <div class="brand"> <div class="brand-container container"> <p class="copyright"> Copyright © 2000 - 2025 by <a class="" href="http://www.wiley.com">John Wiley &amp; Sons, Inc.</a> All Rights Reserved <br> Review our <a href="https://www.wiley.com/privacy"><strong>Privacy Policy</strong></a> <a href="https://www.wiley.com/cookies"><strong>Cookie Policy</strong></a> <a href="#" onclick="Osano.cm.showDrawer('osano-cm-dom-info-dialog-open')"><strong>Cookie Preferences</strong></a> </br></p> <a href="http://eu.wiley.com/"><img alt="Wiley logo" class="logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_wiley-footer-logo.png"/></a> </div> </div> <span class="wiley-semi-circle"></span> </div> <!--BEGIN QUALTRICS WEBSITE FEEDBACK SNIPPET--> <script type="text/javascript"> (function(){var g=function(e,h,f,g){ this.get=function(a){for(var a=a+"=",c=document.cookie.split(";"),b=0,e=c.length;b<e;b++){for(var d=c[b];" "==d.charAt(0);)d=d.substring(1,d.length);if(0==d.indexOf(a))return d.substring(a.length,d.length)}return null}; this.set=function(a,c){var b="",b=new Date;b.setTime(b.getTime()+6048E5);b="; expires="+b.toGMTString();document.cookie=a+"="+c+b+"; path=/; "}; this.check=function(){var a=this.get(f);if(a)a=a.split(":");else if(100!=e)"v"==h&&(e=Math.random()>=e/100?0:100),a=[h,e,0],this.set(f,a.join(":"));else return!0;var c=a[1];if(100==c)return!0;switch(a[0]){case "v":return!1;case "r":return c=a[2]%Math.floor(100/c),a[2]++,this.set(f,a.join(":")),!c}return!0}; this.go=function(){if(this.check()){var a=document.createElement("script");a.type="text/javascript";a.src=g;document.body&&document.body.appendChild(a)}}; this.start=function(){var t=this;"complete"!==document.readyState?window.addEventListener?window.addEventListener("load",function(){t.go()},!1):window.attachEvent&&window.attachEvent("onload",function(){t.go()}):t.go()};}; try{(new g(100,"r","QSI_S_ZN_cGCHHvWNpnJb1zf","https://zncgchhvwnpnjb1zf-wiley.siteintercept.qualtrics.com/SIE/?Q_ZID=ZN_cGCHHvWNpnJb1zf")).start()}catch(i){}})(); </script><div id="ZN_cGCHHvWNpnJb1zf"><!--DO NOT REMOVE-CONTENTS PLACED HERE--></div> <!--END WEBSITE FEEDBACK SNIPPET--> </footer> <div class="scolaris-modal-overlay"></div> <div class="scolaris-modal"> <div class="scolaris-modal-titlebar clearfix"> <p class="scolaris-modal-title"></p> <a class="scolaris-modal-close" href="#"><span>close</span><span class="icon fa fa-times"></span></a> <div class="scolaris-modal-ui"></div> </div> <!-- Static injection of addtoAny as dynamic injection not working properly--> <div class="scolaris-share-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"> <div class="a2a_kit a2a_kit_size_32 a2a_default_style"> <a class="a2a_button_facebook share-button">  Facebook</a> <a class="a2a_button_x share-button">  X(Twitter)</a> <a class="a2a_button_whatsapp share-button">  WhatsApp</a> <a class="a2a_dd share-button">  View more</a> </div> </div> </div> <div class="scolaris-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="english-only-modal-wrapper" data-modal-class="english-only-modal" data-modal-title="Feature in English only" style="display: none"> <div class="english-only-modal"> <p class="message"></p> <button class="btn primary ok-btn pull-right" type="button">OK</button> <button class="btn primary border-only cancel-btn pull-right" type="button">Cancel</button> </div> </div> <!--[if gte IE 9]><!--> <script src="/cochrane-theme/vendor/ie9.js?t=1738734064000" type="text/javascript"></script> <!--<![endif]--> <script src="https://www.cochranelibrary.com/cochrane-theme/js/theme.js?t=1738734064000" type="text/javascript"></script> <script src="https://content.readcube.com/cochrane/checkout.js"></script> <script src="https://content.readcube.com/cochrane/epdf_linker.js" type="text/javascript"></script> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js" type="text/javascript"></script> <script src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/hit-highlighting.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/topics-lookup.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/institution.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/api-manager.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/pico.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/reference-linking.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/rightsLink.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.submit.failed.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.comment.form.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/safety-alerts.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.translation-notes-modal.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/notifications-portlet/notifications/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772751000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-search/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772894000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-topics/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772894000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-language-portlet/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772746000" type="text/javascript"></script> <script type="text/javascript">Liferay.Util.addInputFocus();</script> <script type="text/javascript">Liferay.Portlet.register("scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_",portletId:"scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eMR000050\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eMR000050\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eMR000050\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eMR000050\x2epub2"});Liferay.Portlet.register("scolariscontentdisplay_WAR_scolariscontentdisplay");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_",portletId:"scolariscontentdisplay_WAR_scolariscontentdisplay",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentdisplay_WAR_scolariscontentdisplay\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dcolumn-1\x26p_p_col_pos\x3d0\x26p_p_col_count\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eMR000050\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eMR000050\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D"});Liferay.provide(Liferay.Util,"openKaleoDesignerPortlet",function(c){var b=AUI();var e=Liferay.PortletURL.createURL("https://www.cochranelibrary.com/en/content?p_p_id=2_WAR_kaleodesignerportlet&p_p_lifecycle=0");e.setParameter("mvcPath","/designer/edit_kaleo_draft_definition.jsp");e.setParameter("availableFields",c.availableFields);e.setParameter("availablePropertyModels",c.availablePropertyModels);e.setParameter("ddmStructureId",c.ddmStructureId);e.setParameter("draftVersion",c.draftVersion);e.setParameter("kaleoProcessId",c.kaleoProcessId);e.setParameter("name",c.name);e.setParameter("openerWindowName",c.openerWindowName);e.setParameter("portletResourceNamespace",c.portletResourceNamespace);e.setParameter("propertiesSaveCallback",c.propertiesSaveCallback);e.setParameter("refreshOpenerOnClose",c.refreshOpenerOnClose);e.setParameter("saveCallback",c.saveCallback);e.setParameter("version",c.version);e.setWindowState("pop_up");c.uri=e.toString();var d=c.dialog;if(!d){var f=b.one(Liferay.Util.getOpener()).get("region");d={destroyOnHide:true};c.dialog=d}if(!("align" in d)){d.align=Liferay.Util.Window.ALIGN_CENTER}var a=c.dialogIframe;if(!a){a={closeOnEscape:false};c.dialogIframe=a}Liferay.Util.openWindow(c)},["liferay-portlet-url"]);Liferay.Portlet.register("1_WAR_kaleodesignerportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_1_WAR_kaleodesignerportlet_",portletId:"1_WAR_kaleodesignerportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3d1_WAR_kaleodesignerportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eMR000050\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eMR000050\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eMR000050\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eMR000050\x2epub2"});Liferay.Portlet.register("scolarissearchportlet_WAR_scolarissearch");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarissearchportlet_WAR_scolarissearch_",portletId:"scolarissearchportlet_WAR_scolarissearch",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarissearchportlet_WAR_scolarissearch\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eMR000050\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eMR000050\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eMR000050\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eMR000050\x2epub2"});Liferay.Portlet.register("scolariscontentlanguagebanner_WAR_scolarislanguageportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_",portletId:"scolariscontentlanguagebanner_WAR_scolarislanguageportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentlanguagebanner_WAR_scolarislanguageportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eMR000050\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eMR000050\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eMR000050\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eMR000050\x2epub2"});AUI().use("aui-base","liferay-menu","liferay-notice","liferay-poller","liferay-session",function(a){(function(){Liferay.Util.addInputType();Liferay.Portlet.ready(function(b,c){Liferay.Util.addInputType(c)});if(a.UA.mobile){Liferay.Util.addInputCancel()}})();(function(){new Liferay.Menu();var b=Liferay.Data.notices;for(var c=1;c<b.length;c++){new Liferay.Notice(b[c])}})();(function(){Liferay.Session=new Liferay.SessionBase({autoExtend:true,sessionLength:1800,redirectOnExpire:false,redirectUrl:"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane",warningLength:0})})()});</script> <script src="https://www.cochranelibrary.com/cochrane-theme/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" type="text/javascript"></script> <script type="text/javascript"></script> <div class="mobile-righthand-nav"> <a class="rh-nav-close-btn" href="#"> <span>Close</span> <span class="fa fa-chevron-down"></span> </a> <div class="wrapper"> </div> <a class="rh-nav-open-btn" href="#"> <span>Review tools &amp; navigation</span> </a> </div> <iframe aria-hidden="true" id="printframe" name="printframe" style="position: absolute; left: -2000px; top: 0;" title="Print frame"></iframe> <iframe aria-hidden="true" id="citationExportFrame" name="citationExportFrame" style="position: absolute; left: -2000px; top: 0;" title="scolaris.citation.export.frame"></iframe> <nav> <div class="mobile-navigation"> <div class="close-container"> <a aria-label="Navigate back" class="main-nav-back-btn" href="#"><i class="fa fa-chevron-left"></i></a> <a class="main-nav-close-btn" href="#" title="Close menu">Close menu <i class="fa fa-times"></i></a> </div> <div class="mobile-search basic-search-container"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="ymag__null__null" src="/scolaris-search/icon.png"> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </img></span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=BqmVIxTs&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"> <input name="facetDisplayName" type="hidden" value=""> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</input></input></form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.MR000050.pub2&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.MR000050.pub2';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<a class="btn secondary" href="/en/browse-by-topic">Browse </a>
<a class="btn secondary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
<div class="menu-items parent">
<div>
<div class="nav-root-item parent">
<a class="language-selection-title-link" href="#" title="Select language">
<span class="mobile-nav-language-title">Select your preferred language </span></a> <span class="icon fa fa-caret-down"></span>
<div class="mob-child">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="fdkn__null__null" src="/scolaris-language-portlet/icon.png"> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </img></span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> English </a> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> English </a> </div> <div class="form-content language-selector-modal child"> <div class="row-fluid"> <h3><i class="fa fa-file-text"></i> Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> <div class="dropdown-trigger" id="active-content-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="content-language-selector" data-languagecode="de" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=de">Deutsch</a> <a class="content-language-selector is-active" data-languagecode="en" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=en">English</a> <a class="content-language-selector" data-languagecode="es" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=es">Español</a> <a class="content-language-selector" data-languagecode="fa" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fa">فارسی</a> <a class="content-language-selector" data-languagecode="fr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fr">Français</a> <a class="content-language-selector" data-languagecode="hi" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hi">हिन्दी</a> <a class="content-language-selector" data-languagecode="hr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hr">Hrvatski</a> <a class="content-language-selector" data-languagecode="id" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=id">Bahasa Indonesia</a> <a class="content-language-selector" data-languagecode="ja" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ja">日本語</a> <a class="content-language-selector" data-languagecode="ko" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ko">한국어</a> <a class="content-language-selector" data-languagecode="hu" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hu">Magyar</a> <a class="content-language-selector" data-languagecode="ms" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ms">Bahasa Malaysia</a> <a class="content-language-selector" data-languagecode="nl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=nl">Nederlands</a> <a class="content-language-selector" data-languagecode="pl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pl">Polski</a> <a class="content-language-selector" data-languagecode="pt" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pt">Português</a> <a class="content-language-selector" data-languagecode="ru" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ru">Русский</a> <a class="content-language-selector" data-languagecode="ro" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ro">Română</a> <a class="content-language-selector" data-languagecode="ta" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ta">தமிழ்</a> <a class="content-language-selector" data-languagecode="th" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=th">ภาษาไทย</a> <a class="content-language-selector" data-languagecode="zh_HANT" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANT">繁體中文</a> <a class="content-language-selector" data-languagecode="zh_HANS" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANS">简体中文</a> </div> </div> <div class="row-fluid"> <h3 class="portal-language-header"><i class="fa fa-globe"></i> Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> <div class="dropdown-trigger" id="active-portal-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="portal-language-selector is-active" data-portallanguage="en" href="/en/cdsr/doi/10.1002/14651858.MR000050.pub2/full/en">English</a> <a class="portal-language-selector" data-portallanguage="es" href="/es/cdsr/doi/10.1002/14651858.MR000050.pub2/full/es">Español</a> </div> </div> <a class="btn secondary ok-btn pull-right" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
<div class="parent">
<a class="mobile-link signin" data-redirect="false" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.MR000050.pub2%2Ffull" rel="nofollow">
                        Sign In
                    </a>
</div>
</div>
<div class="menu-items-footer">
<div class="utility-links">
<a class="cochrane-link" href="http://www.cochrane.org/" target="_blank">Visit Cochrane.org</a>
</div>
</div>
</div>
<div class="menu-items child"></div>
</div>
</nav><div class="basic-login-form-content" data-modal-title="Sign in" style="display: none;">
<div class="form-content">
<div class="row-fluid">
<div class="span12">
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_MODAL_">
<span id="p_58_INSTANCE_MODAL"></span>
<section class="portlet" id="portlet_58_INSTANCE_MODAL">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="dbam__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_MODAL" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_MODAL&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_MODAL_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_MODAL_fm" method="post" name="_58_INSTANCE_MODAL_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_MODAL_formDate" type="hidden" value="1740725111833"> <input class="field" id="_58_INSTANCE_MODAL_saveLastPath" name="_58_INSTANCE_MODAL_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_MODAL_redirect" name="_58_INSTANCE_MODAL_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.MR000050.pub2/full"> <input class="field" id="_58_INSTANCE_MODAL_doActionAfterLogin" name="_58_INSTANCE_MODAL_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_login"> Email Address </label> <input class="field clearable" id="_58_INSTANCE_MODAL_login" name="_58_INSTANCE_MODAL_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_password"> Password </label> <input class="field" id="_58_INSTANCE_MODAL_password" name="_58_INSTANCE_MODAL_password" type="password" value=""/> </div> <span id="_58_INSTANCE_MODAL_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="clearfix"> <div class="checkbox-list pull-left"> <div class="checkbox-list-item"> <div class="control-group form-inline input-checkbox-wrapper"> <label for="_58_INSTANCE_MODAL_rememberMeCheckbox"> <input id="_58_INSTANCE_MODAL_rememberMe" name="_58_INSTANCE_MODAL_rememberMe" type="hidden" value="true"/> <input checked="" class="field" id="_58_INSTANCE_MODAL_rememberMeCheckbox" name="_58_INSTANCE_MODAL_rememberMeCheckbox" onclick="Liferay.Util.updateCheckboxValue(this); " type="checkbox" value="true"/> Remember Me </label> </div> </div> </div> <div class="pull-right"> <a href="https://onlinelibrary.wiley.com/user/forgottenpassword" target="_blank">Forgotten password?</a> </div> </div> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> <a class="btn secondary" href="https://onlinelibrary.wiley.com/user-registration" target="_blank">Register</a> </div> <div class="pull-right"> <a class="institutional-login-form-button" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=0&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolariscontentdisplay_WAR_scolariscontentdisplay_action=institution-access">Institutional login</a> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div></div>
<div class="institution-login-form-content" data-modal-title="Institutional login" style="display: none;">
<div class="form-content">
<div class="row-fluid access-content-wrapper">
<div class="span12">
<div class="section">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="obft__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="access-content-section"> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/>
</div>
<button class="btn primary" name="button" type="submit">Go</button>
</div>
<div class="message error" id="institutionLookupErrorDiv" style="display:none">
                        '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access.
                    </div>
</div>
<input id="entityId" name="entityId" type="hidden" value=""/>
</form>
<h4>Previously accessed institutions</h4>
<ul class="plain" id="previousInstitutions">
<li>(none)</li>
</ul>
</div>
<div class="section-content">
<div class="open-athens-login">
                Login using <a href="/openathens">OpenAthens</a>
</div>
</div>
</div>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_4_">
<span id="p_58_INSTANCE_4"></span>
<section class="portlet" id="portlet_58_INSTANCE_4">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="joiu__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_4" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <p>If you have a <strong>Wiley Online Library</strong> institutional username and password, enter them here.</p> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_4&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_4_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_4_fm" method="post" name="_58_INSTANCE_4_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_4_formDate" type="hidden" value="1740725111837"> <input class="field" id="_58_INSTANCE_4_saveLastPath" name="_58_INSTANCE_4_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_4_redirect" name="_58_INSTANCE_4_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.MR000050.pub2/full"> <input class="field" id="_58_INSTANCE_4_doActionAfterLogin" name="_58_INSTANCE_4_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_login"> Username </label> <input class="field clearable" id="_58_INSTANCE_4_login" name="_58_INSTANCE_4_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_password"> Password </label> <input class="field" id="_58_INSTANCE_4_password" name="_58_INSTANCE_4_password" type="password" value=""> </input></div> <input class="field" id="_58_INSTANCE_4_institutionalLogin" name="_58_INSTANCE_4_institutionalLogin" type="hidden" value="true"/> <span id="_58_INSTANCE_4_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div></div>
<div class="get-access-form-content" data-modal-title="Unlock gold-standard Cochrane evidence" style="display: none;">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="wpdq__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="readcube-checkout-container-outer"> <div class="row-fluid access-content-wrapper"> <div class="span6 access-left-content"> <div class="section"> <div class="section-content"> <p>Improve your health decisions with access to trusted, independent evidence from the Cochrane Library. Unlock this review for uninterrupted access.</p> <p>Still deciding? <a href="https://m.info.wiley.com/webApp/cochranenewsletter"> Sign up to our newsletter to learn more </a> </p> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title">Institutional users</h3> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/> </div> <button class="btn primary" name="button" type="submit">Go</button> </div> <div class="message error" id="institutionLookupErrorDiv" style="display:none"> '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access. </div> </div> <input id="entityId" name="entityId" type="hidden" value=""/> </form> <h4>Previously accessed institutions</h4> <ul class="plain" id="previousInstitutions"> <li>(none)</li> </ul> </div> <div class="section-content"> <div class="open-athens-login"> Login using <a href="/openathens">OpenAthens</a> </div> </div> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title"> Other access options </h3> <div class="section-content"> <ul class="plain"> <li> <a class="get-access-individual-login-button" href="/c/portal/login"> Individual access - via Wiley Online Library </a> </li> </ul> </div> </div> </div> </div> <div class="span6 access-right-content readcube-checkout-container"> <div class="section"> </div> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/> <input id="openlabel" name="openlabel" type="hidden" value="Open access"/> </div> </section> </div> </div> <!-- Scolaris Version: --> <script type="text/javascript">if(window._satellite){_satellite.pageBottom()};</script> </div> <script>(function(){function c(){var b=a.contentDocument||a.contentWindow.document;if(b){var d=b.createElement('script');d.innerHTML="window.__CF$cv$params={r:'918e732a3bad1be5',t:'MTc0MDcyNTExMi4wMDAwMDA='};var a=document.createElement('script');a.nonce='';a.src='/cdn-cgi/challenge-platform/scripts/jsd/main.js';document.getElementsByTagName('head')[0].appendChild(a);";b.getElementsByTagName('head')[0].appendChild(d)}}if(document.body){var a=document.createElement('iframe');a.height=1;a.width=1;a.style.position='absolute';a.style.top=0;a.style.left=0;a.style.border='none';a.style.visibility='hidden';document.body.appendChild(a);if('loading'!==document.readyState)c();else if(window.addEventListener)document.addEventListener('DOMContentLoaded',c);else{var e=document.onreadystatechange||function(){};document.onreadystatechange=function(b){e(b);'loading'!==document.readyState&&(document.onreadystatechange=e,c())}}}})();</script></body> </html> 